Citrus Sinensis ID: 010891
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 498 | 2.2.26 [Sep-21-2011] | |||||||
| Q8LEB6 | 484 | Probable receptor-like pr | yes | no | 0.943 | 0.971 | 0.744 | 0.0 | |
| Q9LRP3 | 467 | Probable receptor-like pr | no | no | 0.917 | 0.978 | 0.678 | 0.0 | |
| Q9SJG2 | 494 | Probable receptor-like pr | no | no | 0.939 | 0.947 | 0.624 | 1e-165 | |
| Q3EDL4 | 472 | Probable serine/threonine | no | no | 0.911 | 0.961 | 0.511 | 1e-134 | |
| Q6NKZ9 | 437 | Probable receptor-like se | no | no | 0.825 | 0.940 | 0.521 | 1e-120 | |
| Q9CAL8 | 710 | Proline-rich receptor-lik | no | no | 0.773 | 0.542 | 0.407 | 2e-80 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.600 | 0.415 | 0.470 | 2e-78 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.568 | 0.399 | 0.482 | 2e-77 | |
| Q9C821 | 509 | Proline-rich receptor-lik | no | no | 0.572 | 0.559 | 0.486 | 2e-76 | |
| Q9SGY7 | 718 | Putative proline-rich rec | no | no | 0.644 | 0.447 | 0.448 | 3e-76 |
| >sp|Q8LEB6|Y5185_ARATH Probable receptor-like protein kinase At5g18500 OS=Arabidopsis thaliana GN=At5g18500 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 718 bits (1854), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 364/489 (74%), Positives = 414/489 (84%), Gaps = 19/489 (3%)
Query: 1 MASDLNKSLSKTYIGMQLWVLIVICLAVVFVVILGVSLWLTFRKKKSRRANDMLPVSRF- 59
M S LN +LS+ Y G++LW +IVI L+ +FVV+L +SLWLTFR+K SR +++++PVSR
Sbjct: 1 MGSGLNDTLSRNYNGLELWEIIVIVLSAIFVVVLAISLWLTFRRKTSRSSSNLIPVSRQI 60
Query: 60 -PVVSEEIKEIRVDQVSSSNGG--FSVHNEKFNDRESEKELIPQENGDDSVQSGSFNNLE 116
P V EEIKEIRVD+VSSSNGG + +EKF D+E EK + + DS +SGSFN+LE
Sbjct: 61 PPSVPEEIKEIRVDEVSSSNGGNGYPSISEKFGDKEPEKGIKAESENGDSSRSGSFNHLE 120
Query: 117 KDVVGSQLGEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRF 176
K K + S++PLTAPSPLSGLPEFSHLGWGHWFTLRDLQ ATN+F
Sbjct: 121 K--------------KDGSSVSSANPLTAPSPLSGLPEFSHLGWGHWFTLRDLQMATNQF 166
Query: 177 SKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLL 236
S+DNIIGDGGYGVVYRG L+NGT VAVKKLLNN GQADKDFRVEVEAIGHVRHKNLVRLL
Sbjct: 167 SRDNIIGDGGYGVVYRGNLVNGTPVAVKKLLNNLGQADKDFRVEVEAIGHVRHKNLVRLL 226
Query: 237 GYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEP 296
GYC+EGTQR+LVYEYVNNGNLEQWLRGD + YLTWEAR+KIL+GTAKALAYLHEAIEP
Sbjct: 227 GYCMEGTQRMLVYEYVNNGNLEQWLRGDNQNHEYLTWEARVKILIGTAKALAYLHEAIEP 286
Query: 297 KVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLN 356
KVVHRDIKSSNILID+ F++KISDFGLAKLLGA KS ITTRVMGTFGYVAPEYANSGLLN
Sbjct: 287 KVVHRDIKSSNILIDDKFNSKISDFGLAKLLGADKSFITTRVMGTFGYVAPEYANSGLLN 346
Query: 357 EKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPST 416
EKSDVYSFGVVLLEAITGRYPVDY RP EV+LVEWLKMMVQ RRSE+VVDPN+ET+PST
Sbjct: 347 EKSDVYSFGVVLLEAITGRYPVDYARPPPEVHLVEWLKMMVQQRRSEEVVDPNLETKPST 406
Query: 417 SALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIPREDRRRRRNQAGAS-EAESQR 475
SALKR LLTALRCVDP S+KRP+MSQV RMLESEEYPI REDRRRRR+Q G + +++ R
Sbjct: 407 SALKRTLLTALRCVDPMSEKRPRMSQVARMLESEEYPIAREDRRRRRSQNGTTRDSDPPR 466
Query: 476 ESSDTDKNE 484
S+DTDK+E
Sbjct: 467 NSTDTDKSE 475
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LRP3|Y3174_ARATH Probable receptor-like protein kinase At3g17420 OS=Arabidopsis thaliana GN=At3g17420 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 642 bits (1655), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 331/488 (67%), Positives = 388/488 (79%), Gaps = 31/488 (6%)
Query: 1 MASDLNKSLSKTYIGMQLWVLIVICLAVVFVVILGVSLWLTFRKKKSRRANDMLPVSRFP 60
M S L ++L+K Y ++LW +IVI L F+VIL +S+WL+FRKK R LPV++ P
Sbjct: 1 MTSQLKRTLTKRYGVLELWEIIVIALFAAFIVILVLSVWLSFRKKSKRSNATTLPVTQSP 60
Query: 61 VVSEEIKEIRVDQVSSSNGGFSVH--NEKFNDRESEKELIPQENGDDSVQSGSFNNLEKD 118
+EEIKEI VD SS+N G S +EKF + ENGD SGS +K
Sbjct: 61 RFTEEIKEISVDHGSSNNNGTSYQTLDEKFVED--------IENGDKF--SGSLE--KKP 108
Query: 119 VVGSQLGEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSK 178
+VGS L PS+ TAPSPL GLPE SH+GWGHWFTLRDLQ ATN FSK
Sbjct: 109 LVGSHLP------------PSTPSTTAPSPLLGLPEVSHIGWGHWFTLRDLQLATNHFSK 156
Query: 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGY 238
++IIGDGGYGVVY G L N T VAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGY
Sbjct: 157 ESIIGDGGYGVVYHGTLTNKTPVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGY 216
Query: 239 CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKV 298
C+EGT R+LVYEY+NNGNLEQWL GDM +G+LTWEAR+K+L+GTAKALAYLHEAIEPKV
Sbjct: 217 CVEGTHRMLVYEYMNNGNLEQWLHGDMIHKGHLTWEARIKVLVGTAKALAYLHEAIEPKV 276
Query: 299 VHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEK 358
VHRDIKSSNIL+D+NFDAK+SDFGLAKLLGA ++++TRVMGTFGYVAPEYANSGLLNEK
Sbjct: 277 VHRDIKSSNILMDDNFDAKLSDFGLAKLLGADSNYVSTRVMGTFGYVAPEYANSGLLNEK 336
Query: 359 SDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSA 418
SDVYS+GVVLLEAITGRYPVDY RP+ EV++VEWLK+MVQ ++ E+VVD +E +P+TS
Sbjct: 337 SDVYSYGVVLLEAITGRYPVDYARPKEEVHMVEWLKLMVQQKQFEEVVDKELEIKPTTSE 396
Query: 419 LKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPI-PREDRRRRRNQAGASEAESQRES 477
LKRALLTALRCVDPD+DKRPKMSQV RMLES+EYP+ PRE+RRRRRNQ AE+ RES
Sbjct: 397 LKRALLTALRCVDPDADKRPKMSQVARMLESDEYPVMPREERRRRRNQ----NAETHRES 452
Query: 478 SDTDKNEN 485
+DT+K+ +
Sbjct: 453 TDTNKDND 460
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SJG2|Y2296_ARATH Probable receptor-like protein kinase At2g42960 OS=Arabidopsis thaliana GN=At2g42960 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 580 bits (1495), Expect = e-165, Method: Compositional matrix adjust.
Identities = 304/487 (62%), Positives = 367/487 (75%), Gaps = 19/487 (3%)
Query: 3 SDLNKSLSKTYI-----GMQLWVLIVICLAVVFVVILGV-SLWLTFRKKKSRRANDMLPV 56
S LN +SK G++LWV + + + V V+IL + SLW+TFR+K R ++ P
Sbjct: 5 SSLNAEMSKKISFFGLKGLKLWVWVCLVVGVFIVMILCILSLWITFRRKSRRSSS-KFPF 63
Query: 57 SRFPVVSEEIKEIRVDQVSSSNGGFSVHNEKFNDRESEKELIPQ------ENGDDSVQSG 110
++ P VS K+IRVD+ N + ND+ + K ++ + D Q
Sbjct: 64 NQIPHVS---KDIRVDRAGFQNPHPESLYIEMNDKSTGKTMMSHLGRTKSSDNDTLSQCS 120
Query: 111 SFNNLEKDVVGSQLGEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQ 170
S N+ E+ S GEEGG G + P+TA SPL GLPE SHLGWGHWFTLRDL+
Sbjct: 121 SVNHHER-ACSSHSGEEGGFGSAGR-QYGGGPVTA-SPLVGLPEISHLGWGHWFTLRDLE 177
Query: 171 SATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHK 230
ATNRF+ N++G+GGYGVVYRG+L+NGT VAVKKLLNN GQA+K+FRVEVEAIGHVRHK
Sbjct: 178 LATNRFAPVNVLGEGGYGVVYRGKLVNGTEVAVKKLLNNLGQAEKEFRVEVEAIGHVRHK 237
Query: 231 NLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYL 290
NLVRLLGYCIEG R+LVYEYVN+GNLEQWL G M G LTWEARMKI+ GTA+ALAYL
Sbjct: 238 NLVRLLGYCIEGVHRMLVYEYVNSGNLEQWLHGAMRQHGNLTWEARMKIITGTAQALAYL 297
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYA 350
HEAIEPKVVHRDIK+SNILID+ F+AK+SDFGLAKLL +G+SHITTRVMGTFGYVAPEYA
Sbjct: 298 HEAIEPKVVHRDIKASNILIDDEFNAKLSDFGLAKLLDSGESHITTRVMGTFGYVAPEYA 357
Query: 351 NSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNI 410
N+GLLNEKSD+YSFGV+LLEAITGR PVDYGRP +EVNLVEWLKMMV RR+E+VVDP +
Sbjct: 358 NTGLLNEKSDIYSFGVLLLEAITGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPRL 417
Query: 411 ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIPREDRRRRRNQAGASE 470
E RPS SALKRALL +LRCVDP+++KRP+MSQV RMLES+E+P +E R +R AG
Sbjct: 418 EPRPSKSALKRALLVSLRCVDPEAEKRPRMSQVARMLESDEHPFHKERRNKRSKTAGMEI 477
Query: 471 AESQRES 477
E++ ES
Sbjct: 478 VETKDES 484
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q3EDL4|Y1154_ARATH Probable serine/threonine-protein kinase At1g01540 OS=Arabidopsis thaliana GN=At1g01540 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 478 bits (1230), Expect = e-134, Method: Compositional matrix adjust.
Identities = 259/506 (51%), Positives = 333/506 (65%), Gaps = 52/506 (10%)
Query: 2 ASDLNKSLSK--TYIGMQLWVLIVICLAVVFVVILGV-SLWLTFRKKKSR-RANDMLPVS 57
A+ LN LSK + G++LWV+I I L + V+ L + SL LT R+K + RA+
Sbjct: 6 AAFLNTELSKPTSIFGLRLWVVIGILLGSLIVIALFLLSLCLTSRRKNRKPRADFASAAI 65
Query: 58 RFPVVSEEIKEIRVDQVSSSNGGFSV------HNEKFNDRESEKELIPQENGDDSVQSGS 111
P +S+EIKEI Q S V H F+DR S E G S
Sbjct: 66 ATPPISKEIKEIVPAQNQSVPAEIQVDIGKIEHRVVFSDRVSSGE----SRGTAS----- 116
Query: 112 FNNLEKDVVGSQLGEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQS 171
S+ G+G PE SHLGWG W+TLR+L++
Sbjct: 117 ---------ASETASYSGSGNCG------------------PEVSHLGWGRWYTLRELEA 149
Query: 172 ATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN 231
ATN ++N+IG+GGYG+VYRG L +GT VAVK LLNN GQA+K+F+VEVE IG VRHKN
Sbjct: 150 ATNGLCEENVIGEGGYGIVYRGILTDGTKVAVKNLLNNRGQAEKEFKVEVEVIGRVRHKN 209
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
LVRLLGYC+EG R+LVY++V+NGNLEQW+ GD+ D LTW+ RM I+LG AK LAYLH
Sbjct: 210 LVRLLGYCVEGAYRMLVYDFVDNGNLEQWIHGDVGDVSPLTWDIRMNIILGMAKGLAYLH 269
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYAN 351
E +EPKVVHRDIKSSNIL+D ++AK+SDFGLAKLLG+ S++TTRVMGTFGYVAPEYA
Sbjct: 270 EGLEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLLGSESSYVTTRVMGTFGYVAPEYAC 329
Query: 352 SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411
+G+LNEKSD+YSFG++++E ITGR PVDY RPQ E NLV+WLK MV RRSE+VVDP I
Sbjct: 330 TGMLNEKSDIYSFGILIMEIITGRNPVDYSRPQGETNLVDWLKSMVGNRRSEEVVDPKIP 389
Query: 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIPREDRRRRRNQAGASEA 471
PS+ ALKR LL ALRCVDPD++KRPKM ++ MLE+E+ + R++RR R+
Sbjct: 390 EPPSSKALKRVLLVALRCVDPDANKRPKMGHIIHMLEAEDL-LYRDERRTTRDHGSRERQ 448
Query: 472 ESQRESSDTDKNENPESRLKTRRNQQ 497
E+ ++ ++ E+ +R +QQ
Sbjct: 449 ETAVVAAGSESGES-----GSRHHQQ 469
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6NKZ9|Y4345_ARATH Probable receptor-like serine/threonine-protein kinase At4g34500 OS=Arabidopsis thaliana GN=At4g34500 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 431 bits (1108), Expect = e-120, Method: Compositional matrix adjust.
Identities = 235/451 (52%), Positives = 302/451 (66%), Gaps = 40/451 (8%)
Query: 12 TYIGMQLWVLIVICLAVVFVVILGVSLWLTF-RKKKSRRANDMLPVSRFPVVSEEIKEIR 70
+ G+ L+++I IC + ++ L + L++ R ++RR P+VS+EI EI+
Sbjct: 17 SVFGLNLYLVIAICSVFILLISLLIFLFVCLNRVSRARRMRVKHSSGSIPLVSKEISEIK 76
Query: 71 VDQVSSSNGGFSVHNEKFNDRESEKELIPQENGDDSVQSGSFNNLEKDVVGSQLGEEGGN 130
+ G F N DDS G N E VV S +E +
Sbjct: 77 ------TVGKFI-------------------NSDDS--KGKIGN-EVVVVVSATSKEATS 108
Query: 131 GKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYGVV 190
G F S A S G E +GWG W++L+DL+ AT FS DN+IG+GGYGVV
Sbjct: 109 G----FDTLS---VASSGDVGTSE--AMGWGKWYSLKDLEIATRGFSDDNMIGEGGYGVV 159
Query: 191 YRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG--TQRILV 248
YR +G+ AVK LLNN GQA+K+F+VEVEAIG VRHKNLV L+GYC + +QR+LV
Sbjct: 160 YRADFSDGSVAAVKNLLNNKGQAEKEFKVEVEAIGKVRHKNLVGLMGYCADSAQSQRMLV 219
Query: 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNI 308
YEY++NGNLEQWL GD+ LTW+ RMKI +GTAK LAYLHE +EPKVVHRD+KSSNI
Sbjct: 220 YEYIDNGNLEQWLHGDVGPVSPLTWDIRMKIAIGTAKGLAYLHEGLEPKVVHRDVKSSNI 279
Query: 309 LIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVL 368
L+D+ ++AK+SDFGLAKLLG+ S++TTRVMGTFGYV+PEYA++G+LNE SDVYSFGV+L
Sbjct: 280 LLDKKWNAKVSDFGLAKLLGSETSYVTTRVMGTFGYVSPEYASTGMLNECSDVYSFGVLL 339
Query: 369 LEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALR 428
+E ITGR PVDY RP E+NLV+W K MV RR E+V+DP I+T P ALKRALL LR
Sbjct: 340 MEIITGRSPVDYSRPPGEMNLVDWFKGMVASRRGEEVIDPKIKTSPPPRALKRALLVCLR 399
Query: 429 CVDPDSDKRPKMSQVVRMLESEEYPIPREDR 459
C+D DS KRPKM Q++ MLE+E++P E R
Sbjct: 400 CIDLDSSKRPKMGQIIHMLEAEDFPFRPEHR 430
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 300 bits (767), Expect = 2e-80, Method: Compositional matrix adjust.
Identities = 184/451 (40%), Positives = 251/451 (55%), Gaps = 66/451 (14%)
Query: 11 KTYIGMQLWVLIVICL-AVVFVVILGVSLWLTFRKKKSRRAN-----DMLPVSRFPVVSE 64
KT G + VI L AVVF+V R+KK R + LP S F + S+
Sbjct: 234 KTMAGFAIAGFAVIALMAVVFLV----------RRKKKRNIDAYSDSQYLPPSNFSIKSD 283
Query: 65 EIKEIRVDQVSSSNGGFSVHNEKFNDRESEKELIPQENGDDSVQSGSFNNLEKDVVGSQL 124
GF L Q G +N+ ++ G+
Sbjct: 284 ---------------GF---------------LYGQNPTKGYSGPGGYNSQQQSNSGNSF 313
Query: 125 GEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGH-WFTLRDLQSATNRFSKDNIIG 183
G + G G + R S P +A +G G FT +L T FSK NI+G
Sbjct: 314 GSQRGGGGYT--RSGSAPDSAV-----------MGSGQTHFTYEELTDITEGFSKHNILG 360
Query: 184 DGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT 243
+GG+G VY+G+L +G VAVK+L GQ D++F+ EVE I V H++LV L+GYCI +
Sbjct: 361 EGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEIISRVHHRHLVSLVGYCIADS 420
Query: 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDI 303
+R+L+YEYV N LE L G R L W R++I +G+AK LAYLHE PK++HRDI
Sbjct: 421 ERLLIYEYVPNQTLEHHLHGK--GRPVLEWARRVRIAIGSAKGLAYLHEDCHPKIIHRDI 478
Query: 304 KSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYS 363
KS+NIL+D+ F+A+++DFGLAKL + ++H++TRVMGTFGY+APEYA SG L ++SDV+S
Sbjct: 479 KSANILLDDEFEAQVADFGLAKLNDSTQTHVSTRVMGTFGYLAPEYAQSGKLTDRSDVFS 538
Query: 364 FGVVLLEAITGRYPVDYGRPQSEVNLVEW----LKMMVQLRRSEDVVDPNIETRPSTSAL 419
FGVVLLE ITGR PVD +P E +LVEW L ++ ++VD +E + +
Sbjct: 539 FGVVLLELITGRKPVDQYQPLGEESLVEWARPLLHKAIETGDFSELVDRRLEKHYVENEV 598
Query: 420 KRALLTALRCVDPDSDKRPKMSQVVRMLESE 450
R + TA CV KRP+M QVVR L+SE
Sbjct: 599 FRMIETAAACVRHSGPKRPRMVQVVRALDSE 629
|
Regulates negatively root hairs elongation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 293 bits (750), Expect = 2e-78, Method: Compositional matrix adjust.
Identities = 144/306 (47%), Positives = 205/306 (66%), Gaps = 7/306 (2%)
Query: 150 SGLPEFSHLGWGH-WFTLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLN 208
SG P+ + LG G F+ +L T F++ NI+G+GG+G VY+G L +G VAVK+L
Sbjct: 344 SGTPDSAILGSGQTHFSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKA 403
Query: 209 NPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDR 268
GQ D++F+ EVE I V H++LV L+GYCI R+L+YEYV+N LE L G
Sbjct: 404 GSGQGDREFKAEVEIISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHGKGLP- 462
Query: 269 GYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328
L W R++I +G+AK LAYLHE PK++HRDIKS+NIL+D+ ++A+++DFGLA+L
Sbjct: 463 -VLEWSKRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLARLND 521
Query: 329 AGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVN 388
++H++TRVMGTFGY+APEYA+SG L ++SDV+SFGVVLLE +TGR PVD +P E +
Sbjct: 522 TTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEES 581
Query: 389 LVEWLKMM----VQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVV 444
LVEW + + ++ +++D +E R + R + TA CV KRP+M QVV
Sbjct: 582 LVEWARPLLLKAIETGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVV 641
Query: 445 RMLESE 450
R L+ +
Sbjct: 642 RALDCD 647
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 290 bits (742), Expect = 2e-77, Method: Compositional matrix adjust.
Identities = 140/290 (48%), Positives = 200/290 (68%), Gaps = 7/290 (2%)
Query: 164 FTLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEA 223
F+ +L ATN FS++N++G+GG+G VY+G L +G VAVK+L GQ D++F+ EVE
Sbjct: 365 FSYEELVKATNGFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVET 424
Query: 224 IGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGT 283
+ + H++LV ++G+CI G +R+L+Y+YV+N +L L G+ + L W R+KI G
Sbjct: 425 LSRIHHRHLVSIVGHCISGDRRLLIYDYVSNNDLYFHLHGE---KSVLDWATRVKIAAGA 481
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
A+ LAYLHE P+++HRDIKSSNIL+++NFDA++SDFGLA+L +HITTRV+GTFG
Sbjct: 482 ARGLAYLHEDCHPRIIHRDIKSSNILLEDNFDARVSDFGLARLALDCNTHITTRVIGTFG 541
Query: 344 YVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMM----VQL 399
Y+APEYA+SG L EKSDV+SFGVVLLE ITGR PVD +P + +LVEW + + ++
Sbjct: 542 YMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEWARPLISHAIET 601
Query: 400 RRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449
+ + DP + S + R + A CV + KRP+M Q+VR ES
Sbjct: 602 EEFDSLADPKLGGNYVESEMFRMIEAAGACVRHLATKRPRMGQIVRAFES 651
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C821|PEK15_ARATH Proline-rich receptor-like protein kinase PERK15 OS=Arabidopsis thaliana GN=PERK15 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 286 bits (733), Expect = 2e-76, Method: Compositional matrix adjust.
Identities = 142/292 (48%), Positives = 200/292 (68%), Gaps = 7/292 (2%)
Query: 162 HWFTLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEV 221
+ FT DL AT+ FS N++G GG+G V+RG L++GT VA+K+L + GQ +++F+ E+
Sbjct: 129 NLFTYEDLSKATSNFSNTNLLGQGGFGYVHRGVLVDGTLVAIKQLKSGSGQGEREFQAEI 188
Query: 222 EAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILL 281
+ I V H++LV LLGYCI G QR+LVYE+V N LE L +R + W RMKI L
Sbjct: 189 QTISRVHHRHLVSLLGYCITGAQRLLVYEFVPNKTLEFHLHEK--ERPVMEWSKRMKIAL 246
Query: 282 GTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
G AK LAYLHE PK +HRD+K++NILID++++AK++DFGLA+ +H++TR+MGT
Sbjct: 247 GAAKGLAYLHEDCNPKTIHRDVKAANILIDDSYEAKLADFGLARSSLDTDTHVSTRIMGT 306
Query: 342 FGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVN-LVEWLK-MMVQL 399
FGY+APEYA+SG L EKSDV+S GVVLLE ITGR PVD +P ++ + +V+W K +M+Q
Sbjct: 307 FGYLAPEYASSGKLTEKSDVFSIGVVLLELITGRRPVDKSQPFADDDSIVDWAKPLMIQA 366
Query: 400 RRS---EDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448
+ +VDP +E + + R + A V + +RPKMSQ+VR E
Sbjct: 367 LNDGNFDGLVDPRLENDFDINEMTRMVACAAASVRHSAKRRPKMSQIVRAFE 418
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 286 bits (731), Expect = 3e-76, Method: Compositional matrix adjust.
Identities = 147/328 (44%), Positives = 209/328 (63%), Gaps = 7/328 (2%)
Query: 129 GNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGH-WFTLRDLQSATNRFSKDNIIGDGGY 187
GN P ++ L P G P+ + +G FT +L T F K ++G+GG+
Sbjct: 322 GNSSAQNSSPDTNSLGNPKHGRGTPDSAVIGTSKIHFTYEELSQITEGFCKSFVVGEGGF 381
Query: 188 GVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247
G VY+G L G VA+K+L + + ++F+ EVE I V H++LV L+GYCI R L
Sbjct: 382 GCVYKGILFEGKPVAIKQLKSVSAEGYREFKAEVEIISRVHHRHLVSLVGYCISEQHRFL 441
Query: 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSN 307
+YE+V N L+ L G + L W R++I +G AK LAYLHE PK++HRDIKSSN
Sbjct: 442 IYEFVPNNTLDYHLHGK--NLPVLEWSRRVRIAIGAAKGLAYLHEDCHPKIIHRDIKSSN 499
Query: 308 ILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVV 367
IL+D+ F+A+++DFGLA+L +SHI+TRVMGTFGY+APEYA+SG L ++SDV+SFGVV
Sbjct: 500 ILLDDEFEAQVADFGLARLNDTAQSHISTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVV 559
Query: 368 LLEAITGRYPVDYGRPQSEVNLVEWL--KMMVQLRRSE--DVVDPNIETRPSTSALKRAL 423
LLE ITGR PVD +P E +LVEW +++ + + + +VVDP +E S + + +
Sbjct: 560 LLELITGRKPVDTSQPLGEESLVEWARPRLIEAIEKGDISEVVDPRLENDYVESEVYKMI 619
Query: 424 LTALRCVDPDSDKRPKMSQVVRMLESEE 451
TA CV + KRP+M QVVR L++ +
Sbjct: 620 ETAASCVRHSALKRPRMVQVVRALDTRD 647
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 498 | ||||||
| 224130298 | 487 | predicted protein [Populus trichocarpa] | 0.975 | 0.997 | 0.801 | 0.0 | |
| 225432165 | 513 | PREDICTED: probable receptor-like protei | 0.997 | 0.968 | 0.770 | 0.0 | |
| 356565467 | 503 | PREDICTED: probable receptor-like protei | 0.995 | 0.986 | 0.745 | 0.0 | |
| 225450464 | 511 | PREDICTED: probable receptor-like protei | 0.987 | 0.962 | 0.731 | 0.0 | |
| 147780241 | 510 | hypothetical protein VITISV_037750 [Viti | 0.979 | 0.956 | 0.737 | 0.0 | |
| 224124542 | 506 | predicted protein [Populus trichocarpa] | 0.985 | 0.970 | 0.723 | 0.0 | |
| 356521703 | 504 | PREDICTED: probable receptor-like protei | 0.995 | 0.984 | 0.740 | 0.0 | |
| 388518751 | 501 | unknown [Medicago truncatula] | 0.989 | 0.984 | 0.726 | 0.0 | |
| 351727925 | 504 | receptor-like protein kinase 3-like [Gly | 0.997 | 0.986 | 0.743 | 0.0 | |
| 357479169 | 478 | Protein kinase domain containing protein | 0.945 | 0.985 | 0.743 | 0.0 |
| >gi|224130298|ref|XP_002328575.1| predicted protein [Populus trichocarpa] gi|222838557|gb|EEE76922.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 790 bits (2040), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 392/489 (80%), Positives = 438/489 (89%), Gaps = 3/489 (0%)
Query: 1 MASDLNKSLSKTYIGMQLWVLIVICLAVVFVVILGVSLWLTFRKKKSRRANDMLPVSRFP 60
MASDL SL+K YIGM+ WV+I++CL +V V +L VSLWL+FRKK SRR+N+MLP+S+ P
Sbjct: 1 MASDLKNSLTKEYIGMEFWVVIMVCLGLVCVFVLFVSLWLSFRKK-SRRSNNMLPISQIP 59
Query: 61 VVSEEIKEIRVDQVSSSNGGFSVHNEKFNDRESEKELIPQENGDDSVQSGSFNNLEKDVV 120
V EEIKEI +DQ S++N GF N+KF+D+ESEK LI ENGDDS QSGS N++EKD V
Sbjct: 60 KVPEEIKEIGIDQNSANNDGFLSLNDKFSDKESEKVLIQLENGDDSSQSGSLNHVEKDGV 119
Query: 121 GSQLGEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDN 180
GSQ GEEGG S +PSSHP+TAPSP+SGLPEFS LGWGHWFTLRDLQ ATNRFSKDN
Sbjct: 120 GSQSGEEGGTKVASANQPSSHPITAPSPMSGLPEFSQLGWGHWFTLRDLQVATNRFSKDN 179
Query: 181 IIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCI 240
IIGDGGYGVVY+G L+NGT VAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYC+
Sbjct: 180 IIGDGGYGVVYQGHLINGTPVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCM 239
Query: 241 EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVH 300
EGTQR+LVYEYVNNGNLEQWL G M GYLTWEARMKILLGTAKALAYLHEAIEPKVVH
Sbjct: 240 EGTQRMLVYEYVNNGNLEQWLHGGMRQHGYLTWEARMKILLGTAKALAYLHEAIEPKVVH 299
Query: 301 RDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSD 360
RDIKSSNILID+NF+AK+SDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSD
Sbjct: 300 RDIKSSNILIDDNFNAKLSDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSD 359
Query: 361 VYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALK 420
VYSFGVVLLEAITGR PVD+GRP++EV+LVEWLK MV RRSE+VVDP IETRPSTSALK
Sbjct: 360 VYSFGVVLLEAITGRDPVDHGRPENEVHLVEWLKTMVARRRSEEVVDPMIETRPSTSALK 419
Query: 421 RALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIPREDRRRRRNQAGASEAESQRESSDT 480
R LLTALRCVDPD+DKRPKMS+VVRMLESEEYP+PR+DRR RR++AG E ESQ E+SDT
Sbjct: 420 RGLLTALRCVDPDADKRPKMSRVVRMLESEEYPMPRQDRRHRRSRAG--EGESQMENSDT 477
Query: 481 DKNENPESR 489
D+NENP+++
Sbjct: 478 DRNENPDTK 486
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225432165|ref|XP_002267270.1| PREDICTED: probable receptor-like protein kinase At5g18500 [Vitis vinifera] gi|297736805|emb|CBI26006.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 777 bits (2007), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 390/506 (77%), Positives = 444/506 (87%), Gaps = 9/506 (1%)
Query: 1 MASDLNKSLSK-TYI-GMQLWVLIVICLAVVFVVILGV-SLWLTFRKKKSRRANDMLPVS 57
MAS L LSK T++ G+++WVL+ I + V V+IL + SL LT RKK SRRAN+ +P+S
Sbjct: 1 MASGLQAELSKKTFLFGLKVWVLVGIFVGVFIVIILLLMSLCLTSRKK-SRRANNKIPLS 59
Query: 58 RFPVVSEEIKEIRVDQVSSSNGG-----FSVHNEKFNDRESEKELIPQENGDDSVQSGSF 112
+ P +S+EIKE+RVDQVS+ N G F N+KF+D+ESEK LIP +NGD+S QSGSF
Sbjct: 60 QIPAISKEIKEVRVDQVSADNCGPHDGVFLALNDKFSDKESEKVLIPTKNGDNSSQSGSF 119
Query: 113 NNLEKDVVGSQLGEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSA 172
N++EKD VGSQ GEE G+G ++ +RPSSHP+TAPSPL GLPEFSHLGWGHWFTLRDL+ A
Sbjct: 120 NHVEKDGVGSQSGEEVGSGTINVYRPSSHPITAPSPLIGLPEFSHLGWGHWFTLRDLELA 179
Query: 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL 232
TNRFSK+N++G+GGYG+VYRG L+NGT VAVKKLLNN GQA+K+FRVEVEAIGHVRHKNL
Sbjct: 180 TNRFSKENVLGEGGYGIVYRGHLINGTPVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNL 239
Query: 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE 292
VRLLGYCIEGT R+LVYEYVNNGNLEQWL G M GYLTWEARMKILLGTAKALAYLHE
Sbjct: 240 VRLLGYCIEGTHRLLVYEYVNNGNLEQWLHGAMRQHGYLTWEARMKILLGTAKALAYLHE 299
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANS 352
AIEPKVVHRDIKSSNILID+ F+AKISDFGLAKLLGAG+SHITTRVMGTFGYVAPEYANS
Sbjct: 300 AIEPKVVHRDIKSSNILIDDEFNAKISDFGLAKLLGAGRSHITTRVMGTFGYVAPEYANS 359
Query: 353 GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIET 412
GLLNEKSDVYSFGVVLLEAITGR PVDYGRP EVNLV+WLKMMV RRSE+VVDPNIET
Sbjct: 360 GLLNEKSDVYSFGVVLLEAITGRDPVDYGRPAHEVNLVDWLKMMVGSRRSEEVVDPNIET 419
Query: 413 RPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIPREDRRRRRNQAGASEAE 472
RPSTSALKR LLTALRCVDPD+DKRPKMSQVVRMLESEEYPIPREDRRRRR+ AG +EAE
Sbjct: 420 RPSTSALKRGLLTALRCVDPDADKRPKMSQVVRMLESEEYPIPREDRRRRRSHAGNNEAE 479
Query: 473 SQRESSDTDKNENPESRLKTRRNQQS 498
SQRE+SDTD++E P+SR + RR ++
Sbjct: 480 SQRENSDTDRSEIPDSRAENRRKHRT 505
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356565467|ref|XP_003550961.1| PREDICTED: probable receptor-like protein kinase At5g18500-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 745 bits (1924), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/503 (74%), Positives = 430/503 (85%), Gaps = 7/503 (1%)
Query: 1 MASDLNKSLSK--TYIGMQLWVLIVICLAVVFVVILGVSLWLTFRKKKSRRANDMLPVSR 58
MASDLN LS+ + G++ W L+ I + + ++IL V +KKSRR N MLP+S
Sbjct: 1 MASDLNSGLSQETSVFGLKAWELMGIIVGLFIIIILVVISICLTSRKKSRRVNGMLPLSH 60
Query: 59 FPVVSEEIKEIRVDQVSSSN----GGFSVHNEKFNDRESEKELIPQENGDDSVQSGSFNN 114
VS+EIKEIRVDQVS++N G F ++F+DR+SEK LI NG++S QSGSF +
Sbjct: 61 MLSVSDEIKEIRVDQVSANNHPQNGAFVSLYDRFSDRDSEKVLIQTNNGENSSQSGSFVH 120
Query: 115 LEKDVVGSQLGEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATN 174
L+KD GSQ GEE G VST+R SSHP+TAPSPL GLPEFSHLGWGHWFTLRDL+ ATN
Sbjct: 121 LKKDD-GSQSGEESGAKSVSTYRSSSHPITAPSPLCGLPEFSHLGWGHWFTLRDLELATN 179
Query: 175 RFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVR 234
RFSKDN+IG+GGYGVVY+GQL+NG+ VAVKKLLNN GQA+K+FRVEVEAIGHVRHKNLVR
Sbjct: 180 RFSKDNVIGEGGYGVVYQGQLINGSPVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVR 239
Query: 235 LLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI 294
LLGYCIEGT R+LVYEYVNNGNLEQWL G M G+LTW+AR+KILLGTAKALAYLHEAI
Sbjct: 240 LLGYCIEGTHRLLVYEYVNNGNLEQWLHGAMRQYGFLTWDARIKILLGTAKALAYLHEAI 299
Query: 295 EPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGL 354
EPKVVHRDIKSSNILID++F+AKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGL
Sbjct: 300 EPKVVHRDIKSSNILIDDDFNAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGL 359
Query: 355 LNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRP 414
LNEKSDVYSFGV+LLEAITGR PVDY RP +EVNLV+WLKMMV RR+E+VVDPNIETRP
Sbjct: 360 LNEKSDVYSFGVLLLEAITGRDPVDYSRPATEVNLVDWLKMMVGNRRAEEVVDPNIETRP 419
Query: 415 STSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIPREDRRRRRNQAGASEAESQ 474
STS+LKRALLTALRCVDPDS+KRPKMSQVVRMLESEEYPIPREDRRRR++QAG E E+Q
Sbjct: 420 STSSLKRALLTALRCVDPDSEKRPKMSQVVRMLESEEYPIPREDRRRRKSQAGNMELEAQ 479
Query: 475 RESSDTDKNENPESRLKTRRNQQ 497
+E+SDT+ ENP+S+ RRNQ+
Sbjct: 480 KETSDTEMTENPDSKSNGRRNQR 502
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225450464|ref|XP_002280159.1| PREDICTED: probable receptor-like protein kinase At2g42960 [Vitis vinifera] gi|296089839|emb|CBI39658.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 741 bits (1914), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 371/507 (73%), Positives = 433/507 (85%), Gaps = 15/507 (2%)
Query: 1 MASDLNKSLSKT--YIGMQLWVLIVICLAVVFVVILGV-SLWLTFRKKKSRRANDMLPVS 57
M +DLN LSK +G+++W LI I +A+ ++IL V SL LT RKK SR + D LPV+
Sbjct: 1 MTTDLNAELSKKTDVLGLKVWELIGIVVALFIIIILCVLSLCLTSRKK-SRSSRDRLPVN 59
Query: 58 RFPVVSEEIKEIRVDQVSSS-----NGGFSVHNEKFNDRESEKELI-----PQENGDDSV 107
+ P VS+EIKE+RV+QVS++ +G ++K +D+ES+K L+ +NGD+S
Sbjct: 60 QIPTVSKEIKEVRVEQVSTNEFVPRDGILLTIHDKSSDKESDKVLVHLGMGKTKNGDNSS 119
Query: 108 QSGSFNNLEKDVVGSQLGEEGGNGKVSTFRPSS-HPLTAPSPLSGLPEFSHLGWGHWFTL 166
QSGSF++LEKD GSQ GEEG +G V+ ++PSS +P+TAPSPL GLPEFSHLGWGHWFTL
Sbjct: 120 QSGSFHHLEKDGCGSQSGEEGSSGTVTVYKPSSSYPITAPSPLVGLPEFSHLGWGHWFTL 179
Query: 167 RDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGH 226
RDL+ ATNRFSK+N++G+GGYGVVYRGQL+NGT VAVKK+LNN GQA+K+FRVEVEAIGH
Sbjct: 180 RDLELATNRFSKENVLGEGGYGVVYRGQLINGTPVAVKKILNNLGQAEKEFRVEVEAIGH 239
Query: 227 VRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKA 286
VRHKNLVRLLGYCIEGT R+LVYEYV+NGNLEQWL G M G+LTW+ARMKILLGTAKA
Sbjct: 240 VRHKNLVRLLGYCIEGTHRMLVYEYVSNGNLEQWLHGAMRQHGFLTWDARMKILLGTAKA 299
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVA 346
LAYLHEAIEPKVVHRDIKSSNILID++F+AK+SDFGLAKLLGAGKSHITTRVMGTFGYVA
Sbjct: 300 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHITTRVMGTFGYVA 359
Query: 347 PEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVV 406
PEYAN+GLLNEKSDVYSFGVVLLEAITGR PVDYGRP EVNLV+WLKMMV RRSE+VV
Sbjct: 360 PEYANTGLLNEKSDVYSFGVVLLEAITGRDPVDYGRPAQEVNLVDWLKMMVGSRRSEEVV 419
Query: 407 DPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIPREDRRRRRNQA 466
DPNIE RPST ALKRALLTALRCVDPDS+KRPKM QVVRMLESEEYPIPREDRR RR QA
Sbjct: 420 DPNIEVRPSTRALKRALLTALRCVDPDSEKRPKMGQVVRMLESEEYPIPREDRRHRRTQA 479
Query: 467 GASEAESQRESSDTDKNENPESRLKTR 493
G+ E ESQ+E+SDTD++EN SR ++R
Sbjct: 480 GSMEIESQKENSDTDQSENLGSRSESR 506
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147780241|emb|CAN65734.1| hypothetical protein VITISV_037750 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 741 bits (1912), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 371/503 (73%), Positives = 430/503 (85%), Gaps = 15/503 (2%)
Query: 1 MASDLNKSLSKT--YIGMQLWVLIVICLAVVFVVILGV-SLWLTFRKKKSRRANDMLPVS 57
M +DLN LSK +G+++W LI I +A+ V+IL V SL LT RKK SR + D LPV+
Sbjct: 1 MTTDLNAELSKKTDVLGLKVWELIGIVVALFIVIILCVLSLCLTSRKK-SRSSRDRLPVN 59
Query: 58 RFPVVSEEIKEIRVDQVSSS-----NGGFSVHNEKFNDRESEKELI-----PQENGDDSV 107
+ P VS+EIKE+RV+QVS++ +G ++K +D+ES+K L+ +NGD+S
Sbjct: 60 QIPTVSKEIKEVRVEQVSTNEFVPRDGILLTIHDKSSDKESDKVLVHLGMGKTKNGDNSS 119
Query: 108 QSGSFNNLEKDVVGSQLGEEGGNGKVSTFRPSS-HPLTAPSPLSGLPEFSHLGWGHWFTL 166
QSGSF++LEKD GSQ GEEG +G V+ ++PSS +P+TAPSPL GLPEFSHLGWGHWFTL
Sbjct: 120 QSGSFHHLEKDGCGSQSGEEGSSGTVTVYKPSSSYPITAPSPLVGLPEFSHLGWGHWFTL 179
Query: 167 RDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGH 226
RDL+ ATNRFSK+N++G+GGYGVVYRGQL+NGT VAVKK+LNN GQA+K+FRVEVEAIGH
Sbjct: 180 RDLELATNRFSKENVLGEGGYGVVYRGQLINGTPVAVKKILNNLGQAEKEFRVEVEAIGH 239
Query: 227 VRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKA 286
VRHKNLVRLLGYCIEGT R+LVYEYV+NGNLEQWL G M G+LTW+ARMKILLGTAKA
Sbjct: 240 VRHKNLVRLLGYCIEGTHRMLVYEYVSNGNLEQWLHGAMRQHGFLTWDARMKILLGTAKA 299
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVA 346
LAYLHEAIEPKVVHRDIKSSNILID++F+AK+SDFGLAKLLGAGKSHITTRVMGTFGYVA
Sbjct: 300 LAYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHITTRVMGTFGYVA 359
Query: 347 PEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVV 406
PEYAN+GLLNEKSDVYSFGVVLLEAITGR PVDYGRP EVNLV+WLKMMV RRSE+VV
Sbjct: 360 PEYANTGLLNEKSDVYSFGVVLLEAITGRDPVDYGRPAQEVNLVDWLKMMVGSRRSEEVV 419
Query: 407 DPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIPREDRRRRRNQA 466
DPNIE RPST ALKRALLTALRCVDPDS+KRPKM QVVRMLESEEYPIPREDRR RR QA
Sbjct: 420 DPNIEVRPSTRALKRALLTALRCVDPDSEKRPKMGQVVRMLESEEYPIPREDRRHRRTQA 479
Query: 467 GASEAESQRESSDTDKNENPESR 489
G+ E ESQ+E+SDTD++EN SR
Sbjct: 480 GSMEIESQKENSDTDQSENLGSR 502
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224124542|ref|XP_002330049.1| predicted protein [Populus trichocarpa] gi|222871474|gb|EEF08605.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 735 bits (1898), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 366/506 (72%), Positives = 429/506 (84%), Gaps = 15/506 (2%)
Query: 1 MASDLNKSLSK--TYIGMQLWVLIVICLAVVFVVILGVSLWLTFRKKKSRRANDMLPVSR 58
MASDLN LSK +G+++W +I IC+A+ V+IL V + +KKSRR + LP S+
Sbjct: 1 MASDLNAELSKKTAILGLKVWEVIGICVALFIVIILSVLSFCLTSRKKSRRDRNHLPPSQ 60
Query: 59 FPVVSEEIKEIRVDQVSSS-----NGGFSVHNEKFNDRESEKELI-----PQENGDDSVQ 108
P VS+EI E+RV+QVS++ +G ++K +D+ES+K L+ +NGD+ +
Sbjct: 61 IPTVSKEITEVRVEQVSTNEFVPRDGILLTIHDKSSDKESDKVLVHLGMGKVKNGDNMSR 120
Query: 109 SGSFNNLEKDVVGSQLGEEGGNGKVSTFRPSS-HPLTAPSPLSGLPEFSHLGWGHWFTLR 167
SGSF++LEKD GSQ GEEG +GKV+ ++PSS +P+TAPSPLSGLPEFSHLGWGHWFTLR
Sbjct: 121 SGSFHHLEKDC-GSQSGEEGSSGKVTVYKPSSSYPITAPSPLSGLPEFSHLGWGHWFTLR 179
Query: 168 DLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV 227
DL+ ATNRFSK+N++G+GGYGVVY+G L+NGT VAVKK+LNN GQA+K+FRVEV+AIGHV
Sbjct: 180 DLELATNRFSKENVLGEGGYGVVYQGHLINGTPVAVKKILNNLGQAEKEFRVEVDAIGHV 239
Query: 228 RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKAL 287
RHKNLVRLLGYCIEGT RILVYEYVNNGNLEQWL G M GYLTWEARMK+LLGTAKAL
Sbjct: 240 RHKNLVRLLGYCIEGTHRILVYEYVNNGNLEQWLHGAMRQHGYLTWEARMKVLLGTAKAL 299
Query: 288 AYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAP 347
AYLHEAIEPKVVHRDIKSSNILID++F+AK+SDFGLAKLLGAGKSH+TTRVMGTFGYVAP
Sbjct: 300 AYLHEAIEPKVVHRDIKSSNILIDDDFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAP 359
Query: 348 EYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407
EYAN+GLLNEKSDVYSFGVVLLEAITGR PVDYGRP EVNLV+WLKMMV RRSE+VVD
Sbjct: 360 EYANTGLLNEKSDVYSFGVVLLEAITGRDPVDYGRPTHEVNLVDWLKMMVGNRRSEEVVD 419
Query: 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIPREDRRRRRNQAG 467
PNIE RPST ALKRALLTALRCVDPDS+KRPKMSQVVRMLESEEYPIPREDRR RR Q G
Sbjct: 420 PNIEVRPSTRALKRALLTALRCVDPDSEKRPKMSQVVRMLESEEYPIPREDRRHRRTQGG 479
Query: 468 ASEAESQRESSDTDKNENPESRLKTR 493
E ESQ+E+SDTD+++ P SR ++R
Sbjct: 480 M-EIESQKENSDTDRSDYPGSRTESR 504
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356521703|ref|XP_003529491.1| PREDICTED: probable receptor-like protein kinase At5g18500-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 733 bits (1892), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 373/504 (74%), Positives = 427/504 (84%), Gaps = 8/504 (1%)
Query: 1 MASDLNKSLSK--TYIGMQLWVLIVICLAVVFVVILGVSLWLTFRKKKSRRANDMLPVSR 58
MASDLN LSK + G++ W L+ I + + ++IL V +KKSRR N MLP+S
Sbjct: 1 MASDLNSGLSKETSVFGLKAWELMGIIVGLFIIIILVVISICLTSRKKSRRVNGMLPLSH 60
Query: 59 FPVVSEEIKEIRVDQVSSSN----GGFSVHNEKFNDRESEKELI-PQENGDDSVQSGSFN 113
+S+EIKEIRVDQVS++N G F ++F+DR+SEK LI NG++S QSGSF
Sbjct: 61 MLSISDEIKEIRVDQVSANNHPQNGAFVSLYDRFSDRDSEKVLIQTNNNGENSSQSGSFV 120
Query: 114 NLEKDVVGSQLGEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSAT 173
+L+KD GSQ GEE G VST+ SSHP+TAPSPL GLPEFSHLGWGHWFTLRDL+ AT
Sbjct: 121 HLKKDD-GSQSGEESGAKSVSTYWSSSHPITAPSPLCGLPEFSHLGWGHWFTLRDLELAT 179
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLV 233
NRFSKDN+IG+GGYGVVY+GQL+NG+ VAVKKLLNN GQA+K+FRVEVEAIGHVRHKNLV
Sbjct: 180 NRFSKDNVIGEGGYGVVYQGQLINGSPVAVKKLLNNLGQAEKEFRVEVEAIGHVRHKNLV 239
Query: 234 RLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEA 293
RLLGYCIEGT R+LVYEYVNNGNLEQWL G M G+LTW+AR+KILLGTAKALAYLHEA
Sbjct: 240 RLLGYCIEGTHRLLVYEYVNNGNLEQWLHGAMQQYGFLTWDARIKILLGTAKALAYLHEA 299
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSG 353
IEPKVVHRDIKSSNILID++F+AKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSG
Sbjct: 300 IEPKVVHRDIKSSNILIDDDFNAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSG 359
Query: 354 LLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETR 413
LLNEKSDVYSFGV+LLEAITGR PVDY RP +EVNLV+WLKMMV RR+E+VVDPNIETR
Sbjct: 360 LLNEKSDVYSFGVLLLEAITGRDPVDYNRPAAEVNLVDWLKMMVGNRRAEEVVDPNIETR 419
Query: 414 PSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIPREDRRRRRNQAGASEAES 473
PSTS+LKRALLTALRCVDPDS+KRPKMSQVVRMLESEEYPIPREDRRRR++ AG E
Sbjct: 420 PSTSSLKRALLTALRCVDPDSEKRPKMSQVVRMLESEEYPIPREDRRRRKSLAGNIELGD 479
Query: 474 QRESSDTDKNENPESRLKTRRNQQ 497
Q+E+SDT+K ENP+S+ RRNQ+
Sbjct: 480 QKETSDTEKTENPDSKSNGRRNQR 503
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|388518751|gb|AFK47437.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 733 bits (1891), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 366/504 (72%), Positives = 428/504 (84%), Gaps = 11/504 (2%)
Query: 1 MASDLNKSLSK--TYIGMQLWVLIVICLAVVFVVILG-VSLWLTFRKKKSRRANDMLPVS 57
MAS+L+ LSK + G+++W L+ + + + V+IL VS+ LT KKKSRR N +LP+S
Sbjct: 1 MASNLSSRLSKKTSVFGLEVWELMGLIVGLFIVIILLLVSICLT-SKKKSRRVNGLLPLS 59
Query: 58 RFPVVSEEIKEIRVDQVSSS----NGGFSVHNEKFNDRESEKELIPQENGDDSVQSGSFN 113
VSEEIK+I++DQVS++ NG F +KFND+ESEK L+ +NG+ S QSGSF
Sbjct: 60 HRLSVSEEIKDIKMDQVSTNSHPQNGAFMSLYDKFNDKESEKILLHTKNGEYSSQSGSFV 119
Query: 114 NLEKDVVGSQLGEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSAT 173
++EKD GSQ GEE G VS RPS LT+PSPLSGLPEFSHLGWGHWFTLRDL+ AT
Sbjct: 120 HIEKDAAGSQSGEESGAKSVSAHRPS---LTSPSPLSGLPEFSHLGWGHWFTLRDLELAT 176
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLV 233
N+FSKDNIIG+GGYGVVY+GQL+NG VA+KKLLNN GQA+K+FRVEVEAIGHVRHKNLV
Sbjct: 177 NKFSKDNIIGEGGYGVVYQGQLINGNPVAIKKLLNNLGQAEKEFRVEVEAIGHVRHKNLV 236
Query: 234 RLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEA 293
RLLG+CIEGT R+L+YEYVNNGNLEQWL G M GYLTW+AR+KILLGTAKALAYLHEA
Sbjct: 237 RLLGFCIEGTHRLLIYEYVNNGNLEQWLHGAMRQYGYLTWDARIKILLGTAKALAYLHEA 296
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSG 353
IEPKVVHRDIKSSNILID++F+AKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSG
Sbjct: 297 IEPKVVHRDIKSSNILIDDDFNAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSG 356
Query: 354 LLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETR 413
LLNEKSDVYSFGV+LLEAITGR PVDY R +EVNLV+WLKMMV R +E+VVDPNIETR
Sbjct: 357 LLNEKSDVYSFGVLLLEAITGRDPVDYNRSAAEVNLVDWLKMMVGNRHAEEVVDPNIETR 416
Query: 414 PSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIPREDRRRRRNQAGASEAES 473
PSTSALKR LLTALRCVDPDS+KRPKMSQVVRMLESEEYPIPREDRRRR++ A +++ E
Sbjct: 417 PSTSALKRVLLTALRCVDPDSEKRPKMSQVVRMLESEEYPIPREDRRRRKSNARSTDVEM 476
Query: 474 QRESSDTDKNENPESRLKTRRNQQ 497
Q+E+ DTDK+++P+S+ RRNQ+
Sbjct: 477 QKEAFDTDKSDHPDSKSNGRRNQR 500
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351727925|ref|NP_001238457.1| receptor-like protein kinase 3-like [Glycine max] gi|51847836|gb|AAU10525.1| putative receptor-like protein kinase 3 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 731 bits (1886), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 374/503 (74%), Positives = 428/503 (85%), Gaps = 6/503 (1%)
Query: 1 MASDLNKSLSK-TYI-GMQLWVLIVICLAVVFVVILGVSLWLTFRKKKSRRANDMLPVSR 58
MASDLN LSK T++ G+++WVL+ I + + ++IL V +KK RR N LP+S
Sbjct: 1 MASDLNSGLSKKTFVFGLKVWVLMGIIVGLFIIIILVVLSICLTLRKKFRRVNGKLPLSH 60
Query: 59 FPVVSEEIKEIRVDQVSSSN----GGFSVHNEKFNDRESEKELIPQENGDDSVQSGSFNN 114
VS+EIKEI+VDQV ++N G F+ N+KF DRESEK L +NGD+S QSGS N+
Sbjct: 61 VISVSDEIKEIKVDQVPANNHPQNGVFTSLNDKFGDRESEKVLNQTKNGDNSSQSGSSNH 120
Query: 115 LEKDVVGSQLGEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATN 174
LEKD GSQ GE+ G VS +R SSHP+TAPSPLSGLPEFSHLGWGHWFTLRDL+ ATN
Sbjct: 121 LEKDANGSQSGEDSGVKSVSAYRSSSHPITAPSPLSGLPEFSHLGWGHWFTLRDLELATN 180
Query: 175 RFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVR 234
RF+KDN+IG+GGYG+VY GQL+NG VA+KKLLNN GQA+K+FRVEVEAIGHVRHKNLVR
Sbjct: 181 RFAKDNVIGEGGYGIVYHGQLINGNPVAIKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVR 240
Query: 235 LLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI 294
LLGYCIEGT R+LVYEYVNNGNLEQWL G M G+LTW+AR+KILLGTAKALAYLHEAI
Sbjct: 241 LLGYCIEGTHRLLVYEYVNNGNLEQWLHGAMRQHGFLTWDARIKILLGTAKALAYLHEAI 300
Query: 295 EPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGL 354
EPKVVHRDIKSSNILIDE+F+AKISDFGLAKLLGAGK HITTRVMGTFGYVAPEYANSGL
Sbjct: 301 EPKVVHRDIKSSNILIDEDFNAKISDFGLAKLLGAGKCHITTRVMGTFGYVAPEYANSGL 360
Query: 355 LNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRP 414
LNEKSDVYSFGV+LLEAITGR PVDY RP +EVNLV+WLKMMV RRSE V+DPNIETRP
Sbjct: 361 LNEKSDVYSFGVLLLEAITGRDPVDYSRPAAEVNLVDWLKMMVGCRRSEGVLDPNIETRP 420
Query: 415 STSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIPREDRRRRRNQAGASEAESQ 474
STSALKRALLTALRCVDPD++KRP+MSQVVRMLESEEYPI REDRRRRR+QAG E E+Q
Sbjct: 421 STSALKRALLTALRCVDPDAEKRPRMSQVVRMLESEEYPILREDRRRRRSQAGNMEVETQ 480
Query: 475 RESSDTDKNENPESRLKTRRNQQ 497
RE+SDTDK++NP+ + RRNQ+
Sbjct: 481 RENSDTDKSDNPDYKPSGRRNQR 503
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357479169|ref|XP_003609870.1| Protein kinase domain containing protein expressed [Medicago truncatula] gi|355510925|gb|AES92067.1| Protein kinase domain containing protein expressed [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 723 bits (1867), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 357/480 (74%), Positives = 415/480 (86%), Gaps = 9/480 (1%)
Query: 22 IVICLAVVFVVILGVSLWLTFRKKKSRRANDMLPVSRFPVVSEEIKEIRVDQVSSS---- 77
+++ L +V +++L VS+ LT KKKSRR N +LP+S VSEEIK+I++DQVS++
Sbjct: 3 LIVGLFIVIILLL-VSICLT-SKKKSRRVNGLLPLSHRLSVSEEIKDIKMDQVSTNSHPQ 60
Query: 78 NGGFSVHNEKFNDRESEKELIPQENGDDSVQSGSFNNLEKDVVGSQLGEEGGNGKVSTFR 137
NG F +KFND+ESEK L+ +NG+ S QSGSF ++EKD GSQ GEE G VS R
Sbjct: 61 NGAFMSLYDKFNDKESEKILLHTKNGEYSSQSGSFVHIEKDAAGSQSGEESGAKSVSAHR 120
Query: 138 PSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMN 197
PS LT+PSPLSGLPEFSHLGWGHWFTLRDL+ ATN+FSKDNIIG+GGYGVVY+GQL+N
Sbjct: 121 PS---LTSPSPLSGLPEFSHLGWGHWFTLRDLELATNKFSKDNIIGEGGYGVVYQGQLIN 177
Query: 198 GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNL 257
G VA+KKLLNN GQA+K+FRVEVEAIGHVRHKNLVRLLG+CIEGT R+L+YEYVNNGNL
Sbjct: 178 GNPVAIKKLLNNLGQAEKEFRVEVEAIGHVRHKNLVRLLGFCIEGTHRLLIYEYVNNGNL 237
Query: 258 EQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAK 317
EQWL G M GYLTW+AR+KILLGTAKALAYLHEAIEPKVVHRDIKSSNILID++F+AK
Sbjct: 238 EQWLHGAMRQYGYLTWDARIKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDDDFNAK 297
Query: 318 ISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYP 377
ISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGV+LLEAITGR P
Sbjct: 298 ISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVLLLEAITGRDP 357
Query: 378 VDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKR 437
VDY R +EVNLV+WLKMMV R +E+VVDPNIETRPSTSALKR LLTALRCVDPDS+KR
Sbjct: 358 VDYNRSAAEVNLVDWLKMMVGNRHAEEVVDPNIETRPSTSALKRVLLTALRCVDPDSEKR 417
Query: 438 PKMSQVVRMLESEEYPIPREDRRRRRNQAGASEAESQRESSDTDKNENPESRLKTRRNQQ 497
PKMSQVVRMLESEEYPIPREDRRRR++ A +++ E Q+E+SDTDK+++P+S+ RRNQ+
Sbjct: 418 PKMSQVVRMLESEEYPIPREDRRRRKSNARSTDVEMQKEASDTDKSDHPDSKSNGRRNQR 477
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 498 | ||||||
| TAIR|locus:2146203 | 484 | AT5G18500 [Arabidopsis thalian | 0.941 | 0.969 | 0.742 | 1.5e-186 | |
| TAIR|locus:2027559 | 492 | AT1G56720 [Arabidopsis thalian | 0.963 | 0.975 | 0.671 | 7.6e-167 | |
| TAIR|locus:2012325 | 466 | AT1G09440 [Arabidopsis thalian | 0.919 | 0.982 | 0.647 | 3.6e-160 | |
| TAIR|locus:2045620 | 494 | AT2G42960 [Arabidopsis thalian | 0.937 | 0.945 | 0.627 | 1.5e-152 | |
| TAIR|locus:2077730 | 512 | AT3G59110 [Arabidopsis thalian | 0.951 | 0.925 | 0.618 | 3.7e-151 | |
| TAIR|locus:2093591 | 467 | GPK1 "glyoxysomal protein kina | 0.781 | 0.832 | 0.708 | 3.1e-147 | |
| TAIR|locus:2132353 | 492 | AT4G02630 [Arabidopsis thalian | 0.696 | 0.705 | 0.595 | 1.9e-121 | |
| TAIR|locus:2025396 | 472 | AT1G01540 [Arabidopsis thalian | 0.775 | 0.817 | 0.567 | 6.2e-117 | |
| TAIR|locus:2139559 | 437 | AT4G34500 [Arabidopsis thalian | 0.767 | 0.874 | 0.553 | 1.6e-109 | |
| TAIR|locus:2026925 | 708 | PERK9 "proline-rich extensin-l | 0.672 | 0.473 | 0.447 | 1.6e-75 |
| TAIR|locus:2146203 AT5G18500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1809 (641.9 bits), Expect = 1.5e-186, P = 1.5e-186
Identities = 364/490 (74%), Positives = 416/490 (84%)
Query: 1 MASDLNKSLSKTYIGMQLWVLIVICLAVVFVVILGVSLWLTFRKKKSRRANDMLPVSRF- 59
M S LN +LS+ Y G++LW +IVI L+ +FVV+L +SLWLTFR+K SR +++++PVSR
Sbjct: 1 MGSGLNDTLSRNYNGLELWEIIVIVLSAIFVVVLAISLWLTFRRKTSRSSSNLIPVSRQI 60
Query: 60 -PVVSEEIKEIRVDQVSSSNGG--FSVHNEKFNDRESEKELIPQ-ENGDDSVQSGSFNNL 115
P V EEIKEIRVD+VSSSNGG + +EKF D+E EK + + ENGD S +SGSFN+L
Sbjct: 61 PPSVPEEIKEIRVDEVSSSNGGNGYPSISEKFGDKEPEKGIKAESENGDSS-RSGSFNHL 119
Query: 116 EKDVVGSQLGEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNR 175
EK ++G + VS S++PLTAPSPLSGLPEFSHLGWGHWFTLRDLQ ATN+
Sbjct: 120 EK--------KDGSS--VS----SANPLTAPSPLSGLPEFSHLGWGHWFTLRDLQMATNQ 165
Query: 176 FSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRL 235
FS+DNIIGDGGYGVVYRG L+NGT VAVKKLLNN GQADKDFRVEVEAIGHVRHKNLVRL
Sbjct: 166 FSRDNIIGDGGYGVVYRGNLVNGTPVAVKKLLNNLGQADKDFRVEVEAIGHVRHKNLVRL 225
Query: 236 LGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIE 295
LGYC+EGTQR+LVYEYVNNGNLEQWLRGD + YLTWEAR+KIL+GTAKALAYLHEAIE
Sbjct: 226 LGYCMEGTQRMLVYEYVNNGNLEQWLRGDNQNHEYLTWEARVKILIGTAKALAYLHEAIE 285
Query: 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLL 355
PKVVHRDIKSSNILID+ F++KISDFGLAKLLGA KS ITTRVMGTFGYVAPEYANSGLL
Sbjct: 286 PKVVHRDIKSSNILIDDKFNSKISDFGLAKLLGADKSFITTRVMGTFGYVAPEYANSGLL 345
Query: 356 NEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPS 415
NEKSDVYSFGVVLLEAITGRYPVDY RP EV+LVEWLKMMVQ RRSE+VVDPN+ET+PS
Sbjct: 346 NEKSDVYSFGVVLLEAITGRYPVDYARPPPEVHLVEWLKMMVQQRRSEEVVDPNLETKPS 405
Query: 416 TSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIPREDXXXXXNQAGAS-EAESQ 474
TSALKR LLTALRCVDP S+KRP+MSQV RMLESEEYPI RED +Q G + +++
Sbjct: 406 TSALKRTLLTALRCVDPMSEKRPRMSQVARMLESEEYPIAREDRRRRRSQNGTTRDSDPP 465
Query: 475 RESSDTDKNE 484
R S+DTDK+E
Sbjct: 466 RNSTDTDKSE 475
|
|
| TAIR|locus:2027559 AT1G56720 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1623 (576.4 bits), Expect = 7.6e-167, P = 7.6e-167
Identities = 339/505 (67%), Positives = 401/505 (79%)
Query: 1 MASDLNKSLSK-TYI-GMQLWVLIVICLAVVFVVILGV-SLWLTFRKKKSRRANDMLPVS 57
M DL LS+ +++ G+++W +I I +A++ + IL V S LT KKKSRR+ LPV
Sbjct: 1 MGGDLKSQLSRESHVFGLKVWEVIGIAVALLIIAILSVLSCCLT-SKKKSRRSKTGLPVI 59
Query: 58 RFP-VVSEEIKEIRVDQVSSSN---G-GFSVHNEKFNDRESEKELIP---QENGDDSVQS 109
+ P VVS+EI+E+RV+ VS+SN G G + + N+++SEK ++ ++ S +S
Sbjct: 60 QTPPVVSKEIREVRVEHVSASNFAPGEGILLTIQDKNNKDSEKVMVHLDMRKKRSSSGRS 119
Query: 110 GSFNNLEKDVVGSQLGEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDL 169
GSF++LE S EE VS S + + PSPLSGLPE SHLGWGHWFTLRDL
Sbjct: 120 GSFHHLEIIDKHSDSAEE-----VSA-SSSLYNIATPSPLSGLPE-SHLGWGHWFTLRDL 172
Query: 170 QSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRH 229
++ATNRFSK+N+IG+GGYGVVYRG+LMNGT VAVKK+LN GQA+K+FRVEV+AIGHVRH
Sbjct: 173 ETATNRFSKENVIGEGGYGVVYRGELMNGTPVAVKKILNQLGQAEKEFRVEVDAIGHVRH 232
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
KNLVRLLGYCIEGT RILVYEYVNNGNLEQWL G M GYLTWEARMK+L+GT+KALAY
Sbjct: 233 KNLVRLLGYCIEGTHRILVYEYVNNGNLEQWLHGAMRQHGYLTWEARMKVLIGTSKALAY 292
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEY 349
LHEAIEPKVVHRDIKSSNILI++ F+AK+SDFGLAKLLGAGKSH+TTRVMGTFGYVAPEY
Sbjct: 293 LHEAIEPKVVHRDIKSSNILINDEFNAKVSDFGLAKLLGAGKSHVTTRVMGTFGYVAPEY 352
Query: 350 ANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409
ANSGLLNEKSDVYSFGVVLLEAITGR PVDYGRP EVNLV+WLKMMV RRSE+VVDPN
Sbjct: 353 ANSGLLNEKSDVYSFGVVLLEAITGRDPVDYGRPAHEVNLVDWLKMMVGTRRSEEVVDPN 412
Query: 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIPREDXXXXXNQAGAS 469
IE +P T +LKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIPRED + G+
Sbjct: 413 IEVKPPTRSLKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIPREDRRRSRTREGSM 472
Query: 470 EAESQRESSDTDKNENPESRLKTRR 494
E +SDTD + P SR +++R
Sbjct: 473 EI-----NSDTDMS-TPVSRSQSKR 491
|
|
| TAIR|locus:2012325 AT1G09440 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1560 (554.2 bits), Expect = 3.6e-160, P = 3.6e-160
Identities = 314/485 (64%), Positives = 381/485 (78%)
Query: 15 GMQLWVLIVICLAVVFVVILGVSLWLTFRKKKSRRANDM-LPVSRFPVVSEEIKEIRVDQ 73
G+++W I I +A++ +V+L V + KKKSRR+ + LP+ + PVVS+EIKE+R++
Sbjct: 3 GLKIWQAIFITIALIIIVVLSVLSFCLIWKKKSRRSKTLSLPIIQTPVVSKEIKEVRIEH 62
Query: 74 VSSSNGGFSVHNEKFNDRESEKELIPQENGDDSVQSGSFNNLEKDVVGSQLGEEG----G 129
V S++ F +E N+ ES+K L+ E ++ N L GS G+EG
Sbjct: 63 VVSTSSNFDPQDE--NNNESDKFLLNLE-----MEKNRENGLSSSRSGS--GKEGYLCVA 113
Query: 130 NGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYGV 189
N S+ + P +PSPLSGLPE SHLGWGHWFTLRDL+ ATNRFSK+N+IG+GGYGV
Sbjct: 114 NRSTSSLYEMATP--SPSPLSGLPE-SHLGWGHWFTLRDLEIATNRFSKENVIGEGGYGV 170
Query: 190 VYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249
VYRG+L+NG+ VAVKK+LN+ GQA+K+FRVEV+AIGHVRHKNLVRLLGYCIEGT RILVY
Sbjct: 171 VYRGELVNGSLVAVKKILNHLGQAEKEFRVEVDAIGHVRHKNLVRLLGYCIEGTNRILVY 230
Query: 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNIL 309
EY+NNGNLE+WL G M GYLTWEARMK+L GT+KALAYLHEAIEPKVVHRDIKSSNIL
Sbjct: 231 EYMNNGNLEEWLHGAMKHHGYLTWEARMKVLTGTSKALAYLHEAIEPKVVHRDIKSSNIL 290
Query: 310 IDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLL 369
ID+ F+AKISDFGLAKLLG GKSH+TTRVMGTFGYVAPEYAN+GLLNEKSDVYSFGV++L
Sbjct: 291 IDDRFNAKISDFGLAKLLGDGKSHVTTRVMGTFGYVAPEYANTGLLNEKSDVYSFGVLVL 350
Query: 370 EAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRC 429
EAITGR PVDY RP +EVNLVEWLKMMV +R E+V+DPNI RP+T ALKR LLTALRC
Sbjct: 351 EAITGRDPVDYARPANEVNLVEWLKMMVGSKRLEEVIDPNIAVRPATRALKRVLLTALRC 410
Query: 430 VDPDSDKRPKMSQVVRMLESEEYPIPREDXXXXXNQAGASEAESQRESSDTDKNENPESR 489
+DPDS+KRPKMSQVVRMLESEEYP+PRE+ +Q E+SDTD++ P SR
Sbjct: 411 IDPDSEKRPKMSQVVRMLESEEYPVPREERRVR---------RTQEENSDTDRSR-PVSR 460
Query: 490 LKTRR 494
+++R
Sbjct: 461 SQSKR 465
|
|
| TAIR|locus:2045620 AT2G42960 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1488 (528.9 bits), Expect = 1.5e-152, P = 1.5e-152
Identities = 306/488 (62%), Positives = 375/488 (76%)
Query: 3 SDLNKSLSK--TYIGMQ---LWVLIVICLAVVFVVILGV-SLWLTFRKKKSRRANDMLPV 56
S LN +SK ++ G++ LWV + + + V V+IL + SLW+TFR+K SRR++ P
Sbjct: 5 SSLNAEMSKKISFFGLKGLKLWVWVCLVVGVFIVMILCILSLWITFRRK-SRRSSSKFPF 63
Query: 57 SRFPVVSEEIKEIRVDQVSSSNGG-FSVHNEKFNDRESEKELIP-----QENGDDSV-QS 109
++ P VS K+IRVD+ N S++ E ND+ + K ++ + + +D++ Q
Sbjct: 64 NQIPHVS---KDIRVDRAGFQNPHPESLYIE-MNDKSTGKTMMSHLGRTKSSDNDTLSQC 119
Query: 110 GSFNNLEKDVVGSQLGEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDL 169
S N+ E+ S GEEGG G + P+TA SPL GLPE SHLGWGHWFTLRDL
Sbjct: 120 SSVNHHER-ACSSHSGEEGGFGSAGR-QYGGGPVTA-SPLVGLPEISHLGWGHWFTLRDL 176
Query: 170 QSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRH 229
+ ATNRF+ N++G+GGYGVVYRG+L+NGT VAVKKLLNN GQA+K+FRVEVEAIGHVRH
Sbjct: 177 ELATNRFAPVNVLGEGGYGVVYRGKLVNGTEVAVKKLLNNLGQAEKEFRVEVEAIGHVRH 236
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
KNLVRLLGYCIEG R+LVYEYVN+GNLEQWL G M G LTWEARMKI+ GTA+ALAY
Sbjct: 237 KNLVRLLGYCIEGVHRMLVYEYVNSGNLEQWLHGAMRQHGNLTWEARMKIITGTAQALAY 296
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEY 349
LHEAIEPKVVHRDIK+SNILID+ F+AK+SDFGLAKLL +G+SHITTRVMGTFGYVAPEY
Sbjct: 297 LHEAIEPKVVHRDIKASNILIDDEFNAKLSDFGLAKLLDSGESHITTRVMGTFGYVAPEY 356
Query: 350 ANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409
AN+GLLNEKSD+YSFGV+LLEAITGR PVDYGRP +EVNLVEWLKMMV RR+E+VVDP
Sbjct: 357 ANTGLLNEKSDIYSFGVLLLEAITGRDPVDYGRPANEVNLVEWLKMMVGTRRAEEVVDPR 416
Query: 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIPREDXXXXXNQAGAS 469
+E RPS SALKRALL +LRCVDP+++KRP+MSQV RMLES+E+P +E AG
Sbjct: 417 LEPRPSKSALKRALLVSLRCVDPEAEKRPRMSQVARMLESDEHPFHKERRNKRSKTAGME 476
Query: 470 EAESQRES 477
E++ ES
Sbjct: 477 IVETKDES 484
|
|
| TAIR|locus:2077730 AT3G59110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1475 (524.3 bits), Expect = 3.7e-151, P = 3.7e-151
Identities = 308/498 (61%), Positives = 377/498 (75%)
Query: 1 MASDLNKSLSKTYI-GMQLWVLIVICLAV-VFVVILG--VSLWLTFRKKKSRRANDMLPV 56
+++D++K +S + GM+LWVLI CL V FVV++ +SLW+ FR+K R ++ +LP
Sbjct: 7 LSADMSKKVSFLGLKGMKLWVLI--CLVVGTFVVLVFCILSLWIAFRRKSRRSSHKLLPF 64
Query: 57 SRFPVVSEEIKEIRVDQ---VSSSNGGFSVHN-EKFNDRESEKELI----PQENGDDSV- 107
S+ P V+ K+IRVD + N S+ N +K +DR S K + + + +DS+
Sbjct: 65 SQIPRVA---KDIRVDDRVGFQNHNENLSITNADKSSDRNSGKMMSYLGRTKSSDNDSIS 121
Query: 108 QSGSFNNLEKDVVGSQLGEEGGNGKVSTFRPSSHP---LTAPSPLSGLPEFSHLGWGHWF 164
Q S ++ E+ S GE+G G + +R +S L SPL GLPE SHLGWGHWF
Sbjct: 122 QCSSVHHHER-ACSSHSGEDGSFG--AAWRQNSLSQGGLVTASPLVGLPEISHLGWGHWF 178
Query: 165 TLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAI 224
TLRDLQ ATNRF+ +N+IG+GGYGVVY+G+L+NG VAVKKLLNN GQA+K+FRVEVEAI
Sbjct: 179 TLRDLQLATNRFAAENVIGEGGYGVVYKGRLINGNDVAVKKLLNNLGQAEKEFRVEVEAI 238
Query: 225 GHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTA 284
GHVRHKNLVRLLGYCIEG R+LVYEYVN+GNLEQWL G M + LTWEARMKIL+GTA
Sbjct: 239 GHVRHKNLVRLLGYCIEGVNRMLVYEYVNSGNLEQWLHGAMGKQSTLTWEARMKILVGTA 298
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGY 344
+ALAYLHEAIEPKVVHRDIK+SNILID++F+AK+SDFGLAKLL +G+SHITTRVMGTFGY
Sbjct: 299 QALAYLHEAIEPKVVHRDIKASNILIDDDFNAKLSDFGLAKLLDSGESHITTRVMGTFGY 358
Query: 345 VAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSED 404
VAPEYAN+GLLNEKSD+YSFGV+LLE ITGR PVDY RP +EVNLVEWLKMMV RR+E+
Sbjct: 359 VAPEYANTGLLNEKSDIYSFGVLLLETITGRDPVDYERPANEVNLVEWLKMMVGTRRAEE 418
Query: 405 VVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIPREDXXXXXN 464
VVD IE P+T ALKRALL ALRCVDP++ KRPKMSQVVRMLES+E+P E
Sbjct: 419 VVDSRIEPPPATRALKRALLVALRCVDPEAQKRPKMSQVVRMLESDEHPFREERRNRKSR 478
Query: 465 QAGASEAESQRESSDTDK 482
A E+ ES+DT K
Sbjct: 479 TASMEIVETTEESADTSK 496
|
|
| TAIR|locus:2093591 GPK1 "glyoxysomal protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1438 (511.3 bits), Expect = 3.1e-147, P = 3.1e-147
Identities = 285/402 (70%), Positives = 331/402 (82%)
Query: 92 ESEKELIPQENGDDSVQSGSFNNL-EKDVVGSQLGEE--GGNGK---VSTFRPSSHP-LT 144
E KE I ++G + S+ L EK V + G++ G K V + P S P T
Sbjct: 64 EEIKE-ISVDHGSSNNNGTSYQTLDEKFVEDIENGDKFSGSLEKKPLVGSHLPPSTPSTT 122
Query: 145 APSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVK 204
APSPL GLPE SH+GWGHWFTLRDLQ ATN FSK++IIGDGGYGVVY G L N T VAVK
Sbjct: 123 APSPLLGLPEVSHIGWGHWFTLRDLQLATNHFSKESIIGDGGYGVVYHGTLTNKTPVAVK 182
Query: 205 KLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGD 264
KLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYC+EGT R+LVYEY+NNGNLEQWL GD
Sbjct: 183 KLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCVEGTHRMLVYEYMNNGNLEQWLHGD 242
Query: 265 MCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324
M +G+LTWEAR+K+L+GTAKALAYLHEAIEPKVVHRDIKSSNIL+D+NFDAK+SDFGLA
Sbjct: 243 MIHKGHLTWEARIKVLVGTAKALAYLHEAIEPKVVHRDIKSSNILMDDNFDAKLSDFGLA 302
Query: 325 KLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQ 384
KLLGA ++++TRVMGTFGYVAPEYANSGLLNEKSDVYS+GVVLLEAITGRYPVDY RP+
Sbjct: 303 KLLGADSNYVSTRVMGTFGYVAPEYANSGLLNEKSDVYSYGVVLLEAITGRYPVDYARPK 362
Query: 385 SEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVV 444
EV++VEWLK+MVQ ++ E+VVD +E +P+TS LKRALLTALRCVDPD+DKRPKMSQV
Sbjct: 363 EEVHMVEWLKLMVQQKQFEEVVDKELEIKPTTSELKRALLTALRCVDPDADKRPKMSQVA 422
Query: 445 RMLESEEYPI-PREDXXXXXNQAGASEAESQRESSDTDKNEN 485
RMLES+EYP+ PRE+ NQ AE+ RES+DT+K+ +
Sbjct: 423 RMLESDEYPVMPREERRRRRNQ----NAETHRESTDTNKDND 460
|
|
| TAIR|locus:2132353 AT4G02630 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1105 (394.0 bits), Expect = 1.9e-121, Sum P(2) = 1.9e-121
Identities = 209/351 (59%), Positives = 269/351 (76%)
Query: 149 LSGLPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLN 208
LSG PE SHLGWGHW+TLR+L+ +TN F+ +N+IG GGYG+VYRG L + + VA+K LLN
Sbjct: 136 LSG-PEVSHLGWGHWYTLRELEVSTNGFADENVIGQGGYGIVYRGVLEDKSMVAIKNLLN 194
Query: 209 NPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGD-MCD 267
N GQA+K+F+VEVEAIG VRHKNLVRLLGYC+EG R+LVYEYV+NGNLEQW+ G +
Sbjct: 195 NRGQAEKEFKVEVEAIGRVRHKNLVRLLGYCVEGAHRMLVYEYVDNGNLEQWIHGGGLGF 254
Query: 268 RGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
+ LTWE RM I+LGTAK L YLHE +EPKVVHRDIKSSNIL+D+ +++K+SDFGLAKLL
Sbjct: 255 KSPLTWEIRMNIVLGTAKGLMYLHEGLEPKVVHRDIKSSNILLDKQWNSKVSDFGLAKLL 314
Query: 328 GAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEV 387
G+ S++TTRVMGTFGYVAPEYA++G+LNE+SDVYSFGV+++E I+GR PVDY R EV
Sbjct: 315 GSEMSYVTTRVMGTFGYVAPEYASTGMLNERSDVYSFGVLVMEIISGRSPVDYSRAPGEV 374
Query: 388 NLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447
NLVEWLK +V R +E V+DP + +PS +LKR LL ALRCVDP++ KRPKM ++ ML
Sbjct: 375 NLVEWLKRLVTNRDAEGVLDPRMVDKPSLRSLKRTLLVALRCVDPNAQKRPKMGHIIHML 434
Query: 448 ESEEYPIPREDXXXXXNQAGASE-AESQRESSDTDKNENPESRLKTRRNQQ 497
E+E+ + ++D G E S R ++ +++E+ N Q
Sbjct: 435 EAEDL-VSKDDRRNSGGGGGGIEQGRSPRRKTNVNESEDESGNSVLINNDQ 484
|
|
| TAIR|locus:2025396 AT1G01540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1152 (410.6 bits), Expect = 6.2e-117, P = 6.2e-117
Identities = 223/393 (56%), Positives = 287/393 (73%)
Query: 95 KELIPQENGDDSVQ-SGSFNNLEKDVVGSQLGEEG-GNGKVSTFRPSSHPLTAPSPLSGL 152
KE++P +N + +E VV S G G S +S+ + S G
Sbjct: 75 KEIVPAQNQSVPAEIQVDIGKIEHRVVFSDRVSSGESRGTASASETASY---SGSGNCG- 130
Query: 153 PEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQ 212
PE SHLGWG W+TLR+L++ATN ++N+IG+GGYG+VYRG L +GT VAVK LLNN GQ
Sbjct: 131 PEVSHLGWGRWYTLRELEAATNGLCEENVIGEGGYGIVYRGILTDGTKVAVKNLLNNRGQ 190
Query: 213 ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT 272
A+K+F+VEVE IG VRHKNLVRLLGYC+EG R+LVY++V+NGNLEQW+ GD+ D LT
Sbjct: 191 AEKEFKVEVEVIGRVRHKNLVRLLGYCVEGAYRMLVYDFVDNGNLEQWIHGDVGDVSPLT 250
Query: 273 WEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332
W+ RM I+LG AK LAYLHE +EPKVVHRDIKSSNIL+D ++AK+SDFGLAKLLG+ S
Sbjct: 251 WDIRMNIILGMAKGLAYLHEGLEPKVVHRDIKSSNILLDRQWNAKVSDFGLAKLLGSESS 310
Query: 333 HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEW 392
++TTRVMGTFGYVAPEYA +G+LNEKSD+YSFG++++E ITGR PVDY RPQ E NLV+W
Sbjct: 311 YVTTRVMGTFGYVAPEYACTGMLNEKSDIYSFGILIMEIITGRNPVDYSRPQGETNLVDW 370
Query: 393 LKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEY 452
LK MV RRSE+VVDP I PS+ ALKR LL ALRCVDPD++KRPKM ++ MLE+E+
Sbjct: 371 LKSMVGNRRSEEVVDPKIPEPPSSKALKRVLLVALRCVDPDANKRPKMGHIIHMLEAEDL 430
Query: 453 PIPREDXXXXXNQAGASEAESQRESSDTDKNEN 485
+ R++ + E+ ++ ++ E+
Sbjct: 431 -LYRDERRTTRDHGSRERQETAVVAAGSESGES 462
|
|
| TAIR|locus:2139559 AT4G34500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1082 (385.9 bits), Expect = 1.6e-109, P = 1.6e-109
Identities = 221/399 (55%), Positives = 283/399 (70%)
Query: 61 VVSEEIKEIRVDQVSSSNGGFSVHNEKFNDRESEKELIPQENGDDSVQSGSFNNLEKDVV 120
V + R +V S+G + +++ ++ ++ + I N DDS G N E VV
Sbjct: 45 VCLNRVSRARRMRVKHSSGSIPLVSKEISEIKTVGKFI---NSDDS--KGKIGN-EVVVV 98
Query: 121 GSQLGEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDN 180
S +E +G F S A S G E +GWG W++L+DL+ AT FS DN
Sbjct: 99 VSATSKEATSG----FDTLS---VASSGDVGTSEA--MGWGKWYSLKDLEIATRGFSDDN 149
Query: 181 IIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCI 240
+IG+GGYGVVYR +G+ AVK LLNN GQA+K+F+VEVEAIG VRHKNLV L+GYC
Sbjct: 150 MIGEGGYGVVYRADFSDGSVAAVKNLLNNKGQAEKEFKVEVEAIGKVRHKNLVGLMGYCA 209
Query: 241 EG--TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKV 298
+ +QR+LVYEY++NGNLEQWL GD+ LTW+ RMKI +GTAK LAYLHE +EPKV
Sbjct: 210 DSAQSQRMLVYEYIDNGNLEQWLHGDVGPVSPLTWDIRMKIAIGTAKGLAYLHEGLEPKV 269
Query: 299 VHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEK 358
VHRD+KSSNIL+D+ ++AK+SDFGLAKLLG+ S++TTRVMGTFGYV+PEYA++G+LNE
Sbjct: 270 VHRDVKSSNILLDKKWNAKVSDFGLAKLLGSETSYVTTRVMGTFGYVSPEYASTGMLNEC 329
Query: 359 SDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSA 418
SDVYSFGV+L+E ITGR PVDY RP E+NLV+W K MV RR E+V+DP I+T P A
Sbjct: 330 SDVYSFGVLLMEIITGRSPVDYSRPPGEMNLVDWFKGMVASRRGEEVIDPKIKTSPPPRA 389
Query: 419 LKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIPRE 457
LKRALL LRC+D DS KRPKM Q++ MLE+E++P E
Sbjct: 390 LKRALLVCLRCIDLDSSKRPKMGQIIHMLEAEDFPFRPE 428
|
|
| TAIR|locus:2026925 PERK9 "proline-rich extensin-like receptor kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 730 (262.0 bits), Expect = 1.6e-75, Sum P(2) = 1.6e-75
Identities = 158/353 (44%), Positives = 227/353 (64%)
Query: 136 FR-PSSHPLTAPSPLSGLPEFSHLGWGH---WFTLRDLQSATNRFSKDNIIGDGGYGVVY 191
FR SS P+ A S SG + G G+ F+ +L ATN FS++N++G+GG+G VY
Sbjct: 334 FRMQSSAPVGA-SKRSGSYQSQSGGLGNSKALFSYEELVKATNGFSQENLLGEGGFGCVY 392
Query: 192 RGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251
+G L +G VAVK+L GQ D++F+ EVE + + H++LV ++G+CI G +R+L+Y+Y
Sbjct: 393 KGILPDGRVVAVKQLKIGGGQGDREFKAEVETLSRIHHRHLVSIVGHCISGDRRLLIYDY 452
Query: 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID 311
V+N +L L G+ + L W R+KI G A+ LAYLHE P+++HRDIKSSNIL++
Sbjct: 453 VSNNDLYFHLHGE---KSVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLE 509
Query: 312 ENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEA 371
+NFDA++SDFGLA+L +HITTRV+GTFGY+APEYA+SG L EKSDV+SFGVVLLE
Sbjct: 510 DNFDARVSDFGLARLALDCNTHITTRVIGTFGYMAPEYASSGKLTEKSDVFSFGVVLLEL 569
Query: 372 ITGRYPVDYGRPQSEVNLVEWLKMMV----QLRRSEDVVDPNIETRPSTSALKRALLTAL 427
ITGR PVD +P + +LVEW + ++ + + + DP + S + R + A
Sbjct: 570 ITGRKPVDTSQPLGDESLVEWARPLISHAIETEEFDSLADPKLGGNYVESEMFRMIEAAG 629
Query: 428 RCVDPDSDKRPKMSQVVRMLESEEYPIPREDXXXXXNQAGASEA-ESQRESSD 479
CV + KRP+M Q+VR ES + ED + G SE S ++S++
Sbjct: 630 ACVRHLATKRPRMGQIVRAFES----LAAEDLTNGM-RLGESEVFNSAQQSAE 677
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q8LEB6 | Y5185_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7443 | 0.9437 | 0.9710 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 498 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 6e-55 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-51 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-51 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-51 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-50 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 3e-47 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-47 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-39 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-35 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-34 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-33 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-31 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-30 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-30 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 6e-30 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-30 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-29 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-28 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-28 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 8e-28 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-27 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-27 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 9e-27 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-26 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-26 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-26 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-25 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-25 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-25 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-25 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-25 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 7e-25 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-24 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-24 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-24 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-23 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-23 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-23 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-23 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-22 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-22 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-22 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-22 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-22 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-22 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-21 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-21 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-21 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-21 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 7e-21 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-21 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-20 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-20 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-20 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-20 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-20 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-20 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-19 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-19 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 4e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-19 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-19 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-19 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-19 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 7e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-18 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-18 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-18 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-18 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-17 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-17 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 3e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-17 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-17 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 7e-17 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 8e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-17 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 9e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-16 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-16 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-16 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-16 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-16 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-16 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-16 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-16 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-16 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 6e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 7e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 7e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 9e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 9e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-15 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-15 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-15 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 7e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-15 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 9e-15 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-14 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-14 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-14 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-14 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-14 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-14 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 4e-14 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 5e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-13 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-13 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-13 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 9e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-12 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-12 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-12 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-12 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 4e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 5e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-12 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 8e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 8e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 9e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-11 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-11 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-11 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-11 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 4e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 5e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-11 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-11 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 9e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-10 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-10 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 3e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-10 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-10 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-09 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-09 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 7e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-08 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-08 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-08 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-08 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-08 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-08 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-08 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 4e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 8e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 9e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-07 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 7e-07 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-07 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 8e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-06 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 9e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-05 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-05 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 5e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 5e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 3e-04 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-04 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.001 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.002 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 6e-55
Identities = 70/193 (36%), Positives = 108/193 (55%), Gaps = 11/193 (5%)
Query: 182 IGDGGYGVVYRGQLMN-GTAVAVKKL-LNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYC 239
+G+GG+G VY + G VA+K + + ++ E+E + + H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 240 IEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVV 299
+ LV EY G+L+ L+ + G L+ + ++ILL + L YLH ++
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILEGLEYLHSN---GII 114
Query: 300 HRDIKSSNILIDE-NFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPE-YANSGLLNE 357
HRD+K NIL+D N K++DFGL+KLL + KS + T V GT Y+APE G +E
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSE 173
Query: 358 KSDVYSFGVVLLE 370
KSD++S GV+L E
Sbjct: 174 KSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 2e-51
Identities = 83/274 (30%), Positives = 126/274 (45%), Gaps = 26/274 (9%)
Query: 176 FSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL-LNNPGQADKDFRVEVEAIGHVRHKNLV 233
+ +G+G +G VY + G VA+K + + + E++ + ++H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 234 RLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEARMKILLGTAKALAYLHE 292
RL + + LV EY G+L L+ RG L+ EAR L AL YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLK----KRGRLSEDEAR-FYLRQILSALEYLHS 115
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANS 352
+VHRD+K NIL+DE+ K++DFGLA+ L G +TT V GT Y+APE
Sbjct: 116 K---GIVHRDLKPENILLDEDGHVKLADFGLARQLDPG-EKLTTFV-GTPEYMAPEVLLG 170
Query: 353 GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIET 412
+ D++S GV+L E +TG+ P G Q L + + P E
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGKPPF-PGDDQ--------LLELFKKIGKPKPPFPPPEW 221
Query: 413 RPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446
S A + L+ L DP +KR + ++
Sbjct: 222 DISPEA--KDLIRKLLVKDP--EKRLTAEEALQH 251
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 174 bits (444), Expect = 3e-51
Identities = 82/274 (29%), Positives = 129/274 (47%), Gaps = 34/274 (12%)
Query: 181 IIGDGGYGVVYRGQLMN-GTAVAVKKL---LNNPGQADKDFRVEVEAIGHVRHKNLVRLL 236
+G G +G VY+ + G VAVK L + R E+ + + H N+VRL+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARR-EIRILRRLSHPNIVRLI 64
Query: 237 GYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEP 296
+ LV EY G+L +L G L+ + KI L + L YLH
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYLS----RGGPLSEDEAKKIALQILRGLEYLHSN--- 117
Query: 297 KVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLN 356
++HRD+K NIL+DEN KI+DFGLAK L S +TT V GT Y+APE +L
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPE-----VLL 171
Query: 357 E------KSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNI 410
K DV+S GV+L E +TG+ P ++ ++ ++ +++ +
Sbjct: 172 GGNGYGPKVDVWSLGVILYELLTGKPPF---SGENILDQLQ----LIRRILGPPLEFDEP 224
Query: 411 ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVV 444
+ + K L+ +C++ D KRP +++
Sbjct: 225 KWSSGSEEAK-DLIK--KCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 173 bits (442), Expect = 7e-51
Identities = 81/278 (29%), Positives = 126/278 (45%), Gaps = 29/278 (10%)
Query: 177 SKDNIIGDGGYGVVYRGQL-----MNGTAVAVKKLLNN-PGQADKDFRVEVEAIGHVRHK 230
+ +G+G +G VY+G+L VAVK L + Q ++F E + + H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 231 NLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYL 290
N+V+LLG C E +V EY+ G+L +LR +R L+ + L A+ + YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRK---NRPKLSLSDLLSFALQIARGMEYL 118
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYA 350
+HRD+ + N L+ EN KISDFGL++ L + ++APE
Sbjct: 119 ESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESL 175
Query: 351 NSGLLNEKSDVYSFGVVLLEAITGRYPVDYG-RPQSEVNLVEWLKMMVQLRRSEDVVDPN 409
G KSDV+SFGV+L E T G +P ++ E L E + +
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFT------LGEQPYPGMSNEEVL---------EYLKNGY 220
Query: 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447
+P + L L+C D + RP S++V +L
Sbjct: 221 RLPQPPNCPPELYDL-MLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 171 bits (437), Expect = 3e-50
Identities = 80/278 (28%), Positives = 122/278 (43%), Gaps = 28/278 (10%)
Query: 177 SKDNIIGDGGYGVVYRGQL-----MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHK 230
+ +G+G +G VY+G L VAVK L + Q ++F E + + H
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 231 NLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYL 290
N+V+LLG C E ++V EY+ G+L +LR L+ + L A+ + YL
Sbjct: 62 NIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLR--KNRPKELSLSDLLSFALQIARGMEYL 119
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYA 350
+HRD+ + N L+ EN KISDFGL++ L + ++APE
Sbjct: 120 ESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESL 176
Query: 351 NSGLLNEKSDVYSFGVVLLEAITGRYPVDYG-RPQSEVNLVEWLKMMVQLRRSEDVVDPN 409
G KSDV+SFGV+L E T G P ++ E L E +
Sbjct: 177 KEGKFTSKSDVWSFGVLLWEIFT------LGEEPYPGMSNAEVL---------EYLKKGY 221
Query: 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447
+P + L L+C D + RP S++V +L
Sbjct: 222 RLPKPPNCPPELYKL-MLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 3e-47
Identities = 92/288 (31%), Positives = 132/288 (45%), Gaps = 45/288 (15%)
Query: 180 NIIGDGGYGVVYRGQLMNG----TAVAVKKLLNNPGQAD-KDFRVEVEAIGHVRHKNLVR 234
+G+G +G VY+G+L T VAVK L + + + KDF E + + H N+VR
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 235 LLGYCIEGTQRILVYEYVNNGNLEQWLR-----GDMCDRGYLTWEARMKILLGTAKALAY 289
LLG C E LV EY+ G+L +LR ++ L+ + + + AK + Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITT-------RVMGTF 342
L K VHRD+ + N L+ E+ KISDFGL++ + + R M
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM--- 174
Query: 343 GYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDY-GRPQSEVNLVEWLKMMVQLR 400
APE G+ KSDV+SFGV+L E T G P Y G EV +E+L+ +L
Sbjct: 175 ---APESLKDGIFTSKSDVWSFGVLLWEIFTLGATP--YPGLSNEEV--LEYLRKGYRLP 227
Query: 401 RSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448
+ E D E L C D + RP S++V LE
Sbjct: 228 KPEYCPDELYE-------------LMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 5e-47
Identities = 89/281 (31%), Positives = 130/281 (46%), Gaps = 32/281 (11%)
Query: 176 FSKDNIIGDGGYGVVYRGQLM-----NGTAVAVKKLLNNPGQADK-DFRVEVEAIGHVRH 229
+G+G +G VY+G L T VAVK L + ++ +F E + + H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
N+VRLLG C +G +V EY+ G+L +LR LT + +++ L AK + Y
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK---HGEKLTLKDLLQMALQIAKGMEY 117
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF--GYVAP 347
L VHRD+ + N L+ EN KISDFGL++ + + R G ++AP
Sbjct: 118 LESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDI-YEDDYYRKRGGGKLPIKWMAP 173
Query: 348 EYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVV 406
E G KSDV+SFGV+L E T G P G EV +E L+ +L R E+
Sbjct: 174 ESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPY-PGMSNEEV--LELLEDGYRLPRPEN-- 228
Query: 407 DPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447
L + L+C D + RP S++V L
Sbjct: 229 --------CPDELYELM---LQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 143 bits (364), Expect = 1e-39
Identities = 77/280 (27%), Positives = 127/280 (45%), Gaps = 39/280 (13%)
Query: 175 RFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKK--LLNNPGQADKDFRVEVEAIGHVRHKN 231
+++ ++G G +G VY G +AVK L + + + E+ + ++H N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 232 LVRLLGYCIEGTQR-ILVY-EYVNNGNLEQWLRG------DMCDRGYLTWEARMKILLGT 283
+VR G + + + ++ EYV+ G+L L+ + R Y R IL G
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVI-RKY----TRQ-ILEG- 113
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVM-GTF 342
LAYLH +VHRDIK +NIL+D + K++DFG AK LG ++ T + GT
Sbjct: 114 ---LAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTP 167
Query: 343 GYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRS 402
++APE +D++S G ++E TG+ P SE+ + ++ S
Sbjct: 168 YWMAPEVIRGEEYGRAADIWSLGCTVIEMATGK------PPWSELGNPMAA--LYKIGSS 219
Query: 403 EDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQ 442
+ P I S A + L +C+ D KRP +
Sbjct: 220 GEP--PEIPEHLSEEA--KDFL--RKCLRRDPKKRPTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 1e-35
Identities = 57/197 (28%), Positives = 99/197 (50%), Gaps = 9/197 (4%)
Query: 182 IGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCI 240
IG GG+G VY+ G VA+K + + + E++ + +H N+V+ G +
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 241 EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVH 300
+ + +V E+ + G+L+ L+ LT + K L YLH ++H
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIH 121
Query: 301 RDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSD 360
RDIK++NIL+ + + K+ DFGL+ L K+ T +GT ++APE N + K+D
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM--VGTPYWMAPEVINGKPYDYKAD 179
Query: 361 VYSFGVVLLEAITGRYP 377
++S G+ +E G+ P
Sbjct: 180 IWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 132 bits (331), Expect = 4e-34
Identities = 79/276 (28%), Positives = 127/276 (46%), Gaps = 23/276 (8%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKL---LNNPGQADKDFRVEVEAIGHVRH-KNLVRLLG 237
+G+G +G VY + + VA+K L L + + + F E++ + + H N+V+L
Sbjct: 8 LGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 238 YCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK 297
+ + LV EYV+ G+LE L+ +G L+ + IL AL YLH
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIG-RKGPLSESEALFILAQILSALEYLHSK---G 121
Query: 298 VVHRDIKSSNILIDEN-FDAKISDFGLAKLLGAGKSH-----ITTRVMGTFGYVAPEYAN 351
++HRDIK NIL+D + K+ DFGLAKLL S + + +GT GY+APE
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 352 SGLLNE---KSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408
L SD++S G+ L E +TG P + ++ + LK++++L
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFE--GEKNSSATSQTLKIILELPTPSLASPL 239
Query: 409 NIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVV 444
+ S LL + + D R S +
Sbjct: 240 SPSNPELISKAASDLLK--KLLAKDPKNRLSSSSDL 273
|
Length = 384 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 5e-33
Identities = 72/283 (25%), Positives = 133/283 (46%), Gaps = 39/283 (13%)
Query: 175 RFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL-LNNPGQADKDFRV-EVEAIGHVRHKN 231
++ IG G +G VY + +G +K++ L+N + +++ + EV+ + + H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
+++ E + +V EY + G+L Q ++ + E + + AL YLH
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPE--- 348
K++HRDIK NI + N K+ DFG++K+L + T V GT Y++PE
Sbjct: 121 SR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPELCQ 176
Query: 349 ---YANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV 405
Y N KSD++S G VL E T ++P + G E+ +++ + +
Sbjct: 177 NKPY------NYKSDIWSLGCVLYELCTLKHPFE-GENLLEL--------ALKILKGQ-- 219
Query: 406 VDPNIETRPSTSALKRALLTAL--RCVDPDSDKRPKMSQVVRM 446
P I ++ S+ L L + D ++RP ++Q+++
Sbjct: 220 YPP-IPSQYSSE------LRNLVSSLLQKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 72/208 (34%), Positives = 106/208 (50%), Gaps = 15/208 (7%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIE 241
IG G +G V G VAVK L ++ A F E + +RH NLV+LLG ++
Sbjct: 14 IGKGEFGDVMLGDYRGQK-VAVKCLKDDSTAAQA-FLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 242 GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHR 301
G +V EY+ G+L +LR R +T ++ L + + YL E VHR
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHR 126
Query: 302 DIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDV 361
D+ + N+L+ E+ AK+SDFGLAK A + + ++ + APE + KSDV
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKL--PVKWTAPEALREKKFSTKSDV 182
Query: 362 YSFGVVLLEAIT-GRYPVDYGR-PQSEV 387
+SFG++L E + GR P Y R P +V
Sbjct: 183 WSFGILLWEIYSFGRVP--YPRIPLKDV 208
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 9e-31
Identities = 65/212 (30%), Positives = 109/212 (51%), Gaps = 23/212 (10%)
Query: 175 RFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKK--LLNNPGQADKDFRVEVEAIGHVRHKN 231
+ ++IG G +GVVY+G L G VA+K+ L +A K E++ + +++H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRG------DMCDRGYLTWEARMKILLGTAK 285
+V+ +G ++ EY NG+L Q ++ + Y+ ++L G
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAV-YVY-----QVLQG--- 111
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYV 345
LAYLHE V+HRDIK++NIL ++ K++DFG+A L + V+GT ++
Sbjct: 112 -LAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS-VVGTPYWM 166
Query: 346 APEYANSGLLNEKSDVYSFGVVLLEAITGRYP 377
APE + SD++S G ++E +TG P
Sbjct: 167 APEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 1e-30
Identities = 87/292 (29%), Positives = 141/292 (48%), Gaps = 30/292 (10%)
Query: 164 FTLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEA 223
T+ D+ S+ ++N+I G G Y+G+ + V K +N+ + E+
Sbjct: 683 ITINDILSSLK---EENVISRGKKGASYKGKSIKNGMQFVVKEIND---VNSIPSSEIAD 736
Query: 224 IGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGT 283
+G ++H N+V+L+G C L++EY+ NL + LR L+WE R KI +G
Sbjct: 737 MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGI 789
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
AKAL +LH P VV ++ I+ID + + L LL T+ +
Sbjct: 790 AKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC-----TDTKCFISSA 843
Query: 344 YVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVN--LVEWLKMMVQLRR 401
YVAPE + + EKSD+Y FG++L+E +TG+ P D + V+ +VEW +
Sbjct: 844 YVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD---AEFGVHGSIVEWARYCYSDCH 900
Query: 402 SEDVVDPNIETRPSTSALKRALLT----ALRCVDPDSDKRPKMSQVVRMLES 449
+ +DP+I R S + ++ AL C D RP + V++ LES
Sbjct: 901 LDMWIDPSI--RGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 1e-30
Identities = 71/200 (35%), Positives = 102/200 (51%), Gaps = 13/200 (6%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQAD-KDFRVEVEAIGHVRHKNLVRLLGYCI 240
+G G +G V+ G T VAVK L PG + F E + + +RH LV+L C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTL--KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 241 EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVH 300
E +V EY++ G+L +L+ + L + + A+ +AYL +H
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIH 126
Query: 301 RDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF--GYVAPEYANSGLLNEK 358
RD+ + NIL+ EN KI+DFGLA+L+ T R F + APE AN G K
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLI--EDDEYTAREGAKFPIKWTAPEAANYGRFTIK 184
Query: 359 SDVYSFGVVLLEAIT-GRYP 377
SDV+SFG++L E +T GR P
Sbjct: 185 SDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 6e-30
Identities = 83/278 (29%), Positives = 131/278 (47%), Gaps = 41/278 (14%)
Query: 181 IIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYC 239
++G G YG+VY + L +A+K++ + + E+ +++H+N+V+ LG
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD 74
Query: 240 IEGTQRILVYEYVNNGNLEQWLR---GDMCDRGYLTWEARMK-----ILLGTAKALAYLH 291
E + E V G+L LR G + D E + IL G L YLH
Sbjct: 75 SENGFFKIFMEQVPGGSLSALLRSKWGPLKDN-----EQTIIFYTKQILEG----LKYLH 125
Query: 292 EAIEPKVVHRDIKSSNILIDENFDA-KISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYA 350
+ ++VHRDIK N+L++ KISDFG +K L AG + T GT Y+APE
Sbjct: 126 DN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL-AGINPCTETFTGTLQYMAPEVI 181
Query: 351 NSGL--LNEKSDVYSFGVVLLEAITGRYP-VDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407
+ G +D++S G ++E TG+ P ++ G PQ+ + V K +
Sbjct: 182 DKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK-----------IH 230
Query: 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVR 445
P I S SA + + LRC +PD DKR +++
Sbjct: 231 PEIPE--SLSAEAKNFI--LRCFEPDPDKRASAHDLLQ 264
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 9e-30
Identities = 88/284 (30%), Positives = 140/284 (49%), Gaps = 43/284 (15%)
Query: 179 DNIIGDGGYGVVYRGQL-MNG---TAVAVKKLLNNPGQADK---DFRVEVEAIGHVRHKN 231
+ +IG G +G V RG+L + G VA+K L G +DK DF E +G H N
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTL--KAGSSDKQRLDFLTEASIMGQFDHPN 66
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
++RL G + +++ EY+ NG+L+++LR + G T + +L G A + YL
Sbjct: 67 IIRLEGVVTKSRPVMIITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLS 123
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG------YV 345
E VHRD+ + NIL++ N K+SDFGL++ L ++ TT+ G +
Sbjct: 124 EM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK-----GGKIPIRWT 175
Query: 346 APEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYG-RPQSEVNLVEWLKMMVQLRRSED 404
APE SDV+SFG+V+ E ++ YG RP +++ + +K + R
Sbjct: 176 APEAIAYRKFTSASDVWSFGIVMWEVMS------YGERPYWDMSNQDVIKAVEDGYRLPP 229
Query: 405 VVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448
+D SAL + +L C D ++RP SQ+V L+
Sbjct: 230 PMD-------CPSALYQLMLD---CWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 3e-29
Identities = 77/266 (28%), Positives = 126/266 (47%), Gaps = 35/266 (13%)
Query: 176 FSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKL-LNNPGQADKDFRV-EVEAIGHVRHKNL 232
F N IG G +GVV++ + + A+K++ L+ + +++ + E + + +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDR--GYLTWEARMKILLGTAKALAYL 290
+R ++ + +V EY NG+L + L+ W ++ILLG LA+L
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG----LAHL 117
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYA 350
H K++HRDIKS N+ +D + KI D G+AKLL ++ ++GT Y++PE
Sbjct: 118 HSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD-NTNFANTIVGTPYYLSPELC 173
Query: 351 NSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMM-------------- 396
NEKSDV++ GVVL E TG++P D ++ L+ LK++
Sbjct: 174 EDKPYNEKSDVWALGVVLYECCTGKHPFD---ANNQGALI--LKIIRGVFPPVSQMYSQQ 228
Query: 397 -VQLRRSEDVVDPNIETRPSTSALKR 421
QL D RP T L R
Sbjct: 229 LAQLIDQCLTKDYR--QRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-28
Identities = 64/207 (30%), Positives = 109/207 (52%), Gaps = 9/207 (4%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIE 241
IG G +G+V+ G + VA+K + +++DF E + + + H LV+L G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 242 GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHR 301
+ LV+E++ +G L +LR RG + E + + L + +AYL + V+HR
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESS---NVIHR 124
Query: 302 DIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDV 361
D+ + N L+ EN K+SDFG+ + + + +T + +PE + + KSDV
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDV 184
Query: 362 YSFGVVLLEAIT-GRYPVDYGRPQSEV 387
+SFGV++ E + G+ P + R SEV
Sbjct: 185 WSFGVLMWEVFSEGKTPYE-NRSNSEV 210
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 74/273 (27%), Positives = 122/273 (44%), Gaps = 41/273 (15%)
Query: 182 IGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFR----VEVEAIGHVRHKNLVRLL 236
+G G GVVY+ + G A+KK+ D++FR E++ + +V+
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKI---HVDGDEEFRKQLLRELKTLRSCESPYVVKCY 65
Query: 237 G-YCIEGTQRILVYEYVNNGNLEQWLRGD------MCDRGYLTWEARMKILLGTAKALAY 289
G + EG I V EY++ G+L L+ + Y+ +IL G L Y
Sbjct: 66 GAFYKEGEISI-VLEYMDGGSLADLLKKVGKIPEPVL--AYIAR----QILKG----LDY 114
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEY 349
LH + ++HRDIK SN+LI+ + KI+DFG++K+L T V GT Y++PE
Sbjct: 115 LHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPER 171
Query: 350 ANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409
+ +D++S G+ LLE G++P + ++M + P
Sbjct: 172 IQGESYSYAADIWSLGLTLLECALGKFPF------LPPGQPSFFELMQAICDGPPPSLPA 225
Query: 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQ 442
E P R ++ C+ D KRP ++
Sbjct: 226 EEFSPEF----RDFIS--ACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 8e-28
Identities = 72/242 (29%), Positives = 112/242 (46%), Gaps = 25/242 (10%)
Query: 182 IGDGGYGVVYRGQLMNG------TAVAVKKLLN-NPGQADKDFRVEVEAIGHVRHKNLVR 234
+G+G +G V+ G+ + VAVK L A KDF E E + + +H+N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 235 LLGYCIEGTQRILVYEYVNNGNLEQWLR----------GDMCDRGYLTWEARMKILLGTA 284
G C EG I+V+EY+ +G+L ++LR G LT ++I + A
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK-LLGAGKSHITTRVMGTFG 343
+ YL VHRD+ + N L+ + KI DFG+++ + + M
Sbjct: 133 SGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 344 YVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRS 402
++ PE +SDV+SFGVVL E T G+ P YG EV +E + L+R
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPW-YGLSNEEV--IECITQGRLLQRP 246
Query: 403 ED 404
Sbjct: 247 RT 248
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 1e-27
Identities = 68/201 (33%), Positives = 101/201 (50%), Gaps = 15/201 (7%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQAD-KDFRVEVEAIGHVRHKNLVRLLGYCI 240
+G G +G V+ G N T VAVK L PG D KDF E + + +RH L++L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTL--KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 241 EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVH 300
+V E + G+L ++L+G L + + A +AYL +H
Sbjct: 72 LEEPIYIVTELMKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEAQ---NYIH 126
Query: 301 RDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT---FGYVAPEYANSGLLNE 357
RD+ + N+L+ EN K++DFGLA+++ K I G + APE A +
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVI---KEDIYEAREGAKFPIKWTAPEAALYNRFSI 183
Query: 358 KSDVYSFGVVLLEAIT-GRYP 377
KSDV+SFG++L E +T GR P
Sbjct: 184 KSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 65/203 (32%), Positives = 112/203 (55%), Gaps = 7/203 (3%)
Query: 176 FSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRL 235
F+ + +G G +G V+ G N VA+K L ++ +DF+ EV+A+ +RHK+L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 236 LGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIE 295
C G ++ E + G+L +LR + L + + + A+ +AYL E
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ-- 123
Query: 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLL 355
+HRD+ + NIL+ E+ K++DFGLA+L+ ++++ + + APE A+ G
Sbjct: 124 -NSIHRDLAARNILVGEDLVCKVADFGLARLI-KEDVYLSSDKKIPYKWTAPEAASHGTF 181
Query: 356 NEKSDVYSFGVVLLEAIT-GRYP 377
+ KSDV+SFG++L E T G+ P
Sbjct: 182 STKSDVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 9e-27
Identities = 68/205 (33%), Positives = 105/205 (51%), Gaps = 8/205 (3%)
Query: 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLN--NPGQADKDFRV-EVEAIGHVRHKNLVRLL 236
IG G +G V + + + + V K ++ N + +K V EV + ++H N+VR
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 237 GYCIEGTQRIL--VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI 294
I+ + + L V EY G+L Q ++ +R Y+ E +IL AL H
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125
Query: 295 EPK--VVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANS 352
+P V+HRD+K +NI +D N + K+ DFGLAK+LG S T V GT Y++PE N
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQLNH 184
Query: 353 GLLNEKSDVYSFGVVLLEAITGRYP 377
+EKSD++S G ++ E P
Sbjct: 185 MSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 74/235 (31%), Positives = 112/235 (47%), Gaps = 31/235 (13%)
Query: 175 RFSKDNIIGDGGYGVVYRGQLMN-----GTAVAVKKL-LNNPGQADKDFRVEVEAIGHVR 228
+F K +G+G +G V + G VAVK L + Q DF E+E + +
Sbjct: 7 KFIKQ--LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD 64
Query: 229 HKNLVRLLGYCIEGTQRI--LVYEYVNNGNLEQWLRG--DMCDRGYLTWEARMKILLGTA 284
H+N+V+ G C + R L+ EY+ +G+L +L+ D + L +
Sbjct: 65 HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRL-----LLFSSQIC 119
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMG---T 341
K + YL + +HRD+ + NIL++ KISDFGLAK+L K + + G
Sbjct: 120 KGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPI 176
Query: 342 FGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMM 396
F Y APE + + SDV+SFGV L E T YG P S+ E+L+M+
Sbjct: 177 FWY-APECLRTSKFSSASDVWSFGVTLYELFT------YGDP-SQSPPAEFLRMI 223
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 6e-26
Identities = 68/217 (31%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 175 RFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKN 231
R+ + N IG G +G VY L G +AVK++ K+ E++ + ++H N
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPN 60
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRG-----DMCDRGYLTWEARMKILLGTAKA 286
LV+ G + + + EY + G LE+ L + R Y LL +
Sbjct: 61 LVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVY------TLQLL---EG 111
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRV---MGTFG 343
LAYLH +VHRDIK +NI +D N K+ DFG A L + + V GT
Sbjct: 112 LAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPA 168
Query: 344 YVAPEYANSGLLNEK---SDVYSFGVVLLEAITGRYP 377
Y+APE G +D++S G V+LE TG+ P
Sbjct: 169 YMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 7e-26
Identities = 85/285 (29%), Positives = 139/285 (48%), Gaps = 34/285 (11%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQL-MNG---TAVAVKKLLNNPGQADK---DFRVEVEAIGH 226
+ +K +IG G +G V+RG L M G AVA+K L PG +K DF E +G
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTL--KPGYTEKQRQDFLSEASIMGQ 62
Query: 227 VRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKA 286
H N++RL G + +++ EY+ NG L+++LR G + + +L G A
Sbjct: 63 FSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAG 119
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG--Y 344
+ YL + VHRD+ + NIL++ N + K+SDFGL+++L T G +
Sbjct: 120 MKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRW 176
Query: 345 VAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYG-RPQSEVNLVEWLKMMVQLRRSE 403
APE SDV+SFG+V+ E ++ +G RP +++ E +K + R
Sbjct: 177 TAPEAIAYRKFTSASDVWSFGIVMWEVMS------FGERPYWDMSNHEVMKAINDGFRLP 230
Query: 404 DVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448
+D SA+ + + L+C D +RP+ +V +L+
Sbjct: 231 APMD-------CPSAVYQLM---LQCWQQDRARRPRFVDIVNLLD 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 8e-26
Identities = 68/214 (31%), Positives = 105/214 (49%), Gaps = 32/214 (14%)
Query: 176 FSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNN------PGQADKDFRVEVEAIGHVR 228
+ K +G+G YGVVY+ + G VA+KK+ + P A R E+ + ++
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA---LR-EISLLKELK 56
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEAR--MKILLGTAKA 286
H N+V+LL + LV+EY + +L+++L D + M LL +
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYL--DKRPGPLSPNLIKSIMYQLL---RG 110
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVA 346
LAY H +++HRD+K NILI+ + K++DFGLA+ G T V+ T Y A
Sbjct: 111 LAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRA 166
Query: 347 PEYANSGLLNEKS-----DVYSFGVVLLEAITGR 375
PE LL K D++S G + E ITG+
Sbjct: 167 PEI----LLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 80/276 (28%), Positives = 119/276 (43%), Gaps = 36/276 (13%)
Query: 182 IGDGGYGVVYRG--QLMNGT--AVAVKKLLNNPGQADKD-FRVEVEAIGHVRHKNLVRLL 236
+G G +G V +G + +G VAVK L A K F E + + H +VRL+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 237 GYCIEGTQRILVYEYVNNGNLEQWL--RGDMCDRGYLTWEARMKILLGTAKALAYLHEAI 294
G C +G +LV E G L ++L R ++ A +AYL
Sbjct: 63 GVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLESK- 114
Query: 295 EPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF--GYVAPEYANS 352
VHRD+ + N+L+ AKISDFG+++ LGAG + G + + APE N
Sbjct: 115 --HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 353 GLLNEKSDVYSFGVVLLEAITGRYPVDYG-RPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411
G + KSDV+S+GV L EA + YG +P E+ E + M+ R P E
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFS------YGAKPYGEMKGAEVIAMLESGERLP---RPE-E 222
Query: 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447
++ L C + RP S++
Sbjct: 223 CPQEIYSI------MLSCWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 62/228 (27%), Positives = 100/228 (43%), Gaps = 45/228 (19%)
Query: 181 IIGDGGYGVVYRGQLM-NGTAVAVK----KLLNNPGQADKDFRVEVEAIGHV-RHKNLVR 234
IIG+G + V + A+K + L + E E + + H +++
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKI-EKEVLTRLNGHPGIIK 66
Query: 235 LLGYCIEGTQRI-LVYEYVNNGNLEQWLR-----GDMCDRGYLTWEARMKILLGTAKALA 288
L Y + + + V EY NG L Q++R + C R Y +ILL AL
Sbjct: 67 LY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAA-----EILL----ALE 116
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVM--------- 339
YLH ++HRD+K NIL+D++ KI+DFG AK+L S + +
Sbjct: 117 YLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 340 ----------GTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYP 377
GT YV+PE N + SD+++ G ++ + +TG+ P
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 74/283 (26%), Positives = 131/283 (46%), Gaps = 39/283 (13%)
Query: 175 RFSKDNIIGDGGYGVVYRGQLM-----NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVR 228
K ++G G +G VY+G + VA+K L +A+K+ E + V
Sbjct: 8 ELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD 67
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLR---GDMCDRGYLTWEARMKILLGTAK 285
H ++VRLLG C+ +Q L+ + + G L ++R ++ + L W ++ AK
Sbjct: 68 HPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AK 120
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGY 344
++YL E ++VHRD+ + N+L+ KI+DFGLAKLL + +
Sbjct: 121 GMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKW 177
Query: 345 VAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEV-NLVEWLKMMVQLRRS 402
+A E + KSDV+S+GV + E +T G P + G P E+ +L+E +
Sbjct: 178 MALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYE-GIPAVEIPDLLE---------KG 227
Query: 403 EDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVR 445
E + +P + + ++C D++ RP +++
Sbjct: 228 ERL------PQPPICTID-VYMVLVKCWMIDAESRPTFKELIN 263
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 85/274 (31%), Positives = 133/274 (48%), Gaps = 36/274 (13%)
Query: 181 IIGDGGYGVVYRGQLMNGTAVAVKKL-LNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYC 239
IIG+G +G V +G+ G VAVK + + QA F E + + HKNLVRLLG
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68
Query: 240 IEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVV 299
+ I V E ++ GNL +LR R ++ ++ L A+ + YL K+V
Sbjct: 69 LHNGLYI-VMELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLV 122
Query: 300 HRDIKSSNILIDENFDAKISDFGLAKL--LGAGKSHITTRVMGTFGYVAPEYANSGLLNE 357
HRD+ + NIL+ E+ AK+SDFGLA++ +G S + + + APE +
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHKKFSS 176
Query: 358 KSDVYSFGVVLLEAITGRYPVDYGR-PQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPST 416
KSDV+S+GV+L E + YGR P +++L E + + + R ++P
Sbjct: 177 KSDVWSYGVLLWEVFS------YGRAPYPKMSLKEVKECVEKGYR----MEPPEGCPADV 226
Query: 417 SALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450
L + C + + KRP ++ LE E
Sbjct: 227 YVLMTS------CWETEPKKRPSFHKLREKLEKE 254
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-25
Identities = 74/265 (27%), Positives = 119/265 (44%), Gaps = 42/265 (15%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIE 241
+G G +GVV+ G+ VA+K ++ ++ DF E + + + H NLV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIK-MIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 242 GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTA----KALAYLHEAIEPK 297
+V EY+ NG L +LR +G L + LL +A+ YL
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRE---RKGKL----GTEWLLDMCSDVCEAMEYLESN---G 120
Query: 298 VVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG------YVAPEYAN 351
+HRD+ + N L+ E+ K+SDFGLA+ + + + + G + PE +
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYV------LDDQYTSSQGTKFPVKWAPPEVFD 174
Query: 352 SGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRR----SEDVV 406
+ KSDV+SFGV++ E + G+ P + SEV VE + +L R +V
Sbjct: 175 YSRFSSKSDVWSFGVLMWEVFSEGKMPYE-RFSNSEV--VESVSAGYRLYRPKLAPTEVY 231
Query: 407 D-------PNIETRPSTSALKRALL 424
E RP+ L L
Sbjct: 232 TIMYSCWHEKPEDRPAFKKLLSQLT 256
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-25
Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVKKLL---NNPGQADKDFRVEVEAIGHVRHKNLVRLLG 237
IG+G YGVVY+ + + G VA+KK+ + G R E++ + + H N+++LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALR-EIKLLKELNHPNIIKLLD 65
Query: 238 YCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-ILLGTAKALAYLHEAIEP 296
LV+E+++ +L + ++ DR E+ +K L + LA+ H
Sbjct: 66 VFRHKGDLYLVFEFMDT-DLYKLIK----DRQRGLPESLIKSYLYQLLQGLAFCHSH--- 117
Query: 297 KVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPE-YANSGLL 355
++HRD+K N+LI+ K++DFGLA+ G T + T Y APE
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARSFG-SPVRPYTHYVVTRWYRAPELLLGDKGY 176
Query: 356 NEKSDVYSFGVVLLEAITGR 375
+ D++S G + E ++ R
Sbjct: 177 STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 7e-25
Identities = 68/219 (31%), Positives = 109/219 (49%), Gaps = 31/219 (14%)
Query: 175 RFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLL-NNPGQADKDFRVEVEAIGHV 227
RF ++ +G+G +G VY+G+L + T+VA+K L N + ++FR E E + +
Sbjct: 8 RFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL 65
Query: 228 RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWL--RGDMCDRGYLTWEARMKILLGTAK 285
+H N+V LLG C + +++EY+ +G+L ++L D G + + +K L
Sbjct: 66 QHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSL---D 122
Query: 286 ALAYLHEAIE----------PKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHIT 335
+LH AI+ VHRD+ + N L+ E KISDFGL++ S
Sbjct: 123 CSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRD---IYSADY 179
Query: 336 TRVMGT----FGYVAPEYANSGLLNEKSDVYSFGVVLLE 370
RV ++ PE G +SD++SFGVVL E
Sbjct: 180 YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWE 218
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 23/212 (10%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQADKDFRV----EVEAIGHVR 228
N++ ++G+G YGVV + + G VA+KK + D+D + EV+ + +R
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED--DEDVKKTALREVKVLRQLR 58
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALA 288
H+N+V L + LV+EYV LE G L +A + +A+A
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEA----SPGGLPPDAVRSYIWQLLQAIA 114
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPE 348
Y H ++HRDIK NIL+ E+ K+ DFG A+ L A + T + T Y APE
Sbjct: 115 YCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPE 171
Query: 349 YANSGLLNEKS-----DVYSFGVVLLEAITGR 375
L+ + + DV++ G ++ E + G
Sbjct: 172 L----LVGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 62/218 (28%), Positives = 108/218 (49%), Gaps = 10/218 (4%)
Query: 175 RFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL-LNNPGQADKDFRV-EVEAIGHVRHKN 231
F +G G YG VY+ + L + A+K++ L + Q +++ V E+ + V H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
++ ++G + +V EY G+L + + R + + +I + + L LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYAN 351
E K++HRD+KS+NIL+ N KI D G++K+L K ++ +GT Y+APE
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMAKTQIGTPHYMAPEVWK 174
Query: 352 SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNL 389
+ KSD++S G +L E T P + R ++
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPFE-ARSMQDLRY 211
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 3e-24
Identities = 73/281 (25%), Positives = 126/281 (44%), Gaps = 32/281 (11%)
Query: 165 TLRDLQSATNRFSK-DNI--IGDGGYGVVYRG-QLMNGTAVAVKKL-LNNPGQADKDFRV 219
L+D+ S + N+ IG+G G VY+ G VA+KK+ L Q +
Sbjct: 7 ALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK--QNKELIIN 64
Query: 220 EVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK- 278
E+ + +H N+V + G + +V EY++ G+L + + + E ++
Sbjct: 65 EILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIIT---QNFVRMN-EPQIAY 120
Query: 279 ILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRV 338
+ + L YLH V+HRDIKS NIL+ ++ K++DFG A L KS + V
Sbjct: 121 VCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV 177
Query: 339 MGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYP-VDYGRPQSEVNLVEWLKMMV 397
GT ++APE K D++S G++ +E G P + P L+ +
Sbjct: 178 -GTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE-PP---------LRALF 226
Query: 398 QLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRP 438
+ ++ + P ++ S + L +C+ D +KRP
Sbjct: 227 LI-TTKGI--PPLKNPEKWSPEFKDFLN--KCLVKDPEKRP 262
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 99.6 bits (249), Expect = 1e-23
Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 10/203 (4%)
Query: 176 FSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVR 234
F +G+G YG VY+ G VA+K + ++ E+ + +V+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62
Query: 235 LLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI 294
G + T +V EY G++ ++ + ++ LT E IL T K L YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMK--ITNKT-LTEEEIAAILYQTLKGLEYLHSN- 118
Query: 295 EPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGL 354
K +HRDIK+ NIL++E AK++DFG++ L + T V+GT ++APE
Sbjct: 119 --KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQEIG 175
Query: 355 LNEKSDVYSFGVVLLEAITGRYP 377
N K+D++S G+ +E G+ P
Sbjct: 176 YNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 2e-23
Identities = 67/219 (30%), Positives = 101/219 (46%), Gaps = 34/219 (15%)
Query: 175 RFSKDNIIGDGGYGVVYRG-QLMNGTAVAVK--KLLNNPGQAD---KDFRVEVEAIGHVR 228
R+ K ++G G +G VY G L +G AVK L ++ K E+ + ++
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEA-RM---KILLGTA 284
H N+V+ LG E + E V G+L + L+ G R+ +ILLG
Sbjct: 61 HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLK----KYGSFPEPVIRLYTRQILLG-- 114
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVM----- 339
L YLH+ VHRDIK +NIL+D N K++DFG+AK +
Sbjct: 115 --LEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAK-------QVVEFSFAKSFK 162
Query: 340 GTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYP 377
G+ ++APE G +D++S G +LE TG+ P
Sbjct: 163 GSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.7 bits (247), Expect = 2e-23
Identities = 73/270 (27%), Positives = 111/270 (41%), Gaps = 55/270 (20%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGH----------VRHK 230
+G G +G V + G A+K L K ++ + + H + H
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVL-------KKKKIIKRKEVEHTLTERNILSRINHP 53
Query: 231 NLVRLLGYCIEGTQR--ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLGT 283
+V+L Y + T+ LV EY G L L G + E R + I+L
Sbjct: 54 FIVKLH-YAFQ-TEEKLYLVLEYAPGGELFSHLS----KEGRFS-EERARFYAAEIVL-- 104
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
AL YLH +++RD+K NIL+D + K++DFGLAK L + S T GT
Sbjct: 105 --ALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPE 158
Query: 344 YVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSE 403
Y+APE + D +S GV+L E +TG+ P Y + K + + +
Sbjct: 159 YLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPF-YAEDR---------KEIYEKILKD 208
Query: 404 DVVDPNIETRPSTSALKRALLTALRCVDPD 433
+ P S R L++ L DP
Sbjct: 209 PLRFP-----EFLSPEARDLISGLLQKDPT 233
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 2e-23
Identities = 84/305 (27%), Positives = 130/305 (42%), Gaps = 61/305 (20%)
Query: 176 FSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKD-FRV----EVEAIGHVRH 229
+ K IG+G YG VY+ + G VA+KK+ + +K+ F + E++ + +RH
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKI---RMENEKEGFPITAIREIKLLQKLRH 57
Query: 230 KNLVRLLGYCIE--GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEAR----MKILLGT 283
N+VRL +V+EY ++ L G + E++ MK LL
Sbjct: 58 PNIVRLKEIVTSKGKGSIYMVFEY-----MDHDLTGLLDSPEVKFTESQIKCYMKQLL-- 110
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL-GAGKSHITTRVMGTF 342
+ L YLH ++HRDIK SNILI+ + K++DFGLA+ + T RV+ T
Sbjct: 111 -EGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TL 165
Query: 343 GYVAPEYANSGLLNEKS-----DVYSFGVVLLEAITGRYPVDYGR--------------- 382
Y PE LL D++S G +L E G+ P+ G
Sbjct: 166 WYRPPEL----LLGATRYGPEVDMWSVGCILAELFLGK-PIFQGSTELEQLEKIFELCGS 220
Query: 383 PQSE----VNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRP 438
P E V+ + W + + + + + + SAL LL L +DP KR
Sbjct: 221 PTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALD--LLDKLLTLDP--KKRI 276
Query: 439 KMSQV 443
Q
Sbjct: 277 SADQA 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 2e-23
Identities = 66/218 (30%), Positives = 107/218 (49%), Gaps = 28/218 (12%)
Query: 176 FSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLL---NNPGQADKDFRV---EVEAIGHVRH 229
++K ++G G YG VY G G +AVK++ +N A+K++ EV+ + ++H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRG-----DMCDRGYLTWEARMKILLGTA 284
N+V+ LG C++ + E+V G++ L + Y +IL G
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-----QILDG-- 114
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG-----AGKSHITTRVM 339
+AYLH VVHRDIK +N+++ N K+ DFG A+ L S++ +
Sbjct: 115 --VAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH 169
Query: 340 GTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYP 377
GT ++APE N KSD++S G + E TG+ P
Sbjct: 170 GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 3e-23
Identities = 75/272 (27%), Positives = 125/272 (45%), Gaps = 21/272 (7%)
Query: 180 NIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQAD-KDFRVEVEAIGHVRHKNLVRLLG 237
+IG G VVY L N VA+K++ Q + R EV+A+ H N+V+
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYT 66
Query: 238 YCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK 297
+ G + LV Y++ G+L ++ RG L +L K L YLH
Sbjct: 67 SFVVGDELWLVMPYLSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSN---G 122
Query: 298 VVHRDIKSSNILIDENFDAKISDFGL-AKLLGAGKSHITTR--VMGTFGYVAPEYANSGL 354
+HRDIK+ NIL+ E+ KI+DFG+ A L G R +GT ++APE
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182
Query: 355 -LNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETR 413
+ K+D++SFG+ +E TG P P +V +M+ L+ ++ + +
Sbjct: 183 GYDFKADIWSFGITAIELATGAAPY-SKYPPMKV-------LMLTLQNDPPSLETGADYK 234
Query: 414 PSTSALKRALLTALRCVDPDSDKRPKMSQVVR 445
+ + ++ + C+ D KRP ++++
Sbjct: 235 KYSKSFRKMISL---CLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 3e-23
Identities = 64/208 (30%), Positives = 106/208 (50%), Gaps = 15/208 (7%)
Query: 176 FSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKL-LNNPGQADKDFRVEVEAIGHVRH---K 230
+ + +IG G YG VYRG + G VA+K + L+ P D + EV + +R
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 231 NLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYL 290
N+ + G ++G + ++ EY G++ ++ Y++ I+ AL Y+
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYIS-----VIIREVLVALKYI 117
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYA 350
H+ V+HRDIK++NIL+ + K+ DFG+A LL S +T V GT ++APE
Sbjct: 118 HKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVI 173
Query: 351 NSG-LLNEKSDVYSFGVVLLEAITGRYP 377
G + K+D++S G+ + E TG P
Sbjct: 174 TEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.0 bits (247), Expect = 3e-23
Identities = 63/212 (29%), Positives = 96/212 (45%), Gaps = 29/212 (13%)
Query: 182 IGDGGYGVVYRGQLMN------GTAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKNLVR 234
+G G +G+VY G T VA+K + N ++ +F E + ++VR
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 235 LLGYCIEGTQRILVYEYVNNGNLEQWLRGDM------CDRGYLTWEARMKILLGTAKALA 288
LLG G ++V E + G+L+ +LR G T + +++ A +A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL-------GAGKSHITTRVMGT 341
YL K VHRD+ + N ++ E+ KI DFG+ + + GK + R M
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-- 188
Query: 342 FGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT 373
APE G+ KSDV+SFGVVL E T
Sbjct: 189 ----APESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 6e-23
Identities = 65/202 (32%), Positives = 99/202 (49%), Gaps = 22/202 (10%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKNLVRLLGYCI 240
IG G +G VY+G L T VAVK + K F E E + H N+V+L+G C+
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV 62
Query: 241 EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK-VV 299
+ +V E V G+L +LR + LT + +++ L A + YL E K +
Sbjct: 63 QKQPIYIVMELVPGGSLLTFLRKK---KNRLTVKKLLQMSLDAAAGMEYL----ESKNCI 115
Query: 300 HRDIKSSNILIDENFDAKISDFGLAK-------LLGAGKSHITTRVMGTFGYVAPEYANS 352
HRD+ + N L+ EN KISDFG+++ + G I + + APE N
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIK------WTAPEALNY 169
Query: 353 GLLNEKSDVYSFGVVLLEAITG 374
G +SDV+S+G++L E +
Sbjct: 170 GRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 1e-22
Identities = 64/198 (32%), Positives = 101/198 (51%), Gaps = 21/198 (10%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCI 240
IG G YG VY+ + + G VA+K + PG + + E+ + RH N+V G +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 241 EGTQRILVYEYVNNGNLE---QWLRGDMCDR--GYLTWEARMKILLGTAKALAYLHEAIE 295
+ +V EY G+L+ Q RG + + Y+ E L G LAYLHE
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRET----LKG----LAYLHET-- 120
Query: 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYAN---S 352
+HRDIK +NIL+ E+ D K++DFG++ L A + + + GT ++APE A
Sbjct: 121 -GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVERK 178
Query: 353 GLLNEKSDVYSFGVVLLE 370
G + K D+++ G+ +E
Sbjct: 179 GGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 1e-22
Identities = 76/282 (26%), Positives = 118/282 (41%), Gaps = 45/282 (15%)
Query: 182 IGDGGYGVVYRGQLMNGTA----VAVKKLL-NNPGQADKDFRVEVEAIGHVRHKNLVRLL 236
+GDG +GVV RG+ VAVK L + DF E + + H+NL+RL
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 237 GYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLT--WEARMKILLGTAKALAYLHEA 293
G + T + +V E G+L LR D ++ + ++I A + YL
Sbjct: 63 GVVL--THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQI----ANGMRYLESK 116
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITT----RVMGTFGYVAPEY 349
+ +HRD+ + NIL+ + KI DFGL + L + H +V F + APE
Sbjct: 117 ---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPES 171
Query: 350 ANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGR-PQSEVNLVEWLKMMVQLRRSEDVVDP 408
+ + SDV+ FGV L E T YG P + ++ + LK +D
Sbjct: 172 LRTRTFSHASDVWMFGVTLWEMFT------YGEEPWAGLSGSQILKK----------IDK 215
Query: 409 NIE--TRPSTSALK-RALLTALRCVDPDSDKRPKMSQVVRML 447
E RP ++ L+C + RP + + L
Sbjct: 216 EGERLERPEACPQDIYNVM--LQCWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 2e-22
Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 30/210 (14%)
Query: 182 IGDGGYGVVYR------GQLMNGTAVAVKKLLNNPGQA-DKDFRVEVEAIGHVRHKNLVR 234
+G G GVV + G++M AVK + +A K E++ + +V
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIM-----AVKTIRLEINEAIQKQILRELDILHKCNSPYIVG 63
Query: 235 LLGYCIEGTQRILVYEYVNNGNLEQWLR---GDMCDRGYLTWEARMKILLGTAKALAYLH 291
G + EY++ G+L++ L+ G + +R L KI + K L YLH
Sbjct: 64 FYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPER-ILG-----KIAVAVLKGLTYLH 117
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL--GAGKSHITTRVMGTFGYVAPEY 349
E K++HRD+K SNIL++ K+ DFG++ L K+ + GT Y+APE
Sbjct: 118 EKH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV-----GTSSYMAPER 170
Query: 350 ANSGLLNEKSDVYSFGVVLLEAITGRYPVD 379
+ KSD++S G+ L+E TGR+P
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGRFPYP 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 3e-22
Identities = 82/284 (28%), Positives = 130/284 (45%), Gaps = 44/284 (15%)
Query: 175 RFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKD----------FRVEVEA 223
++ K +IG G YG VY + G +AVK++ A + R E+E
Sbjct: 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIET 61
Query: 224 IGHVRHKNLVRLLGYCIEGTQRIL--VYEYVNNGNLEQWLRGDMCDRGYLTWEARM--KI 279
+ + H N+V+ LG+ E T+ L EYV G++ C R Y +E ++
Sbjct: 62 LKDLDHLNIVQYLGF--ETTEEYLSIFLEYVPGGSIGS------CLRTYGRFEEQLVRFF 113
Query: 280 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVM 339
+ LAYLH ++HRD+K+ N+L+D + KISDFG++K + M
Sbjct: 114 TEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSM 170
Query: 340 -GTFGYVAPEYANSGL--LNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMM 396
G+ ++APE +S + K D++S G V+LE GR RP S+ E + M
Sbjct: 171 QGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR------RPWSD---EEAIAAM 221
Query: 397 VQL--RRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRP 438
+L +RS + P + + S + L A C + D RP
Sbjct: 222 FKLGNKRSAPPIPP--DVSMNLSPVALDFLNA--CFTINPDNRP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 3e-22
Identities = 60/206 (29%), Positives = 105/206 (50%), Gaps = 27/206 (13%)
Query: 182 IGDGGYGVVYR-GQLMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVRHKNLVRLLG 237
IG+G +G+V++ G VA+KK+ G ++ R E++A+ +H +V+LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALR-EIKALQACQHPYVVKLLD 66
Query: 238 YCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEAR--MKILLGTAKALAYLHEAIE 295
G+ +LV EY+ + L + LR +R + + M++LL K +AY+H
Sbjct: 67 VFPHGSGFVLVMEYMPSD-LSEVLRD--EERPLPEAQVKSYMRMLL---KGVAYMHAN-- 118
Query: 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLL 355
++HRD+K +N+LI + KI+DFGLA+L + + + + T Y APE LL
Sbjct: 119 -GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE-----LL 172
Query: 356 ------NEKSDVYSFGVVLLEAITGR 375
+ D+++ G + E + G
Sbjct: 173 YGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 3e-22
Identities = 81/282 (28%), Positives = 124/282 (43%), Gaps = 36/282 (12%)
Query: 179 DNIIGDGGYGVVYRGQLM----NGTAVAVKKLLNNPGQADK---DFRVEVEAIGHVRHKN 231
+ +IG G +G V RG+L VA+K L G +K DF E +G H N
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTL--KSGYTEKQRRDFLSEASIMGQFDHPN 66
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
++ L G + +++ E++ NG L+ +LR + G T + +L G A + YL
Sbjct: 67 IIHLEGVVTKSRPVMIITEFMENGALDSFLR---QNDGQFTVIQLVGMLRGIAAGMKYLS 123
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHIT-TRVMG---TFGYVAP 347
E VHRD+ + NIL++ N K+SDFGL++ L S T T +G + AP
Sbjct: 124 EM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 348 EYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVV 406
E SDV+S+G+V+ E ++ G P Q +N +E
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQ-------------- 226
Query: 407 DPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448
D + L+ L C D + RPK Q+V L+
Sbjct: 227 DYRLPPPMDCPTALHQLM--LDCWQKDRNARPKFGQIVSTLD 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 5e-22
Identities = 74/290 (25%), Positives = 138/290 (47%), Gaps = 43/290 (14%)
Query: 175 RFSKDNIIGDGGYG--VVYRGQLMNGTAVAVKKL----LNNPGQADKDFRVEVEAIGHVR 228
+ ++G G +G +YR + + + V K++ L+ + +D E+ + ++
Sbjct: 1 HYIPIRVLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKER--RDALNEIVILSLLQ 57
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWL---RGDMCDRGYLTWEARMKILLGTAK 285
H N++ + ++ ++ EY N G L + +G + + + W L
Sbjct: 58 HPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-----YLFQIVS 112
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYV 345
A++Y+H+A ++HRDIK+ NI + + K+ DFG++K+LG+ S T V+GT Y+
Sbjct: 113 AVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYM 168
Query: 346 APEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV 405
+PE N KSD+++ G VL E +T + D P +NLV +K++ V
Sbjct: 169 SPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP---LNLV--VKIVQGNY--TPV 221
Query: 406 VDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIP 455
V +S L +L+ +L DP +KRP +V+ + P+
Sbjct: 222 VS------VYSSEL-ISLVHSLLQQDP--EKRPTADEVL------DQPLL 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 5e-22
Identities = 69/241 (28%), Positives = 114/241 (47%), Gaps = 28/241 (11%)
Query: 182 IGDGGYGVVYRGQLMN------GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRL 235
+G+G +G V+ + N VAVK L A +DF+ E E + ++H+++VR
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 236 LGYCIEGTQRILVYEYVNNGNLEQWLR-----------GDMCDRGYLTWEARMKILLGTA 284
G C EG ++V+EY+ +G+L ++LR G+ G LT + I A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK-LLGAGKSHITTRVMGTFG 343
+ YL VHRD+ + N L+ + KI DFG+++ + + R M
Sbjct: 133 SGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 344 YVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGR-PQSEVNLVEWLKMMVQLRRS 402
++ PE +SD++SFGVVL E T YG+ P +++ E ++ + Q R
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFT------YGKQPWYQLSNTEAIECITQGREL 243
Query: 403 E 403
E
Sbjct: 244 E 244
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 6e-22
Identities = 73/231 (31%), Positives = 109/231 (47%), Gaps = 24/231 (10%)
Query: 177 SKDNI-----IGDGGYGVVYRGQL--MNGTA----VAVKKLLNNPGQADK-DFRVEVEAI 224
+D+I +G G +G VY G +G A VAVK L + + D+ DF +E +
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 225 GHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGY---LTWEARMKILL 281
H+N+VRL+G E R ++ E + G+L+ +LR + LT + +
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 282 GTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD---AKISDFGLAK-LLGAGKSHITTR 337
AK YL E +HRDI + N L+ AKI+DFG+A+ + A R
Sbjct: 124 DVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180
Query: 338 VMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEV 387
M ++ PE G+ K+DV+SFGV+L E + G P GR EV
Sbjct: 181 AMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYP-GRTNQEV 230
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 6e-22
Identities = 61/198 (30%), Positives = 96/198 (48%), Gaps = 13/198 (6%)
Query: 180 NIIGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGY 238
+ +G G YG VY G VAVK L + ++F E + ++H NLV+LLG
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 239 CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKV 298
C ++ E++ GNL +LR C+R + + + + A+ YL +
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRE--CNRQEVNAVVLLYMATQISSAMEYLEKK---NF 125
Query: 299 VHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT---FGYVAPEYANSGLL 355
+HRD+ + N L+ EN K++DFGL++L+ T G + APE
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPESLAYNKF 182
Query: 356 NEKSDVYSFGVVLLEAIT 373
+ KSDV++FGV+L E T
Sbjct: 183 SIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 6e-22
Identities = 72/221 (32%), Positives = 111/221 (50%), Gaps = 19/221 (8%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKD-FRVEVEAIGHVRHKNLVRLLGYCI 240
+G G +G V+ G T VA+K L G + F E + ++H LVRL Y +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSL--KQGSMSPEAFLAEANLMKQLQHPRLVRL--YAV 69
Query: 241 EGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVV 299
+ I ++ EY+ NG+L +L+ + LT + + A+ +A++ +
Sbjct: 70 VTQEPIYIITEYMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYI 124
Query: 300 HRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF--GYVAPEYANSGLLNE 357
HRD++++NIL+ E KI+DFGLA+L+ + T R F + APE N G
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLI--EDNEYTAREGAKFPIKWTAPEAINYGTFTI 182
Query: 358 KSDVYSFGVVLLEAIT-GRYPVDYGRPQSEV--NLVEWLKM 395
KSDV+SFG++L E +T GR P G EV NL +M
Sbjct: 183 KSDVWSFGILLTEIVTYGRIPYP-GMTNPEVIQNLERGYRM 222
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 1e-21
Identities = 71/201 (35%), Positives = 108/201 (53%), Gaps = 16/201 (7%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKD-FRVEVEAIGHVRHKNLVRLLGYCI 240
+G G +G V+ G T VA+K L PG + F E + + +RH+ LV+L Y +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQL--YAV 69
Query: 241 EGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVV 299
+ I +V EY++ G+L +L+G+M YL + + A +AY+ V
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERM---NYV 124
Query: 300 HRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF--GYVAPEYANSGLLNE 357
HRD++++NIL+ EN K++DFGLA+L+ + T R F + APE A G
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 358 KSDVYSFGVVLLEAIT-GRYP 377
KSDV+SFG++L E T GR P
Sbjct: 183 KSDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 94.4 bits (234), Expect = 2e-21
Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 20/213 (9%)
Query: 182 IGDGGYGVVYRGQLMN------GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRL 235
+G+G +G V+ + N VAVK L + A KDF E E + +++H+++V+
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 236 LGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDR---------GYLTWEARMKILLGTAKA 286
G C+EG I+V+EY+ +G+L ++LR D LT + I A
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK-LLGAGKSHITTRVMGTFGYV 345
+ YL VHRD+ + N L+ EN KI DFG+++ + + M ++
Sbjct: 133 MVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 346 APEYANSGLLNEKSDVYSFGVVLLEAIT-GRYP 377
PE +SDV+S GVVL E T G+ P
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 81/302 (26%), Positives = 129/302 (42%), Gaps = 53/302 (17%)
Query: 175 RFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPGQAD-KDFRVEVE---AI 224
R + +G+G +G V + + + + VAVK L ++ + D D E+E I
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMI 72
Query: 225 GHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLR------------GDMCDRGYLT 272
G +HKN++ LLG C + +V EY +GNL +LR LT
Sbjct: 73 G--KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130
Query: 273 WEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332
+ + A+ + +L K +HRD+ + N+L+ E+ KI+DFGLA+
Sbjct: 131 QKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLAR----DIH 183
Query: 333 HI-----TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSE 386
HI TT ++APE + +SDV+SFGV+L E T G G P
Sbjct: 184 HIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLG------GSPYPG 237
Query: 387 VNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446
+ + E K++ + R E +P + L C +RP Q+V
Sbjct: 238 IPVEELFKLLKEGYRME---------KPQNCTQELYHLM-RDCWHEVPSQRPTFKQLVED 287
Query: 447 LE 448
L+
Sbjct: 288 LD 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 2e-21
Identities = 75/211 (35%), Positives = 107/211 (50%), Gaps = 19/211 (9%)
Query: 181 IIGDGGYGVVYRGQLMNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYC 239
IG G +G V G G VAVK + N+ QA F E + +RH NLV+LLG
Sbjct: 13 TIGKGEFGDVMLGD-YRGNKVAVKCIKNDATAQA---FLAEASVMTQLRHSNLVQLLGVI 68
Query: 240 IEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKV 298
+E + +V EY+ G+L +LR R L + +K L +A+ YL
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NF 123
Query: 299 VHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEK 358
VHRD+ + N+L+ E+ AK+SDFGL K A + T ++ + APE + K
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTK--EASSTQDTGKL--PVKWTAPEALREKKFSTK 179
Query: 359 SDVYSFGVVLLEAIT-GRYPVDYGR-PQSEV 387
SDV+SFG++L E + GR P Y R P +V
Sbjct: 180 SDVWSFGILLWEIYSFGRVP--YPRIPLKDV 208
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 2e-21
Identities = 82/285 (28%), Positives = 133/285 (46%), Gaps = 34/285 (11%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLM----NGTAVAVKKLLNNPGQADK---DFRVEVEAIGH 226
+ + +IG G +G V G+L VA+K L G +K DF E +G
Sbjct: 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTL--KAGYTEKQRRDFLSEASIMGQ 61
Query: 227 VRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKA 286
H N++ L G + ++V EY+ NG+L+ +LR G T + +L G A
Sbjct: 62 FDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASG 118
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG--Y 344
+ YL + VHRD+ + NIL++ N K+SDFGL+++L T G +
Sbjct: 119 MKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW 175
Query: 345 VAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYG-RPQSEVNLVEWLKMMVQLRRSE 403
APE SDV+S+G+V+ E ++ YG RP E++ + +K + + R
Sbjct: 176 TAPEAIAYRKFTSASDVWSYGIVMWEVMS------YGERPYWEMSNQDVIKAIEEGYRLP 229
Query: 404 DVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448
+D +AL + +L C D ++RPK Q+V +L+
Sbjct: 230 APMD-------CPAALHQLMLD---CWQKDRNERPKFEQIVSILD 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 93.8 bits (234), Expect = 2e-21
Identities = 61/214 (28%), Positives = 106/214 (49%), Gaps = 27/214 (12%)
Query: 175 RFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKD------FRVEVEAIGHV 227
R+ K +G+G Y VVY+ G VA+KK+ + KD R E++ + +
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR-EIKLLQEL 59
Query: 228 RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-ILLGTAKA 286
+H N++ LL + LV+E++ +LE+ ++ D+ + A +K +L T +
Sbjct: 60 KHPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIK----DKSIVLTPADIKSYMLMTLRG 114
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVA 346
L YLH ++HRD+K +N+LI + K++DFGLA+ G+ +T +V+ T Y A
Sbjct: 115 LEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRA 170
Query: 347 PEYANSGLLNEKS-----DVYSFGVVLLEAITGR 375
PE L + D++S G + E +
Sbjct: 171 PEL----LFGARHYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 5e-21
Identities = 63/220 (28%), Positives = 105/220 (47%), Gaps = 26/220 (11%)
Query: 175 RFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRV---------EVEAI 224
++ K +IG G +G VY G +G +AVK++ A R E+ +
Sbjct: 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALL 60
Query: 225 GHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARM--KILLG 282
++H+N+V+ LG ++ + EYV G++ L Y +E + +
Sbjct: 61 KELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNN------YGAFEETLVRNFVRQ 114
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR----- 337
K L YLH ++HRDIK +NIL+D KISDFG++K L A T
Sbjct: 115 ILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS 171
Query: 338 VMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYP 377
+ G+ ++APE K+D++S G +++E +TG++P
Sbjct: 172 LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 7e-21
Identities = 64/208 (30%), Positives = 107/208 (51%), Gaps = 18/208 (8%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVR 228
TNR+ +G G +G+V + + G VA+KK++ P A + +R E++ + H+R
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLR 67
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALA 288
H+N++ L I + I + +L + L ++ ++ + +IL G L
Sbjct: 68 HENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFL-YQILRG----LK 122
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPE 348
Y+H A VVHRD+K SNILI+EN D KI DFGLA++ + T + T Y APE
Sbjct: 123 YVHSA---GVVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRYYRAPE 175
Query: 349 YANS-GLLNEKSDVYSFGVVLLEAITGR 375
+ + + D++S G + E + G+
Sbjct: 176 IMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 7e-21
Identities = 76/238 (31%), Positives = 118/238 (49%), Gaps = 26/238 (10%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQAD-KDFRVEVEAIGHVRHKNLVRLLGYCI 240
+G G +G V+ G N T VAVK L PG + F E + ++H LVRL
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTL--KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 241 EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK-VV 299
+ ++ EY+ G+L +L+ D + G + + A+ +AY IE K +
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAY----IERKNYI 125
Query: 300 HRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF--GYVAPEYANSGLLNE 357
HRD++++N+L+ E+ KI+DFGLA+++ + T R F + APE N G
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSFTI 183
Query: 358 KSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRP 414
KSDV+SFG++L E +T G+ P G S+V M L+R + P +E P
Sbjct: 184 KSDVWSFGILLYEIVTYGKIPYP-GMSNSDV--------MSALQRGYRM--PRMENCP 230
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 1e-20
Identities = 67/229 (29%), Positives = 99/229 (43%), Gaps = 53/229 (23%)
Query: 175 RFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVRHK 230
R+ IG G YGVV G VA+KK+ N + A + R E++ + H+RH+
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR-EIKLLRHLRHE 59
Query: 231 NLVRLLGYCIEGTQRILVYEYVNNGN------------LEQWLRGDMCDRGYLTWEARMK 278
N++ LL IL + N L + ++ LT + ++
Sbjct: 60 NIIGLL--------DILRPPSPEDFNDVYIVTELMETDLHKVIK----SPQPLT-DDHIQ 106
Query: 279 -ILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337
L + L YLH A V+HRD+K SNIL++ N D KI DFGLA+ G
Sbjct: 107 YFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLAR--GVDPDEDEKG 161
Query: 338 VMGTFGYV------APEYANSGLLNEKS-----DVYSFGVVLLEAITGR 375
+ T YV APE LL+ D++S G + E +T +
Sbjct: 162 FL-T-EYVVTRWYRAPEL----LLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 1e-20
Identities = 56/211 (26%), Positives = 99/211 (46%), Gaps = 18/211 (8%)
Query: 178 KDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLL---NNPGQADK---DFRVEVEAIGHVRHK 230
K +G G + Y+ + + GT +AVK++ N + ++ R E+ + + H
Sbjct: 4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHP 63
Query: 231 NLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYL 290
+++R+LG E + L E++ G++ L G + + L+YL
Sbjct: 64 HIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGLSYL 119
Query: 291 HEAIEPKVVHRDIKSSNILIDEN-FDAKISDFGLAKLLGA---GKSHITTRVMGTFGYVA 346
HE +++HRD+K +N+LID +I+DFG A L A G +++GT ++A
Sbjct: 120 HEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 347 PEYANSGLLNEKSDVYSFGVVLLEAITGRYP 377
PE DV+S G V++E T + P
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 2e-20
Identities = 68/201 (33%), Positives = 106/201 (52%), Gaps = 16/201 (7%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCI 240
+G+G +G V+ G T VAVK L PG + + F E + + +RH LV+L Y +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTL--KPGTMSPESFLEEAQIMKKLRHDKLVQL--YAV 69
Query: 241 EGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVV 299
+ I +V EY++ G+L +L+ + L + + A +AY+ +
Sbjct: 70 VSEEPIYIVTEYMSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYI 124
Query: 300 HRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF--GYVAPEYANSGLLNE 357
HRD++S+NIL+ + KI+DFGLA+L+ + T R F + APE A G
Sbjct: 125 HRDLRSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 358 KSDVYSFGVVLLEAIT-GRYP 377
KSDV+SFG++L E +T GR P
Sbjct: 183 KSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 63/216 (29%), Positives = 104/216 (48%), Gaps = 23/216 (10%)
Query: 182 IGDGGYGVVYRGQLMNGTA------VAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRL 235
+G+G +G V+ + N + VAVK L + A KDF+ E E + +++H+++V+
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 236 LGYCIEGTQRILVYEYVNNGNLEQWLRGDMCD------------RGYLTWEARMKILLGT 283
G C +G I+V+EY+ +G+L ++LR D +G L + I
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK-LLGAGKSHITTRVMGTF 342
A + YL VHRD+ + N L+ N KI DFG+++ + + M
Sbjct: 133 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189
Query: 343 GYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYP 377
++ PE +SDV+SFGV+L E T G+ P
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 2e-20
Identities = 67/188 (35%), Positives = 93/188 (49%), Gaps = 26/188 (13%)
Query: 198 GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQR--ILVYEYVNNG 255
G VAVKKL ++ + +DF E+E + ++H N+V+ G C +R LV EY+ G
Sbjct: 33 GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYG 92
Query: 256 NLEQWLRGDMCDRGYLT-WEARM---KILLGTA---KALAYLHEAIEPKVVHRDIKSSNI 308
+L R YL R+ K+LL + K + YL + VHRD+ + NI
Sbjct: 93 SL----------RDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNI 139
Query: 309 LIDENFDAKISDFGLAKLLGAGKSHITTRVMG---TFGYVAPEYANSGLLNEKSDVYSFG 365
L++ KI DFGL K+L K + R G F Y APE + SDV+SFG
Sbjct: 140 LVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLTESKFSVASDVWSFG 198
Query: 366 VVLLEAIT 373
VVL E T
Sbjct: 199 VVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 2e-20
Identities = 74/281 (26%), Positives = 124/281 (44%), Gaps = 31/281 (11%)
Query: 181 IIGDGGYGVVYRGQLMNG------TAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLV 233
+G G +G V+ + T V VK L + +FR E++ + HKN+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 234 RLLGYCIEGTQRILVYEYVNNGNLEQWLR-----GDMCDRGYLTWEARMKILLGTAKALA 288
RLLG C E ++ EY + G+L+Q+LR + L+ + ++ + A +
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPE 348
+L A + VHRD+ + N L+ + K+S L+K + + + + ++APE
Sbjct: 132 HLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 349 YANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407
+ KSDV+SFGV++ E T G P YG EV + ++ +
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGELPF-YGLSDEEV---------LNRLQAGKLEL 238
Query: 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448
P E PS L + + RC + RP S++V L
Sbjct: 239 PVPEGCPSR--LYKLM---TRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 4e-20
Identities = 81/262 (30%), Positives = 132/262 (50%), Gaps = 49/262 (18%)
Query: 176 FSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL-LNNPGQADKD------FRVEVEAIGHV 227
F K N IG+G YG+VYR + +G VA+KK+ ++N ++D R E+ + ++
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDN----ERDGIPISSLR-EITLLLNL 63
Query: 228 RHKNLVRLLGYCIEGTQR---ILVYEYVNNGNLEQWLRGDMCDRGYLTW-EARMK-ILLG 282
RH N+V L + G LV EY EQ L + D + E+++K ++L
Sbjct: 64 RHPNIVELK-EVVVGKHLDSIFLVMEYC-----EQDL-ASLLDNMPTPFSESQVKCLMLQ 116
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF 342
+ L YLHE ++HRD+K SN+L+ + KI+DFGLA+ G +T +V+ T
Sbjct: 117 LLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TL 172
Query: 343 GYVAPEYANSGLLNEKS-----DVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMV 397
Y APE LL + D+++ G +L E + + P+ G+ SE+ ++ +++
Sbjct: 173 WYRAPEL----LLGCTTYTTAIDMWAVGCILAELLAHK-PLLPGK--SEIEQLD---LII 222
Query: 398 QLRRSEDVVDPNIETRPSTSAL 419
QL + PN P S L
Sbjct: 223 QLLGT-----PNESIWPGFSDL 239
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 4e-20
Identities = 74/253 (29%), Positives = 115/253 (45%), Gaps = 16/253 (6%)
Query: 181 IIGDGGYGVVYRGQLMNGTAVAVKKLLNN-PGQADKDFRVEVEAIGHVRHKNLVRLLGYC 239
++G G +G V++G L + T VAVK + P + F E + H N+V+L+G C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 240 IEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVV 299
+ +V E V G+ +LR + L + +K L A +AYL +
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDE---LKTKQLVKFALDAAAGMAYLESK---NCI 115
Query: 300 HRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKS 359
HRD+ + N L+ EN KISDFG+++ G + + APE N G + +S
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 360 DVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVE-WLKMMVQLRRSEDVV-------DPNI 410
DV+S+G++L E + G P Q VE +M + +DV D
Sbjct: 176 DVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKP 235
Query: 411 ETRPSTSALKRAL 423
E RP S L++ L
Sbjct: 236 ENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 6e-20
Identities = 78/290 (26%), Positives = 124/290 (42%), Gaps = 59/290 (20%)
Query: 182 IGDGGYGVVYRGQLM----NGTAVAVKKL-LNNPGQADKDFRVEVEAIGHVRH-KNLVRL 235
IG G +G V + M +GT +AVK++ + K ++++ + +V+
Sbjct: 12 IGRGAFGTVNK---MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKF 68
Query: 236 LG---------YCIE--GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTA 284
G C+E Y+YV + + E KI + T
Sbjct: 69 YGALFREGDCWICMELMDISLDKFYKYVY-----------EVLKSVIPEEILGKIAVATV 117
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGY 344
KAL YL E E K++HRD+K SNIL+D N + K+ DFG++ L S TR G Y
Sbjct: 118 KALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIAKTRDAGCRPY 173
Query: 345 VAPEYANSGLLNE---KSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRR 401
+APE + + +SDV+S G+ L E TG++P +W + QL +
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP-----------KWNSVFDQLTQ 222
Query: 402 SEDVV--DPNIETRPSTSALKRALLTAL---RCVDPDSDKRPKMSQVVRM 446
VV DP I ++ + + C+ D KRPK +++
Sbjct: 223 ---VVKGDPPI--LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 6e-20
Identities = 52/200 (26%), Positives = 101/200 (50%), Gaps = 11/200 (5%)
Query: 175 RFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKD---FRVEVEAIGHVRHKN 231
++ K ++G G +G+V+ + + + K + + + E + + + H N
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
++ +E ++V EY G L ++++ C L + + + AL ++H
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQ-KRC-NSLLDEDTILHFFVQILLALHHVH 118
Query: 292 EAIEPKVVHRDIKSSNILIDEN-FDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYA 350
+ ++HRD+K+ NIL+D++ KI DFG++K+L + KS T V+GT Y++PE
Sbjct: 119 TKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSS-KSKAYT-VVGTPCYISPELC 173
Query: 351 NSGLLNEKSDVYSFGVVLLE 370
N+KSD+++ G VL E
Sbjct: 174 EGKPYNQKSDIWALGCVLYE 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 9e-20
Identities = 79/276 (28%), Positives = 127/276 (46%), Gaps = 38/276 (13%)
Query: 180 NIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRV----EVEAIGHVRHKNLVR 234
N IG G G VY+ G A+K + G + R E+E + V H N+V+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIY---GNHEDTVRRQICREIEILRDVNHPNVVK 136
Query: 235 LLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI 294
+ ++ E+++ G+LE + D +L AR +IL G +AYLH
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEG---THIADEQFLADVAR-QILSG----IAYLHRR- 187
Query: 295 EPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGL 354
+VHRDIK SN+LI+ + KI+DFG++++L + V GT Y++PE N+ L
Sbjct: 188 --HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTDL 244
Query: 355 LNEK-----SDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409
+ D++S GV +LE GR+P GR +W +M + S P
Sbjct: 245 NHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG------DWASLMCAICMS----QPP 294
Query: 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVR 445
E + S R ++ C+ + KR Q+++
Sbjct: 295 -EAPATASREFRHFIS--CCLQREPAKRWSAMQLLQ 327
|
Length = 353 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 76/276 (27%), Positives = 122/276 (44%), Gaps = 24/276 (8%)
Query: 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVRHKNLVRLL 236
+ +G+G G V + +L N + K + NP + R E+E + +V+
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR-ELEINKSCKSPYIVKYY 65
Query: 237 GYCI-EGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARM-KILLGTAKALAYLHEA 293
G + E + I + EY G+L+ + + RG E + KI K L+YLH
Sbjct: 66 GAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR 124
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLA-KLLGAGKSHITTRVMGTFGYVAPEYANS 352
K++HRDIK SNIL+ K+ DFG++ +L+ + T GT Y+APE
Sbjct: 125 ---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT----GTSFYMAPERIQG 177
Query: 353 GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIET 412
+ SDV+S G+ LLE R+P + +E L +V + E +P
Sbjct: 178 KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPIELLSYIVNMPNPELKDEPGNGI 236
Query: 413 RPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448
+ S K + +C++ D +RP MLE
Sbjct: 237 KWSEE-FKDFI---KQCLEKDPTRRPTPWD---MLE 265
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 1e-19
Identities = 69/269 (25%), Positives = 124/269 (46%), Gaps = 27/269 (10%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVKKL----LNNPGQADKDFRVEVEAIGHVRHKNLVRLL 236
IG G + VVY+ L++G VA+KK+ + + + E++ + + H N+++ L
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQLDHPNVIKYL 68
Query: 237 GYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEP 296
IE + +V E + G+L + ++ + + K + AL ++H
Sbjct: 69 ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK--- 125
Query: 297 KVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLN 356
+++HRDIK +N+ I K+ D GL + + + + V GT Y++PE + N
Sbjct: 126 RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERIHENGYN 184
Query: 357 EKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPST 416
KSD++S G +L E + P YG ++NL K + + + P
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPF-YG---DKMNLYSLCKKIEK-----------CDYPPLP 229
Query: 417 SALKRALLTAL--RCVDPDSDKRPKMSQV 443
+ L L RC++PD +KRP +S V
Sbjct: 230 ADHYSEELRDLVSRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-19
Identities = 71/277 (25%), Positives = 131/277 (47%), Gaps = 25/277 (9%)
Query: 176 FSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKK-----LLNNPGQADKDFRVEVEAIGHVRH 229
F + IG G + VYR L++G VA+KK L++ +A D E++ + + H
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMD--AKARADCIKEIDLLKQLNH 61
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
N+++ IE + +V E + G+L + ++ + + + K + AL +
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEY 349
+H +V+HRDIK +N+ I K+ D GL + + K+ ++GT Y++PE
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPER 177
Query: 350 ANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409
+ N KSD++S G +L E + P YG ++NL K + Q P
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPF-YG---DKMNLYSLCKKIEQCDY------PP 227
Query: 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446
+ + + L++ + C++PD +KRP ++ V +
Sbjct: 228 LPSDHYSEELRQLVNM---CINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 2e-19
Identities = 71/222 (31%), Positives = 106/222 (47%), Gaps = 33/222 (14%)
Query: 180 NIIGDGGYGVVYRGQLMN----GTA---VAVKKLLNN-PGQADKDFRVEVEAIGHVRHKN 231
N +G G +G VY G + G+ VAVK L Q K+F E + + H N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGY---LTWEARMKILLGTAKALA 288
+V+LLG C+ + ++ E + G+L +LR +R LT + + I L AK
Sbjct: 61 IVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120
Query: 289 YLHEAIEPKVVHRDIKSSNILIDE-NFDA----KISDFGLAKLL-------GAGKSHITT 336
YL + +HRD+ + N L+ E +DA KI DFGLA+ + G+ +
Sbjct: 121 YLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 337 RVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYP 377
R M APE G +SDV+SFGV++ E +T G+ P
Sbjct: 178 RWM------APESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 3e-19
Identities = 81/281 (28%), Positives = 137/281 (48%), Gaps = 39/281 (13%)
Query: 176 FSKDNIIGDGGYGVVYRGQLMN-----GTAVAVKKL--LNNPGQADKDFRVEVEAIGHVR 228
F K ++G G +G VY+G + VA+K+L +P +A+K+ E + V
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKEILDEAYVMASVD 67
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLR---GDMCDRGYLTWEARMKILLGTAK 285
+ ++ RLLG C+ T + L+ + + G L ++R ++ + L W ++ AK
Sbjct: 68 NPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AK 120
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG-KSHITTRVMGTFGY 344
+ YL E ++VHRD+ + N+L+ KI+DFGLAKLLGA K + +
Sbjct: 121 GMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKW 177
Query: 345 VAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSE 403
+A E + +SDV+S+GV + E +T G P D G P SE++ + L + E
Sbjct: 178 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSI--------LEKGE 228
Query: 404 DVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVV 444
+ P I T + ++C D+D RPK +++
Sbjct: 229 RLPQPPICT-------IDVYMIMVKCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 3e-19
Identities = 77/299 (25%), Positives = 129/299 (43%), Gaps = 48/299 (16%)
Query: 179 DNIIGDGGYGVVYRGQ------LMNGTAVAVKKLLNNPGQAD-KDFRVEVEAIGHVRHKN 231
+G+G +G V + T VAVK L N ++ +D E + V H +
Sbjct: 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPH 64
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLR----------GDMCDRGYLTWEA------ 275
+++L G C + +L+ EY G+L +LR G +R +
Sbjct: 65 VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124
Query: 276 RMKILLGTA----KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331
M L+ A + + YL E K+VHRD+ + N+L+ E KISDFGL++ +
Sbjct: 125 TMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181
Query: 332 SHIT-TRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNL 389
S++ ++ ++A E + +SDV+SFGV+L E +T G P P+ L
Sbjct: 182 SYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE---RL 238
Query: 390 VEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448
LK ++ R E+ + + + L C + DKRP + + + LE
Sbjct: 239 FNLLKTGYRMERPENC----------SEEMYNLM---LTCWKQEPDKRPTFADISKELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 4e-19
Identities = 68/236 (28%), Positives = 105/236 (44%), Gaps = 46/236 (19%)
Query: 169 LQSATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAI-GH 226
L T F +IG+G YG VY+ + G VA+K +++ +++ + E + +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIEDEEEEIKEEYNILRKY 59
Query: 227 VRHKNLVRLLG------YCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-- 278
H N+ G Q LV E G++ D+ +G R+K
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVT-----DLV-KGLRKKGKRLKEE 113
Query: 279 ----ILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334
IL T + LAYLHE KV+HRDIK NIL+ +N + K+ DFG++ L S +
Sbjct: 114 WIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQL---DSTL 167
Query: 335 TTR--VMGTFGYVAPE-----------YANSGLLNEKSDVYSFGVVLLEAITGRYP 377
R +GT ++APE Y +SDV+S G+ +E G+ P
Sbjct: 168 GRRNTFIGTPYWMAPEVIACDEQPDASYDA------RSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 4e-19
Identities = 69/283 (24%), Positives = 125/283 (44%), Gaps = 36/283 (12%)
Query: 174 NRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRVEVEAI-------G 225
+ + ++G G +G VY + G +AVK++ + + EV A+
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQV--PFDPDSPETKKEVNALECEIQLLK 59
Query: 226 HVRHKNLVRLLGYCIEGTQRILVY-EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTA 284
+++H+ +V+ G C+ + + ++ EY+ G+++ L+ +T + +IL G
Sbjct: 60 NLQHERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEG-- 116
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHIT--TRVMGTF 342
+ YLH +VHRDIK +NIL D + K+ DFG +K L S T V GT
Sbjct: 117 --VEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTP 171
Query: 343 GYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRS 402
+++PE + K+DV+S G ++E +T + P + + K+ Q
Sbjct: 172 YWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI-----FKIATQ---- 222
Query: 403 EDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVR 445
N + S R L R ++ KRP +++R
Sbjct: 223 ----PTNPQLPSHVSPDARNFLR--RTFVENAKKRPSAEELLR 259
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 5e-19
Identities = 81/285 (28%), Positives = 132/285 (46%), Gaps = 42/285 (14%)
Query: 180 NIIGDGGYGVVYRGQLM----NGTAVAVKKL--LNNPGQADKDFRVEVEAIGHVRHKNLV 233
+IG G +G VY G L+ AVK L + + + ++ F E + H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ-FLKEGIIMKDFSHPNVL 59
Query: 234 RLLGYCI--EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG----TAKAL 287
LLG C+ EG+ ++V Y+ +G+L ++R + T +K L+G AK +
Sbjct: 60 SLLGICLPSEGSP-LVVLPYMKHGDLRNFIRSE-------THNPTVKDLIGFGLQVAKGM 111
Query: 288 AYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG---KSHITTRVMGTFGY 344
YL K VHRD+ + N ++DE+F K++DFGLA+ + H T +
Sbjct: 112 EYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKW 168
Query: 345 VAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSED 404
+A E + KSDV+SFGV+L E +T P P +V+ + ++Q RR
Sbjct: 169 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVDSFDITVYLLQGRR--- 220
Query: 405 VVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449
++ P P + L C P + RP S++V +E
Sbjct: 221 LLQPEYCPDPLYEVM-------LSCWHPKPEMRPTFSELVSRIEQ 258
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 7e-19
Identities = 68/201 (33%), Positives = 104/201 (51%), Gaps = 16/201 (7%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKD-FRVEVEAIGHVRHKNLVRLLGYCI 240
+G G +G V+ G T VA+K L PG + F E + + +RH LV L Y +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTL--KPGTMMPEAFLQEAQIMKKLRHDKLVPL--YAV 69
Query: 241 EGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVV 299
+ I +V E++ G+L +L+ D YL + + A +AY+ +
Sbjct: 70 VSEEPIYIVTEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYI 124
Query: 300 HRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF--GYVAPEYANSGLLNE 357
HRD++++NIL+ +N KI+DFGLA+L+ + T R F + APE A G
Sbjct: 125 HRDLRAANILVGDNLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 358 KSDVYSFGVVLLEAIT-GRYP 377
KSDV+SFG++L E +T GR P
Sbjct: 183 KSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 7e-19
Identities = 74/250 (29%), Positives = 109/250 (43%), Gaps = 48/250 (19%)
Query: 176 FSKDNI-----IGDGGYGVVYRGQ---LMNG---TAVAVKKLLNNPG-QADKDFRVEVEA 223
+ ++NI IG G +G V++ + L+ T VAVK L DF+ E
Sbjct: 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 61
Query: 224 IGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLR------------GDMCDRGY- 270
+ H N+V+LLG C G L++EY+ G+L ++LR R
Sbjct: 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCG 121
Query: 271 -----LTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325
L+ ++ I A +AYL E K VHRD+ + N L+ EN KI+DFGL++
Sbjct: 122 LNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR 178
Query: 326 LL-------GAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYP 377
+ + I R M PE +SDV+++GVVL E + G P
Sbjct: 179 NIYSADYYKASENDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
Query: 378 VDYGRPQSEV 387
YG EV
Sbjct: 233 Y-YGMAHEEV 241
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 7e-19
Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRV---EVEAIGHVRH 229
F+ IG G +G VY+ VA+K + + +A+ + E++ + R
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVI--DLEEAEDEIEDIQQEIQFLSQCRS 58
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
+ + G ++G++ ++ EY G+ L+ D Y+ + IL L Y
Sbjct: 59 PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF-----ILREVLLGLEY 113
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEY 349
LHE +HRDIK++NIL+ E D K++DFG++ L + S T V GT ++APE
Sbjct: 114 LHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEV 169
Query: 350 ANSGLLNEKSDVYSFGVVLLEAITGRYP 377
+EK+D++S G+ +E G P
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 1e-18
Identities = 75/277 (27%), Positives = 136/277 (49%), Gaps = 41/277 (14%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLN-NPGQADKDFRVEVEAIGHVRHKNLVRLL-GYC 239
+GDG +G VY+ Q A K++ + +DF VE++ + +H N+V L Y
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 240 IEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEAR--MKILLGTAKALAYLHEAIEPK 297
E IL+ E+ + G L+ + +RG + R + +L +AL +LH K
Sbjct: 73 YENKLWILI-EFCDGGALDSIM--LELERGLTEPQIRYVCRQML---EALNFLHSH---K 123
Query: 298 VVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR--VMGTFGYVAPEYAN---- 351
V+HRD+K+ NIL+ + D K++DFG++ KS + R +GT ++APE
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAK---NKSTLQKRDTFIGTPYWMAPEVVACETF 180
Query: 352 -SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNI 410
+ K+D++S G+ L+E P P E+N +++++++ +S +P
Sbjct: 181 KDNPYDYKADIWSLGITLIELAQME-P-----PHHELNP---MRVLLKILKS----EPPT 227
Query: 411 ETRPS--TSALKRALLTALRCVDPDSDKRPKMSQVVR 445
+PS +S+ L C+ D D RP +++++
Sbjct: 228 LDQPSKWSSSFNDFL---KSCLVKDPDDRPTAAELLK 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 1e-18
Identities = 56/203 (27%), Positives = 97/203 (47%), Gaps = 20/203 (9%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIE 241
+G G +GVV+ G+ VA+K + N +++DF E + + + H LV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ 70
Query: 242 GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHR 301
+V E++ NG L +LR +G L+ + + + + + YL +HR
Sbjct: 71 QKPLYIVTEFMENGCLLNYLRQ---RQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHR 124
Query: 302 DIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG------YVAPEYANSGLL 355
D+ + N L+ K+SDFG+ + + + + G + PE N
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYV------LDDEYTSSSGAKFPVKWSPPEVFNFSKY 178
Query: 356 NEKSDVYSFGVVLLEAIT-GRYP 377
+ KSDV+SFGV++ E T G+ P
Sbjct: 179 SSKSDVWSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 2e-18
Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 14/203 (6%)
Query: 182 IGDGGYGVVYRGQLM---NGTAVAVKKLLNNPGQADKD-FRVEVEAIGHVRHKNLVRLLG 237
+G G +G V +G VA+K L N ++ +D E E + + + +VR++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 238 YCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK 297
C E +LV E + G L ++L G + +T ++++ + + YL
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---N 115
Query: 298 VVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF--GYVAPEYANSGLL 355
VHRD+ + N+L+ AKISDFGL+K LGA S+ R G + + APE N
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF 175
Query: 356 NEKSDVYSFGVVLLEAIT-GRYP 377
+ +SDV+S+G+ + EA + G+ P
Sbjct: 176 SSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 3e-18
Identities = 57/184 (30%), Positives = 91/184 (49%), Gaps = 16/184 (8%)
Query: 201 VAVKKLLNNPGQAD---KDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNL 257
VAVK L P +D +DF EV+ + + N+ RLLG C ++ EY+ NG+L
Sbjct: 49 VAVKVLR--PDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL 106
Query: 258 EQWLR-------GDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI 310
Q+L+ G C+ L++ + + A + YL VHRD+ + N L+
Sbjct: 107 NQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLV 163
Query: 311 DENFDAKISDFGLAKLLGAGK-SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLL 369
+N+ KI+DFG+++ L + + R ++A E G KSDV++FGV L
Sbjct: 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLW 223
Query: 370 EAIT 373
E +T
Sbjct: 224 EILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 3e-18
Identities = 74/272 (27%), Positives = 117/272 (43%), Gaps = 26/272 (9%)
Query: 182 IGDGGYGVVYRGQL-MNGTAVAVKKLLNN-PGQADKDFRVEVEAIGHVRHKNLVRLLGYC 239
IG G +G V+ G+L + T VAVK P F E + H N+VRL+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 240 IEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK-V 298
+ +V E V G+ +LR + ++K L+ + A E +E K
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLRTEGP-------RLKVKELIQMVENAAAGMEYLESKHC 115
Query: 299 VHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT-FGYVAPEYANSGLLNE 357
+HRD+ + N L+ E KISDFG+++ G T + + APE N G +
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSS 175
Query: 358 KSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTS 417
+SDV+SFG++L EA + + V + + Q R + ++ +
Sbjct: 176 ESDVWSFGILLWEAFS-------------LGAVPYANLSNQQTR--EAIEQGVRLPCPEL 220
Query: 418 ALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449
RC + D +RP S V + L+S
Sbjct: 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 4e-18
Identities = 74/274 (27%), Positives = 128/274 (46%), Gaps = 36/274 (13%)
Query: 182 IGDGGYGVVYRGQLMNGTA---VAVK--KLLNNPGQADKDFRVEVEAIGHVRHKNLVRLL 236
+G+G +G V GQL + VAVK K+ +DF E + H N++RL+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 237 GYCIEGTQR------ILVYEYVNNGNLEQWLR----GDMCDRGYLTWEARMKILLGTAKA 286
G C++ + +++ ++ +G+L +L GD YL + +K + A
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQ--YLPTQMLVKFMTDIASG 124
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT-FGYV 345
+ YL +HRD+ + N +++EN + ++DFGL+K + G + R+ ++
Sbjct: 125 MEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWI 181
Query: 346 APEYANSGLLNEKSDVYSFGVVLLE-AITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSED 404
A E + KSDV+SFGV + E A G+ P G SE+ ++L+ +L++ D
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYP-GVENSEI--YDYLRQGNRLKQPPD 238
Query: 405 VVDP-----------NIETRPSTSALKRALLTAL 427
+D N + RPS L+ L AL
Sbjct: 239 CLDGLYSLMSSCWLLNPKDRPSFETLRCELEKAL 272
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 4e-18
Identities = 74/279 (26%), Positives = 124/279 (44%), Gaps = 32/279 (11%)
Query: 182 IGDGGYGVVYRGQLMNGTA--VAVKKL-LNNPG------QADKDFRVEVEAIG----HVR 228
+G G +G VY+ + N +A+K++ ++NP + DK V + +R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALA 288
H N+VR +E + +V + + L + + T E I + AL
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPE 348
YLH+ E ++VHRD+ +NI++ E+ I+DFGLAK T V+GT Y PE
Sbjct: 128 YLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTILYSCPE 183
Query: 349 YANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408
+ EK+DV++FG +L + T + P Y N+ L + + +V+
Sbjct: 184 IVKNEPYGEKADVWAFGCILYQMCTLQ-PPFY-----STNM---LSLATK------IVEA 228
Query: 409 NIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447
E P + C+ PD++ RP + QV M+
Sbjct: 229 VYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 62/215 (28%), Positives = 106/215 (49%), Gaps = 30/215 (13%)
Query: 180 NIIGDGGYGVVYRGQLMNG---TAVAVKKLLNNPGQAD-KDFRVEVEAI---GHVRHKNL 232
++IG+G +G V + ++ A+K++ + D +DF E+E + GH H N+
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH--HPNI 70
Query: 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMC---DRGY---------LTWEARMKIL 280
+ LLG C L EY +GNL +LR D + L+ + +
Sbjct: 71 INLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 130
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMG 340
A+ + YL + + +HRD+ + NIL+ EN+ AKI+DFGL++ G+ + MG
Sbjct: 131 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMG 183
Query: 341 TFG--YVAPEYANSGLLNEKSDVYSFGVVLLEAIT 373
++A E N + SDV+S+GV+L E ++
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 1e-17
Identities = 65/215 (30%), Positives = 103/215 (47%), Gaps = 23/215 (10%)
Query: 176 FSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL---LNNPGQADKDFRVEVEAIGHVRHKN 231
F K IG+G YGVVY+ + + G VA+KK+ G R E+ + + H N
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPN 60
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
+V+LL + LV+E+++ +L++++ D + L + LA+ H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQ-DLKKFM--DASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYAN 351
+V+HRD+K N+LI+ K++DFGLA+ G T V+ T Y APE
Sbjct: 118 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEI-- 171
Query: 352 SGLLNEK-----SDVYSFGVVLLEAITGR--YPVD 379
LL K D++S G + E +T R +P D
Sbjct: 172 --LLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 64/227 (28%), Positives = 101/227 (44%), Gaps = 51/227 (22%)
Query: 175 RFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKL--LNNPGQADKDFRVEVEAIGHVRHKN 231
R+ + IG+G YG+V G VA+KK+ + + R E++ + +H+N
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-EIKILRRFKHEN 64
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNL--------------EQWLRGDMCDRGYLTWEARM 277
++ +L R +E N+ + Q L D Y ++
Sbjct: 65 IIGILD-----IIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQ--YFLYQ--- 114
Query: 278 KILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337
IL + L Y+H A V+HRD+K SN+L++ N D KI DFGLA++ A H T
Sbjct: 115 -IL----RGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPEHDHTG 164
Query: 338 VM----GTFGYVAPEYANSGLLNEKS-----DVYSFGVVLLEAITGR 375
+ T Y APE +LN K D++S G +L E ++ R
Sbjct: 165 FLTEYVATRWYRAPEI----MLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 3e-17
Identities = 72/275 (26%), Positives = 129/275 (46%), Gaps = 21/275 (7%)
Query: 176 FSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLL---NNPGQADKDFRVEVEAIGHVRHKN 231
F + IG G + VYR L++ VA+KK+ +A +D E++ + + H N
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
+++ L IE + +V E + G+L Q ++ + + K + A+ ++H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYAN 351
+V+HRDIK +N+ I K+ D GL + + K+ ++GT Y++PE +
Sbjct: 124 SR---RVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMSPERIH 179
Query: 352 SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411
N KSD++S G +L E + P YG ++NL + + Q P +
Sbjct: 180 ENGYNFKSDIWSLGCLLYEMAALQSPF-YG---DKMNLFSLCQKIEQCDY------PPLP 229
Query: 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446
T + L R L++ C+ PD D+RP + V ++
Sbjct: 230 TEHYSEKL-RELVSM--CIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 76/254 (29%), Positives = 121/254 (47%), Gaps = 35/254 (13%)
Query: 175 RFSKDNIIGDGGYGVVYRGQLM-----NGTAVAVKKL--LNNPGQADKDFRVEVEAIGHV 227
RF ++ +G+ +G +Y+G L + VA+K L +NNP Q +F+ E + +
Sbjct: 8 RFMEE--LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNP-QQWGEFQQEASLMAEL 64
Query: 228 RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWL--RGDMCDRGYLTWEARMKILLGTAK 285
H N+V LLG + +++EY+N G+L ++L R D G + E GT K
Sbjct: 65 HHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDED------GTVK 118
Query: 286 ALA----YLHEAIEPKV----------VHRDIKSSNILIDENFDAKISDFGLAK-LLGAG 330
+ +LH AI+ VH+D+ + NILI E KISD GL++ + A
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSAD 178
Query: 331 KSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLV 390
+ + + ++ PE G + SD++SFGVVL E + YG EV +
Sbjct: 179 YYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV--I 236
Query: 391 EWLKMMVQLRRSED 404
E ++ L SED
Sbjct: 237 EMVRKRQLLPCSED 250
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 69/240 (28%), Positives = 109/240 (45%), Gaps = 55/240 (22%)
Query: 171 SATNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKD------FRVEVEA 223
S + +G+G +G VY+ Q+ G VA+KK+L +KD R E++
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILM---HNEKDGFPITALR-EIKI 60
Query: 224 IGHVRHKNLVRLLGYCIE---GTQRI-----LVYEYVN---NGNLE-QWLRGDMCD-RGY 270
+ ++H N+V L+ +E ++R +V Y++ +G LE ++ + Y
Sbjct: 61 LKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCY 120
Query: 271 LTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL--- 327
M LL + + YLHE ++HRDIK++NILID KI+DFGLA+
Sbjct: 121 ------MLQLL---EGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGP 168
Query: 328 -------GAGKSHITTRVMGTFGYVAPEYANSGLLNEKS-----DVYSFGVVLLEAITGR 375
G G + T ++ T Y PE LL E+ D++ G V E T R
Sbjct: 169 PPNPKGGGGGGTRKYTNLVVTRWYRPPEL----LLGERRYTTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 179 DNIIGDGGYGVVYRGQLM---NGTAVAVKKLLNNPGQAD-KDFRVEVEAIGHV-RHKNLV 233
+++IG+G +G V R + A+K L + D +DF E+E + + H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 234 RLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMC---------DRGYLTWEARMKILLGTA 284
LLG C + EY GNL +LR + G + ++L +
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG- 343
+ E + +HRD+ + N+L+ EN +KI+DFGL++ G+ + MG
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVKKTMGRLPV 182
Query: 344 -YVAPEYANSGLLNEKSDVYSFGVVLLEAIT 373
++A E N + KSDV+SFGV+L E ++
Sbjct: 183 RWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 4e-17
Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 11/204 (5%)
Query: 176 FSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADK--DFRVEVEAIGHVRHKNLV 233
F+K IG G +G VY+G V K+++ D+ D + E+ + +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 234 RLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEA 293
R G ++GT+ ++ EY+ G+ L+ + Y+ IL K L YLH
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILREILKGLDYLHSE 120
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSG 353
+ +HRDIK++N+L+ E D K++DFG+A L + T V GT ++APE
Sbjct: 121 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQS 176
Query: 354 LLNEKSDVYSFGVVLLEAITGRYP 377
+ K+D++S G+ +E G P
Sbjct: 177 AYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 5e-17
Identities = 63/226 (27%), Positives = 107/226 (47%), Gaps = 31/226 (13%)
Query: 176 FSKDNI-----IGDGGYGVVYRGQLM--------NGTAVAVKKLLNNPGQAD-KDFRVEV 221
FS+D + +G+G +G V + + VAVK L ++ + D D E+
Sbjct: 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEM 71
Query: 222 EAIGHV-RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRG------------DMCDR 268
E + + +HKN++ LLG C + ++ EY + GNL ++LR
Sbjct: 72 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPD 131
Query: 269 GYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328
+T++ + A+ + YL K +HRD+ + N+L+ EN KI+DFGLA+ +
Sbjct: 132 EQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVN 188
Query: 329 AGKSH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT 373
+ TT ++APE + +SDV+SFGV++ E T
Sbjct: 189 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 6e-17
Identities = 66/205 (32%), Positives = 108/205 (52%), Gaps = 18/205 (8%)
Query: 182 IGDGGYGVVYRGQL-MNGTA--VAVKKLLN---NPGQADKDFRVEVEAIGHVRHKNLVRL 235
+G G +G V +G M + VAVK L N +P D+ R E + + + +VR+
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLR-EANVMQQLDNPYIVRM 61
Query: 236 LGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIE 295
+G C E +LV E G L ++L+ + ++T + +++ + + YL E
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNK----HVTEKNITELVHQVSMGMKYLEET-- 114
Query: 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF--GYVAPEYANSG 353
VHRD+ + N+L+ AKISDFGL+K LGA +++ + G + + APE N
Sbjct: 115 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173
Query: 354 LLNEKSDVYSFGVVLLEAIT-GRYP 377
+ KSDV+SFGV++ EA + G+ P
Sbjct: 174 KFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 7e-17
Identities = 78/274 (28%), Positives = 131/274 (47%), Gaps = 37/274 (13%)
Query: 181 IIGDGGYGVVYRGQLMN-----GTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVR 234
++G G +G VY+G + VA+K L G +A+ +F E + + H +LVR
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 235 LLGYCIEGTQRILVYEYVNNGNLEQWL---RGDMCDRGYLTWEARMKILLGTAKALAYLH 291
LLG C+ T + LV + + +G L ++ + ++ + L W ++ AK + YL
Sbjct: 74 LLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 126
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL-GAGKSHITTRVMGTFGYVAPEYA 350
E ++VHRD+ + N+L+ KI+DFGLA+LL G K + ++A E
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECI 183
Query: 351 NSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409
+ +SDV+S+GV + E +T G P D G P E+ + L + E + P
Sbjct: 184 HYRKFTHQSDVWSYGVTIWELMTFGGKPYD-GIPTREIPDL--------LEKGERLPQPP 234
Query: 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQV 443
I T + ++C D+D RPK ++
Sbjct: 235 ICT-------IDVYMVMVKCWMIDADSRPKFKEL 261
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 8e-17
Identities = 63/213 (29%), Positives = 97/213 (45%), Gaps = 41/213 (19%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIG-------------HV 227
IG+G YGVVY+ + + G VA+KK+ R+E E G +
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKI-----------RLETEDEGVPSTAIREISLLKEL 55
Query: 228 RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKAL 287
H N+VRLL + LV+E+++ +L++++ D L L + +
Sbjct: 56 NHPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYM--DSSPLTGLDPPLIKSYLYQLLQGI 112
Query: 288 AYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAP 347
AY H +V+HRD+K N+LID K++DFGLA+ G T V+ T Y AP
Sbjct: 113 AYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAP 168
Query: 348 EYANSGLLNEKS-----DVYSFGVVLLEAITGR 375
E LL + D++S G + E + R
Sbjct: 169 EI----LLGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 8e-17
Identities = 81/316 (25%), Positives = 135/316 (42%), Gaps = 62/316 (19%)
Query: 176 FSKDNII-----GDGGYGVVYRGQLM--------NGTAVAVKKLLNNPGQAD-KDFRVEV 221
F +D ++ G+G +G V R + VAVK L +N D D E+
Sbjct: 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEM 68
Query: 222 EAIGHV-RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLR------------GDMCDR 268
E + + +HKN++ LLG C + ++ EY GNL ++LR
Sbjct: 69 ELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPE 128
Query: 269 GYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328
L+++ + A+ + YL + +HRD+ + N+L+ E+ KI+DFGLA+
Sbjct: 129 EQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLAR--- 182
Query: 329 AGKSHI-----TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGR 382
G I T+ ++APE + +SDV+SFG+++ E T G G
Sbjct: 183 -GVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLG------GS 235
Query: 383 PQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQ 442
P + + E K++ + R + +PS + +L C +RP Q
Sbjct: 236 PYPGIPVEELFKLLREGHRMD---------KPSNCTHELYMLMR-ECWHAVPTQRPTFKQ 285
Query: 443 VVRMLE------SEEY 452
+V L+ SEEY
Sbjct: 286 LVEALDKVLAAVSEEY 301
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 9e-17
Identities = 72/277 (25%), Positives = 116/277 (41%), Gaps = 49/277 (17%)
Query: 201 VAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQ 259
VAVK L + + A DF EV+ + ++ N++RLLG C++ ++ EY+ NG+L Q
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 260 WLRGDMCDRG---------------YLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIK 304
+L D +++ + + + L A + YL VHRD+
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLA 165
Query: 305 SSNILIDENFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYS 363
+ N L+ EN KI+DFG+++ L AG + I R + ++A E G SDV++
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225
Query: 364 FGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE-----------T 412
FGV L E + + +P E+ E V++ E
Sbjct: 226 FGVTLWEILM----LCKEQPYGELT-------------DEQVIENAGEFFRDQGRQVYLF 268
Query: 413 RPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449
RP L L+C D +RP S + L
Sbjct: 269 RPPPCPQGLYELM-LQCWSRDCRERPSFSDIHAFLTE 304
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 57/182 (31%), Positives = 85/182 (46%), Gaps = 30/182 (16%)
Query: 278 KILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337
KI + KAL YLH + V+HRD+K SN+LI+ N K+ DFG++ L S T
Sbjct: 107 KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTI 162
Query: 338 VMGTFGYVAPEYANSGL----LNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWL 393
G Y+APE N L + KSDV+S G+ ++E TGR+P D W
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYD-----------SWK 211
Query: 394 KMMVQLRRSEDVVDPNIETRPSTSALKRAL----LTALRCVDPDSDKRPKMSQVVRMLES 449
QL++ VV+ E P A K + +C+ + +RP ++++
Sbjct: 212 TPFQQLKQ---VVE---EPSPQLPAEKFSPEFQDFVN-KCLKKNYKERPNYPELLQHPFF 264
Query: 450 EE 451
E
Sbjct: 265 EL 266
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 1e-16
Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 182 IGDGGYGVVYRGQLMN-GTAVAVKKL----LNNPGQADKDFRVEVEAIGHVRHKNLVRLL 236
I G YG V+ + + G A+K + + Q D+ E + + + +V+L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVL-TERDILSQAQSPYVVKLY 59
Query: 237 GYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIE 295
Y +G + + LV EY+ G+L L + G L + + AL YLH
Sbjct: 60 -YSFQGKKNLYLVMEYLPGGDLASLLE----NVGSLDEDVARIYIAEIVLALEYLHSN-- 112
Query: 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI--------TTRVMGTFGYVAP 347
++HRD+K NILID N K++DFGL+K +G + I R++GT Y+AP
Sbjct: 113 -GIIHRDLKPDNILIDSNGHLKLTDFGLSK-VGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 348 EYANSGLLNEKSDVYSFGVVLLEAITGRYP 377
E ++ D +S G +L E + G P
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLVG-IP 199
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 67/217 (30%), Positives = 102/217 (47%), Gaps = 38/217 (17%)
Query: 175 RFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLL---NNPGQADKDFRVEVEAIGHVRHK 230
++ K + IG+G YGVV++ + G VA+KK + ++P R E+ + ++H
Sbjct: 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR-EIRMLKQLKHP 60
Query: 231 NLVRLLGYCIEGTQRI----LVYEYVNN---GNLEQWLRGDMCDRGYLTWEARMKILLGT 283
NLV L IE +R LV+EY ++ LE+ RG + KI+ T
Sbjct: 61 NLVNL----IEVFRRKRKLHLVFEYCDHTVLNELEKNPRG--VPEHLI-----KKIIWQT 109
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
+A+ + H+ +HRD+K NILI + K+ DFG A++L T V T
Sbjct: 110 LQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRW 165
Query: 344 YVAPEYANSGLL------NEKSDVYSFGVVLLEAITG 374
Y APE LL DV++ G V E +TG
Sbjct: 166 YRAPE-----LLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 58/212 (27%), Positives = 86/212 (40%), Gaps = 19/212 (8%)
Query: 176 FSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRV-----EVEAIGHVRH 229
F +IG G +G V Q A+K + N + + V E + + H
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYM--NKQKCVEKGSVRNVLNERRILQELNH 59
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG-TAKALA 288
LV L + LV + + G+L L + E ++K + AL
Sbjct: 60 PFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL-----SQKVKFSEEQVKFWICEIVLALE 114
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPE 348
YLH ++HRDIK NIL+DE I+DF +A + +TT GT GY+APE
Sbjct: 115 YLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPE 169
Query: 349 YANSGLLNEKSDVYSFGVVLLEAITGRYPVDY 380
+ D +S GV E + G+ P
Sbjct: 170 VLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 2e-16
Identities = 60/215 (27%), Positives = 104/215 (48%), Gaps = 30/215 (13%)
Query: 180 NIIGDGGYGVVYRGQL------MNGTAVAVKKLLNNPGQAD-KDFRVEVEAI---GHVRH 229
++IG+G +G V + ++ M+ A+K++ + D +DF E+E + GH H
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDA---AIKRMKEYASKDDHRDFAGELEVLCKLGH--H 55
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMC---------DRGYLTWEARMKIL 280
N++ LLG C L EY +GNL +LR + + ++L
Sbjct: 56 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMG 340
A + + + +HRD+ + NIL+ EN+ AKI+DFGL++ G+ + MG
Sbjct: 116 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMG 171
Query: 341 TFG--YVAPEYANSGLLNEKSDVYSFGVVLLEAIT 373
++A E N + SDV+S+GV+L E ++
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 2e-16
Identities = 62/214 (28%), Positives = 108/214 (50%), Gaps = 20/214 (9%)
Query: 175 RFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVRHKN 231
R+ IG+G +G +Y + + + V K ++ P + + + EV + ++H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARM-----KILLGTAKA 286
+V E + +V EY + G+L + R + RG L E ++ +I LG
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMK--RINR-QRGVLFSEDQILSWFVQISLG---- 113
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDEN-FDAKISDFGLAKLLGAGKSHITTRVMGTFGYV 345
L ++H+ K++HRDIKS NI + +N AK+ DFG+A+ L + +GT Y+
Sbjct: 114 LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTPYYL 169
Query: 346 APEYANSGLLNEKSDVYSFGVVLLEAITGRYPVD 379
+PE + N K+D++S G VL E T ++P +
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 2e-16
Identities = 78/292 (26%), Positives = 130/292 (44%), Gaps = 44/292 (15%)
Query: 181 IIGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQA--DKDFRVEVEAIGHVRHKNLVRLLG 237
++G+G YG+V + + G VA+KK L + K E+ + +RH+NLV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 238 YCIEGTQRILVYEYVNN---GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI 294
+ LV+E+V++ +LE++ G L K L + + + H
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEKYPNG-------LDESRVRKYLFQILRGIEFCHSH- 119
Query: 295 EPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGL 354
++HRDIK NIL+ ++ K+ DFG A+ L A + T + T Y APE L
Sbjct: 120 --NIIHRDIKPENILVSQSGVVKLCDFGFARTL-AAPGEVYTDYVATRWYRAPEL----L 172
Query: 355 LNEKS-----DVYSFGVVLLEAITGR--YPVD------YGRPQSEVNLVEWLKMMVQLR- 400
+ + D+++ G ++ E +TG +P D Y + NL+ + + Q
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232
Query: 401 -----RSEDVVDP-NIETR-PSTSALKRALLTALRCVDPDSDKRPKMSQVVR 445
R +V + +E R P S L L C+ D D RP SQ++
Sbjct: 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQ--CLRIDPDDRPSSSQLLH 282
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 2e-16
Identities = 75/280 (26%), Positives = 126/280 (45%), Gaps = 29/280 (10%)
Query: 168 DLQSATNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRV-EVEAIG 225
D + RF K IG G G VY + G VA+K++ N Q K+ + E+ +
Sbjct: 16 DPKKKYTRFEK---IGQGASGTVYTAIDIATGQEVAIKQM-NLQQQPKKELIINEILVMR 71
Query: 226 HVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAK 285
++ N+V L + G + +V EY+ G+L + D G + R + +
Sbjct: 72 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----Q 126
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYV 345
AL +LH +V+HRDIKS NIL+ + K++DFG + +S +T V GT ++
Sbjct: 127 ALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWM 182
Query: 346 APEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV 405
APE K D++S G++ +E + G P P + L+
Sbjct: 183 APEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT---------- 232
Query: 406 VDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVR 445
P ++ SA+ R L RC++ D D+R ++++
Sbjct: 233 --PELQNPERLSAVFRDFLN--RCLEMDVDRRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 3e-16
Identities = 64/227 (28%), Positives = 109/227 (48%), Gaps = 15/227 (6%)
Query: 173 TNRFSKDNIIGDGGYGVVYRG-QLMNGTA----VAVKKLLNNPG-QADKDFRVEVEAIGH 226
K ++G G +G V++G + G + VA+K + + G Q ++ + A+G
Sbjct: 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGS 65
Query: 227 VRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKA 286
+ H +VRLLG C G LV + G+L +R R L + + + AK
Sbjct: 66 LDHAYIVRLLGIC-PGASLQLVTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKG 121
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA-GKSHITTRVMGTFGYV 345
+ YL E ++VHR++ + NIL+ + +I+DFG+A LL K + + ++
Sbjct: 122 MYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM 178
Query: 346 APEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVE 391
A E G +SDV+S+GV + E ++ G P RP +L+E
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE 225
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 3e-16
Identities = 74/280 (26%), Positives = 126/280 (45%), Gaps = 29/280 (10%)
Query: 168 DLQSATNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRV-EVEAIG 225
D + RF K IG G G VY + G VA++++ N Q K+ + E+ +
Sbjct: 17 DPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQM-NLQQQPKKELIINEILVMR 72
Query: 226 HVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAK 285
++ N+V L + G + +V EY+ G+L + D G + R + +
Sbjct: 73 ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----Q 127
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYV 345
AL +LH +V+HRDIKS NIL+ + K++DFG + +S + ++GT ++
Sbjct: 128 ALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWM 183
Query: 346 APEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV 405
APE K D++S G++ +E I G P P + L+
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT---------- 233
Query: 406 VDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVR 445
P ++ SA+ R L RC+D D +KR ++++
Sbjct: 234 --PELQNPEKLSAIFRDFLN--RCLDMDVEKRGSAKELLQ 269
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 79/295 (26%), Positives = 130/295 (44%), Gaps = 51/295 (17%)
Query: 182 IGDGGYGVVYRGQLM--------NGTAVAVKKLLNNPGQAD-KDFRVEVEAIGHV-RHKN 231
+G+G +G V + + T VAVK L ++ + D D E+E + + +HKN
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRG------------DMCDRGYLTWEARMKI 279
++ LLG C + ++ EY + GNL ++LR L+++ +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 280 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVM 339
A+ + YL K +HRD+ + N+L+ E+ KI+DFGLA+ + HI
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----HHIDYYKK 198
Query: 340 GTFG-----YVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLK 394
T G ++APE + +SDV+SFGV+L E T G P V + E K
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLG-----GSPYPGVPVEELFK 253
Query: 395 MMVQLRRSEDVVDPNIETRPSTSALKRALLTALR-CVDPDSDKRPKMSQVVRMLE 448
++ + R + +PS L +R C +RP Q+V L+
Sbjct: 254 LLKEGHRMD---------KPSNCT--NELYMMMRDCWHAVPSQRPTFKQLVEDLD 297
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 3e-16
Identities = 41/104 (39%), Positives = 61/104 (58%), Gaps = 8/104 (7%)
Query: 278 KILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337
K+ + KAL YL E + V+HRD+K SNIL+D + + K+ DFG++ L K+ TR
Sbjct: 118 KMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TR 173
Query: 338 VMGTFGYVAPEYANSGLLNEK----SDVYSFGVVLLEAITGRYP 377
G Y+APE + N K +DV+S G+ L+E TG++P
Sbjct: 174 SAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 71/267 (26%), Positives = 114/267 (42%), Gaps = 37/267 (13%)
Query: 181 IIGDGGYGVVY----RGQLMNGTAVAVKKL----LNNPGQADKDFRVEVEAIGHVRHKNL 232
++G G YG V+ G G A+K L + + + R E + + VR
Sbjct: 7 VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF 66
Query: 233 VRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG-TAKALAYL 290
+ L Y + ++ L+ +YVN G L L R + T E+ +++ + AL +L
Sbjct: 67 LVTLHYAFQTDTKLHLILDYVNGGELFTHL----YQREHFT-ESEVRVYIAEIVLALDHL 121
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYA 350
H+ +++RDIK NIL+D ++DFGL+K A + GT Y+APE
Sbjct: 122 HQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVI 178
Query: 351 NSGLL--NEKSDVYSFGVVLLEAITGRYP--VDYGR-PQSEVNLVEWLKMMVQLRRSEDV 405
G ++ D +S GV+ E +TG P VD + QSE+ S +
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI--------------SRRI 224
Query: 406 VDPNIETRPSTSALKRALLTALRCVDP 432
+ + SA R + L DP
Sbjct: 225 LKSKPPFPKTMSAEARDFIQKLLEKDP 251
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-16
Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 18/204 (8%)
Query: 181 IIGDGGYGVVYRGQLMNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGY 238
++G+G +G Q +N K + P A +D R E + ++H N+V
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAF-KE 65
Query: 239 CIEGTQRI-LVYEYVNNGNLEQWL---RGDM-CDRGYLTWEARMKILLGTAKALAYLHEA 293
E + +V EY + G+L Q + RG + + L W +M + + ++HE
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHEK 119
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSG 353
+V+HRDIKS NI + +N K+ DFG A+LL + ++ T V GT YV PE +
Sbjct: 120 ---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPEIWENM 175
Query: 354 LLNEKSDVYSFGVVLLEAITGRYP 377
N KSD++S G +L E T ++P
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 4e-16
Identities = 59/202 (29%), Positives = 92/202 (45%), Gaps = 15/202 (7%)
Query: 179 DNIIGDGGYGVVYRGQLM----NGTAVAVKKLLNNPGQADKD---FRVEVEAIGHVRHKN 231
+ I+G G +G + RG L VA+ L G +DK F E +G H N
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTL--RAGCSDKQRRGFLAEALTLGQFDHSN 67
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
+VRL G G ++V EY++NG L+ +LR G L M +L G A + YL
Sbjct: 68 IVRLEGVITRGNTMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLS 124
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYAN 351
E VH+ + + +L++ + KIS F + + + T + APE
Sbjct: 125 EM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQ 181
Query: 352 SGLLNEKSDVYSFGVVLLEAIT 373
+ SDV+SFG+V+ E ++
Sbjct: 182 YHHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 4e-16
Identities = 61/205 (29%), Positives = 100/205 (48%), Gaps = 13/205 (6%)
Query: 176 FSKDNIIGDGGYGVVYRGQLMNGT--AVAVKKL-LNNPGQADKDFRVEVEAIGHVRHKNL 232
F+K IG G +G V++G + N T VA+K + L +D + E+ + +
Sbjct: 6 FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 64
Query: 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE 292
+ G ++GT+ ++ EY+ G+ LR D + +L K L YLH
Sbjct: 65 TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIA-----TMLKEILKGLDYLHS 119
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANS 352
K +HRDIK++N+L+ E D K++DFG+A L + T V GT ++APE
Sbjct: 120 E---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQ 175
Query: 353 GLLNEKSDVYSFGVVLLEAITGRYP 377
+ K+D++S G+ +E G P
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 26/215 (12%)
Query: 182 IGDGGYGVVYRGQLM--------NGTAVAVKKLLNNPGQAD-KDFRVEVEAIGHV-RHKN 231
+G+G +G V + + VAVK L ++ D D E+E + + +HKN
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRG----------DMCD--RGYLTWEARMKI 279
++ LLG C + ++ EY + GNL ++LR D C LT++ +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 280 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK-LLGAGKSHITTRV 338
A+ + YL K +HRD+ + N+L+ E+ KI+DFGLA+ + TT
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 339 MGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT 373
++APE + +SDV+SFGV+L E T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 6e-16
Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 178 KDNIIGDGGYGVV--YRGQLMN---GTAVAVKKLLNNPGQADKD-FRVEVEAIGHVRHKN 231
K ++G+G +G V Y N G VAVK L GQ + ++ E+ + + H+N
Sbjct: 8 KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHEN 67
Query: 232 LVRLLGYCIEGTQRI--LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
+V+ G C E + L+ EYV G+L +L + L + + +AY
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-----PKHKLNLAQLLLFAQQICEGMAY 122
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMG---TFGYVA 346
LH +HRD+ + N+L+D + KI DFGLAK + G + R G F Y A
Sbjct: 123 LHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-A 178
Query: 347 PEYANSGLLNEKSDVYSFGVVLLEAIT 373
E + SDV+SFGV L E +T
Sbjct: 179 VECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 6e-16
Identities = 66/270 (24%), Positives = 129/270 (47%), Gaps = 33/270 (12%)
Query: 181 IIGDGGYGVVYRGQLM--NGTA--VAVKKL-LNNPGQAD-KDFRVEVEAIGHVRHKNLVR 234
I+G+G +G V GQL +G+ VAVK + L+ ++ ++F E + H N+++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 235 LLGYCIEGTQR------ILVYEYVNNGNLEQWLRGDMCDRG--YLTWEARMKILLGTAKA 286
L+G C E + +++ ++ +G+L +L L + +K ++ A
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALG 125
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT-FGYV 345
+ YL +HRD+ + N ++ E+ ++DFGL+K + +G + R+ ++
Sbjct: 126 MEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 182
Query: 346 APEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSED 404
A E + KSDV++FGV + E T G+ P G E+ ++L+ +L++ ED
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYP-GVENHEI--YDYLRHGNRLKQPED 239
Query: 405 VVDP-----------NIETRPSTSALKRAL 423
+D + + RP+ + L+ L
Sbjct: 240 CLDELYDLMYSCWRADPKDRPTFTKLREVL 269
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 7e-16
Identities = 71/241 (29%), Positives = 107/241 (44%), Gaps = 28/241 (11%)
Query: 196 MNGTAVAVKKLLNNPGQAD---KDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL-VYEY 251
M G VA+K L + + + FR E + H N+V LL + V+EY
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI- 310
V L + L D G L +++L ALA H +VHRD+K NI++
Sbjct: 61 VPGRTLREVLAAD----GALPAGETGRLMLQVLDALACAHNQ---GIVHRDLKPQNIMVS 113
Query: 311 --DENFDAKISDFGLAKLL-GAGKSHI-----TTRVMGTFGYVAPEYANSGLLNEKSDVY 362
AK+ DFG+ LL G + + TT V+GT Y APE + SD+Y
Sbjct: 114 QTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLY 173
Query: 363 SFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRA 422
++G++ LE +TG+ V G +E+ + QL + + P I P L++A
Sbjct: 174 AWGLIFLECLTGQ-RVVQGASVAEI-------LYQQLSPVDVSLPPWIAGHPLGQVLRKA 225
Query: 423 L 423
L
Sbjct: 226 L 226
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 7e-16
Identities = 50/180 (27%), Positives = 88/180 (48%), Gaps = 7/180 (3%)
Query: 201 VAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQ 259
VAVK L + + A DF E++ + +++ N++RLLG C+ ++ EY+ NG+L Q
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 260 WL-----RGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF 314
+L + + +L + + + VHRD+ + N L+ ++
Sbjct: 107 FLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHY 166
Query: 315 DAKISDFGLAKLLGAGKSH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT 373
KI+DFG+++ L +G + I R + ++A E G SDV++FGV L E T
Sbjct: 167 TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 8e-16
Identities = 55/201 (27%), Positives = 99/201 (49%), Gaps = 12/201 (5%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIE 241
+G G +GVV G+ VA+K ++ ++ +F E + + + H+ LV+L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 242 GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHR 301
+V EY++NG L +LR +++ + +AYL + +HR
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLRE---HGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHR 124
Query: 302 DIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF--GYVAPEYANSGLLNEKS 359
D+ + N L+D+ K+SDFGL++ + T+ V F + PE + KS
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKS 182
Query: 360 DVYSFGVVLLEAIT-GRYPVD 379
DV++FGV++ E + G+ P +
Sbjct: 183 DVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 8e-16
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 34/209 (16%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRV-EVEAIGHV-RHKNLVRLLGY 238
+GDG +G VY + G VA+KK+ ++ + EV+++ + H N+V+L
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEV 66
Query: 239 CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-ILLGTAKALAYLHEAIEPK 297
E + V+EY+ GNL Q ++ + E+ ++ I+ + LA++H+
Sbjct: 67 FRENDELYFVFEYME-GNLYQLMKDR--KGKPFS-ESVIRSIIYQILQGLAHIHKH---G 119
Query: 298 VVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI------TTRVMGTFGYVAPEYAN 351
HRD+K N+L+ KI+DFGLA+ I T V T Y APE
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAR-------EIRSRPPYTDYV-STRWYRAPEI-- 169
Query: 352 SGLLNEKS-----DVYSFGVVLLEAITGR 375
LL S D+++ G ++ E T R
Sbjct: 170 --LLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 9e-16
Identities = 72/273 (26%), Positives = 125/273 (45%), Gaps = 26/273 (9%)
Query: 175 RFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRV-EVEAIGHVRHKNL 232
++++ IG G G VY + G VA+K++ N Q K+ + E+ + +H N+
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQM-NLQQQPKKELIINEILVMRENKHPNI 78
Query: 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE 292
V L + G + +V EY+ G+L + D G + R + +AL +LH
Sbjct: 79 VNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-----QALEFLHS 133
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANS 352
+V+HRDIKS NIL+ + K++DFG + +S +T V GT ++APE
Sbjct: 134 N---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTR 189
Query: 353 GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIET 412
K D++S G++ +E + G P P + L+ P ++
Sbjct: 190 KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------------ATNGTPELQN 237
Query: 413 RPSTSALKRALLTALRCVDPDSDKRPKMSQVVR 445
SA+ R L RC++ D +KR ++++
Sbjct: 238 PEKLSAIFRDFLN--RCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 9e-16
Identities = 74/296 (25%), Positives = 126/296 (42%), Gaps = 48/296 (16%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNGTA-----------VAVKKLLNNPGQADKD-FRVEV 221
N S +G G +G V + TA VAVK L ++++ E+
Sbjct: 35 NNLSFGKTLGAGAFGKV-----VEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSEL 89
Query: 222 EAIGHV-RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKIL 280
+ + H+ H+N+V LLG C G +++ EY G+L +LR +LT E +
Sbjct: 90 KIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFS 147
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI---TTR 337
AK +A+L +HRD+ + N+L+ KI DFGLA+ + +++ R
Sbjct: 148 YQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNAR 204
Query: 338 VMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT---GRYPVDYGRPQSEVNLVEWLK 394
+ ++APE + + +SDV+S+G++L E + YP G P K
Sbjct: 205 L--PVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYP---GMPVDS-------K 252
Query: 395 MMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450
++ + P +K C D D KRP Q+V+++ +
Sbjct: 253 FYKLIKEGYRMAQPEHAPAEIYDIMK-------TCWDADPLKRPTFKQIVQLIGKQ 301
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 70/268 (26%), Positives = 129/268 (48%), Gaps = 51/268 (19%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQAD-KDFRVEVEAIGHVRHKNLVRLLG-YC 239
+GDG +G VY+ + A+A K++ + + +D+ VE+E + H +V+LLG +
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 240 IEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVV 299
+G I++ E+ G ++ + DRG + ++ I +AL YLH K++
Sbjct: 80 WDGKLWIMI-EFCPGGAVDAIML--ELDRGLTEPQIQV-ICRQMLEALQYLHSM---KII 132
Query: 300 HRDIKSSNILIDENFDAKISDFGLA----KLLGAGKSHITTRVMGTFGYVAPEYANSGLL 355
HRD+K+ N+L+ + D K++DFG++ K L S I GT ++APE +
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI-----GTPYWMAPEVVMCETM 187
Query: 356 NE-----KSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSE------- 403
+ K+D++S G+ L+E P E+N +++++++ +SE
Sbjct: 188 KDTPYDYKADIWSLGITLIEM------AQIEPPHHELNP---MRVLLKIAKSEPPTLSQP 238
Query: 404 ------------DVVDPNIETRPSTSAL 419
+D + ETRPS + L
Sbjct: 239 SKWSMEFRDFLKTALDKHPETRPSAAQL 266
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 70/222 (31%), Positives = 105/222 (47%), Gaps = 43/222 (19%)
Query: 182 IGDGGYGVVYRG-QLMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVRHKNLVRLLG 237
IG G YG+V VA+KK+ N N A + R E++ + H+ H+N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAIKD 71
Query: 238 YCIEGTQR------ILVYEYVNNGNLEQWLRG------DMCDRGYLTWEARMKILLGTAK 285
+ R +VYE ++ +L Q +R D C Y ++ +L G
Sbjct: 72 -IMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQ--YFLYQ----LLRG--- 120
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYV 345
L Y+H A V+HRD+K SN+L++ N D KI DFGLA+ +T V+ T Y
Sbjct: 121 -LKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYR 175
Query: 346 APEYANSGLLNEKS-----DVYSFGVVLLEAITGRYPVDYGR 382
APE LLN DV+S G + E + GR P+ G+
Sbjct: 176 APEL----LLNCSEYTTAIDVWSVGCIFAE-LLGRKPLFPGK 212
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 60/203 (29%), Positives = 102/203 (50%), Gaps = 14/203 (6%)
Query: 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQAD-KDFRVEVEAIGHVRHKNLVRLLG 237
+ +G G +G V+ T VAVK + PG + F E + ++H LV+L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTM--KPGSMSVEAFLAEANVMKTLQHDKLVKLHA 68
Query: 238 YCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK 297
+ I+ E++ G+L +L+ D + L + A+ +A++ +
Sbjct: 69 VVTKEPIYIIT-EFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQR---N 122
Query: 298 VVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF--GYVAPEYANSGLL 355
+HRD++++NIL+ + KI+DFGLA+++ + T R F + APE N G
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLARVI--EDNEYTAREGAKFPIKWTAPEAINFGSF 180
Query: 356 NEKSDVYSFGVVLLEAIT-GRYP 377
KSDV+SFG++L+E +T GR P
Sbjct: 181 TIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 52/201 (25%), Positives = 92/201 (45%), Gaps = 13/201 (6%)
Query: 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKS 305
+ E+++ G+L++ + G + E KI + + L YL+ +++HRDIK
Sbjct: 79 CMCMEFMDCGSLDRIYK----KGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKP 132
Query: 306 SNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFG 365
SNIL++ K+ DFG++ G + I +GT Y++PE G KSDV+S G
Sbjct: 133 SNILVNSRGQIKLCDFGVS---GELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLG 189
Query: 366 VVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLT 425
+ ++E G++P + S ++ M L + +V PS+ +
Sbjct: 190 ISIIELALGKFPFAF----SNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDF 245
Query: 426 ALRCVDPDSDKRPKMSQVVRM 446
C+ D +RP Q+ M
Sbjct: 246 VDACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 73/277 (26%), Positives = 139/277 (50%), Gaps = 41/277 (14%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQAD-KDFRVEVEAIGHVRHKNLVRLL-GYC 239
+GDG +G VY+ Q +A K+++ + + +D+ VE++ + H N+V+LL +
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 240 IEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG-TAKALAYLHEAIEPKV 298
E IL+ E+ G ++ M + E +++++ T +AL YLHE K+
Sbjct: 73 YENNLWILI-EFCAGGAVD----AVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KI 124
Query: 299 VHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR---VMGTFGYVAPEY-----A 350
+HRD+K+ NIL + D K++DFG++ A + R +GT ++APE +
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVS----AKNTRTIQRRDSFIGTPYWMAPEVVMCETS 180
Query: 351 NSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNI 410
+ K+DV+S G+ L+E P E+N +++++++ +SE P
Sbjct: 181 KDRPYDYKADVWSLGITLIEM------AQIEPPHHELNP---MRVLLKIAKSE----PPT 227
Query: 411 ETRPS--TSALKRALLTALRCVDPDSDKRPKMSQVVR 445
+PS +S K L +C++ + D R +Q+++
Sbjct: 228 LAQPSRWSSEFKDFL---KKCLEKNVDARWTTTQLLQ 261
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 2e-15
Identities = 65/221 (29%), Positives = 115/221 (52%), Gaps = 17/221 (7%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVK--KLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGY 238
+G+G Y VY+G+ G VA+K L G R E+ + ++H+N+VRL
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHENIVRLHDV 66
Query: 239 CIEGTQRILVYEYVNNGNLEQWL--RGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEP 296
+ +LV+EY++ +L++++ G T ++ LL K +A+ HE
Sbjct: 67 IHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLL---KGIAFCHEN--- 119
Query: 297 KVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPE-YANSGLL 355
+V+HRD+K N+LI++ + K++DFGLA+ G + + V+ T Y AP+ S
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTY 178
Query: 356 NEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMM 396
+ D++S G ++ E ITGR P+ G + L++ ++M
Sbjct: 179 STSIDIWSVGCIMAEMITGR-PLFPGTNNED-QLLKIFRIM 217
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 3e-15
Identities = 53/182 (29%), Positives = 92/182 (50%), Gaps = 12/182 (6%)
Query: 201 VAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQ 259
VAVK L + + A DF E++ + ++ N++RLL CI ++ EY+ NG+L Q
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 260 WL-------RGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE 312
+L + D +++ + + A + YL VHRD+ + N L+ +
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGK 165
Query: 313 NFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEA 371
N+ KI+DFG+++ L +G + I R + +++ E G SDV++FGV L E
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225
Query: 372 IT 373
+T
Sbjct: 226 LT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 71/251 (28%), Positives = 117/251 (46%), Gaps = 26/251 (10%)
Query: 175 RFSKDNIIGDGGYGVVYRGQLMN-GTAVAVKKLL---NNPGQADKDFRVEVEAIGHVRHK 230
++ K IG+G YG V++ + VA+K++ ++ G R E+ + ++HK
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHK 59
Query: 231 NLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYL 290
N+VRL + LV+EY + +L+++ D C G + E + K LA+
Sbjct: 60 NIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYF--DSC-NGDIDPEIVKSFMFQLLKGLAFC 115
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYA 350
H V+HRD+K N+LI++N + K++DFGLA+ G + V+ T Y P+
Sbjct: 116 HSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVL 171
Query: 351 NSGLLNEKS-DVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVV-DP 408
L S D++S G + E GRP N V+ QL+R ++ P
Sbjct: 172 FGAKLYSTSIDMWSAGCIFAELANA------GRPLFPGNDVD-----DQLKRIFRLLGTP 220
Query: 409 NIETRPSTSAL 419
E+ P S L
Sbjct: 221 TEESWPGVSKL 231
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 3e-15
Identities = 72/283 (25%), Positives = 128/283 (45%), Gaps = 35/283 (12%)
Query: 182 IGDGGYGVVYRGQLMNGTAVA---VKKLLNNPGQADKD-FRVEVEAIGHVRHKNLVRLLG 237
IG+G +G V G+ G + A VK+L + ++ F EV+ + H N+++ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 238 YCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTA----KALAYLHEA 293
CIE +LV E+ G+L+ +LR +RG + A+ +L A L +LH+A
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRS---NRGMVAQMAQKDVLQRMACEVASGLLWLHQA 119
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG--YVAPEYAN 351
+H D+ N + + KI D+GLA L + + T+ ++APE
Sbjct: 120 ---DFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVE 175
Query: 352 ---SGLL----NEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSED 404
LL +KS+++S GV + E T +P +++ + LK +V+ + +
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFTAA-----DQPYPDLSDEQVLKQVVREQDIK- 229
Query: 405 VVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447
+ P ++ + S + L D + RP +V +L
Sbjct: 230 LPKPQLDLKYSDRWYEVMQFCWL-----DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 4e-15
Identities = 57/197 (28%), Positives = 90/197 (45%), Gaps = 12/197 (6%)
Query: 179 DNIIGDGGYGVVYRGQLMN----GTAVAVKKLLNNPGQADKD-FRVEVEAIGHVRHKNLV 233
IG+G +G VY+G M+ AVAVK N + ++ F E + H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 234 RLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEA 293
+L+G E I V E G L +L+ + + L + + + ALAYL
Sbjct: 71 KLIGVITENPVWI-VMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK 126
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSG 353
+ VHRDI + N+L+ K+ DFGL++ L + ++ ++APE N
Sbjct: 127 ---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR 183
Query: 354 LLNEKSDVYSFGVVLLE 370
SDV+ FGV + E
Sbjct: 184 RFTSASDVWMFGVCMWE 200
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 6e-15
Identities = 79/264 (29%), Positives = 123/264 (46%), Gaps = 52/264 (19%)
Query: 180 NIIGDGGYGVVYRGQLMN-GTAVAVKKL---LNNPGQADKDFRVEVEAIGHVR---HKNL 232
IG+G YG VY+ + +N G VA+KK+ L+ G R E+ + + H N+
Sbjct: 5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFEHPNI 63
Query: 233 VRLLGYCI-----EGTQRILVYEYVNNGNLEQWLRGDMC-DRGYLTWEAR--MKILLGTA 284
VRLL C + LV+E+V+ +L +L C G + M+ LL
Sbjct: 64 VRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYL--SKCPKPGLPPETIKDLMRQLL--- 117
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGY 344
+ + +LH ++VHRD+K NIL+ + KI+DFGLA++ + +T+ V+ T Y
Sbjct: 118 RGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSF-EMALTSVVV-TLWY 172
Query: 345 VAPE------YANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQ 398
APE YA D++S G + E + R P+ G SE + Q
Sbjct: 173 RAPEVLLQSSYATP------VDMWSVGCIFAE-LFRRRPLFRG--TSEAD---------Q 214
Query: 399 LRRSEDVVD-PNIETRPSTSALKR 421
L + DV+ P+ E P +L R
Sbjct: 215 LDKIFDVIGLPSEEEWPRNVSLPR 238
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 7e-15
Identities = 65/202 (32%), Positives = 99/202 (49%), Gaps = 22/202 (10%)
Query: 247 LVYEYVNNGNLEQWLRG-DMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKS 305
LV +Y N G+L Q ++ +R + EA + + + L +H ++HRDIKS
Sbjct: 116 LVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFI----QVLLAVHHVHSKHMIHRDIKS 171
Query: 306 SNILIDENFDAKISDFGLAKLLGAGKSHITTRVM-GTFGYVAPEYANSGLLNEKSDVYSF 364
+NIL+ N K+ DFG +K+ A S R GT YVAPE ++K+D++S
Sbjct: 172 ANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSL 231
Query: 365 GVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALL 424
GV+L E +T + P D G EV M L D + P+I S + ++
Sbjct: 232 GVLLYELLTLKRPFD-GENMEEV-------MHKTLAGRYDPLPPSI------SPEMQEIV 277
Query: 425 TALRCVDPDSDKRPKMSQVVRM 446
TAL DP +RP S+++ M
Sbjct: 278 TALLSSDP--KRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 9e-15
Identities = 59/198 (29%), Positives = 91/198 (45%), Gaps = 23/198 (11%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQAD---KDFRVEVEAIGHVRHKNLVRLLG 237
IG G +G VY + + VA+KK+ + Q++ +D EV + +RH N + G
Sbjct: 23 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG 82
Query: 238 YCIEGTQRILVYEYVNNGNLEQWLRGDMCD--RGYLTWEARMKILLGTAKALAYLHEAIE 295
+ LV EY D+ + + L I G + LAYLH
Sbjct: 83 CYLREHTAWLVMEYCLGS------ASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH-- 134
Query: 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEY---ANS 352
+ +HRDIK+ NIL+ E K++DFG A L+ S + GT ++APE +
Sbjct: 135 -ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDE 188
Query: 353 GLLNEKSDVYSFGVVLLE 370
G + K DV+S G+ +E
Sbjct: 189 GQYDGKVDVWSLGITCIE 206
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 9e-15
Identities = 80/286 (27%), Positives = 130/286 (45%), Gaps = 53/286 (18%)
Query: 178 KDNIIGDGGYGVVYRG-QLMNG----TAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKN 231
K ++G G +G VY+G + +G VA+K L N +A+K+ E + V
Sbjct: 11 KVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPY 70
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLR---GDMCDRGYLTWEARMKILLGTAKALA 288
+ RLLG C+ T + LV + + G L ++R + + L W ++ AK ++
Sbjct: 71 VCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKGMS 123
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL---------GAGKSHITTRVM 339
YL E ++VHRD+ + N+L+ KI+DFGLA+LL GK I
Sbjct: 124 YLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK---- 176
Query: 340 GTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQ 398
++A E +SDV+S+GV + E +T G P D G P E+ +
Sbjct: 177 ----WMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD-GIPAREIPDL-------- 223
Query: 399 LRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVV 444
L + E + P I T + ++C DS+ RP+ ++V
Sbjct: 224 LEKGERLPQPPICT-------IDVYMIMVKCWMIDSECRPRFRELV 262
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 1e-14
Identities = 68/283 (24%), Positives = 127/283 (44%), Gaps = 26/283 (9%)
Query: 165 TLRDLQSATNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRV-EVE 222
T+ + ++++ IG G G V+ + G VA+K++ N Q K+ + E+
Sbjct: 10 TIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQI-NLQKQPKKELIINEIL 68
Query: 223 AIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG 282
+ +++ N+V L + G + +V EY+ G+L + D + R +
Sbjct: 69 VMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL--- 125
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF 342
+AL +LH +V+HRDIKS N+L+ + K++DFG + +S +T V GT
Sbjct: 126 --QALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTP 179
Query: 343 GYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRS 402
++APE K D++S G++ +E + G P P + L+
Sbjct: 180 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT------- 232
Query: 403 EDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVR 445
P ++ S + R L RC++ D +KR ++++
Sbjct: 233 -----PELQNPEKLSPIFRDFLN--RCLEMDVEKRGSAKELLQ 268
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 32/215 (14%)
Query: 176 FSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL-LNN-----PGQADKDFRVEVEAIGHVR 228
++K IG+G YGVVY+G+ G VA+KK+ L + P A + E+ + ++
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR----EISLLKELQ 57
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVN---NGNLEQWLRGDMCD----RGYLTWEARMKILL 281
H N+V L ++ ++ L++E+++ L+ +G D + YL +IL
Sbjct: 58 HPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYL-----YQILQ 112
Query: 282 GTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
G + + H +V+HRD+K N+LID K++DFGLA+ G T V+ T
Sbjct: 113 G----ILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-T 164
Query: 342 FGYVAPE-YANSGLLNEKSDVYSFGVVLLEAITGR 375
Y APE S + D++S G + E T +
Sbjct: 165 LWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 69/242 (28%), Positives = 110/242 (45%), Gaps = 41/242 (16%)
Query: 175 RFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVRHK 230
R+ IG G YGVV +G VA+KK+ + P A + R E++ + H +H
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRHFKHD 64
Query: 231 NLVRLLGYCIEGTQRILVYEYVN--------NGNLEQWLRGDMCDRGYLTWEARMKILLG 282
N++ I R ++ + +L + D LT E L
Sbjct: 65 NII-----AIRDILRPPGADFKDVYVVMDLMESDLHHIIHSD----QPLTEEHIRYFLYQ 115
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG----KSHITTRV 338
+ L Y+H A V+HRD+K SN+L++E+ + +I DFG+A+ L + K +T V
Sbjct: 116 LLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYV 172
Query: 339 MGTFGYVAPEYANSGLLNEKS---DVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKM 395
T Y APE S L E + D++S G + E + GR + G+ N V LK+
Sbjct: 173 -ATRWYRAPELLLS--LPEYTTAIDMWSVGCIFAEML-GRRQLFPGK-----NYVHQLKL 223
Query: 396 MV 397
++
Sbjct: 224 IL 225
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 2e-14
Identities = 62/237 (26%), Positives = 114/237 (48%), Gaps = 24/237 (10%)
Query: 169 LQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIG-HV 227
L+ F ++G+G YG VY+G+ + +A K+++ G +++ + E+ + +
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYS 60
Query: 228 RHKNLVRLLGYCIEGT------QRILVYEYVNNGNLEQWLR---GDMCDRGYLTWEARMK 278
H+N+ G I+ Q LV E+ G++ ++ G+ ++ + R +
Sbjct: 61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICR-E 119
Query: 279 ILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRV 338
IL G L++LH+ KV+HRDIK N+L+ EN + K+ DFG++ L T
Sbjct: 120 ILRG----LSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-F 171
Query: 339 MGTFGYVAPEYAN-----SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLV 390
+GT ++APE + KSD++S G+ +E G P+ P + L+
Sbjct: 172 IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 228
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 47/191 (24%), Positives = 78/191 (40%), Gaps = 33/191 (17%)
Query: 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSS 306
LV EY+N G+ ++ G L + + + + LH+ ++HRDIK
Sbjct: 74 LVMEYLNGGDCASLIK----TLGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPE 126
Query: 307 NILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGV 366
N+LID+ K++DFGL++ + +GT Y+APE ++ SD +S G
Sbjct: 127 NLLIDQTGHLKLTDFGLSRN-----GLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGC 181
Query: 367 VLLEAITGRYPVDYGRPQS-----EVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKR 421
V+ E + G P P + + W + E + S
Sbjct: 182 VIFEFLFGYPPFHAETPDAVFDNILSRRINWPE----------------EVKEFCSPEAV 225
Query: 422 ALLTALRCVDP 432
L+ L C+DP
Sbjct: 226 DLINRLLCMDP 236
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 2e-14
Identities = 55/204 (26%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 176 FSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADK--DFRVEVEAIGHVRHKNLV 233
F+K IG G +G V++G V K+++ D+ D + E+ + +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 234 RLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEA 293
+ G ++ T+ ++ EY+ G+ D+ + G L IL K L YLH
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGSAL-----DLLEPGPLDETQIATILREILKGLDYLHSE 120
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSG 353
K +HRDIK++N+L+ E+ + K++DFG+A L + +GT ++APE
Sbjct: 121 ---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNTFVGTPFWMAPEVIKQS 176
Query: 354 LLNEKSDVYSFGVVLLEAITGRYP 377
+ K+D++S G+ +E G P
Sbjct: 177 AYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-14
Identities = 58/197 (29%), Positives = 97/197 (49%), Gaps = 20/197 (10%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCI 240
+G G YG VY+ + L G AVK + PG + E+ + +H N+V G +
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 241 EGTQRILVYEYVNNGNLEQ--WLRGDM--CDRGYLTWEARMKILLGTAKALAYLHEAIEP 296
+ + EY G+L+ + G + Y+ E T + LAYLH +
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRE--------TLQGLAYLHSKGK- 127
Query: 297 KVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYA---NSG 353
+HRDIK +NIL+ +N D K++DFG+A + A + + +GT ++APE A +G
Sbjct: 128 --MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS-FIGTPYWMAPEVAAVEKNG 184
Query: 354 LLNEKSDVYSFGVVLLE 370
N+ D+++ G+ +E
Sbjct: 185 GYNQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 3e-14
Identities = 65/217 (29%), Positives = 104/217 (47%), Gaps = 35/217 (16%)
Query: 180 NIIGDGGYGVVYRGQ-LMNGTAVAVKKL-LNNPGQADKDFRV----EVEAIGHVRHKNLV 233
IG+G YG VY+ + G VA+KK+ L+N + F + E++ + + H+N+V
Sbjct: 13 GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG---FPITAIREIKILRQLNHRNIV 69
Query: 234 RLLGYCIEGTQRI----------LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGT 283
L + + LV+EY+++ +L L + ++ MK LL
Sbjct: 70 NLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLL-- 126
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
+ L Y H+ +HRDIK SNIL++ K++DFGLA+L + +S T + T
Sbjct: 127 -EGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLW 182
Query: 344 YVAPEYANSGLLNEKS-----DVYSFGVVLLEAITGR 375
Y PE LL E+ DV+S G +L E T +
Sbjct: 183 YRPPEL----LLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 3e-14
Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 182 IGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCI 240
IG+G G+V G VAVKK+ Q + EV + +H N+V + +
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86
Query: 241 EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVH 300
G + +V E++ G L D+ + E + L KAL++LH V+H
Sbjct: 87 VGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVIH 138
Query: 301 RDIKSSNILIDENFDAKISDFG----LAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLN 356
RDIKS +IL+ + K+SDFG ++K + KS ++GT ++APE +
Sbjct: 139 RDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS-----LVGTPYWMAPEVISRLPYG 193
Query: 357 EKSDVYSFGVVLLEAITGRYP 377
+ D++S G++++E + G P
Sbjct: 194 TEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 29/212 (13%)
Query: 182 IGDGGYGVVYRG---QLMNG---TAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKNLVR 234
+G G +G+VY G ++ G T VAVK + + ++ +F E + ++VR
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 235 LLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCD------RGYLTWEARMKILLGTAKALA 288
LLG +G ++V E + +G+L+ +LR + R T + +++ A +A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL-------GAGKSHITTRVMGT 341
YL+ K VHRD+ + N ++ +F KI DFG+ + + GK + R M
Sbjct: 134 YLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-- 188
Query: 342 FGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT 373
APE G+ SD++SFGVVL E +
Sbjct: 189 ----APESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 55/206 (26%), Positives = 102/206 (49%), Gaps = 13/206 (6%)
Query: 176 FSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVRHKNL 232
F K + +G G GVV++ + +KL++ P ++ R E++ + +
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIR-ELQVLHECNSPYI 65
Query: 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE 292
V G + + E+++ G+L+Q L+ G + + K+ + K L YL E
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE 121
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANS 352
+ K++HRD+K SNIL++ + K+ DFG++ G + +GT Y++PE
Sbjct: 122 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQG 176
Query: 353 GLLNEKSDVYSFGVVLLEAITGRYPV 378
+ +SD++S G+ L+E GRYP+
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 3e-14
Identities = 66/254 (25%), Positives = 114/254 (44%), Gaps = 26/254 (10%)
Query: 182 IGDGGYGVV-YRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCI 240
IG+G G+V + G VAVKK+ Q + EV + H+N+V + +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 241 EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVH 300
G + +V E++ G L D+ + E + L +AL+YLH V+H
Sbjct: 90 VGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIATVCLSVLRALSYLHNQ---GVIH 141
Query: 301 RDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR--VMGTFGYVAPEYANSGLLNEK 358
RDIKS +IL+ + K+SDFG + + R ++GT ++APE + +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQV---SKEVPKRKSLVGTPYWMAPEVISRLPYGTE 198
Query: 359 SDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSA 418
D++S G++++E I G P + P + +RR D + P ++ S+
Sbjct: 199 VDIWSLGIMVIEMIDGEPPY-FNEPPLQA-----------MRRIRDNLPPRVKDSHKVSS 246
Query: 419 LKRALLTALRCVDP 432
+ R L + +P
Sbjct: 247 VLRGFLDLMLVREP 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 54/215 (25%), Positives = 101/215 (46%), Gaps = 23/215 (10%)
Query: 175 RFSKDNIIGDGGYGVVYRGQLMNGT-----AVAVKKLLNNPGQADKDFRV-EVEAIGHVR 228
R + +++ +G +G ++ G L++ V VK + ++ + + E + +
Sbjct: 7 RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLS 66
Query: 229 HKNLVRLLGYCIEGTQRILV-YEYVNNGNLEQWLRG--DMCDRGYLTWEARMKILLGT-- 283
H+N++ +L CIE + V Y Y+N GNL+ +L+ + + +
Sbjct: 67 HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT-- 341
A ++YLH+ V+H+DI + N +IDE KI+D L++ L H +G
Sbjct: 127 ACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH----CLGDNE 179
Query: 342 ---FGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT 373
++A E + + SDV+SFGV+L E +T
Sbjct: 180 NRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 4e-14
Identities = 68/248 (27%), Positives = 115/248 (46%), Gaps = 48/248 (19%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRV----EVEAIGHVR 228
+++ K IG G +G V++ + VA+KK+L + F + E++ + ++
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLME--NEKEGFPITALREIKILQLLK 69
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDR---GYLTW----------EA 275
H+N+V L+ C R Y N +L + C+ G L+ +
Sbjct: 70 HENVVNLIEIC-----RTKATPY-NRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKK 123
Query: 276 RMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK---- 331
MK+LL L Y+H K++HRD+K++NILI ++ K++DFGLA+ K
Sbjct: 124 VMKMLL---NGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKP 177
Query: 332 SHITTRVMGTFGYVAPEYANSGLLNEKS-----DVYSFGVVLLEAITGRYPVDYGRP-QS 385
+ T RV+ T Y PE LL E+ D++ G ++ E T R P+ G Q
Sbjct: 178 NRYTNRVV-TLWYRPPEL----LLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNTEQH 231
Query: 386 EVNLVEWL 393
++ L+ L
Sbjct: 232 QLTLISQL 239
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 4e-14
Identities = 64/206 (31%), Positives = 99/206 (48%), Gaps = 23/206 (11%)
Query: 182 IGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQADKDFR---VEVEAIGHVRHKNLVRLLG 237
+G GG+G V Q+ G A KKL + K + E + + V + L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLA 59
Query: 238 YCIEG-TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARM-----KILLGTAKALAYLH 291
Y E LV +N G+L+ + ++ + G+ EAR +I+ G L +LH
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIY-NVGEPGFP--EARAIFYAAQIICG----LEHLH 112
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYAN 351
+ ++V+RD+K N+L+D++ + +ISD GLA L GK I R GT GY+APE
Sbjct: 113 QR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK-IKGRA-GTPGYMAPEVLQ 167
Query: 352 SGLLNEKSDVYSFGVVLLEAITGRYP 377
+ + D ++ G L E I GR P
Sbjct: 168 GEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 31/213 (14%)
Query: 182 IGDGGYGVVYRGQLMNG-------TAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKNLV 233
+G G +G+VY G + G T VA+K + ++ +F E + ++V
Sbjct: 14 LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 234 RLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEA-----RMKILLG-TAKAL 287
RLLG +G +++ E + G+L+ +LR + +A +M + G A +
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 288 AYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL-------GAGKSHITTRVMG 340
AYL+ K VHRD+ + N ++ E+F KI DFG+ + + GK + R M
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM- 188
Query: 341 TFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT 373
+PE G+ SDV+SFGVVL E T
Sbjct: 189 -----SPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 5e-14
Identities = 67/217 (30%), Positives = 108/217 (49%), Gaps = 44/217 (20%)
Query: 182 IGDGGYGVVYRG-QLMNGTAVAVKKLLN---NPGQADKDFRVEV---EAIGHVRHKNLVR 234
+G G YG+V++ VA+KK+ + N A + FR E+ + +G H N+V+
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGD--HPNIVK 71
Query: 235 LLG-YCIEGTQRI-LVYEYVNNGNLEQWLRGDMCD---RGYLTWEARMKILLGTAKALAY 289
LL E + I LV+EY+ +L +R ++ + + Y+ ++ LL KAL Y
Sbjct: 72 LLNVIKAENDKDIYLVFEYMET-DLHAVIRANILEDVHKRYIMYQ-----LL---KALKY 122
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVM----GTFGYV 345
+H V+HRD+K SNIL++ + K++DFGLA+ L + + V+ T Y
Sbjct: 123 IHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYR 179
Query: 346 APEYANSGLLNEKSDVYSFGV-------VLLEAITGR 375
APE LL S Y+ GV +L E + G+
Sbjct: 180 APEI----LL--GSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 6e-14
Identities = 72/280 (25%), Positives = 128/280 (45%), Gaps = 37/280 (13%)
Query: 166 LRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIG 225
L L+ F ++G+G YG VY+G+ + +A K+++ +++ ++E+ +
Sbjct: 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLK 67
Query: 226 -HVRHKNLVRLLGYCIEGT------QRILVYEYVNNG---NLEQWLRGDMCDRGYLTWEA 275
+ H+N+ G I+ + Q LV E+ G +L + +G+ ++ +
Sbjct: 68 KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYIC 127
Query: 276 RMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHIT 335
R +IL G LA+LH KV+HRDIK N+L+ EN + K+ DFG++ L
Sbjct: 128 R-EILRG----LAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN 179
Query: 336 TRVMGTFGYVAPEYAN-----SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLV 390
T +GT ++APE + +SD++S G+ +E G P+ P + L+
Sbjct: 180 T-FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI 238
Query: 391 -----------EWLKMMVQLRRSEDVVDPNIETRPSTSAL 419
+W K + E + N +RPST L
Sbjct: 239 PRNPPPKLKSKKWSKKFIDF--IEGCLVKNYLSRPSTEQL 276
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 8e-14
Identities = 56/215 (26%), Positives = 104/215 (48%), Gaps = 23/215 (10%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVRHKNLVRLLGY 238
+G G GVV + Q + +KL++ P ++ R E++ + +V G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIR-ELQVLHECNSPYIVGFYGA 71
Query: 239 CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKV 298
+ + E+++ G+L+Q L+ + + E K+ + + LAYL E + ++
Sbjct: 72 FYSDGEISICMEHMDGGSLDQVLK----EAKRIPEEILGKVSIAVLRGLAYLRE--KHQI 125
Query: 299 VHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEK 358
+HRD+K SNIL++ + K+ DFG++ G + +GT Y++PE + +
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYSVQ 182
Query: 359 SDVYSFGVVLLEAITGRYPVD----------YGRP 383
SD++S G+ L+E GRYP+ +GRP
Sbjct: 183 SDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRP 217
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 71.1 bits (175), Expect = 8e-14
Identities = 47/129 (36%), Positives = 64/129 (49%), Gaps = 11/129 (8%)
Query: 250 EYVNNGNLEQWLRGDMCDRGYL-TWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNI 308
EY G L LR DRG + AR + A YLH +++RD+K N+
Sbjct: 73 EYCLGGELWTILR----DRGLFDEYTARF-YIACVVLAFEYLHNR---GIIYRDLKPENL 124
Query: 309 LIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVL 368
L+D N K+ DFG AK L +G+ T GT YVAPE + + D +S G++L
Sbjct: 125 LLDSNGYVKLVDFGFAKKLKSGQK--TWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILL 182
Query: 369 LEAITGRYP 377
E +TGR P
Sbjct: 183 YELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 67/218 (30%), Positives = 106/218 (48%), Gaps = 38/218 (17%)
Query: 176 FSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRV----EVEAIGHVRHK 230
+ K N I +G YGVVYR + G VA+KKL + F + E+ + ++H
Sbjct: 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEK--EKEGFPITSLREINILLKLQHP 64
Query: 231 NLVRL----LGYCIEGTQRILVYEYVNNGNLEQWLRGDMCD--RGYLTWEAR--MKILLG 282
N+V + +G ++ + +V EYV E L+ M + +L E + M LL
Sbjct: 65 NIVTVKEVVVGSNLD--KIYMVMEYV-----EHDLKSLMETMKQPFLQSEVKCLMLQLL- 116
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF 342
+A+LH+ ++HRD+K+SN+L++ KI DFGLA+ G+ T V+ T
Sbjct: 117 --SGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TL 170
Query: 343 GYVAPEYANSGLLNEKS-----DVYSFGVVLLEAITGR 375
Y APE LL K D++S G + E +T +
Sbjct: 171 WYRAPEL----LLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 2e-13
Identities = 67/284 (23%), Positives = 127/284 (44%), Gaps = 41/284 (14%)
Query: 176 FSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRV-----EVEAIGHVRH 229
+ + ++G G +G VY + G +A K++ +P + V E++ + +++H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63
Query: 230 KNLVRLLGYCIEGTQRILV--YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKAL 287
+ +V+ G + ++ L EY+ G+++ L+ G LT K + +
Sbjct: 64 ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGM 119
Query: 288 AYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL------GAGKSHITTRVMGT 341
+YLH + +VHRDIK +NIL D + K+ DFG +K L G G +T GT
Sbjct: 120 SYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT----GT 172
Query: 342 FGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRR 401
+++PE + K+DV+S G ++E +T + P E+ M +
Sbjct: 173 PYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP-----------WAEYEAMAAIFKI 221
Query: 402 SEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVR 445
+ +P + + S A L C+ ++ RP +++R
Sbjct: 222 ATQPTNPQLPSHISEHARD-----FLGCIFVEARHRPSAEELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 41/129 (31%), Positives = 70/129 (54%), Gaps = 9/129 (6%)
Query: 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNIL 309
E+++ G+L+Q L+ G + KI + + L YL E + K++HRD+K SNIL
Sbjct: 79 EHMDGGSLDQVLK----KAGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNIL 132
Query: 310 IDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLL 369
++ + K+ DFG++ L + +GT Y++PE +SD++S G+ L+
Sbjct: 133 VNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLV 189
Query: 370 EAITGRYPV 378
E GRYP+
Sbjct: 190 EMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-13
Identities = 55/182 (30%), Positives = 90/182 (49%), Gaps = 13/182 (7%)
Query: 198 GTAVAVKKLL-NNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQR--ILVYEYVNN 254
G VAVK L + G D + E+E + ++ H+N+V+ G C E L+ E++ +
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF 314
G+L+++L + + + + ++K + K + YL + VHRD+ + N+L++
Sbjct: 93 GSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEH 146
Query: 315 DAKISDFGLAKLLGAGKSHITT---RVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEA 371
KI DFGL K + K + T F Y APE SDV+SFGV L E
Sbjct: 147 QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLIQSKFYIASDVWSFGVTLYEL 205
Query: 372 IT 373
+T
Sbjct: 206 LT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 68/254 (26%), Positives = 114/254 (44%), Gaps = 26/254 (10%)
Query: 182 IGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCI 240
IG+G G+V + +G VAVKK+ Q + EV + +H+N+V + +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 241 EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVH 300
G + +V E++ G L D+ + E + L KAL+ LH V+H
Sbjct: 88 VGDELWVVMEFLEGGALT-----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQ---GVIH 139
Query: 301 RDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR--VMGTFGYVAPEYANSGLLNEK 358
RDIKS +IL+ + K+SDFG + + R ++GT ++APE + +
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQV---SKEVPRRKSLVGTPYWMAPELISRLPYGPE 196
Query: 359 SDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSA 418
D++S G++++E + G P + P LK M +R D + P ++ S
Sbjct: 197 VDIWSLGIMVIEMVDGEPPY-FNEPP--------LKAMKMIR---DNLPPKLKNLHKVSP 244
Query: 419 LKRALLTALRCVDP 432
+ L L DP
Sbjct: 245 SLKGFLDRLLVRDP 258
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-13
Identities = 63/201 (31%), Positives = 107/201 (53%), Gaps = 19/201 (9%)
Query: 182 IGDGGYGVVYRGQL-MNGTAVAVK--KLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGY 238
+G+G Y V++G+ + VA+K +L + G R EV + +++H N+V L +
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTL--H 69
Query: 239 CIEGTQR--ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILL-GTAKALAYLHEAIE 295
I T+R LV+EY+++ +L+Q+L D C G L +KI + + L+Y H+
Sbjct: 70 DIIHTERCLTLVFEYLDS-DLKQYL--DNC--GNLMSMHNVKIFMFQLLRGLSYCHKR-- 122
Query: 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPE-YANSGL 354
K++HRD+K N+LI+E + K++DFGLA+ + V+ T Y P+ S
Sbjct: 123 -KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTE 180
Query: 355 LNEKSDVYSFGVVLLEAITGR 375
+ D++ G +L E TGR
Sbjct: 181 YSTPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 3e-13
Identities = 64/227 (28%), Positives = 105/227 (46%), Gaps = 21/227 (9%)
Query: 166 LRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIG 225
L L T+ + IG G YG VY+ ++A K+L+ D++ E +
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQ 73
Query: 226 HV-RHKNLVRLLGYCIE-----GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK- 278
+ H N+V+ G + G Q LV E N G++ + ++G + G EA +
Sbjct: 74 SLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKG-LLICGQRLDEAMISY 132
Query: 279 ILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRV 338
IL G L +LH +++HRD+K +NIL+ K+ DFG++ L + + T V
Sbjct: 133 ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV 189
Query: 339 MGTFGYVAPE-------YANSGLLNEKSDVYSFGVVLLEAITGRYPV 378
GT ++APE Y S + + DV+S G+ +E G P+
Sbjct: 190 -GTPFWMAPEVIACEQQYDYS--YDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 3e-13
Identities = 48/165 (29%), Positives = 86/165 (52%), Gaps = 8/165 (4%)
Query: 218 RVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEAR- 276
R EV + +++H N+V+ E +V +Y G+L + + RG L E +
Sbjct: 47 RKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQ---RGVLFPEDQI 103
Query: 277 MKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITT 336
+ + AL ++H+ K++HRDIKS NI + ++ K+ DFG+A++L + +
Sbjct: 104 LDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS-TVELAR 159
Query: 337 RVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYG 381
+GT Y++PE + N KSD+++ G VL E T ++ + G
Sbjct: 160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 67/238 (28%), Positives = 110/238 (46%), Gaps = 28/238 (11%)
Query: 175 RFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVRHK 230
R+ +IG G YGVV G VA+KK+ + + A + R E++ + +RH
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILR-EIKLLRLLRHP 59
Query: 231 NLVRLLGYCIEGTQR-----ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAK 285
++V + + ++R +V+E + + +L Q ++ + LT E L +
Sbjct: 60 DIVEIKHIMLPPSRREFKDIYVVFELMES-DLHQVIKAN----DDLTPEHHQFFLYQLLR 114
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK--LLGAGKSHITTRVMGTFG 343
AL Y+H A V HRD+K NIL + + KI DFGLA+ + T + T
Sbjct: 115 ALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171
Query: 344 YVAPEYANS--GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQL 399
Y APE S D++S G + E +TG+ P+ G+ N+V L ++ L
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGK-----NVVHQLDLITDL 223
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 4e-13
Identities = 63/229 (27%), Positives = 102/229 (44%), Gaps = 34/229 (14%)
Query: 182 IGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQADKDFRVEVEAIGHV----------RHK 230
+G GGYG V+ + + G VA+K++ K ++ + HV + +
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRM-------KKSLLFKLNEVRHVLTERDILTTTKSE 61
Query: 231 NLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
LV+LL Y + + + L EYV G+ R + + G L+ + + +A+
Sbjct: 62 WLVKLL-YAFQDDEYLYLAMEYVPGGDF----RTLLNNLGVLSEDHARFYMAEMFEAVDA 116
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEY 349
LHE +HRD+K N LID + K++DFGL+K G V+G+ Y+APE
Sbjct: 117 LHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYMAPEV 169
Query: 350 ANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEV--NLVEWLKMM 396
+ D +S G +L E + G P P E NL W + +
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN-ETWENLKYWKETL 217
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 7e-13
Identities = 66/221 (29%), Positives = 105/221 (47%), Gaps = 30/221 (13%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ--LMNGTAVAVKKL---LNNPGQADKDFRVEVEAIGHVR 228
+++ K IG+G YGVVY+ + + N T +A+KK+ + G R E+ + ++
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNET-IALKKIRLEQEDEGVPSTAIR-EISLLKEMQ 59
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARM--KILLGTAKA 286
H N+VRL + LV+EY L+ L+ M R+ L +
Sbjct: 60 HGNIVRLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRG 114
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDA-KISDFGLAKLLGAGKSHITTRVMGTFGYV 345
+AY H +V+HRD+K N+LID +A K++DFGLA+ G T V+ T Y
Sbjct: 115 IAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYR 170
Query: 346 APEYANSGLLNEKS-----DVYSFGVVLLEAITGR--YPVD 379
APE LL + D++S G + E + + +P D
Sbjct: 171 APEI----LLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207
|
Length = 294 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 8e-13
Identities = 56/211 (26%), Positives = 101/211 (47%), Gaps = 25/211 (11%)
Query: 181 IIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRV-----EVEAIGHVRHKNLVR 234
++G G +G VY G +AVK++ +P + V E++ + ++RH +V+
Sbjct: 9 LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQ 68
Query: 235 LLGYCIEGTQRIL--VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE 292
G + ++ L EY+ G+++ L+ G LT + + ++YLH
Sbjct: 69 YYGCLRDPEEKKLSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHS 124
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAK------LLGAGKSHITTRVMGTFGYVA 346
+ +VHRDIK +NIL D + K+ DFG +K + G G +T GT +++
Sbjct: 125 NM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT----GTPYWMS 177
Query: 347 PEYANSGLLNEKSDVYSFGVVLLEAITGRYP 377
PE + K+DV+S ++E +T + P
Sbjct: 178 PEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 9e-13
Identities = 58/212 (27%), Positives = 103/212 (48%), Gaps = 23/212 (10%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLL---NNPGQADKDFRVEVEAIGHVRH 229
+R+ + +G G YG V G VA+KKL + A + +R E+ + H+ H
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDH 73
Query: 230 KNLVRLL-----GYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTA 284
+N++ LL +E Q + + ++ +L ++ C + L+ + ++
Sbjct: 74 ENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVK---CQK--LSDDHIQFLVYQIL 128
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGY 344
+ L Y+H A ++HRD+K SNI ++E+ + KI DFGLA+ T + T Y
Sbjct: 129 RGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARH----TDDEMTGYVATRWY 181
Query: 345 VAPEYA-NSGLLNEKSDVYSFGVVLLEAITGR 375
APE N N+ D++S G ++ E +TG+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 1e-12
Identities = 57/211 (27%), Positives = 102/211 (48%), Gaps = 25/211 (11%)
Query: 181 IIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRV-----EVEAIGHVRHKNLVR 234
++G G +G VY G +AVK++ +P + V E++ + ++ H+ +V+
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 235 LLGYCIEGTQRIL--VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE 292
G + +R L E++ G+++ L+ G LT K + ++YLH
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHS 124
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL------GAGKSHITTRVMGTFGYVA 346
+ +VHRDIK +NIL D + K+ DFG +K L G G +T GT +++
Sbjct: 125 NM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT----GTPYWMS 177
Query: 347 PEYANSGLLNEKSDVYSFGVVLLEAITGRYP 377
PE + K+D++S G ++E +T + P
Sbjct: 178 PEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 60/204 (29%), Positives = 90/204 (44%), Gaps = 24/204 (11%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNP-----GQADKDFRVEVEAIGHVRHKNLVRLL 236
+G G +G V + K+L+ Q + E + +RH LV L
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLN-EKRILQSIRHPFLVNLY 67
Query: 237 GYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARM---KILLGTAKALAYLHEA 293
G + + LV EYV G L LR R AR +++L AL YLH
Sbjct: 68 GSFQDDSNLYLVMEYVPGGELFSHLR--KSGRFPEPV-ARFYAAQVVL----ALEYLHSL 120
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSG 353
+V+RD+K N+L+D + KI+DFG AK + T + GT Y+APE S
Sbjct: 121 ---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYTLCGTPEYLAPEIILSK 173
Query: 354 LLNEKSDVYSFGVVLLEAITGRYP 377
+ D ++ G+++ E + G YP
Sbjct: 174 GYGKAVDWWALGILIYEMLAG-YP 196
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 62/252 (24%), Positives = 108/252 (42%), Gaps = 22/252 (8%)
Query: 182 IGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCI 240
IG+G G+V + +G VAVK + Q + EV + +H+N+V + +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 241 EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVH 300
G + ++ E++ G L D+ + L E + +AL YLH V+H
Sbjct: 89 VGEELWVLMEFLQGGALT-----DIVSQTRLNEEQIATVCESVLQALCYLHSQ---GVIH 140
Query: 301 RDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSD 360
RDIKS +IL+ + K+SDFG + + V GT ++APE + + D
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEVD 199
Query: 361 VYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALK 420
++S G++++E + G P P ++R D P ++ S +
Sbjct: 200 IWSLGIMVIEMVDGEPPYFSDSPVQ------------AMKRLRDSPPPKLKNAHKISPVL 247
Query: 421 RALLTALRCVDP 432
R L + +P
Sbjct: 248 RDFLERMLTREP 259
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 2e-12
Identities = 59/210 (28%), Positives = 108/210 (51%), Gaps = 22/210 (10%)
Query: 175 RFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQ----ADKDFRVEVEAIGHVRH 229
R++ +G G YG V G VA+KKL + P Q A + +R E+ + H++H
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL-SRPFQSEIFAKRAYR-ELTLLKHMQH 73
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCD-RGYLTWEARMKILL-GTAKAL 287
+N++ LL T + E+ + + +++ D+ G+ E +++ L+ L
Sbjct: 74 ENVIGLLDVF---TSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGL 130
Query: 288 AYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS-HITTRVMGTFGYVA 346
Y+H A ++HRD+K N+ ++E+ + KI DFGLA+ A + ++ TR Y A
Sbjct: 131 KYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRA 182
Query: 347 PEYANSGL-LNEKSDVYSFGVVLLEAITGR 375
PE + + N+ D++S G ++ E +TG+
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 181 IIGDGGYGVVYRGQLMNG--------TAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL 232
++G G YG V+ + ++G V K + + + R E + + H+R
Sbjct: 7 VLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 66
Query: 233 VRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG-TAKALAYL 290
+ L Y + ++ L+ +Y+N G L L R E ++I G AL +L
Sbjct: 67 LVTLHYAFQTDTKLHLILDYINGGELFTHL----SQRERFK-EQEVQIYSGEIVLALEHL 121
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYA 350
H+ +++RDIK NIL+D N ++DFGL+K + GT Y+AP+
Sbjct: 122 HKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIV 178
Query: 351 NSGLL--NEKSDVYSFGVVLLEAITGRYP 377
G ++ D +S GV++ E +TG P
Sbjct: 179 RGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 3e-12
Identities = 66/216 (30%), Positives = 103/216 (47%), Gaps = 33/216 (15%)
Query: 175 RFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQ----ADKDFRVEVEAIGHVRH 229
R+ + +G G YG V G VAVKKL + P Q A + +R E+ + H++H
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYR-ELRLLKHMKH 75
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRG-DM-----CDRGYLTWEARMKILLGT 283
+N++ LL E N+ L L G D+ C + LT + ++
Sbjct: 76 ENVIGLLDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIYQI 129
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMG--- 340
+ L Y+H A ++HRD+K SN+ ++E+ + KI DFGLA+ H + G
Sbjct: 130 LRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMTGYVA 179
Query: 341 TFGYVAPEYA-NSGLLNEKSDVYSFGVVLLEAITGR 375
T Y APE N N+ D++S G ++ E +TGR
Sbjct: 180 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 70/219 (31%), Positives = 104/219 (47%), Gaps = 28/219 (12%)
Query: 181 IIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFR---VEVEAIGHV-RHKNLVRL 235
++G G +G V+ +L A+K L + D D VE + H L L
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHL 61
Query: 236 LGYCIEGTQRIL--VYEYVNNGNLEQWLRGDMCDRGYL---TWEARMKILLGTAKALAYL 290
YC T+ L V EY+N G+L ++ C + L T+ A +I+ G L +L
Sbjct: 62 --YCTFQTKENLFFVMEYLNGGDLMFHIQS--CHKFDLPRATFYA-AEIICG----LQFL 112
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK--LLGAGKSHITTRVMGTFGYVAPE 348
H +V+RD+K NIL+D + KI+DFG+ K +LG K T GT Y+APE
Sbjct: 113 HSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK---TCTFCGTPDYIAPE 166
Query: 349 YANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEV 387
N D +SFGV+L E + G+ P +G + E+
Sbjct: 167 ILLGQKYNTSVDWWSFGVLLYEMLIGQSPF-HGHDEEEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 59/229 (25%), Positives = 110/229 (48%), Gaps = 31/229 (13%)
Query: 168 DLQSATNRFSKDNIIGDGGYGVVYRGQLMNGT------AVAVKKLLNN-PGQADKDFRVE 220
++ +T RF ++ +G+ +G VY+G L AVA+K L + G ++F+ E
Sbjct: 1 EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 221 VEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWL--RGDMCDRGYLTWEARMK 278
++H N+V LLG + +++ Y ++ +L ++L R D G + +K
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 279 ----------ILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328
I+ A + +L VVH+D+ + N+L+ + + KISD GL + +
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175
Query: 329 AGKSHITTRVMGT----FGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT 373
A + ++MG +++PE G + SD++S+GVVL E +
Sbjct: 176 AADYY---KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 69/225 (30%), Positives = 104/225 (46%), Gaps = 43/225 (19%)
Query: 182 IGDGGYGVVYRGQLM---NGTAVAVKKLLNNPGQ---ADKDFRVEVEAIGHVR-HKNLVR 234
+G G YG+V + VA+KK+ N + A + R E++ + H R HKN+
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALR-ELKLLRHFRGHKNITC 66
Query: 235 LLGYCI---EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLGTAKA 286
L I + +YE + +L Q +R LT +A + IL G
Sbjct: 67 LYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQ----PLT-DAHFQSFIYQILCG---- 117
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK----SHITTRVMGTF 342
L Y+H A V+HRD+K N+L++ + + KI DFGLA+ +T V T
Sbjct: 118 LKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-ATR 173
Query: 343 GYVAPEYANSGLLNEKS-----DVYSFGVVLLEAITGRYPVDYGR 382
Y APE +L+ +S DV+S G +L E + GR PV G+
Sbjct: 174 WYRAPEI----MLSFQSYTKAIDVWSVGCILAE-LLGRKPVFKGK 213
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 5e-12
Identities = 70/215 (32%), Positives = 101/215 (46%), Gaps = 20/215 (9%)
Query: 181 IIGDGGYG-VVYRGQLMNGTAVAVKKL-----LNNPGQADKDFRVEVEAI-GHVRHKNLV 233
+IG G +G V+ + ++G AVK L LN Q K E + +V+H LV
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQ--KHIMAERNVLLKNVKHPFLV 59
Query: 234 RLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE 292
L Y + T+++ V ++VN G L L+ + R + AR A AL YLH
Sbjct: 60 GL-HYSFQTTEKLYFVLDFVNGGELFFHLQRE---RSFPEPRARFYAA-EIASALGYLHS 114
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANS 352
+V+RD+K NIL+D ++DFGL K G +S TT GT Y+APE
Sbjct: 115 I---NIVYRDLKPENILLDSQGHVVLTDFGLCK-EGIAQSDTTTTFCGTPEYLAPEVIRK 170
Query: 353 GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEV 387
+ D + G VL E + G P Y R +E+
Sbjct: 171 QPYDNTVDWWCLGAVLYEMLYGLPPF-YCRDVAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 63/207 (30%), Positives = 105/207 (50%), Gaps = 19/207 (9%)
Query: 176 FSKDNIIGDGGYGVVYRGQL-MNGTAVAVK--KLLNNPGQADKDFRVEVEAIGHVRHKNL 232
+ K + +G+G Y VY+G+ + VA+K +L + G R EV + ++H N+
Sbjct: 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANI 66
Query: 233 VRLLGYCIEGTQR--ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILL-GTAKALAY 289
V L + I T++ LV+EY++ +L+Q+L D C G +K+ L + L Y
Sbjct: 67 VTL--HDIIHTEKSLTLVFEYLDK-DLKQYL--DDC--GNSINMHNVKLFLFQLLRGLNY 119
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPE- 348
H KV+HRD+K N+LI+E + K++DFGLA+ + V+ T Y P+
Sbjct: 120 CHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDI 175
Query: 349 YANSGLLNEKSDVYSFGVVLLEAITGR 375
S + + D++ G + E TGR
Sbjct: 176 LLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 8e-12
Identities = 52/162 (32%), Positives = 73/162 (45%), Gaps = 21/162 (12%)
Query: 222 EAIGHVRHKNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKIL 280
E RH LV L C + + V EY G+L + D+ + A +L
Sbjct: 54 ETANSERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVL 112
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMG 340
L YLHE K+V+RD+K N+L+D KI+DFGL K G G T+ G
Sbjct: 113 -----GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCG 163
Query: 341 TFGYVAPEYANSGLLNEKS-----DVYSFGVVLLEAITGRYP 377
T ++APE +L E S D + GV++ E + G P
Sbjct: 164 TPEFLAPE-----VLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 8e-12
Identities = 59/199 (29%), Positives = 98/199 (49%), Gaps = 15/199 (7%)
Query: 182 IGDGGYGVVYRGQL-MNGTAVAVK--KLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGY 238
+G+G Y V++G+ + VA+K +L + G R EV + ++H N+V L
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHDI 72
Query: 239 CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILL-GTAKALAYLHEAIEPK 297
LV+EY++ +L+Q+ M D G + +KI L + LAY H K
Sbjct: 73 VHTDKSLTLVFEYLDK-DLKQY----MDDCGNIMSMHNVKIFLYQILRGLAYCHRR---K 124
Query: 298 VVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPE-YANSGLLN 356
V+HRD+K N+LI+E + K++DFGLA+ + V+ T Y P+ S +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSSEYS 183
Query: 357 EKSDVYSFGVVLLEAITGR 375
+ D++ G + E +GR
Sbjct: 184 TQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 8e-12
Identities = 79/280 (28%), Positives = 124/280 (44%), Gaps = 36/280 (12%)
Query: 182 IGDGGYGVVYRGQ-LMNGTA-VAVKKL---LNNPGQADKDFRVEVEAIGHVR---HKNLV 233
IG+G YG V++ + L NG VA+K++ G R EV + H+ H N+V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIR-EVAVLRHLETFEHPNVV 67
Query: 234 RLLGYCI-----EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALA 288
RL C T+ LV+E+V+ +L +L + + G T E ++ + L
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLD-KVPEPGVPT-ETIKDMMFQLLRGLD 124
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPE 348
+LH +VVHRD+K NIL+ + K++DFGLA++ T V+ T Y APE
Sbjct: 125 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRAPE 179
Query: 349 YANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD- 407
D++S G + E R P+ G S+V+ QL + DV+
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFR-RKPLFRG--SSDVD---------QLGKILDVIGL 227
Query: 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447
P E P AL R + + P + ++ + L
Sbjct: 228 PGEEDWPRDVALPRQAFHS-KSAQPIEKFVTDIDELGKDL 266
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 8e-12
Identities = 55/202 (27%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 180 NIIGDGGYGVVYRG-QLMNGTAVAVKKL-LNNPGQADKDFRVEVEAIGHVRHKNLVRLLG 237
I+G G G VY+ L+ +AVK + L+ + K E+E + ++ G
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 238 -YCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIE 295
+ +E RI + E+++ G+L+ + + +I + K L YL
Sbjct: 67 AFFVE--NRISICTEFMDGGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLWSL-- 114
Query: 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLL 355
K++HRD+K SN+L++ K+ DFG++ L + I +GT Y+APE +
Sbjct: 115 -KILHRDVKPSNMLVNTRGQVKLCDFGVSTQL---VNSIAKTYVGTNAYMAPERISGEQY 170
Query: 356 NEKSDVYSFGVVLLEAITGRYP 377
SDV+S G+ +E GR+P
Sbjct: 171 GIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 9e-12
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 25/211 (11%)
Query: 175 RFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKL---LNNPGQADKDFRVEVEAIGHVRHK 230
R+ + IG G G+V + G VAVKKL N A + +R E+ + V HK
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHK 80
Query: 231 NLVRLLGY-----CIEGTQRILVYEYVNNGNLEQWLRGDMCDR--GYLTWEARMKILLGT 283
N++ LL +E Q + + + + NL Q + ++ YL ++ +L G
Sbjct: 81 NIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQ----MLCG- 135
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
+ +LH A ++HRD+K SNI++ + KI DFGLA+ A + + T + T
Sbjct: 136 ---IKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART--ACTNFMMTPYVVTRY 187
Query: 344 YVAPEYANSGLLNEKSDVYSFGVVLLEAITG 374
Y APE E D++S G ++ E + G
Sbjct: 188 YRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 19/204 (9%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQAD---KDFRVEVEAIGHVRHKNLVRLLG 237
IG G +G VY + + N VA+KK+ + Q++ +D EV + +RH N ++ G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 238 YCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK 297
+ LV EY G+ L + L + G + LAYLH
Sbjct: 83 CYLREHTAWLVMEYCL-GSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHSH---N 135
Query: 298 VVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEY---ANSGL 354
++HRD+K+ NIL+ E K+ DFG A ++ + GT ++APE + G
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEVILAMDEGQ 190
Query: 355 LNEKSDVYSFGVVLLEAITGRYPV 378
+ K DV+S G+ +E + P+
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 1e-11
Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 18/196 (9%)
Query: 182 IGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQADKDFRV---EVEAIGHVRHKNLVRLLG 237
IG G YG VY+ + +N G A+K + PG+ DF V E+ + +H N+V G
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGE---DFAVVQQEIIMMKDCKHSNIVAYFG 73
Query: 238 YCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK 297
+ + + E+ G+L+ G L+ + T + L YLH +
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLHSKGK-- 127
Query: 298 VVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYA---NSGL 354
+HRDIK +NIL+ +N K++DFG++ + A + + +GT ++APE A G
Sbjct: 128 -MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS-FIGTPYWMAPEVAAVERKGG 185
Query: 355 LNEKSDVYSFGVVLLE 370
N+ D+++ G+ +E
Sbjct: 186 YNQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 20/204 (9%)
Query: 182 IGDGGYGVVYRGQLMNG---TAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLG 237
IG+G +G V G++ +G V VK+L + Q F E + ++H NL++ LG
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 238 YCIEGTQRILVYEYVNNGNLEQWLRGDMCDRG-YLTWEARM--KILLGTAKALAYLHEAI 294
C E T +LV E+ G+L+ +LR C + +T + ++ A L +LH+
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRS--CRKAELMTPDPTTLQRMACEIALGLLHLHKN- 119
Query: 295 EPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITT-RVMGTFGYVAPEYAN-- 351
+H D+ N L+ + KI D+GL+ ++T ++ ++APE +
Sbjct: 120 --NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177
Query: 352 -SGLL----NEKSDVYSFGVVLLE 370
LL ++S+V+S GV + E
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWE 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 49/159 (30%), Positives = 76/159 (47%), Gaps = 9/159 (5%)
Query: 236 LGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI 294
L C + T R+ LV EYVN G+L M + L E AL +LHE
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDL----MFHMQRQRKLPEEHARFYAAEICIALNFLHER- 115
Query: 295 EPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGL 354
+++RD+K N+L+D + K++D+G+ K G G T+ GT Y+APE
Sbjct: 116 --GIIYRDLKLDNVLLDADGHIKLTDYGMCK-EGLGPGDTTSTFCGTPNYIAPEILRGEE 172
Query: 355 LNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWL 393
D ++ GV++ E + GR P D ++N ++L
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYL 211
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 37/210 (17%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGY 238
+G+G Y VY+G+ + G VA+K++ G R E + ++H N+V L +
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTL--H 69
Query: 239 CIEGTQRIL--VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEP 296
I T++ L V+EY++ +L+Q++ D C G R+ L + LAY H+
Sbjct: 70 DIIHTKKTLTLVFEYLDT-DLKQYM--DDCGGGLSMHNVRL-FLFQLLRGLAYCHQR--- 122
Query: 297 KVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMG----TFGYVAP----- 347
+V+HRD+K N+LI E + K++DFGLA+ KS + ++ T Y P
Sbjct: 123 RVLHRDLKPQNLLISERGELKLADFGLAR----AKS-VPSKTYSNEVVTLWYRPPDVLLG 177
Query: 348 --EYANSGLLNEKSDVYSFGVVLLEAITGR 375
EY+ S D++ G + E TGR
Sbjct: 178 STEYSTS------LDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 62/237 (26%), Positives = 105/237 (44%), Gaps = 42/237 (17%)
Query: 171 SATNRFS-KDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQAD-KDFRVEVEAIG-- 225
S + R+ K +G+G YG V + + G VA+KK+ D R V G
Sbjct: 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIH 64
Query: 226 -----------HVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWE 274
++H+N++ L+ +EG LV + + +L++ + DR E
Sbjct: 65 FTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVV-----DRKIRLTE 118
Query: 275 ARMK-ILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG----- 328
+++K ILL L LH+ +HRD+ +NI I+ KI+DFGLA+ G
Sbjct: 119 SQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYS 175
Query: 329 ---------AGKSHITTRVMGTFGYVAPE-YANSGLLNEKSDVYSFGVVLLEAITGR 375
+ +T++V+ T Y APE + + D++S G + E +TG+
Sbjct: 176 DTLSKDETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 65/220 (29%), Positives = 104/220 (47%), Gaps = 46/220 (20%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPG---QADKDFRVEVEAIG--------HVRHK 230
+G G YG VY K+L+ P A K+ R+E++ + HK
Sbjct: 9 LGKGNYGSVY-------------KVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHK 55
Query: 231 ----NLVRLLG-YCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAK 285
+V G + IEG + + EY++ G+L++ L + + +I K
Sbjct: 56 AVSPYIVDFYGAFFIEGAVYMCM-EYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVK 113
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA--GKSHITTRVMGTFG 343
L +L E E ++HRD+K +N+L++ N K+ DFG++ L A K++I G
Sbjct: 114 GLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQS 166
Query: 344 YVAPEYANSGLLNE------KSDVYSFGVVLLEAITGRYP 377
Y+APE SG N+ +SDV+S G+ +LE GRYP
Sbjct: 167 YMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 182 IGDGGYGVVYR-GQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-HKNLVRLLGY- 238
IG G YG V++ NG+ AVK +L+ D++ E + + H N+V+ G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84
Query: 239 ----CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTA-KALAYLHEA 293
G Q LV E N G++ ++G RG E + +L A L +LH
Sbjct: 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKG-FLKRGERMEEPIIAYILHEALMGLQHLHVN 143
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYAN-- 351
K +HRD+K +NIL+ K+ DFG++ L + + T V GT ++APE
Sbjct: 144 ---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACE 199
Query: 352 ---SGLLNEKSDVYSFGVVLLEAITGRYPV 378
+ + DV+S G+ +E G P+
Sbjct: 200 QQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 38/101 (37%), Positives = 57/101 (56%), Gaps = 11/101 (10%)
Query: 278 KILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337
+I+LG L ++H VV+RD+K +NIL+DE+ +ISD GLA K H +
Sbjct: 105 EIILG----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-- 155
Query: 338 VMGTFGYVAPEYANSGLLNEKS-DVYSFGVVLLEAITGRYP 377
+GT GY+APE G+ + S D +S G +L + + G P
Sbjct: 156 -VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 69/237 (29%), Positives = 118/237 (49%), Gaps = 38/237 (16%)
Query: 170 QSATNRFSKDNIIGDGGYGVVYRGQLMNGT-AVAVKKLLNNPGQADKDFRVEVEAIGHVR 228
+S + NIIG+G +GVVY ++ + VA+KK+L +P +++ + + ++
Sbjct: 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLI----MKNLN 117
Query: 229 HKNLVRLLGY----CIEGTQRIL----VYEYVN---NGNLEQWLRGDMCDRGYLTWEARM 277
H N++ L Y C + ++ + V E++ + ++ + R + +L
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSY 177
Query: 278 KILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDA-KISDFGLAKLLGAGK---SH 333
++ +ALAY+H + HRD+K N+LID N K+ DFG AK L AG+ S+
Sbjct: 178 QL----CRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSY 230
Query: 334 ITTRVMGTFGYVAPEYANSGLLNEKS--DVYSFGVVLLEAITGRYPVDYGRPQSEVN 388
I +R Y APE G N + D++S G ++ E I G YP+ G QS V+
Sbjct: 231 ICSRF-----YRAPELM-LGATNYTTHIDLWSLGCIIAEMILG-YPIFSG--QSSVD 278
|
Length = 440 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 3e-11
Identities = 70/285 (24%), Positives = 119/285 (41%), Gaps = 48/285 (16%)
Query: 182 IGDGGYGVVYRGQL-------MNGTAVAVKKLLNNPGQADKDFRVEVEAIG---HVRHKN 231
+G G + +Y+G L + G V +L G +D E + HK+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
LV+L G C+ + I+V EYV G L+ +L + + ++ ++ + A AL YL
Sbjct: 63 LVKLYGVCVR-DENIMVEEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLE 118
Query: 292 EAIEPKVVHRDIKSSNILI-----DENF--DAKISDFGLAKLLGAGKSHITTRVMGTFGY 344
+ K+VH ++ NIL+ +E + K+SD G+ + + + R+ +
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS-REERVERI----PW 170
Query: 345 VAPEYANSGL--LNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRS 402
+APE +G L +D +SFG LLE I P S ++ E + R
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLE-ICSNGE----EPLSTLSSSE------KERFY 219
Query: 403 EDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447
+D + P + L + C D KRP ++R L
Sbjct: 220 QD---QHRLPMPDCAELANLINQ---CWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 49/148 (33%), Positives = 75/148 (50%), Gaps = 22/148 (14%)
Query: 238 YCIEGTQRIL--VYEYVNNGNL----EQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
+C T+ L V EY+N G+L + R D + E I+ G L +LH
Sbjct: 62 FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAE----IICG----LQFLH 113
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK--LLGAGKSHITTRVMGTFGYVAPEY 349
+ +++RD+K N+L+D++ KI+DFG+ K + G GK + GT Y+APE
Sbjct: 114 KK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK---ASTFCGTPDYIAPEI 167
Query: 350 ANSGLLNEKSDVYSFGVVLLEAITGRYP 377
NE D +SFGV+L E + G+ P
Sbjct: 168 LKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 54/268 (20%), Positives = 104/268 (38%), Gaps = 35/268 (13%)
Query: 190 VYRGQLMNGTAVAV---KKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQR- 245
+Y+G N V + KK E++ + + N++++ G+ I+
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 246 ---ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRD 302
L+ EY G L + L + L+++ ++ + + K L L++ +++
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKN 148
Query: 303 IKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGL--LNEKSD 360
+ S + L+ EN+ KI GL K+L S + + Y + + N K D
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKIL----SSPPFKNVNFMVYFSYKMLNDIFSEYTIKDD 204
Query: 361 VYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALK 420
+YS GVVL E TG+ P + + +L +++ N +
Sbjct: 205 IYSLGVVLWEIFTGKIPFENLTTKEIYDL---------------IINKNNSLKLPLDCPL 249
Query: 421 RALLTALRCVDPDSDKRPKMSQVVRMLE 448
C DS KRP + +++ L
Sbjct: 250 EIKCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 4e-11
Identities = 62/202 (30%), Positives = 96/202 (47%), Gaps = 15/202 (7%)
Query: 182 IGDGGYGVVYRGQLMN-GTAVAVKKL----LNNPGQADKDFRVEVEAIGHVRHKNLVRLL 236
+G GG+G V Q+ N G A KKL L +K +E E + V +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKS-GEKMALLEKEILEKVNSPFIVNL- 58
Query: 237 GYCIEG-TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIE 295
Y E T LV +N G+L+ + ++ +RG L E + + +LH
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIY-NVGERG-LEMERVIHYSAQITCGILHLHSM-- 114
Query: 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLL 355
+V+RD+K N+L+D+ + ++SD GLA L GK+ T+ GT GY+APE
Sbjct: 115 -DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPY 171
Query: 356 NEKSDVYSFGVVLLEAITGRYP 377
+ D ++ G + E + GR P
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 23/209 (11%)
Query: 181 IIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFR---VEVEAIGHVRHKNLVRLL 236
++G G +G V +L +G AVK L + D D E + R+ + L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 237 GYCIEGTQRIL-VYEYVNNGNL----EQWLRGDMCDRGYLTWEARMKILLG-TAKALAYL 290
C + R+ V E+VN G+L ++ R D EAR + AL +L
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD---------EARARFYAAEITSALMFL 112
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYA 350
H+ +++RD+K N+L+D K++DFG+ K G T+ GT Y+APE
Sbjct: 113 HDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGIFNGKTTSTFCGTPDYIAPEIL 168
Query: 351 NSGLLNEKSDVYSFGVVLLEAITGRYPVD 379
L D ++ GV+L E + G P +
Sbjct: 169 QEMLYGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 4e-11
Identities = 53/208 (25%), Positives = 94/208 (45%), Gaps = 29/208 (13%)
Query: 182 IGDGGYGVVYRGQLMNGTAVA---VKKLLNNPGQADKD-FRVEVEAIGHVRHKNLVRLLG 237
IG+G +G V ++ T VA VK+L N +++ F + + ++H N+++ LG
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 238 YCIEGTQRILVYEYVNNGNL------EQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
C+E +LV+EY G+L EQW R + L RM + A + ++H
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRN----SQLLLLQRMACEI--AAGVTHMH 116
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITT--RVMGTFGYVAPEY 349
+ +H D+ N + + K+ D+G+ + +I T ++APE
Sbjct: 117 KH---NFLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWLAPEL 172
Query: 350 ANS---GLL----NEKSDVYSFGVVLLE 370
GL+ + S+V++ GV L E
Sbjct: 173 VGEFHGGLITAEQTKPSNVWALGVTLWE 200
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 4e-11
Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 18/205 (8%)
Query: 182 IGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFR---VEVEAIGHVRHKNLVRLLG 237
+G GG+G V Q+ G A KKL + K + VE + V H + L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLA 59
Query: 238 YCIE-GTQRILVYEYVNNGNLEQWLRG-DMCDRGYLTWEA---RMKILLGTAKALAYLHE 292
Y + T LV +N G+L + D + G+ A +I+ G L +LH+
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG----LEHLHQ 115
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANS 352
++++RD+K N+L+D + + +ISD GLA L G+S T GT G++APE
Sbjct: 116 R---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQG 171
Query: 353 GLLNEKSDVYSFGVVLLEAITGRYP 377
+ D ++ GV L E I R P
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 18/214 (8%)
Query: 181 IIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEA-----IGHVRHKNLVRL 235
+IG G +G V + + + K+L K + + A + +++H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 236 LGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG-TAKALAYLHEA 293
Y + +++ V +YVN G L L+ + C E R + A A+ YLH
Sbjct: 62 -HYSFQTAEKLYFVLDYVNGGELFFHLQRERCFL-----EPRARFYAAEVASAIGYLHSL 115
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSG 353
+++RD+K NIL+D ++DFGL K G T+ GT Y+APE
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGVEPEETTSTFCGTPEYLAPEVLRKE 171
Query: 354 LLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEV 387
+ D + G VL E + G P Y R S++
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPF-YSRDVSQM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 5e-11
Identities = 47/158 (29%), Positives = 73/158 (46%), Gaps = 20/158 (12%)
Query: 228 RHKNLVRLLGYCIEGTQRI-LVYEYVNNGNL----EQWLRGDMCDRGYLTWEARMKILLG 282
+H L +L C + R+ V EYVN G+L ++ R D E R +
Sbjct: 54 KHPFLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFD---------EPRARFYAA 103
Query: 283 -TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
L +LHE +++RD+K N+L+D KI+DFG+ K G T+ GT
Sbjct: 104 EIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK-EGILGGVTTSTFCGT 159
Query: 342 FGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVD 379
Y+APE + D ++ GV+L E + G+ P +
Sbjct: 160 PDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 76/262 (29%), Positives = 119/262 (45%), Gaps = 24/262 (9%)
Query: 176 FSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRV---EVEAIGHVRHKN 231
F + ++G GG+G V Q+ G A KKL + K + E + + V +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 232 LVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYL 290
+V L Y E + LV +N G+L+ + M + G+ E R + A+ L
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIY-HMGEAGFE--EGRA--VFYAAEICCGL 115
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYA 350
+ + ++V+RD+K NIL+D++ +ISD GLA + G++ I RV GT GY+APE
Sbjct: 116 EDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVV 173
Query: 351 NSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNI 410
+ D ++ G +L E I G+ P + + + VE L VQ SE
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKF----- 228
Query: 411 ETRPSTSALKRALLTALRCVDP 432
S R+L L C DP
Sbjct: 229 ------SPDARSLCKMLLCKDP 244
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 5e-11
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 176 FSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQAD---KDFRVEVEAIGHVRHKN 231
F+ IG G +G VY + + VA+KK+ + Q++ +D EV+ + ++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
+ G + LV EY G+ L + L I G + LAYLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCL-GSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLH 142
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEY-- 349
++HRDIK+ NIL+ E K++DFG A + S + GT ++APE
Sbjct: 143 SH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEVIL 194
Query: 350 -ANSGLLNEKSDVYSFGVVLLEAITGRYPV 378
+ G + K DV+S G+ +E + P+
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 6e-11
Identities = 70/266 (26%), Positives = 110/266 (41%), Gaps = 36/266 (13%)
Query: 181 IIGDGGYGVVYRGQLMNG--------TAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL 232
++G G YG V+ + + G V K L + + R E + HVR
Sbjct: 7 VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPF 66
Query: 233 VRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG-TAKALAYL 290
+ L Y + ++ L+ +YV+ G + L R + E ++ G AL +L
Sbjct: 67 LVTLHYAFQTEAKLHLILDYVSGGEMFTHLY----QRDNFS-EDEVRFYSGEIILALEHL 121
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYA 350
H+ +V+RDIK NIL+D ++DFGL+K + + T GT Y+APE
Sbjct: 122 HKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEII 178
Query: 351 NSGLLNEKS-DVYSFGVVLLEAITGRYPVDY---GRPQSEVNLVEWLKMMVQLRRSEDVV 406
+ K+ D +S G+++ E +TG P QSEV+ LK
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR-RILKC----------- 226
Query: 407 DPNIETRPSTSALKRALLTALRCVDP 432
DP + + LL L DP
Sbjct: 227 DPPFPSF--IGPEAQDLLHKLLRKDP 250
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 6e-11
Identities = 74/265 (27%), Positives = 120/265 (45%), Gaps = 40/265 (15%)
Query: 175 RFSKDNIIGDGGYGVV---YRGQLMNGTAVAVKKL---LNNPGQADKDFRVEVEAIGHVR 228
R+ IG G G+V Y L VA+KKL N A + +R E+ + V
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVN 74
Query: 229 HKNLVRLLGY-----CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGT 283
HKN++ LL +E Q + + + + NL Q ++ + L E +L
Sbjct: 75 HKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME------LDHERMSYLLYQM 128
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
+ +LH A ++HRD+K SNI++ + KI DFGLA+ AG S + T + T
Sbjct: 129 LCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRY 183
Query: 344 YVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDY-GRPQSEVNLVEWLKMMVQL--- 399
Y APE E D++S G ++ E + R+ + + GR + +W K++ QL
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMV--RHKILFPGRDYID----QWNKVIEQLGTP 237
Query: 400 -----RRSEDVVDPNIETRPSTSAL 419
++ + V +E RP + L
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYAGL 262
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 7e-11
Identities = 70/213 (32%), Positives = 101/213 (47%), Gaps = 25/213 (11%)
Query: 174 NRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKL---LNNPGQADKDFRVEVEAIGHVRH 229
R+ IG G G+V + G VA+KKL N A + +R E+ + V H
Sbjct: 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNH 74
Query: 230 KNLVRLLGY-----CIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILL-G 282
KN++ LL +E Q + LV E ++ NL Q ++ D L E RM LL
Sbjct: 75 KNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD------LDHE-RMSYLLYQ 126
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF 342
+ +LH A ++HRD+K SNI++ + KI DFGLA+ AG S + T + T
Sbjct: 127 MLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTR 181
Query: 343 GYVAPEYANSGLLNEKSDVYSFGVVLLEAITGR 375
Y APE E D++S G ++ E I G
Sbjct: 182 YYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 8e-11
Identities = 62/214 (28%), Positives = 93/214 (43%), Gaps = 18/214 (8%)
Query: 181 IIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEA-----IGHVRHKNLVRL 235
+IG G +G V + K+L K + + A + +V+H LV L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 236 LGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG-TAKALAYLHEA 293
Y + ++ V +YVN G L L+ + R + E R + A AL YLH
Sbjct: 62 -HYSFQTADKLYFVLDYVNGGELFFHLQRE---RSFP--EPRARFYAAEIASALGYLHSL 115
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSG 353
+++RD+K NIL+D ++DFGL K G S T+ GT Y+APE
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCGTPEYLAPEVLRKQ 171
Query: 354 LLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEV 387
+ D + G VL E + G P Y R +E+
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPF-YSRDTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 9e-11
Identities = 66/250 (26%), Positives = 96/250 (38%), Gaps = 67/250 (26%)
Query: 174 NRFSKDNIIGDGGYGVVY------RGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV 227
+ F +IG G +G V+ GQ+ A+K L K ++ I HV
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQV-----YAMKVLR-------KSDMIKRNQIAHV 48
Query: 228 RHKN----------LVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWE-A 275
R + +V+L Y + + + LV EY+ G+L L + E A
Sbjct: 49 RAERDILADADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLL----IRKDVFPEETA 103
Query: 276 RMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK---- 331
R I A+ + L + +HRDIK NILID + K++DFGL K + K
Sbjct: 104 RFYI----AELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159
Query: 332 -------------------SHITTRVM-----GTFGYVAPEYANSGLLNEKSDVYSFGVV 367
H RV GT Y+APE + D +S GV+
Sbjct: 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVI 219
Query: 368 LLEAITGRYP 377
L E + G P
Sbjct: 220 LYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 10/205 (4%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNGTA-VAVKKLLNNPGQAD-KDFRV-EVEAIGHVRHK 230
N+F ++G+G YGVV + + VA+KK ++ + K+ + E++ + ++ +
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 231 NLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYL 290
N+V L + LV+EYV LE L +M + G + R I KA+ +
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPN-GVPPEKVRSYIY-QLIKAIHWC 116
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYA 350
H+ +VHRDIK N+LI N K+ DFG A+ L G + T + T Y +PE
Sbjct: 117 HKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELL 173
Query: 351 NSGLLNEKSDVYSFGVVLLEAITGR 375
+ D++S G +L E G+
Sbjct: 174 LGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 1e-10
Identities = 74/261 (28%), Positives = 116/261 (44%), Gaps = 42/261 (16%)
Query: 175 RFSKDNIIGDGGYGVV---YRGQLMNGTAVAVKKL---LNNPGQADKDFRVEVEAIGHVR 228
R+ IG G G+V Y L VA+KKL N A + +R E+ + V
Sbjct: 25 RYQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVN 81
Query: 229 HKNLVRLLGY-----CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGT 283
HKN++ LL +E Q + + + + NL Q ++ + L E +L
Sbjct: 82 HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME------LDHERMSYLLYQM 135
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
+ +LH A ++HRD+K SNI++ + KI DFGLA+ AG S + T + T
Sbjct: 136 LCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRY 190
Query: 344 YVAPEYANSGLLNEKSDVYSFGVVLLEAITGR--YPVDYGRPQSEVNLVEWLKMMVQL-- 399
Y APE E D++S G ++ E I G +P G + +W K++ QL
Sbjct: 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFP---GTDHID----QWNKVIEQLGT 243
Query: 400 ------RRSEDVVDPNIETRP 414
++ + V +E RP
Sbjct: 244 PCPEFMKKLQPTVRTYVENRP 264
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 60/206 (29%), Positives = 100/206 (48%), Gaps = 27/206 (13%)
Query: 182 IGDGGYGVV-YRGQLMNGTAVAVKKLLNNPGQAD----KDFRVEVEAIGHVRHKNLVRLL 236
+G G YG V G VA+KKL P Q++ + +R E+ + H++H+N++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKL-YRPFQSELFAKRAYR-ELRLLKHMKHENVIGLL 80
Query: 237 GYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-----WEARMKILL-GTAKALAYL 290
+ ++ L G D G L E R++ L+ K L Y+
Sbjct: 81 DVFTPDLS----LDRFHDFYLVMPFMG--TDLGKLMKHEKLSEDRIQFLVYQMLKGLKYI 134
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYA 350
H A ++HRD+K N+ ++E+ + KI DFGLA+ S +T V+ T Y APE
Sbjct: 135 HAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVV-TRWYRAPEVI 187
Query: 351 NSGL-LNEKSDVYSFGVVLLEAITGR 375
+ + + D++S G ++ E +TG+
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 62/208 (29%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 179 DNIIGDGGYGVVY-----RGQLMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVRHK 230
D IG G +GVV+ R +G VA+KK+ N N + FR E++ + +H
Sbjct: 5 DRPIGYGAFGVVWSVTDPR----DGKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHD 59
Query: 231 NLVRLLGYCIEGTQRILVYE--YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALA 288
N++ L I I +E YV ++ L + L+ + L + L
Sbjct: 60 NVLSALD--ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLK 117
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPE 348
YLH A ++HRDIK N+L++ N KI DFGLA++ +S T+ + T Y APE
Sbjct: 118 YLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPE 174
Query: 349 -YANSGLLNEKSDVYSFGVVLLEAITGR 375
S D++S G + E + R
Sbjct: 175 ILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 66/216 (30%), Positives = 93/216 (43%), Gaps = 27/216 (12%)
Query: 220 EVEAIGHVRHKNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK 278
E + + RH L L Y + R+ V EYVN G L L R + E R +
Sbjct: 45 ESRVLKNTRHPFLTSL-KYSFQTKDRLCFVMEYVNGGELFFHL-----SRERVFSEDRTR 98
Query: 279 ILLG-TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337
AL YLH K+V+RD+K N+++D++ KI+DFGL K G +
Sbjct: 99 FYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK-EGITDAATMKT 154
Query: 338 VMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMV 397
GT Y+APE D + GVV+ E + GR P Q L E + M
Sbjct: 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF---YNQDHEKLFELILM-- 209
Query: 398 QLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPD 433
ED+ P + SA ++LL+ L DP+
Sbjct: 210 -----EDIKFPR-----TLSADAKSLLSGLLIKDPN 235
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 2e-10
Identities = 67/263 (25%), Positives = 111/263 (42%), Gaps = 32/263 (12%)
Query: 181 IIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEA-----IGHVRHKNLVRL 235
+IG G +G V + K+L K + + + +V+H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 236 LGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI 294
+ + ++ V +Y+N G L L+ + C +L AR A AL YLH
Sbjct: 62 -HFSFQTADKLYFVLDYINGGELFYHLQRERC---FLEPRARF-YAAEIASALGYLHSL- 115
Query: 295 EPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGL 354
+V+RD+K NIL+D ++DFGL K + T+ GT Y+APE +
Sbjct: 116 --NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 355 LNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRP 414
+ D + G VL E + G P Y R +E+ +++++ ++ +P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAEM--------------YDNILNKPLQLKP 217
Query: 415 STSALKRALLTALRCVDPDSDKR 437
+ + R LL L + D KR
Sbjct: 218 NITNSARHLLEGL--LQKDRTKR 238
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 38/101 (37%), Positives = 56/101 (55%), Gaps = 11/101 (10%)
Query: 278 KILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337
+I+LG L ++H VV+RD+K +NIL+DE+ +ISD GLA K H +
Sbjct: 105 EIILG----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS-- 155
Query: 338 VMGTFGYVAPEYANSGLLNEKS-DVYSFGVVLLEAITGRYP 377
+GT GY+APE G + S D +S G +L + + G P
Sbjct: 156 -VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 64/209 (30%), Positives = 89/209 (42%), Gaps = 31/209 (14%)
Query: 228 RHKNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARM---KILLGT 283
RH L L Y + R+ V EY N G L L + R + AR +I+
Sbjct: 53 RHPFLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRE---RVFSEDRARFYGAEIVS-- 106
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
AL YLH VV+RD+K N+++D++ KI+DFGL K G GT
Sbjct: 107 --ALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPE 160
Query: 344 YVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSE 403
Y+APE D + GVV+ E + GR P Y + + L E + M E
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHEK--LFELILM-------E 210
Query: 404 DVVDPNIETRPSTSALKRALLTALRCVDP 432
++ P S A ++LL L DP
Sbjct: 211 EIRFP---RTLSPEA--KSLLAGLLKKDP 234
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 56/200 (28%), Positives = 87/200 (43%), Gaps = 19/200 (9%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEA-----IGHVRHKNLVRL 235
IG G YG VY+ + +G VA+K + + E + H N+VRL
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 236 LGYCI-----EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYL 290
+ C T+ LV+E+V+ +L +L D L E ++ + L +L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQ-DLRTYL--DKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYA 350
H +VHRD+K NIL+ K++DFGLA++ + T V+ T Y APE
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA--LTPVVVTLWYRAPEVL 179
Query: 351 NSGLLNEKSDVYSFGVVLLE 370
D++S G + E
Sbjct: 180 LQSTYATPVDMWSVGCIFAE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 59/196 (30%), Positives = 88/196 (44%), Gaps = 19/196 (9%)
Query: 182 IGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQAD---KDFRVEVEAIGHVRHKNLVRLLG 237
IG G +G VY VAVKK+ + Q + +D EV+ + ++H N + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 238 YCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK 297
++ LV EY G+ L + L I G + LAYLH
Sbjct: 89 CYLKEHTAWLVMEYCL-GSASDLLE---VHKKPLQEVEIAAITHGALQGLAYLHSH---N 141
Query: 298 VVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEY---ANSGL 354
++HRDIK+ NIL+ E K++DFG A S + GT ++APE + G
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEVILAMDEGQ 196
Query: 355 LNEKSDVYSFGVVLLE 370
+ K DV+S G+ +E
Sbjct: 197 YDGKVDVWSLGITCIE 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 52/172 (30%), Positives = 81/172 (47%), Gaps = 20/172 (11%)
Query: 220 EVEAIGHVRHKNLVRLLGYCIEGTQRIL--VYEYVNNGNLEQWLRGDMCDRGYLTWEARM 277
E + V H ++RL + E QR L + EYV G L +LR + G +
Sbjct: 51 EKRVLKEVSHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLR----NSG--RFSNST 102
Query: 278 KILLGT--AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHIT 335
+ + AL YLH ++V+RD+K NIL+D+ K++DFG AK L T
Sbjct: 103 GLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKL----RDRT 155
Query: 336 TRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEV 387
+ GT Y+APE S N+ D ++ G+++ E + G YP + +
Sbjct: 156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG-YPPFFDDNPFGI 206
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 4e-10
Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 23/210 (10%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVK--KLLNNPGQADKDFRVEVEAIGHVRHK 230
+ + K +G+G Y VY+G+ +NG VA+K +L G R E + ++H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63
Query: 231 NLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDR-----GYLTWEARMKILLGTAK 285
N+V L LV+EYV+ D+C G L E L +
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHT---------DLCQYMDKHPGGLHPENVKLFLFQLLR 114
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYV 345
L+Y+H+ ++HRD+K N+LI + + K++DFGLA+ SH + + T Y
Sbjct: 115 GLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVVTLWYR 170
Query: 346 APE-YANSGLLNEKSDVYSFGVVLLEAITG 374
P+ S + D++ G + +E I G
Sbjct: 171 PPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 35/94 (37%), Positives = 52/94 (55%), Gaps = 4/94 (4%)
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
A AL +LH +++RD+K NIL+DE K++DFGL+K + GT
Sbjct: 108 ALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK-AYSFCGTVE 163
Query: 344 YVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYP 377
Y+APE N + +D +SFGV++ E +TG P
Sbjct: 164 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 5e-10
Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 11/206 (5%)
Query: 176 FSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADK--DFRVEVEAIGHVRHKNL 232
F + ++G GG+G V Q+ G A K+L + K + + I +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 233 VRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
V L Y E + LV +N G+L+ + +M + G+ + L A+ L L
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIY-NMGNPGF----EEERALFYAAEILCGLE 116
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYAN 351
+ V+RD+K NIL+D+ +ISD GLA + G+S I RV GT GY+APE N
Sbjct: 117 DLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-IRGRV-GTVGYMAPEVLN 174
Query: 352 SGLLNEKSDVYSFGVVLLEAITGRYP 377
+ D + G ++ E I G+ P
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 53/201 (26%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 181 IIGDGGYG-VVYRGQLMNGTAVAVKKL--LNNPGQADKDFRVEVEAIGHVRHKNLVRLL- 236
++G G YG V +G +KKL N + K E + + ++H N+V
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 237 GYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEAR-MKILLGTAKALAYLHEAIE 295
+ E +V + G+L L+ +G L E + ++ + A AL YLHE
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKLKEQ---KGKLLPENQVVEWFVQIAMALQYLHEK-- 121
Query: 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLL 355
++HRD+K+ N+ + K+ D G+A++L + + + ++GT Y++PE ++
Sbjct: 122 -HILHRDLKTQNVFLTRTNIIKVGDLGIARVL-ENQCDMASTLIGTPYYMSPELFSNKPY 179
Query: 356 NEKSDVYSFGVVLLEAITGRY 376
N KSDV++ G + E T ++
Sbjct: 180 NYKSDVWALGCCVYEMATLKH 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 62/212 (29%), Positives = 95/212 (44%), Gaps = 29/212 (13%)
Query: 181 IIGDGGYGVVYRGQLMNGTAV----AVKKLLNNPGQADKDFRVEVEAIGHV-----RHKN 231
+IG G Y V +L + +KK L N + D D+ V+ HV H
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDE-DIDW---VQTEKHVFETASNHPF 57
Query: 232 LVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARM---KILLGTAKAL 287
LV L C + R+ V E+V+ G+L ++ R AR +I L AL
Sbjct: 58 LVGLHS-CFQTESRLFFVIEFVSGGDLMFHMQRQ---RKLPEEHARFYSAEISL----AL 109
Query: 288 AYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAP 347
+LHE +++RD+K N+L+D K++D+G+ K G T+ GT Y+AP
Sbjct: 110 NFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EGIRPGDTTSTFCGTPNYIAP 165
Query: 348 EYANSGLLNEKSDVYSFGVVLLEAITGRYPVD 379
E D ++ GV++ E + GR P D
Sbjct: 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 46/135 (34%), Positives = 61/135 (45%), Gaps = 14/135 (10%)
Query: 287 LAYLHEAI----EPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF 342
LA L AI + VHRDIK N+LID K++DFG A L A K + +GT
Sbjct: 108 LAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTP 167
Query: 343 GYVAPEYANS------GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLV----EW 392
Y+APE + G + D +S GV+ E I GR P G N + +
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRF 227
Query: 393 LKMMVQLRRSEDVVD 407
LK + S D +D
Sbjct: 228 LKFPEDPKVSSDFLD 242
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 17/209 (8%)
Query: 176 FSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-----H 229
F ++G GG+G V Q+ G A KKL + K + E A+ R +
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKL---EKKRIKKRKGEAMALNEKRILEKVN 58
Query: 230 KNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALA 288
V L Y E + LV +N G+L+ + +M + G+ + + A+
Sbjct: 59 SRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIY-NMGNPGF----DEQRAIFYAAELCC 113
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPE 348
L + ++V+RD+K NIL+D+ +ISD GLA + G++ + RV GT GY+APE
Sbjct: 114 GLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPE 171
Query: 349 YANSGLLNEKSDVYSFGVVLLEAITGRYP 377
N+ D + G ++ E I G+ P
Sbjct: 172 VINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 57/204 (27%), Positives = 86/204 (42%), Gaps = 13/204 (6%)
Query: 181 IIGDGGYGVVYRGQLMNGTAV----AVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLL 236
+IG G Y V +L + VKK L N + + E + + L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 237 GYCIEGTQRIL-VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIE 295
C + R+ V EYVN G+L M + L E + AL YLHE
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDL----MFHMQRQRKLPEEHARFYSAEISLALNYLHER-- 115
Query: 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLL 355
+++RD+K N+L+D K++D+G+ K G T+ GT Y+APE
Sbjct: 116 -GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 356 NEKSDVYSFGVVLLEAITGRYPVD 379
D ++ GV++ E + GR P D
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 61/230 (26%), Positives = 99/230 (43%), Gaps = 37/230 (16%)
Query: 227 VRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKA 286
+ HK+LV G C+ G + I+V EYV G+L+ +L+ + + ++W+ L AK
Sbjct: 56 LSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNK-NLINISWK------LEVAKQ 108
Query: 287 LAY-LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR----VMGT 341
LA+ LH + + H ++ + N+L+ D K + KL G S IT ++
Sbjct: 109 LAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS-ITVLPKEILLER 167
Query: 342 FGYVAPE-YANSGLLNEKSDVYSFGVVLLEAITG-RYPVDYGRPQSEVNLVEWLKMMVQL 399
+V PE N L+ +D +SFG L E +G P+ Q ++
Sbjct: 168 IPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY--------- 218
Query: 400 RRSEDVVDPNIETRPSTSALKRALLTAL--RCVDPDSDKRPKMSQVVRML 447
E R A K L L +C+D + D RP ++R L
Sbjct: 219 -----------EDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 68/247 (27%), Positives = 104/247 (42%), Gaps = 27/247 (10%)
Query: 181 IIGDGGYGVVYRGQLMNGTAV-AVKKLLNNPGQADKDFR---VEVEAIGHVRHKNLVRLL 236
++G G +G V +L V A+K L + D D E + + L
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTAL 61
Query: 237 GYCIEGTQRIL-VYEYVNNGNLE-QWLRGDMCDRGYLTWEARMKILLG-TAKALAYLHEA 293
C + R+ V EYVN G+L Q R D E R + AL +LH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFD------EPRSRFYAAEVTLALMFLHRH 115
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSG 353
V++RD+K NIL+D K++DFG+ K G TT GT Y+APE
Sbjct: 116 ---GVIYRDLKLDNILLDAEGHCKLADFGMCK-EGILNGVTTTTFCGTPDYIAPEILQEL 171
Query: 354 LLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETR 413
D ++ GV++ E + G+ P + +E +L E + +DV+ P ++
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQPPFE---ADNEDDLFESI-------LHDDVLYPVWLSK 221
Query: 414 PSTSALK 420
+ S LK
Sbjct: 222 EAVSILK 228
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 2e-09
Identities = 33/94 (35%), Positives = 55/94 (58%), Gaps = 9/94 (9%)
Query: 277 MKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITT 336
+++LLG + Y+H+ +++HRD+K+ NI + N KI DFG+++LL G + T
Sbjct: 113 IQLLLG----VHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLAT 163
Query: 337 RVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLE 370
GT Y++PE + KSD++S G +L E
Sbjct: 164 TFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 4e-09
Identities = 60/214 (28%), Positives = 103/214 (48%), Gaps = 29/214 (13%)
Query: 175 RFSKDNIIGDGGYGVV---YRGQLMNGTAVAVKKLLNNPGQ----ADKDFRVEVEAIGHV 227
R+ +G G YG V Y +L VAVKKL + P Q A + +R E+ + H+
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQ--KVAVKKL-SRPFQSLIHARRTYR-ELRLLKHM 71
Query: 228 RHKNLVRLL-----GYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG 282
+H+N++ LL IE + + + +L ++ C + L+ E ++
Sbjct: 72 KHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVK---CQK--LSDEHVQFLIYQ 126
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF 342
+ L Y+H A ++HRD+K SN+ ++E+ + +I DFGLA+ T + T
Sbjct: 127 LLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLAR----QADDEMTGYVATR 179
Query: 343 GYVAPEYA-NSGLLNEKSDVYSFGVVLLEAITGR 375
Y APE N N+ D++S G ++ E + G+
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 52/160 (32%), Positives = 69/160 (43%), Gaps = 12/160 (7%)
Query: 220 EVEAIGHVRHKNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK 278
E + + RH L L Y + R+ V EY N G L L R + E R +
Sbjct: 45 ESRVLQNTRHPFLTAL-KYAFQTHDRLCFVMEYANGGELFFHL-----SRERVFTEERAR 98
Query: 279 ILLG-TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337
AL YLH VV+RDIK N+++D++ KI+DFGL K G
Sbjct: 99 FYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKT 154
Query: 338 VMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYP 377
GT Y+APE D + GVV+ E + GR P
Sbjct: 155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 57/200 (28%), Positives = 93/200 (46%), Gaps = 6/200 (3%)
Query: 189 VVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248
V RG VA +LN+ QA R E+ + H +V+ + +L+
Sbjct: 85 VATRGSDPKEKVVAKFVMLNDERQAAYA-RSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143
Query: 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNI 308
EY + G+L + ++ + + L ++ LL LA L E K++HRD+KS+NI
Sbjct: 144 MEYGSGGDLNKQIKQRLKEH--LPFQEYEVGLLFYQIVLA-LDEVHSRKMMHRDLKSANI 200
Query: 309 LIDENFDAKISDFGLAKLLGAGKS-HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVV 367
+ K+ DFG +K S + + GT Y+APE ++K+D++S GV+
Sbjct: 201 FLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVI 260
Query: 368 LLEAITGRYPVDYGRPQSEV 387
L E +T P G Q E+
Sbjct: 261 LYELLTLHRPFK-GPSQREI 279
|
Length = 478 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 48/144 (33%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 236 LGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG-TAKALAYLHEA 293
L Y + R+ V EY N G L L R + E R + AL YLH
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHL-----SRERVFSEDRARFYGAEIVSALDYLHS- 113
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSG 353
E VV+RD+K N+++D++ KI+DFGL K G GT Y+APE
Sbjct: 114 -EKNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPEVLEDN 171
Query: 354 LLNEKSDVYSFGVVLLEAITGRYP 377
D + GVV+ E + GR P
Sbjct: 172 DYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 7e-09
Identities = 33/92 (35%), Positives = 48/92 (52%), Gaps = 8/92 (8%)
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYV 345
A YLH +++RD+K N+L+D K++DFG AK + T + GT Y+
Sbjct: 130 AFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEYL 182
Query: 346 APEYANSGLLNEKSDVYSFGVVLLEAITGRYP 377
APE S + D ++ GV+L E I G YP
Sbjct: 183 APEVIQSKGHGKAVDWWTMGVLLYEFIAG-YP 213
|
Length = 329 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 1e-08
Identities = 68/251 (27%), Positives = 113/251 (45%), Gaps = 32/251 (12%)
Query: 181 IIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFR---VEVEAIGHVRHKNLVRLL 236
++G G +G V +L G AVK L + D D VE + + L
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHL 61
Query: 237 GYCIEGTQRIL--VYEYVNNGNLEQWLRGDMCDRG----YLTWEARMKILLGTAKALAYL 290
YC T+ L V E++N G+L ++ D+G Y +I+ G L +L
Sbjct: 62 -YCTFQTKEHLFFVMEFLNGGDLMFHIQ----DKGRFDLYRATFYAAEIVCG----LQFL 112
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYA 350
H +++RD+K N+++D + KI+DFG+ K G + +T GT Y+APE
Sbjct: 113 HSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEIL 168
Query: 351 NSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQ------LRRSED 404
D +SFGV+L E + G+ P +G + E L E +++ + S+D
Sbjct: 169 QGLKYTFSVDWWSFGVLLYEMLIGQSPF-HGDDEDE--LFESIRVDTPHYPRWITKESKD 225
Query: 405 VVDPNIETRPS 415
+++ E P+
Sbjct: 226 ILEKLFERDPT 236
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 47/192 (24%), Positives = 81/192 (42%), Gaps = 17/192 (8%)
Query: 197 NGTAVAVKKLLNNPGQADKDFRV---EVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253
T VAVKK+ N + +D ++ E+ ++H N++ + I ++ +V +
Sbjct: 24 TNTLVAVKKI-NLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82
Query: 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN 313
G+ E L+ + L A IL AL Y+H +HR +K+S+IL+ +
Sbjct: 83 YGSCEDLLKTHFPEG--LPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGD 137
Query: 314 FDAKISDFGLA-KLLGAGKSHITTRVMGTFG-----YVAPEYANSGLL--NEKSDVYSFG 365
+S + ++ GK +++PE L NEKSD+YS G
Sbjct: 138 GKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVG 197
Query: 366 VVLLEAITGRYP 377
+ E G P
Sbjct: 198 ITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 64/215 (29%), Positives = 94/215 (43%), Gaps = 33/215 (15%)
Query: 181 IIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKD----FRVEVEAIGHVRHKNLVRLL 236
+IG G +G V +L N V K+LN + FR E + + + ++ + L
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ-WITTL 66
Query: 237 GYCIEGTQRI-LVYEYVNNGNL-------EQWLRGDMCDRGYLTWEARMKILLGTAKALA 288
Y + + LV +Y G+L E L DM R YL A M I + + L
Sbjct: 67 HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMA-RFYL---AEMVIAIDSVHQLH 122
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFG-LAKLLGAGKSHITTRVMGTFGYVAP 347
Y VHRDIK NIL+D N +++DFG KL+ G + V GT Y++P
Sbjct: 123 Y---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISP 172
Query: 348 EYANS-----GLLNEKSDVYSFGVVLLEAITGRYP 377
E + G + D +S GV + E + G P
Sbjct: 173 EILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 2e-08
Identities = 61/212 (28%), Positives = 98/212 (46%), Gaps = 30/212 (14%)
Query: 181 IIGDGGYGVVYRGQLMNGT------AVAV-KKLLNNPGQADKDF-RVEVEAIGHVRHKNL 232
++G GGYG V++ + + G A+ V KK Q D + E + V+H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGD---MCDRG--YLTWEARMKILLGTAKAL 287
V L+ G + L+ EY++ G L L + M D YL+ +I L AL
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS-----EISL----AL 113
Query: 288 AYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK--LLGAGKSHITTRVMGTFGYV 345
+LH+ +++RD+K NIL+D K++DFGL K + +H GT Y+
Sbjct: 114 EHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEYM 167
Query: 346 APEYANSGLLNEKSDVYSFGVVLLEAITGRYP 377
APE + D +S G ++ + +TG P
Sbjct: 168 APEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 2e-08
Identities = 57/216 (26%), Positives = 96/216 (44%), Gaps = 27/216 (12%)
Query: 176 FSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLL---NNPGQADKDFRVEVEAIGHVRHKN 231
+ K IG+G YG VY+ + G VA+KK + G R E+ + +
Sbjct: 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALR-EISLLQMLSESI 61
Query: 232 -LVRLLGYCIEGTQR-------ILVYEYVNNGNLEQWLRGDMCDRGY---LTWEARMKIL 280
+VRLL +E + LV+EY+++ +L++++ D RG L + +
Sbjct: 62 YIVRLL--DVEHVEEKNGKPSLYLVFEYLDS-DLKKFM--DSNGRGPGRPLPAKTIKSFM 116
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDA-KISDFGLAKLLGAGKSHITTRVM 339
K +A+ H+ V+HRD+K N+L+D+ KI+D GL + T ++
Sbjct: 117 YQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173
Query: 340 GTFGYVAPE-YANSGLLNEKSDVYSFGVVLLEAITG 374
T Y APE S + D++S G + E
Sbjct: 174 -TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 43/148 (29%), Positives = 72/148 (48%), Gaps = 15/148 (10%)
Query: 236 LGYCIEGTQRI-LVYEYVNNGNLEQWLR--GDMCDRGYLTWEARMKILLGTAKALAYLHE 292
L C + R+ V EYVN G+L ++ G + + + A + + L +LH
Sbjct: 66 LHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISV------GLFFLHR 119
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVM-GTFGYVAPEYAN 351
+++RD+K N+++D KI+DFG+ K +TTR GT Y+APE
Sbjct: 120 R---GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIA 174
Query: 352 SGLLNEKSDVYSFGVVLLEAITGRYPVD 379
+ D +++GV+L E + G+ P D
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 55/199 (27%), Positives = 96/199 (48%), Gaps = 18/199 (9%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRV-EVEAIGHVR-HKNLVRLLGY 238
IG+G + V + Q G A+K + + ++ + E++A+ + H N++RL+
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66
Query: 239 CIE-GTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-ILLGTAKALAYLHEAIE 295
+ T R+ LV+E ++ NL + ++G R E R+K + K+L ++H
Sbjct: 67 LFDRKTGRLALVFELMD-MNLYELIKG----RKRPLPEKRVKSYMYQLLKSLDHMHRN-- 119
Query: 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPE-YANSGL 354
+ HRDIK NILI ++ K++DFG + G T + T Y APE G
Sbjct: 120 -GIFHRDIKPENILIKDDI-LKLADFGSCR--GIYSKPPYTEYISTRWYRAPECLLTDGY 175
Query: 355 LNEKSDVYSFGVVLLEAIT 373
K D+++ G V E ++
Sbjct: 176 YGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 31/81 (38%), Positives = 47/81 (58%), Gaps = 2/81 (2%)
Query: 297 KVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLN 356
++V+RD+K NIL+D+ +ISD GLA + G++ I RV GT GY+APE +
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYMAPEVVKNERYT 179
Query: 357 EKSDVYSFGVVLLEAITGRYP 377
D + G ++ E I G+ P
Sbjct: 180 FSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 42/134 (31%), Positives = 61/134 (45%), Gaps = 14/134 (10%)
Query: 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARM---KILLGTAKALAYLHEAIEPKVVHRDI 303
LV ++N G L L+ + + AR ++L AL LH+ V++RD+
Sbjct: 70 LVLAFINGGELFHHLQREGR---FDLSRARFYTAELLC----ALENLHKF---NVIYRDL 119
Query: 304 KSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYS 363
K NIL+D + DFGL K L T GT Y+APE + D ++
Sbjct: 120 KPENILLDYQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWT 178
Query: 364 FGVVLLEAITGRYP 377
GV+L E +TG P
Sbjct: 179 LGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 70/229 (30%), Positives = 101/229 (44%), Gaps = 39/229 (17%)
Query: 174 NRFSKDNIIGDGGYGVVY--RGQLMNGTAVAVKK------LLNNPGQADKDFRVEVEAIG 225
F +I +G YG VY R + A+KK +L N Q + F VE + +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETR-QRFAMKKINKQNLILRN--QIQQVF-VERDILT 56
Query: 226 HVRHKNLVRLLGYCIEGTQRIL--VYEYVNNGNLEQWLRGDMCDRGYLTWE-ARMKILLG 282
+ +V + +C T+R L V EYV G+ L+ + G L + ARM
Sbjct: 57 FAENPFVVSM--FCSFETKRHLCMVMEYVEGGDCATLLK----NIGALPVDMARM-YFAE 109
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL--------LGAGKSHI 334
T AL YLH +VHRD+K N+LI K++DFGL+K+ L G
Sbjct: 110 TVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166
Query: 335 TTR------VMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYP 377
TR V GT Y+APE + D ++ G++L E + G P
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 3e-08
Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 7/93 (7%)
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGY 344
+ L YLH +++HRD+K+ NI I++ I D G A+ + + + GT
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--LAGTVET 222
Query: 345 VAPEYANSGLLNEKSDVYSFGVVLLEAITGRYP 377
APE N K+D++S G+VL E + YP
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEMLA--YP 253
|
Length = 357 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 4e-08
Identities = 63/234 (26%), Positives = 100/234 (42%), Gaps = 53/234 (22%)
Query: 182 IGDGGYGVVYRGQLMN---GTAVAVKKLLNNPGQADKDFRV--------EVEAIGHVRHK 230
IG G YG VY+ + N G A+KK + DK+ E+ + ++H+
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKF-----KGDKEQYTGISQSACREIALLRELKHE 62
Query: 231 NLVRLLGYCIEGTQRI--LVYEYVNNGNLE--QWLR---GDMCDRGY---LTWEARMKIL 280
N+V L+ +E + L+++Y + + ++ R L W+ IL
Sbjct: 63 NVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ----IL 118
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILI----DENFDAKISDFGLAKLLGAGKSHITT 336
G + YLH V+HRD+K +NIL+ E KI D GLA+L A +
Sbjct: 119 NG----VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLAD 171
Query: 337 --RVMGTFGYVAPEYANSGLLNEKS-----DVYSFGVVLLEAITGRYPVDYGRP 383
V+ T Y APE LL + D+++ G + E +T P+ GR
Sbjct: 172 LDPVVVTIWYRAPEL----LLGARHYTKAIDIWAIGCIFAELLTLE-PIFKGRE 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 4e-08
Identities = 42/155 (27%), Positives = 75/155 (48%), Gaps = 19/155 (12%)
Query: 224 IGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGT 283
+ V H +L + G C+ G++ I+V E+V +G L+ LR ++G + ++ +
Sbjct: 70 MSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQL 126
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNIL-----IDENFDA--KISDFGLAKLLGAGKSHITT 336
A AL+YL + +VH ++ + NIL + E K+SD G++ +
Sbjct: 127 ASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS-FTALSREERVE 182
Query: 337 RVMGTFGYVAPE-YANSGLLNEKSDVYSFGVVLLE 370
R+ ++APE L+ +D +SFG LLE
Sbjct: 183 RI----PWIAPECVPGGNSLSTAADKWSFGTTLLE 213
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 5e-08
Identities = 34/101 (33%), Positives = 52/101 (51%), Gaps = 14/101 (13%)
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI----TTRVM 339
A L +LH +++RD+K N+++D KI+DFG+ K +I TTR
Sbjct: 111 AIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMC------KENIFGGKTTRTF 161
Query: 340 -GTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVD 379
GT Y+APE + D ++FGV+L E + G+ P D
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 57/234 (24%), Positives = 91/234 (38%), Gaps = 49/234 (20%)
Query: 181 IIGDGGYGVVYRG-QLMNGTAVAVKK----LLNNPGQADKDFRVEVEAIGHVRHKNLVRL 235
+IG GG G VY + VA+KK L NP K F E + + H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENP-LLKKRFLREAKIAADLIHPGIVPV 67
Query: 236 LGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWE---------------ARMKIL 280
C +G Y+ L+ L+ W+ A + I
Sbjct: 68 YSICSDGDPVYYTMPYIEGYTLKSLLKS--------VWQKESLSKELAEKTSVGAFLSIF 119
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK--------- 331
+ Y+H V+HRD+K NIL+ + I D+G A +
Sbjct: 120 HKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176
Query: 332 ------SHITT--RVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYP 377
S +T +++GT Y+APE +E +D+Y+ GV+L + +T +P
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 5e-08
Identities = 44/149 (29%), Positives = 74/149 (49%), Gaps = 17/149 (11%)
Query: 236 LGYCIEGTQRI-LVYEYVNNGNLEQWLR--GDMCDRGYLTWEARMKILLGTAKALAYLHE 292
L C + R+ V EYVN G+L ++ G + + + A + I L +LH
Sbjct: 66 LHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAI------GLFFLHS 119
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL-LGAGKSHITTRVM-GTFGYVAPEYA 350
+++RD+K N+++D KI+DFG+ K + G +TT+ GT Y+APE
Sbjct: 120 K---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG---VTTKTFCGTPDYIAPEII 173
Query: 351 NSGLLNEKSDVYSFGVVLLEAITGRYPVD 379
+ D ++FGV+L E + G+ P +
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 6e-08
Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 21/155 (13%)
Query: 297 KVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI---TTRVMGTFGYVAPEYANSG 353
K +HRD+ + NIL+ EN KI DFGLA+ + ++ + R+ ++APE
Sbjct: 194 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL--PLKWMAPESIFDK 251
Query: 354 LLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIET 412
+ +SDV+SFGV+L E + G P Y Q + LK ++R E+
Sbjct: 252 VYTTQSDVWSFGVLLWEIFSLGASP--YPGVQINEEFCQRLKDGTRMRAPEN-------- 301
Query: 413 RPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447
+T + R +L C D +RP S +V +L
Sbjct: 302 --ATPEIYRIMLA---CWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 8e-08
Identities = 46/159 (28%), Positives = 71/159 (44%), Gaps = 29/159 (18%)
Query: 297 KVVHRDIKSSNILIDENFDAKISDFGLAK-------LLGAGKSHITTRVMGTFGYVAPEY 349
K +HRD+ + NIL+ EN KI DFGLA+ + G + + + M APE
Sbjct: 193 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM------APES 246
Query: 350 ANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408
+ +SDV+SFGV+L E + G P Y Q + LK ++R E
Sbjct: 247 IFDKVYTTQSDVWSFGVLLWEIFSLGASP--YPGVQIDEEFCRRLKEGTRMRAPEY---- 300
Query: 409 NIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447
+T + +L C + + RP S++V +L
Sbjct: 301 ------ATPEIYSIMLD---CWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 9e-08
Identities = 52/199 (26%), Positives = 94/199 (47%), Gaps = 15/199 (7%)
Query: 182 IGDGGYGVVYRG-QLMNGTAVAVK--KLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGY 238
+G+G Y VY+G +NG VA+K + G R E + ++H N+V LL
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR-EASLLKGLKHANIV-LLHD 70
Query: 239 CIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK 297
I + + V+EY++ +L Q++ + G L + + LAY+H
Sbjct: 71 IIHTKETLTFVFEYMHT-DLAQYM---IQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---H 123
Query: 298 VVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPE-YANSGLLN 356
++HRD+K N+LI + K++DFGLA+ ++ V+ T Y P+ + +
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVLLGATDYS 182
Query: 357 EKSDVYSFGVVLLEAITGR 375
D++ G + +E + G+
Sbjct: 183 SALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 35/97 (36%), Positives = 49/97 (50%), Gaps = 13/97 (13%)
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYV 345
AL +LH+ +V+RD+K NIL+D + DFGL+K + T GT Y+
Sbjct: 108 ALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYL 163
Query: 346 APEYANSGLLNEKS-----DVYSFGVVLLEAITGRYP 377
APE LL+EK D +S GV++ E G P
Sbjct: 164 APEV----LLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 32/215 (14%)
Query: 182 IGDGGYGVVYRGQLMNGT--AVAVKKL----LNNPGQADKDFRVEVEAIGHVRHKNLVRL 235
+G G +G V N VA+K+ + Q D F E + + ++ H V L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFS-ERKILNYINHPFCVNL 96
Query: 236 LGYCIEGTQRILVYEYVNNGNLEQWLRGDM---CDRGYLTWEARMKILLGTAKALAYLHE 292
G + + LV E+V G +LR + D G + A++ ++ ++L
Sbjct: 97 YGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF-YAAQIVLIFEYLQSL----- 150
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANS 352
+V+RD+K N+L+D++ K++DFG AK++ T + GT Y+APE
Sbjct: 151 ----NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR----TYTLCGTPEYIAPEI--- 199
Query: 353 GLLN----EKSDVYSFGVVLLEAITGRYPVDYGRP 383
LLN + +D ++ G+ + E + G P P
Sbjct: 200 -LLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233
|
Length = 340 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 45/154 (29%), Positives = 71/154 (46%), Gaps = 21/154 (13%)
Query: 299 VHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF---GYVAPEYANSGLL 355
VHRD+ + N+LI E KI DFGLA+ + ++I+ TF ++APE + L
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKG--STFLPLKWMAPESIFNNLY 318
Query: 356 NEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRP 414
SDV+SFG++L E T G G P E+ + E + ++R + P
Sbjct: 319 TTLSDVWSFGILLWEIFTLG------GTPYPELPMNE--QFYNAIKRGYRMAKP------ 364
Query: 415 STSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448
A +C + + RP SQ+V ++
Sbjct: 365 -AHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVG 397
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 62/255 (24%), Positives = 97/255 (38%), Gaps = 61/255 (23%)
Query: 176 FSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN---- 231
F +IG G +G V Q + V K+L +AD +E E +GH+R +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILR---KADM---LEKEQVGHIRAERDILV 56
Query: 232 ------LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAK 285
+V++ + L+ E++ G++ L + LT E + T
Sbjct: 57 EADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM----KKDTLTEEETQFYIAETVL 112
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITT--------- 336
A+ +H+ +HRDIK N+L+D K+SDFGL G K+H T
Sbjct: 113 AIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCT--GLKKAHRTEFYRNLNHSL 167
Query: 337 ---------------------------RVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLL 369
+GT Y+APE N+ D +S GV++
Sbjct: 168 PSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227
Query: 370 EAITGRYPVDYGRPQ 384
E + G P PQ
Sbjct: 228 EMLIGYPPFCSETPQ 242
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 67/249 (26%), Positives = 98/249 (39%), Gaps = 71/249 (28%)
Query: 181 IIGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQADKDFRVEVEAIGHVR---------HK 230
+IG G +G V Q + G A+KKL K +E E + HVR
Sbjct: 8 VIGRGAFGEVRLVQKKDTGHIYAMKKL-------RKSEMLEKEQVAHVRAERDILAEADN 60
Query: 231 NLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWL-RGDMCDRGYLTWEARMKILLGTAKALA 288
V L Y + + L+ EY+ G++ L + D T E + T A+
Sbjct: 61 PWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDT-----FTEEETRFYIAETILAID 115
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITT------------ 336
+H+ +HRDIK N+L+D K+SDFGL G KSH T
Sbjct: 116 SIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCT--GLKKSHRTEFYRILSHALPSN 170
Query: 337 ----------------------RVM-----GTFGYVAPE-YANSGLLNEKSDVYSFGVVL 368
R + GT Y+APE + +G N++ D +S GV++
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIM 229
Query: 369 LEAITGRYP 377
E + G YP
Sbjct: 230 YEMLVG-YP 237
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 51/196 (26%), Positives = 87/196 (44%), Gaps = 33/196 (16%)
Query: 201 VAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI-------------- 246
VAVKK++ Q+ K E++ I + H N+V++ +
Sbjct: 33 VAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVY 92
Query: 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSS 306
+V EY+ E L + ++G L+ E + + L Y+H A V+HRD+K +
Sbjct: 93 IVQEYM-----ETDLANVL-EQGPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPA 143
Query: 307 NILID-ENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLL------NEKS 359
N+ I+ E+ KI DFGLA+++ SH G V Y + LL +
Sbjct: 144 NVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGL---VTKWYRSPRLLLSPNNYTKAI 200
Query: 360 DVYSFGVVLLEAITGR 375
D+++ G + E +TG+
Sbjct: 201 DMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 57/222 (25%), Positives = 98/222 (44%), Gaps = 20/222 (9%)
Query: 166 LRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNN---PGQADKDFRVEVE 222
+RDL+ + +IG G +G V + + V KLL+ ++D F E
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 223 AIGHVRHKNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRG-DMCDRGYLTWEARMKIL 280
I + V L Y + + + +V EY+ G+L + D+ ++ + A + +
Sbjct: 95 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLA 154
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA-KLLGAGKSHITTRVM 339
L ++ + +HRD+K N+L+D++ K++DFG K+ G T V
Sbjct: 155 LDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV- 204
Query: 340 GTFGYVAPEYANS----GLLNEKSDVYSFGVVLLEAITGRYP 377
GT Y++PE S G + D +S GV L E + G P
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 5e-07
Identities = 47/178 (26%), Positives = 74/178 (41%), Gaps = 29/178 (16%)
Query: 204 KKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRG 263
KK++ K E++ + + H+ ++ L ++ Y + +
Sbjct: 120 KKVIVKAVTGGKTPGREIDILKTISHRAIINL------------IHAYRWKSTVCMVMPK 167
Query: 264 DMCD-------RGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDA 316
CD G L E + I +ALAYLH ++HRD+K+ NI +DE +A
Sbjct: 168 YKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENA 224
Query: 317 KISDFGLAKLLGAGKSHITTRV----MGTFGYVAPEYANSGLLNEKSDVYSFGVVLLE 370
+ DFG A L A H T GT +PE K+D++S G+VL E
Sbjct: 225 VLGDFGAACKLDA---HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFE 279
|
Length = 392 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 5e-07
Identities = 54/222 (24%), Positives = 94/222 (42%), Gaps = 20/222 (9%)
Query: 166 LRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKD----FRVEV 221
+R LQ + +IG G +G V + + V KLL+ + F E
Sbjct: 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 222 EAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRG-DMCDRGYLTWEARMKIL 280
+ + +V+L + +V EY+ G+L + D+ ++ + A + +
Sbjct: 95 DIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLA 154
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA-KLLGAGKSHITTRVM 339
L ++ ++HRD+K N+L+D++ K++DFG K+ G T V
Sbjct: 155 LDAIHSMG---------LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV- 204
Query: 340 GTFGYVAPEYANS----GLLNEKSDVYSFGVVLLEAITGRYP 377
GT Y++PE S G + D +S GV L E + G P
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 7e-07
Identities = 53/225 (23%), Positives = 102/225 (45%), Gaps = 33/225 (14%)
Query: 176 FSKDNIIGDGGYGVVYRGQLM----NGTAVAVKKLLNNPGQAD-------KDFRVEVEAI 224
F+ ++G G +G V QL + VAVK L +AD ++F E +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-----KADIFSSSDIEEFLREAACM 55
Query: 225 GHVRHKNLVRLLGYCIEGTQR------ILVYEYVNNGNLEQWLRGDMCDRG----YLTWE 274
H N+++L+G + + +++ ++ +G+L +L M G L +
Sbjct: 56 KEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL--MSRIGEEPFTLPLQ 113
Query: 275 ARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334
++ ++ A + YL +HRD+ + N +++EN ++DFGL+K + +G +
Sbjct: 114 TLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYR 170
Query: 335 TTRVMG-TFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYP 377
++A E + SDV++FGV + E +T G+ P
Sbjct: 171 QGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (123), Expect = 7e-07
Identities = 57/238 (23%), Positives = 108/238 (45%), Gaps = 30/238 (12%)
Query: 168 DLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKD---FRVEVEAI 224
D +S N + IG+G +G V+ + K ++ G +++ +EV +
Sbjct: 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVM 66
Query: 225 GHVRHKNLVRLLG-YCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG 282
++HKN+VR + + + Q++ ++ E+ + G+L + ++ G + A + I
Sbjct: 67 RELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQ 126
Query: 283 TAKALAYLHEAIE----PKVVHRDIKSSNILIDENFD-----------------AKISDF 321
ALAY H + +V+HRD+K NI + AKI DF
Sbjct: 127 LLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDF 186
Query: 322 GLAKLLGAGKSHITTRVMGTFGYVAPEYA--NSGLLNEKSDVYSFGVVLLEAITGRYP 377
GL+K +G + +GT Y +PE + ++KSD+++ G ++ E +G+ P
Sbjct: 187 GLSKNIGI--ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 8e-07
Identities = 42/152 (27%), Positives = 75/152 (49%), Gaps = 17/152 (11%)
Query: 229 HKNLVRLLGYCIEGTQR--ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKA 286
+ N ++L Y + T + +L+ +Y+ +G+L L+ + G L+ KI+ +A
Sbjct: 68 NPNFIKLY-YSV-TTLKGHVLIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEA 121
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFD-AKISDFGLAKLLGAGKSHITTRVMGTFGYV 345
L LH+ ++H DIK N+L D D + D+GL K++G + GT Y
Sbjct: 122 LNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYF 173
Query: 346 APEYANSGLLNEKSDVYSFGVVLLEAITGRYP 377
+PE + D ++ GV+ E +TG++P
Sbjct: 174 SPEKIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 8e-07
Identities = 40/117 (34%), Positives = 57/117 (48%), Gaps = 16/117 (13%)
Query: 279 ILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRV 338
IL G + L YLH+ +HR+IK+S+ILI D +S GL+ L ++ +V
Sbjct: 106 ILFGALRGLNYLHQN---GYIHRNIKASHILISG--DGLVSLSGLSHLYSLVRNGQKAKV 160
Query: 339 MGTFG--------YVAPEYANSGL--LNEKSDVYSFGVVLLEAITGRYP-VDYGRPQ 384
+ F +++PE L N KSD+YS G+ E TGR P D R Q
Sbjct: 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 9e-07
Identities = 33/97 (34%), Positives = 48/97 (49%), Gaps = 9/97 (9%)
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA-GKSHITTRVMGTFGY 344
AL +H +HRD+K N+L+D++ K++DFG + A G T V GT Y
Sbjct: 154 ALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDY 209
Query: 345 VAPEYANS----GLLNEKSDVYSFGVVLLEAITGRYP 377
++PE S G + D +S GV L E + G P
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 53/190 (27%), Positives = 82/190 (43%), Gaps = 29/190 (15%)
Query: 264 DMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323
D+ + LT E + AK + +L K +HRD+ + NIL+ EN KI DFGL
Sbjct: 170 DLY-KKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGL 225
Query: 324 AKLLGAGKSHI---TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVD 379
A+ + ++ R+ ++APE + +SDV+SFGV+L E + G P
Sbjct: 226 ARDIYKDPDYVRKGDARL--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 283
Query: 380 YGRPQSEV--NLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKR 437
+ E L E +M R+ D P + T L C + +R
Sbjct: 284 GVKIDEEFCRRLKEGTRM-----RAPDYTTPEMYQ------------TMLDCWHGEPSQR 326
Query: 438 PKMSQVVRML 447
P S++V L
Sbjct: 327 PTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 43/150 (28%), Positives = 73/150 (48%), Gaps = 13/150 (8%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDF----RVEVEAIGHVRHKNLVRLLG 237
I G +G VY G+ N + + K++ +K+ + E +A+ + +V L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLY- 70
Query: 238 YCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEP 296
Y ++ + LV EY+ G+++ L GY E +K + A AL YLH
Sbjct: 71 YSLQSANNVYLVMEYLIGGDVKSLLH----IYGYFDEEMAVKYISEVALALDYLHRH--- 123
Query: 297 KVVHRDIKSSNILIDENFDAKISDFGLAKL 326
++HRD+K N+LI K++DFGL+K+
Sbjct: 124 GIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 3e-06
Identities = 30/91 (32%), Positives = 43/91 (47%), Gaps = 3/91 (3%)
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGY 344
+A+ YLHE +++HRDIK+ NI I+ D + DFG A ++ GT
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIAT 249
Query: 345 VAPEYANSGLLNEKSDVYSFGVVLLEAITGR 375
APE D++S G+VL E T
Sbjct: 250 NAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 9e-06
Identities = 65/269 (24%), Positives = 105/269 (39%), Gaps = 62/269 (23%)
Query: 176 FSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN--LV 233
F +IG G +G V Q + + K+L +AD +E E + H+R + LV
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILR---KADM---LEKEQVAHIRAERDILV 56
Query: 234 RLLG-------YCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAK 285
G Y + + + L+ E++ G++ L + L+ EA + T
Sbjct: 57 EADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM----KKDTLSEEATQFYIAETVL 112
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITT--------- 336
A+ +H+ +HRDIK N+L+D K+SDFGL G K+H T
Sbjct: 113 AIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCT--GLKKAHRTEFYRNLTHNP 167
Query: 337 ---------------------------RVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLL 369
+GT Y+APE N+ D +S GV++
Sbjct: 168 PSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227
Query: 370 EAITGRYPVDYGRPQSEV-NLVEWLKMMV 397
E + G P PQ ++ W + +V
Sbjct: 228 EMLIGYPPFCSETPQETYRKVMNWKETLV 256
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 28/99 (28%), Positives = 49/99 (49%), Gaps = 5/99 (5%)
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
A+ + +H + VHRDIK N+L+D N +++DFG + + ++ +GT
Sbjct: 109 AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPD 168
Query: 344 YVAPEYANS-----GLLNEKSDVYSFGVVLLEAITGRYP 377
Y++PE + G + D +S GV + E + G P
Sbjct: 169 YISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 44/153 (28%), Positives = 73/153 (47%), Gaps = 19/153 (12%)
Query: 226 HVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAK 285
V HK++V L G C+ + I+V E+V G L+ ++ LT + K+ A
Sbjct: 60 QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLAS 116
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILI-DENFDA------KISDFGLAKLLGAGKSHITTRV 338
AL+YL + +VH ++ + NIL+ E D K+SD G+ + + R+
Sbjct: 117 ALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP-ITVLSRQECVERI 172
Query: 339 MGTFGYVAPE-YANSGLLNEKSDVYSFGVVLLE 370
++APE +S L+ +D +SFG L E
Sbjct: 173 ----PWIAPECVEDSKNLSIAADKWSFGTTLWE 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 44/181 (24%), Positives = 80/181 (44%), Gaps = 23/181 (12%)
Query: 203 VKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRL--------LGYCIEGTQRILVYEYVNN 254
+ K + +A E+ A+G + H+N++++ Y I +Y ++ +
Sbjct: 196 IAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYD 255
Query: 255 GNLEQWLRGDMCDRGYLTWEAR--MKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE 312
W DR L + R MK LL A+ Y+H+ K++HRDIK NI ++
Sbjct: 256 EAF-DWK-----DRPLL-KQTRAIMKQLLC---AVEYIHDK---KLIHRDIKLENIFLNC 302
Query: 313 NFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAI 372
+ + DFG A + +GT +PE E +D++S G++LL+ +
Sbjct: 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362
Query: 373 T 373
+
Sbjct: 363 S 363
|
Length = 501 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 46/178 (25%), Positives = 81/178 (45%), Gaps = 38/178 (21%)
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT-- 341
AK +++L +HRD+ + NIL+ KI DFGLA+ + +++ V G
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV---VKGNAR 277
Query: 342 --FGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT------GRYPVDYGRPQSEVNLVEWL 393
++APE + + +SDV+S+G++L E + PVD ++
Sbjct: 278 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD----------SKFY 327
Query: 394 KMMVQLRRSEDVVDPNIETRPSTSALKRALLTALR-CVDPDSDKRPKMSQVVRMLESE 450
KM+ + R + E PS + ++ C D D KRP Q+V+++E +
Sbjct: 328 KMIKEGYRML-----SPECAPS------EMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 4e-05
Identities = 26/122 (21%), Positives = 47/122 (38%), Gaps = 13/122 (10%)
Query: 207 LNNPGQADKDFRVEVEAIGHVRHKNLV--RLLGYCIEGTQRILVYEYVNNGNLEQWLRGD 264
+N + D EV + + K L ++L L+ E++ L++
Sbjct: 28 INPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDE----- 82
Query: 265 MCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324
++ E + I A+ LA LH+ + H D+ NIL+D+ I D+ A
Sbjct: 83 ------VSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYA 136
Query: 325 KL 326
Sbjct: 137 GY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 5e-05
Identities = 36/109 (33%), Positives = 49/109 (44%), Gaps = 15/109 (13%)
Query: 279 ILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRV 338
IL G KAL Y+H VHR +K+S+ILI + D K+ GL L RV
Sbjct: 106 ILQGVLKALDYIHHM---GYVHRSVKASHILI--SVDGKVYLSGLRSNLSMINHGQRLRV 160
Query: 339 MGTFG--------YVAPEYANSGL--LNEKSDVYSFGVVLLEAITGRYP 377
+ F +++PE L + KSD+YS G+ E G P
Sbjct: 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 5e-05
Identities = 44/143 (30%), Positives = 65/143 (45%), Gaps = 25/143 (17%)
Query: 247 LVYEYVNNGNL-------EQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVV 299
LV +Y G+L E L DM R YL A M + + + L Y V
Sbjct: 78 LVMDYYVGGDLLTLLSKFEDRLPEDMA-RFYL---AEMVLAIDSVHQLGY---------V 124
Query: 300 HRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANS-----GL 354
HRDIK N+L+D+N +++DFG L A + + +GT Y++PE + G
Sbjct: 125 HRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGR 184
Query: 355 LNEKSDVYSFGVVLLEAITGRYP 377
+ D +S GV + E + G P
Sbjct: 185 YGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 34/125 (27%), Positives = 60/125 (48%), Gaps = 10/125 (8%)
Query: 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNI 308
Y+ N+ ++ L D + LT + A+ + +L VHRD+ + N+
Sbjct: 214 YKGSNDSEVKNLLSDDGSEG--LTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNV 268
Query: 309 LIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF---GYVAPEYANSGLLNEKSDVYSFG 365
L+ + KI DFGLA+ + ++++ TF ++APE L SDV+S+G
Sbjct: 269 LLAQGKIVKICDFGLARDIMHDSNYVSKG--STFLPVKWMAPESIFDNLYTTLSDVWSYG 326
Query: 366 VVLLE 370
++L E
Sbjct: 327 ILLWE 331
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 33/122 (27%), Positives = 44/122 (36%), Gaps = 44/122 (36%)
Query: 299 VHRDIKSSNILIDENFDAKISDFGL---------AKLLGAGKSHITTRVM---------- 339
+HRDIK NILID + K++DFGL +K G H M
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKG-DHHRQDSMEPSEEWSEID 181
Query: 340 ------------------------GTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGR 375
GT Y+APE + D +S GV+L E + G+
Sbjct: 182 RCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQ 241
Query: 376 YP 377
P
Sbjct: 242 PP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 2e-04
Identities = 41/159 (25%), Positives = 75/159 (47%), Gaps = 27/159 (16%)
Query: 299 VHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT----FGYVAPEYANSGL 354
+HRD+ + N+L+ + AKI DFGLA+ + +++ V G ++APE +
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV---VKGNARLPVKWMAPESIFDCV 290
Query: 355 LNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVN--LVEWLKMMVQLRRSEDVVDPNIE 411
+SDV+S+G++L E + G+ P P VN + +K Q+ R D P I
Sbjct: 291 YTVQSDVWSYGILLWEIFSLGKSPY----PGILVNSKFYKMVKRGYQMSRP-DFAPPEIY 345
Query: 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450
+ C + + +RP SQ+ ++++ +
Sbjct: 346 SIMKM------------CWNLEPTERPTFSQISQLIQRQ 372
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 63/240 (26%), Positives = 94/240 (39%), Gaps = 47/240 (19%)
Query: 175 RFSKDNIIGDGGYGVVYRGQLMNGTAV--AVKKLLNNP-GQADKDFRVEVEA--IGHVRH 229
F K ++G G G V+ +L GT A+K L + +K RV E + + H
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRL-KGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDH 60
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWE-ARM---KILLGTAK 285
L L T LV +Y G L + L+ L+ E AR ++LL
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGELFRLLQ--RQPGKCLSEEVARFYAAEVLL---- 114
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI----------- 334
AL YLH +V+RD+K NIL+ E+ +SDF L+K +
Sbjct: 115 ALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 335 --------------TTRVM---GTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYP 377
+ R GT Y+APE + D ++ G++L E + G P
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 42.4 bits (99), Expect = 3e-04
Identities = 53/219 (24%), Positives = 100/219 (45%), Gaps = 22/219 (10%)
Query: 182 IGDGGYGVVYRGQLMNGT---AVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGY 238
+G G YG VY+ + +G A+K++ G + R E+ + ++H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQI-EGTGISMSACR-EIALLRELKHPNVIALQKV 66
Query: 239 CIEGTQR--ILVYEYVNNG--NLEQWLRGDMCDRGYLTWEARM--KILLGTAKALAYLHE 292
+ + R L+++Y + ++ ++ R ++ + M +L + YLH
Sbjct: 67 FLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 293 AIEPKVVHRDIKSSNILI----DENFDAKISDFGLAKLLGAGKSHIT--TRVMGTFGYVA 346
V+HRD+K +NIL+ E KI+D G A+L + + V+ TF Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 347 PEYANSGLLNEKS-DVYSFGVVLLEAITGRYPVDYGRPQ 384
PE K+ D+++ G + E +T P+ + R +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQE 221
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-04
Identities = 42/160 (26%), Positives = 63/160 (39%), Gaps = 52/160 (32%)
Query: 299 VHRDIKSSNILIDENFDAKISDFGL---------AKLLGAGKSHITTRVM---------- 339
+HRDIK NILID + K++DFGL +K G SHI M
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKG-SHIRQDSMEPSDLWDDVS 181
Query: 340 ----------------------------GTFGYVAPEYANSGLLNEKSDVYSFGVVLLEA 371
GT Y+APE + D +S GV+L E
Sbjct: 182 NCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEM 241
Query: 372 ITGRYPVDYGRP-QSEVNLVEW---LKMMVQLRRSEDVVD 407
+ G+ P P ++++ ++ W L + Q++ S + VD
Sbjct: 242 LVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVD 281
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 29/88 (32%), Positives = 44/88 (50%), Gaps = 6/88 (6%)
Query: 286 ALAYLH-EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL-GAGKSHITTRVMGTFG 343
A+ Y+H E I +HRDIK+ N+L++ D + DFG A G+ + + GT
Sbjct: 272 AIDYIHGEGI----IHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVD 327
Query: 344 YVAPEYANSGLLNEKSDVYSFGVVLLEA 371
APE D++S G+V+ EA
Sbjct: 328 TNAPEVLAGDPYTPSVDIWSAGLVIFEA 355
|
Length = 461 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 6e-04
Identities = 40/175 (22%), Positives = 69/175 (39%), Gaps = 31/175 (17%)
Query: 231 NLVRLLGYCIEGTQRILVYEYVNNGNLEQWL------RGDMCDRGYLTWEARMKILLGTA 284
N+V L Y + LV ++ G L + + R W A M +
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKR----WAAEMVV----- 96
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFG-LAKLLGAGKSHITTRVMGTFG 343
AL LH +V RD+ +NIL+D+ +++ F +++ + +
Sbjct: 97 -ALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM----- 147
Query: 344 YVAPEYANSGLLNEKSDVYSFGVVLLEAITGR-----YPVDYGRPQSEVNLVEWL 393
Y APE E D +S G +L E +TG+ +P + +N+ EW+
Sbjct: 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINT-HTTLNIPEWV 201
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 8e-04
Identities = 53/219 (24%), Positives = 99/219 (45%), Gaps = 22/219 (10%)
Query: 182 IGDGGYGVVYRGQLMNGTA---VAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGY 238
+G G YG VY+ + +G A+K++ G + R E+ + ++H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI-EGTGISMSACR-EIALLRELKHPNVISLQKV 66
Query: 239 CIEGTQR--ILVYEYVNNG--NLEQWLRGDMCDRGYLTWEARM--KILLGTAKALAYLHE 292
+ R L+++Y + ++ ++ R ++ + M +L + YLH
Sbjct: 67 FLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 293 AIEPKVVHRDIKSSNILI----DENFDAKISDFGLAKLLGAGKSHIT--TRVMGTFGYVA 346
V+HRD+K +NIL+ E KI+D G A+L + + V+ TF Y A
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183
Query: 347 PEYANSGLLNEKS-DVYSFGVVLLEAITGRYPVDYGRPQ 384
PE K+ D+++ G + E +T P+ + R +
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQE 221
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.001
Identities = 34/103 (33%), Positives = 50/103 (48%), Gaps = 19/103 (18%)
Query: 176 FSKDN-----IIGDGGYGVVYR------GQLMNGTAVAVKKLLNNPGQADKDFR----VE 220
F +DN +G G +G V G+ N VAVK L + A D R E
Sbjct: 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKAS---AHTDEREALMSE 91
Query: 221 VEAIGHV-RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLR 262
++ + H+ +HKN+V LLG C G +++ EY G+L +LR
Sbjct: 92 LKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLR 134
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 19/35 (54%), Positives = 22/35 (62%), Gaps = 2/35 (5%)
Query: 299 VHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333
+HRDIK NILID K+SDFGL+ G K H
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLS--TGFHKQH 155
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 38/159 (23%), Positives = 63/159 (39%), Gaps = 50/159 (31%)
Query: 299 VHRDIKSSNILIDENFDAKISDFGL---------AKLLGAG------------------- 330
+HRDIK NILID + K++DFGL +K +G
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 331 ---------------KSH---ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAI 372
+ H + ++GT Y+APE + D +S GV+L E +
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 373 TGRYPVDYGRP-QSEVNLVEW---LKMMVQLRRSEDVVD 407
G+ P P ++++ ++ W L + Q + S + D
Sbjct: 243 VGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASD 281
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 498 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.86 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.84 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.84 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.83 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.82 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.81 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.81 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.79 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.78 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.77 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.77 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.76 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.71 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.7 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.69 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.65 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.54 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.53 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.52 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.45 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.42 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.39 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.34 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.33 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.28 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.28 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.26 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.21 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.12 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.05 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.02 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.98 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.87 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.8 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.79 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.71 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.59 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.59 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.57 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.49 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.44 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.43 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.32 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.28 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.26 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.2 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.18 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.17 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.1 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.07 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.0 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.9 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.9 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.87 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.79 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.77 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.72 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.64 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.55 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.55 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.4 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.26 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.0 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.98 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.95 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.93 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.93 | |
| PLN02236 | 344 | choline kinase | 96.89 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.8 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.77 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.47 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.43 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.38 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.34 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.12 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.98 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.96 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.8 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.61 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.46 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 94.64 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 94.49 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-55 Score=438.43 Aligned_cols=289 Identities=54% Similarity=0.922 Sum_probs=253.1
Q ss_pred CCccccHHHHHHHccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEE
Q 010891 160 WGHWFTLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYC 239 (498)
Q Consensus 160 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 239 (498)
....|++.++..+|++|....+||+|+||.||+|.+.+|..||||++.....+..++|..|+.++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 34669999999999999999999999999999999989999999988655443145699999999999999999999999
Q ss_pred EeCC-eeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEE
Q 010891 240 IEGT-QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKI 318 (498)
Q Consensus 240 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL 318 (498)
.+.+ +.+||||||++|+|.++|+..... +|+|..+++|+.++|+||+|||..+.|.||||||||+|||||+++++||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9988 599999999999999999864322 8999999999999999999999998889999999999999999999999
Q ss_pred eeeccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHh
Q 010891 319 SDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQ 398 (498)
Q Consensus 319 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 398 (498)
+|||+|+..........+...||.+|+|||++..+..+.|+|||||||+|+||+||+.|.+...+....++.+|......
T Consensus 219 sDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 219 SDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred cCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 99999976543111211111799999999999999999999999999999999999999887666666678999888888
Q ss_pred hccccCCcCCCCC-CCCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 399 LRRSEDVVDPNIE-TRPST-SALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 399 ~~~~~~~~~~~~~-~~~~~-~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
......++|+.+. ..... ..+.+++.++++|++.+|.+||+|.||++.|+..
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~ 352 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI 352 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence 8888999999987 44343 6888899999999999999999999999999544
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-51 Score=388.38 Aligned_cols=254 Identities=26% Similarity=0.455 Sum_probs=205.7
Q ss_pred CCccceEcccCcEEEEEEEE-cCCcEEEEEEecCC-CCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCC-eeEEEEeec
Q 010891 176 FSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNN-PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT-QRILVYEYV 252 (498)
Q Consensus 176 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-~~~lv~e~~ 252 (498)
++..+.||+|..|+||++++ .+++.+|+|.+... .....+++.+|+++++..+|||||.+||.|..+. ..+|+||||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 34477999999999999975 46889999999443 3344578999999999999999999999999988 599999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHH-ccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE-AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
++|+|.+++.. .+.+++....+|+.+|++||.|||. + +||||||||+||||+..|.+||||||.+..+.+.
T Consensus 161 DgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 161 DGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred CCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 99999999973 3779999999999999999999996 6 9999999999999999999999999999987554
Q ss_pred ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCC
Q 010891 332 SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (498)
....++||..|||||.+.+..|+.++||||||+.++|+.+|++||....+. .. .|+..+..+.... .|.++
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~-~~---~~~~Ll~~Iv~~p---pP~lP 303 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPP-YL---DIFELLCAIVDEP---PPRLP 303 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCC-CC---CHHHHHHHHhcCC---CCCCC
Confidence 467789999999999999999999999999999999999999999764221 11 2223332222211 12232
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 412 ~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
......+... +.-.||++||.+|||+.|+++|---
T Consensus 304 ~~~fS~ef~~---FV~~CL~Kdp~~R~s~~qLl~Hpfi 338 (364)
T KOG0581|consen 304 EGEFSPEFRS---FVSCCLRKDPSERPSAKQLLQHPFI 338 (364)
T ss_pred cccCCHHHHH---HHHHHhcCCcccCCCHHHHhcCHHH
Confidence 2212223333 3337999999999999999987543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-50 Score=386.55 Aligned_cols=257 Identities=27% Similarity=0.399 Sum_probs=205.3
Q ss_pred HccCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCCCc-------hhHHHHHHHHHHcCCCCCceEEEeEEEeCC
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQA-------DKDFRVEVEAIGHVRHKNLVRLLGYCIEGT 243 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 243 (498)
..+.|.+.+.||+|+||.|-+|. ..+|+.||||++.+..... .....+|+++|++|+|||||+++++|...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 45678889999999999999996 6789999999995432211 123568999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCC---CCeEEee
Q 010891 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN---FDAKISD 320 (498)
Q Consensus 244 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~---~~~kL~D 320 (498)
..||||||++||+|.+++. .++.+.+.....++.|++.|+.|||+. ||+||||||+|||+..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecc
Confidence 9999999999999999997 446788889999999999999999999 99999999999999766 7799999
Q ss_pred eccceecCCCCceeeecccccccccCcccccCCC---CCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHH
Q 010891 321 FGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGL---LNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMV 397 (498)
Q Consensus 321 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 397 (498)
||+|+..+ ....+.++||||.|.|||++.++. +..++|+||+|||||-+++|.+||....... .+.+
T Consensus 323 FGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~e------ 392 (475)
T KOG0615|consen 323 FGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKE------ 392 (475)
T ss_pred cchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHH------
Confidence 99999876 345678899999999999997654 3348899999999999999999998654432 1111
Q ss_pred hhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 398 QLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
+.......+-|.. +...+ .+.+.++.+||..||++|||+.|+|+|--.
T Consensus 393 QI~~G~y~f~p~~--w~~Is--eea~dlI~~mL~VdP~~R~s~~eaL~hpW~ 440 (475)
T KOG0615|consen 393 QILKGRYAFGPLQ--WDRIS--EEALDLINWMLVVDPENRPSADEALNHPWF 440 (475)
T ss_pred HHhcCcccccChh--hhhhh--HHHHHHHHHhhEeCcccCcCHHHHhcChhh
Confidence 1111111111111 22222 344555568999999999999999986543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-49 Score=398.22 Aligned_cols=249 Identities=27% Similarity=0.441 Sum_probs=208.5
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCC---CCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNN---PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
.+|...++||+|||+.||.++. .+|+.||+|++.+. .....+.+.+||++.+.|+|||||+++++|++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5789999999999999999986 88999999999653 2334456888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
|+|..++|..+++ .++++++.++..++.||+.||.|||++ +|||||||..|+||+++.++||+|||||..+..
T Consensus 98 ELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999997 457899999999999999999999999 999999999999999999999999999998875
Q ss_pred CCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
+.. ...+.||||.|.|||++.....+..+||||+|||||.||+|++||+...- .+.+..+. ..+
T Consensus 171 ~~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v------kety~~Ik---~~~------ 234 (592)
T KOG0575|consen 171 DGE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV------KETYNKIK---LNE------ 234 (592)
T ss_pred ccc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH------HHHHHHHH---hcC------
Confidence 432 23457999999999999999999999999999999999999999974322 22222221 111
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
...+...+...+.++. ++|++||.+|||+.+||.+-
T Consensus 235 Y~~P~~ls~~A~dLI~--~lL~~~P~~Rpsl~~vL~h~ 270 (592)
T KOG0575|consen 235 YSMPSHLSAEAKDLIR--KLLRPNPSERPSLDEVLDHP 270 (592)
T ss_pred cccccccCHHHHHHHH--HHhcCCcccCCCHHHHhcCH
Confidence 1112233334444443 79999999999999999654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-49 Score=393.17 Aligned_cols=252 Identities=35% Similarity=0.544 Sum_probs=203.8
Q ss_pred CccceEcccCcEEEEEEEEcCCcE-EEEEEecCCCCCc--hhHHHHHHHHHHcCCCCCceEEEeEEEeCC-eeEEEEeec
Q 010891 177 SKDNIIGDGGYGVVYRGQLMNGTA-VAVKKLLNNPGQA--DKDFRVEVEAIGHVRHKNLVRLLGYCIEGT-QRILVYEYV 252 (498)
Q Consensus 177 ~~~~~lg~G~~g~Vy~~~~~~~~~-vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-~~~lv~e~~ 252 (498)
.+.+.||+|+||+||+|.+. |+. ||||++....... .+.|.+|+.+|.+++|||||+++|+|.+.. .+++||||+
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~-g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~ 122 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWR-GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM 122 (362)
T ss_pred hhhhhcccCCceeEEEEEeC-CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence 44556999999999999985 555 9999996544332 458999999999999999999999999887 799999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCC-eeecCCCCCCEEEcCCC-CeEEeeeccceecCCC
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK-VVHRDIKSSNILIDENF-DAKISDFGLAKLLGAG 330 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~-iiHrDikp~NIll~~~~-~~kL~DfGla~~~~~~ 330 (498)
++|+|.++|+.. ....+++..++.++.|||+||.|||++ + ||||||||+||||+.++ ++||+|||+++.....
T Consensus 123 ~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 123 PGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 999999999864 357799999999999999999999998 7 99999999999999998 9999999999986543
Q ss_pred CceeeecccccccccCccccc--CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCC
Q 010891 331 KSHITTRVMGTFGYVAPEYAN--SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (498)
. ..++...||+.|||||++. ...|+.|+||||||++||||+||+.||....+ . .....+...... +
T Consensus 198 ~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~-----~~~~~v~~~~~R-----p 265 (362)
T KOG0192|consen 198 K-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-V-----QVASAVVVGGLR-----P 265 (362)
T ss_pred c-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-H-----HHHHHHHhcCCC-----C
Confidence 2 2244468999999999999 66999999999999999999999999986554 1 111122211111 1
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 409 NIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
.++.. .. ..+..++.+||+.||.+||++.+++..|+..
T Consensus 266 ~~p~~-~~---~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~ 303 (362)
T KOG0192|consen 266 PIPKE-CP---PHLSSLMERCWLVDPSRRPSFLEIVSRLESI 303 (362)
T ss_pred CCCcc-CC---HHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence 11111 22 2333344479999999999999999999854
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-49 Score=380.81 Aligned_cols=202 Identities=33% Similarity=0.574 Sum_probs=180.9
Q ss_pred ccCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCC--CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
..+|...+.||+|+||+||+|+ ..++..||||.+.... ....+.+..|+.+|+.++|||||.+++++++++.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 3568888899999999999998 4568999999996653 334456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCC------CCeEEeeecc
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN------FDAKISDFGL 323 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~------~~~kL~DfGl 323 (498)
|||+||||.+||+ ..+.+++..+..++.|+|.||++||++ +||||||||.||||+.. -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~----~~~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIR----RRGRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 9999999999998 446799999999999999999999999 99999999999999765 4589999999
Q ss_pred ceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCC
Q 010891 324 AKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRP 383 (498)
Q Consensus 324 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~ 383 (498)
|+.+..+ ......||++.|||||++..+.|+.|+|+||+|+|||+|++|+.||....+
T Consensus 162 AR~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 162 ARFLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred hhhCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 9998754 334568999999999999999999999999999999999999999985443
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=370.35 Aligned_cols=258 Identities=28% Similarity=0.407 Sum_probs=205.5
Q ss_pred CCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCC--CCchhHHHHHHHHHHcCCCCCceEEEe-EEEeCCe-eEEEE
Q 010891 175 RFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLG-YCIEGTQ-RILVY 249 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~-~~~~~~~-~~lv~ 249 (498)
.|++.++||+|.||+||++. ..+|..||.|.+.-.. ....++...|+.+|++|+|||||++++ .|.++.. ++|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 46778999999999999996 6789999999986322 233456888999999999999999999 5555555 89999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCC--eeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK--VVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
|||++|+|..+++....++..+++..+|+++.|++.||.++|+. -++ |+||||||.||+|+.+|.+||+||||++.+
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 99999999999987777788899999999999999999999983 225 999999999999999999999999999998
Q ss_pred CCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcC
Q 010891 328 GAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407 (498)
Q Consensus 328 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (498)
.... ...+..+|||.||+||++.+.+|+.||||||+||++|||+.-+.||.+. ++...-..+.. .
T Consensus 179 ~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI~q---g----- 243 (375)
T KOG0591|consen 179 SSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKIEQ---G----- 243 (375)
T ss_pred cchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHHHc---C-----
Confidence 6543 4466789999999999999999999999999999999999999999754 22222222221 1
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 408 ~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
.....|..--...+..++..|+..||+.||+...++..+..
T Consensus 244 -d~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 244 -DYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred -CCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 11111111111223333446999999999996666655543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-49 Score=390.86 Aligned_cols=260 Identities=30% Similarity=0.478 Sum_probs=213.9
Q ss_pred HHHccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 170 QSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 170 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
+.....+.+++.||+|.||+||.|.+.....||+|.+... ....++|.+|+++|++|+|+|||+++++|..++.+||||
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVt 280 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVT 280 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEE
Confidence 3334445668899999999999999977779999999655 334567999999999999999999999999988999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
|||+.|+|.+||+.. .+..+...+.+.++.|||+|++||+++ ++|||||.++||||++++.+||+|||||+...+
T Consensus 281 E~m~~GsLl~yLr~~--~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 281 EYMPKGSLLDYLRTR--EGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred EecccCcHHHHhhhc--CCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCC
Confidence 999999999999863 457799999999999999999999999 999999999999999999999999999997665
Q ss_pred CCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (498)
+.........-...|.|||.+..+.|+.|||||||||+||||+| |+.||..... .+.+.... +...+..|
T Consensus 356 ~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn------~ev~~~le---~GyRlp~P 426 (468)
T KOG0197|consen 356 DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN------EEVLELLE---RGYRLPRP 426 (468)
T ss_pred CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH------HHHHHHHh---ccCcCCCC
Confidence 55444444445678999999999999999999999999999999 8888865432 22233332 23333223
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 409 NIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
.. +...+..++..||+.+|++|||++.+...|+...
T Consensus 427 ~~-------CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~ 462 (468)
T KOG0197|consen 427 EG-------CPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF 462 (468)
T ss_pred CC-------CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence 22 2234555666899999999999999999887653
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-48 Score=367.26 Aligned_cols=247 Identities=26% Similarity=0.347 Sum_probs=201.1
Q ss_pred cCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCC---CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
+.|++.++||+|+||+||+++ .++++.+|+|++.+... ...+....|..+|..++||+||+++..|++.+++|||+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 457889999999999999997 45689999999865433 23456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+.||.|+..|+ ..+.+++..+..++..|+.||.|||++ +||||||||+|||||.+|+++|+||||++....
T Consensus 105 d~~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 105 DYLNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred eccCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 9999999999997 346799999999999999999999999 999999999999999999999999999996543
Q ss_pred CCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
.. ..+..+|||+.|||||++.+..|+..+|+||||+++|||++|.+||...+. .++.+.+.... .
T Consensus 178 ~~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~------~~~~~~I~~~k--------~ 242 (357)
T KOG0598|consen 178 DG-DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV------KKMYDKILKGK--------L 242 (357)
T ss_pred CC-CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH------HHHHHHHhcCc--------C
Confidence 32 234458999999999999999999999999999999999999999975432 23333332211 0
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCC----CHHHHH
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRP----KMSQVV 444 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RP----t~~ell 444 (498)
...+...+...+.+. .+.|..||++|. ++.++-
T Consensus 243 ~~~p~~ls~~ardll--~~LL~rdp~~RLg~~~d~~~ik 279 (357)
T KOG0598|consen 243 PLPPGYLSEEARDLL--KKLLKRDPRQRLGGPGDAEEIK 279 (357)
T ss_pred CCCCccCCHHHHHHH--HHHhccCHHHhcCCCCChHHhh
Confidence 111111233333333 378999999995 556654
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-48 Score=356.87 Aligned_cols=261 Identities=26% Similarity=0.346 Sum_probs=202.7
Q ss_pred cCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCC-Cc-hhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPG-QA-DKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
++|+...++|+|+||+||+|+ ..+|+.||||++..... .. .+-..+|+++|++|+|||+|.++++|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 468888999999999999998 45699999999965443 22 2446789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
||+. ++.+-|... ..-++.+.+.+++.|++.|+.|+|++ ++|||||||+||||+.+|.+||||||+|+.+...
T Consensus 82 ~~dh-TvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p 154 (396)
T KOG0593|consen 82 YCDH-TVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP 154 (396)
T ss_pred ecch-HHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence 9987 555556543 23478899999999999999999999 9999999999999999999999999999988742
Q ss_pred CceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccc-------
Q 010891 331 KSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRS------- 402 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~------- 402 (498)
....+.++.|.||+|||++-+ ..|+..+||||+||++.||++|.+.|.+...-+.. -.+. ...+..
T Consensus 155 -gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQL---y~I~--ktLG~L~prhq~i 228 (396)
T KOG0593|consen 155 -GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQL---YLIR--KTLGNLIPRHQSI 228 (396)
T ss_pred -cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHH---HHHH--HHHcccCHHHHHH
Confidence 234567889999999998766 78999999999999999999999888754432221 1111 111111
Q ss_pred ------------cCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 403 ------------EDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 403 ------------~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
....+++......+....-.+.++..||+.||++|++-+|++.|-
T Consensus 229 F~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~ 285 (396)
T KOG0593|consen 229 FSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHP 285 (396)
T ss_pred hccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcCh
Confidence 111111111111122233566677799999999999999999654
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-46 Score=365.17 Aligned_cols=264 Identities=27% Similarity=0.327 Sum_probs=206.3
Q ss_pred ccCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCC--CCchhHHHHHHHHHHcCCCCCceEEEeEEEeC--CeeEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG--TQRIL 247 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~l 247 (498)
.+.|+.+++||+|.||.||+|+ ..+|+.||+|++.... ........+||.+|++|+||||++|.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 4568889999999999999997 6789999999996554 34445677899999999999999999988876 68899
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
|+|||+. ||.-++.. ..-.|++.++..++.|++.||.|||.+ +|+|||||.+|||||.+|.+||+|||||+++
T Consensus 196 VFeYMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEecccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeec
Confidence 9999987 99998864 234699999999999999999999999 9999999999999999999999999999988
Q ss_pred CCCCceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhcccc---
Q 010891 328 GAGKSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSE--- 403 (498)
Q Consensus 328 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--- 403 (498)
........+..+-|+||+|||++.+ ..|+.++|+||.||||.||++|++.|.+..... .+..+..+....
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve------Ql~kIfklcGSP~e~ 342 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE------QLHKIFKLCGSPTED 342 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH------HHHHHHHHhCCCChh
Confidence 7766666777889999999997765 689999999999999999999999987543222 222222222110
Q ss_pred ----------CCcCCCCCCCCCHHH-----HHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 404 ----------DVVDPNIETRPSTSA-----LKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 404 ----------~~~~~~~~~~~~~~~-----~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
..+.+.........+ ....+.++-.+|..||.+|.||.++|..=-.
T Consensus 343 ~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF 403 (560)
T KOG0600|consen 343 YWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF 403 (560)
T ss_pred ccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence 111111111111111 1123334446888999999999999965433
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=370.25 Aligned_cols=252 Identities=25% Similarity=0.352 Sum_probs=206.3
Q ss_pred ccCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCC---CCchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCeeEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 247 (498)
.++|.+++.||+|+|++|++|+ ..+++.||||++.+.- ....+.+..|-++|.+| .||.|++|+..|+|...+|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 4679999999999999999997 5679999999885432 22334566799999999 89999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
|+||+++|+|.++|+. -+.|++..+..++.+|+.||+|||++ |||||||||+|||||+++++||+|||.|+.+
T Consensus 152 vLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccC
Confidence 9999999999999984 47899999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCce------------eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 010891 328 GAGKSH------------ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKM 395 (498)
Q Consensus 328 ~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 395 (498)
...... ....++||..|.+||++..+..+..+|+|+||||||+|+.|.+||....+.-. ++.
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli------Fqk 298 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI------FQK 298 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH------HHH
Confidence 543221 11448999999999999999999999999999999999999999986553221 122
Q ss_pred HHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 396 MVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
+.. -.....+......+. +..+.|..||.+|+|++||-+|.-
T Consensus 299 I~~---------l~y~fp~~fp~~a~d--Lv~KLLv~dp~~Rlt~~qIk~HpF 340 (604)
T KOG0592|consen 299 IQA---------LDYEFPEGFPEDARD--LIKKLLVRDPSDRLTSQQIKAHPF 340 (604)
T ss_pred HHH---------hcccCCCCCCHHHHH--HHHHHHccCccccccHHHHhhCcc
Confidence 111 122222222233333 334789999999999999987753
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=373.80 Aligned_cols=253 Identities=24% Similarity=0.400 Sum_probs=215.3
Q ss_pred HccCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
....|...++||+|+.|.||.|+ ..+++.||||++........+-+.+|+.+|+..+|+|||.+++.|...+.+|+|||
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 45678888999999999999996 56789999999976665666678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
||+||+|.|.+.. -.+++.++..|+.++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++..+...
T Consensus 351 ym~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~ 422 (550)
T KOG0578|consen 351 YMEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE 422 (550)
T ss_pred ecCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence 9999999999854 4589999999999999999999999 9999999999999999999999999999988665
Q ss_pred CceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCC
Q 010891 331 KSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNI 410 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (498)
... ....+|||+|||||++....|++|+||||||++++||+-|.+||-...|... +..+. ..-.+.+
T Consensus 423 ~~K-R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA------lyLIa------~ng~P~l 489 (550)
T KOG0578|consen 423 QSK-RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIA------TNGTPKL 489 (550)
T ss_pred cCc-cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHH------HHHHh------hcCCCCc
Confidence 543 3446899999999999999999999999999999999999999986555321 12222 1223455
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 411 ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 411 ~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
..+...+...+.+.- +||..|+++|+++.|||+|-
T Consensus 490 k~~~klS~~~kdFL~--~cL~~dv~~RasA~eLL~Hp 524 (550)
T KOG0578|consen 490 KNPEKLSPELKDFLD--RCLVVDVEQRASAKELLEHP 524 (550)
T ss_pred CCccccCHHHHHHHH--HHhhcchhcCCCHHHHhcCh
Confidence 555555555555554 89999999999999999864
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-47 Score=368.17 Aligned_cols=262 Identities=25% Similarity=0.325 Sum_probs=206.2
Q ss_pred HHccCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCCCchhH--HHHHHHHHHcCC-CCCceEEEeEEEeCC-ee
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKD--FRVEVEAIGHVR-HKNLVRLLGYCIEGT-QR 245 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l~-hpnIv~l~~~~~~~~-~~ 245 (498)
..-++|.+.++||.|.||.||+|+ ..+|..||||++++.-.. .++ -.+|++.|++|+ |||||++.+++.+.+ .+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 455789999999999999999997 667999999998665443 333 357999999998 999999999999887 99
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccce
Q 010891 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~ 325 (498)
|+|||||+. +|++++... +..+++..+..|+.||++||+|+|.+ |+.|||+||+|||+..+..+||+|||+|+
T Consensus 86 ~fVfE~Md~-NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLAR 158 (538)
T KOG0661|consen 86 YFVFEFMDC-NLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAR 158 (538)
T ss_pred eeeHHhhhh-hHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccc
Confidence 999999965 999999754 56799999999999999999999999 99999999999999988899999999999
Q ss_pred ecCCCCceeeecccccccccCcccc-cCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhh-cccc
Q 010891 326 LLGAGKSHITTRVMGTFGYVAPEYA-NSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQL-RRSE 403 (498)
Q Consensus 326 ~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~ 403 (498)
..... ...+.++-|.||+|||++ +.+.|+.+.|+|++|||++|+++-++.|.+....++. .++... +...
T Consensus 159 ev~Sk--pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi------~KIc~VLGtP~ 230 (538)
T KOG0661|consen 159 EVRSK--PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQI------YKICEVLGTPD 230 (538)
T ss_pred ccccC--CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHH------HHHHHHhCCCc
Confidence 87543 346778999999999966 6688999999999999999999999999765432211 111111 0000
Q ss_pred --------------CCcCCCCCCC----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 404 --------------DVVDPNIETR----PSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 404 --------------~~~~~~~~~~----~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
...-|..... --.......+.++.+||..||++||||.|++++--
T Consensus 231 ~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pf 293 (538)
T KOG0661|consen 231 KDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPF 293 (538)
T ss_pred cccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcc
Confidence 0000111000 00113344555556899999999999999998753
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=333.55 Aligned_cols=274 Identities=24% Similarity=0.361 Sum_probs=211.8
Q ss_pred cCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCCCc--hhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQA--DKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
.+|...++||+|.||.||+|+ ..+|+.||||++......+ .....+|++.|+.++||||+.++++|...+.+.||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 468888999999999999997 5789999999996553321 2356789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
||+. +|+..++. ....|+..++..++.++++||+|||++ .|+||||||+|+|++.+|.+||+|||+|+.+...
T Consensus 82 fm~t-dLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMPT-DLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred eccc-cHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 9977 99999975 446789999999999999999999999 9999999999999999999999999999998765
Q ss_pred CceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHh-hccc------
Q 010891 331 KSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQ-LRRS------ 402 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~-~~~~------ 402 (498)
...... .+-|.+|+|||++.+ ..|+..+||||.|||+.||+-|.+-|.+...-+. +..+.+ ++..
T Consensus 155 ~~~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ------L~~If~~LGTP~~~~WP 227 (318)
T KOG0659|consen 155 NRIQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ------LSKIFRALGTPTPDQWP 227 (318)
T ss_pred Cccccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH------HHHHHHHcCCCCcccCc
Confidence 433332 378999999997755 6799999999999999999998766654332111 111111 1111
Q ss_pred -----------cCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCCCcchhhcc
Q 010891 403 -----------EDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIPREDRRRR 462 (498)
Q Consensus 403 -----------~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~~~~~~~~~~~~ 462 (498)
.....+....- -+.+....+.++.+++..||.+|+|+.|++++-.....|.|...-...
T Consensus 228 ~~~~lpdY~~~~~~P~~~~~~l-f~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp 297 (318)
T KOG0659|consen 228 EMTSLPDYVKIQQFPKPPLNNL-FPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSKLP 297 (318)
T ss_pred cccccccHHHHhcCCCCccccc-cccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhhCc
Confidence 11111111111 112233446666789999999999999999987766656555444333
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-45 Score=366.76 Aligned_cols=252 Identities=27% Similarity=0.450 Sum_probs=203.5
Q ss_pred HHccCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCC----CC-CchhHHHHHHHHHHcCC-CCCceEEEeEEEeCC
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNN----PG-QADKDFRVEVEAIGHVR-HKNLVRLLGYCIEGT 243 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~ 243 (498)
...++|.+.+.||+|+||.|+.|+ ..++..||+|.+... .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 345689999999999999999996 557899999966443 11 23445778999999998 999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCC-CCeEEeeec
Q 010891 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN-FDAKISDFG 322 (498)
Q Consensus 244 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~-~~~kL~DfG 322 (498)
+.|+||||+.||+|++++. ..+++.+.++..++.|++.|++|||++ +|+||||||+|||++.+ +++||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~----~~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIV----NKGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHH----HcCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 9999999999999999997 357899999999999999999999999 99999999999999999 999999999
Q ss_pred cceecCCCCceeeecccccccccCcccccCCC-CC-ccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhc
Q 010891 323 LAKLLGAGKSHITTRVMGTFGYVAPEYANSGL-LN-EKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLR 400 (498)
Q Consensus 323 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 400 (498)
++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||...... ..... ..
T Consensus 167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~------~l~~k---i~ 236 (370)
T KOG0583|consen 167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP------NLYRK---IR 236 (370)
T ss_pred cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH------HHHHH---Hh
Confidence 999874 2223456689999999999999877 86 6899999999999999999999863221 11111 11
Q ss_pred cccCCcCCCCCCCCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 401 RSEDVVDPNIETRPST-SALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 401 ~~~~~~~~~~~~~~~~-~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.. .+..+... +.... .++.+||..||.+|+|+.+++.+-
T Consensus 237 ~~------~~~~p~~~~S~~~~--~Li~~mL~~~P~~R~t~~~i~~h~ 276 (370)
T KOG0583|consen 237 KG------EFKIPSYLLSPEAR--SLIEKMLVPDPSTRITLLEILEHP 276 (370)
T ss_pred cC------CccCCCCcCCHHHH--HHHHHHcCCCcccCCCHHHHhhCh
Confidence 11 22222221 22222 233379999999999999999543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-45 Score=352.58 Aligned_cols=259 Identities=25% Similarity=0.349 Sum_probs=203.7
Q ss_pred ccCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
...|++.++||.|..++||+|+ ...++.||||++.-.... ..+.++.|+..|+.++||||++++..|..++.+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4578999999999999999997 566899999999544333 34789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
||.+|++.+.+...... -+++..+..|+.++++||.|||.+ |.||||||+.||||+.+|.+||+|||.+..+...
T Consensus 105 fMa~GS~ldIik~~~~~--Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPD--GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhcCCcHHHHHHHHccc--cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 99999999999866433 389999999999999999999999 9999999999999999999999999988766433
Q ss_pred Cce---eeecccccccccCcccccC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCC
Q 010891 331 KSH---ITTRVMGTFGYVAPEYANS--GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV 405 (498)
Q Consensus 331 ~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (498)
... ..+.++||+.|||||++.. ..|+.|+||||||++..||.+|+.||....|-.. .+..+.+....
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv--------Ll~tLqn~pp~ 251 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV--------LLLTLQNDPPT 251 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH--------HHHHhcCCCCC
Confidence 211 1255789999999999543 5799999999999999999999999986554221 11122222111
Q ss_pred cCCCCCCCCCHHH----HHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 406 VDPNIETRPSTSA----LKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 406 ~~~~~~~~~~~~~----~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.+ ......+. ......++-.||.+||.+|||+.+++++-
T Consensus 252 ~~---t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~ 294 (516)
T KOG0582|consen 252 LL---TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHA 294 (516)
T ss_pred cc---cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccH
Confidence 11 00001100 01122223369999999999999999643
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=356.89 Aligned_cols=256 Identities=30% Similarity=0.459 Sum_probs=200.1
Q ss_pred CCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCC--eeEEEEee
Q 010891 175 RFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT--QRILVYEY 251 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--~~~lv~e~ 251 (498)
+|...+.||+|+||.||++... +|..+|||.+........+.+.+|+.+|.+++|||||+++|...... .+++.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 4577889999999999999754 48999999886553333566889999999999999999999755444 68999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcC-CCCeEEeeeccceecCC-
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE-NFDAKISDFGLAKLLGA- 329 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~-~~~~kL~DfGla~~~~~- 329 (498)
+++|+|.+++.... +.|++..+..++.||++||+|||++ +|+||||||+|||++. ++.+||+|||++.....
T Consensus 98 ~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 98 APGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred cCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 99999999998642 2699999999999999999999999 9999999999999999 79999999999987763
Q ss_pred -CCceeeecccccccccCcccccCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcC
Q 010891 330 -GKSHITTRVMGTFGYVAPEYANSGL-LNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407 (498)
Q Consensus 330 -~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (498)
..........||+.|||||++..+. ...++|||||||++.||+||+.||..- ..... .+....... ..
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~---~~~~ig~~~--~~ 241 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAE---ALLLIGRED--SL 241 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHH---HHHHHhccC--CC
Confidence 1222234578999999999998643 335999999999999999999999742 11111 112222111 12
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 408 ~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
|.+ +...+...+.+. .+|+..||++||||.++|.|....
T Consensus 242 P~i--p~~ls~~a~~Fl--~~C~~~~p~~Rpta~eLL~hpf~~ 280 (313)
T KOG0198|consen 242 PEI--PDSLSDEAKDFL--RKCFKRDPEKRPTAEELLEHPFLK 280 (313)
T ss_pred CCC--CcccCHHHHHHH--HHHhhcCcccCcCHHHHhhChhhh
Confidence 222 223333334433 379999999999999999987543
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=360.12 Aligned_cols=266 Identities=28% Similarity=0.422 Sum_probs=212.7
Q ss_pred HHccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCc-hhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQA-DKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
.......+.++||+|-||.|.+|....+..||||++....... .++|..|+++|.+|+|||||+++|+|..++.+|+|+
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 3456678889999999999999998778999999997765544 478999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
|||++|+|.+||..+.. ..+.-.....|+.||+.|++||.+. +++||||.++|+|++.++++||+|||+++-+-.
T Consensus 615 EYmEnGDLnqFl~ahea--pt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHEL--PTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYS 689 (807)
T ss_pred HHHhcCcHHHHHHhccC--cccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCccccccccc
Confidence 99999999999986632 2244566778999999999999998 999999999999999999999999999997655
Q ss_pred CCceee-ecccccccccCcccccCCCCCccchHHHHHHHHHHHHh--CCCCCCCCCCcchhhHHHHHHHHHhhccccCCc
Q 010891 330 GKSHIT-TRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT--GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVV 406 (498)
Q Consensus 330 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt--g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (498)
+..+.. ...+-..+|||||.+..++++.++|||+||++|||+++ ...||..... .+.++....+......+.+
T Consensus 690 g~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~---e~vven~~~~~~~~~~~~~- 765 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTD---EQVVENAGEFFRDQGRQVV- 765 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhH---HHHHHhhhhhcCCCCccee-
Confidence 554433 34566789999999999999999999999999999865 6788864332 2223332333222222211
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 407 DPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 407 ~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
...| ......+..++++||..|-.+||+++++..+|+..
T Consensus 766 ----l~~P-~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 766 ----LSRP-PACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred ----ccCC-CcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1111 12234556777799999999999999999998764
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=362.24 Aligned_cols=248 Identities=26% Similarity=0.409 Sum_probs=204.6
Q ss_pred cCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
++|.+.+.||+|.||.||+|+ ..+.+.||+|.+.+... .+.+.+++|+++++.++|||||.++++|+...++|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 568888999999999999997 56788999998865433 334568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
|+.| +|+.+|. +.+.++++.+..|+.+++.||.|||+. +|+|||+||.|||++.+|.+|+||||+|+.+...
T Consensus 82 ~a~g-~L~~il~----~d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILE----QDGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN 153 (808)
T ss_pred hhhh-hHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence 9977 9999998 557899999999999999999999999 9999999999999999999999999999988754
Q ss_pred CceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCC
Q 010891 331 KSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNI 410 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (498)
. ...+.+.|||.|||||++.+++|+..+|+||+|||||||++|++||... .+....+.+. . ...
T Consensus 154 t-~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~----~-----d~v 217 (808)
T KOG0597|consen 154 T-SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSIL----K-----DPV 217 (808)
T ss_pred c-eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHh----c-----CCC
Confidence 3 4456688999999999999999999999999999999999999999632 1222222211 1 111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 411 ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 411 ~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
..+...+.....+ ....|.+||.+|.|-.+++.|-
T Consensus 218 ~~p~~~S~~f~nf--l~gLL~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 218 KPPSTASSSFVNF--LQGLLIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred CCcccccHHHHHH--HHHHhhcChhhcccHHHHhcCh
Confidence 1122222223333 3367999999999999998653
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=358.37 Aligned_cols=254 Identities=24% Similarity=0.339 Sum_probs=201.5
Q ss_pred HccCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCCC---chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQ---ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
-.++|++++.||+|+||.||+|+ ..+|..+|+|++.+.... ..+..+.|-++|...++|+||++|..|++.+++||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 45678999999999999999997 567999999999765433 33457889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
||||++||++..+|. ..+.|+++.+..++.+++.|+.-||.. |+|||||||+|+|||..|++||+||||+.-+
T Consensus 219 iMEylPGGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEecCCccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchh
Confidence 999999999999997 457899999999999999999999999 9999999999999999999999999999532
Q ss_pred CC----------------------CC-c------e-----------------eeecccccccccCcccccCCCCCccchH
Q 010891 328 GA----------------------GK-S------H-----------------ITTRVMGTFGYVAPEYANSGLLNEKSDV 361 (498)
Q Consensus 328 ~~----------------------~~-~------~-----------------~~~~~~gt~~y~aPE~~~~~~~~~~sDv 361 (498)
.. .. . . .....+|||-|||||++.+..|+..+|+
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 11 00 0 0 0112579999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCCCcchhh-HHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCC--
Q 010891 362 YSFGVVLLEAITGRYPVDYGRPQSEVN-LVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRP-- 438 (498)
Q Consensus 362 wSlGvvl~elltg~~P~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RP-- 438 (498)
||||||+||||.|.+||....+..... ++.| +... .++.....+. ++..++.+||. ||++|.
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nw-r~~l-----------~fP~~~~~s~--eA~DLI~rll~-d~~~RLG~ 436 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNW-RETL-----------KFPEEVDLSD--EAKDLITRLLC-DPENRLGS 436 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-hhhc-----------cCCCcCcccH--HHHHHHHHHhc-CHHHhcCc
Confidence 999999999999999998877654332 2222 1111 0111111122 23333346666 999996
Q ss_pred -CHHHHHHHH
Q 010891 439 -KMSQVVRML 447 (498)
Q Consensus 439 -t~~ell~~L 447 (498)
.++||-+|-
T Consensus 437 ~G~~EIK~HP 446 (550)
T KOG0605|consen 437 KGAEEIKKHP 446 (550)
T ss_pred ccHHHHhcCC
Confidence 477776543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=335.29 Aligned_cols=198 Identities=30% Similarity=0.420 Sum_probs=178.6
Q ss_pred CCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCCCch---hHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 175 RFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQAD---KDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
+|++.+.||.|+||.|.+++ ..+|..+|+|++.+...-.. +....|..+|+.+.||+++++++.|.+...+|||||
T Consensus 45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme 124 (355)
T KOG0616|consen 45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME 124 (355)
T ss_pred hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence 56778999999999999998 45688999999865433222 345679999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
|++||.|+.+|+ ..+++++..+..++.||+.||+|||++ +|++|||||+|||||.+|.+||+|||+|+.....
T Consensus 125 yv~GGElFS~Lr----k~~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 125 YVPGGELFSYLR----KSGRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred ccCCccHHHHHH----hcCCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 999999999998 447799999999999999999999999 9999999999999999999999999999987543
Q ss_pred CceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCC
Q 010891 331 KSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRP 383 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~ 383 (498)
+.+.||||.|+|||++..++|+.++|+|||||++|||+.|.+||....+
T Consensus 198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~ 246 (355)
T KOG0616|consen 198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP 246 (355)
T ss_pred ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence 4558999999999999999999999999999999999999999986654
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=355.18 Aligned_cols=249 Identities=26% Similarity=0.415 Sum_probs=207.0
Q ss_pred cCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCC-CCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNN-PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
..|+..++||+|.||.||+|. ...++.||+|++.-. .....+++++|+.+|..++++||.++|+.+..+..+|++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 346667899999999999997 456899999998543 334567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
|.||++.+.|. ....+.+....-++.+++.||.|||.+ +.+|||||+.|||+..+|.+||+|||.+..+....
T Consensus 93 ~~gGsv~~lL~----~~~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 93 CGGGSVLDLLK----SGNILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred hcCcchhhhhc----cCCCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechh
Confidence 99999999996 334458888888999999999999999 99999999999999999999999999999876654
Q ss_pred ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCC
Q 010891 332 SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (498)
... ..++||+.|||||++....|+.|+||||||++.+||.+|.+|+....|.... .....-..|.+.
T Consensus 166 ~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl------------flIpk~~PP~L~ 232 (467)
T KOG0201|consen 166 KRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL------------FLIPKSAPPRLD 232 (467)
T ss_pred hcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE------------EeccCCCCCccc
Confidence 443 6689999999999999999999999999999999999999999866653211 111222334444
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 412 ~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
. .....+...+. .||++||+.||+|.++|+|
T Consensus 233 ~-~~S~~~kEFV~---~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 233 G-DFSPPFKEFVE---ACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred c-ccCHHHHHHHH---HHhhcCcccCcCHHHHhhh
Confidence 4 22233344333 6999999999999999965
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-45 Score=377.94 Aligned_cols=261 Identities=28% Similarity=0.473 Sum_probs=209.3
Q ss_pred HccCCCccceEcccCcEEEEEEEEc------CCcEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEeEEEeCCe
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQ 244 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 244 (498)
.+.+..+.+.||+|+||+||+|+.. +...||||.++..... ...+|++|++++..++|||||+|+|+|.+++.
T Consensus 484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P 563 (774)
T KOG1026|consen 484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP 563 (774)
T ss_pred chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence 3445567789999999999999742 3467999999877665 67899999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcccC------C----CCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCC
Q 010891 245 RILVYEYVNNGNLEQWLRGDMC------D----RGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF 314 (498)
Q Consensus 245 ~~lv~e~~~~g~L~~~l~~~~~------~----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~ 314 (498)
.|+|+|||..|||.+||..... . ..+|+..+.+.|+.|||.|+.||-++ .++||||..+|+||.++.
T Consensus 564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENL 640 (774)
T ss_pred eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccce
Confidence 9999999999999999964321 1 23488999999999999999999999 999999999999999999
Q ss_pred CeEEeeeccceecCCCCceeee-cccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHH
Q 010891 315 DAKISDFGLAKLLGAGKSHITT-RVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEW 392 (498)
Q Consensus 315 ~~kL~DfGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~ 392 (498)
.|||+||||++..-....+... .-.-..+|||||.+..+.||.+||||||||+|||+++ |+.||..-..++ .++.
T Consensus 641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E---VIe~ 717 (774)
T KOG1026|consen 641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE---VIEC 717 (774)
T ss_pred EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH---HHHH
Confidence 9999999999976444333222 2234678999999999999999999999999999999 899987544322 2222
Q ss_pred HHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 393 LKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
+ +.++. + +. +......+..+++.||+.+|.+||+++||-..|+...
T Consensus 718 ---i-~~g~l--L--~~-----Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 718 ---I-RAGQL--L--SC-----PENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred ---H-HcCCc--c--cC-----CCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 1 11111 1 11 1112345555666899999999999999999988654
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=354.79 Aligned_cols=267 Identities=27% Similarity=0.448 Sum_probs=212.7
Q ss_pred cHHHHHHHccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCc--hhHHHHHHHHHHcCCCCCceEEEeEEEeC
Q 010891 165 TLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQA--DKDFRVEVEAIGHVRHKNLVRLLGYCIEG 242 (498)
Q Consensus 165 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 242 (498)
+..++++..+.+.+...||+|.||+||+|+|. ..||||++....... .+.|+.|+..+++-+|.||+-++|+|..+
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP 460 (678)
T ss_pred cccccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC
Confidence 34677888888899999999999999999984 459999996655443 36799999999999999999999999988
Q ss_pred CeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeec
Q 010891 243 TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFG 322 (498)
Q Consensus 243 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfG 322 (498)
.. .||+.+|+|-+|+.+|+. ....|.....+.|+.|||+|+.|||.+ +|||||||..||++.+++.|||+|||
T Consensus 461 ~~-AIiTqwCeGsSLY~hlHv---~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFG 533 (678)
T KOG0193|consen 461 PL-AIITQWCEGSSLYTHLHV---QETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFG 533 (678)
T ss_pred ce-eeeehhccCchhhhhccc---hhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEeccc
Confidence 77 999999999999999985 335688899999999999999999999 99999999999999999999999999
Q ss_pred cceecCCC-CceeeecccccccccCccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHh
Q 010891 323 LAKLLGAG-KSHITTRVMGTFGYVAPEYAN---SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQ 398 (498)
Q Consensus 323 la~~~~~~-~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 398 (498)
|+..-..- .........|...|||||+++ ..+|++.+||||||||+|||+||..||.....+. .+..
T Consensus 534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq---------Iifm 604 (678)
T KOG0193|consen 534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ---------IIFM 604 (678)
T ss_pred ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh---------eEEE
Confidence 99753211 011122235778899999885 3579999999999999999999999998433221 1122
Q ss_pred hccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 010891 399 LRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEY 452 (498)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~~ 452 (498)
.++.....+..........++.+++. .||..++++||.+.+|+..|+....
T Consensus 605 VGrG~l~pd~s~~~s~~pk~mk~Ll~---~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 605 VGRGYLMPDLSKIRSNCPKAMKRLLS---DCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ecccccCccchhhhccCHHHHHHHHH---HHHhcCcccCccHHHHHHHHHHhhh
Confidence 33333333333333344445555444 6999999999999999998887654
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=356.58 Aligned_cols=262 Identities=27% Similarity=0.404 Sum_probs=200.3
Q ss_pred HHccCCCccceEcccCcEEEEEEEE------cCCcEEEEEEecCCCC-CchhHHHHHHHHHHcC-CCCCceEEEeEEEeC
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQL------MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHV-RHKNLVRLLGYCIEG 242 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~ 242 (498)
...++|++.+.||+|+||.||+|.. .++..||+|++..... ...+.+..|+.++..+ +||||+++++++...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 3456899999999999999999963 2356899999864432 2335688899999999 899999999988764
Q ss_pred -CeeEEEEeecCCCCHHHHHhcccC-------------------------------------------------------
Q 010891 243 -TQRILVYEYVNNGNLEQWLRGDMC------------------------------------------------------- 266 (498)
Q Consensus 243 -~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------- 266 (498)
...++||||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 457899999999999999974311
Q ss_pred ---CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCce-eeecccccc
Q 010891 267 ---DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH-ITTRVMGTF 342 (498)
Q Consensus 267 ---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~ 342 (498)
...++++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++........ ......+++
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 023588889999999999999999998 9999999999999999999999999999865432211 122234678
Q ss_pred cccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHH
Q 010891 343 GYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKR 421 (498)
Q Consensus 343 ~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (498)
.|+|||++.+..++.++|||||||+||||++ |..||........ ....+.. ... ... .... ...
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-----~~~~~~~---~~~---~~~--~~~~--~~~ 305 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-----FCQRLKD---GTR---MRA--PENA--TPE 305 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-----HHHHHhc---CCC---CCC--CCCC--CHH
Confidence 8999999999999999999999999999997 9999975432211 1111111 110 011 1111 123
Q ss_pred HHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 422 ALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 422 ~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
+..++.+||+.||++|||+.++++.|+..
T Consensus 306 l~~li~~cl~~dp~~RPs~~el~~~l~~~ 334 (338)
T cd05102 306 IYRIMLACWQGDPKERPTFSALVEILGDL 334 (338)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 44455689999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=360.09 Aligned_cols=252 Identities=27% Similarity=0.414 Sum_probs=201.5
Q ss_pred HHHHccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 169 LQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 169 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
+++..+.+.-++-||.|+.|.||+|++ .++.||||++..- -..+|+-|++|+||||+.|.|+|.....+|||
T Consensus 119 WeiPFe~IsELeWlGSGaQGAVF~Grl-~netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIi 190 (904)
T KOG4721|consen 119 WEIPFEEISELEWLGSGAQGAVFLGRL-HNETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCII 190 (904)
T ss_pred ccCCHHHhhhhhhhccCcccceeeeec-cCceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEe
Confidence 344444445567799999999999998 5689999988322 22478889999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
||||..|-|...|+ .+.+++......+..+||.|+.|||.+ .|||||||.-||||..+..+||+|||-++.+.
T Consensus 191 MEfCa~GqL~~VLk----a~~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~ 263 (904)
T KOG4721|consen 191 MEFCAQGQLYEVLK----AGRPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELS 263 (904)
T ss_pred eeccccccHHHHHh----ccCccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhh
Confidence 99999999999998 556788899999999999999999999 99999999999999999999999999999875
Q ss_pred CCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (498)
.. .....++||..|||||++++.+.++|+|||||||||||||||..||.+-... .-+... -.-
T Consensus 264 ~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss------------AIIwGV---GsN 326 (904)
T KOG4721|consen 264 DK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS------------AIIWGV---GSN 326 (904)
T ss_pred hh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh------------eeEEec---cCC
Confidence 43 3345589999999999999999999999999999999999999999643211 111110 001
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 010891 409 NIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEY 452 (498)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~~ 452 (498)
.+...-...+..-+.+++.+||+-.|..||++.+++.||.-...
T Consensus 327 sL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~p 370 (904)
T KOG4721|consen 327 SLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASP 370 (904)
T ss_pred cccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCH
Confidence 11111111112223333448999999999999999999987653
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=359.80 Aligned_cols=256 Identities=26% Similarity=0.385 Sum_probs=210.7
Q ss_pred CCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCCC---chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 175 RFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQ---ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
-|++++.||.|+-|.|-+|+ ..+|+.+|||++.+.... ....+.+|+-+|+-+.|||++++|+++.+..++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 35778999999999999997 568999999999655322 12347789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
|++||.|+++|. .+++|++.++.+++.||+.|+.|||.. +|+||||||+|+|||.++++||+|||+|.....+
T Consensus 93 yv~gGELFdylv----~kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 93 YVPGGELFDYLV----RKGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred ecCCchhHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 999999999997 558899999999999999999999999 9999999999999999999999999999876544
Q ss_pred CceeeecccccccccCcccccCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 331 KSHITTRVMGTFGYVAPEYANSGLLN-EKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
. .-.+.||.|.|.|||++.+.+|+ .++||||.|||||.||||++||++.+ +...+.+.. .+.
T Consensus 166 k--lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN------ir~LLlKV~---------~G~ 228 (786)
T KOG0588|consen 166 K--LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN------IRVLLLKVQ---------RGV 228 (786)
T ss_pred c--cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc------HHHHHHHHH---------cCc
Confidence 3 23456899999999999998886 58999999999999999999998432 222222221 133
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCCCc
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIPR 456 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~~~~~~ 456 (498)
+..+...+...+.++. +||+.||.+|.|++||++|.--......+
T Consensus 229 f~MPs~Is~eaQdLLr--~ml~VDp~~RiT~~eI~kHP~l~g~~~~~ 273 (786)
T KOG0588|consen 229 FEMPSNISSEAQDLLR--RMLDVDPSTRITTEEILKHPFLSGYTSLP 273 (786)
T ss_pred ccCCCcCCHHHHHHHH--HHhccCccccccHHHHhhCchhhcCCCCC
Confidence 3444444444455444 79999999999999999987655444433
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=342.12 Aligned_cols=250 Identities=24% Similarity=0.408 Sum_probs=209.5
Q ss_pred HccCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCCCchh---HHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADK---DFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
...+|++.+.||+|.||.|-+|. ...|+.||||.+.+....+.+ .+++||+||..|+||||+.+|.+|++.+...|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 34678999999999999999997 478999999999776554444 47889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
||||..+|.|+||+. .++.|++.++..++.||..|+.|||.+ +++|||||.+|||||.++++||+||||+-.+
T Consensus 131 vMEYaS~GeLYDYiS----er~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 131 VMEYASGGELYDYIS----ERGSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred EEEecCCccHHHHHH----HhccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhh
Confidence 999999999999997 457799999999999999999999999 9999999999999999999999999999887
Q ss_pred CCCCceeeecccccccccCcccccCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCc
Q 010891 328 GAGKSHITTRVMGTFGYVAPEYANSGLLN-EKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVV 406 (498)
Q Consensus 328 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (498)
.... ..+++||++-|.+||++++.+|. +.+|-|||||+||.|+.|..||++.+ ....++++..
T Consensus 204 ~~~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D------hk~lvrQIs~-------- 267 (668)
T KOG0611|consen 204 ADKK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD------HKRLVRQISR-------- 267 (668)
T ss_pred cccc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch------HHHHHHHhhc--------
Confidence 6543 45678999999999999999885 68999999999999999999997532 2222222221
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 407 DPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 407 ~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
+....+..++...-+ +.+||-.||++|.|+.++..|+-
T Consensus 268 -GaYrEP~~PSdA~gL---IRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 268 -GAYREPETPSDASGL---IRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred -ccccCCCCCchHHHH---HHHHHhcCcccchhHHHHhhhhe
Confidence 222223333333332 33799999999999999998774
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=337.75 Aligned_cols=267 Identities=28% Similarity=0.418 Sum_probs=204.7
Q ss_pred HHHccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHc--CCCCCceEEEeEEEeC----C
Q 010891 170 QSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGH--VRHKNLVRLLGYCIEG----T 243 (498)
Q Consensus 170 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~~~~----~ 243 (498)
..+..+..+.+.||+|.||+||+|+| .|+.||||++...+ .+.+.+|.++++. |+|+||+.|++.-..+ .
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred HhhhheeEEEEEecCccccceeeccc-cCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 34566778899999999999999998 68999999996543 3445667777665 5999999999987644 5
Q ss_pred eeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHc-----cCCCeeecCCCCCCEEEcCCCCeEE
Q 010891 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEA-----IEPKVVHRDIKSSNILIDENFDAKI 318 (498)
Q Consensus 244 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-----~~~~iiHrDikp~NIll~~~~~~kL 318 (498)
++|||++|.+.|+|+|||.. ..++.+..++++..+|.||+|||.. ..|.|.|||||+.||||.++|.+.|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I 357 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 357 (513)
T ss_pred EEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence 67999999999999999954 5689999999999999999999975 3889999999999999999999999
Q ss_pred eeeccceecCCCCce---eeecccccccccCcccccCCCC----C--ccchHHHHHHHHHHHHh----------CCCCCC
Q 010891 319 SDFGLAKLLGAGKSH---ITTRVMGTFGYVAPEYANSGLL----N--EKSDVYSFGVVLLEAIT----------GRYPVD 379 (498)
Q Consensus 319 ~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~----~--~~sDvwSlGvvl~ellt----------g~~P~~ 379 (498)
+|+|||......... ..+..+||.+|||||++..... . ..+||||||.|+||+.. -+.||.
T Consensus 358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy 437 (513)
T KOG2052|consen 358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY 437 (513)
T ss_pred eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence 999999987655332 2445789999999999976431 1 25899999999999986 246776
Q ss_pred CCCCcchhhHHHHHHHHHhhccccCCcCCCC-CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 380 YGRPQSEVNLVEWLKMMVQLRRSEDVVDPNI-ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
+--+.+. ++ ..|...--.+. ..|.. ..+.+.+.+..+..++.-||..+|.-|.|+-.+-+.|....
T Consensus 438 d~Vp~DP-s~----eeMrkVVCv~~-~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 438 DVVPSDP-SF----EEMRKVVCVQK-LRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred cCCCCCC-CH----HHHhcceeecc-cCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 4333211 11 22222222222 22222 33445566666777777899999999999999888776543
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=328.07 Aligned_cols=267 Identities=24% Similarity=0.319 Sum_probs=202.5
Q ss_pred CCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCCCch--hHHHHHHHHHHcCCCCCceEEEeEEEe--CCeeEEEE
Q 010891 175 RFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQAD--KDFRVEVEAIGHVRHKNLVRLLGYCIE--GTQRILVY 249 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~ 249 (498)
.|+.+..|++|+||.||+|+ ..+++.||+|+++......- -.-.+||.+|.+.+|||||.+..+..- -+..||||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 36678899999999999997 45689999999965543221 235679999999999999999988764 36789999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
|||+. +|...+... ..++...++..+..|+++||+|||.+ .|+|||||++|+|++..|.+||+|||+|+.++.
T Consensus 157 e~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 157 EYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcC
Confidence 99977 999999753 35789999999999999999999999 999999999999999999999999999999987
Q ss_pred CCceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhcc-ccCCcC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRR-SEDVVD 407 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 407 (498)
.. ..++..+-|.+|+|||++.+ ..|+.+.|+||+|||+.||+++++.|.+...... +..+..... ....+-
T Consensus 230 p~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ------l~~If~llGtPte~iw 302 (419)
T KOG0663|consen 230 PL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ------LDKIFKLLGTPSEAIW 302 (419)
T ss_pred Cc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH------HHHHHHHhCCCccccC
Confidence 64 33677889999999997765 6799999999999999999999998875443222 122221111 000000
Q ss_pred C-----------CCCC--------CCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCCC
Q 010891 408 P-----------NIET--------RPS-TSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIP 455 (498)
Q Consensus 408 ~-----------~~~~--------~~~-~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~~~~~ 455 (498)
| .+.. .+. ..-....+.+....|..||.+|.|+.|.|++=-....|.|
T Consensus 303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p 370 (419)
T KOG0663|consen 303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLP 370 (419)
T ss_pred CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCC
Confidence 0 0000 000 0011233444447899999999999999987655554433
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=338.24 Aligned_cols=245 Identities=21% Similarity=0.347 Sum_probs=194.4
Q ss_pred ceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCc---hhHHHHHHHHHHcCCCCCceEEEeEEEe----CCeeEEEEeec
Q 010891 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQA---DKDFRVEVEAIGHVRHKNLVRLLGYCIE----GTQRILVYEYV 252 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~~lv~e~~ 252 (498)
..||+|++|.||+|.+ +|+.||||++....... .+.+.+|+.+|.+++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999987 78999999986544333 3567899999999999999999999877 35679999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~ 332 (498)
++|+|.+++.. .+.+++.....++.|++.||.|||+.. +++||||||+|||+++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 99999999974 356899999999999999999999732 78899999999999999999999999998654322
Q ss_pred eeeecccccccccCcccccC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCC
Q 010891 333 HITTRVMGTFGYVAPEYANS--GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNI 410 (498)
Q Consensus 333 ~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (498)
....||..|+|||++.+ ..++.++|||||||++|||++|+.||...... +.......... .+.+
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~------~~~~~i~~~~~-----~~~~ 243 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK------EIYDLIINKNN-----SLKL 243 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhcCC-----CCCC
Confidence 23468899999999976 68999999999999999999999999754321 11111111111 0111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 411 ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 411 ~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
.. .... .+..++.+||+.||++|||+.++++.|+..
T Consensus 244 ~~-~~~~---~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 244 PL-DCPL---EIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred CC-cCcH---HHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 10 1122 233444589999999999999999998764
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=349.64 Aligned_cols=254 Identities=24% Similarity=0.337 Sum_probs=200.7
Q ss_pred cCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCC---CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
++|++.+.||+|+||.||+|+.. +++.||+|++.... ......+..|++++..++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46889999999999999999864 58899999986432 223456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+++|+|.+++.. .+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999963 35689999999999999999999999 999999999999999999999999999986543
Q ss_pred CCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
......||+.|+|||++.+..++.++|||||||++|||++|..||......... ......... ...+.
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~------~~i~~~~~~--~~~~~ 221 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW------ENLKYWKET--LQRPV 221 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHH------HHHHhcccc--ccCCC
Confidence 233467999999999999999999999999999999999999999754332211 111110000 00111
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.. .+.......+..++.+||..+|.+||++.+++++.
T Consensus 222 ~~-~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 222 YD-DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred CC-ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 10 00000112233444579999999999999999874
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=338.59 Aligned_cols=266 Identities=23% Similarity=0.286 Sum_probs=199.7
Q ss_pred cCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
++|++.+.||+|+||.||+|+.. +++.||+|++..... ...+.+.+|+++++.++||||+++++++..+...|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47899999999999999999864 578999999865432 234567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
|++++.|..+.. ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 999876665543 234689999999999999999999998 9999999999999999999999999999876543
Q ss_pred CceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHH---------HHHHHhhcc
Q 010891 331 KSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEW---------LKMMVQLRR 401 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~---------~~~~~~~~~ 401 (498)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||.............. .........
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd07848 154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR 233 (287)
T ss_pred ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence 32233446799999999999888899999999999999999999999975432221110000 000000000
Q ss_pred ccCCcCCCCCCCCCH------HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 402 SEDVVDPNIETRPST------SALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 402 ~~~~~~~~~~~~~~~------~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
......+........ .....+..++.+||+.||++|||+.++++|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000111000000 011234455568999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=340.16 Aligned_cols=252 Identities=23% Similarity=0.284 Sum_probs=197.9
Q ss_pred CCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC---CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 176 FSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 176 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
|+..+.||+|+||.||+|.. .+|+.||+|.+..... .....+.+|+.++..++|+||+++++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 67788999999999999974 5789999998854322 2234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+++|+|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||++.......
T Consensus 82 ~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 82 MNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred cCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 9999999888532 234689999999999999999999999 99999999999999999999999999998764332
Q ss_pred ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCC
Q 010891 332 SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (498)
......||..|+|||++.+..++.++|||||||++|||++|+.||......... +.+.... .. ....
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~--~~------~~~~ 223 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRV--KE------DQEE 223 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHh--hc------cccc
Confidence 123457999999999999999999999999999999999999999754432111 1011100 00 1111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHH
Q 010891 412 TRPSTSALKRALLTALRCVDPDSDKRPK-----MSQVVRML 447 (498)
Q Consensus 412 ~~~~~~~~~~~l~~~~~cl~~dP~~RPt-----~~ell~~L 447 (498)
.....+. ....++.+||+.||.+||+ +.+++++-
T Consensus 224 ~~~~~s~--~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~ 262 (285)
T cd05631 224 YSEKFSE--DAKSICRMLLTKNPKERLGCRGNGAAGVKQHP 262 (285)
T ss_pred CCccCCH--HHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCH
Confidence 1111111 2333445899999999997 88888753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=334.57 Aligned_cols=271 Identities=27% Similarity=0.356 Sum_probs=205.3
Q ss_pred HHccCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecC--CCCCchhHHHHHHHHHHcCCCCCceEEEeEEEe-----C
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLN--NPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIE-----G 242 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-----~ 242 (498)
.+..+|...+.||+|+||.|+.|. ..+|+.||||++.. ......+...+|+++|+.++|+||+.+++++.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 344566778899999999999997 56789999999963 334455677889999999999999999999875 3
Q ss_pred CeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeec
Q 010891 243 TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFG 322 (498)
Q Consensus 243 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfG 322 (498)
...|+|+|+| +-+|...++ .+..|+.+.+..+++|+++||.|+|+. +|+||||||+|+|++.+..+||||||
T Consensus 99 ~DvYiV~elM-etDL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred ceeEEehhHH-hhHHHHHHH----cCccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccc
Confidence 5679999999 449999997 445599999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCC-CceeeecccccccccCcccc-cCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHH---------
Q 010891 323 LAKLLGAG-KSHITTRVMGTFGYVAPEYA-NSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVE--------- 391 (498)
Q Consensus 323 la~~~~~~-~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~--------- 391 (498)
+|+..... ....++.++-|.+|.|||++ ....|+.+.||||.||||.||++|+..|.+.+......++-
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE 250 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence 99987542 23346778899999999976 55789999999999999999999999997654322221111
Q ss_pred ---HHH---HHHhhccccCCcCCCCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 392 ---WLK---MMVQLRRSEDVVDPNIE-TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 392 ---~~~---~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
.+. ...-...........+. .-+. .....+.+.-+||..||.+|+|++|+|+|---..
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~--a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~ 315 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPN--ANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAP 315 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcCC--CCHHHHHHHHHHhccCccccCCHHHHhcChhhhh
Confidence 010 00000001111001110 0111 1223444555899999999999999998865443
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=338.80 Aligned_cols=264 Identities=27% Similarity=0.431 Sum_probs=199.8
Q ss_pred ccCCCccceEcccCcEEEEEEEEcC-----------------CcEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLMN-----------------GTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVR 234 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~ 234 (498)
.++|.+.+.||+|+||.||+|.+.+ +..||+|.+...... ...+|.+|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578899999999999999997532 346999988654322 2356889999999999999999
Q ss_pred EEeEEEeCCeeEEEEeecCCCCHHHHHhcccC---------------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCee
Q 010891 235 LLGYCIEGTQRILVYEYVNNGNLEQWLRGDMC---------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVV 299 (498)
Q Consensus 235 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ii 299 (498)
+++++.+.+..++||||+.+|+|.+++..... ....+++...+.++.||+.||.|||+. +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 99999999999999999999999999864321 113478889999999999999999998 999
Q ss_pred ecCCCCCCEEEcCCCCeEEeeeccceecCCCCce-eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh--CCC
Q 010891 300 HRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT--GRY 376 (498)
Q Consensus 300 HrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt--g~~ 376 (498)
||||||+|||++.++.+||+|||+++........ ......++..|+|||++.++.++.++|||||||++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999876443221 1223456889999999988899999999999999999987 556
Q ss_pred CCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 377 PVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 377 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
||...... .................. .. .....+ ..+..++.+||+.||++|||+.+|.+.|+
T Consensus 241 p~~~~~~~---~~~~~~~~~~~~~~~~~~--~~-~~~~~~---~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDE---QVIENAGEFFRDQGRQVY--LF-RPPPCP---QGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHH---HHHHHHHHHhhhcccccc--cc-CCCCCC---HHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 77643321 112221111111110000 00 001111 23445556899999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=349.63 Aligned_cols=255 Identities=24% Similarity=0.332 Sum_probs=195.4
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC---CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
++|++.+.||+|+||+||+|+. .+++.||+|++.... ......+..|+.++..++||||+++++.+.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4688899999999999999974 468899999985432 122345778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+++|+|.+++.. .+.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999973 45799999999999999999999999 999999999999999999999999999975432
Q ss_pred CCc----------------------------------eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCC
Q 010891 330 GKS----------------------------------HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGR 375 (498)
Q Consensus 330 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~ 375 (498)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 0012357999999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 376 YPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 376 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
.||....+.. ......... .... +......+...+.+...+.|...++..||++.|+++|
T Consensus 234 ~Pf~~~~~~~------~~~~i~~~~--~~~~---~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 234 PPFCSETPQE------TYKKVMNWK--ETLI---FPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCCCCCHHH------HHHHHHcCc--Cccc---CCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 9997543321 111111110 1111 1111112223333333333443445567999999976
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=343.04 Aligned_cols=246 Identities=24% Similarity=0.296 Sum_probs=198.5
Q ss_pred cCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCC---CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36888999999999999999854 689999999854322 22345788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+++|+|.+++.. .+.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999973 35689999999999999999999999 999999999999999999999999999986543
Q ss_pred CCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
. ....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...... +........ .
T Consensus 154 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~------~~~~~i~~~---------~ 214 (291)
T cd05612 154 R----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF------GIYEKILAG---------K 214 (291)
T ss_pred C----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhC---------C
Confidence 2 22357999999999999999999999999999999999999999754321 111111111 1
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHH
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRPK-----MSQVVRML 447 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt-----~~ell~~L 447 (498)
.......+. .+..++.+||..||.+||+ +.++++|-
T Consensus 215 ~~~~~~~~~--~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 215 LEFPRHLDL--YAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred cCCCccCCH--HHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 111111111 2333445899999999995 89988764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=340.37 Aligned_cols=258 Identities=25% Similarity=0.374 Sum_probs=198.9
Q ss_pred HHHccCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCC--------------CchhHHHHHHHHHHcCCCCCceE
Q 010891 170 QSATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPG--------------QADKDFRVEVEAIGHVRHKNLVR 234 (498)
Q Consensus 170 ~~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~hpnIv~ 234 (498)
....|+|++.+.||+|.||.|-+|+ ..+++.||||++.+... ...+..++||.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 3456899999999999999999997 45789999999854321 11246788999999999999999
Q ss_pred EEeEEEeC--CeeEEEEeecCCCCHHHHHhcccCCCCC-CCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEc
Q 010891 235 LLGYCIEG--TQRILVYEYVNNGNLEQWLRGDMCDRGY-LTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID 311 (498)
Q Consensus 235 l~~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~-l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~ 311 (498)
|+++..+. +.+|||+|||..|.+...= ..++ |++.++++++.++..||+|||.+ +||||||||+|+||+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~ 244 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLS 244 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEc
Confidence 99998864 7889999999998876432 3344 99999999999999999999999 999999999999999
Q ss_pred CCCCeEEeeeccceecCCCCc----eeeecccccccccCcccccCC---C-CCccchHHHHHHHHHHHHhCCCCCCCCCC
Q 010891 312 ENFDAKISDFGLAKLLGAGKS----HITTRVMGTFGYVAPEYANSG---L-LNEKSDVYSFGVVLLEAITGRYPVDYGRP 383 (498)
Q Consensus 312 ~~~~~kL~DfGla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~---~-~~~~sDvwSlGvvl~elltg~~P~~~~~~ 383 (498)
++|++||+|||.+..+..+.. ......+|||.|+|||...++ . -+.+.||||+||+||.|+.|+.||.+...
T Consensus 245 ~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~ 324 (576)
T KOG0585|consen 245 SDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE 324 (576)
T ss_pred CCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence 999999999999987733311 112236899999999987652 2 34678999999999999999999974321
Q ss_pred cchhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 384 QSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
.+....+.. ..+ .++..+...+..++++ +++|++||++|.+..+|..|.--.
T Consensus 325 ------~~l~~KIvn----~pL---~fP~~pe~~e~~kDli--~~lL~KdP~~Ri~l~~ik~Hpwvt 376 (576)
T KOG0585|consen 325 ------LELFDKIVN----DPL---EFPENPEINEDLKDLI--KRLLEKDPEQRITLPDIKLHPWVT 376 (576)
T ss_pred ------HHHHHHHhc----Ccc---cCCCcccccHHHHHHH--HHHhhcChhheeehhhheecceec
Confidence 122222211 111 1122223344445444 489999999999999998876543
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=347.44 Aligned_cols=242 Identities=24% Similarity=0.297 Sum_probs=193.0
Q ss_pred ceEcccCcEEEEEEEE-cCCcEEEEEEecCCC---CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCCC
Q 010891 180 NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNG 255 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g 255 (498)
+.||+|+||.||+|+. .+|+.||+|++.... ......+..|+.++.+++||||+++++++.+....|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999974 568999999986432 222345778999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCceee
Q 010891 256 NLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHIT 335 (498)
Q Consensus 256 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 335 (498)
+|.+++.. .+.+++..+..++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~ 152 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccc
Confidence 99999973 35689999999999999999999999 99999999999999999999999999997542221 123
Q ss_pred ecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCC
Q 010891 336 TRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPS 415 (498)
Q Consensus 336 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (498)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.. . . ..+. ..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~~~~~~~~-~---~---~~~p--~~ 217 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILM-E---E---IRFP--RT 217 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH------HHHHHHHc-C---C---CCCC--CC
Confidence 3467999999999999999999999999999999999999999743321 11111111 0 0 1111 11
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 010891 416 TSALKRALLTALRCVDPDSDKRP-----KMSQVVRM 446 (498)
Q Consensus 416 ~~~~~~~l~~~~~cl~~dP~~RP-----t~~ell~~ 446 (498)
.+ ..+..++.+||..||++|| ++.++++|
T Consensus 218 ~~--~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 218 LS--PEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CC--HHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 11 1233344589999999999 89999865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=364.05 Aligned_cols=258 Identities=24% Similarity=0.382 Sum_probs=206.8
Q ss_pred HHccCCCccceEcccCcEEEEEEEEcCC-cEEEEEEecCCCCCchhHHHHHHHHHHcCC-CCCceEEEe-EEEe------
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQLMNG-TAVAVKKLLNNPGQADKDFRVEVEAIGHVR-HKNLVRLLG-YCIE------ 241 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~-~~~~------ 241 (498)
+...++++.+.|.+|||+.||+|++..+ ..||+|++...+....+.+.+|+++|+.|. |||||.|++ ....
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 3445678899999999999999997666 999999998887777888999999999996 999999999 3322
Q ss_pred CCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeee
Q 010891 242 GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDF 321 (498)
Q Consensus 242 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~Df 321 (498)
.-+++|+||||.||.|-||+..... ..|++.++++|+.++++|+++||. +.|+|||||||-+||||+.+|+.|||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcc
Confidence 1356899999999999999975532 339999999999999999999998 5778999999999999999999999999
Q ss_pred ccceecCCCC-cee-e------ecccccccccCcccc---cCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHH
Q 010891 322 GLAKLLGAGK-SHI-T------TRVMGTFGYVAPEYA---NSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLV 390 (498)
Q Consensus 322 Gla~~~~~~~-~~~-~------~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~ 390 (498)
|.|.-..... ... . -...-|+.|+|||++ .+.+.++|+|||+|||+||-|+....||+.....
T Consensus 191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l------ 264 (738)
T KOG1989|consen 191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL------ 264 (738)
T ss_pred cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce------
Confidence 9997532221 100 0 012368999999976 6788999999999999999999999999865321
Q ss_pred HHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 391 EWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 391 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
.+++..+..++...-...+-.++..||++||++||++.++++.+...
T Consensus 265 -------------aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 265 -------------AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred -------------eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 23344444444333344444445579999999999999999887654
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=348.01 Aligned_cols=246 Identities=23% Similarity=0.302 Sum_probs=198.5
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC---CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
++|.+.+.||+|+||.||+|+. .+++.||+|.+.... ....+.+.+|+.++..++||||+++++++.+++..|+||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 4688899999999999999985 468899999985432 223356888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+.+|+|.+++.. .+.+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 98 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999973 35688999999999999999999999 999999999999999999999999999987643
Q ss_pred CCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
.. ....||+.|+|||++.+..++.++|||||||++|||++|+.||....+. +....... . .
T Consensus 171 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~---~------~ 231 (329)
T PTZ00263 171 RT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF------RIYEKILA---G------R 231 (329)
T ss_pred Cc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH------HHHHHHhc---C------C
Confidence 22 2357999999999999999999999999999999999999999754321 11111111 1 1
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHH
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRPK-----MSQVVRML 447 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt-----~~ell~~L 447 (498)
+......+. ....++.+||+.||.+||+ +.+++.|-
T Consensus 232 ~~~p~~~~~--~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp 272 (329)
T PTZ00263 232 LKFPNWFDG--RARDLVKGLLQTDHTKRLGTLKGGVADVKNHP 272 (329)
T ss_pred cCCCCCCCH--HHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence 111111112 2233445899999999997 68888664
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=354.24 Aligned_cols=265 Identities=28% Similarity=0.415 Sum_probs=204.8
Q ss_pred HHHHHccCCCccceEcccCcEEEEEEEEcC--C---cEEEEEEecCCC---CCchhHHHHHHHHHHcCCCCCceEEEeEE
Q 010891 168 DLQSATNRFSKDNIIGDGGYGVVYRGQLMN--G---TAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYC 239 (498)
Q Consensus 168 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--~---~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~ 239 (498)
.|+...++..+.++||+|+||.||+|++.. + ..||+|...... .....+|..|+++|+.++|||||++||++
T Consensus 151 ~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa 230 (474)
T KOG0194|consen 151 KWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVA 230 (474)
T ss_pred ccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 345555667778999999999999997533 2 238999886422 33456799999999999999999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEe
Q 010891 240 IEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKIS 319 (498)
Q Consensus 240 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~ 319 (498)
.....+++|||+|+||+|.+||+.. .+.++..+...++.+.|.||+|||++ ++|||||.++|+|++.++.+||+
T Consensus 231 ~~~~Pl~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKIS 304 (474)
T KOG0194|consen 231 VLEEPLMLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKIS 304 (474)
T ss_pred cCCCccEEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeC
Confidence 9999999999999999999999854 23699999999999999999999999 99999999999999999999999
Q ss_pred eeccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHh
Q 010891 320 DFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQ 398 (498)
Q Consensus 320 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 398 (498)
|||+++.-........ ...-...|+|||.+..+.|+.++|||||||++||+++ |..||...... +.......
T Consensus 305 DFGLs~~~~~~~~~~~-~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------~v~~kI~~ 377 (474)
T KOG0194|consen 305 DFGLSRAGSQYVMKKF-LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------EVKAKIVK 377 (474)
T ss_pred ccccccCCcceeeccc-cccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH------HHHHHHHh
Confidence 9999876431111110 1124678999999999999999999999999999999 88898754332 11111111
Q ss_pred hccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCC
Q 010891 399 LRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPI 454 (498)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~~~~ 454 (498)
.. ... ..+......+..+..+||..||++||||.++.+.|+......
T Consensus 378 ~~--~r~-------~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 378 NG--YRM-------PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred cC--ccC-------CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 11 111 111122223333344899999999999999999998765443
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=353.41 Aligned_cols=255 Identities=22% Similarity=0.270 Sum_probs=197.0
Q ss_pred CCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC---CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
.|++.+.||+|+||+||+|+. .+++.||+|++..... .....+..|+++++.++||||+++++++.+....|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 578899999999999999974 5688999999865322 223568889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
|+++|+|.+++.. .+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999973 35688999999999999999999998 9999999999999999999999999998643110
Q ss_pred C----------------------------------------------ceeeecccccccccCcccccCCCCCccchHHHH
Q 010891 331 K----------------------------------------------SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSF 364 (498)
Q Consensus 331 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 364 (498)
. .......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 0 001123579999999999998899999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 010891 365 GVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVV 444 (498)
Q Consensus 365 Gvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell 444 (498)
||++|||++|..||....+.... ..+..... . .........+.....+...+.|+..+|..||++.+++
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~------~~i~~~~~--~---~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQ------LKVINWEN--T---LHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHH------HHHHcccc--c---cCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 99999999999999754432110 11110000 0 1111111122223333333357888888899999999
Q ss_pred HHH
Q 010891 445 RML 447 (498)
Q Consensus 445 ~~L 447 (498)
.|-
T Consensus 304 ~hp 306 (381)
T cd05626 304 AHP 306 (381)
T ss_pred cCc
Confidence 864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=345.54 Aligned_cols=200 Identities=27% Similarity=0.407 Sum_probs=175.0
Q ss_pred ccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
.++|++.+.||+|+||.||+++.. ++..||+|.+..... ...+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999854 688899998865422 233568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 9999999999974 346899999999999999999999852 6999999999999999999999999999865432
Q ss_pred CceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 010891 331 KSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYG 381 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~ 381 (498)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 ~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 158 M---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred c---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 1 23457999999999999999999999999999999999999999643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=360.61 Aligned_cols=257 Identities=30% Similarity=0.497 Sum_probs=214.0
Q ss_pred ccCCCccceEcccCcEEEEEEEEcC----CcEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLMN----GTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
.+...+.++||.|.||+||+|+++- ...||||.++....+ ...+|+.|+.||.+++||||++|.|+.......+|
T Consensus 628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI 707 (996)
T KOG0196|consen 628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI 707 (996)
T ss_pred hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence 3456778999999999999998532 357999999765443 34679999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
|+|||++|+|..||+.+ .+.+++.+..-++++||.|+.||-+. +++||||.++||||+.+..+|++||||++.+
T Consensus 708 iTEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 708 ITEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred EhhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeec
Confidence 99999999999999864 46699999999999999999999999 9999999999999999999999999999988
Q ss_pred CCCCceeeecccc--cccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccC
Q 010891 328 GAGKSHITTRVMG--TFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSED 404 (498)
Q Consensus 328 ~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (498)
.++.....+...| ..+|.|||.+...+++.+|||||||+||||+++ |..||.+...++.. +.+..
T Consensus 782 edd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI------kaIe~------ 849 (996)
T KOG0196|consen 782 EDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI------KAIEQ------ 849 (996)
T ss_pred ccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH------HHHHh------
Confidence 6654222332222 468999999999999999999999999999887 99999876654332 22222
Q ss_pred CcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 405 VVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
.+..+++.+....+.++++.||++|-.+||++.||+.+|.+.-
T Consensus 850 ----gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 850 ----GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred ----ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 2233344445566777788999999999999999999997643
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=333.34 Aligned_cols=255 Identities=26% Similarity=0.405 Sum_probs=199.3
Q ss_pred ccCCCccceEcccCcEEEEEEEEc----CCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM----NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
.++|++.+.||+|+||.||+|.+. .+..||+|.+..... .....+..|+.++..++||||+++++++..+...++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 356888999999999999999742 356899998865432 223468889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+|||++.++.++|+|||.+...
T Consensus 84 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 84 VTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 99999999999999742 34689999999999999999999999 9999999999999999999999999987654
Q ss_pred CCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCc
Q 010891 328 GAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVV 406 (498)
Q Consensus 328 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (498)
............++..|+|||++.+..++.++|||||||++||+++ |..||...... +.+..+.. ....
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~------~~~~~~~~---~~~~- 227 (266)
T cd05064 158 KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ------DVIKAVED---GFRL- 227 (266)
T ss_pred cccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH------HHHHHHHC---CCCC-
Confidence 3222111222345678999999999999999999999999999775 99999754322 11121111 1111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 407 DPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 407 ~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
.. ... ....+..++.+||+.+|.+|||+.++++.|..
T Consensus 228 --~~--~~~--~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~ 264 (266)
T cd05064 228 --PA--PRN--CPNLLHQLMLDCWQKERGERPRFSQIHSILSK 264 (266)
T ss_pred --CC--CCC--CCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence 11 111 11233444558999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=349.06 Aligned_cols=195 Identities=23% Similarity=0.265 Sum_probs=170.5
Q ss_pred HccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
..++|++.+.||+|+||.||+|.. .+++.||+|+.. ...+.+|++++++++||||+++++++......++|||
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 346899999999999999999974 568899999653 2346789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
++. ++|..++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 164 ~~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~ 235 (391)
T PHA03212 164 RYK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI 235 (391)
T ss_pred cCC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccc
Confidence 995 699998863 35689999999999999999999999 9999999999999999999999999999754332
Q ss_pred CceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 010891 331 KSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDY 380 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~ 380 (498)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 236 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 236 NANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred cccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 22223446799999999999999999999999999999999999988753
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=329.20 Aligned_cols=251 Identities=24% Similarity=0.445 Sum_probs=200.8
Q ss_pred cCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecC
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ 253 (498)
++|++.+.||+|+||.||++++.++..+|+|.+... ......+..|++++++++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457888999999999999999878889999987533 2334678889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCce
Q 010891 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333 (498)
Q Consensus 254 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~ 333 (498)
+|+|.++++.. .+.+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 83 NGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 99999999742 24589999999999999999999998 9999999999999999999999999999865433222
Q ss_pred eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCC
Q 010891 334 ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIET 412 (498)
Q Consensus 334 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (498)
......++..|+|||++.+..++.++||||||+++|||++ |+.||....... . +..... ......+..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~---~~~i~~---~~~~~~~~~-- 225 (256)
T cd05114 157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---V---VEMISR---GFRLYRPKL-- 225 (256)
T ss_pred ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---H---HHHHHC---CCCCCCCCC--
Confidence 2222345678999999998899999999999999999999 899996543211 1 111111 111111111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 413 RPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 413 ~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.. ..+..++.+||+.||++||++.++++.|
T Consensus 226 --~~---~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 226 --AS---MTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred --CC---HHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11 2345556689999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=313.30 Aligned_cols=249 Identities=27% Similarity=0.400 Sum_probs=205.2
Q ss_pred cCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCC---CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
++|++++.||+|-||.||+|+ ..++..||+|++.+.. .+...++++|+++-..|+||||+++|++|.+....||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 457889999999999999997 5678899999986543 233467899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||..+|+|+..|... ....+++.....++.|+|.||.|+|.. +||||||||+|+|++.++.+||+|||-+.....
T Consensus 102 Eya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred EecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 999999999999754 345688999999999999999999999 999999999999999999999999999987543
Q ss_pred CCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
+. ....|||..|.+||...+..++..+|+|++|++.||++.|..||...... +..+.+... +...|
T Consensus 177 ~k---R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~------etYkrI~k~----~~~~p- 242 (281)
T KOG0580|consen 177 NK---RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS------ETYKRIRKV----DLKFP- 242 (281)
T ss_pred CC---ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH------HHHHHHHHc----cccCC-
Confidence 22 34578999999999999999999999999999999999999999854411 112222211 11111
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
...+.-.++ ++.+|+..+|.+|.+..|++.+.
T Consensus 243 ----~~is~~a~d--lI~~ll~~~p~~r~~l~~v~~hp 274 (281)
T KOG0580|consen 243 ----STISGGAAD--LISRLLVKNPIERLALTEVMDHP 274 (281)
T ss_pred ----cccChhHHH--HHHHHhccCccccccHHHHhhhH
Confidence 222333333 34489999999999999999875
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=335.56 Aligned_cols=257 Identities=22% Similarity=0.351 Sum_probs=196.8
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
++|++.+.||.|+||.||+|+. .++..||+|.+..... .....+.+|+.+++.++||||+++++++.+....++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 4688899999999999999975 4688999998864332 2334677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+++ +|.+++... ...+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LDS-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CCc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 975 999998642 34578999999999999999999999 99999999999999999999999999998654322
Q ss_pred ceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhcc---------
Q 010891 332 SHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRR--------- 401 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~--------- 401 (498)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ..+.....
T Consensus 158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~------~~~~~~~~~~~~~~~~~ 230 (288)
T cd07871 158 K-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEEL------HLIFRLLGTPTEETWPG 230 (288)
T ss_pred c-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHHHhCCCChHHhhc
Confidence 1 1233568999999998765 57899999999999999999999999754432211 11111000
Q ss_pred ---c---cCCcCCCCC------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 402 ---S---EDVVDPNIE------TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 402 ---~---~~~~~~~~~------~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
. .....+... ..+..+ .....++.+||..||.+|||+.|+++|
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 231 ITSNEEFRSYLFPQYRAQPLINHAPRLD--TDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred cccchhhhccccCccCCCchHHhCCCCC--HHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0 000001100 001111 223445558999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=352.62 Aligned_cols=244 Identities=23% Similarity=0.307 Sum_probs=197.2
Q ss_pred HHccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC---CchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCee
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQR 245 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 245 (498)
...++|.+.++||+|.||+|+++.. .+++.+|||.+++... .+.+....|..++... +||.+++++..|++.+++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 3446789999999999999999974 5688999999977653 3345577788888877 599999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccce
Q 010891 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~ 325 (498)
|+||||+.||++..+. ..+.+++..+..++..|+.||.|||++ +|||||||.+|||||.+|++||+|||+++
T Consensus 445 ~fvmey~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEecCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccc
Confidence 9999999999954443 336799999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCC
Q 010891 326 LLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV 405 (498)
Q Consensus 326 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (498)
..-... ..+.++||||.|||||++.+..|+.++|+|||||+||||+.|..||.+.+.+... ..+.. .+
T Consensus 517 e~m~~g-~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~F------dsI~~----d~- 584 (694)
T KOG0694|consen 517 EGMGQG-DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVF------DSIVN----DE- 584 (694)
T ss_pred ccCCCC-CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH------HHHhc----CC-
Confidence 753222 2466799999999999999999999999999999999999999999865433221 11111 11
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 010891 406 VDPNIETRPSTSALKRALLTALRCVDPDSDKRPKM 440 (498)
Q Consensus 406 ~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~ 440 (498)
+..+.. -..+.+.++.++|.+||++|.-+
T Consensus 585 --~~yP~~----ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 585 --VRYPRF----LSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred --CCCCCc----ccHHHHHHHHHHhccCcccccCC
Confidence 111111 12344445557999999999855
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=330.48 Aligned_cols=255 Identities=25% Similarity=0.433 Sum_probs=204.6
Q ss_pred ccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeec
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 252 (498)
.++|++.++||+|+||.||+|...++..||+|.+.... ...+.+..|+.+++.++||||+++++++.+....+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 35688899999999999999998788899999875433 23567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~ 332 (498)
++++|.+++... ....+++..++.++.|++.||+|||+. +++||||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 84 AKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 999999999754 345688999999999999999999998 999999999999999999999999999987654332
Q ss_pred eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCC
Q 010891 333 HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411 (498)
Q Consensus 333 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (498)
.......++..|+|||++....++.++|||||||++|+|++ |..||....... .. ..+.... .. +..
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~---~~~~~~~---~~--~~~- 226 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VM---SALQRGY---RM--PRM- 226 (261)
T ss_pred eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HH---HHHHcCC---CC--CCC-
Confidence 22233446778999999988889999999999999999998 999996433211 11 1111111 00 111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 412 ~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
... ......++.+||..+|++|||+.++++.|+.
T Consensus 227 --~~~--~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 227 --ENC--PDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred --CCC--CHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 111 1234445568999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=350.45 Aligned_cols=253 Identities=24% Similarity=0.338 Sum_probs=196.2
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC---CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
++|++.+.||+|+||+||+|+. .+|+.||||++.... ......+..|+.++..++||||+++++++.++...|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4688999999999999999985 468999999986432 223345778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+.+|+|.+++.. .+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..+..
T Consensus 81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999973 35689999999999999999999999 999999999999999999999999999976532
Q ss_pred CCce-------------------------------------eeecccccccccCcccccCCCCCccchHHHHHHHHHHHH
Q 010891 330 GKSH-------------------------------------ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAI 372 (498)
Q Consensus 330 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ell 372 (498)
.... .....+||+.|+|||++.+..++.++|||||||++|||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 2100 111246999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHHH
Q 010891 373 TGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPK---MSQVVRML 447 (498)
Q Consensus 373 tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt---~~ell~~L 447 (498)
+|..||....+.. ......... ... ........+.... .++.+|+. +|.+|++ +.+++.+-
T Consensus 234 ~G~~Pf~~~~~~~------~~~~i~~~~--~~~---~~~~~~~~s~~~~--~li~~ll~-~p~~R~~~~~~~~ll~h~ 297 (364)
T cd05599 234 VGYPPFCSDNPQE------TYRKIINWK--ETL---QFPDEVPLSPEAK--DLIKRLCC-EAERRLGNNGVNEIKSHP 297 (364)
T ss_pred cCCCCCCCCCHHH------HHHHHHcCC--Ccc---CCCCCCCCCHHHH--HHHHHHcc-CHhhcCCCCCHHHHhcCC
Confidence 9999997543221 111111111 111 0111111122222 22335775 8999998 99998764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=350.12 Aligned_cols=260 Identities=27% Similarity=0.412 Sum_probs=200.6
Q ss_pred HccCCCccceEcccCcEEEEEEEE------cCCcEEEEEEecCCCC-CchhHHHHHHHHHHcC-CCCCceEEEeEEEeCC
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL------MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGT 243 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~ 243 (498)
..++|++.+.||+|+||.||+|++ .++..||||++..... ...+.+.+|+.++..+ +||||+++++++.+..
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 345788999999999999999963 2456899998864432 2345688899999999 8999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcccC---------------------------------------------------------
Q 010891 244 QRILVYEYVNNGNLEQWLRGDMC--------------------------------------------------------- 266 (498)
Q Consensus 244 ~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 266 (498)
..++||||+++|+|.++++....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 99999999999999999964210
Q ss_pred --------------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010891 267 --------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (498)
Q Consensus 267 --------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~ 332 (498)
....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 112578899999999999999999998 999999999999999999999999999987644322
Q ss_pred ee-eecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCC
Q 010891 333 HI-TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNI 410 (498)
Q Consensus 333 ~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (498)
.. .....++..|+|||++.+..++.++|||||||++|||++ |..||....... .....+ .. . .....+
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~---~~-~--~~~~~~-- 339 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMI---KE-G--YRMLSP-- 339 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHH---Hh-C--ccCCCC--
Confidence 11 112345678999999999999999999999999999998 888986433221 111111 11 0 000001
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 411 ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 411 ~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
..... .+..++.+||+.||++|||+.++++.|+.
T Consensus 340 --~~~~~---~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 340 --ECAPS---EMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred --CCCCH---HHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 11122 33445558999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=358.71 Aligned_cols=253 Identities=21% Similarity=0.276 Sum_probs=200.8
Q ss_pred CCCccceEcccCcEEEEEEEE-cC-CcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeec
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-MN-GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 252 (498)
.|.+.+.||+|+||.||+|.. .+ +..||+|.+..........++.|+.+++.++|||||++++++..++..||||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 478899999999999999964 33 6788888775544444456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~ 332 (498)
++|+|.++|........++++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 99999999865443456789999999999999999999998 999999999999999999999999999997654322
Q ss_pred -eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCC
Q 010891 333 -HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411 (498)
Q Consensus 333 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (498)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+.+...... .. .+ ..
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~------~~~~~~~~~~-~~----~~-~~ 292 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ------REIMQQVLYG-KY----DP-FP 292 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHhC-CC----CC-CC
Confidence 123446799999999999999999999999999999999999999964322 1111211111 00 00 11
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 412 ~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
...+ ..+..++.+||..||++||++.+++.+
T Consensus 293 --~~~s--~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 293 --CPVS--SGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred --ccCC--HHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 1111 223344458999999999999999753
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=345.95 Aligned_cols=247 Identities=22% Similarity=0.275 Sum_probs=197.8
Q ss_pred ccCCCccceEcccCcEEEEEEEEcC--CcEEEEEEecCCC---CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLMN--GTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
.++|.+.+.||+|+||.||+|.+.+ +..||+|++.... ....+.+..|+.++..++||||+++++++.+....|+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3568889999999999999997433 3689999885432 2234567889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
||||+.+|+|.+++.. .+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 109 v~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999973 35689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcC
Q 010891 328 GAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407 (498)
Q Consensus 328 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (498)
... ....+||+.|+|||++.+..++.++|||||||++|||++|..||....+.. ....+.. ..
T Consensus 182 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~------~~~~i~~---~~---- 244 (340)
T PTZ00426 182 DTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL------IYQKILE---GI---- 244 (340)
T ss_pred CCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH------HHHHHhc---CC----
Confidence 432 234579999999999998889999999999999999999999997543211 1111111 11
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 010891 408 PNIETRPSTSALKRALLTALRCVDPDSDKRP-----KMSQVVRML 447 (498)
Q Consensus 408 ~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RP-----t~~ell~~L 447 (498)
...+...+. ....++.+||+.||.+|+ ++++++++-
T Consensus 245 --~~~p~~~~~--~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp 285 (340)
T PTZ00426 245 --IYFPKFLDN--NCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHP 285 (340)
T ss_pred --CCCCCCCCH--HHHHHHHHHcccCHHHcCCCCCCCHHHHHcCC
Confidence 111111111 123344489999999995 899998763
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=341.97 Aligned_cols=242 Identities=26% Similarity=0.296 Sum_probs=192.0
Q ss_pred ceEcccCcEEEEEEEE-cCCcEEEEEEecCCC---CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCCC
Q 010891 180 NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNG 255 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g 255 (498)
+.||+|+||.||+++. .+|..||+|++.... ......+..|+.+++.++||||+++++++......|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4799999999999974 568999999986432 223345678999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCceee
Q 010891 256 NLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHIT 335 (498)
Q Consensus 256 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 335 (498)
+|..++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~ 152 (323)
T cd05595 81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATM 152 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccc
Confidence 99998863 35689999999999999999999999 99999999999999999999999999987543222 122
Q ss_pred ecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCC
Q 010891 336 TRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPS 415 (498)
Q Consensus 336 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (498)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ........ .......
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~~~~~---------~~~~p~~ 217 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELILME---------EIRFPRT 217 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHhcC---------CCCCCCC
Confidence 34679999999999999999999999999999999999999997543211 11111110 0111111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 010891 416 TSALKRALLTALRCVDPDSDKRP-----KMSQVVRM 446 (498)
Q Consensus 416 ~~~~~~~l~~~~~cl~~dP~~RP-----t~~ell~~ 446 (498)
.+. ....++.+||+.||++|| ++.+++++
T Consensus 218 ~~~--~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 218 LSP--EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCH--HHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 111 223344479999999998 89998865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=342.74 Aligned_cols=243 Identities=25% Similarity=0.308 Sum_probs=193.3
Q ss_pred ceEcccCcEEEEEEEE-cCCcEEEEEEecCCC---CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCCC
Q 010891 180 NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNG 255 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g 255 (498)
+.||+|+||.||+++. .+|+.||+|++.... ......+..|+.+++.++||||+++++++.+.+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999974 568999999986532 223356778999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCceee
Q 010891 256 NLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHIT 335 (498)
Q Consensus 256 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 335 (498)
+|.+++.. ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 152 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATM 152 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccc
Confidence 99999863 35689999999999999999999999 99999999999999999999999999997643221 223
Q ss_pred ecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCC
Q 010891 336 TRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPS 415 (498)
Q Consensus 336 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (498)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||...... +...... ... ..+. ..
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~------~~~~~~~---~~~----~~~p--~~ 217 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELIL---MED----IKFP--RT 217 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH------HHHHHhc---cCC----ccCC--CC
Confidence 3467999999999999999999999999999999999999999754321 1111111 000 1111 11
Q ss_pred HHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 010891 416 TSALKRALLTALRCVDPDSDKRP-----KMSQVVRML 447 (498)
Q Consensus 416 ~~~~~~~l~~~~~cl~~dP~~RP-----t~~ell~~L 447 (498)
.+. .+..++.+||..||++|| ++.+++++.
T Consensus 218 ~~~--~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 252 (328)
T cd05593 218 LSA--DAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHS 252 (328)
T ss_pred CCH--HHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCC
Confidence 111 233344489999999997 899998763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=335.51 Aligned_cols=201 Identities=26% Similarity=0.402 Sum_probs=171.9
Q ss_pred ccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
.++|.+.+.||+|+||.||+|+.. +++.||+|++...... ....+.+|+.+++.++||||+++++++.++...|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467999999999999999999854 6889999998644322 23457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
|+. ++|.+++... .+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 995 6888888642 35688999999999999999999999 9999999999999999999999999999865332
Q ss_pred CceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 010891 331 KSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYG 381 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~ 381 (498)
. .......||+.|+|||++.+ ..++.++|||||||++|||++|..||...
T Consensus 157 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 157 S-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred C-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 2 22234568999999998765 56889999999999999999999999754
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=326.66 Aligned_cols=256 Identities=29% Similarity=0.428 Sum_probs=203.5
Q ss_pred HccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
..++|++.+.||+|+||.||+|...+++.||+|.+.... ...+++.+|+.++++++||||+++++++......|+||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 346789999999999999999987778889999886543 3356788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+++++|.+++... ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 83 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 83 MKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred ccCCcHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 9999999999753 234689999999999999999999998 99999999999999999999999999998875332
Q ss_pred ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCC
Q 010891 332 SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNI 410 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (498)
........++..|+|||++.+..++.++||||||+++|||++ |+.||....... ....+... ... + .
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~~~~~~---~~~--~-~ 225 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE------VLQQVDQG---YRM--P-C 225 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH------HHHHHHcC---CCC--C-C
Confidence 211111223457999999998899999999999999999999 999996433211 11111111 100 0 0
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 411 ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 411 ~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
... ....+..++.+||+.||++||++.++++.|+.
T Consensus 226 --~~~--~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 226 --PPG--CPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred --CCc--CCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 111 11234445568999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=328.98 Aligned_cols=261 Identities=26% Similarity=0.334 Sum_probs=197.6
Q ss_pred CCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCC-----eeEEE
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT-----QRILV 248 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----~~~lv 248 (498)
.|.-.+++|.|+||.||+|.. .+++.||||++..+... -.+|+++|+.++|||||+++.+|.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 456678999999999999984 45799999999765432 235899999999999999999887532 23689
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCC-CCeEEeeeccceec
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN-FDAKISDFGLAKLL 327 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~-~~~kL~DfGla~~~ 327 (498)
||||+. +|..+++.....+..++...+.-+..||++||+|||+. +|+||||||.|+|+|.+ |.+||||||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999976 99999986544566788888999999999999999998 99999999999999986 99999999999998
Q ss_pred CCCCceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHH-------hh
Q 010891 328 GAGKSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMV-------QL 399 (498)
Q Consensus 328 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~-------~~ 399 (498)
..++.. ..+..|..|+|||++.+ ..|+.+.||||.|||+.||+-|++-|.+..... .+.+.++.+. ..
T Consensus 177 ~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d--QL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 177 VKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD--QLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred ccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH--HHHHHHHHhCCCCHHHHhh
Confidence 766543 34567899999997755 689999999999999999999999997644322 2222221110 00
Q ss_pred cccc--CCcCCCCCCC-----CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 400 RRSE--DVVDPNIETR-----PSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 400 ~~~~--~~~~~~~~~~-----~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.... ....+.+... .........+.++.++|..+|.+|.++.|++.+-
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~ 307 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHP 307 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcch
Confidence 0000 0001111111 1122234566666789999999999999999764
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=341.72 Aligned_cols=253 Identities=25% Similarity=0.313 Sum_probs=196.5
Q ss_pred CCCccceEcccCcEEEEEEEE----cCCcEEEEEEecCCC----CCchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCee
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL----MNGTAVAVKKLLNNP----GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQR 245 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 245 (498)
+|++.+.||+|+||.||+++. .+++.||+|++.... ....+.+..|+.++..+ +||||+++++++.++...
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999974 357899999985422 22234577899999999 599999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccce
Q 010891 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~ 325 (498)
++||||+++|+|.+++.. +..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999999963 35689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCceeeecccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccC
Q 010891 326 LLGAGKSHITTRVMGTFGYVAPEYANSG-LLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSED 404 (498)
Q Consensus 326 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (498)
.............+||+.|+|||++.+. .++.++|||||||++|||++|+.||......... ......+..
T Consensus 154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~------ 225 (332)
T cd05614 154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SEVSRRILK------ 225 (332)
T ss_pred cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--HHHHHHHhc------
Confidence 7544333333456799999999998765 4789999999999999999999999743322111 111111111
Q ss_pred CcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 010891 405 VVDPNIETRPSTSALKRALLTALRCVDPDSDKRP-----KMSQVVRML 447 (498)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RP-----t~~ell~~L 447 (498)
.++.+. ...+. ....++.+||+.||++|| ++.+++++-
T Consensus 226 -~~~~~~--~~~~~--~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 268 (332)
T cd05614 226 -CDPPFP--SFIGP--EAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268 (332)
T ss_pred -CCCCCC--CCCCH--HHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence 111111 11112 223334489999999999 778888764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=329.97 Aligned_cols=256 Identities=28% Similarity=0.479 Sum_probs=207.6
Q ss_pred HccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
...+|++.+.||.|+||.||+|...++..+++|.+..........+..|+.+++.++||||+++++++.+....++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34568889999999999999999877999999998766655567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+++++|.+++... ....+++..++.++.|++.||.|||+. +++|+||||+||++++++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 84 MEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred cccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 9999999999753 335689999999999999999999998 99999999999999999999999999998764332
Q ss_pred ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCC
Q 010891 332 SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNI 410 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (498)
.. .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... +.+..+..... ...
T Consensus 159 ~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~------~~~~~~~~~~~------~~~ 225 (261)
T cd05148 159 YL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH------EVYDQITAGYR------MPC 225 (261)
T ss_pred cc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH------HHHHHHHhCCc------CCC
Confidence 21 223346778999999988899999999999999999998 89999654321 11111111100 011
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 411 ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 411 ~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
. . .....+..++.+||..||.+|||+.++++.|+.
T Consensus 226 ~--~--~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 226 P--A--KCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred C--C--CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 1 1 111234455568999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=342.46 Aligned_cols=200 Identities=27% Similarity=0.433 Sum_probs=174.2
Q ss_pred ccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
.++|++.+.||+|+||.||++... ++..+|+|.+..... .....+.+|+++++.++||||++++++|.+++..|+|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 478999999999999999999854 578889988754422 223568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
|+++|+|.+++.. .+.+++..+..++.|++.||.|||+.. +++||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 9999999999973 356889999999999999999999742 7999999999999999999999999999765322
Q ss_pred CceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 010891 331 KSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYG 381 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~ 381 (498)
......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 123357899999999999889999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=348.25 Aligned_cols=202 Identities=24% Similarity=0.335 Sum_probs=173.5
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC---CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
++|++.+.||+|+||.||+|+. .+++.||+|++.... ......+.+|+++++.++||||+++++.+.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 4689999999999999999974 468999999985432 123355788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+++|+|.+++.. .+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+..
T Consensus 81 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999999973 35688999999999999999999999 999999999999999999999999999853210
Q ss_pred CC------------------------------------------ceeeecccccccccCcccccCCCCCccchHHHHHHH
Q 010891 330 GK------------------------------------------SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVV 367 (498)
Q Consensus 330 ~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvv 367 (498)
.. .......+||+.|+|||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 00 001123579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCC
Q 010891 368 LLEAITGRYPVDYGR 382 (498)
Q Consensus 368 l~elltg~~P~~~~~ 382 (498)
+|||++|+.||....
T Consensus 234 lyell~G~~Pf~~~~ 248 (376)
T cd05598 234 LYEMLVGQPPFLADT 248 (376)
T ss_pred eeehhhCCCCCCCCC
Confidence 999999999997654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=332.97 Aligned_cols=260 Identities=24% Similarity=0.353 Sum_probs=192.3
Q ss_pred cCCCccceEcccCcEEEEEEEE--cCCcEEEEEEecCCCCC--chhHHHHHHHHHHcC---CCCCceEEEeEEEe-----
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL--MNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHV---RHKNLVRLLGYCIE----- 241 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~----- 241 (498)
++|++.+.||+|+||+||+|+. .++..||+|.+...... ....+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3688999999999999999975 24678999988543322 223466677777665 69999999999852
Q ss_pred CCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeee
Q 010891 242 GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDF 321 (498)
Q Consensus 242 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~Df 321 (498)
....++||||++ ++|.+++... ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence 456799999996 5999999643 234589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhcc
Q 010891 322 GLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRR 401 (498)
Q Consensus 322 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 401 (498)
|++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...+........
T Consensus 155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~---~~~i~~~~~~~~ 229 (290)
T cd07862 155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIGLPG 229 (290)
T ss_pred cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH---HHHHHHHhCCCC
Confidence 999876433 223345789999999999888999999999999999999999999976443211 111111000000
Q ss_pred cc----------CCcCCCCC-----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 402 SE----------DVVDPNIE-----TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 402 ~~----------~~~~~~~~-----~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
.. ....+... ..+..+ .....++.+||..||++|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDID--ELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCC--HHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 00 00000000 001111 122345558999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=339.36 Aligned_cols=253 Identities=26% Similarity=0.358 Sum_probs=210.1
Q ss_pred HHccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCc---hhHHHHHHHHHHcCC-CCCceEEEeEEEeCCee
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQA---DKDFRVEVEAIGHVR-HKNLVRLLGYCIEGTQR 245 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~ 245 (498)
.....|++.+.||+|.||.||+++. .+|+.+|+|.+.+..... .+.+.+|+.+|+++. |||||.++++|.+....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 3456789999999999999999985 459999999997655433 357899999999998 99999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCC----CCeEEeee
Q 010891 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN----FDAKISDF 321 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~----~~~kL~Df 321 (498)
++|||++.||.|++.+... .+++..+..++.|++.|+.|||+. +|+||||||+|+|+... +.+|++||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred EEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 9999999999999999753 399999999999999999999998 99999999999999543 57999999
Q ss_pred ccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhcc
Q 010891 322 GLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRR 401 (498)
Q Consensus 322 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 401 (498)
|++..... .......+||+.|+|||++....|+..+||||+||++|.|++|..||.......... ....
T Consensus 184 Gla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~---------~i~~ 252 (382)
T KOG0032|consen 184 GLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL---------AILR 252 (382)
T ss_pred CCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH---------HHHc
Confidence 99998876 334566899999999999999999999999999999999999999998654322111 1111
Q ss_pred ccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 402 SEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
... +-....++..+...+.+.. +|+..||.+|+|+.++|+|
T Consensus 253 ~~~--~f~~~~w~~is~~akd~i~--~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 253 GDF--DFTSEPWDDISESAKDFIR--KLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred CCC--CCCCCCccccCHHHHHHHH--HhcccCcccCCCHHHHhcC
Confidence 111 2222334445555555554 7999999999999999997
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=341.50 Aligned_cols=200 Identities=29% Similarity=0.425 Sum_probs=168.7
Q ss_pred CCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEeC-----CeeE
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEG-----TQRI 246 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~~~ 246 (498)
+|++.+.||+|+||.||+|.. .+|..||||++..... .....+.+|+++++.++||||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 578899999999999999974 4689999999864322 2334678899999999999999999988643 3479
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecccee
Q 010891 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (498)
Q Consensus 247 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~ 326 (498)
+||||+. ++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence 9999995 699999863 35689999999999999999999999 999999999999999999999999999986
Q ss_pred cCCCCc--eeeecccccccccCcccccC--CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 010891 327 LGAGKS--HITTRVMGTFGYVAPEYANS--GLLNEKSDVYSFGVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 327 ~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~P~~~~~ 382 (498)
...... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~ 212 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 532211 11234579999999999876 678999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=322.94 Aligned_cols=265 Identities=23% Similarity=0.285 Sum_probs=202.3
Q ss_pred cCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCC-ceEEEeEEEeCC------
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKN-LVRLLGYCIEGT------ 243 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~------ 243 (498)
..|...++||+|+||+||+|+ ..+|+.||+|++.-... .......+|+.+|++|+|+| ||.+++++.+.+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 346667789999999999997 56789999999955433 23345678999999999999 999999999887
Q ss_pred eeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecc
Q 010891 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (498)
Q Consensus 244 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGl 323 (498)
.+++|+||++. +|..++.........++...+..++.||+.||+|||++ +|+||||||+||||+++|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 78999999966 99999976432223467788999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeecccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccc
Q 010891 324 AKLLGAGKSHITTRVMGTFGYVAPEYANSG-LLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRS 402 (498)
Q Consensus 324 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (498)
|+...-+... .+..++|.+|+|||++.+. .|+...||||+|||++||++++..|.+.... +.+..+......
T Consensus 167 Ara~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~------~ql~~If~~lGt 239 (323)
T KOG0594|consen 167 ARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI------DQLFRIFRLLGT 239 (323)
T ss_pred HHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH------HHHHHHHHHcCC
Confidence 9977644322 4556799999999988765 7999999999999999999999888765431 112222222111
Q ss_pred c---------CCcCC--CCCCCC---CH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 403 E---------DVVDP--NIETRP---ST-----SALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 403 ~---------~~~~~--~~~~~~---~~-----~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
. ...+- .+..+. .. ........++.+||+.+|.+|.|+..++.|-..
T Consensus 240 P~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf 305 (323)
T KOG0594|consen 240 PNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYF 305 (323)
T ss_pred CCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhh
Confidence 1 00010 111111 00 001245556668999999999999999988443
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=368.38 Aligned_cols=257 Identities=28% Similarity=0.451 Sum_probs=205.3
Q ss_pred CCCccceEcccCcEEEEEEEEc--CCc----EEEEEEecCCC-CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 175 RFSKDNIIGDGGYGVVYRGQLM--NGT----AVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~~--~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
+.++.+.||+|+||.||.|... +|. .||||.+.... .+...+|..|..+|+.++|||||+++|++.+....+|
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 4466789999999999999743 343 49999986553 4556789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccC---CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccc
Q 010891 248 VYEYVNNGNLEQWLRGDMC---DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla 324 (498)
++|||+||+|..||+..+. ....|+..+.+.++.|||+|+.||+++ ++|||||..+|+||+....+||+|||+|
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchh
Confidence 9999999999999986532 235689999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCceeeecc-cccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccc
Q 010891 325 KLLGAGKSHITTRV-MGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRS 402 (498)
Q Consensus 325 ~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (498)
+.+.....+..... .-...|||||.+..+.|+.|+|||||||+|||++| |..||...+.... +.......
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v------~~~~~~gg-- 921 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV------LLDVLEGG-- 921 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH------HHHHHhCC--
Confidence 96544443332222 34568999999999999999999999999999999 8899975543221 11112211
Q ss_pred cCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 403 EDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
.++.+. .....+..++..||+.+|++||++..+++.+...
T Consensus 922 ------RL~~P~--~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 922 ------RLDPPS--YCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred ------ccCCCC--CCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence 111111 1223444666689999999999999999987664
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=344.73 Aligned_cols=260 Identities=25% Similarity=0.402 Sum_probs=199.7
Q ss_pred ccCCCccceEcccCcEEEEEEEE------cCCcEEEEEEecCCCCC-chhHHHHHHHHHHcC-CCCCceEEEeEEEeCCe
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL------MNGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQ 244 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~ 244 (498)
.++|++.+.||+|+||.||+|.. .++..||+|++...... ....+..|+++++.+ +||||+++++++.....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 35788999999999999999863 23357999998654332 234678899999999 89999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcccC----------------------------------------------------------
Q 010891 245 RILVYEYVNNGNLEQWLRGDMC---------------------------------------------------------- 266 (498)
Q Consensus 245 ~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------------------- 266 (498)
.|+||||+++|+|.+++.....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999999864210
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCcee-eec
Q 010891 267 --------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI-TTR 337 (498)
Q Consensus 267 --------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~-~~~ 337 (498)
...++++..++.++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++......... ...
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 113578899999999999999999998 99999999999999999999999999998764332211 122
Q ss_pred ccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCH
Q 010891 338 VMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPST 416 (498)
Q Consensus 338 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (498)
..++..|+|||++.+..++.++|||||||++|||++ |+.||....... . .... .... .. +.... ...
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~---~~~~-~~~~--~~---~~~~~-~~~ 341 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--K---FYKM-VKRG--YQ---MSRPD-FAP 341 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--H---HHHH-HHcc--cC---ccCCC-CCC
Confidence 335678999999998999999999999999999997 999997543221 1 1111 1111 00 11111 111
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 417 SALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 417 ~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
..+..++.+||+.||++|||+.++++.|+..
T Consensus 342 ---~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 342 ---PEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred ---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 2334444589999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=343.26 Aligned_cols=254 Identities=24% Similarity=0.273 Sum_probs=199.7
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC---CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
++|.+.+.||+|+||+||+|+. .+|+.||+|++..... ...+.+..|+.++..++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4688999999999999999974 4689999999865322 23456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+++|+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++..+..
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999999743 25689999999999999999999999 999999999999999999999999999988755
Q ss_pred CCceeeecccccccccCccccc------CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhcccc
Q 010891 330 GKSHITTRVMGTFGYVAPEYAN------SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSE 403 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (498)
..........||+.|+|||++. ...++.++|||||||++|||++|+.||....... .+..+.......
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~ 228 (330)
T cd05601 155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK------TYNNIMNFQRFL 228 (330)
T ss_pred CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH------HHHHHHcCCCcc
Confidence 4433334457999999999886 4668899999999999999999999997543321 112211111110
Q ss_pred CCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 404 DVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.+...+..+.. ...++.+||. ||.+|||+.+++.+-
T Consensus 229 -----~~~~~~~~~~~--~~~li~~ll~-~p~~R~t~~~l~~h~ 264 (330)
T cd05601 229 -----KFPEDPKVSSD--FLDLIQSLLC-GQKERLGYEGLCCHP 264 (330)
T ss_pred -----CCCCCCCCCHH--HHHHHHHHcc-ChhhCCCHHHHhCCC
Confidence 11111122222 2233336887 999999999998653
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=336.89 Aligned_cols=240 Identities=23% Similarity=0.256 Sum_probs=190.0
Q ss_pred EcccCcEEEEEEEE-cCCcEEEEEEecCCC---CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCCCCH
Q 010891 182 IGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNL 257 (498)
Q Consensus 182 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L 257 (498)
||+|+||.||+|+. .+++.||+|++.... ......+..|+.++.+++||||+++++++.+....|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999985 458899999985432 22345677899999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCceeeec
Q 010891 258 EQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337 (498)
Q Consensus 258 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~ 337 (498)
.+++.. .+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~ 152 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT 152 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence 999973 35689999999999999999999999 99999999999999999999999999998643222 22344
Q ss_pred ccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHH
Q 010891 338 VMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTS 417 (498)
Q Consensus 338 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (498)
.+||+.|+|||++.+..++.++|||||||++|||++|+.||..... .+....... .........+
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~~~---------~~~~~~~~~~ 217 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKILQ---------EPLRFPDGFD 217 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHHHc---------CCCCCCCcCC
Confidence 6799999999999999999999999999999999999999975322 111121111 0111111122
Q ss_pred HHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 010891 418 ALKRALLTALRCVDPDSDKRPK---MSQVVRM 446 (498)
Q Consensus 418 ~~~~~l~~~~~cl~~dP~~RPt---~~ell~~ 446 (498)
. .+..++.+||..||.+||+ +.+++.|
T Consensus 218 ~--~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 218 R--DAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred H--HHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 2 2233444899999999975 5666654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=324.43 Aligned_cols=252 Identities=23% Similarity=0.389 Sum_probs=200.0
Q ss_pred cCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecC
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ 253 (498)
.+|.+.+.||+|+||.||+|++.++..||+|.+.... .....+.+|+.++.+++||||+++++++.+....++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 3578889999999999999987777789999886433 334678999999999999999999999998888999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCce
Q 010891 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333 (498)
Q Consensus 254 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~ 333 (498)
+|+|.+++... ...+++..++.++.||+.||.|||+. +++|+||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 83 NGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 99999999743 23689999999999999999999999 9999999999999999999999999999876543322
Q ss_pred eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCC
Q 010891 334 ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIET 412 (498)
Q Consensus 334 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (498)
......++..|+|||.+.+..++.++|||||||++|+|++ |..||....... . ........ .. ....
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~---~~~~~~~~---~~---~~~~ 224 (256)
T cd05113 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---T---VEKVSQGL---RL---YRPH 224 (256)
T ss_pred ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---H---HHHHhcCC---CC---CCCC
Confidence 2222345678999999988889999999999999999999 999986433211 1 11111111 10 0011
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 413 RPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 413 ~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
.. ......++.+||..||.+|||+.++++.|+
T Consensus 225 -~~---~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 225 -LA---SEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -CC---CHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 11 133444555899999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=329.06 Aligned_cols=256 Identities=29% Similarity=0.484 Sum_probs=201.9
Q ss_pred cCCCccceEcccCcEEEEEEEEcC------CcEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLMN------GTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI 246 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 246 (498)
++|.+.+.||+|+||.||+|...+ +..||+|.+...... ..+.+.+|++++..++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457888999999999999997533 478999998655443 3467899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhccc----------CCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCe
Q 010891 247 LVYEYVNNGNLEQWLRGDM----------CDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDA 316 (498)
Q Consensus 247 lv~e~~~~g~L~~~l~~~~----------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~ 316 (498)
+||||+++++|.+++.... .....+++..+..++.|++.||.|||++ +++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 9999999999999997532 1234588999999999999999999999 99999999999999999999
Q ss_pred EEeeeccceecCCCCc-eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHH
Q 010891 317 KISDFGLAKLLGAGKS-HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLK 394 (498)
Q Consensus 317 kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~ 394 (498)
||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||....... .. .
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~---~ 235 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VI---E 235 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HH---H
Confidence 9999999986533221 11223446788999999999999999999999999999998 999986543221 11 1
Q ss_pred HHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 395 MMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
.... ... .... .... ..+..++.+||..||++|||+.|+++.|+
T Consensus 236 ~~~~-~~~-----~~~~-~~~~---~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 236 CITQ-GRL-----LQRP-RTCP---SEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHc-CCc-----CCCC-CCCC---HHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1111 100 0000 1111 23344555899999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=344.68 Aligned_cols=253 Identities=25% Similarity=0.339 Sum_probs=200.4
Q ss_pred cCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCC---CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
++|.+.+.||+|+||+||+|+.. +|+.||+|++.... ......+..|++++..++||||+++++++.++...|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46889999999999999999854 68999999986432 233456888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+++++|.+++... +.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 999999999999743 5789999999999999999999998 999999999999999999999999999987644
Q ss_pred CC----------------------------ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 010891 330 GK----------------------------SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYG 381 (498)
Q Consensus 330 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~ 381 (498)
.. ........||+.|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 32 11223457999999999999999999999999999999999999999754
Q ss_pred CCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHHH
Q 010891 382 RPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPK-MSQVVRML 447 (498)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt-~~ell~~L 447 (498)
.... ....+..... .. .+......+. .+..++.+|+. ||.+||+ +.+++++.
T Consensus 234 ~~~~------~~~~i~~~~~--~~---~~p~~~~~~~--~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 234 TLQE------TYNKIINWKE--SL---RFPPDPPVSP--EAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred CHHH------HHHHHhccCC--cc---cCCCCCCCCH--HHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 4211 1111111000 00 1111111122 23333347887 9999999 99999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=337.70 Aligned_cols=243 Identities=24% Similarity=0.357 Sum_probs=193.0
Q ss_pred ceEcccCcEEEEEEEE----cCCcEEEEEEecCCC----CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 180 NIIGDGGYGVVYRGQL----MNGTAVAVKKLLNNP----GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
+.||+|+||.||+++. .+++.||+|.+.... ......+..|+.+++.++||||+++++++..+...|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5899999999999974 357899999986432 12234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+++++|.+++.. .+.+.+..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999999963 35688899999999999999999999 99999999999999999999999999998643222
Q ss_pred ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCC
Q 010891 332 SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (498)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+..+.. . ...
T Consensus 155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~~~~~~---~------~~~ 218 (323)
T cd05584 155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTIDKILK---G------KLN 218 (323)
T ss_pred -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHHHHHHc---C------CCC
Confidence 1233457999999999999888999999999999999999999999754321 11111111 1 111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 010891 412 TRPSTSALKRALLTALRCVDPDSDKRP-----KMSQVVRML 447 (498)
Q Consensus 412 ~~~~~~~~~~~l~~~~~cl~~dP~~RP-----t~~ell~~L 447 (498)
..+..+. .+..++.+||..||++|| ++.+++.+-
T Consensus 219 ~~~~~~~--~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~ 257 (323)
T cd05584 219 LPPYLTP--EARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP 257 (323)
T ss_pred CCCCCCH--HHHHHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence 1111111 233444589999999999 899988753
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=344.66 Aligned_cols=255 Identities=20% Similarity=0.237 Sum_probs=198.7
Q ss_pred HccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC---CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
..++|++.+.||+|+||.||+|+. .+++.||+|.+.... ......+..|+.+++.++||||+++++++.++...|+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 346789999999999999999975 468899999985422 2233457789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
||||+++|+|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 121 v~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 121 VMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 9999999999999863 3478889999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCceeeecccccccccCcccccCC----CCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhcccc
Q 010891 328 GAGKSHITTRVMGTFGYVAPEYANSG----LLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSE 403 (498)
Q Consensus 328 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (498)
...........+||+.|+|||++.+. .++.++|||||||++|||++|+.||...... .....+.... .
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~--~ 264 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMDHK--N 264 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCC--C
Confidence 54332223446799999999988643 4889999999999999999999999754321 1111111111 0
Q ss_pred CCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHH
Q 010891 404 DVVDPNIETRPSTSALKRALLTALRCVDPDSDK--RPKMSQVVRML 447 (498)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~--RPt~~ell~~L 447 (498)
.. .+......+.. ...++.+||..+|.+ |+|+.+++.|-
T Consensus 265 ~~---~~~~~~~~s~~--~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 265 SL---TFPDDIEISKQ--AKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred cC---CCCCcCCCCHH--HHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 01 11111112222 223334799999988 99999999774
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=326.11 Aligned_cols=254 Identities=25% Similarity=0.398 Sum_probs=201.2
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeec
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 252 (498)
..|.+.+.||+|+||.||+|.+ .+++.|++|.+... .....++..|+++++.++||||+++++++..+...++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 4577889999999999999974 45889999988643 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~ 332 (498)
++++|.+++... ....+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 85 TYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 999999999643 234689999999999999999999998 999999999999999999999999999987654322
Q ss_pred eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCC
Q 010891 333 HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411 (498)
Q Consensus 333 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (498)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||...... +........ ..+...
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~------~~~~~~~~~------~~~~~~ 227 (263)
T cd05052 160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QVYELLEKG------YRMERP 227 (263)
T ss_pred eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHHCC------CCCCCC
Confidence 22222334668999999998999999999999999999998 99998643321 111221111 011111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 412 ~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
... ...+..++.+||+.||++|||+.++++.|+.
T Consensus 228 --~~~--~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~ 261 (263)
T cd05052 228 --EGC--PPKVYELMRACWQWNPSDRPSFAEIHQAFET 261 (263)
T ss_pred --CCC--CHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence 111 1234445558999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=328.21 Aligned_cols=257 Identities=28% Similarity=0.489 Sum_probs=200.9
Q ss_pred cCCCccceEcccCcEEEEEEEEcC------CcEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLMN------GTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI 246 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 246 (498)
++|++.+.||+|+||.||+|.... ...|++|.+...... ....+.+|+.++..++||||+++++++.+....|
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 357888999999999999997532 257999988644322 2356889999999999999999999999989999
Q ss_pred EEEeecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCC
Q 010891 247 LVYEYVNNGNLEQWLRGDMC------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF 314 (498)
Q Consensus 247 lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~ 314 (498)
++|||+++++|.+++..... ....+++..++.++.|++.||.|||+. +++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 99999999999999965321 114688999999999999999999999 999999999999999999
Q ss_pred CeEEeeeccceecCCCCc-eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHH
Q 010891 315 DAKISDFGLAKLLGAGKS-HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEW 392 (498)
Q Consensus 315 ~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~ 392 (498)
.+||+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||....... ..
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~~-- 236 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---VI-- 236 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HH--
Confidence 999999999986543321 12233457889999999988899999999999999999998 999997543321 11
Q ss_pred HHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 393 LKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
..+.. .... .. .. .....+..++.+||+.||++||++.+++++|+.
T Consensus 237 -~~i~~-~~~~-----~~--~~--~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 237 -EMIRS-RQLL-----PC--PE--DCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred -HHHHc-CCcC-----CC--cc--cCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111 1100 01 11 112334455568999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=340.88 Aligned_cols=251 Identities=24% Similarity=0.368 Sum_probs=204.2
Q ss_pred cCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCCC--chhHHHHHHHHHHcCCCCCceEEEeEEEeCCe-eEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQ-RILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~-~~lv~ 249 (498)
++|..++++|+|+||.+++.+ ..++..|++|++.-.... ..+...+|+.++++++|||||.+++.|.+++. .||||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 578889999999999999996 456789999988544332 33457789999999999999999999998888 89999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
+|++||+|.+.|... .+..++++.+..++.|++.|+.|||++ +|+|||||+.||+++.++.+||.|||+|+.+..
T Consensus 84 ~Y~eGg~l~~~i~~~--k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQ--KGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred eecCCCCHHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 999999999999754 345688999999999999999999998 999999999999999999999999999999876
Q ss_pred CCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
.. .....++||+.||.||++.+.+|+.|+|||||||++|||++-+.+|...+... .+..+.+.. ..|
T Consensus 159 ~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~------Li~ki~~~~-----~~P- 225 (426)
T KOG0589|consen 159 ED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE------LILKINRGL-----YSP- 225 (426)
T ss_pred ch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH------HHHHHhhcc-----CCC-
Confidence 54 23556889999999999999999999999999999999999999997654322 111111111 111
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
+. .....++..+ +..||..+|..||++.++|.+
T Consensus 226 lp-~~ys~el~~l---v~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 LP-SMYSSELRSL---VKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CC-ccccHHHHHH---HHHHhhcCCccCCCHHHHhhC
Confidence 11 1112223333 237999999999999999965
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=345.44 Aligned_cols=258 Identities=20% Similarity=0.252 Sum_probs=197.6
Q ss_pred HHHHccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCC---CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCe
Q 010891 169 LQSATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQ 244 (498)
Q Consensus 169 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 244 (498)
+....++|++.+.||+|+||.||+++.. +++.||+|.+.... ......+.+|+.+++.++||||+++++++.++..
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 3444578999999999999999999854 57899999885421 2223457789999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccc
Q 010891 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (498)
Q Consensus 245 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla 324 (498)
.|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a 189 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTC 189 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccc
Confidence 9999999999999999953 3478899999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCceeeecccccccccCcccccCC----CCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhc
Q 010891 325 KLLGAGKSHITTRVMGTFGYVAPEYANSG----LLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLR 400 (498)
Q Consensus 325 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 400 (498)
..............+||+.|+|||++.+. .++.++|||||||+||||++|+.||...... ..........
T Consensus 190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~------~~~~~i~~~~ 263 (370)
T cd05621 190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV------GTYSKIMDHK 263 (370)
T ss_pred eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC
Confidence 87654333233456799999999998653 3788999999999999999999999754321 1112211111
Q ss_pred cccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCC--CCCCHHHHHHHH
Q 010891 401 RSEDVVDPNIETRPSTSALKRALLTALRCVDPDSD--KRPKMSQVVRML 447 (498)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~--~RPt~~ell~~L 447 (498)
.. ..+......+...+.+. .+||..++. .|+|+.|+++|-
T Consensus 264 ~~-----~~~p~~~~~s~~~~~li--~~~L~~~~~r~~R~~~~e~l~hp 305 (370)
T cd05621 264 NS-----LNFPEDVEISKHAKNLI--CAFLTDREVRLGRNGVEEIKQHP 305 (370)
T ss_pred cc-----cCCCCcccCCHHHHHHH--HHHccCchhccCCCCHHHHhcCc
Confidence 10 11111112222223332 357765443 389999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=323.60 Aligned_cols=254 Identities=28% Similarity=0.416 Sum_probs=201.1
Q ss_pred ccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeec
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 252 (498)
.++|++.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++||||+++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 357888999999999999999887888899999865433 3456889999999999999999999885 45679999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~ 332 (498)
++++|.+++... ....+++..++.++.|++.||.|||+. +++||||||+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05070 83 SKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCccc
Confidence 999999999753 234589999999999999999999998 999999999999999999999999999987654332
Q ss_pred eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCC
Q 010891 333 HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411 (498)
Q Consensus 333 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (498)
.......++..|+|||++.+..++.++||||||+++|+|++ |..||...... +....+.... . ....
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~------~~~~~~~~~~---~---~~~~ 225 (260)
T cd05070 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR------EVLEQVERGY---R---MPCP 225 (260)
T ss_pred ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHHcCC---C---CCCC
Confidence 22222345678999999988889999999999999999999 88999643321 1122221110 0 1111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 412 ~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
.. ....+..++.+||.+||++|||+.++++.|+.
T Consensus 226 --~~--~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 226 --QD--CPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred --Cc--CCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 11 11234445558999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=340.51 Aligned_cols=243 Identities=24% Similarity=0.288 Sum_probs=192.1
Q ss_pred ceEcccCcEEEEEEEE-cCCcEEEEEEecCCC---CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCCC
Q 010891 180 NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNG 255 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g 255 (498)
+.||+|+||.||+++. .+|+.||+|.+.... ......+..|++++..++||||+++++++.+....|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999974 578999999986432 223345678999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHH-ccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCcee
Q 010891 256 NLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE-AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (498)
Q Consensus 256 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 334 (498)
+|.+++.. ...+++..+..++.||+.||.|||+ . +|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (325)
T cd05594 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-T 152 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-c
Confidence 99999863 3568999999999999999999997 6 999999999999999999999999999986432221 2
Q ss_pred eecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCC
Q 010891 335 TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRP 414 (498)
Q Consensus 335 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (498)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....... . . ..+. .
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~------~~~~i~~-~--~----~~~p--~ 217 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LFELILM-E--E----IRFP--R 217 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH------HHHHHhc-C--C----CCCC--C
Confidence 334579999999999999999999999999999999999999997543211 1111110 0 0 0111 1
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 010891 415 STSALKRALLTALRCVDPDSDKRP-----KMSQVVRML 447 (498)
Q Consensus 415 ~~~~~~~~l~~~~~cl~~dP~~RP-----t~~ell~~L 447 (498)
..+ ..+..++.+||+.||++|+ ++.+++++.
T Consensus 218 ~~~--~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 253 (325)
T cd05594 218 TLS--PEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK 253 (325)
T ss_pred CCC--HHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence 111 1233344489999999996 899998763
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=324.58 Aligned_cols=254 Identities=28% Similarity=0.434 Sum_probs=200.8
Q ss_pred ccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeec
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 252 (498)
.++|++.++||+|+||.||+|++.++..||+|++.... ...+.+..|+++++.++||||+++++++.+ ...++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcC
Confidence 46789999999999999999987676789999886433 234578899999999999999999998754 5679999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~ 332 (498)
++|+|.+++... ....+++..+..++.|++.||+|||+. +++||||||+||++++++.+||+|||++........
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 83 SKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 999999999753 234578999999999999999999998 999999999999999999999999999987654332
Q ss_pred eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCC
Q 010891 333 HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411 (498)
Q Consensus 333 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (498)
.......++..|+|||++.+..++.++|||||||++|||++ |..||....... ....... .... ..
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~------~~~~~~~---~~~~---~~- 224 (262)
T cd05071 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQVER---GYRM---PC- 224 (262)
T ss_pred ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH------HHHHHhc---CCCC---CC-
Confidence 22223346778999999988899999999999999999999 888886443211 1111111 0000 00
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 412 ~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
.......+..++.+|++.||++|||+.++++.|+.
T Consensus 225 ---~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~ 259 (262)
T cd05071 225 ---PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259 (262)
T ss_pred ---ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence 01112334556668999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=341.15 Aligned_cols=248 Identities=27% Similarity=0.431 Sum_probs=190.7
Q ss_pred CCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeec
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 252 (498)
+|+..+.||+|+||.||+|+. .+++.||||++...... ....+.+|+++++.++||||+++++++.+....++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 456678999999999999985 46899999998654332 2356889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~ 332 (498)
++|+|.+.. .+.+..+..++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++.+....
T Consensus 155 ~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~- 222 (353)
T PLN00034 155 DGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM- 222 (353)
T ss_pred CCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence 999986532 356778889999999999999999 99999999999999999999999999998764322
Q ss_pred eeeecccccccccCcccccC-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcC
Q 010891 333 HITTRVMGTFGYVAPEYANS-----GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407 (498)
Q Consensus 333 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (498)
......+||..|+|||++.. ...+.++|||||||++|||++|+.||....... |...+........
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~------~~~~~~~~~~~~~--- 293 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD------WASLMCAICMSQP--- 293 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc------HHHHHHHHhccCC---
Confidence 11234579999999998743 334568999999999999999999997433221 1111111111100
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 408 ~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
+.. .... ...+..++.+||..||++|||+.|++++-
T Consensus 294 ~~~--~~~~--~~~l~~li~~~l~~~P~~Rpt~~ell~hp 329 (353)
T PLN00034 294 PEA--PATA--SREFRHFISCCLQREPAKRWSAMQLLQHP 329 (353)
T ss_pred CCC--CCcc--CHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 011 1111 12334444589999999999999999864
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=329.49 Aligned_cols=248 Identities=25% Similarity=0.294 Sum_probs=193.2
Q ss_pred EcccCcEEEEEEEE-cCCcEEEEEEecCCCCC---chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCCCCH
Q 010891 182 IGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ---ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNL 257 (498)
Q Consensus 182 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L 257 (498)
||+|+||+||++.. .+++.||+|++...... ..+.+..|+++++.++||||+++++++......|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999974 46889999998643322 224567899999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCceeeec
Q 010891 258 EQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337 (498)
Q Consensus 258 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~ 337 (498)
.+++.........+++..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++......... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccc
Confidence 998854333446799999999999999999999999 9999999999999999999999999999876543322 334
Q ss_pred ccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHH
Q 010891 338 VMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTS 417 (498)
Q Consensus 338 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (498)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......... ....... ...........+
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~---------~~~~~~~~~~~~ 225 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQRI---------LNDSVTYPDKFS 225 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHHHHhh---------cccCCCCcccCC
Confidence 57999999999999999999999999999999999999999754322110 0111100 011111111111
Q ss_pred HHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 010891 418 ALKRALLTALRCVDPDSDKRP-----KMSQVVRM 446 (498)
Q Consensus 418 ~~~~~l~~~~~cl~~dP~~RP-----t~~ell~~ 446 (498)
.....++.+||+.||++|| |+.+++++
T Consensus 226 --~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 226 --PASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred --HHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 1233344479999999999 77888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=347.31 Aligned_cols=201 Identities=24% Similarity=0.332 Sum_probs=172.6
Q ss_pred CCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC---CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
+|++.++||+|+||+||+|+. .+++.||+|++..... .....+..|+.+++.++||||+++++++.++...|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588899999999999999974 5688999999854321 223467889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
|+++|+|.+++.. .+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+...
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 9999999999963 35688999999999999999999999 9999999999999999999999999997532100
Q ss_pred C----------------------------------------------ceeeecccccccccCcccccCCCCCccchHHHH
Q 010891 331 K----------------------------------------------SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSF 364 (498)
Q Consensus 331 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSl 364 (498)
. .......+||+.|+|||++.+..|+.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 001123579999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCC
Q 010891 365 GVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 365 Gvvl~elltg~~P~~~~~ 382 (498)
||+||||++|+.||....
T Consensus 235 Gvil~elltG~~Pf~~~~ 252 (382)
T cd05625 235 GVILYEMLVGQPPFLAQT 252 (382)
T ss_pred hHHHHHHHhCCCCCCCCC
Confidence 999999999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=336.34 Aligned_cols=246 Identities=24% Similarity=0.310 Sum_probs=192.0
Q ss_pred CCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC---CCchhHHHHHHHHH---HcCCCCCceEEEeEEEeCCeeEEE
Q 010891 176 FSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAI---GHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 176 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+..|+.++ +.++||||+++++++.+....|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 56788999999999999975 468999999986432 22234566666554 567899999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+++++|..++.. +.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999988853 4689999999999999999999999 99999999999999999999999999987543
Q ss_pred CCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (498)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... +........ ..
T Consensus 153 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~------~~~~~i~~~---~~---- 218 (324)
T cd05589 153 GFG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE------EVFDSIVND---EV---- 218 (324)
T ss_pred CCC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhC---CC----
Confidence 222 1233467999999999999999999999999999999999999999754321 111111111 00
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 010891 409 NIETRPSTSALKRALLTALRCVDPDSDKRP-----KMSQVVRML 447 (498)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~~~cl~~dP~~RP-----t~~ell~~L 447 (498)
.. ....+ .....++.+||..||.+|| ++.+++++.
T Consensus 219 ~~--p~~~~--~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~ 258 (324)
T cd05589 219 RY--PRFLS--REAISIMRRLLRRNPERRLGSGEKDAEDVKKQP 258 (324)
T ss_pred CC--CCCCC--HHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence 11 11111 2233445589999999999 677877653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=336.16 Aligned_cols=247 Identities=24% Similarity=0.301 Sum_probs=193.6
Q ss_pred CCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCC---CCchhHHHHHHHHHHcCCCC-CceEEEeEEEeCCeeEEEE
Q 010891 175 RFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHK-NLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hp-nIv~l~~~~~~~~~~~lv~ 249 (498)
+|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+..|+.++..+.|+ +|+.+++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999754 57899999986432 23345677899999999765 5888999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999999963 35689999999999999999999999 999999999999999999999999999875432
Q ss_pred CCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.+..+.. .. ..
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~------~~~~~i~~---~~----~~ 219 (324)
T cd05587 154 GG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED------ELFQSIME---HN----VS 219 (324)
T ss_pred CC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHc---CC----CC
Confidence 22 1233467999999999999999999999999999999999999999754321 11111111 00 11
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRPKM-----SQVVRM 446 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~-----~ell~~ 446 (498)
+. ...+ .....++.+||..||.+|++. .+++++
T Consensus 220 ~~--~~~~--~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 220 YP--KSLS--KEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred CC--CCCC--HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 11 1111 233444558999999999986 666654
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=323.31 Aligned_cols=260 Identities=24% Similarity=0.374 Sum_probs=204.7
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC---CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
++|++.+.||+|+||.||+|+. .+++.||+|.+..... .....+..|+++++.++||||+++++++.+....++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4788999999999999999974 5789999998754322 22345788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+++++|.+++.........+++..++.++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999999864333345688999999999999999999998 999999999999999999999999999987653
Q ss_pred CCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
... ......|++.|+|||.+.+..++.++|+||||+++|||++|+.||....... ..+........ .+.
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~~~~~~~~~~------~~~ 227 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----FSLCQKIEQCD------YPP 227 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH----HHHHHHHhcCC------CCC
Confidence 321 1223568899999999988889999999999999999999999986433211 11111111100 111
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
.. ..........++.+||..+|++||++.++++.++..
T Consensus 228 ~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 LP---TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred CC---hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 11 111112344455589999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=321.93 Aligned_cols=250 Identities=26% Similarity=0.420 Sum_probs=197.9
Q ss_pred CCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCC
Q 010891 175 RFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNN 254 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (498)
+|++.+.||+|+||.||+|++.++..+|+|.+.... .....+..|+++++.++||||+++++++......|+||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 477889999999999999988777789999875432 2345688899999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCcee
Q 010891 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (498)
Q Consensus 255 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 334 (498)
++|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++.........
T Consensus 84 ~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 84 GCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 9999999743 23689999999999999999999999 99999999999999999999999999998764332211
Q ss_pred eecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCC
Q 010891 335 TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETR 413 (498)
Q Consensus 335 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (498)
.....++..|+|||.+.+..++.++||||||+++|||++ |..||....+.. . ...... .... ...
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~---~~~~~~---~~~~---~~~-- 223 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---V---VESVSA---GYRL---YRP-- 223 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---H---HHHHHc---CCcC---CCC--
Confidence 112224457999999998899999999999999999999 899996433211 1 111111 1111 111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 414 PSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 414 ~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.. .......++.+||..+|++|||+.++++.|
T Consensus 224 ~~--~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 224 KL--APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CC--CCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 11 122344555689999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=315.98 Aligned_cols=254 Identities=23% Similarity=0.355 Sum_probs=202.9
Q ss_pred HccCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCC--CCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNN--PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
..+.|++-+.||+|.|+.||++- ..+|+.+|+|.+... .....+++.+|+.|-+.|+|||||++.+.+.+....|||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 34577888899999999999994 567899999877322 223557788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcC---CCCeEEeeeccce
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE---NFDAKISDFGLAK 325 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~---~~~~kL~DfGla~ 325 (498)
+|+|.|++|..-+- ++..+++..+-.++.||++||.|+|.+ +|+|||+||.|+|+.. .--+||+|||+|.
T Consensus 89 Fe~m~G~dl~~eIV----~R~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 89 FDLVTGGELFEDIV----AREFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EecccchHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence 99999999987664 234578888999999999999999999 9999999999999953 3459999999999
Q ss_pred ecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCC
Q 010891 326 LLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV 405 (498)
Q Consensus 326 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (498)
.++.+ .....++|||.|||||+++..+|+..+|||+.|||||-|+.|.+||.+..... + ... +.....
T Consensus 162 ~l~~g--~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r---l---ye~---I~~g~y- 229 (355)
T KOG0033|consen 162 EVNDG--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---L---YEQ---IKAGAY- 229 (355)
T ss_pred EeCCc--cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH---H---HHH---Hhcccc-
Confidence 98733 33455789999999999999999999999999999999999999998643321 1 111 111111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 406 VDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 406 ~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
+-.-+.++..++..+.+.. +||..||.+|.|+.|.|+|-
T Consensus 230 -d~~~~~w~~is~~Ak~Lvr--rML~~dP~kRIta~EAL~Hp 268 (355)
T KOG0033|consen 230 -DYPSPEWDTVTPEAKSLIR--RMLTVNPKKRITADEALKHP 268 (355)
T ss_pred -CCCCcccCcCCHHHHHHHH--HHhccChhhhccHHHHhCCc
Confidence 1222234444444455444 79999999999999998653
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=327.14 Aligned_cols=264 Identities=30% Similarity=0.484 Sum_probs=194.4
Q ss_pred CccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHc--CCCCCceEEEeEEEeCC----eeEEEEe
Q 010891 177 SKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGH--VRHKNLVRLLGYCIEGT----QRILVYE 250 (498)
Q Consensus 177 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~~~~~----~~~lv~e 250 (498)
++.++||+|.||.||+|++ +++.||||++. .+..+.|..|-+|+.. ++|+||++|+++-.... .++||++
T Consensus 213 ~l~eli~~Grfg~V~KaqL-~~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 213 QLLELIGRGRFGCVWKAQL-DNRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hhHHHhhcCccceeehhhc-cCceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 4467899999999999998 45999999984 3445678888888775 58999999999876555 7899999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHcc------CCCeeecCCCCCCEEEcCCCCeEEeeeccc
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI------EPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~------~~~iiHrDikp~NIll~~~~~~kL~DfGla 324 (498)
|.+.|+|.+||.. ..++|....+|+..+++||+|||+.. .|+|+|||||++||||.+|+++.|+|||||
T Consensus 289 fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA 363 (534)
T KOG3653|consen 289 FHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA 363 (534)
T ss_pred eccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence 9999999999964 46999999999999999999999854 778999999999999999999999999999
Q ss_pred eecCCCCce-eeecccccccccCcccccCCC-CC-----ccchHHHHHHHHHHHHhCCCCCCCCC-Ccc----------h
Q 010891 325 KLLGAGKSH-ITTRVMGTFGYVAPEYANSGL-LN-----EKSDVYSFGVVLLEAITGRYPVDYGR-PQS----------E 386 (498)
Q Consensus 325 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~-----~~sDvwSlGvvl~elltg~~P~~~~~-~~~----------~ 386 (498)
..+..+... .....+||.+|||||++.+.. +. .+.||||+|.|||||++...-+..+. +.- .
T Consensus 364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h 443 (534)
T KOG3653|consen 364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH 443 (534)
T ss_pred EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence 998755432 233378999999999997642 22 25899999999999999654432111 100 0
Q ss_pred hhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCC
Q 010891 387 VNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYP 453 (498)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~~~ 453 (498)
..+.+.-...+..+....+ ............+.+ .+--||+.||+-|.|+.=+-+.+......
T Consensus 444 Pt~e~mq~~VV~kK~RP~~-p~~W~~h~~~~~l~e---t~EeCWDhDaeARLTA~Cv~eR~~~l~~~ 506 (534)
T KOG3653|consen 444 PTLEEMQELVVRKKQRPKI-PDAWRKHAGMAVLCE---TIEECWDHDAEARLTAGCVEERMAELMML 506 (534)
T ss_pred CCHHHHHHHHHhhccCCCC-hhhhhcCccHHHHHH---HHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence 0111111122222222222 222222233333333 33379999999999999888877665443
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=322.60 Aligned_cols=255 Identities=25% Similarity=0.373 Sum_probs=200.2
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
.++|++.+.||+|+||.||+|+. .+++.||+|++..........+..|+.++..++||||+++++++......|+||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 35789999999999999999985 56889999998655444556688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+++++|.++++. .+.+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06646 88 CGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATI 160 (267)
T ss_pred CCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccc
Confidence 999999999863 35689999999999999999999998 99999999999999999999999999998764322
Q ss_pred ceeeecccccccccCccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCC
Q 010891 332 SHITTRVMGTFGYVAPEYAN---SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (498)
. ......|+..|+|||.+. ...++.++|||||||++|||++|+.||....+.... ... .......+
T Consensus 161 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~---------~~~-~~~~~~~~ 229 (267)
T cd06646 161 A-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL---------FLM-SKSNFQPP 229 (267)
T ss_pred c-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh---------eee-ecCCCCCC
Confidence 1 123356889999999874 455788999999999999999999998644322110 000 00011111
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 409 NIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
........+ ..+..++.+||..||++|||+++++++|
T Consensus 230 ~~~~~~~~~--~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 230 KLKDKTKWS--STFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCccccccC--HHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 111111111 2334445589999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=321.93 Aligned_cols=256 Identities=26% Similarity=0.405 Sum_probs=203.7
Q ss_pred HHccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
+..++|++.++||+|+||.||+|...+++.||+|.+.... .....+..|+.++++++||||+++++++. ....+++||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 3456789999999999999999998889999999886443 33467889999999999999999999874 456899999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
|+.+++|.+++... ....+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05067 81 YMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155 (260)
T ss_pred cCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence 99999999998643 335689999999999999999999998 9999999999999999999999999999876533
Q ss_pred CceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 331 KSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
.........++..|+|||++....++.++||||||+++|||++ |+.||....... ....+..... ..
T Consensus 156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~------~~ 223 (260)
T cd05067 156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE------VIQNLERGYR------MP 223 (260)
T ss_pred CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH------HHHHHHcCCC------CC
Confidence 2222223446778999999998899999999999999999999 999997543211 1111111110 01
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
... ... ..+..++.+||+.+|++|||+.+++..|+.
T Consensus 224 ~~~-~~~---~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 224 RPD-NCP---EELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCC-CCC---HHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 111 111 234445558999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=341.07 Aligned_cols=262 Identities=24% Similarity=0.305 Sum_probs=197.3
Q ss_pred CCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEeCC-----eeE
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT-----QRI 246 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----~~~ 246 (498)
+|++.+.||+|+||.||+|.. .+|+.||+|++..... ...+.+.+|+++++.++||||+++++++.... ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 367889999999999999985 5789999998854322 23456888999999999999999999998776 789
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecccee
Q 010891 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (498)
Q Consensus 247 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~ 326 (498)
+||||+. ++|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999996 58888885 345699999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHH-------------
Q 010891 327 LGAGKSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEW------------- 392 (498)
Q Consensus 327 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~------------- 392 (498)
.............+|+.|+|||++.+ ..++.++|||||||++|||++|+.||....+......+..
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 65443333444568999999998876 4589999999999999999999999976543221111100
Q ss_pred ---HHHHHhhccccCC--cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 393 ---LKMMVQLRRSEDV--VDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 393 ---~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
...... ...... ........... ......++.+||+.||++|||+.|++.+-
T Consensus 233 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~--~~~~~~li~~mL~~dP~~R~t~~e~l~hp 289 (372)
T cd07853 233 CEGARAHIL-RGPHKPPSLPVLYTLSSQA--THEAVHLLCRMLVFDPDKRISAADALAHP 289 (372)
T ss_pred hHHHHHHHH-hCCCCCCchHHhcccCCCC--CHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence 000000 000000 00000000111 12344555689999999999999999764
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=345.38 Aligned_cols=202 Identities=25% Similarity=0.344 Sum_probs=173.3
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC---CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
++|.+.+.||+|+||.||+++. .+++.||||++.... ....+.+..|++++..++||||+++++++.++...|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688899999999999999974 578999999985432 223356788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+++|+|.+++.. .+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999963 35688999999999999999999999 999999999999999999999999999964321
Q ss_pred CCc----------------------------------------------eeeecccccccccCcccccCCCCCccchHHH
Q 010891 330 GKS----------------------------------------------HITTRVMGTFGYVAPEYANSGLLNEKSDVYS 363 (498)
Q Consensus 330 ~~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwS 363 (498)
... ......+||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 000 0001246999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCC
Q 010891 364 FGVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 364 lGvvl~elltg~~P~~~~~ 382 (498)
|||++|||++|..||....
T Consensus 234 lGvil~elltG~~Pf~~~~ 252 (377)
T cd05629 234 LGAIMFECLIGWPPFCSEN 252 (377)
T ss_pred cchhhhhhhcCCCCCCCCC
Confidence 9999999999999997543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=352.88 Aligned_cols=257 Identities=26% Similarity=0.348 Sum_probs=201.8
Q ss_pred HHccCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEeCC----
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT---- 243 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~---- 243 (498)
...++|.+.+.||+|+||+||+|+ ..+|+.||||++..... .....+..|+.++..++|+||+++++.+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 345789999999999999999997 45789999999855432 23345778999999999999999988775432
Q ss_pred ----eeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEe
Q 010891 244 ----QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKIS 319 (498)
Q Consensus 244 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~ 319 (498)
..++||||+++|+|.+++.........+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEE
Confidence 36899999999999999975544556799999999999999999999999 99999999999999999999999
Q ss_pred eeccceecCCCCc-eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHh
Q 010891 320 DFGLAKLLGAGKS-HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQ 398 (498)
Q Consensus 320 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 398 (498)
|||+++.+..... ......+||+.|+|||++.+..++.++|||||||+||||++|+.||..... .+.+.....
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~------~~~~~~~~~ 259 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM------EEVMHKTLA 259 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHhc
Confidence 9999987643321 223346799999999999999999999999999999999999999974322 122221111
Q ss_pred hccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 399 LRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
.. ..+ + .+... ..+..++.+||..||.+||++.+++.+
T Consensus 260 ~~-----~~~-~--~~~~~--~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 260 GR-----YDP-L--PPSIS--PEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CC-----CCC-C--CCCCC--HHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 10 001 1 11111 233344558999999999999999875
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=340.21 Aligned_cols=262 Identities=21% Similarity=0.257 Sum_probs=200.5
Q ss_pred HHHHHHHccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC---CCchhHHHHHHHHHHcCCCCCceEEEeEEEe
Q 010891 166 LRDLQSATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIE 241 (498)
Q Consensus 166 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 241 (498)
+.++....++|++.+.||+|+||.||+|+. .+++.||+|.+.... ......+..|+.+++.++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 445556678999999999999999999985 468899999885422 1223457789999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeee
Q 010891 242 GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDF 321 (498)
Q Consensus 242 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~Df 321 (498)
+...|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence 9999999999999999999863 3478889999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCceeeecccccccccCcccccCC----CCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHH
Q 010891 322 GLAKLLGAGKSHITTRVMGTFGYVAPEYANSG----LLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMV 397 (498)
Q Consensus 322 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 397 (498)
|++..............+||+.|+|||++.+. .++.++|||||||++|||++|..||...... .....+.
T Consensus 187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~ 260 (371)
T cd05622 187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIM 260 (371)
T ss_pred CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHHHHH
Confidence 99987654333333456799999999998653 3889999999999999999999999754321 1112211
Q ss_pred hhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHh
Q 010891 398 QLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDK--RPKMSQVVRMLE 448 (498)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~--RPt~~ell~~L~ 448 (498)
..... ..+......+...+.+ +.+||..++.+ |+++.+++++.-
T Consensus 261 ~~~~~-----~~~~~~~~~s~~~~~l--i~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 261 NHKNS-----LTFPDDNDISKEAKNL--ICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred cCCCc-----ccCCCcCCCCHHHHHH--HHHHcCChhhhcCCCCHHHHhcCcc
Confidence 11110 1111112222333333 33688744433 789999998763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=307.89 Aligned_cols=264 Identities=23% Similarity=0.321 Sum_probs=209.3
Q ss_pred HHccCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeC-----Ce
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG-----TQ 244 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~ 244 (498)
+..++|.+.+.||+|||+-||+++ ..++..||+|++.....+..+..++|++..++++|||+++++++...+ ..
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 456799999999999999999997 678999999999877767778889999999999999999999987544 34
Q ss_pred eEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccc
Q 010891 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (498)
Q Consensus 245 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla 324 (498)
.||+++|...|+|.+.++....++..+++.+.+.|+.+|++||.+||.. .|.++||||||.|||+.+.+.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCc
Confidence 7999999999999999987665667899999999999999999999986 556999999999999999999999999998
Q ss_pred eecCCCCce--------eeecccccccccCccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 010891 325 KLLGAGKSH--------ITTRVMGTFGYVAPEYAN---SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWL 393 (498)
Q Consensus 325 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~ 393 (498)
....-.-.. ....-..|..|+|||++. +...++++|||||||+||+|+.|..||+.....
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~--------- 247 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ--------- 247 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc---------
Confidence 764221100 011234688999999885 456788999999999999999999999732211
Q ss_pred HHHHhhccc-cCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 394 KMMVQLRRS-EDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 394 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
.... -.+..+.+..+....-...+..++.+||+.||.+||++.+++..+..
T Consensus 248 -----GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~ 299 (302)
T KOG2345|consen 248 -----GGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD 299 (302)
T ss_pred -----CCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence 1111 11122233222222233445556668999999999999999998865
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=334.43 Aligned_cols=242 Identities=23% Similarity=0.319 Sum_probs=190.3
Q ss_pred ceEcccCcEEEEEEEE-cCCcEEEEEEecCCC---CCchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCeeEEEEeecCC
Q 010891 180 NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVYEYVNN 254 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (498)
+.||+|+||+||+|+. .+++.||+|++.... ....+.+..|..++..+ +||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3799999999999985 458899999986432 22334567788888876 799999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCcee
Q 010891 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (498)
Q Consensus 255 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 334 (498)
|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~ 152 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KT 152 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cc
Confidence 999999863 35689999999999999999999999 99999999999999999999999999998643222 22
Q ss_pred eecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCC
Q 010891 335 TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRP 414 (498)
Q Consensus 335 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (498)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +....+.. . .. ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~---~-~~-----~~~~ 217 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAILN---D-EV-----VYPT 217 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHHHHHhc---C-CC-----CCCC
Confidence 33467999999999999999999999999999999999999999754321 11111111 0 01 1111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 010891 415 STSALKRALLTALRCVDPDSDKRPKM------SQVVRM 446 (498)
Q Consensus 415 ~~~~~~~~l~~~~~cl~~dP~~RPt~------~ell~~ 446 (498)
..+ .....++.+||+.||.+||++ .+++.|
T Consensus 218 ~~~--~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h 253 (320)
T cd05590 218 WLS--QDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH 253 (320)
T ss_pred CCC--HHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence 111 123334458999999999998 666654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=331.81 Aligned_cols=255 Identities=27% Similarity=0.485 Sum_probs=198.2
Q ss_pred cCCCccceEcccCcEEEEEEEEc-CCc----EEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM-NGT----AVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
++|++.+.||+|+||.||+|.+. ++. .||+|.+..... ...+++..|+.+++.++||||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46888999999999999999753 344 389998864432 3345788899999999999999999999764 5689
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
|+||+++|+|.+++... ...+++...+.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccc
Confidence 99999999999999753 34588999999999999999999999 9999999999999999999999999999976
Q ss_pred CCCCcee-eecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCC
Q 010891 328 GAGKSHI-TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV 405 (498)
Q Consensus 328 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (498)
....... .....++..|+|||++.+..++.++|||||||++|||++ |..||....... ... ... .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~~~----~~~--~~~~~ 230 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILE--KGERL 230 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HHh--CCCCC
Confidence 5433221 122334678999999999999999999999999999998 999996432211 111 111 11111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 406 VDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 406 ~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
.. .+. .......++.+||..||.+|||+.+++..+....
T Consensus 231 ~~-----~~~--~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~ 269 (316)
T cd05108 231 PQ-----PPI--CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 269 (316)
T ss_pred CC-----CCC--CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 11 111 1123445556899999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=333.36 Aligned_cols=258 Identities=23% Similarity=0.282 Sum_probs=196.9
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCC---CCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNN---PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
++|++.+.||+|+||+||+++. .+++.||+|++... .....+.+..|+.++..++||||+++++++.++...|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4688999999999999999985 45899999998542 1223345788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+++|+|.+++.. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++..+..
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999964 234689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCceeeecccccccccCcccccC-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANS-----GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSED 404 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (498)
.........+||+.|+|||++.. ..++.++|||||||++|||++|+.||...... +.............
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~------~~~~~i~~~~~~~~ 228 (331)
T cd05597 155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKEHFQ 228 (331)
T ss_pred CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHH------HHHHHHHcCCCccc
Confidence 33322333579999999998863 56788999999999999999999999754321 11111111111111
Q ss_pred CcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 405 VVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
. .+ .....+...+.+...+.|...++..||++.+++.+-
T Consensus 229 ~-~~---~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp 267 (331)
T cd05597 229 F-PP---DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHP 267 (331)
T ss_pred C-CC---ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence 1 01 111122233333333345566666689999999874
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=375.71 Aligned_cols=261 Identities=31% Similarity=0.544 Sum_probs=207.1
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeec
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 252 (498)
..|...++||+|+||.||+|+. .++..||||++...... ...|++.+++++|||||+++++|.+....|+||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 4567778999999999999985 57899999988543221 234688999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~ 332 (498)
++|+|.++++ .++|..+..++.|+++||+|||..+.++|+||||||+||+++.++..++. ||.......
T Consensus 766 ~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--- 834 (968)
T PLN00113 766 EGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--- 834 (968)
T ss_pred CCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---
Confidence 9999999995 27899999999999999999996656699999999999999999888875 666554322
Q ss_pred eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCC
Q 010891 333 HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIET 412 (498)
Q Consensus 333 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (498)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||..... ......+|.+...........+++.+..
T Consensus 835 --~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 835 --DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred --CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccC
Confidence 1223688999999999999999999999999999999999999964322 2334555554433323333344444422
Q ss_pred --CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 010891 413 --RPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEY 452 (498)
Q Consensus 413 --~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~~ 452 (498)
............++.+||+.||++||||.|+++.|+....
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 2234555667777889999999999999999999987643
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=339.87 Aligned_cols=261 Identities=24% Similarity=0.362 Sum_probs=201.4
Q ss_pred HccCCCccceEcccCcEEEEEEEEc------CCcEEEEEEecCCCCC-chhHHHHHHHHHHcCC-CCCceEEEeEEEeCC
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVR-HKNLVRLLGYCIEGT 243 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~ 243 (498)
..++|.+.++||+|+||.||+|... .+..||||++...... ..+.+..|++++.++. ||||+++++++.+..
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 4568899999999999999999742 2346999998654332 3356889999999995 999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcccC---------------------------------------------------------
Q 010891 244 QRILVYEYVNNGNLEQWLRGDMC--------------------------------------------------------- 266 (498)
Q Consensus 244 ~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 266 (498)
..||||||+++|+|.++|.....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 99999999999999999864210
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEc
Q 010891 267 -----------------------------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID 311 (498)
Q Consensus 267 -----------------------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~ 311 (498)
....+++..+..++.||+.||.|||+. +|+||||||+|||++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEe
Confidence 012478888999999999999999998 999999999999999
Q ss_pred CCCCeEEeeeccceecCCCCce-eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhH
Q 010891 312 ENFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNL 389 (498)
Q Consensus 312 ~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~ 389 (498)
.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||........ .
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--~ 349 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--F 349 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--H
Confidence 9999999999999876433221 1223457788999999998999999999999999999997 9999875332111 1
Q ss_pred HHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 390 VEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
. ..+.. ... ... ... ....+..++.+||..||++|||+.+|.+.|+..
T Consensus 350 ~---~~~~~---~~~---~~~--~~~--~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l 397 (400)
T cd05105 350 Y---NKIKS---GYR---MAK--PDH--ATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL 397 (400)
T ss_pred H---HHHhc---CCC---CCC--Ccc--CCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence 1 11111 000 011 111 112344555689999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=319.80 Aligned_cols=254 Identities=28% Similarity=0.419 Sum_probs=199.5
Q ss_pred ccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeec
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 252 (498)
.++|.+.+.||+|+||.||+|.+..+..+|+|.+.... ...+.+.+|+++++.++||||+++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 35688899999999999999987777789999875433 23456888999999999999999999875 45679999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~ 332 (498)
.+++|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05069 83 GKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcc
Confidence 999999999753 234588999999999999999999998 999999999999999999999999999987644332
Q ss_pred eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCC
Q 010891 333 HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411 (498)
Q Consensus 333 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (498)
.......++..|+|||.+.+..++.++||||||+++|||++ |..||....+.. . ...+... .. ...
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~---~~~~~~~---~~---~~~- 224 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---V---LEQVERG---YR---MPC- 224 (260)
T ss_pred cccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---H---HHHHHcC---CC---CCC-
Confidence 22223346778999999988889999999999999999999 899997543211 1 1111111 00 000
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 412 ~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
.... ...+..++.+||.+||++||++.++++.|+.
T Consensus 225 -~~~~--~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 225 -PQGC--PESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -Cccc--CHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1111 1233444458999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=325.44 Aligned_cols=259 Identities=23% Similarity=0.400 Sum_probs=199.5
Q ss_pred HHccCCCccceEcccCcEEEEEEEEc------CCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCC
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT 243 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 243 (498)
..+++|++.+.||+|+||.||+|... ++..||+|++..... ....++.+|+.+++.++||||+++++++.++.
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 35678999999999999999998642 356799998854322 23346888999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcccCC------CCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeE
Q 010891 244 QRILVYEYVNNGNLEQWLRGDMCD------RGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAK 317 (498)
Q Consensus 244 ~~~lv~e~~~~g~L~~~l~~~~~~------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~k 317 (498)
..++||||+++++|.+++...... ...+++..+..++.|++.||.|||+. +++||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence 999999999999999999643211 23467888999999999999999998 999999999999999999999
Q ss_pred EeeeccceecCCCCcee-eecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHH
Q 010891 318 ISDFGLAKLLGAGKSHI-TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKM 395 (498)
Q Consensus 318 L~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~ 395 (498)
|+|||++.......... .....+++.|+|||++.+..++.++|||||||++|||++ |..||...... +....
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~------~~~~~ 233 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE------QVLRF 233 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHH
Confidence 99999998654332211 112345788999999998899999999999999999999 78888643321 11111
Q ss_pred HHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 396 MVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
... .... ... .... ..+..++.+||+.||++|||+.|++++|+
T Consensus 234 ~~~-~~~~-----~~~-~~~~---~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 234 VME-GGLL-----DKP-DNCP---DMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHc-CCcC-----CCC-CCCC---HHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 111 1110 011 1111 23344555899999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=320.56 Aligned_cols=255 Identities=30% Similarity=0.491 Sum_probs=200.7
Q ss_pred cCCCccceEcccCcEEEEEEEEcC----CcEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLMN----GTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
++|++.+.||+|+||.||+|.+.. ...||+|.+...... ....|..|+.++..++||||+++++++.+....++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568889999999999999998632 457999988654322 345688899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+++++|.+++... .+.+++..++.++.|++.||.|||+. +|+|+||||+|||+++++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999999753 34789999999999999999999998 99999999999999999999999999999875
Q ss_pred CCCce-eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCc
Q 010891 329 AGKSH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVV 406 (498)
Q Consensus 329 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (498)
..... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||...... +....+... ...
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~------~~~~~~~~~---~~~- 227 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ------DVIKAVEDG---YRL- 227 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH------HHHHHHHcC---CCC-
Confidence 22211 1122345678999999998899999999999999999998 99998643321 111111111 000
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 407 DPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 407 ~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
+. . .... ..+..++.+||+.+|++||++.+++++|+..
T Consensus 228 -~~-~-~~~~---~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 228 -PP-P-MDCP---SALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -CC-C-CCCC---HHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 0 1111 2344555689999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=326.39 Aligned_cols=249 Identities=32% Similarity=0.576 Sum_probs=190.5
Q ss_pred ccceEcccCcEEEEEEEEc-----CCcEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 178 KDNIIGDGGYGVVYRGQLM-----NGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 178 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
+.+.||.|.||.||+|.+. .+..|+||.+...... ..+.|..|++.+++++||||++++|++......++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999875 3678999999553332 356799999999999999999999999988889999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+++|+|.++|... ....+++..++.|+.||+.||.|||+. +++|+||+++|||++.++.+||+|||++.......
T Consensus 83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred ccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999864 346799999999999999999999999 99999999999999999999999999999873322
Q ss_pred c-eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 332 S-HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 332 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
. .......+...|+|||.+.+..++.++||||||+++|||++ |+.||..... .+....+.......
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~------~~~~~~~~~~~~~~------ 225 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN------EEIIEKLKQGQRLP------ 225 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH------HHHHHHHHTTEETT------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccccccccccce------
Confidence 2 22233457789999999988889999999999999999999 7888864421 12222222211111
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.. ..... .+..++.+||+.||++|||+.++++.|
T Consensus 226 ~~-~~~~~---~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 226 IP-DNCPK---DIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp SB-TTSBH---HHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ec-cchhH---HHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 00 11122 233445589999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=332.51 Aligned_cols=242 Identities=25% Similarity=0.365 Sum_probs=187.8
Q ss_pred ceEcccCcEEEEEEEE-cCCcEEEEEEecCCC---CCchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCeeEEEEeecCC
Q 010891 180 NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVYEYVNN 254 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (498)
++||+|+||.||+|+. .+++.||+|.+.... ....+.+..|..++..+ +||||+++++++..+...|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999985 457889999986432 22234455677777654 899999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCcee
Q 010891 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (498)
Q Consensus 255 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 334 (498)
|+|.+++.. .+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~ 152 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence 999999863 35689999999999999999999998 99999999999999999999999999998654322 22
Q ss_pred eecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCC
Q 010891 335 TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRP 414 (498)
Q Consensus 335 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (498)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... +....+.. .. +.+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~---~~----~~~~~~- 218 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED------ELFDSILN---DR----PHFPRW- 218 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHc---CC----CCCCCC-
Confidence 34467999999999999999999999999999999999999999754321 11111111 11 111111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHH
Q 010891 415 STSALKRALLTALRCVDPDSDKRPKMS-QVVRM 446 (498)
Q Consensus 415 ~~~~~~~~l~~~~~cl~~dP~~RPt~~-ell~~ 446 (498)
.+ .....++.+||+.||.+||++. +++++
T Consensus 219 -~~--~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 219 -IS--KEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred -CC--HHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 11 1223344489999999999875 55543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=327.29 Aligned_cols=261 Identities=27% Similarity=0.449 Sum_probs=204.7
Q ss_pred cCCCccceEcccCcEEEEEEEEc------CCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
.+|.+.+.||+|+||.||+|+.. ++..+++|.+........+.+.+|++++++++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35777889999999999999742 345688898865554455678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCC
Q 010891 248 VYEYVNNGNLEQWLRGDMC------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD 315 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~ 315 (498)
||||+++++|.+++..... ..+.+++..++.++.|++.||+|||++ +++||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCc
Confidence 9999999999999965321 224589999999999999999999999 9999999999999999999
Q ss_pred eEEeeeccceecCCCCc-eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHH
Q 010891 316 AKISDFGLAKLLGAGKS-HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWL 393 (498)
Q Consensus 316 ~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~ 393 (498)
++|+|||++........ .......++..|+|||.+.+..++.++|||||||++|||+| |..||....... .+
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------~~ 235 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE------VI 235 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HH
Confidence 99999999986543321 12233457889999999999999999999999999999999 999986543211 11
Q ss_pred HHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCC
Q 010891 394 KMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYP 453 (498)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~~~ 453 (498)
..+.... .. ... ...+ ..+..++.+||..||++|||+.++++.|+....+
T Consensus 236 ~~~~~~~----~~--~~~-~~~~---~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 236 ECITQGR----VL--ERP-RVCP---KEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHhCCC----CC--CCC-ccCC---HHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1111110 00 000 1111 2344555589999999999999999999876443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-41 Score=334.20 Aligned_cols=243 Identities=23% Similarity=0.293 Sum_probs=191.7
Q ss_pred ceEcccCcEEEEEEEEc-CCcEEEEEEecCCC---CCchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCeeEEEEeecCC
Q 010891 180 NIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVYEYVNN 254 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (498)
++||+|+||.||+|+.. +++.||+|++.... ......+..|.+++..+ +||||+++++++.+....|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999854 57899999986532 22334567788888866 899999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCcee
Q 010891 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (498)
Q Consensus 255 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 334 (498)
|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VT 152 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cc
Confidence 999999863 35689999999999999999999999 99999999999999999999999999998643222 12
Q ss_pred eecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCC
Q 010891 335 TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRP 414 (498)
Q Consensus 335 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (498)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.+..+.. .. . ..+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~------~~~~~i~~---~~-~-----~~p~ 217 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED------DLFESILH---DD-V-----LYPV 217 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH------HHHHHHHc---CC-C-----CCCC
Confidence 33467999999999999999999999999999999999999999754321 11111111 11 1 0111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCC-------CHHHHHHHH
Q 010891 415 STSALKRALLTALRCVDPDSDKRP-------KMSQVVRML 447 (498)
Q Consensus 415 ~~~~~~~~l~~~~~cl~~dP~~RP-------t~~ell~~L 447 (498)
..+ .....++.+||+.||++|| ++.+++++-
T Consensus 218 ~~~--~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp 255 (321)
T cd05591 218 WLS--KEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHP 255 (321)
T ss_pred CCC--HHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCC
Confidence 111 1233444589999999999 888888663
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=333.38 Aligned_cols=249 Identities=24% Similarity=0.313 Sum_probs=191.0
Q ss_pred ceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC---CchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCeeEEEEeecCC
Q 010891 180 NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVYEYVNN 254 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (498)
+.||+|+||.||+|+. .+++.||+|.+..... ...+.+..|+.++.++ +||||+++++++.+....|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999985 4678999999865422 2334577888888877 899999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCcee
Q 010891 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (498)
Q Consensus 255 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 334 (498)
|+|..++.. .+.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~ 152 (329)
T cd05618 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DT 152 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cc
Confidence 999998863 35689999999999999999999999 99999999999999999999999999997543221 12
Q ss_pred eecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCc--chhhHHHHHHHHHhhccccCCcCCCCCC
Q 010891 335 TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQ--SEVNLVEWLKMMVQLRRSEDVVDPNIET 412 (498)
Q Consensus 335 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (498)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... .......++........ ...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~--------~~~ 224 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ--------IRI 224 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC--------CCC
Confidence 33467999999999999999999999999999999999999999632111 11111122221111111 111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 010891 413 RPSTSALKRALLTALRCVDPDSDKRPK------MSQVVRM 446 (498)
Q Consensus 413 ~~~~~~~~~~l~~~~~cl~~dP~~RPt------~~ell~~ 446 (498)
+...+ .....++.+||..||++||+ +.++++|
T Consensus 225 p~~~~--~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 225 PRSLS--VKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred CCCCC--HHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 11111 22334445899999999998 4677655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=333.31 Aligned_cols=249 Identities=23% Similarity=0.297 Sum_probs=192.3
Q ss_pred ceEcccCcEEEEEEEE-cCCcEEEEEEecCCC---CCchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCeeEEEEeecCC
Q 010891 180 NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVYEYVNN 254 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (498)
++||+|+||.||+|+. .+++.||+|.+.... ....+.+..|..++..+ +||||+++++++.+....|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999975 468899999986532 22334577899999988 799999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCcee
Q 010891 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (498)
Q Consensus 255 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 334 (498)
|+|.+++.. .+.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~ 152 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DT 152 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cc
Confidence 999998863 35699999999999999999999999 99999999999999999999999999997532211 12
Q ss_pred eecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcc--hhhHHHHHHHHHhhccccCCcCCCCCC
Q 010891 335 TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQS--EVNLVEWLKMMVQLRRSEDVVDPNIET 412 (498)
Q Consensus 335 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (498)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... .....+++....... ....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~ 224 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK--------QIRI 224 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC--------CCCC
Confidence 334679999999999999999999999999999999999999996322111 111122222211111 1111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 010891 413 RPSTSALKRALLTALRCVDPDSDKRPK------MSQVVRM 446 (498)
Q Consensus 413 ~~~~~~~~~~l~~~~~cl~~dP~~RPt------~~ell~~ 446 (498)
+...+ .....++.+||..||.+||+ +.++++|
T Consensus 225 p~~~~--~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 225 PRSLS--VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred CCCCC--HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 11111 12333445899999999997 6788765
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=319.70 Aligned_cols=257 Identities=30% Similarity=0.470 Sum_probs=204.8
Q ss_pred HHccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
...++|.+.+.||+|+||.||+|...++..|++|.+.... ...+++..|+.+++.++||||+++++++.+....++|||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 3457899999999999999999988778889999886443 345678999999999999999999999998889999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
|+++++|.+++... ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++..+...
T Consensus 82 ~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (261)
T cd05034 82 YMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156 (261)
T ss_pred ccCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccch
Confidence 99999999999753 234689999999999999999999999 9999999999999999999999999999876532
Q ss_pred CceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 331 KSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
.........++..|+|||.+.+..++.++||||||+++|+|++ |+.||...... ..+..+.... ....+
T Consensus 157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~------~~~~~~~~~~---~~~~~- 226 (261)
T cd05034 157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR------EVLEQVERGY---RMPRP- 226 (261)
T ss_pred hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCC---CCCCC-
Confidence 2111222234678999999998889999999999999999999 99999643321 1112211110 00000
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
.... ..+..++.+||..+|++||++.++++.|+.
T Consensus 227 ---~~~~---~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 ---PNCP---EELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---CCCC---HHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0111 234445568999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=325.89 Aligned_cols=259 Identities=27% Similarity=0.438 Sum_probs=203.1
Q ss_pred cCCCccceEcccCcEEEEEEEE------cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL------MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
++|.+.+.||+|+||.||++.. .++..+|+|.+........+.+..|++++.+++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 5688899999999999999974 2345689998865544455678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhccc---------CCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEE
Q 010891 248 VYEYVNNGNLEQWLRGDM---------CDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKI 318 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL 318 (498)
||||+++++|.+++.... .....+++..++.++.|++.||+|||++ +++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEe
Confidence 999999999999996432 1223589999999999999999999998 9999999999999999999999
Q ss_pred eeeccceecCCCCce-eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHH
Q 010891 319 SDFGLAKLLGAGKSH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMM 396 (498)
Q Consensus 319 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 396 (498)
+|||++......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||....... .....
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~------~~~~i 235 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE------VIECI 235 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHH
Confidence 999999865433211 1223346778999999998999999999999999999998 899986443211 11111
Q ss_pred HhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 397 VQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
... ... ..... .. ..+..++.+||+.||.+|||+.+++..|+...
T Consensus 236 ~~~---~~~---~~~~~-~~---~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~ 280 (288)
T cd05093 236 TQG---RVL---QRPRT-CP---KEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA 280 (288)
T ss_pred HcC---CcC---CCCCC-CC---HHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence 111 100 01111 11 23455556899999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=318.17 Aligned_cols=260 Identities=25% Similarity=0.421 Sum_probs=205.9
Q ss_pred cCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCC---CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
++|++.+.||+|+||.||+|... +|+.||+|.+.... ....+.+.+|++++++++|+||+++++++.++...++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999865 78999999885422 223456889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+++++|.+++.........+++..++.++.+++.||.|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999999975433455689999999999999999999998 999999999999999999999999999987643
Q ss_pred CCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
.... .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||..... +..+....... .. .+.
T Consensus 159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~-~~-----~~~ 227 (267)
T cd08224 159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEK-CD-----YPP 227 (267)
T ss_pred CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhhhhc-CC-----CCC
Confidence 3221 2334688999999999888899999999999999999999999964332 11111111111 00 011
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
.. ..........++.+||..+|++|||+.++++.|+..
T Consensus 228 ~~---~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 228 LP---ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred CC---hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 11 111112334445589999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=347.41 Aligned_cols=264 Identities=24% Similarity=0.332 Sum_probs=192.8
Q ss_pred HccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeC--------
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG-------- 242 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-------- 242 (498)
...+|.+.++||+|+||.||+|.. .+++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 346799999999999999999975 468899999885432 2345699999999999999999987532
Q ss_pred CeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCC-CeEEeee
Q 010891 243 TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF-DAKISDF 321 (498)
Q Consensus 243 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~-~~kL~Df 321 (498)
..+++||||+++ +|.+++.........+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeecc
Confidence 246789999975 78887764433556799999999999999999999999 999999999999998664 6999999
Q ss_pred ccceecCCCCceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH----
Q 010891 322 GLAKLLGAGKSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMM---- 396 (498)
Q Consensus 322 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~---- 396 (498)
|+++.+..... .....||+.|+|||++.+ ..|+.++|||||||+||||++|.+||........ +...+...
T Consensus 216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~i~~~~~~p~ 291 (440)
T PTZ00036 216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVRIIQVLGTPT 291 (440)
T ss_pred ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCC
Confidence 99987643322 234578999999998765 4799999999999999999999999975443211 11111100
Q ss_pred ----Hhhcc-ccCCcCCCCCC-----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 397 ----VQLRR-SEDVVDPNIET-----RPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 397 ----~~~~~-~~~~~~~~~~~-----~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
..... .....-+.... .........+..++.+||..||.+|||+.|++.|-
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp 352 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP 352 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCCh
Confidence 00000 00000000000 00000112345555689999999999999999664
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=332.84 Aligned_cols=247 Identities=23% Similarity=0.293 Sum_probs=193.0
Q ss_pred CCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCC---CchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCeeEEEE
Q 010891 175 RFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG---QADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
+|.+.+.||+|+||.||+|+.. +++.||+|.+..... ...+.+..|..++..+ +||+|+++++++.+.+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999754 578999999865322 2223466688888777 6899999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+++|+|.+++.. .+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999999863 35689999999999999999999998 999999999999999999999999999986432
Q ss_pred CCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+... .
T Consensus 154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~------~~~~~i~~~---------~ 217 (323)
T cd05616 154 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIMEH---------N 217 (323)
T ss_pred CC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH------HHHHHHHhC---------C
Confidence 22 1233467999999999999999999999999999999999999999754321 111111110 0
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRPKM-----SQVVRM 446 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~-----~ell~~ 446 (498)
.......+ .....++.+||+.||.+|++. .+++++
T Consensus 218 ~~~p~~~s--~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 218 VAYPKSMS--KEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred CCCCCcCC--HHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 11111111 223444558999999999984 666543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=334.89 Aligned_cols=238 Identities=25% Similarity=0.324 Sum_probs=188.7
Q ss_pred ceEcccCcEEEEEEEE----cCCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecC
Q 010891 180 NIIGDGGYGVVYRGQL----MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ 253 (498)
+.||+|+||.||+++. .+|+.||+|++..... .....+..|++++.+++||||+++++++.++...|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999864 3678999999864322 223456779999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCce
Q 010891 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333 (498)
Q Consensus 254 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~ 333 (498)
+|+|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~- 153 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK- 153 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-
Confidence 9999999963 35689999999999999999999999 999999999999999999999999999986543322
Q ss_pred eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCC
Q 010891 334 ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETR 413 (498)
Q Consensus 334 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (498)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... +....+... .....
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~------~~~~~i~~~---------~~~~p 218 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK------ETMTMILKA---------KLGMP 218 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH------HHHHHHHcC---------CCCCC
Confidence 233467999999999999888999999999999999999999999754321 111111110 11111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 010891 414 PSTSALKRALLTALRCVDPDSDKRPKMSQ 442 (498)
Q Consensus 414 ~~~~~~~~~l~~~~~cl~~dP~~RPt~~e 442 (498)
...+. .+..++.+||+.||++||++.+
T Consensus 219 ~~~~~--~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 219 QFLSP--EAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCH--HHHHHHHHHhhcCHhHcCCCCC
Confidence 11111 2233445899999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=331.74 Aligned_cols=242 Identities=23% Similarity=0.320 Sum_probs=188.8
Q ss_pred ceEcccCcEEEEEEEE-cCCcEEEEEEecCCC---CCchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCeeEEEEeecCC
Q 010891 180 NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVYEYVNN 254 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (498)
++||+|+||.||+|+. .+|+.||+|.+.... ......+..|..++..+ +||||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4799999999999985 468899999986432 22334566788888754 899999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCcee
Q 010891 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (498)
Q Consensus 255 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 334 (498)
|+|.+++.. .+.+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NR 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cc
Confidence 999999863 35689999999999999999999999 99999999999999999999999999987542222 22
Q ss_pred eecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCC
Q 010891 335 TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRP 414 (498)
Q Consensus 335 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (498)
....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... +....+.. . .+.+....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~------~~~~~~~~-~------~~~~~~~~ 219 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED------ELFESIRV-D------TPHYPRWI 219 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHh-C------CCCCCCCC
Confidence 34467999999999999999999999999999999999999999754321 11111111 0 11111111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHH
Q 010891 415 STSALKRALLTALRCVDPDSDKRPKMS-QVVRM 446 (498)
Q Consensus 415 ~~~~~~~~l~~~~~cl~~dP~~RPt~~-ell~~ 446 (498)
.. .+..++.+||+.||++||++. +++.|
T Consensus 220 -~~---~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 220 -TK---ESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred -CH---HHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 11 223344489999999999985 66543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=330.51 Aligned_cols=241 Identities=24% Similarity=0.329 Sum_probs=188.1
Q ss_pred ceEcccCcEEEEEEEEc-CCcEEEEEEecCCC---CCchhHHHHHHHHHHc-CCCCCceEEEeEEEeCCeeEEEEeecCC
Q 010891 180 NIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGH-VRHKNLVRLLGYCIEGTQRILVYEYVNN 254 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (498)
+.||+|+||+||+|+.. +++.||+|.+.... ......+..|..++.. ++||||+++++++.+....|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999854 57899999986432 2233446667788876 4999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCcee
Q 010891 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (498)
Q Consensus 255 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 334 (498)
|+|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++........ .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-K 152 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-c
Confidence 999999963 35688999999999999999999999 999999999999999999999999999986432221 2
Q ss_pred eecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCC
Q 010891 335 TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRP 414 (498)
Q Consensus 335 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (498)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +...... ... +.....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~i~---~~~----~~~~~~- 218 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE------ELFQSIR---MDN----PCYPRW- 218 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH------HHHHHHH---hCC----CCCCcc-
Confidence 33457999999999999999999999999999999999999999754321 1111111 000 111111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 010891 415 STSALKRALLTALRCVDPDSDKRPKMS-QVVR 445 (498)
Q Consensus 415 ~~~~~~~~l~~~~~cl~~dP~~RPt~~-ell~ 445 (498)
.+. ....++.+||+.||++||++. ++++
T Consensus 219 -~~~--~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 219 -LTR--EAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred -CCH--HHHHHHHHHhccCHhhcCCChHHHHc
Confidence 111 223344589999999999997 6654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=309.00 Aligned_cols=256 Identities=25% Similarity=0.387 Sum_probs=204.1
Q ss_pred HHHccCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCC----Cch----hHHHHHHHHHHcC-CCCCceEEEeEE
Q 010891 170 QSATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPG----QAD----KDFRVEVEAIGHV-RHKNLVRLLGYC 239 (498)
Q Consensus 170 ~~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~----~~~----~~~~~E~~~l~~l-~hpnIv~l~~~~ 239 (498)
....+.|...+.||.|..++|.++. ..+|..+|+|++..... ... +.-++|+.+|+++ .||||+.+.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 3456778888999999999999985 56789999998843221 112 2345799999998 799999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEe
Q 010891 240 IEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKIS 319 (498)
Q Consensus 240 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~ 319 (498)
+.+...|+|+|.|+.|.|+|+|.. .-.+++.....|+.|+.+|+.|||.+ +|+||||||+|||++++.++||+
T Consensus 93 es~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~is 165 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKIS 165 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEe
Confidence 999999999999999999999974 35699999999999999999999999 99999999999999999999999
Q ss_pred eeccceecCCCCceeeecccccccccCcccccC------CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 010891 320 DFGLAKLLGAGKSHITTRVMGTFGYVAPEYANS------GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWL 393 (498)
Q Consensus 320 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~ 393 (498)
|||+++.+..++. ....||||+|+|||.+.. ..|+..+|+|++|||+|.|+.|.+||..... . -.+
T Consensus 166 DFGFa~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ---m---lML 237 (411)
T KOG0599|consen 166 DFGFACQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ---M---LML 237 (411)
T ss_pred ccceeeccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH---H---HHH
Confidence 9999999877643 456899999999998843 4688899999999999999999999974321 1 111
Q ss_pred HHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 394 KMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
+.+.. +.- .-..+.+.+.++..+++.. +||..||.+|.|++|+|.|-
T Consensus 238 R~Ime-Gky----qF~speWadis~~~KdLIs--rlLqVdp~~Ritake~LaHp 284 (411)
T KOG0599|consen 238 RMIME-GKY----QFRSPEWADISATVKDLIS--RLLQVDPTKRITAKEALAHP 284 (411)
T ss_pred HHHHh-ccc----ccCCcchhhccccHHHHHH--HHHeeCchhcccHHHHhcCh
Confidence 11111 111 1112233444455555544 89999999999999999764
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-41 Score=321.97 Aligned_cols=254 Identities=24% Similarity=0.295 Sum_probs=203.6
Q ss_pred cCCCccceEcccCcEEEEEEEEcC-CcEEEEEEecCCCCCch---hHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQAD---KDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
+.|++.+.||+|.-|+||++++.+ +..+|+|++.+...... .....|-+||..++||.++.||..|+.+...|+||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 456778899999999999998644 58899999966544333 34566999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
|||+||+|..+++.. ..+.+++..+..++..|+.||+|||.. |||+|||||+||||.++|++.|+||.|+.....
T Consensus 157 eyCpGGdL~~LrqkQ--p~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQ--PGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred ecCCCccHHHHHhhC--CCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 999999999999764 567899999999999999999999999 999999999999999999999999998843210
Q ss_pred ----------------------------------CCc---------------------eeeecccccccccCcccccCCC
Q 010891 330 ----------------------------------GKS---------------------HITTRVMGTFGYVAPEYANSGL 354 (498)
Q Consensus 330 ----------------------------------~~~---------------------~~~~~~~gt~~y~aPE~~~~~~ 354 (498)
... .....++||-.|+|||++.+..
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 000 0122368999999999999999
Q ss_pred CCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCC
Q 010891 355 LNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDS 434 (498)
Q Consensus 355 ~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP 434 (498)
.+.++|+|+|||+||||+.|..||.+..... .+.+.+. -+..+...+..+...++++. +.|.+||
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~--Tl~NIv~-----------~~l~Fp~~~~vs~~akDLIr--~LLvKdP 376 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE--TLRNIVG-----------QPLKFPEEPEVSSAAKDLIR--KLLVKDP 376 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchh--hHHHHhc-----------CCCcCCCCCcchhHHHHHHH--HHhccCh
Confidence 9999999999999999999999998655432 1111110 11233334444444555544 7899999
Q ss_pred CCCCC----HHHHHHHH
Q 010891 435 DKRPK----MSQVVRML 447 (498)
Q Consensus 435 ~~RPt----~~ell~~L 447 (498)
.+|.- +.||-+|-
T Consensus 377 ~kRlg~~rGA~eIK~Hp 393 (459)
T KOG0610|consen 377 SKRLGSKRGAAEIKRHP 393 (459)
T ss_pred hhhhccccchHHhhcCc
Confidence 99998 88887654
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=342.95 Aligned_cols=203 Identities=25% Similarity=0.368 Sum_probs=167.5
Q ss_pred HHHHHHccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCC------CCceEEEeEE
Q 010891 167 RDLQSATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRH------KNLVRLLGYC 239 (498)
Q Consensus 167 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------pnIv~l~~~~ 239 (498)
+++....++|.+.++||+|+||+||+|.. .+++.||||++.... ....++..|++++..++| ++++.+++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 34455678999999999999999999975 457889999985432 223445667777777654 4589999988
Q ss_pred EeC-CeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHH-ccCCCeeecCCCCCCEEEcCCC---
Q 010891 240 IEG-TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE-AIEPKVVHRDIKSSNILIDENF--- 314 (498)
Q Consensus 240 ~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiHrDikp~NIll~~~~--- 314 (498)
... .+.|+|||++ +++|.+++.. .+.+++..+..|+.||+.||.|||+ . +||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVV 272 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccc
Confidence 764 5789999998 7799998863 3579999999999999999999997 5 999999999999998765
Q ss_pred -------------CeEEeeeccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 010891 315 -------------DAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYG 381 (498)
Q Consensus 315 -------------~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~ 381 (498)
.+||+|||++..... .....+||+.|+|||++.+..|+.++|||||||+||||++|+.||...
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 499999998864322 234468999999999999999999999999999999999999999754
Q ss_pred C
Q 010891 382 R 382 (498)
Q Consensus 382 ~ 382 (498)
.
T Consensus 349 ~ 349 (467)
T PTZ00284 349 D 349 (467)
T ss_pred C
Confidence 4
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=327.35 Aligned_cols=249 Identities=24% Similarity=0.305 Sum_probs=192.6
Q ss_pred ceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC---CchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCeeEEEEeecCC
Q 010891 180 NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVYEYVNN 254 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (498)
+.||+|+||.||+|+. .+++.||+|++..... ...+.+..|+.++.++ +||||+++++++.+....|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999985 4678999999865422 2334577899999888 699999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCcee
Q 010891 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (498)
Q Consensus 255 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 334 (498)
|+|..++.. .+.+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (327)
T cd05617 81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DT 152 (327)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cc
Confidence 999998863 35699999999999999999999999 99999999999999999999999999998532221 12
Q ss_pred eecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCC
Q 010891 335 TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRP 414 (498)
Q Consensus 335 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (498)
....+||+.|+|||++.+..++.++|||||||+||||++|+.||............+++....... ....+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------~~~~p~ 224 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--------PIRIPR 224 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--------CCCCCC
Confidence 334679999999999999999999999999999999999999996433222222222222221111 011111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 010891 415 STSALKRALLTALRCVDPDSDKRPKM------SQVVRM 446 (498)
Q Consensus 415 ~~~~~~~~l~~~~~cl~~dP~~RPt~------~ell~~ 446 (498)
..+ .....++.+||..||.+|+++ .+++.|
T Consensus 225 ~~~--~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 260 (327)
T cd05617 225 FLS--VKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH 260 (327)
T ss_pred CCC--HHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence 111 123344458999999999984 577655
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=325.90 Aligned_cols=253 Identities=23% Similarity=0.293 Sum_probs=197.8
Q ss_pred CCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC---CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
.|++.++||+|+||+||++.. .+++.||+|++..... .....+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 477889999999999999985 4689999999854322 222446789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
|+++|+|.+++... ....+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999999988642 234689999999999999999999999 9999999999999999999999999999876433
Q ss_pred CceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCC
Q 010891 331 KSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNI 410 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (498)
.. .....|++.|+|||++.+..++.++|||||||++|||++|+.||......... ....... .... ...
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~--~~~~~~~---~~~~----~~~ 224 (285)
T cd05605 156 ET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR--EEVERRV---KEDQ----EEY 224 (285)
T ss_pred Cc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH--HHHHHHh---hhcc----ccc
Confidence 21 23347899999999999889999999999999999999999999754322111 1111111 0000 011
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 010891 411 ETRPSTSALKRALLTALRCVDPDSDKRP-----KMSQVVRML 447 (498)
Q Consensus 411 ~~~~~~~~~~~~l~~~~~cl~~dP~~RP-----t~~ell~~L 447 (498)
....+ .....++.+||..||++|| ++.+++++-
T Consensus 225 --~~~~~--~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~ 262 (285)
T cd05605 225 --SEKFS--EAARSICRQLLTKDPGFRLGCRGEGAEEVKAHP 262 (285)
T ss_pred --CcccC--HHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCc
Confidence 11111 2233445589999999999 888987763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=334.00 Aligned_cols=261 Identities=28% Similarity=0.429 Sum_probs=199.8
Q ss_pred HccCCCccceEcccCcEEEEEEEE------cCCcEEEEEEecCCCCC-chhHHHHHHHHHHcC-CCCCceEEEeEEEeC-
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL------MNGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHV-RHKNLVRLLGYCIEG- 242 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~- 242 (498)
..++|++.+.||+|+||.||+|.. .+++.||+|++...... ..+.+..|+.++.++ +||||+++++++...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 345799999999999999999953 23478999988643322 234577899999999 899999999988654
Q ss_pred CeeEEEEeecCCCCHHHHHhcccCC-------------------------------------------------------
Q 010891 243 TQRILVYEYVNNGNLEQWLRGDMCD------------------------------------------------------- 267 (498)
Q Consensus 243 ~~~~lv~e~~~~g~L~~~l~~~~~~------------------------------------------------------- 267 (498)
...+++|||+++++|.+++......
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 5678999999999999998642110
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCcee-eecccccccc
Q 010891 268 --RGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI-TTRVMGTFGY 344 (498)
Q Consensus 268 --~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~-~~~~~gt~~y 344 (498)
...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+....... .....++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 13689999999999999999999998 99999999999999999999999999998764332211 2234567789
Q ss_pred cCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHH
Q 010891 345 VAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRAL 423 (498)
Q Consensus 345 ~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 423 (498)
+|||++.+..++.++|||||||+||||++ |..||........ +. ..+ ... .....+ . .....+.
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~---~~~-~~~--~~~~~~----~---~~~~~~~ 306 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FC---RRL-KEG--TRMRAP----E---YATPEIY 306 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HH---HHH-hcc--CCCCCC----c---cCCHHHH
Confidence 99999999999999999999999999998 9999975332211 11 111 111 000001 0 1123445
Q ss_pred HHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 424 LTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 424 ~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
.++.+||+.+|++||++.|++++|+..
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~ 333 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDL 333 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 566689999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=335.24 Aligned_cols=200 Identities=24% Similarity=0.295 Sum_probs=172.8
Q ss_pred HHccCCCccceEcccCcEEEEEEEEc---CCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQLM---NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
....+|.+.+.||+|+||.||+|... .+..|++|.+... ..+.+|+++++.++||||+++++++......|+
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 34568999999999999999999642 3578999987532 345679999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
|||++. ++|.+++. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 164 v~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~ 235 (392)
T PHA03207 164 VMPKYK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKL 235 (392)
T ss_pred EehhcC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence 999995 68999984 346799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCce-eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCC
Q 010891 328 GAGKSH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRP 383 (498)
Q Consensus 328 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~ 383 (498)
...... ......||+.|+|||++.+..|+.++|||||||++|||++|+.||.....
T Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 292 (392)
T PHA03207 236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQV 292 (392)
T ss_pred CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCC
Confidence 543221 22346799999999999999999999999999999999999999975443
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=317.11 Aligned_cols=252 Identities=25% Similarity=0.386 Sum_probs=198.7
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC-----chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ-----ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
++|.+.+.||+|+||.||+|.. .++..|++|.+...... ..+.+.+|++++++++||||+++++++.++...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688899999999999999974 56899999988543221 22457889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
||||+++++|.+++.. .+.+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++...
T Consensus 82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999999863 35688999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCceee--ecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCC
Q 010891 328 GAGKSHIT--TRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV 405 (498)
Q Consensus 328 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (498)
........ ....|+..|+|||++.+..++.++||||||+++|||++|+.||....... . ........
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~-~~~~~~~~----- 223 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA-----A-IFKIATQP----- 223 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH-----H-HHHHhccC-----
Confidence 43221111 33568889999999999889999999999999999999999996432211 1 01111100
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 406 VDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 406 ~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
..+.+.. ... ..+..++.+||..+|.+|||+.+++++.
T Consensus 224 ~~~~~~~--~~~--~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 224 TNPQLPS--HVS--PDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred CCCCCCc--cCC--HHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 0111111 111 2233344589999999999999998763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=340.04 Aligned_cols=246 Identities=28% Similarity=0.413 Sum_probs=200.0
Q ss_pred CCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCCC---chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 175 RFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQ---ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
.|.-++.||.|+||.||-|+ ..+.+.||||++.-...+ .+.++..|+..|++++|||++.+.|+|......|||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 45667889999999999997 457889999998544333 35678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
||- |+-.|+|.-+ .+++-+.++..|+.+.+.||+|||++ +.||||||+.|||+++.|.|||+|||.|....+
T Consensus 107 YCl-GSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P- 178 (948)
T KOG0577|consen 107 YCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMAP- 178 (948)
T ss_pred HHh-ccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcCc-
Confidence 994 5888887542 36789999999999999999999999 999999999999999999999999999977643
Q ss_pred CceeeecccccccccCcccc---cCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcC
Q 010891 331 KSHITTRVMGTFGYVAPEYA---NSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (498)
.+.++|||+|||||++ ..+.|+-|+||||||++..||...++|+..++. |..+......-.
T Consensus 179 ----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA------------MSALYHIAQNes 242 (948)
T KOG0577|consen 179 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA------------MSALYHIAQNES 242 (948)
T ss_pred ----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH------------HHHHHHHHhcCC
Confidence 5668999999999987 468899999999999999999999999764321 222222222223
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 408 ~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
|.+............+. .||.+-|.+|||.+++++|-
T Consensus 243 PtLqs~eWS~~F~~Fvd---~CLqKipqeRptse~ll~H~ 279 (948)
T KOG0577|consen 243 PTLQSNEWSDYFRNFVD---SCLQKIPQERPTSEELLKHR 279 (948)
T ss_pred CCCCCchhHHHHHHHHH---HHHhhCcccCCcHHHHhhcc
Confidence 44443333344444444 69999999999999998653
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=321.71 Aligned_cols=256 Identities=27% Similarity=0.455 Sum_probs=196.6
Q ss_pred cCCCccceEcccCcEEEEEEEEc-CCc----EEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM-NGT----AVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
++|++.+.||+|+||+||+|.+. ++. .+++|.+..... ....++..|+.++.+++||||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 45778899999999999999853 344 477777743322 22346777888999999999999999875 456789
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
++||+++|+|.+++.. ..+.+++..+..++.||+.||.|||+. +++||||||+|||++.++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence 9999999999999974 235689999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCc-eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCC
Q 010891 328 GAGKS-HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV 405 (498)
Q Consensus 328 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (498)
..... .......++..|+|||.+.++.++.++|||||||++|||++ |..||....+.. ..+. .. .....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~----~~--~~~~~ 230 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VPDL----LE--KGERL 230 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HH--CCCcC
Confidence 43322 12233457788999999998899999999999999999998 999997543321 1111 11 11111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 010891 406 VDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEY 452 (498)
Q Consensus 406 ~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~~ 452 (498)
..+.. .. .....++.+||..||++|||+.|+++.|.....
T Consensus 231 ~~~~~----~~---~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 231 AQPQI----CT---IDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CCCCC----CC---HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 11111 11 223444558999999999999999998877543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=325.65 Aligned_cols=265 Identities=23% Similarity=0.350 Sum_probs=196.6
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
++|.+.+.||+|+||.||+|+. .+++.||+|.+..... .....+.+|+.++++++||||+++++++..+...++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 5688899999999999999975 4678899999864432 2334577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+++ +|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 86 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 975 898888642 34588999999999999999999998 99999999999999999999999999998654332
Q ss_pred ceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHH---------HHHHhhcc
Q 010891 332 SHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWL---------KMMVQLRR 401 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~---------~~~~~~~~ 401 (498)
.. .....+|+.|+|||++.+ ..++.++|||||||++|+|+||+.||............... ........
T Consensus 159 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (309)
T cd07872 159 KT-YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDE 237 (309)
T ss_pred cc-cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhh
Confidence 21 223468999999998754 56899999999999999999999999755432211111000 00000000
Q ss_pred ccCCcCCC------CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 402 SEDVVDPN------IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 402 ~~~~~~~~------~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
......+. ....+..+. ....++.+||..||.+|||+.|++++--
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~li~~~L~~dp~~R~t~~e~l~h~~ 288 (309)
T cd07872 238 FKNYNFPKYKPQPLINHAPRLDT--EGIELLTKFLQYESKKRISAEEAMKHAY 288 (309)
T ss_pred hhhhhcCccCCCchhhhccCCCH--HHHHHHHHhccCChhhCCCHHHHhcChh
Confidence 00000000 000111111 2334555899999999999999997553
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=321.98 Aligned_cols=257 Identities=26% Similarity=0.430 Sum_probs=198.5
Q ss_pred cCCCccceEcccCcEEEEEEEE-----cCCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-----MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
+.|++.+.||+|+||.||+|.. .++..|++|.+..... .....+.+|+++++.++||||+++++++......|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3577889999999999999974 2467899999864332 223568889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCC
Q 010891 248 VYEYVNNGNLEQWLRGDMC-------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF 314 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~-------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~ 314 (498)
||||+++++|.+++..... ....+++.+...++.|++.||.|||++ +++||||||+|||++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 9999999999999953210 123478899999999999999999999 999999999999999999
Q ss_pred CeEEeeeccceecCCCCc-eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHH
Q 010891 315 DAKISDFGLAKLLGAGKS-HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEW 392 (498)
Q Consensus 315 ~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~ 392 (498)
.+||+|||++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||....+. ...+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~~~~ 238 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EVIEM 238 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHH
Confidence 999999999987643321 11223446778999999988889999999999999999998 98998643321 11111
Q ss_pred HHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 393 LKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
...... ........ ..+..++.+||+.||.+||++.+++++|..
T Consensus 239 ----~~~~~~-------~~~~~~~~--~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 ----VRKRQL-------LPCSEDCP--PRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ----HHcCCc-------CCCCCCCC--HHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111110 00111111 233344458999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=329.85 Aligned_cols=237 Identities=27% Similarity=0.330 Sum_probs=184.8
Q ss_pred ceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC---CchhHHHHHHH-HHHcCCCCCceEEEeEEEeCCeeEEEEeecCC
Q 010891 180 NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG---QADKDFRVEVE-AIGHVRHKNLVRLLGYCIEGTQRILVYEYVNN 254 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (498)
+.||+|+||+||+|+. .+|+.||+|++..... .....+..|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4799999999999985 4689999999854321 22234444544 56789999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCcee
Q 010891 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (498)
Q Consensus 255 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 334 (498)
|+|.+++.. .+.+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KT 152 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cc
Confidence 999999963 35689999999999999999999999 99999999999999999999999999997543222 22
Q ss_pred eecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCC
Q 010891 335 TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRP 414 (498)
Q Consensus 335 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (498)
....+||+.|+|||++.+..++.++|||||||++|||++|..||...... +....+.. . .....+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~~~~i~~---~------~~~~~~ 217 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EMYDNILN---K------PLRLKP 217 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HHHHHHHc---C------CCCCCC
Confidence 34467999999999999999999999999999999999999999753321 11111111 1 111111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHH
Q 010891 415 STSALKRALLTALRCVDPDSDKRPKMS 441 (498)
Q Consensus 415 ~~~~~~~~l~~~~~cl~~dP~~RPt~~ 441 (498)
..+. ....++.+||+.||.+||++.
T Consensus 218 ~~~~--~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 218 NISV--SARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCH--HHHHHHHHHhhcCHHhCCCCC
Confidence 1222 233344489999999999984
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=318.13 Aligned_cols=259 Identities=25% Similarity=0.401 Sum_probs=203.9
Q ss_pred cCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCC---CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
++|++.+.||+|+||.||+|+ ..++..|+||.+..... ....++..|+.+++.++||||+++++++.++...+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 467888999999999999998 45789999998854322 22346888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+++++|.+++.........+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 99999999999875433456789999999999999999999999 999999999999999999999999999987643
Q ss_pred CCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||...... ......... ....+.
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~------~~~~~~ 227 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIE------QCDYPP 227 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhhhh------cCCCCC
Confidence 322 123356899999999999888999999999999999999999999643221 111111111 111111
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
....... ..+..++.+||+.||++|||+.+|++.+..
T Consensus 228 ~~~~~~~---~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~ 264 (267)
T cd08229 228 LPSDHYS---EELRQLVNMCINPDPEKRPDITYVYDVAKR 264 (267)
T ss_pred CCccccc---HHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence 1111111 223344458999999999999999988864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=327.90 Aligned_cols=242 Identities=24% Similarity=0.326 Sum_probs=191.4
Q ss_pred ceEcccCcEEEEEEEEc-CCcEEEEEEecCCC---CCchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCeeEEEEeecCC
Q 010891 180 NIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVYEYVNN 254 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (498)
+.||+|+||+||+|+.. +++.||+|.+.... ......+..|+.++..+ +||||+++++++.+....|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999754 57899999986432 22344567788999888 799999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCcee
Q 010891 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (498)
Q Consensus 255 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 334 (498)
|+|.+++.. .+.+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||+++....... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~ 152 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-T 152 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-c
Confidence 999999863 35699999999999999999999999 999999999999999999999999999975322221 2
Q ss_pred eecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCC
Q 010891 335 TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRP 414 (498)
Q Consensus 335 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (498)
....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ........ ... .. ..
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~------~~~~~i~~---~~~----~~--~~ 217 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED------ELFQSILE---DEV----RY--PR 217 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH------HHHHHHHc---CCC----CC--CC
Confidence 23457999999999999999999999999999999999999999743321 11111111 110 11 11
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 010891 415 STSALKRALLTALRCVDPDSDKRPKM-----SQVVRM 446 (498)
Q Consensus 415 ~~~~~~~~l~~~~~cl~~dP~~RPt~-----~ell~~ 446 (498)
..+ .....++.+||..||.+|||+ .+++++
T Consensus 218 ~~~--~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 218 WLS--KEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred cCC--HHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 111 223344458999999999999 888765
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=326.04 Aligned_cols=262 Identities=27% Similarity=0.405 Sum_probs=203.4
Q ss_pred HHHccCCCccceEcccCcEEEEEEEEc------CCcEEEEEEecCCCC-CchhHHHHHHHHHHcC-CCCCceEEEeEEEe
Q 010891 170 QSATNRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHV-RHKNLVRLLGYCIE 241 (498)
Q Consensus 170 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~ 241 (498)
....++|++.+.||+|+||.||++... ....+|+|.+..... .....+.+|++++.++ +||||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 344567889999999999999999753 236789998865322 2334688899999999 89999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhccc------------CCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEE
Q 010891 242 GTQRILVYEYVNNGNLEQWLRGDM------------CDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNIL 309 (498)
Q Consensus 242 ~~~~~lv~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIl 309 (498)
+...+++|||+++|+|.++++... .....+++..++.++.|++.||.|||+. +|+||||||+|||
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEE
Confidence 999999999999999999996431 2345689999999999999999999998 9999999999999
Q ss_pred EcCCCCeEEeeeccceecCCCCcee-eecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchh
Q 010891 310 IDENFDAKISDFGLAKLLGAGKSHI-TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEV 387 (498)
Q Consensus 310 l~~~~~~kL~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~ 387 (498)
++.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||.......
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-- 242 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-- 242 (293)
T ss_pred EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH--
Confidence 9999999999999998765432211 222335678999999998999999999999999999998 999986433211
Q ss_pred hHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 388 NLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
....+... .. ... .. .....+..++.+||..||++|||+.++++.|+..
T Consensus 243 ----~~~~~~~~---~~---~~~--~~--~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~ 291 (293)
T cd05053 243 ----LFKLLKEG---YR---MEK--PQ--NCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291 (293)
T ss_pred ----HHHHHHcC---Cc---CCC--CC--CCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence 11111111 00 011 11 1123445566689999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=324.01 Aligned_cols=268 Identities=24% Similarity=0.372 Sum_probs=196.8
Q ss_pred cCC-CccceEcccCcEEEEEEEE-----cCCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeC--Ce
Q 010891 174 NRF-SKDNIIGDGGYGVVYRGQL-----MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEG--TQ 244 (498)
Q Consensus 174 ~~y-~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~ 244 (498)
++| .+.+.||+|+||+||++.. .++..||+|.+..... .....+.+|+++++.++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 345 8889999999999988642 3578899998865432 2345688899999999999999999988753 45
Q ss_pred eEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccc
Q 010891 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (498)
Q Consensus 245 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla 324 (498)
.++||||+++++|.+++.. ..+++..++.++.|++.||.|||+. +|+||||||+|||+++++.+||+|||++
T Consensus 83 ~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~ 154 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLA 154 (283)
T ss_pred EEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccc
Confidence 7999999999999999963 3489999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCcee--eecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccc
Q 010891 325 KLLGAGKSHI--TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRS 402 (498)
Q Consensus 325 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (498)
.......... .....++..|+|||.+.+..++.++||||||+++|||++|..||......- ................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~ 233 (283)
T cd05080 155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMTVVRL 233 (283)
T ss_pred cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccchhhh
Confidence 8765432211 122345677999999988889999999999999999999999986432210 0000000000000000
Q ss_pred cCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 403 EDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
....+..............+..++.+||+.||++|||+.++++.|+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~ 281 (283)
T cd05080 234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281 (283)
T ss_pred hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence 000000000000111123444555689999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=327.15 Aligned_cols=248 Identities=25% Similarity=0.370 Sum_probs=209.5
Q ss_pred ccCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCCCch--hHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQAD--KDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
.+-|.+.+.||+|.|++|-+|+ ..+|+.||||++.+....+. ..+.+|+..|+.++|||||++|++......+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 4557788899999999999997 56899999999976654433 46888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEc-CCCCeEEeeeccceecC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID-ENFDAKISDFGLAKLLG 328 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~-~~~~~kL~DfGla~~~~ 328 (498)
|+=++|+|+|||..+ ..-++++.+.+++.||+.|+.|+|+. .++||||||+|+.+- +-|-+||+|||++-.+.
T Consensus 97 ELGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 999999999999754 23489999999999999999999999 999999999999875 45889999999999887
Q ss_pred CCCceeeecccccccccCcccccCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANSGLLN-EKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (498)
+++. .+..||.+.|-|||++.+..|+ +++||||||||||.|++|+.||+..+..... ..++|
T Consensus 171 PG~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL---------------TmImD 233 (864)
T KOG4717|consen 171 PGKK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL---------------TMIMD 233 (864)
T ss_pred Ccch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh---------------hhhhc
Confidence 7653 3457899999999999998887 5789999999999999999999855443221 12344
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 010891 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVR 445 (498)
Q Consensus 408 ~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~ 445 (498)
-....+...+...+.++. .||..||.+|.+.+||..
T Consensus 234 CKYtvPshvS~eCrdLI~--sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 234 CKYTVPSHVSKECRDLIQ--SMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ccccCchhhhHHHHHHHH--HHHhcCchhhccHHHHhc
Confidence 555555566666666665 799999999999999984
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=317.21 Aligned_cols=256 Identities=24% Similarity=0.427 Sum_probs=202.6
Q ss_pred HHccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
+...+|.+.+.||+|+||.||++...++..+++|.+.... .....+.+|+++++.++|+||+++++++.+ ...+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 4457889999999999999999987777889999876432 234568889999999999999999999887 77899999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
|+++++|.+++... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 155 (260)
T cd05073 81 FMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN 155 (260)
T ss_pred eCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence 99999999999753 334688899999999999999999998 9999999999999999999999999999876543
Q ss_pred CceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 331 KSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
.........++..|+|||++....++.++|+|||||++|++++ |+.||...... .....+ . ..... +
T Consensus 156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~---~---~~~~~--~- 223 (260)
T cd05073 156 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRAL---E---RGYRM--P- 223 (260)
T ss_pred CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH---h---CCCCC--C-
Confidence 3222222346678999999998889999999999999999999 99999743321 111111 1 11100 0
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
. ... ....+..++.+||+.||++||++.++++.|+.
T Consensus 224 ~--~~~--~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 224 R--PEN--CPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred C--ccc--CCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0 111 11234455568999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=318.70 Aligned_cols=251 Identities=22% Similarity=0.372 Sum_probs=195.8
Q ss_pred CCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeec
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 252 (498)
+|++.++||+|+||.||+|.. .+++.||+|.+..... ...+.+..|++++.+++||||+++++++......++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 578889999999999999974 5788999998864422 23356888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~ 332 (498)
++++|..+. .+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 82 DGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred CCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 999997653 367888999999999999999999 99999999999999999999999999998764322
Q ss_pred eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchh-hHHHHHHHHHhhccccCCcCCCCC
Q 010891 333 HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEV-NLVEWLKMMVQLRRSEDVVDPNIE 411 (498)
Q Consensus 333 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 411 (498)
.....||..|+|||++.+..++.++|||||||++|+|++|+.||......... ........... .. .+.+.
T Consensus 150 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~-----~~~~~ 221 (279)
T cd06619 150 --AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD-ED-----PPVLP 221 (279)
T ss_pred --ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc-cC-----CCCCC
Confidence 23357899999999999889999999999999999999999999643221111 01111111100 00 01111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 412 ~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
..... .....++.+||+.||++||++.+++++.-
T Consensus 222 ~~~~~---~~~~~li~~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 222 VGQFS---EKFVHFITQCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred CCcCC---HHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence 11111 23344455899999999999999998743
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=324.28 Aligned_cols=262 Identities=27% Similarity=0.394 Sum_probs=197.7
Q ss_pred cCCCccceEcccCcEEEEEEEE-----cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEe--CCeeE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-----MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIE--GTQRI 246 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~ 246 (498)
.+|++.+.||+|+||.||+|.. .++..||+|++........+.+..|++++..++||||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4678899999999999999964 3578999999876555555678899999999999999999998754 34679
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecccee
Q 010891 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (498)
Q Consensus 247 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~ 326 (498)
+||||+++++|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||++++++.+||+|||++..
T Consensus 84 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCccccc
Confidence 999999999999999642 34689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCcee--eecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcc---------hhhHHHHHHH
Q 010891 327 LGAGKSHI--TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQS---------EVNLVEWLKM 395 (498)
Q Consensus 327 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~---------~~~~~~~~~~ 395 (498)
........ .....++..|+|||++.+..++.++|||||||++|||++|..|+......- .......+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIE 237 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHH
Confidence 64432211 111234456999999998899999999999999999999887754221100 0000000000
Q ss_pred HHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 396 MVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
... ... ........ ...+..++.+||+.+|++|||+.++++.|+..
T Consensus 238 ~~~--~~~-----~~~~~~~~--~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 238 LLK--NNG-----RLPAPPGC--PAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHh--cCC-----cCCCCCCC--CHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 000 000 00111111 12344555689999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=318.70 Aligned_cols=253 Identities=24% Similarity=0.365 Sum_probs=198.8
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeec
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 252 (498)
++|.+.+.||+|+||.||+|+. .+++.||+|.+..........+.+|+.+++.++||||+++++++......|+||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4678889999999999999974 468899999886655444556788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~ 332 (498)
++++|.+++.. .+.+++.+++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06645 89 GGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATI- 160 (267)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence 99999999863 35689999999999999999999999 99999999999999999999999999998764322
Q ss_pred eeeecccccccccCccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 333 HITTRVMGTFGYVAPEYAN---SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 333 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
.......|+..|+|||++. ...++.++|||||||++|+|++|..||....+.... ...... ....+.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~------~~~~~~----~~~~~~ 230 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------FLMTKS----NFQPPK 230 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH------Hhhhcc----CCCCCc
Confidence 1223457899999999874 456889999999999999999999998654332110 011100 011111
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
.......+. .+..++.+||..||++|||+.+++++
T Consensus 231 ~~~~~~~~~--~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 231 LKDKMKWSN--SFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ccccCCCCH--HHHHHHHHHccCCchhCcCHHHHhcC
Confidence 111111111 23344558999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=313.69 Aligned_cols=247 Identities=28% Similarity=0.450 Sum_probs=194.7
Q ss_pred ceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCc-hhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCCCCHH
Q 010891 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQA-DKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLE 258 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~ 258 (498)
++||+|+||.||+|...++..||+|.+....... ...+.+|+++++.++||||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3699999999999988788999999886543322 345888999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCceeeecc
Q 010891 259 QWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRV 338 (498)
Q Consensus 259 ~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~ 338 (498)
+++... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (250)
T cd05085 81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK 154 (250)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence 998642 34588999999999999999999998 999999999999999999999999999976543322111222
Q ss_pred cccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHH
Q 010891 339 MGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTS 417 (498)
Q Consensus 339 ~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (498)
.++..|+|||++.+..++.++||||||+++|+|++ |..||....... .. .... ..... .. ....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---~~---~~~~---~~~~~---~~--~~~~- 219 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---AR---EQVE---KGYRM---SC--PQKC- 219 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---HH---HHHH---cCCCC---CC--CCCC-
Confidence 34677999999998899999999999999999998 999996443211 11 1111 11110 11 1111
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 418 ALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 418 ~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
...+..++.+||..+|++||++.++++.|.
T Consensus 220 -~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 -PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred -CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 133445556899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=315.16 Aligned_cols=247 Identities=29% Similarity=0.423 Sum_probs=192.1
Q ss_pred ceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCCCCH
Q 010891 180 NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNL 257 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L 257 (498)
+.||+|+||.||+|+. .+++.||+|.+..... .....+..|+++++.++||||+++++++......|+||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3699999999999975 4789999998764432 2335688999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCceee-e
Q 010891 258 EQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHIT-T 336 (498)
Q Consensus 258 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~~-~ 336 (498)
.+++.. ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++........... .
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRT---EGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 999964 234689999999999999999999999 999999999999999999999999999976543211111 1
Q ss_pred cccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCC
Q 010891 337 RVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPS 415 (498)
Q Consensus 337 ~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (498)
...++..|+|||.+.++.++.++|||||||++|||++ |..||....... .. ..... ... ..... ..
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~---~~---~~~~~---~~~---~~~~~-~~ 221 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ---TR---EAIEQ---GVR---LPCPE-LC 221 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH---HH---HHHHc---CCC---CCCcc-cC
Confidence 1123457999999998899999999999999999998 888886432211 11 11111 000 11111 11
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 416 TSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 416 ~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
...+..++.+||..||++|||+.++++.|.
T Consensus 222 ---~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 222 ---PDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ---CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 123444556899999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=332.00 Aligned_cols=193 Identities=23% Similarity=0.310 Sum_probs=165.5
Q ss_pred HccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
...+|.+.+.||+|+||.||+|+.. ++..||+|.... .....|+.++++++||||+++++++.+....++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3467999999999999999999854 567899986432 223569999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
|+. ++|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 138 ~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 138 HYS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred ccC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 995 589998864 335689999999999999999999999 9999999999999999999999999999754322
Q ss_pred CceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 010891 331 KSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVD 379 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~ 379 (498)
. ......||+.|+|||++.+..++.++|||||||++|||+++..|+.
T Consensus 211 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 211 P--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred c--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 1 1234569999999999999999999999999999999999666553
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=332.27 Aligned_cols=200 Identities=30% Similarity=0.345 Sum_probs=169.9
Q ss_pred HHccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC--CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCC----
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT---- 243 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~---- 243 (498)
...++|++.+.||+|+||.||+|.. .+|..||+|++.... ......+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 3457899999999999999999975 468999999985432 223456778999999999999999999986543
Q ss_pred --eeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeee
Q 010891 244 --QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDF 321 (498)
Q Consensus 244 --~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~Df 321 (498)
..|+||||+++ +|.+++.. .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Df 167 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 167 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecC
Confidence 46999999965 67777642 378899999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 010891 322 GLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 322 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~ 382 (498)
|+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 168 g~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 168 GLARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred CCccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 999865332 12334578999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=336.05 Aligned_cols=203 Identities=27% Similarity=0.375 Sum_probs=175.1
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC---CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
++|++.+.||+|+||.||+++. .+++.||+|++.... ......+..|+.++..++||||+++++.+.+....|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3688899999999999999975 468999999985432 223456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+++|+|.+++.. .+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999999963 35689999999999999999999999 999999999999999999999999999875432
Q ss_pred CCc----------------------------------eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCC
Q 010891 330 GKS----------------------------------HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGR 375 (498)
Q Consensus 330 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~ 375 (498)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 110 0112357999999999999999999999999999999999999
Q ss_pred CCCCCCCC
Q 010891 376 YPVDYGRP 383 (498)
Q Consensus 376 ~P~~~~~~ 383 (498)
.||....+
T Consensus 234 ~Pf~~~~~ 241 (360)
T cd05627 234 PPFCSETP 241 (360)
T ss_pred CCCCCCCH
Confidence 99975543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=337.01 Aligned_cols=203 Identities=25% Similarity=0.356 Sum_probs=173.8
Q ss_pred HHHccCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCC-C-----CCceEEEeEEEeC
Q 010891 170 QSATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-H-----KNLVRLLGYCIEG 242 (498)
Q Consensus 170 ~~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----pnIv~l~~~~~~~ 242 (498)
..+.-+|.++++||+|+||.|-+|. ..+++.||||++++.. ....+-..|+.+|..|+ | -|+|+++++|...
T Consensus 182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence 3445589999999999999999996 5679999999986543 23344566999999996 4 3899999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCC--CCeEEee
Q 010891 243 TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN--FDAKISD 320 (498)
Q Consensus 243 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~--~~~kL~D 320 (498)
+++|||+|.+.. +|+++|+.+.. ..|+...+..|+.||+.||.+||+. +|||+||||+||||.+. ..+||+|
T Consensus 261 ~HlciVfELL~~-NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVID 334 (586)
T KOG0667|consen 261 NHLCIVFELLST-NLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVID 334 (586)
T ss_pred cceeeeehhhhh-hHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEe
Confidence 999999999954 99999987643 4489999999999999999999998 99999999999999654 4699999
Q ss_pred eccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCC
Q 010891 321 FGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRP 383 (498)
Q Consensus 321 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~ 383 (498)
||.|+...... ..++-+..|+|||++.+.+|+.+.||||||||++||++|.+.|.+...
T Consensus 335 FGSSc~~~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne 393 (586)
T KOG0667|consen 335 FGSSCFESQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNE 393 (586)
T ss_pred cccccccCCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence 99999765432 256678899999999999999999999999999999999887876543
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=322.79 Aligned_cols=251 Identities=24% Similarity=0.386 Sum_probs=201.6
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
..+|++.+.||+|+||.||+|.. .++..|++|.+........+.+..|+.+++.++||||+++++.+..+...|+||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 35788999999999999999974 56889999998766555567788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+++++|.+++.. ..+++.++..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 999999999853 3578999999999999999999999 99999999999999999999999999988654322
Q ss_pred ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCC
Q 010891 332 SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (498)
.. .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||....+.. ......... .+...
T Consensus 171 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~------~~~~~~~~~------~~~~~ 237 (296)
T cd06654 171 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNG------TPELQ 237 (296)
T ss_pred cc-cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHH------hHHHHhcCC------CCCCC
Confidence 11 223468999999999998889999999999999999999999997543321 111111100 01111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 412 ~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
...... ..+..++.+||..||++|||+.+++++
T Consensus 238 ~~~~~~--~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 238 NPEKLS--AIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CccccC--HHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 111111 223344458999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=318.10 Aligned_cols=248 Identities=25% Similarity=0.305 Sum_probs=190.7
Q ss_pred EcccCcEEEEEEEE-cCCcEEEEEEecCCCC---CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCCCCH
Q 010891 182 IGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNL 257 (498)
Q Consensus 182 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L 257 (498)
||+|+||.||+++. .+|+.||+|++..... .....+..|++++++++||||+++++++.++.+.|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999974 4689999999854322 1223456799999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCceeeec
Q 010891 258 EQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337 (498)
Q Consensus 258 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~ 337 (498)
.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~ 153 (277)
T cd05607 81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ 153 (277)
T ss_pred HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence 9988643 234588999999999999999999998 99999999999999999999999999998765432 2233
Q ss_pred ccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHH
Q 010891 338 VMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTS 417 (498)
Q Consensus 338 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (498)
..||..|+|||++.+..++.++|||||||++|||++|+.||....... ........... .. . .........
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~----~~-~--~~~~~~~~~ 224 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTLE----DE-V--KFEHQNFTE 224 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhhc----cc-c--ccccccCCH
Confidence 568999999999988889999999999999999999999997433211 11111111110 00 0 001111112
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 418 ALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 418 ~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
....++.+||+.||++||++.|+++.+.
T Consensus 225 ---~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 225 ---ESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred ---HHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 2334445899999999999977664443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=314.17 Aligned_cols=250 Identities=28% Similarity=0.441 Sum_probs=200.5
Q ss_pred CCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC--CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
+|++.+.||+|+||.||+|.. .+++.|++|.+.... ......+..|+++++.++||||+++++++.+....|+||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 367788999999999999975 468999999885432 23345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+++++|.+++... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 9999999999753 235689999999999999999999998 99999999999999999999999999998765433
Q ss_pred ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCC
Q 010891 332 SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (498)
.. .....|++.|+|||++.+..++.++|+|||||++|+|++|+.||...... .. ...... . .. +...
T Consensus 156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~---~~~~~~-~----~~-~~~~ 222 (256)
T cd08529 156 NF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---AL---ILKIIR-G----VF-PPVS 222 (256)
T ss_pred ch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HH---HHHHHc-C----CC-CCCc
Confidence 22 23456899999999999999999999999999999999999999744311 11 111111 0 00 1111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 412 ~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
. .....+..++.+||+.+|++||++.+++++
T Consensus 223 ~----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 223 Q----MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred c----ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1 111234445558999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=331.84 Aligned_cols=238 Identities=27% Similarity=0.347 Sum_probs=185.6
Q ss_pred ceEcccCcEEEEEEEE-cCCcEEEEEEecCCC---CCchhHHHHHHH-HHHcCCCCCceEEEeEEEeCCeeEEEEeecCC
Q 010891 180 NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVE-AIGHVRHKNLVRLLGYCIEGTQRILVYEYVNN 254 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (498)
+.||+|+||+||+|+. .+|+.||+|++.... ......+..|.. +++.++||||+++++++...+..|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999974 568999999985432 122334555554 56779999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCcee
Q 010891 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (498)
Q Consensus 255 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 334 (498)
|+|..++. ..+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~ 152 (325)
T cd05604 81 GELFFHLQ----RERSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DT 152 (325)
T ss_pred CCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CC
Confidence 99999886 345689999999999999999999999 99999999999999999999999999997543222 12
Q ss_pred eecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCC
Q 010891 335 TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRP 414 (498)
Q Consensus 335 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (498)
....+||+.|+|||++.+..++.++|||||||++|||++|..||...... +....... . .....+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~------~~~~~~~~---~------~~~~~~ 217 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA------EMYDNILH---K------PLVLRP 217 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH------HHHHHHHc---C------CccCCC
Confidence 34467999999999999999999999999999999999999999754321 11111111 1 111111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHH
Q 010891 415 STSALKRALLTALRCVDPDSDKRPKMSQ 442 (498)
Q Consensus 415 ~~~~~~~~l~~~~~cl~~dP~~RPt~~e 442 (498)
..+ .....++.+||..||.+||++.+
T Consensus 218 ~~~--~~~~~ll~~ll~~~p~~R~~~~~ 243 (325)
T cd05604 218 GAS--LTAWSILEELLEKDRQRRLGAKE 243 (325)
T ss_pred CCC--HHHHHHHHHHhccCHHhcCCCCC
Confidence 111 22333445899999999998853
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=320.33 Aligned_cols=257 Identities=26% Similarity=0.405 Sum_probs=197.8
Q ss_pred ccCCCccceEcccCcEEEEEEEEc------CCcEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEeEEEeCCee
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQR 245 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 245 (498)
.++|.+.+.||+|+||.||+|.+. .+..|++|.+...... ....+..|+.+++.++||||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 457888999999999999999764 3567889987544322 334688899999999999999999999998899
Q ss_pred EEEEeecCCCCHHHHHhcccC---CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCC---CeEEe
Q 010891 246 ILVYEYVNNGNLEQWLRGDMC---DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF---DAKIS 319 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~---~~kL~ 319 (498)
++||||+++++|.+++..... ....+++..++.++.||+.||.|||+. +++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence 999999999999999965421 113589999999999999999999999 999999999999998765 59999
Q ss_pred eeccceecCCCCcee-eecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHH
Q 010891 320 DFGLAKLLGAGKSHI-TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMV 397 (498)
Q Consensus 320 DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 397 (498)
|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||....... ......
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~ 235 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE------VMEFVT 235 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHH
Confidence 999998763322111 112234568999999988899999999999999999997 999997543321 111111
Q ss_pred hhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 398 QLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
.... .... ... ...+..++.+||..||++|||+.+|+++|+
T Consensus 236 ~~~~------~~~~--~~~--~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 236 GGGR------LDPP--KGC--PGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred cCCc------CCCC--CCC--CHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1110 0111 111 123444556899999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=321.66 Aligned_cols=256 Identities=23% Similarity=0.384 Sum_probs=198.0
Q ss_pred CCCccceEcccCcEEEEEEEEc------CCcEEEEEEecCCCCCc-hhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 175 RFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPGQA-DKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
+|.+.+.||+|+||.||+|... ++..||+|++....... ...+..|+.++..++||||+++++++.+....++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4677889999999999999753 25789999986543322 3568889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhccc------------CCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCC
Q 010891 248 VYEYVNNGNLEQWLRGDM------------CDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD 315 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~ 315 (498)
++||+.+++|.+++.... .....+++..++.++.|++.||.|||+. +|+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 999999999999985321 1124588899999999999999999998 9999999999999999999
Q ss_pred eEEeeeccceecCCCCc-eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHH
Q 010891 316 AKISDFGLAKLLGAGKS-HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWL 393 (498)
Q Consensus 316 ~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~ 393 (498)
+||+|||+++....... .......+++.|+|||.+.++.++.++|||||||++|||++ |..||...... ++.
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~ 236 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------DVI 236 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH------HHH
Confidence 99999999986543321 11223456789999999988889999999999999999998 88888643221 222
Q ss_pred HHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 394 KMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
........ . ... .... ..+..++..||+.+|++||++.+++..|+.
T Consensus 237 ~~i~~~~~-~-----~~~-~~~~---~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 237 EMIRNRQV-L-----PCP-DDCP---AWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHcCCc-C-----CCC-CCCC---HHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 22211110 0 011 1111 223445558999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=324.34 Aligned_cols=199 Identities=27% Similarity=0.409 Sum_probs=172.2
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
++|++.+.||+|+||.||++.. .++..+|+|.+..... .....+.+|++++.+++||||+++++++.+++..|+||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 3688899999999999999974 4678888888754322 2234578899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+++++|.+++.. .+.+++..+..++.|++.||.|||+.+ +++|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 81 MDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 999999999974 356899999999999999999999732 89999999999999999999999999987653321
Q ss_pred ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 010891 332 SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYG 381 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~ 381 (498)
.....|+..|+|||.+.+..++.++|||||||++|+|++|+.||...
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~ 201 (308)
T cd06615 155 ---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPP 201 (308)
T ss_pred ---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCc
Confidence 23357899999999998888999999999999999999999999643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=328.15 Aligned_cols=241 Identities=23% Similarity=0.298 Sum_probs=189.3
Q ss_pred CCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC---CCchhHHHHHHHHHHcCC-CCCceEEEeEEEeCCeeEEEE
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVR-HKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~ 249 (498)
+|++.+.||+|+||+||+|+. .+|+.||+|++.... ....+.+..|+.++..+. |++|+++++++.+.+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 367789999999999999974 468899999986432 223345777889998885 577888999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+++|+|.+++.. .+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999999863 35699999999999999999999999 999999999999999999999999999986432
Q ss_pred CCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+....
T Consensus 154 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~------~~~~~i~~~~--------- 217 (323)
T cd05615 154 DGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED------ELFQSIMEHN--------- 217 (323)
T ss_pred CCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC---------
Confidence 221 123456999999999999999999999999999999999999999754321 1111111100
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRPKM 440 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~ 440 (498)
.......+ .....++.+||+.||.+|++.
T Consensus 218 ~~~p~~~~--~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 218 VSYPKSLS--KEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred CCCCccCC--HHHHHHHHHHcccCHhhCCCC
Confidence 01111111 223344558999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=316.19 Aligned_cols=256 Identities=23% Similarity=0.399 Sum_probs=196.8
Q ss_pred CCccceEcccCcEEEEEEEEcC----CcEEEEEEecCCCCC--chhHHHHHHHHHHcCCCCCceEEEeEEEeCCe-----
Q 010891 176 FSKDNIIGDGGYGVVYRGQLMN----GTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQ----- 244 (498)
Q Consensus 176 y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~----- 244 (498)
|.+.+.||+|+||.||+|.... +..||+|++...... ....+..|++.++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999997532 367999998643322 23568889999999999999999998876554
Q ss_pred -eEEEEeecCCCCHHHHHhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeee
Q 010891 245 -RILVYEYVNNGNLEQWLRGDMC--DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDF 321 (498)
Q Consensus 245 -~~lv~e~~~~g~L~~~l~~~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~Df 321 (498)
.+++|||+++|+|..++..... ....+++..+..++.|++.||.|||+. +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 6999999999999999854322 224689999999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCcee-eecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhh
Q 010891 322 GLAKLLGAGKSHI-TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQL 399 (498)
Q Consensus 322 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 399 (498)
|+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||...... +........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~------~~~~~~~~~ 231 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH------EIYDYLRHG 231 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcC
Confidence 9998764432221 112235678999999988899999999999999999999 88888643321 111111111
Q ss_pred ccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 400 RRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
.. ..... . ....+..++.+||+.||++|||+.++++.|+..
T Consensus 232 ---~~---~~~~~-~---~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 ---NR---LKQPE-D---CLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ---CC---CCCCc-C---CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 10 11111 1 122445555689999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-40 Score=328.72 Aligned_cols=257 Identities=23% Similarity=0.266 Sum_probs=194.4
Q ss_pred cCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCC---CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
++|.+.+.||+|+||+||+++.. +++.||+|.+.+.. ......+..|+.++..++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888999999999999999854 57789999885321 122345788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+++|+|.+++... ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 999999999999742 34689999999999999999999998 999999999999999999999999999986543
Q ss_pred CCceeeecccccccccCccccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccC
Q 010891 330 GKSHITTRVMGTFGYVAPEYAN-----SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSED 404 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (498)
.........+||+.|+|||++. ...++.++|||||||++|||++|+.||...... +....+..... .
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~--~ 226 (332)
T cd05623 155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHKE--R 226 (332)
T ss_pred CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHH------HHHHHHhCCCc--c
Confidence 3333333457999999999885 356889999999999999999999999754321 11222211110 0
Q ss_pred CcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 405 VVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
..-+.. ....+.....+...+.|...++..|+++.++++|
T Consensus 227 ~~~p~~--~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 227 FQFPAQ--VTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ccCCCc--cccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 000110 1111222333333233555566668999999987
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=329.91 Aligned_cols=241 Identities=25% Similarity=0.304 Sum_probs=185.3
Q ss_pred ceEcccCcEEEEEEEEc-CCcEEEEEEecCCCC---CchhHHHHHH-HHHHcCCCCCceEEEeEEEeCCeeEEEEeecCC
Q 010891 180 NIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG---QADKDFRVEV-EAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNN 254 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~-~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (498)
+.||+|+||+||+|+.. +++.||+|++..... .....+..|. .+++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999854 578899999854321 1223344444 456788999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCcee
Q 010891 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (498)
Q Consensus 255 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 334 (498)
|+|.+++.. .+.+.+..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~ 152 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GT 152 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CC
Confidence 999999973 35688889999999999999999999 99999999999999999999999999997543222 22
Q ss_pred eecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCC
Q 010891 335 TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRP 414 (498)
Q Consensus 335 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (498)
....+||+.|+|||++.+..++.++|||||||++|||++|..||...... +.+..... . .....+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~---~------~~~~~~ 217 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA------EMYDNILN---K------PLQLKP 217 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH------HHHHHHHh---C------CcCCCC
Confidence 34467999999999999999999999999999999999999999743321 11111111 0 111111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 010891 415 STSALKRALLTALRCVDPDSDKRPKMSQVVR 445 (498)
Q Consensus 415 ~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~ 445 (498)
..+. ....+..+||+.||.+||++.+.+.
T Consensus 218 ~~~~--~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 218 NITN--SARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CCCH--HHHHHHHHHcccCHHHCCCCCCCHH
Confidence 2222 2233334899999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=320.26 Aligned_cols=257 Identities=28% Similarity=0.421 Sum_probs=198.4
Q ss_pred CCCccceEcccCcEEEEEEEEc------CCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 175 RFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
+|++.+.||+|+||.||+|... ....+++|.+..... .....+..|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4678899999999999999742 235688887764433 223568889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCC
Q 010891 248 VYEYVNNGNLEQWLRGDMC--------------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSN 307 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~N 307 (498)
+|||+.+++|.+++..... ....+++..++.++.|++.||.|||+. +++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence 9999999999999864211 123588999999999999999999998 99999999999
Q ss_pred EEEcCCCCeEEeeeccceecCCCCce-eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcc
Q 010891 308 ILIDENFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQS 385 (498)
Q Consensus 308 Ill~~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~ 385 (498)
||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..||....+..
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 99999999999999999865332211 1122345778999999988889999999999999999999 999996443221
Q ss_pred hhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 386 EVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
+.+. ... .. ...... .. ...+..++.+||+.||++||++.++++.|+..
T Consensus 238 ---~~~~---~~~---~~---~~~~~~-~~---~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~ 286 (290)
T cd05045 238 ---LFNL---LKT---GY---RMERPE-NC---SEEMYNLMLTCWKQEPDKRPTFADISKELEKM 286 (290)
T ss_pred ---HHHH---HhC---CC---CCCCCC-CC---CHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence 1111 111 00 011111 11 12344555689999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=320.13 Aligned_cols=258 Identities=26% Similarity=0.416 Sum_probs=201.3
Q ss_pred HccCCCccceEcccCcEEEEEEEEc------CCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCe
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQ 244 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 244 (498)
..++|.+.+.||+|+||.||+|... .+..||+|.+..... .....+..|+.++..++||||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 3467889999999999999999753 236899998854432 223468889999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcccC------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEE
Q 010891 245 RILVYEYVNNGNLEQWLRGDMC------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKI 318 (498)
Q Consensus 245 ~~lv~e~~~~g~L~~~l~~~~~------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL 318 (498)
.++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEE
Confidence 9999999999999999964321 223578899999999999999999998 9999999999999999999999
Q ss_pred eeeccceecCCCCce-eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHH
Q 010891 319 SDFGLAKLLGAGKSH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMM 396 (498)
Q Consensus 319 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 396 (498)
+|||+++........ ......++..|+|||.+.++.++.++|||||||++|||++ |..||....... ..+ ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~---~~ 234 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLK---FV 234 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHH---HH
Confidence 999999865433211 1223456789999999988889999999999999999998 999986443221 111 11
Q ss_pred HhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 397 VQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
. .... ...... . ...+..++.+||..+|++|||+.+++..|+
T Consensus 235 ~-~~~~-----~~~~~~-~---~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 235 I-DGGH-----LDLPEN-C---PDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred h-cCCC-----CCCCCC-C---CHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1 1100 111111 1 223445556899999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=320.01 Aligned_cols=264 Identities=26% Similarity=0.417 Sum_probs=201.1
Q ss_pred ccCCCccceEcccCcEEEEEEEEcC-----------------CcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLMN-----------------GTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVR 234 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~ 234 (498)
.++|++.+.||+|+||.||+|.... +..||+|.+..... ...+.+..|++++.+++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578999999999999999987532 24589998865433 23457888999999999999999
Q ss_pred EEeEEEeCCeeEEEEeecCCCCHHHHHhcccC-------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCC
Q 010891 235 LLGYCIEGTQRILVYEYVNNGNLEQWLRGDMC-------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSN 307 (498)
Q Consensus 235 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~N 307 (498)
+++++..+...+++|||+.+++|.+++..... ....+++..++.++.|++.||.|||+. +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 99999999999999999999999999975421 123689999999999999999999998 99999999999
Q ss_pred EEEcCCCCeEEeeeccceecCCCCc-eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh--CCCCCCCCCCc
Q 010891 308 ILIDENFDAKISDFGLAKLLGAGKS-HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT--GRYPVDYGRPQ 384 (498)
Q Consensus 308 Ill~~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt--g~~P~~~~~~~ 384 (498)
|+++.++.++|+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999986543321 12233456789999999988889999999999999999998 67787643221
Q ss_pred chhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 385 SEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
................. ....... ....+..++.+||+.||.+|||+.++++.|+
T Consensus 241 ---~~~~~~~~~~~~~~~~~----~~~~~~~--~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 ---QVIENAGHFFRDDGRQI----YLPRPPN--CPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred ---HHHHHHHhccccccccc----cCCCccC--CCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 11111111110000000 0111111 1134555666899999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=312.85 Aligned_cols=250 Identities=31% Similarity=0.487 Sum_probs=200.7
Q ss_pred ccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeec
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 252 (498)
.++|++.+.||.|+||.||+|.. .|+.||+|.+..... ..+.+..|+.+++.++|+||+++++++.+....++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 35678899999999999999976 588999999965543 4567889999999999999999999999889999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~ 332 (498)
++++|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~- 156 (256)
T cd05039 83 AKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ- 156 (256)
T ss_pred CCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence 999999999743 223689999999999999999999999 99999999999999999999999999998763221
Q ss_pred eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCC
Q 010891 333 HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411 (498)
Q Consensus 333 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (498)
....++..|+|||.+.+..++.++||||||+++|||++ |..||...... .+.. .... . .. ....
T Consensus 157 ---~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~---~~~~-~--~~---~~~~ 221 (256)
T cd05039 157 ---DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVP---HVEK-G--YR---MEAP 221 (256)
T ss_pred ---ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HHHH---HHhc-C--CC---CCCc
Confidence 12335668999999988889999999999999999997 99998643221 1111 1111 0 00 1111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 412 ~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
... ...+..++.+||..+|++|||+.+++..|+.
T Consensus 222 --~~~--~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 222 --EGC--PPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred --cCC--CHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 111 1234445568999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=318.17 Aligned_cols=254 Identities=25% Similarity=0.428 Sum_probs=196.5
Q ss_pred HHccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcC-CCCCceEEEeEEEeC------
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEG------ 242 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~------ 242 (498)
.+++.|++.+.||+|+||.||+|.. .+++.||+|.+.... .....+..|+.++.++ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 3567788899999999999999975 458889999885443 3445688899999998 799999999998753
Q ss_pred CeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeec
Q 010891 243 TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFG 322 (498)
Q Consensus 243 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfG 322 (498)
...|+||||+.+++|.+++... ....+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+||+|||
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCC
Confidence 4579999999999999999753 234689999999999999999999998 99999999999999999999999999
Q ss_pred cceecCCCCceeeecccccccccCccccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHH
Q 010891 323 LAKLLGAGKSHITTRVMGTFGYVAPEYAN-----SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMV 397 (498)
Q Consensus 323 la~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 397 (498)
++....... .......|+..|+|||++. +..++.++|||||||++|||++|..||....+... .. ...
T Consensus 157 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~-----~~-~~~ 229 (272)
T cd06637 157 VSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-----LF-LIP 229 (272)
T ss_pred Cceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH-----HH-HHh
Confidence 998754322 1233457899999999885 34688899999999999999999999964332111 00 000
Q ss_pred hhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 398 QLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
.. ............ ....++.+||..||.+|||+.+++++
T Consensus 230 ---~~---~~~~~~~~~~~~---~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 230 ---RN---PAPRLKSKKWSK---KFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred ---cC---CCCCCCCCCcCH---HHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 00 011111111112 23344458999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=313.04 Aligned_cols=251 Identities=27% Similarity=0.496 Sum_probs=200.1
Q ss_pred cCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecC
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ 253 (498)
.+|++.+.||+|+||.||+|.+.++..+|+|.+.... .....+..|+++++.++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 3577889999999999999987778899999885433 234578899999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCce
Q 010891 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333 (498)
Q Consensus 254 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~ 333 (498)
+++|.+++... .+.+++..++.++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++.........
T Consensus 83 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 83 HGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred CCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 99999999642 34688999999999999999999998 9999999999999999999999999999876433222
Q ss_pred eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCC
Q 010891 334 ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIET 412 (498)
Q Consensus 334 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (498)
......++..|+|||.+.++.++.++||||||+++|||++ |..||...... +....+.. ......+..
T Consensus 157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~---~~~~~~~~~-- 225 (256)
T cd05112 157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS------EVVETINA---GFRLYKPRL-- 225 (256)
T ss_pred ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH------HHHHHHhC---CCCCCCCCC--
Confidence 1222335678999999988899999999999999999998 99999643321 11122111 111111111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 413 RPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 413 ~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.. ..+..++.+||..+|++|||+.+++++|
T Consensus 226 --~~---~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 226 --AS---QSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred --CC---HHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 11 3455556689999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=316.14 Aligned_cols=255 Identities=25% Similarity=0.412 Sum_probs=193.3
Q ss_pred CCccceEcccCcEEEEEEEEcC-Cc--EEEEEEecCCC--CCchhHHHHHHHHHHcCCCCCceEEEeEEEeC------Ce
Q 010891 176 FSKDNIIGDGGYGVVYRGQLMN-GT--AVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG------TQ 244 (498)
Q Consensus 176 y~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~~ 244 (498)
|.+.+.||+|+||.||+|++.+ +. .||+|.+.... ....+.+..|+++++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999998644 32 58999875432 22345688899999999999999999987532 24
Q ss_pred eEEEEeecCCCCHHHHHhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeec
Q 010891 245 RILVYEYVNNGNLEQWLRGDMC--DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFG 322 (498)
Q Consensus 245 ~~lv~e~~~~g~L~~~l~~~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfG 322 (498)
.+++|||+.+|+|.+++..... ....+++..+..++.|++.||.|||+. +|+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence 6899999999999998853221 234589999999999999999999998 99999999999999999999999999
Q ss_pred cceecCCCCcee-eecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhc
Q 010891 323 LAKLLGAGKSHI-TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLR 400 (498)
Q Consensus 323 la~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 400 (498)
+++......... .....+++.|+|||.+.+..++.++|||||||++|||++ |+.||...... +.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~~~~~-- 229 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS------EIYDYLRQ-- 229 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHHHHc--
Confidence 998765432211 122346778999999999999999999999999999999 88898643221 11111111
Q ss_pred cccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 401 RSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
.... ...... ...+..++.+||+.||++|||+.++++.|+.
T Consensus 230 -~~~~-----~~~~~~--~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~ 270 (272)
T cd05075 230 -GNRL-----KQPPDC--LDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270 (272)
T ss_pred -CCCC-----CCCCCC--CHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 1110 011111 1223445558999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=327.22 Aligned_cols=237 Identities=24% Similarity=0.299 Sum_probs=184.0
Q ss_pred ceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC---CchhHHHHHH-HHHHcCCCCCceEEEeEEEeCCeeEEEEeecCC
Q 010891 180 NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG---QADKDFRVEV-EAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNN 254 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~-~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (498)
++||+|+||.||+|+. .+++.||+|.+..... .....+..|. .+++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999985 4688999999854321 2223444454 467889999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCcee
Q 010891 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (498)
Q Consensus 255 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 334 (498)
|+|..++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~ 152 (321)
T cd05603 81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ET 152 (321)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cc
Confidence 999998863 35688999999999999999999998 99999999999999999999999999987542222 22
Q ss_pred eecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCC
Q 010891 335 TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRP 414 (498)
Q Consensus 335 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (498)
....+||+.|+|||++.+..++.++|||||||++|||++|..||..... ......+.. ......+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~i~~---------~~~~~~~ 217 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV------SQMYDNILH---------KPLQLPG 217 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH------HHHHHHHhc---------CCCCCCC
Confidence 3446799999999999999999999999999999999999999975421 111111111 0111111
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHH
Q 010891 415 STSALKRALLTALRCVDPDSDKRPKMS 441 (498)
Q Consensus 415 ~~~~~~~~l~~~~~cl~~dP~~RPt~~ 441 (498)
... .....++.+||+.||.+||++.
T Consensus 218 ~~~--~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 GKT--VAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCC--HHHHHHHHHHccCCHhhcCCCC
Confidence 111 2233445589999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=319.25 Aligned_cols=256 Identities=26% Similarity=0.437 Sum_probs=199.6
Q ss_pred cCCCccceEcccCcEEEEEEEE------cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL------MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
.+|...++||+|+||.||++.. .++..+++|.+..........+..|+++++.++||||+++++++.+....++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 4677889999999999999963 2356789998866555555679999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCe
Q 010891 248 VYEYVNNGNLEQWLRGDMC-----------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDA 316 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~ 316 (498)
+|||+++++|.+++..... ....+++..++.++.|++.||+|||+. +++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCE
Confidence 9999999999999974321 113588999999999999999999998 99999999999999999999
Q ss_pred EEeeeccceecCCCCcee-eecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHH
Q 010891 317 KISDFGLAKLLGAGKSHI-TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLK 394 (498)
Q Consensus 317 kL~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~ 394 (498)
||+|||++.......... .....+++.|+|||++.+..++.++|||||||++|||++ |..||....... ...
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~~ 235 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE------AIE 235 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH------HHH
Confidence 999999998654332211 222345788999999999999999999999999999998 899986433211 111
Q ss_pred HHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 395 MMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
.... .... ... ..... .+..++.+||..||.+||++.++++.|+
T Consensus 236 ~~~~---~~~~---~~~-~~~~~---~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 236 CITQ---GREL---ERP-RTCPP---EVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred HHHc---CccC---CCC-CCCCH---HHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 1111 1111 000 11112 2334445899999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=320.96 Aligned_cols=259 Identities=24% Similarity=0.346 Sum_probs=191.1
Q ss_pred CCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC--chhHHHHHHHHHHcC---CCCCceEEEeEEEe-----CC
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHV---RHKNLVRLLGYCIE-----GT 243 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~-----~~ 243 (498)
+|++.+.||+|+||+||+|+. .+++.||+|.+...... ....+..|+.++..+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 578899999999999999975 46889999988643222 223456677777665 79999999998864 24
Q ss_pred eeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecc
Q 010891 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (498)
Q Consensus 244 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGl 323 (498)
..++||||+.+ +|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence 57999999975 899998643 234589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccc-
Q 010891 324 AKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRS- 402 (498)
Q Consensus 324 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~- 402 (498)
+....... ......||..|+|||++.+..++.++|||||||++|+|++|+.||........ +.+....+ .....
T Consensus 155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~-~~~~~~ 229 (288)
T cd07863 155 ARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGKIFDLI-GLPPED 229 (288)
T ss_pred cccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--HHHHHHHh-CCCChh
Confidence 98764322 12345689999999999888999999999999999999999999965432211 11111100 00000
Q ss_pred ---------cCCcCCCC-----CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 403 ---------EDVVDPNI-----ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 403 ---------~~~~~~~~-----~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
.....+.. ...+..+ .....++.+||+.||++|||+.|++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIE--ESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcC--HHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000 0001111 223445558999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=336.25 Aligned_cols=194 Identities=23% Similarity=0.275 Sum_probs=167.9
Q ss_pred ccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
...|.+.+.||+|+||.||+|... .++.||||... ...+.+|+++|++++|||||++++++..+...++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999854 47889999542 23467899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+. ++|.+++... ...+++..++.|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++......
T Consensus 242 ~~-~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 242 YR-SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred cC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 95 6999988642 24699999999999999999999999 99999999999999999999999999998764332
Q ss_pred ce-eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 010891 332 SH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVD 379 (498)
Q Consensus 332 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~ 379 (498)
.. ......||+.|+|||++.+..++.++|||||||+||||++|..|+.
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 11 1234579999999999999999999999999999999999887654
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=318.89 Aligned_cols=253 Identities=28% Similarity=0.492 Sum_probs=197.7
Q ss_pred CCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCCchh--HHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeec
Q 010891 176 FSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADK--DFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (498)
Q Consensus 176 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 252 (498)
|++.+.||+|+||+||+++.. +++.||+|.+......... ....|+.++++++||||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567899999999999999864 4668999999665433322 2355999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~ 332 (498)
++++|.+++. ....+++..++.++.|+++||.|||+. +++|+||||+||++++++.++|+|||++...... .
T Consensus 81 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~-~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN-N 152 (260)
T ss_dssp TTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTST-T
T ss_pred cccccccccc----ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc-c
Confidence 9999999997 235689999999999999999999999 9999999999999999999999999999875222 2
Q ss_pred eeeecccccccccCccccc-CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCC
Q 010891 333 HITTRVMGTFGYVAPEYAN-SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411 (498)
Q Consensus 333 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (498)
.......+|..|+|||++. +..++.++||||||+++|+|++|..||........... +.......... ....
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~---~~~~~~~~~~~----~~~~ 225 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEI---IEKILKRPLPS----SSQQ 225 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHH---HHHHHHTHHHH----HTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhh---hhhcccccccc----cccc
Confidence 2344567899999999998 88899999999999999999999999985421111111 11111000000 0000
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 412 ~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
..... ..+..++.+||+.||++|||+.+++++
T Consensus 226 ~~~~~---~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 226 SREKS---EELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp HTTSH---HHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred cchhH---HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00111 344455558999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=312.50 Aligned_cols=250 Identities=23% Similarity=0.326 Sum_probs=198.3
Q ss_pred CCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC-CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeec
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 252 (498)
+|++.+.||+|+||.||+++. .++..||+|.+.... ....+.+..|+.+++.++||||+++++++.++...|++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 478889999999999999974 468899999885432 233456888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~ 332 (498)
++++|.+++... ....+++..++.++.|++.||.|||+. +++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 154 (255)
T cd08219 81 DGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG- 154 (255)
T ss_pred CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccc-
Confidence 999999998643 334588999999999999999999999 99999999999999999999999999998764322
Q ss_pred eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCC
Q 010891 333 HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIET 412 (498)
Q Consensus 333 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (498)
.......|++.|+|||++.+..++.++|+||||+++|+|++|..||....... ....... .... .+.
T Consensus 155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~~-~~~~-----~~~- 221 (255)
T cd08219 155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN------LILKVCQ-GSYK-----PLP- 221 (255)
T ss_pred cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH------HHHHHhc-CCCC-----CCC-
Confidence 12234568999999999998889999999999999999999999997432211 1111111 1000 011
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 413 RPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 413 ~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
...+ ..+..++.+||+.||++|||+.+++..
T Consensus 222 -~~~~--~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 222 -SHYS--YELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred -cccC--HHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1111 123344458999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=320.39 Aligned_cols=251 Identities=24% Similarity=0.384 Sum_probs=202.0
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
..+|++.+.||+|+||.||+|.. .+++.||+|.+........+.+..|+.+++.++||||+++++++..+...|+||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 46789999999999999999984 57899999999765555556788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+++++|.+++.. ..+++.++..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 98 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 999999999853 3578999999999999999999998 99999999999999999999999999998764432
Q ss_pred ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCC
Q 010891 332 SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (498)
.. .....|++.|+|||.+.+..++.++|+|||||++|+|++|..||....+.... ..... ...+...
T Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~------~~~~~------~~~~~~~ 236 (297)
T cd06656 170 SK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIAT------NGTPELQ 236 (297)
T ss_pred cC-cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe------eeecc------CCCCCCC
Confidence 21 23356899999999999888999999999999999999999999754332110 00000 0011111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 412 ~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
...... ..+..++.+||..||++||++.+++++
T Consensus 237 ~~~~~~--~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 237 NPERLS--AVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CccccC--HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111111 223334458999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=324.06 Aligned_cols=197 Identities=23% Similarity=0.357 Sum_probs=162.0
Q ss_pred cceEcccCcEEEEEEEEc---CCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEe--CCeeEEEEeecC
Q 010891 179 DNIIGDGGYGVVYRGQLM---NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIE--GTQRILVYEYVN 253 (498)
Q Consensus 179 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~e~~~ 253 (498)
.++||+|+||+||+|+.. +++.||+|.+.... ....+.+|++++++++||||+++++++.. +...|++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999753 46789999885432 23457789999999999999999998864 456799999995
Q ss_pred CCCHHHHHhcccC-----CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEE----cCCCCeEEeeeccc
Q 010891 254 NGNLEQWLRGDMC-----DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI----DENFDAKISDFGLA 324 (498)
Q Consensus 254 ~g~L~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll----~~~~~~kL~DfGla 324 (498)
++|.+++..... ....+++..+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 589888753211 123588999999999999999999999 99999999999999 45678999999999
Q ss_pred eecCCCCc--eeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 010891 325 KLLGAGKS--HITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYG 381 (498)
Q Consensus 325 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~ 381 (498)
+....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 87654321 12334678999999998876 56899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=317.82 Aligned_cols=252 Identities=23% Similarity=0.299 Sum_probs=196.2
Q ss_pred CCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC---chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 176 FSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ---ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 176 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
|+..+.||+|+||.||++.. .+++.||+|.+...... ....+..|+.++++++|+||+.+++.+.+.+..|+||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 67788999999999999974 46889999988644322 223467899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+.+++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred cCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 9999999998643 224588999999999999999999998 99999999999999999999999999998654332
Q ss_pred ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCC
Q 010891 332 SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (498)
. .....||..|+|||++.+..++.++|||||||++|+|++|+.||........... ........ . ....
T Consensus 157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~---~~~~~~~~--~----~~~~ 225 (285)
T cd05630 157 T--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE---VERLVKEV--Q----EEYS 225 (285)
T ss_pred c--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH---HHhhhhhh--h----hhcC
Confidence 1 2234799999999999999999999999999999999999999975432211110 11110000 0 0011
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHH
Q 010891 412 TRPSTSALKRALLTALRCVDPDSDKRPK-----MSQVVRML 447 (498)
Q Consensus 412 ~~~~~~~~~~~l~~~~~cl~~dP~~RPt-----~~ell~~L 447 (498)
.. ... ....++.+||..||++||| +.|++++-
T Consensus 226 ~~-~~~---~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~ 262 (285)
T cd05630 226 EK-FSP---DARSLCKMLLCKDPKERLGCQGGGAREVKEHP 262 (285)
T ss_pred cc-CCH---HHHHHHHHHhhcCHHHccCCCCCchHHHHcCh
Confidence 11 111 2333444799999999999 88998754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=320.89 Aligned_cols=257 Identities=26% Similarity=0.405 Sum_probs=200.2
Q ss_pred ccCCCccceEcccCcEEEEEEEE------cCCcEEEEEEecCCCC-CchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCe
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL------MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQ 244 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~ 244 (498)
.++|.+.+.||+|+||.||+|.. ..+..||+|++..... ...+.+..|+++++++ +||||+++++++.....
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 35688899999999999999963 2345799998865432 2335688999999999 89999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccc
Q 010891 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (498)
Q Consensus 245 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla 324 (498)
.|+||||+.+|+|.++++.. ....+++.++..++.|++.||.|||+. +++|+||||+|||++.++.++|+|||++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccc
Confidence 99999999999999999743 223489999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCce-eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccc
Q 010891 325 KLLGAGKSH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRS 402 (498)
Q Consensus 325 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (498)
......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||........ ... .....
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~----~~~~~-- 260 (302)
T cd05055 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYK----LIKEG-- 260 (302)
T ss_pred ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHH----HHHcC--
Confidence 866433221 1222346788999999998899999999999999999998 9999875432211 111 11100
Q ss_pred cCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 403 EDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
.. ... .... ...+..++.+||+.+|++|||+.++++.|+.
T Consensus 261 ~~---~~~--~~~~--~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~ 300 (302)
T cd05055 261 YR---MAQ--PEHA--PAEIYDIMKTCWDADPLKRPTFKQIVQLIGK 300 (302)
T ss_pred Cc---CCC--CCCC--CHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence 00 000 1111 1234445558999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=318.36 Aligned_cols=264 Identities=25% Similarity=0.414 Sum_probs=198.0
Q ss_pred ccCCCccceEcccCcEEEEEEEEcC---------------CcEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLMN---------------GTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLL 236 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~ 236 (498)
.++|++.+.||+|+||.||+++... ...||+|.+...... ....+..|++++.+++||||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 3578999999999999999986432 235899988654322 235688999999999999999999
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhcccC--------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCE
Q 010891 237 GYCIEGTQRILVYEYVNNGNLEQWLRGDMC--------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNI 308 (498)
Q Consensus 237 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NI 308 (498)
+++......++||||+.+++|.+++..... ....+++..++.++.|++.||.|||+. +++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 999999999999999999999999964211 112478899999999999999999999 999999999999
Q ss_pred EEcCCCCeEEeeeccceecCCCCce-eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh--CCCCCCCCCCcc
Q 010891 309 LIDENFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT--GRYPVDYGRPQS 385 (498)
Q Consensus 309 ll~~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt--g~~P~~~~~~~~ 385 (498)
++++++.+||+|||++......... ......++..|+|||++.++.++.++|||||||++|+|++ |..||.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 9999999999999999865433211 1222345778999999988899999999999999999998 667776433211
Q ss_pred hhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 386 EVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
.................. ...+. ....+..++.+||+.||++|||+.++++.|.
T Consensus 241 ---~~~~~~~~~~~~~~~~~~----~~~~~--~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 ---VIENTGEFFRNQGRQIYL----SQTPL--CPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred ---HHHHHHHhhhhccccccC----CCCCC--CCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 111111111110000000 00111 1124555666899999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=332.70 Aligned_cols=262 Identities=24% Similarity=0.382 Sum_probs=200.4
Q ss_pred HHccCCCccceEcccCcEEEEEEEEc------CCcEEEEEEecCCCCC-chhHHHHHHHHHHcCC-CCCceEEEeEEEeC
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVR-HKNLVRLLGYCIEG 242 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~ 242 (498)
...++|.+.+.||+|+||.||+|++. .+..||+|++...... ..+.+..|+++|.++. ||||+++++++...
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 34456788899999999999999753 3468999999654332 2346888999999997 99999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcccC--------------------------------------------------------
Q 010891 243 TQRILVYEYVNNGNLEQWLRGDMC-------------------------------------------------------- 266 (498)
Q Consensus 243 ~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------- 266 (498)
...++||||+++|+|.++++....
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 999999999999999999964311
Q ss_pred --------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCE
Q 010891 267 --------------------------------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNI 308 (498)
Q Consensus 267 --------------------------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NI 308 (498)
....+++..+..++.|++.||.|||+. +++||||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceE
Confidence 112467888899999999999999998 999999999999
Q ss_pred EEcCCCCeEEeeeccceecCCCCc-eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcch
Q 010891 309 LIDENFDAKISDFGLAKLLGAGKS-HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSE 386 (498)
Q Consensus 309 ll~~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~ 386 (498)
|+++++.+||+|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~ 350 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence 999999999999999986533221 11223457889999999998889999999999999999998 8899864322111
Q ss_pred hhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 387 VNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
...... ..... .. .... ...+..++.+||..+|.+||++.++++.|+..
T Consensus 351 ------~~~~~~--~~~~~---~~--p~~~--~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 351 ------FYNAIK--RGYRM---AK--PAHA--SDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred ------HHHHHH--cCCCC---CC--CCCC--CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111111 11111 11 1111 12344445589999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=318.56 Aligned_cols=264 Identities=25% Similarity=0.384 Sum_probs=202.3
Q ss_pred cHHHHHHHccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcC-CCCCceEEEeEEE--
Q 010891 165 TLRDLQSATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCI-- 240 (498)
Q Consensus 165 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~-- 240 (498)
.++.+..+.++|++.+.||+|+||.||+|.. .+++.+|+|.+.... .....+..|+.++..+ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 4455667788999999999999999999975 457899999875422 2235678899999999 7999999999874
Q ss_pred ---eCCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeE
Q 010891 241 ---EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAK 317 (498)
Q Consensus 241 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~k 317 (498)
.+...++||||+++++|.+++.........+++..+..++.|++.||.|||+. +++||||||+||+++.++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~k 164 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVK 164 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEE
Confidence 34568999999999999999865433456788999999999999999999998 999999999999999999999
Q ss_pred EeeeccceecCCCCceeeecccccccccCccccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 010891 318 ISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYAN-----SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEW 392 (498)
Q Consensus 318 L~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~ 392 (498)
|+|||++........ ......|++.|+|||++. +..++.++|||||||++|||++|+.||....+...
T Consensus 165 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~------ 237 (286)
T cd06638 165 LVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA------ 237 (286)
T ss_pred EccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH------
Confidence 999999987643221 123346899999999875 34578899999999999999999999975432111
Q ss_pred HHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 393 LKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
....... ..+......... ..+..++.+||+.||++|||+.|+++++
T Consensus 238 ---~~~~~~~---~~~~~~~~~~~~--~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 238 ---LFKIPRN---PPPTLHQPELWS--NEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred ---Hhhcccc---CCCcccCCCCcC--HHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 1111100 001111111111 1234445589999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=318.88 Aligned_cols=251 Identities=25% Similarity=0.301 Sum_probs=195.4
Q ss_pred CCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC---chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 176 FSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ---ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 176 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
|+..+.||+|+||+||+|.. .+++.||+|.+...... ....+..|+++++.++|+||+.+++++.+++..|+||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 66778999999999999975 46889999988544322 224467899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+++++|.+++... ....+++..+..++.|++.||.|||+. +|+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE 156 (285)
T ss_pred ccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCC
Confidence 9999999988643 234699999999999999999999998 99999999999999999999999999998754322
Q ss_pred ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCC
Q 010891 332 SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (498)
. .....|+..|+|||++.+..++.++|+|||||++|||++|..||........ ........ ..... ..
T Consensus 157 ~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~--~~~~~~~~---~~~~~----~~- 224 (285)
T cd05632 157 S--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK--REEVDRRV---LETEE----VY- 224 (285)
T ss_pred c--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhh---hcccc----cc-
Confidence 1 2335789999999999988999999999999999999999999975432111 11111111 11010 11
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 010891 412 TRPSTSALKRALLTALRCVDPDSDKRPK-----MSQVVRM 446 (498)
Q Consensus 412 ~~~~~~~~~~~l~~~~~cl~~dP~~RPt-----~~ell~~ 446 (498)
..... .....++.+||+.||++||+ +.+++.+
T Consensus 225 -~~~~~--~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 225 -SAKFS--EEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred -CccCC--HHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 11111 12334445799999999999 6777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=318.08 Aligned_cols=261 Identities=25% Similarity=0.389 Sum_probs=202.6
Q ss_pred HccCCCccceEcccCcEEEEEEEEcC-----CcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEe-CCe
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLMN-----GTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIE-GTQ 244 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~ 244 (498)
..++|.+.+.||+|+||.||+|...+ +..|++|++..... ...+.+.+|+.+++.++||||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35678899999999999999998655 68899998864432 234568889999999999999999998776 467
Q ss_pred eEEEEeecCCCCHHHHHhcccCC----CCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEee
Q 010891 245 RILVYEYVNNGNLEQWLRGDMCD----RGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISD 320 (498)
Q Consensus 245 ~~lv~e~~~~g~L~~~l~~~~~~----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~D 320 (498)
.++++||+.+++|.+++...... ...+++..++.++.|++.||.|||+. +++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence 79999999999999999654221 14689999999999999999999998 999999999999999999999999
Q ss_pred eccceecCCCCcee-eecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHh
Q 010891 321 FGLAKLLGAGKSHI-TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQ 398 (498)
Q Consensus 321 fGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 398 (498)
||+++.+....... .....++..|+|||++.+..++.++|||||||++||+++ |+.||....+. ....+ ...
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~---~~~ 234 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMAAY---LKD 234 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHHHH---HHc
Confidence 99998664332221 222346778999999988889999999999999999999 99999754322 11111 111
Q ss_pred hccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 399 LRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
.... .... ... ..+..++.+||..||++|||+.++++.|+...
T Consensus 235 ---~~~~---~~~~-~~~---~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~ 277 (280)
T cd05043 235 ---GYRL---AQPI-NCP---DELFAVMACCWALDPEERPSFSQLVQCLTDFH 277 (280)
T ss_pred ---CCCC---CCCC-cCC---HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 1110 0000 111 23445556899999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=311.67 Aligned_cols=248 Identities=30% Similarity=0.441 Sum_probs=195.8
Q ss_pred cCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEE-eCCeeEEEEeec
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCI-EGTQRILVYEYV 252 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-~~~~~~lv~e~~ 252 (498)
.+|.+.+.||+|+||.||++.. .|..|++|.+... ...+.+..|+.++++++|||++++++++. ++...+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4688899999999999999976 5788999988543 23457889999999999999999999764 456789999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~ 332 (498)
++++|.+++... ....+++..++.++.|++.||+|||++ +++||||||+||++++++.+||+|||++.......
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 83 AKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 999999999753 234588999999999999999999998 99999999999999999999999999998654322
Q ss_pred eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCC
Q 010891 333 HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411 (498)
Q Consensus 333 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (498)
....++..|+|||++.+..++.++|||||||++|||++ |+.||..... .+....... .. .+...
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~------~~~~~~~~~---~~---~~~~~ 221 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDVVPRVEK---GY---KMDAP 221 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHHHhc---CC---CCCCC
Confidence 22345678999999998899999999999999999998 9999864322 111111111 10 01111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 412 ~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
.... .....++.+||..||++|||+.++++.|+.
T Consensus 222 -~~~~---~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 222 -DGCP---PVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred -CCCC---HHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 1111 233444558999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=317.68 Aligned_cols=264 Identities=25% Similarity=0.407 Sum_probs=198.9
Q ss_pred ccCCCccceEcccCcEEEEEEEEc-----------------CCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM-----------------NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVR 234 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~ 234 (498)
.++|++.+.||+|+||.||+++.. ++..||+|.+..... .....+..|+++++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 357899999999999999998532 234689998865432 23457889999999999999999
Q ss_pred EEeEEEeCCeeEEEEeecCCCCHHHHHhcccC-------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCC
Q 010891 235 LLGYCIEGTQRILVYEYVNNGNLEQWLRGDMC-------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSN 307 (498)
Q Consensus 235 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~N 307 (498)
+++++..+...++||||+++++|.+++..... ....+++..+..++.|++.||+|||+. +++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 99999999999999999999999999975321 123478889999999999999999999 99999999999
Q ss_pred EEEcCCCCeEEeeeccceecCCCCce-eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh--CCCCCCCCCCc
Q 010891 308 ILIDENFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT--GRYPVDYGRPQ 384 (498)
Q Consensus 308 Ill~~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt--g~~P~~~~~~~ 384 (498)
||++.++.++|+|||++..+...... ......++..|+|||...++.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 99999999999999999865433211 1222345678999999888889999999999999999998 77888643322
Q ss_pred chhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 385 SEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
. ............. .....+. .... ...+..++.+||+.||.+|||+.+|++.|+
T Consensus 241 ~---~~~~~~~~~~~~~-~~~~~~~---~~~~--~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 Q---VIENTGEFFRDQG-RQVYLPK---PALC--PDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred H---HHHHHHHHHhhcc-ccccCCC---CCCC--CHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1 1111111111000 0000011 1111 133445556899999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=326.87 Aligned_cols=202 Identities=24% Similarity=0.308 Sum_probs=174.4
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC---CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
++|.+.+.||+|+||+||+++. .+++.||+|.+.... ......+..|+.++..++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4789999999999999999985 467889999885421 122345778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||++||+|.+++... ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.....
T Consensus 81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999742 35689999999999999999999999 999999999999999999999999999987654
Q ss_pred CCceeeecccccccccCcccccC-----CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANS-----GLLNEKSDVYSFGVVLLEAITGRYPVDYG 381 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~P~~~~ 381 (498)
.........+||+.|+|||++.+ +.++.++|||||||+||||++|+.||...
T Consensus 155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 211 (331)
T cd05624 155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence 43333334579999999998865 56889999999999999999999999754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=323.28 Aligned_cols=259 Identities=27% Similarity=0.420 Sum_probs=198.9
Q ss_pred ccCCCccceEcccCcEEEEEEEEc--------CCcEEEEEEecCCCC-CchhHHHHHHHHHHcC-CCCCceEEEeEEEeC
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM--------NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHV-RHKNLVRLLGYCIEG 242 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~ 242 (498)
.++|.+.+.||+|+||.||+++.. ++..+|+|.+..... .....+..|+.++..+ +||||+++++++...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 467899999999999999999742 235699998865432 2335688899999999 899999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEE
Q 010891 243 TQRILVYEYVNNGNLEQWLRGDMC------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI 310 (498)
Q Consensus 243 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll 310 (498)
...|+||||+++|+|.+++..... ....+++.+++.++.|++.||+|||+. +++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 999999999999999999975321 123588999999999999999999998 99999999999999
Q ss_pred cCCCCeEEeeeccceecCCCCcee-eecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhh
Q 010891 311 DENFDAKISDFGLAKLLGAGKSHI-TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVN 388 (498)
Q Consensus 311 ~~~~~~kL~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~ 388 (498)
+.++.+||+|||++.......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~----- 248 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----- 248 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH-----
Confidence 999999999999997654322111 112234578999999988889999999999999999998 8888864321
Q ss_pred HHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 389 LVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
.+....+.... .. ...... ...+..++.+||..+|.+|||+.++++.|...
T Consensus 249 -~~~~~~~~~~~----~~----~~~~~~--~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~ 299 (307)
T cd05098 249 -EELFKLLKEGH----RM----DKPSNC--TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 299 (307)
T ss_pred -HHHHHHHHcCC----CC----CCCCcC--CHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence 11111111110 00 111111 12333445589999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=313.68 Aligned_cols=255 Identities=30% Similarity=0.512 Sum_probs=199.5
Q ss_pred ccCCCccceEcccCcEEEEEEEEc-CCc---EEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGT---AVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~---~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
.++|+..+.||+|+||.||+|... ++. .+++|++..... ...+.+..|++++..++||||+++++++.+....++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 356788899999999999999854 333 689998865432 234568889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
||||+++++|.+++... .+.+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++...
T Consensus 84 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence 99999999999999642 35689999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCceeee--cccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccC
Q 010891 328 GAGKSHITT--RVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSED 404 (498)
Q Consensus 328 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (498)
......... ....+..|+|||++.+..++.++|||||||++|||++ |+.||...... +....+.... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~------~~~~~i~~~~---~ 228 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH------EVMKAINDGF---R 228 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH------HHHHHHhcCC---C
Confidence 433221111 1223457999999988889999999999999999998 99999644321 2222222111 1
Q ss_pred CcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 405 VVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
. +.. .... .....++.+||..||++||++.++++.|+.
T Consensus 229 ~--~~~--~~~~---~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~ 266 (268)
T cd05063 229 L--PAP--MDCP---SAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266 (268)
T ss_pred C--CCC--CCCC---HHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence 0 111 1111 234455568999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=314.74 Aligned_cols=254 Identities=29% Similarity=0.468 Sum_probs=198.4
Q ss_pred cCCCccceEcccCcEEEEEEEEc-C---CcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM-N---GTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
++|.+.+.||+|+||.||+|... + +..+|+|.+..... ...+.+..|+.++.+++||||+++++++.+++..|+|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46888999999999999999753 2 33799998864332 2235688899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+++++|.+++... .+.+++.+++.++.|++.||.|||+. +++||||||+|||++.++.++|+|||++....
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999999743 34689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCceeee--cccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCC
Q 010891 329 AGKSHITT--RVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV 405 (498)
Q Consensus 329 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (498)
........ ...++..|+|||++.+..++.++|+|||||++||+++ |..||....... .. ..+.... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~---~~~~~~~---~~ 228 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VI---KAIEEGY---RL 228 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HH---HHHhCCC---cC
Confidence 43322111 1233568999999998889999999999999999886 999997543211 11 1111110 00
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 406 VDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 406 ~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
..... ....+..++.+||+.+|.+||++.++++.|..
T Consensus 229 -----~~~~~--~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 265 (267)
T cd05066 229 -----PAPMD--CPAALHQLMLDCWQKDRNERPKFEQIVSILDK 265 (267)
T ss_pred -----CCCCC--CCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence 00111 11223444558999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=320.08 Aligned_cols=257 Identities=26% Similarity=0.381 Sum_probs=195.8
Q ss_pred cCCCccceEcccCcEEEEEEEEcC-Cc--EEEEEEecCCC-CCchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCeeEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLMN-GT--AVAVKKLLNNP-GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv 248 (498)
++|++.+.||+|+||.||+|...+ +. .+++|.+.... ....+.+..|++++.++ +||||+++++++.+....|+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 468889999999999999997543 33 46888775322 22345688899999999 799999999999999999999
Q ss_pred EeecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCe
Q 010891 249 YEYVNNGNLEQWLRGDMC------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDA 316 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~ 316 (498)
|||+++++|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence 999999999999964321 113588999999999999999999998 99999999999999999999
Q ss_pred EEeeeccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHH
Q 010891 317 KISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKM 395 (498)
Q Consensus 317 kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~ 395 (498)
||+|||++....... .......+..|+|||++.+..++.++|||||||++|||++ |..||....... ....
T Consensus 159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~------~~~~ 230 (297)
T cd05089 159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE------LYEK 230 (297)
T ss_pred EECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHH
Confidence 999999986432111 1111223557999999998899999999999999999997 999997543321 1111
Q ss_pred HHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 396 MVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
.... ...... ...+ ..+..++.+||+.||.+|||+.++++.|....
T Consensus 231 ~~~~------~~~~~~--~~~~--~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~ 276 (297)
T cd05089 231 LPQG------YRMEKP--RNCD--DEVYELMRQCWRDRPYERPPFAQISVQLSRML 276 (297)
T ss_pred HhcC------CCCCCC--CCCC--HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1110 001111 1111 22344555899999999999999999887543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=355.36 Aligned_cols=260 Identities=23% Similarity=0.372 Sum_probs=198.0
Q ss_pred HHHHHccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEe--C
Q 010891 168 DLQSATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIE--G 242 (498)
Q Consensus 168 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~ 242 (498)
+.....++|.+.+.||+|+||+||+|+. .++..||+|.+..... .....|..|+.++..|+|||||+++++|.+ .
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 3455667899999999999999999985 4577889998854322 234568889999999999999999998865 3
Q ss_pred CeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccC----CCeeecCCCCCCEEEcC------
Q 010891 243 TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIE----PKVVHRDIKSSNILIDE------ 312 (498)
Q Consensus 243 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~----~~iiHrDikp~NIll~~------ 312 (498)
..+||||||+++|+|.++|.......+.+++..++.|+.||+.||.|||+... .+||||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 56899999999999999997543344679999999999999999999998521 25999999999999964
Q ss_pred -----------CCCeEEeeeccceecCCCCceeeecccccccccCcccccC--CCCCccchHHHHHHHHHHHHhCCCCCC
Q 010891 313 -----------NFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANS--GLLNEKSDVYSFGVVLLEAITGRYPVD 379 (498)
Q Consensus 313 -----------~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~P~~ 379 (498)
.+.+||+|||++..+.... ......||+.|+|||++.+ ..++.++||||||||||||++|..||.
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 2358999999998764322 2234579999999998854 468999999999999999999999997
Q ss_pred CCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 010891 380 YGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVR 445 (498)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~ 445 (498)
..... ...+..+. .. +.+....... .+..++..||..+|.+||++.|+|.
T Consensus 245 ~~~~~-----~qli~~lk---~~-----p~lpi~~~S~---eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 245 KANNF-----SQLISELK---RG-----PDLPIKGKSK---ELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred cCCcH-----HHHHHHHh---cC-----CCCCcCCCCH---HHHHHHHHHhcCChhHCcCHHHHhc
Confidence 44321 11111111 11 1111111122 2334445899999999999999994
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=322.34 Aligned_cols=256 Identities=26% Similarity=0.410 Sum_probs=195.9
Q ss_pred cCCCccceEcccCcEEEEEEEEc-CCc--EEEEEEecCCCC-CchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCeeEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM-NGT--AVAVKKLLNNPG-QADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv 248 (498)
++|++.+.||+|+||.||+|.+. ++. .+++|.+..... .....+.+|++++.++ +||||+++++++.++...|+|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46788899999999999999853 454 457777654322 2335688899999999 899999999999999999999
Q ss_pred EeecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCe
Q 010891 249 YEYVNNGNLEQWLRGDMC------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDA 316 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~ 316 (498)
|||+++++|.+++..... ....+++..++.++.|++.||+|||++ +++||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 999999999999964321 123588999999999999999999998 99999999999999999999
Q ss_pred EEeeeccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHH
Q 010891 317 KISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKM 395 (498)
Q Consensus 317 kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~ 395 (498)
||+|||++....... ......++..|+|||++.+..++.++|||||||++|||+| |..||...... +....
T Consensus 164 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~~ 235 (303)
T cd05088 164 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYEK 235 (303)
T ss_pred EeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH------HHHHH
Confidence 999999986432111 1111234667999999988889999999999999999998 99999643321 11111
Q ss_pred HHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 396 MVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
+... ........ .. ..+..++.+||+.+|++||++.+++..|...
T Consensus 236 ~~~~------~~~~~~~~-~~---~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~ 280 (303)
T cd05088 236 LPQG------YRLEKPLN-CD---DEVYDLMRQCWREKPYERPSFAQILVSLNRM 280 (303)
T ss_pred HhcC------CcCCCCCC-CC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1110 00011111 11 2334455589999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=311.34 Aligned_cols=245 Identities=29% Similarity=0.416 Sum_probs=190.8
Q ss_pred eEcccCcEEEEEEEE---cCCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCCC
Q 010891 181 IIGDGGYGVVYRGQL---MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNG 255 (498)
Q Consensus 181 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g 255 (498)
.||+|+||.||+|.+ .++..+|+|++..... ...+++..|+.+++.++||||+++++++. ....++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999964 3578899998854432 23456888999999999999999999885 45679999999999
Q ss_pred CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCcee-
Q 010891 256 NLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI- 334 (498)
Q Consensus 256 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~- 334 (498)
+|.+++.. ...+++..+..++.|++.||.|||+. +++||||||.||+++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999963 34689999999999999999999998 99999999999999999999999999998765433221
Q ss_pred -eecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCC
Q 010891 335 -TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIET 412 (498)
Q Consensus 335 -~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (498)
.....++..|+|||.+....++.++|||||||++|||++ |..||...... +....... . .. +....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~i~~-~--~~---~~~~~ 221 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN------EVTQMIES-G--ER---MECPQ 221 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHC-C--CC---CCCCC
Confidence 112234678999999988889999999999999999998 99999754321 11122111 1 11 11111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 413 RPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 413 ~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
..... +..++.+||+.||++||++.+|.+.|++
T Consensus 222 -~~~~~---l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 222 -RCPPE---MYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred -CCCHH---HHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 11122 3344458999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=315.30 Aligned_cols=256 Identities=27% Similarity=0.439 Sum_probs=197.7
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCc----EEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGT----AVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI 246 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 246 (498)
.++|++.+.||+|+||+||+|++ .+|. .||+|.+..... .....+..|+.++..++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 35678889999999999999974 3444 489998864432 234568889999999999999999999875 4568
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecccee
Q 010891 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (498)
Q Consensus 247 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~ 326 (498)
++|||+++|+|.+++... .+.+++..++.++.||+.||.|||+. +|+||||||+|||+++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceee
Confidence 999999999999999742 34689999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCcee-eecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccC
Q 010891 327 LGAGKSHI-TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSED 404 (498)
Q Consensus 327 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (498)
........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||....... ...++. .. ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~----~~--~~ 229 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDLLE----KG--ER 229 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHH----CC--Cc
Confidence 75432221 122335678999999988899999999999999999998 899986433211 111111 11 10
Q ss_pred CcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 405 VVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
. ... ... ...+..++.+||+.||++||++.++++.|....
T Consensus 230 ~---~~~-~~~---~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05109 230 L---PQP-PIC---TIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA 269 (279)
T ss_pred C---CCC-ccC---CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 0 000 111 123444556899999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=318.16 Aligned_cols=255 Identities=24% Similarity=0.332 Sum_probs=199.9
Q ss_pred HccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
..+.|++.+.||.|+||.||+|+. .++..|++|.+........+.+..|+.+++.++||||+++++++..+...|+|||
T Consensus 10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 346789999999999999999985 4588999999876655556678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
|+++++|..++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 90 ~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 90 FCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred cCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 99999999887532 34689999999999999999999998 9999999999999999999999999998764332
Q ss_pred CceeeecccccccccCccccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCC
Q 010891 331 KSHITTRVMGTFGYVAPEYAN-----SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV 405 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (498)
. .......+++.|+|||++. ...++.++|||||||++|||++|..||....+. .....+.. .
T Consensus 164 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~~~~~~---~--- 230 (292)
T cd06644 164 L-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAK---S--- 230 (292)
T ss_pred c-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHHHHHhc---C---
Confidence 2 1123356889999999884 455788999999999999999999999643321 11111111 0
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 406 VDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 406 ~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
..+........+ .....++.+||..||++||++.+++++-
T Consensus 231 ~~~~~~~~~~~~--~~~~~li~~~l~~~p~~Rp~~~~il~~~ 270 (292)
T cd06644 231 EPPTLSQPSKWS--MEFRDFLKTALDKHPETRPSAAQLLEHP 270 (292)
T ss_pred CCccCCCCcccC--HHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 011111111111 2234445589999999999999998753
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=318.61 Aligned_cols=262 Identities=25% Similarity=0.397 Sum_probs=200.2
Q ss_pred HHccCCCccceEcccCcEEEEEEEEc------CCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCC
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT 243 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 243 (498)
...++|++.+.||+|+||.||+|... .+..||+|.+..... .....+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 45678999999999999999999642 245799998754332 12235778999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcccC------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeE
Q 010891 244 QRILVYEYVNNGNLEQWLRGDMC------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAK 317 (498)
Q Consensus 244 ~~~lv~e~~~~g~L~~~l~~~~~------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~k 317 (498)
..|+||||+++|+|.+++..... ....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence 99999999999999999964211 123456788899999999999999999 999999999999999999999
Q ss_pred EeeeccceecCCCCce-eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHH
Q 010891 318 ISDFGLAKLLGAGKSH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKM 395 (498)
Q Consensus 318 L~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~ 395 (498)
|+|||+++........ ......++..|+|||.+.++.++.++|||||||++|||++ |..||...... +....
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------~~~~~ 233 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------QVLKF 233 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHH
Confidence 9999999865432211 1222345778999999998899999999999999999999 78888643221 11111
Q ss_pred HHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 396 MVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
...... .... ... ...+..++.+||+.||++|||+.++++.|....
T Consensus 234 ~~~~~~------~~~~--~~~--~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 234 VMDGGY------LDQP--DNC--PERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred HHcCCC------CCCC--CCC--CHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 111100 0011 111 123444555899999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=315.34 Aligned_cols=254 Identities=30% Similarity=0.491 Sum_probs=197.0
Q ss_pred cCCCccceEcccCcEEEEEEEEc-CC---cEEEEEEecCCC-CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM-NG---TAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
+.|.+.+.||+|+||.||+|... ++ ..||+|.+.... ......|..|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 34788899999999999999753 33 369999886542 22345788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+++++|.+++... .+.+++.+++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999999742 35689999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCcee--eeccc--ccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhcccc
Q 010891 329 AGKSHI--TTRVM--GTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSE 403 (498)
Q Consensus 329 ~~~~~~--~~~~~--gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (498)
...... ..... .+..|+|||.+.+..++.++|||||||++|||++ |..||...... ...+++ .. ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i---~~---~~ 228 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAI---EQ---DY 228 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHH---Hc---CC
Confidence 332111 11111 2457999999999999999999999999999886 99999754321 111211 11 11
Q ss_pred CCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 404 DVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
. ....... ...+..++.+||..+|++||++.+++..|+.
T Consensus 229 ~-----~~~~~~~--~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 267 (269)
T cd05065 229 R-----LPPPMDC--PTALHQLMLDCWQKDRNARPKFGQIVSTLDK 267 (269)
T ss_pred c-----CCCcccC--CHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence 0 0001111 1223445558999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=311.02 Aligned_cols=255 Identities=27% Similarity=0.411 Sum_probs=202.4
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
.++|++.+.||.|+||.||+|.. .+++.+++|.+........+.+..|+++++.++||||+++++++.+....|++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 35788999999999999999975 45788999998766555667789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+.+++|.+++... ...+++..+..++.|++.||.|||+. +++|+||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 82 CGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred CCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 9999999998642 25689999999999999999999998 99999999999999999999999999998654322
Q ss_pred ceeeecccccccccCcccccCC---CCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCC
Q 010891 332 SHITTRVMGTFGYVAPEYANSG---LLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (498)
.......++..|+|||.+.+. .++.++||||||+++|||++|..||....+.... ..... .. ...+
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~------~~~~~-~~---~~~~ 224 (262)
T cd06613 156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL------FLISK-SN---FPPP 224 (262)
T ss_pred -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHh-cc---CCCc
Confidence 112335688999999998776 8899999999999999999999999754322111 11110 00 0001
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 409 NIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
..... ......+..++.+||..||.+|||+.+++.+
T Consensus 225 ~~~~~--~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 225 KLKDK--EKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred cccch--hhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 11111 1112234455568999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=312.50 Aligned_cols=240 Identities=25% Similarity=0.369 Sum_probs=186.1
Q ss_pred ceEcccCcEEEEEEEEcC-------------CcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeE
Q 010891 180 NIIGDGGYGVVYRGQLMN-------------GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI 246 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 246 (498)
+.||+|+||.||+|.+.. ...|++|.+..........+..|+.++..++||||+++++++..+...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999997422 2358888876554444557888999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCC-------eEEe
Q 010891 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD-------AKIS 319 (498)
Q Consensus 247 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~-------~kL~ 319 (498)
+||||+++|+|..++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++. ++++
T Consensus 81 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence 99999999999998864 235689999999999999999999999 9999999999999987664 8999
Q ss_pred eeccceecCCCCceeeecccccccccCccccc-CCCCCccchHHHHHHHHHHHH-hCCCCCCCCCCcchhhHHHHHHHHH
Q 010891 320 DFGLAKLLGAGKSHITTRVMGTFGYVAPEYAN-SGLLNEKSDVYSFGVVLLEAI-TGRYPVDYGRPQSEVNLVEWLKMMV 397 (498)
Q Consensus 320 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~ell-tg~~P~~~~~~~~~~~~~~~~~~~~ 397 (498)
|||++..... .....|+..|+|||.+. +..++.++|||||||++|||+ +|..||........ ....
T Consensus 155 d~g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-------~~~~ 222 (262)
T cd05077 155 DPGIPITVLS-----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-------ERFY 222 (262)
T ss_pred CCCCCccccC-----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-------HHHH
Confidence 9999875532 22345788999999886 567899999999999999998 58888764322110 0111
Q ss_pred hhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 398 QLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
. .... ...+... .+..++.+||+.||.+||++.++++.|+
T Consensus 223 ~--~~~~------~~~~~~~---~~~~li~~cl~~dp~~Rp~~~~il~~~~ 262 (262)
T cd05077 223 E--GQCM------LVTPSCK---ELADLMTHCMNYDPNQRPFFRAIMRDIN 262 (262)
T ss_pred h--cCcc------CCCCChH---HHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence 0 0000 0111222 2334455899999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=316.66 Aligned_cols=201 Identities=27% Similarity=0.430 Sum_probs=170.8
Q ss_pred CCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
+|++.+.||+|+||.||+|+. .++..||+|++..... ...+.+..|+.++..++||||+++++++.++...|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 477889999999999999985 4689999998854322 2335688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+. ++|.+++.... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 97 58999886432 235689999999999999999999998 99999999999999999999999999998664332
Q ss_pred ceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 010891 332 SHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYG 381 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~ 381 (498)
. ......+++.|+|||++.+ ..++.++|||||||++|+|+||+.||...
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~ 205 (285)
T cd07861 156 R-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205 (285)
T ss_pred c-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 1 1233457899999998765 45789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=317.22 Aligned_cols=257 Identities=24% Similarity=0.387 Sum_probs=201.6
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
++|++.+.||+|+||+||++.. .+|..||+|++..... ...+.+..|+++++.++||||+++++++......++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 5678889999999999999975 4688999998765432 3346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+++++|.+++.. .+.+++..+..++.+++.||.|||+.. +++||||||+||++++++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~ 158 (284)
T cd06620 85 MDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI 158 (284)
T ss_pred CCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc
Confidence 999999999863 356899999999999999999999632 89999999999999999999999999987543221
Q ss_pred ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCc-----chhhHHHHHHHHHhhccccCCc
Q 010891 332 SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQ-----SEVNLVEWLKMMVQLRRSEDVV 406 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 406 (498)
.....|+..|+|||++.+..++.++|||||||++|+|++|+.||...... ......+....+....
T Consensus 159 ---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 229 (284)
T cd06620 159 ---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP------ 229 (284)
T ss_pred ---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc------
Confidence 22357899999999998889999999999999999999999999754332 1111222222221110
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 407 DPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 407 ~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
.+.+.... ....+..++.+||..||++|||+.|++++..
T Consensus 230 ~~~~~~~~---~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 230 PPRLPSSD---FPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred CCCCCchh---cCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 11111111 1123444556899999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=314.58 Aligned_cols=257 Identities=26% Similarity=0.414 Sum_probs=199.4
Q ss_pred cCCCccceEcccCcEEEEEEEEc------CCcEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI 246 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 246 (498)
.+|++.+.||+|+||.||+|+.. +.+.|++|.+...... ....+..|++++++++||||+++++++.+....|
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888999999999999999753 2467899987554333 3467899999999999999999999999989999
Q ss_pred EEEeecCCCCHHHHHhcccCC-----CCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeee
Q 010891 247 LVYEYVNNGNLEQWLRGDMCD-----RGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDF 321 (498)
Q Consensus 247 lv~e~~~~g~L~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~Df 321 (498)
+||||+++|+|.+++...... ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999754211 12689999999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhc
Q 010891 322 GLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLR 400 (498)
Q Consensus 322 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 400 (498)
|++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||....... ....... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~------~~~~~~~-~ 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE------VLNRLQA-G 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH------HHHHHHc-C
Confidence 9987553332222333456788999999988888999999999999999999 788886432211 1111110 0
Q ss_pred cccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 401 RSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
.... ... .... ..+..++.+||..||.+|||+.+++..|.
T Consensus 235 ~~~~----~~~-~~~~---~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 KLEL----PVP-EGCP---SRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CcCC----CCC-CCCC---HHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1000 000 1111 23444555899999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=310.37 Aligned_cols=247 Identities=26% Similarity=0.429 Sum_probs=190.8
Q ss_pred eEcccCcEEEEEEEEc---CCcEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCCCC
Q 010891 181 IIGDGGYGVVYRGQLM---NGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGN 256 (498)
Q Consensus 181 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~ 256 (498)
.||+|+||.||+|.+. .+..||+|.+...... ..+.+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999653 3557999988654332 2356889999999999999999999885 457799999999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCceee-
Q 010891 257 LEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHIT- 335 (498)
Q Consensus 257 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~~- 335 (498)
|.+++... ...+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||++...........
T Consensus 81 L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 99999642 35689999999999999999999998 999999999999999999999999999986544332211
Q ss_pred -ecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCC
Q 010891 336 -TRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETR 413 (498)
Q Consensus 336 -~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (498)
....++..|+|||.+.+..++.++|||||||++|||++ |..||....... .......... .... .
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~~~~------~~~~-~ 221 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE------VMSFIEQGKR------LDCP-A 221 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH------HHHHHHCCCC------CCCC-C
Confidence 11234578999999988889999999999999999996 999997543321 1111111110 1111 1
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 414 PSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 414 ~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
.... .+..++.+||..||++||++.++.+.|+..
T Consensus 222 ~~~~---~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 222 ECPP---EMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1122 333445589999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=309.98 Aligned_cols=250 Identities=33% Similarity=0.512 Sum_probs=199.2
Q ss_pred ceEcccCcEEEEEEEEcC----CcEEEEEEecCCCCCc-hhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCC
Q 010891 180 NIIGDGGYGVVYRGQLMN----GTAVAVKKLLNNPGQA-DKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNN 254 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (498)
+.||+|+||.||+|.... +..|++|.+....... .+.+..|++++..++|+||+++++++.+....++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999998543 7889999986554433 56788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCC-----CCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 255 GNLEQWLRGDMCD-----RGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 255 g~L~~~l~~~~~~-----~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
++|.+++...... ...+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999754211 36799999999999999999999998 999999999999999999999999999987654
Q ss_pred CCc-eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcC
Q 010891 330 GKS-HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407 (498)
Q Consensus 330 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (498)
... .......++..|+|||.+....++.++|||||||++|||++ |..||...... +....... ......
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~---~~~~~~ 228 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE------EVLEYLRK---GYRLPK 228 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHHc---CCCCCC
Confidence 321 11233457889999999988899999999999999999999 69999755221 11122211 111101
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 408 ~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
.... ...+..++.+||..||.+|||+.+++++|+
T Consensus 229 -----~~~~--~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 229 -----PEYC--PDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -----CccC--ChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1111 233445556899999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=350.60 Aligned_cols=259 Identities=24% Similarity=0.351 Sum_probs=196.8
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC---chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ---ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
++|++.++||+|+||.||+|.. .+|+.||+|++...... ..+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5789999999999999999985 45899999998654322 2346888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccC-------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeec
Q 010891 250 EYVNNGNLEQWLRGDMC-------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFG 322 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~-------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfG 322 (498)
||++||+|.+++..... ....+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864211 123456778899999999999999999 99999999999999999999999999
Q ss_pred cceecCCCC-----------------ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcc
Q 010891 323 LAKLLGAGK-----------------SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQS 385 (498)
Q Consensus 323 la~~~~~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~ 385 (498)
+++...... .......+||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 998762110 011123579999999999999999999999999999999999999997532211
Q ss_pred hhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhc
Q 010891 386 EVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRP-KMSQVVRMLES 449 (498)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RP-t~~ell~~L~~ 449 (498)
.. .. . ....+. ...+.......+..++.+||..||++|| +++++++.|+.
T Consensus 239 i~---------~~-~---~i~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~ 289 (932)
T PRK13184 239 IS---------YR-D---VILSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP 289 (932)
T ss_pred hh---------hh-h---hccChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 00 00 0 000010 0000000112233445589999999996 55666666654
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=337.70 Aligned_cols=254 Identities=22% Similarity=0.347 Sum_probs=201.7
Q ss_pred cCCCccceEcccCcEEEEEEEEcC-CcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeec
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 252 (498)
+.|.++..||.|+||.||+|...+ +-..|.|.+........++|..||+||..+.||+||++++.|...+.+||+.|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 345677899999999999997544 4455678776667777789999999999999999999999999899999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~ 332 (498)
.||-....+-. -...|++.++..+++|++.||.|||++ +|||||||+.|||++-+|.++|+|||.+...... .
T Consensus 112 ~GGAVDaimlE---L~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~ 184 (1187)
T KOG0579|consen 112 GGGAVDAIMLE---LGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-R 184 (1187)
T ss_pred CCchHhHHHHH---hccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhH-H
Confidence 99998887753 346799999999999999999999999 9999999999999999999999999998654322 1
Q ss_pred eeeecccccccccCcccc-----cCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcC
Q 010891 333 HITTRVMGTFGYVAPEYA-----NSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407 (498)
Q Consensus 333 ~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (498)
.....+.|||+|||||++ ...+|+.++||||||++|.||..+.+|... .+.+..+-.+.. --.
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe------lnpMRVllKiaK------SeP 252 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE------LNPMRVLLKIAK------SEP 252 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc------cchHHHHHHHhh------cCC
Confidence 224558899999999976 457899999999999999999999988653 222332222221 112
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 408 ~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
|.+..+...+....++. .+||.+||+.||++.++++|--
T Consensus 253 PTLlqPS~Ws~~F~DfL--k~cL~Knp~~Rp~aaqll~Hpf 291 (1187)
T KOG0579|consen 253 PTLLQPSHWSRSFSDFL--KRCLVKNPRNRPPAAQLLKHPF 291 (1187)
T ss_pred CcccCcchhhhHHHHHH--HHHHhcCCccCCCHHHHhhCcc
Confidence 33333333333334433 3899999999999999998754
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=319.89 Aligned_cols=259 Identities=27% Similarity=0.426 Sum_probs=200.0
Q ss_pred ccCCCccceEcccCcEEEEEEEE--------cCCcEEEEEEecCCC-CCchhHHHHHHHHHHcC-CCCCceEEEeEEEeC
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL--------MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEG 242 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~ 242 (498)
..+|.+.+.||+|+||.||+|+. .++..||+|.+.... ......+..|+.++..+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 45678899999999999999963 124579999886432 23345688999999999 899999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEE
Q 010891 243 TQRILVYEYVNNGNLEQWLRGDMC------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI 310 (498)
Q Consensus 243 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll 310 (498)
...|+||||+++|+|.+++..... ....+++..++.++.||+.||.|||++ +++||||||+||++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEE
Confidence 999999999999999999975321 124578899999999999999999999 99999999999999
Q ss_pred cCCCCeEEeeeccceecCCCCcee-eecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhh
Q 010891 311 DENFDAKISDFGLAKLLGAGKSHI-TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVN 388 (498)
Q Consensus 311 ~~~~~~kL~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~ 388 (498)
+.++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|+|++ |..||.....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----- 245 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV----- 245 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH-----
Confidence 999999999999998764432221 222346678999999988899999999999999999998 7888854321
Q ss_pred HHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 389 LVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
.+.......... . ... .... ..+..++.+||..+|++|||+.++++.|+..
T Consensus 246 -~~~~~~~~~~~~---~---~~~-~~~~---~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~ 296 (304)
T cd05101 246 -EELFKLLKEGHR---M---DKP-ANCT---NELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296 (304)
T ss_pred -HHHHHHHHcCCc---C---CCC-CCCC---HHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence 122222211110 0 000 1111 2333445589999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=317.89 Aligned_cols=250 Identities=23% Similarity=0.398 Sum_probs=201.0
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeec
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 252 (498)
.+|++.+.||.|+||.||+|.. .+++.|++|.+........+.+..|+.+++.++||||+++++++......|+|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4688999999999999999974 578999999986655555667889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~ 332 (498)
++++|.+++.. ..+++.++..++.|++.||+|||+. +++|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 99999999853 3589999999999999999999999 999999999999999999999999999886543322
Q ss_pred eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCC
Q 010891 333 HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIET 412 (498)
Q Consensus 333 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (498)
. .....|+..|+|||.+.+..++.++|||||||++|+|++|+.||....+... ....... . .+.+..
T Consensus 171 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~------~~~~~~~-~-----~~~~~~ 237 (296)
T cd06655 171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA------LYLIATN-G-----TPELQN 237 (296)
T ss_pred c-CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhc-C-----CcccCC
Confidence 1 2234688999999999988899999999999999999999999975443211 1111110 0 011111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 413 RPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 413 ~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
...... ....++.+||..||.+|||+.+++.+
T Consensus 238 ~~~~~~--~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 238 PEKLSP--IFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred cccCCH--HHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 111112 23334458999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=311.56 Aligned_cols=249 Identities=27% Similarity=0.459 Sum_probs=196.3
Q ss_pred CCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCc---------hhHHHHHHHHHHcCCCCCceEEEeEEEeCCe
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQA---------DKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQ 244 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 244 (498)
+|.+.+.||+|+||.||+|.. .+++.||+|.+....... .+.+..|+.+++.++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 467889999999999999974 468899999886543322 1457789999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccc
Q 010891 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (498)
Q Consensus 245 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla 324 (498)
.++||||+++++|.+++.. .+.+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence 9999999999999999963 35688999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCce-----eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhh
Q 010891 325 KLLGAGKSH-----ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQL 399 (498)
Q Consensus 325 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 399 (498)
+........ ......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||....... .+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---------~~~~~ 224 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ---------AIFKI 224 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH---------HHHHH
Confidence 876522111 1122458899999999998889999999999999999999999997532211 11111
Q ss_pred ccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 400 RRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
.. ...+.+... .. ..+..++.+||+.||.+||++.+++++
T Consensus 225 ~~---~~~~~~~~~-~~---~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 225 GE---NASPEIPSN-IS---SEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred hc---cCCCcCCcc-cC---HHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 11 111111111 11 223334458999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=327.15 Aligned_cols=200 Identities=29% Similarity=0.340 Sum_probs=170.0
Q ss_pred HHccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEeC-----
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEG----- 242 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~----- 242 (498)
...++|.+.+.||+|+||.||+|.. ..++.||+|++..... .....+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 3557899999999999999999974 4688999999864322 2235677899999999999999999988643
Q ss_pred -CeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeee
Q 010891 243 -TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDF 321 (498)
Q Consensus 243 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~Df 321 (498)
...|+||||+++ +|.+++.. .+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeC
Confidence 346999999965 77777742 378899999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 010891 322 GLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 322 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~ 382 (498)
|+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 164 g~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 164 GLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred cccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999865432 22334578999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=329.18 Aligned_cols=199 Identities=29% Similarity=0.339 Sum_probs=169.6
Q ss_pred HccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC--CCchhHHHHHHHHHHcCCCCCceEEEeEEEeC------
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG------ 242 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------ 242 (498)
..++|.+.+.||+|+||.||+|.. ..++.||||++.... ......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 457899999999999999999974 468899999986432 22345677899999999999999999987643
Q ss_pred CeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeec
Q 010891 243 TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFG 322 (498)
Q Consensus 243 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfG 322 (498)
...|+||||+++ +|.+++.. .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCC
Confidence 357999999965 78887752 378899999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 010891 323 LAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 323 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~ 382 (498)
+++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 172 ~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 172 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred CccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 998654322 2334578999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=308.01 Aligned_cols=247 Identities=29% Similarity=0.452 Sum_probs=194.9
Q ss_pred ceEcccCcEEEEEEEEcCCcEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCCCCHH
Q 010891 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLE 258 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~ 258 (498)
++||.|+||.||+|...+++.|++|.+...... ....+..|++++++++||||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 369999999999998766999999988654443 3457889999999999999999999999999999999999999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCceee-ec
Q 010891 259 QWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHIT-TR 337 (498)
Q Consensus 259 ~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~~-~~ 337 (498)
+++... ...+++..++.++.+++.||.|||++ +++||||||+||+++.++.+||+|||++........... ..
T Consensus 81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 999642 34688999999999999999999999 999999999999999999999999999986543221111 11
Q ss_pred ccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCH
Q 010891 338 VMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPST 416 (498)
Q Consensus 338 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (498)
..++..|+|||.+.++.++.++|+|||||++|||++ |..||........ . .... ....... . .
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~---~---~~~~---~~~~~~~-----~--~ 218 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQT---R---ERIE---SGYRMPA-----P--Q 218 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHH---H---HHHh---cCCCCCC-----C--c
Confidence 234567999999988899999999999999999999 8888865432211 1 1111 0000000 0 0
Q ss_pred HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 417 SALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 417 ~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
.....+..++.+||..+|++|||+.|+++.|.
T Consensus 219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred cCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 11223444556899999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=315.87 Aligned_cols=252 Identities=25% Similarity=0.344 Sum_probs=196.4
Q ss_pred CCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCC
Q 010891 176 FSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNN 254 (498)
Q Consensus 176 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (498)
|++.+.||+|+||.||+|... ++..+++|.+........+.+..|+++++.++||||+++++++..+...|+||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 567789999999999999854 5778888888655444556788899999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCcee
Q 010891 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (498)
Q Consensus 255 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 334 (498)
++|..++.. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....... ..
T Consensus 87 ~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~ 159 (282)
T cd06643 87 GAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR 159 (282)
T ss_pred CcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-cc
Confidence 999998864 235689999999999999999999998 99999999999999999999999999997654322 12
Q ss_pred eecccccccccCccccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 335 TTRVMGTFGYVAPEYAN-----SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 335 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
.....|+..|+|||++. +..++.++|||||||++|||++|+.||....+. +....+.... . +.
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~------~~~~~~~~~~-~-----~~ 227 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSE-P-----PT 227 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH------HHHHHHhhcC-C-----CC
Confidence 23356899999999873 456788999999999999999999998643321 1111111110 0 11
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
.......+ ..+..++.+||+.||.+|||+.+++++--
T Consensus 228 ~~~~~~~~--~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 228 LAQPSRWS--SEFKDFLKKCLEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred CCCccccC--HHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence 11111111 22334445899999999999999987653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=320.36 Aligned_cols=201 Identities=26% Similarity=0.401 Sum_probs=170.7
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
++|.+.+.||.|+||.||+|+. .+++.||+|.+..... .....+..|+.+++.++||||+++++++.+....++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 4688899999999999999975 4688999999854432 2334677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
++ ++|.+++... ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 86 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 97 5999988642 34588999999999999999999998 99999999999999999999999999997654322
Q ss_pred ceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 010891 332 SHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~ 382 (498)
.. .....+++.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 159 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~ 209 (301)
T cd07873 159 KT-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST 209 (301)
T ss_pred Cc-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 11 223457899999998765 458889999999999999999999997543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=312.64 Aligned_cols=255 Identities=26% Similarity=0.388 Sum_probs=198.2
Q ss_pred cCCCccceEcccCcEEEEEEEEcC----CcEEEEEEecCCC-CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLMN----GTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
++|.+.+.||+|+||.||+|.+.+ ...|++|...... ....+.+..|+.+++.++||||+++++++.+ ...|+|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457888999999999999997533 2468999876544 2334578899999999999999999999875 557899
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+++++|.+++... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||+++...
T Consensus 85 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 85 MELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecc
Confidence 9999999999999642 23589999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (498)
...........++..|+|||.+....++.++||||||+++|||++ |..||....... ... ... ......
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~---~~~---~~~~~~- 228 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND---VIG---RIE---NGERLP- 228 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH---HHH---HHH---cCCcCC-
Confidence 443222223335568999999988889999999999999999996 999997543221 111 111 111111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 408 ~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
. .... ...+..++.+|+..+|++|||+.++++.|+...
T Consensus 229 --~--~~~~--~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~ 266 (270)
T cd05056 229 --M--PPNC--PPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL 266 (270)
T ss_pred --C--CCCC--CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1 1111 123444455899999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=327.54 Aligned_cols=198 Identities=26% Similarity=0.385 Sum_probs=169.2
Q ss_pred HHccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEeC-----
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEG----- 242 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~----- 242 (498)
...++|.+.+.||+|+||+||+|.. .+++.||||++..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 4567899999999999999999974 5688999999864322 2234577899999999999999999987643
Q ss_pred -CeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeee
Q 010891 243 -TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDF 321 (498)
Q Consensus 243 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~Df 321 (498)
...|++++++ +++|.+++. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df 162 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDF 162 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCC
Confidence 3468999998 779998874 24589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 010891 322 GLAKLLGAGKSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYG 381 (498)
Q Consensus 322 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~ 381 (498)
|+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus 163 g~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 219 (343)
T cd07878 163 GLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219 (343)
T ss_pred ccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 999875432 234578999999998866 57899999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=317.02 Aligned_cols=253 Identities=25% Similarity=0.366 Sum_probs=199.5
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
.++|++.+.||.|+||.||+|.. .++..||+|.+........+.+..|++++++++||||+++++++.++...|+||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 45788899999999999999985 46889999998655544556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+++++|.+++... ...+++..+..++.|++.||.|||+. +|+|+||||+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (280)
T cd06611 84 CDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL 157 (280)
T ss_pred cCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccc
Confidence 9999999998642 34689999999999999999999999 99999999999999999999999999987654322
Q ss_pred ceeeecccccccccCccccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCc
Q 010891 332 SHITTRVMGTFGYVAPEYAN-----SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVV 406 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (498)
. ......|++.|+|||.+. ...++.++||||||+++|||++|+.||....... .+..+.. . .
T Consensus 158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~---~---~ 224 (280)
T cd06611 158 Q-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR------VLLKILK---S---E 224 (280)
T ss_pred c-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH------HHHHHhc---C---C
Confidence 1 123356899999999874 3557889999999999999999999997543211 1111111 1 0
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 407 DPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 407 ~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
.+.+......+ .....++.+||+.||.+||++.+++++
T Consensus 225 ~~~~~~~~~~~--~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 225 PPTLDQPSKWS--SSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred CCCcCCcccCC--HHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 11111111111 123334458999999999999999876
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=309.53 Aligned_cols=250 Identities=27% Similarity=0.412 Sum_probs=200.9
Q ss_pred cCCCccceEcccCcEEEEEEEEcC-CcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeec
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 252 (498)
++|++.+.||+|+||.||+|...+ +..|++|.+..... .+++.+|+++++.++||||+++++++.+....|+++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578899999999999999998654 78999998854432 567999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~ 332 (498)
.+++|.+++.. ....+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 81 GAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 99999999964 235689999999999999999999998 999999999999999999999999999987644321
Q ss_pred eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCC
Q 010891 333 HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIET 412 (498)
Q Consensus 333 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (498)
......|+..|+|||++.+..++.++||||||+++|+|++|+.||....+.... ..... ...+.+..
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~---------~~~~~---~~~~~~~~ 221 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI---------FMIPN---KPPPTLSD 221 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh---------hhhcc---CCCCCCCc
Confidence 223355889999999999889999999999999999999999999754332110 00000 00111111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 413 RPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 413 ~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
..... ..+..++.+||+.||++|||+.+++.+
T Consensus 222 ~~~~~--~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 222 PEKWS--PEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred hhhcC--HHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 11111 234445558999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=313.02 Aligned_cols=250 Identities=26% Similarity=0.406 Sum_probs=200.3
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC-CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
++|++.+.||.|+||.||+|.. .+++.|++|.+.... ......+.+|+++++.++||||+++++++.++...|+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 4688889999999999999985 468899999886443 23345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+++++|.+++.. .++++..++.++.|++.||.|||+. +++|+||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 999999999963 2689999999999999999999998 99999999999999999999999999998875432
Q ss_pred ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCC
Q 010891 332 SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (498)
. ......|+..|+|||++.+..++.++|||||||++|+|++|+.||....+.. ....... . ..+.+.
T Consensus 153 ~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~------~~~~~~~-~-----~~~~~~ 219 (274)
T cd06609 153 S-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR------VLFLIPK-N-----NPPSLE 219 (274)
T ss_pred c-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH------HHHHhhh-c-----CCCCCc
Confidence 2 2233568899999999998889999999999999999999999997543211 1111111 0 111111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 412 ~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
...... ....++.+||..||++|||+.+++++-
T Consensus 220 ~~~~~~---~~~~~l~~~l~~~p~~Rpt~~~il~~~ 252 (274)
T cd06609 220 GNKFSK---PFKDFVSLCLNKDPKERPSAKELLKHK 252 (274)
T ss_pred ccccCH---HHHHHHHHHhhCChhhCcCHHHHhhCh
Confidence 111111 233344589999999999999998753
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=307.78 Aligned_cols=251 Identities=24% Similarity=0.371 Sum_probs=200.8
Q ss_pred CCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCC--CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 175 RFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
+|+..+.||.|+||.||.++ ..++..+++|++.... ....+.+.+|++++++++|+||+++++++.+....+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 58889999999999999997 4568899999885432 23345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+++++|.+++... ....+++.++..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQ--KGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 9999999999753 235689999999999999999999998 99999999999999999999999999998764433
Q ss_pred ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCC
Q 010891 332 SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (498)
. ......|++.|+|||.+.+..++.++||||||+++|||++|..||...... +....... ... .+. .
T Consensus 156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~~-~~~----~~~-~ 222 (256)
T cd08221 156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVKIVQ-GNY----TPV-V 222 (256)
T ss_pred c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHc-CCC----CCC-c
Confidence 2 233456899999999998888999999999999999999999999754321 11111111 100 010 0
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 412 ~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.... .....++.+||..+|++||++.++++++
T Consensus 223 -~~~~---~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 223 -SVYS---SELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -cccC---HHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1111 2233444589999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=308.76 Aligned_cols=247 Identities=29% Similarity=0.460 Sum_probs=192.2
Q ss_pred ceEcccCcEEEEEEEEc-C---CcEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCC
Q 010891 180 NIIGDGGYGVVYRGQLM-N---GTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNN 254 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (498)
++||+|+||.||+|.+. . +..||+|.+...... ..+.+..|+++++.+.||||+++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999642 2 268999988655432 3456888999999999999999999876 4567999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCcee
Q 010891 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (498)
Q Consensus 255 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 334 (498)
++|.+++... +.+++..++.++.|++.||.|||.. +++|+||||+|||++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999999743 4689999999999999999999998 99999999999999999999999999998764433221
Q ss_pred ee--cccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCC
Q 010891 335 TT--RVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411 (498)
Q Consensus 335 ~~--~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (498)
.. ...++..|+|||.+.+..++.++|||||||++|+|++ |..||...... ....++ ... ... .
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~---~~~---~~~-----~ 218 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAML---ESG---ERL-----P 218 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHH---HcC---CcC-----C
Confidence 11 1223567999999998899999999999999999998 99999654321 112211 111 111 0
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 412 ~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
..... ...+..++.+||..||++|||+.++++.|+..
T Consensus 219 ~~~~~--~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 219 RPEEC--PQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred CCCCC--CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 11111 12344555689999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=320.39 Aligned_cols=260 Identities=26% Similarity=0.419 Sum_probs=198.9
Q ss_pred ccCCCccceEcccCcEEEEEEEEc--------CCcEEEEEEecCCCC-CchhHHHHHHHHHHcC-CCCCceEEEeEEEeC
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM--------NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHV-RHKNLVRLLGYCIEG 242 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~ 242 (498)
..+|.+.+.||+|+||.||+|+.. ....||+|.+..... .....+..|++++.++ +||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 457888999999999999999642 245789998764432 2335688899999999 699999999999998
Q ss_pred CeeEEEEeecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEE
Q 010891 243 TQRILVYEYVNNGNLEQWLRGDMC------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI 310 (498)
Q Consensus 243 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll 310 (498)
...|+||||+++|+|.+++..... ....+++..+..++.|++.||.|||++ +++||||||+|||+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence 999999999999999999965321 224589999999999999999999998 99999999999999
Q ss_pred cCCCCeEEeeeccceecCCCCce-eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhh
Q 010891 311 DENFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVN 388 (498)
Q Consensus 311 ~~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~ 388 (498)
+.++.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~---- 243 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE---- 243 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH----
Confidence 99999999999999865432211 1112234567999999988899999999999999999999 88898643221
Q ss_pred HHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 389 LVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
+......... .. .. .... ...+..++.+||..||++|||+.++++.|....
T Consensus 244 --~~~~~~~~~~----~~--~~--~~~~--~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~ 294 (314)
T cd05099 244 --ELFKLLREGH----RM--DK--PSNC--THELYMLMRECWHAVPTQRPTFKQLVEALDKVL 294 (314)
T ss_pred --HHHHHHHcCC----CC--CC--CCCC--CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 1111111110 00 11 1111 123334555899999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=313.34 Aligned_cols=250 Identities=25% Similarity=0.362 Sum_probs=205.0
Q ss_pred CCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCC
Q 010891 176 FSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNN 254 (498)
Q Consensus 176 y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (498)
|.++++||+|+||.||+|. ...|..+|||++.. ..+.+++..|+.+|.++..|++|++||.+.....+|+|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 4567899999999999995 56799999998843 34567889999999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCcee
Q 010891 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (498)
Q Consensus 255 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 334 (498)
|++.|.++. .+++|+++++..++...++||.|||.. .-||||||..|||++.+|.+||+|||.|-.+.+.- ..
T Consensus 113 GSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-AK 185 (502)
T KOG0574|consen 113 GSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-AK 185 (502)
T ss_pred CcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhH-Hh
Confidence 999999975 457899999999999999999999998 89999999999999999999999999998764332 22
Q ss_pred eecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCC
Q 010891 335 TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRP 414 (498)
Q Consensus 335 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (498)
.+.+.|||.|||||++..-.|+.++||||||++..||..|++||.+-.|.. .+-.......|.+..+.
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR------------AIFMIPT~PPPTF~KPE 253 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR------------AIFMIPTKPPPTFKKPE 253 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc------------eeEeccCCCCCCCCChH
Confidence 345789999999999999999999999999999999999999997544321 11111222223333222
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 415 STSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 415 ~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
..+....+ +..+||-++|++|-|+.++++|--
T Consensus 254 ~WS~~F~D--Fi~~CLiK~PE~R~TA~~L~~H~F 285 (502)
T KOG0574|consen 254 EWSSEFND--FIRSCLIKKPEERKTALRLCEHTF 285 (502)
T ss_pred hhhhHHHH--HHHHHhcCCHHHHHHHHHHhhhhh
Confidence 22333333 344899999999999999998753
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=324.55 Aligned_cols=260 Identities=27% Similarity=0.420 Sum_probs=197.7
Q ss_pred ccCCCccceEcccCcEEEEEEEE------cCCcEEEEEEecCCCCC-chhHHHHHHHHHHcC-CCCCceEEEeEEEeC-C
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL------MNGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHV-RHKNLVRLLGYCIEG-T 243 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~-~ 243 (498)
.++|++.+.||+|+||+||+|.+ .+++.||||++...... ....+..|+.++.++ +||||+++++++... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 45789999999999999999963 35788999998654322 234678899999999 789999999988654 5
Q ss_pred eeEEEEeecCCCCHHHHHhcccC---------------------------------------------------------
Q 010891 244 QRILVYEYVNNGNLEQWLRGDMC--------------------------------------------------------- 266 (498)
Q Consensus 244 ~~~lv~e~~~~g~L~~~l~~~~~--------------------------------------------------------- 266 (498)
..++||||+++|+|.++++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 67899999999999999964210
Q ss_pred ------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCce-eeeccc
Q 010891 267 ------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH-ITTRVM 339 (498)
Q Consensus 267 ------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~-~~~~~~ 339 (498)
....+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+||+|||++......... ......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 012478888999999999999999999 9999999999999999999999999999865332211 112234
Q ss_pred ccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHHH
Q 010891 340 GTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSA 418 (498)
Q Consensus 340 gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (498)
++..|+|||.+.+..++.++||||||+++|+|++ |..||........ .. ..+.. .... ..... ..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~---~~~~~---~~~~---~~~~~-~~-- 308 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FC---RRLKE---GTRM---RAPDY-TT-- 308 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HH---HHHhc---cCCC---CCCCC-CC--
Confidence 5678999999988899999999999999999997 9999865332211 11 11111 1111 11111 11
Q ss_pred HHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 419 LKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 419 ~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
..+..++.+||+.||++|||+.+++++|+..
T Consensus 309 -~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~ 339 (343)
T cd05103 309 -PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339 (343)
T ss_pred -HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 2345556689999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=314.91 Aligned_cols=239 Identities=25% Similarity=0.411 Sum_probs=184.8
Q ss_pred eEcccCcEEEEEEEEcC-------------------------CcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEE
Q 010891 181 IIGDGGYGVVYRGQLMN-------------------------GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRL 235 (498)
Q Consensus 181 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l 235 (498)
.||+|+||.||+|.+.. ...|++|.+..........+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999996421 13588888755443334568889999999999999999
Q ss_pred EeEEEeCCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCC-
Q 010891 236 LGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF- 314 (498)
Q Consensus 236 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~- 314 (498)
++++.++...++||||+++|+|..++.. ..+.+++..++.++.||+.||+|||+. +|+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence 9999999999999999999999999864 345689999999999999999999998 999999999999997654
Q ss_pred ------CeEEeeeccceecCCCCceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHH-hCCCCCCCCCCcch
Q 010891 315 ------DAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAI-TGRYPVDYGRPQSE 386 (498)
Q Consensus 315 ------~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~ell-tg~~P~~~~~~~~~ 386 (498)
.+||+|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||....+...
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3899999998654321 22357888999998865 56899999999999999995 69999975433211
Q ss_pred hhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 387 VNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
..... . .. .... +.. ..+..++.+||+.+|++|||+.++++.|.
T Consensus 231 ---~~~~~----~--~~-----~~~~-~~~---~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 231 ---ERFYE----K--KH-----RLPE-PSC---KELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred ---HHHHH----h--cc-----CCCC-CCC---hHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11111 0 00 0111 111 23445556899999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=311.08 Aligned_cols=262 Identities=25% Similarity=0.360 Sum_probs=197.7
Q ss_pred cCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
++|++.+.||+|+||.||+|+.. +|+.||+|++..... ...+.+..|+.+++.++||||+++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46888999999999999999864 589999998864332 223567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
|++++.|..++.. ...+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9999888887652 34589999999999999999999998 9999999999999999999999999999876543
Q ss_pred CceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHh--------hcc
Q 010891 331 KSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQ--------LRR 401 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~--------~~~ 401 (498)
.. ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||......... ..+..... ...
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07847 154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQL---YLIRKTLGDLIPRHQQIFS 229 (286)
T ss_pred cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCChHHhhhcc
Confidence 21 1223457889999998865 56889999999999999999999999754432211 10000000 000
Q ss_pred c----cCCcCCCCCCCCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 402 S----EDVVDPNIETRPST-----SALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 402 ~----~~~~~~~~~~~~~~-----~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
. .....+........ .....+..++.+||+.||++|||+.|++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 230 TNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0 00000111100000 011234455568999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=309.65 Aligned_cols=251 Identities=29% Similarity=0.438 Sum_probs=197.0
Q ss_pred CCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCC------chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 175 RFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQ------ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
+|.+.+.||.|+||.||+|...+++.+|+|.+...... ....+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47788999999999999998878999999988543221 124578899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+++++|.+++.. .+.+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 999999999999963 34688999999999999999999998 99999999999999999999999999997653
Q ss_pred CCC-----ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhcccc
Q 010891 329 AGK-----SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSE 403 (498)
Q Consensus 329 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (498)
... ........|+..|+|||++.+..++.++|||||||++|+|++|..||........ . ..... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-----~-~~~~~---~~ 224 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-----M-FYIGA---HR 224 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-----H-HHhhh---cc
Confidence 211 1112235689999999999998899999999999999999999999974332111 0 01110 00
Q ss_pred CCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 404 DVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
. ..+.+.. ... ..+..++.+||+.+|++|||+.+++.+
T Consensus 225 ~-~~~~~~~--~~~--~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 225 G-LMPRLPD--SFS--AAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred C-CCCCCCC--CCC--HHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 0 1111111 111 223344458999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=310.35 Aligned_cols=255 Identities=28% Similarity=0.429 Sum_probs=196.1
Q ss_pred HHccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
..++.+.....||+|+||.||+|.+ .++..|++|.+........+.+.+|+.+++.++||||+++++++..++..++|+
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 3445555667999999999999984 467889999887665555677899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCC--CHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcC-CCCeEEeeecccee
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYL--TWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE-NFDAKISDFGLAKL 326 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l--~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~-~~~~kL~DfGla~~ 326 (498)
||+++++|.+++... ...+ ++..+..++.||+.||+|||+. +|+||||||+||+++. ++.++|+|||++..
T Consensus 85 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 85 EQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred ecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 999999999999743 1334 7888899999999999999998 9999999999999976 67999999999986
Q ss_pred cCCCCceeeecccccccccCcccccCC--CCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccC
Q 010891 327 LGAGKSHITTRVMGTFGYVAPEYANSG--LLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSED 404 (498)
Q Consensus 327 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (498)
...... ......|++.|+|||++.+. .++.++||||||+++|+|++|+.||......... .+ .. . ...
T Consensus 159 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~-~~-~-~~~--- 228 (268)
T cd06624 159 LAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MF-KV-G-MFK--- 228 (268)
T ss_pred cccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hh-hh-h-hhc---
Confidence 643222 12234589999999998654 3788999999999999999999999643221110 00 00 0 000
Q ss_pred CcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 405 VVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
..+.+. ... ...+..++.+||+.+|.+|||+.+++.+
T Consensus 229 -~~~~~~--~~~--~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 -IHPEIP--ESL--SAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred -cCCCCC--ccc--CHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 011111 111 1223344558999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=314.82 Aligned_cols=258 Identities=28% Similarity=0.405 Sum_probs=199.6
Q ss_pred ccCCCccceEcccCcEEEEEEEEc------CCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCee
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQR 245 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 245 (498)
.++|++.+.||+|+||.||+|... ++..||+|.+..... .....+.+|+.++++++||||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467889999999999999999753 467899998864432 2345688899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcccC------------------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCC
Q 010891 246 ILVYEYVNNGNLEQWLRGDMC------------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSN 307 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~N 307 (498)
++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+. +++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhh
Confidence 999999999999999964210 113478889999999999999999998 99999999999
Q ss_pred EEEcCCCCeEEeeeccceecCCCCce-eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcc
Q 010891 308 ILIDENFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQS 385 (498)
Q Consensus 308 Ill~~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~ 385 (498)
|+++.++.++|+|||++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~- 239 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE- 239 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence 99999999999999999865432211 1112234677999999988899999999999999999998 88888643221
Q ss_pred hhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 386 EVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
+....... .. .. .. ... ....+..++.+||..||.+|||+.|+++.|+.
T Consensus 240 -----~~~~~~~~-~~---~~--~~--~~~--~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 -----EVIYYVRD-GN---VL--SC--PDN--CPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -----HHHHHHhc-CC---CC--CC--CCC--CCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 11111111 11 00 00 011 11334455668999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=321.32 Aligned_cols=263 Identities=27% Similarity=0.415 Sum_probs=201.9
Q ss_pred HHHccCCCccceEcccCcEEEEEEEEc--------CCcEEEEEEecCCCC-CchhHHHHHHHHHHcC-CCCCceEEEeEE
Q 010891 170 QSATNRFSKDNIIGDGGYGVVYRGQLM--------NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHV-RHKNLVRLLGYC 239 (498)
Q Consensus 170 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~ 239 (498)
+....+|.+.+.||+|+||.||+|+.. .+..||+|.+..... ...+.+..|++++.++ +||||+++++++
T Consensus 8 ~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 8 ELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred ccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 334457899999999999999999642 123689998764332 2345788999999999 899999999999
Q ss_pred EeCCeeEEEEeecCCCCHHHHHhccc------------CCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCC
Q 010891 240 IEGTQRILVYEYVNNGNLEQWLRGDM------------CDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSN 307 (498)
Q Consensus 240 ~~~~~~~lv~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~N 307 (498)
......+++|||+++|+|.+++.... .....+++..++.++.|++.||.|||++ +++||||||+|
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~N 164 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARN 164 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceeccccccce
Confidence 99999999999999999999997432 1224588899999999999999999998 99999999999
Q ss_pred EEEcCCCCeEEeeeccceecCCCCce-eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcc
Q 010891 308 ILIDENFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQS 385 (498)
Q Consensus 308 Ill~~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~ 385 (498)
||++.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-- 242 (334)
T cd05100 165 VLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV-- 242 (334)
T ss_pred EEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 99999999999999999876433211 1122334568999999999999999999999999999998 8888864322
Q ss_pred hhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 386 EVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
.+.......... ..... .. ...+..++.+||+.+|.+|||+.++++.|....
T Consensus 243 ----~~~~~~~~~~~~------~~~~~-~~---~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 243 ----EELFKLLKEGHR------MDKPA-NC---THELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred ----HHHHHHHHcCCC------CCCCC-CC---CHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 122222111100 01111 11 123445556899999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=308.38 Aligned_cols=248 Identities=29% Similarity=0.454 Sum_probs=195.0
Q ss_pred ceEcccCcEEEEEEEEcC--C--cEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCC
Q 010891 180 NIIGDGGYGVVYRGQLMN--G--TAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNN 254 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (498)
+.||+|+||.||+|.+.+ + ..||+|.+..... ...+.+..|+.++++++||||+++++++.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999997533 3 3689999876655 445678899999999999999999999988 888999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCce-
Q 010891 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH- 333 (498)
Q Consensus 255 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~- 333 (498)
++|.+++.... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++..+......
T Consensus 80 ~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDA--LGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhcc--cccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 99999997542 14689999999999999999999999 9999999999999999999999999999876543221
Q ss_pred -eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCC
Q 010891 334 -ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411 (498)
Q Consensus 334 -~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (498)
......++..|+|||.+.+..++.++|||||||++|||++ |..||...... +....... ..... .
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~------~~~~~~~~--~~~~~-----~ 221 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS------QILKKIDK--EGERL-----E 221 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHh--cCCcC-----C
Confidence 1122457789999999999999999999999999999999 99999643221 11111111 00110 0
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 412 ~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
.... ....+..++.+||..+|++|||+.++++.|.
T Consensus 222 ~~~~--~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 222 RPEA--CPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCcc--CCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0011 1123444555899999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=318.75 Aligned_cols=197 Identities=23% Similarity=0.361 Sum_probs=161.3
Q ss_pred cceEcccCcEEEEEEEEc---CCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEe--CCeeEEEEeecC
Q 010891 179 DNIIGDGGYGVVYRGQLM---NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIE--GTQRILVYEYVN 253 (498)
Q Consensus 179 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~e~~~ 253 (498)
..+||+|+||+||+|+.. ++..||+|.+.... ....+.+|+++++.++||||+++++++.. +...|+||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 358999999999999854 35789999885432 23457789999999999999999998854 467799999996
Q ss_pred CCCHHHHHhcccC-----CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEE----cCCCCeEEeeeccc
Q 010891 254 NGNLEQWLRGDMC-----DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI----DENFDAKISDFGLA 324 (498)
Q Consensus 254 ~g~L~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll----~~~~~~kL~DfGla 324 (498)
+ +|.+++..... ....+++..+..++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 4 88888753211 223588999999999999999999999 99999999999999 56678999999999
Q ss_pred eecCCCCce--eeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 010891 325 KLLGAGKSH--ITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYG 381 (498)
Q Consensus 325 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~ 381 (498)
+........ ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 876543221 2234578999999998866 46899999999999999999999999643
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=310.93 Aligned_cols=250 Identities=25% Similarity=0.393 Sum_probs=199.7
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC-CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
..|+..+.||.|+||.||+|.. .++..||+|.+.... ......+..|+.++++++||||+++++++.++...|+||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 3567788999999999999985 458899999886443 23345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+++++|.+++.. +.+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 84 LGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 999999999853 4588999999999999999999998 99999999999999999999999999998764432
Q ss_pred ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCC
Q 010891 332 SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (498)
. ......++..|+|||++.+..++.++|+|||||++|||++|..||....+.... ..... ...+.+
T Consensus 156 ~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~------~~~~~------~~~~~~- 221 (277)
T cd06640 156 I-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL------FLIPK------NNPPTL- 221 (277)
T ss_pred c-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh------hhhhc------CCCCCC-
Confidence 2 223356888999999998888999999999999999999999999754332110 10000 000111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 412 ~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
..........++.+||+.+|++||++.+++.+--
T Consensus 222 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 222 ---TGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred ---chhhhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence 1112233445556899999999999999987643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=315.03 Aligned_cols=264 Identities=25% Similarity=0.377 Sum_probs=202.1
Q ss_pred ccHHHHHHHccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcC-CCCCceEEEeEEEe
Q 010891 164 FTLRDLQSATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIE 241 (498)
Q Consensus 164 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~ 241 (498)
+++.++..+.++|.+.+.||+|+||.||++.. .+++.+|+|.+.... .....+..|+.++.++ +||||+++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 34455566788999999999999999999975 568899999885432 2245677899999999 89999999999875
Q ss_pred C-----CeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCe
Q 010891 242 G-----TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDA 316 (498)
Q Consensus 242 ~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~ 316 (498)
. ...|+||||+++++|.++++........+++..++.++.|++.||.|||+. +++||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence 4 357999999999999999875433456789999999999999999999998 99999999999999999999
Q ss_pred EEeeeccceecCCCCceeeecccccccccCcccccCC-----CCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHH
Q 010891 317 KISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSG-----LLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVE 391 (498)
Q Consensus 317 kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~ 391 (498)
||+|||++......... .....|+..|+|||++... .++.++|||||||++|||++|+.||....+... .
T Consensus 168 kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~-- 242 (291)
T cd06639 168 KLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--L-- 242 (291)
T ss_pred EEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--H--
Confidence 99999999865432211 2234688999999987543 368899999999999999999999975432211 1
Q ss_pred HHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 392 WLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
..... ... +.+..... ....+..++.+||+.||++||++.+++.+
T Consensus 243 --~~~~~-~~~-----~~~~~~~~--~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 243 --FKIPR-NPP-----PTLLHPEK--WCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred --HHHhc-CCC-----CCCCcccc--cCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 11110 000 11111111 11234445558999999999999999876
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=324.24 Aligned_cols=259 Identities=22% Similarity=0.345 Sum_probs=202.4
Q ss_pred HccCCCccceEcccCcEEEEEEEEcCCcEEEEEEec--CCCCCchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCeeEEE
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLL--NNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv 248 (498)
....|+++++||+||.+.||++...+.+.||+|++. ..+.+...-|+.|+..|.+| .|.+||+||+|-..++.+|||
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 346789999999999999999988778889999873 33445556799999999999 699999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||= ..+|..+|+... ..++.-.++.+..||+.|+.++|.+ ||||.||||.|+|+-+ |.+||+|||+|..+.
T Consensus 439 mE~G-d~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred eecc-cccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 9986 459999997532 2223237889999999999999999 9999999999999975 599999999999887
Q ss_pred CCCcee-eecccccccccCcccccCCC-----------CCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH
Q 010891 329 AGKSHI-TTRVMGTFGYVAPEYANSGL-----------LNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMM 396 (498)
Q Consensus 329 ~~~~~~-~~~~~gt~~y~aPE~~~~~~-----------~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 396 (498)
.+.... ....+||+.||+||.+.... .+.++||||||||||+|+.|+.||.. +...+..+
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~--------~~n~~aKl 582 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ--------IINQIAKL 582 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH--------HHHHHHHH
Confidence 665433 44578999999999774322 45789999999999999999999962 12222222
Q ss_pred HhhccccCCcCCCC----CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCCC
Q 010891 397 VQLRRSEDVVDPNI----ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIP 455 (498)
Q Consensus 397 ~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~~~~~ 455 (498)
. .+.+|.. +..+... .++.++..||..||++|||+.++|++---..++.+
T Consensus 583 ~------aI~~P~~~Iefp~~~~~~---~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i~ 636 (677)
T KOG0596|consen 583 H------AITDPNHEIEFPDIPEND---ELIDVMKCCLARDPKKRWSIPELLQHPFLQIQPIP 636 (677)
T ss_pred H------hhcCCCccccccCCCCch---HHHHHHHHHHhcCcccCCCcHHHhcCccccccccc
Confidence 2 3334422 2222222 26777778999999999999999987544443443
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=308.09 Aligned_cols=254 Identities=23% Similarity=0.354 Sum_probs=188.2
Q ss_pred ceEcccCcEEEEEEEEcC---CcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCCC
Q 010891 180 NIIGDGGYGVVYRGQLMN---GTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNG 255 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g 255 (498)
+.||+|+||.||+|...+ +..+++|++..... .....+..|+.++++++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999997533 45789998865433 23346888999999999999999999999999999999999999
Q ss_pred CHHHHHhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCcee
Q 010891 256 NLEQWLRGDMC-DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (498)
Q Consensus 256 ~L~~~l~~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 334 (498)
+|.+++..... ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975321 223466778889999999999999999 99999999999999999999999999997543322111
Q ss_pred -eecccccccccCcccccCC-------CCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCC
Q 010891 335 -TTRVMGTFGYVAPEYANSG-------LLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV 405 (498)
Q Consensus 335 -~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (498)
.....|+..|+|||++.+. .++.++||||||+++|||++ |..||......... .. .........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~---~~----~~~~~~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL---TY----TVREQQLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH---HH----HhhcccCCC
Confidence 2234678899999988542 35789999999999999996 99999754332111 00 111111122
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 406 VDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 406 ~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
..+.+.. ........ ++.+|+ .+|++|||+.+|++.|+
T Consensus 231 ~~~~~~~-~~~~~~~~---l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PKPRLKL-PLSDRWYE---VMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCccCC-CCChHHHH---HHHHHh-cCcccCCCHHHHHHHhc
Confidence 2222221 11222222 333688 68999999999998875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=306.65 Aligned_cols=250 Identities=22% Similarity=0.333 Sum_probs=197.0
Q ss_pred CCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEe-CCeeEEEEe
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIE-GTQRILVYE 250 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~e 250 (498)
+|++.+.||+|+||.||++.. .+++.|++|++..... ...+.+..|++++++++|||++++++.+.. +...|++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 478899999999999999974 4578899999854332 234568889999999999999999998764 446799999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
|+++++|.+++... ....+++.++..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 99999999999753 235689999999999999999999999 9999999999999999999999999999876433
Q ss_pred CceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCC
Q 010891 331 KSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNI 410 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (498)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|+.||..... ........... . +..
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~~~~~~-~-----~~~ 222 (257)
T cd08223 156 CD-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYRIIEGK-L-----PPM 222 (257)
T ss_pred CC-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHhcC-C-----CCC
Confidence 22 23345689999999999999999999999999999999999999964321 11111111100 0 111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 411 ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 411 ~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
. .. .......++.+||+.||++|||+.+++++
T Consensus 223 ~--~~--~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 223 P--KD--YSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred c--cc--cCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 1 11 11234455568999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=310.85 Aligned_cols=250 Identities=27% Similarity=0.412 Sum_probs=190.3
Q ss_pred ceEcccCcEEEEEEEEcC-Cc--EEEEEEecCCC-CCchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCeeEEEEeecCC
Q 010891 180 NIIGDGGYGVVYRGQLMN-GT--AVAVKKLLNNP-GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVYEYVNN 254 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (498)
+.||+|+||.||+|++.+ +. .+++|.+.... ....+.+..|++++.++ +||||+++++++......|+||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999998643 43 46888775432 23345688899999999 899999999999999999999999999
Q ss_pred CCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeec
Q 010891 255 GNLEQWLRGDMC------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFG 322 (498)
Q Consensus 255 g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfG 322 (498)
|+|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 999999975321 123588999999999999999999998 99999999999999999999999999
Q ss_pred cceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhcc
Q 010891 323 LAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRR 401 (498)
Q Consensus 323 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 401 (498)
++....... .......+..|+|||++....++.++|||||||++|||++ |..||...... +..........
T Consensus 158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~------~~~~~~~~~~~ 229 (270)
T cd05047 158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYEKLPQGYR 229 (270)
T ss_pred Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH------HHHHHHhCCCC
Confidence 986322111 1111234567999999988899999999999999999997 99999643321 11121111100
Q ss_pred ccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 402 SEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
.... ... ...+..++.+||..||.+|||+.+++..|...
T Consensus 230 ------~~~~--~~~--~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 230 ------LEKP--LNC--DDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred ------CCCC--CcC--CHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 0011 111 12344555689999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=309.27 Aligned_cols=250 Identities=24% Similarity=0.385 Sum_probs=193.1
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC-----CchhHHHHHHHHHHcCCCCCceEEEeEEEeC--Cee
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG-----QADKDFRVEVEAIGHVRHKNLVRLLGYCIEG--TQR 245 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~ 245 (498)
.+|+..+.||+|+||.||+|.. .++..|++|++..... .....+.+|+.+++.++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4688899999999999999975 4689999998854322 1224578899999999999999999988763 567
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccce
Q 010891 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~ 325 (498)
+++|||+++++|.+++.. .+.+++...+.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 899999999999999963 34588999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCc--eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhcccc
Q 010891 326 LLGAGKS--HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSE 403 (498)
Q Consensus 326 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (498)
....... .......++..|+|||.+.+..++.++|||||||++|||++|+.||....... .+.... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~------~~~~~~---~~- 224 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA------AIFKIA---TQ- 224 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH------HHHHHh---cC-
Confidence 6532111 11223458899999999998889999999999999999999999997432211 111111 00
Q ss_pred CCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 404 DVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
...+.+. .... ..+..+++||..+|++||++.|+++|
T Consensus 225 -~~~~~~~--~~~~---~~~~~li~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 225 -PTNPQLP--SHIS---EHARDFLGCIFVEARHRPSAEELLRH 261 (266)
T ss_pred -CCCCCCc--hhcC---HHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0111111 1111 22223336888999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=312.18 Aligned_cols=260 Identities=23% Similarity=0.411 Sum_probs=197.9
Q ss_pred CCCccceEcccCcEEEEEEEE-----cCCcEEEEEEecCCC-CCchhHHHHHHHHHHcCCCCCceEEEeEEEeC--CeeE
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-----MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG--TQRI 246 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~ 246 (498)
.|++.+.||+|+||.||+++. .++..||+|.+.... ......+.+|+++++.++||||+++++++.+. ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 467889999999999999973 357889999986443 22345688999999999999999999998875 5679
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecccee
Q 010891 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (498)
Q Consensus 247 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~ 326 (498)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||+++.
T Consensus 85 lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccc
Confidence 999999999999999642 23589999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCce--eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCC---------cchhhHHHHHHH
Q 010891 327 LGAGKSH--ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRP---------QSEVNLVEWLKM 395 (498)
Q Consensus 327 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~---------~~~~~~~~~~~~ 395 (498)
+...... ......|+..|+|||++.+..++.++|||||||++|||++++.|+..... ..+.........
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV 238 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence 6543221 12234577789999999888899999999999999999998776532110 001111111111
Q ss_pred HHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 396 MVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
+... .. ...... ....+..++.+||+.||++|||+.++++.|+..
T Consensus 239 ~~~~---~~-----~~~~~~--~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 239 LEEG---KR-----LPRPPN--CPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHcC---cc-----CCCCCC--CCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1110 00 000111 123455556689999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=311.19 Aligned_cols=258 Identities=25% Similarity=0.354 Sum_probs=197.8
Q ss_pred CCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC--CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
+|++.+.||+|+||.||+|.+ .+|+.|++|++.... ....+.+..|+.++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 478889999999999999985 468999999986543 23345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+ +++|.+++... ...+++.+++.++.||+.||.|||+. +++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 99999998643 25689999999999999999999998 99999999999999999999999999998765443
Q ss_pred ceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhcccc-------
Q 010891 332 SHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSE------- 403 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~------- 403 (498)
........|+..|+|||.+.+ ..++.++|||||||++|||++|..||....... .... .+.......
T Consensus 154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~--~~~~~~~~~~~~~~~~ 228 (286)
T cd07832 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAI--VFRTLGTPNEETWPGL 228 (286)
T ss_pred CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHH--HHHHcCCCChHHHhhc
Confidence 222334568999999998765 456899999999999999999987775433211 1111 111000000
Q ss_pred -------CCcCCCCC------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 404 -------DVVDPNIE------TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 404 -------~~~~~~~~------~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
....+... ..+.. ...+..++.+||..||++|||+.+++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 229 TSLPDYNKITFPESKPIPLEEIFPDA--SPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cCcchhhcccCCCCCcchHHHhCCCc--cHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000 00011 1344455568999999999999999976
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=317.87 Aligned_cols=253 Identities=24% Similarity=0.292 Sum_probs=199.1
Q ss_pred cCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCC---chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ---ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
++|++.+.||+|+||.||+|... +++.||+|.+...... ..+.+..|++++..++||||+++++++.++...|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999854 5899999998655433 3356888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+.+++|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 999999999998643 335689999999999999999999998 999999999999999999999999999876432
Q ss_pred CCce----------------------------eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 010891 330 GKSH----------------------------ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYG 381 (498)
Q Consensus 330 ~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~ 381 (498)
.... ......||..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 2110 111346889999999999888999999999999999999999999754
Q ss_pred CCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCC----HHHHHHH
Q 010891 382 RPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPK----MSQVVRM 446 (498)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt----~~ell~~ 446 (498)
.... .+..+.. . . ........ ....+..++.+||..||++||| +.+++.+
T Consensus 236 ~~~~------~~~~~~~---~-~---~~~~~~~~--~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~ 289 (316)
T cd05574 236 NRDE------TFSNILK---K-E---VTFPGSPP--VSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH 289 (316)
T ss_pred chHH------HHHHHhc---C-C---ccCCCccc--cCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence 3221 1111110 0 0 01111111 1233444555899999999999 8888774
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=317.18 Aligned_cols=248 Identities=24% Similarity=0.341 Sum_probs=196.2
Q ss_pred CccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCCC
Q 010891 177 SKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNG 255 (498)
Q Consensus 177 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g 255 (498)
.....||+|+||.||++.. .++..||||++........+.+..|+.+++.++||||+++++.+..++..|+||||++++
T Consensus 25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 104 (292)
T cd06658 25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG 104 (292)
T ss_pred hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence 3346799999999999975 468899999986554455567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCceee
Q 010891 256 NLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHIT 335 (498)
Q Consensus 256 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 335 (498)
+|.+++.. +.+++..+..++.||+.||.|||+. +++||||||+||++++++.++|+|||++........ ..
T Consensus 105 ~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~ 175 (292)
T cd06658 105 ALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KR 175 (292)
T ss_pred cHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cC
Confidence 99998842 4588999999999999999999999 999999999999999999999999999976533221 12
Q ss_pred ecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCC
Q 010891 336 TRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPS 415 (498)
Q Consensus 336 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (498)
....|+..|+|||.+.+..++.++||||||+++|||++|+.||....+... +..+.. ...+.+.....
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~------~~~~~~~~~~~ 243 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQA------MRRIRD------NLPPRVKDSHK 243 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHh------cCCCccccccc
Confidence 335689999999999888899999999999999999999999975433211 111111 11111111111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 416 TSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 416 ~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.+.. +..++.+||..||.+|||+.+++++-
T Consensus 244 ~~~~--~~~li~~~l~~~P~~Rpt~~~il~~~ 273 (292)
T cd06658 244 VSSV--LRGFLDLMLVREPSQRATAQELLQHP 273 (292)
T ss_pred cCHH--HHHHHHHHccCChhHCcCHHHHhhCh
Confidence 2222 22333479999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=305.64 Aligned_cols=251 Identities=30% Similarity=0.491 Sum_probs=197.2
Q ss_pred CCccceEcccCcEEEEEEEEcC-----CcEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 176 FSKDNIIGDGGYGVVYRGQLMN-----GTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 176 y~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
+++.+.||.|+||.||++++.+ +..||+|.+...... ..+.+..|+.++..++||||+++++++.+....+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567899999999999998643 388999998655433 4567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+++++|.+++.... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 9999999999997431 11289999999999999999999999 999999999999999999999999999987755
Q ss_pred CCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (498)
..........+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... . .......... ..
T Consensus 156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~---~~~~~~~~~~---~~--- 223 (258)
T smart00219 156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---E---EVLEYLKKGY---RL--- 223 (258)
T ss_pred ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---H---HHHHHHhcCC---CC---
Confidence 43222222337789999999988889999999999999999998 7888864221 1 1111111111 10
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 409 NIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
..... .. ..+..++.+||..||++|||+.++++.|
T Consensus 224 ~~~~~-~~---~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 224 PKPEN-CP---PEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCc-CC---HHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11111 12 2344455689999999999999999864
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=330.69 Aligned_cols=243 Identities=33% Similarity=0.508 Sum_probs=197.7
Q ss_pred eEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCCCCHHH
Q 010891 181 IIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQ 259 (498)
Q Consensus 181 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~ 259 (498)
+||+|.||+||.|++ .+...+|||.+........+-+..||.+-++|+|.|||+++|.+-+++.+-|.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 599999999999985 4466799999977777777778999999999999999999999999999999999999999999
Q ss_pred HHhcccCCCCCC--CHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEc-CCCCeEEeeeccceecCCCCceeee
Q 010891 260 WLRGDMCDRGYL--TWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID-ENFDAKISDFGLAKLLGAGKSHITT 336 (498)
Q Consensus 260 ~l~~~~~~~~~l--~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~-~~~~~kL~DfGla~~~~~~~~~~~~ 336 (498)
+|+. .=+++ ++...-.+..||++||.|||.+ .|+|||||-.|+||+ -.|.+||+|||-++.+..-. ..+.
T Consensus 662 LLrs---kWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin-P~TE 734 (1226)
T KOG4279|consen 662 LLRS---KWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN-PCTE 734 (1226)
T ss_pred HHHh---ccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCC-cccc
Confidence 9985 34667 6788888999999999999999 999999999999996 47899999999998774322 3345
Q ss_pred cccccccccCcccccCC--CCCccchHHHHHHHHHHHHhCCCCCCC-CCCcchhhHHHHHHHHHhhccccCCcCCCCCCC
Q 010891 337 RVMGTFGYVAPEYANSG--LLNEKSDVYSFGVVLLEAITGRYPVDY-GRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETR 413 (498)
Q Consensus 337 ~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg~~P~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (498)
++.||..|||||++..+ .|+.++|||||||++.||.||++||.. +.|+. .|.+.+.. ...|. .+
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA---------AMFkVGmy--KvHP~--iP 801 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA---------AMFKVGMY--KVHPP--IP 801 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH---------hhhhhcce--ecCCC--Cc
Confidence 57899999999999765 589999999999999999999999963 33322 22222211 11122 22
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 010891 414 PSTSALKRALLTALRCVDPDSDKRPKMSQVVR 445 (498)
Q Consensus 414 ~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~ 445 (498)
...++..+.++ ++|+.+||.+||++.++|.
T Consensus 802 eelsaeak~Fi--lrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 802 EELSAEAKNFI--LRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHH--HHHcCCCcccCccHHHhcc
Confidence 33444444444 4999999999999999985
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=308.40 Aligned_cols=254 Identities=28% Similarity=0.424 Sum_probs=197.7
Q ss_pred CCCccceEcccCcEEEEEEEEcC--CcEEEEEEecCCCC----------CchhHHHHHHHHHHc-CCCCCceEEEeEEEe
Q 010891 175 RFSKDNIIGDGGYGVVYRGQLMN--GTAVAVKKLLNNPG----------QADKDFRVEVEAIGH-VRHKNLVRLLGYCIE 241 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~~ 241 (498)
.|++.+.||+|+||.||+|.... ++.+|+|.+..... ....++..|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 37788899999999999998654 68899998753221 122346678888865 799999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHH-ccCCCeeecCCCCCCEEEcCCCCeEEee
Q 010891 242 GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE-AIEPKVVHRDIKSSNILIDENFDAKISD 320 (498)
Q Consensus 242 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiHrDikp~NIll~~~~~~kL~D 320 (498)
+...++||||+++++|.+++.........+++..++.++.|++.||.|||. . +++|+||+|+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999986433344578999999999999999999996 5 899999999999999999999999
Q ss_pred eccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhc
Q 010891 321 FGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLR 400 (498)
Q Consensus 321 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 400 (498)
||++....... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||....... .......
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~------~~~~~~~-- 227 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS------LATKIVE-- 227 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH------HHHHHhh--
Confidence 99998765432 2334568999999999998889999999999999999999999996432211 1111111
Q ss_pred cccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 401 RSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
. ...+... .... ..+..++.+||..||++||++.|+..+++
T Consensus 228 -~--~~~~~~~-~~~~---~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 228 -A--VYEPLPE-GMYS---EDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred -c--cCCcCCc-ccCC---HHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 0 0011111 0111 23344455899999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=318.68 Aligned_cols=199 Identities=22% Similarity=0.246 Sum_probs=165.2
Q ss_pred ccceEccc--CcEEEEEEE-EcCCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeec
Q 010891 178 KDNIIGDG--GYGVVYRGQ-LMNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (498)
Q Consensus 178 ~~~~lg~G--~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 252 (498)
+.++||+| +|++||+++ ..+|+.||+|++..... ...+.+..|+++++.++||||+++++++.+++..|+||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 789999997 45789999999854432 22345778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~ 332 (498)
++|+|.+++... ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.++++||+.+........
T Consensus 82 ~~~~l~~~~~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTH--FMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 999999999643 224589999999999999999999998 999999999999999999999999987654321110
Q ss_pred e------eeecccccccccCcccccC--CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 010891 333 H------ITTRVMGTFGYVAPEYANS--GLLNEKSDVYSFGVVLLEAITGRYPVDYG 381 (498)
Q Consensus 333 ~------~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~P~~~~ 381 (498)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 0 0112356788999999875 46899999999999999999999999743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=313.55 Aligned_cols=248 Identities=27% Similarity=0.409 Sum_probs=196.8
Q ss_pred CCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC-CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeec
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 252 (498)
.|+..+.||+|+||.||+|.. .++..||+|.+.... ....+.+..|++++++++||||+++++++..+...|+||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 466678899999999999974 457889999885443 233456889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~ 332 (498)
++++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||+|+||++++++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06642 85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence 99999999852 4688999999999999999999998 999999999999999999999999999987643321
Q ss_pred eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCC
Q 010891 333 HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIET 412 (498)
Q Consensus 333 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (498)
......|+..|+|||.+.+..++.++|||||||++|||++|+.||....+... ..... ....+.+..
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~~~~------~~~~~~~~~ 223 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV------LFLIP------KNSPPTLEG 223 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH------Hhhhh------cCCCCCCCc
Confidence 12234688999999999998999999999999999999999999864332110 00000 000111111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 413 RPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 413 ~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.....+..++.+||..+|++|||+.+++++-
T Consensus 224 ----~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 254 (277)
T cd06642 224 ----QYSKPFKEFVEACLNKDPRFRPTAKELLKHK 254 (277)
T ss_pred ----ccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence 1112334455589999999999999999864
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=312.05 Aligned_cols=255 Identities=24% Similarity=0.404 Sum_probs=196.4
Q ss_pred cCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
++|++.+.||+|+||.||++... ++..||+|.+..... .....+.+|++++.+++||||+++++++......++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36788999999999999999864 689999998864322 2235688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+++++|..++.... ....+++..+..++.|++.||.|||+.. +++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 99999999986431 2346899999999999999999999632 89999999999999999999999999997653322
Q ss_pred ceeeecccccccccCcccccCC------CCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCC
Q 010891 332 SHITTRVMGTFGYVAPEYANSG------LLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV 405 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (498)
.....|+..|+|||.+.+. .++.++|+|||||++|+|++|+.||......... ..+.......
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~------~~~~~~~~~~-- 226 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF------AQLSAIVDGD-- 226 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH------HHHHHHhhcC--
Confidence 2234588899999988543 3588999999999999999999999754322111 1111111100
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 406 VDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 406 ~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.+.+. ...+ .....++.+||..+|++||++.+++.+-
T Consensus 227 -~~~~~--~~~~--~~~~~li~~~l~~~p~~Rp~~~~l~~~~ 263 (286)
T cd06622 227 -PPTLP--SGYS--DDAQDFVAKCLNKIPNRRPTYAQLLEHP 263 (286)
T ss_pred -CCCCC--cccC--HHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence 01111 1111 2233444589999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=307.46 Aligned_cols=253 Identities=22% Similarity=0.370 Sum_probs=185.6
Q ss_pred eEcccCcEEEEEEEEcCCc---EEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCCCC
Q 010891 181 IIGDGGYGVVYRGQLMNGT---AVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGN 256 (498)
Q Consensus 181 ~lg~G~~g~Vy~~~~~~~~---~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~ 256 (498)
.||+|+||.||+|...++. .+++|.+..... ...+.+.+|+.+++.++||||+++++++.+....|+||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 5999999999999754433 456666644332 334678899999999999999999999999999999999999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC-ceee
Q 010891 257 LEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK-SHIT 335 (498)
Q Consensus 257 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~-~~~~ 335 (498)
|.+++.........+.+.....++.||+.||.|||+. +++||||||+|||++.++.+||+|||++....... ....
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999975432334567778889999999999999998 99999999999999999999999999986432111 1112
Q ss_pred ecccccccccCcccccC-------CCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcC
Q 010891 336 TRVMGTFGYVAPEYANS-------GLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407 (498)
Q Consensus 336 ~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (498)
....|+..|+|||++.. ..++.++|||||||++|||++ |..||....+. +.+..... .......+
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~-~~~~~~~~ 231 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR------EVLNHVIK-DQQVKLFK 231 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHh-hcccccCC
Confidence 34568899999998743 245789999999999999997 56677543321 11111111 11222333
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 408 ~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
+.+..... ... ..+...|| .+|++||++.++++.|.
T Consensus 232 ~~~~~~~~-~~~---~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLELPYS-ERW---YEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccCCCCc-HHH---HHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 33332211 222 22333688 67999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=326.43 Aligned_cols=241 Identities=22% Similarity=0.239 Sum_probs=183.4
Q ss_pred EcccCcEEEEEEEE-cCCcEEEEEEecCCCC---CchhHHHHHHHHHHcC---CCCCceEEEeEEEeCCeeEEEEeecCC
Q 010891 182 IGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHV---RHKNLVRLLGYCIEGTQRILVYEYVNN 254 (498)
Q Consensus 182 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (498)
||+|+||+||+|+. .+++.||+|++..... .....+..|..++..+ +||||+++++++.+....|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999975 4689999999854321 1222344566666655 799999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCcee
Q 010891 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (498)
Q Consensus 255 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 334 (498)
|+|.+++. ..+.+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~l~----~~~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~ 152 (330)
T cd05586 81 GELFWHLQ----KEGRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KT 152 (330)
T ss_pred ChHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CC
Confidence 99999986 345689999999999999999999999 99999999999999999999999999997643222 12
Q ss_pred eecccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCC
Q 010891 335 TTRVMGTFGYVAPEYANSG-LLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETR 413 (498)
Q Consensus 335 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (498)
....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...... +....... .. ..+...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~------~~~~~i~~---~~----~~~~~~ 219 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ------QMYRNIAF---GK----VRFPKN 219 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH------HHHHHHHc---CC----CCCCCc
Confidence 3346799999999988654 5899999999999999999999999754321 11111111 00 011111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCC----CHHHHHHH
Q 010891 414 PSTSALKRALLTALRCVDPDSDKRP----KMSQVVRM 446 (498)
Q Consensus 414 ~~~~~~~~~l~~~~~cl~~dP~~RP----t~~ell~~ 446 (498)
...... ..++.+||..||.+|| ++.+++++
T Consensus 220 ~~~~~~---~~li~~~L~~~P~~R~~~~~~~~~ll~h 253 (330)
T cd05586 220 VLSDEG---RQFVKGLLNRNPQHRLGAHRDAVELKEH 253 (330)
T ss_pred cCCHHH---HHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence 111222 2334489999999998 57777764
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=305.98 Aligned_cols=247 Identities=31% Similarity=0.503 Sum_probs=195.2
Q ss_pred cCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecC
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ 253 (498)
++|++.+.||+|+||.||++.. +++.||+|.+... .....+..|+.++..++||||+++++++..+ ..++||||+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4588899999999999999975 6788999988543 2345688999999999999999999998754 5799999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCce
Q 010891 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333 (498)
Q Consensus 254 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~ 333 (498)
+++|.+++... ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-- 154 (254)
T cd05083 82 KGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-- 154 (254)
T ss_pred CCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceeccccC--
Confidence 99999999753 234588999999999999999999998 99999999999999999999999999998643221
Q ss_pred eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCC
Q 010891 334 ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIET 412 (498)
Q Consensus 334 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (498)
.....+..|+|||.+.+..++.++|+|||||++|||++ |+.||...... +....... .. ...+
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~~~~~---~~-~~~~---- 218 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK------EVKECVEK---GY-RMEP---- 218 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH------HHHHHHhC---CC-CCCC----
Confidence 12234568999999988899999999999999999998 99999654321 11111111 10 0111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 413 RPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 413 ~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
.... ...+..++.+||+.+|++||++.+++..|+.
T Consensus 219 ~~~~--~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 219 PEGC--PADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCcC--CHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 1111 1233445558999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=323.23 Aligned_cols=258 Identities=26% Similarity=0.434 Sum_probs=206.9
Q ss_pred HHHccCCCccceEcccCcEEEEEEEEcC---C--cEEEEEEecCC-CCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCC
Q 010891 170 QSATNRFSKDNIIGDGGYGVVYRGQLMN---G--TAVAVKKLLNN-PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT 243 (498)
Q Consensus 170 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~---~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 243 (498)
+..+......++||.|-||.||+|.+.+ | -.||||..+.+ .....+.|.+|+-+|+.++|||||+++|+|.+ .
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~ 463 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-Q 463 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-c
Confidence 3444556677899999999999997533 2 35899998764 44456779999999999999999999999976 6
Q ss_pred eeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecc
Q 010891 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (498)
Q Consensus 244 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGl 323 (498)
..|||||.++-|.|..||+. ....|+......++.||+.||+|||+. +++||||..+|||+....-+||+|||+
T Consensus 464 P~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 464 PMWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred ceeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccch
Confidence 78999999999999999985 345688899999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccc
Q 010891 324 AKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRS 402 (498)
Q Consensus 324 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (498)
++.+.....+..+...-...|||||.++-..++.++|||-|||.+||++. |..||.+-...+.. ..+...
T Consensus 538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI---------~~iEnG 608 (974)
T KOG4257|consen 538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI---------GHIENG 608 (974)
T ss_pred hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE---------EEecCC
Confidence 99998776665554455678999999999999999999999999999988 99999754332211 112222
Q ss_pred cCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 403 EDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
+.... ++. +...+..++.+||+.||.+||++.|+...|...
T Consensus 609 eRlP~-----P~n--CPp~LYslmskcWayeP~kRPrftei~~~lsdv 649 (974)
T KOG4257|consen 609 ERLPC-----PPN--CPPALYSLMSKCWAYEPSKRPRFTEIKAILSDV 649 (974)
T ss_pred CCCCC-----CCC--CChHHHHHHHHHhccCcccCCcHHHHHHHHHHH
Confidence 22222 121 122334455589999999999999998777543
|
|
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=307.84 Aligned_cols=253 Identities=25% Similarity=0.363 Sum_probs=184.6
Q ss_pred eEcccCcEEEEEEEEcC---CcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCCCC
Q 010891 181 IIGDGGYGVVYRGQLMN---GTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGN 256 (498)
Q Consensus 181 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~ 256 (498)
.||+|+||.||+|...+ ...+++|.+..... .....+.+|+.+++.++||||+++++++.+....|+||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 69999999999997433 35688887654332 223467889999999999999999999999999999999999999
Q ss_pred HHHHHhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCce-e
Q 010891 257 LEQWLRGDMC-DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH-I 334 (498)
Q Consensus 257 L~~~l~~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~-~ 334 (498)
|.+++..... .....++.....++.||+.||+|||+. +|+||||||+|||++.++.+||+|||++......... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999975432 123456788899999999999999999 9999999999999999999999999998754322211 1
Q ss_pred eecccccccccCccccc-------CCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCc
Q 010891 335 TTRVMGTFGYVAPEYAN-------SGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVV 406 (498)
Q Consensus 335 ~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (498)
.....++..|+|||++. ...++.++|||||||++|||++ |..||....+.. .+..... .......
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~-~~~~~~~ 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ------VLKQVVR-EQDIKLP 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhh-ccCccCC
Confidence 22234677899999864 3457889999999999999999 788886433211 1111111 1111222
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 407 DPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 407 ~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
.+.... ...... ..+...|+ .||++|||+++|++.|.
T Consensus 232 ~~~~~~--~~~~~~--~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KPQLDL--KYSDRW--YEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCcccc--cCCHHH--HHHHHHHh-cCcccccCHHHHHHHhc
Confidence 222221 111112 22333577 59999999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=305.50 Aligned_cols=248 Identities=28% Similarity=0.409 Sum_probs=196.7
Q ss_pred CCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCC-----CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 175 RFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG-----QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
+|+..+.||+|+||.||+|... ++..|++|.+..... ...+.+..|+.+++.++||||+++++++.++...+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777899999999999999865 789999998854332 2335688899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+++++|.+++.. .+.+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999973 34688999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCceeeecccccccccCcccccCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANSGL-LNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (498)
... ......|+..|+|||.+.... ++.++|+|||||++|+|++|+.||....+.. ...........
T Consensus 154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~~~----- 220 (258)
T cd06632 154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA------AVFKIGRSKEL----- 220 (258)
T ss_pred ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH------HHHHHHhcccC-----
Confidence 332 223456899999999887766 8999999999999999999999997543211 11111110000
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 408 ~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
+... .... ..+..++.+||..+|++||++.+++.+
T Consensus 221 ~~~~--~~~~--~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 221 PPIP--DHLS--DEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred CCcC--CCcC--HHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 1111 1111 223334458999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=309.58 Aligned_cols=261 Identities=26% Similarity=0.418 Sum_probs=200.5
Q ss_pred cCCCccceEcccCcEEEEEEEEc-----CCcEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEeEEEe--CCee
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM-----NGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIE--GTQR 245 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~ 245 (498)
..|++.+.||+|+||.||+|.+. ++..||+|.+...... ..+.+..|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 35677889999999999999753 3688999998655443 35678999999999999999999999887 5678
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccce
Q 010891 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~ 325 (498)
++||||+++++|.+++... ...+++..++.++.|++.||+|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence 9999999999999999743 23589999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCcee--eecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcch---------hhHHHHHH
Q 010891 326 LLGAGKSHI--TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSE---------VNLVEWLK 394 (498)
Q Consensus 326 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~---------~~~~~~~~ 394 (498)
......... .....++..|+|||.+.+..++.++||||||+++|||++|..|+........ .....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLE 237 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHH
Confidence 775332211 1123456679999999888999999999999999999999999864321110 00111111
Q ss_pred HHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 395 MMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
.+.. .... .... .....+..++.+||..+|++|||+.|++++|+..
T Consensus 238 ~~~~---~~~~-----~~~~--~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKE---GERL-----PRPP--SCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHc---CCcC-----CCCc--cCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 1111 0000 0001 1113455566689999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=305.16 Aligned_cols=252 Identities=29% Similarity=0.433 Sum_probs=199.0
Q ss_pred CCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC--chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
+|.+.+.||+|+||.||+|.. .+++.|++|.+...... ..+.+..|+.+++.++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 578889999999999999975 46889999998665443 456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+++++|.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999999973 34588999999999999999999998 99999999999999999999999999998765433
Q ss_pred ceee---ecccccccccCcccccCCC---CCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCC
Q 010891 332 SHIT---TRVMGTFGYVAPEYANSGL---LNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV 405 (498)
Q Consensus 332 ~~~~---~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (498)
.... ....++..|+|||++.+.. ++.++||||||+++|+|++|+.||....... ... ..... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-----~~~---~~~~~---~ 222 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-----QIM---FHVGA---G 222 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-----HHH---HHHhc---C
Confidence 2211 1356789999999988766 8899999999999999999999996443211 000 00111 1
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 406 VDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 406 ~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
..+.++..... ......++.+||+.||.+|||+.+++.+
T Consensus 223 ~~~~~~~~~~~--~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 223 HKPPIPDSLQL--SPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred CCCCCCccccc--CHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 11112111111 1223344558999999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=306.01 Aligned_cols=250 Identities=22% Similarity=0.371 Sum_probs=198.9
Q ss_pred CCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC--CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
+|++.+.||+|+||.||+++. .+|+.|++|++.... ....+++..|+.++++++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 578899999999999999974 568899999985432 23345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+.+++|.+++... ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 9999999999643 223578999999999999999999998 99999999999999999999999999998764432
Q ss_pred ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCC
Q 010891 332 SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (498)
. ......|++.|+|||++.+..++.++|+|||||++|+|++|+.||...... +.......... +...
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~~~~~------~~~~ 222 (256)
T cd08218 156 E-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK------NLVLKIIRGSY------PPVS 222 (256)
T ss_pred h-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH------HHHHHHhcCCC------CCCc
Confidence 1 122346889999999999889999999999999999999999999754321 11111111100 1111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 412 ~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
... ...+..++.+||+.+|++||++.+++++
T Consensus 223 --~~~--~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 223 --SHY--SYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred --ccC--CHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 111 1233444558999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=306.27 Aligned_cols=249 Identities=28% Similarity=0.430 Sum_probs=187.4
Q ss_pred ceEcccCcEEEEEEEEc----CCcEEEEEEecCCC-CCchhHHHHHHHHHHcCCCCCceEEEeEEEe-CCeeEEEEeecC
Q 010891 180 NIIGDGGYGVVYRGQLM----NGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIE-GTQRILVYEYVN 253 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~e~~~ 253 (498)
+.||+|+||.||+|.+. +...||+|.+.... ....+.+..|+.+++.++||||+++++++.. +...++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999753 23579999875432 2334578889999999999999999998764 556799999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCce
Q 010891 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333 (498)
Q Consensus 254 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~ 333 (498)
+|+|.+++... ...+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999999742 23467788899999999999999998 9999999999999999999999999999865332111
Q ss_pred ---eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhC-CCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 334 ---ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITG-RYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 334 ---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
......++..|+|||.+.+..++.++|||||||++|||++| ..||..... . +....... .... .
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~---~~~~~~~~---~~~~---~ 222 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---F---DITVYLLQ---GRRL---L 222 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---H---HHHHHHhc---CCCC---C
Confidence 11223467789999999888999999999999999999995 555653221 1 11111111 1111 0
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
.. .... ..+..++.+||..+|++||++.++++.|+..
T Consensus 223 ~~-~~~~---~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~ 259 (262)
T cd05058 223 QP-EYCP---DPLYEVMLSCWHPKPEMRPTFSELVSRIEQI 259 (262)
T ss_pred CC-CcCC---HHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 00 0111 2344455589999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=311.18 Aligned_cols=201 Identities=30% Similarity=0.425 Sum_probs=173.6
Q ss_pred cCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCC--CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
++|++.+.||+|+||.||+|... +++.|++|++.... ....+.+..|++++++++||||+++++++.++...++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 46889999999999999999854 58899999885432 2334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
|++++.+..++. ....+++..++.++.||+.||.|||.. +++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEA----SPGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 999877766654 234589999999999999999999999 9999999999999999999999999999876544
Q ss_pred CceeeecccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCC
Q 010891 331 KSHITTRVMGTFGYVAPEYANSG-LLNEKSDVYSFGVVLLEAITGRYPVDYG 381 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~ 381 (498)
.........++..|+|||++.+. .++.++||||||+++|+|++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~ 205 (288)
T cd07833 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGD 205 (288)
T ss_pred ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 33233446788999999999887 8899999999999999999999999744
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=308.28 Aligned_cols=263 Identities=24% Similarity=0.361 Sum_probs=200.1
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeC--CeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEG--TQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~lv~ 249 (498)
++|...+.||.|++|.||+|.. .+++.+|+|.+..... .....+.+|++++++++||||+++++++.+. ...|+||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 3678889999999999999986 4688999998865433 2345688899999999999999999998654 4679999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+++++|.+++.........+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999998865433456689999999999999999999998 999999999999999999999999999876533
Q ss_pred CCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
.. .....++..|+|||.+.+..++.++|||||||++|+|++|..||....... ....+........ .... +...
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~-~~~~-~~~~ 231 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPIELLSYIVNM-PNPE-LKDE 231 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC-CChHHHHHHHhcC-Cchh-hccC
Confidence 21 223457889999999999999999999999999999999999997553211 1111111111110 1000 1111
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
...... -...+..++.+||..||.+|||+.|++++-
T Consensus 232 ~~~~~~--~~~~~~~li~~~l~~~p~~Rpt~~eil~~~ 267 (287)
T cd06621 232 PGNGIK--WSEEFKDFIKQCLEKDPTRRPTPWDMLEHP 267 (287)
T ss_pred CCCCCc--hHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence 110011 122344555689999999999999999854
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=313.28 Aligned_cols=199 Identities=27% Similarity=0.442 Sum_probs=168.9
Q ss_pred CCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
+|++.+.||+|+||.||+|+. .+|+.||+|.+..... .....+..|+++++.++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 478889999999999999985 4689999998854322 2234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
++ ++|.+++... .+.+++..++.++.||++||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 96 5888887642 35689999999999999999999999 99999999999999999999999999998664332
Q ss_pred ceeeecccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCC
Q 010891 332 SHITTRVMGTFGYVAPEYANSG-LLNEKSDVYSFGVVLLEAITGRYPVDYG 381 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~ 381 (498)
.. .....++..|+|||++.+. .++.++|||||||++|+|++|..||...
T Consensus 154 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~ 203 (284)
T cd07839 154 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 203 (284)
T ss_pred CC-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCC
Confidence 22 2334678999999987664 5789999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=306.08 Aligned_cols=252 Identities=27% Similarity=0.398 Sum_probs=198.7
Q ss_pred CCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEe--CCeeEEEE
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIE--GTQRILVY 249 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~ 249 (498)
+|++.+.||.|+||.||++.. .++..|++|.+..... ...+.+..|+++++.++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999974 5688999998854332 223467889999999999999999998764 45679999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH-----HccCCCeeecCCCCCCEEEcCCCCeEEeeeccc
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH-----EAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH-----~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla 324 (498)
||+++++|.+++.........+++..++.++.|++.||.||| +. +++|+||||+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999999754434567999999999999999999999 66 9999999999999999999999999999
Q ss_pred eecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccC
Q 010891 325 KLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSED 404 (498)
Q Consensus 325 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (498)
......... .....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||..... ..+. .... ....
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~---~~~~-~~~~-- 227 (265)
T cd08217 158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLA---SKIK-EGKF-- 227 (265)
T ss_pred ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHH---HHHh-cCCC--
Confidence 877543321 2335689999999999988899999999999999999999999975431 1111 1111 1110
Q ss_pred CcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 405 VVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
+.+.. .. ...+..++.+||..+|++|||+.+++++
T Consensus 228 ---~~~~~--~~--~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 228 ---RRIPY--RY--SSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---CCCcc--cc--CHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11111 11 1234445558999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=310.65 Aligned_cols=240 Identities=23% Similarity=0.396 Sum_probs=185.5
Q ss_pred ceEcccCcEEEEEEEEcC--------CcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 180 NIIGDGGYGVVYRGQLMN--------GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
+.||+|+||.||+|.... ...|++|.+........+.+..|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999997432 234888877554444456788899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCC--------eEEeeecc
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD--------AKISDFGL 323 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~--------~kL~DfGl 323 (498)
+++|+|.+++... ...+++..++.++.||+.||+|||+. +|+||||||+||+++.++. ++++|||+
T Consensus 81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999999743 23589999999999999999999999 9999999999999987765 69999999
Q ss_pred ceecCCCCceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCC-CCCCCCCCcchhhHHHHHHHHHhhcc
Q 010891 324 AKLLGAGKSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGR-YPVDYGRPQSEVNLVEWLKMMVQLRR 401 (498)
Q Consensus 324 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~-~P~~~~~~~~~~~~~~~~~~~~~~~~ 401 (498)
+...... ....++..|+|||++.+ ..++.++|||||||++|||++|. .||....+.. ..... ..
T Consensus 155 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~------~~~~~---~~ 220 (258)
T cd05078 155 SITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQK------KLQFY---ED 220 (258)
T ss_pred ccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHH------HHHHH---Hc
Confidence 8755332 23468889999999876 45899999999999999999995 5554322211 11110 00
Q ss_pred ccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 402 SEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
.. .+... .. ..+..++.+||+.||++|||+.++++.|+
T Consensus 221 ~~-----~~~~~-~~---~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 221 RH-----QLPAP-KW---TELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred cc-----cCCCC-Cc---HHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 01 11111 11 23444555899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=312.99 Aligned_cols=200 Identities=27% Similarity=0.432 Sum_probs=171.6
Q ss_pred cCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCC--chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
++|++.+.||+|+||.||+|... +++.||+|++...... ..+.+..|+++++.++||||+++++++.++...|+|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46888999999999999999864 5899999987543322 24567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
|+++++|..+... ...+++..++.++.||+.||+|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9999988887752 24589999999999999999999998 9999999999999999999999999999876443
Q ss_pred CceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 010891 331 KSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYG 381 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~ 381 (498)
. .......++..|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~ 204 (286)
T cd07846 154 G-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGD 204 (286)
T ss_pred c-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCC
Confidence 3 22334568899999998765 45788999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=308.33 Aligned_cols=254 Identities=28% Similarity=0.418 Sum_probs=194.0
Q ss_pred CCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC----------chhHHHHHHHHHHcCCCCCceEEEeEEEeCC
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ----------ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT 243 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 243 (498)
+|.+.+.||.|+||.||+|.. .+|+.||+|.+...... ..+.+..|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 467788999999999999974 46899999987432111 1235778999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecc
Q 010891 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (498)
Q Consensus 244 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGl 323 (498)
..++||||+++++|.+++... +.+++..+..++.|++.||.|||+. +++||||+|+||+++.++.++|+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence 999999999999999999743 5689999999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCce-eeecccccccccCcccccCCC--CCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhc
Q 010891 324 AKLLGAGKSH-ITTRVMGTFGYVAPEYANSGL--LNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLR 400 (498)
Q Consensus 324 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 400 (498)
+......... ......|+..|+|||.+.... ++.++|+||||+++|+|++|..||....... .. ..... .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-----~~-~~~~~-~ 227 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA-----AM-FKLGN-K 227 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH-----HH-HHhhc-c
Confidence 9865432111 123356889999999887654 8899999999999999999999996432211 11 11110 0
Q ss_pred cccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 401 RSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
.......... ..... .....++.+||.+||++|||+.+++++
T Consensus 228 ~~~~~~~~~~--~~~~~--~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 228 RSAPPIPPDV--SMNLS--PVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred ccCCcCCccc--cccCC--HHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 0011111111 11111 233334458999999999999999876
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=304.02 Aligned_cols=257 Identities=29% Similarity=0.441 Sum_probs=200.8
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
++|++.+.||.|+||+||+|.. .++..+++|++..... ...+.+.+|+++++.++||||+++++.+..+...++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4688999999999999999974 4678999998854332 2456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+++++|.+++.... ....+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||++..+....
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSY-PRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 99999999997432 124689999999999999999999998 99999999999999999999999999998765432
Q ss_pred ce---eeecccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcC
Q 010891 332 SH---ITTRVMGTFGYVAPEYANSG-LLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407 (498)
Q Consensus 332 ~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (498)
.. ......|+..|+|||++... .++.++|+|||||++|+|++|+.||....+... ..+ ... .. .
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~----~~~--~~----~ 224 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LML----TLQ--ND----P 224 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHH----Hhc--CC----C
Confidence 22 12335689999999988766 789999999999999999999999975433211 111 111 10 1
Q ss_pred CCCCCCCC-HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 408 PNIETRPS-TSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 408 ~~~~~~~~-~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
+.+..... ..-......++.+||..||++|||+.+++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11111110 0111233444558999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=335.39 Aligned_cols=205 Identities=20% Similarity=0.313 Sum_probs=163.7
Q ss_pred HHHccCCCccceEcccCcEEEEEEEEcC--CcEEEEEEe--------------c---CCCCCchhHHHHHHHHHHcCCCC
Q 010891 170 QSATNRFSKDNIIGDGGYGVVYRGQLMN--GTAVAVKKL--------------L---NNPGQADKDFRVEVEAIGHVRHK 230 (498)
Q Consensus 170 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~--------------~---~~~~~~~~~~~~E~~~l~~l~hp 230 (498)
....++|++.+.||+|+||+||+|.... +..++.|.+ . .........+.+|+.+|.+++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 3456789999999999999999986422 222222211 0 01112234578899999999999
Q ss_pred CceEEEeEEEeCCeeEEEEeecCCCCHHHHHhcccCC-CCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEE
Q 010891 231 NLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCD-RGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNIL 309 (498)
Q Consensus 231 nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIl 309 (498)
||+++++++.+.+..|+|+|++. ++|.+++...... ........+..|+.||+.||.|||++ +|+||||||+|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence 99999999999999999999994 5888887543211 22334567788999999999999999 9999999999999
Q ss_pred EcCCCCeEEeeeccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCC
Q 010891 310 IDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPV 378 (498)
Q Consensus 310 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~ 378 (498)
++.++.+||+|||+++.+...........+||..|+|||++.+..++.++|||||||+||||++|..++
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred ECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 999999999999999887654433344567999999999999999999999999999999999988654
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=304.54 Aligned_cols=238 Identities=26% Similarity=0.430 Sum_probs=186.2
Q ss_pred ceEcccCcEEEEEEEEcCCc-----------EEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 180 NIIGDGGYGVVYRGQLMNGT-----------AVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
+.||+|+||.||+|.+.+.. .|++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999864432 4777776544333 5678899999999999999999999988 778999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCC-------CeEEeee
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF-------DAKISDF 321 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~-------~~kL~Df 321 (498)
|||+++|+|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++ .+||+||
T Consensus 79 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCC
Confidence 9999999999999743 22689999999999999999999998 999999999999999887 7999999
Q ss_pred ccceecCCCCceeeecccccccccCcccccCC--CCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHh
Q 010891 322 GLAKLLGAGKSHITTRVMGTFGYVAPEYANSG--LLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQ 398 (498)
Q Consensus 322 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 398 (498)
|++..... .....++..|+|||++.+. .++.++|||||||++|||++ |..||........ ..+ ..
T Consensus 153 g~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~---~~~---~~- 220 (259)
T cd05037 153 GIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK---ERF---YQ- 220 (259)
T ss_pred Cccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH---HHH---Hh-
Confidence 99986543 1224567889999998776 78999999999999999999 5777765432111 111 11
Q ss_pred hccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 399 LRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
.... .. .+.. ..+..++.+||..+|.+|||+.++++.|+
T Consensus 221 --~~~~-----~~-~~~~---~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 --DQHR-----LP-MPDC---AELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred --cCCC-----CC-CCCc---hHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 00 1111 34445556899999999999999998773
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=311.50 Aligned_cols=258 Identities=24% Similarity=0.317 Sum_probs=198.0
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC---CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
++|.+.+.||+|+||.||++.. .+++.|++|.+..... .....+..|+++++.++||||+++++.+..+...++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 4688899999999999999974 4578999998865432 22346778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||++|++|.+++.. .+.+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999999963 35689999999999999999999998 999999999999999999999999999874211
Q ss_pred CC--------------ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 010891 330 GK--------------SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKM 395 (498)
Q Consensus 330 ~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 395 (498)
.. ........|+..|+|||.+.+..++.++|+|||||++|||++|..||....+. +....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~~ 227 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQ 227 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH
Confidence 10 00111245788999999998888999999999999999999999999743321 11121
Q ss_pred HHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 010891 396 MVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEY 452 (498)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~~ 452 (498)
.... ....+... ...+ ..+..++.+||+.||++||++.++++.|+...+
T Consensus 228 ~~~~----~~~~~~~~--~~~~--~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~ 276 (305)
T cd05609 228 VISD----DIEWPEGD--EALP--ADAQDLISRLLRQNPLERLGTGGAFEVKQHRFF 276 (305)
T ss_pred HHhc----ccCCCCcc--ccCC--HHHHHHHHHHhccChhhccCccCHHHHHhCccc
Confidence 1111 01111111 1111 223444558999999999997666666665443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=311.75 Aligned_cols=201 Identities=27% Similarity=0.422 Sum_probs=170.1
Q ss_pred cCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
++|++.+.||+|+||.||+|... +++.||+|.+...... ....+..|+++++.++||||+++++++.++...++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57889999999999999999854 6899999998654322 234567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+.+ +|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+++......
T Consensus 85 ~~~-~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LDT-DLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 975 999998643 24688999999999999999999999 99999999999999999999999999987643221
Q ss_pred ceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 010891 332 SHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~ 382 (498)
.. .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 158 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 158 KT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred cc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 11 122346889999998865 568899999999999999999999996443
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=308.42 Aligned_cols=255 Identities=27% Similarity=0.466 Sum_probs=198.8
Q ss_pred cCCCccceEcccCcEEEEEEEEc-CCc----EEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM-NGT----AVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
.+|++.+.||+|+||.||+|.+. +|. .||+|.+...... ....+.+|+.++.+++||||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 56788899999999999999753 333 5889987654432 33568889999999999999999999987 78899
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
||||+++|+|.+++... ...+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccc
Confidence 99999999999999742 34589999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCcee-eecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCC
Q 010891 328 GAGKSHI-TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV 405 (498)
Q Consensus 328 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (498)
....... .....++..|+|||.+....++.++|+|||||++||+++ |+.||....... ....+.. ....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~---~~~~ 230 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE------IPDLLEK---GERL 230 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH------HHHHHhC---CCCC
Confidence 5433221 111224568999999988899999999999999999998 999997543211 1111111 1111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 406 VDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 406 ~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
.. ... .......++.+||..||++|||+.++++.|....
T Consensus 231 ~~-----~~~--~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~ 269 (279)
T cd05057 231 PQ-----PPI--CTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA 269 (279)
T ss_pred CC-----CCC--CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 11 111 1123444556899999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=306.93 Aligned_cols=253 Identities=24% Similarity=0.442 Sum_probs=197.4
Q ss_pred CCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC------chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ------ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
+|+..+.||+|+||.||+|.. .+++.||+|.+...... ..+.+..|++++++++||||+++++++.+....++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999974 67899999988643321 23568889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCC-CeEEeeecccee
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF-DAKISDFGLAKL 326 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~-~~kL~DfGla~~ 326 (498)
||||+++++|.+++.. .+++++..+..++.|++.||.|||+. +++|+||||+||+++.++ .+||+|||++..
T Consensus 81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999999963 35688999999999999999999999 999999999999998776 599999999987
Q ss_pred cCCCCc---eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhcccc
Q 010891 327 LGAGKS---HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSE 403 (498)
Q Consensus 327 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (498)
...... .......|+..|+|||.+.+..++.++||||||+++|+|++|..||......... ........ .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~~~~~~---~- 226 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL---ALIFKIAS---A- 226 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH---HHHHHHhc---c-
Confidence 643311 1122346889999999998888999999999999999999999999644332211 11111100 0
Q ss_pred CCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 404 DVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
...+... . .....+..++.+||..||++|||+.+++.+
T Consensus 227 -~~~~~~~--~--~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 227 -TTAPSIP--E--HLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred -CCCCCCc--h--hhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 0011111 1 111234445558999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=308.40 Aligned_cols=250 Identities=28% Similarity=0.475 Sum_probs=192.5
Q ss_pred eEcccCcEEEEEEEEcC-------CcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeec
Q 010891 181 IIGDGGYGVVYRGQLMN-------GTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (498)
Q Consensus 181 ~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 252 (498)
.||+|+||.||+|+..+ +..+++|.+..... .....+.+|+++++.++||||+++++++......++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 69999999999997532 25789998754432 33457888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccC---CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCC-----CeEEeeeccc
Q 010891 253 NNGNLEQWLRGDMC---DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF-----DAKISDFGLA 324 (498)
Q Consensus 253 ~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~-----~~kL~DfGla 324 (498)
++++|.+++..... ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++ .++|+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 99999999975322 224578899999999999999999998 999999999999999887 8999999999
Q ss_pred eecCCCCce-eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccc
Q 010891 325 KLLGAGKSH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRS 402 (498)
Q Consensus 325 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (498)
......... ......++..|+|||++.++.++.++|||||||++|||++ |..||...... +....... .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~------~~~~~~~~---~ 229 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ------EVLQHVTA---G 229 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH------HHHHHHhc---C
Confidence 765432211 1122345788999999999999999999999999999998 99999643221 11111111 0
Q ss_pred cCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 403 EDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
. ........ ...+..++.+||..+|.+||++.++++.|+.
T Consensus 230 ~-----~~~~~~~~--~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 230 G-----RLQKPENC--PDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred C-----ccCCcccc--hHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 0 00111111 1233455558999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=310.81 Aligned_cols=260 Identities=25% Similarity=0.429 Sum_probs=199.1
Q ss_pred cHHHHHHHccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcC-CCCCceEEEeEEEe-
Q 010891 165 TLRDLQSATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIE- 241 (498)
Q Consensus 165 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~- 241 (498)
++.++....+.|++.+.||.|+||.||+|+. .+++.||+|.+.... .....+..|+.++.++ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 3445556678899999999999999999985 568899999875432 2345678899999998 79999999999853
Q ss_pred -----CCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCe
Q 010891 242 -----GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDA 316 (498)
Q Consensus 242 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~ 316 (498)
....|++|||+.+|+|.+++... ....+++..++.++.|++.||.|||+. +++|+||||+||++++++.+
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT--KGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence 46789999999999999999653 234588888999999999999999998 99999999999999999999
Q ss_pred EEeeeccceecCCCCceeeecccccccccCccccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHH
Q 010891 317 KISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYAN-----SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVE 391 (498)
Q Consensus 317 kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~ 391 (498)
+|+|||++........ ......|++.|+|||.+. +..++.++|||||||++|||++|..||....+....
T Consensus 161 ~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~---- 235 (282)
T cd06636 161 KLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL---- 235 (282)
T ss_pred EEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh----
Confidence 9999999876532211 123356899999999875 356888999999999999999999999644322111
Q ss_pred HHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 392 WLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
... .. ...+........ ..+..++.+||..||.+|||+.|++++
T Consensus 236 --~~~---~~---~~~~~~~~~~~~---~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 236 --FLI---PR---NPPPKLKSKKWS---KKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred --hhH---hh---CCCCCCcccccC---HHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 000 00 001111111111 234445558999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=313.66 Aligned_cols=248 Identities=24% Similarity=0.335 Sum_probs=196.5
Q ss_pred CccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCCC
Q 010891 177 SKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNG 255 (498)
Q Consensus 177 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g 255 (498)
.....||+|+||.||+|.. .+++.||+|.+........+.+.+|+.++..++||||+++++++..+...|+||||++++
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 3345799999999999975 468999999986555455567889999999999999999999999999999999999999
Q ss_pred CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCceee
Q 010891 256 NLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHIT 335 (498)
Q Consensus 256 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~~ 335 (498)
+|.+++.. ..+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....... ...
T Consensus 104 ~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~ 174 (297)
T cd06659 104 ALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKR 174 (297)
T ss_pred CHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccc
Confidence 99998742 4588999999999999999999999 99999999999999999999999999997654322 112
Q ss_pred ecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCC
Q 010891 336 TRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPS 415 (498)
Q Consensus 336 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (498)
....|+..|+|||++.+..++.++|||||||++|||++|+.||....+.. .+..+.. .. .+.......
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~~~~---~~---~~~~~~~~~ 242 (297)
T cd06659 175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ------AMKRLRD---SP---PPKLKNAHK 242 (297)
T ss_pred cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHhc---cC---CCCccccCC
Confidence 33568999999999998889999999999999999999999997543221 1111111 00 111111111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 416 TSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 416 ~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.. ..+..++.+||..+|.+||++.+++++-
T Consensus 243 ~~--~~l~~~i~~~l~~~P~~Rps~~~ll~~~ 272 (297)
T cd06659 243 IS--PVLRDFLERMLTREPQERATAQELLDHP 272 (297)
T ss_pred CC--HHHHHHHHHHhcCCcccCcCHHHHhhCh
Confidence 11 1233444589999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=308.79 Aligned_cols=256 Identities=28% Similarity=0.411 Sum_probs=197.9
Q ss_pred HccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcC-CCCCceEEEeEEEeCC------
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGT------ 243 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~------ 243 (498)
..++|++.+.||+|+||.||+|.. .+++.+++|.+..... ..+.+..|+.+++++ .||||+++++++.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 457899999999999999999986 4578899998865433 346788999999999 7999999999997644
Q ss_pred eeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecc
Q 010891 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (498)
Q Consensus 244 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGl 323 (498)
..|+||||+++++|.+++.........+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||+
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCcc
Confidence 47999999999999999875433356799999999999999999999998 999999999999999999999999999
Q ss_pred ceecCCCCceeeecccccccccCcccccC-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHh
Q 010891 324 AKLLGAGKSHITTRVMGTFGYVAPEYANS-----GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQ 398 (498)
Q Consensus 324 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 398 (498)
+........ ......|+..|+|||++.. ..++.++|||||||++|+|++|+.||....+.. .+..+..
T Consensus 160 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~ 232 (275)
T cd06608 160 SAQLDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR------ALFKIPR 232 (275)
T ss_pred ceecccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH------HHHHhhc
Confidence 987543221 1233568999999998743 357789999999999999999999996432211 1111111
Q ss_pred hccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 399 LRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
. ..+........ ...+..++.+||..||++|||+.+++++
T Consensus 233 ~------~~~~~~~~~~~--~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 233 N------PPPTLKSPENW--SKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred c------CCCCCCchhhc--CHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0 01111111101 1233344558999999999999999874
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=309.85 Aligned_cols=202 Identities=23% Similarity=0.356 Sum_probs=170.1
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
+++|.+.+.||+|+||.||+|.. .+|..|++|.+...... ....+.+|+++++.++|+||+++++++.++...|+|||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 46789999999999999999974 46889999998654332 23457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
|+. ++|.+++... ...+++..+..++.|++.||.|||+. +|+|+||||+|||++.++.+||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 84 YMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred ccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 995 6888777532 24578888999999999999999998 9999999999999999999999999999764332
Q ss_pred CceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 010891 331 KSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~ 382 (498)
.. ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||....
T Consensus 157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 157 SQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred CC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 21 1223457899999998865 458889999999999999999999997543
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=323.16 Aligned_cols=261 Identities=25% Similarity=0.415 Sum_probs=210.1
Q ss_pred HHHHHHccCCCccceEcccCcEEEEEEEEcC-CcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCee
Q 010891 167 RDLQSATNRFSKDNIIGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQR 245 (498)
Q Consensus 167 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 245 (498)
+.|+--+.++....+||-|-||.||.|.|+. .-.||||.++.+ ....++|+.|+.+|+.++|||+|+|+|+|.....+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 4555566677788899999999999998654 567999988543 45578899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccce
Q 010891 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~ 325 (498)
|||+|||..|+|.+||+.. .+.-++....+.++.||+.|+.||..+ ++|||||..+|+|+.++..+|++||||++
T Consensus 339 YIiTEfM~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred EEEEecccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhh
Confidence 9999999999999999754 556678888899999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccC
Q 010891 326 LLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSED 404 (498)
Q Consensus 326 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (498)
.+..+.........-...|.|||-+....++.|+|||+|||+|||+.| |..||.+ .++......+....+.
T Consensus 414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPG------idlSqVY~LLEkgyRM-- 485 (1157)
T KOG4278|consen 414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPG------IDLSQVYGLLEKGYRM-- 485 (1157)
T ss_pred hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCC------ccHHHHHHHHhccccc--
Confidence 986554332222334568999999999999999999999999999999 7777753 2332222222221111
Q ss_pred CcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 405 VVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
.....+..+...++..||+.+|.+||++.|+-+.++.
T Consensus 486 --------~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt 522 (1157)
T KOG4278|consen 486 --------DGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET 522 (1157)
T ss_pred --------cCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence 1112233456667778999999999999999877664
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=302.36 Aligned_cols=253 Identities=25% Similarity=0.431 Sum_probs=202.8
Q ss_pred cCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
++|++.+.||+|++|.||+|+.. +++.|++|++..... .....+..|+..+.+++||||+++++++..+...++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 46888999999999999999854 589999999865544 3456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHH-ccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE-AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
+++++|.+++... ..+++..++.++.|+++||.|||+ . +++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 9999999999742 668999999999999999999999 8 9999999999999999999999999999876543
Q ss_pred CceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCC
Q 010891 331 KSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNI 410 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (498)
... .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||............ ..+.. . ..+..
T Consensus 154 ~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~---~~~~~---~---~~~~~ 223 (264)
T cd06623 154 LDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM---QAICD---G---PPPSL 223 (264)
T ss_pred CCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH---HHHhc---C---CCCCC
Confidence 322 22456889999999999999999999999999999999999999755431211111 11111 0 00111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 411 ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 411 ~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
...... ..+..++.+||..+|++|||+.+++++
T Consensus 224 ~~~~~~---~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 224 PAEEFS---PEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CcccCC---HHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 111011 233444457999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=311.26 Aligned_cols=245 Identities=26% Similarity=0.319 Sum_probs=197.2
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC---CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
++|++.+.||+|+||.||++.. .+++.||+|.+..... ...+.+..|++++++++||||+++++++.++...|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4688899999999999999975 4689999998854322 23356788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+++++|.+++.. .+.+++..+..++.|++.||.|||+. +++|+||+|+|||++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 99999999999974 35689999999999999999999998 999999999999999999999999999987654
Q ss_pred CCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
. .....|++.|+|||.+.+..++.++||||||+++|+|++|..||...... ....... .. .
T Consensus 154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~---~~------~ 214 (290)
T cd05580 154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI------QIYEKIL---EG------K 214 (290)
T ss_pred C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHh---cC------C
Confidence 3 23356899999999998888999999999999999999999999744311 1111111 11 1
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRP-----KMSQVVRM 446 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RP-----t~~ell~~ 446 (498)
.......+ ..+..++.+||..||.+|+ ++.+++++
T Consensus 215 ~~~~~~~~--~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 215 VRFPSFFS--PDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred ccCCccCC--HHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 11111111 2233344589999999999 88888765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=312.42 Aligned_cols=254 Identities=27% Similarity=0.465 Sum_probs=195.1
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCc----EEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGT----AVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
++|+..+.||+|+||.||+|.+ .+|. .||+|.+...... ...++..|+.+++.++||||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 4677889999999999999974 3444 4788877544322 233678899999999999999999998754 4679
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
++||+++|+|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccc
Confidence 99999999999998642 34588999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCce-eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCC
Q 010891 328 GAGKSH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV 405 (498)
Q Consensus 328 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (498)
...... ......++..|+|||.+.+..++.++|||||||++|||++ |..||...... ...++ ... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~---~~~~~----~~~--~~~~ 230 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR---EIPDL----LEK--GERL 230 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHH----HHC--CCCC
Confidence 433221 1222345778999999998999999999999999999997 89998643211 11111 111 1111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 406 VDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 406 ~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
.. ... ....+..++.+||..||++||++.++++.|...
T Consensus 231 ~~-----~~~--~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~ 268 (303)
T cd05110 231 PQ-----PPI--CTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM 268 (303)
T ss_pred CC-----CCC--CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11 111 112344455689999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=309.88 Aligned_cols=250 Identities=24% Similarity=0.394 Sum_probs=199.7
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeec
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 252 (498)
++|.+.+.||+|+||.||++.. .++..|++|.+........+.+..|+.+++.++||||+++++++...+..|+|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 5788999999999999999974 468899999986544444567888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~ 332 (498)
++++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 99999999853 3578999999999999999999999 999999999999999999999999999876644322
Q ss_pred eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCC
Q 010891 333 HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIET 412 (498)
Q Consensus 333 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (498)
. .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||....+.... .... .. ..+....
T Consensus 171 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~------~~~~---~~---~~~~~~~ 237 (293)
T cd06647 171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIA---TN---GTPELQN 237 (293)
T ss_pred c-cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhe------eehh---cC---CCCCCCC
Confidence 2 23346889999999998888999999999999999999999999754332110 0000 00 0011111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 413 RPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 413 ~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
..... .....++.+||..+|++||++.+++.+
T Consensus 238 ~~~~~--~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 238 PEKLS--AIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ccccC--HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111 123334458999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=304.31 Aligned_cols=250 Identities=24% Similarity=0.350 Sum_probs=190.7
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC-----CchhHHHHHHHHHHcCCCCCceEEEeEEEeC--Cee
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG-----QADKDFRVEVEAIGHVRHKNLVRLLGYCIEG--TQR 245 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~ 245 (498)
++|.+.+.||+|+||.||+|.. .++..|++|.+..... ...+.+.+|+.++.+++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4688899999999999999975 4589999998853321 1234678899999999999999999998764 467
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccce
Q 010891 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~ 325 (498)
+++|||+++++|.+++.. ...+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence 899999999999999863 24588899999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCc--eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhcccc
Q 010891 326 LLGAGKS--HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSE 403 (498)
Q Consensus 326 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (498)
....... .......|+..|+|||++.+..++.++|||||||++|||++|+.||....... . ..... ..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-----~-~~~~~---~~- 224 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-----A-IFKIA---TQ- 224 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-----H-HHHHh---cC-
Confidence 6532211 11233568999999999988889999999999999999999999996432111 1 11111 00
Q ss_pred CCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 404 DVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
...+.. ...... ....++.+|+ .+|++||++.+++++
T Consensus 225 -~~~~~~--~~~~~~--~~~~~i~~~l-~~p~~Rp~~~~il~~ 261 (265)
T cd06652 225 -PTNPVL--PPHVSD--HCRDFLKRIF-VEAKLRPSADELLRH 261 (265)
T ss_pred -CCCCCC--chhhCH--HHHHHHHHHh-cChhhCCCHHHHhcC
Confidence 001111 111112 2222333577 489999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=301.78 Aligned_cols=249 Identities=23% Similarity=0.393 Sum_probs=196.8
Q ss_pred CCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC--CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
+|++.+.||+|+||.||++.. .+++.+|+|.+.... ....+.+..|+++++.++||||+++++.+..+...++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 578889999999999999974 568899999885432 22345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCC-CeEEeeeccceecCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF-DAKISDFGLAKLLGAG 330 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~-~~kL~DfGla~~~~~~ 330 (498)
+++++|.+++... ....+++..++.++.+++.||.|||++ +++|+||||+||+++.++ .+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 9999999999753 234589999999999999999999998 999999999999998654 5899999999876543
Q ss_pred CceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCC
Q 010891 331 KSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNI 410 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (498)
.. .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||....... ....... ..... +
T Consensus 156 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~------~~~~~~~-~~~~~-----~ 221 (256)
T cd08220 156 SK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA------LVLKIMS-GTFAP-----I 221 (256)
T ss_pred cc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH------HHHHHHh-cCCCC-----C
Confidence 21 223568899999999998889999999999999999999999997543321 1111111 00010 1
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 411 ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 411 ~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
. ... ...+..++.+||..||++|||+.|++.+
T Consensus 222 ~--~~~--~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 222 S--DRY--SPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred C--CCc--CHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 1 111 1223344458999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=304.31 Aligned_cols=249 Identities=26% Similarity=0.321 Sum_probs=199.5
Q ss_pred ccCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCCCchh---HHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADK---DFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
-++|..+++||+|.||.|-+++ ..+|+.+|+|++++....... .-..|-.+|...+||.+..+...|+..+++|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 4678889999999999999997 567999999998765443333 345689999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||.+||.|+-+|.. ...++++....+-..|+.||.|||++ +|++||||.+|+|+|++|++||+||||++.-.
T Consensus 247 MeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I 319 (516)
T KOG0690|consen 247 MEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI 319 (516)
T ss_pred EEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc
Confidence 999999999988864 24588888899999999999999999 99999999999999999999999999998643
Q ss_pred CCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (498)
... ..+..+||||.|+|||++....|+.++|+|.+|||+|||+||+.||...+...-..++- + .
T Consensus 320 ~~g-~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl----~-----------e 383 (516)
T KOG0690|consen 320 KYG-DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL----M-----------E 383 (516)
T ss_pred ccc-ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH----h-----------h
Confidence 322 23567899999999999999999999999999999999999999997544332221111 1 1
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 010891 409 NIETRPSTSALKRALLTALRCVDPDSDKRP-----KMSQVVRM 446 (498)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~~~cl~~dP~~RP-----t~~ell~~ 446 (498)
.+..+...+...+.+.. ..|.+||.+|. .+.|+.++
T Consensus 384 d~kFPr~ls~eAktLLs--GLL~kdP~kRLGgGpdDakEi~~h 424 (516)
T KOG0690|consen 384 DLKFPRTLSPEAKTLLS--GLLKKDPKKRLGGGPDDAKEIMRH 424 (516)
T ss_pred hccCCccCCHHHHHHHH--HHhhcChHhhcCCCchhHHHHHhh
Confidence 12222222222333332 47899999995 46777654
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=312.31 Aligned_cols=204 Identities=25% Similarity=0.366 Sum_probs=170.9
Q ss_pred CCCccceEcccCcEEEEEEEEc---CCcEEEEEEecCCC---CCchhHHHHHHHHHHcCCCCCceEEEeEEEeC--CeeE
Q 010891 175 RFSKDNIIGDGGYGVVYRGQLM---NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG--TQRI 246 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~ 246 (498)
+|.+.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++..++||||+++++++.+. ...|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999854 47899999987643 33345678899999999999999999999988 8899
Q ss_pred EEEeecCCCCHHHHHhcccCCC-CCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcC----CCCeEEeee
Q 010891 247 LVYEYVNNGNLEQWLRGDMCDR-GYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE----NFDAKISDF 321 (498)
Q Consensus 247 lv~e~~~~g~L~~~l~~~~~~~-~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~----~~~~kL~Df 321 (498)
+||||+++ +|.+++....... ..+++..++.++.|++.||.|||+. +++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999965 7888775433222 3789999999999999999999999 9999999999999999 899999999
Q ss_pred ccceecCCCCc--eeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 010891 322 GLAKLLGAGKS--HITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 322 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~ 382 (498)
|++........ .......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 99987643322 11233568899999998765 468899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=307.66 Aligned_cols=200 Identities=28% Similarity=0.449 Sum_probs=169.8
Q ss_pred CCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
+|+..+.||.|+||.||+|+. .+|+.|++|++..... .....+..|++++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 478889999999999999975 4689999998854332 2234688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+. ++|.+++... ....+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 95 5899998643 345689999999999999999999998 99999999999999999999999999998654332
Q ss_pred ceeeecccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCC
Q 010891 332 SHITTRVMGTFGYVAPEYANSG-LLNEKSDVYSFGVVLLEAITGRYPVDYG 381 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~ 381 (498)
.. .....++..|+|||++.+. .++.++|||||||++|||+||+.||...
T Consensus 155 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 204 (284)
T cd07860 155 RT-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204 (284)
T ss_pred cc-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 11 2234578899999987654 4688999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=306.56 Aligned_cols=262 Identities=25% Similarity=0.322 Sum_probs=195.5
Q ss_pred CCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC-----chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ-----ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
+|.+.+.||+|+||.||+|.. .+|+.|++|++...... ....+..|+++++.++||||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 477889999999999999985 46899999998654432 224567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+ +++|.+++... ...+++..++.++.||++||.|||+. +++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~e~~-~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 88999999743 13699999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHH--------hh
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMV--------QL 399 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~--------~~ 399 (498)
..... .....+++.|+|||.+.+ ..++.++|||||||++|||++|..||....+... ......... ..
T Consensus 154 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 154 SPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ--LGKIFEALGTPTEENWPGV 230 (298)
T ss_pred CCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH--HHHHHHHcCCCchhhhhhc
Confidence 43221 223356888999998754 5678999999999999999999777764332211 111100000 00
Q ss_pred ccccCCcCCCCCCCCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 400 RRSEDVVDPNIETRPS-----TSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 400 ~~~~~~~~~~~~~~~~-----~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
................ ......+..++.+||..||++|||+.|++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000000000000 0112334455668999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=323.30 Aligned_cols=249 Identities=28% Similarity=0.446 Sum_probs=201.0
Q ss_pred CCCccceEcccCcEEEEEEEEcC--C--cEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 175 RFSKDNIIGDGGYGVVYRGQLMN--G--TAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
+..+.++||+|.||+||+|.|.. | ..||||++...... ...+|++|+.+|.+|+|||+++|||+..+ ....|||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 34567899999999999998643 3 36899999776654 56789999999999999999999999987 7789999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
|+++.|+|.+.|+.. ....|.......++.|||.|+.||.++ ++|||||..+|+||...-.+||+||||.+.++.
T Consensus 190 ELaplGSLldrLrka--~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRKA--KKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hhcccchHHHHHhhc--cccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 999999999999862 456788889999999999999999999 999999999999999998999999999999876
Q ss_pred CCce-eeec-ccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCc
Q 010891 330 GKSH-ITTR-VMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVV 406 (498)
Q Consensus 330 ~~~~-~~~~-~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (498)
+... .++. ..-...|+|||.++...++.++|||+|||+||||+| |..||.+-.. ...++.+. ..+.+.
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g------~qIL~~iD---~~erLp 335 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG------IQILKNID---AGERLP 335 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH------HHHHHhcc---ccccCC
Confidence 5432 2221 234668999999999999999999999999999999 7788865432 22222221 112221
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 010891 407 DPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVR 445 (498)
Q Consensus 407 ~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~ 445 (498)
.+ ..+...+..+++.||..+|++|||+..|.+
T Consensus 336 RP-------k~csedIY~imk~cWah~paDRptFsair~ 367 (1039)
T KOG0199|consen 336 RP-------KYCSEDIYQIMKNCWAHNPADRPTFSAIRE 367 (1039)
T ss_pred CC-------CCChHHHHHHHHHhccCCccccccHHHHHH
Confidence 11 123345666677899999999999999974
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-38 Score=306.06 Aligned_cols=254 Identities=26% Similarity=0.400 Sum_probs=192.2
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC-CchhHHHHHHHH-HHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG-QADKDFRVEVEA-IGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
++|++.+.||+|+||.||+|.. .+|+.||+|++..... .....+..|+.+ ++.++||||+++++++..+...|++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 4688899999999999999985 4699999998865432 223345556665 566799999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
|++ |+|.+++.........+++..++.++.||+.||.|||+++ +++||||||+||+++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 6899888654334467999999999999999999999743 8999999999999999999999999999865432
Q ss_pred CceeeecccccccccCcccccC----CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCc
Q 010891 331 KSHITTRVMGTFGYVAPEYANS----GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVV 406 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (498)
. ..+...|+..|+|||.+.+ ..++.++|+|||||++|+|++|+.||....... +.+...... .
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~------~ 224 (283)
T cd06617 158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-----QQLKQVVEE------P 224 (283)
T ss_pred c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-----HHHHHHHhc------C
Confidence 1 1223468899999998754 457889999999999999999999996422111 111111110 0
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 407 DPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 407 ~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
.+.+...... ..+..++.+||..+|++|||+.+++.+
T Consensus 225 ~~~~~~~~~~---~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 225 SPQLPAEKFS---PEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred CCCCCccccC---HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111111111 233444558999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=303.26 Aligned_cols=248 Identities=26% Similarity=0.465 Sum_probs=196.8
Q ss_pred CCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC-CCchhHHHHHHHHHHcCC---CCCceEEEeEEEeCCeeEEEE
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVR---HKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~~lv~ 249 (498)
.|++.+.||.|+||.||+|.+ .+++.|++|.+.... ......+..|+.+++.++ |||++++++++.++...|+||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477788999999999999984 578999999886442 234456888999999986 999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+++++|.+++.. +.+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999999853 3689999999999999999999999 999999999999999999999999999987754
Q ss_pred CCceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (498)
.... .....|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||........ .. .. .....+
T Consensus 154 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~~---~~---~~~~~~ 220 (277)
T cd06917 154 NSSK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------MM---LI---PKSKPP 220 (277)
T ss_pred Cccc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------hh---cc---ccCCCC
Confidence 4322 233568999999998765 4578999999999999999999999975432111 00 00 011111
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 409 NIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
.+...... ..+..++.+||+.||++||++.+++++
T Consensus 221 ~~~~~~~~---~~~~~~i~~~l~~~p~~R~~~~~il~~ 255 (277)
T cd06917 221 RLEDNGYS---KLLREFVAACLDEEPKERLSAEELLKS 255 (277)
T ss_pred CCCcccCC---HHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence 22211111 234445558999999999999999874
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=305.57 Aligned_cols=254 Identities=26% Similarity=0.399 Sum_probs=199.8
Q ss_pred cCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
++|++.+.||.|+||.||++... +++.|++|.+..... ...+.+.+|+++++.++||||+++++++..+...++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35778889999999999999864 688999998865533 3345688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHH-ccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE-AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
+++++|.+++... ...+++.....++.|++.||+|||+ . +++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 9999999999743 1578999999999999999999999 7 9999999999999999999999999998765332
Q ss_pred CceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCC
Q 010891 331 KSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNI 410 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (498)
.. ....++..|+|||.+.+..++.++||||||+++|+|++|..||....... ....+.++...... .+.+
T Consensus 155 ~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~------~~~~ 224 (265)
T cd06605 155 LA---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNEP------PPRL 224 (265)
T ss_pred Hh---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcCC------CCCC
Confidence 21 12568899999999998999999999999999999999999997543211 11122222221110 1111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 411 ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 411 ~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
...... ..+..++.+||..||++|||+.+++.+
T Consensus 225 ~~~~~~---~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 225 PSGKFS---PDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred ChhhcC---HHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 111111 223444458999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=303.87 Aligned_cols=247 Identities=26% Similarity=0.412 Sum_probs=196.4
Q ss_pred CCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeec
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 252 (498)
-|++.+.||+|+||.||+|.. .++..||+|.+..... .....+.+|+.++.+++||||+++++++.++...|+||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 367788999999999999975 4688999998754322 23356888999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~ 332 (498)
++++|.+++.. ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06641 85 GGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence 99999999853 4589999999999999999999998 999999999999999999999999999987643221
Q ss_pred eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCC
Q 010891 333 HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIET 412 (498)
Q Consensus 333 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (498)
......|+..|+|||.+.+..++.++|+|||||++|+|++|..||....+. ........ .. .+.+..
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~-~~-----~~~~~~ 223 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPM------KVLFLIPK-NN-----PPTLEG 223 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchH------HHHHHHhc-CC-----CCCCCc
Confidence 123356889999999998888999999999999999999999999643221 11111111 00 111111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 413 RPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 413 ~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
. . ...+..++.+||..+|.+||++.+++++
T Consensus 224 ~--~--~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 224 N--Y--SKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred c--c--CHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1 1 1223344558999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=303.85 Aligned_cols=256 Identities=22% Similarity=0.413 Sum_probs=194.7
Q ss_pred CCccceEcccCcEEEEEEEEc----CCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEeCC------
Q 010891 176 FSKDNIIGDGGYGVVYRGQLM----NGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT------ 243 (498)
Q Consensus 176 y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------ 243 (498)
|.+.+.||+|+||.||+|.+. ++..||+|.+..... ...+++.+|+++++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 566789999999999999742 368899998865432 23456888999999999999999999886532
Q ss_pred eeEEEEeecCCCCHHHHHhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeee
Q 010891 244 QRILVYEYVNNGNLEQWLRGDMC--DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDF 321 (498)
Q Consensus 244 ~~~lv~e~~~~g~L~~~l~~~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~Df 321 (498)
..++++||+.+|+|.+++..... ....+++...+.++.|++.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 23788999999999998853321 123578899999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCce-eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhh
Q 010891 322 GLAKLLGAGKSH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQL 399 (498)
Q Consensus 322 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 399 (498)
|+++........ ......+++.|++||.+.+..++.++|||||||++|||++ |+.||...... ....+ ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~---~~~- 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNY---LIK- 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHH---HHc-
Confidence 999876433211 1223345678999999998899999999999999999999 88888643321 11111 111
Q ss_pred ccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 400 RRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
.... ...+. ....+..++.+||+.+|++||++.+++..|+..
T Consensus 231 --~~~~-----~~~~~--~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 --GNRL-----KQPPD--CLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred --CCcC-----CCCCC--CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1100 00111 123455566689999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=305.88 Aligned_cols=250 Identities=25% Similarity=0.345 Sum_probs=197.9
Q ss_pred CCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecC
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ 253 (498)
.|...+.||+|++|.||++.. .+++.+++|++........+.+.+|+.+++.++||||+++++++...+..|+++||+.
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~ 99 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE 99 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence 344567999999999999974 5688999998865444445668889999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCce
Q 010891 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333 (498)
Q Consensus 254 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~ 333 (498)
+++|.+++.. +.+++..+..++.|++.||+|||+. +++||||+|+||+++.++.++|+|||++........
T Consensus 100 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~- 170 (285)
T cd06648 100 GGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP- 170 (285)
T ss_pred CCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-
Confidence 9999999863 4589999999999999999999999 999999999999999999999999998876543221
Q ss_pred eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCC
Q 010891 334 ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETR 413 (498)
Q Consensus 334 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (498)
......|++.|+|||.+.+..++.++|||||||++|||++|+.||....+. ......... ..+.....
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~------~~~~~~~~~------~~~~~~~~ 238 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL------QAMKRIRDN------LPPKLKNL 238 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHHhc------CCCCCccc
Confidence 123356899999999998888999999999999999999999999654321 111111111 01111111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 414 PSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 414 ~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.... ..+..++.+||+.||++|||+.+++++-
T Consensus 239 ~~~~--~~l~~li~~~l~~~p~~Rpt~~~il~~~ 270 (285)
T cd06648 239 HKVS--PRLRSFLDRMLVRDPAQRATAAELLNHP 270 (285)
T ss_pred ccCC--HHHHHHHHHHcccChhhCcCHHHHccCc
Confidence 1111 2344445589999999999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=303.72 Aligned_cols=248 Identities=24% Similarity=0.293 Sum_probs=198.4
Q ss_pred CCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCC---CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 175 RFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
+|++.+.||.|+||.||+|+.. +++.||+|.+..... ...+.+.+|++++++++||||+++++++.++...|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4788999999999999999854 689999999865432 234678889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
|+.+++|.+++.. ...+++..+..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 9999999999963 25789999999999999999999998 9999999999999999999999999999876543
Q ss_pred CceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCC
Q 010891 331 KSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNI 410 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (498)
. ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||.......... +...... .. +..
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~--~~----~~~ 221 (258)
T cd05578 154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ----IRAKQET--AD----VLY 221 (258)
T ss_pred c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHH----HHHHhcc--cc----ccC
Confidence 2 2233568899999999988889999999999999999999999998655421111 1111110 11 111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCH--HHHHH
Q 010891 411 ETRPSTSALKRALLTALRCVDPDSDKRPKM--SQVVR 445 (498)
Q Consensus 411 ~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~--~ell~ 445 (498)
. .... .....++.+||..||.+||++ .|++.
T Consensus 222 ~--~~~~--~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 222 P--ATWS--TEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred c--ccCc--HHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 1 1111 233344458999999999999 77654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=307.14 Aligned_cols=250 Identities=27% Similarity=0.371 Sum_probs=194.8
Q ss_pred HccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC---chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ---ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
...+|.+.+.||+|+||.||+|.. .+++.||+|++...... ..+.+..|+++++.++||||+++++++.++...|+
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l 92 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL 92 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence 345688899999999999999975 46899999988543332 22468889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
||||+. |+|.+++... ...+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++...
T Consensus 93 v~e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~ 165 (307)
T cd06607 93 VMEYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLV 165 (307)
T ss_pred EHHhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceec
Confidence 999996 5888877532 34689999999999999999999998 9999999999999999999999999999765
Q ss_pred CCCCceeeecccccccccCccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccC
Q 010891 328 GAGKSHITTRVMGTFGYVAPEYAN---SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSED 404 (498)
Q Consensus 328 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (498)
... ....|+..|+|||++. ...++.++||||||+++|||++|..||........ ..... ...
T Consensus 166 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~~~~~---~~~- 230 (307)
T cd06607 166 SPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIA---QND- 230 (307)
T ss_pred CCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------HHHHh---cCC-
Confidence 432 2346888999999874 46688999999999999999999999975432111 01110 000
Q ss_pred CcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 405 VVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
.+...... ....+..++.+||..||++||++.+++.+.-
T Consensus 231 --~~~~~~~~---~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 231 --SPTLSSND---WSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred --CCCCCchh---hCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 01111111 1123344445899999999999999998653
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=295.65 Aligned_cols=250 Identities=26% Similarity=0.441 Sum_probs=201.4
Q ss_pred CCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecC
Q 010891 175 RFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ 253 (498)
.|...+.||+|++|.||++... ++..+++|++........+.+.+|+++++.++||||+++++++..+...++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3677889999999999999864 688999999876555456778999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCce
Q 010891 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333 (498)
Q Consensus 254 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~ 333 (498)
+++|.+++... ...+++..+..++.|++.||.|||.. +++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 99999999743 25689999999999999999999998 999999999999999999999999999987654332
Q ss_pred eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCC
Q 010891 334 ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETR 413 (498)
Q Consensus 334 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (498)
.....|+..|+|||.+.+..++.++||||||+++|+|++|+.||........ +..... ... +.....
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~-~~~-----~~~~~~ 220 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA------LFKIAT-NGP-----PGLRNP 220 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH------HHHHHh-cCC-----CCcCcc
Confidence 2345689999999999888899999999999999999999999975432211 111111 111 111111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 414 PSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 414 ~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
... ...+..++.+||+.||.+|||+.+++++
T Consensus 221 ~~~--~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 221 EKW--SDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ccc--CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 110 1234444558999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=305.25 Aligned_cols=263 Identities=22% Similarity=0.275 Sum_probs=193.2
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC--CchhHHHHHHHHHHcCC-CCCceEEEeEEEeCCe-----
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVR-HKNLVRLLGYCIEGTQ----- 244 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~----- 244 (498)
++|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+|+.+++.+. ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4688899999999999999985 4689999998754332 22356788999999994 6999999999887665
Q ss_pred eEEEEeecCCCCHHHHHhcccCC-CCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcC-CCCeEEeeec
Q 010891 245 RILVYEYVNNGNLEQWLRGDMCD-RGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE-NFDAKISDFG 322 (498)
Q Consensus 245 ~~lv~e~~~~g~L~~~l~~~~~~-~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~-~~~~kL~DfG 322 (498)
.|+||||+++ +|.+++...... ...+++..++.++.||+.||.|||+. +++||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 899988653322 35689999999999999999999999 9999999999999998 8899999999
Q ss_pred cceecCCCCceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhcc
Q 010891 323 LAKLLGAGKSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRR 401 (498)
Q Consensus 323 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 401 (498)
++..+...... .....+++.|+|||++.+ ..++.++||||||+++|+|++|..||....+... ....+.....
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~-----~~~~~~~~~~ 230 (295)
T cd07837 157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQ-----LLHIFKLLGT 230 (295)
T ss_pred cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHH-----HHHHHHHhCC
Confidence 99865432211 222357889999998754 5678999999999999999999999975432211 1111111000
Q ss_pred ccCCcC------------CCCCC----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 402 SEDVVD------------PNIET----RPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 402 ~~~~~~------------~~~~~----~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
.....- +.... .........+..++.+||.+||.+|||+.|++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred CChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000 00000 0000112234445568999999999999999865
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=313.51 Aligned_cols=200 Identities=30% Similarity=0.356 Sum_probs=170.5
Q ss_pred HHccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC--CCchhHHHHHHHHHHcCCCCCceEEEeEEEeC-----
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG----- 242 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~----- 242 (498)
...++|++.+.||+|+||.||+|.. .+|+.||+|.+.... ......+..|+.+++.++||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 3567899999999999999999974 478999999885432 22335677899999999999999999988643
Q ss_pred -CeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeee
Q 010891 243 -TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDF 321 (498)
Q Consensus 243 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~Df 321 (498)
...|+||||+. ++|.+++.. .++...+..++.|++.||.|||+. +|+||||||+||+++.++.+||+||
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Df 162 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF 162 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccC
Confidence 35699999995 488888852 288899999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 010891 322 GLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 322 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~ 382 (498)
|+++...... ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||...+
T Consensus 163 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 163 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred ccceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 9998764432 1233568899999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=311.86 Aligned_cols=203 Identities=28% Similarity=0.358 Sum_probs=178.8
Q ss_pred HHccCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCC---CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeE
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI 246 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 246 (498)
...+.|..-++||+||||.||-++ ..+|+.+|+|++.+... +.......|-.+|.+++.+.||.+-..|++.+.+|
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 345778889999999999999997 56799999998854322 22234667999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecccee
Q 010891 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (498)
Q Consensus 247 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~ 326 (498)
+||..|+||+|.-+|-.. ..+-+++..+..++.+|+.||.+||+. +|++|||||+|||||++|++.|+|+|||..
T Consensus 262 lVLtlMNGGDLkfHiyn~--g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAve 336 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNH--GNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVE 336 (591)
T ss_pred EEEEeecCCceeEEeecc--CCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEe
Confidence 999999999999888643 234699999999999999999999999 999999999999999999999999999999
Q ss_pred cCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 010891 327 LGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDY 380 (498)
Q Consensus 327 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~ 380 (498)
+..++.. ...+||.+|||||++.++.|+...|+|||||+||||+.|+.||..
T Consensus 337 i~~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~ 388 (591)
T KOG0986|consen 337 IPEGKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ 388 (591)
T ss_pred cCCCCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence 8766543 334899999999999999999999999999999999999999974
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=305.00 Aligned_cols=260 Identities=17% Similarity=0.215 Sum_probs=182.3
Q ss_pred HHccCCCccceEcccCcEEEEEEEEcCC----cEEEEEEecCCCCCchh-----------HHHHHHHHHHcCCCCCceEE
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQLMNG----TAVAVKKLLNNPGQADK-----------DFRVEVEAIGHVRHKNLVRL 235 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~-----------~~~~E~~~l~~l~hpnIv~l 235 (498)
+..++|.+.++||+|+||.||+|...++ ..+++|+.......... ....+...+..+.|+||+++
T Consensus 9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~ 88 (294)
T PHA02882 9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY 88 (294)
T ss_pred cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence 3446899999999999999999986443 45566543222211111 11223445567799999999
Q ss_pred EeEEEeCC----eeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEc
Q 010891 236 LGYCIEGT----QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID 311 (498)
Q Consensus 236 ~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~ 311 (498)
++++.... ..++++|++. .++.+.+... ...++..+..++.|++.||.|||+. +|+||||||+|||++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~ 160 (294)
T PHA02882 89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVD 160 (294)
T ss_pred EEeeeEecCCceEEEEEEehhc-cCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEc
Confidence 99766543 3477888874 4777776532 3357888899999999999999998 999999999999999
Q ss_pred CCCCeEEeeeccceecCCCCc------eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcc
Q 010891 312 ENFDAKISDFGLAKLLGAGKS------HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQS 385 (498)
Q Consensus 312 ~~~~~kL~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~ 385 (498)
.++.++|+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~ 240 (294)
T PHA02882 161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG 240 (294)
T ss_pred CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence 999999999999987643221 11223469999999999999999999999999999999999999997553222
Q ss_pred hhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 386 EVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
............. +..+......... ....++..|+..+|++||++.++++.+
T Consensus 241 ~~~~~~~~~~~~~------~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 241 NLIHAAKCDFIKR------LHEGKIKIKNANK---FIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHhHHHHHHH------hhhhhhccCCCCH---HHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1111000000011 1111111122222 333444579999999999999999876
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=304.10 Aligned_cols=202 Identities=28% Similarity=0.463 Sum_probs=171.6
Q ss_pred CCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeec
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 252 (498)
+|++.+.||.|++|.||+|+. .+|..||+|++...... ....+..|+++++.++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 478899999999999999986 46889999998654332 3456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~ 332 (498)
++ +|.+++.... ....+++..+..++.|++.||.|||+. +++||||||+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 81 DK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred Cc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 75 8999886432 234689999999999999999999998 999999999999999999999999999976543221
Q ss_pred eeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 010891 333 HITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 333 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~ 382 (498)
. .....++..|++||.+.+ ..++.++|||||||++|+|++|+.||....
T Consensus 156 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 205 (284)
T cd07836 156 T-FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN 205 (284)
T ss_pred c-cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 223457899999998755 457899999999999999999999997554
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=303.01 Aligned_cols=255 Identities=25% Similarity=0.380 Sum_probs=201.9
Q ss_pred HHccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
..++.|+..+.||+|+||.||+|... ++..|++|.+..... ..+.+..|+++++.++|+||+++++++......|+|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 34567888899999999999999865 688999999865443 4567888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+++++|.+++.... ..+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 168 (286)
T cd06614 95 EYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTK 168 (286)
T ss_pred eccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhcc
Confidence 9999999999997531 3799999999999999999999998 999999999999999999999999999876543
Q ss_pred CCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
... ......++..|+|||.+.+..++.++|+|||||++|+|++|+.||....+... ...... ... +.
T Consensus 169 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~------~~~~~~-~~~-----~~ 235 (286)
T cd06614 169 EKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA------LFLITT-KGI-----PP 235 (286)
T ss_pred chh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHh-cCC-----CC
Confidence 221 12334578899999999888899999999999999999999999974432211 111111 000 11
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
....... ...+..++.+||+.+|.+|||+.+++++.
T Consensus 236 ~~~~~~~--~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 271 (286)
T cd06614 236 LKNPEKW--SPEFKDFLNKCLVKDPEKRPSAEELLQHP 271 (286)
T ss_pred CcchhhC--CHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence 1111101 12233445589999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=316.31 Aligned_cols=248 Identities=26% Similarity=0.403 Sum_probs=207.6
Q ss_pred ccCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCCCch--hHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQAD--KDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
.+.|.+.+.||+|.|+.|.+|+ ..++..||||.+.+...... ..+.+|+++|..|+|||||+++.+......+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 4568889999999999999997 45699999999866544332 34788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+.+|.+++||.. .+...+..+..++.|+..|++|||++ +|+|||||++||||+.+.++||+|||++..+..
T Consensus 135 eya~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 135 EYASGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EeccCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecc
Confidence 99999999999984 46677789999999999999999999 999999999999999999999999999998864
Q ss_pred CCceeeecccccccccCcccccCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANSGLL-NEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (498)
+ .....++|++.|.|||++.+..| ++.+|+||+|++||-|++|.+||++..-.. -.+.++..
T Consensus 208 ~--~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~---------------Lr~rvl~g 270 (596)
T KOG0586|consen 208 G--LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE---------------LRPRVLRG 270 (596)
T ss_pred c--ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc---------------ccchheee
Confidence 3 34566899999999999988766 478999999999999999999998644321 11223334
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 409 NIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
.+......+...+.++. ++|-.+|.+|++++++.++
T Consensus 271 k~rIp~~ms~dce~lLr--k~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 271 KYRIPFYMSCDCEDLLR--KFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eecccceeechhHHHHH--HhhccCccccCCHHHhhhh
Confidence 44455555554555443 7899999999999999864
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=312.01 Aligned_cols=201 Identities=27% Similarity=0.415 Sum_probs=168.4
Q ss_pred HccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeC-----Ce
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEG-----TQ 244 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~ 244 (498)
..++|++.+.||+|+||.||+|.. .+|+.||+|++..... .....+..|+.++++++||||+++++++... ..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 356899999999999999999974 5689999999864322 2335577899999999999999999987654 35
Q ss_pred eEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccc
Q 010891 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (498)
Q Consensus 245 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla 324 (498)
.|+|+||+.+ +|.+++. ...+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 83 ~~lv~e~~~~-~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 83 VYIVQELMET-DLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred EEEEehhccc-CHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccce
Confidence 7999999965 8888874 24689999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCce--eeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 010891 325 KLLGAGKSH--ITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYG 381 (498)
Q Consensus 325 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~ 381 (498)
......... ......||+.|+|||.+.+ ..++.++|||||||++|+|++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~ 213 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 876432211 1233578999999998654 57899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=307.61 Aligned_cols=267 Identities=26% Similarity=0.344 Sum_probs=197.2
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC--chhHHHHHHHHHHcCCCCCceEEEeEEEeC--CeeEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEG--TQRIL 247 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~l 247 (498)
.++|++.+.||+|+||.||+|.. .+|+.||+|++...... ....+.+|+.++++++||||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 35789999999999999999985 46899999988543322 223466799999999999999999998765 56799
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
||||+.+ +|.+++... ...+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++...
T Consensus 86 v~e~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999965 899888642 25689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhcccc-CC
Q 010891 328 GAGKSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSE-DV 405 (498)
Q Consensus 328 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 405 (498)
..... ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||....+... +..+....... ..
T Consensus 159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~------~~~~~~~~~~~~~~ 231 (309)
T cd07845 159 GLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ------LDLIIQLLGTPNES 231 (309)
T ss_pred CCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHHhcCCCChh
Confidence 54321 1223346888999998865 5688999999999999999999999975433221 11111100000 00
Q ss_pred c-----------CCCCCCCC--CH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCC
Q 010891 406 V-----------DPNIETRP--ST-----SALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYP 453 (498)
Q Consensus 406 ~-----------~~~~~~~~--~~-----~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~~~ 453 (498)
. .-.....+ .. ........++.+||..||++|||+.+++.+--....+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 232 IWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred hchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence 0 00000000 00 0012334455689999999999999999875544333
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=299.54 Aligned_cols=250 Identities=24% Similarity=0.403 Sum_probs=196.5
Q ss_pred CCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC--CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
+|.+.+.||+|+||.||+|.. .+|..||+|.+.... ....+.+.+|+++++.++||||+++++.+.+....++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 478889999999999999975 458899999885432 22345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCC-eEEeeeccceecCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD-AKISDFGLAKLLGAG 330 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~-~kL~DfGla~~~~~~ 330 (498)
+++++|.+++... ....+++..+..++.|++.||.|||+. +++|+||||+||++++++. +||+|||.+......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999999999643 223578999999999999999999998 9999999999999998864 699999999876543
Q ss_pred CceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCC
Q 010891 331 KSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNI 410 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (498)
.. ......|++.|+|||++.+..++.++|+||||+++|||++|..||..... .+....... ....+ .
T Consensus 156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~------~~~~~~~~~-----~~~~~-~ 222 (257)
T cd08225 156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL------HQLVLKICQ-----GYFAP-I 222 (257)
T ss_pred cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHhc-----ccCCC-C
Confidence 22 22234689999999999888899999999999999999999999964322 111111111 00111 0
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 411 ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 411 ~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
.+..+ ..+..++.+||..+|++|||+.+++++
T Consensus 223 --~~~~~--~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 223 --SPNFS--RDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred --CCCCC--HHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 11111 233344458999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=301.48 Aligned_cols=260 Identities=24% Similarity=0.359 Sum_probs=193.7
Q ss_pred CCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeec
Q 010891 176 FSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (498)
Q Consensus 176 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 252 (498)
|++.+.||.|++|.||+|.. .+|..|++|++..... .....+..|+++++.++||||+++++++.++...|++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56788999999999999975 4799999998864432 22356788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~ 332 (498)
+ ++|.+++... ....+++..++.++.|+++||.|||+. +++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 D-LDLKKYMDSS--PLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred C-cCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 5 6999998643 224689999999999999999999998 999999999999999999999999999986543321
Q ss_pred eeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH--------------H
Q 010891 333 HITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMM--------------V 397 (498)
Q Consensus 333 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~--------------~ 397 (498)
. .....++..|+|||++.+ ..++.++||||||+++|+|++|+.||....... ...+..+.. .
T Consensus 155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07835 155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSLP 231 (283)
T ss_pred c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhch
Confidence 1 222356889999998765 457899999999999999999999997543211 111111100 0
Q ss_pred hhcc-ccCCcCCCC-CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 398 QLRR-SEDVVDPNI-ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 398 ~~~~-~~~~~~~~~-~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
.... ......... ...+..+ ..+..++.+||+.||.+|||+.|++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 232 DYKPTFPKWARQDLSKVVPNLD--EDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhcccccccchhhhcCCCC--HHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 0000 000000000 0011111 234455568999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=306.46 Aligned_cols=204 Identities=25% Similarity=0.376 Sum_probs=168.2
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC--chhHHHHHHHHHHcCCCCCceEEEeEEEeCC------
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT------ 243 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------ 243 (498)
.++|++.+.||+|+||.||+|.. .+++.||+|++...... ....+.+|++++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 35789999999999999999975 46899999988543322 2234667999999999999999999987654
Q ss_pred --eeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeee
Q 010891 244 --QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDF 321 (498)
Q Consensus 244 --~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~Df 321 (498)
..++||||+.+ +|.+++.. ....+++.+++.++.|++.||.|||+. +++|+||||+||+++.++.+||+||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcC
Confidence 34999999964 88888864 224689999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCce---eeecccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCC
Q 010891 322 GLAKLLGAGKSH---ITTRVMGTFGYVAPEYANSG-LLNEKSDVYSFGVVLLEAITGRYPVDYGRP 383 (498)
Q Consensus 322 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~ 383 (498)
|++......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||....+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~ 229 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE 229 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 999876433211 12234678899999987654 478899999999999999999999975543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=302.77 Aligned_cols=261 Identities=26% Similarity=0.318 Sum_probs=196.1
Q ss_pred CCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCC--CCchhHHHHHHHHHHcCCCCCceEEEeEEEeC--CeeEEEEe
Q 010891 176 FSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG--TQRILVYE 250 (498)
Q Consensus 176 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~lv~e 250 (498)
|++.+.||.|+||.||+|... +++.+|+|++.... ......+..|+++++.++|||++++++++.+. ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999854 58899999997653 23345688899999999999999999999988 88999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
|+++ +|.+++... ...+++..++.++.||+.||+|||+. +++|+||||+||++++++.+||+|||++......
T Consensus 81 ~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 899988642 24689999999999999999999998 9999999999999999999999999999877554
Q ss_pred CceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccC---C-
Q 010891 331 KSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSED---V- 405 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~---~- 405 (498)
.....+...++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... ..+........... .
T Consensus 154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 230 (287)
T cd07840 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQL---EKIFELCGSPTDENWPGVS 230 (287)
T ss_pred CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCchhhccccc
Confidence 3222333467889999997654 56889999999999999999999999754432111 11111000000000 0
Q ss_pred -------cCCCCCCCCC------HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 406 -------VDPNIETRPS------TSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 406 -------~~~~~~~~~~------~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
..+....... .......+.++.+||..||.+||++.+++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred cchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000000000 0002345566668999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=295.67 Aligned_cols=252 Identities=26% Similarity=0.395 Sum_probs=203.0
Q ss_pred CCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 175 RFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
+|.+.+.||.|+||.||++... ++..|++|++..... ...+.+..|+++++.++|||++++++.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4788899999999999999853 688999999865433 3456688899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+++++|.+++.........+++..+..++.+++.||.|||+. +++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 999999999976433357799999999999999999999999 99999999999999999999999999998765443
Q ss_pred ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCC
Q 010891 332 SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (498)
.......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...... +....... ... +.+.
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~-~~~-----~~~~ 224 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------ELALKILK-GQY-----PPIP 224 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------HHHHHHhc-CCC-----CCCC
Confidence 2233457899999999998888999999999999999999999999654321 11111111 111 1111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 412 ~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
. ... ..+..++.+||..+|++|||+.+++++
T Consensus 225 ~-~~~---~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 225 S-QYS---SELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred C-CCC---HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1 111 233344558999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=288.38 Aligned_cols=251 Identities=27% Similarity=0.442 Sum_probs=191.6
Q ss_pred CCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC-CCchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCeeEEEEeec
Q 010891 176 FSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVYEYV 252 (498)
Q Consensus 176 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~ 252 (498)
.+.+..||.|..|+||+++. .+|..+|||.+.... .+..+.++..++++... .+|+||+.+|+|..+...++.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 34567899999999999984 568999999986543 33445677777777665 4899999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~ 332 (498)
.. -++.+|.. -.+++++..+-++...+.+||.||..++ +|||||+||+|||+|+.|++||||||++-.+-+...
T Consensus 174 s~-C~ekLlkr---ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 174 ST-CAEKLLKR---IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HH-HHHHHHHH---hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc
Confidence 44 55555543 3467899999999999999999999876 999999999999999999999999999987765443
Q ss_pred eeeecccccccccCccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 333 HITTRVMGTFGYVAPEYAN---SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 333 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
+ +...|.+.|||||.+. ...|+.++||||||+.|+||.||+.||.....+ .... ..+.. ... |.
T Consensus 248 h--trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe~l---tkvln--~eP----P~ 314 (391)
T KOG0983|consen 248 H--TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FEVL---TKVLN--EEP----PL 314 (391)
T ss_pred c--ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HHHH---HHHHh--cCC----CC
Confidence 3 3456889999999884 457999999999999999999999999864432 2111 11111 111 22
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
+......+. ....+...||.+|+.+||...++|+|-
T Consensus 315 L~~~~gFSp--~F~~fv~~CL~kd~r~RP~Y~~Ll~h~ 350 (391)
T KOG0983|consen 315 LPGHMGFSP--DFQSFVKDCLTKDHRKRPKYNKLLEHP 350 (391)
T ss_pred CCcccCcCH--HHHHHHHHHhhcCcccCcchHHHhcCc
Confidence 222211122 223334479999999999999999764
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=305.03 Aligned_cols=257 Identities=26% Similarity=0.401 Sum_probs=191.0
Q ss_pred CCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC-CchhHHHHHHHHHHcCC-CCCceEEEeEEEeCCeeEEEEee
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVR-HKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
+|...+.||+|+||.||++.. .+++.||+|.+..... .....+..|+.++.++. ||||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 345567899999999999974 4689999999864432 23456888999999996 99999999999999999999999
Q ss_pred cCCCCHHHHHhcc-cCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 252 VNNGNLEQWLRGD-MCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 252 ~~~g~L~~~l~~~-~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
+.. +|.++.... ......+++..+..++.|++.||+|||+.. +++||||||+||+++.++.+||+|||++......
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 854 665544211 112356899999999999999999999632 8999999999999999999999999999765432
Q ss_pred CceeeecccccccccCcccccCC---CCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcC
Q 010891 331 KSHITTRVMGTFGYVAPEYANSG---LLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (498)
.. .....|+..|+|||++.+. .++.++|||||||++|||++|+.||.... ...+ .+....... .
T Consensus 162 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~---~~~~~~~~~---~ 228 (288)
T cd06616 162 IA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFD---QLTQVVKGD---P 228 (288)
T ss_pred Cc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHH---HHhhhcCCC---C
Confidence 21 2234688999999998765 68999999999999999999999996432 1111 111111111 1
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 408 ~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
+.+...........+..++.+||..||++|||+.+++.+-
T Consensus 229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~ 268 (288)
T cd06616 229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHP 268 (288)
T ss_pred CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 1111111011122344455589999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=301.38 Aligned_cols=245 Identities=24% Similarity=0.279 Sum_probs=185.0
Q ss_pred eEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC---chhHHHHHHHH---HHcCCCCCceEEEeEEEeCCeeEEEEeecC
Q 010891 181 IIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ---ADKDFRVEVEA---IGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253 (498)
Q Consensus 181 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~---l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ 253 (498)
.||+|+||.||++.. .+++.||+|.+...... ....+..|..+ +...+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999985 46889999988544321 11223444433 334579999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCce
Q 010891 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333 (498)
Q Consensus 254 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~ 333 (498)
+++|.+++.. .+.+++..+..++.|++.||.|||+. +++||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 9999999863 35699999999999999999999999 99999999999999999999999999997654322
Q ss_pred eeecccccccccCccccc-CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCC
Q 010891 334 ITTRVMGTFGYVAPEYAN-SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIET 412 (498)
Q Consensus 334 ~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (498)
.....||..|+|||.+. +..++.++|||||||++|+|++|..||......... .+..+... ....+.
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~~~------~~~~~~- 219 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTLT------VNVELP- 219 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH----HHHHHhhc------CCcCCc-
Confidence 22346899999999886 456899999999999999999999999754332211 11111110 011111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhc
Q 010891 413 RPSTSALKRALLTALRCVDPDSDKRP-----KMSQVVRMLES 449 (498)
Q Consensus 413 ~~~~~~~~~~l~~~~~cl~~dP~~RP-----t~~ell~~L~~ 449 (498)
.... ..+..++.+||..||.+|| |++++++|.-.
T Consensus 220 -~~~~--~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~ 258 (279)
T cd05633 220 -DSFS--PELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFF 258 (279)
T ss_pred -cccC--HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccc
Confidence 1111 2233344589999999999 69999887543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=303.10 Aligned_cols=201 Identities=27% Similarity=0.375 Sum_probs=169.9
Q ss_pred cCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCC--chhHHHHHHHHHHcCCCCCceEEEeEEEeC--CeeEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEG--TQRILV 248 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~lv 248 (498)
++|++.+.||.|+||.||+|... +++.+++|.+...... ....+.+|+.++.+++||||+++++++... ...|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888899999999999999864 5889999998644322 223567899999999999999999998877 889999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+.+ +|.+++... ...+++..++.++.||+.||.|||+. +++|+||||+||+++.++.+||+|||++....
T Consensus 85 ~e~~~~-~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVEH-DLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcCc-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 999975 999998643 23689999999999999999999998 99999999999999999999999999998765
Q ss_pred CCCceeeecccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANSG-LLNEKSDVYSFGVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~ 382 (498)
.... ......+++.|+|||.+.+. .++.++|+||||+++|+|++|..||....
T Consensus 158 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~ 211 (293)
T cd07843 158 SPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS 211 (293)
T ss_pred CCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 4321 12334578899999988654 46899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=296.38 Aligned_cols=251 Identities=22% Similarity=0.281 Sum_probs=190.8
Q ss_pred HHHHHHHccCCCccceE--cccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcC-CCCCceEEEeEEEe
Q 010891 166 LRDLQSATNRFSKDNII--GDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIE 241 (498)
Q Consensus 166 ~~~~~~~~~~y~~~~~l--g~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~ 241 (498)
..+.....++|.+.+.+ |.|+||.||++.. .++..+|+|.+........ |+.....+ +||||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec
Confidence 44555666788887776 9999999999974 5688899998854322211 22222222 79999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCC-CeEEee
Q 010891 242 GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF-DAKISD 320 (498)
Q Consensus 242 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~-~~kL~D 320 (498)
.+..|+||||+++++|.+++.. ...+++..+..++.|+++||.|||+. +++||||||+||+++.++ .++|+|
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~d 153 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCD 153 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEec
Confidence 9999999999999999999974 24799999999999999999999999 999999999999999998 999999
Q ss_pred eccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhc
Q 010891 321 FGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLR 400 (498)
Q Consensus 321 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 400 (498)
||++....... ...|+..|+|||++.+..++.++||||||+++|||++|+.||..... ...+...+....
T Consensus 154 fg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~---- 223 (267)
T PHA03390 154 YGLCKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED-EELDLESLLKRQ---- 223 (267)
T ss_pred CccceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc-chhhHHHHHHhh----
Confidence 99998764321 24588999999999998999999999999999999999999974332 222222221111
Q ss_pred cccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 010891 401 RSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPK-MSQVVRM 446 (498)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt-~~ell~~ 446 (498)
. .........+. .+..++.+||+.||.+||+ +++++++
T Consensus 224 -~-----~~~~~~~~~~~--~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 224 -Q-----KKLPFIKNVSK--NANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred -c-----ccCCcccccCH--HHHHHHHHHhccChhhCCchHHHHhcC
Confidence 0 01111111112 2333344899999999996 6998864
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=297.45 Aligned_cols=243 Identities=25% Similarity=0.315 Sum_probs=193.3
Q ss_pred EcccCcEEEEEEEEc-CCcEEEEEEecCCCC---CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCCCCH
Q 010891 182 IGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNL 257 (498)
Q Consensus 182 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L 257 (498)
||.|+||.||+|+.. +++.|++|.+..... ...+.+..|+.+++.++||||+++++++.++...|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999854 489999999865432 2335688999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCceeeec
Q 010891 258 EQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337 (498)
Q Consensus 258 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~ 337 (498)
.+++.. ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~ 151 (262)
T cd05572 81 WTILRD----RGLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT 151 (262)
T ss_pred HHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence 999974 34589999999999999999999998 99999999999999999999999999998765432 1233
Q ss_pred ccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHH
Q 010891 338 VMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTS 417 (498)
Q Consensus 338 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (498)
..|+..|+|||.+.+..++.++|+||||+++|+|++|..||....... .+....+... ... ...+ ...
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~--~~~---~~~~--~~~- 219 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYNDILKG--NGK---LEFP--NYI- 219 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHHHHhcc--CCC---CCCC--ccc-
Confidence 568999999999988889999999999999999999999997554211 1111221110 000 1111 111
Q ss_pred HHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 010891 418 ALKRALLTALRCVDPDSDKRPK-----MSQVVRM 446 (498)
Q Consensus 418 ~~~~~l~~~~~cl~~dP~~RPt-----~~ell~~ 446 (498)
...+..++.+||..||++||+ +.|++++
T Consensus 220 -~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~ 252 (262)
T cd05572 220 -DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH 252 (262)
T ss_pred -CHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence 223444555899999999999 8888774
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=301.20 Aligned_cols=258 Identities=22% Similarity=0.287 Sum_probs=190.6
Q ss_pred CCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC-chhHHHHHHHHHHcCC-CCCceEEEeEEEeC--CeeEEEEe
Q 010891 176 FSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVR-HKNLVRLLGYCIEG--TQRILVYE 250 (498)
Q Consensus 176 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~--~~~~lv~e 250 (498)
|++.+.||+|+||.||+|.. .+++.||+|++...... .......|+.++.++. ||||+++++++.++ ...++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 56788999999999999974 46889999988654222 2233456888999885 99999999999987 88999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
|++ ++|.+++... ...+++..++.++.|++.||.|||+. +++||||||+||+++. +.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 996 5888888642 25689999999999999999999999 9999999999999999 99999999999876433
Q ss_pred CceeeecccccccccCccccc-CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHh--------hcc
Q 010891 331 KSHITTRVMGTFGYVAPEYAN-SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQ--------LRR 401 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~--------~~~ 401 (498)
.. .....++..|+|||++. ++.++.++|||||||++|||++|..||....+.. .......... ...
T Consensus 153 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 153 PP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred CC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhc
Confidence 22 23356889999999764 4567899999999999999999999997543321 1111111000 000
Q ss_pred ccCCcCCCCCCCC-------CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 402 SEDVVDPNIETRP-------STSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 402 ~~~~~~~~~~~~~-------~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
.....+....... .......+..++.+||.+||++|||+.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 0000000000000 00112345555668999999999999999875
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=291.74 Aligned_cols=277 Identities=22% Similarity=0.278 Sum_probs=202.8
Q ss_pred cCCCccceEcccCcEEEEEEEEcC-----CcEEEEEEecCCCCC--chhHHHHHHHHHHcCCCCCceEEEeEEEe-CCee
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLMN-----GTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIE-GTQR 245 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~ 245 (498)
..|+..+.||+|.||.||+|...+ ...+|+|+++..... -.....+|+.+++.++||||+.+..+|.. +..+
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 468899999999999999994221 237899999654332 22456779999999999999999999987 7888
Q ss_pred EEEEeecCCCCHHHHHhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCC----CCeEEee
Q 010891 246 ILVYEYVNNGNLEQWLRGDMC-DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN----FDAKISD 320 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~----~~~kL~D 320 (498)
++++||.+. +|.+.|+.++. ....++...+..|+.||+.|+.|||++ -|+||||||.||||..+ |.+||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeec
Confidence 999999977 99999965432 235688999999999999999999999 99999999999999877 9999999
Q ss_pred eccceecCCCCce--eeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcc----hhhHHHHH
Q 010891 321 FGLAKLLGAGKSH--ITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQS----EVNLVEWL 393 (498)
Q Consensus 321 fGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~----~~~~~~~~ 393 (498)
||+++.+.+.-.. ....++.|.+|+|||++.+ ..|+.+.|||+.|||+.||+|-.+.|....... .... +.+
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~-dQl 258 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQH-DQL 258 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchH-HHH
Confidence 9999998765433 2445788999999998765 679999999999999999999988886432110 1111 111
Q ss_pred HHHHhhcccc-CCcCCCCC---------------CCCCH--H--------HHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 394 KMMVQLRRSE-DVVDPNIE---------------TRPST--S--------ALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 394 ~~~~~~~~~~-~~~~~~~~---------------~~~~~--~--------~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
..+....... ...=|.+. ...+. . .....+.+..++|..||-+|.|+++++++.
T Consensus 259 ~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~ 338 (438)
T KOG0666|consen 259 DRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP 338 (438)
T ss_pred HHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence 1111111100 00000000 00000 0 001145555689999999999999999988
Q ss_pred hcCCCCCC
Q 010891 448 ESEEYPIP 455 (498)
Q Consensus 448 ~~~~~~~~ 455 (498)
-....+.|
T Consensus 339 yF~~d~lp 346 (438)
T KOG0666|consen 339 YFTEDPLP 346 (438)
T ss_pred ccccCCCC
Confidence 76665554
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=302.93 Aligned_cols=202 Identities=26% Similarity=0.399 Sum_probs=168.1
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
++|++.+.||+|++|+||+|.. .+|+.||+|++..... ...+.+..|++++++++||||+++++++.++...|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 4688999999999999999985 4688999998854322 223568889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcC-CCCeEEeeeccceecCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE-NFDAKISDFGLAKLLGA 329 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~-~~~~kL~DfGla~~~~~ 329 (498)
|++ ++|.+++... ....+++..+..++.||+.||.|||+. +++|+||+|+||+++. ++.+||+|||++.....
T Consensus 82 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 996 5888887543 223467888899999999999999998 9999999999999985 55799999999986543
Q ss_pred CCceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~ 382 (498)
... ......+++.|+|||++.+ ..++.++|||||||++|+|+||+.||....
T Consensus 156 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~ 208 (294)
T PLN00009 156 PVR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS 208 (294)
T ss_pred Ccc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 221 1233467899999998765 468899999999999999999999997543
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=297.39 Aligned_cols=250 Identities=26% Similarity=0.364 Sum_probs=200.4
Q ss_pred CCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
+|++.+.||+|+||.||++.. .+++.+++|.+..... .....+..|+++++.++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 478889999999999999974 4688999999865432 2334677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+++++|.+++.........+++..++.++.|++.||.|||+. +++|+||+|.||+++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 999999999975433446789999999999999999999999 9999999999999999999999999999876543
Q ss_pred ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCC
Q 010891 332 SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (498)
......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||....... . ......... +...
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~----~~~~~~~~~-----~~~~ 222 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---L----RYKVQRGKY-----PPIP 222 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H----HHHHhcCCC-----CCCc
Confidence 1223458899999999999999999999999999999999999997543211 1 111111111 1111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 412 ~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
. .....+..++.+||..+|++|||+.+++++
T Consensus 223 ~----~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 223 P----IYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred h----hhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 1 122334455568999999999999999876
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=303.05 Aligned_cols=245 Identities=25% Similarity=0.360 Sum_probs=194.4
Q ss_pred cceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCCCCH
Q 010891 179 DNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNL 257 (498)
Q Consensus 179 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L 257 (498)
..+||+|+||.||++.. .++..||+|++..........+..|+.+++.++||||+++++++..++..++||||+++++|
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 46799999999999975 57899999988654444556688899999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCceeeec
Q 010891 258 EQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337 (498)
Q Consensus 258 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~ 337 (498)
.+++. ...+++..+..++.|++.||+|||+. +++|+||+|+||++++++.++|+|||++........ ....
T Consensus 105 ~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~ 175 (292)
T cd06657 105 TDIVT-----HTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS 175 (292)
T ss_pred HHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccc
Confidence 99874 24588999999999999999999998 999999999999999999999999999876543221 1233
Q ss_pred ccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHH
Q 010891 338 VMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTS 417 (498)
Q Consensus 338 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (498)
..|+..|+|||.+.+..++.++|+||||+++|+|++|..||........ ....... ..+.+.......
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~------~~~~~~~------~~~~~~~~~~~~ 243 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA------MKMIRDN------LPPKLKNLHKVS 243 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhh------CCcccCCcccCC
Confidence 5689999999999888899999999999999999999999975432211 1111110 011111111111
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 418 ALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 418 ~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
..+..++.+||+.||.+||++.+++++
T Consensus 244 --~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 244 --PSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred --HHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 122334458999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=304.02 Aligned_cols=250 Identities=26% Similarity=0.366 Sum_probs=194.1
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC---chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ---ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
..|...+.||+|+||.||+|+. .++..||+|++...... ....+..|+++++.++|||++++++++.++...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 3467788999999999999984 46889999988643322 2346788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+.+ +|.+++.. ...++++.++..++.|++.||.|||+. +|+||||+|+||+++.++.+||+|||++.....
T Consensus 105 e~~~g-~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 105 EYCLG-SASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred eCCCC-CHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 99965 88887753 235689999999999999999999999 999999999999999999999999999875432
Q ss_pred CCceeeecccccccccCcccc---cCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCc
Q 010891 330 GKSHITTRVMGTFGYVAPEYA---NSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVV 406 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (498)
.....|+..|+|||++ ..+.++.++|||||||++|||++|..||....... ..........
T Consensus 178 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~~~~~~~----- 241 (317)
T cd06635 178 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNES----- 241 (317)
T ss_pred -----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHHhccC-----
Confidence 2234688999999987 34678899999999999999999999986432211 1111111110
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 407 DPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 407 ~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
+.... ...+ ..+..++.+||+.+|.+||++.++++++...
T Consensus 242 -~~~~~-~~~~--~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 281 (317)
T cd06635 242 -PTLQS-NEWS--DYFRNFVDSCLQKIPQDRPTSEELLKHMFVL 281 (317)
T ss_pred -CCCCC-cccc--HHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence 01111 1111 2233444589999999999999999876543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=336.08 Aligned_cols=254 Identities=26% Similarity=0.437 Sum_probs=187.9
Q ss_pred HHHccCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCC-CCchhHHHHHHHHHHcCCCCCceEEEeEEEeC-----
Q 010891 170 QSATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG----- 242 (498)
Q Consensus 170 ~~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~----- 242 (498)
....++|+..++||+||||.||+++ .-||+.||||++.-.. ......+.+|+..|++|+|||||+++..+.+.
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 3456678889999999999999998 5689999999996553 22234578899999999999999998643210
Q ss_pred --------------------------------------------------------------------------------
Q 010891 243 -------------------------------------------------------------------------------- 242 (498)
Q Consensus 243 -------------------------------------------------------------------------------- 242 (498)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CeeEEEEeecCCCCHHHHHhcccCCCCCC-CHHHHHHHHHHHHHHH
Q 010891 243 ----------------------------------TQRILVYEYVNNGNLEQWLRGDMCDRGYL-TWEARMKILLGTAKAL 287 (498)
Q Consensus 243 ----------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l-~~~~~~~i~~~ia~aL 287 (498)
..+||-||||+.-.|.++++.+. .. .....++++.+|++||
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~----~~~~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH----FNSQRDEAWRLFREILEGL 710 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc----cchhhHHHHHHHHHHHHHH
Confidence 01478899999988888886442 22 3578999999999999
Q ss_pred HHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC-----------------CCCceeeecccccccccCcccc
Q 010891 288 AYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG-----------------AGKSHITTRVMGTFGYVAPEYA 350 (498)
Q Consensus 288 ~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~ 350 (498)
+|+|+. |||||||||.||+|+++..|||+|||+|.... .......+..+||.-|+|||++
T Consensus 711 aYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 711 AYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 999999 99999999999999999999999999998721 0011134557899999999999
Q ss_pred cCC---CCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHH
Q 010891 351 NSG---LLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTAL 427 (498)
Q Consensus 351 ~~~---~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 427 (498)
.+. .|+.|+|+|||||||+||+. ||... ++....+..++... +..+ .............++.
T Consensus 788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--------MERa~iL~~LR~g~-iP~~---~~f~~~~~~~e~slI~ 852 (1351)
T KOG1035|consen 788 SDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS--------MERASILTNLRKGS-IPEP---ADFFDPEHPEEASLIR 852 (1351)
T ss_pred cccccccccchhhhHHHHHHHHHHhc---cCCch--------HHHHHHHHhcccCC-CCCC---cccccccchHHHHHHH
Confidence 764 49999999999999999986 56521 12122222222111 1111 1112222233344445
Q ss_pred HccCCCCCCCCCHHHHHH
Q 010891 428 RCVDPDSDKRPKMSQVVR 445 (498)
Q Consensus 428 ~cl~~dP~~RPt~~ell~ 445 (498)
++++.||.+||||.|+|.
T Consensus 853 ~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 853 WLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHhcCCCccCCCHHHHhh
Confidence 799999999999999985
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=291.22 Aligned_cols=251 Identities=28% Similarity=0.412 Sum_probs=200.4
Q ss_pred CCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEeC--CeeEEEE
Q 010891 175 RFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEG--TQRILVY 249 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~lv~ 249 (498)
+|.+.+.||+|++|.||+|... +++.|++|.+..... ...+.+..|++++++++||||+++++.+.+. ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677899999999999999865 689999998865443 3356788999999999999999999999988 8899999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+++++|.+++... ..+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 999999999999743 3799999999999999999999998 999999999999999999999999999988755
Q ss_pred CCce-eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCC
Q 010891 330 GKSH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408 (498)
Q Consensus 330 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (498)
.... ......++..|+|||.+.+..++.++||||||+++|+|++|..||....... ..+......... +
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--------~~~~~~~~~~~~--~ 223 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM--------AALYKIGSSGEP--P 223 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--------HHHHhccccCCC--c
Confidence 4321 1233568899999999988889999999999999999999999997544111 111111110000 1
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 409 NIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
.... .. ...+..++.+|+..||++||++.+++.+
T Consensus 224 ~~~~--~~--~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 224 EIPE--HL--SEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred CCCc--cc--CHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 1111 11 2334445558999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=291.88 Aligned_cols=256 Identities=23% Similarity=0.285 Sum_probs=197.0
Q ss_pred HHccCCCcc-ceEcccCcEEEEEEE-EcCCcEEEEEEecCCCCCchhHHHHHHHHHHcC-CCCCceEEEeEEEeC----C
Q 010891 171 SATNRFSKD-NIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEG----T 243 (498)
Q Consensus 171 ~~~~~y~~~-~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~----~ 243 (498)
.++++|.+. ++||-|-.|.|..+. ..+|+.+|+|++... ...++|+++--.. .|||||.++++|.+. .
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk 132 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRK 132 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence 356677776 789999999999996 567999999988543 4466788876655 799999999998753 4
Q ss_pred eeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcC---CCCeEEee
Q 010891 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE---NFDAKISD 320 (498)
Q Consensus 244 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~---~~~~kL~D 320 (498)
.+.+|||.|+||.|++.++.. ....+++.++..|+.||+.|+.|||+. +|.||||||+|+|... |-.+||+|
T Consensus 133 cLLiVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 133 CLLIVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred eeEeeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecc
Confidence 557899999999999999854 345699999999999999999999999 9999999999999964 45699999
Q ss_pred eccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhc
Q 010891 321 FGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLR 400 (498)
Q Consensus 321 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 400 (498)
||+|+..... ......+-||.|.|||++....|+...|+||+||++|-|++|.+||.......- . .-|....
T Consensus 208 fGFAK~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai---s---pgMk~rI 279 (400)
T KOG0604|consen 208 FGFAKETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---S---PGMKRRI 279 (400)
T ss_pred cccccccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC---C---hhHHhHh
Confidence 9999976432 234456789999999999999999999999999999999999999975432111 0 1111111
Q ss_pred cccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 401 RSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
+....--|. +.+...++..++++. .+|..+|.+|.|+.+++.+-
T Consensus 280 ~~gqy~FP~-pEWs~VSe~aKdlIR--~LLkt~PteRlTI~~~m~hp 323 (400)
T KOG0604|consen 280 RTGQYEFPE-PEWSCVSEAAKDLIR--KLLKTEPTERLTIEEVMDHP 323 (400)
T ss_pred hccCccCCC-hhHhHHHHHHHHHHH--HHhcCCchhheeHHHhhcCc
Confidence 111111111 223344555555544 67999999999999999754
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=292.56 Aligned_cols=248 Identities=29% Similarity=0.460 Sum_probs=199.1
Q ss_pred CCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 175 RFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
+|++.+.||+|++|.||++... +++.|++|.+..... .....+..|++++.+++|||++++++++.++...+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4778899999999999999754 678999999866544 3445788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+++++|.+++... +.+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999999742 5789999999999999999999998 99999999999999999999999999998775443
Q ss_pred ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCC
Q 010891 332 SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (498)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|..||....+.. .. ..... ... +.+
T Consensus 154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~-----~~-~~~~~--~~~----~~~- 219 (254)
T cd06627 154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA-----AL-FRIVQ--DDH----PPL- 219 (254)
T ss_pred cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH-----HH-HHHhc--cCC----CCC-
Confidence 22 233568899999999988888999999999999999999999997433211 11 11111 100 111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 412 ~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
..... ..+..++.+||..+|++|||+.+++.+
T Consensus 220 -~~~~~--~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 220 -PEGIS--PELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred -CCCCC--HHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 11111 223344458999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=301.41 Aligned_cols=252 Identities=25% Similarity=0.337 Sum_probs=194.3
Q ss_pred CCCccceEcccCcEEEEEEEE----cCCcEEEEEEecCCCC----CchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCee
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL----MNGTAVAVKKLLNNPG----QADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQR 245 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 245 (498)
+|++.+.||.|+||.||+++. .+|..||+|.+..... ...+.+..|++++.++ +||||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 477889999999999999975 3689999999864322 2235678899999999 699999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccce
Q 010891 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~ 325 (498)
|+||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +++||||+|+|||++.++.+||+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999999973 35688999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCceeeecccccccccCcccccC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhcccc
Q 010891 326 LLGAGKSHITTRVMGTFGYVAPEYANS--GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSE 403 (498)
Q Consensus 326 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (498)
..............|+..|+|||.+.+ ..++.++||||||+++|+|++|..||....... ...+........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~---- 227 (290)
T cd05613 154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKS---- 227 (290)
T ss_pred ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhcc----
Confidence 765433233334568999999998865 357889999999999999999999996432211 111111111110
Q ss_pred CCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 010891 404 DVVDPNIETRPSTSALKRALLTALRCVDPDSDKRP-----KMSQVVRM 446 (498)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RP-----t~~ell~~ 446 (498)
.+.. ..... ..+..++.+||..||++|| ++.+++.+
T Consensus 228 ---~~~~--~~~~~--~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 228 ---EPPY--PQEMS--ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ---CCCC--CccCC--HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 0111 11111 2233444589999999997 67777665
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=308.69 Aligned_cols=202 Identities=28% Similarity=0.416 Sum_probs=169.0
Q ss_pred HccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCC--CCchhHHHHHHHHHHcC-CCCCceEEEeEEEeC--Cee
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP--GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEG--TQR 245 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~--~~~ 245 (498)
+.++|++.+.||+|+||.||+|.+. +++.+|+|++.... ......+..|+.++.++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4578899999999999999999854 68899999885432 22334577899999999 999999999998653 467
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccce
Q 010891 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~ 325 (498)
|+||||++ ++|.+++.. ..+.+..+..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~ 155 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLAR 155 (337)
T ss_pred EEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchh
Confidence 99999997 599998863 2688999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCc----eeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 010891 326 LLGAGKS----HITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 326 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~ 382 (498)
....... .......||..|+|||.+.+ ..++.++||||||+++|+|++|+.||....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~ 217 (337)
T cd07852 156 SLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTS 217 (337)
T ss_pred ccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 7643321 12233568999999997754 568899999999999999999999996543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=312.83 Aligned_cols=260 Identities=24% Similarity=0.315 Sum_probs=195.1
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC--CCchhHHHHHHHHHHcCCCCCceEEEeEEEeC-----Ce
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG-----TQ 244 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~ 244 (498)
.++|.+.+.||+|+||+||+|+. .+++.||+|.+.... ......+..|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 46799999999999999999974 568999999886432 22344577899999999999999999988654 34
Q ss_pred eEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccc
Q 010891 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (498)
Q Consensus 245 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla 324 (498)
.|+||||+. ++|.+++. ..+.+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR----SSQTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999995 68999886 335699999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhh----
Q 010891 325 KLLGAGKSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQL---- 399 (498)
Q Consensus 325 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~---- 399 (498)
....... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||......... ..+......
T Consensus 156 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~ 231 (337)
T cd07858 156 RTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQL---KLITELLGSPSEE 231 (337)
T ss_pred cccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHH---HHHHHHhCCCChH
Confidence 8764332 22334568899999998764 56899999999999999999999999654321111 000000000
Q ss_pred --------------ccccCCcCCCCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 400 --------------RRSEDVVDPNIE-TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 400 --------------~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
........+... ..+. ....+..++.+||+.||++|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 232 DLGFIRNEKARRYIRSLPYTPRQSFARLFPH--ANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred HhhhcCchhhhHHHHhcCcccccCHHHHccc--CCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 000000000000 0011 12334455668999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=295.17 Aligned_cols=250 Identities=23% Similarity=0.342 Sum_probs=192.0
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC-----CCchhHHHHHHHHHHcCCCCCceEEEeEEEeC--Cee
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP-----GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG--TQR 245 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~ 245 (498)
.+|.+.+.||+|+||.||+|.. .++..|++|.+.... ......+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4688899999999999999974 568999999874321 22335688899999999999999999998764 457
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccce
Q 010891 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~ 325 (498)
+++|||+++++|.+++.. .+.+++.....++.|++.||.|||+. +++|+||||+||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence 899999999999999863 34588999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCc--eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhcccc
Q 010891 326 LLGAGKS--HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSE 403 (498)
Q Consensus 326 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (498)
....... .......|+..|+|||++.+..++.++|+|||||++|+|++|+.||....... . +... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~-~~~~---~~~- 224 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA-----A-IFKI---ATQ- 224 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH-----H-HHHH---HcC-
Confidence 6532111 11233568999999999988889999999999999999999999996432111 1 1111 100
Q ss_pred CCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 404 DVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
...+.+ +..... ....++.+||. +|..|||+.+++.|
T Consensus 225 -~~~~~~--p~~~~~--~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 225 -PTKPML--PDGVSD--ACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred -CCCCCC--CcccCH--HHHHHHHHHhc-CcccCccHHHHhcC
Confidence 001111 112222 23333347888 57999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=303.17 Aligned_cols=265 Identities=25% Similarity=0.313 Sum_probs=196.1
Q ss_pred HHHccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEeCC---
Q 010891 170 QSATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT--- 243 (498)
Q Consensus 170 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--- 243 (498)
....++|++.+.||+|+||.||+|... +|+.||+|.+..... .....+..|+++++.++||||+++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 345678999999999999999999864 588999999864432 22345778999999999999999999987654
Q ss_pred -------eeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCe
Q 010891 244 -------QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDA 316 (498)
Q Consensus 244 -------~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~ 316 (498)
..++|+||+++ +|.+++... ...+++..+..++.|++.||+|||+. +|+|+||||+||++++++.+
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~ 155 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQI 155 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcE
Confidence 78999999976 788877642 34689999999999999999999999 99999999999999999999
Q ss_pred EEeeeccceecCCCCceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 010891 317 KISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKM 395 (498)
Q Consensus 317 kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 395 (498)
||+|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... ....+..
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~---~~~~~~~ 232 (302)
T cd07864 156 KLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA---QLELISR 232 (302)
T ss_pred EeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHH
Confidence 999999998765433222223356788999998754 457899999999999999999999997543221 1111111
Q ss_pred HHhhccccC---C--------cCCCC-------CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 396 MVQLRRSED---V--------VDPNI-------ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 396 ~~~~~~~~~---~--------~~~~~-------~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
......... + .++.. ...... ...+..++.+||..||.+|||+.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFI--PTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhhcCCC--CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 111000000 0 00000 000001 1234445558999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=299.01 Aligned_cols=245 Identities=27% Similarity=0.323 Sum_probs=188.5
Q ss_pred EcccCcEEEEEEEE-cCCcEEEEEEecCCCC---CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCCCCH
Q 010891 182 IGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNL 257 (498)
Q Consensus 182 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L 257 (498)
||+|+||+||+|.. .+|+.||+|.+..... .....+..|+++++.++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999974 4689999998854321 2234567899999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCceeeec
Q 010891 258 EQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337 (498)
Q Consensus 258 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~ 337 (498)
.+++... ....+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++....... ....
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~ 153 (277)
T cd05577 81 KYHIYNV--GEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKG 153 (277)
T ss_pred HHHHHHc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccc
Confidence 9999743 224689999999999999999999998 99999999999999999999999999997654321 1223
Q ss_pred ccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHH
Q 010891 338 VMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTS 417 (498)
Q Consensus 338 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (498)
..++..|+|||++.+..++.++|||||||++|+|++|+.||.......... . +... .. . .........+
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~-~~~~---~~-~----~~~~~~~~~~ 222 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE--E-LKRR---TL-E----MAVEYPDKFS 222 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH--H-HHhc---cc-c----ccccCCccCC
Confidence 467889999999988889999999999999999999999997543311110 0 0100 00 0 0001111111
Q ss_pred HHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 010891 418 ALKRALLTALRCVDPDSDKRP-----KMSQVVRM 446 (498)
Q Consensus 418 ~~~~~l~~~~~cl~~dP~~RP-----t~~ell~~ 446 (498)
.....++.+||+.||.+|| ++.+++.+
T Consensus 223 --~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h 254 (277)
T cd05577 223 --PEAKDLCEALLQKDPEKRLGCRGGSADEVREH 254 (277)
T ss_pred --HHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence 1233344489999999999 77777754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=331.49 Aligned_cols=291 Identities=24% Similarity=0.285 Sum_probs=223.8
Q ss_pred HHHHHHHccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC---CCchhHHHHHHHHHHcCCCCCceEEEeEEEe
Q 010891 166 LRDLQSATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIE 241 (498)
Q Consensus 166 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 241 (498)
+.++....++|.+.++||+|+||.|.+++. .+++.||+|++.+.. ..+..-|+.|-++|..-+.+=|+.++..|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 456677788999999999999999999984 568899999986532 2334568899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeee
Q 010891 242 GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDF 321 (498)
Q Consensus 242 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~Df 321 (498)
+.++|+|||||+||+|..++... ++++++.+..++..|+.||.-||+. |+|||||||+|||||..|++||+||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccc
Confidence 99999999999999999999743 4799999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCceeeecccccccccCccccc----C-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH
Q 010891 322 GLAKLLGAGKSHITTRVMGTFGYVAPEYAN----S-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMM 396 (498)
Q Consensus 322 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 396 (498)
|.+-.+..+..-.....+|||-|.+||++. + +.|+..+|+||+||++|||+.|..||... ++++.+..+
T Consensus 220 GsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad------slveTY~KI 293 (1317)
T KOG0612|consen 220 GSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD------SLVETYGKI 293 (1317)
T ss_pred hhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH------HHHHHHHHH
Confidence 999888765555566678999999999883 3 67999999999999999999999999632 233333332
Q ss_pred HhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCC---HHHHHHHHhcCCCCCCcchhhcccccCCcchhcc
Q 010891 397 VQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPK---MSQVVRMLESEEYPIPREDRRRRRNQAGASEAES 473 (498)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt---~~ell~~L~~~~~~~~~~~~~~~~~~~~~~~~~~ 473 (498)
..-...-. ++.....+.-.+.++.++-| +|+.|.. ++++-.|.-.... ..++.+....+-..+-.+
T Consensus 294 m~hk~~l~-----FP~~~~VSeeakdLI~~ll~---~~e~RLgrngiedik~HpFF~g~---~W~~iR~~~pP~vPevss 362 (1317)
T KOG0612|consen 294 MNHKESLS-----FPDETDVSEEAKDLIEALLC---DREVRLGRNGIEDIKNHPFFEGI---DWDNIRESVPPVVPEVSS 362 (1317)
T ss_pred hchhhhcC-----CCcccccCHHHHHHHHHHhc---ChhhhcccccHHHHHhCccccCC---ChhhhhhcCCCCCCcCCC
Confidence 22221111 11122345556666655445 6778887 9998877543221 123333333344455555
Q ss_pred ccCCCCc
Q 010891 474 QRESSDT 480 (498)
Q Consensus 474 ~~~~~~~ 480 (498)
..+++..
T Consensus 363 d~DTsnF 369 (1317)
T KOG0612|consen 363 DDDTSNF 369 (1317)
T ss_pred CCccccc
Confidence 5566655
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=342.58 Aligned_cols=257 Identities=31% Similarity=0.420 Sum_probs=202.4
Q ss_pred HHccCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCC--CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
..+-++.....||.|.||.||-|. ..+|+..|+|.+.-.. ....+.+.+|+.++..++|||+|++||+-.+.+..+|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 345577788899999999999996 6779999999774332 3344678889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
.||||++|+|.+.++. ++..++.....+..|++.|++|||++ |||||||||+||+|+.+|.+|++|||.|..+
T Consensus 1312 FMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEe
Confidence 9999999999999963 23345555667889999999999999 9999999999999999999999999999988
Q ss_pred CCCCce---eeecccccccccCcccccCC---CCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhcc
Q 010891 328 GAGKSH---ITTRVMGTFGYVAPEYANSG---LLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRR 401 (498)
Q Consensus 328 ~~~~~~---~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 401 (498)
...... ..+..+||+.|||||++.+. .-..++||||||||+.||.||+.||...+. +| +.|.....
T Consensus 1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~-aIMy~V~~ 1456 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EW-AIMYHVAA 1456 (1509)
T ss_pred cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hh-HHHhHHhc
Confidence 655311 12346899999999998653 345689999999999999999999963321 12 33333332
Q ss_pred ccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 402 SEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
.. .|.++.+ .+...++++- +||..||.+|.++.|++++--.
T Consensus 1457 gh---~Pq~P~~--ls~~g~dFle--~Cl~~dP~~Rw~~~qlle~~f~ 1497 (1509)
T KOG4645|consen 1457 GH---KPQIPER--LSSEGRDFLE--HCLEQDPKMRWTASQLLEHAFG 1497 (1509)
T ss_pred cC---CCCCchh--hhHhHHHHHH--HHHhcCchhhhHHHHHHHhhcc
Confidence 22 2333333 4444444443 7999999999999999987543
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=306.78 Aligned_cols=266 Identities=23% Similarity=0.294 Sum_probs=196.4
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEe----CCee
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIE----GTQR 245 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~ 245 (498)
..+|++.+.||.|+||.||+|.. .+|+.||+|++..... ...+.+..|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 36889999999999999999974 4699999999865422 334567789999999999999999998763 3567
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccce
Q 010891 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~ 325 (498)
|+||||+. ++|.+++.. .+.+++..+..++.||+.||.|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999995 599999863 35589999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCc---eeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhh--
Q 010891 326 LLGAGKS---HITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQL-- 399 (498)
Q Consensus 326 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-- 399 (498)
....... .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.......... .+..+...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~---~~~~~~g~~~ 232 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLK---LILSVLGSPS 232 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHH---HHHHHhCCCh
Confidence 7643221 11234578999999998765 568999999999999999999999997543321111 00000000
Q ss_pred ---------cccc---CCcCCCCCCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 400 ---------RRSE---DVVDPNIETR---PSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 400 ---------~~~~---~~~~~~~~~~---~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
.... .......... ........+..++.+||+.||++|||+.+++.+.-.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~ 297 (334)
T cd07855 233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297 (334)
T ss_pred hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhh
Confidence 0000 0000000000 000012334455568999999999999999986543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=296.77 Aligned_cols=246 Identities=26% Similarity=0.374 Sum_probs=191.8
Q ss_pred EcccCcEEEEEEEEc-CCcEEEEEEecCCCC---CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCCCCH
Q 010891 182 IGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNL 257 (498)
Q Consensus 182 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L 257 (498)
||.|+||.||++... +|+.|++|.+..... ...+.+..|++++.+++||||+++++.+..+...|++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999865 489999998865433 2345688899999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc-----
Q 010891 258 EQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS----- 332 (498)
Q Consensus 258 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~----- 332 (498)
.+++... +.+++..++.++.||+.||.|||.. +++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 9999742 4689999999999999999999998 999999999999999999999999999886543211
Q ss_pred --eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCC
Q 010891 333 --HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNI 410 (498)
Q Consensus 333 --~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (498)
.......++..|+|||.+.+..++.++||||||+++|+|++|..||....+. +....... .. .
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~~~~-~~--------~ 218 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE------EIFQNILN-GK--------I 218 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhc-CC--------c
Confidence 1223356888999999998888999999999999999999999999754422 11111111 00 0
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 411 ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 411 ~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
...........+..++.+||+.+|.+|||+.++.+.|+.
T Consensus 219 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~ 257 (265)
T cd05579 219 EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257 (265)
T ss_pred CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence 001110011233444558999999999999555555543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=308.83 Aligned_cols=200 Identities=32% Similarity=0.417 Sum_probs=172.8
Q ss_pred CCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCC--CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCC-----eeE
Q 010891 175 RFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT-----QRI 246 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----~~~ 246 (498)
+|.+.+.||.|+||.||+|+.. +++.|++|++.... ....+.+..|+.+++.++||||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5788999999999999999854 58999999986543 334467888999999999999999999988775 789
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecccee
Q 010891 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (498)
Q Consensus 247 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~ 326 (498)
+||||+. ++|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||.|||++.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 489998863 34799999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCc--eeeecccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 010891 327 LGAGKS--HITTRVMGTFGYVAPEYANSG-LLNEKSDVYSFGVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 327 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~ 382 (498)
...... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~ 211 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD 211 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence 754431 123345689999999999877 89999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=304.57 Aligned_cols=197 Identities=25% Similarity=0.294 Sum_probs=161.3
Q ss_pred ceEccc--CcEEEEEEEE-cCCcEEEEEEecCCCCC--chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCC
Q 010891 180 NIIGDG--GYGVVYRGQL-MNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNN 254 (498)
Q Consensus 180 ~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (498)
..||+| +||+||+++. .+|+.||+|.+...... ..+.+.+|+.+++.++||||++++++|..+...++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 9999999985 57999999988643322 235688899999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCce-
Q 010891 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH- 333 (498)
Q Consensus 255 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~- 333 (498)
++|.+++.... ...+++..+..++.|++.||+|||+. +++||||||+|||++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999997542 23588999999999999999999998 9999999999999999999999999865433211100
Q ss_pred --e---eecccccccccCcccccC--CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 010891 334 --I---TTRVMGTFGYVAPEYANS--GLLNEKSDVYSFGVVLLEAITGRYPVDYG 381 (498)
Q Consensus 334 --~---~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~P~~~~ 381 (498)
. .....++..|+|||++.+ ..++.++|||||||++|||++|..||...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 0 011235667999999876 35789999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=296.40 Aligned_cols=258 Identities=24% Similarity=0.314 Sum_probs=196.5
Q ss_pred CCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC--chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeec
Q 010891 176 FSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (498)
Q Consensus 176 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 252 (498)
|.+.+.||.|++|.||+|.. .+++.+++|.+...... ....+..|++++++++||||+++++++.++...++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56678999999999999975 46889999988654332 3456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~ 332 (498)
++ +|.+++... ...+++..++.++.|++.||.|||+. +++|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 75 899888642 25789999999999999999999999 99999999999999999999999999998775443
Q ss_pred eeeecccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhcccc--------
Q 010891 333 HITTRVMGTFGYVAPEYANSG-LLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSE-------- 403 (498)
Q Consensus 333 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 403 (498)
.......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.......... ... .......
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~--~~~---~~~~~~~~~~~~~~~ 227 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLF--KIF---RTLGTPDPEVWPKFT 227 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHH---HHcCCCchHhcccch
Confidence 122335688899999988766 78999999999999999999999996544321110 000 0000000
Q ss_pred --------CCcCCCCCC--CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 404 --------DVVDPNIET--RPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 404 --------~~~~~~~~~--~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
......... .........+..++.+||++||.+||++.+++.+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 228 SLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 000000000 0001112345556668999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=294.33 Aligned_cols=243 Identities=23% Similarity=0.277 Sum_probs=184.8
Q ss_pred eEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCc---hhHHHHHH---HHHHcCCCCCceEEEeEEEeCCeeEEEEeecC
Q 010891 181 IIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQA---DKDFRVEV---EAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253 (498)
Q Consensus 181 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~---~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ 253 (498)
+||+|+||.||+|.. .+++.||+|.+....... ...+..|. ..++...||||+.+++++.+....|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999974 468899999886543221 11233343 34555689999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCce
Q 010891 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333 (498)
Q Consensus 254 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~ 333 (498)
|++|.+++.. .+.+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||++..+....
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 9999998863 35699999999999999999999998 99999999999999999999999999997654322
Q ss_pred eeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCC
Q 010891 334 ITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIET 412 (498)
Q Consensus 334 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (498)
.....|+..|+|||++.+ ..++.++|||||||++|||++|+.||............ .... .....+..
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~------~~~~~~~~ 220 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTL------TMAVELPD 220 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH----HHhh------ccCCCCCC
Confidence 223468999999999865 46899999999999999999999999755332211111 0000 01111111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 010891 413 RPSTSALKRALLTALRCVDPDSDKRP-----KMSQVVRML 447 (498)
Q Consensus 413 ~~~~~~~~~~l~~~~~cl~~dP~~RP-----t~~ell~~L 447 (498)
. .+ .....++.+||..||.+|| ++.+++++-
T Consensus 221 ~--~s--~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~ 256 (278)
T cd05606 221 S--FS--PELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHP 256 (278)
T ss_pred c--CC--HHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCc
Confidence 1 11 2333444589999999999 999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=300.68 Aligned_cols=199 Identities=22% Similarity=0.238 Sum_probs=164.4
Q ss_pred CccceEcccCcEEEEEEEEcCCcEEEEEEecCC--CCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCC
Q 010891 177 SKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNN--PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNN 254 (498)
Q Consensus 177 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (498)
.+.+.+|.|+++.||++.. +++.||+|++... .....+.+..|+++++.++||||+++++++.+.+..+++|||+++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 3445566666666666644 7899999998654 233446788999999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc--
Q 010891 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS-- 332 (498)
Q Consensus 255 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~-- 332 (498)
|+|.+++... ....+++.....++.|++.||.|||+. +|+||||||+||+++.++.+||+|||.+........
T Consensus 84 ~~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 84 GSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred CCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence 9999999754 224588999999999999999999999 999999999999999999999999999876532211
Q ss_pred ----eeeecccccccccCcccccC--CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 010891 333 ----HITTRVMGTFGYVAPEYANS--GLLNEKSDVYSFGVVLLEAITGRYPVDYG 381 (498)
Q Consensus 333 ----~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~P~~~~ 381 (498)
.......++..|+|||++.. ..++.++|||||||++|||++|..||...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~ 213 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM 213 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 11223457888999999865 45889999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=302.83 Aligned_cols=202 Identities=31% Similarity=0.425 Sum_probs=171.2
Q ss_pred HHHHHccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC--CCchhHHHHHHHHHHcCCCCCceEEEeEEEe-CC
Q 010891 168 DLQSATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIE-GT 243 (498)
Q Consensus 168 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~ 243 (498)
++..++++|++.+.||.|+||.||+|.. .+++.||+|++.... ....+.+..|++++..++||||+++++++.. ..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 3445788999999999999999999974 478999999885432 2234567889999999999999999999876 56
Q ss_pred eeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecc
Q 010891 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (498)
Q Consensus 244 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGl 323 (498)
..|+||||+ +++|.+++.. ..+++.....++.|+++||.|||+. +++||||+|+||++++++.++|+|||+
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~ 154 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGL 154 (328)
T ss_pred cEEEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccc
Confidence 789999999 5699988852 4578888999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 010891 324 AKLLGAGKSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 324 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~ 382 (498)
+...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....
T Consensus 155 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~ 210 (328)
T cd07856 155 ARIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD 210 (328)
T ss_pred ccccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9754322 223467889999998765 578999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=299.52 Aligned_cols=249 Identities=26% Similarity=0.383 Sum_probs=198.5
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC---CCchhHHHHHHHHHHcCC-CCCceEEEeEEEeCCeeEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVR-HKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv 248 (498)
++|.+.+.||+|+||.||+|.. .+++.|++|.+.... ....+.+..|++++.+++ ||||+++++++.++...++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4688899999999999999975 478999999885432 222356788999999998 99999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+++++|.+++.. .+.+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 999999999999974 34799999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCc-------------------eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhH
Q 010891 329 AGKS-------------------HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNL 389 (498)
Q Consensus 329 ~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~ 389 (498)
.... .......|+..|+|||++.+..++.++|+||||+++|++++|+.||.......
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---- 229 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL---- 229 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH----
Confidence 3321 11223467899999999988889999999999999999999999997543111
Q ss_pred HHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCH----HHHHHH
Q 010891 390 VEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKM----SQVVRM 446 (498)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~----~ell~~ 446 (498)
....... .. ....... ......++.+||+.||.+|||+ .+++.+
T Consensus 230 --~~~~~~~---~~------~~~~~~~--~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 230 --TFQKILK---LE------YSFPPNF--PPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred --HHHHHHh---cC------CCCCCcc--CHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 1111111 10 0111111 1234445558999999999999 888764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=298.89 Aligned_cols=257 Identities=27% Similarity=0.331 Sum_probs=196.9
Q ss_pred CCCccceEcccCcEEEEEEEE----cCCcEEEEEEecCCC----CCchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCee
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL----MNGTAVAVKKLLNNP----GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQR 245 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 245 (498)
+|++.+.||+|+||.||+++. .++..||+|.+.... ....+.+..|++++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 377889999999999999964 357889999885432 12234577899999999 699999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccce
Q 010891 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~ 325 (498)
++||||+.+++|.+++.. ...+++..+..++.|++.||.|||+. +++||||||.||+++.++.++|+|||++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999999863 35688999999999999999999998 99999999999999999999999999998
Q ss_pred ecCCCCceeeecccccccccCcccccCCC--CCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhcccc
Q 010891 326 LLGAGKSHITTRVMGTFGYVAPEYANSGL--LNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSE 403 (498)
Q Consensus 326 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (498)
..............|+..|+|||.+.+.. .+.++||||||+++|||++|..||....... ...+....+....
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~--- 228 (288)
T cd05583 154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKSK--- 228 (288)
T ss_pred ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHccC---
Confidence 76443322233356899999999987654 7889999999999999999999996432211 1111111111110
Q ss_pred CCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 404 DVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
+.. ...... .+..++.+||+.||++|||+.++.+.|+...
T Consensus 229 ----~~~--~~~~~~--~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~ 268 (288)
T cd05583 229 ----PPF--PKTMSA--EARDFIQKLLEKDPKKRLGANGADEIKNHPF 268 (288)
T ss_pred ----CCC--CcccCH--HHHHHHHHHhcCCHhhccCcchHHHHhcCcc
Confidence 111 111111 2233445899999999999888877766543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=315.09 Aligned_cols=245 Identities=24% Similarity=0.426 Sum_probs=188.6
Q ss_pred ccceEcccCcEEEEEEEE-cCCcEEEEEEe--cC--CCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCe--eEEEEe
Q 010891 178 KDNIIGDGGYGVVYRGQL-MNGTAVAVKKL--LN--NPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQ--RILVYE 250 (498)
Q Consensus 178 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~--~~--~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~--~~lv~e 250 (498)
...+||+|+|-+||+|.+ .+|..||=-.+ .. ......+.|..|+.+|+.|+||||+++|+++.+... .-+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 356899999999999964 34666652222 11 122334678899999999999999999999987655 678999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCC-CCeEEeeeccceecCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN-FDAKISDFGLAKLLGA 329 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~-~~~kL~DfGla~~~~~ 329 (498)
.+..|+|..|+.++ +.++......++.||++||.|||++ .|+|||||||-.||+|+.+ |.|||+|+|||.....
T Consensus 124 L~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 124 LFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred cccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999854 5688899999999999999999995 8899999999999999765 8999999999998754
Q ss_pred CCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
.. ...++|||.|||||+.. ..|++.+||||||++++||+|+.+||..-. +.....++....... .
T Consensus 199 s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~-----n~AQIYKKV~SGiKP------~ 263 (632)
T KOG0584|consen 199 SH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECT-----NPAQIYKKVTSGIKP------A 263 (632)
T ss_pred cc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhC-----CHHHHHHHHHcCCCH------H
Confidence 32 34478999999999988 789999999999999999999999996322 222223333222211 1
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
.-..-...+.. .++.+||.. ..+|||+.|+|.+
T Consensus 264 sl~kV~dPevr---~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 264 ALSKVKDPEVR---EFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HhhccCCHHHH---HHHHHHhcC-chhccCHHHHhhC
Confidence 11111122223 333489999 8999999999964
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=291.09 Aligned_cols=242 Identities=24% Similarity=0.288 Sum_probs=183.3
Q ss_pred ceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCc---hhHHHHHHHHH-HcCCCCCceEEEeEEEeCCeeEEEEeecCC
Q 010891 180 NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQA---DKDFRVEVEAI-GHVRHKNLVRLLGYCIEGTQRILVYEYVNN 254 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l-~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (498)
+.||+|+||.||+|.. .+++.||+|.+....... ...+..|..++ ...+||||+++++++..++..|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5699999999999975 468899999886443221 12344454444 455899999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCcee
Q 010891 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (498)
Q Consensus 255 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 334 (498)
++|.+++.. .+.+++..+..++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999999963 35689999999999999999999998 999999999999999999999999999986432
Q ss_pred eecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCC
Q 010891 335 TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRP 414 (498)
Q Consensus 335 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (498)
.....|+..|+|||.+.+..++.++||||||+++|+|++|..||...... ............ ..... ..
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~~---~~~~~--~~ 218 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD------AVFDNILSRRIN---WPEEV--KE 218 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhcccC---CCCcc--cc
Confidence 22346889999999998888999999999999999999999999643321 111111111100 00000 00
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 415 STSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 415 ~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
. ....+..++.+||..||++||++.++.+.
T Consensus 219 ~--~~~~~~~~i~~~l~~~p~~R~~~~~~~~~ 248 (260)
T cd05611 219 F--CSPEAVDLINRLLCMDPAKRLGANGYQEI 248 (260)
T ss_pred c--CCHHHHHHHHHHccCCHHHccCCCcHHHH
Confidence 1 11234455558999999999976544433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=307.72 Aligned_cols=201 Identities=27% Similarity=0.383 Sum_probs=167.9
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeC---------
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG--------- 242 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--------- 242 (498)
.++|.+.+.||.|+||.||+|.. .+|+.||+|++........+.+..|+++++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 46899999999999999999975 56899999998666555566788899999999999999999876543
Q ss_pred -----CeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcC-CCCe
Q 010891 243 -----TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE-NFDA 316 (498)
Q Consensus 243 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~-~~~~ 316 (498)
...|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||+. +++||||||+||+++. ++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence 35789999997 599988842 4588999999999999999999998 9999999999999974 5678
Q ss_pred EEeeeccceecCCCCce--eeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 010891 317 KISDFGLAKLLGAGKSH--ITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 317 kL~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~ 382 (498)
||+|||++......... ......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||....
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~ 223 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH 223 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999875432111 1123457889999997644 568889999999999999999999997544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=305.34 Aligned_cols=205 Identities=28% Similarity=0.391 Sum_probs=172.9
Q ss_pred cHHHHHHHccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEe
Q 010891 165 TLRDLQSATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIE 241 (498)
Q Consensus 165 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 241 (498)
...++..+.++|.+.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.++.+++||||+++++++..
T Consensus 8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~ 87 (345)
T cd07877 8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 87 (345)
T ss_pred HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence 4556777889999999999999999999974 5789999999865322 223557789999999999999999998864
Q ss_pred C------CeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCC
Q 010891 242 G------TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD 315 (498)
Q Consensus 242 ~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~ 315 (498)
. ...|++++++ +++|.+++.. ..+++..++.++.|+++||.|||+. +|+||||||+||++++++.
T Consensus 88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 88 ARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred cccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCC
Confidence 3 3467888887 7799988852 3589999999999999999999999 9999999999999999999
Q ss_pred eEEeeeccceecCCCCceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 010891 316 AKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 316 ~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~ 382 (498)
+||+|||++...... .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 159 ~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 222 (345)
T cd07877 159 LKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 222 (345)
T ss_pred EEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999865322 233568899999998765 578899999999999999999999996543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=297.98 Aligned_cols=245 Identities=29% Similarity=0.378 Sum_probs=190.6
Q ss_pred CCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC---chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 176 FSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ---ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 176 y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
|...+.||+|+||+||+|+. .++..|++|++...... ....+..|+++++.++|||++++++++.+....|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 56678899999999999975 46889999988543322 224577899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+. |+|.+++.. ....+++.+++.++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 95 588888753 235689999999999999999999998 999999999999999999999999999864322
Q ss_pred ceeeecccccccccCccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCC
Q 010891 332 SHITTRVMGTFGYVAPEYAN---SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (498)
.....|+..|+|||++. ...++.++|||||||++|+|++|..||........ ........ . +
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~~~-~-----~ 238 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQND-S-----P 238 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHhcC-C-----C
Confidence 23356899999999873 46688999999999999999999999875432211 11111110 0 1
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 409 NIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
......... .+..++.+||+.+|.+||++.+++.+-
T Consensus 239 ~~~~~~~~~---~l~~li~~~l~~~P~~Rp~~~~~l~~~ 274 (313)
T cd06633 239 TLQSNEWTD---SFRGFVDYCLQKIPQERPASAELLRHD 274 (313)
T ss_pred CCCccccCH---HHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 111111111 233344489999999999999999763
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=291.92 Aligned_cols=261 Identities=25% Similarity=0.346 Sum_probs=191.8
Q ss_pred CCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCC--chhHHHHHHHHHHcC---CCCCceEEEeEEEeCCe-----
Q 010891 176 FSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHV---RHKNLVRLLGYCIEGTQ----- 244 (498)
Q Consensus 176 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~~~~----- 244 (498)
|++.+.||+|+||.||+|+.. +++.||+|++...... ....+..|+.++.++ +||||+++++++.+...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999865 4899999998643322 123466687777665 69999999999988776
Q ss_pred eEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccc
Q 010891 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (498)
Q Consensus 245 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla 324 (498)
.+++|||+.+ +|.+++... ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++.+||+|||++
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~--~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKC--PKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhccc-CHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence 8999999975 899988643 223589999999999999999999998 9999999999999999999999999999
Q ss_pred eecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhcccc-
Q 010891 325 KLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSE- 403 (498)
Q Consensus 325 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~- 403 (498)
........ .....++..|+|||++.+..++.++|+|||||++|||++|..||....... .....+..........
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 230 (287)
T cd07838 155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIGLPSEEEW 230 (287)
T ss_pred eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcCCCChHhc
Confidence 87643321 223457889999999998899999999999999999999999987533211 1111111110000000
Q ss_pred --CC--cCCCCCC--CCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 404 --DV--VDPNIET--RPS-----TSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 404 --~~--~~~~~~~--~~~-----~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
.. ....+.. ... ..-......++.+||+.||.+||++.+++.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00 0000000 000 0112333455568999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=300.97 Aligned_cols=265 Identities=22% Similarity=0.252 Sum_probs=194.9
Q ss_pred HccCCCc-cceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCc--------------hhHHHHHHHHHHcCCCCCceEE
Q 010891 172 ATNRFSK-DNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQA--------------DKDFRVEVEAIGHVRHKNLVRL 235 (498)
Q Consensus 172 ~~~~y~~-~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~hpnIv~l 235 (498)
..++|.. .+.||.|+||+||+|.. .+++.||+|++....... ...+.+|+++++.++||||+++
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~ 85 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL 85 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence 3456764 57899999999999974 468999999885432221 1246789999999999999999
Q ss_pred EeEEEeCCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCC
Q 010891 236 LGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD 315 (498)
Q Consensus 236 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~ 315 (498)
++++......++||||+. |+|.+++.. ...+++.....++.|++.||.|||+. +++|+||+|+||+++.++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~ 157 (335)
T PTZ00024 86 VDVYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGI 157 (335)
T ss_pred eEEEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCC
Confidence 999999999999999996 599999863 35689999999999999999999998 9999999999999999999
Q ss_pred eEEeeeccceecCCCC-------------ceeeecccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCC
Q 010891 316 AKISDFGLAKLLGAGK-------------SHITTRVMGTFGYVAPEYANSG-LLNEKSDVYSFGVVLLEAITGRYPVDYG 381 (498)
Q Consensus 316 ~kL~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~ 381 (498)
++|+|||++....... ........++..|+|||.+.+. .++.++|||||||++|||++|..||...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999998765111 0111223568899999988654 4789999999999999999999999754
Q ss_pred CCcchhhHHHHHHHHHhhccccCC----------cCCCCCC-CCC-----HHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 010891 382 RPQSEVNLVEWLKMMVQLRRSEDV----------VDPNIET-RPS-----TSALKRALLTALRCVDPDSDKRPKMSQVVR 445 (498)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~-~~~-----~~~~~~~l~~~~~cl~~dP~~RPt~~ell~ 445 (498)
.+... ...+.. ........ ..+.... ... ......+..++.+||+.||++|||+.+++.
T Consensus 238 ~~~~~---~~~i~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 238 NEIDQ---LGRIFE--LLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CHHHH---HHHHHH--HhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 43211 111110 00000000 0000000 000 001223445556899999999999999997
Q ss_pred HHhc
Q 010891 446 MLES 449 (498)
Q Consensus 446 ~L~~ 449 (498)
+.-.
T Consensus 313 ~~~~ 316 (335)
T PTZ00024 313 HEYF 316 (335)
T ss_pred Cccc
Confidence 6544
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=302.13 Aligned_cols=261 Identities=24% Similarity=0.308 Sum_probs=192.5
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC--chhHHHHHHHHHHcCCCCCceEEEeEEEeCC------
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT------ 243 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------ 243 (498)
.++|++.+.||+|+||.||+|.. .+++.|++|++...... ....+.+|+++++.++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 46899999999999999999985 46899999988544322 2345778999999999999999999875433
Q ss_pred --eeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeee
Q 010891 244 --QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDF 321 (498)
Q Consensus 244 --~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~Df 321 (498)
..++||||+.+ +|..++.. ....+++..+..++.|+++||.|||+. +++|+||||+||++++++.++|+||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence 46999999965 78887764 234699999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCce----------eeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHH
Q 010891 322 GLAKLLGAGKSH----------ITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLV 390 (498)
Q Consensus 322 Gla~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~ 390 (498)
|++......... ..+...|++.|+|||.+.+ ..++.++|||||||++|||++|+.||.........
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~--- 236 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL--- 236 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH---
Confidence 999865432211 1223467889999998754 46889999999999999999999999754432211
Q ss_pred HHHHHHHhhcc------------ccCCcC--CCCCCCCCH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 391 EWLKMMVQLRR------------SEDVVD--PNIETRPST-----SALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 391 ~~~~~~~~~~~------------~~~~~~--~~~~~~~~~-----~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
........ .....+ ......+.. ........++.+||..||.+|||+.+++.+
T Consensus 237 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 237 ---HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred ---HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 11111000 000000 000000000 011234455668999999999999999865
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=298.87 Aligned_cols=251 Identities=26% Similarity=0.352 Sum_probs=193.2
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC---CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
+.|...+.||+|+||.||+|+. .++..|++|.+..... .....+..|+++++.++|||++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 3467778999999999999985 4678899998854322 22346778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+. |+|.+++.. ....+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++.....
T Consensus 95 e~~~-~~l~~~~~~---~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 95 EYCL-GSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EccC-CCHHHHHHH---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 9996 588887753 234588999999999999999999998 999999999999999999999999999986543
Q ss_pred CCceeeecccccccccCccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCc
Q 010891 330 GKSHITTRVMGTFGYVAPEYAN---SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVV 406 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (498)
. ....|+..|+|||.+. ...++.++|||||||++|+|++|..||....... .........
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~------ 230 (308)
T cd06634 168 A-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQNE------ 230 (308)
T ss_pred c-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH------HHHHHhhcC------
Confidence 2 2346889999999874 4568889999999999999999999986432211 111111100
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 407 DPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 407 ~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
.+..... .. ...+..++.+||..+|++||++.+++++.....
T Consensus 231 ~~~~~~~-~~--~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 231 SPALQSG-HW--SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred CCCcCcc-cc--cHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 0111111 11 122334455899999999999999998755433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=287.55 Aligned_cols=257 Identities=23% Similarity=0.380 Sum_probs=196.3
Q ss_pred cceEcccCcEEEEEEE-EcCCcEEEEEEecCCCCCchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCeeEEEEeecCCCC
Q 010891 179 DNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVYEYVNNGN 256 (498)
Q Consensus 179 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~g~ 256 (498)
.+.||+|+|+.|--+. ..+|..||||++.+..........+|++++.+. .|+||++++++|++++..|||||-|.||+
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp 162 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP 162 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence 4789999999999996 788999999999888778888899999999998 69999999999999999999999999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCC---eEEeeeccceecCCCC--
Q 010891 257 LEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD---AKISDFGLAKLLGAGK-- 331 (498)
Q Consensus 257 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~---~kL~DfGla~~~~~~~-- 331 (498)
|...|+ ++..+++.++..++.+|+.||.|||.+ ||.||||||+|||..+... +|||||.|..-.....
T Consensus 163 lLshI~----~~~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~ 235 (463)
T KOG0607|consen 163 LLSHIQ----KRKHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC 235 (463)
T ss_pred HHHHHH----HhhhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence 999998 456799999999999999999999999 9999999999999976543 8999999886432111
Q ss_pred ----ceeeecccccccccCcccc-----cCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcc----hhhHHHHHH-HHH
Q 010891 332 ----SHITTRVMGTFGYVAPEYA-----NSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQS----EVNLVEWLK-MMV 397 (498)
Q Consensus 332 ----~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~----~~~~~~~~~-~~~ 397 (498)
.....+.+|+..|||||+. ....|+.+.|.||||||||-||+|.+||.+.-... .-...+.-+ ...
T Consensus 236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF 315 (463)
T KOG0607|consen 236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF 315 (463)
T ss_pred CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH
Confidence 1112346899999999976 23579999999999999999999999997532210 000001001 111
Q ss_pred -hhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 398 -QLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 398 -~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
.+.... .--|. ..+..++...+.++- ..|..|+.+|.++.+++.+
T Consensus 316 esIQEGk-YeFPd-kdWahIS~eakdlis--nLlvrda~~rlsa~~vlnh 361 (463)
T KOG0607|consen 316 ESIQEGK-YEFPD-KDWAHISSEAKDLIS--NLLVRDAKQRLSAAQVLNH 361 (463)
T ss_pred HHHhccC-CcCCh-hhhHHhhHHHHHHHH--HHHhccHHhhhhhhhccCC
Confidence 111111 00111 113344444554443 5677999999999999863
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=291.87 Aligned_cols=251 Identities=21% Similarity=0.316 Sum_probs=192.5
Q ss_pred CCCccceEcccCcEEEEEEEEcC-CcEEEEEEecCCC-----CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 175 RFSKDNIIGDGGYGVVYRGQLMN-GTAVAVKKLLNNP-----GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
+|.+.+.||+|+||.||++.... +..+++|.+.... ......+..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 57888999999999999997533 4455666553321 12233566799999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+++++|.+++.........+++..++.++.|++.||.|||+. +++|+||||+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999999875443456799999999999999999999998 9999999999999975 579999999998764
Q ss_pred CCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (498)
... .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||..... ........ .. ..+
T Consensus 157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~~---~~---~~~ 223 (260)
T cd08222 157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLRIV---EG---PTP 223 (260)
T ss_pred CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHH---cC---CCC
Confidence 332 122335688999999999888899999999999999999999999963321 11111111 00 011
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 409 NIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
... . ........++.+||..||++||++.+++++
T Consensus 224 ~~~--~--~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 224 SLP--E--TYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred CCc--c--hhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 111 1 111234445558999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=314.67 Aligned_cols=250 Identities=29% Similarity=0.483 Sum_probs=199.5
Q ss_pred CccceEcccCcEEEEEEEE-cCC----cEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 177 SKDNIIGDGGYGVVYRGQL-MNG----TAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 177 ~~~~~lg~G~~g~Vy~~~~-~~~----~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
..+++||+|+||+||+|.+ ..| -+||+|++..... +...++..|+.+|.+|+|||++++++++..+. +.||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 4578999999999999974 334 3689998865543 34578999999999999999999999998866 889999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
|+++|+|.||++. .+..+.....+.+..|||+|+.|||.+ .++||||..+||||.....+||+|||+++.+..+
T Consensus 778 ~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 778 LMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred hcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 9999999999986 446788999999999999999999999 9999999999999999999999999999988765
Q ss_pred Cceee-ecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCC
Q 010891 331 KSHIT-TRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408 (498)
Q Consensus 331 ~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (498)
..... ....-.+.|||-|.+....|+.++|||||||++||++| |..||......+.-++. . ..++
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dll-------e--~geR---- 918 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLL-------E--KGER---- 918 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHH-------h--cccc----
Confidence 44322 22334568999999999999999999999999999999 88998754432211111 1 1111
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 409 NIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
+..++ .....+..++.+||..|++.||+++++...+..
T Consensus 919 -LsqPp--iCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~ 956 (1177)
T KOG1025|consen 919 -LSQPP--ICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR 956 (1177)
T ss_pred -CCCCC--CccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence 11112 123345555669999999999999999876654
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=292.55 Aligned_cols=263 Identities=24% Similarity=0.298 Sum_probs=193.5
Q ss_pred CCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCC-chhHHHHHHHHHHcCC-CCCceEEEeEEEeCCeeEEEEeec
Q 010891 176 FSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVR-HKNLVRLLGYCIEGTQRILVYEYV 252 (498)
Q Consensus 176 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~ 252 (498)
|.+.+.||+|+||+||+|... +++.|++|++...... ......+|+..+.+++ ||||+++++++.++...++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 567889999999999999864 5788999988654322 2223456999999998 999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~ 332 (498)
+|+|.+++... ....+++..+..++.|++.+|.|||++ +++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 81 -EGNLYQLMKDR--KGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred -CCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 78999998743 224689999999999999999999998 999999999999999999999999999987643321
Q ss_pred eeeecccccccccCccccc-CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHH----------HHHHHHHhhcc
Q 010891 333 HITTRVMGTFGYVAPEYAN-SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLV----------EWLKMMVQLRR 401 (498)
Q Consensus 333 ~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~----------~~~~~~~~~~~ 401 (498)
.....++..|+|||++. +..++.++|+||||+++|||++|+.||............ .|.........
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence 23356889999999774 456889999999999999999999999654332211000 00000000000
Q ss_pred ccCCcCCCCCCC---CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 402 SEDVVDPNIETR---PSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 402 ~~~~~~~~~~~~---~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
............ ...........++.+||..||++|||+.|++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000000000 000002334555668999999999999999865
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=295.53 Aligned_cols=253 Identities=27% Similarity=0.443 Sum_probs=191.1
Q ss_pred ccCCCccceEcccCcEEEEEEEEcC-CcEEEEEEecCCCC-CchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCeeEEEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLMN-GTAVAVKKLLNNPG-QADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
.++|++.+.||+|+||.||+|.+.+ ++.||||.+..... .....+..|+.++..+ .||||+++++++.++...|+||
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3568889999999999999998654 89999999865432 2334566677777666 5999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHH-ccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE-AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
||+. ++|.+++... ...+++..+..++.|++.||.|||+ . +|+||||+|+||++++++.+||+|||++..+.
T Consensus 94 e~~~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 94 ELMS-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eccC-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 9985 4787777542 3478999999999999999999997 5 89999999999999999999999999997654
Q ss_pred CCCceeeecccccccccCcccccCCC----CCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANSGL----LNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSED 404 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (498)
.... .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||...... . +.+....... .
T Consensus 167 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~---~~~~~~~~~~-~-- 236 (296)
T cd06618 167 DSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--F---EVLTKILQEE-P-- 236 (296)
T ss_pred CCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--H---HHHHHHhcCC-C--
Confidence 3221 22345788999999886543 888999999999999999999999643221 1 1111111110 0
Q ss_pred CcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 405 VVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
+........ ...+..++.+||..||++||++.+++++.
T Consensus 237 ---~~~~~~~~~--~~~l~~li~~~l~~~p~~Rp~~~~il~~~ 274 (296)
T cd06618 237 ---PSLPPNEGF--SPDFCSFVDLCLTKDHRKRPKYRELLQHP 274 (296)
T ss_pred ---CCCCCCCCC--CHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 111111111 12344455589999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=301.40 Aligned_cols=196 Identities=28% Similarity=0.406 Sum_probs=165.8
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEeC------C
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEG------T 243 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~ 243 (498)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++..... .....+..|+.+++.++||||+++++++... .
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 57899999999999999999985 4689999999864322 2234578899999999999999999998754 3
Q ss_pred eeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecc
Q 010891 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (498)
Q Consensus 244 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGl 323 (498)
..|+|+||+.. +|..++. ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 45899999964 7877653 3588999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 010891 324 AKLLGAGKSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 324 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~ 382 (498)
++..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....
T Consensus 164 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 164 ARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred CcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9764322 223467899999998866 568899999999999999999999997543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=302.04 Aligned_cols=198 Identities=27% Similarity=0.408 Sum_probs=168.6
Q ss_pred HHccCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCCC--chhHHHHHHHHHHcCCCCCceEEEeEEEeCC----
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT---- 243 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~---- 243 (498)
...++|++.+.||+|+||.||+|. ..++..||||++...... ....+..|+++++.++||||+++++++..+.
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 356789999999999999999997 457899999988543222 2345778999999999999999999987653
Q ss_pred --eeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeee
Q 010891 244 --QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDF 321 (498)
Q Consensus 244 --~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~Df 321 (498)
..++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence 358999999 7799988852 4689999999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 010891 322 GLAKLLGAGKSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYG 381 (498)
Q Consensus 322 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~ 381 (498)
|++...... .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||...
T Consensus 163 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 219 (343)
T cd07880 163 GLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219 (343)
T ss_pred ccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999865432 223467899999998865 46889999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=313.21 Aligned_cols=201 Identities=31% Similarity=0.453 Sum_probs=172.6
Q ss_pred CccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCC------eeEEE
Q 010891 177 SKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT------QRILV 248 (498)
Q Consensus 177 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------~~~lv 248 (498)
...+.||+|+||.||+|+ ..+|+.||||.+..... ...+....|+++|++|+|||||+++++-.+.. ...+|
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlv 95 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLV 95 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEE
Confidence 346789999999999998 67899999999865432 33456778999999999999999999865543 45899
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEc--CCC--CeEEeeeccc
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID--ENF--DAKISDFGLA 324 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~--~~~--~~kL~DfGla 324 (498)
||||.||+|...|+... +..-|++.+.+.++.+++.||.|||++ +|+||||||.||++- .+| ..||+|||.|
T Consensus 96 mEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 96 MEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 99999999999997543 334599999999999999999999998 999999999999993 333 4899999999
Q ss_pred eecCCCCceeeecccccccccCccccc-CCCCCccchHHHHHHHHHHHHhCCCCCCCCCC
Q 010891 325 KLLGAGKSHITTRVMGTFGYVAPEYAN-SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRP 383 (498)
Q Consensus 325 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~ 383 (498)
+.+.++. ..+.++||..|++||+.. .+.|+..+|.|||||++|++.||..||.....
T Consensus 172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~ 229 (732)
T KOG4250|consen 172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG 229 (732)
T ss_pred ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence 9987654 577899999999999998 58999999999999999999999999975443
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=297.87 Aligned_cols=200 Identities=29% Similarity=0.369 Sum_probs=164.8
Q ss_pred CCCccceEcccCcEEEEEEEEc-C--CcEEEEEEecCCCC--CchhHHHHHHHHHHcC-CCCCceEEEeEEEeC----Ce
Q 010891 175 RFSKDNIIGDGGYGVVYRGQLM-N--GTAVAVKKLLNNPG--QADKDFRVEVEAIGHV-RHKNLVRLLGYCIEG----TQ 244 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~----~~ 244 (498)
+|.+.+.||+|+||.||+++.. + +..||+|++..... ...+.+..|++++.++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4778899999999999999853 3 67899998854322 2245677899999999 599999999975432 45
Q ss_pred eEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccc
Q 010891 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (498)
Q Consensus 245 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla 324 (498)
.|+++||+. ++|.+++. ....+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 688899985 69999986 345689999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCce---eeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 010891 325 KLLGAGKSH---ITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 325 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~ 382 (498)
..+...... ......||..|+|||++.+ ..++.++|||||||++|+|++|..||....
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~ 214 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD 214 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence 876433211 1233578999999998755 568999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=291.43 Aligned_cols=260 Identities=24% Similarity=0.352 Sum_probs=195.2
Q ss_pred CCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCC--CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeec
Q 010891 176 FSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (498)
Q Consensus 176 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 252 (498)
|++.+.||+|+||.||+|+.. +++.|++|.+.... ....+.+..|+.+++.++||||+++++++.+....++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999854 58999999986653 233456788999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~ 332 (498)
+ ++|.+++.... ..+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||++........
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 59999997431 4689999999999999999999999 999999999999999999999999999987644322
Q ss_pred eeeecccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHh---------hccc
Q 010891 333 HITTRVMGTFGYVAPEYANSG-LLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQ---------LRRS 402 (498)
Q Consensus 333 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~---------~~~~ 402 (498)
......++..|+|||.+.+. .++.++|||||||++|||++|+.||........ ...+..... ....
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 229 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGTPTEESWPGVTKL 229 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCCCcHHHHHhhccc
Confidence 12234567889999988766 889999999999999999999999965432111 110000000 0000
Q ss_pred --cCCcCCCCCCCCC----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 403 --EDVVDPNIETRPS----TSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 403 --~~~~~~~~~~~~~----~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
....-+....... ......+..++.+||..||++||++.+++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 230 PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000000000000 0012345555668999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=303.10 Aligned_cols=259 Identities=24% Similarity=0.322 Sum_probs=194.6
Q ss_pred HHccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCC--CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCe---
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQ--- 244 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~--- 244 (498)
.+.++|++.+.||+|+||.||+|+.. ++..||+|++.... ....+.+..|+.+++.++||||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999854 57899999885432 1223457789999999999999999998876554
Q ss_pred ---eEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeee
Q 010891 245 ---RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDF 321 (498)
Q Consensus 245 ---~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~Df 321 (498)
.++|+||+ +++|.+++.. ..+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccc
Confidence 89999999 6699999853 4689999999999999999999998 9999999999999999999999999
Q ss_pred ccceecCCCCceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhh-
Q 010891 322 GLAKLLGAGKSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQL- 399 (498)
Q Consensus 322 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~- 399 (498)
|++...... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......... ..+......
T Consensus 163 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~---~~i~~~~~~~ 235 (343)
T cd07851 163 GLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQL---KRIMNLVGTP 235 (343)
T ss_pred ccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHhcCCC
Confidence 999865432 233568899999998755 46889999999999999999999999754432111 000000000
Q ss_pred -----------------ccccCCcCCCCCC-CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 400 -----------------RRSEDVVDPNIET-RPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 400 -----------------~~~~~~~~~~~~~-~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
........+.+.. .... ...+..++.+||+.||.+|||+.+++.+-
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--s~~l~dli~~~l~~~P~~Rpt~~ell~h~ 299 (343)
T cd07851 236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGA--NPLAIDLLEKMLVLDPDKRITAAEALAHP 299 (343)
T ss_pred CHHHHhhccchhHHHHHHhccccCCCCHHHHhccC--CHHHHHHHHHhCCCChhhCCCHHHHhcCC
Confidence 0000000000000 0001 23445566689999999999999998763
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=286.44 Aligned_cols=253 Identities=26% Similarity=0.357 Sum_probs=189.9
Q ss_pred cceEcccCcEEEEEEE-EcCCcEEEEEEecCCCC-CchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCeeEEEEeecCCC
Q 010891 179 DNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVYEYVNNG 255 (498)
Q Consensus 179 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~g 255 (498)
...||.|+||+|++-. ...|+.+|||++..... .+.++++.|.+...+- +.||||++||.+..+...||.||+|+-
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~- 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI- 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence 4589999999999986 45799999999976554 4556788888766554 799999999999999999999999955
Q ss_pred CHHHHHhc-ccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCcee
Q 010891 256 NLEQWLRG-DMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (498)
Q Consensus 256 ~L~~~l~~-~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 334 (498)
+|..+-.. ...+...+++...-.|...+..||.||-... .|||||+||+||||+..|.+||||||++-.+...- .
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si--A 223 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI--A 223 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHH--H
Confidence 66654421 1224456899999999999999999999765 99999999999999999999999999997664321 2
Q ss_pred eecccccccccCccccc--CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCC
Q 010891 335 TTRVMGTFGYVAPEYAN--SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIET 412 (498)
Q Consensus 335 ~~~~~gt~~y~aPE~~~--~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (498)
.+.-.|...|||||.+. +..|+.+|||||||++|||+.||..||..- .+..+.+.+.+... ...+......
T Consensus 224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w-----~svfeql~~Vv~gd--pp~l~~~~~~ 296 (361)
T KOG1006|consen 224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW-----DSVFEQLCQVVIGD--PPILLFDKEC 296 (361)
T ss_pred hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH-----HHHHHHHHHHHcCC--CCeecCcccc
Confidence 23346888999999884 346999999999999999999999999732 22333333332211 1122222221
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 413 RPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 413 ~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
.... ..+..++-.||.+|-..||...+++++
T Consensus 297 ~~~s---~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 297 VHYS---FSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred cccC---HHHHHHHHHHhhcccccCcchhhhhcC
Confidence 1222 233444446999999999999998754
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=321.44 Aligned_cols=145 Identities=30% Similarity=0.431 Sum_probs=130.1
Q ss_pred cCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCC---chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ---ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
++|.+.+.||+|+||.||+|.+. +++.||||++...... ....+..|+.++..++||||+++++++......||||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57889999999999999999864 6899999998654322 2256788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccce
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~ 325 (498)
||+.+++|.+++.. .+.+++..++.|+.||+.||.|||.+ +|+||||||+||||+.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999963 34688999999999999999999998 99999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=309.53 Aligned_cols=259 Identities=26% Similarity=0.412 Sum_probs=208.4
Q ss_pred HHHHccCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCCCchhHHHHHHHHHHcC-CCCCceEEEeEEEe-----
Q 010891 169 LQSATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIE----- 241 (498)
Q Consensus 169 ~~~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~----- 241 (498)
+...++.|++.++||.|.+|.||+++ .++++.+|+|+.... ....+++..|.++|+.+ .|||++.++++|..
T Consensus 14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 34456678999999999999999997 667889999977543 34456788899999988 79999999999863
Q ss_pred CCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeee
Q 010891 242 GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDF 321 (498)
Q Consensus 242 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~Df 321 (498)
++++|||||||.||+..|+++... +..+.|+.+..|++.++.||.+||.. .++|||||-.|||++.++.+||+||
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDF 167 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDF 167 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeee
Confidence 578999999999999999998763 67899999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCceeeecccccccccCcccccC-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH
Q 010891 322 GLAKLLGAGKSHITTRVMGTFGYVAPEYANS-----GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMM 396 (498)
Q Consensus 322 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 396 (498)
|++..+..... .....+||+.|||||++.. ..|+..+|+||||++..||.-|.+|+-+..|.. .+
T Consensus 168 GvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr---------aL 237 (953)
T KOG0587|consen 168 GVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR---------AL 237 (953)
T ss_pred eeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh---------hh
Confidence 99988765432 3445789999999999853 357889999999999999999999997665521 11
Q ss_pred HhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 397 VQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
. .......|.+..+.. =..+...++..||.+|-.+||++.++|+|--
T Consensus 238 F---~IpRNPPPkLkrp~k--Ws~~FndFIs~cL~Kd~e~RP~~~~ll~hpF 284 (953)
T KOG0587|consen 238 F---LIPRNPPPKLKRPKK--WSKKFNDFISTCLVKDYEQRPSTEELLKHPF 284 (953)
T ss_pred c---cCCCCCCccccchhh--HHHHHHHHHHHHHhhccccCcchhhhccCCc
Confidence 1 122222233332222 2334455556899999999999999997643
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=317.46 Aligned_cols=263 Identities=29% Similarity=0.465 Sum_probs=206.0
Q ss_pred HHHHccCCCccceEcccCcEEEEEEEEc--------CCcEEEEEEecCCCCC-chhHHHHHHHHHHcC-CCCCceEEEeE
Q 010891 169 LQSATNRFSKDNIIGDGGYGVVYRGQLM--------NGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHV-RHKNLVRLLGY 238 (498)
Q Consensus 169 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpnIv~l~~~ 238 (498)
++...++..+.+.||+|+||.||+|... ....||||.++..... ..+.+..|+++|..+ .||||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 4555566677789999999999999632 1457999998765444 446789999999999 69999999999
Q ss_pred EEeCCeeEEEEeecCCCCHHHHHhccc---C-------CC--CCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCC
Q 010891 239 CIEGTQRILVYEYVNNGNLEQWLRGDM---C-------DR--GYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSS 306 (498)
Q Consensus 239 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---~-------~~--~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~ 306 (498)
|......++|+||+..|+|.+||+..+ . .. ..|+..+.+.++.|||.|++||++. +++||||..+
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhhh
Confidence 999999999999999999999998654 0 11 2389999999999999999999999 9999999999
Q ss_pred CEEEcCCCCeEEeeeccceecCCCCceeeecccc--cccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCC
Q 010891 307 NILIDENFDAKISDFGLAKLLGAGKSHITTRVMG--TFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRP 383 (498)
Q Consensus 307 NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~ 383 (498)
|||+.++..+||+|||+|+............-.| ...|||||.+....|+.++|||||||+|||++| |..||..-..
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~ 527 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP 527 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc
Confidence 9999999999999999999765544443332233 345999999999999999999999999999999 8888865221
Q ss_pred cchhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 384 QSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
.. ++.++++. ......|. . +......++..||+.+|++||++.++.+.++.
T Consensus 528 ~~--~l~~~l~~------G~r~~~P~------~-c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~ 578 (609)
T KOG0200|consen 528 TE--ELLEFLKE------GNRMEQPE------H-CSDEIYDLMKSCWNADPEDRPTFSECVEFFEK 578 (609)
T ss_pred HH--HHHHHHhc------CCCCCCCC------C-CCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence 11 22222221 11111111 1 12345566678999999999999999999987
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=284.98 Aligned_cols=266 Identities=25% Similarity=0.329 Sum_probs=207.3
Q ss_pred cHHHHHHHccCCCccceEcccCcEEEEEEEE------cCCcEEEEEEecCCCCCc-hhHHHHHHHHHHcCCCCCceEEEe
Q 010891 165 TLRDLQSATNRFSKDNIIGDGGYGVVYRGQL------MNGTAVAVKKLLNNPGQA-DKDFRVEVEAIGHVRHKNLVRLLG 237 (498)
Q Consensus 165 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~ 237 (498)
.+.++..-..+++...++-+|.||.||.|.| .+.+.|.+|.++....+- ...+..|...+..+.|||+.++.+
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 3567778888999999999999999999954 334567888776544332 345788999999999999999999
Q ss_pred EEEeC-CeeEEEEeecCCCCHHHHHhccc----CCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcC
Q 010891 238 YCIEG-TQRILVYEYVNNGNLEQWLRGDM----CDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE 312 (498)
Q Consensus 238 ~~~~~-~~~~lv~e~~~~g~L~~~l~~~~----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~ 312 (498)
++.++ +..+.++.++.-|+|..||..-+ .....++-.+...++.|++.|++|||++ +|||.||..+|++|++
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehh
Confidence 88765 56688999999999999997211 1224577788999999999999999999 9999999999999999
Q ss_pred CCCeEEeeeccceecCCCCce-eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHH
Q 010891 313 NFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLV 390 (498)
Q Consensus 313 ~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~ 390 (498)
..++||+|-.+++.+.+...+ ....-.....||+||.+.+..|+.++|||||||+||||+| |+.||..-+|.
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPf------ 505 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPF------ 505 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHH------
Confidence 999999999999987554432 2233345678999999999999999999999999999999 88998644332
Q ss_pred HHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 391 EWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 391 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
+.........+... +..+..+++.++..||..+|++||+++|+..-|..
T Consensus 506 Em~~ylkdGyRlaQ----------P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse 554 (563)
T KOG1024|consen 506 EMEHYLKDGYRLAQ----------PFNCPDELFTVMACCWALLPEERPSFSQLVICLSE 554 (563)
T ss_pred HHHHHHhccceecC----------CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence 22122222222211 11223456666668999999999999999988764
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=257.09 Aligned_cols=198 Identities=27% Similarity=0.429 Sum_probs=170.1
Q ss_pred CCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCC--CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 175 RFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
+|...++||+|.||+||+|+ +.+++.||+|++.-+. ..-.....+|+-+|+.++|.|||+++++...+..+-+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 46667899999999999997 5678999999885432 23335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
|+. +|..|... -++.++.+.+..++.|+++||.|+|++ ++.|||+||.|+||+.+|.+||+|||+++.++-..
T Consensus 83 cdq-dlkkyfds---lng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv 155 (292)
T KOG0662|consen 83 CDQ-DLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV 155 (292)
T ss_pred hhH-HHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence 955 89998864 457799999999999999999999999 99999999999999999999999999999887654
Q ss_pred ceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHh-CCCCCCC
Q 010891 332 SHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAIT-GRYPVDY 380 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~ellt-g~~P~~~ 380 (498)
.. ....+.|.+|.+|.++.+ +-|+...|+||-|||+.|+.. |++.|.+
T Consensus 156 rc-ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg 205 (292)
T KOG0662|consen 156 RC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_pred Ee-eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC
Confidence 33 233467999999998866 568999999999999999988 5555543
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=298.81 Aligned_cols=252 Identities=23% Similarity=0.379 Sum_probs=196.0
Q ss_pred HccCCCc--cceEcccCcEEEEEEE-EcCCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeE
Q 010891 172 ATNRFSK--DNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI 246 (498)
Q Consensus 172 ~~~~y~~--~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 246 (498)
+..-|++ .++||+|-||+||-|+ .++|+.||||.+.+... .....+++|+.||..++||.||.+.-.|+..+..|
T Consensus 560 ~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervF 639 (888)
T KOG4236|consen 560 ISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVF 639 (888)
T ss_pred HHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEE
Confidence 3344554 5899999999999996 56899999999965432 23356899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCC---CCeEEeeecc
Q 010891 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN---FDAKISDFGL 323 (498)
Q Consensus 247 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~---~~~kL~DfGl 323 (498)
+|||-+.| ++.++|-.. +.++|++.....++.||+.||.|||-+ +|+|+||||+|||+... -++||||||+
T Consensus 640 VVMEKl~G-DMLEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGf 713 (888)
T KOG4236|consen 640 VVMEKLHG-DMLEMILSS--EKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGF 713 (888)
T ss_pred EEehhhcc-hHHHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccc
Confidence 99999955 666666433 668899999999999999999999999 99999999999999654 4699999999
Q ss_pred ceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhcccc
Q 010891 324 AKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSE 403 (498)
Q Consensus 324 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (498)
|+.++.. .....++|||.|+|||++.++.|...-|+||.|||+|--++|..||..+.. +.+.++ +..
T Consensus 714 ARiIgEk--sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-----IndQIQ------NAa 780 (888)
T KOG4236|consen 714 ARIIGEK--SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-----INDQIQ------NAA 780 (888)
T ss_pred eeecchh--hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-----hhHHhh------ccc
Confidence 9998653 334568999999999999999999999999999999999999999974322 222211 111
Q ss_pred CCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 404 DVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
.+-|.-++. .-....++++...|+..-++|-+....+.+
T Consensus 781 -FMyPp~PW~---eis~~AidlIn~LLqVkm~kRysvdk~lsh 819 (888)
T KOG4236|consen 781 -FMYPPNPWS---EISPEAIDLINNLLQVKMRKRYSVDKSLSH 819 (888)
T ss_pred -cccCCCchh---hcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence 111221111 112233444446677777888888877654
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=280.41 Aligned_cols=240 Identities=26% Similarity=0.295 Sum_probs=190.3
Q ss_pred EcccCcEEEEEEEEc-CCcEEEEEEecCCCCC---chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCCCCH
Q 010891 182 IGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ---ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNL 257 (498)
Q Consensus 182 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L 257 (498)
||.|+||.||++... +++.|++|.+...... ....+..|+++++.++||||+++++.+..+...|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999854 5899999988654332 334688899999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCceeeec
Q 010891 258 EQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337 (498)
Q Consensus 258 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~ 337 (498)
.+++... ..+++.....++.|++.||.|||+. +++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~ 152 (250)
T cd05123 81 FSHLSKE----GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT 152 (250)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence 9999742 4689999999999999999999998 99999999999999999999999999998764432 12334
Q ss_pred ccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHH
Q 010891 338 VMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTS 417 (498)
Q Consensus 338 ~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (498)
..++..|+|||...+..++.++|+||||+++|+|++|..||..... . ........ .........
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~---~~~~~~~~---------~~~~~~~~~- 216 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---K---EIYEKILK---------DPLRFPEFL- 216 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---H---HHHHHHhc---------CCCCCCCCC-
Confidence 5688999999999888889999999999999999999999964432 1 11111111 011111111
Q ss_pred HHHHHHHHHHHccCCCCCCCCCH---HHHHHH
Q 010891 418 ALKRALLTALRCVDPDSDKRPKM---SQVVRM 446 (498)
Q Consensus 418 ~~~~~l~~~~~cl~~dP~~RPt~---~ell~~ 446 (498)
...+..++.+||..||++|||+ .+++.+
T Consensus 217 -~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 217 -SPEARDLISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred -CHHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence 1233445558999999999999 555543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=286.95 Aligned_cols=274 Identities=20% Similarity=0.250 Sum_probs=206.4
Q ss_pred ccHHHHHHHccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCC-C-CC----ceEEE
Q 010891 164 FTLRDLQSATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-H-KN----LVRLL 236 (498)
Q Consensus 164 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-pn----Iv~l~ 236 (498)
+-+......+++|.+...+|+|.||.|..+.+ ..+..||+|+++.- ....+..+-|+++|.++. + |+ +|.+.
T Consensus 79 ~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~ 157 (415)
T KOG0671|consen 79 YVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMR 157 (415)
T ss_pred EEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeee
Confidence 33444445689999999999999999999963 34789999987532 223345667999999993 2 33 78888
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEc-----
Q 010891 237 GYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID----- 311 (498)
Q Consensus 237 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~----- 311 (498)
++|.-.++.|||+|.+ |-++++||..+ .-.+++..++..|+.|++++++|||+. +++|-||||+|||+.
T Consensus 158 ~wFdyrghiCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 158 DWFDYRGHICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYF 231 (415)
T ss_pred hhhhccCceEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceE
Confidence 8999999999999999 66999999865 335688899999999999999999999 999999999999993
Q ss_pred ---------------CCCCeEEeeeccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCC
Q 010891 312 ---------------ENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRY 376 (498)
Q Consensus 312 ---------------~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~ 376 (498)
++..+||+|||.|..-.... ..++-|..|.|||++.+-+++..+||||+||||+|++||..
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~ 307 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGET 307 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccce
Confidence 13459999999998765443 44678999999999999999999999999999999999999
Q ss_pred CCCCCCCcchhhHHHHHH-----HHHhhc---------ccc-----------CCcCCCC----CCCCCHHHHHHHHHHHH
Q 010891 377 PVDYGRPQSEVNLVEWLK-----MMVQLR---------RSE-----------DVVDPNI----ETRPSTSALKRALLTAL 427 (498)
Q Consensus 377 P~~~~~~~~~~~~~~~~~-----~~~~~~---------~~~-----------~~~~~~~----~~~~~~~~~~~~l~~~~ 427 (498)
.|...+......+++.+- .|.... +.. .+.++.. .......+...+++++.
T Consensus 308 LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~ 387 (415)
T KOG0671|consen 308 LFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR 387 (415)
T ss_pred ecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence 998665433333332210 000000 000 0000000 01122344566778888
Q ss_pred HccCCCCCCCCCHHHHHHHHh
Q 010891 428 RCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 428 ~cl~~dP~~RPt~~ell~~L~ 448 (498)
+||..||.+|+|+.|+|.|--
T Consensus 388 ~mL~fDP~~RiTl~EAL~HpF 408 (415)
T KOG0671|consen 388 RMLEFDPARRITLREALSHPF 408 (415)
T ss_pred HHHccCccccccHHHHhcCHH
Confidence 999999999999999998743
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=286.73 Aligned_cols=206 Identities=25% Similarity=0.314 Sum_probs=176.5
Q ss_pred HHHccCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCCCc---hhHHHHHHHHHHcC-CCCCceEEEeEEEeCCe
Q 010891 170 QSATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQA---DKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQ 244 (498)
Q Consensus 170 ~~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~ 244 (498)
.+-..+|.++.+||+|+||.|.+|. ..+.+.+|||+++++.... .+--..|-++|... +-|.+++++..|+.-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 4456689999999999999999996 4456789999987654322 22234577777766 57889999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccc
Q 010891 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (498)
Q Consensus 245 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla 324 (498)
+|+||||+.||+|--.++ +-+.+.+..+..++..||-||-|||++ +||+||||..||+|+.+|++||+|||++
T Consensus 425 LyFVMEyvnGGDLMyhiQ----Q~GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmc 497 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQ----QVGKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC 497 (683)
T ss_pred eeeEEEEecCchhhhHHH----HhcccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccc
Confidence 999999999999998887 457788999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCC
Q 010891 325 KLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRP 383 (498)
Q Consensus 325 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~ 383 (498)
+.---+. ..+.+++|||.|+|||++..++|+.++|+|||||+||||+.|+.||++.+.
T Consensus 498 KEni~~~-~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE 555 (683)
T KOG0696|consen 498 KENIFDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 555 (683)
T ss_pred cccccCC-cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 8643222 234568999999999999999999999999999999999999999986543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=300.55 Aligned_cols=242 Identities=25% Similarity=0.311 Sum_probs=192.0
Q ss_pred HccCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCCCchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCeeEEEE
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
.+..|.+...+|.|+|+.|-.+. ..+++..++|++.+... +...|+.++... +||||+++.+++.++.+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 46678888899999999999986 55688899999965522 233466665555 8999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEE-cCCCCeEEeeeccceecC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI-DENFDAKISDFGLAKLLG 328 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll-~~~~~~kL~DfGla~~~~ 328 (498)
|++.|+-|.+.+... .... .++..|+.+|+.|+.|||.+ ||+||||||+|||+ +..++++|+|||.++...
T Consensus 396 e~l~g~ell~ri~~~----~~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSK----PEFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHHhc----chhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 999999888887632 2233 77888999999999999998 99999999999999 689999999999999775
Q ss_pred CCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (498)
.. ....+-|..|.|||++....|++++||||||++||+||+|+.||...... .+.+.+ ... +
T Consensus 468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-----~ei~~~---i~~------~ 529 (612)
T KOG0603|consen 468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-----IEIHTR---IQM------P 529 (612)
T ss_pred hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-----HHHHHh---hcC------C
Confidence 54 22345688999999999999999999999999999999999999865443 111111 111 1
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 409 NIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.+. ...+...+.+.. +||+.||.+||+|.+++.+-
T Consensus 530 ~~s--~~vS~~AKdLl~--~LL~~dP~~Rl~~~~i~~h~ 564 (612)
T KOG0603|consen 530 KFS--ECVSDEAKDLLQ--QLLQVDPALRLGADEIGAHP 564 (612)
T ss_pred ccc--cccCHHHHHHHH--HhccCChhhCcChhhhccCc
Confidence 111 333444444444 79999999999999998654
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-36 Score=262.41 Aligned_cols=216 Identities=27% Similarity=0.417 Sum_probs=178.8
Q ss_pred ccccHHHHHHHccCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCC-CCchhHHHHHHHHHHcC-CCCCceEEEeE
Q 010891 162 HWFTLRDLQSATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHV-RHKNLVRLLGY 238 (498)
Q Consensus 162 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~ 238 (498)
-+...+.+++..+....+..||+|+||.|=+-+ ..+|...|+|.+...- .+..+....|+++..+. .+|.+|.+||.
T Consensus 34 i~I~~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa 113 (282)
T KOG0984|consen 34 IYIGDRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGA 113 (282)
T ss_pred EEEecCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehh
Confidence 334444456666777778899999999998776 5689999999986543 34445677788876655 89999999999
Q ss_pred EEeCCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEE
Q 010891 239 CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKI 318 (498)
Q Consensus 239 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL 318 (498)
.......|+.||.|+. +|..|-..-...++.+++...-+|+..|.+||.|||++. .+||||+||+||||+.+|++|+
T Consensus 114 ~~regdvwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKi 190 (282)
T KOG0984|consen 114 LFREGDVWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKI 190 (282)
T ss_pred hhccccEEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEE
Confidence 9889999999999966 888887665557788999999999999999999999986 9999999999999999999999
Q ss_pred eeeccceecCCCCceeeecccccccccCccccc----CCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 010891 319 SDFGLAKLLGAGKSHITTRVMGTFGYVAPEYAN----SGLLNEKSDVYSFGVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 319 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~sDvwSlGvvl~elltg~~P~~~~~ 382 (498)
||||++-.+.+.-. .+...|...|||||.+. ...|+.|+||||||+++.||.++++||....
T Consensus 191 CDFGIsG~L~dSiA--kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 191 CDFGISGYLVDSIA--KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred cccccceeehhhhH--HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 99999988754321 12245788999999874 3579999999999999999999999997543
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=297.66 Aligned_cols=203 Identities=26% Similarity=0.366 Sum_probs=172.7
Q ss_pred CCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCCCch---hHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 175 RFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQAD---KDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
-|..++.||-|+||+|.+++ .++...||+|.+.+.+.-.. ...+.|-+||..-+.+-||+||..|++.+.+|+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 35667889999999999996 44567899998865543222 346779999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec---
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL--- 327 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~--- 327 (498)
|++||++-.+|.. .+.+.+..+..++..+.+|+++.|.. |+|||||||+|||||.+|++||+||||+.-+
T Consensus 710 YIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred ccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999999973 46788899999999999999999999 9999999999999999999999999999532
Q ss_pred ------CCCCc--------------------------------eeeecccccccccCcccccCCCCCccchHHHHHHHHH
Q 010891 328 ------GAGKS--------------------------------HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLL 369 (498)
Q Consensus 328 ------~~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ 369 (498)
..+.. ......+||+.|+|||++....|+..+|+||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 11000 0112257999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCc
Q 010891 370 EAITGRYPVDYGRPQ 384 (498)
Q Consensus 370 elltg~~P~~~~~~~ 384 (498)
||+.|+.||....+.
T Consensus 863 em~~g~~pf~~~tp~ 877 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPG 877 (1034)
T ss_pred HHhhCCCCccCCCCC
Confidence 999999999876654
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=276.32 Aligned_cols=274 Identities=23% Similarity=0.338 Sum_probs=200.0
Q ss_pred ccCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEe--------
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIE-------- 241 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-------- 241 (498)
.+.|+...+||+|.||+||+|+ ...|+.||+|++.-..+ .-.....+|+++|..|.|+|++.+++.|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~ 95 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD 95 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence 3457778899999999999997 45678899987754322 223456779999999999999999988753
Q ss_pred CCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeee
Q 010891 242 GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDF 321 (498)
Q Consensus 242 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~Df 321 (498)
...+|+||.+|+. +|..+|.. ....++..++.++..++..||.|+|+. .|+|||+|++|+||+.+|.+||+||
T Consensus 96 r~t~ylVf~~ceh-DLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 96 RATFYLVFDFCEH-DLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred cceeeeeHHHhhh-hHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeecc
Confidence 2347999999977 99998863 225689999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCce---eeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH---
Q 010891 322 GLAKLLGAGKSH---ITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLK--- 394 (498)
Q Consensus 322 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~--- 394 (498)
|+++.+...... ..+..+.|.+|++||.+.+ ..|+++.|||.-|||+.||.|+.+-+..........++..+-
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 999877544322 2445677999999997654 679999999999999999999998887654433332222110
Q ss_pred ------------HHHhhccccCCcCCCCCC-----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCCC
Q 010891 395 ------------MMVQLRRSEDVVDPNIET-----RPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIP 455 (498)
Q Consensus 395 ------------~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~~~~~ 455 (498)
.+.. ...+.+....... .+.. .....+.++-+++..||.+|+++.+++.+.-....+.|
T Consensus 249 tkevWP~~d~lpL~~s-ie~ePl~~~~~rkv~n~~kp~~-kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 249 TKEVWPNVDNLPLYQS-IELEPLPKGQKRKVKNRLKPYV-KDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred CcccCCCcccchHHHh-ccCCCCCcchhhhhhhhccccc-CChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 0000 0000000000000 0000 01133444447899999999999999988766665555
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=290.56 Aligned_cols=258 Identities=26% Similarity=0.444 Sum_probs=196.9
Q ss_pred HccCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCC--Cc-----hhHHHHHHHHHHcCCCCCceEEEeEEEe-C
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPG--QA-----DKDFRVEVEAIGHVRHKNLVRLLGYCIE-G 242 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~-----~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~ 242 (498)
..++|-++.+||+|||+.||+|. +...+.||||+-..+.. .. .+...+|..|-+.|+||.||++|++|.- .
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 44578888999999999999996 55678889997532211 11 1335679999999999999999999864 4
Q ss_pred CeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEc---CCCCeEEe
Q 010891 243 TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID---ENFDAKIS 319 (498)
Q Consensus 243 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~---~~~~~kL~ 319 (498)
+.+|-|+|||+|.+|.-||. ....+++.++..|+.||+.||.||.. ..|+|||-||||.||||. ..|.+||+
T Consensus 541 dsFCTVLEYceGNDLDFYLK----QhklmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKIT 615 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLK----QHKLMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKIT 615 (775)
T ss_pred ccceeeeeecCCCchhHHHH----hhhhhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEee
Confidence 66789999999999999997 44668999999999999999999998 488999999999999994 45889999
Q ss_pred eeccceecCCCCc------eeeecccccccccCcccccC----CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhH
Q 010891 320 DFGLAKLLGAGKS------HITTRVMGTFGYVAPEYANS----GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNL 389 (498)
Q Consensus 320 DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~ 389 (498)
||||++.+..+.. ..+....||.||++||.+-- ...+.|+||||+|||+|.++.|+.||....... ++
T Consensus 616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ--dI 693 (775)
T KOG1151|consen 616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ--DI 693 (775)
T ss_pred ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH--HH
Confidence 9999999865432 23445789999999997632 357889999999999999999999997654322 11
Q ss_pred HHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 010891 390 VEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVR 445 (498)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~ 445 (498)
.+. ...-..-.-.++..|..+...++++. +||+..-++|....++..
T Consensus 694 Lqe-------NTIlkAtEVqFP~KPvVsseAkaFIR--RCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 694 LQE-------NTILKATEVQFPPKPVVSSEAKAFIR--RCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred Hhh-------hchhcceeccCCCCCccCHHHHHHHH--HHHHhhhhhhhhHHHHcc
Confidence 111 00011111123344444555555554 899999999998887754
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=277.42 Aligned_cols=179 Identities=22% Similarity=0.217 Sum_probs=154.2
Q ss_pred cCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCCCCHHHHHhc
Q 010891 185 GGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRG 263 (498)
Q Consensus 185 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 263 (498)
|.||.||+++. .+++.||+|++.... .+..|...+....||||+++++++.+....|+||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999974 568999999986542 233455555566799999999999999999999999999999999964
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCceeeeccccccc
Q 010891 264 DMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343 (498)
Q Consensus 264 ~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~ 343 (498)
. ..+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+|||++...... .....++..
T Consensus 79 ~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~ 147 (237)
T cd05576 79 F----LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENM 147 (237)
T ss_pred h----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcc
Confidence 2 4589999999999999999999998 9999999999999999999999999988765432 222446778
Q ss_pred ccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 010891 344 YVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVD 379 (498)
Q Consensus 344 y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~ 379 (498)
|+|||.+.+..++.++||||||+++|||++|..|+.
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~ 183 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVE 183 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhh
Confidence 999999988889999999999999999999998875
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=294.37 Aligned_cols=249 Identities=24% Similarity=0.288 Sum_probs=199.7
Q ss_pred CCCccceEcccCcEEEEEEEEcCCc-EEEEEEecCCCCC---chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 175 RFSKDNIIGDGGYGVVYRGQLMNGT-AVAVKKLLNNPGQ---ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
+++++..||-|+||.|=+++..+.. .+|+|++++...- ..+.+..|-.+|...+.|.||++|..|.++...|++||
T Consensus 421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE 500 (732)
T KOG0614|consen 421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME 500 (732)
T ss_pred hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence 4456678999999999999864433 3888888654332 23457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
-|-||.|+..|+ +++.+....+..++..+++|++|||++ +||+|||||+|++|+.+|-+||.|||+|+.+..+
T Consensus 501 aClGGElWTiLr----dRg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 501 ACLGGELWTILR----DRGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred hhcCchhhhhhh----hcCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 999999999998 668899999999999999999999999 9999999999999999999999999999998776
Q ss_pred CceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCC
Q 010891 331 KSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNI 410 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (498)
..+ -++||||.|.|||++.++..+.++|.||||+++|||++|.+||...+|....+.+-.--.+ +--|.
T Consensus 574 ~KT--wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~--------i~~Pr- 642 (732)
T KOG0614|consen 574 RKT--WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK--------IEFPR- 642 (732)
T ss_pred Cce--eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh--------hhccc-
Confidence 543 4589999999999999999999999999999999999999999987765444333211111 00011
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHH
Q 010891 411 ETRPSTSALKRALLTALRCVDPDSDKRPK-----MSQVVRML 447 (498)
Q Consensus 411 ~~~~~~~~~~~~l~~~~~cl~~dP~~RPt-----~~ell~~L 447 (498)
.. ......++.+.+..+|.+|.- +.++-+|-
T Consensus 643 ----~I--~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~ 678 (732)
T KOG0614|consen 643 ----RI--TKTATDLIKKLCRDNPTERLGYQKGGINDIKKHR 678 (732)
T ss_pred ----cc--chhHHHHHHHHHhcCcHhhhccccCChHHHHhhh
Confidence 11 122333344667889999975 67776654
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=275.98 Aligned_cols=265 Identities=24% Similarity=0.320 Sum_probs=201.2
Q ss_pred CccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEeCC-----eeEEE
Q 010891 177 SKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT-----QRILV 248 (498)
Q Consensus 177 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-----~~~lv 248 (498)
+..+-||.|+||+||... -.+|+.||+|++...-. ...+.+.+|+++|..++|.|++..++..+-.+ ++|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 456789999999999997 45799999999854322 23356788999999999999999999876543 45778
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
+|.|.. +|...+- ....|+.+.+.-+++||++||.|||+. +|.||||||.|+|++.|..+||||||+++...
T Consensus 136 TELmQS-DLHKIIV----SPQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 136 TELMQS-DLHKIIV----SPQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHh-hhhheec----cCCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccc
Confidence 888854 7777765 556799999999999999999999999 99999999999999999999999999999887
Q ss_pred CCCceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHH------HHHHhhcc
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWL------KMMVQLRR 401 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~------~~~~~~~~ 401 (498)
.+....++.-+.|.+|.|||++.+ ..|+.+.||||.|||+.||+..+..|....|-...+++.-+ ..|.....
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 666666777778999999998876 57999999999999999999999999877665444333211 11111000
Q ss_pred c--cCCc-----CCCC----CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 402 S--EDVV-----DPNI----ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 402 ~--~~~~-----~~~~----~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
. ..++ .|.+ ............+.+.++++..||++|.+..+.+.++..
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~ 346 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL 346 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence 0 0000 0111 111111223344555567999999999999999987754
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=304.27 Aligned_cols=201 Identities=23% Similarity=0.294 Sum_probs=144.6
Q ss_pred HccCCCccceEcccCcEEEEEEEEc-C----CcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeE------EE
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLM-N----GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGY------CI 240 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~------~~ 240 (498)
..++|.+.+.||+|+||.||+|++. + +..||+|++..... .+.+..+ .+....+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4578999999999999999999854 4 68999998754321 1111111 1222223333322221 23
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcccCC----------------CCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCC
Q 010891 241 EGTQRILVYEYVNNGNLEQWLRGDMCD----------------RGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIK 304 (498)
Q Consensus 241 ~~~~~~lv~e~~~~g~L~~~l~~~~~~----------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDik 304 (498)
.+...++||||+.+++|.+++...... ........+..++.||+.||.|||+. +|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence 556789999999999999998643100 00112344668999999999999998 99999999
Q ss_pred CCCEEEcC-CCCeEEeeeccceecCCCCceeeecccccccccCcccccCC----------------------CCCccchH
Q 010891 305 SSNILIDE-NFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSG----------------------LLNEKSDV 361 (498)
Q Consensus 305 p~NIll~~-~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sDv 361 (498)
|+|||++. ++.+||+|||+++.+............||+.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999986 57999999999987654444444567899999999965321 24456799
Q ss_pred HHHHHHHHHHHhCCCCCC
Q 010891 362 YSFGVVLLEAITGRYPVD 379 (498)
Q Consensus 362 wSlGvvl~elltg~~P~~ 379 (498)
|||||+||||+++..|+.
T Consensus 363 wSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred HHHHHHHHHHHhCcCCCc
Confidence 999999999999876654
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=270.71 Aligned_cols=248 Identities=24% Similarity=0.311 Sum_probs=195.4
Q ss_pred ccCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCC---CCchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCeeEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 247 (498)
.++|.+.++||+|+|+.|.+++ ..+.+.+|+|++++.- .++..-.+.|-.+...- +||.+|.++.+|+....+|+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 4678889999999999999998 4567889999886532 33334456677777666 89999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
|.||++||+|--.++ ....|+++.+..+...|..||.|||++ |||+||||..|+|+|..|++||+|+|+++.-
T Consensus 329 vieyv~ggdlmfhmq----rqrklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQ----RQRKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEecCcceeeehh----hhhcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcC
Confidence 999999999977665 345699999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCC-CCCcchhhHHHHHHHHHhhccccCCc
Q 010891 328 GAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDY-GRPQSEVNLVEWLKMMVQLRRSEDVV 406 (498)
Q Consensus 328 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (498)
-.+. ..+.+++|||.|.|||++.+..|+..+|+|+|||+++||+.|+.||+. +...++.+..+++-+..-.
T Consensus 402 l~~g-d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvile------- 473 (593)
T KOG0695|consen 402 LGPG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILE------- 473 (593)
T ss_pred CCCC-cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhh-------
Confidence 3222 335668999999999999999999999999999999999999999974 2233444444554433211
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 010891 407 DPNIETRPSTSALKRALLTALRCVDPDSDKRP 438 (498)
Q Consensus 407 ~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RP 438 (498)
..+..+.+.+ .+...+...-|++||.+|.
T Consensus 474 -kqiriprsls--vkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 474 -KQIRIPRSLS--VKASHVLKGFLNKDPKERL 502 (593)
T ss_pred -hcccccceee--hhhHHHHHHhhcCCcHHhc
Confidence 1111122221 2233333467999999985
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=274.56 Aligned_cols=281 Identities=21% Similarity=0.253 Sum_probs=206.0
Q ss_pred CCccccHHHHHHHc-cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCC-----C---
Q 010891 160 WGHWFTLRDLQSAT-NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-----H--- 229 (498)
Q Consensus 160 ~~~~~~~~~~~~~~-~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h--- 229 (498)
.+.+.++.-...+. ++|.+.++||.|.|++||+|.+ .+.+.||+|+.+.. ....+....||++|++++ |
T Consensus 63 kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~ 141 (590)
T KOG1290|consen 63 KGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGK 141 (590)
T ss_pred cCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCC
Confidence 34445555445555 8999999999999999999974 45678999987543 333455667999999883 3
Q ss_pred CCceEEEeEEE----eCCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCC
Q 010891 230 KNLVRLLGYCI----EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKS 305 (498)
Q Consensus 230 pnIv~l~~~~~----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp 305 (498)
.+||+|++.|. ++.|+|||+|++ |.+|..+|... ...-++...+.+|+.||+.||.|||..| +|||-||||
T Consensus 142 ~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKP 216 (590)
T KOG1290|consen 142 KCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKP 216 (590)
T ss_pred ceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCc
Confidence 36999999987 468899999999 77999999765 3345889999999999999999999988 999999999
Q ss_pred CCEEEc--------------------------------------------------------------------------
Q 010891 306 SNILID-------------------------------------------------------------------------- 311 (498)
Q Consensus 306 ~NIll~-------------------------------------------------------------------------- 311 (498)
+|||+.
T Consensus 217 ENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~ 296 (590)
T KOG1290|consen 217 ENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEE 296 (590)
T ss_pred ceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccc
Confidence 999993
Q ss_pred ----------------------------------------C---------------------------------------
Q 010891 312 ----------------------------------------E--------------------------------------- 312 (498)
Q Consensus 312 ----------------------------------------~--------------------------------------- 312 (498)
.
T Consensus 297 ~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~ 376 (590)
T KOG1290|consen 297 EPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIAS 376 (590)
T ss_pred cccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccccc
Confidence 0
Q ss_pred -------------CCCeEEeeeccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 010891 313 -------------NFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVD 379 (498)
Q Consensus 313 -------------~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~ 379 (498)
+.++||+|||-|+..... .+.-..|..|+|||++.+..|+..+|||||+|++|||+||...|+
T Consensus 377 n~~v~p~~~~~~~di~vKIaDlGNACW~~kh----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFe 452 (590)
T KOG1290|consen 377 NPLVNPDIPLPECDIRVKIADLGNACWVHKH----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFE 452 (590)
T ss_pred ccccCCCCCCCccceeEEEeeccchhhhhhh----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeec
Confidence 013788899888875432 344457889999999999999999999999999999999999997
Q ss_pred CCCCcchhhHHHHHHHHHhhcc-c-----------cCCcCC--------CCCC-----------CCCHHHHHHHHHHHHH
Q 010891 380 YGRPQSEVNLVEWLKMMVQLRR-S-----------EDVVDP--------NIET-----------RPSTSALKRALLTALR 428 (498)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~-~-----------~~~~~~--------~~~~-----------~~~~~~~~~~l~~~~~ 428 (498)
.........-.+++..|..+.. . ...++. .+.. ..+......+..+++-
T Consensus 453 PhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~P 532 (590)
T KOG1290|consen 453 PHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSP 532 (590)
T ss_pred CCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHH
Confidence 5433221111122222211110 0 000000 1111 2334556666677778
Q ss_pred ccCCCCCCCCCHHHHHHHHhcC
Q 010891 429 CVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 429 cl~~dP~~RPt~~ell~~L~~~ 450 (498)
||+.+|++||||.+.|+|---.
T Consensus 533 mLef~PeKR~tA~~cl~hPwLn 554 (590)
T KOG1290|consen 533 MLEFDPEKRPTAAQCLKHPWLN 554 (590)
T ss_pred HHhcCccccccHHHHhcCcccc
Confidence 9999999999999999765433
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=289.80 Aligned_cols=205 Identities=23% Similarity=0.346 Sum_probs=155.2
Q ss_pred HccCCCccceEcccCcEEEEEEEE-----------------cCCcEEEEEEecCCCCCchhH--------------HHHH
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL-----------------MNGTAVAVKKLLNNPGQADKD--------------FRVE 220 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~--------------~~~E 220 (498)
..++|.+.++||+|+||+||+|.+ ..++.||||++........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 367899999999999999999953 235679999986543322222 3347
Q ss_pred HHHHHcCCCCCc-----eEEEeEEEe--------CCeeEEEEeecCCCCHHHHHhcccC--------------------C
Q 010891 221 VEAIGHVRHKNL-----VRLLGYCIE--------GTQRILVYEYVNNGNLEQWLRGDMC--------------------D 267 (498)
Q Consensus 221 ~~~l~~l~hpnI-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~ 267 (498)
+.++.+++|.++ ++++++|.. ....||||||+.+++|.++|+.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 677777653 3567999999999999999974211 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCceeeecccccccccCc
Q 010891 268 RGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAP 347 (498)
Q Consensus 268 ~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aP 347 (498)
...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...............+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 12356778899999999999999998 999999999999999999999999999976544322222223458999999
Q ss_pred ccccCCC--------------------CC--ccchHHHHHHHHHHHHhCCC-CCC
Q 010891 348 EYANSGL--------------------LN--EKSDVYSFGVVLLEAITGRY-PVD 379 (498)
Q Consensus 348 E~~~~~~--------------------~~--~~sDvwSlGvvl~elltg~~-P~~ 379 (498)
|.+.... |+ .+.||||+||++|+|++|.. ||.
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 9875322 11 24799999999999999886 664
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=264.84 Aligned_cols=239 Identities=28% Similarity=0.395 Sum_probs=190.3
Q ss_pred CcEEEEEEEEc-CCcEEEEEEecCCCCCc-hhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCCCCHHHHHhc
Q 010891 186 GYGVVYRGQLM-NGTAVAVKKLLNNPGQA-DKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRG 263 (498)
Q Consensus 186 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 263 (498)
+||.||+|... +|+.+++|++....... .+.+..|++.+++++|+||+++++++......+++|||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999865 48999999997655544 67899999999999999999999999999999999999999999999964
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCceeeeccccccc
Q 010891 264 DMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343 (498)
Q Consensus 264 ~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~ 343 (498)
. ..+++..++.++.+++.++.|||+. +++|+||+|.||++++++.++|+|||++....... ......++..
T Consensus 81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~ 151 (244)
T smart00220 81 R----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE 151 (244)
T ss_pred c----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence 3 2388999999999999999999998 99999999999999999999999999998875432 2334568899
Q ss_pred ccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHH
Q 010891 344 YVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRAL 423 (498)
Q Consensus 344 y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 423 (498)
|++||.+.+..++.++||||||+++|+|++|..||...... .... ......... ....... ....+.
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~---~~~~~~~~~------~~~~~~~--~~~~~~ 218 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELF---KKIGKPKPP------FPPPEWK--ISPEAK 218 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHH---HHHhccCCC------Ccccccc--CCHHHH
Confidence 99999998888999999999999999999999999753211 1111 111110000 0000000 112344
Q ss_pred HHHHHccCCCCCCCCCHHHHHHH
Q 010891 424 LTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 424 ~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
.++.+||..+|++||++.+++++
T Consensus 219 ~~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 219 DLIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred HHHHHHccCCchhccCHHHHhhC
Confidence 45568999999999999999873
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=296.01 Aligned_cols=247 Identities=30% Similarity=0.417 Sum_probs=186.4
Q ss_pred CccceEcccCcE-EEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCeeEEEEeecCC
Q 010891 177 SKDNIIGDGGYG-VVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVYEYVNN 254 (498)
Q Consensus 177 ~~~~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (498)
.-.+++|.|+-| .||+|.. +|+.||||++.... .....+|+..|+.- .|||||++++.-.+....||..|.|..
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~ 587 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC 587 (903)
T ss_pred ccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh
Confidence 345689999988 6799977 78999999985432 23456799999988 799999999999999999999999955
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcC---C--CCeEEeeeccceecCC
Q 010891 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE---N--FDAKISDFGLAKLLGA 329 (498)
Q Consensus 255 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~---~--~~~kL~DfGla~~~~~ 329 (498)
+|.+++.....+.........+.++.|++.||++||+. +||||||||.||||+. + ..++|+|||+++.+..
T Consensus 588 -sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 588 -SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred -hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 99999976311222222245678999999999999998 9999999999999976 2 5799999999999876
Q ss_pred CCcee--eecccccccccCcccccCCCCCccchHHHHHHHHHHHHhC-CCCCCCCCCcchhhHHHHHHHHHhhccccCCc
Q 010891 330 GKSHI--TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITG-RYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVV 406 (498)
Q Consensus 330 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (498)
+.... .....||.+|+|||++....-+.++||||||||+|+.++| .+||....... .++ ......+
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~-~NI----------l~~~~~L 732 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ-ANI----------LTGNYTL 732 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh-hhh----------hcCccce
Confidence 65443 3346799999999999988888899999999999999996 89997432211 111 1111100
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 407 DPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 407 ~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
....+.... ....++-+|+++||..||+|.+||.|-
T Consensus 733 ---~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~HP 768 (903)
T KOG1027|consen 733 ---VHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLNHP 768 (903)
T ss_pred ---eeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhCCC
Confidence 011111111 333444489999999999999998654
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-32 Score=252.98 Aligned_cols=262 Identities=27% Similarity=0.321 Sum_probs=194.9
Q ss_pred ccCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCC--CCCchhHHHHHHHHHHcCCCCCceEEEeEEEeC------C
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNN--PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG------T 243 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~ 243 (498)
..+|.-.+.+|.|.- .|..|. .-.++.||+|++... .....+...+|..++..+.|+||++++.+|.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 346777788999998 555553 346899999988443 223445677899999999999999999998643 3
Q ss_pred eeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecc
Q 010891 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (498)
Q Consensus 244 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGl 323 (498)
..|+|||+|.. +|...++. .++-+....|+.|++.|+.|||+. +|+||||||+||++..+..+||.|||+
T Consensus 95 e~y~v~e~m~~-nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVILM------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred hHHHHHHhhhh-HHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchh
Confidence 46999999955 99988862 266788899999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhh-HH--------HHHH
Q 010891 324 AKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVN-LV--------EWLK 394 (498)
Q Consensus 324 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~-~~--------~~~~ 394 (498)
|+.-+.. ..++.++.|..|.|||++.+..|.+.+||||+||++.||++|+..|.+..--+... .+ .++.
T Consensus 165 ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 165 ARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred hcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence 9865433 35777899999999999998889999999999999999999999997432111100 00 0011
Q ss_pred HHHhhc--------------cc----cCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 395 MMVQLR--------------RS----EDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 395 ~~~~~~--------------~~----~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
++.... .. ...+....+..+......+++.. +||-.||++|.++.++|+|-.-
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~--~MLvi~pe~Risv~daL~HPY~ 313 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLS--KMLVIDPEKRISVDDALRHPYI 313 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHH--HhhccChhhcccHHHHhcCCee
Confidence 111000 00 11122222333333444444443 8999999999999999998654
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=270.67 Aligned_cols=213 Identities=25% Similarity=0.258 Sum_probs=181.6
Q ss_pred CccccHHHHHHHccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCC------CCCce
Q 010891 161 GHWFTLRDLQSATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR------HKNLV 233 (498)
Q Consensus 161 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------hpnIv 233 (498)
..||.+.-.+...++|.+....|+|-|++|..|.+ ..|..||||++.++... .+.=+.|+++|++|+ --|++
T Consensus 419 EGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 419 EGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred cceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHH
Confidence 35778888888999999999999999999999974 44889999999765332 344566999999995 34899
Q ss_pred EEEeEEEeCCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCC
Q 010891 234 RLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN 313 (498)
Q Consensus 234 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~ 313 (498)
+|+..|...+++|||+|-+ .-+|.+.|.... .+--|....+..++.|+..||..|-.+ +|+|.||||.|||+++.
T Consensus 498 rl~r~F~hknHLClVFE~L-slNLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~ 572 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPL-SLNLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNES 572 (752)
T ss_pred HHHHHhhhcceeEEEehhh-hchHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccC
Confidence 9999999999999999998 459999998654 334478899999999999999999998 99999999999999875
Q ss_pred -CCeEEeeeccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 010891 314 -FDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 314 -~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~ 382 (498)
..+||||||.|....... .+.+..+..|.|||++.+.+|+...|+||.||+||||+||+..|.+..
T Consensus 573 k~iLKLCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 573 KNILKLCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred cceeeeccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 568999999998766543 344556778999999999999999999999999999999999997543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=278.39 Aligned_cols=254 Identities=25% Similarity=0.380 Sum_probs=203.5
Q ss_pred HccCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
...+|+....+|.|.||.||+++ ...++..|+|.++-.......-+.+|+-+++..+|||||.+++.+...+.+|++||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 45678889999999999999998 45689999999988777777888899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
||.||+|++.-+ -.+++++.+...+++..++||+|||+. +-+|||||-.|||+++.|.+||+|||.+..+...
T Consensus 93 ycgggslQdiy~----~TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 93 YCGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred ecCCCcccceee----ecccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhh
Confidence 999999999876 347899999999999999999999999 9999999999999999999999999999766432
Q ss_pred CceeeecccccccccCcccc---cCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcC
Q 010891 331 KSHITTRVMGTFGYVAPEYA---NSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (498)
-. ....+.||++|||||+. +.+.|...+|||++|+...|+---+.|..+-.+.. .+..|....- -.
T Consensus 166 i~-KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr------~l~LmTkS~~----qp 234 (829)
T KOG0576|consen 166 IA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR------ALFLMTKSGF----QP 234 (829)
T ss_pred hh-hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH------HHHHhhccCC----CC
Confidence 21 13447899999999976 56789999999999999999988887754333321 1122221111 11
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 010891 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVR 445 (498)
Q Consensus 408 ~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~ 445 (498)
+.+.......+... .++..||.++|++|||++.+|.
T Consensus 235 p~lkDk~kws~~fh--~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 235 PTLKDKTKWSEFFH--NFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CcccCCccchHHHH--HHHHHHhcCCCccCCChhhhee
Confidence 22222222233333 3344799999999999988764
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-32 Score=269.90 Aligned_cols=196 Identities=22% Similarity=0.350 Sum_probs=168.2
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCc------h--hHHHHHHHHHHcCC---CCCceEEEeEEEe
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQA------D--KDFRVEVEAIGHVR---HKNLVRLLGYCIE 241 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~------~--~~~~~E~~~l~~l~---hpnIv~l~~~~~~ 241 (498)
..|...+.+|+|+||.|++|.+ .+...|+||.+.+..--. . -..-.||+||..|+ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 4588899999999999999974 456778899885543211 0 11345999999997 9999999999999
Q ss_pred CCeeEEEEeec-CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEee
Q 010891 242 GTQRILVYEYV-NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISD 320 (498)
Q Consensus 242 ~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~D 320 (498)
++.+||+||-. +|.+|++|+.. ...+++.++..|+.||+.|+++||+. +|||||||-+|+.++.+|-+||+|
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid 713 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID 713 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence 99999999976 45699999973 35699999999999999999999999 999999999999999999999999
Q ss_pred eccceecCCCCceeeecccccccccCcccccCCCCC-ccchHHHHHHHHHHHHhCCCCCC
Q 010891 321 FGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLN-EKSDVYSFGVVLLEAITGRYPVD 379 (498)
Q Consensus 321 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~elltg~~P~~ 379 (498)
||.+.....+ ....++||..|.|||++.+..|- ..-|||++|++||.++....||.
T Consensus 714 fgsaa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 714 FGSAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ccchhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999876543 45668999999999999988764 45799999999999999998885
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=237.25 Aligned_cols=211 Identities=34% Similarity=0.589 Sum_probs=179.9
Q ss_pred EcccCcEEEEEEEEcC-CcEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCCCCHHH
Q 010891 182 IGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQ 259 (498)
Q Consensus 182 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~ 259 (498)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++.++.++|++|+++++++......+++|||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999998643 899999998655433 34678899999999999999999999999999999999999999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcC-CCCeEEeeeccceecCCCCceeeecc
Q 010891 260 WLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE-NFDAKISDFGLAKLLGAGKSHITTRV 338 (498)
Q Consensus 260 ~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~-~~~~kL~DfGla~~~~~~~~~~~~~~ 338 (498)
++.... ..+++..+..++.+++.+|.|||+. +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~ 153 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI 153 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence 996421 4688999999999999999999999 9999999999999999 89999999999987654321 12334
Q ss_pred cccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHH
Q 010891 339 MGTFGYVAPEYANSG-LLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTS 417 (498)
Q Consensus 339 ~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 417 (498)
.+...|++||..... .++.++|+|+||+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------------------- 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------------------- 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence 578899999998877 888999999999999999
Q ss_pred HHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 418 ALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 418 ~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.....++..|++.||++||++.++++++
T Consensus 188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1233334479999999999999998754
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=239.28 Aligned_cols=197 Identities=25% Similarity=0.418 Sum_probs=167.4
Q ss_pred ccCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCC-CCCceEEEeEEEeC--CeeEEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-HKNLVRLLGYCIEG--TQRILV 248 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~--~~~~lv 248 (498)
.++|++.+++|+|-|++||.|. ..+.+.++||++++. ..+.+.+|+.+|..|. ||||+.++++..+. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4678999999999999999996 567889999998654 2466889999999996 99999999998875 445799
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCC-CCeEEeeeccceec
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN-FDAKISDFGLAKLL 327 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~-~~~kL~DfGla~~~ 327 (498)
+||+++.+...+. +.|+..++..++.+++.||.|||+. ||+|||+||.|++||.. -.++|+|+|+|.+.
T Consensus 114 FE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhc
Confidence 9999997766654 3478888999999999999999999 99999999999999864 56999999999988
Q ss_pred CCCCceeeecccccccccCcccc-cCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCc
Q 010891 328 GAGKSHITTRVMGTFGYVAPEYA-NSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQ 384 (498)
Q Consensus 328 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~ 384 (498)
.++... +-.+.+..|--||++ .-..|+..-|+|||||+|..|+..+-||..+...
T Consensus 184 Hp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN 239 (338)
T KOG0668|consen 184 HPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 239 (338)
T ss_pred CCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC
Confidence 765433 234567789999977 4577899999999999999999999999877654
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-30 Score=239.71 Aligned_cols=199 Identities=33% Similarity=0.497 Sum_probs=173.0
Q ss_pred CCccceEcccCcEEEEEEEEcC-CcEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecC
Q 010891 176 FSKDNIIGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253 (498)
Q Consensus 176 y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ 253 (498)
|.+.+.||.|++|.||++...+ ++.+++|.+...... ..+.+..|++.++.++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4567899999999999998654 889999998765544 56778899999999999999999999999899999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCce
Q 010891 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333 (498)
Q Consensus 254 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~ 333 (498)
+++|.+++.... ..+++.....++.+++.+|.|||.. +++|+||+|.||+++.++.++|+|||++.........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 81 GGDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred CCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 999999997432 1178999999999999999999998 9999999999999999999999999999887544211
Q ss_pred eeecccccccccCcccc-cCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 010891 334 ITTRVMGTFGYVAPEYA-NSGLLNEKSDVYSFGVVLLEAITGRYPVDY 380 (498)
Q Consensus 334 ~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvvl~elltg~~P~~~ 380 (498)
......++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 22345678899999998 777788899999999999999999999964
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=228.19 Aligned_cols=252 Identities=21% Similarity=0.400 Sum_probs=180.0
Q ss_pred HHccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCCchhHHHHHHHHHHcC-CCCCceEEEeE-EEeCCeeEE
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGY-CIEGTQRIL 247 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~-~~~~~~~~l 247 (498)
...+.|.+.+.||+|.||.+-++++. ..+.+++|.+. ......++|.+|..---.| .|.||+.-|++ |+..+.+++
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp-~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVP-RPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccC-cchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 34567899999999999999999854 46678888764 3445567899998776666 68999998875 666778889
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEc--CCCCeEEeeeccce
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID--ENFDAKISDFGLAK 325 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~--~~~~~kL~DfGla~ 325 (498)
++||++.|+|.+-+.. .-+.+.....++.|++.||.|+|++ +++|||||.+||||- +..++||||||+.+
T Consensus 100 ~qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTR 171 (378)
T ss_pred eeccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccc
Confidence 9999999999987742 3478888999999999999999999 999999999999993 34579999999998
Q ss_pred ecCCCCceeeecccccccccCcccccCC-----CCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhc
Q 010891 326 LLGAGKSHITTRVMGTFGYVAPEYANSG-----LLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLR 400 (498)
Q Consensus 326 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 400 (498)
..+.. .....-+..|.+||+.... ...+.+|+|.||+|+|.++||.+||..... ......+|++-.. +
T Consensus 172 k~g~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~-~d~~Y~~~~~w~~--r 244 (378)
T KOG1345|consen 172 KVGTT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI-MDKPYWEWEQWLK--R 244 (378)
T ss_pred ccCce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc-cCchHHHHHHHhc--c
Confidence 65432 2223345679999976432 245688999999999999999999984321 1222333322111 1
Q ss_pred cccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 010891 401 RSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVV 444 (498)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell 444 (498)
....+ |..- .+-.+...+++ .+-|.++|++|--..++-
T Consensus 245 k~~~~--P~~F-~~fs~~a~r~F---kk~lt~~~~drcki~~~k 282 (378)
T KOG1345|consen 245 KNPAL--PKKF-NPFSEKALRLF---KKSLTPRFKDRCKIWTAK 282 (378)
T ss_pred cCccC--chhh-cccCHHHHHHH---HHhcCCcccccchhHHHH
Confidence 11111 1111 11222233333 367899999994444443
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=240.10 Aligned_cols=203 Identities=28% Similarity=0.410 Sum_probs=168.8
Q ss_pred HHHHHccCCCccceEcccCcEEEEEEEEc----CCcEEEEEEecCCCCCchhHHHHHHHHHHcC-CCCCceEEEeEEEeC
Q 010891 168 DLQSATNRFSKDNIIGDGGYGVVYRGQLM----NGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEG 242 (498)
Q Consensus 168 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~ 242 (498)
++....+.|....+||+|.|++||++.+. ..+.||+|.+.... ....+..|+++|..+ .+.||+++.+++..+
T Consensus 30 ~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 30 DIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 45566778999999999999999999643 46789999985443 345588999999999 699999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCC-CCeEEeee
Q 010891 243 TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN-FDAKISDF 321 (498)
Q Consensus 243 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~-~~~kL~Df 321 (498)
++.++|+||++..+-.+++.. ++..++..+++.++.||.++|.. |||||||||+|+|.+.. +.-.|+||
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~-------l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDF 177 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS-------LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDF 177 (418)
T ss_pred CeeEEEecccCccCHHHHHhc-------CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEec
Confidence 999999999999999998853 67889999999999999999999 99999999999999764 67899999
Q ss_pred ccceecCCCC---------------------------------c----------eeeecccccccccCcccccC-CCCCc
Q 010891 322 GLAKLLGAGK---------------------------------S----------HITTRVMGTFGYVAPEYANS-GLLNE 357 (498)
Q Consensus 322 Gla~~~~~~~---------------------------------~----------~~~~~~~gt~~y~aPE~~~~-~~~~~ 357 (498)
|+|....... . .......||++|.|||++.. ...+.
T Consensus 178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt 257 (418)
T KOG1167|consen 178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT 257 (418)
T ss_pred hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence 9997210000 0 00112469999999998754 56788
Q ss_pred cchHHHHHHHHHHHHhCCCCCCCCC
Q 010891 358 KSDVYSFGVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 358 ~sDvwSlGvvl~elltg~~P~~~~~ 382 (498)
++||||.|||+.-++++++||....
T Consensus 258 aiDiws~GVI~Lslls~~~PFf~a~ 282 (418)
T KOG1167|consen 258 AIDIWSAGVILLSLLSRRYPFFKAK 282 (418)
T ss_pred ccceeeccceeehhhccccccccCc
Confidence 9999999999999999999997543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-29 Score=278.86 Aligned_cols=197 Identities=19% Similarity=0.242 Sum_probs=138.6
Q ss_pred cCCC-CCceEEEeEE-------EeCCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCC
Q 010891 226 HVRH-KNLVRLLGYC-------IEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK 297 (498)
Q Consensus 226 ~l~h-pnIv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ 297 (498)
.++| +||++++++| .....+++++||+ +++|.++|.. ....+++.+++.++.||++||.|||++ +
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---g 100 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQ---G 100 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence 4455 5888888877 2334567788988 5699999963 235699999999999999999999998 9
Q ss_pred eeecCCCCCCEEEcCC-------------------CCeEEeeeccceecCCCC---------------ceeeeccccccc
Q 010891 298 VVHRDIKSSNILIDEN-------------------FDAKISDFGLAKLLGAGK---------------SHITTRVMGTFG 343 (498)
Q Consensus 298 iiHrDikp~NIll~~~-------------------~~~kL~DfGla~~~~~~~---------------~~~~~~~~gt~~ 343 (498)
|+||||||+||||+.. +.+||+|||+++...... .......+||++
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 9999999999999653 455666666665421100 000112468999
Q ss_pred ccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHH
Q 010891 344 YVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRAL 423 (498)
Q Consensus 344 y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 423 (498)
|||||++.+..|+.++|||||||+||||++|..|+.... ..+...... ...+.. ........
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--------~~~~~~~~~-----~~~~~~-----~~~~~~~~ 242 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--------RTMSSLRHR-----VLPPQI-----LLNWPKEA 242 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--------HHHHHHHHh-----hcChhh-----hhcCHHHH
Confidence 999999999999999999999999999999888764211 111111110 011111 01112234
Q ss_pred HHHHHccCCCCCCCCCHHHHHHHH
Q 010891 424 LTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 424 ~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.++.+||.+||.+||++.|++++.
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~h~ 266 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQSE 266 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhhch
Confidence 455689999999999999998754
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.5e-27 Score=212.79 Aligned_cols=169 Identities=24% Similarity=0.193 Sum_probs=124.3
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCcee
Q 010891 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (498)
Q Consensus 255 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 334 (498)
|+|.+++... +..+++..++.++.||+.||.|||+. + ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--- 63 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ--- 63 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence 6899999742 35699999999999999999999998 5 999999999999999 99998764322
Q ss_pred eecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCC
Q 010891 335 TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRP 414 (498)
Q Consensus 335 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 414 (498)
..||+.|||||++.+..|+.++|||||||++|||++|+.||........ ........+.. .. ........
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~----~~--~~~~~~~~ 133 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-ILEILLNGMPA----DD--PRDRSNLE 133 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHHHHHHHhcc----CC--ccccccHH
Confidence 2589999999999999999999999999999999999999964432111 11111111110 00 00000001
Q ss_pred CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 415 STSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 415 ~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
.......+..++.+||..||.+|||+.|+++++...
T Consensus 134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 111111355566689999999999999999998654
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.4e-26 Score=226.23 Aligned_cols=164 Identities=24% Similarity=0.295 Sum_probs=128.5
Q ss_pred HHccCCCccceEcccCcEEEEEEEEc--CCcEEEEEEecCCC-----CCchhHHHHHHHHHHcCCCCCceE-EEeEEEeC
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQLM--NGTAVAVKKLLNNP-----GQADKDFRVEVEAIGHVRHKNLVR-LLGYCIEG 242 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~hpnIv~-l~~~~~~~ 242 (498)
...++|.+.+.||+|+||+||+|+.. +++.||||++.... ......|.+|+++|.+++|+||+. ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 44568999999999999999999753 57778999875331 112345889999999999999985 5432
Q ss_pred CeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCC-CCCCEEEcCCCCeEEeee
Q 010891 243 TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDI-KSSNILIDENFDAKISDF 321 (498)
Q Consensus 243 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDi-kp~NIll~~~~~~kL~Df 321 (498)
...|+||||++|++|.. +. ..+ ...++.|+++||.|||+. +|+|||| ||+|||++.++.+||+||
T Consensus 91 ~~~~LVmE~~~G~~L~~-~~----~~~------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHL-AR----PHG------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred CCcEEEEEccCCCCHHH-hC----ccc------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEEC
Confidence 45799999999999973 21 111 146788999999999999 9999999 999999999999999999
Q ss_pred ccceecCCCCce-------eeecccccccccCcccccC
Q 010891 322 GLAKLLGAGKSH-------ITTRVMGTFGYVAPEYANS 352 (498)
Q Consensus 322 Gla~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~ 352 (498)
|+|+.+...... ..+..++++.|+|||.+..
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 999977543211 1134678999999998854
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.9e-25 Score=218.68 Aligned_cols=258 Identities=19% Similarity=0.254 Sum_probs=190.2
Q ss_pred CCCccceEcccCcEEEEEEEEcCC--cEEEEEEecCCCCCchhHHHHHHHHHHcCCC----CCceEEEeEE-EeCCeeEE
Q 010891 175 RFSKDNIIGDGGYGVVYRGQLMNG--TAVAVKKLLNNPGQADKDFRVEVEAIGHVRH----KNLVRLLGYC-IEGTQRIL 247 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----pnIv~l~~~~-~~~~~~~l 247 (498)
+|.+.+.||+|+||.||++..... ..+|+|............+..|..++..+.. +++..+++.. ......|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999986443 4788887755433333367789999998863 6899999999 47778899
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCC-----CCeEEeeec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN-----FDAKISDFG 322 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~-----~~~kL~DfG 322 (498)
||+.+ |.+|.++..... .+.++..++..|+.|++.+|.+||+. |++||||||+|+++... ..+.|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99998 889999886542 56799999999999999999999999 99999999999999765 369999999
Q ss_pred cce--ecCCCCc----ee---eecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 010891 323 LAK--LLGAGKS----HI---TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWL 393 (498)
Q Consensus 323 la~--~~~~~~~----~~---~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~ 393 (498)
+++ .+..... .. ...+.||..|+++....+...+.+.|+||++.++.|++.|..||......... ..+
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~---~~~ 249 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLK---SKF 249 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchH---HHH
Confidence 998 3321111 00 12356999999999999999999999999999999999999999754432221 111
Q ss_pred HHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 394 KMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
.......... . .....+........ .+-..+...+|....+...+...
T Consensus 250 ~~~~~~~~~~----~--~~~~~~~~~~~~~~---~~~~~~~~~~Pdy~~~~~~l~~~ 297 (322)
T KOG1164|consen 250 EKDPRKLLTD----R--FGDLKPEEFAKILE---YIDSLDYEDKPDYEKLAELLKDV 297 (322)
T ss_pred HHHhhhhccc----c--ccCCChHHHHHHHH---HhhccCCcCCCCHHHHHHHHHHH
Confidence 1111111100 0 11112222222222 24446788999999998887554
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-23 Score=205.33 Aligned_cols=261 Identities=29% Similarity=0.414 Sum_probs=194.3
Q ss_pred CCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCc---hhHHHHHHHHHHcCCCC-CceEEEeEEEeCCeeEEEEee
Q 010891 176 FSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQA---DKDFRVEVEAIGHVRHK-NLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 176 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hp-nIv~l~~~~~~~~~~~lv~e~ 251 (498)
|.+.+.||.|+||.||++... ..+++|.+....... ...+.+|+.++..+.|+ +|+++++++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 567789999999999999875 788999886554433 56788999999999988 799999999777778999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCC-CeEEeeeccceecCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF-DAKISDFGLAKLLGAG 330 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~-~~kL~DfGla~~~~~~ 330 (498)
+.+++|.+++...... ..+.......++.|++.++.|+|.. +++|||+||+||+++..+ .++++|||++......
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999777643211 3688999999999999999999999 999999999999999998 6999999999866543
Q ss_pred Cce-----eeecccccccccCcccccC---CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccc
Q 010891 331 KSH-----ITTRVMGTFGYVAPEYANS---GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRS 402 (498)
Q Consensus 331 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (498)
... ......||..|+|||.+.+ ..++...|+||+|++++++++|..||...... .........+......
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~~~ 233 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS--SATSQTLKIILELPTP 233 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc--ccHHHHHHHHHhcCCc
Confidence 322 2355789999999999987 57889999999999999999999997644321 0001111111111100
Q ss_pred cCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 403 EDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
....................+...|+..+|..|.+..+....
T Consensus 234 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 --SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred --ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000001111233344447899999999999887764
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.7e-24 Score=201.48 Aligned_cols=200 Identities=23% Similarity=0.323 Sum_probs=171.8
Q ss_pred cCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCCCchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCeeEEEEee
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
-.|.++++||+|.||+.+.|+ +.+++.||||.-. ......+++.|....+.| ..++|...|.+..++-+-.||+|+
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEP--rkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEP--RKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEecc--ccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 368999999999999999997 6789999999542 233456788899888888 579999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCC-----CCeEEeeecccee
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN-----FDAKISDFGLAKL 326 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~-----~~~kL~DfGla~~ 326 (498)
+ |.+|+|++.- .+..++..++..++.|++.-++|+|++ .+|+|||||+|+||... ..+.|+|||+|+.
T Consensus 106 L-GPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 106 L-GPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred h-CcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 9 8899998853 456799999999999999999999999 99999999999999643 3599999999998
Q ss_pred cCCCCcee------eecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 010891 327 LGAGKSHI------TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 327 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~ 382 (498)
+.+..+.. .....||.+||+--...+...+.+.|+-|||-++++.|-|.+||.+-.
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 86654321 233679999999999999999999999999999999999999998644
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.9e-25 Score=197.98 Aligned_cols=212 Identities=21% Similarity=0.266 Sum_probs=174.8
Q ss_pred HHccCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCC-CCceEEEeEEEeCCeeEEE
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRH-KNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~~~lv 248 (498)
+..++|.++++||+|+||.+|+|. ..+|+.||||.-.... ...++..|..+.+.|++ ..|..+..++.+..+..+|
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 456789999999999999999996 6789999999764433 23457789999999965 6788888888899999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcC---CCCeEEeeeccce
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE---NFDAKISDFGLAK 325 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~---~~~~kL~DfGla~ 325 (498)
|+.+ |.+|++++.- ....++..+++.++-|++.-++|+|.+ ++|||||||+|+|+.- ...+.|+|||+|+
T Consensus 90 MdLL-GPsLEdLfnf---C~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK 162 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNF---CSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK 162 (341)
T ss_pred eecc-CccHHHHHHH---HhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchh
Confidence 9999 8899999863 335689999999999999999999999 9999999999999953 3569999999999
Q ss_pred ecCCCCce------eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHH
Q 010891 326 LLGAGKSH------ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVE 391 (498)
Q Consensus 326 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~ 391 (498)
.+-+.... ......||.+|.+--...+...+.+.|+-|+|.+|.++.-|..||.+-....-....+
T Consensus 163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE 234 (341)
T KOG1163|consen 163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE 234 (341)
T ss_pred hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH
Confidence 87543321 1234679999999887777777888999999999999999999998766554433333
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-24 Score=231.22 Aligned_cols=252 Identities=23% Similarity=0.319 Sum_probs=180.8
Q ss_pred CccceEcccCcEEEEEEE-EcCCcEEEEEEecCC--CCCchh----HHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 177 SKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNN--PGQADK----DFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 177 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~--~~~~~~----~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
....++|.|++|.|+... .......+.|.+... ...... .+..|+.+-..+.|||++..+..+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 356789999999888775 333444555543211 111111 2455777888899999988888777665555559
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
|||++ +|+.++.. .+.++..++..++.|++.|+.|||.. ||.|||+|++|+++..+|.+||+|||.+..+..
T Consensus 401 E~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred hcccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeecc
Confidence 99999 99999963 25788899999999999999999999 999999999999999999999999999988754
Q ss_pred CCc---eeeecccccccccCcccccCCCCCc-cchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCC
Q 010891 330 GKS---HITTRVMGTFGYVAPEYANSGLLNE-KSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV 405 (498)
Q Consensus 330 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (498)
+.. ......+|+..|+|||++.+..|++ ..||||.|++++.|++|+.||.......... ..+.. .....+
T Consensus 473 ~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~-~~~~~~ 546 (601)
T KOG0590|consen 473 PWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNY-SDQRNI 546 (601)
T ss_pred CcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhcc-cccccc
Confidence 322 3455678999999999999999987 5799999999999999999998654432210 00000 000011
Q ss_pred cCCCCCCCCCHHHHHHHHH-HHHHccCCCCCCCCCHHHHHH
Q 010891 406 VDPNIETRPSTSALKRALL-TALRCVDPDSDKRPKMSQVVR 445 (498)
Q Consensus 406 ~~~~~~~~~~~~~~~~~l~-~~~~cl~~dP~~RPt~~ell~ 445 (498)
..+.. .-...+..... ++-++|+.||.+|.|+++|++
T Consensus 547 ~~~~~---~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 547 FEGPN---RLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccChH---HHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 11111 11111111111 223899999999999999985
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=196.12 Aligned_cols=173 Identities=13% Similarity=0.137 Sum_probs=136.3
Q ss_pred HHccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhH---------HHHHHHHHHcCCCCCceEEEeEEEe
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKD---------FRVEVEAIGHVRHKNLVRLLGYCIE 241 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~hpnIv~l~~~~~~ 241 (498)
...++|...++||.|+||.||+... ++..+|+|.+.......... +.+|+..+.++.||+|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 5679999999999999999999866 57789999986544333322 5789999999999999999998664
Q ss_pred C--------CeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCC
Q 010891 242 G--------TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN 313 (498)
Q Consensus 242 ~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~ 313 (498)
. ...+|||||++|.+|.++.. ++. ....+++.+|..||.. +++|||+||+||+++.+
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~ 171 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKN 171 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCC
Confidence 3 34789999999999988742 222 2466999999999999 99999999999999998
Q ss_pred CCeEEeeeccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh
Q 010891 314 FDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT 373 (498)
Q Consensus 314 ~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt 373 (498)
| ++|+|||.......... . ..++....|+.++|+|+||+++..+..
T Consensus 172 g-i~liDfg~~~~~~e~~a--~-----------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKA--K-----------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred C-EEEEECCCcccccchhh--H-----------HHHHHHhHhcccccccceeEeehHHHH
Confidence 8 99999998875432110 0 013444557789999999999876543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-24 Score=230.52 Aligned_cols=252 Identities=23% Similarity=0.280 Sum_probs=181.6
Q ss_pred CCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCC-CCchhHHHH---HHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 175 RFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNP-GQADKDFRV---EVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~---E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
.|...+.||++.|=.|.+|++..|. |+||++.+.. .-....|.+ |++ ...++|||.+++..+...+...|||-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5666789999999999999987877 8999885544 334444544 444 555699999999988777788899999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec--C
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL--G 328 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~--~ 328 (498)
|+.+ +|+|.|. .++.|...+.+.|+.|++.||..+|.. +|+|||||.+||||+.-.-+.|+||..-+.. .
T Consensus 102 yvkh-nLyDRlS----TRPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP 173 (1431)
T KOG1240|consen 102 YVKH-NLYDRLS----TRPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLP 173 (1431)
T ss_pred HHhh-hhhhhhc----cchHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCC
Confidence 9966 9999996 567788899999999999999999999 9999999999999999999999999866532 1
Q ss_pred CCCc----eeeecccccccccCcccccCC----------C-CCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHH
Q 010891 329 AGKS----HITTRVMGTFGYVAPEYANSG----------L-LNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEW 392 (498)
Q Consensus 329 ~~~~----~~~~~~~gt~~y~aPE~~~~~----------~-~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~ 392 (498)
.+.. ....+-..-..|.|||.+... . .+++.||||+||+++||++ |++||..
T Consensus 174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------------ 241 (1431)
T KOG1240|consen 174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------------ 241 (1431)
T ss_pred CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------------
Confidence 1111 111222233469999976331 2 6678999999999999999 7888862
Q ss_pred HHHHHhhcccc-CCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCC
Q 010891 393 LKMMVQLRRSE-DVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYP 453 (498)
Q Consensus 393 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~~~ 453 (498)
.+....+... ......++.-.+. .... +++.|++.||.+|.++++.|+.-.+..||
T Consensus 242 -SQL~aYr~~~~~~~e~~Le~Ied~-~~Rn---lil~Mi~rdPs~RlSAedyL~~yrG~~FP 298 (1431)
T KOG1240|consen 242 -SQLLAYRSGNADDPEQLLEKIEDV-SLRN---LILSMIQRDPSKRLSAEDYLQKYRGLVFP 298 (1431)
T ss_pred -HHHHhHhccCccCHHHHHHhCcCc-cHHH---HHHHHHccCchhccCHHHHHHhhhccccH
Confidence 1122222221 0000000111111 1222 23379999999999999999886666554
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-24 Score=195.95 Aligned_cols=245 Identities=23% Similarity=0.384 Sum_probs=180.8
Q ss_pred CccceEcccCcEEEEEEEEcCCcEEEEEEecCCC--CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCC
Q 010891 177 SKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNN 254 (498)
Q Consensus 177 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (498)
.+..+|.+...|+.|+|++ .|..+++|++.... ....++|..|.-.|+-+.||||+.+++.|....++.++..||+.
T Consensus 193 nl~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~ 271 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF 271 (448)
T ss_pred hhhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence 4456899999999999999 46677778774332 23346799999999999999999999999999999999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEe--eeccceecCCCCc
Q 010891 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKIS--DFGLAKLLGAGKS 332 (498)
Q Consensus 255 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~--DfGla~~~~~~~~ 332 (498)
|+|+..|++. ..-.++-.++.+++.+||+|++|||+. +|-|.---|.+..++||++.+++|+ |--++..
T Consensus 272 gslynvlhe~--t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfq------ 342 (448)
T KOG0195|consen 272 GSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ------ 342 (448)
T ss_pred hHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeee------
Confidence 9999999864 333466788999999999999999995 4445555799999999999887764 2222211
Q ss_pred eeeecccccccccCcccccCCCCC---ccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 333 HITTRVMGTFGYVAPEYANSGLLN---EKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 333 ~~~~~~~gt~~y~aPE~~~~~~~~---~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
.....-.|.||+||.+..++-+ .++|+|||+++||||.|...||..-.+..- .+-..+.... .
T Consensus 343 --e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec-------gmkialeglr----v- 408 (448)
T KOG0195|consen 343 --EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC-------GMKIALEGLR----V- 408 (448)
T ss_pred --ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh-------hhhhhhcccc----c-
Confidence 1112346889999999776544 478999999999999999999976544221 0111111111 1
Q ss_pred CCCCCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 410 IETRPST-SALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 410 ~~~~~~~-~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
..+|.. ..+.++.. -|++.||.+||.+..++-.|+.
T Consensus 409 -~ippgis~hm~klm~---icmnedpgkrpkfdmivpilek 445 (448)
T KOG0195|consen 409 -HIPPGISRHMNKLMN---ICMNEDPGKRPKFDMIVPILEK 445 (448)
T ss_pred -cCCCCccHHHHHHHH---HHhcCCCCcCCCcceehhhHHH
Confidence 112222 23334433 4999999999999999888775
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.5e-23 Score=188.61 Aligned_cols=140 Identities=16% Similarity=0.171 Sum_probs=108.9
Q ss_pred cceEcccCcEEEEEEEEcCCcEEEEEEecCCCCC--c-------hhH-----------------HHHHHHHHHcCCCCCc
Q 010891 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQ--A-------DKD-----------------FRVEVEAIGHVRHKNL 232 (498)
Q Consensus 179 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~E~~~l~~l~hpnI 232 (498)
.+.||+|+||.||+|...+|+.||||++...... . ... ...|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999998778999999998654221 1 011 2349999999988776
Q ss_pred eEEEeEEEeCCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHH-HHccCCCeeecCCCCCCEEEc
Q 010891 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYL-HEAIEPKVVHRDIKSSNILID 311 (498)
Q Consensus 233 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~iiHrDikp~NIll~ 311 (498)
.....+.. ...+|||||++|+++...+. ....++...+..++.|++.+|.|| |+. +|+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE
Confidence 44333222 22389999999887765532 235688999999999999999999 688 999999999999998
Q ss_pred CCCCeEEeeeccceecC
Q 010891 312 ENFDAKISDFGLAKLLG 328 (498)
Q Consensus 312 ~~~~~kL~DfGla~~~~ 328 (498)
++.++|+|||+|....
T Consensus 153 -~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 -DGKLYIIDVSQSVEHD 168 (190)
T ss_pred -CCcEEEEEccccccCC
Confidence 4789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-21 Score=181.14 Aligned_cols=141 Identities=18% Similarity=0.140 Sum_probs=111.4
Q ss_pred cceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCc--------------------------hhHHHHHHHHHHcCCCCCc
Q 010891 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQA--------------------------DKDFRVEVEAIGHVRHKNL 232 (498)
Q Consensus 179 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------------~~~~~~E~~~l~~l~hpnI 232 (498)
.+.||+|+||.||+|...+|+.||||++....... ...+..|.+.+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999987689999999986542210 0113568999999999987
Q ss_pred eEEEeEEEeCCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHH-ccCCCeeecCCCCCCEEEc
Q 010891 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE-AIEPKVVHRDIKSSNILID 311 (498)
Q Consensus 233 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiHrDikp~NIll~ 311 (498)
.....+... ..||||||++|+++..... ....++......++.|++.+|.+||. . +|+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE
Confidence 544444332 3489999999885544321 22457788999999999999999999 8 999999999999999
Q ss_pred CCCCeEEeeeccceecCC
Q 010891 312 ENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 312 ~~~~~kL~DfGla~~~~~ 329 (498)
++.++|+|||++.....
T Consensus 153 -~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 -DGKPYIIDVSQAVELDH 169 (190)
T ss_pred -CCCEEEEEcccceecCC
Confidence 78999999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.7e-21 Score=176.60 Aligned_cols=184 Identities=17% Similarity=0.118 Sum_probs=138.9
Q ss_pred ccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCc----hhHHHHHHHHHHcCC-CCCceEEEeEEEeCCeeEEEEeec
Q 010891 178 KDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQA----DKDFRVEVEAIGHVR-HKNLVRLLGYCIEGTQRILVYEYV 252 (498)
Q Consensus 178 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~ 252 (498)
+...|++|+||+||.+.. .+.+++.+.+.....-. ...+.+|+++|++|. |++|.+++++ ...+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457899999999998865 67888877775443311 124788999999995 5889999886 3469999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCC-CCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDI-KSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDi-kp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
.|.+|...+.. ....++.|++.+|.++|++ ||+|||| ||+|||++.++.++|+|||++.......
T Consensus 81 ~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 81 AGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred cCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 99998764321 1135788999999999999 9999999 7999999999999999999998654322
Q ss_pred ce----e--------eecccccccccCcccccCC-CCC-ccchHHHHHHHHHHHHhCCCCCCC
Q 010891 332 SH----I--------TTRVMGTFGYVAPEYANSG-LLN-EKSDVYSFGVVLLEAITGRYPVDY 380 (498)
Q Consensus 332 ~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~sDvwSlGvvl~elltg~~P~~~ 380 (498)
.. . ..-...++.|+.|+...-. ..+ ...++++.|+-+|.++|++.++..
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 10 0 0112357788888843221 222 567999999999999999988653
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.9e-23 Score=207.71 Aligned_cols=186 Identities=28% Similarity=0.329 Sum_probs=157.3
Q ss_pred eEcccCcEEEEEEE----EcCCcEEEEEEecCCCCC--chhHHHHHHHHHHcCC-CCCceEEEeEEEeCCeeEEEEeecC
Q 010891 181 IIGDGGYGVVYRGQ----LMNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVR-HKNLVRLLGYCIEGTQRILVYEYVN 253 (498)
Q Consensus 181 ~lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~ 253 (498)
++|+|+||.|++++ .+.|..+|+|.+.+.... .......|..++..++ ||.+|++...++.+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999874 345778898877544322 1123455888888886 9999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCce
Q 010891 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333 (498)
Q Consensus 254 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~ 333 (498)
||+|...+. ....+.+.....+...++-|++++|.. +++|||+|++||+++.+|++++.|||+++..-..+.
T Consensus 81 gg~lft~l~----~~~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~- 152 (612)
T KOG0603|consen 81 GGDLFTRLS----KEVMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI- 152 (612)
T ss_pred cchhhhccc----cCCchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence 999998886 345577788888889999999999999 999999999999999999999999999987644332
Q ss_pred eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 010891 334 ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDY 380 (498)
Q Consensus 334 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~ 380 (498)
.|||..|||||+++ ....++|.||||++++||+||..||..
T Consensus 153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 28999999999998 556789999999999999999999974
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=180.74 Aligned_cols=233 Identities=21% Similarity=0.334 Sum_probs=144.5
Q ss_pred CCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCC---CchhHHHHHHHHHHcCCC----------CCceEEEeEE--
Q 010891 176 FSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVRH----------KNLVRLLGYC-- 239 (498)
Q Consensus 176 y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h----------pnIv~l~~~~-- 239 (498)
+...+.||.|+|+.||.+++. +|+.+|+|.+..... ...+.+++|.-....+.+ -.++-.++..
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 456789999999999999864 489999998854332 233556666655444322 1222222221
Q ss_pred -------EeC---C-----eeEEEEeecCCCCHHHHHhc---ccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeec
Q 010891 240 -------IEG---T-----QRILVYEYVNNGNLEQWLRG---DMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHR 301 (498)
Q Consensus 240 -------~~~---~-----~~~lv~e~~~~g~L~~~l~~---~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHr 301 (498)
... . ..+++|+-+ -+||.+++.. .......+....++.+..|+++.+++||.. |++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 111 1 236788888 4588888642 211122344556677789999999999999 99999
Q ss_pred CCCCCCEEEcCCCCeEEeeeccceecCCCCceeeecccccccccCcccccC--------CCCCccchHHHHHHHHHHHHh
Q 010891 302 DIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANS--------GLLNEKSDVYSFGVVLLEAIT 373 (498)
Q Consensus 302 Dikp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwSlGvvl~ellt 373 (498)
||+|+|++++.+|.++|+||+.....+.. ......+..|.+||.... -.++.+.|.|+||+++|.|.|
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTR----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEE----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCce----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 99999999999999999999988865432 111345678999997633 357889999999999999999
Q ss_pred CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCC
Q 010891 374 GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKR 437 (498)
Q Consensus 374 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~R 437 (498)
|..||....+..... ..+..+....+..+.++. .+|+.||.+|
T Consensus 246 ~~lPf~~~~~~~~~~-------------------~~f~~C~~~Pe~v~~LI~--~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPE-------------------WDFSRCRDMPEPVQFLIR--GLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSG-------------------GGGTTSS---HHHHHHHH--HHT-SSGGGS
T ss_pred ccCCCCCCCcccccc-------------------ccchhcCCcCHHHHHHHH--HHccCCcccC
Confidence 999998543322110 022222233344444433 6899999987
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.3e-20 Score=172.40 Aligned_cols=135 Identities=17% Similarity=0.227 Sum_probs=105.8
Q ss_pred ccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcC-----CCCCceEEEeEEEeCC---ee-EEE
Q 010891 178 KDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-----RHKNLVRLLGYCIEGT---QR-ILV 248 (498)
Q Consensus 178 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~l~~~~~~~~---~~-~lv 248 (498)
-.+.||+|+||.||. ...++.. +||++........+.+.+|+.+++.+ .||||+++++++.++. .. .+|
T Consensus 6 ~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 6 EQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 356899999999996 3334444 69988665444567799999999999 5799999999999874 33 378
Q ss_pred Eee--cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHH-HHHHHccCCCeeecCCCCCCEEEcC----CCCeEEeee
Q 010891 249 YEY--VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKAL-AYLHEAIEPKVVHRDIKSSNILIDE----NFDAKISDF 321 (498)
Q Consensus 249 ~e~--~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL-~yLH~~~~~~iiHrDikp~NIll~~----~~~~kL~Df 321 (498)
+|| +.+|+|.+++.. +.+++. ..++.+++.++ .|||++ +|+||||||+|||++. ++.++|+||
T Consensus 84 ~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred ecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 999 557999999953 235554 35677888777 999999 9999999999999974 347999995
Q ss_pred ccc
Q 010891 322 GLA 324 (498)
Q Consensus 322 Gla 324 (498)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 444
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.3e-20 Score=178.67 Aligned_cols=197 Identities=23% Similarity=0.301 Sum_probs=132.0
Q ss_pred CCCCceEEEeEEEeC---------------------------CeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHH
Q 010891 228 RHKNLVRLLGYCIEG---------------------------TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKIL 280 (498)
Q Consensus 228 ~hpnIv~l~~~~~~~---------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~ 280 (498)
+|||||++.++|.+. ..+|+||..++. +|..|+-. ...+......|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-----CCCchHHHHHHH
Confidence 599999999887632 236899988855 99999953 335666777899
Q ss_pred HHHHHHHHHHHHccCCCeeecCCCCCCEEE--cCCC--CeEEeeeccceecCCCC-----ceeeecccccccccCccccc
Q 010891 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILI--DENF--DAKISDFGLAKLLGAGK-----SHITTRVMGTFGYVAPEYAN 351 (498)
Q Consensus 281 ~~ia~aL~yLH~~~~~~iiHrDikp~NIll--~~~~--~~kL~DfGla~~~~~~~-----~~~~~~~~gt~~y~aPE~~~ 351 (498)
.|+++|+.|||.+ +|.|||+|++|||| ++|+ .+.|+|||++-.-.... ........|.-.-||||+..
T Consensus 348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 9999999999999 99999999999999 3333 47899999886432211 11122245788899999875
Q ss_pred CCCC------CccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHH
Q 010891 352 SGLL------NEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLT 425 (498)
Q Consensus 352 ~~~~------~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 425 (498)
..+- -.|+|.|+.|.+.||+++...||..... -..+... -+..--|.+...-+ ...+.+.
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe-m~L~~r~----------Yqe~qLPalp~~vp--p~~rqlV- 490 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE-MLLDTRT----------YQESQLPALPSRVP--PVARQLV- 490 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch-heechhh----------hhhhhCCCCcccCC--hHHHHHH-
Confidence 4321 1489999999999999999999964211 0111000 00101122221111 1222222
Q ss_pred HHHccCCCCCCCCCHHHHHHHHh
Q 010891 426 ALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 426 ~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
...|+.||.+|++..-....|+
T Consensus 491 -~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 491 -FDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred -HHHhcCCccccCCccHHHhHHH
Confidence 2579999999998765555444
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.9e-20 Score=187.22 Aligned_cols=217 Identities=27% Similarity=0.455 Sum_probs=159.4
Q ss_pred HHcCCCCCceEEEeEEEeCCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCC
Q 010891 224 IGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDI 303 (498)
Q Consensus 224 l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDi 303 (498)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.|.+.. ....+++.-...++++|+.||.|||.- +-..|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeee
Confidence 4578999999999999999999999999999999999975 234588888899999999999999976 23399999
Q ss_pred CCCCEEEcCCCCeEEeeeccceecCCC-CceeeecccccccccCcccccCC-------CCCccchHHHHHHHHHHHHhCC
Q 010891 304 KSSNILIDENFDAKISDFGLAKLLGAG-KSHITTRVMGTFGYVAPEYANSG-------LLNEKSDVYSFGVVLLEAITGR 375 (498)
Q Consensus 304 kp~NIll~~~~~~kL~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwSlGvvl~elltg~ 375 (498)
++.|++++....+||+|||+....... .........-..-|.|||.+.+. ..+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999999876421 00111112234569999998763 1466799999999999999999
Q ss_pred CCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 376 YPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 376 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
.||......... .+.+..... .....+.|.+.... .....++.++..||..+|.+||++.++-..++...
T Consensus 156 ~~~~~~~~~~~~--~eii~~~~~--~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 156 GPFDLRNLVEDP--DEIILRVKK--GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred CccccccccCCh--HHHHHHHHh--cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 999754332211 122222111 12333333333221 11224556666899999999999999988877654
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2e-19 Score=195.29 Aligned_cols=199 Identities=19% Similarity=0.253 Sum_probs=159.4
Q ss_pred HHHHHccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCC---CCCceEEEeEEEeCCe
Q 010891 168 DLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR---HKNLVRLLGYCIEGTQ 244 (498)
Q Consensus 168 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~ 244 (498)
+.+.-...|.+.+.||+|+||.||+|...+|+.||+|.-.+....+ |.--.+++.+|+ -+.|..+...+.-.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 4445566788899999999999999997789999999875544332 222234445554 3445555555556677
Q ss_pred eEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcC-------CCCeE
Q 010891 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE-------NFDAK 317 (498)
Q Consensus 245 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~-------~~~~k 317 (498)
.+||+||.+.|+|.+++. ..+.++|..++.++.|++.-+.+||.. +|||+||||+|+||.. ..-++
T Consensus 769 S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred ceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceE
Confidence 789999999999999997 446689999999999999999999999 9999999999999942 34599
Q ss_pred EeeeccceecCCC-CceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCC
Q 010891 318 ISDFGLAKLLGAG-KSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRY 376 (498)
Q Consensus 318 L~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~ 376 (498)
|+|||.+..+..- ........++|-.+-.+|+..+.+|+..+|.|.|+.+++-||.|++
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9999999765321 1134556789999999999999999999999999999999999974
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.2e-19 Score=172.63 Aligned_cols=142 Identities=17% Similarity=0.137 Sum_probs=111.3
Q ss_pred CCCccceEcccCcEEEEEEE--EcCCcEEEEEEecCCCCCc------------------------hhHHHHHHHHHHcCC
Q 010891 175 RFSKDNIIGDGGYGVVYRGQ--LMNGTAVAVKKLLNNPGQA------------------------DKDFRVEVEAIGHVR 228 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~------------------------~~~~~~E~~~l~~l~ 228 (498)
-|.+.+.||+|+||.||+|. ..+|+.||+|++....... ...+..|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47888999999999999997 5689999999986432110 012467999999997
Q ss_pred CC--CceEEEeEEEeCCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCC-eeecCCCC
Q 010891 229 HK--NLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK-VVHRDIKS 305 (498)
Q Consensus 229 hp--nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~-iiHrDikp 305 (498)
+. .+.+++++ ...++||||++|++|..++. ....+.......++.|++.+|.+||.. + ++||||||
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp 177 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL----KDVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE 177 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccc----ccCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence 53 33444443 23489999999988876542 223456667789999999999999999 9 99999999
Q ss_pred CCEEEcCCCCeEEeeeccceecC
Q 010891 306 SNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 306 ~NIll~~~~~~kL~DfGla~~~~ 328 (498)
+||+++ ++.++|+|||++....
T Consensus 178 ~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 178 YNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred hhEEEE-CCCEEEEEChhhhccC
Confidence 999999 8899999999987543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=8.9e-19 Score=164.16 Aligned_cols=134 Identities=20% Similarity=0.367 Sum_probs=113.4
Q ss_pred ceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCc--------hhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQA--------DKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
+.||+|++|.||+|.. +|..|++|+........ ...+..|+.++..+.|++|.....++.+....+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 77889999875433211 13467799999999999988777777777888999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecccee
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~ 326 (498)
++|++|.+++... .. ....++.+++.+|.+||.. +++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998632 12 7889999999999999999 999999999999999 78999999999864
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.78 E-value=6e-20 Score=183.82 Aligned_cols=124 Identities=28% Similarity=0.471 Sum_probs=108.4
Q ss_pred CeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeec
Q 010891 243 TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFG 322 (498)
Q Consensus 243 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfG 322 (498)
.++||.|++|.-.+|.++|.+.. .....++.....++.|++.|+.| + +.+|+|+||.||+...+..+||.|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhh
Confidence 35789999999999999997443 34557788899999999999999 6 89999999999999999999999999
Q ss_pred cceecCCCC-----ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh
Q 010891 323 LAKLLGAGK-----SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT 373 (498)
Q Consensus 323 la~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt 373 (498)
+........ ....+..+||.+||+||.+.+..|+.|+||||||+||+||+.
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 998765443 223455789999999999999999999999999999999998
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-18 Score=161.53 Aligned_cols=131 Identities=22% Similarity=0.405 Sum_probs=107.3
Q ss_pred eEcccCcEEEEEEEEcCCcEEEEEEecCCCCCc--------hhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeec
Q 010891 181 IIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQA--------DKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (498)
Q Consensus 181 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 252 (498)
.||+|+||.||+|.+ +|..|++|......... ...+.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999985 67889999875432211 144678999999999887665555556667779999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
+|++|.+++... .. .++.+++.+|.+||+. +++|+|++|.||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~----~~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEG----ND-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhc----HH-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999999987531 10 7899999999999999 999999999999999 789999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.1e-18 Score=183.96 Aligned_cols=141 Identities=21% Similarity=0.392 Sum_probs=114.0
Q ss_pred HHHccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCC-CC-------chhHHHHHHHHHHcCCCCCceEEEeEEEe
Q 010891 170 QSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNP-GQ-------ADKDFRVEVEAIGHVRHKNLVRLLGYCIE 241 (498)
Q Consensus 170 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~-------~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 241 (498)
......|...+.||+|+||+||+|.+.. ..+++|+..... .. ..+.+.+|++++..++|++|+..+.++.+
T Consensus 329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 407 (535)
T PRK09605 329 EEVKRRKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD 407 (535)
T ss_pred cccccccCccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence 3344556678999999999999998744 445555432211 11 12357789999999999999988888877
Q ss_pred CCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeee
Q 010891 242 GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDF 321 (498)
Q Consensus 242 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~Df 321 (498)
....++||||++|++|.+++. ....++.+++.+|.|||+. +++||||||+|||+ +++.++|+||
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDF 471 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDF 471 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeC
Confidence 778899999999999999884 3467899999999999999 99999999999999 5779999999
Q ss_pred ccceec
Q 010891 322 GLAKLL 327 (498)
Q Consensus 322 Gla~~~ 327 (498)
|+++..
T Consensus 472 Gla~~~ 477 (535)
T PRK09605 472 GLGKYS 477 (535)
T ss_pred cccccC
Confidence 999753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.8e-18 Score=159.27 Aligned_cols=145 Identities=19% Similarity=0.161 Sum_probs=112.2
Q ss_pred HHHHHccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCC----------------------chhHHHHHHHHHH
Q 010891 168 DLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQ----------------------ADKDFRVEVEAIG 225 (498)
Q Consensus 168 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~ 225 (498)
.+......|.+.+.||+|+||.||+|...+|+.||||++...... ....+..|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 334444458888999999999999998878999999987543210 0112566888999
Q ss_pred cCCCCC--ceEEEeEEEeCCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCC
Q 010891 226 HVRHKN--LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDI 303 (498)
Q Consensus 226 ~l~hpn--Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDi 303 (498)
.+.|++ +...++ ....++||||++|++|..+.. ......++.+++.++.++|.. +++||||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~----------~~~~~~~~~~i~~~l~~lh~~---gi~H~Dl 151 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV----------LEDPEEVLDEILEEIVKAYKH---GIIHGDL 151 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhccc----------cccHHHHHHHHHHHHHHHHHC---CCCcCCC
Confidence 888774 444443 244589999999999876542 034567889999999999998 9999999
Q ss_pred CCCCEEEcCCCCeEEeeeccceecCC
Q 010891 304 KSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 304 kp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+||++++++.++|+|||++.....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.5e-19 Score=187.48 Aligned_cols=167 Identities=28% Similarity=0.401 Sum_probs=124.0
Q ss_pred cCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeec
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 252 (498)
+.|..+++|..|+||.||..++. ..+.+|+| +.+.. .+.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~-----lilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN-----LILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccc-----hhhhc--cccccCCccee-------------------
Confidence 56788999999999999999754 46678874 42221 11111 33333444444
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~ 332 (498)
|+-...+. .-++++.+. +.+++|||+. +|+|||+||+|.+|+.-|++|++|||+++.......
T Consensus 136 --gDc~tllk----~~g~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 --GDCATLLK----NIGPLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred --chhhhhcc----cCCCCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 45555554 224455433 7789999999 999999999999999999999999999976321100
Q ss_pred --------------eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCc
Q 010891 333 --------------HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQ 384 (498)
Q Consensus 333 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~ 384 (498)
.....++||+.|.|||++....|+..+|+|++|+|+||.+.|..||.+..+.
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe 264 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE 264 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH
Confidence 0112368999999999999999999999999999999999999999876553
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.3e-17 Score=143.26 Aligned_cols=135 Identities=20% Similarity=0.176 Sum_probs=113.3
Q ss_pred ccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCC--CCceEEEeEEEeCCeeEEEEeecCCC
Q 010891 178 KDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRH--KNLVRLLGYCIEGTQRILVYEYVNNG 255 (498)
Q Consensus 178 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~~~~lv~e~~~~g 255 (498)
+.+.||.|.++.||++... +..+++|....... ...+..|+.++..++| .++.++++++...+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEec-CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 3568999999999999874 47899998754433 4568889999999976 58999999888888899999999887
Q ss_pred CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecccee
Q 010891 256 NLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (498)
Q Consensus 256 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~ 326 (498)
.+..+ +......++.+++++|++||.....+++|+|++|+||++++.+.++++|||.+..
T Consensus 79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 66543 4566678899999999999986444799999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.2e-16 Score=146.77 Aligned_cols=136 Identities=22% Similarity=0.261 Sum_probs=98.1
Q ss_pred cceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCch--hHH----------------------HHHHHHHHcCCCCC--c
Q 010891 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQAD--KDF----------------------RVEVEAIGHVRHKN--L 232 (498)
Q Consensus 179 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--~~~----------------------~~E~~~l~~l~hpn--I 232 (498)
.+.||+|+||+||+|...+|+.||||.+........ ..+ ..|...+..+.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 468999999999999877899999998865322111 111 24555666654432 4
Q ss_pred eEEEeEEEeCCeeEEEEeecCCCCHHHH-HhcccCCCCCCCHHHHHHHHHHHHHHHHHHHH-ccCCCeeecCCCCCCEEE
Q 010891 233 VRLLGYCIEGTQRILVYEYVNNGNLEQW-LRGDMCDRGYLTWEARMKILLGTAKALAYLHE-AIEPKVVHRDIKSSNILI 310 (498)
Q Consensus 233 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiHrDikp~NIll 310 (498)
.+.+++ ...++||||++++.+... +... .. ...+..++.+++.++.++|. . +|+|+||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-----~~-~~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-----RL-LEDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh-----hh-cccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence 444443 245899999999543221 1110 01 16678899999999999999 7 99999999999999
Q ss_pred cCCCCeEEeeeccceecC
Q 010891 311 DENFDAKISDFGLAKLLG 328 (498)
Q Consensus 311 ~~~~~~kL~DfGla~~~~ 328 (498)
+ ++.++|+|||.+....
T Consensus 149 ~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 149 D-DGKVYIIDVPQAVEID 165 (187)
T ss_pred E-CCcEEEEECccccccc
Confidence 9 8899999999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.4e-16 Score=149.20 Aligned_cols=135 Identities=20% Similarity=0.265 Sum_probs=105.3
Q ss_pred cceEc-ccCcEEEEEEEEcCCcEEEEEEecCCC-------------CCchhHHHHHHHHHHcCCCCCc--eEEEeEEEeC
Q 010891 179 DNIIG-DGGYGVVYRGQLMNGTAVAVKKLLNNP-------------GQADKDFRVEVEAIGHVRHKNL--VRLLGYCIEG 242 (498)
Q Consensus 179 ~~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~hpnI--v~l~~~~~~~ 242 (498)
...|| .||.|+||.+.. ++..++||.+.... ......+.+|++++..|.|++| +..+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35788 899999999977 47889999874311 1122457789999999998875 6777765443
Q ss_pred Ce----eEEEEeecCC-CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeE
Q 010891 243 TQ----RILVYEYVNN-GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAK 317 (498)
Q Consensus 243 ~~----~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~k 317 (498)
.. .++|||+++| .+|.+++.. ..++.. .+.+++.+|.+||.. ||+||||||.|||++.++.++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~ 182 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW 182 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence 22 2599999997 699998853 335543 367899999999999 999999999999999999999
Q ss_pred Eeeecccee
Q 010891 318 ISDFGLAKL 326 (498)
Q Consensus 318 L~DfGla~~ 326 (498)
|+|||.+..
T Consensus 183 LIDfg~~~~ 191 (239)
T PRK01723 183 LIDFDRGEL 191 (239)
T ss_pred EEECCCccc
Confidence 999999875
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.1e-17 Score=178.22 Aligned_cols=252 Identities=24% Similarity=0.319 Sum_probs=182.0
Q ss_pred CCCccceEcccCcEEEEEEEE--cCCcEEEEEEecCCC--CCchhHHHHHHHHHHcCC-CCCceEEEeEEEeCCeeEEEE
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL--MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVR-HKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~ 249 (498)
.|.+.+.||+|+|+.|-.... .....+|+|.+.... ....+....|..+-..+. |+|++.+++...+.+..++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 456677899999999988864 234456666554332 122233445777777776 999999999999999999999
Q ss_pred eecCCCCHHHHH-hcccCCCCCCCHHHHHHHHHHHHHHHHHHH-HccCCCeeecCCCCCCEEEcCCC-CeEEeeecccee
Q 010891 250 EYVNNGNLEQWL-RGDMCDRGYLTWEARMKILLGTAKALAYLH-EAIEPKVVHRDIKSSNILIDENF-DAKISDFGLAKL 326 (498)
Q Consensus 250 e~~~~g~L~~~l-~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH-~~~~~~iiHrDikp~NIll~~~~-~~kL~DfGla~~ 326 (498)
+|..|+++.+.+ +.. ....+...+-.++.|+..++.|+| .. ++.|+||||+|.+++..+ ..+++|||+|..
T Consensus 101 ~~s~g~~~f~~i~~~~---~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPD---STGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred CcccccccccccccCC---ccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999988 422 114566777889999999999999 77 999999999999999999 999999999988
Q ss_pred cCC--CCceeeecccc-cccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccc
Q 010891 327 LGA--GKSHITTRVMG-TFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRS 402 (498)
Q Consensus 327 ~~~--~~~~~~~~~~g-t~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (498)
+.. +........+| ++.|+|||...+ ....+..|+||.|+++.-+++|..||........ ....|...- ..
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~~~~~~~---~~- 249 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYSSWKSNK---GR- 249 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cceeecccc---cc-
Confidence 755 33334445678 999999998877 4556789999999999999999999975443221 111111100 00
Q ss_pred cCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 010891 403 EDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVV 444 (498)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell 444 (498)
.....+... ......+..+++..+|..|.+..++-
T Consensus 250 -----~~~~~~~~~--~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 250 -----FTQLPWNSI--SDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred -----cccCccccC--ChhhhhcccccccCCchhcccccccc
Confidence 001111111 12223333368889999999988775
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.54 E-value=2.4e-14 Score=148.05 Aligned_cols=141 Identities=22% Similarity=0.264 Sum_probs=101.0
Q ss_pred ceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCch------------------------------h----------HHHH
Q 010891 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQAD------------------------------K----------DFRV 219 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------------------------------~----------~~~~ 219 (498)
+.||.|++|.||+|++.+|+.||||+..+...... + +|..
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 57999999999999999999999999855421100 0 2344
Q ss_pred HHHHHHcC----CCCCceEEEeEEEe-CCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHH-HHHHHHHc
Q 010891 220 EVEAIGHV----RHKNLVRLLGYCIE-GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAK-ALAYLHEA 293 (498)
Q Consensus 220 E~~~l~~l----~hpnIv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~-aL~yLH~~ 293 (498)
|+..+.++ +|.+-+.+-.++.+ .+..+|||||++|++|.++..... ..+ ....++..++. .+..+|..
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHHHHHHhC
Confidence 55555544 33333444444432 355699999999999998765321 112 23456666665 46788988
Q ss_pred cCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 294 ~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
|++|+|++|.||++++++.++|+|||++..+..
T Consensus 277 ---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 ---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.7e-14 Score=136.60 Aligned_cols=207 Identities=23% Similarity=0.327 Sum_probs=143.7
Q ss_pred HHHHHHcCCCCCceEEEeEEEeC-----CeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHcc
Q 010891 220 EVEAIGHVRHKNLVRLLGYCIEG-----TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI 294 (498)
Q Consensus 220 E~~~l~~l~hpnIv~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~ 294 (498)
-..-|-.+.|-|||+++.|+.+. ....+++|||..|+|..||++.......+......+++.||+.||.|||+ +
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~ 195 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-C 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-c
Confidence 34455567899999999987654 34588999999999999998876667778888999999999999999998 6
Q ss_pred CCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc----eeeecccccccccCcccccCCCCCccchHHHHHHHHHH
Q 010891 295 EPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS----HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLE 370 (498)
Q Consensus 295 ~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~e 370 (498)
.|.|+|+++..+-|++..+|-+|+. .+-......... .......+-++|.|||.=.....+.++|||+||....|
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig-~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIG-SVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred CCccccCCcchhheeecCCceEEec-ccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 8999999999999999999888873 222111111100 00111246789999998766677789999999999999
Q ss_pred HHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 371 AITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 371 lltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
|..+..--..+....+. .+.+... ...... ...+.+ ..+|++..|..||+|.+++.|.
T Consensus 275 mailEiq~tnseS~~~~--ee~ia~~--i~~len-------------~lqr~~--i~kcl~~eP~~rp~ar~llfHp 332 (458)
T KOG1266|consen 275 MAILEIQSTNSESKVEV--EENIANV--IIGLEN-------------GLQRGS--ITKCLEGEPNGRPDARLLLFHP 332 (458)
T ss_pred HHHheeccCCCcceeeh--hhhhhhh--eeeccC-------------ccccCc--CcccccCCCCCCcchhhhhcCc
Confidence 99887543322211110 0000000 000000 011111 2279999999999999998654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.1e-14 Score=148.81 Aligned_cols=248 Identities=26% Similarity=0.309 Sum_probs=179.7
Q ss_pred cCCCccceEcc--cCcEEEEEEEE---cCCcEEEEEEecCCC--CCchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCee
Q 010891 174 NRFSKDNIIGD--GGYGVVYRGQL---MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQR 245 (498)
Q Consensus 174 ~~y~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 245 (498)
..|.+.+.+|. |.+|.||.++. .++..+|+|+-+... ......=.+|+...+.+ .|+|.++.+..+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 45677888999 99999999964 467889999743222 22233333466666666 599999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHH----HHHHHHHccCCCeeecCCCCCCEEEcCC-CCeEEee
Q 010891 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAK----ALAYLHEAIEPKVVHRDIKSSNILIDEN-FDAKISD 320 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~----aL~yLH~~~~~~iiHrDikp~NIll~~~-~~~kL~D 320 (498)
|+-+|++. .+|.++.+.. ...++....+.++.+... ||.++|+. +++|-|+||.||++..+ ...+++|
T Consensus 194 fiqtE~~~-~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred eeeecccc-chhHHhhhcc---cccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCC
Confidence 99999994 6899888742 234777888888888888 99999999 99999999999999999 8899999
Q ss_pred eccceecCCCCcee----eecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH
Q 010891 321 FGLAKLLGAGKSHI----TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMM 396 (498)
Q Consensus 321 fGla~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 396 (498)
||+...+....... .....|...|++||..++ .++.++|+|+||.++.+..++..++..+.... |.
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------W~--- 336 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSS------WS--- 336 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCC------cc---
Confidence 99999887654221 122357889999998874 57889999999999999999887765441111 10
Q ss_pred HhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 010891 397 VQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVR 445 (498)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~ 445 (498)
...... +. .++. ......+. .....+++.+|..|++++.+..
T Consensus 337 -~~r~~~-ip-~e~~-~~~s~~l~---~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 337 -QLRQGY-IP-LEFC-EGGSSSLR---SVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -cccccc-Cc-hhhh-cCcchhhh---hHHHHhcCcchhhhhHHHHHhc
Confidence 001100 00 0111 11111222 2445799999999999888764
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.45 E-value=2.5e-13 Score=142.24 Aligned_cols=147 Identities=16% Similarity=0.181 Sum_probs=99.1
Q ss_pred HccCCCccceEcccCcEEEEEEEEcC-CcEEEEEEecCCCCCc----------------------------------hh-
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQA----------------------------------DK- 215 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~- 215 (498)
....|.. +.||+|++|+||+|++.+ |+.||||++.+..... .+
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3445666 789999999999999877 9999999986542110 01
Q ss_pred -----HHHHHHHHHHcC----CCCCceEEEeEEEe-CCeeEEEEeecCCCCHHHHH--hcccCCCCCCCHHHHHHHHHHH
Q 010891 216 -----DFRVEVEAIGHV----RHKNLVRLLGYCIE-GTQRILVYEYVNNGNLEQWL--RGDMCDRGYLTWEARMKILLGT 283 (498)
Q Consensus 216 -----~~~~E~~~l~~l----~hpnIv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~l~~~~~~~i~~~i 283 (498)
+|.+|+..+.++ .+.+.+.+-.++++ ....+|||||++|+.|.++- .....+...+....+..++.|+
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 134455444444 35555655555554 46678999999999998753 2111011123333333344443
Q ss_pred HHHHHHHHHccCCCeeecCCCCCCEEEcCCC----CeEEeeeccceecCC
Q 010891 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENF----DAKISDFGLAKLLGA 329 (498)
Q Consensus 284 a~aL~yLH~~~~~~iiHrDikp~NIll~~~~----~~kL~DfGla~~~~~ 329 (498)
... |++|+|+||.||+++.++ .++++|||++..+..
T Consensus 277 -------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 -------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 345 999999999999999988 999999999987754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.42 E-value=6.6e-13 Score=119.68 Aligned_cols=130 Identities=18% Similarity=0.130 Sum_probs=95.9
Q ss_pred cceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCce-EEEeEEEeCCeeEEEEeecCCCCH
Q 010891 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLV-RLLGYCIEGTQRILVYEYVNNGNL 257 (498)
Q Consensus 179 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~l~~~~~~~~~~~lv~e~~~~g~L 257 (498)
.+.|+.|.++.||+++. .+..|++|....... ....+..|+.++..+.+.+++ +++.+. ....++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEE-CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 35789999999999986 478899998754322 223467899999988665544 455443 3345899999999877
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHcc--CCCeeecCCCCCCEEEcCCCCeEEeeeccce
Q 010891 258 EQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI--EPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (498)
Q Consensus 258 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~iiHrDikp~NIll~~~~~~kL~DfGla~ 325 (498)
.+.- .....++.+++++|+.||... ...++|+|++|.||+++ ++.++|+|||.+.
T Consensus 79 ~~~~------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 79 LTED------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccc------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 5420 111345778999999999872 12359999999999999 6689999999885
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.4e-12 Score=131.96 Aligned_cols=168 Identities=20% Similarity=0.250 Sum_probs=127.8
Q ss_pred EEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCCCCHHHHHhcccCCCCCCCH
Q 010891 194 QLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTW 273 (498)
Q Consensus 194 ~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~ 273 (498)
+..++.+|.|...............+-++.|+.++||||+++++.+......|||+|.+. .|..++.. +..
T Consensus 33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~ 103 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGK 103 (690)
T ss_pred eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHH
Confidence 355788888888866655333456778899999999999999999999999999999983 57777753 346
Q ss_pred HHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCceeeecccccccccCcccccCC
Q 010891 274 EARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSG 353 (498)
Q Consensus 274 ~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 353 (498)
......+.||+.||.|||..+ +++|++|.-.-|+|+..|..||++|-++........ ......---.|..|+.+...
T Consensus 104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCcc
Confidence 677778999999999999655 999999999999999999999999998875432111 00111112235666655433
Q ss_pred CCCccchHHHHHHHHHHHHhCC
Q 010891 354 LLNEKSDVYSFGVVLLEAITGR 375 (498)
Q Consensus 354 ~~~~~sDvwSlGvvl~elltg~ 375 (498)
. -..|.|-|||+++|++.|.
T Consensus 181 ~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred c--cchhhhhHHHHHHHHhCcc
Confidence 2 3469999999999999993
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.34 E-value=2.7e-11 Score=110.83 Aligned_cols=137 Identities=17% Similarity=0.179 Sum_probs=98.1
Q ss_pred cceEcccCcEEEEEEEEcC-------CcEEEEEEecCCC-------------C---------CchhHHH----HHHHHHH
Q 010891 179 DNIIGDGGYGVVYRGQLMN-------GTAVAVKKLLNNP-------------G---------QADKDFR----VEVEAIG 225 (498)
Q Consensus 179 ~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-------------~---------~~~~~~~----~E~~~l~ 225 (498)
...||.|--+.||.|...+ +..+|||...... . ...+.+. .|+..|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3579999999999997442 4789999763211 0 0011233 6999998
Q ss_pred cCCC--CCceEEEeEEEeCCeeEEEEeecCCCCHHH-HHhcccCCCCCCCHHHHHHHHHHHHHHHHHH-HHccCCCeeec
Q 010891 226 HVRH--KNLVRLLGYCIEGTQRILVYEYVNNGNLEQ-WLRGDMCDRGYLTWEARMKILLGTAKALAYL-HEAIEPKVVHR 301 (498)
Q Consensus 226 ~l~h--pnIv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yL-H~~~~~~iiHr 301 (498)
++.. -++..++++ ...+|||||+.+..+.. .|. ...++......+..+++.+|..| |.. +++|+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence 8843 345555554 45689999997654422 222 12355566778889999999999 887 99999
Q ss_pred CCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 302 DIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 302 Dikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
||++.|||+++ +.+.|+|||.+....
T Consensus 150 DLs~~NIL~~~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 150 DLSEYNMLWHD-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCHHHEEEEC-CcEEEEECCCceeCC
Confidence 99999999974 689999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.33 E-value=5.6e-13 Score=136.47 Aligned_cols=250 Identities=23% Similarity=0.237 Sum_probs=177.1
Q ss_pred HHHHccCCCccceEcccCcEEEEEEEE--cCCcEEEEEEecCCCCCchhHH--HHHHHHHHcC-CCCCceEEEeEEEeCC
Q 010891 169 LQSATNRFSKDNIIGDGGYGVVYRGQL--MNGTAVAVKKLLNNPGQADKDF--RVEVEAIGHV-RHKNLVRLLGYCIEGT 243 (498)
Q Consensus 169 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~--~~E~~~l~~l-~hpnIv~l~~~~~~~~ 243 (498)
......+|..+..||.|.|+.|+.... .++..|++|.+.+.......++ ..|+-+...+ .|.++++++..+....
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 344566788899999999999999853 5688899998876655544433 2356565555 6999999888888888
Q ss_pred eeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCC-CCeEEeeec
Q 010891 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN-FDAKISDFG 322 (498)
Q Consensus 244 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~-~~~kL~DfG 322 (498)
+.|+--||++++++...+. ....+.+...+.+..|++.++.++|+. .++|+|+||+||++..+ +..++.|||
T Consensus 340 ~~~ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~ 412 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFG 412 (524)
T ss_pred cccCchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccc
Confidence 8889999999998887763 223477788899999999999999998 99999999999999886 889999999
Q ss_pred cceecCCCCceeeecccccccc-cCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhcc
Q 010891 323 LAKLLGAGKSHITTRVMGTFGY-VAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRR 401 (498)
Q Consensus 323 la~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 401 (498)
++..+.-. ......++..| .+++......+..+.|+||||.-+.|.+++...-+... .|.
T Consensus 413 ~~t~~~~~---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~~-------- 473 (524)
T KOG0601|consen 413 CWTRLAFS---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QSL-------- 473 (524)
T ss_pred ccccccee---cccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------cce--------
Confidence 98642111 11111123334 35556677788899999999999999999874332111 111
Q ss_pred ccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 402 SEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
.+........+... .....++..+..+++..||.+.++..+..
T Consensus 474 --~i~~~~~p~~~~~~--~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 474 --TIRSGDTPNLPGLK--LQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred --eeecccccCCCchH--HhhhhhhhhhcCCccccchhhhhhcccch
Confidence 11111111112211 23333344688999999999998876554
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.28 E-value=5.8e-11 Score=104.64 Aligned_cols=143 Identities=19% Similarity=0.295 Sum_probs=107.4
Q ss_pred ccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCC--------chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 178 KDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQ--------ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 178 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
....|-+|+-+.|+++.+ .|+.+.||.-...... ..+...+|+++|.++.--.|.-..=++.+...-+|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 357899999999999977 6888888865332211 1234667999999986556655555566667778999
Q ss_pred eecCC-CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCC---CeEEeeeccce
Q 010891 250 EYVNN-GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF---DAKISDFGLAK 325 (498)
Q Consensus 250 e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~---~~kL~DfGla~ 325 (498)
||++| -++.+|+..... ..........++..|-+.+.-||.. +|||+||..+||+|..++ .+.|+|||++.
T Consensus 90 E~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence 99977 488999875532 1222333478899999999999999 999999999999996654 35899999987
Q ss_pred e
Q 010891 326 L 326 (498)
Q Consensus 326 ~ 326 (498)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 5
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.28 E-value=3.2e-11 Score=113.42 Aligned_cols=142 Identities=22% Similarity=0.269 Sum_probs=109.6
Q ss_pred ceEcccCcEEEEEEEEcCCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCC--CCceEEEeEEEeCC---eeEEEEeecC
Q 010891 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRH--KNLVRLLGYCIEGT---QRILVYEYVN 253 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~---~~~lv~e~~~ 253 (498)
+.|+.|.++.||++...+|..+++|....... .....+..|++++..+.+ .++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999876678999998754332 134568889999999965 34566777766532 5689999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHcc---------------------------------------
Q 010891 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI--------------------------------------- 294 (498)
Q Consensus 254 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--------------------------------------- 294 (498)
|.++.+.+. ...++..+...++.+++++|.+||+..
T Consensus 84 G~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLL-----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 988876542 134677788888889999999888521
Q ss_pred --------------CCCeeecCCCCCCEEEcC--CCCeEEeeecccee
Q 010891 295 --------------EPKVVHRDIKSSNILIDE--NFDAKISDFGLAKL 326 (498)
Q Consensus 295 --------------~~~iiHrDikp~NIll~~--~~~~kL~DfGla~~ 326 (498)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246799999999999998 56789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=7.6e-11 Score=104.42 Aligned_cols=131 Identities=24% Similarity=0.421 Sum_probs=99.4
Q ss_pred ceEcccCcEEEEEEEEcCCcEEEEEEecCCCCC---ch-----hHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQ---AD-----KDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~-----~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
..+++|+-+.+|.+.+. |..+++|.-.++... .. ...++|+.++.+++--.|.-.+=++.+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 36889999999999764 455777755333211 11 2345699999988655555444455667777899999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecccee
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~ 326 (498)
++|..|.+++... ...++..|-.-+.-||.. +|+|+||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999998632 245777788888899999 999999999999998774 99999999974
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=4.9e-12 Score=136.10 Aligned_cols=204 Identities=25% Similarity=0.298 Sum_probs=149.6
Q ss_pred CCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC---CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
.+.+.+-+-+|.++.++.+.- ..|...+.|...... ....+..+.+-.++-..+||-++.....+......+|+++
T Consensus 805 ~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~ 884 (1205)
T KOG0606|consen 805 GFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGH 884 (1205)
T ss_pred cceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhH
Confidence 455666788999999998852 234333333321111 1122333444455555567877776666666778899999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
|+.+++|...|+.. +.++.+.+...+..+..+++|||.. .+.|+|++|.|+|+..++..+++|||.....+.-
T Consensus 885 ~~~~~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 885 YLNGGDLPSKLHNS----GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLI 957 (1205)
T ss_pred HhccCCchhhhhcC----CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccc
Confidence 99999999999843 4566667777788889999999997 7999999999999999999999999844321100
Q ss_pred ---------------------C---------ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCC
Q 010891 331 ---------------------K---------SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDY 380 (498)
Q Consensus 331 ---------------------~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~ 380 (498)
. ........||+.|.+||.+.+......+|+|++|++++|.++|..||..
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCC
Confidence 0 0012235799999999999998889999999999999999999999987
Q ss_pred CCCcc
Q 010891 381 GRPQS 385 (498)
Q Consensus 381 ~~~~~ 385 (498)
..++.
T Consensus 1038 ~tpq~ 1042 (1205)
T KOG0606|consen 1038 ETPQQ 1042 (1205)
T ss_pred cchhh
Confidence 76654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=4.5e-09 Score=103.49 Aligned_cols=193 Identities=16% Similarity=0.179 Sum_probs=131.2
Q ss_pred ccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcC-CCCCceEEEeE------EEeC-CeeEEEE
Q 010891 178 KDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGY------CIEG-TQRILVY 249 (498)
Q Consensus 178 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~------~~~~-~~~~lv~ 249 (498)
.++-||+|+-+.+|..-- -...+.|+..........+. +..|... .||-+-.-+.+ .-+. ...-++|
T Consensus 15 ~gr~LgqGgea~ly~l~e--~~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLGE--VRDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecch--hhchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 456899999999997532 12235576654433322222 2333333 56644331111 0112 2256788
Q ss_pred eecCCC-CHHHHHhc--ccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecccee
Q 010891 250 EYVNNG-NLEQWLRG--DMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (498)
Q Consensus 250 e~~~~g-~L~~~l~~--~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~ 326 (498)
+.+.|. ...+++.- .+..-....|+..++.+..++.+.+-||.. |..-+|++++|+|+++++.+.|.|-..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccceee
Confidence 888774 34444421 122334578999999999999999999999 999999999999999999999998765554
Q ss_pred cCCCCceeeecccccccccCccccc-----CCCCCccchHHHHHHHHHHHHhC-CCCCCC
Q 010891 327 LGAGKSHITTRVMGTFGYVAPEYAN-----SGLLNEKSDVYSFGVVLLEAITG-RYPVDY 380 (498)
Q Consensus 327 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg-~~P~~~ 380 (498)
..++. .....+|...|.+||.-. +..-+...|.|.||+++++++.| ++||.+
T Consensus 167 ~~ng~--~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG 224 (637)
T COG4248 167 NANGT--LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG 224 (637)
T ss_pred ccCCc--eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence 33322 233467999999999654 23446678999999999999997 999964
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.05 E-value=3.5e-09 Score=102.29 Aligned_cols=142 Identities=13% Similarity=0.097 Sum_probs=100.8
Q ss_pred cceEcccCcEEEEEEEEcCCcEEEEEEecCCCCC-----------chhHHHHHHHHHHcCCCCCc--eEEEeEEEe----
Q 010891 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQ-----------ADKDFRVEVEAIGHVRHKNL--VRLLGYCIE---- 241 (498)
Q Consensus 179 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~hpnI--v~l~~~~~~---- 241 (498)
++.+-......|++..+ +|+.|.||........ ....+.+|...+.+|..-+| ..+++++..
T Consensus 27 ~e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 27 GEVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred CcEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 35566555666777765 7889999977432211 01136678888877743222 233444432
Q ss_pred -CCeeEEEEeecCCC-CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcC-------
Q 010891 242 -GTQRILVYEYVNNG-NLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE------- 312 (498)
Q Consensus 242 -~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~------- 312 (498)
....+||||++++. +|.+++.... ....+......++.+++..+.-||.. ||+|+|+++.|||++.
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCC
Confidence 23468999999885 8999985321 23455677789999999999999999 9999999999999975
Q ss_pred CCCeEEeeecccee
Q 010891 313 NFDAKISDFGLAKL 326 (498)
Q Consensus 313 ~~~~kL~DfGla~~ 326 (498)
++.+.|+||+.+..
T Consensus 181 ~~~~~LIDl~r~~~ 194 (268)
T PRK15123 181 DLKLSVIDLHRAQI 194 (268)
T ss_pred CceEEEEECCcccc
Confidence 46899999998864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.02 E-value=4.8e-09 Score=105.81 Aligned_cols=170 Identities=21% Similarity=0.268 Sum_probs=130.2
Q ss_pred CcEEEEEEE-EcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEe----CCeeEEEEeecCC-CCHHH
Q 010891 186 GYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIE----GTQRILVYEYVNN-GNLEQ 259 (498)
Q Consensus 186 ~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~~lv~e~~~~-g~L~~ 259 (498)
--.+.|++. ..+|..|++|++.....+.....-.-+++++++.|+|||++.++|.. +..+++||+|.++ ++|.+
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 345789996 56899999999954443333333346789999999999999998873 4567999999987 67887
Q ss_pred HHhccc-----------CCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 260 WLRGDM-----------CDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 260 ~l~~~~-----------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
+--... .++...++...|.++.|+..||.++|+. |+.-+-|.+.+||++.+.+++|+..|....+.
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence 652211 1234577899999999999999999999 99999999999999999999999999887765
Q ss_pred CCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRY 376 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~ 376 (498)
.+.. |.+.+ -.+-|.=-||.+++.|.||..
T Consensus 445 ~d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 445 EDPT---------------EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCCC---------------cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 4331 11111 135699999999999999954
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.98 E-value=4.7e-09 Score=95.71 Aligned_cols=126 Identities=25% Similarity=0.306 Sum_probs=82.2
Q ss_pred EEEEEEEcCCcEEEEEEecCCCC---------------------Cch-----hHHHHHHHHHHcCCCC--CceEEEeEEE
Q 010891 189 VVYRGQLMNGTAVAVKKLLNNPG---------------------QAD-----KDFRVEVEAIGHVRHK--NLVRLLGYCI 240 (498)
Q Consensus 189 ~Vy~~~~~~~~~vavK~~~~~~~---------------------~~~-----~~~~~E~~~l~~l~hp--nIv~l~~~~~ 240 (498)
.||.|...+|..+|+|....... ... ....+|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 48999888899999998632110 001 1245699999999765 455565442
Q ss_pred eCCeeEEEEeecC--CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHH-HHHccCCCeeecCCCCCCEEEcCCCCeE
Q 010891 241 EGTQRILVYEYVN--NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY-LHEAIEPKVVHRDIKSSNILIDENFDAK 317 (498)
Q Consensus 241 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~y-LH~~~~~~iiHrDikp~NIll~~~~~~k 317 (498)
..+|||||++ |..+..+.... ++.+....++.+++..+.. +|.. ||+|+||.+.|||++++ .+.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence 3479999998 65554433311 1134456677788886665 5677 99999999999999988 999
Q ss_pred EeeeccceecC
Q 010891 318 ISDFGLAKLLG 328 (498)
Q Consensus 318 L~DfGla~~~~ 328 (498)
|+|||.+....
T Consensus 147 iIDf~qav~~~ 157 (188)
T PF01163_consen 147 IIDFGQAVDSS 157 (188)
T ss_dssp E--GTTEEETT
T ss_pred EEecCcceecC
Confidence 99999998654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.87 E-value=7.3e-08 Score=88.54 Aligned_cols=138 Identities=17% Similarity=0.161 Sum_probs=102.6
Q ss_pred EcccCcEEEEEEEEcCCcEEEEEEecCCC------CCchhHHHHHHHHHHcCCCC--CceEEEeEEE---eC--CeeEEE
Q 010891 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNP------GQADKDFRVEVEAIGHVRHK--NLVRLLGYCI---EG--TQRILV 248 (498)
Q Consensus 182 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~hp--nIv~l~~~~~---~~--~~~~lv 248 (498)
-|+||.+-|+.-.. +|..+.+|+-.... +.....|.+|+..|.+|..- .+.+++ ++. .+ ...+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 56689999999766 55679999864211 22446789999999988432 244444 332 11 235899
Q ss_pred EeecCC-CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCC--eEEeeeccce
Q 010891 249 YEYVNN-GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD--AKISDFGLAK 325 (498)
Q Consensus 249 ~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~--~kL~DfGla~ 325 (498)
+|-++| -+|.+++... ...+.+...+..++.+++.++.-||.. |+.|+|+.+.|||++.++. ++++||--++
T Consensus 104 Te~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 998865 5899998643 123457777889999999999999999 9999999999999986667 9999998766
Q ss_pred e
Q 010891 326 L 326 (498)
Q Consensus 326 ~ 326 (498)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 4
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.80 E-value=6.7e-08 Score=90.11 Aligned_cols=124 Identities=22% Similarity=0.242 Sum_probs=89.4
Q ss_pred CCcEEEEEEecCCCC-------CchhHHHHHHHHHHcCCCCC--ceEEEeEEEeC----CeeEEEEeecCC-CCHHHHHh
Q 010891 197 NGTAVAVKKLLNNPG-------QADKDFRVEVEAIGHVRHKN--LVRLLGYCIEG----TQRILVYEYVNN-GNLEQWLR 262 (498)
Q Consensus 197 ~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~hpn--Iv~l~~~~~~~----~~~~lv~e~~~~-g~L~~~l~ 262 (498)
.++.+.+|....... -......+|...+..|..-+ ....+++.... ...+||+|++++ .+|.+++.
T Consensus 31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~ 110 (206)
T PF06293_consen 31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ 110 (206)
T ss_pred cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence 456667765432111 12334667888777764322 33455555442 234899999988 48999997
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCC---CeEEeeeccceec
Q 010891 263 GDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF---DAKISDFGLAKLL 327 (498)
Q Consensus 263 ~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~---~~kL~DfGla~~~ 327 (498)
.. ..++......++.+++..+.-||.. ||+|+|+++.|||++.++ .+.|+||+-++..
T Consensus 111 ~~----~~~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 111 QW----EQLDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hh----cccchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 42 1256677889999999999999999 999999999999999887 8999999988753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.79 E-value=3.7e-08 Score=92.62 Aligned_cols=135 Identities=23% Similarity=0.204 Sum_probs=96.8
Q ss_pred CCccceEcccCcEEEEEEEEcCCcEEEEEEecCCC-----------------CCc-----hhHHHHHHHHHHcCCCC--C
Q 010891 176 FSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNP-----------------GQA-----DKDFRVEVEAIGHVRHK--N 231 (498)
Q Consensus 176 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------------~~~-----~~~~~~E~~~l~~l~hp--n 231 (498)
+.++..||.|--+.||.|....|.++|||.-.... ..+ .....+|.++|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45678999999999999998899999999531110 001 12245799999998654 5
Q ss_pred ceEEEeEEEeCCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEc
Q 010891 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID 311 (498)
Q Consensus 232 Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~ 311 (498)
+.+.+++ +.-.+||||++|-.|...- +..+..-.++..|++-+.-+-.. ||+|+|+++-||+++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVT 236 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEe
Confidence 6666553 4558999999996665421 22333444555555555555566 999999999999999
Q ss_pred CCCCeEEeeecccee
Q 010891 312 ENFDAKISDFGLAKL 326 (498)
Q Consensus 312 ~~~~~kL~DfGla~~ 326 (498)
++|.+.++||--+..
T Consensus 237 ~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 237 EDGDIVVIDWPQAVP 251 (304)
T ss_pred cCCCEEEEeCccccc
Confidence 999999999976654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.71 E-value=4e-09 Score=110.01 Aligned_cols=151 Identities=23% Similarity=0.319 Sum_probs=98.2
Q ss_pred HHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCceeeec--------ccccccccCccccc
Q 010891 280 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR--------VMGTFGYVAPEYAN 351 (498)
Q Consensus 280 ~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~--------~~gt~~y~aPE~~~ 351 (498)
+.+++.|+.|+|.. +++||++|.|++|.++.++..||+.|+++.....+....... ..-...|.|||++.
T Consensus 105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 34455899999965 599999999999999999999999999987654422111111 12456799999999
Q ss_pred CCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHcc
Q 010891 352 SGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCV 430 (498)
Q Consensus 352 ~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl 430 (498)
+...+.++|+|||||++|-+.. |+.-+.............. ....... -....-++++.. -+.+++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~------~~~~~~~----~~s~~~p~el~~---~l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN------LLNAGAF----GYSNNLPSELRE---SLKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc------ccccccc----cccccCcHHHHH---HHHHHh
Confidence 9888999999999999999995 4444433221111110000 0000000 000112223333 334689
Q ss_pred CCCCCCCCCHHHHHH
Q 010891 431 DPDSDKRPKMSQVVR 445 (498)
Q Consensus 431 ~~dP~~RPt~~ell~ 445 (498)
..++.-||++.+++.
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998877764
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.59 E-value=8.7e-07 Score=81.81 Aligned_cols=139 Identities=14% Similarity=0.189 Sum_probs=93.8
Q ss_pred HHccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHH---------HHHHHHHHcCCC---CCceEEEeE
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDF---------RVEVEAIGHVRH---KNLVRLLGY 238 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~h---pnIv~l~~~ 238 (498)
...++|...+++-.....-|.+-.. +|+.+++|..........+.| .+.+..+.+++. -.+..++-+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 4567888888888888777877766 678899998755433222222 234444444432 222232222
Q ss_pred EE-----eCCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCC
Q 010891 239 CI-----EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN 313 (498)
Q Consensus 239 ~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~ 313 (498)
.. -....+++|||++|..|.++.. ++. .++..+.+++.-||.. |+.|+|..|.|++++++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC
Confidence 22 2244568999999988876542 222 2456677789999999 99999999999999966
Q ss_pred CCeEEeeecccee
Q 010891 314 FDAKISDFGLAKL 326 (498)
Q Consensus 314 ~~~kL~DfGla~~ 326 (498)
.++++||+..+.
T Consensus 172 -~i~iID~~~k~~ 183 (229)
T PF06176_consen 172 -GIRIIDTQGKRM 183 (229)
T ss_pred -cEEEEECccccc
Confidence 599999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.59 E-value=8.4e-07 Score=83.87 Aligned_cols=140 Identities=17% Similarity=0.173 Sum_probs=84.8
Q ss_pred ceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCC--ceEEEeEEEeCCeeEEEEeecCCCC-
Q 010891 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN--LVRLLGYCIEGTQRILVYEYVNNGN- 256 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~~~~~~~~~lv~e~~~~g~- 256 (498)
..||.|..+.||+. .|..+++|...... ......+|.+++..+..-+ +.+.+++..+.+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 47999999999984 25567788764322 3445788999998885433 4567777777777889999999863
Q ss_pred HHHHHh--------------c-----ccCCCCCCCHHHHH-HHHHH----------HHH-HHHHHHHc-cCCCeeecCCC
Q 010891 257 LEQWLR--------------G-----DMCDRGYLTWEARM-KILLG----------TAK-ALAYLHEA-IEPKVVHRDIK 304 (498)
Q Consensus 257 L~~~l~--------------~-----~~~~~~~l~~~~~~-~i~~~----------ia~-aL~yLH~~-~~~~iiHrDik 304 (498)
+...+. . +............. .+..+ +.. ...+|... ..+.++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 221110 0 00000011111100 01000 011 12222211 13467899999
Q ss_pred CCCEEEcCCCCeEEeeeccce
Q 010891 305 SSNILIDENFDAKISDFGLAK 325 (498)
Q Consensus 305 p~NIll~~~~~~kL~DfGla~ 325 (498)
|.||++++++ +.|+||+.+.
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCcEEEcCCC-cEEEechhcC
Confidence 9999999988 9999999875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.57 E-value=2.3e-07 Score=97.06 Aligned_cols=141 Identities=21% Similarity=0.226 Sum_probs=94.0
Q ss_pred ceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCc------------------------------hh----------HHHH
Q 010891 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQA------------------------------DK----------DFRV 219 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------------------------------~~----------~~~~ 219 (498)
+-|+.++-|.||+|++.+|+.||||+..++-... .+ ++..
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5799999999999999999999999875432110 01 1334
Q ss_pred HHHHHHcC----CCCCceEEEeEEEe-CCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHH-HHHHHHc
Q 010891 220 EVEAIGHV----RHKNLVRLLGYCIE-GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKA-LAYLHEA 293 (498)
Q Consensus 220 E~~~l~~l----~hpnIv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~a-L~yLH~~ 293 (498)
|+.-+.++ +...-+.+=.++++ .+...|+|||++|-.+.+..... . ..++... ++..++++ +..+-..
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~--~-~g~d~k~---ia~~~~~~f~~q~~~d 284 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK--S-AGIDRKE---LAELLVRAFLRQLLRD 284 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH--h-cCCCHHH---HHHHHHHHHHHHHHhc
Confidence 55555544 23333444455554 46668999999998888874321 1 2233222 33333222 2222224
Q ss_pred cCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 294 ~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
|++|.|..|.||+++.+|.+.+.|||+...+..
T Consensus 285 ---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 285 ---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 999999999999999999999999999987654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.49 E-value=2.7e-06 Score=79.44 Aligned_cols=153 Identities=20% Similarity=0.225 Sum_probs=101.5
Q ss_pred ccHHHHHHHccCCCccce---EcccCcEEEEEEEEcCCcEEEEEEecCCCCCc-------------------hhH-----
Q 010891 164 FTLRDLQSATNRFSKDNI---IGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQA-------------------DKD----- 216 (498)
Q Consensus 164 ~~~~~~~~~~~~y~~~~~---lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-------------------~~~----- 216 (498)
.++..+....++..+... |+.|--+.||+|...++..+|+|++....... .+.
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 456667777777776655 55667779999987789999999884322111 111
Q ss_pred HHHHHHHHHcCC--CCCceEEEeEEEeCCeeEEEEeecCCC-CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHc
Q 010891 217 FRVEVEAIGHVR--HKNLVRLLGYCIEGTQRILVYEYVNNG-NLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEA 293 (498)
Q Consensus 217 ~~~E~~~l~~l~--hpnIv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~ 293 (498)
...|+.-|.++. +=.+.+-+++. +..|||||+... .-.-.| ..-.+..++...+..++++.+.-|-..
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~L-----kDv~~e~~e~~~~~~~~v~~~~~l~~~ 185 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRL-----KDVPLELEEAEGLYEDVVEYMRRLYKE 185 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCc-----ccCCcCchhHHHHHHHHHHHHHHHHHh
Confidence 134666666662 22333344432 346999999553 111111 122234446778888888888888762
Q ss_pred cCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 294 ~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
+ +++|+||..-|||+. ++.+.|+|||-|....
T Consensus 186 a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 186 A--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred c--CcccccchhhheEEE-CCeEEEEECccccccC
Confidence 2 999999999999999 7799999999987654
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.4e-08 Score=104.78 Aligned_cols=190 Identities=20% Similarity=0.136 Sum_probs=136.4
Q ss_pred HccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCC-ceEEEeEEEeCCeeEEEEe
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN-LVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~~~~lv~e 250 (498)
.+..+....-+++|+++.+++.+..-.+....+.+... ...+-++++|.+++||| .+..++-++.+...+++++
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 34444555678999999999987433333334444322 44566899999999999 7777777777788899999
Q ss_pred ecCCC-CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 251 YVNNG-NLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 251 ~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
++.++ +-..-... ....+...+...+...-+++++|||+. .-+|+| ||+..+ +..+..||+....+..
T Consensus 315 i~s~~rs~~~~~~~---se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~ 383 (829)
T KOG0576|consen 315 ICSTGRSSALEMTV---SEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDFAVPPQLTR 383 (829)
T ss_pred hhcCCccccccCCh---hhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccccCCcccCc
Confidence 99887 22111100 111233444556677778899999986 568998 888776 5899999999887654
Q ss_pred CCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVD 379 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~ 379 (498)
.. ......+|+.|+|||+.....+..+.|+|++|+--.+|--|-.|-.
T Consensus 384 ~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 384 TM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 32 2344679999999999999999999999999987777777766643
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.43 E-value=2.8e-06 Score=80.26 Aligned_cols=145 Identities=20% Similarity=0.199 Sum_probs=85.1
Q ss_pred cceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCC--CceEEEeEEEe---CCeeEEEEeecC
Q 010891 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHK--NLVRLLGYCIE---GTQRILVYEYVN 253 (498)
Q Consensus 179 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp--nIv~l~~~~~~---~~~~~lv~e~~~ 253 (498)
++.|+.|..+.||+....+ ..+++|..... .....+..|..++..+... .+.+++.+... ....+++|++++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3579999999999998866 68999986443 3446677898888887433 34566664433 234689999999
Q ss_pred CCCHHH----------------HH---hcccCCCCCCCHHHH--HH-------H------------HHHHHH-HHHHHHH
Q 010891 254 NGNLEQ----------------WL---RGDMCDRGYLTWEAR--MK-------I------------LLGTAK-ALAYLHE 292 (498)
Q Consensus 254 ~g~L~~----------------~l---~~~~~~~~~l~~~~~--~~-------i------------~~~ia~-aL~yLH~ 292 (498)
|..+.. ++ +........+..... .. . ...+.. .+..++.
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 11 111001111111100 00 0 112222 3334443
Q ss_pred c----cCCCeeecCCCCCCEEEc-CCCCeEEeeecccee
Q 010891 293 A----IEPKVVHRDIKSSNILID-ENFDAKISDFGLAKL 326 (498)
Q Consensus 293 ~----~~~~iiHrDikp~NIll~-~~~~~kL~DfGla~~ 326 (498)
. ....++|+|+.|.|||++ +++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2 234799999999999999 666678999998753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.32 E-value=7.4e-06 Score=78.41 Aligned_cols=141 Identities=16% Similarity=0.144 Sum_probs=85.0
Q ss_pred eEcccCc-EEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCC-CCCceEEEeEEEeCCeeEEEEeecCCCCHH
Q 010891 181 IIGDGGY-GVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-HKNLVRLLGYCIEGTQRILVYEYVNNGNLE 258 (498)
Q Consensus 181 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~ 258 (498)
.|..|.. ..||+... ++..+++|...... ...+..|+++++.+. +--+.+++++...++..++|||+++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~-~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDG-KNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcC-CCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4555665 78999965 35678888764332 345677998888873 444557777777666789999999997776
Q ss_pred HHH-------------------hcccCCCCCCCH--HHHHHHHH--------------------HHHHHHHHHHHc----
Q 010891 259 QWL-------------------RGDMCDRGYLTW--EARMKILL--------------------GTAKALAYLHEA---- 293 (498)
Q Consensus 259 ~~l-------------------~~~~~~~~~l~~--~~~~~i~~--------------------~ia~aL~yLH~~---- 293 (498)
... +.......++.. .....-.. .+...+..|-..
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 431 111000111110 00000000 011112222111
Q ss_pred cCCCeeecCCCCCCEEEcCCCCeEEeeeccce
Q 010891 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (498)
Q Consensus 294 ~~~~iiHrDikp~NIll~~~~~~kL~DfGla~ 325 (498)
..+.++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 13569999999999999998778899999775
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.28 E-value=2.1e-05 Score=72.36 Aligned_cols=128 Identities=20% Similarity=0.313 Sum_probs=92.9
Q ss_pred cceEcccCcEEEEEEEEcCCcEEEEEEecCCC----------------CCchhHHHHHHHHHHcCC------CCCceEEE
Q 010891 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNP----------------GQADKDFRVEVEAIGHVR------HKNLVRLL 236 (498)
Q Consensus 179 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------hpnIv~l~ 236 (498)
...||+|+.-.||. +.+.....||+..... ....+++++|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 45799999999998 4455667888876554 122355667777666665 88999999
Q ss_pred eEEEeCCeeEEEEeecCC------CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEE
Q 010891 237 GYCIEGTQRILVYEYVNN------GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI 310 (498)
Q Consensus 237 ~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll 310 (498)
|+.+++...-+|+|.+.+ .+|.+++.. +.++. .+...+-+-..||-.. +|+.+|++|.||++
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-----~~~~~----~~~~~L~~f~~~l~~~---~Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKE-----GGLTE----ELRQALDEFKRYLLDH---HIVIRDLNPHNIVV 151 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHc-----CCccH----HHHHHHHHHHHHHHHc---CCeecCCCcccEEE
Confidence 999999999999998743 278888843 33544 3333444556677777 99999999999999
Q ss_pred cCCC----CeEEee
Q 010891 311 DENF----DAKISD 320 (498)
Q Consensus 311 ~~~~----~~kL~D 320 (498)
.... .+.|+|
T Consensus 152 ~~~~~~~~~lvlID 165 (199)
T PF10707_consen 152 QRRDSGEFRLVLID 165 (199)
T ss_pred EecCCCceEEEEEe
Confidence 5432 477777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.26 E-value=3.4e-05 Score=70.54 Aligned_cols=125 Identities=24% Similarity=0.400 Sum_probs=89.3
Q ss_pred cCCCccceEcccCc-EEEEEEEEcCCcEEEEEEecC---CCC------------------CchhHHHHHHHHHHcCC---
Q 010891 174 NRFSKDNIIGDGGY-GVVYRGQLMNGTAVAVKKLLN---NPG------------------QADKDFRVEVEAIGHVR--- 228 (498)
Q Consensus 174 ~~y~~~~~lg~G~~-g~Vy~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~~l~~l~--- 228 (498)
..++.++.||.|.- |.||+++. +|+.+|+|.+.. ... .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888999999999 99999987 688999998421 000 01124677888877774
Q ss_pred CCCc--eEEEeEEEeC------------------CeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHH
Q 010891 229 HKNL--VRLLGYCIEG------------------TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALA 288 (498)
Q Consensus 229 hpnI--v~l~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~ 288 (498)
+.++ |+.+||..-. ....||.||++... .+.. .-+.+|.+-|.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~----~~~~~~~~dl~ 178 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQI----RDIPQMLRDLK 178 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccch----hHHHHHHHHHH
Confidence 5566 8999987422 11257788776532 1222 33556667788
Q ss_pred HHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccc
Q 010891 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (498)
Q Consensus 289 yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla 324 (498)
.+|.. +|+-+|+++.|.. .-||+|||.+
T Consensus 179 ~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence 89998 9999999999987 4689999864
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.20 E-value=1.8e-05 Score=89.03 Aligned_cols=148 Identities=16% Similarity=0.244 Sum_probs=91.5
Q ss_pred cceEcccCcEEEEEEEEcCC---cEEEEEEecCCCC-CchhHHHHHHHHHHcCC-CCCc--eEEEeEEEeC---CeeEEE
Q 010891 179 DNIIGDGGYGVVYRGQLMNG---TAVAVKKLLNNPG-QADKDFRVEVEAIGHVR-HKNL--VRLLGYCIEG---TQRILV 248 (498)
Q Consensus 179 ~~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-hpnI--v~l~~~~~~~---~~~~lv 248 (498)
.+.|+.|.+..+|+....++ ..+++|+...... .....+.+|+++|+.+. |+++ .+++.+|.+. ...|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999876554 3677776543221 23356889999999995 6665 7788887664 457899
Q ss_pred EeecCCCCHHH--------------------H---HhcccCC-------CCCCCH--HHHHHHH---------------H
Q 010891 249 YEYVNNGNLEQ--------------------W---LRGDMCD-------RGYLTW--EARMKIL---------------L 281 (498)
Q Consensus 249 ~e~~~~g~L~~--------------------~---l~~~~~~-------~~~l~~--~~~~~i~---------------~ 281 (498)
|||++|..+.+ . ||..... ..+..+ .+...+. -
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99998854321 1 1111000 001111 1111111 1
Q ss_pred HHHHHHHHHHHccC--------CCeeecCCCCCCEEEcCC-CC-eEEeeecccee
Q 010891 282 GTAKALAYLHEAIE--------PKVVHRDIKSSNILIDEN-FD-AKISDFGLAKL 326 (498)
Q Consensus 282 ~ia~aL~yLH~~~~--------~~iiHrDikp~NIll~~~-~~-~kL~DfGla~~ 326 (498)
.+...+.+|..+.. +.+||+|+++.|||++.+ +. .-|.||.++..
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 12334566654331 359999999999999853 33 57999998865
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.18 E-value=1.3e-05 Score=71.03 Aligned_cols=129 Identities=19% Similarity=0.274 Sum_probs=90.2
Q ss_pred CccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCce-EEEeEEEeCCeeEEEEeecCCC
Q 010891 177 SKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLV-RLLGYCIEGTQRILVYEYVNNG 255 (498)
Q Consensus 177 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~l~~~~~~~~~~~lv~e~~~~g 255 (498)
...+.|++|.+|.||+|.+ .|..+|+|+-..+. ....+..|+++|..+.-.++. ++|.|.. .++.|||++|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~-~~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEW-RGGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeec-cCceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCc
Confidence 3467899999999999988 45688999764432 346688899999999776665 4555432 34669999998
Q ss_pred CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCC-CCCEEEcCCCCeEEeeecccee
Q 010891 256 NLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIK-SSNILIDENFDAKISDFGLAKL 326 (498)
Q Consensus 256 ~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDik-p~NIll~~~~~~kL~DfGla~~ 326 (498)
.|.+.-... + .+-+..++++---|-.. ||-|+.|. |..++|..++.+.|+||.-|..
T Consensus 98 ~L~~~~~~~-------~----rk~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIGG-------D----RKHLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhcc-------c----HHHHHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 887765321 1 22334455554445555 99999987 4444454555999999998874
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.17 E-value=8.5e-06 Score=85.17 Aligned_cols=142 Identities=23% Similarity=0.283 Sum_probs=89.6
Q ss_pred ceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCc---------------------------hh----------HHHHHHH
Q 010891 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQA---------------------------DK----------DFRVEVE 222 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---------------------------~~----------~~~~E~~ 222 (498)
+-||.-+.|.||+|++.+|+.||||+-.+.-... .+ +|..|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5799999999999999999999999864432111 00 1334444
Q ss_pred HHHc----CCCCC---ceEEEeEEEe-CCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHcc
Q 010891 223 AIGH----VRHKN---LVRLLGYCIE-GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI 294 (498)
Q Consensus 223 ~l~~----l~hpn---Iv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~ 294 (498)
-..+ +.|-+ -|.+=.++++ .....|+||||+|..+.|.-.- ....++...+.. .+.++ |++...
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~i~~---~l~~~--~~~qIf 318 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI---DKRGISPHDILN---KLVEA--YLEQIF 318 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH---HHcCCCHHHHHH---HHHHH--HHHHHH
Confidence 3333 34555 2223334443 3566899999999866554321 112345443333 33333 222222
Q ss_pred CCCeeecCCCCCCEEEcC----CCCeEEeeeccceecCC
Q 010891 295 EPKVVHRDIKSSNILIDE----NFDAKISDFGLAKLLGA 329 (498)
Q Consensus 295 ~~~iiHrDikp~NIll~~----~~~~kL~DfGla~~~~~ 329 (498)
..|++|+|=.|.||++.. ++.+.+-|||+......
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 238999999999999984 67899999999987643
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.10 E-value=1.3e-05 Score=73.47 Aligned_cols=104 Identities=23% Similarity=0.241 Sum_probs=80.0
Q ss_pred HHHHHHHcCCC-CCceEEEeEEEeCCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCC
Q 010891 219 VEVEAIGHVRH-KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK 297 (498)
Q Consensus 219 ~E~~~l~~l~h-pnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ 297 (498)
.|.-++..+++ +++.+++|+|- .++|.||...+++...- .....--.-+|..+.+|+.++++.+.+|+....-.
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~-~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIY-RPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccc-cccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 47888888876 69999999983 36789999877554210 00001123689999999999999999999843335
Q ss_pred eeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 298 VVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 298 iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
+...|++++|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 777999999999999999999999877643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.07 E-value=5.1e-05 Score=74.89 Aligned_cols=78 Identities=10% Similarity=0.055 Sum_probs=55.9
Q ss_pred CccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCC---CCceEEEeEEEeC---CeeEEEEe
Q 010891 177 SKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRH---KNLVRLLGYCIEG---TQRILVYE 250 (498)
Q Consensus 177 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---pnIv~l~~~~~~~---~~~~lv~e 250 (498)
.-.+.||.|..+.||.....++ .+++|.... ......+..|++.|+.|.- -.+.++++++... +..+||||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE 93 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE 93 (297)
T ss_pred heeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence 3356799999999999876555 466665422 1123578889999998843 3577788877543 56799999
Q ss_pred ecCCCCH
Q 010891 251 YVNNGNL 257 (498)
Q Consensus 251 ~~~~g~L 257 (498)
+++|+++
T Consensus 94 ~i~G~~~ 100 (297)
T PRK10593 94 RLRGVSV 100 (297)
T ss_pred ccCCEec
Confidence 9998754
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.00 E-value=3.3e-05 Score=73.51 Aligned_cols=73 Identities=16% Similarity=0.209 Sum_probs=44.5
Q ss_pred ceEcccCcE-EEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCC---CceEEEeEEEeC---CeeEEEEeec
Q 010891 180 NIIGDGGYG-VVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHK---NLVRLLGYCIEG---TQRILVYEYV 252 (498)
Q Consensus 180 ~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~l~~~~~~~---~~~~lv~e~~ 252 (498)
+.|+.|+.. .||+. +..+++|.... ......+..|++++..+... .+..+++..... ...|++|+++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 467777776 58975 23466775432 22345688899999887421 233444433322 2348899999
Q ss_pred CCCCHH
Q 010891 253 NNGNLE 258 (498)
Q Consensus 253 ~~g~L~ 258 (498)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 987653
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.90 E-value=7.5e-05 Score=72.04 Aligned_cols=139 Identities=14% Similarity=0.085 Sum_probs=78.8
Q ss_pred EcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCc-eEEEeEEEeCCeeEEEEeecCCCCHHH-
Q 010891 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL-VRLLGYCIEGTQRILVYEYVNNGNLEQ- 259 (498)
Q Consensus 182 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~e~~~~g~L~~- 259 (498)
+..|-...+|+... ++..+++|..........-+..+|..+++.+..-++ .+++..+. .++||||++|..+..
T Consensus 4 ~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~~ 78 (256)
T TIGR02721 4 LSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITLD 78 (256)
T ss_pred CCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccccc
Confidence 55677889999874 677888886543322211235678888888854333 23443322 368999999865432
Q ss_pred -------------H---HhcccCCCCCCCHHH-HHHHHHHH---------HHHHHHHHHc-----cCCCeeecCCCCCCE
Q 010891 260 -------------W---LRGDMCDRGYLTWEA-RMKILLGT---------AKALAYLHEA-----IEPKVVHRDIKSSNI 308 (498)
Q Consensus 260 -------------~---l~~~~~~~~~l~~~~-~~~i~~~i---------a~aL~yLH~~-----~~~~iiHrDikp~NI 308 (498)
. ||.......+++... ...+..++ ...+..+-.. ..+.++|+|+.|.||
T Consensus 79 ~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Ni 158 (256)
T TIGR02721 79 QFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNL 158 (256)
T ss_pred cccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcE
Confidence 1 121111112222221 11211111 1112222211 123689999999999
Q ss_pred EEcCCCCeEEeeecccee
Q 010891 309 LIDENFDAKISDFGLAKL 326 (498)
Q Consensus 309 ll~~~~~~kL~DfGla~~ 326 (498)
++++++ +.|+||..+..
T Consensus 159 l~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 159 VVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEeCCC-CEEEeccccCc
Confidence 999876 78999998853
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.90 E-value=0.00017 Score=68.57 Aligned_cols=73 Identities=18% Similarity=0.127 Sum_probs=47.6
Q ss_pred ceEcccCcEEEEEEEEcC--CcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCc-eEEEeEEEeCCeeEEEEeecCCCC
Q 010891 180 NIIGDGGYGVVYRGQLMN--GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL-VRLLGYCIEGTQRILVYEYVNNGN 256 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~e~~~~g~ 256 (498)
+.|..|-...+|+....+ +..|++|........ .-+..+|+.++..+...++ .++++.+. ..+||||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 567888888999997653 678888866433221 1234468888888854333 34444332 248999999876
Q ss_pred H
Q 010891 257 L 257 (498)
Q Consensus 257 L 257 (498)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.87 E-value=4.9e-05 Score=84.28 Aligned_cols=196 Identities=22% Similarity=0.258 Sum_probs=136.5
Q ss_pred HHHHHHHHcCCCCCceEEEeEEEeCCee----EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHc
Q 010891 218 RVEVEAIGHVRHKNLVRLLGYCIEGTQR----ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEA 293 (498)
Q Consensus 218 ~~E~~~l~~l~hpnIv~l~~~~~~~~~~----~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~ 293 (498)
..|+..+....|+|++.++.|..+.... .+..+++..-++...+. .-+.++....+.+..+..+||.|+|+.
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q----~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ----SVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh----hccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 3477778888999999999987654322 34567888888888886 346788899999999999999999998
Q ss_pred cCCCeeecCCCCC---CEEEcCCCCeEEe--eeccceecCCCCceeeecccccccccCcccccCCCCCcc--chHHHHHH
Q 010891 294 IEPKVVHRDIKSS---NILIDENFDAKIS--DFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEK--SDVYSFGV 366 (498)
Q Consensus 294 ~~~~iiHrDikp~---NIll~~~~~~kL~--DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--sDvwSlGv 366 (498)
...|.-+... +-..+..+.+.++ ||+.++.+........ ..-+..|.|+|......++.+ .|+|.+|.
T Consensus 306 ---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 306 ---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred ---ccceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHHHHH
Confidence 6666655554 5555666777777 9998887654433222 233556788888876665554 79999999
Q ss_pred HHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 367 VLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 367 vl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
.+..+..|..+-...... . .+....... .......+|+..++++|+.+.+++.+
T Consensus 381 l~~~~~~~~~i~~~~~~~------------~-----------~~l~~~~~~---~~~d~~~~~~~~~~~~Rl~~~~ll~~ 434 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKSAVP------------V-----------SLLDVLSTS---ELLDALPKCLDEDSEERLSALELLTH 434 (1351)
T ss_pred HHhhhhhcCcccccccch------------h-----------hhhccccch---hhhhhhhhhcchhhhhccchhhhhhc
Confidence 999999987654321110 0 000011111 23333347999999999999999987
Q ss_pred Hh
Q 010891 447 LE 448 (498)
Q Consensus 447 L~ 448 (498)
.-
T Consensus 435 ~f 436 (1351)
T KOG1035|consen 435 PF 436 (1351)
T ss_pred hh
Confidence 64
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.0002 Score=70.51 Aligned_cols=144 Identities=15% Similarity=0.120 Sum_probs=84.9
Q ss_pred cceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCC--ceEEEeE------EEeCCeeEEEEe
Q 010891 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN--LVRLLGY------CIEGTQRILVYE 250 (498)
Q Consensus 179 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~------~~~~~~~~lv~e 250 (498)
.+.|..|....+|+.... +..+++|.... .....+..|++++..+.+-+ +.+++.. ....+..++|++
T Consensus 19 i~~i~~G~~n~~y~v~~~-~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTD-SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeC-CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 456777888899998764 45788887753 23345666888877774322 4444331 123455689999
Q ss_pred ecCCCCHHH-----------H---HhcccC--CC-----CCCCHHHHH----------HHHHHHHHHHHHHHH----ccC
Q 010891 251 YVNNGNLEQ-----------W---LRGDMC--DR-----GYLTWEARM----------KILLGTAKALAYLHE----AIE 295 (498)
Q Consensus 251 ~~~~g~L~~-----------~---l~~~~~--~~-----~~l~~~~~~----------~i~~~ia~aL~yLH~----~~~ 295 (498)
|++|..+.. . ||.... .. ....|.... .....+..++.++.. ...
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 998865421 1 111100 00 111221110 111223344555543 123
Q ss_pred CCeeecCCCCCCEEEcCCCCeEEeeecccee
Q 010891 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (498)
Q Consensus 296 ~~iiHrDikp~NIll~~~~~~kL~DfGla~~ 326 (498)
.+++|+|+.|.|||+++++.+.|+||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4799999999999999987778999998753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00047 Score=70.31 Aligned_cols=76 Identities=24% Similarity=0.302 Sum_probs=53.7
Q ss_pred cceEcccCcEEEEEEEEcCC-cEEEEEEecCCC-------CCchhHHHHHHHHHHcCC---CCCceEEEeEEEeCCeeEE
Q 010891 179 DNIIGDGGYGVVYRGQLMNG-TAVAVKKLLNNP-------GQADKDFRVEVEAIGHVR---HKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 179 ~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~~l 247 (498)
.+.||.|.+..||++...+| +.|+||.-.+.. ....+.+..|.+.|..+. -.++.+++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 35799999999999988776 489999753211 123455677888888762 2456677766 3455789
Q ss_pred EEeecCCCC
Q 010891 248 VYEYVNNGN 256 (498)
Q Consensus 248 v~e~~~~g~ 256 (498)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998643
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.0007 Score=67.20 Aligned_cols=156 Identities=13% Similarity=0.156 Sum_probs=87.0
Q ss_pred HHHHHHccCCCc-----cceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCC--ceEEEeE-
Q 010891 167 RDLQSATNRFSK-----DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN--LVRLLGY- 238 (498)
Q Consensus 167 ~~~~~~~~~y~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~- 238 (498)
+++.....+|.+ .+.++.|....+|+....+| .+++|...... ....+..|++++..|..-+ +.+++..
T Consensus 10 ~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~ 86 (307)
T TIGR00938 10 EEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSR 86 (307)
T ss_pred HHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCC
Confidence 344444444544 35577777789999876544 57788764321 2344556777777763222 3333331
Q ss_pred -----EEeCCeeEEEEeecCCCCHH-----H------H---HhcccCC--CC------CCCHHHHH------------HH
Q 010891 239 -----CIEGTQRILVYEYVNNGNLE-----Q------W---LRGDMCD--RG------YLTWEARM------------KI 279 (498)
Q Consensus 239 -----~~~~~~~~lv~e~~~~g~L~-----~------~---l~~~~~~--~~------~l~~~~~~------------~i 279 (498)
....+..+++++|++|..+. + . +|..... .. .-.|.... ..
T Consensus 87 ~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~ 166 (307)
T TIGR00938 87 DGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHM 166 (307)
T ss_pred CCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHH
Confidence 12245678999999885421 1 1 1211000 00 01111100 01
Q ss_pred HHHHHHHHHHHHH----ccCCCeeecCCCCCCEEEcCCCCeEEeeeccce
Q 010891 280 LLGTAKALAYLHE----AIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (498)
Q Consensus 280 ~~~ia~aL~yLH~----~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~ 325 (498)
...+...+.++.. ....+++|+|+.+.||++++++...|+||+.+.
T Consensus 167 ~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 167 GAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 1223344555543 224589999999999999998777899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.0014 Score=65.42 Aligned_cols=156 Identities=16% Similarity=0.133 Sum_probs=82.8
Q ss_pred HHHHHHHccCCCc-----cceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCC-----CCCceEE
Q 010891 166 LRDLQSATNRFSK-----DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-----HKNLVRL 235 (498)
Q Consensus 166 ~~~~~~~~~~y~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----hpnIv~l 235 (498)
..++......|.+ .+.|+.|....+|+....+| .+++|++.. ...+.+..|+.++..|. .|.++.-
T Consensus 9 ~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~ 84 (319)
T PRK05231 9 DDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVAR 84 (319)
T ss_pred HHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeC
Confidence 3444444445544 34566777789999876555 688887641 12334444555555552 3333321
Q ss_pred Ee---EEEeCCeeEEEEeecCCCCHH-----------HHH---hcccCC-------CCCCCH-HHHHH------------
Q 010891 236 LG---YCIEGTQRILVYEYVNNGNLE-----------QWL---RGDMCD-------RGYLTW-EARMK------------ 278 (498)
Q Consensus 236 ~~---~~~~~~~~~lv~e~~~~g~L~-----------~~l---~~~~~~-------~~~l~~-~~~~~------------ 278 (498)
.+ +....+..++++||++|..+. ..| |..... ...+.| .....
T Consensus 85 ~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (319)
T PRK05231 85 RDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAA 164 (319)
T ss_pred CCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHH
Confidence 10 122345678999999886431 111 111000 001111 11111
Q ss_pred HHHH-HHHHHHHHHHc----cCCCeeecCCCCCCEEEcCCCCeEEeeeccce
Q 010891 279 ILLG-TAKALAYLHEA----IEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (498)
Q Consensus 279 i~~~-ia~aL~yLH~~----~~~~iiHrDikp~NIll~~~~~~kL~DfGla~ 325 (498)
.+.+ +...+..+... ...++||+|+.+.|||++.+...-|+||+.+.
T Consensus 165 ~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 165 LLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 1111 11122233211 34589999999999999976556899999885
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.55 E-value=1.2e-05 Score=90.70 Aligned_cols=161 Identities=14% Similarity=0.035 Sum_probs=119.7
Q ss_pred HHHHHHHHHcCCCCCceEEEeEEEe--CCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHcc
Q 010891 217 FRVEVEAIGHVRHKNLVRLLGYCIE--GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI 294 (498)
Q Consensus 217 ~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~ 294 (498)
...|.+.++...|+++...+.-... +...+.+++|+.+|.+++.|.....+...+...-+...-.+...+..-+|+..
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 3345566667789998887765543 34558999999999999999755444444544444333333366666666543
Q ss_pred --CCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHH
Q 010891 295 --EPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAI 372 (498)
Q Consensus 295 --~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ell 372 (498)
..-.+|+++|+-|.+|..+..+|+.++|+.+...+. .......++++.|+.|+..+.-.++.++|+|..|+-+|+..
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 334689999999999999999999999999943332 22234456888999999999889999999999999999999
Q ss_pred hCCCCC
Q 010891 373 TGRYPV 378 (498)
Q Consensus 373 tg~~P~ 378 (498)
.|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 888776
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00063 Score=67.30 Aligned_cols=141 Identities=21% Similarity=0.241 Sum_probs=82.0
Q ss_pred ceEcccCcEEEEEEEEcC-------CcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCc-eEEEeEEEeCCeeEEEEee
Q 010891 180 NIIGDGGYGVVYRGQLMN-------GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL-VRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~e~ 251 (498)
+.|..|-...+|+....+ ++.+++|...... ....+..+|.+++..+..-++ .++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456667777999987654 5788889864433 223345678888888743333 345555432 368999
Q ss_pred cCCCCHHHH-----------------HhcccCCC-C----CCC--HHHHHH--------------------------HHH
Q 010891 252 VNNGNLEQW-----------------LRGDMCDR-G----YLT--WEARMK--------------------------ILL 281 (498)
Q Consensus 252 ~~~g~L~~~-----------------l~~~~~~~-~----~l~--~~~~~~--------------------------i~~ 281 (498)
++|..+... ||...... . ..+ +..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988765431 11111110 0 110 111100 111
Q ss_pred HHHHHHHHHHH------ccCCCeeecCCCCCCEEEcCC----CCeEEeeeccce
Q 010891 282 GTAKALAYLHE------AIEPKVVHRDIKSSNILIDEN----FDAKISDFGLAK 325 (498)
Q Consensus 282 ~ia~aL~yLH~------~~~~~iiHrDikp~NIll~~~----~~~kL~DfGla~ 325 (498)
.+...+.+|-. .....++|+|+.+.|||++++ +.++|+||..|.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22223334432 134578999999999999985 789999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.00083 Score=65.66 Aligned_cols=75 Identities=16% Similarity=0.240 Sum_probs=48.9
Q ss_pred CccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCC---CCCceEEEeEEEeCCeeEEEEeecC
Q 010891 177 SKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR---HKNLVRLLGYCIEGTQRILVYEYVN 253 (498)
Q Consensus 177 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~~lv~e~~~ 253 (498)
+..+.|+-|....+|+.+ .+++.+.||.-. ......|..|++-|+.|. --.+.+++++....+..||||||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 335679999999999986 678899999764 233456888998888883 3456788888887777899999997
Q ss_pred CC
Q 010891 254 NG 255 (498)
Q Consensus 254 ~g 255 (498)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 76
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.00027 Score=68.55 Aligned_cols=136 Identities=16% Similarity=0.099 Sum_probs=91.9
Q ss_pred CCCccceEcccCcEEEEEEEEcCCcEEEEEEec----------CCC-------CCchh-----HHHHHHHHHHcCC-CC-
Q 010891 175 RFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLL----------NNP-------GQADK-----DFRVEVEAIGHVR-HK- 230 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~----------~~~-------~~~~~-----~~~~E~~~l~~l~-hp- 230 (498)
-+.+++.||-|--+.||.+-..+|++.++|.-. .+. ...+- ....|+..|+.|. |-
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 467889999999999999998889999988421 000 01111 1335888888773 32
Q ss_pred CceEEEeEEEeCCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEE
Q 010891 231 NLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI 310 (498)
Q Consensus 231 nIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll 310 (498)
-+.+.+++ ..-|+|||++.|-.|...-+ ..+.. .+...+..-+--|-.+ |+||+|.+--||++
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~-------v~d~~---~ly~~lm~~Iv~la~~---GlIHgDFNEFNimv 235 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRH-------VEDPP---TLYDDLMGLIVRLANH---GLIHGDFNEFNIMV 235 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeee-------cCChH---HHHHHHHHHHHHHHHc---CceecccchheeEE
Confidence 23344443 45589999999987765432 11222 2333333445556667 99999999999999
Q ss_pred cCCCCeEEeeeccceec
Q 010891 311 DENFDAKISDFGLAKLL 327 (498)
Q Consensus 311 ~~~~~~kL~DfGla~~~ 327 (498)
++++.++++||--....
T Consensus 236 ~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 236 KDDDKIVVIDFPQMVST 252 (465)
T ss_pred ecCCCEEEeechHhhcc
Confidence 99999999999765543
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0046 Score=60.32 Aligned_cols=31 Identities=35% Similarity=0.548 Sum_probs=26.0
Q ss_pred CCeeecCCCCCCEEEcCCCC-eEEeeecccee
Q 010891 296 PKVVHRDIKSSNILIDENFD-AKISDFGLAKL 326 (498)
Q Consensus 296 ~~iiHrDikp~NIll~~~~~-~kL~DfGla~~ 326 (498)
+.++|+|+.+.|||+++++. .-|+||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 46899999999999997555 56999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0053 Score=60.83 Aligned_cols=141 Identities=16% Similarity=0.188 Sum_probs=94.7
Q ss_pred ccceEcccCcEEEEEEEEcCCcEEEEEEecCC------CC----------------CchhH----HHHHHHHHHcCCCCC
Q 010891 178 KDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNN------PG----------------QADKD----FRVEVEAIGHVRHKN 231 (498)
Q Consensus 178 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~------~~----------------~~~~~----~~~E~~~l~~l~hpn 231 (498)
+..+|..|--+.||.|...+|..+|||+++-. .. ...+. ...|+.-|.+|+.-.
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 45678899999999999889999999986321 00 00111 123677777775433
Q ss_pred ceEEEeEEEeCCeeEEEEeecCCCC-HHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEE
Q 010891 232 LVRLLGYCIEGTQRILVYEYVNNGN-LEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI 310 (498)
Q Consensus 232 Iv~l~~~~~~~~~~~lv~e~~~~g~-L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll 310 (498)
|.-.--... ....|||+|+.... -.-.| ..-.++...+..+-.+++.-+.-|...| +++|.||.=-|+|+
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrdgw~aPkL-----Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly 298 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRDGWAAPKL-----KDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY 298 (520)
T ss_pred CCCCCceee--ecceEeeeeccCCCCcCccc-----ccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE
Confidence 221111111 12368999995321 11112 3345777788888899999888888776 99999999999999
Q ss_pred cCCCCeEEeeeccceecC
Q 010891 311 DENFDAKISDFGLAKLLG 328 (498)
Q Consensus 311 ~~~~~~kL~DfGla~~~~ 328 (498)
.+ |.+.|+|-+-+....
T Consensus 299 hd-G~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 299 HD-GKLYIIDVSQSVEHD 315 (520)
T ss_pred EC-CEEEEEEccccccCC
Confidence 75 589999998887543
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.95 E-value=0.016 Score=59.21 Aligned_cols=80 Identities=16% Similarity=0.164 Sum_probs=52.7
Q ss_pred cceEcccCcEEEEEEEEcCCcEEEEEEecCCCC-------CchhHHHHHHHHHHcCC---CCCceEEEeEEEeCCeeEEE
Q 010891 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPG-------QADKDFRVEVEAIGHVR---HKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 179 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~~lv 248 (498)
.+.||-|....||+... .+..++||.-..... .....-..|+..|..+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 46799999999999876 456789997542111 12333444677776653 246777888776 445789
Q ss_pred EeecCC--CCHHHHH
Q 010891 249 YEYVNN--GNLEQWL 261 (498)
Q Consensus 249 ~e~~~~--g~L~~~l 261 (498)
|||+++ ..+.+.+
T Consensus 114 ME~L~~~~~ilr~~L 128 (418)
T PLN02756 114 MRYLEPPHIILRKGL 128 (418)
T ss_pred EeecCCcceehhhhh
Confidence 999977 3454443
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.0066 Score=59.91 Aligned_cols=137 Identities=23% Similarity=0.286 Sum_probs=79.2
Q ss_pred ceEcccCcEEEEEEEEcCCcEEEEEEecC--CCCCchhHHHHHHHHHHcCCC--CCceEEEeEEEeCC--eeEEEEeecC
Q 010891 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLN--NPGQADKDFRVEVEAIGHVRH--KNLVRLLGYCIEGT--QRILVYEYVN 253 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~--~~~lv~e~~~ 253 (498)
+.+..|..-.+|.... +++.+++. ... ..........+|+.+++.+.- --+...+++|.++. ..|.||+|++
T Consensus 31 ~~~~~G~sn~t~~~~~-~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve 108 (321)
T COG3173 31 EEISGGWSNDTFRLGD-TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE 108 (321)
T ss_pred eeccCCcccceEEEec-CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence 3443443334555433 37777777 321 122233456678888887632 23445566776665 5699999998
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHH-HHHHHHH---------------------------------------------
Q 010891 254 NGNLEQWLRGDMCDRGYLTWEARMKIL-LGTAKAL--------------------------------------------- 287 (498)
Q Consensus 254 ~g~L~~~l~~~~~~~~~l~~~~~~~i~-~~ia~aL--------------------------------------------- 287 (498)
|..+.+.+... ... ..++ ..++..|
T Consensus 109 Ge~~~~~~~~~-----~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~ 179 (321)
T COG3173 109 GEVVWSALPPE-----SLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPL 179 (321)
T ss_pred ceeccCcCCcc-----cch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCch
Confidence 84332221100 000 0111 1233333
Q ss_pred -----HHHHHcc-----CCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 288 -----AYLHEAI-----EPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 288 -----~yLH~~~-----~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
.+|+.+. .+.++|+|+.+.||+++..+-+=+.||+++..-
T Consensus 180 ~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 180 ADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 3444332 447999999999999999888999999999753
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.021 Score=56.53 Aligned_cols=30 Identities=23% Similarity=0.374 Sum_probs=26.1
Q ss_pred CCCeeecCCCCCCEEEcCCCCeEEeeeccce
Q 010891 295 EPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (498)
Q Consensus 295 ~~~iiHrDikp~NIll~~~~~~kL~DfGla~ 325 (498)
..+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 358999999999999988 678999999765
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.017 Score=58.17 Aligned_cols=142 Identities=20% Similarity=0.204 Sum_probs=80.9
Q ss_pred ceEcccCcEEEEEEEEcC-----CcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCce-EEEeEEEeCCeeEEEEeecC
Q 010891 180 NIIGDGGYGVVYRGQLMN-----GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLV-RLLGYCIEGTQRILVYEYVN 253 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~l~~~~~~~~~~~lv~e~~~ 253 (498)
..|..|-.-.+|+....+ ++.|++|.......... +-.+|..++..+..-++. ++++.+..+ .|++|++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 456567788999987532 36788887754432222 235688888888543333 455655332 5899998
Q ss_pred CCCHHHH-----------------HhcccCCCC--CCCHHHHHHHHHH-----------------HHHHHHHHHHc----
Q 010891 254 NGNLEQW-----------------LRGDMCDRG--YLTWEARMKILLG-----------------TAKALAYLHEA---- 293 (498)
Q Consensus 254 ~g~L~~~-----------------l~~~~~~~~--~l~~~~~~~i~~~-----------------ia~aL~yLH~~---- 293 (498)
+.+|... +|....... ...+.....+..+ +...+..|...
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7665321 121111111 1122333233211 11222222221
Q ss_pred -cCCCeeecCCCCCCEEEcC-CCCeEEeeecccee
Q 010891 294 -IEPKVVHRDIKSSNILIDE-NFDAKISDFGLAKL 326 (498)
Q Consensus 294 -~~~~iiHrDikp~NIll~~-~~~~kL~DfGla~~ 326 (498)
....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1336899999999999986 46899999988753
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.014 Score=58.49 Aligned_cols=79 Identities=20% Similarity=0.227 Sum_probs=50.1
Q ss_pred eEcccCcEEEEEEEEcCC-cEEEEEEecC-------CCCCchhHHHHHHHHHHcCC--CCC-ceEEEeEEEeCCeeEEEE
Q 010891 181 IIGDGGYGVVYRGQLMNG-TAVAVKKLLN-------NPGQADKDFRVEVEAIGHVR--HKN-LVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 181 ~lg~G~~g~Vy~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--hpn-Iv~l~~~~~~~~~~~lv~ 249 (498)
.||-|....||++...+| +.|+||.-.. .-.-..+....|.+.|.... -|. +.++|.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 479999999999987554 5899996421 11223345566888887662 353 4445443 345556899
Q ss_pred eecCCC-CHHHHH
Q 010891 250 EYVNNG-NLEQWL 261 (498)
Q Consensus 250 e~~~~g-~L~~~l 261 (498)
|+++.. .|.+.|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 998543 444444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.014 Score=57.83 Aligned_cols=32 Identities=25% Similarity=0.336 Sum_probs=28.4
Q ss_pred CCCeeecCCCCCCEEEcCCCCeEEeeecccee
Q 010891 295 EPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (498)
Q Consensus 295 ~~~iiHrDikp~NIll~~~~~~kL~DfGla~~ 326 (498)
..+++|+|+.+.|||+++++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 34799999999999999999999999988763
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.029 Score=55.91 Aligned_cols=140 Identities=21% Similarity=0.266 Sum_probs=83.1
Q ss_pred EcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCC---CCC---ceEEEe----EEEeCCeeEEEEee
Q 010891 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR---HKN---LVRLLG----YCIEGTQRILVYEY 251 (498)
Q Consensus 182 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpn---Iv~l~~----~~~~~~~~~lv~e~ 251 (498)
|.+ .-..||+....+|+. ++|..... ....++..|+..|..|. .|- +..+=| ........+-+++|
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 444 556799998877766 77766443 45566777888888873 121 222222 11112366789999
Q ss_pred cCCCCHHH------------H---Hhc----cc----CCCCCCCHH-------------HHHHHHHHHHHHHHHHHHcc-
Q 010891 252 VNNGNLEQ------------W---LRG----DM----CDRGYLTWE-------------ARMKILLGTAKALAYLHEAI- 294 (498)
Q Consensus 252 ~~~g~L~~------------~---l~~----~~----~~~~~l~~~-------------~~~~i~~~ia~aL~yLH~~~- 294 (498)
++|..+.. + |+. .. .......|. .......++...+..+.+..
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99877662 1 111 10 011123333 01123444455555555432
Q ss_pred ---CCC---eeecCCCCCCEEEcCCCC-eEEeeeccce
Q 010891 295 ---EPK---VVHRDIKSSNILIDENFD-AKISDFGLAK 325 (498)
Q Consensus 295 ---~~~---iiHrDikp~NIll~~~~~-~kL~DfGla~ 325 (498)
... +||+|+.|.||+++.+.. +.++|||.+.
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 223 899999999999999875 8999999886
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.43 E-value=0.026 Score=56.53 Aligned_cols=142 Identities=18% Similarity=0.218 Sum_probs=78.4
Q ss_pred ceEcccCcEEEEEEEEcC----CcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCc-eEEEeEEEeCCeeEEEEeecCC
Q 010891 180 NIIGDGGYGVVYRGQLMN----GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL-VRLLGYCIEGTQRILVYEYVNN 254 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~e~~~~ 254 (498)
+.|..|=.-.+|+....+ +..|++|........ .-+-.+|..+++.+..-++ .++++++.. . +|.+|++|
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~-G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGN-G---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCC-c---EeehhhcC
Confidence 455557777899886432 237888877543322 2233568888888855444 355655532 2 58899977
Q ss_pred CCHHH--------------H---HhcccCCC--CCCCHHHHHHHHHHH----------------------HHHHHHHHHc
Q 010891 255 GNLEQ--------------W---LRGDMCDR--GYLTWEARMKILLGT----------------------AKALAYLHEA 293 (498)
Q Consensus 255 g~L~~--------------~---l~~~~~~~--~~l~~~~~~~i~~~i----------------------a~aL~yLH~~ 293 (498)
..|.. . ||...... .+-.+.....+..++ ..-+..+...
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 65421 0 12111011 111233322222221 1122222211
Q ss_pred -----cCCCeeecCCCCCCEEEcC-CCCeEEeeecccee
Q 010891 294 -----IEPKVVHRDIKSSNILIDE-NFDAKISDFGLAKL 326 (498)
Q Consensus 294 -----~~~~iiHrDikp~NIll~~-~~~~kL~DfGla~~ 326 (498)
...-++|+|+.+.|||+++ ++.++++||..|..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1224799999999999975 57899999998853
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.017 Score=53.41 Aligned_cols=152 Identities=17% Similarity=0.170 Sum_probs=94.0
Q ss_pred cCcEEEEEEEEcCCcEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCCCCHHHHHhc
Q 010891 185 GGYGVVYRGQLMNGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRG 263 (498)
Q Consensus 185 G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 263 (498)
|+-.+.-.++..= .+..+|++...... ...-|..+..+++++. .|+++..- +...+-++.|+|.....
T Consensus 73 ~gNsTl~~~kt~i-G~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------ 141 (308)
T PF07387_consen 73 NGNSTLLIGKTKI-GPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------ 141 (308)
T ss_pred CCceEEEEecccc-chhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence 4445555554322 34667777555444 4456778888888764 57777621 34455789999854211
Q ss_pred ccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCceeeeccccccc
Q 010891 264 DMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343 (498)
Q Consensus 264 ~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~ 343 (498)
. . ..++..=+.+|.-.|+. ..+.+|+|..|+||+-|+.|.+||.|=+..-. .+..
T Consensus 142 -------~---~-~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~-------------~~V~ 196 (308)
T PF07387_consen 142 -------N---F-SNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE-------------NQVN 196 (308)
T ss_pred -------c---h-hHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh-------------heee
Confidence 0 1 11222224678888963 45899999999999999999999999775431 1112
Q ss_pred ccCcccccCCCCCccchHHHHHHHHHHHHhCC
Q 010891 344 YVAPEYANSGLLNEKSDVYSFGVVLLEAITGR 375 (498)
Q Consensus 344 y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~ 375 (498)
|.--|+ ...+.++.+-+|=.-++++....
T Consensus 197 ~vN~~Y---~~lT~~aE~~~fv~s~l~~v~~~ 225 (308)
T PF07387_consen 197 MVNIEY---ESLTQEAEVKVFVKSCLKLVEKQ 225 (308)
T ss_pred EEeeec---cccChHHHHHHHHHHHHHHHHHH
Confidence 222111 33566777777777777776643
|
The function of this family is unknown. |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.0071 Score=62.31 Aligned_cols=48 Identities=21% Similarity=0.271 Sum_probs=38.7
Q ss_pred hHHHHHHHHHHcCCCCCceEEEeEEEeC-CeeEEEEeecCCCCHHHHHhc
Q 010891 215 KDFRVEVEAIGHVRHKNLVRLLGYCIEG-TQRILVYEYVNNGNLEQWLRG 263 (498)
Q Consensus 215 ~~~~~E~~~l~~l~hpnIv~l~~~~~~~-~~~~lv~e~~~~g~L~~~l~~ 263 (498)
..+.-...+++.+.|+|...++++.... ....+|||++ +-+|++++..
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~ 75 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKT 75 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHh
Confidence 3466678899999999999999987654 4467899999 5599999864
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.089 Score=60.69 Aligned_cols=143 Identities=17% Similarity=0.224 Sum_probs=79.9
Q ss_pred ceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcC-------CCCCceEEEe-----EEEe-CC--e
Q 010891 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-------RHKNLVRLLG-----YCIE-GT--Q 244 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-------~hpnIv~l~~-----~~~~-~~--~ 244 (498)
+.|+ |..-.+|+.+..+|..+++|+..... .......|.+.|..| .-|.+++..+ .... +. .
T Consensus 31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~--~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~ 107 (1013)
T PRK06148 31 TPLD-GERDLNFRLTTDDGADYILKIVNPSE--PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR 107 (1013)
T ss_pred eecC-CcCCceEEEEeCCCCeEEEEEcCCcc--chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence 4464 45678899987788889999875432 233344455566544 2344443221 1111 12 4
Q ss_pred eEEEEeecCCCCHHHH-----------------Hhc----c--cCCCCCCCHHH-----------------HHHHHHHHH
Q 010891 245 RILVYEYVNNGNLEQW-----------------LRG----D--MCDRGYLTWEA-----------------RMKILLGTA 284 (498)
Q Consensus 245 ~~lv~e~~~~g~L~~~-----------------l~~----~--~~~~~~l~~~~-----------------~~~i~~~ia 284 (498)
.+-+++|++|..|.+. ++. . ......+.|.. ...++.++.
T Consensus 108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~ 187 (1013)
T PRK06148 108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL 187 (1013)
T ss_pred EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence 5678999999777651 111 0 00011122321 122223333
Q ss_pred HHHH-----HHHHccCCCeeecCCCCCCEEEcCCC--CeE-Eeeecccee
Q 010891 285 KALA-----YLHEAIEPKVVHRDIKSSNILIDENF--DAK-ISDFGLAKL 326 (498)
Q Consensus 285 ~aL~-----yLH~~~~~~iiHrDikp~NIll~~~~--~~k-L~DfGla~~ 326 (498)
..+. .|. ....++||+|+.+.|||++.++ .+. |+|||.+..
T Consensus 188 ~~~~~~v~p~l~-~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 188 ARFERNVAPRLA-ALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHHh-cCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 3222 121 2345899999999999999875 555 999998864
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.14 Score=51.12 Aligned_cols=71 Identities=15% Similarity=0.046 Sum_probs=43.6
Q ss_pred cCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCC--ceEEE---e--EEEeCCeeEEEEeecCCCC
Q 010891 185 GGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN--LVRLL---G--YCIEGTQRILVYEYVNNGN 256 (498)
Q Consensus 185 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~---~--~~~~~~~~~lv~e~~~~g~ 256 (498)
+.-..||+....+|..+++|..... .....++..|++.+..|.... ++... | +...++..+.++++++|..
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 4556899998777888888876422 234556777888877663111 22211 1 1223456788999998753
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.96 E-value=0.055 Score=53.77 Aligned_cols=105 Identities=17% Similarity=0.177 Sum_probs=70.4
Q ss_pred CCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeee
Q 010891 242 GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDF 321 (498)
Q Consensus 242 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~Df 321 (498)
..+.|++|++. |++|.-. ....+++...++.+.+.-+.-+.... .+=|||+.-.||||+ +|++-|+||
T Consensus 298 ~~y~yl~~kdh-gt~is~i--------k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDf 365 (488)
T COG5072 298 TLYLYLHFKDH-GTPISII--------KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDF 365 (488)
T ss_pred ceEEEEEEecC-Cceeeee--------ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEe
Confidence 34557778876 5555421 23568899999999888877777653 789999999999999 899999999
Q ss_pred ccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHH
Q 010891 322 GLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFG 365 (498)
Q Consensus 322 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlG 365 (498)
-+++.......-..+ ..--|-.+.| .-+..-|||-+-
T Consensus 366 klsRl~~~q~~isy~------rldhp~lF~G-~dd~QFeIYrlM 402 (488)
T COG5072 366 KLSRLSYSQGIISYN------RLDHPDLFNG-VDDYQFEIYRLM 402 (488)
T ss_pred eeeecccCCceeecc------ccCchhhhcC-ccceeeeHHHHH
Confidence 999953322211111 1223444443 225566777643
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.065 Score=54.48 Aligned_cols=81 Identities=19% Similarity=0.202 Sum_probs=51.5
Q ss_pred cceEcccCcEEEEEEEEcC-CcEEEEEEecCC------CCCchhHHHHHHHHHHcCC--CCC-ceEEEeEEEeCCeeEEE
Q 010891 179 DNIIGDGGYGVVYRGQLMN-GTAVAVKKLLNN------PGQADKDFRVEVEAIGHVR--HKN-LVRLLGYCIEGTQRILV 248 (498)
Q Consensus 179 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~------~~~~~~~~~~E~~~l~~l~--hpn-Iv~l~~~~~~~~~~~lv 248 (498)
.+.||-|.-.-||++...+ ++.|+||.-... -.-..+....|.+.|+.+. .|. +.++|.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4578999999999998643 568999964221 1223355666888888763 354 4455544 34555788
Q ss_pred EeecCC-CCHHHHH
Q 010891 249 YEYVNN-GNLEQWL 261 (498)
Q Consensus 249 ~e~~~~-g~L~~~l 261 (498)
||+++. ..|.+.|
T Consensus 112 MEdL~~~~ilR~~L 125 (409)
T PRK12396 112 MEDLSDHTILRTAL 125 (409)
T ss_pred HHhCcccHHHHHHH
Confidence 998854 2344443
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.61 E-value=0.17 Score=51.69 Aligned_cols=74 Identities=18% Similarity=0.296 Sum_probs=44.0
Q ss_pred ceEcccCcEEEEEEEEcCC--cE-----EEEEEecCCCCCchhHHHHHHHHHHcCCCCCce-EEEeEEEeCCeeEEEEee
Q 010891 180 NIIGDGGYGVVYRGQLMNG--TA-----VAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLV-RLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv-~l~~~~~~~~~~~lv~e~ 251 (498)
+.|..|-...+|++...++ .. |.+... .......-+-.+|+++++.+..-++- ++++.+.. ++|+||
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~-g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef 130 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKS-STYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW 130 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEec-cCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence 4566688889999975432 23 333322 11111112235689999998655554 55665532 699999
Q ss_pred cCCCCHH
Q 010891 252 VNNGNLE 258 (498)
Q Consensus 252 ~~~g~L~ 258 (498)
++|..|.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9987653
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.46 E-value=0.04 Score=55.51 Aligned_cols=60 Identities=20% Similarity=0.172 Sum_probs=42.6
Q ss_pred eEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEc
Q 010891 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID 311 (498)
Q Consensus 245 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~ 311 (498)
..|+=+|..|.++..++... ..++.-+.+++.-.+.||.-+--.. +++|.|+.|.||++.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~-----~~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWK-----SQPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhhcc-----cChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEE
Confidence 35666788888999998542 2444556666666666665444332 899999999999994
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=94.64 E-value=0.21 Score=46.70 Aligned_cols=75 Identities=16% Similarity=0.220 Sum_probs=51.5
Q ss_pred ceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCC---CCCceEEEeEEEeCCeeEEEEeecCCCC
Q 010891 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR---HKNLVRLLGYCIEGTQRILVYEYVNNGN 256 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~~lv~e~~~~g~ 256 (498)
+.+.-|..-..|...+ ...++.||+= .......|..|+.-|..|. .-.+.+++.+..+..+.|+||||++.+.
T Consensus 22 ~~v~gG~inea~~v~d-g~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 22 EEVSGGDINEAWRLRD-GTDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred cccCCccccceeEeec-CCcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 4455566556666543 4567888853 2223355778888777764 3456778888888899999999998765
Q ss_pred HH
Q 010891 257 LE 258 (498)
Q Consensus 257 L~ 258 (498)
+.
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 54
|
|
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=94.49 E-value=0.21 Score=47.92 Aligned_cols=79 Identities=19% Similarity=0.176 Sum_probs=54.4
Q ss_pred cceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecC-CCCH
Q 010891 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN-NGNL 257 (498)
Q Consensus 179 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~-~g~L 257 (498)
...+-.|..+.|+.++..+|.++++|.......... +.. ....|+..+-...|++++.-. ....|++|.+. +.+|
T Consensus 7 ~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~-E~~-g~~~L~~w~G~GaVrll~~d~--~~~AlLLErl~~g~~L 82 (253)
T PF04655_consen 7 DGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEH-EAR-GEAALRWWNGRGAVRLLAADP--ERGALLLERLDPGRSL 82 (253)
T ss_pred CCCCCCCcceEEEEEEcCCCCeEEEEecCCcccchh-hhh-HHhHhheeCCCCceeeecccc--ccchhhhhhccCCCch
Confidence 345677999999999988999999998754332211 111 224577778888999998753 34568889984 4467
Q ss_pred HHHH
Q 010891 258 EQWL 261 (498)
Q Consensus 258 ~~~l 261 (498)
.+..
T Consensus 83 ~~~~ 86 (253)
T PF04655_consen 83 ASLP 86 (253)
T ss_pred hhcc
Confidence 6554
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 498 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-68 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-66 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-54 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-54 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-42 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-42 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-42 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-41 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-25 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-25 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 7e-25 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-25 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 8e-25 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-25 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-24 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-24 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-24 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-23 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-23 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-22 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 7e-22 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-22 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-21 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-21 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-21 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-21 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-21 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-21 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-21 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-21 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-21 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-21 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-21 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-21 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 8e-21 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 9e-21 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-20 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-20 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-20 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-20 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-20 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-20 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-20 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 4e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-20 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-20 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 6e-20 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-20 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 6e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-20 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 7e-20 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 8e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 8e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 9e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 9e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-19 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-19 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-19 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-19 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-19 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-19 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-19 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-19 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-19 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-19 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-19 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-19 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-19 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-19 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-19 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-19 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-19 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-19 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-19 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-19 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-19 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-19 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-19 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-19 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-19 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-19 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-19 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-19 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-19 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-19 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-19 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-19 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-19 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-19 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 7e-19 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 7e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-19 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 9e-19 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-18 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-18 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-18 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-18 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-18 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-18 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-18 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-18 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-18 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-18 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-18 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-18 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-18 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-18 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-18 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 3e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-18 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-18 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-18 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-18 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-18 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 6e-18 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-18 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 7e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 8e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 8e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-18 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 9e-18 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 9e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-17 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-17 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-17 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-17 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-17 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-17 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-17 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-17 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-17 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-17 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-17 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-17 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-17 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-17 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 4e-17 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-17 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-16 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-16 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-16 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-16 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-16 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-16 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-16 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-16 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-16 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-16 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-16 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-16 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-16 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-16 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-16 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-16 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-16 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 5e-16 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-16 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-16 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-16 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 5e-16 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-16 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-16 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-16 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-16 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-16 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 7e-16 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-16 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 8e-16 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 8e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-16 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-15 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-15 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-15 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-15 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-15 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-15 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-15 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-15 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-15 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-15 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-15 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-15 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-15 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-15 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-15 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-15 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-15 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 3e-15 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-15 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-15 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 5e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 6e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 6e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 6e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-15 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-15 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 7e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-15 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-15 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 7e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 8e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 8e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 8e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-15 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 8e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-15 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-15 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 9e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 9e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 9e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 9e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 9e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 9e-15 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-14 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-14 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-14 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 1e-14 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-14 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-14 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-14 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-14 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-14 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-14 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-14 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-14 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-14 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-14 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-14 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-14 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-14 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-14 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-14 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-14 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-14 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-14 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 2e-14 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-14 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-14 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-14 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-14 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-14 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-14 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-14 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-14 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-14 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-14 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-14 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-14 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-14 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-14 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-14 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 4e-14 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-14 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-14 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-14 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 6e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-14 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 6e-14 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-14 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 7e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-14 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-14 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 7e-14 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-14 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-14 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-14 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 8e-14 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-14 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 8e-14 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-14 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-14 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-14 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 9e-14 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 9e-14 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 9e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-14 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-14 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-14 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-14 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-13 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-13 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-13 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-13 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-13 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-13 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-13 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-13 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-13 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-13 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-13 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-13 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-13 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-13 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-13 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-13 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-13 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-13 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-13 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-13 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-13 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-13 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 4e-13 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-13 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-13 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-13 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-13 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-13 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-13 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-13 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-13 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-13 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-13 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 6e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 6e-13 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-13 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 7e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-13 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-13 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-13 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-13 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-13 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 8e-13 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-13 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-13 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-13 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-13 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-13 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-13 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 9e-13 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-13 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-13 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-13 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-13 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 9e-13 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 9e-13 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-13 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-13 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 9e-13 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-13 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-12 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-12 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-12 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-12 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-12 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-12 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-12 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 3e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 3e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 3e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 3e-12 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-12 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 3e-12 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-12 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 3e-12 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-12 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-12 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-12 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-12 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-12 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-12 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 4e-12 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-12 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 5e-12 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-12 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-12 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 5e-12 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 5e-12 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-12 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-12 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 5e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 5e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-12 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-12 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-12 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-12 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 6e-12 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-12 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 7e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-12 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 7e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 7e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 8e-12 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-12 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-12 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-12 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 8e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 8e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 9e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 9e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-11 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-11 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-11 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-11 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-11 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-11 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-11 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-11 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-11 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-11 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-11 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-11 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-11 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-11 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-11 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-11 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-11 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 1e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-11 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-11 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-11 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-11 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-11 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-11 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-11 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-11 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-11 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 4e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 4e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-11 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 5e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-11 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-11 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 9e-11 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 9e-11 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 9e-11 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-10 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-10 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-10 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-10 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 3e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 3e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 3e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-10 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-10 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-10 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-10 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-10 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 5e-10 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-10 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-10 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-10 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-10 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-10 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-10 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 8e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-09 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-09 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-09 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-09 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 1e-09 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-09 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-09 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-09 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-09 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-09 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-09 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-09 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-09 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 2e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-09 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-09 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-09 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 3e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-09 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-09 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-09 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-09 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-09 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 7e-09 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-09 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-09 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-09 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 9e-09 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-08 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 3e-08 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 6e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-08 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-08 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 7e-08 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-08 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-08 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 9e-08 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-07 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-07 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-07 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-07 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-07 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 5e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 6e-07 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 6e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 6e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 6e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-07 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 508 bits (1310), Expect = e-180
Identities = 134/319 (42%), Positives = 206/319 (64%), Gaps = 5/319 (1%)
Query: 148 PLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLL 207
P PE HLG F+LR+LQ A++ FS NI+G GG+G VY+G+L +GT VAVK+L
Sbjct: 5 PAEEDPEV-HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLK 63
Query: 208 NNPGQA-DKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMC 266
Q + F+ EVE I H+NL+RL G+C+ T+R+LVY Y+ NG++ LR
Sbjct: 64 EERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPE 123
Query: 267 DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326
+ L W R +I LG+A+ LAYLH+ +PK++HRD+K++NIL+DE F+A + DFGLAKL
Sbjct: 124 SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL 183
Query: 327 LGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSE 386
+ +H+TT V GT G++APEY ++G +EK+DV+ +GV+LLE ITG+ D R ++
Sbjct: 184 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAND 243
Query: 387 --VNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVV 444
V L++W+K +++ ++ E +VD +++ +++ + AL C +RPKMS+VV
Sbjct: 244 DDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVV 303
Query: 445 RMLESEEYPIPREDRRRRR 463
RMLE + R + ++
Sbjct: 304 RMLEGDGLA-ERWEEWQKE 321
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 484 bits (1249), Expect = e-171
Identities = 121/316 (38%), Positives = 180/316 (56%), Gaps = 8/316 (2%)
Query: 134 STFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYGVVYRG 193
S + +++ + S L F + L DL+ ATN F +IG G +G VY+G
Sbjct: 3 SKYSKATNSINDALSSSYLVPFE----SYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKG 58
Query: 194 QLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253
L +G VA+K+ Q ++F E+E + RH +LV L+G+C E + IL+Y+Y+
Sbjct: 59 VLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYME 118
Query: 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN 313
NGNL++ L G ++WE R++I +G A+ L YLH ++HRD+KS NIL+DEN
Sbjct: 119 NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDEN 175
Query: 314 FDAKISDFGLAKL-LGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAI 372
F KI+DFG++K ++H++T V GT GY+ PEY G L EKSDVYSFGVVL E +
Sbjct: 176 FVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235
Query: 373 TGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDP 432
R + P+ VNL EW + E +VDPN+ + +L++ TA++C+
Sbjct: 236 CARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLAL 295
Query: 433 DSDKRPKMSQVVRMLE 448
S+ RP M V+ LE
Sbjct: 296 SSEDRPSMGDVLWKLE 311
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 406 bits (1047), Expect = e-141
Identities = 113/300 (37%), Positives = 168/300 (56%), Gaps = 21/300 (7%)
Query: 162 HWFTLRDLQSATNRFSK------DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNP----G 211
H F+ +L++ TN F + N +G+GG+GVVY+G + N T VAVKKL
Sbjct: 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71
Query: 212 QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYL 271
+ + F E++ + +H+NLV LLG+ +G LVY Y+ NG+L L + L
Sbjct: 72 ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSC-LDGTPPL 130
Query: 272 TWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG- 330
+W R KI G A + +LH E +HRDIKS+NIL+DE F AKISDFGLA+
Sbjct: 131 SWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 331 KSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLV 390
++ +T+R++GT Y+APE G + KSD+YSFGVVLLE ITG VD R L+
Sbjct: 188 QTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLLL 244
Query: 391 EWLKMMVQLRRS-EDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449
+ + + ++ ED +D + STS + A +C+ +KRP + +V ++L+
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSV-ASQCLHEKKNKRPDIKKVQQLLQE 303
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 299 bits (768), Expect = 8e-99
Identities = 75/309 (24%), Positives = 125/309 (40%), Gaps = 30/309 (9%)
Query: 164 FTLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEA 223
+L + + G +G V++ Q + VAVK + EV +
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQ-DKQSWQNEYEVYS 71
Query: 224 IGHVRHKNLVRLLGYCIEG----TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKI 279
+ ++H+N+++ +G G L+ + G+L +L+ ++W I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK-----ANVVSWNELCHI 126
Query: 280 LLGTAKALAYLHEAI-------EPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332
A+ LAYLHE I +P + HRDIKS N+L+ N A I+DFGLA AGKS
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 333 HI-TTRVMGTFGYVAPEYANSGLLNE-----KSDVYSFGVVLLEAITGRYPVDYGRPQSE 386
T +GT Y+APE + + + D+Y+ G+VL E + D +
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 387 VNLVEWLKMMVQLRRSEDVV-----DPNIETR-PSTSALKRALLTALRCVDPDSDKRPKM 440
+ E + L ++VV P + + + T C D D++ R
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306
Query: 441 SQVVRMLES 449
V +
Sbjct: 307 GCVGERITQ 315
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 223 bits (569), Expect = 5e-69
Identities = 67/330 (20%), Positives = 115/330 (34%), Gaps = 45/330 (13%)
Query: 164 FTLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVE- 222
+ + +IG G YG VY+G L + VAVK ++F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEKNI 58
Query: 223 -AIGHVRHKNLVRLLGYCIEG-----TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEAR 276
+ + H N+ R + + +LV EY NG+L ++L W +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVSS 113
Query: 277 MKILLGTAKALAYLHEAIE------PKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330
++ + LAYLH + P + HRD+ S N+L+ + ISDFGL+ L
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 331 K-------SHITTRVMGTFGYVAPEYANSGL-------LNEKSDVYSFGVVLLEAITGRY 376
+ + +GT Y+APE + ++ D+Y+ G++ E
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 377 PVDYGRPQSEVNLV--EWLKMMVQLRRSEDVVD-----PNIETRPSTSALKRALLTAL-- 427
+ G E + + + +V P ++L L
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 428 RCVDPDSDKRPKMSQVVRMLESEEYPIPRE 457
C D D++ R + R
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERN 323
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 6e-68
Identities = 81/285 (28%), Positives = 135/285 (47%), Gaps = 26/285 (9%)
Query: 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLL--NNPGQADKDFRVEVEAIGHVRHKNLVRLLG 237
IG G +G V+R + +G+ VAVK L+ + + +F EV + +RH N+V +G
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 238 YCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK 297
+ +V EY++ G+L + L R L R+ + AK + YLH P
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLH-NRNPP 159
Query: 298 VVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNE 357
+VHR++KS N+L+D+ + K+ DFGL++L A + GT ++APE NE
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLK-ASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218
Query: 358 KSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQ--LRRSEDVVDPNIETRPS 415
KSDVYSFGV+L E T + +P +N + + + R I +
Sbjct: 219 KSDVYSFGVILWELATLQ------QPWGNLNPAQVVAAVGFKCKR-------LEI--PRN 263
Query: 416 TSALKRALLTALRCVDPDSDKRPKMSQVVRMLES-EEYPIPREDR 459
+ A++ C + KRP + ++ +L + +P +R
Sbjct: 264 LNPQVAAIIE--GCWTNEPWKRPSFATIMDLLRPLIKSAVPPPNR 306
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 8e-66
Identities = 80/309 (25%), Positives = 129/309 (41%), Gaps = 35/309 (11%)
Query: 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGY 238
+ ++G G +GVV + + VA+K++ + K F VE+ + V H N+V+L G
Sbjct: 13 EEVVGRGAFGVVCKAKW-RAKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 239 CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKV 298
C+ LV EY G+L L G Y T M L ++ +AYLH +
Sbjct: 70 CLN--PVCLVMEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126
Query: 299 VHRDIKSSNILIDENFD-AKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNE 357
+HRD+K N+L+ KI DFG A T G+ ++APE +E
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNKGSAAWMAPEVFEGSNYSE 182
Query: 358 KSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRP--- 414
K DV+S+G++L E IT R P + ++ R V RP
Sbjct: 183 KCDVFSWGIILWEVITRRKP--------------FDEIGGPAFRIMWAVHNGT--RPPLI 226
Query: 415 -STSALKRALLTALRCVDPDSDKRPKMSQVVRMLES--EEYPIPREDRRRRRNQAGASEA 471
+ +L+T RC D +RP M ++V+++ +P E + +
Sbjct: 227 KNLPKPIESLMT--RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGE 284
Query: 472 ESQRESSDT 480
+ + E
Sbjct: 285 DGRVEPYVD 293
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 5e-65
Identities = 73/289 (25%), Positives = 132/289 (45%), Gaps = 46/289 (15%)
Query: 180 NIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQAD-------KDFRVEVEAIGHVRHKN 231
IG GG+G+V++G+L+ + + VA+K L+ + + ++F+ EV + ++ H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
+V+L G +V E+V G+L L + W +++++L A + Y+
Sbjct: 85 IVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 292 EAIEPKVVHRDIKSSNILIDE-----NFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVA 346
P +VHRD++S NI + AK++DFGL++ H + ++G F ++A
Sbjct: 140 -NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQWMA 194
Query: 347 PE--YANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSED 404
PE A EK+D YSF ++L +TG P E + +++
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGE------GPFDEYS-------YGKIKFINM 241
Query: 405 VVDPNIETRP----STSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449
+ + + RP R ++ C D KRP S +V+ L
Sbjct: 242 IREEGL--RPTIPEDCPPRLRNVIE--LCWSGDPKKRPHFSYIVKELSE 286
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 4e-63
Identities = 69/305 (22%), Positives = 123/305 (40%), Gaps = 40/305 (13%)
Query: 180 NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGY 238
++G G +G + G + +K+L+ + + F EV+ + + H N+++ +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 239 CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKV 298
+ + + EY+ G L ++ W R+ A +AYLH +
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NI 129
Query: 299 VHRDIKSSNILIDENFDAKISDFGLAKLL-------------GAGKSHITTRVMGTFGYV 345
+HRD+ S N L+ EN + ++DFGLA+L+ V+G ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 346 APEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV 405
APE N +EK DV+SFG+VL E I P++ + + +
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL-DRYCPPNC 248
Query: 406 VDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE------SEEYPIPREDR 459
P PS + +RC D D +KRP ++ LE + P+ +
Sbjct: 249 --P-----PSFFPI------TVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLGPQLE 295
Query: 460 RRRRN 464
+ R
Sbjct: 296 QLDRG 300
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 1e-62
Identities = 63/279 (22%), Positives = 113/279 (40%), Gaps = 36/279 (12%)
Query: 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLL--NNPGQADKDFRVEVEAIGHVRHKNLVRLLG 237
+ + G +++G+ G + VK L + + +DF E + H N++ +LG
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 238 YCIEGTQRIL--VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIE 295
C + ++ G+L L + +K L A+ +A+LH +E
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV--VDQSQAVKFALDMARGMAFLH-TLE 131
Query: 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPE---YANS 352
P + + S +++IDE+ A+IS + S + M +VAPE
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADVK------FSFQSPGRMYAPAWVAPEALQKKPE 185
Query: 353 GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQ--LRRSEDVVDPNI 410
+D++SF V+L E +T P ++++ +E + LR P I
Sbjct: 186 DTNRRSADMWSFAVLLWELVTRE------VPFADLSNMEIGMKVALEGLR-------PTI 232
Query: 411 ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449
P S L+ C++ D KRPK +V +LE
Sbjct: 233 --PPGISPHVSKLMK--ICMNEDPAKRPKFDMIVPILEK 267
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 5e-62
Identities = 78/286 (27%), Positives = 128/286 (44%), Gaps = 44/286 (15%)
Query: 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNP----GQADKDFRVEVEAIGHVRHKNLVRL 235
IIG GG+G VYR G VAVK ++P Q ++ R E + ++H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 236 LGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIE 295
G C++ LV E+ G L + L G + + + + A+ + YLH+
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGKR-----IPPDILVNWAVQIARGMNYLHDEAI 126
Query: 296 PKVVHRDIKSSNILIDENFD--------AKISDFGLAKLLGAGKSHITTRVMGTFGYVAP 347
++HRD+KSSNILI + + KI+DFGLA+ G + ++AP
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW---HRTTKMSAAGAYAWMAP 183
Query: 348 EYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQ--LRRSEDV 405
E + + ++ SDV+S+GV+L E +TG P ++ + + L
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGE------VPFRGIDGLAVAYGVAMNKLA----- 232
Query: 406 VDPNIETRPST--SALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449
I PST + L+ C +PD RP + ++ L +
Sbjct: 233 --LPI---PSTCPEPFAK-LME--DCWNPDPHSRPSFTNILDQLTT 270
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 9e-60
Identities = 76/341 (22%), Positives = 128/341 (37%), Gaps = 46/341 (13%)
Query: 134 STFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYGVVYRG 193
+ R + SGLP + +Q IG G YG V+ G
Sbjct: 9 ESLRDLIEQSQSSGSGSGLPLLVQ-----RTIAKQIQ-------MVKQIGKGRYGEVWMG 56
Query: 194 QLMNGTAVAVKKLLNNPGQADKDFRVEVE--AIGHVRHKNLVRLLGYCIEGTQRI----L 247
+ G VAVK + + E E +RH+N++ + I+GT L
Sbjct: 57 KW-RGEKVAVKVF---FTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYL 112
Query: 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIE-----PKVVHRD 302
+ +Y NG+L +L+ L ++ +K+ + L +LH I P + HRD
Sbjct: 113 ITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRD 167
Query: 303 IKSSNILIDENFDAKISDFGLAKLLGAGKSHI---TTRVMGTFGYVAPE------YANSG 353
+KS NIL+ +N I+D GLA + + + +GT Y+ PE N
Sbjct: 168 LKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHF 227
Query: 354 LLNEKSDVYSFGVVLLEAITGRYPV----DYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409
+D+YSFG++L E +Y P ++ + ++ + P+
Sbjct: 228 QSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPS 287
Query: 410 IETRPSTSALKRALL-TALRCVDPDSDKRPKMSQVVRMLES 449
R S+ R + C + R +V + L
Sbjct: 288 FPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 3e-59
Identities = 75/300 (25%), Positives = 120/300 (40%), Gaps = 44/300 (14%)
Query: 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVE--AIGHVRHKNLVRLLG 237
+G G YG V+RG G VAVK + +K + E E +RH+N++ +
Sbjct: 14 ECVGKGRYGEVWRGS-WQGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 238 YCIEG----TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEA 293
+ TQ L+ Y G+L +L+ L + ++I+L A LA+LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 294 IE-----PKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVM---GTFGYV 345
I P + HRD+KS NIL+ +N I+D GLA + + + GT Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 346 APE------YANSGLLNEKSDVYSFGVVLLEAITGRYPV----DYGRP-QSEVNLVEWLK 394
APE + ++ D+++FG+VL E DY P V +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244
Query: 395 MMVQLRRSEDVVD----PNIETRPSTSALKRALL-TALRCVDPDSDKRPKMSQVVRMLES 449
M ++ V PNI R + +L C + R ++ + L
Sbjct: 245 DMRKV-----VCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 8e-59
Identities = 76/283 (26%), Positives = 127/283 (44%), Gaps = 32/283 (11%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLL--NNPGQADKDFRVEVEAIGHVRHKNLVRLLGYC 239
IG G +G VY+G+ +G VAVK L Q + F+ EV + RH N++ +GY
Sbjct: 32 IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 240 IEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVV 299
I V ++ +L L + + I TA+ + YLH ++
Sbjct: 90 TAPQLAI-VTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHA---KSII 142
Query: 300 HRDIKSSNILIDENFDAKISDFGLAKLLGA-GKSHITTRVMGTFGYVAPE---YANSGLL 355
HRD+KS+NI + E+ KI DFGLA SH ++ G+ ++APE +S
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202
Query: 356 NEKSDVYSFGVVLLEAITGRYPVDYGRPQSEV-NLVEWLKMMVQLRRSEDVVDPNIETRP 414
+ +SDVY+FG+VL E +TG+ P + ++ +V + L + +
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM---- 258
Query: 415 STSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIPRE 457
+ L+ C+ D+RP +++ +E + RE
Sbjct: 259 ------KRLMA--ECLKKKRDERPSFPRILAEIEE----LARE 289
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 2e-58
Identities = 63/296 (21%), Positives = 116/296 (39%), Gaps = 43/296 (14%)
Query: 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQAD--KDFRVEVEAIGHVRHKNLVRLLG 237
+IG G +G VY G+ +G VA++ + D K F+ EV A RH+N+V +G
Sbjct: 39 ELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 238 YCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK 297
C+ ++ L +R + L +I K + YLH
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHA---KG 150
Query: 298 VVHRDIKSSNILIDENFDAKISDFGLAKL----LGAGKSHITTRVMGTFGYVAPE----- 348
++H+D+KS N+ D I+DFGL + + G ++APE
Sbjct: 151 ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 349 ----YANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSED 404
+ ++ SDV++ G + E +P ++ + + ++ +
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT-----GMKPN-- 262
Query: 405 VVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIPREDRR 460
I S + L C + ++RP ++++ MLE +P+ +RR
Sbjct: 263 --LSQIGMGKEISDI------LLFCWAFEQEERPTFTKLMDMLEK----LPKRNRR 306
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 5e-58
Identities = 75/329 (22%), Positives = 127/329 (38%), Gaps = 54/329 (16%)
Query: 150 SGLPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNN 209
SGLP R + IG G +G V+RG+ G VAVK
Sbjct: 30 SGLPLLVQ-----RTIARTIV-------LQESIGKGRFGEVWRGKW-RGEEVAVKIF--- 73
Query: 210 PGQADKDFRVEVE--AIGHVRHKNLVRLLGYCI----EGTQRILVYEYVNNGNLEQWLRG 263
+ ++ + E E +RH+N++ + TQ LV +Y +G+L +L
Sbjct: 74 SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN- 132
Query: 264 DMCDRGYLTWEARMKILLGTAKALAYLHEAIE-----PKVVHRDIKSSNILIDENFDAKI 318
R +T E +K+ L TA LA+LH I P + HRD+KS NIL+ +N I
Sbjct: 133 ----RYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 188
Query: 319 SDFGLAKLLGAGKSHIT---TRVMGTFGYVAPE------YANSGLLNEKSDVYSFGVVLL 369
+D GLA + I +GT Y+APE +++D+Y+ G+V
Sbjct: 189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 248
Query: 370 EAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVV---------DPNIETRPSTSALK 420
E R + ++ + + + VV ++ + +
Sbjct: 249 EIAR-RCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMA 307
Query: 421 RALLTALRCVDPDSDKRPKMSQVVRMLES 449
+ ++ C + R ++ + L
Sbjct: 308 K-IMR--ECWYANGAARLTALRIKKTLSQ 333
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-42
Identities = 63/209 (30%), Positives = 98/209 (46%), Gaps = 13/209 (6%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKD----FRVEVEAIGHVR 228
R+ + +G GG VY + + VA+K + P + ++ F EV +
Sbjct: 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALA 288
H+N+V ++ E LV EY+ L +++ G L+ + + +
Sbjct: 70 HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE----SHGPLSVDTAINFTNQILDGIK 125
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPE 348
+ H+ ++VHRDIK NILID N KI DFG+AK L T V+GT Y +PE
Sbjct: 126 HAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182
Query: 349 YANSGLLNEKSDVYSFGVVLLEAITGRYP 377
A +E +D+YS G+VL E + G P
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 5e-41
Identities = 63/217 (29%), Positives = 93/217 (42%), Gaps = 18/217 (8%)
Query: 170 QSATNRFSK-DNIIGDGGYGVVYRG-QLMNGTAVAVK--KLLNNPGQADKDFRVEVEAIG 225
S RF K D IG G + VY+G VA + + F+ E E +
Sbjct: 21 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK 80
Query: 226 HVRHKNLVRLLGYCIEGTQR----ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILL 281
++H N+VR + +LV E + +G L+ +L+ + +
Sbjct: 81 GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCR 136
Query: 282 GTAKALAYLHEAIEPKVVHRDIKSSNILID-ENFDAKISDFGLAKLLGAGKSHITTRVMG 340
K L +LH P ++HRD+K NI I KI D GLA L A + V+G
Sbjct: 137 QILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIG 192
Query: 341 TFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYP 377
T ++APE +E DVY+FG+ +LE T YP
Sbjct: 193 TPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYP 228
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 5e-41
Identities = 74/324 (22%), Positives = 123/324 (37%), Gaps = 37/324 (11%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLM-----NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR 228
+ +G G +G V + G VAVK+L ++ +DF+ E++ + +
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 229 HKNLVRLLGYCIEGTQR--ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKA 286
+V+ G ++ LV EY+ +G L +L+ R L + K
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKG 139
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF--GY 344
+ YL + VHRD+ + NIL++ KI+DFGLAKLL K + R G +
Sbjct: 140 MEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW 196
Query: 345 VAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSE 403
APE + + + +SDV+SFGVVL E T + E +
Sbjct: 197 YAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS----- 251
Query: 404 DVVDPNIET-----RPS--TSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIPR 456
+++ +E P + + + C P RP S + L+
Sbjct: 252 RLLE-LLEEGQRLPAPPACPAEVHELM---KLCWAPSPQDRPSFSALGPQLDML-----W 302
Query: 457 EDRRRRRNQAGASEAESQRESSDT 480
R A + E + S
Sbjct: 303 SGSRGCETHAFTAHPEGKHHSLSF 326
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-40
Identities = 73/234 (31%), Positives = 106/234 (45%), Gaps = 33/234 (14%)
Query: 171 SATNRFSKD------------NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFR 218
+A + F + IG G +G V G G VAVK + + F
Sbjct: 6 AAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFL 62
Query: 219 VEVEAIGHVRHKNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARM 277
E + +RH NLV+LLG +E + +V EY+ G+L +LR R L + +
Sbjct: 63 AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--RGRSVLGGDCLL 120
Query: 278 KILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337
K L +A+ YL VHRD+ + N+L+ E+ AK+SDFGL K +T+
Sbjct: 121 KFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA------SSTQ 171
Query: 338 VMGTFGY--VAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDY-GRPQSEV 387
G APE + KSDV+SFG++L E + GR P Y P +V
Sbjct: 172 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP--YPRIPLKDV 223
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 5e-40
Identities = 66/206 (32%), Positives = 103/206 (50%), Gaps = 14/206 (6%)
Query: 179 DNIIGDGGYGVVYRGQLMNG---TAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKNLVR 234
D +G G +G V +G VA+K L +AD + E + + + + +VR
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 235 LLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI 294
L+G C + +LV E G L ++L G R + ++L + + YL E
Sbjct: 75 LIGVC-QAEALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK- 129
Query: 295 EPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF--GYVAPEYANS 352
VHRD+ + N+L+ AKISDFGL+K LGA S+ T R G + + APE N
Sbjct: 130 --NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187
Query: 353 GLLNEKSDVYSFGVVLLEAIT-GRYP 377
+ +SDV+S+GV + EA++ G+ P
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKP 213
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 8e-40
Identities = 61/215 (28%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKD----FRVEVEAIGHVR 228
+R+ I+G GG V+ + L + VAVK +L D FR E + +
Sbjct: 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALN 70
Query: 229 HKNLVRLLGYCIE-GTQRILVY---EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTA 284
H +V + L Y EYV+ L + G +T + ++++
Sbjct: 71 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADAC 126
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITT--RVMGTF 342
+AL + H+ ++HRD+K +NI+I K+ DFG+A+ + + +T V+GT
Sbjct: 127 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 343 GYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYP 377
Y++PE A ++ +SDVYS G VL E +TG P
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 9e-40
Identities = 63/297 (21%), Positives = 120/297 (40%), Gaps = 39/297 (13%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLM-----NGTAVAVKKLLNNPGQAD-KDFRVEVEAIGHV 227
+ +G+G +G V + G VAVK L G D + E+E + ++
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 228 RHKNLVRLLGYCIEGTQR--ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAK 285
H+N+V+ G C E L+ E++ +G+L+++L + + + + ++K + K
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICK 137
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF--G 343
+ YL + VHRD+ + N+L++ KI DFGL K + K + T +
Sbjct: 138 GMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF 194
Query: 344 YVAPEYANSGLLNEKSDVYSFGVVLLEAIT---------GRYPVDYGRPQSEVNLVEWLK 394
+ APE SDV+SFGV L E +T + G ++ + +
Sbjct: 195 WYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254
Query: 395 MMVQLRRSEDVVDPNIETRPS--TSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449
+ + +R P + + + +C + R ++ E+
Sbjct: 255 TLKEGKRLP---------CPPNCPDEVYQLM---RKCWEFQPSNRTSFQNLIEGFEA 299
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-39
Identities = 72/279 (25%), Positives = 116/279 (41%), Gaps = 40/279 (14%)
Query: 182 IGDGGYGVVYRGQL-MNGTAVAVKKL-LNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYC 239
IG G +G V+ G+L + T VAVK P F E + H N+VRL+G C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 240 IEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVV 299
+ +V E V G+ +LR + L + ++++ A + YL +
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK---CCI 235
Query: 300 HRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYV-----APEYANSGL 354
HRD+ + N L+ E KISDFG+++ + G V APE N G
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREE---ADGVYAASGGL-RQVPVKWTAPEALNYGR 291
Query: 355 LNEKSDVYSFGVVLLEAIT-GRYPVDY-GRPQSEVNLVEWLKMMVQLRRSEDVVDPNIET 412
+ +SDV+SFG++L E + G P Y + + + + R
Sbjct: 292 YSSESDVWSFGILLWETFSLGASP--YPNLSNQQT-----REFVEKGGRLP--------- 335
Query: 413 RPST--SALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449
P A+ R + +C + +RP S + + L+S
Sbjct: 336 CPELCPDAVFRLM---EQCWAYEPGQRPSFSTIYQELQS 371
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-39
Identities = 63/249 (25%), Positives = 111/249 (44%), Gaps = 25/249 (10%)
Query: 145 APSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVK 204
P P + LG+G W + +G G +GVV G+ VA+K
Sbjct: 1 GPLGSKNAPSTAGLGYGSWEIDPK------DLTFLKELGTGQFGVVKYGKWRGQYDVAIK 54
Query: 205 KLLNNPGQADK-DFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRG 263
+ G + +F E + + ++ H+ LV+L G C + ++ EY+ NG L +LR
Sbjct: 55 MI--KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE 112
Query: 264 DMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323
R + +++ +A+ YL + +HRD+ + N L+++ K+SDFGL
Sbjct: 113 ---MRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGL 166
Query: 324 AKLLGAGKSHITTRVMGTFGYV---APEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVD 379
++ + T +G+ V PE + KSD+++FGV++ E + G+ P
Sbjct: 167 SRYV---LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP-- 221
Query: 380 Y-GRPQSEV 387
Y SE
Sbjct: 222 YERFTNSET 230
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 1e-39
Identities = 69/310 (22%), Positives = 124/310 (40%), Gaps = 37/310 (11%)
Query: 167 RDLQSATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIG 225
+ + +G+GG+ V + L +G A+K++L + Q ++ + E +
Sbjct: 22 HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR 81
Query: 226 HVRHKNLVRLLGYCIEGTQR----ILVYEYVNNGNLEQWLRGDMCDRGYLTWEAR-MKIL 280
H N++RL+ YC+ L+ + G L + +LT E + + +L
Sbjct: 82 LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLT-EDQILWLL 140
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVM- 339
LG + L +H HRD+K +NIL+ + + D G +
Sbjct: 141 LGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 340 -------GTFGYVAPE----YANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVN 388
T Y APE ++ ++E++DV+S G VL + G P D + +
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCV-IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV 256
Query: 389 LVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448
L + QL I P S+ LL ++ VDP +RP + ++ LE
Sbjct: 257 A---LAVQNQLS---------IPQSPRHSSALWQLLNSMMTVDP--HQRPHIPLLLSQLE 302
Query: 449 SEEYPIPRED 458
+ + P P +
Sbjct: 303 ALQPPAPGQH 312
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-39
Identities = 75/253 (29%), Positives = 107/253 (42%), Gaps = 28/253 (11%)
Query: 141 HPLTAPSPLSG-LPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGT 199
L P + G + W IG G +G V G G
Sbjct: 165 TRLIKPKVMEGTVAAQDEFYRSGWALNMK------ELKLLQTIGKGEFGDVMLGDY-RGN 217
Query: 200 AVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI-LVYEYVNNGNLE 258
VAVK + + F E + +RH NLV+LLG +E + +V EY+ G+L
Sbjct: 218 KVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 275
Query: 259 QWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKI 318
+LR R L + +K L +A+ YL VHRD+ + N+L+ E+ AK+
Sbjct: 276 DYLRS--RGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKV 330
Query: 319 SDFGLAKLLGAGKSHITTRVMGTFGY--VAPEYANSGLLNEKSDVYSFGVVLLEAIT-GR 375
SDFGL K +T+ G APE + KSDV+SFG++L E + GR
Sbjct: 331 SDFGLT------KEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 384
Query: 376 YPVDY-GRPQSEV 387
P Y P +V
Sbjct: 385 VP--YPRIPLKDV 395
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-39
Identities = 71/219 (32%), Positives = 109/219 (49%), Gaps = 17/219 (7%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKNL 232
+ + IG G +G+V+ G +N VA+K + G + DF E E + + H L
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI--REGAMSEEDFIEEAEVMMKLSHPKL 65
Query: 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE 292
V+L G C+E LV E++ +G L +LR RG E + + L + +AYL E
Sbjct: 66 VQLYGVCLEQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEE 122
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGY--VAPEYA 350
A V+HRD+ + N L+ EN K+SDFG+ + + T+ F +PE
Sbjct: 123 A---CVIHRDLAARNCLVGENQVIKVSDFGMTRFV--LDDQYTSSTGTKFPVKWASPEVF 177
Query: 351 NSGLLNEKSDVYSFGVVLLEAIT-GRYPVDY-GRPQSEV 387
+ + KSDV+SFGV++ E + G+ P Y R SEV
Sbjct: 178 SFSRYSSKSDVWSFGVLMWEVFSEGKIP--YENRSNSEV 214
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-39
Identities = 64/234 (27%), Positives = 109/234 (46%), Gaps = 31/234 (13%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNG-----TAVAVKKLLNNPGQADK-DFRVEVEAIGHV 227
F K ++G G +G VY+G + VA+K+L + E + V
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 228 RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKAL 287
+ ++ RLLG C+ T ++ + + + G L ++R + + + + + AK +
Sbjct: 75 DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGM 130
Query: 288 AYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRV-------MG 340
YL + ++VHRD+ + N+L+ KI+DFGLAKLLGA + M
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM- 186
Query: 341 TFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDY-GRPQSEV-NLVE 391
A E + +SDV+S+GV + E +T G P Y G P SE+ +++E
Sbjct: 187 -----ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSILE 233
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 3e-39
Identities = 55/201 (27%), Positives = 87/201 (43%), Gaps = 13/201 (6%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRV----EVEAIGHVRHKNLVRLL 236
+G GG G VY + + VA+K L++ +D FR E G ++ ++V +
Sbjct: 42 VGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 237 GYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEP 296
+ Q + +N +L LR +G L + I+ AL H A
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLR----RQGPLAPPRAVAIVRQIGSALDAAHAA--- 153
Query: 297 KVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLN 356
HRD+K NIL+ + A + DFG+A K +GT Y+APE +
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHAT 213
Query: 357 EKSDVYSFGVVLLEAITGRYP 377
++D+Y+ VL E +TG P
Sbjct: 214 YRADIYALTCVLYECLTGSPP 234
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-39
Identities = 60/209 (28%), Positives = 95/209 (45%), Gaps = 15/209 (7%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLM-----NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR 228
+G G +G V + G VAVKKL ++ + +DF E+E + ++
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 229 HKNLVRLLGYCIEGTQR--ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKA 286
H N+V+ G C +R L+ EY+ G+L +L+ + + ++ K
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKG 126
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF--GY 344
+ YL + +HRD+ + NIL++ KI DFGL K+L K + G +
Sbjct: 127 MEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFW 183
Query: 345 VAPEYANSGLLNEKSDVYSFGVVLLEAIT 373
APE + SDV+SFGVVL E T
Sbjct: 184 YAPESLTESKFSVASDVWSFGVVLYELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-38
Identities = 60/209 (28%), Positives = 96/209 (45%), Gaps = 15/209 (7%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLM-----NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR 228
+G G +G V + G VAVKKL ++ + +DF E+E + ++
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 229 HKNLVRLLGYCIEGTQR--ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKA 286
H N+V+ G C +R L+ EY+ G+L +L+ + + ++ K
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKG 157
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF--GY 344
+ YL + +HRD+ + NIL++ KI DFGL K+L K + + G +
Sbjct: 158 MEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFW 214
Query: 345 VAPEYANSGLLNEKSDVYSFGVVLLEAIT 373
APE + SDV+SFGVVL E T
Sbjct: 215 YAPESLTESKFSVASDVWSFGVVLYELFT 243
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 1e-38
Identities = 75/293 (25%), Positives = 124/293 (42%), Gaps = 34/293 (11%)
Query: 180 NIIGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKNLVRLLG 237
+ +G G YG VY G VAVK L + +F E + ++H NLV+LLG
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 238 YCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK 297
C ++ E++ GNL +LR +R ++ + + + A+ YL +
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---N 338
Query: 298 VVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNE 357
+HR++ + N L+ EN K++DFGL++L+ + APE +
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 358 KSDVYSFGVVLLEAIT-GRYPVDY-GRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPS 415
KSDV++FGV+L E T G P Y G S+V E L+ ++ R E + E
Sbjct: 399 KSDVWAFGVLLWEIATYGMSP--YPGIDLSQV--YELLEKDYRMERPEGCPEKVYELM-- 452
Query: 416 TSALKRALLTALRCVDPDSDKRPKMSQVVRMLE------SEEYPIPREDRRRR 462
C + RP +++ + E S + +E +R
Sbjct: 453 -----------RACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKRG 494
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-38
Identities = 74/316 (23%), Positives = 127/316 (40%), Gaps = 57/316 (18%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN 231
+ F + ++G G +G V + + ++ A+KK+ + + EV + + H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILS-EVMLLASLNHQY 63
Query: 232 LVRLLGYCIEGTQRI-------------LVYEYVNNGNLEQWLRGDMCDRGYLTWEAR-M 277
+VR +E + + EY NG L +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH----SENLNQQRDEYW 119
Query: 278 KILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL---------- 327
++ +AL+Y+H ++HRD+K NI IDE+ + KI DFGLAK +
Sbjct: 120 RLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 328 ----GAGKSHITTRVMGTFGYVAPE-YANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGR 382
++T+ + GT YVA E +G NEK D+YS G++ E I YP G
Sbjct: 177 SQNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI---YPFSTGM 232
Query: 383 PQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQ 442
E + ++ +LR P+ + + ++ L DP +KRP
Sbjct: 233 --------ERVNILKKLRSVSIEFPPDFDDNKMKVE--KKIIRLLIDHDP--NKRPGART 280
Query: 443 VVRMLESEEYPIPRED 458
+ L S P+ +D
Sbjct: 281 L---LNSGWLPVKHQD 293
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-38
Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 19/213 (8%)
Query: 181 IIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKNLVRLLGYC 239
+G G +GVV G+ VAVK + G + +F E + + + H LV+ G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMI--KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 240 IEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVV 299
+ +V EY++NG L +LR L +++ + +A+L + +
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRS---HGKGLEPSQLLEMCYDVCEGMAFLESH---QFI 126
Query: 300 HRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT---FGYVAPEYANSGLLN 356
HRD+ + N L+D + K+SDFG+ + + +GT + APE + +
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYV---LDDQYVSSVGTKFPVKWSAPEVFHYFKYS 183
Query: 357 EKSDVYSFGVVLLEAIT-GRYPVDY-GRPQSEV 387
KSDV++FG+++ E + G+ P Y SEV
Sbjct: 184 SKSDVWAFGILMWEVFSLGKMP--YDLYTNSEV 214
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 2e-38
Identities = 63/230 (27%), Positives = 103/230 (44%), Gaps = 21/230 (9%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLM----NGTAVAVKKL---LNNPGQADKDFRVEVEAIGH 226
+GDG +GVV RG+ +VAVK L + + +A DF EV A+
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 227 VRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKA 286
+ H+NL+RL G + ++ V E G+L LR +G+ + + A+
Sbjct: 78 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEG 133
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGY-- 344
+ YL + +HRD+ + N+L+ KI DFGL + L H + +
Sbjct: 134 MGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190
Query: 345 VAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDY-GRPQSEV-NLVE 391
APE + + SD + FGV L E T G+ P + G S++ + ++
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP--WIGLNGSQILHKID 238
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-38
Identities = 61/208 (29%), Positives = 103/208 (49%), Gaps = 16/208 (7%)
Query: 178 KDNIIGDGGYGVVYRGQLMNG---TAVAVKKLLNN--PGQADKDFRVEVEAIGHVRHKNL 232
+D +G G +G V +G VAVK L N + E + + + +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE 292
VR++G C E +LV E G L ++L+ ++ + ++++ + + YL E
Sbjct: 81 VRMIGIC-EAESWMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE 135
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF--GYVAPEYA 350
+ VHRD+ + N+L+ AKISDFGL+K L A +++ + G + + APE
Sbjct: 136 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 192
Query: 351 NSGLLNEKSDVYSFGVVLLEAIT-GRYP 377
N + KSDV+SFGV++ EA + G+ P
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 6e-38
Identities = 65/214 (30%), Positives = 100/214 (46%), Gaps = 8/214 (3%)
Query: 171 SATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL-LNNPGQADKDF-RVEVEAIGHV 227
S + IG G YG + + +G + K+L + +A+K EV + +
Sbjct: 3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 62
Query: 228 RHKNLVRLLGYCIEGTQRIL--VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAK 285
+H N+VR I+ T L V EY G+L + +R YL E ++++
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122
Query: 286 ALAYLHE--AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
AL H V+HRD+K +N+ +D + K+ DFGLA++L S T V GT
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPY 181
Query: 344 YVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYP 377
Y++PE N NEKSD++S G +L E P
Sbjct: 182 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 8e-38
Identities = 73/326 (22%), Positives = 133/326 (40%), Gaps = 41/326 (12%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLM-----NGTAVAVKKLLNNPGQAD-KDFRVEVEAIGHV 227
K ++G G +G V++G + V +K + + G+ + + AIG +
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 228 RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKAL 287
H ++VRLLG C + ++ V +Y+ G+L +R RG L + + + AK +
Sbjct: 73 DHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGM 128
Query: 288 AYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT---FGY 344
YL E +VHR++ + N+L+ +++DFG+A LL + +
Sbjct: 129 YYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYS--EAKTPIKW 183
Query: 345 VAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDY-GRPQSEVNLVEWLKMMVQLRRS 402
+A E + G +SDV+S+GV + E +T G P Y G +EV L +
Sbjct: 184 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEP--YAGLRLAEV--------PDLLEKG 233
Query: 403 EDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVV----RMLESEEYPIPRED 458
E + P I T + + ++C D + RP ++ RM + +
Sbjct: 234 ERLAQPQI----CTIDVYMVM---VKCWMIDENIRPTFKELANEFTRMARDPPRYLVIKR 286
Query: 459 RRRRRNQAGASEAESQRESSDTDKNE 484
G + + + E
Sbjct: 287 ESGPGIAPGPEPHGLTNKKLEEVELE 312
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 8e-38
Identities = 65/340 (19%), Positives = 139/340 (40%), Gaps = 40/340 (11%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL-LNNPGQADK-DFRVEVEAIGHVRHK 230
++ + IG+G +G + +G +K++ ++ ++ + R EV + +++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 231 NLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYL 290
N+V+ E +V +Y G+L + + + + + AL ++
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRIN--AQKGVLFQEDQILDWFVQICLALKHV 141
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYA 350
H+ K++HRDIKS NI + ++ ++ DFG+A++L + + GT Y++PE
Sbjct: 142 HD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEIC 197
Query: 351 NSGLLNEKSDVYSFGVVLLEAITGRYP------------VDYGRPQ------SEVNLVEW 392
+ N KSD+++ G VL E T ++ + G S +L
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSY-DLRSL 256
Query: 393 LKMMVQLRRSEDVVDPNIETRPSTSA-LKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451
+ + + +P RPS ++ L++ + + ++ + + S+
Sbjct: 257 VSQLFK-------RNP--RDRPSVNSILEKGFIA--KRIEKFLSPQLIAEEFCLKTFSKF 305
Query: 452 YPIPREDRRRRRNQAGASEAESQRESSDTDKNENPESRLK 491
P +R Q S +Q+ + K P + K
Sbjct: 306 GSQPIPAKRPASGQNSISVMPAQKITKPAAKYGIPLAYKK 345
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 8e-38
Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 14/206 (6%)
Query: 179 DNIIGDGGYGVVYRGQLMNG---TAVAVKKL-LNNPGQADKDFRVEVEAIGHVRHKNLVR 234
D +G G +G V +G VA+K L ++ E + + + + +VR
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 235 LLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI 294
L+G C + +LV E G L ++L G R + ++L + + YL E
Sbjct: 401 LIGVC-QAEALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK- 455
Query: 295 EPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGY--VAPEYANS 352
VHR++ + N+L+ AKISDFGL+K LGA S+ T R G + APE N
Sbjct: 456 --NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 513
Query: 353 GLLNEKSDVYSFGVVLLEAIT-GRYP 377
+ +SDV+S+GV + EA++ G+ P
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKP 539
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-37
Identities = 75/259 (28%), Positives = 112/259 (43%), Gaps = 30/259 (11%)
Query: 129 GNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYG 188
G+ K+ R P T P + EF+ S D ++G G +G
Sbjct: 12 GHLKLPGLRTFVDPHTFEDPTQTVHEFA------KELDAT------NISIDKVVGAGEFG 59
Query: 189 VVYRGQL----MNGTAVAVKKLLNNPGQADK---DFRVEVEAIGHVRHKNLVRLLGYCIE 241
V G+L +VA+K L G +K DF E +G H N++RL G +
Sbjct: 60 EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 242 GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHR 301
++V EY+ NG+L+ +LR T + +L G A + YL + VHR
Sbjct: 118 SKPVMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHR 171
Query: 302 DIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGY--VAPEYANSGLLNEKS 359
D+ + NILI+ N K+SDFGL ++L T G +PE S
Sbjct: 172 DLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSAS 231
Query: 360 DVYSFGVVLLEAIT-GRYP 377
DV+S+G+VL E ++ G P
Sbjct: 232 DVWSYGIVLWEVMSYGERP 250
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-37
Identities = 77/273 (28%), Positives = 124/273 (45%), Gaps = 28/273 (10%)
Query: 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKNLVRLLGY 238
+G G +G V+ G T VA+K L PG F E + + +RH+ LV+L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 239 CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKV 298
E I V EY++ G+L +L+G+ YL + + A +AY+
Sbjct: 248 VSEEPIYI-VTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NY 301
Query: 299 VHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEK 358
VHRD++++NIL+ EN K++DFGLA+L+ + + APE A G K
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 361
Query: 359 SDVYSFGVVLLEAIT-GRYPVDY-GRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPST 416
SDV+SFG++L E T GR P Y G EV ++ ++ ++ + +
Sbjct: 362 SDVWSFGILLTELTTKGRVP--YPGMVNREV--LDQVERGYRMPCPPECPES-------- 409
Query: 417 SALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449
L + +C + ++RP + LE
Sbjct: 410 --LHDLM---CQCWRKEPEERPTFEYLQAFLED 437
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-37
Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 25/224 (11%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNG-TAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKN 231
+ + +G G YG VY G VAVK L + +F E + ++H N
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL--KEDTMEVEEFLKEAAVMKEIKHPN 70
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
LV+LLG C ++ E++ GNL +LR C+R ++ + + + A+ YL
Sbjct: 71 LVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLE 128
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL------GAGKSHITTRVMGTFGYV 345
+ +HRD+ + N L+ EN K++DFGL++L+ + +
Sbjct: 129 KK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT------ 179
Query: 346 APEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDY-GRPQSEV 387
APE + KSDV++FGV+L E T G P Y G S+V
Sbjct: 180 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSP--YPGIDLSQV 221
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-37
Identities = 70/216 (32%), Positives = 106/216 (49%), Gaps = 23/216 (10%)
Query: 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKNLVRLLGY 238
+G G +G V+ G T VAVK L G F E + ++H+ LVRL
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSL--KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 239 CIEGTQR--ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEP 296
TQ ++ EY+ NG+L +L+ LT + + A+ +A++ E
Sbjct: 77 V---TQEPIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER--- 128
Query: 297 KVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT---FGYVAPEYANSG 353
+HRD++++NIL+ + KI+DFGLA+L+ + + T G + APE N G
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 354 LLNEKSDVYSFGVVLLEAIT-GRYPVDY-GRPQSEV 387
KSDV+SFG++L E +T GR P Y G EV
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIP--YPGMTNPEV 219
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 5e-37
Identities = 68/277 (24%), Positives = 122/277 (44%), Gaps = 21/277 (7%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKK--LLNNPGQADK-DFRVEVEAIGHVRH 229
F + IG G + VYR L++G VA+KK + + + D E++ + + H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
N+++ IE + +V E + G+L + ++ + + K + AL +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEY 349
+H +V+HRDIK +N+ I K+ D GL + + + + V GT Y++PE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207
Query: 350 ANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409
+ N KSD++S G +L E + P YG + +L + + P
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNLYSLC--------KKIEQCDYPPL 258
Query: 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446
S R L+ C++PD +KRP ++ V +
Sbjct: 259 PSDHYSEEL--RQLVN--MCINPDPEKRPDVTYVYDV 291
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 6e-37
Identities = 71/324 (21%), Positives = 130/324 (40%), Gaps = 40/324 (12%)
Query: 129 GNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYG 188
G + + AP + P + L D +S R+ + +G GG+
Sbjct: 1 GPAPADPGKAGVPGVAAPGAPAAAPPAKEIPE----VLVDPRSR-RRYVRGRFLGKGGFA 55
Query: 189 VVYRGQ-LMNGTAVAVK----KLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT 243
+ A K LL P Q +K E+ + H+++V G+ E
Sbjct: 56 KCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM-EISIHRSLAHQHVVGFHGF-FEDN 113
Query: 244 QRI-LVYEYVNNGNLEQWLRGDMCDRGYLT-WEARMKILLGTAKALAYLHEAIEPKVVHR 301
+ +V E +L + + R LT EAR L YLH +V+HR
Sbjct: 114 DFVFVVLELCRRRSLLELHK----RRKALTEPEAR-YYLRQIVLGCQYLHRN---RVIHR 165
Query: 302 DIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDV 361
D+K N+ ++E+ + KI DFGLA + + GT Y+APE + + + DV
Sbjct: 166 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSFEVDV 224
Query: 362 YSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKR 421
+S G ++ + G+ P + L E +++++E + +I + A
Sbjct: 225 WSIGCIMYTLLVGKPPFE------TSCLKETYL---RIKKNEYSIPKHI----NPVA--A 269
Query: 422 ALLTALRCVDPDSDKRPKMSQVVR 445
+L+ + + D RP +++++
Sbjct: 270 SLIQ--KMLQTDPTARPTINELLN 291
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 6e-37
Identities = 67/297 (22%), Positives = 121/297 (40%), Gaps = 41/297 (13%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMN-----GTAVAVKKLLNNPGQAD-KDFRVEVEAIGHV 227
K +G+G +G V G VAVK L + G ++ E++ + +
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 228 RHKNLVRLLGYCIEGTQR--ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAK 285
H+++++ G C + LV EYV G+L +L + + +
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICE 145
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF--G 343
+AYLH +HRD+ + N+L+D + KI DFGLAK + G + R G
Sbjct: 146 GMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF 202
Query: 344 YVAPEYANSGLLNEKSDVYSFGVVLLEAIT---------GRYPVDYGRPQSEVNLVEWLK 394
+ APE SDV+SFGV L E +T ++ G Q ++ ++ +
Sbjct: 203 WYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262
Query: 395 MMVQLRRSEDVVDPNIETRPS--TSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449
++ + R RP + + + C + ++ RP ++ +L++
Sbjct: 263 LLERGERLP---------RPDKCPAEVYHLM---KNCWETEASFRPTFENLIPILKT 307
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 136 bits (346), Expect = 6e-37
Identities = 64/278 (23%), Positives = 118/278 (42%), Gaps = 35/278 (12%)
Query: 175 RFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVK----KLLNNPGQADKDFRVEVEAIGHVRH 229
R+ + +G GG+ + A K LL P Q +K E+ + H
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSM-EISIHRSLAH 74
Query: 230 KNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLT-WEARMKILLGTAKAL 287
+++V G+ E + +V E +L + + R LT EAR L
Sbjct: 75 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHK----RRKALTEPEAR-YYLRQIVLGC 128
Query: 288 AYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAP 347
YLH +V+HRD+K N+ ++E+ + KI DFGLA + + GT Y+AP
Sbjct: 129 QYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAP 184
Query: 348 EYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407
E + + + DV+S G ++ + G+ P + L E +++++E +
Sbjct: 185 EVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFE------TSCLKETYL---RIKKNEYSIP 235
Query: 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVR 445
+I + A +L+ + + D RP +++++
Sbjct: 236 KHI----NPVA--ASLIQ--KMLQTDPTARPTINELLN 265
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 6e-37
Identities = 86/312 (27%), Positives = 136/312 (43%), Gaps = 35/312 (11%)
Query: 141 HPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTA 200
H LT P S P+ L W R+ + +G G +G V+ G T
Sbjct: 241 HRLTTVCPTSK-PQTQGLAKDAWEIPRE------SLRLEVKLGQGCFGEVWMGTWNGTTR 293
Query: 201 VAVKKLLNNPGQADK-DFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQ 259
VA+K L PG F E + + +RH+ LV+L E I V EY++ G+L
Sbjct: 294 VAIKTL--KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYI-VTEYMSKGSLLD 350
Query: 260 WLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKIS 319
+L+G+ YL + + A +AY+ VHRD++++NIL+ EN K++
Sbjct: 351 FLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVA 405
Query: 320 DFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPV 378
DFGLA+L+ + + APE A G KSDV+SFG++L E T GR P
Sbjct: 406 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP- 464
Query: 379 DY-GRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKR 437
Y G EV ++ ++ ++ + + L + +C + ++R
Sbjct: 465 -YPGMVNREV--LDQVERGYRMPCPPECPES----------LHDLM---CQCWRKEPEER 508
Query: 438 PKMSQVVRMLES 449
P + LE
Sbjct: 509 PTFEYLQAFLED 520
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 9e-37
Identities = 67/207 (32%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 179 DNIIGDGGYGVVYRGQLM----NGTAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKNLV 233
+ IIG G G V G+L VA+K L + + DF E +G H N++
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 234 RLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEA 293
RL G G ++V EY+ NG+L+ +LR G T + +L G + YL +
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDL 170
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGY--VAPEYAN 351
VHRD+ + N+L+D N K+SDFGL+++L T G APE
Sbjct: 171 ---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227
Query: 352 SGLLNEKSDVYSFGVVLLEAIT-GRYP 377
+ SDV+SFGVV+ E + G P
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 9e-37
Identities = 64/230 (27%), Positives = 111/230 (48%), Gaps = 23/230 (10%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNG-----TAVAVKKLLNNPGQADK-DFRVEVEAIGHV 227
F K ++G G +G VY+G + VA+K+L + E + V
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 228 RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKAL 287
+ ++ RLLG C+ T ++ + + + G L ++R + + + + + AK +
Sbjct: 75 DNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGM 130
Query: 288 AYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT---FGY 344
YL + ++VHRD+ + N+L+ KI+DFGLAKLLGA + G +
Sbjct: 131 NYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKW 185
Query: 345 VAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDY-GRPQSEV-NLVE 391
+A E + +SDV+S+GV + E +T G P Y G P SE+ +++E
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKP--YDGIPASEISSILE 233
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-36
Identities = 80/296 (27%), Positives = 125/296 (42%), Gaps = 49/296 (16%)
Query: 179 DNIIGDGGYGVVYRGQLMNG----TAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKNLV 233
+ +IG G +G VY G L++ AVK L + F E + H N++
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89
Query: 234 RLLGYCIEGTQRIL-VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE 292
LLG C+ L V Y+ +G+L ++R + T + + L AK + YL
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLAS 146
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG------YVA 346
K VHRD+ + N ++DE F K++DFGLA+ + V G ++A
Sbjct: 147 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDM---YDKEYYSVHNKTGAKLPVKWMA 200
Query: 347 PEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYG-RPQSEVNLVEWLKMMVQLRRSEDV 405
E + KSDV+SFGV+L E +T G P +VN + ++Q RR
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRLL-- 252
Query: 406 VDPNIETRPS--TSALKRALLTALRCVDPDSDKRPKMSQVVRMLE-------SEEY 452
+P L + L+C P ++ RP S++V + E Y
Sbjct: 253 -------QPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 298
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-36
Identities = 67/317 (21%), Positives = 125/317 (39%), Gaps = 49/317 (15%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL-LNNPGQADKDFRVEVEAIGHVRHKN 231
F +G GG+GVV+ + ++ A+K++ L N A + EV+A+ + H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 232 LVRLLGYCIEGT---------QRILVY---EYVNNGNLEQWLRGDMCDRGYLTWEARMKI 279
+VR +E ++ +Y + NL+ W+ C + I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN-GRCTIEERERSVCLHI 123
Query: 280 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVM 339
L A+A+ +LH ++HRD+K SNI + K+ DFGL + + T
Sbjct: 124 FLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 340 -----------GTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVN 388
GT Y++PE + + K D++S G++L E + +++
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY--------PFSTQME 232
Query: 389 LVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM-- 446
V L + L+ P + T+ ++ + P +RP+ ++
Sbjct: 233 RVRTLTDVRNLKF------PPLFTQKYPCE--YVMVQDMLSPSP--MERPEAINIIENAV 282
Query: 447 LESEEYPIPREDRRRRR 463
E ++P R+R R
Sbjct: 283 FEDLDFPGKTVLRQRSR 299
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-36
Identities = 67/215 (31%), Positives = 104/215 (48%), Gaps = 19/215 (8%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNGTA-----VAVKKLLNNPGQADK---DFRVEVEAIG 225
+ ++ +IG G +G VY+G L + VA+K L G +K DF E +G
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL--KAGYTEKQRVDFLGEAGIMG 101
Query: 226 HVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAK 285
H N++RL G + +++ EY+ NG L+++LR G + + +L G A
Sbjct: 102 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAA 158
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGY- 344
+ YL VHRD+ + NIL++ N K+SDFGL+++L T G
Sbjct: 159 GMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 215
Query: 345 -VAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYP 377
APE + SDV+SFG+V+ E +T G P
Sbjct: 216 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKNLVRLLGY 238
+G G +G V+ T VAVK + PG F E + ++H LV+L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTM--KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 239 CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKV 298
+ I + E++ G+L +L+ D + + A+ +A++ +
Sbjct: 252 VTKEPIYI-ITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NY 305
Query: 299 VHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYV---APEYANSGLL 355
+HRD++++NIL+ + KI+DFGLA+++ + + T G + APE N G
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSF 362
Query: 356 NEKSDVYSFGVVLLEAIT-GRYPVDY-GRPQSEV 387
KSDV+SFG++L+E +T GR P Y G EV
Sbjct: 363 TIKSDVWSFGILLMEIVTYGRIP--YPGMSNPEV 394
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 4e-36
Identities = 65/291 (22%), Positives = 113/291 (38%), Gaps = 49/291 (16%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL 232
F + +IG GG+G V++ + ++G +K++ ++ EV+A+ + H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV----KYNNEKAEREVKALAKLDHVNI 66
Query: 233 VRLLGYCIEGTQRI----------------LVYEYVNNGNLEQWLRGDMCDRGYLTWEAR 276
V G + E+ + G LEQW+ L
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE--KRRGEKLDKVLA 124
Query: 277 MKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITT 336
+++ K + Y+H K+++RD+K SNI + + KI DFGL L T
Sbjct: 125 LELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--T 179
Query: 337 RVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMM 396
R GT Y++PE +S ++ D+Y+ G++L E +
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----AFETSKFF------ 228
Query: 397 VQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447
D+ D I + LL L P + RP S+++R L
Sbjct: 229 ------TDLRDGIISDIFDKKE--KTLLQKLLSKKP--EDRPNTSEILRTL 269
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 7e-36
Identities = 32/311 (10%), Positives = 65/311 (20%), Gaps = 49/311 (15%)
Query: 169 LQSATNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLL---NNPGQADKDFRVEVEAI 224
L + + G VV+ + A+K N + A
Sbjct: 57 LSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAA 116
Query: 225 GHVRHKNLVRLLGYC----------IEGTQRI----------------LVYEYV--NNGN 256
+ ++ ++ L+ +
Sbjct: 117 ARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLEL 176
Query: 257 LEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDA 316
L L RG A + + A L +VH N+ I +
Sbjct: 177 LFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRL 233
Query: 317 KISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSG--LLNEKSDVYSFGVVLLEAITG 374
+ D +G Y E+ N+ + + G+ +
Sbjct: 234 MLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289
Query: 375 RYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDS 434
P P + R + + L+ D
Sbjct: 290 FLPFGLVTPGIK------GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDR-- 341
Query: 435 DKRPKMSQVVR 445
+R + +
Sbjct: 342 RRRLLPLEAME 352
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-36
Identities = 77/325 (23%), Positives = 129/325 (39%), Gaps = 63/325 (19%)
Query: 167 RDLQSATNRFSKD-------------NIIGDGGYGVVYRGQLMNG----TAVAVKKLLNN 209
RDL SA KD +IG G +GVVY G+ ++ A+K L
Sbjct: 1 RDLDSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI 60
Query: 210 PGQADK-DFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL-VYEYVNNGNLEQWLRGDMCD 267
F E + + H N++ L+G + + Y+ +G+L Q++R
Sbjct: 61 TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP--- 117
Query: 268 RGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
+ T + + L A+ + YL E K VHRD+ + N ++DE+F K++DFGLA+ +
Sbjct: 118 QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDI 174
Query: 328 ---------GAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYP 377
+ + + A E + KSDV+SFGV+L E +T G P
Sbjct: 175 LDREYYSVQQHRHARLPVKWT------ALESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228
Query: 378 VDY-GRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPS--TSALKRALLTALRCVDPDS 434
Y ++ + Q RR +P +L + + +C + D
Sbjct: 229 --YRHIDPFDL-----THFLAQGRRLP---------QPEYCPDSLYQVM---QQCWEADP 269
Query: 435 DKRPKMSQVVRMLESEEYPIPREDR 459
RP +V +E + +
Sbjct: 270 AVRPTFRVLVGEVEQIVSALLGDHY 294
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 9e-36
Identities = 78/303 (25%), Positives = 121/303 (39%), Gaps = 49/303 (16%)
Query: 170 QSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-R 228
QS N + I+G G G V G VAVK++L +E++ +
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLI---DFCDIALMEIKLLTESDD 67
Query: 229 HKNLVRLLGYCIEGTQR--ILVYEYVNNGNLEQWL--RGDMCDRGYLTWEARMK-ILLGT 283
H N++R YC E T R + E N NL+ + + + L E +L
Sbjct: 68 HPNVIRY--YCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILID-------------ENFDAKISDFGLAKLLGAG 330
A +A+LH K++HRD+K NIL+ EN ISDFGL K L +G
Sbjct: 125 ASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 331 KSHITTRVM---GTFGYVAPE-------YANSGLLNEKSDVYSFGVVLLEAITGRYPVDY 380
+S T + GT G+ APE L D++S G V ++
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241
Query: 381 GRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKM 440
+ E N+ ++ + L + + D ++ A L++ + DP KRP
Sbjct: 242 DKYSRESNI---IRGIFSLDEMKCLHDRSL----IAEA--TDLISQMIDHDP--LKRPTA 290
Query: 441 SQV 443
+V
Sbjct: 291 MKV 293
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 9e-36
Identities = 57/270 (21%), Positives = 98/270 (36%), Gaps = 32/270 (11%)
Query: 182 IGDGGYGVVYRG--QLMNGTAVAVKKLLNNPGQADKD-FRVEVEAIGHVRHKNLVRLLGY 238
I GG G +Y + +NG V +K L+++ + E + + V H ++V++ +
Sbjct: 88 IAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNF 147
Query: 239 CIEGTQRI-----LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEA 293
+ +V EYV +L++ L + LL AL+YLH
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK------LPVAEAIAYLLEILPALSYLHSI 201
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSG 353
+V+ D+K NI++ E K+ D G + + + GT G+ APE
Sbjct: 202 ---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS-----FGYLYGTPGFQAPEIV-RT 251
Query: 354 LLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVV----DPN 409
+D+Y+ G L + LK R ++ DP+
Sbjct: 252 GPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLKTYDSYGR---LLRRAIDPD 308
Query: 410 IETRP-STSALKRALLTALRCVDPDSDKRP 438
R + + L LR V P
Sbjct: 309 PRQRFTTAEEMSAQLTGVLREVVAQDTGVP 338
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 9e-36
Identities = 72/298 (24%), Positives = 122/298 (40%), Gaps = 56/298 (18%)
Query: 180 NIIGDGGYGVVYRGQLMNG------TAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLV 233
+G+G +G V+ + N VAVK L A +DF+ E E + ++H+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 234 RLLGYCIEGTQRILVYEYVNNGNLEQWLR-----------GDMCDRGYLTWEARMKILLG 282
R G C EG ++V+EY+ +G+L ++LR G+ G L + +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL-------GAGKSHIT 335
A + YL VHRD+ + N L+ + KI DFG+++ + G++ +
Sbjct: 167 VAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 223
Query: 336 TRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDY-GRPQSEVNLVEWL 393
R M PE +SDV+SFGVVL E T G+ P + +E ++ +
Sbjct: 224 IRWM------PPESILYRKFTTESDVWSFGVVLWEIFTYGKQP--WYQLSNTEA--IDCI 273
Query: 394 KMMVQLRRSEDVVDP--NIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449
+L R I C + +R + V L++
Sbjct: 274 TQGRELERPRACPPEVYAI---------------MRGCWQREPQQRHSIKDVHARLQA 316
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-35
Identities = 59/216 (27%), Positives = 91/216 (42%), Gaps = 25/216 (11%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNG----TAVAVKKL-LNNPGQADKDFRVEVEAIGHVR 228
R IG+G +G V++G M+ AVA+K + F E +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALA 288
H ++V+L+G E I + E G L +L+ + L + + + ALA
Sbjct: 75 HPHIVKLIGVITENPVWI-IMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALA 130
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG------AGKSHITTRVMGTF 342
YL + VHRDI + N+L+ N K+ DFGL++ + A K + + M
Sbjct: 131 YLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM--- 184
Query: 343 GYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYP 377
APE N SDV+ FGV + E + G P
Sbjct: 185 ---APESINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 2e-35
Identities = 67/281 (23%), Positives = 108/281 (38%), Gaps = 36/281 (12%)
Query: 175 RFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLV 233
F +++G G G + + + VAVK++L + EV+ + H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVI 81
Query: 234 RLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-ILLGTAKALAYLHE 292
R + + + E L+++ + + + +L T LA+LH
Sbjct: 82 RYFCTEKDRQFQYIAIELC-AATLQEY----VEQKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 293 AIEPKVVHRDIKSSNILIDENFD-----AKISDFGLAKLLGAGKSHITTR--VMGTFGYV 345
+VHRD+K NILI A ISDFGL K L G+ + R V GT G++
Sbjct: 137 L---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWI 193
Query: 346 APEY---ANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRS 402
APE D++S G V I+ Q + N+ L +
Sbjct: 194 APEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI---------LLGA 244
Query: 403 EDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQV 443
+ + E A R L+ + +DP KRP V
Sbjct: 245 CSLDCLHPEKHEDVIA--RELIEKMIAMDP--QKRPSAKHV 281
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 2e-35
Identities = 76/299 (25%), Positives = 126/299 (42%), Gaps = 48/299 (16%)
Query: 179 DNIIGDGGYGVVYRGQLMNG----TAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKNLV 233
+ +IG G +G VY G L++ AVK L + F E + H N++
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 234 RLLGYCIEG-TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE 292
LLG C+ ++V Y+ +G+L ++R + T + + L AK + +L
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLAS 210
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL---------GAGKSHITTRVMGTFG 343
K VHRD+ + N ++DE F K++DFGLA+ + + + + M
Sbjct: 211 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM---- 263
Query: 344 YVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYG-RPQSEVNLVEWLKMMVQLRRS 402
A E + KSDV+SFGV+L E +T G P +VN + ++Q RR
Sbjct: 264 --ALESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRRL 315
Query: 403 EDVVDPNIETRPS--TSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIPREDR 459
+P L + L+C P ++ RP S++V + + E
Sbjct: 316 L---------QPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY 362
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-35
Identities = 57/209 (27%), Positives = 89/209 (42%), Gaps = 25/209 (11%)
Query: 181 IIGDGGYGVVYRGQLMNG----TAVAVKKL-LNNPGQADKDFRVEVEAIGHVRHKNLVRL 235
I+G+G +G VY G N VAVK + + F E + ++ H ++V+L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 236 LGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIE 295
+G E I + E G L +L + + L + L KA+AYL
Sbjct: 79 IGIIEEEPTWI-IMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI-- 132
Query: 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKLLG------AGKSHITTRVMGTFGYVAPEY 349
VHRDI NIL+ K+ DFGL++ + A + + + M +PE
Sbjct: 133 -NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM------SPES 185
Query: 350 ANSGLLNEKSDVYSFGVVLLEAIT-GRYP 377
N SDV+ F V + E ++ G+ P
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 5e-35
Identities = 70/292 (23%), Positives = 117/292 (40%), Gaps = 50/292 (17%)
Query: 180 NIIGDGGYGVVYRGQLMNG------TAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKNL 232
+G G +G VY GQ+ VAVK L + D+ DF +E I H+N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLR---GDMCDRGYLTWEARMKILLGTAKALAY 289
VR +G ++ R ++ E + G+L+ +LR L + + A Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 290 LHEAIEPKVVHRDIKSSNILID---ENFDAKISDFGLAKLL-------GAGKSHITTRVM 339
L E +HRDI + N L+ AKI DFG+A+ + G + + + M
Sbjct: 156 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212
Query: 340 GTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQ 398
PE G+ K+D +SFGV+L E + G P + EV +E++ +
Sbjct: 213 ------PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQEV--LEFVTSGGR 263
Query: 399 LRRSEDVVDP--NIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448
+ ++ P I +C + RP + ++ +E
Sbjct: 264 MDPPKNCPGPVYRI---------------MTQCWQHQPEDRPNFAIILERIE 300
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-35
Identities = 62/238 (26%), Positives = 104/238 (43%), Gaps = 36/238 (15%)
Query: 176 FSKDNI-----IGDGGYGVVYRGQLMNG------TAVAVKKLLNNPGQADK-DFRVEVEA 223
+++ I +G G +G+VY G T VA+K + ++ +F E
Sbjct: 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASV 81
Query: 224 IGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLR------GDMCDRGYLTWEARM 277
+ ++VRLLG +G +++ E + G+L+ +LR + + +
Sbjct: 82 MKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 278 KILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL-------GAG 330
++ A +AYL+ K VHRD+ + N ++ E+F KI DFG+ + + G
Sbjct: 142 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 198
Query: 331 KSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEV 387
K + R M +PE G+ SDV+SFGVVL E T P G +V
Sbjct: 199 KGLLPVRWM------SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY-QGLSNEQV 249
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 6e-35
Identities = 58/286 (20%), Positives = 106/286 (37%), Gaps = 39/286 (13%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVK--KLLNNPGQADKDFRVEVEAIGHVRHKN 231
+S IG GG V++ A+K L Q +R E+ + ++ +
Sbjct: 28 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 232 L--VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
+RL Y I +V E N +L WL+ + + R +A+
Sbjct: 88 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHT 142
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR-VMGTFGYVAPE 348
+H+ +VH D+K +N LI + K+ DFG+A + + + +GT Y+ PE
Sbjct: 143 IHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 198
Query: 349 -----------YANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMV 397
+ ++ KSDV+S G +L G+ P +N + L ++
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHAII 253
Query: 398 QLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQV 443
+ P + +L DP +R + ++
Sbjct: 254 DPN-----HEIEFPDIPEKDL--QDVLKCCLKRDP--KQRISIPEL 290
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 9e-35
Identities = 66/232 (28%), Positives = 107/232 (46%), Gaps = 36/232 (15%)
Query: 182 IGDGGYGVVYRGQLMNG------TAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRL 235
+G+G +G V+ + N VAVK L + A KDF+ E E + +++H+++V+
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 236 LGYCIEGTQRILVYEYVNNGNLEQWLR------------GDMCDRGYLTWEARMKILLGT 283
G C +G I+V+EY+ +G+L ++LR +G L + I
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL-------GAGKSHITT 336
A + YL VHRD+ + N L+ N KI DFG+++ + G + +
Sbjct: 143 ASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 337 RVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEV 387
R M PE +SDV+SFGV+L E T G+ P + +EV
Sbjct: 200 RWM------PPESIMYRKFTTESDVWSFGVILWEIFTYGKQPW-FQLSNTEV 244
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-34
Identities = 59/286 (20%), Positives = 115/286 (40%), Gaps = 39/286 (13%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVK--KLLNNPGQADKDFRVEVEAIGHVRHKN 231
+S IG GG V++ A+K L Q +R E+ + ++ +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 232 L--VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
+RL Y I +V E N +L WL+ + + R +A+
Sbjct: 69 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHT 123
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR-VMGTFGYVAPE 348
+H+ +VH D+K +N LI + K+ DFG+A + + + +GT Y+ PE
Sbjct: 124 IHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179
Query: 349 -----------YANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMV 397
+ ++ KSDV+S G +L G+ P + + ++++ K+
Sbjct: 180 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--FQQIINQIS-----KLHA 232
Query: 398 QLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQV 443
+ + ++ P+I P + +L C+ D +R + ++
Sbjct: 233 IIDPNHEIEFPDI---PEKDL--QDVL--KCCLKRDPKQRISIPEL 271
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-34
Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 17/211 (8%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVK----KLLNNPGQADKDFRVEVEAIGHVR 228
F N++G G + VYR + + G VA+K K + G + EV+ ++
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN-EVKIHCQLK 69
Query: 229 HKNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLT-WEARMKILLGTAKA 286
H +++ L Y E + + LV E +NG + ++L+ + EAR +
Sbjct: 70 HPSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNR---VKPFSENEAR-HFMHQIITG 124
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVA 346
+ YLH ++HRD+ SN+L+ N + KI+DFGLA L T + GT Y++
Sbjct: 125 MLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYIS 180
Query: 347 PEYANSGLLNEKSDVYSFGVVLLEAITGRYP 377
PE A +SDV+S G + + GR P
Sbjct: 181 PEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-34
Identities = 64/282 (22%), Positives = 105/282 (37%), Gaps = 37/282 (13%)
Query: 108 QSGSFNNLEKDVVGSQLGEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLR 167
+ ++ K + G VS + + + + R
Sbjct: 336 GERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYTMPSTR------DYEIQR 389
Query: 168 DLQSATNRFSKDNIIGDGGYGVVYRGQLMNG----TAVAVKKL-LNNPGQADKDFRVEVE 222
+ R IG+G +G V++G M+ AVA+K + F E
Sbjct: 390 E------RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEAL 443
Query: 223 AIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG 282
+ H ++V+L+G E I + E G L +L+ + L + +
Sbjct: 444 TMRQFDHPHIVKLIGVITENPVWI-IMELCTLGELRSFLQVR---KFSLDLASLILYAYQ 499
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG------AGKSHITT 336
+ ALAYL + VHRDI + N+L+ N K+ DFGL++ + A K +
Sbjct: 500 LSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 556
Query: 337 RVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYP 377
+ M APE N SDV+ FGV + E + G P
Sbjct: 557 KWM------APESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-34
Identities = 62/309 (20%), Positives = 115/309 (37%), Gaps = 59/309 (19%)
Query: 181 IIGDGGYGVVYRGQL--------MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL 232
+G G + +++G ++ T V +K L + F + + HK+L
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE 292
V G C+ G + ILV E+V G+L+ +L+ ++ + ++++ A A+ +L E
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEE 131
Query: 293 AIEPKVVHRDIKSSNILID--------ENFDAKISDFGLAKLLGAGKSHITTRV----MG 340
++H ++ + NIL+ K+SD G++ + + +
Sbjct: 132 N---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV---LPKDILQERIPWV- 184
Query: 341 TFGYVAPE-YANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDY-GRPQSEVNLVEWLKMMV 397
PE N LN +D +SFG L E + G P L+
Sbjct: 185 -----PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP--LSALDSQRK-----LQFYE 232
Query: 398 QLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYP--IP 455
+ P + L + C+D + D RP ++R L S P +P
Sbjct: 233 DRHQLP---------APKAAELANLI---NNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280
Query: 456 REDRRRRRN 464
R +
Sbjct: 281 RGSHHHHHH 289
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-34
Identities = 71/278 (25%), Positives = 109/278 (39%), Gaps = 36/278 (12%)
Query: 175 RFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKD---FRVEVEAIGHV-RH 229
F + + +G G YG V++ + +G AVK+ +P + KD EV + V +H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRS-MSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEAR-MKILLGTAKALA 288
VRL EG L E +L+Q G EA+ L T ALA
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELCG-PSLQQHCE----AWGASLPEAQVWGYLRDTLLALA 171
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPE 348
+LH +VH D+K +NI + K+ DFGL LG + G Y+APE
Sbjct: 172 HLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV--QEGDPRYMAPE 226
Query: 349 YANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408
+DV+S G+ +LE G + QLR+ + P
Sbjct: 227 LLQGS-YGTAADVFSLGLTILEVACNMELPHGG------------EGWQQLRQG--YLPP 271
Query: 409 NIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446
S+ R++L ++PD R ++ +
Sbjct: 272 EFTAGLSSEL--RSVLV--MMLEPDPKLRATAEALLAL 305
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-34
Identities = 70/298 (23%), Positives = 122/298 (40%), Gaps = 54/298 (18%)
Query: 180 NIIGDGGYGVVYRGQLMNG------TAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKNL 232
+G+ +G VY+G L AVA+K L + + +FR E ++H N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLR------------GDMCDRGYLTWEARMKIL 280
V LLG + +++ Y ++G+L ++L D + L + ++
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL-------GAGKSH 333
A + YL VVH+D+ + N+L+ + + KISD GL + + G S
Sbjct: 135 AQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 334 ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEW 392
+ R M APE G + SD++S+GVVL E + G P G +V
Sbjct: 192 LPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPY-CGYSNQDV----- 239
Query: 393 LKMMVQLRRSEDVVDPNIETRPS-TSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449
++M+ + P A AL+ + C + +RP+ + L +
Sbjct: 240 VEMIRNRQVLP---------CPDDCPAWVYALM--IECWNEFPSRRPRFKDIHSRLRA 286
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-34
Identities = 49/353 (13%), Positives = 94/353 (26%), Gaps = 65/353 (18%)
Query: 175 RFSKDNIIGDGGYGVVYRG-QLMNGTAVAVK---KLLNNPGQADKDFRVEVEAIGHVRH- 229
+ ++G G + V P A K + EV + +R
Sbjct: 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 230 ---------------KNLVRLLGYC-----IEGTQRILVYEYV--------NNGNLEQWL 261
+LV+ + + V N + L
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198
Query: 262 RGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDF 321
L AR+++ L + LA LH +VH ++ +I++D+ ++ F
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGF 255
Query: 322 GLAKLLGAGKSHITTRVMGTFGYVAPE-----YANSGLLNEKSDVYSFGVVLLEAITGRY 376
GA R A + L+ D ++ G+ +
Sbjct: 256 EHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADL 315
Query: 377 PVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDK 436
P + + EW+ R +++ RALL +
Sbjct: 316 P--NTDD-AALGGSEWI-----FRSCKNI-----------PQPVRALLEGFLRYPK--ED 354
Query: 437 RPKMSQVVRMLESEEYPIPREDRRRRRNQAGASEAESQRESSDTDKNENPESR 489
R Q +E+ EY R + ++ + P+
Sbjct: 355 RLLPLQA---METPEYEQLRTELSAALPLYQTDGEPTREGGAPPSGTSQPDEA 404
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-34
Identities = 57/230 (24%), Positives = 102/230 (44%), Gaps = 33/230 (14%)
Query: 180 NIIGDGGYGVVYRGQLMNG----TAVAVK--KLLNNPGQADKDFRVEVEAIGHVRHKNLV 233
I+G+G +G V G L VAVK KL N+ + ++F E + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 234 RLLGYCIEGTQRI-----LVYEYVNNGNLEQWLRG--DMCDRGYLTWEARMKILLGTAKA 286
RLLG CIE + + ++ ++ G+L +L ++ + +K ++ A
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL-------GAGKSHITTRVM 339
+ YL +HRD+ + N ++ ++ ++DFGL+K + + + + +
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 340 GTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDY-GRPQSEV 387
A E + KSDV++FGV + E T G P Y G E+
Sbjct: 217 ------AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP--YPGVQNHEM 258
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-34
Identities = 61/226 (26%), Positives = 101/226 (44%), Gaps = 31/226 (13%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNG---TAVAVKKLLNNPGQADK-DFRVEVEAIGHV-R 228
N ++IG+G +G V + ++ A+K++ + D DF E+E + +
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLR------------GDMCDRGYLTWEAR 276
H N++ LLG C L EY +GNL +LR L+ +
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 277 MKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITT 336
+ A+ + YL + + +HRD+ + NIL+ EN+ AKI+DFGL++
Sbjct: 145 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 201
Query: 337 RV----MGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYP 377
R+ M A E N + SDV+S+GV+L E ++ G P
Sbjct: 202 RLPVRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 8e-34
Identities = 70/292 (23%), Positives = 117/292 (40%), Gaps = 50/292 (17%)
Query: 180 NIIGDGGYGVVYRGQLMNG------TAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKNL 232
+G G +G VY GQ+ VAVK L + D+ DF +E I H+N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLR---GDMCDRGYLTWEARMKILLGTAKALAY 289
VR +G ++ R ++ E + G+L+ +LR L + + A Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 290 LHEAIEPKVVHRDIKSSNILID---ENFDAKISDFGLAKLL-------GAGKSHITTRVM 339
L E +HRDI + N L+ AKI DFG+A+ + G + + + M
Sbjct: 197 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM 253
Query: 340 GTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQ 398
PE G+ K+D +SFGV+L E + G P + EV +E++ +
Sbjct: 254 ------PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY-PSKSNQEV--LEFVTSGGR 304
Query: 399 LRRSEDVVDP--NIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448
+ ++ P I +C + RP + ++ +E
Sbjct: 305 MDPPKNCPGPVYRI---------------MTQCWQHQPEDRPNFAIILERIE 341
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 65/290 (22%), Positives = 104/290 (35%), Gaps = 65/290 (22%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL-LNNPGQADK-DFRVEVEAIGHV-R 228
T F + IG G +G V++ ++G A+K+ G D+ + EV A + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALA 288
H ++VR E ++ EY N G+L + + Y +LL + L
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 289 YLHEAIEPKVVHRDIKSSNILIDEN-------------------FDAKISDFGLAKLLGA 329
Y+H +VH DIK SNI I KI D G + +
Sbjct: 130 YIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 330 GKSHITTRVMGTFGYVAPEYANSGLLNE------KSDVYSFGVVLLEAITGRYPVDYGRP 383
+ G ++A E +L E K+D+++ + ++ A G
Sbjct: 187 PQVEE-----GDSRFLANE-----VLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ 236
Query: 384 QSEVN--------------LVEWLKMMVQLRRSEDVVDPNIETRPSTSAL 419
E+ E LK+M+ DP E RPS AL
Sbjct: 237 WHEIRQGRLPRIPQVLSQEFTELLKVMIH-------PDP--ERRPSAMAL 277
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-33
Identities = 61/211 (28%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL----LNNPGQADKDFRVEVEAIGHVR 228
F +G G +G VY + + +A+K L L G + R EVE H+R
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQ-LRREVEIQSHLR 67
Query: 229 HKNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLT-WEARMKILLGTAKA 286
H N++RL GY R+ L+ EY G + + L+ + A A
Sbjct: 68 HPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTA-TYITELANA 121
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVA 346
L+Y H +V+HRDIK N+L+ + KI+DFG + + + GT Y+
Sbjct: 122 LSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT-DL--CGTLDYLP 175
Query: 347 PEYANSGLLNEKSDVYSFGVVLLEAITGRYP 377
PE + +EK D++S GV+ E + G+ P
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-33
Identities = 50/231 (21%), Positives = 98/231 (42%), Gaps = 34/231 (14%)
Query: 180 NIIGDGGYGVVYRGQLMNG----TAVAVKKL-LNNPGQAD-KDFRVEVEAIGHVRHKNLV 233
++G G +G V QL VAVK L + +D ++F E + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 234 RLLGYCIEGTQRI------LVYEYVNNGNLEQWLRGDMCDR--GYLTWEARMKILLGTAK 285
+L+G + + ++ ++ +G+L +L L + ++ ++ A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL-------GAGKSHITTRV 338
+ YL +HRD+ + N ++ E+ ++DFGL++ + S + +
Sbjct: 149 GMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKW 205
Query: 339 MGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDY-GRPQSEV 387
+ A E L SDV++FGV + E +T G+ P Y G +E+
Sbjct: 206 L------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP--YAGIENAEI 248
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-33
Identities = 81/278 (29%), Positives = 124/278 (44%), Gaps = 39/278 (14%)
Query: 173 TNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN 231
+ ++G G YG+VY G L N +A+K++ + + E+ H++HKN
Sbjct: 21 YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKN 80
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLR--------GDMCDRGYLTWEARMKILLGT 283
+V+ LG E + E V G+L LR + Y +IL G
Sbjct: 81 IVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTK-----QILEG- 134
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILID-ENFDAKISDFGLAKLLGAGKSHITTRVMGTF 342
L YLH+ ++VHRDIK N+LI+ + KISDFG +K L T GT
Sbjct: 135 ---LKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTL 187
Query: 343 GYVAPEYANSGLL--NEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLR 400
Y+APE + G + +D++S G ++E TG+ P + L E M ++
Sbjct: 188 QYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP--FY------ELGEPQAAMFKVG 239
Query: 401 RSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRP 438
+ P I S A +A + L+C +PD DKR
Sbjct: 240 MFKVH--PEIPESMSAEA--KAFI--LKCFEPDPDKRA 271
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-33
Identities = 65/305 (21%), Positives = 108/305 (35%), Gaps = 40/305 (13%)
Query: 170 QSATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL--LNNPGQADKDFRVEVEAIGH 226
++ + + +I+G G V+RG+ G A+K ++ D R E E +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKK 63
Query: 227 VRHKNLVRLLGYCIEGTQR--ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTA 284
+ HKN+V+L E T R +L+ E+ G+L L G E +L
Sbjct: 64 LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVV 122
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDA----KISDFGLAKLLGAGKSHITTRVMG 340
+ +L E +VHR+IK NI+ D K++DFG A+ L + G
Sbjct: 123 GGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-G 177
Query: 341 TFGYVAPEYANSGLL--------NEKSDVYSFGVVLLEAITGRYP-VDYGRPQSEVNLVE 391
T Y+ P+ +L D++S GV A TG P + P+ ++
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237
Query: 392 -------------WLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRP 438
K + + L +L + D +K
Sbjct: 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQ--EKCW 295
Query: 439 KMSQV 443
Q
Sbjct: 296 GFDQF 300
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 57/286 (19%), Positives = 106/286 (37%), Gaps = 39/286 (13%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVK--KLLNNPGQADKDFRVEVEAIGHVRHKN 231
+S IG GG V++ A+K L Q +R E+ + ++ +
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 232 L--VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
+RL Y I +V E N +L WL+ + + R +A+
Sbjct: 116 DKIIRLYDYEITDQYIYMVMECG-NIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHT 170
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR-VMGTFGYVAPE 348
+H+ +VH D+K +N LI + K+ DFG+A + + + +G Y+ PE
Sbjct: 171 IHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226
Query: 349 -----------YANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMV 397
+ ++ KSDV+S G +L G+ P +N + L ++
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ-----QIINQISKLHAII 281
Query: 398 QLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQV 443
+ P + +L C+ D +R + ++
Sbjct: 282 D-----PNHEIEFPDIPEKDL--QDVL--KCCLKRDPKQRISIPEL 318
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 66/314 (21%), Positives = 110/314 (35%), Gaps = 46/314 (14%)
Query: 170 QSATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL--LNNPGQADKDFRVEVEAIGH 226
++ + + +I+G G V+RG+ G A+K ++ D R E E +
Sbjct: 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEVLKK 63
Query: 227 VRHKNLVRLLGYCIEGTQR--ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTA 284
+ HKN+V+L E T R +L+ E+ G+L L G E +L
Sbjct: 64 LNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFL-IVLRDVV 122
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDA----KISDFGLAKLLGAGKSHITTRVMG 340
+ +L E +VHR+IK NI+ D K++DFG A+ L + G
Sbjct: 123 GGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-G 177
Query: 341 TFGYVAPEYANSGLL--------NEKSDVYSFGVVLLEAITGRYP-VDYGRPQSEVNLVE 391
T Y+ P+ +L D++S GV A TG P + P+ E
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPR---RNKE 234
Query: 392 WLKMMVQLRRSEDVVDPNIETR----------------PSTSALKRALLTALRCVDPDSD 435
+ ++ + S + L +L + D +
Sbjct: 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQ--E 292
Query: 436 KRPKMSQVVRMLES 449
K Q
Sbjct: 293 KCWGFDQFFAETSD 306
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-32
Identities = 62/203 (30%), Positives = 94/203 (46%), Gaps = 20/203 (9%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVKKL----LNNPGQADKDFRVEVEAIGHVRHKNLVRLL 236
+G G +G VY + N +A+K L L G + R E+E H+RH N++R+
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRR-EIEIQSHLRHPNILRMY 80
Query: 237 GYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLT-WEARMKILLGTAKALAYLHEAI 294
Y +RI L+ E+ G L + L+ G + + A AL Y HE
Sbjct: 81 NY-FHDRKRIYLMLEFAPRGELYKELQ----KHGRFDEQRSATFMEE-LADALHYCHER- 133
Query: 295 EPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGL 354
KV+HRDIK N+L+ + KI+DFG + + + T GT Y+ PE
Sbjct: 134 --KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR-TM--CGTLDYLPPEMIEGKT 188
Query: 355 LNEKSDVYSFGVVLLEAITGRYP 377
+EK D++ GV+ E + G P
Sbjct: 189 HDEKVDLWCAGVLCYEFLVGMPP 211
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 129 bits (324), Expect = 5e-32
Identities = 71/291 (24%), Positives = 110/291 (37%), Gaps = 32/291 (10%)
Query: 175 RFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVK--KLLNNPGQADKDFRVEVEAIGHVRHKN 231
+ +G GG+G V R G VA+K + +P ++ E++ + + H N
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL-EIQIMKKLNHPN 73
Query: 232 LVRLL------GYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAK 285
+V +L EY G+L ++L G R +L +
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR-TLLSDISS 132
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDA---KISDFGLAKLLGAGKSHITTRVMGTF 342
AL YLHE +++HRD+K NI++ KI D G AK L G T V GT
Sbjct: 133 ALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFV-GTL 187
Query: 343 GYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQ----------SEVNLVEW 392
Y+APE D +SFG + E ITG P S ++V +
Sbjct: 188 QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247
Query: 393 LKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQV 443
+ ++ S + PN + L+R L + +R Q
Sbjct: 248 DDLTGAVKFSSVLPTPNHLSGILAGKLER-WLQCMLMWHQ--RQRGTDPQN 295
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 9e-32
Identities = 65/245 (26%), Positives = 111/245 (45%), Gaps = 42/245 (17%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLM--------NGTAVAVKKLLNNPGQADK-DFRVEVEAI 224
++ + +G+G +G V + + VAVK L ++ + D D E+E +
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 225 GHV-RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLR------------GDMCDRGYL 271
+ +HKN++ LLG C + ++ EY + GNL ++LR + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 272 TWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL---- 327
T++ + A+ + YL K +HRD+ + N+L+ EN KI+DFGLA+ +
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 328 ---GAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDY-GR 382
+ + M APE + +SDV+SFGV++ E T G P Y G
Sbjct: 212 YYKKTTNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YPGI 263
Query: 383 PQSEV 387
P E+
Sbjct: 264 PVEEL 268
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-31
Identities = 72/253 (28%), Positives = 108/253 (42%), Gaps = 52/253 (20%)
Query: 176 FSKDNI-----IGDGGYGVVYRGQLMNG------TAVAVKKLLNNPGQADK-DFRVEVEA 223
+ ++NI IG+G +G V++ + T VAVK L + DF+ E
Sbjct: 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAAL 103
Query: 224 IGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLR--------------------G 263
+ + N+V+LLG C G L++EY+ G+L ++LR
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163
Query: 264 DMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323
L+ ++ I A +AYL E K VHRD+ + N L+ EN KI+DFGL
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGL 220
Query: 324 AKLL-------GAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GR 375
++ + G I R M PE +SDV+++GVVL E + G
Sbjct: 221 SRNIYSADYYKADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFSYGL 274
Query: 376 YPVDY-GRPQSEV 387
P Y G EV
Sbjct: 275 QP--YYGMAHEEV 285
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-31
Identities = 67/250 (26%), Positives = 103/250 (41%), Gaps = 47/250 (18%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNG------TAVAVKKLLNNPGQADK-DFRVEVEAIGH 226
+G+G +G V + + T VAVK L N ++ D E +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 227 VRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLR--------------------GDMC 266
V H ++++L G C + +L+ EY G+L +LR D
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 267 DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326
D LT + ++ + YL E K+VHRD+ + NIL+ E KISDFGL++
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 327 L-------GAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPV 378
+ + I + M A E + +SDV+SFGV+L E +T G P
Sbjct: 200 VYEEDSYVKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP- 252
Query: 379 DY-GRPQSEV 387
Y G P +
Sbjct: 253 -YPGIPPERL 261
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-31
Identities = 56/277 (20%), Positives = 104/277 (37%), Gaps = 32/277 (11%)
Query: 168 DLQSATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGH 226
+ + + + +G G +G V+R + G AVKK+ + + E+ A
Sbjct: 52 EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV-----RLEVFRVEELVACAG 106
Query: 227 VRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKA 286
+ +V L G EG + E + G+L Q ++ G L + + L +
Sbjct: 107 LSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIK----QMGCLPEDRALYYLGQALEG 162
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDEN-FDAKISDFGLAKLLGAGKSHITTR----VMGT 341
L YLH +++H D+K+ N+L+ + A + DFG A L + + GT
Sbjct: 163 LEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219
Query: 342 FGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRR 401
++APE + K D++S ++L + G P ++ +
Sbjct: 220 ETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC------HPWTQYFRGPLCLKIASEPP 273
Query: 402 SEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRP 438
P E PS + L + + + R
Sbjct: 274 ------PIREIPPSCAPLTAQAI--QEGLRKEPVHRA 302
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-31
Identities = 63/233 (27%), Positives = 98/233 (42%), Gaps = 38/233 (16%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMN------GTAVAVKKLLNNPGQADK-DFRVEVEAIGH 226
+R +G G +G V VAVK L ++ E++ + H
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 227 V-RHKNLVRLLGYC-IEGTQRILVYEYVNNGNLEQWLR------------GDMCDRGYLT 272
+ H N+V LLG C G +++ E+ GNL +LR + + +LT
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 273 WEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL----- 327
E + AK + +L K +HRD+ + NIL+ E KI DFGLA+ +
Sbjct: 147 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 203
Query: 328 --GAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYP 377
G + + + M APE + +SDV+SFGV+L E + G P
Sbjct: 204 YVRKGDARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 122 bits (306), Expect = 8e-31
Identities = 47/315 (14%), Positives = 90/315 (28%), Gaps = 73/315 (23%)
Query: 175 RFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVK---KLLNNPGQADKDFRVEVEAIGHVR-- 228
+ ++G G + V P A K + EV + +R
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 229 -----------------------HKNLVRLLGYC--IEGTQRILVYE--YVNNGNLEQWL 261
K ++R+ + R +Y N + L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 262 RGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDF 321
L AR+++ L + LA LH +VH ++ +I++D+ ++ F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGF 250
Query: 322 GLAKLLGAGKSHITTRVMGTFGYVAPEY-----------ANSGLLNEKSDVYSFGVVLLE 370
GA + G+ PE L+ D ++ G+V+
Sbjct: 251 EHLVRDGA-----RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW 305
Query: 371 AITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCV 430
P+ + + EW+ R +++ RALL +
Sbjct: 306 IWCADLPIT---KDAALGGSEWI-----FRSCKNI-----------PQPVRALLE--GFL 344
Query: 431 DPDSDKRPKMSQVVR 445
+ R Q +
Sbjct: 345 RYPKEDRLLPLQAME 359
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 9e-31
Identities = 62/290 (21%), Positives = 114/290 (39%), Gaps = 35/290 (12%)
Query: 163 WFTLRDLQSATNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLL--NNPGQADKDFRV 219
F + + + +G G YG V + A+K + + ++
Sbjct: 26 MFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLE 85
Query: 220 EVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR-- 276
EV + + H N+++L + + LV E G L ++ R +A
Sbjct: 86 EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFD----EIIHRMKFNEVDAAVI 141
Query: 277 MKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLLGAGKSH 333
+K +L + YLH+ +VHRD+K N+L+ +++ KI DFGL+ + K
Sbjct: 142 IKQVLS---GVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM 195
Query: 334 ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWL 393
+GT Y+APE +EK DV+S GV+L + G P G+ E
Sbjct: 196 --KERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPF-GGQTDQE------- 244
Query: 394 KMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQV 443
++ ++ + + + + S + L+ + D +R Q
Sbjct: 245 -ILRKVEKGK--YTFDSPEWKNVSEGAKDLIKQMLQFDS--QRRISAQQA 289
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 9e-31
Identities = 51/324 (15%), Positives = 117/324 (36%), Gaps = 55/324 (16%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKL------------------LNNPGQADKDFRVEVEA 223
+ G + + + + A+KK ++ + D E++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKN-ELQI 96
Query: 224 IGHVRHKNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWL----RGDMCDRGYLT-WEARM 277
I ++++ + G I + ++YEY+ N ++ ++ D ++ +
Sbjct: 97 ITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK- 154
Query: 278 KILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337
I+ + +Y+H E + HRD+K SNIL+D+N K+SDFG ++ + K +
Sbjct: 155 CIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK-GS- 210
Query: 338 VMGTFGYVAPEYANSGLL--NEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLK- 394
GT+ ++ PE+ ++ K D++S G+ L P +++LVE
Sbjct: 211 -RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS-----LKISLVELFNN 264
Query: 395 ---------MMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVR 445
+ + + S L +P +R ++
Sbjct: 265 IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNP--AERITSEDALK 322
Query: 446 ---MLESEEYPIPREDRRRRRNQA 466
+ ++ + + + +
Sbjct: 323 HEWLADTNIEDLREFSKELYKKRK 346
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 65/245 (26%), Positives = 111/245 (45%), Gaps = 42/245 (17%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLM--------NGTAVAVKKLLNNPGQADK-DFRVEVEAI 224
++ + +G+G +G V + + VAVK L ++ + D D E+E +
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 225 GHV-RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLR------------GDMCDRGYL 271
+ +HKN++ LLG C + ++ EY + GNL ++LR + +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 272 TWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL---- 327
T++ + A+ + YL K +HRD+ + N+L+ EN KI+DFGLA+ +
Sbjct: 201 TFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 328 ---GAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDY-GR 382
+ + M APE + +SDV+SFGV++ E T G P Y G
Sbjct: 258 YYKKTTNGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP--YPGI 309
Query: 383 PQSEV 387
P E+
Sbjct: 310 PVEEL 314
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 61/234 (26%), Positives = 96/234 (41%), Gaps = 39/234 (16%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMN------GTAVAVKKLLNNPGQADK-DFRVEVEAIGH 226
NR S +G G +G V VAVK L + ++ E++ + +
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 227 V-RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLR--------------GDMCDRGYL 271
+ H N+V LLG C G +++ EY G+L +LR D L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 272 TWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL---- 327
E + AK +A+L +HRD+ + NIL+ KI DFGLA+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 328 ---GAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYP 377
G + + + M APE + + +SDV+S+G+ L E + G P
Sbjct: 200 NYVVKGNARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 66/248 (26%), Positives = 110/248 (44%), Gaps = 47/248 (18%)
Query: 176 FSKDNI-----IGDGGYGVVYRGQLMN--------GTAVAVKKLLNNPGQADK-DFRVEV 221
+D + +G+G +G V + + T VAVK L ++ + D D E+
Sbjct: 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEM 125
Query: 222 EAIGHV-RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLR------------GDMCDR 268
E + + +HKN++ LLG C + ++ EY + GNL ++L+
Sbjct: 126 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185
Query: 269 GYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL- 327
L+ + + A+ + YL K +HRD+ + N+L+ E+ KI+DFGLA+ +
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIH 242
Query: 328 ------GAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDY 380
+ + M APE + +SDV+SFGV+L E T G P Y
Sbjct: 243 HIDYYKKTTNGRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP--Y 294
Query: 381 -GRPQSEV 387
G P E+
Sbjct: 295 PGVPVEEL 302
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-30
Identities = 57/230 (24%), Positives = 95/230 (41%), Gaps = 35/230 (15%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPGQADK-DFRVEVEAIGH 226
N +G G +G V VAVK L + +K E++ + H
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 227 V-RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLR----------GDMCDRGYLTWEA 275
+ +H+N+V LLG C G +++ EY G+L +LR +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 276 RMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL-------G 328
+ A+ +A+L +HRD+ + N+L+ AKI DFGLA+ +
Sbjct: 166 LLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIV 222
Query: 329 AGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYP 377
G + + + M APE + +SDV+S+G++L E + G P
Sbjct: 223 KGNARLPVKWM------APESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-30
Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 173 TNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN 231
F ++G G + V+ Q + G A+K + +P D E+ + ++H+N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--MKILLGTAKALA 288
+V L T LV + V+ G L + +RG T +A ++ +L A+
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGELFDRI----LERGVYTEKDASLVIQQVLS---AVK 120
Query: 289 YLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYV 345
YLHE +VHRD+K N+L +EN I+DFGL+K+ G ++T GT GYV
Sbjct: 121 YLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTAC-GTPGYV 174
Query: 346 APEYANSGLLNEKSDVYSFGVVL 368
APE ++ D +S GV+
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVIT 197
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-30
Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 11/205 (5%)
Query: 175 RFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKNL 232
F+K IG G +G V++G VA+K + + + D + E+ + +
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE 292
+ G ++ T+ ++ EY+ G+ D+ + G L IL K L YLH
Sbjct: 83 TKYYGSYLKDTKLWIIMEYLGGGSAL-----DLLEPGPLDETQIATILREILKGLDYLHS 137
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANS 352
K +HRDIK++N+L+ E+ + K++DFG+A L + T +GT ++APE
Sbjct: 138 E---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQ 193
Query: 353 GLLNEKSDVYSFGVVLLEAITGRYP 377
+ K+D++S G+ +E G P
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPP 218
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 72/329 (21%), Positives = 133/329 (40%), Gaps = 52/329 (15%)
Query: 167 RDLQSATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIG 225
+ ++ R ++ +GG+ VY Q + +G A+K+LL+N + ++ EV +
Sbjct: 21 QTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMK 80
Query: 226 HVR-HKNLVRLLGYCIEGTQR-------ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARM 277
+ H N+V+ G + L+ + G L ++L+ M RG L+ + +
Sbjct: 81 KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLK-KMESRGPLSCDTVL 139
Query: 278 KILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337
KI T +A+ ++H +P ++HRD+K N+L+ K+ DFG A + + +
Sbjct: 140 KIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSA 198
Query: 338 VM-----------GTFGYVAPE----YANSGLLNEKSDVYSFGVVLLEAITGRYP----- 377
T Y PE Y+N + EK D+++ G +L ++P
Sbjct: 199 QRRALVEEEITRNTTPMYRTPEIIDLYSNFP-IGEKQDIWALGCILYLLCFRQHPFEDGA 257
Query: 378 ------VDYGRPQSEV---NLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRAL--LTA 426
Y P + ++ M+Q V+P E R S + + L + A
Sbjct: 258 KLRIVNGKYSIPPHDTQYTVFHSLIRAMLQ-------VNP--EERLSIAEVVHQLQEIAA 308
Query: 427 LRCVDPDSDKRPKMSQVVRMLESEEYPIP 455
R V+P S + Q + P
Sbjct: 309 ARNVNPKSPITELLEQNGGYGSATLSRGP 337
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 57/217 (26%), Positives = 100/217 (46%), Gaps = 13/217 (5%)
Query: 165 TLRDLQSATN---RFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRVE 220
LR + S + ++++ IG G G VY + G VA++++ + E
Sbjct: 8 KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE 67
Query: 221 VEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKIL 280
+ + ++ N+V L + G + +V EY+ G+L D+ + +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT-----DVVTETCMDEGQIAAVC 122
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMG 340
+AL +LH +V+HRDIKS NIL+ + K++DFG + +S +T V G
Sbjct: 123 RECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-G 178
Query: 341 TFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYP 377
T ++APE K D++S G++ +E I G P
Sbjct: 179 TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 59/204 (28%), Positives = 101/204 (49%), Gaps = 13/204 (6%)
Query: 182 IGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQAD-KDFRVEVEAIGH-VRHKNLVRLLGY 238
IG G YG V + +G +AVK++ + + + K ++++ + +V+ G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 239 CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARM-KILLGTAKALAYLHEAIEPK 297
+ E ++ + +++ + + E + KI L T KAL +L E K
Sbjct: 90 LFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE--NLK 146
Query: 298 VVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPE----YANSG 353
++HRDIK SNIL+D + + K+ DFG++ L + TR G Y+APE A+
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK--TRDAGCRPYMAPERIDPSASRQ 204
Query: 354 LLNEKSDVYSFGVVLLEAITGRYP 377
+ +SDV+S G+ L E TGR+P
Sbjct: 205 GYDVRSDVWSLGITLYELATGRFP 228
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 51/203 (25%), Positives = 93/203 (45%), Gaps = 12/203 (5%)
Query: 182 IGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQAD-KDFRVEVEAIGH-VRHKNLVRLLGY 238
+G G YGVV + + + +G +AVK++ + K ++++ V V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 239 CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKV 298
+ E ++ +L+++ + + + + KI + KAL +LH + V
Sbjct: 75 LFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS--KLSV 131
Query: 299 VHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPE----YANSGL 354
+HRD+K SN+LI+ K+ DFG++ L G Y+APE N
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYLVD--DVAKDIDAGCKPYMAPERINPELNQKG 189
Query: 355 LNEKSDVYSFGVVLLEAITGRYP 377
+ KSD++S G+ ++E R+P
Sbjct: 190 YSVKSDIWSLGITMIELAILRFP 212
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 63/291 (21%), Positives = 118/291 (40%), Gaps = 36/291 (12%)
Query: 163 WFTLRDLQSATNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVK---KLLNNPGQADKDFR 218
F ++R+ ++G G +G V + G AVK K +
Sbjct: 15 MFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLL 74
Query: 219 VEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR- 276
EV+ + + H N+++L + + LV E G L ++ R + +A
Sbjct: 75 REVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFD----EIISRKRFSEVDAAR 130
Query: 277 -MKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLLGAGKS 332
++ +L + Y+H+ K+VHRD+K N+L+ ++ + +I DFGL+ A K
Sbjct: 131 IIRQVLS---GITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK 184
Query: 333 HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEW 392
+GT Y+APE + G +EK DV+S GV+L ++G P G + +
Sbjct: 185 M--KDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGCPPF-NGANEYD------ 234
Query: 393 LKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQV 443
++ ++ + + + S + L+ + P R
Sbjct: 235 --ILKKVEKGK--YTFELPQWKKVSESAKDLIRKMLTYVP--SMRISARDA 279
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 60/239 (25%), Positives = 96/239 (40%), Gaps = 44/239 (18%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNG------TAVAVKKLLNNPGQADK-DFRVEVEAIGH 226
++G G +G V VAVK L +++ E++ +
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 227 V-RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLR-------------------GDMC 266
+ H+N+V LLG C L++EY G+L +LR +
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 267 DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326
D LT+E + AK + +L VHRD+ + N+L+ KI DFGLA+
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARD 221
Query: 327 L-------GAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYP 377
+ G + + + M APE G+ KSDV+S+G++L E + G P
Sbjct: 222 IMSDSNYVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 58/217 (26%), Positives = 98/217 (45%), Gaps = 13/217 (5%)
Query: 165 TLRDLQSATN---RFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVE 220
LR + + IG+G G+V + +G VAVK + Q + E
Sbjct: 33 ALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNE 92
Query: 221 VEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKIL 280
V + +H N+V + + G + ++ E++ G L D+ + L E +
Sbjct: 93 VVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT-----DIVSQVRLNEEQIATVC 147
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMG 340
+ALAYLH V+HRDIKS +IL+ + K+SDFG + + V G
Sbjct: 148 EAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-G 203
Query: 341 TFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYP 377
T ++APE + L + D++S G++++E + G P
Sbjct: 204 TPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 56/204 (27%), Positives = 100/204 (49%), Gaps = 11/204 (5%)
Query: 176 FSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQAD-KDFRVEVEAIGHVRHKNLV 233
F K + +G G GVV++ +G +A K + A E++ + +V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 234 RLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEA 293
G + + E+++ G+L+Q L+ G + + K+ + K L YL E
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE- 149
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSG 353
+ K++HRD+K SNIL++ + K+ DFG++ L ++ + V GT Y++PE
Sbjct: 150 -KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFV-GTRSYMSPERLQGT 205
Query: 354 LLNEKSDVYSFGVVLLEAITGRYP 377
+ +SD++S G+ L+E GRYP
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 7e-29
Identities = 60/238 (25%), Positives = 97/238 (40%), Gaps = 35/238 (14%)
Query: 151 GLPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVK----- 204
G P S G G D + + +IG G + VV R G AVK
Sbjct: 1 GSPGISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVA 60
Query: 205 KLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGD 264
K ++PG + +D + E ++H ++V LL +V+E+++ +L
Sbjct: 61 KFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADL------- 113
Query: 265 MCDR---------GYLTWEAR--MKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI--- 310
C Y A M+ +L +AL Y H+ ++HRD+K +L+
Sbjct: 114 -CFEIVKRADAGFVYSEAVASHYMRQIL---EALRYCHDN---NIIHRDVKPHCVLLASK 166
Query: 311 DENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVL 368
+ + K+ FG+A LG RV GT ++APE + DV+ GV+L
Sbjct: 167 ENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVIL 223
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 8e-29
Identities = 63/285 (22%), Positives = 119/285 (41%), Gaps = 45/285 (15%)
Query: 173 TNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLL--NNPGQADKDFRVEVEAIGHVRH 229
R++ ++G G +G V + + AVK + + + EVE + + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--MKILLGTAKA 286
N+++L + + +V E G L + R + +A +K +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDEI----IKRKRFSEHDAARIIKQVFS---G 133
Query: 287 LAYLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
+ Y+H+ +VHRD+K NIL+ +++ D KI DFGL+ + R+ GT
Sbjct: 134 ITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRI-GTAY 188
Query: 344 YVAPE-----YANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQ 398
Y+APE Y +EK DV+S GV+L ++G P YG+ + + ++ +
Sbjct: 189 YIAPEVLRGTY------DEKCDVWSAGVILYILLSGTPPF-YGKNEYD--------ILKR 233
Query: 399 LRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQV 443
+ + ++ + S + L+ + P R +Q
Sbjct: 234 VETGK--YAFDLPQWRTISDDAKDLIRKMLTFHP--SLRITATQC 274
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 9e-29
Identities = 67/254 (26%), Positives = 109/254 (42%), Gaps = 28/254 (11%)
Query: 122 SQLGEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDNI 181
S + G S AP S +P++ G + + ++ F ++
Sbjct: 8 SSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDG-------SNRDALSDFFEVESE 60
Query: 182 IGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCI 240
+G G +VYR Q A+K L K R E+ + + H N+++L
Sbjct: 61 LGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 241 EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--MKILLGTAKALAYLHEAIEPK 297
T+ LV E V G L + ++GY + +A +K +L A+AYLHE
Sbjct: 119 TPTEISLVLELVTGGELFDRI----VEKGYYSERDAADAVKQILE---AVAYLHEN---G 168
Query: 298 VVHRDIKSSNILI---DENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGL 354
+VHRD+K N+L + KI+DFGL+K++ + T GT GY APE
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-MKTVC-GTPGYCAPEILRGCA 226
Query: 355 LNEKSDVYSFGVVL 368
+ D++S G++
Sbjct: 227 YGPEVDMWSVGIIT 240
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 51/217 (23%), Positives = 89/217 (41%), Gaps = 31/217 (14%)
Query: 170 QSATNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVK-----KLLNNPGQADKD---FRVE 220
++ + + +G G G V + VA+K K + E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 221 VEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--M 277
+E + + H ++++ + + +V E + G L + L +
Sbjct: 66 IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKV----VGNKRLKEATCKLYF 120
Query: 278 KILLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLLGAGKSHI 334
+L A+ YLHE ++HRD+K N+L+ +E+ KI+DFG +K+LG S +
Sbjct: 121 YQMLL---AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLM 173
Query: 335 TTRVMGTFGYVAPE---YANSGLLNEKSDVYSFGVVL 368
T GT Y+APE + N D +S GV+L
Sbjct: 174 RTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 50/214 (23%), Positives = 87/214 (40%), Gaps = 31/214 (14%)
Query: 173 TNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVK-----KLLNNPGQADKD---FRVEVEA 223
+ + +G G G V + VA++ K + E+E
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 224 IGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--MKIL 280
+ + H ++++ + + +V E + G L + L + +
Sbjct: 194 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQM 248
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLLGAGKSHITTR 337
L A+ YLHE ++HRD+K N+L+ +E+ KI+DFG +K+LG S + T
Sbjct: 249 L---LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTL 301
Query: 338 VMGTFGYVAPE---YANSGLLNEKSDVYSFGVVL 368
GT Y+APE + N D +S GV+L
Sbjct: 302 C-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 55/210 (26%), Positives = 94/210 (44%), Gaps = 26/210 (12%)
Query: 173 TNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVK-----KLLNNPGQADK-DFRVEVEAIG 225
+ + +G G + +V + Q G A K +L ++ + + EV +
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 226 HVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--MKILLG 282
+RH N++ L T +L+ E V+ G L +L ++ LT EA +K +L
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL----AEKESLTEDEATQFLKQILD 119
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILI----DENFDAKISDFGLAKLLGAGKSHITTRV 338
+ YLH ++ H D+K NI++ N K+ DFG+A + AG +
Sbjct: 120 ---GVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--I 171
Query: 339 MGTFGYVAPEYANSGLLNEKSDVYSFGVVL 368
GT +VAPE N L ++D++S GV+
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-28
Identities = 39/281 (13%), Positives = 83/281 (29%), Gaps = 28/281 (9%)
Query: 167 RDLQSATNRFSKDNIIGDGGYGVVYRGQ------LMNGTAVAVKKLLNNPGQADKDFRVE 220
+ Q + +++G+G + VY N +K
Sbjct: 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117
Query: 221 VEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWL-RGDMCDRGYLTWEARMKI 279
+E + ++ + +LV E + G L + + +
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177
Query: 280 LLGTAKALAYLHEAIEPKVVHRDIKSSNILI-----------DENFDAKISDFGLAKLLG 328
+ + +H+ +++H DIK N ++ D + + D G + +
Sbjct: 178 AMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234
Query: 329 A-GKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEV 387
K I T T G+ E ++ N + D + + + G Y E
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM-KVKNEGGEC 293
Query: 388 NLVEWLKMMVQLRRSEDVVD-----PNIETRPSTSALKRAL 423
+ + L + P+ PS L++ L
Sbjct: 294 KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKL 334
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-28
Identities = 65/306 (21%), Positives = 117/306 (38%), Gaps = 56/306 (18%)
Query: 163 WFTLRDLQSATNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVK-----KLLNNPGQAD-- 214
+ + + K +G G YG V + + A+K + D
Sbjct: 25 MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNK 84
Query: 215 ------KDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDR 268
++ E+ + + H N+++L + LV E+ G L + + +R
Sbjct: 85 NIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI----INR 140
Query: 269 GYLT-WEAR--MKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFG 322
+A MK +L + YLH+ +VHRDIK NIL+ + + KI DFG
Sbjct: 141 HKFDECDAANIMKQILS---GICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFG 194
Query: 323 LAKLLGAGKSHITTRVMGTFGYVAPE-----YANSGLLNEKSDVYSFGVVLLEAITGRYP 377
L+ + R+ GT Y+APE Y NEK DV+S GV++ + G P
Sbjct: 195 LSSFFSKDYK-LRDRL-GTAYYIAPEVLKKKY------NEKCDVWSCGVIMYILLCGYPP 246
Query: 378 VDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKR 437
G+ + ++ ++ + + + + S + L+ + D +KR
Sbjct: 247 F-GGQNDQD--------IIKKVEKGK--YYFDFNDWKNISDEAKELIKLMLTYDY--NKR 293
Query: 438 PKMSQV 443
+
Sbjct: 294 CTAEEA 299
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 72/272 (26%), Positives = 120/272 (44%), Gaps = 43/272 (15%)
Query: 128 GGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLR------DLQSATNRFSKDNI 181
G + ++F S P+ PS + T+ + ++ +
Sbjct: 2 SGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKV 61
Query: 182 IGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRV-EVEAIGHVRHKNLVRLLGYC 239
IG+G +GVVY+ +L +G VA+KK+L DK F+ E++ + + H N+VRL +
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLRYFF 116
Query: 240 IEGTQRI------LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILL-GTAKALAYLHE 292
++ LV +YV + + R + L +K+ + ++LAY+H
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP-VIYVKLYMYQLFRSLAYIHS 174
Query: 293 AIEPKVVHRDIKSSNILIDENFDA-KISDFGLAKLLGAGK---SHITTRVMGTFGYVAPE 348
+ HRDIK N+L+D + K+ DFG AK L G+ S+I +R Y APE
Sbjct: 175 F---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPE 226
Query: 349 YANSGLLNEKS-----DVYSFGVVLLEAITGR 375
+ DV+S G VL E + G+
Sbjct: 227 L----IFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 50/207 (24%), Positives = 94/207 (45%), Gaps = 25/207 (12%)
Query: 173 TNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVK----KLLNNPGQADKDFRVEVEAIGHV 227
++ + +G G + VV R G A K K L+ + + E +
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS--ARDFQKLEREARICRKL 62
Query: 228 RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--MKILLGTA 284
+H N+VRL E + LV++ V G L + + R + + +A ++ +L
Sbjct: 63 QHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI----VAREFYSEADASHCIQQIL--- 115
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
+++AY H +VHR++K N+L+ + K++DFGLA + ++ GT
Sbjct: 116 ESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFA-GT 170
Query: 342 FGYVAPEYANSGLLNEKSDVYSFGVVL 368
GY++PE ++ D+++ GV+L
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-28
Identities = 72/329 (21%), Positives = 123/329 (37%), Gaps = 55/329 (16%)
Query: 134 STFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYGVVYRG 193
S+ H S + + L ++ + +++ ++G GG+G VY G
Sbjct: 3 SSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSG 62
Query: 194 Q-LMNGTAVAVKKL----LNNPGQADKDFRV--EVEAIGHVRHK--NLVRLLGYCIEGTQ 244
+ + VA+K + +++ G+ RV EV + V ++RLL + E
Sbjct: 63 IRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-FERPD 121
Query: 245 RI-LVYEYVNNGNLEQWLRGDMCD----RGYLT-WEARMKILLGTAKALAYLHEAIEPKV 298
L+ E D+ D RG L AR +A+ + H V
Sbjct: 122 SFVLILERPEPV-------QDLFDFITERGALQEELAR-SFFWQVLEAVRHCHNC---GV 170
Query: 299 VHRDIKSSNILIDEN-FDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLN- 356
+HRDIK NILID N + K+ DFG LL T GT Y PE+ +
Sbjct: 171 LHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFD-GTRVYSPPEWIRYHRYHG 227
Query: 357 EKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPST 416
+ V+S G++L + + G P + E+++ + R
Sbjct: 228 RSAAVWSLGILLYDMVCGDIPFE---------------------HDEEIIRGQVFFRQRV 266
Query: 417 SALKRALLTALRCVDPDSDKRPKMSQVVR 445
S+ + L+ C+ RP ++
Sbjct: 267 SSECQHLIR--WCLALRPSDRPTFEEIQN 293
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-28
Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 32/216 (14%)
Query: 173 TNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVK-----KLLNNPGQADKDFRV----EVE 222
+ I+G G VV R AVK + + ++ R EV+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 223 AIGHV-RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--MK 278
+ V H N+++L T LV++ + G L +L ++ L+ E R M+
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRKIMR 131
Query: 279 ILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRV 338
LL + + LH+ +VHRD+K NIL+D++ + K++DFG + L G+ +
Sbjct: 132 ALL---EVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-LREVC 184
Query: 339 MGTFGYVAPE------YANSGLLNEKSDVYSFGVVL 368
GT Y+APE N ++ D++S GV++
Sbjct: 185 -GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 61/259 (23%), Positives = 103/259 (39%), Gaps = 31/259 (11%)
Query: 129 GNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYG 188
P L S + ++ ++IG G
Sbjct: 49 SQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSS 108
Query: 189 VVYRG-QLMNGTAVAVK-----KLLNNPGQADK---DFRVEVEAIGHVR-HKNLVRLLGY 238
VV R G AVK +P Q ++ R E + V H +++ L+
Sbjct: 109 VVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168
Query: 239 CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--MKILLGTAKALAYLHEAIE 295
+ LV++ + G L +L ++ L+ E R M+ LL +A+++LH
Sbjct: 169 YESSSFMFLVFDLMRKGELFDYL----TEKVALSEKETRSIMRSLL---EAVSFLHAN-- 219
Query: 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPE------Y 349
+VHRD+K NIL+D+N ++SDFG + L G+ + GT GY+APE
Sbjct: 220 -NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-LRELC-GTPGYLAPEILKCSMD 276
Query: 350 ANSGLLNEKSDVYSFGVVL 368
++ D+++ GV+L
Sbjct: 277 ETHPGYGKEVDLWACGVIL 295
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 9e-28
Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 26/202 (12%)
Query: 181 IIGDGGYGVVYRG-QLMNGTAVAVK-----KLLNNPGQADK-DFRVEVEAIGHVRHKNLV 233
+G G + +V + + G A K + + + + EV + V H N++
Sbjct: 19 ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 234 RLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--MKILLGTAKALAYL 290
L T +L+ E V+ G L +L + L+ EA +K +L + YL
Sbjct: 79 TLHDVYENRTDVVLILELVSGGELFDFL----AQKESLSEEEATSFIKQILD---GVNYL 131
Query: 291 HEAIEPKVVHRDIKSSNILI----DENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVA 346
H K+ H D+K NI++ K+ DFGLA + G + GT +VA
Sbjct: 132 HTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV--EFKNIFGTPEFVA 186
Query: 347 PEYANSGLLNEKSDVYSFGVVL 368
PE N L ++D++S GV+
Sbjct: 187 PEIVNYEPLGLEADMWSIGVIT 208
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 54/204 (26%), Positives = 88/204 (43%), Gaps = 17/204 (8%)
Query: 173 TNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHK 230
+ F +G G +G V+ + +G +K + + Q E+E + + H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 231 NLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--MKILLGTAKAL 287
N++++ + +V E G L + + L+ MK ++ AL
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN---AL 137
Query: 288 AYLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLLGAGKSHITTRVMGTFGY 344
AY H VVH+D+K NIL + KI DFGLA+L + + H T GT Y
Sbjct: 138 AYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE-HSTNAA-GTALY 192
Query: 345 VAPEYANSGLLNEKSDVYSFGVVL 368
+APE + K D++S GVV+
Sbjct: 193 MAPEVFK-RDVTFKCDIWSAGVVM 215
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 32/210 (15%)
Query: 173 TNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLL--NNPGQADKDFRVEVEAIGHVRH 229
R++ ++G G +G V + + AVK + + + EVE + + H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--MKILLGTAKA 286
N+++L + + +V E G L + R + +A +K +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGELFDE----IIKRKRFSEHDAARIIKQVFS---G 133
Query: 287 LAYLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
+ Y+H+ +VHRD+K NIL+ +++ D KI DFGL+ + R+ GT
Sbjct: 134 ITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRI-GTAY 188
Query: 344 YVAPE-----YANSGLLNEKSDVYSFGVVL 368
Y+APE Y +EK DV+S GV+L
Sbjct: 189 YIAPEVLRGTY------DEKCDVWSAGVIL 212
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 10/206 (4%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN 231
F +G+G YG VY+ G VA+K++ ++ E+ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPH 85
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
+V+ G + T +V EY G++ +R LT + IL T K L YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIR---LRNKTLTEDEIATILQSTLKGLEYLH 142
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYAN 351
+ +HRDIK+ NIL++ AK++DFG+A L + T + GT ++APE
Sbjct: 143 FM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEVIQ 198
Query: 352 SGLLNEKSDVYSFGVVLLEAITGRYP 377
N +D++S G+ +E G+ P
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 57/334 (17%), Positives = 109/334 (32%), Gaps = 100/334 (29%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL-LNNPGQADKDFRVEVEAIGHVRHKN 231
F +G GG+GVV+ + ++ A+K++ L N A + EV+A+ + H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDM-------------------------- 265
+VR +E E ++ +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 266 -----------------CDRGYLT-------------WEARMKILLGTAKALAYLHEAIE 295
C + L + I + A+A+ +LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK-- 183
Query: 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHIT-----------TRVMGTFGY 344
++HRD+K SNI + K+ DFGL + + T T +GT Y
Sbjct: 184 -GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 345 VAPEYANSGLLNEKSDVYSFGVVLLEAIT-----------------GRYPVDYGRPQSEV 387
++PE + + K D++S G++L E + ++P+ + + +
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVRIITDVRNLKFPLLFTQKYPQ- 301
Query: 388 NLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKR 421
++ M+ P RP + +
Sbjct: 302 -EHMMVQDMLS-------PSP--TERPEATDIIE 325
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-27
Identities = 61/216 (28%), Positives = 90/216 (41%), Gaps = 32/216 (14%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVK-----KLLNNPGQADKDFRVEVEAIGHVRHKNLVRL 235
+G+G YG V AVK KL P + E++ + +RHKN+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKK-EIQLLRRLRHKNVIQL 71
Query: 236 LG-YCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLT-WEARMK---ILLGTAKALAY 289
+ E Q++ +V EY G E D +A ++ G L Y
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEML---DSVPEKRFPVCQAHGYFCQLIDG----LEY 124
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS-HITTRVMGTFGYVAPE 348
LH +VH+DIK N+L+ KIS G+A+ L + G+ + PE
Sbjct: 125 LHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 349 YAN-----SGLLNEKSDVYSFGVVLLEAITGRYPVD 379
AN SG K D++S GV L TG YP +
Sbjct: 182 IANGLDTFSGF---KVDIWSAGVTLYNITTGLYPFE 214
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 54/236 (22%), Positives = 101/236 (42%), Gaps = 28/236 (11%)
Query: 145 APSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAV 203
P + + +G G F + ++ + +G G + VV R G A
Sbjct: 1 GPHM-ASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAA 59
Query: 204 K-----KLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLE 258
K KL + + E ++H N+VRL E + LV++ V G L
Sbjct: 60 KIINTKKL---SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELF 116
Query: 259 QWLRGDMCDRGYLT-WEAR--MKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DE 312
+ + R + + +A ++ +L +++AY H +VHR++K N+L+ +
Sbjct: 117 EDI----VAREFYSEADASHCIQQIL---ESIAYCHSN---GIVHRNLKPENLLLASKAK 166
Query: 313 NFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVL 368
K++DFGLA + ++ GT GY++PE ++ D+++ GV+L
Sbjct: 167 GAAVKLADFGLAIEVNDSEA-WHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-27
Identities = 57/208 (27%), Positives = 88/208 (42%), Gaps = 30/208 (14%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN 231
++ +N IG G +G V A KK+ + F+ E+E + + H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--MKILLGTAKALA 288
++RL + T LV E G L + + + +A MK +L A+A
Sbjct: 68 IIRLYETFEDNTDIYLVMELCTGGELFERV----VHKRVFRESDAARIMKDVL---SAVA 120
Query: 289 YLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYV 345
Y H+ V HRD+K N L + K+ DFGLA GK + T+V GT YV
Sbjct: 121 YCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MRTKV-GTPYYV 175
Query: 346 APE-----YANSGLLNEKSDVYSFGVVL 368
+P+ Y + D +S GV++
Sbjct: 176 SPQVLEGLY------GPECDEWSAGVMM 197
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 26/210 (12%)
Query: 173 TNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVK-----KLLNNPGQADK-DFRVEVEAIG 225
+ + +G G + VV + + G A K + ++ + D EV +
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 226 HVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--MKILLG 282
++H N++ L T IL+ E V G L +L ++ LT EA +K +L
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILN 125
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILI----DENFDAKISDFGLAKLLGAGKSHITTRV 338
+ YLH ++ H D+K NI++ KI DFGLA + G +
Sbjct: 126 ---GVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF--KNI 177
Query: 339 MGTFGYVAPEYANSGLLNEKSDVYSFGVVL 368
GT +VAPE N L ++D++S GV+
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-27
Identities = 48/205 (23%), Positives = 89/205 (43%), Gaps = 20/205 (9%)
Query: 173 TNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLL--NNPGQADKDFRVEVEAIGHVRH 229
T + +G G + VV R +++ G A + + + E ++H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--MKILLGTAKA 286
N+VRL E L+++ V G L + + R Y + +A ++ +L A
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGELFEDI----VAREYYSEADASHCIQQILE---A 122
Query: 287 LAYLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
+ + H+ VVHR++K N+L+ + K++DFGLA + + GT G
Sbjct: 123 VLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPG 178
Query: 344 YVAPEYANSGLLNEKSDVYSFGVVL 368
Y++PE + D+++ GV+L
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 52/210 (24%), Positives = 88/210 (41%), Gaps = 26/210 (12%)
Query: 173 TNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVK-----KLLNNPGQADK-DFRVEVEAIG 225
+ + +G G + +V + + G A K + + + + EV +
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 226 HVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--MKILLG 282
V H N++ L T +L+ E V+ G L +L + L+ EA +K +L
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL----AQKESLSEEEATSFIKQILD 126
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILI----DENFDAKISDFGLAKLLGAGKSHITTRV 338
+ YLH K+ H D+K NI++ K+ DFGLA + G +
Sbjct: 127 ---GVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--I 178
Query: 339 MGTFGYVAPEYANSGLLNEKSDVYSFGVVL 368
GT +VAPE N L ++D++S GV+
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 56/221 (25%), Positives = 96/221 (43%), Gaps = 26/221 (11%)
Query: 174 NRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADK-DFRVEVEAIGHVRHKN 231
+ + +IG G VV VA+K++ Q + E++A+ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNL----EQWLRGDMCDRGYLTWEARMKILLGTAKAL 287
+V + + LV + ++ G++ + + G L IL + L
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 288 AYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF-G--- 343
YLH+ +HRD+K+ NIL+ E+ +I+DFG++ L G +V TF G
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 344 YVAPE-------YANSGLLNEKSDVYSFGVVLLEAITGRYP 377
++APE Y + K+D++SFG+ +E TG P
Sbjct: 192 WMAPEVMEQVRGY------DFKADIWSFGITAIELATGAAP 226
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 6e-27
Identities = 47/218 (21%), Positives = 76/218 (34%), Gaps = 18/218 (8%)
Query: 173 TNRFSKDNIIGDG--GYGVVYRGQ-LMNGTAVAVKK--LLNNPGQADKDFRVEVEAIGHV 227
+ +IG G V + G V V++ L + + E+
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 228 RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKAL 287
H N+V I + +V ++ G+ + + D + A IL G KAL
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDG--MNELAIAYILQGVLKAL 141
Query: 288 AYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYV-- 345
Y+H VHR +K+S+ILI + +S + + V
Sbjct: 142 DYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198
Query: 346 ----APEYANSGLL--NEKSDVYSFGVVLLEAITGRYP 377
+PE L + KSD+YS G+ E G P
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 73/283 (25%), Positives = 127/283 (44%), Gaps = 40/283 (14%)
Query: 177 SKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-HKNLVR 234
KD +G+G + + + + A AVK + + + + E+ A+ H N+V+
Sbjct: 14 LKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVK 70
Query: 235 LLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--MKILLGTAKALAYLH 291
L + LV E +N G L + + + + + EA M+ L+ A++++H
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFE----RIKKKKHFSETEASYIMRKLV---SAVSHMH 123
Query: 292 EAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPE 348
+ VVHRD+K N+L ++N + KI DFG A+L + T T Y APE
Sbjct: 124 DV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPE 179
Query: 349 YANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSE-DVVD 407
N +E D++S GV+L ++G +S +++M ++++ +
Sbjct: 180 LLNQNGYDESCDLWSLGVILYTMLSG-QVPFQSHDRSLTCTSA-VEIMKKIKKGDFSFEG 237
Query: 408 P---NIETRPSTSA--LKRALLTALRCVDPDSDKRPKMSQVVR 445
N+ S A L + LLT VDP +KR KMS +
Sbjct: 238 EAWKNV----SQEAKDLIQGLLT----VDP--NKRLKMSGLRY 270
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 7e-27
Identities = 59/215 (27%), Positives = 92/215 (42%), Gaps = 28/215 (13%)
Query: 167 RDLQSATNRFSKD----NIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRVEV 221
+ L + +F+ IG G Y V R AVK + + +D E+
Sbjct: 11 QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK----RDPTEEI 66
Query: 222 EAIGH-VRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--M 277
E + +H N++ L +G +V E + G L + + + + EA +
Sbjct: 67 EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKI----LRQKFFSEREASAVL 122
Query: 278 KILLGTAKALAYLHEAIEPKVVHRDIKSSNIL-IDENFDA---KISDFGLAKLLGAGKSH 333
+ K + YLH VVHRD+K SNIL +DE+ + +I DFG AK L A
Sbjct: 123 FTIT---KTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL 176
Query: 334 ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVL 368
+ T T +VAPE + D++S GV+L
Sbjct: 177 LMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-27
Identities = 75/275 (27%), Positives = 120/275 (43%), Gaps = 44/275 (16%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVK---KLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLG 237
IG G + V + ++ G VA+K K NP K FR EV + + H N+V+L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKL-- 79
Query: 238 Y-CIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLT-WEARMK---ILLGTAKALAYLH 291
+ IE + + L+ EY + G + +L G + EAR K I+ A+ Y H
Sbjct: 80 FEVIETEKTLYLIMEYASGGEVFDYL----VAHGRMKEKEARSKFRQIVS----AVQYCH 131
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPE-YA 350
+ ++VHRD+K+ N+L+D + + KI+DFG + G + G Y APE +
Sbjct: 132 QK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAFC-GAPPYAAPELFQ 186
Query: 351 NSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNI 410
+ DV+S GV+L ++G P D NL E + V+
Sbjct: 187 GKKYDGPEVDVWSLGVILYTLVSGSLPFD------GQNLKELRER---------VLRGKY 231
Query: 411 ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVR 445
S LL ++P KR + Q+++
Sbjct: 232 RIPFYMSTDCENLLKRFLVLNP--IKRGTLEQIMK 264
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 8e-27
Identities = 48/211 (22%), Positives = 93/211 (44%), Gaps = 13/211 (6%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN 231
+ +GDG +G VY+ + G A K + + +D+ VE+E + H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
+V+LLG + ++ E+ G ++ + LT + +AL +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLH 134
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPE--- 348
+++HRD+K+ N+L+ D +++DFG++ + +GT ++APE
Sbjct: 135 SK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIGTPYWMAPEVVM 190
Query: 349 --YANSGLLNEKSDVYSFGVVLLEAITGRYP 377
+ K+D++S G+ L+E P
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 61/225 (27%), Positives = 105/225 (46%), Gaps = 34/225 (15%)
Query: 167 RDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRV-EVEAIG 225
+ + ++ +IG+G +GVV++ +L+ VA+KK+L DK F+ E++ +
Sbjct: 33 KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQIMR 87
Query: 226 HVRHKNLVRLLGYCIEGTQRI------LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKI 279
V+H N+V L + + LV EYV + + R + +
Sbjct: 88 IVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLY 146
Query: 280 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDA-KISDFGLAKLLGAGK---SHIT 335
+ ++LAY+H + HRDIK N+L+D K+ DFG AK+L AG+ S+I
Sbjct: 147 MYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYIC 203
Query: 336 TRVMGTFGYVAPEYANSGLLNEKS-----DVYSFGVVLLEAITGR 375
+R Y APE + + D++S G V+ E + G+
Sbjct: 204 SRY-----YRAPEL----IFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 62/211 (29%), Positives = 98/211 (46%), Gaps = 22/211 (10%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVRH 229
++ K IG+G YGVV++ + G VA+KK L +P R E+ + ++H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALR-EIRMLKQLKH 61
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
NLV LL + LV+EY ++ + L D RG + I T +A+ +
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVK-SITWQTLQAVNF 117
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEY 349
H+ +HRD+K NILI ++ K+ DFG A+LL + V T Y +PE
Sbjct: 118 CHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPEL 173
Query: 350 ANSGLLNEKS-----DVYSFGVVLLEAITGR 375
L+ + DV++ G V E ++G
Sbjct: 174 ----LVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 38/303 (12%), Positives = 83/303 (27%), Gaps = 52/303 (17%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKD---FRVEVEAIGHVRH 229
R+ G ++ VA+ + D + +
Sbjct: 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK 90
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
+ R+L ++V E++ G+L++ + ++ + A A
Sbjct: 91 PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADA 144
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEY 349
H A V S + + + G L +
Sbjct: 145 AHRA---GVALSIDHPSRVRVSID--------GDVVL-------------AYPATMPDA- 179
Query: 350 ANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409
N + D+ G L + R+P+ +S + + + ++P
Sbjct: 180 ------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP-------AERDTAGQPIEPA 226
Query: 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIPREDRRRRRNQAGAS 469
+ A+ A R V D R S ++ +++ R + ++A S
Sbjct: 227 -DIDRDIPFQISAV--AARSVQGDGGIRSA-STLLNLMQQATAVADRTEVLGPIDEAPVS 282
Query: 470 EAE 472
A
Sbjct: 283 AAP 285
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 52/224 (23%), Positives = 95/224 (42%), Gaps = 31/224 (13%)
Query: 170 QSATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR 228
+ +RF + + G G +G V G+ G +VA+KK++ +P +++ + ++ + +
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLH 77
Query: 229 HKNLVRLLGYCIEGTQR--------ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKIL 280
H N+V+L +V EYV + L + R + L
Sbjct: 78 HPNIVQLQ-SYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILID-ENFDAKISDFGLAKLLGAGK---SHITT 336
+++ LH V HRDIK N+L++ + K+ DFG AK L + ++I +
Sbjct: 136 FQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICS 194
Query: 337 RVMGTFGYVAPEYANSGLLNEKS-----DVYSFGVVLLEAITGR 375
R Y APE + + D++S G + E + G
Sbjct: 195 RY-----YRAPEL----IFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-26
Identities = 58/225 (25%), Positives = 103/225 (45%), Gaps = 20/225 (8%)
Query: 166 LRDLQSATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAI 224
L L+ F ++G+G YG VY+G+ + G A+K + + G +++ + E+ +
Sbjct: 16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINML 74
Query: 225 GHV-RHKNLVRLLG-YCIEGTQRI-----LVYEYVNNGNLEQWLRGDMCDRGYLTWEARM 277
H+N+ G + + + LV E+ G++ ++ L E
Sbjct: 75 KKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK--NTKGNTLKEEWIA 132
Query: 278 KILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR 337
I + L++LH+ KV+HRDIK N+L+ EN + K+ DFG++ L T
Sbjct: 133 YICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT- 188
Query: 338 VMGTFGYVAPE-----YANSGLLNEKSDVYSFGVVLLEAITGRYP 377
+GT ++APE + KSD++S G+ +E G P
Sbjct: 189 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 61/294 (20%), Positives = 119/294 (40%), Gaps = 29/294 (9%)
Query: 84 HNEKFNDRESEKELIPQENGDDSVQSGSFNNLEKDVVGSQLGEEGGNGKVSTFRPSSHPL 143
H+ + + E + ++ +S S + + + V + R S+ +
Sbjct: 5 HHHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAV 64
Query: 144 TAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFS--KDNIIGDGGYGVVYRG-QLMNGTA 200
P+P + H + + ++ K I+G G +G V++ + G
Sbjct: 65 DIPAPPAPFD--------HRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLK 116
Query: 201 VAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQW 260
+A K + + ++ + E+ + + H NL++L +LV EYV+ G L
Sbjct: 117 LAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDR 176
Query: 261 LRGDMCDRGY-LT-WEAR--MKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI--DENF 314
+ D Y LT + MK + + ++H+ ++H D+K NIL +
Sbjct: 177 I----IDESYNLTELDTILFMKQICE---GIRHMHQM---YILHLDLKPENILCVNRDAK 226
Query: 315 DAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVL 368
KI DFGLA+ + GT ++APE N ++ +D++S GV+
Sbjct: 227 QIKIIDFGLARRYKPREKLKV--NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIA 278
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 59/220 (26%), Positives = 107/220 (48%), Gaps = 25/220 (11%)
Query: 168 DLQSATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL-LNNPGQADKDFRV----EV 221
D++S R+ K + +G+G + VY+ + VA+KK+ L + +A E+
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 222 EAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILL 281
+ + + H N++ LL + LV+++ +E L + D + + +K +
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDF-----METDLEVIIKDNSLVLTPSHIKAYM 118
Query: 282 G-TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMG 340
T + L YLH+ ++HRD+K +N+L+DEN K++DFGLAK G+ T +V+
Sbjct: 119 LMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV- 174
Query: 341 TFGYVAPEYANSGLLNEKS-----DVYSFGVVLLEAITGR 375
T Y APE L + D+++ G +L E +
Sbjct: 175 TRWYRAPEL----LFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 24/212 (11%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRV----EVEAIGHVR 228
++ ++G+G YG+V + + G VA+KK L DK + E++ + +R
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLE--SDDDKMVKKIAMREIKLLKQLR 82
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALA 288
H+NLV LL C + + LV+E+V++ + L ++ G + K L +
Sbjct: 83 HENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQ-KYLFQIINGIG 138
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPE 348
+ H ++HRDIK NIL+ ++ K+ DFG A+ L A V T Y APE
Sbjct: 139 FCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPE 194
Query: 349 YANSGLLNEKS-----DVYSFGVVLLEAITGR 375
L+ + DV++ G ++ E G
Sbjct: 195 L----LVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-26
Identities = 62/211 (29%), Positives = 93/211 (44%), Gaps = 29/211 (13%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVK-----KLLNNPGQADKDFRVEVEAIGHVRHKNLVRL 235
+G+G YG V + AVAVK + ++ P K E+ + H+N+V+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVKF 70
Query: 236 LGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEARMK---ILLGTAKALAYLH 291
G+ EG + L EY + G L + + +A+ ++ + YLH
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMA----GVVYLH 122
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL--LGAGKSHITTRVMGTFGYVAPE- 348
+ HRDIK N+L+DE + KISDFGLA + + + GT YVAPE
Sbjct: 123 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 178
Query: 349 YANSGLLNEKSDVYSFGVVLLEAITGRYPVD 379
E DV+S G+VL + G P D
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-26
Identities = 55/204 (26%), Positives = 96/204 (47%), Gaps = 16/204 (7%)
Query: 182 IGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQAD-KDFRVEVEAIGH-VRHKNLVRLLGY 238
+G G G V++ + G +AVK++ + + + K ++++ + +V+ G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 239 CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKV 298
I T + E + + R +G + K+ + KAL YL E + V
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKR----MQGPIPERILGKMTVAIVKALYYLKE--KHGV 146
Query: 299 VHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPE-----YANSG 353
+HRD+K SNIL+DE K+ DFG++ L K+ R G Y+APE
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK--DRSAGCAAYMAPERIDPPDPTKP 204
Query: 354 LLNEKSDVYSFGVVLLEAITGRYP 377
+ ++DV+S G+ L+E TG++P
Sbjct: 205 DYDIRADVWSLGISLVELATGQFP 228
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 62/211 (29%), Positives = 93/211 (44%), Gaps = 29/211 (13%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVK-----KLLNNPGQADKDFRVEVEAIGHVRHKNLVRL 235
+G+G YG V + AVAVK + ++ P K E+ + H+N+V+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK----EICINKMLNHENVVKF 70
Query: 236 LGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEARMK---ILLGTAKALAYLH 291
G+ EG + L EY + G L + + +A+ ++ + YLH
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMA----GVVYLH 122
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL--LGAGKSHITTRVMGTFGYVAPE- 348
+ HRDIK N+L+DE + KISDFGLA + + + GT YVAPE
Sbjct: 123 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 178
Query: 349 YANSGLLNEKSDVYSFGVVLLEAITGRYPVD 379
E DV+S G+VL + G P D
Sbjct: 179 LKRREFHAEPVDVWSCGIVLTAMLAGELPWD 209
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 62/219 (28%), Positives = 107/219 (48%), Gaps = 31/219 (14%)
Query: 170 QSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKL-LNN-----PGQADKDFRVEVEA 223
Q ++ K +G+G YGVVY+ + G VA+K++ L+ P A R E+
Sbjct: 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA---IR-EISL 72
Query: 224 IGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEAR--MKILL 281
+ + H N+V L+ LV+E++ +L++ L D G + + + LL
Sbjct: 73 LKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVL--DENKTGLQDSQIKIYLYQLL 129
Query: 282 GTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGT 341
+ +A+ H+ +++HRD+K N+LI+ + K++DFGLA+ G T V+ T
Sbjct: 130 ---RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-T 182
Query: 342 FGYVAPEYANSGLLNEKS-----DVYSFGVVLLEAITGR 375
Y AP+ L+ K D++S G + E ITG+
Sbjct: 183 LWYRAPDV----LMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 45/203 (22%), Positives = 80/203 (39%), Gaps = 19/203 (9%)
Query: 173 TNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN 231
+ + +G G +GVV+R + G K + + E+ + + H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEAR----MKILLGTAKAL 287
L+ L + + +L+ E+++ G L + Y EA M+ L
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRI----AAEDYKMSEAEVINYMRQACE---GL 162
Query: 288 AYLHEAIEPKVVHRDIKSSNILI--DENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYV 345
++HE +VH DIK NI+ + KI DFGLA L + T +
Sbjct: 163 KHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV--TTATAEFA 217
Query: 346 APEYANSGLLNEKSDVYSFGVVL 368
APE + + +D+++ GV+
Sbjct: 218 APEIVDREPVGFYTDMWAIGVLG 240
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 51/210 (24%), Positives = 95/210 (45%), Gaps = 29/210 (13%)
Query: 178 KDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-HKNLVRL 235
+++++G+G + V L+ AVK + PG EVE + + H+N++ L
Sbjct: 17 QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 236 LGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--MKILLGTAKALAYLHE 292
+ + E + LV+E + G++ + R + EA ++ + AL +LH
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILS----HIHKRRHFNELEASVVVQDVA---SALDFLHN 129
Query: 293 AIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLLGAGKSH--ITTRVM----GTFG 343
+ HRD+K NIL ++ KI DF L + I+T + G+
Sbjct: 130 ---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAE 186
Query: 344 YVAPE-----YANSGLLNEKSDVYSFGVVL 368
Y+APE + + +++ D++S GV+L
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 72/326 (22%), Positives = 117/326 (35%), Gaps = 64/326 (19%)
Query: 139 SSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYGVVYRGQ-LMN 197
+ PL P G P G +D ++ + ++G GG+G V+ G L +
Sbjct: 3 LTKPLQGPPAPPGTPTPPPGG-------KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTD 55
Query: 198 GTAVAVKKL----LNNPGQADKDFRVEVE------AIGHVRHKNLVRLLGYCIEGTQRI- 246
VA+K + + +E H ++RLL + E +
Sbjct: 56 RLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW-FETQEGFM 114
Query: 247 LVYEYVNNGNLEQWLRGDMCD----RGYLT-WEARMKILLGTAKALAYLHEAIEPKVVHR 301
LV E D+ D +G L +R A+ + H VVHR
Sbjct: 115 LVLERPLPA-------QDLFDYITEKGPLGEGPSR-CFFGQVVAAIQHCHSR---GVVHR 163
Query: 302 DIKSSNILID-ENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEY-ANSGLLNEKS 359
DIK NILID AK+ DFG LL GT Y PE+ + +
Sbjct: 164 DIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD---GTRVYSPPEWISRHQYHALPA 220
Query: 360 DVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSAL 419
V+S G++L + + G P + R +++++ + S
Sbjct: 221 TVWSLGILLYDMVCGDIPFE---------------------RDQEILEAELHFPAHVSPD 259
Query: 420 KRALLTALRCVDPDSDKRPKMSQVVR 445
AL+ RC+ P RP + +++
Sbjct: 260 CCALIR--RCLAPKPSSRPSLEEILL 283
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 5e-25
Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 30/217 (13%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL-LNN-----PGQADKDFRVEVEAIGH 226
++ K IG+G YG V++ + VA+K++ L++ P A R E+ +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA---LR-EICLLKE 57
Query: 227 VRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG-TAK 285
++HKN+VRL + LV+E+ +Q L+ +K L K
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEF-----CDQDLKKYFDSCNGDLDPEIVKSFLFQLLK 112
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYV 345
L + H V+HRD+K N+LI+ N + K+++FGLA+ G + V+ T Y
Sbjct: 113 GLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYR 168
Query: 346 APEYANSGLLNEKS-----DVYSFGVVLLEAITGRYP 377
P+ L K D++S G + E P
Sbjct: 169 PPDV----LFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 6e-25
Identities = 50/251 (19%), Positives = 100/251 (39%), Gaps = 15/251 (5%)
Query: 125 GEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSK----DN 180
G+E + + +S + + + ++ +
Sbjct: 104 GDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHE 163
Query: 181 IIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYC 239
+G G +GVV+R + G A K ++ + R E++ + +RH LV L
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 240 IEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVV 299
+ + +++YE+++ G L + + + ++ + ++ + K L ++HE V
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKV---ADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYV 277
Query: 300 HRDIKSSNILIDENFDA--KISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNE 357
H D+K NI+ K+ DFGL L +S GT + APE A +
Sbjct: 278 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS--VKVTTGTAEFAAPEVAEGKPVGY 335
Query: 358 KSDVYSFGVVL 368
+D++S GV+
Sbjct: 336 YTDMWSVGVLS 346
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 6e-25
Identities = 61/222 (27%), Positives = 109/222 (49%), Gaps = 34/222 (15%)
Query: 171 SATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL-LNN----PGQADKDFRVEVEAI 224
S++++F + +G+G Y VY+G G VA+K++ L++ P A R E+ +
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA---IR-EISLM 57
Query: 225 GHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARM------K 278
++H+N+VRL + LV+E+ ++ L+ M R +
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEF-----MDNDLKKYMDSRTVGNTPRGLELNLVKY 112
Query: 279 ILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRV 338
+ LA+ HE K++HRD+K N+LI++ K+ DFGLA+ G + ++ V
Sbjct: 113 FQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEV 169
Query: 339 MGTFGYVAPEYANSGLLNEKS-----DVYSFGVVLLEAITGR 375
+ T Y AP+ L+ ++ D++S G +L E ITG+
Sbjct: 170 V-TLWYRAPDV----LMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 66/255 (25%), Positives = 107/255 (41%), Gaps = 32/255 (12%)
Query: 138 PSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATN---RFSKDNIIGDGGYGVVYRGQ 194
P++ L + +P G + +L + FS IG G +G VY +
Sbjct: 15 PTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFAR 74
Query: 195 -LMNGTAVAVKKLLNNPGQAD---KDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250
+ N VA+KK+ + Q++ +D EV + +RH N ++ G + LV E
Sbjct: 75 DVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 134
Query: 251 YVNNGNLEQWLRGDMCD-----RGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKS 305
Y G D + L + G + LAYLH ++HRD+K+
Sbjct: 135 Y---------CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKA 182
Query: 306 SNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPE---YANSGLLNEKSDVY 362
NIL+ E K+ DFG A ++ S +GT ++APE + G + K DV+
Sbjct: 183 GNILLSEPGLVKLGDFGSASIMAPANS-----FVGTPYWMAPEVILAMDEGQYDGKVDVW 237
Query: 363 SFGVVLLEAITGRYP 377
S G+ +E + P
Sbjct: 238 SLGITCIELAERKPP 252
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 9e-25
Identities = 65/210 (30%), Positives = 103/210 (49%), Gaps = 28/210 (13%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVK----KLLNNPGQADKDFRVEVEAIGHVRHKNLVRLL 236
+G G +G V G+ + G VAVK + + + K R E++ + RH ++++L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR-EIQNLKLFRHPHIIKL- 76
Query: 237 GY-CIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLT-WEARMK---ILLGTAKALAYL 290
Y I +V EYV+ G L ++ C G + EAR IL A+ Y
Sbjct: 77 -YQVISTPTDFFMVMEYVSGGELFDYI----CKHGRVEEMEARRLFQQIL----SAVDYC 127
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPE-Y 349
H VVHRD+K N+L+D + +AKI+DFGL+ ++ G+ T+ G+ Y APE
Sbjct: 128 HRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVI 182
Query: 350 ANSGLLNEKSDVYSFGVVLLEAITGRYPVD 379
+ + D++S GV+L + G P D
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGTLPFD 212
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 37/203 (18%), Positives = 85/203 (41%), Gaps = 20/203 (9%)
Query: 173 TNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN 231
++ +G G +G+V+R + + K + G + E+ + RH+N
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAK-FVKVKGTDQVLVKKEISILNIARHRN 62
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEAR----MKILLGTAKAL 287
++ L + ++++E+++ ++ + + + E + + +AL
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLDIFERI----NTSAFELNEREIVSYVHQVC---EAL 115
Query: 288 AYLHEAIEPKVVHRDIKSSNILI--DENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYV 345
+LH + H DI+ NI+ + KI +FG A+ L G + + Y
Sbjct: 116 QFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL--LFTAPEYY 170
Query: 346 APEYANSGLLNEKSDVYSFGVVL 368
APE +++ +D++S G ++
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLV 193
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 53/261 (20%), Positives = 95/261 (36%), Gaps = 55/261 (21%)
Query: 139 SSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDNIIGDGGYGVVYRGQ-LMN 197
H T + G S ++ +R+ + +G+G YG VY+ +
Sbjct: 6 HHHMGTLEAQTQGPGSMSVSAAPS-------ATSIDRYRRITKLGEGTYGEVYKAIDTVT 58
Query: 198 GTAVAVKKLLNNPGQADKDFRVEVEAIG-------------HVRHKNLVRLLGYCIEGTQ 244
VA+K++ R+E E G ++H+N++ L +
Sbjct: 59 NETVAIKRI-----------RLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHR 107
Query: 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIK 304
L++EY E L+ M ++ L + + H + +HRD+K
Sbjct: 108 LHLIFEY-----AENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLK 159
Query: 305 SSNILIDENFDA-----KISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKS 359
N+L+ + + KI DFGLA+ G T ++ T Y PE LL +
Sbjct: 160 PQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWYRPPEI----LLGSRH 214
Query: 360 -----DVYSFGVVLLEAITGR 375
D++S + E +
Sbjct: 215 YSTSVDIWSIACIWAEMLMKT 235
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 71/336 (21%), Positives = 114/336 (33%), Gaps = 73/336 (21%)
Query: 161 GHWFTLRDLQSATNRFSKDNIIGDGGYGVVYRG-QLMNGTAVAVK-----KLLNNPGQAD 214
+F L ++ IG G YGVV + A+K K+ +
Sbjct: 13 NLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDV 72
Query: 215 KDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNL----------------- 257
+ + EV + + H N+ RL + LV E + G+L
Sbjct: 73 ERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAM 132
Query: 258 --------------------EQWLRGDMCDRGYLTWEAR--MKILLGTAKALAYLHEAIE 295
+ D M+ + AL YLH
Sbjct: 133 DVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS---ALHYLHNQ-- 187
Query: 296 PKVVHRDIKSSNILI--DENFDAKISDFGLAKLLGAGKSH----ITTRVMGTFGYVAPEY 349
+ HRDIK N L +++F+ K+ DFGL+K + +TT+ GT +VAPE
Sbjct: 188 -GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEV 245
Query: 350 ANSGLL--NEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407
N+ K D +S GV+L + G P G ++ + Q+ + +
Sbjct: 246 LNTTNESYGPKCDAWSAGVLLHLLLMGAVPF-PGVNDAD--------TISQVLNKKLCFE 296
Query: 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQV 443
S A R LL+ L + D+R +
Sbjct: 297 NPNYNVLSPLA--RDLLSNLLNRNV--DERFDAMRA 328
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 1e-24
Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 31/215 (14%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKL-LNN-----PGQADKDFRVEVEAIGHV 227
++ IG+G YGVVY+ Q G A+KK+ L P R E+ + +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTT---IR-EISILKEL 57
Query: 228 RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEAR--MKILLGTAK 285
+H N+V+L + +LV+E+++ +L++ L D+C+ G + A+ + LL
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLL--DVCEGGLESVTAKSFLLQLL---N 111
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYV 345
+AY H+ +V+HRD+K N+LI+ + KI+DFGLA+ G T ++ T Y
Sbjct: 112 GIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYR 167
Query: 346 APEYANSGLLNEKS-----DVYSFGVVLLEAITGR 375
AP+ L+ K D++S G + E + G
Sbjct: 168 APDV----LMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 29/214 (13%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKL-LNN----PGQADKDFRVEVEAIGHV 227
+ K + +G+G Y VY+G+ VA+K++ L + P A R EV + +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTA---IR-EVSLLKDL 57
Query: 228 RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG-TAKA 286
+H N+V L LV+EY L++ L+ + D G + +K+ L +
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEY-----LDKDLKQYLDDCGNIINMHNVKLFLFQLLRG 112
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVA 346
LAY H KV+HRD+K N+LI+E + K++DFGLA+ V+ T Y
Sbjct: 113 LAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRP 168
Query: 347 PEYANSGLLNEKS-----DVYSFGVVLLEAITGR 375
P+ LL D++ G + E TGR
Sbjct: 169 PDI----LLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-24
Identities = 67/305 (21%), Positives = 124/305 (40%), Gaps = 78/305 (25%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVK-----KLLNNPGQADKDFRV---------------- 219
IG G YGVV + T A+K KL+ G +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 220 -----EVEAIGHVRHKNLVRLLGYC-IEGTQR---ILVYEYVNNGNLEQWLRGDMCDRGY 270
E+ + + H N+V+L ++ +V+E VN G + ++
Sbjct: 81 EQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVM-----EVPTLKP 133
Query: 271 LT-WEARMK---ILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326
L+ +AR ++ G + YLH K++HRDIK SN+L+ E+ KI+DFG++
Sbjct: 134 LSEDQARFYFQDLIKG----IEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 327 LGAGKSHITTRVMGTFGYVAPEYANSGLLNE--------KSDVYSFGVVLLEAITGRYPV 378
+ ++ V GT ++APE L+E DV++ GV L + G+ P
Sbjct: 187 FKGSDALLSNTV-GTPAFMAPE-----SLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240
Query: 379 DYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRP 438
+ ++ + +S+ + P+ +P + + L+T + +P + R
Sbjct: 241 M------DERIMCLHSKI----KSQALEFPD---QPDIAEDLKDLITRMLDKNP--ESRI 285
Query: 439 KMSQV 443
+ ++
Sbjct: 286 VVPEI 290
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-24
Identities = 50/231 (21%), Positives = 87/231 (37%), Gaps = 37/231 (16%)
Query: 157 HLGWGHWFTLRDLQSATNRFSKD-----NIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNP 210
H G + + + D ++G G G V G A+K L ++
Sbjct: 7 HHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS- 65
Query: 211 GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRI----LVYEYVNNGNLEQWLRGDM 265
R EV+ ++V +L ++ E + G L +
Sbjct: 66 ----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFS----RI 117
Query: 266 CDRGYLTW---EAR--MKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DENFDAK 317
+RG + EA M+ + A+ +LH + HRD+K N+L +++ K
Sbjct: 118 QERGDQAFTEREAAEIMRDIG---TAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLK 171
Query: 318 ISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVL 368
++DFG AK + T T YVAPE ++ D++S GV++
Sbjct: 172 LTDFGFAKETTQNA--LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 219
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-23
Identities = 46/197 (23%), Positives = 84/197 (42%), Gaps = 20/197 (10%)
Query: 182 IGDGGYGVVYRG-QLMNGTAVAVKKLL-NNPGQADK-DFRVEVEAIGHVRH-KNLVRLLG 237
+G G + VV + G A K L GQ + + E+ + + ++ L
Sbjct: 37 LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96
Query: 238 YCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLT-WEAR--MKILLGTAKALAYLHEAI 294
++ IL+ EY G + + ++ + +K +L + YLH+
Sbjct: 97 VYENTSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILE---GVYYLHQN- 150
Query: 295 EPKVVHRDIKSSNILI---DENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYAN 351
+VH D+K NIL+ D KI DFG+++ +G +MGT Y+APE N
Sbjct: 151 --NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE--IMGTPEYLAPEILN 206
Query: 352 SGLLNEKSDVYSFGVVL 368
+ +D+++ G++
Sbjct: 207 YDPITTATDMWNIGIIA 223
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 3e-23
Identities = 57/214 (26%), Positives = 83/214 (38%), Gaps = 30/214 (14%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVK-----KLLNNPGQADKDF---RVEVEAIGHVRHKNL 232
+G G +G V+ V VK K+L + D +E+ + V H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 233 VRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCD----RGYLT-WEARMKILLGTAKA 286
+++L E LV E +G D+ L A I A
Sbjct: 92 IKVLDI-FENQGFFQLVMEKHGSG-------LDLFAFIDRHPRLDEPLAS-YIFRQLVSA 142
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVA 346
+ YL ++HRDIK NI+I E+F K+ DFG A L GK T GT Y A
Sbjct: 143 VGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYTFC-GTIEYCA 197
Query: 347 PE-YANSGLLNEKSDVYSFGVVLLEAITGRYPVD 379
PE + + +++S GV L + P
Sbjct: 198 PEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFC 231
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-23
Identities = 65/210 (30%), Positives = 103/210 (49%), Gaps = 28/210 (13%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVK----KLLNNPGQADKDFRVEVEAIGHVRHKNLVRLL 236
+G G +G V G+ + G VAVK + + + K R E++ + RH ++++L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRR-EIQNLKLFRHPHIIKL- 81
Query: 237 GY-CIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLT-WEARMK---ILLGTAKALAYL 290
Y I I +V EYV+ G L ++ C G L E+R IL + Y
Sbjct: 82 -YQVISTPSDIFMVMEYVSGGELFDYI----CKNGRLDEKESRRLFQQIL----SGVDYC 132
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPE-Y 349
H VVHRD+K N+L+D + +AKI+DFGL+ ++ G+ T+ G+ Y APE
Sbjct: 133 HRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVI 187
Query: 350 ANSGLLNEKSDVYSFGVVLLEAITGRYPVD 379
+ + D++S GV+L + G P D
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCGTLPFD 217
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 57/224 (25%), Positives = 102/224 (45%), Gaps = 37/224 (16%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-HK 230
+ + +G G Y V+ + N V VK L P + K R E++ + ++R
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL--KPVKKKKIKR-EIKILENLRGGP 91
Query: 231 NLVRLLGYCIEGTQR--ILVYEYVNNGNLEQWLR----GDMCDRGYLTWEARMKILLGTA 284
N++ L + R LV+E+VNN + +Q + D+ + +E +L
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIR---FYMYE-----IL--- 140
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILID-ENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
KAL Y H ++HRD+K N++ID E+ ++ D+GLA+ G+ + RV +
Sbjct: 141 KALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY-NVRV-ASRY 195
Query: 344 YVAPEYANSGLLNEKS-----DVYSFGVVLLEAITGRYPVDYGR 382
+ PE L++ + D++S G +L I + P +G
Sbjct: 196 FKGPEL----LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 235
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 5e-23
Identities = 68/274 (24%), Positives = 111/274 (40%), Gaps = 37/274 (13%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGY-C 239
IG G +GV + + VAVK + + R E+ +RH N+VR
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR-EIINHRSLRHPNIVRF--KEV 84
Query: 240 IEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLT-WEARMK---ILLGTAKALAYLHEAI 294
I + ++ EY + G L + + C+ G + EAR +L ++Y H
Sbjct: 85 ILTPTHLAIIMEYASGGELYERI----CNAGRFSEDEARFFFQQLLS----GVSYCHSM- 135
Query: 295 EPKVVHRDIKSSNILIDENFDA--KISDFGLAKLLGAGKSHITTRVMGTFGYVAPE-YAN 351
++ HRD+K N L+D + KI DFG +K S + V GT Y+APE
Sbjct: 136 --QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTV-GTPAYIAPEVLLR 191
Query: 352 SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411
+ +DV+S GV L + G YP + + + +Q S P+ +
Sbjct: 192 QEYDGKIADVWSCGVTLYVMLVGAYPFE------DPEEPRDYRKTIQRILSVKYSIPD-D 244
Query: 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVR 445
R S L++ + DP R + ++
Sbjct: 245 IRISPEC--CHLISRIFVADP--ATRISIPEIKT 274
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 5e-23
Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 27/215 (12%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVR 228
R+ IG G G+V + VA+KKL N A + +R E+ + V
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVN 82
Query: 229 HKNLVRLL-----GYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCD--RGYLTWEARMKIL 280
HKN++ LL +E Q + +V E ++ NL Q ++ ++ YL + ++L
Sbjct: 83 HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLY----QML 137
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMG 340
+ +LH A ++HRD+K SNI++ + KI DFGLA+ AG S + T +
Sbjct: 138 ----CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVV 188
Query: 341 TFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGR 375
T Y APE E D++S G ++ E I G
Sbjct: 189 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 5e-23
Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 42/227 (18%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL-LNNPGQADKD-FRV----EVEAIGH 226
+++ K IG G +G V++ + G VA+KK+ + N +K+ F + E++ +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN----EKEGFPITALREIKILQL 72
Query: 227 VRHKNLVRLLGYCIEGTQRI--------LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK 278
++H+N+V L+ C LV+++ E L G + + + +K
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDF-----CEHDLAGLLSNVLVKFTLSEIK 127
Query: 279 -ILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI--- 334
++ L Y+H K++HRD+K++N+LI + K++DFGLA+ K+
Sbjct: 128 RVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 335 -TTRVMGTFGYVAPEYANSGLLNEKS-----DVYSFGVVLLEAITGR 375
T RV+ T Y PE LL E+ D++ G ++ E T
Sbjct: 185 YTNRVV-TLWYRPPEL----LLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 6e-23
Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 37/214 (17%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVK----KLLNNPGQADKDFRVEVEAIGHVRHKNLVRLL 236
+G+G +G V VA+K +LL + R E+ + +RH ++++L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVER-EISYLKLLRHPHIIKL- 74
Query: 237 GY-CIEGTQRI-LVYEYVNNGNLEQWLRGDMCD----RGYLT-WEARMK---ILLGTAKA 286
Y I I +V EY G++ D + +T E R I+ A
Sbjct: 75 -YDVITTPTDIVMVIEYAG---------GELFDYIVEKKRMTEDEGRRFFQQII----CA 120
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVA 346
+ Y H K+VHRD+K N+L+D+N + KI+DFGL+ ++ G T+ G+ Y A
Sbjct: 121 IEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAA 175
Query: 347 PE-YANSGLLNEKSDVYSFGVVLLEAITGRYPVD 379
PE + DV+S G+VL + GR P D
Sbjct: 176 PEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 1e-22
Identities = 65/269 (24%), Positives = 99/269 (36%), Gaps = 36/269 (13%)
Query: 119 VVGSQLGEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSK 178
+ SQ P P P + P + + LQ N
Sbjct: 2 LSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIID 61
Query: 179 D-----NIIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKN 231
D ++G G G V + A+K L Q R EVE + +
Sbjct: 62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPH 116
Query: 232 LVRLLGYCIEGTQRI----LVYEYVNNGNLEQWLRGDMCDRGYLTW---EAR--MKILLG 282
+VR++ +V E ++ G L + DRG + EA MK +
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFS----RIQDRGDQAFTEREASEIMKSIG- 171
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLLGAGKSHITTRVM 339
+A+ YLH + HRD+K N+L N K++DFG AK + S +TT
Sbjct: 172 --EAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPC- 224
Query: 340 GTFGYVAPEYANSGLLNEKSDVYSFGVVL 368
T YVAPE ++ D++S GV++
Sbjct: 225 YTPYYVAPEVLGPEKYDKSCDMWSLGVIM 253
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-22
Identities = 59/225 (26%), Positives = 98/225 (43%), Gaps = 34/225 (15%)
Query: 171 SATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL-LNNPGQADKDFRVEVEAI---- 224
AT+R+ IG G YG VY+ + +G VA+K + + N + + +
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPN--GGGGGGGLPISTVREVA 63
Query: 225 -----GHVRHKNLVRLL----GYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWE 274
H N+VRL+ + ++ LV+E+V+ +L +L D L E
Sbjct: 64 LLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL--DKAPPPGLPAE 120
Query: 275 ARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334
++ + L +LH +VHRD+K NIL+ K++DFGLA++ + +
Sbjct: 121 TIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-L 176
Query: 335 TTRVMGTFGYVAPEYANSGLLNEK----SDVYSFGVVLLEAITGR 375
T V+ T Y APE LL D++S G + E +
Sbjct: 177 TPVVV-TLWYRAPEV----LLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 8e-22
Identities = 58/232 (25%), Positives = 98/232 (42%), Gaps = 50/232 (21%)
Query: 171 SATNRFSKDNIIGDGGYGVVYRGQ--LMNGTAVAVKKLLNNPGQADKDFRVEVEAIG--- 225
A ++ IG+G YG V++ + G VA+K++ RV+ G
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-----------RVQTGEEGMPL 56
Query: 226 -------------HVRHKNLVRLL----GYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCD 267
H N+VRL + ++ LV+E+V+ +L +L D
Sbjct: 57 STIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL--DKVP 113
Query: 268 RGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327
+ E ++ + L +LH +VVHRD+K NIL+ + K++DFGLA++
Sbjct: 114 EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY 170
Query: 328 GAGKSHITTRVMGTFGYVAPEYANSGLLNEK----SDVYSFGVVLLEAITGR 375
+ +T+ V+ T Y APE LL D++S G + E +
Sbjct: 171 SFQMA-LTSVVV-TLWYRAPEV----LLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 59/217 (27%), Positives = 102/217 (47%), Gaps = 32/217 (14%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVR 228
+ +G G YG V +G VA+KKL + A + +R E+ + H++
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQ 81
Query: 229 HKNLVRLL-----GYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDR--GYLTWEARMKIL 280
H+N++ LL + LV ++ +L++ + + YL ++ +L
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQ----ML 136
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH-ITTRVM 339
K L Y+H A VVHRD+K N+ ++E+ + KI DFGLA+ A + + TR
Sbjct: 137 ----KGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW- 188
Query: 340 GTFGYVAPEYA-NSGLLNEKSDVYSFGVVLLEAITGR 375
Y APE + N+ D++S G ++ E +TG+
Sbjct: 189 ----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 1e-21
Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 27/215 (12%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVR 228
R+ IG G G+V + VA+KKL N A + +R E+ + V
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVN 119
Query: 229 HKNLVRLL-----GYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCD--RGYLTWEARMKIL 280
HKN++ LL +E Q + LV E ++ NL Q ++ ++ YL + ++L
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQMELDHERMSYLLY----QML 174
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMG 340
+ +LH A ++HRD+K SNI++ + KI DFGLA+ AG S + T +
Sbjct: 175 ----CGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVV 225
Query: 341 TFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGR 375
T Y APE E D++S G ++ E + +
Sbjct: 226 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 52/225 (23%), Positives = 83/225 (36%), Gaps = 36/225 (16%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKD--FRVEVEA------- 223
+ ++ I G YG V G G VA+K++ N
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 224 --IGHVRHKNLVRLLG----YCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEAR 276
+ H H N++ L + ++ LV E + +L Q + R ++
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIH---DQRIVIS-PQH 135
Query: 277 MKILL-GTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHIT 335
++ + L LHEA VVHRD+ NIL+ +N D I DF LA+
Sbjct: 136 IQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAR--EDTADANK 190
Query: 336 TRVMGTFGYVAPEYANSGLLNEKS-----DVYSFGVVLLEAITGR 375
T + Y APE ++ K D++S G V+ E +
Sbjct: 191 THYVTHRWYRAPEL----VMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 3e-21
Identities = 74/414 (17%), Positives = 133/414 (32%), Gaps = 110/414 (26%)
Query: 167 RDLQSATNRFSKDNI-IGDGGYGVVYRGQ---LMNGTAVAVKKLLNNPGQADKDFRVEVE 222
+ + + F + +G G YG VY+ + + A+K++ + + +
Sbjct: 13 SERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI--------EGTGISMS 64
Query: 223 AIGHV------RHKNLVRLLGYCIEGTQRI--LVYEYVNNGNLEQWLRGDM-CDRGYLTW 273
A + +H N++ L + R L+++Y E L + R
Sbjct: 65 ACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY-----AEHDLWHIIKFHRASKAN 119
Query: 274 EARMKILLGTAK--------ALAYLHEAIEPKVVHRDIKSSNILIDENFDA----KISDF 321
+ +++ G K + YLH V+HRD+K +NIL+ KI+D
Sbjct: 120 KKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 176
Query: 322 GLAKLLGA---GKSHITTRVMGTFGYVAPEYANSGLLNEKS-----DVYSFGVVLLEAIT 373
G A+L + + + V+ TF Y APE LL + D+++ G + E +T
Sbjct: 177 GFARLFNSPLKPLADLDPVVV-TFWYRAPEL----LLGARHYTKAIDIWAIGCIFAELLT 231
Query: 374 GRYPVDYGRPQSEVNLVEWLKMMVQLRR--------SEDV------------VDPNIETR 413
P+ + R E QL R ++ + +
Sbjct: 232 SE-PIFHCR--QEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRN 288
Query: 414 PSTSALKRA---------------LLTALRCVDPDSDKR---------------PKMSQV 443
T+ LL L +DP KR P +
Sbjct: 289 TYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDP--IKRITSEQAMQDPYFLEDPLPTSD 346
Query: 444 VRMLESEEYPIPREDRRRRRNQAGASEAESQRESSDTDKNENPESRLKTRRNQQ 497
V YP RE + Q++ + N + + Q
Sbjct: 347 VFAGCQIPYP-KREFLTEEEPDDKGDKKNQQQQQGNNHTNGTGHPGNQDSSHTQ 399
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 5e-21
Identities = 54/256 (21%), Positives = 103/256 (40%), Gaps = 67/256 (26%)
Query: 169 LQSATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHV 227
L++++ ++S +G G +G+V + +G A+KK+L +P R E++ + +
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK---NR-ELDIMKVL 57
Query: 228 RHKNLVRLLGYCIEGTQRI--------------------------------------LVY 249
H N+++L+ Y ++
Sbjct: 58 DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117
Query: 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILL-GTAKALAYLHEAIEPKVVHRDIKSSNI 308
EYV + L + L+ + + + I + +A+ ++H + HRDIK N+
Sbjct: 118 EYVPD-TLHKVLKSFIRSGRSIP-MNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNL 172
Query: 309 LIDENFDA-KISDFGLAKLLGAGK---SHITTRVMGTFGYVAPEYANSGLLNEKS----- 359
L++ + K+ DFG AK L + ++I +R Y APE +L
Sbjct: 173 LVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPEL----MLGATEYTPSI 223
Query: 360 DVYSFGVVLLEAITGR 375
D++S G V E I G+
Sbjct: 224 DLWSIGCVFGELILGK 239
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 8e-21
Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 44/219 (20%)
Query: 181 IIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGH----------VRH 229
++G GG+G V+ Q+ G A KKL +K + + V
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKL-------NKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 230 KNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLGT 283
+ +V L Y E + LV +N G++ + D E R I+
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFYTAQIVS-- 300
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
L +LH+ +++RD+K N+L+D++ + +ISD GLA L AG++ GT G
Sbjct: 301 --GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPG 354
Query: 344 YVAPEYANSGLLNEKS-----DVYSFGVVLLEAITGRYP 377
++APE LL + D ++ GV L E I R P
Sbjct: 355 FMAPE-----LLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 59/218 (27%), Positives = 101/218 (46%), Gaps = 33/218 (15%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVR 228
+ +G G YG V G VA+KKL + A + +R E+ + H+R
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMR 82
Query: 229 HKNLVRLL-----GYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG 282
H+N++ LL ++ LV ++ +L + ++ + L + ++
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEK-----LGEDRIQFLVYQ 136
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF 342
K L Y+H A ++HRD+K N+ ++E+ + KI DFGLA+ S +T V+ T
Sbjct: 137 MLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQAD---SEMTGYVV-TR 189
Query: 343 GYVAPEYANSGLLNEKS-----DVYSFGVVLLEAITGR 375
Y APE +LN D++S G ++ E ITG+
Sbjct: 190 WYRAPEV----ILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 57/230 (24%), Positives = 103/230 (44%), Gaps = 46/230 (20%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL--LNNPGQADKDFRVEVEAIGHVRH 229
++ F +++G+G YGVV G VA+KK+ + P A + R E++ + H +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKH 68
Query: 230 KNLVRLL----GYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----I 279
+N++ + E + ++ E + +L + + M L+ + ++
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVISTQM-----LS-DDHIQYFIYQT 121
Query: 280 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVM 339
L +A+ LH + V+HRD+K SN+LI+ N D K+ DFGLA+++ + +
Sbjct: 122 L----RAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174
Query: 340 GTF---GYV------APEYANSGLLNEKS-----DVYSFGVVLLEAITGR 375
+V APE +L DV+S G +L E R
Sbjct: 175 QQSGMVEFVATRWYRAPEV----MLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 55/225 (24%), Positives = 94/225 (41%), Gaps = 48/225 (21%)
Query: 176 FSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGH-------- 226
F I+G+G + V + A+K L +K ++ + +
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKIL-------EKRHIIKENKVPYVTRERDVM 84
Query: 227 --VRHKNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK----- 278
+ H V+L + + +++ Y NG L +++R G E +
Sbjct: 85 SRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFD-ETCTRFYTAE 138
Query: 279 ILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRV 338
I+ AL YLH ++HRD+K NIL++E+ +I+DFG AK+L
Sbjct: 139 IVS----ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANS 191
Query: 339 M-GTFGYVAPEYANSGLLNEK-----SDVYSFGVVLLEAITGRYP 377
GT YV+PE LL EK SD+++ G ++ + + G P
Sbjct: 192 FVGTAQYVSPE-----LLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 37/222 (16%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLN--NPGQADKDFRVEVEAIGHVRH 229
R++ + IG+G YG+V +N VA+KK+ + + R E++ + RH
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRH 84
Query: 230 KNLVRLLG----YCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTA 284
+N++ + IE + + +V + + +L + L+ +L+ + L
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKT-----QHLSNDHICYFLYQIL 138
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGY 344
+ L Y+H A V+HRD+K SN+L++ D KI DFGLA+ A H T + T Y
Sbjct: 139 RGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR--VADPDHDHTGFL-T-EY 191
Query: 345 V------APEYANSGLLNEKS-----DVYSFGVVLLEAITGR 375
V APE +LN K D++S G +L E ++ R
Sbjct: 192 VATRWYRAPEI----MLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 25/214 (11%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVR 228
R+ + +G G YG V G VAVKKL + A + +R E+ + H++
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMK 86
Query: 229 HKNLVRLL-----GYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG 282
H+N++ LL +E + LV + +L ++ LT + ++
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQK-----LTDDHVQFLIYQ 140
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF 342
+ L Y+H A ++HRD+K SN+ ++E+ + KI DFGLA+ +T V T
Sbjct: 141 ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTA---DEMTGYVA-TR 193
Query: 343 GYVAPEYA-NSGLLNEKSDVYSFGVVLLEAITGR 375
Y APE N N+ D++S G ++ E +TGR
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 3e-19
Identities = 62/218 (28%), Positives = 93/218 (42%), Gaps = 44/218 (20%)
Query: 181 IIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDF---RVEVE----------AIGH 226
IIG GG+G VY + G A+K L DK + +
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCL-------DKKRIKMKQGETLALNERIMLSLVST 248
Query: 227 VRHKNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----IL 280
+V + Y ++ + + +N G+L L G + EA M+ I+
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFS-EADMRFYAAEII 302
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMG 340
L L ++H VV+RD+K +NIL+DE+ +ISD GLA K H V G
Sbjct: 303 L----GLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-G 352
Query: 341 TFGYVAPEYANSGLLNEKS-DVYSFGVVLLEAITGRYP 377
T GY+APE G+ + S D +S G +L + + G P
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 7e-19
Identities = 43/213 (20%), Positives = 80/213 (37%), Gaps = 26/213 (12%)
Query: 121 GSQLGEEGGNGKVSTFRPSSHPLTAPSPLSGLPEFSHLGWGHWFTLRDLQSATNRFSKDN 180
+Q G VS + + + +R+ +
Sbjct: 8 AAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPH--SDWQI------PDRYEIRH 59
Query: 181 IIGDGGYGVVYRGQ-LMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVRHKNLVRLL 236
+IG G YG V + VA+KK+L + + R E+ + + H ++V++L
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILR-EIAILNRLNHDHVVKVL 118
Query: 237 ----GYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
+E + +V E + + YLT +L + Y+H
Sbjct: 119 DIVIPKDVEKFDELYVVLEI-----ADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVH 173
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324
A ++HRD+K +N L++++ K+ DFGLA
Sbjct: 174 SA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 8e-19
Identities = 55/231 (23%), Positives = 99/231 (42%), Gaps = 46/231 (19%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL-LNNPGQADKDFRVEVEAIGHVRHK 230
+R+ +G GG G+V+ VA+KK+ L +P R E++ I + H
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLDHD 68
Query: 231 NLVRLL-------------GYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEAR 276
N+V++ + + +V EY+ +L L +G L E
Sbjct: 69 NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLE-----QGPLLEEHA 122
Query: 277 MKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID-ENFDAKISDFGLAKLLGAGKSHIT 335
+ + L Y+H A V+HRD+K +N+ I+ E+ KI DFGLA+++ SH
Sbjct: 123 RLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH-- 177
Query: 336 TRVMGTFGYV------APEYANSGLLNEKS-----DVYSFGVVLLEAITGR 375
+ + + +P LL+ + D+++ G + E +TG+
Sbjct: 178 KGHL-S-EGLVTKWYRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 1e-18
Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 47/219 (21%)
Query: 181 IIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGH----------VRH 229
++G GG+G V Q+ G A KKL +K + + V
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKL-------EKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 230 KNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLGT 283
+ +V L Y E + LV +N G+L+ + + EAR I
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIY--HMGQAGFP-EARAVFYAAEICC-- 297
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
L LH ++V+RD+K NIL+D++ +ISD GLA + G++ I RV GT G
Sbjct: 298 --GLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVG 350
Query: 344 YVAPEYANSGLLNEKS-----DVYSFGVVLLEAITGRYP 377
Y+APE ++ + D ++ G +L E I G+ P
Sbjct: 351 YMAPE-----VVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 86.0 bits (213), Expect = 3e-18
Identities = 48/245 (19%), Positives = 98/245 (40%), Gaps = 58/245 (23%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVR 228
+ + ++IG G YG VY VA+KK+ + + R E+ + ++
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR-EITILNRLK 83
Query: 229 HKNLVRLLGYCIEGTQRI-----LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK----- 278
++RL I +V E ++ +L++ + + +LT E +K
Sbjct: 84 SDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKKLFKTPI----FLT-EEHIKTILYN 137
Query: 279 ILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRV 338
+L ++HE+ ++HRD+K +N L++++ K+ DFGLA+ + + K
Sbjct: 138 LL----LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVND 190
Query: 339 MGTF---------------GYV------APEYANSGLLNEKS-----DVYSFGVVLLEAI 372
+ +V APE +L +++ D++S G + E +
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPEL----ILLQENYTKSIDIWSTGCIFAELL 246
Query: 373 TGRYP 377
Sbjct: 247 NMLQS 251
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 1e-17
Identities = 57/240 (23%), Positives = 101/240 (42%), Gaps = 56/240 (23%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVR 228
++ +G G YG+V++ G VAVKK+ + N A + FR E+ + +
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELS 66
Query: 229 -HKNLVRLLGYCI-EGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----IL 280
H+N+V LL + + + LV++Y+ +L +R ++ L + ++
Sbjct: 67 GHENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRANI-----LE-PVHKQYVVYQLI 119
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMG 340
K + YLH ++HRD+K SNIL++ K++DFGL++ + +
Sbjct: 120 ----KVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172
Query: 341 TF--------------GYV------APEYANSGLLNEKS-----DVYSFGVVLLEAITGR 375
YV APE LL D++S G +L E + G+
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEI----LLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 8e-17
Identities = 66/281 (23%), Positives = 110/281 (39%), Gaps = 66/281 (23%)
Query: 182 IGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGH----------VRHK 230
IG G +G V Q A+K + +K VE + + + H
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYM-------NKQKCVERNEVRNVFKELQIMQGLEHP 75
Query: 231 NLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLGTA 284
LV L Y + + + +V + + G+L L+ + E +K +++
Sbjct: 76 FLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQ----QNVHFK-EETVKLFICELVM--- 126
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGY 344
AL YL +++HRD+K NIL+DE+ I+DF +A +L T + GT Y
Sbjct: 127 -ALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPY 180
Query: 345 VAPEYANSGLLNEKS--------DVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMM 396
+APE + + + D +S GV E + GR P + R + +
Sbjct: 181 MAPE-----MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPY-HIRSSTSSK------EI 228
Query: 397 VQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKR 437
V + V P + S +LL L +P D+R
Sbjct: 229 VHTFETTVVTYP-----SAWSQEMVSLLKKLLEPNP--DQR 262
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 77.7 bits (191), Expect = 9e-16
Identities = 69/349 (19%), Positives = 118/349 (33%), Gaps = 91/349 (26%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMN------GTAVAVKKLLNNPGQAD-KDFRVEVEAIGH 226
+R +G G +G V VAVK L ++ + E++ + H
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 227 V-RHKNLVR----------------------------------LLGYCIEGTQRILVYEY 251
+ H N+V + Y +G + +Y
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDY 141
Query: 252 VNNGNLEQWLRGDMC-----------------------------DRGYLTWEARMKILLG 282
V ++ R D + +LT E +
Sbjct: 142 VGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQ 201
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI-TTRVMGT 341
AK + +L K +HRD+ + NIL+ E KI DFGLA+ + ++
Sbjct: 202 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 342 FGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLR 400
++APE + +SDV+SFGV+L E + G P Y P +++ E+ + + +
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP--Y--PGVKID-EEFCRRLKEGT 313
Query: 401 RSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449
R P T L C + +RP S++V L +
Sbjct: 314 RMR---------AP-DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN 352
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 64/267 (23%), Positives = 105/267 (39%), Gaps = 37/267 (13%)
Query: 181 IIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKD---FRVEVEAIGHVRHKNLVRLL 236
+IG G +G V +L A+K L + FR E + + + K + L
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH 140
Query: 237 GYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLGTAKALAYL 290
Y + + LV +Y G+L L L E + +++ A+ +
Sbjct: 141 -YAFQDDNNLYLVMDYYVGGDLLTLLSKF---EDRLP-EEMARFYLAEMVI----AIDSV 191
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYA 350
H+ VHRDIK NIL+D N +++DFG L + ++ +GT Y++PE
Sbjct: 192 HQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248
Query: 351 NSGLLNEKS-----DVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV 405
+ + D +S GV + E + G P Y +LVE + + E
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF-YAE-----SLVETYGKI--MNHKERF 300
Query: 406 VDPNIETRPSTSALKRALLTALRCVDP 432
P T S +A + L+ L C
Sbjct: 301 QFPTQVTDVSENA--KDLIRRLICSRE 325
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 3e-15
Identities = 49/219 (22%), Positives = 84/219 (38%), Gaps = 29/219 (13%)
Query: 176 FSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKD---FRVEVEAIGHVRHKN 231
F +IG G + V ++ G A+K + + FR E + + + +
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 232 LVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLGTAK 285
+ +L + + + LV EY G+L L G + I++
Sbjct: 123 ITQLH-FAFQDENYLYLVMEYYVGGDLLTLLS----KFGERIPAEMARFYLAEIVM---- 173
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYV 345
A+ +H VHRDIK NIL+D +++DFG L A + + +GT Y+
Sbjct: 174 AIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYL 230
Query: 346 APEYANSGLLNEKSDVY-------SFGVVLLEAITGRYP 377
+PE + + Y + GV E G+ P
Sbjct: 231 SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 75.3 bits (184), Expect = 5e-15
Identities = 48/329 (14%), Positives = 90/329 (27%), Gaps = 88/329 (26%)
Query: 172 ATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKL-LNNPGQADKDFRVEVEAI------ 224
T + + IG+G +G V++ + T VA+K + + P + + E I
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 225 ----------GHVRHKNLVRLLGYCI------------------------------EGTQ 244
R + + L + Q
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIK 304
+V E+ G + + IL +LA + HRD+
Sbjct: 137 LFIVLEFEFGGIDL-----EQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLH 189
Query: 305 SSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAP--EYANSGLLNEKSDVY 362
N+L+ + K+ K + + G +Y S L + V+
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSST----------IPSCGLQVSIIDYTLSRLERDGIVVF 239
Query: 363 SFGVVLLEAITGRY--------------PVDYGRPQSEVNLVEWL-----KMMVQLRRSE 403
+ + TG +G N++ WL KM+ Q+
Sbjct: 240 CDVSMDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVL-WLHYLTDKMLKQMTFKT 298
Query: 404 DVVDPNI-ETRPSTSALKRALLTALRCVD 431
P + + + R +L D
Sbjct: 299 KCNTPAMKQIKRKIQEFHRTMLNFSSATD 327
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 7e-15
Identities = 57/212 (26%), Positives = 90/212 (42%), Gaps = 39/212 (18%)
Query: 182 IGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGH----------VRHK 230
+G G +G V + +G A+K L DK V+++ I H V
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKIL-------DKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 231 NLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLGTAK 285
LV+L + + +V EYV G + LR G + E + I+L
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFS-EPHARFYAAQIVL---- 152
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYV 345
YLH +++RD+K N+LID+ +++DFG AK + T + GT +
Sbjct: 153 TFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWTLCGTPEAL 205
Query: 346 APEYANSGLLNEKSDVYSFGVVLLEAITGRYP 377
APE S N+ D ++ GV++ E G P
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 70/279 (25%), Positives = 105/279 (37%), Gaps = 66/279 (23%)
Query: 182 IGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGH-----------VRH 229
IG G +G V + AVK L K ++ + H V+H
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVL-------QKKAILKKKEEKHIMSERNVLLKNVKH 98
Query: 230 KNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLGT 283
LV L + + ++ V +Y+N G L L+ E R + I
Sbjct: 99 PFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQ----RERCFL-EPRARFYAAEIAS-- 150
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
AL YLH +V+RD+K NIL+D ++DFGL K + T+ GT
Sbjct: 151 --ALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNSTTSTFCGTPE 204
Query: 344 YVAPEYANSGLLNEKS-----DVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQ 398
Y+APE +L+++ D + G VL E + G P Y R +E M
Sbjct: 205 YLAPE-----VLHKQPYDRTVDWWCLGAVLYEMLYGLPPF-YSRNTAE---------MYD 249
Query: 399 LRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKR 437
++ + P+ + R LL L D KR
Sbjct: 250 NILNKPLQLK-----PNITNSARHLLEGLLQKDR--TKR 281
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 47/202 (23%), Positives = 76/202 (37%), Gaps = 52/202 (25%)
Query: 181 IIGDGGYGVVYRG-QLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGY 238
++G G G V + A+K L + R EVE + ++VR++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDV 79
Query: 239 CIEGTQRI----LVYEYVNNGNLEQWLRGDMCDRGYLTW---EAR--MKILLGTAKALAY 289
+V E ++ G L + DRG + EA MK + +A+ Y
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFS----RIQDRGDQAFTEREASEIMKSIG---EAIQY 132
Query: 290 LHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVA 346
LH + HRD+K N+L N K++DFG AK K Y
Sbjct: 133 LHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEK------------Y-- 175
Query: 347 PEYANSGLLNEKSDVYSFGVVL 368
++ D++S GV++
Sbjct: 176 ---------DKSCDMWSLGVIM 188
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 49/216 (22%), Positives = 85/216 (39%), Gaps = 28/216 (12%)
Query: 176 FSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKD---FRVEVEAIGHVRHKN 231
+ +IG G +G V + A+K L D F E + +
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 232 LVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLGTAK 285
+V+L Y + + + +V EY+ G+L + + E + ++L
Sbjct: 131 VVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMS-----NYDVP-EKWARFYTAEVVL---- 179
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYV 345
AL +H +HRD+K N+L+D++ K++DFG + +GT Y+
Sbjct: 180 ALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 236
Query: 346 APE----YANSGLLNEKSDVYSFGVVLLEAITGRYP 377
+PE G + D +S GV L E + G P
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 1e-14
Identities = 63/218 (28%), Positives = 88/218 (40%), Gaps = 48/218 (22%)
Query: 182 IGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGH----------VRHK 230
+G G +G V + G A+K L K+ + + + H RH
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKIL-------RKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 231 NLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLGTA 284
L L Y + R+ V EY N G L L T E R + I+
Sbjct: 66 FLTALK-YAFQTHDRLCFVMEYANGGELFFHLS----RERVFT-EERARFYGAEIVS--- 116
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGY 344
AL YLH VV+RDIK N+++D++ KI+DFGL K G GT Y
Sbjct: 117 -ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEY 171
Query: 345 VAPEYANSGLLNEKS-----DVYSFGVVLLEAITGRYP 377
+APE +L + D + GVV+ E + GR P
Sbjct: 172 LAPE-----VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 61/207 (29%), Positives = 87/207 (42%), Gaps = 25/207 (12%)
Query: 182 IGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDF---RVEVEAIGHVRHKNLVRLLG 237
+G G +G V + G A+K L A + E + + RH L L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 214
Query: 238 YCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG-TAKALAYLHEAIE 295
Y + R+ V EY N G L L + + E R + AL YLH E
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRE----RVFS-EDRARFYGAEIVSALDYLHS--E 267
Query: 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLL 355
VV+RD+K N+++D++ KI+DFGL K G GT Y+APE +L
Sbjct: 268 KNVVYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEYLAPE-----VL 321
Query: 356 NEKS-----DVYSFGVVLLEAITGRYP 377
+ D + GVV+ E + GR P
Sbjct: 322 EDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 7e-14
Identities = 68/268 (25%), Positives = 107/268 (39%), Gaps = 51/268 (19%)
Query: 181 IIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-----------R 228
+IG G Y V +L A+K + K+ + E I V
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVV-------KKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 229 HKNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLG 282
H LV L C + R+ V EYVN G+L ++ + L E + I L
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ----RQRKLP-EEHARFYSAEISL- 121
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF 342
AL YLHE +++RD+K N+L+D K++D+G+ K G T+ GT
Sbjct: 122 ---ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTP 174
Query: 343 GYVAPEYANSGLLNEKS-----DVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMV 397
Y+APE +L + D ++ GV++ E + GR P S+ +
Sbjct: 175 NYIAPE-----ILRGEDYGFSVDWWALGVLMFEMMAGRSPF-DIVGSSDNPDQNTEDYLF 228
Query: 398 QLRRSEDVVDPNIETRPSTSALKRALLT 425
Q+ + + P + + S LK L
Sbjct: 229 QVILEKQIRIPRSLSVKAASVLKS-FLN 255
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 9e-14
Identities = 66/280 (23%), Positives = 107/280 (38%), Gaps = 67/280 (23%)
Query: 182 IGDGGYGVVY----RGQLMNGTAVAVKKLLNNPGQADKDF---RVEVEAIG------HVR 228
+G G +G V+ A+K L K R V V
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVL-------KKATLKVRDRVRTKMERDILVEVN 84
Query: 229 HKNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLG 282
H +V+L Y + ++ L+ +++ G+L L T E +K + L
Sbjct: 85 HPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLS----KEVMFT-EEDVKFYLAELAL- 137
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTF 342
AL +LH +++RD+K NIL+DE K++DFGL+K GT
Sbjct: 138 ---ALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTV 190
Query: 343 GYVAPEYANSGLLNEKS-----DVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMV 397
Y+APE ++N + D +SFGV++ E +TG P G+ + E +
Sbjct: 191 EYMAPE-----VVNRRGHTQSADWWSFGVLMFEMLTGTLPF-QGKDRKE---------TM 235
Query: 398 QLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKR 437
+ + P S ++LL L +P R
Sbjct: 236 TMILKAKLGMP-----QFLSPEAQSLLRMLFKRNP--ANR 268
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 1e-13
Identities = 56/229 (24%), Positives = 94/229 (41%), Gaps = 50/229 (21%)
Query: 182 IGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGH-----------VRH 229
+G G +G V+ + A+K L KD + + + H
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKAL-------KKDVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 230 KNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLGT 283
L + + + + V EY+N G+L ++ +R I+L
Sbjct: 78 PFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFD-LSRATFYAAEIIL-- 129
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
L +LH +V+RD+K NIL+D++ KI+DFG+ K T GT
Sbjct: 130 --GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK-ENMLGDAKTNTFCGTPD 183
Query: 344 YVAPEYANSGLLNEKS-----DVYSFGVVLLEAITGRYPVDYGRPQSEV 387
Y+APE +L + D +SFGV+L E + G+ P +G+ + E+
Sbjct: 184 YIAPE-----ILLGQKYNHSVDWWSFGVLLYEMLIGQSPF-HGQDEEEL 226
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 71.0 bits (175), Expect = 1e-13
Identities = 43/163 (26%), Positives = 72/163 (44%), Gaps = 30/163 (18%)
Query: 226 HVRHKNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----I 279
V+H +V L+ Y + ++ L+ EY++ G L L G E I
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLE----REGIFM-EDTACFYLAEI 130
Query: 280 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVM 339
+ AL +LH+ +++RD+K NI+++ K++DFGL K +T
Sbjct: 131 SM----ALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFC 182
Query: 340 GTFGYVAPEYANSGLLNEKS-----DVYSFGVVLLEAITGRYP 377
GT Y+APE +L D +S G ++ + +TG P
Sbjct: 183 GTIEYMAPE-----ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 53/219 (24%)
Query: 182 IGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGH----------VRHK 230
+G G +G V+ + NG A+K L K+ V ++ + H V H
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVL-------KKEIVVRLKQVEHTNDERLMLSIVTHP 66
Query: 231 NLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLGTA 284
++R+ + Q+I ++ +Y+ G L LR K + L
Sbjct: 67 FIIRMW-GTFQDAQQIFMIMDYIEGGELFSLLR----KSQRFP-NPVAKFYAAEVCL--- 117
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVM-GTFG 343
AL YLH +++RD+K NIL+D+N KI+DFG AK + T + GT
Sbjct: 118 -ALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPD 168
Query: 344 YVAPEYANSGLLNEKS-----DVYSFGVVLLEAITGRYP 377
Y+APE +++ K D +SFG+++ E + G P
Sbjct: 169 YIAPE-----VVSTKPYNKSIDWWSFGILIYEMLAGYTP 202
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 54/222 (24%), Positives = 91/222 (40%), Gaps = 53/222 (23%)
Query: 181 IIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-----------R 228
++G G +G V + AVK L KD ++ + + +
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKIL-------KKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 229 HKNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLG 282
L +L C + R+ V EYVN G+L ++ G E I +
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ----QVGRFK-EPHAVFYAAEIAI- 453
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL-LGAGKSHITTRVM-G 340
L +L +++RD+K N+++D KI+DFG+ K + G TT+ G
Sbjct: 454 ---GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCG 504
Query: 341 TFGYVAPEYANSGLLNEKS-----DVYSFGVVLLEAITGRYP 377
T Y+APE ++ + D ++FGV+L E + G+ P
Sbjct: 505 TPDYIAPE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 55/205 (26%), Positives = 85/205 (41%), Gaps = 46/205 (22%)
Query: 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLGTAKALAYLHEAIEPKVVHR 301
L+ +Y+N G L L R T E ++ I+L AL +LH+ +++R
Sbjct: 136 LILDYINGGELFTHLS----QRERFT-EHEVQIYVGEIVL----ALEHLHKL---GIIYR 183
Query: 302 DIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKS-- 359
DIK NIL+D N ++DFGL+K A ++ GT Y+AP+ + S
Sbjct: 184 DIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI----VRGGDSGH 239
Query: 360 ----DVYSFGVVLLEAITGR---YPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIET 412
D +S GV++ E +TG Q+E + + + P
Sbjct: 240 DKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE---------ISRRILKSEPPYP---- 286
Query: 413 RPSTSALKRALLTALRCVDPDSDKR 437
SAL + L+ L DP KR
Sbjct: 287 -QEMSALAKDLIQRLLMKDP--KKR 308
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 54/221 (24%), Positives = 90/221 (40%), Gaps = 53/221 (23%)
Query: 182 IGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-----------RH 229
+G G +G V + AVK L KD ++ + + +
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKIL-------KKDVVIQDDDVECTMVEKRVLALPGKP 80
Query: 230 KNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLGT 283
L +L C + R+ V EYVN G+L ++ G E I +
Sbjct: 81 PFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ----QVGRFK-EPHAVFYAAEIAI-- 132
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL-LGAGKSHITTRVM-GT 341
L +L +++RD+K N+++D KI+DFG+ K + G TT+ GT
Sbjct: 133 --GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV---TTKTFCGT 184
Query: 342 FGYVAPEYANSGLLNEKS-----DVYSFGVVLLEAITGRYP 377
Y+APE ++ + D ++FGV+L E + G+ P
Sbjct: 185 PDYIAPE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 3e-13
Identities = 58/219 (26%), Positives = 92/219 (42%), Gaps = 49/219 (22%)
Query: 182 IGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-----------H 229
+G G +G V ++ G AVK L KD ++ + + H
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVL-------KKDVILQDDDVECTMTEKRILSLARNH 83
Query: 230 KNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLGT 283
L +L C + R+ V E+VN G+L ++ EAR + I+
Sbjct: 84 PFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQ----KSRRFD-EARARFYAAEIIS-- 135
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
AL +LH+ +++RD+K N+L+D K++DFG+ K G T GT
Sbjct: 136 --ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTPD 189
Query: 344 YVAPEYANSGLLNEKS-----DVYSFGVVLLEAITGRYP 377
Y+APE +L E D ++ GV+L E + G P
Sbjct: 190 YIAPE-----ILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 69/270 (25%), Positives = 108/270 (40%), Gaps = 55/270 (20%)
Query: 181 IIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-----------R 228
+IG G Y V +L A++ + K+ + E I V
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVV-------KKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 229 HKNLVRLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMK-----ILLG 282
H LV L C + R+ V EYVN G+L ++ + L E + I L
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ----RQRKLP-EEHARFYSAEISL- 164
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL-LGAGKSHITTRVM-G 340
AL YLHE +++RD+K N+L+D K++D+G+ K L G TT G
Sbjct: 165 ---ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD---TTSTFCG 215
Query: 341 TFGYVAPEYANSGLLNEKS-----DVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKM 395
T Y+APE +L + D ++ GV++ E + GR P S+
Sbjct: 216 TPNYIAPE-----ILRGEDYGFSVDWWALGVLMFEMMAGRSPF-DIVGSSDNPDQNTEDY 269
Query: 396 MVQLRRSEDVVDPNIETRPSTSALKRALLT 425
+ Q+ + + P + + S LK L
Sbjct: 270 LFQVILEKQIRIPRSLSVKAASVLKS-FLN 298
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 57/228 (25%), Positives = 92/228 (40%), Gaps = 44/228 (19%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVK--KLLNNPGQADKDFRVEVEAIGHVRHK 230
+ IG+G +GV++ G L+N VA+K ++ Q ++R G
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCT--- 66
Query: 231 NLVRLLGYCIEGTQRILVYEYVNNG-NLEQWLRGDMCDRGYLTWEARMKILLGTAK---- 285
+ + + EG +LV + + G +LE L +C R + +K + AK
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLL--GPSLEDLLD--LCGRKF-----SVKTVAMAAKQMLA 117
Query: 286 ALAYLHEAIEPKVVHRDIKSSNILIDENFDAK-----ISDFGLAK--LLGAGKSHITTR- 337
+ +HE +V+RDIK N LI + DFG+ K K HI R
Sbjct: 118 RVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYRE 174
Query: 338 ---VMGTFGYVAPEYA--NSGLLNEKS---DVYSFGVVLLEAITGRYP 377
+ GT Y N+ L E+S D+ + G V + + G P
Sbjct: 175 KKNLSGT-----ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 3e-10
Identities = 55/232 (23%), Positives = 88/232 (37%), Gaps = 52/232 (22%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVK--KLLNNPGQADKDFRVEVEAIGHVRHK 230
F IG G +G + G+ L VA+K + + Q ++R +
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGD--- 65
Query: 231 NLVRLLGYCIEGTQRILVYEYVNNG-NLEQWLRGDMCDRGYLTWEARMKILLGTAKALA- 288
+ ++ + G +V E + G +LE D+CDR L T +A
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELL--GPSLEDLF--DLCDR---------TFSLKTVLMIAI 112
Query: 289 -------YLHEAIEPKVVHRDIKSSNILI--DENFDAK---ISDFGLAK--LLGAGKSHI 334
Y+H +++RD+K N LI N + I DF LAK + K HI
Sbjct: 113 QLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHI 169
Query: 335 TTR----VMGTFGYVAPEYA--NSGLLNEKS---DVYSFGVVLLEAITGRYP 377
R + GT Y N+ L E+S D+ + G + + + G P
Sbjct: 170 PYREHKSLTGT-----ARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 49/251 (19%), Positives = 95/251 (37%), Gaps = 50/251 (19%)
Query: 181 IIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVR-------- 228
+G G + V+ + ++N T VA+K + + A E++ + V
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAA----EDEIKLLQRVNDADNTKED 81
Query: 229 ---HKNLVRLLGY----CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILL 281
++++LL + G ++V+E V NL ++ RG + +I
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIK-KYEHRGIPLIYVK-QISK 138
Query: 282 GTAKALAYLHEAIEPKVVHRDIKSSNILIDE------NFDAKISDFGLAKLLGAGKSHIT 335
L Y+H ++H DIK N+L++ KI+D G A H T
Sbjct: 139 QLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW---YDEHYT 193
Query: 336 TRVMGTFGYVAPE------YANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNL 389
+ Y +PE + +D++S ++ E ITG + + S
Sbjct: 194 NSIQTRE-YRSPEVLLGAPW------GCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 246
Query: 390 VEWLKMMVQLR 400
+ + +++L
Sbjct: 247 DDHIAQIIELL 257
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 58/253 (22%), Positives = 102/253 (40%), Gaps = 58/253 (22%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVR 228
R+ +IG G +G V + VA+K + N QA E+ + H+R
Sbjct: 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLR 151
Query: 229 HK------NLVRLLGY-------CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEA 275
+ N++ +L C+ +E ++ NL + ++ + +G+
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHICM-------TFELLSM-NLYELIKKN-KFQGFSLPLV 202
Query: 276 RMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDA--KISDFGLAKLLGAGKSH 333
R K + L LH+ +++H D+K NIL+ + + K+ DFG +
Sbjct: 203 R-KFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH---QR 255
Query: 334 ITTRVMGTFGYVAPE------YANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEV 387
+ T + F Y APE Y D++S G +L E +TG YP+ G E
Sbjct: 256 VYTYIQSRF-YRAPEVILGARY------GMPIDMWSLGCILAELLTG-YPLLPGE--DEG 305
Query: 388 NLVEWLKMMVQLR 400
+ L M++L
Sbjct: 306 DQ---LACMIELL 315
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 60/253 (23%), Positives = 103/253 (40%), Gaps = 56/253 (22%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVR 228
+R+ D++IG G +G V + + VA+K + N QA ++EV + +
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMN 108
Query: 229 H------KNLVRLLGY-------CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEA 275
+V L + C+ V+E ++ NL LR + ++
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCL-------VFEMLSY-NLYDLLR--NTNFRGVSLNL 158
Query: 276 RMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI--DENFDAKISDFGLAKLLGAGKSH 333
K AL +L E ++H D+K NIL+ + KI DFG + LG
Sbjct: 159 TRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG---QR 214
Query: 334 ITTRVMGTFGYVAPE------YANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEV 387
I + F Y +PE Y + D++S G +L+E TG P+ G +EV
Sbjct: 215 IYQYIQSRF-YRSPEVLLGMPY------DLAIDMWSLGCILVEMHTG-EPLFSGA--NEV 264
Query: 388 NLVEWLKMMVQLR 400
+ + +V++
Sbjct: 265 DQ---MNKIVEVL 274
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 3e-08
Identities = 56/223 (25%), Positives = 86/223 (38%), Gaps = 36/223 (16%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVK--KLLNNPGQADKDFRVEVEAIGHVRHK 230
NR+ IG G +G +Y G + G VA+K + Q +E + ++
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ----LHIESKIYKMMQGG 64
Query: 231 NLV-RLLGYCIEGTQRILVYEYVNNG-NLEQWLRGDMCDRGYLTWEARMKILLGTAKALA 288
+ + EG ++V E + G +LE C R + + + + +
Sbjct: 65 VGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFN--FCSRK-FSLKTVLLLADQMISRIE 119
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAK---ISDFGLAK--LLGAGKSHITTR----VM 339
Y+H +HRD+K N L+ I DFGLAK HI R +
Sbjct: 120 YIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLT 176
Query: 340 GTFGYVAPEYA--NSGLLNEKS---DVYSFGVVLLEAITGRYP 377
GT YA N+ L E+S D+ S G VL+ G P
Sbjct: 177 GT-----ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 38/238 (15%), Positives = 78/238 (32%), Gaps = 46/238 (19%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ---------LMNGTAVAVK-KLLNNPGQADKDFRVEVEA 223
++ + G++Y ++K + +++F
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 224 IGHVRH-KNLVRLLGYCI---------EGTQRILVYEYVNNG-NLEQWLRGDMCDRGYLT 272
V K L I + R LV + G +L+ L D+ + L+
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSAL--DVSPKHVLS 157
Query: 273 WEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKI--SDFGLAKLLGAG 330
+ +++ AL +LHE + VH ++ + NI +D +++ + +G A
Sbjct: 158 ERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPS 214
Query: 331 KSHITTR------VMGTFGYVAPEYA--NSGLLNEKS---DVYSFGVVLLEAITGRYP 377
H+ G E+ + S D+ S G +L+ + G P
Sbjct: 215 GKHVAYVEGSRSPHEGD-----LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 4e-07
Identities = 41/239 (17%), Positives = 83/239 (34%), Gaps = 64/239 (26%)
Query: 182 IGDGGYGVVYRGQLMNGTAV------AVKKLLNNPGQ-----------ADKDFRVEVEAI 224
IG GG+G +Y + + +V VK ++ G A + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 225 GHVRHKNLVRLLGYCIEGTQ----RILVYEYVNNG-NLEQWLRGDMCDRGYLTWEARMKI 279
+++ + + G + R ++ + G +L++ + + +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIY--EANAK---------RF 149
Query: 280 LLGTAKALA--------YLHEAIEPKVVHRDIKSSNILIDENFDAKI--SDFGLAK--LL 327
T L+ Y+HE + VH DIK+SN+L++ ++ D+GLA
Sbjct: 150 SRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCP 206
Query: 328 GAGKSHITTR----VMGTFGYVAPEYA--NSGLLNEKS---DVYSFGVVLLEAITGRYP 377
GT E+ ++ S D+ G +++ +TG P
Sbjct: 207 EGVHKAYAADPKRCHDGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 50.4 bits (120), Expect = 8e-07
Identities = 57/224 (25%), Positives = 87/224 (38%), Gaps = 38/224 (16%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL 232
N+F IG G +G +Y G + VA+K E + ++
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVK--TKHPQLLYESKIYRILQGGTG 64
Query: 233 V-RLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAK----AL 287
+ + + +EG +LV + + +LE C R +K +L A +
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLLGP-SLEDLFN--FCSRKL-----SLKTVLMLADQMINRV 116
Query: 288 AYLHEAIEPKVVHRDIKSSNILIDENFDAK---ISDFGLAKLL--GAGKSHITTR----V 338
++H +HRDIK N L+ A I DFGLAK + HI R +
Sbjct: 117 EFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL 173
Query: 339 MGTFGYVAPEYA--NSGLLNEKS---DVYSFGVVLLEAITGRYP 377
GT YA N+ L E+S D+ S G VL+ + G P
Sbjct: 174 TGT-----ARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 7e-06
Identities = 55/291 (18%), Positives = 97/291 (33%), Gaps = 76/291 (26%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVK--KLLNNPGQADKDFRVEVEAIGHVR- 228
R+ +G G + V+ + VA+K K + + D E+ + VR
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALD---EIRLLKSVRN 92
Query: 229 -------HKNLVRLLGY----CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARM 277
+ +V+LL + GT +V+E V +L +W+ + L
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWII--KSNYQGLPLPCVK 149
Query: 278 KILLGTAKALAYLHEAIEPKVVHRDIKSSNILI--------------------------- 310
KI+ + L YLH + +++H DIK NIL+
Sbjct: 150 KIIQQVLQGLDYLHT--KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 311 ----------------------DENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPE 348
E KI+D G A H T + T Y + E
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW---VHKHFTEDIQ-TRQYRSLE 263
Query: 349 YANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQL 399
N +D++S + E TG Y + + + + ++++L
Sbjct: 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIEL 314
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 3e-05
Identities = 65/478 (13%), Positives = 121/478 (25%), Gaps = 157/478 (32%)
Query: 5 LNKSLSK----TYI---GM----QLWVLIVICLAVVFVVIL--GVSLWLTFRKKKSRRAN 51
L ++L + + G+ + WV + +CL+ + + WL + S
Sbjct: 140 LRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKI-FWLNLKNCNSPETV 198
Query: 52 -DML----------------PVSRFPVVSEEIK-EIR--------------VDQVSSSNG 79
+ML S + I+ E+R + V ++
Sbjct: 199 LEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAK- 257
Query: 80 GFSVHNEKFNDRESEKELIPQENGD--DSVQSGSFNNLEKDVVGSQLGEEGGNG---KVS 134
FN K L+ D + + + ++ D L + K
Sbjct: 258 ----AWNAFNLSC--KILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYL 311
Query: 135 TFRPSSHPLTAP--SPL--SGLPEFSHLG---WGHW-------------FTLRDLQSATN 174
RP P +P S + E G W +W +L L+ A
Sbjct: 312 DCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEY 371
Query: 175 R--------FSKDNII---------GDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDF 217
R F I D V ++N + L+ + K+
Sbjct: 372 RKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDV--MVVVNK--LHKYSLVE---KQPKES 424
Query: 218 RVEVEAIGHVRHKNLVRLLGYCIEGTQ--RILVYEYVNNGNLEQWLRGDMCDRGYLTWEA 275
+ + + L R +V Y + Y
Sbjct: 425 TISI-------PSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSH- 476
Query: 276 RMKILLGTAKALAYLH-EAIEPKVVHRDIKSSNILIDENF-DAKISDFGLAKLLGAG--- 330
+ + H + IE R + +D F + KI A
Sbjct: 477 -----------IGH-HLKNIEH--PERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILN 522
Query: 331 --------KSHIT------TRVMGTFGYVAPEYANS------------GLLNEKSDVY 362
K +I R++ P+ + L+ E ++
Sbjct: 523 TLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKYTDLLRIALMAEDEAIF 580
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 5e-04
Identities = 38/251 (15%), Positives = 81/251 (32%), Gaps = 73/251 (29%)
Query: 220 EVEAIGHVRH-KNLVRLLGYCIEGTQRILVYEYVNNGNLEQ---WL----RGDMCDRGYL 271
E++ I + + L + + Q +V ++V L +L + + +
Sbjct: 50 EIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEV-LRINYKFLMSPIKTEQRQPSMM 108
Query: 272 T--WEARMKILLGTAKALAYLHEAIEPKV------VHRDIKSSNILIDENFDAKISDFGL 323
T + + L + A + + + + N+LI G+
Sbjct: 109 TRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLI----------DGV 158
Query: 324 AKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEK-SDVYSFGVVLLEAITGRYPVDYGR 382
G+GK+ + A L+ K F + + ++
Sbjct: 159 L---GSGKT-----WV----------ALDVCLSYKVQCKMDFKI---------FWLNLKN 191
Query: 383 PQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQ 442
S + L+M+ +L +DPN +R S+ + LR ++ R
Sbjct: 192 CNSPETV---LEMLQKLLY---QIDPNWTSRSDHSSNIK-----LRIHSIQAELR----- 235
Query: 443 VVRMLESEEYP 453
R+L+S+ Y
Sbjct: 236 --RLLKSKPYE 244
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 56/247 (22%), Positives = 85/247 (34%), Gaps = 70/247 (28%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVR 228
N F +GDG +G V Q + N AVK + N A ++E + + ++
Sbjct: 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQ 89
Query: 229 H-----KNLVRLLGY-------CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGY--LTWE 274
+ N+V+ G C+ ++E L L + Y E
Sbjct: 90 NDDINNNNIVKYHGKFMYYDHMCL-------IFE-----PLGPSLYEIITRNNYNGFHIE 137
Query: 275 ARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334
+ KAL YL + + H D+K NIL+D+ + K G
Sbjct: 138 DIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIY 194
Query: 335 TTRVMGT----FG-----------------YVAPE------YANSGLLNEKSDVYSFGVV 367
T+ G FG Y APE + + SD++SFG V
Sbjct: 195 RTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGW------DVSSDMWSFGCV 248
Query: 368 LLEAITG 374
L E TG
Sbjct: 249 LAELYTG 255
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 33/183 (18%), Positives = 61/183 (33%), Gaps = 47/183 (25%)
Query: 182 IGDGGYGVVYRGQ-LMNGTAVAVK--KLLNNP-GQADKDFRVE-----VEAIGHVRHKNL 232
IG GG+G++Y A K+ G + + + I +
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 233 VRLLG-----YC-----IEGTQRILVYEYVNNG-NLEQWLRGDMCDRGYLTWEARMKILL 281
+ LG + R +V E + G +L++ +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISG---QNG---------TFKK 150
Query: 282 GTAKALA--------YLHEAIEPKVVHRDIKSSNILIDENFDAKI--SDFGLAKLLGAGK 331
T L Y+HE + VH DIK++N+L+ ++ +D+GL+
Sbjct: 151 STVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG 207
Query: 332 SHI 334
+H
Sbjct: 208 NHK 210
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 1e-04
Identities = 55/248 (22%), Positives = 90/248 (36%), Gaps = 76/248 (30%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ--LMNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHV 227
+ R+ + +G+G +G V G VAVK + N A R E++ + H+
Sbjct: 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHL 68
Query: 228 RHK------NLVRLLGY-------CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGY--LT 272
V++L + CI V+E L + + G+
Sbjct: 69 NTTDPNSTFRCVQMLEWFEHHGHICI-------VFE-----LLGLSTYDFIKENGFLPFR 116
Query: 273 WEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDA---------------- 316
+ K+ K++ +LH K+ H D+K NIL ++
Sbjct: 117 LDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLIN 173
Query: 317 ---KISDFGLAKLLGAGKSHIT---TRVMGTFGYVAPEYANSGLL----NEKSDVYSFGV 366
K+ DFG A + H T TR Y APE +L ++ DV+S G
Sbjct: 174 PDIKVVDFGSATY--DDEHHSTLVSTRH-----YRAPE----VILALGWSQPCDVWSIGC 222
Query: 367 VLLEAITG 374
+L+E G
Sbjct: 223 ILIEYYLG 230
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 46/250 (18%), Positives = 80/250 (32%), Gaps = 80/250 (32%)
Query: 173 TNRFSKDNIIGDGGYGVVYRG--QLMNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHV 227
R+ +G+G +G V + VA+K + N A R+E+ + +
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKI 73
Query: 228 RHK------NLVRLLGY-------CIEGTQRILVYEYVNNGNLEQWLRGDMCDRGY--LT 272
+ K V + + CI +E L + + + +
Sbjct: 74 KEKDKENKFLCVLMSDWFNFHGHMCI-------AFE-----LLGKNTFEFLKENNFQPYP 121
Query: 273 WEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDA---------------- 316
+ AL +LHE ++ H D+K NIL +
Sbjct: 122 LPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKN 178
Query: 317 ---KISDFGLAKLLGAGKSH---ITTRVMGTFGYVAPE------YANSGLLNEKSDVYSF 364
+++DFG A + H + TR Y PE + + DV+S
Sbjct: 179 TSIRVADFGSATF--DHEHHTTIVATRH-----YRPPEVILELGW------AQPCDVWSI 225
Query: 365 GVVLLEAITG 374
G +L E G
Sbjct: 226 GCILFEYYRG 235
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 498 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.98 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.84 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.72 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.46 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.31 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.13 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.1 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.78 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.66 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.61 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.58 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.51 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.43 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.27 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.22 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.16 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.96 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.85 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.69 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.64 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.54 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.47 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.33 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.28 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.18 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.04 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.02 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.95 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.65 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 96.32 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.22 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 95.98 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 94.72 | |
| 2k9y_A | 41 | Ephrin type-A receptor 2; receptor tyrosine kinase | 94.5 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.43 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 89.21 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 88.73 | |
| 2l8s_A | 54 | Integrin alpha-1; transmembrane region, detergent | 88.26 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 87.93 | |
| 2knc_A | 54 | Integrin alpha-IIB; transmembrane signaling, prote | 86.91 | |
| 1iij_A | 35 | ERBB-2 receptor protein-tyrosine kinase; alpha-hel | 86.78 | |
| 2k1a_A | 42 | Integrin alpha-IIB; single-PASS transmembrane segm | 85.63 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 81.47 | |
| 2knc_B | 79 | Integrin beta-3; transmembrane signaling, protein | 80.84 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 80.27 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-57 Score=446.89 Aligned_cols=259 Identities=27% Similarity=0.438 Sum_probs=208.9
Q ss_pred ccCCCccceEcccCcEEEEEEEEc------CCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI 246 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 246 (498)
.++|.+.+.||+|+||+||+|++. ++..||||++........++|.+|+++|++++|||||+++++|.+++..|
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 91 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI 91 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence 457888999999999999999863 47889999997665555678999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhccc---------CCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeE
Q 010891 247 LVYEYVNNGNLEQWLRGDM---------CDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAK 317 (498)
Q Consensus 247 lv~e~~~~g~L~~~l~~~~---------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~k 317 (498)
||||||++|+|.++|+... .....++|.+++.|+.|||.||.|||++ +||||||||+||||++++.+|
T Consensus 92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEE
Confidence 9999999999999997532 1235799999999999999999999999 999999999999999999999
Q ss_pred EeeeccceecCCCCce-eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHH
Q 010891 318 ISDFGLAKLLGAGKSH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKM 395 (498)
Q Consensus 318 L~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~ 395 (498)
|+|||+|+........ .....+||+.|||||++.++.|+.++|||||||+||||+| |+.||...... +.+..
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~------~~~~~ 242 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN------EVIEC 242 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHH
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH------HHHHH
Confidence 9999999876543322 2334579999999999999999999999999999999999 89999754321 22222
Q ss_pred HHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 396 MVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
+...... .. +... ...+..++.+||+.||++|||+.++++.|+..
T Consensus 243 i~~~~~~------~~--p~~~--~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~ 287 (299)
T 4asz_A 243 ITQGRVL------QR--PRTC--PQEVYELMLGCWQREPHMRKNIKGIHTLLQNL 287 (299)
T ss_dssp HHHTCCC------CC--CTTC--CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHcCCCC------CC--Cccc--hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 2221111 11 1111 12344455689999999999999999999864
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-57 Score=448.47 Aligned_cols=259 Identities=26% Similarity=0.425 Sum_probs=203.1
Q ss_pred cCCCccceEcccCcEEEEEEEEc------CCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
++|.+.++||+|+||+||+|++. +++.||||++........++|.+|+++|++++|||||+++++|.++...||
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45777899999999999999864 478999999976655556789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCe
Q 010891 248 VYEYVNNGNLEQWLRGDMC-----------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDA 316 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~-----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~ 316 (498)
|||||++|+|.++|+.... ..++++|.+++.|+.|||.||.|||++ +||||||||+||||++++.+
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcE
Confidence 9999999999999975421 235699999999999999999999998 99999999999999999999
Q ss_pred EEeeeccceecCCCCc-eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHH
Q 010891 317 KISDFGLAKLLGAGKS-HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLK 394 (498)
Q Consensus 317 kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~ 394 (498)
||+|||+|+....... ...+..+||+.|||||++.+..|+.++|||||||+||||+| |+.||...... +.+.
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~------~~~~ 271 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT------EAID 271 (329)
T ss_dssp EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH------HHHH
T ss_pred EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH------HHHH
Confidence 9999999997644332 23345679999999999999999999999999999999999 89999754321 2222
Q ss_pred HHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 395 MMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
.+....+. ..+. ..+ ..+..++.+||+.||++|||+.||+++|+...
T Consensus 272 ~i~~g~~~------~~p~-~~~---~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~ 318 (329)
T 4aoj_A 272 CITQGREL------ERPR-ACP---PEVYAIMRGCWQREPQQRHSIKDVHARLQALA 318 (329)
T ss_dssp HHHHTCCC------CCCT-TCC---HHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred HHHcCCCC------CCcc-ccc---HHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence 22221111 1111 111 23444556899999999999999999998753
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-57 Score=450.28 Aligned_cols=252 Identities=24% Similarity=0.339 Sum_probs=208.5
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
...|++.+.||+|+||+||+|+. .+|+.||||++........+.+.+|+++|+.++|||||+++++|.+++.+||||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 152 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 152 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence 35699999999999999999986 46999999999766556667789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
|+||+|.+++.. +.+++..+..++.||+.||.|||++ +||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 153 ~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 224 (346)
T 4fih_A 153 LEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 224 (346)
T ss_dssp CTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred CCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence 999999999963 4599999999999999999999999 99999999999999999999999999999875443
Q ss_pred ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCC
Q 010891 332 SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (498)
. .....+||+.|||||++.+..|+.++|||||||+||||++|+.||...... +.+..+... ..+.+.
T Consensus 225 ~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~~~i~~~------~~~~~~ 291 (346)
T 4fih_A 225 P-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------KAMKMIRDN------LPPRLK 291 (346)
T ss_dssp C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHS------SCCCCS
T ss_pred C-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHcC------CCCCCC
Confidence 2 245578999999999999999999999999999999999999999754321 112222111 112222
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 412 ~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.....+.. +..++.+||..||++|||+.|+++|-
T Consensus 292 ~~~~~s~~--~~dli~~~L~~dP~~R~ta~e~l~Hp 325 (346)
T 4fih_A 292 NLHKVSPS--LKGFLDRLLVRDPAQRATAAELLKHP 325 (346)
T ss_dssp CGGGSCHH--HHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred ccccCCHH--HHHHHHHHcCCChhHCcCHHHHhcCH
Confidence 22222222 23344589999999999999999863
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-57 Score=443.36 Aligned_cols=258 Identities=24% Similarity=0.381 Sum_probs=206.4
Q ss_pred cCCCccceEcccCcEEEEEEEE------cCCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL------MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI 246 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 246 (498)
+.+++.+.||+|+||+||+|++ .+++.||||++..... ...++|.+|+.++++++|||||+++|+|.++...|
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 4567789999999999999985 3568899999965433 34567999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCC
Q 010891 247 LVYEYVNNGNLEQWLRGDMC------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF 314 (498)
Q Consensus 247 lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~ 314 (498)
||||||++|+|.++|..... ....+++..++.|+.|||.||.|||++ +||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCC
Confidence 99999999999999964321 124699999999999999999999999 999999999999999999
Q ss_pred CeEEeeeccceecCCCC-ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHH
Q 010891 315 DAKISDFGLAKLLGAGK-SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEW 392 (498)
Q Consensus 315 ~~kL~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~ 392 (498)
.+||+|||+|+...... .......+||+.|||||++.++.|+.++|||||||+||||+| |+.||..... . +.
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~---~---~~ 256 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---Q---DV 256 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCH---H---HH
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCH---H---HH
Confidence 99999999998764332 222445689999999999999999999999999999999998 8999975432 1 22
Q ss_pred HHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 393 LKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
+..+...... + . +... ...+..++.+||+.||++||||.||+++|+..
T Consensus 257 ~~~i~~~~~~-----~-~--p~~~--~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 257 VEMIRNRQVL-----P-C--PDDC--PAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp HHHHHTTCCC-----C-C--CTTC--CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred HHHHHcCCCC-----C-C--cccc--hHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 2222211111 1 1 1111 12344555689999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-56 Score=440.28 Aligned_cols=265 Identities=28% Similarity=0.445 Sum_probs=202.7
Q ss_pred HHHccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 170 QSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 170 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
++..++|.+.+.||+|+||+||+|++. ..||||++..... ...+.|.+|+.+|++++|||||++++++.+ +..||
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 344567889999999999999999863 3699998854332 234679999999999999999999998864 56899
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
|||||+||+|.++|+. ....+++.+++.|+.|||.||+|||++ +||||||||+||||++++.+||+|||+|+..
T Consensus 109 VmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~ 182 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVK 182 (307)
T ss_dssp EEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred EEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceec
Confidence 9999999999999974 345799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCC-ceeeecccccccccCcccccC---CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhcccc
Q 010891 328 GAGK-SHITTRVMGTFGYVAPEYANS---GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSE 403 (498)
Q Consensus 328 ~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (498)
.... .......+||+.|||||++.+ +.|+.++|||||||+||||+||+.||........ +.......
T Consensus 183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~------~~~~~~~~--- 253 (307)
T 3omv_A 183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ------IIFMVGRG--- 253 (307)
T ss_dssp -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHHHTT---
T ss_pred ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH------HHHHHhcC---
Confidence 4322 223455789999999999853 4699999999999999999999999975443211 11111111
Q ss_pred CCcCCCCCC-CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCCC
Q 010891 404 DVVDPNIET-RPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIP 455 (498)
Q Consensus 404 ~~~~~~~~~-~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~~~~~ 455 (498)
...|.+.. ....+ ..+..++.+||+.||++|||+.||+++|+....+.|
T Consensus 254 -~~~p~~~~~~~~~~--~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 254 -YASPDLSKLYKNCP--KAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp -CCCCCSTTSCTTSC--HHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred -CCCCCcccccccch--HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 11121111 11111 233445558999999999999999999887655444
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-56 Score=446.76 Aligned_cols=251 Identities=21% Similarity=0.356 Sum_probs=199.4
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC--chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
++|++.+.||+|+||+||+|+. .+|+.||||++...... ..+.+.+|+++|++|+|||||++++++.+++.+|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5899999999999999999985 56999999999654332 34568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
||+||+|.++|... ....+++..++.|+.||+.||.|||++ +||||||||+||||+.+|.+||+|||+|+.+...
T Consensus 104 y~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST 178 (350)
T ss_dssp CCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred CCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence 99999999999743 345689999999999999999999999 9999999999999999999999999999876432
Q ss_pred CceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCC
Q 010891 331 KSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNI 410 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (498)
. ...+..+||+.|||||++.+..|+.++|||||||+||||+||+.||..... .+.+..+..... +..
T Consensus 179 ~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~------~~~~~~i~~~~~------~~~ 245 (350)
T 4b9d_A 179 V-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM------KNLVLKIISGSF------PPV 245 (350)
T ss_dssp H-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHTCC------CCC
T ss_pred c-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH------HHHHHHHHcCCC------CCC
Confidence 1 223457899999999999999999999999999999999999999975432 122222222111 111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 411 ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 411 ~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
....+. .+..++.+||+.||++|||+.|+++|
T Consensus 246 --~~~~s~--~~~~li~~~L~~dP~~R~s~~e~l~h 277 (350)
T 4b9d_A 246 --SLHYSY--DLRSLVSQLFKRNPRDRPSVNSILEK 277 (350)
T ss_dssp --CTTSCH--HHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred --CccCCH--HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 111122 23334458999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-56 Score=452.40 Aligned_cols=252 Identities=24% Similarity=0.336 Sum_probs=209.8
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
.+.|++.+.||+|+||+||+|+. .+|+.||||++........+.+.+|+.+|+.++|||||+++++|.+++.+||||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 46799999999999999999985 46999999999776666677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
|+||+|.+++.. +.+++..+..++.||+.||.|||++ +||||||||+||||+.+|.+||+|||+|+.+....
T Consensus 230 ~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~ 301 (423)
T 4fie_A 230 LEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV 301 (423)
T ss_dssp CTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred CCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence 999999999963 4599999999999999999999999 99999999999999999999999999999875433
Q ss_pred ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCC
Q 010891 332 SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (498)
......+||+.|||||++.+..|+.++|||||||+||||++|+.||....+. +.+..+... ..+.+.
T Consensus 302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~------~~~~~i~~~------~~~~~~ 368 (423)
T 4fie_A 302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL------KAMKMIRDN------LPPRLK 368 (423)
T ss_dssp -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHS------CCCCCS
T ss_pred -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHcC------CCCCCc
Confidence 2345578999999999999999999999999999999999999999754321 112222111 112222
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 412 ~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.....+... ..++.+||..||++|||+.|+|+|-
T Consensus 369 ~~~~~s~~~--~dli~~~L~~dP~~R~ta~ell~Hp 402 (423)
T 4fie_A 369 NLHKVSPSL--KGFLDRLLVRDPAQRATAAELLKHP 402 (423)
T ss_dssp CTTSSCHHH--HHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred ccccCCHHH--HHHHHHHcCCChhHCcCHHHHhcCH
Confidence 222223222 3334489999999999999999863
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-56 Score=438.42 Aligned_cols=247 Identities=23% Similarity=0.337 Sum_probs=203.7
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCC---CCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNN---PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
++|++.+.||+|+||+||+|+. .+|+.||||++.+. .....+.+.+|+++|++++|||||+++++|.+++.+||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 4699999999999999999985 56899999998542 2234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||++||+|.++|.. .+.+++..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+|+.+..
T Consensus 112 Ey~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~ 184 (311)
T 4aw0_A 112 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 184 (311)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred ecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence 99999999999974 35799999999999999999999999 999999999999999999999999999998754
Q ss_pred CC-ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCC
Q 010891 330 GK-SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408 (498)
Q Consensus 330 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (498)
.. .......+||+.|||||++.+..|+.++|||||||+||||+||+.||..... .+.+..+... . .
T Consensus 185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~------~~~~~~i~~~---~----~ 251 (311)
T 4aw0_A 185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE------GLIFAKIIKL---E----Y 251 (311)
T ss_dssp TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHT---C----C
T ss_pred CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHcC---C----C
Confidence 32 2335567999999999999999999999999999999999999999975432 1222222221 1 1
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHH
Q 010891 409 NIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVV 444 (498)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell 444 (498)
.++ ...+.. +..++.+||.+||++|||+.|++
T Consensus 252 ~~p--~~~s~~--~~dli~~lL~~dp~~R~t~~e~~ 283 (311)
T 4aw0_A 252 DFP--EKFFPK--ARDLVEKLLVLDATKRLGCEEME 283 (311)
T ss_dssp CCC--TTCCHH--HHHHHHHHSCSSGGGSTTSGGGT
T ss_pred CCC--cccCHH--HHHHHHHHccCCHhHCcChHHHc
Confidence 111 112222 23344589999999999999864
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-55 Score=436.69 Aligned_cols=250 Identities=23% Similarity=0.266 Sum_probs=199.8
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeec
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 252 (498)
+.|.+.++||+|+||+||+|++ .+|+.||||++..... ..+|+.+++.++|||||++++++.++..+|||||||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 132 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEecc
Confidence 4577889999999999999985 4689999999964322 246999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCC-CeEEeeeccceecCCCC
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF-DAKISDFGLAKLLGAGK 331 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~-~~kL~DfGla~~~~~~~ 331 (498)
+||+|.++|+. .+.+++..+..++.||+.||.|||++ +||||||||+||||+.+| .+||+|||+|+.+....
T Consensus 133 ~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 133 EGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp TTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999999974 35799999999999999999999999 999999999999999987 69999999999875432
Q ss_pred ce----eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcC
Q 010891 332 SH----ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407 (498)
Q Consensus 332 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (498)
.. .....+||+.|||||++.+..|+.++|||||||+||||+||+.||......... ..+.....
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~------~~i~~~~~------ 273 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC------LKIASEPP------ 273 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH------HHHHHSCC------
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH------HHHHcCCC------
Confidence 11 123468999999999999999999999999999999999999999765443221 11111110
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 408 ~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
+....++..+.. +..++.+||++||.+|||+.|++++|..
T Consensus 274 ~~~~~~~~~s~~--~~~li~~~L~~dP~~R~sa~el~~~l~~ 313 (336)
T 4g3f_A 274 PIREIPPSCAPL--TAQAIQEGLRKEPVHRASAMELRRKVGK 313 (336)
T ss_dssp GGGGSCTTSCHH--HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred CchhcCccCCHH--HHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence 001112222222 2333448999999999999999998864
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-55 Score=422.19 Aligned_cols=246 Identities=24% Similarity=0.366 Sum_probs=187.9
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC---CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
++|++.+.||+|+||+||+|+. .+|+.||||++.+... ...+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999984 5699999999965432 23456889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+ +|+|.+++.. .+.+++.++..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+|+....
T Consensus 93 Ey~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 164 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD 164 (275)
T ss_dssp ECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred eCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence 999 6799999973 46799999999999999999999999 999999999999999999999999999987644
Q ss_pred CCceeeecccccccccCcccccCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANSGLL-NEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (498)
.. .....+||+.|||||++.+..| +.++|||||||+||||+||+.||..... ...+..+.... .
T Consensus 165 ~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~------~~~~~~i~~~~-------~ 229 (275)
T 3hyh_A 165 GN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI------PVLFKNISNGV-------Y 229 (275)
T ss_dssp ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHHTC-------C
T ss_pred CC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH------HHHHHHHHcCC-------C
Confidence 32 2345789999999999988776 5799999999999999999999975321 12222222111 1
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 409 NIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
.++ ...+. ....++.+||+.||++|||+.|+++|
T Consensus 230 ~~p--~~~s~--~~~~li~~~L~~dP~~R~s~~eil~h 263 (275)
T 3hyh_A 230 TLP--KFLSP--GAAGLIKRMLIVNPLNRISIHEIMQD 263 (275)
T ss_dssp CCC--TTSCH--HHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred CCC--CCCCH--HHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111 11222 22334458999999999999999985
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-55 Score=427.40 Aligned_cols=245 Identities=25% Similarity=0.388 Sum_probs=193.2
Q ss_pred CccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEe----CCeeEEEE
Q 010891 177 SKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIE----GTQRILVY 249 (498)
Q Consensus 177 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~~lv~ 249 (498)
++.++||+|+||+||+|.+ .++..||+|++..... ...+.|.+|+++|++|+|||||+++++|.+ +..+||||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 5667899999999999985 4588999999864332 234568999999999999999999999875 35579999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCC--eeecCCCCCCEEEcC-CCCeEEeeecccee
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK--VVHRDIKSSNILIDE-NFDAKISDFGLAKL 326 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--iiHrDikp~NIll~~-~~~~kL~DfGla~~ 326 (498)
|||+||+|.++|.. .+.+++..+..++.||+.||.|||++ + ||||||||+||||+. ++.+||+|||+|+.
T Consensus 109 Ey~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp ECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 99999999999974 35699999999999999999999997 6 999999999999984 79999999999986
Q ss_pred cCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCc
Q 010891 327 LGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVV 406 (498)
Q Consensus 327 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (498)
.... .....+||+.|||||++.+ .|+.++|||||||+||||+||+.||....... .....+.. . . .
T Consensus 182 ~~~~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~-----~~~~~i~~-~--~--~ 247 (290)
T 3fpq_A 182 KRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QIYRRVTS-G--V--K 247 (290)
T ss_dssp CCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----HHHHHHTT-T--C--C
T ss_pred CCCC---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH-----HHHHHHHc-C--C--C
Confidence 4332 2445789999999999875 69999999999999999999999997543221 11111111 0 0 0
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 407 DPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 407 ~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
.+.+.. ..... +..++.+||..||++|||+.|+++|
T Consensus 248 ~~~~~~-~~~~~---~~~li~~~L~~dP~~R~s~~e~l~H 283 (290)
T 3fpq_A 248 PASFDK-VAIPE---VKEIIEGCIRQNKDERYSIKDLLNH 283 (290)
T ss_dssp CGGGGG-CCCHH---HHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCCc-cCCHH---HHHHHHHHccCChhHCcCHHHHhcC
Confidence 011111 11122 3334458999999999999999976
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-55 Score=430.35 Aligned_cols=248 Identities=25% Similarity=0.304 Sum_probs=194.1
Q ss_pred cCCCccceEcccCcEEEEEEEE----cCCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL----MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
++|++.+.||+|+||+||+|+. .+++.||||++..... .....+.+|+++|++++|||||++++++.+++.+||
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 4689999999999999999975 2478999999865322 223458889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
|||||+||+|.++|.. .+.+++.++..++.||+.||.|||++ +|+||||||+|||++.+|.+||+|||+|+..
T Consensus 104 vmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~ 176 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES 176 (304)
T ss_dssp EECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred EEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence 9999999999999974 35799999999999999999999999 9999999999999999999999999999875
Q ss_pred CCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcC
Q 010891 328 GAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407 (498)
Q Consensus 328 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (498)
.... ......+||+.|||||++.+..|+.++|||||||+||||+||+.||...... +.+..+... .
T Consensus 177 ~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~i~~~---~---- 242 (304)
T 3ubd_A 177 IDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK------ETMTMILKA---K---- 242 (304)
T ss_dssp -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHC---C----
T ss_pred cCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH------HHHHHHHcC---C----
Confidence 4332 2244578999999999999999999999999999999999999999754321 222222211 1
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 010891 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPKM-----SQVVRM 446 (498)
Q Consensus 408 ~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~-----~ell~~ 446 (498)
...+...+.. +..++.+||+.||++|||+ +|+++|
T Consensus 243 --~~~p~~~s~~--~~~li~~~L~~dP~~R~ta~~~~~~eil~H 282 (304)
T 3ubd_A 243 --LGMPQFLSPE--AQSLLRMLFKRNPANRLGAGPDGVEEIKRH 282 (304)
T ss_dssp --CCCCTTSCHH--HHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred --CCCCCcCCHH--HHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence 1111112222 2334458999999999984 677765
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-54 Score=434.37 Aligned_cols=268 Identities=26% Similarity=0.403 Sum_probs=213.1
Q ss_pred cHHHHHHHccCCCccceEcccCcEEEEEEEEcC------CcEEEEEEecCCCCC-chhHHHHHHHHHHcCCC-CCceEEE
Q 010891 165 TLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMN------GTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRH-KNLVRLL 236 (498)
Q Consensus 165 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h-pnIv~l~ 236 (498)
...++++..++|++.+.||+|+||+||+|++.. ++.||||++...... ..+.|.+|+++|.+++| ||||+++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 345667788999999999999999999997532 368999999665433 34568999999999965 9999999
Q ss_pred eEEEeC-CeeEEEEeecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCC
Q 010891 237 GYCIEG-TQRILVYEYVNNGNLEQWLRGDMC------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDI 303 (498)
Q Consensus 237 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDi 303 (498)
++|.+. ..+|||||||++|+|.++|+.... ....+++..++.++.|||.||.|||++ +||||||
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDL 211 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL 211 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCcc
Confidence 999764 678999999999999999975321 135689999999999999999999999 9999999
Q ss_pred CCCCEEEcCCCCeEEeeeccceecCCCCc-eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q 010891 304 KSSNILIDENFDAKISDFGLAKLLGAGKS-HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYG 381 (498)
Q Consensus 304 kp~NIll~~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~ 381 (498)
||+||||++++.+||+|||+|+.+..... ......+||+.|||||++.+..|+.++|||||||+||||+| |+.||...
T Consensus 212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~ 291 (353)
T 4ase_A 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 291 (353)
T ss_dssp SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999997754433 23445789999999999999999999999999999999998 99999765
Q ss_pred CCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 382 RPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
..... +. ..+....+ +..+. ... ..+..++.+||+.||++|||+.||+++|+..
T Consensus 292 ~~~~~--~~---~~i~~g~~------~~~p~-~~~---~~~~~li~~c~~~dP~~RPt~~eil~~L~~l 345 (353)
T 4ase_A 292 KIDEE--FC---RRLKEGTR------MRAPD-YTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345 (353)
T ss_dssp CCSHH--HH---HHHHHTCC------CCCCT-TCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CHHHH--HH---HHHHcCCC------CCCCc-cCC---HHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence 43321 11 11111111 11111 111 2344455689999999999999999999753
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-54 Score=427.50 Aligned_cols=263 Identities=28% Similarity=0.412 Sum_probs=198.3
Q ss_pred cCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHH--HHHHHHHHcCCCCCceEEEeEEEeCC----eeEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDF--RVEVEAIGHVRHKNLVRLLGYCIEGT----QRIL 247 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~--~~E~~~l~~l~hpnIv~l~~~~~~~~----~~~l 247 (498)
.+|.+.+.||+|+||+||+|++ +|+.||||++... ..+.+ ..|+..+.+++|||||++++++.+++ .+||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 4678889999999999999987 6899999998543 22333 34666667889999999999998653 5799
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHcc-----CCCeeecCCCCCCEEEcCCCCeEEeeec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI-----EPKVVHRDIKSSNILIDENFDAKISDFG 322 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~iiHrDikp~NIll~~~~~~kL~DfG 322 (498)
|||||++|+|.++|+. ..+++..+.+++.|++.||+|||+++ .++|+||||||+||||+.++.+||+|||
T Consensus 79 V~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG 153 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence 9999999999999964 35899999999999999999999752 4589999999999999999999999999
Q ss_pred cceecCCCCcee---eecccccccccCcccccCC------CCCccchHHHHHHHHHHHHhCCCCCCCCCCcc--------
Q 010891 323 LAKLLGAGKSHI---TTRVMGTFGYVAPEYANSG------LLNEKSDVYSFGVVLLEAITGRYPVDYGRPQS-------- 385 (498)
Q Consensus 323 la~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~-------- 385 (498)
+|+......... ....+||+.|||||++.+. .|+.++|||||||+||||+||..||.......
T Consensus 154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~ 233 (303)
T 3hmm_A 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence 999875543322 2346899999999998764 46789999999999999999988765322110
Q ss_pred -hhhHHHHHHHHHhhccccCCcCCCCCCC-CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 386 -EVNLVEWLKMMVQLRRSEDVVDPNIETR-PSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 386 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
...... +..... ....+|.++.. ........+..++.+||+.||++||||.||++.|+..
T Consensus 234 ~~~~~~~-~~~~~~----~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l 295 (303)
T 3hmm_A 234 SDPSVEE-MRKVVC----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp SSCCHHH-HHHHHT----TSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccchHHH-HHHHHh----cccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 001111 111111 12223333222 1223444556677799999999999999999999764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-53 Score=416.96 Aligned_cols=250 Identities=24% Similarity=0.419 Sum_probs=185.4
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEeEEEeCC--------
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT-------- 243 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-------- 243 (498)
++|++.+.||+|+||+||+|+. .+|+.||||++...... ..+.+.+|+++|++|+|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 3589999999999999999985 46899999998654332 3356889999999999999999999987544
Q ss_pred ----eeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEe
Q 010891 244 ----QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKIS 319 (498)
Q Consensus 244 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~ 319 (498)
.+|+|||||++|+|.+++.... ......+..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEc
Confidence 3699999999999999997432 112356677899999999999999999 99999999999999999999999
Q ss_pred eeccceecCCCCce-----------eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhh
Q 010891 320 DFGLAKLLGAGKSH-----------ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVN 388 (498)
Q Consensus 320 DfGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~ 388 (498)
|||+|+.+...... ..+..+||+.|||||++.+..|+.++|||||||+||||++ ||.. ..+
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~-----~~~ 232 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFST-----QME 232 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSS-----HHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCC-----ccH
Confidence 99999876543211 1234689999999999999999999999999999999996 7752 111
Q ss_pred HHHHHHHHHhhccccCCcCCCCCCCCCH-HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 389 LVEWLKMMVQLRRSEDVVDPNIETRPST-SALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
....+.. ..... . ++.. ........++.+||++||++|||+.|++++
T Consensus 233 ~~~~~~~---~~~~~------~--p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h 280 (299)
T 4g31_A 233 RVRTLTD---VRNLK------F--PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN 280 (299)
T ss_dssp HHHHHHH---HHTTC------C--CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred HHHHHHH---HhcCC------C--CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 1111111 11110 0 0111 111223345568999999999999999985
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-51 Score=414.59 Aligned_cols=262 Identities=25% Similarity=0.346 Sum_probs=200.7
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC--chhHHHHHHHHHHcCCCCCceEEEeEEEeC------C
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEG------T 243 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~ 243 (498)
.++|++.+.||+|+||+||+|+. .+|+.||||++...... ..+.+.+|+++|+.|+|||||++++++... .
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 46899999999999999999985 56999999999654332 235678899999999999999999997643 5
Q ss_pred eeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecc
Q 010891 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (498)
Q Consensus 244 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGl 323 (498)
.+|||||||+ |+|.+++. ..+.+++..+..++.||+.||.|||++ +||||||||+|||++.++.+||+|||+
T Consensus 133 ~~~ivmE~~~-g~L~~~i~----~~~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGl 204 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGM 204 (398)
T ss_dssp CEEEEEECCS-EEHHHHHT----SSSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEEeCCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecce
Confidence 7899999995 68999997 446799999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCC---ceeeecccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhh
Q 010891 324 AKLLGAGK---SHITTRVMGTFGYVAPEYANSG-LLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQL 399 (498)
Q Consensus 324 a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 399 (498)
|+.+.... .......+||+.|||||++.+. .|+.++||||+|||+|||++|+.||...... +.+..+...
T Consensus 205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~------~~l~~I~~~ 278 (398)
T 4b99_A 205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV------HQLQLIMMV 278 (398)
T ss_dssp CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH------HHHHHHHHH
T ss_pred eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH------HHHHHHHHh
Confidence 98764321 2234557899999999988764 6799999999999999999999999754322 112222111
Q ss_pred ccccCC-----------------cCCCCCC-----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 400 RRSEDV-----------------VDPNIET-----RPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 400 ~~~~~~-----------------~~~~~~~-----~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
...... ..+.... .+..+ .....++.+||..||++|||+.|+|+|---.
T Consensus 279 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s--~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~ 349 (398)
T 4b99_A 279 LGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGAD--RQALSLLGRMLRFEPSARISAAAALRHPFLA 349 (398)
T ss_dssp HCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCC--HHHHHHHHHHSCSSTTTSCCHHHHTTSGGGT
T ss_pred cCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCC--HHHHHHHHHHCcCChhHCcCHHHHhcCHhhC
Confidence 110000 0000000 01111 2334455689999999999999999875443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=406.45 Aligned_cols=203 Identities=24% Similarity=0.381 Sum_probs=174.3
Q ss_pred HHHHccCCCccceEcccCcEEEEEEEEc----CCcEEEEEEecCCCCCchhHHHHHHHHHHcC-CCCCceEEEeEEEeCC
Q 010891 169 LQSATNRFSKDNIIGDGGYGVVYRGQLM----NGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGT 243 (498)
Q Consensus 169 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~ 243 (498)
+....++|++.+.||+|+||+||+|+.. +++.||+|++.... ....+.+|+++|..+ +|||||+++++|.+.+
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~ 93 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKND 93 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETT
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECC
Confidence 3456789999999999999999999753 46889999986542 345678899999998 6999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCC-CCeEEeeec
Q 010891 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN-FDAKISDFG 322 (498)
Q Consensus 244 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~-~~~kL~DfG 322 (498)
+.||||||++||+|.+++. .+++.++..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||
T Consensus 94 ~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFG 163 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFG 163 (361)
T ss_dssp EEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCC
Confidence 9999999999999999984 389999999999999999999999 99999999999999876 799999999
Q ss_pred cceecCCCCc---------------------------eeeecccccccccCcccccCC-CCCccchHHHHHHHHHHHHhC
Q 010891 323 LAKLLGAGKS---------------------------HITTRVMGTFGYVAPEYANSG-LLNEKSDVYSFGVVLLEAITG 374 (498)
Q Consensus 323 la~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg 374 (498)
+|+....... ...+..+||+.|||||++.+. .|+.++||||+||++|||++|
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G 243 (361)
T 4f9c_A 164 LAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSG 243 (361)
T ss_dssp TCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHT
T ss_pred CCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHC
Confidence 9987643321 112345899999999998765 589999999999999999999
Q ss_pred CCCCCCCCC
Q 010891 375 RYPVDYGRP 383 (498)
Q Consensus 375 ~~P~~~~~~ 383 (498)
+.||..+..
T Consensus 244 ~~Pf~~~~~ 252 (361)
T 4f9c_A 244 RYPFYKASD 252 (361)
T ss_dssp CSSSSCCSS
T ss_pred CCCCCCCCC
Confidence 999975543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-50 Score=398.12 Aligned_cols=295 Identities=43% Similarity=0.778 Sum_probs=245.8
Q ss_pred CCCccccHHHHHHHccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEe
Q 010891 159 GWGHWFTLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLG 237 (498)
Q Consensus 159 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~ 237 (498)
+....|++.++....++|++.+.||+|+||.||+|+..+|+.||||++...... ....+.+|++++..++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 344567889999999999999999999999999998878999999998654432 3346889999999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeE
Q 010891 238 YCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAK 317 (498)
Q Consensus 238 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~k 317 (498)
++.+....++||||+++|+|.+++.........+++..+..++.|++.||.|||+.+.++|+||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 99999999999999999999999987655556799999999999999999999998777899999999999999999999
Q ss_pred EeeeccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCC--CcchhhHHHHHHH
Q 010891 318 ISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGR--PQSEVNLVEWLKM 395 (498)
Q Consensus 318 L~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~--~~~~~~~~~~~~~ 395 (498)
|+|||++...............||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ........+|+..
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 99999999876555455555679999999999988889999999999999999999999996211 1122234444443
Q ss_pred HHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCC
Q 010891 396 MVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYP 453 (498)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~~~ 453 (498)
...........+..............+..++.+||+.||.+|||+.|++++|+.....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~ 312 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLA 312 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCS
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchh
Confidence 3334444555566666666677777788888899999999999999999999976544
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=395.46 Aligned_cols=282 Identities=41% Similarity=0.708 Sum_probs=240.4
Q ss_pred HHHHHHHccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCee
Q 010891 166 LRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQR 245 (498)
Q Consensus 166 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 245 (498)
+.++....++|.+.+.||+|+||.||+|++.+|+.||+|++........+.+.+|+.+++.++||||+++++++.+....
T Consensus 31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 110 (321)
T 2qkw_B 31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEM 110 (321)
T ss_dssp CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCC
T ss_pred HHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence 34455677899999999999999999999878999999998776666667899999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccce
Q 010891 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~ 325 (498)
++||||+++|+|.+++.........+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 111 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 187 (321)
T 2qkw_B 111 ILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISK 187 (321)
T ss_dssp EEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCE
T ss_pred EEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeeccccc
Confidence 999999999999999975543445699999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCC-ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccC
Q 010891 326 LLGAGK-SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSED 404 (498)
Q Consensus 326 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (498)
...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....+........|............
T Consensus 188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (321)
T 2qkw_B 188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQ 267 (321)
T ss_dssp ECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCS
T ss_pred ccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHH
Confidence 754322 2223445699999999999888999999999999999999999999987766666666666555555555556
Q ss_pred CcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 405 VVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
..++.+...........+..++.+||+.||++|||+.|++++|+..
T Consensus 268 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 313 (321)
T 2qkw_B 268 IVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313 (321)
T ss_dssp SSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 6666665555666667777777899999999999999999999864
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=424.42 Aligned_cols=251 Identities=25% Similarity=0.315 Sum_probs=198.7
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC---CCchhHH---HHHHHHHHcCCCCCceEEEeEEEeCCee
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDF---RVEVEAIGHVRHKNLVRLLGYCIEGTQR 245 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 245 (498)
-++|++.++||+|+||+||+|+. .+|+.||||++.+.. ......+ +.++.+++.++|||||+++++|.+.+.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 36799999999999999999985 469999999985321 1112223 3456777888999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccce
Q 010891 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~ 325 (498)
||||||++||+|.++|.. .+.+++..+..++.||+.||.|||++ +||||||||+||||+.+|++||+|||+|+
T Consensus 268 ylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceee
Confidence 999999999999999974 36799999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCceeeecccccccccCccccc-CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccC
Q 010891 326 LLGAGKSHITTRVMGTFGYVAPEYAN-SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSED 404 (498)
Q Consensus 326 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (498)
.+.... ....+||+.|||||++. +..|+.++|||||||+||||++|+.||......... +.......
T Consensus 341 ~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~---~i~~~i~~------ 408 (689)
T 3v5w_A 341 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRMTLT------ 408 (689)
T ss_dssp ECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH---HHHHHHHH------
T ss_pred ecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHhhcC------
Confidence 875443 34578999999999996 468999999999999999999999999754332221 11111111
Q ss_pred CcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHH
Q 010891 405 VVDPNIETRPSTSALKRALLTALRCVDPDSDKRPK-----MSQVVRML 447 (498)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt-----~~ell~~L 447 (498)
.....+...+...+ .++.+||..||.+|++ +.|+++|-
T Consensus 409 ---~~~~~p~~~S~~a~--dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hp 451 (689)
T 3v5w_A 409 ---MAVELPDSFSPELR--SLLEGLLQRDVNRRLGCLGRGAQEVKESP 451 (689)
T ss_dssp ---CCCCCCTTSCHHHH--HHHHHHTCSCGGGCTTCSSSTHHHHTTSG
T ss_pred ---CCCCCCccCCHHHH--HHHHHHccCCHhHCCCCCCCCHHHHhcCc
Confidence 11111122222223 3344899999999998 78888653
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=425.49 Aligned_cols=254 Identities=22% Similarity=0.329 Sum_probs=207.6
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
.++|++.+.||+|+||+||+|+. .+|+.||+|++........+.+.+|+++|+.|+|||||+++++|.++..+||||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 46899999999999999999985 56999999999765555556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCC--CCeEEeeeccceecCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN--FDAKISDFGLAKLLGA 329 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~--~~~kL~DfGla~~~~~ 329 (498)
|+||+|.++|.. ..+.+++.++..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||+|+.+..
T Consensus 236 ~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~ 309 (573)
T 3uto_A 236 MSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309 (573)
T ss_dssp CCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCT
T ss_pred cCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccC
Confidence 999999999963 335799999999999999999999999 99999999999999854 8999999999998765
Q ss_pred CCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
.. .....+||+.|||||++.+..|+.++|||||||+||||++|+.||...... +.+..+.. ....+...
T Consensus 310 ~~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~------~~~~~i~~---~~~~~~~~ 378 (573)
T 3uto_A 310 KQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLRNVKS---CDWNMDDS 378 (573)
T ss_dssp TS--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHT---TCCCCCSG
T ss_pred CC--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHHHHHHh---CCCCCCcc
Confidence 43 234568999999999999999999999999999999999999999754321 11222211 11111111
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
. ....+.. ...++.+||..||.+|||+.|+|+|-
T Consensus 379 ~--~~~~s~~--~~dli~~~L~~dp~~R~t~~e~l~Hp 412 (573)
T 3uto_A 379 A--FSGISED--GKDFIRKLLLADPNTRMTIHQALEHP 412 (573)
T ss_dssp G--GTTSCHH--HHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred c--ccCCCHH--HHHHHHHHccCChhHCcCHHHHhcCc
Confidence 1 1112222 33344589999999999999999863
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=371.27 Aligned_cols=253 Identities=24% Similarity=0.379 Sum_probs=207.2
Q ss_pred HccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
..++|++.+.||+|+||+||+|.. .+|+.||+|++........+.+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 356899999999999999999974 5789999999976655566778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
|+++|+|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++......
T Consensus 98 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 169 (297)
T 3fxz_A 98 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (297)
T ss_dssp CCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred CCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence 9999999999964 3589999999999999999999999 9999999999999999999999999999887544
Q ss_pred CceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCC
Q 010891 331 KSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNI 410 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (498)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....+.. .......... +.+
T Consensus 170 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~~~~~~~------~~~ 236 (297)
T 3fxz_A 170 QSK-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALYLIATNGT------PEL 236 (297)
T ss_dssp TCC-BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHHCS------CCC
T ss_pred ccc-cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCC------CCC
Confidence 322 344679999999999999999999999999999999999999997543221 1111111111 111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 411 ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 411 ~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
......+ ..+..++.+||+.||++|||+.|++++-
T Consensus 237 ~~~~~~~--~~~~~li~~~l~~dp~~Rps~~ell~h~ 271 (297)
T 3fxz_A 237 QNPEKLS--AIFRDFLNRCLEMDVEKRGSAKELLQHQ 271 (297)
T ss_dssp SCGGGSC--HHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred CCccccC--HHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence 1111111 2233444589999999999999999764
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=370.29 Aligned_cols=254 Identities=27% Similarity=0.480 Sum_probs=206.3
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeec
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 252 (498)
++|.+.++||+|+||+||+|.+ .+++.||+|++........+.+.+|++++++++||||+++++++.++...++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 5788999999999999999986 458999999987665556677999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~ 332 (498)
++|+|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++.......
T Consensus 90 ~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 90 KGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp TTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred CCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 999999999752 45699999999999999999999999 999999999999999999999999999987654322
Q ss_pred ee-------------eecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchh---hHHHHHHHH
Q 010891 333 HI-------------TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEV---NLVEWLKMM 396 (498)
Q Consensus 333 ~~-------------~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~---~~~~~~~~~ 396 (498)
.. .....||+.|+|||++.+..++.++|||||||++|||++|..||....+.... ......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~--- 240 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL--- 240 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH---
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc---
Confidence 11 11457999999999999999999999999999999999999998754432211 111111
Q ss_pred HhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 397 VQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
... ..+. ... .+..++.+||+.||++|||+.++++.|+..
T Consensus 241 -~~~-----~~~~-----~~~---~l~~li~~~l~~dP~~Rps~~~l~~~L~~l 280 (310)
T 3s95_A 241 -DRY-----CPPN-----CPP---SFFPITVRCCDLDPEKRPSFVKLEHWLETL 280 (310)
T ss_dssp -HHT-----CCTT-----CCT---THHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -ccc-----CCCC-----CCH---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 000 0010 111 233445589999999999999999998764
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=371.78 Aligned_cols=261 Identities=29% Similarity=0.428 Sum_probs=199.0
Q ss_pred HHHccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCC--chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 170 QSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 170 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
....++|++.+.||+|+||+||+|+. +|+.||||++...... ..+.+.+|++++++++||||+++++++.+....++
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence 34457899999999999999999977 6899999998655433 23568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCC--eeecCCCCCCEEEcCCCCeEEeeeccce
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK--VVHRDIKSSNILIDENFDAKISDFGLAK 325 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--iiHrDikp~NIll~~~~~~kL~DfGla~ 325 (498)
||||+++|+|.+++.... ....+++..++.++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+++
T Consensus 112 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~ 187 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187 (309)
T ss_dssp EEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred EEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence 999999999999997421 112389999999999999999999998 8 9999999999999999999999999998
Q ss_pred ecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCC
Q 010891 326 LLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV 405 (498)
Q Consensus 326 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (498)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...........
T Consensus 188 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~------~~~~~~~~~~~--- 257 (309)
T 3p86_A 188 LKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ------VVAAVGFKCKR--- 257 (309)
T ss_dssp ---------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHHHHHHSCCC---
T ss_pred cccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhcCCC---
Confidence 654332 12334679999999999999999999999999999999999999997543221 11111111110
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 406 VDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 406 ~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
..+ ....+ ..+..++.+||+.||.+|||+.++++.|+...
T Consensus 258 --~~~--~~~~~--~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~ 297 (309)
T 3p86_A 258 --LEI--PRNLN--PQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI 297 (309)
T ss_dssp --CCC--CTTSC--HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCC--CccCC--HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111 11111 22344455899999999999999999998654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=373.54 Aligned_cols=250 Identities=23% Similarity=0.344 Sum_probs=203.2
Q ss_pred HccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
..++|.+.+.||+|+||.||+|+. .+|+.||||++..... ...+.+.+|+++++.++||||+++++++.+....|+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 346899999999999999999986 6799999999865432 2345688899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+++|+|.+++... +.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 93 ~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp ECCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred EECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 9999999999999743 5699999999999999999999999 99999999999999999999999999998665
Q ss_pred CCCceeeecccccccccCcccccCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANSGLLN-EKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (498)
... .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...... +....+...
T Consensus 166 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~i~~~-------- 229 (328)
T 3fe3_A 166 VGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK------ELRERVLRG-------- 229 (328)
T ss_dssp SSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHC--------
T ss_pred CCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHhC--------
Confidence 432 23456899999999999887765 7999999999999999999999754321 222222211
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 408 ~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
....+...+ .....++.+||..||.+|||+.|++++-
T Consensus 230 -~~~~p~~~s--~~~~~li~~~L~~dP~~R~t~~eil~h~ 266 (328)
T 3fe3_A 230 -KYRIPFYMS--TDCENLLKRFLVLNPIKRGTLEQIMKDR 266 (328)
T ss_dssp -CCCCCTTSC--HHHHHHHHHHCCSSTTTSCCHHHHTTCT
T ss_pred -CCCCCCCCC--HHHHHHHHHHCCCChhHCcCHHHHhcCH
Confidence 111111111 1233344589999999999999999763
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=365.56 Aligned_cols=262 Identities=24% Similarity=0.322 Sum_probs=211.6
Q ss_pred ccHHHHHHHccC----------CCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCc
Q 010891 164 FTLRDLQSATNR----------FSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL 232 (498)
Q Consensus 164 ~~~~~~~~~~~~----------y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI 232 (498)
++.+++..+++. |...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.+++.++||||
T Consensus 25 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni 104 (321)
T 2c30_A 25 VTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNV 104 (321)
T ss_dssp CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTB
T ss_pred CcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCc
Confidence 456666655543 677789999999999999865 799999999977666667789999999999999999
Q ss_pred eEEEeEEEeCCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcC
Q 010891 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE 312 (498)
Q Consensus 233 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~ 312 (498)
+++++++......++||||+++++|.+++.. ..+++..+..++.|++.||.|||+. +|+||||||+|||++.
T Consensus 105 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~ 176 (321)
T 2c30_A 105 VEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTL 176 (321)
T ss_dssp CCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT
T ss_pred ceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECC
Confidence 9999999999999999999999999999853 4699999999999999999999999 9999999999999999
Q ss_pred CCCeEEeeeccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 010891 313 NFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEW 392 (498)
Q Consensus 313 ~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~ 392 (498)
++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..
T Consensus 177 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~------~~ 249 (321)
T 2c30_A 177 DGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV------QA 249 (321)
T ss_dssp TCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HH
T ss_pred CCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HH
Confidence 99999999999987754322 234467999999999999999999999999999999999999999754321 11
Q ss_pred HHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 393 LKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
+..+... ..+.+......+ ..+..++.+||+.||++|||+.+++++.-
T Consensus 250 ~~~~~~~------~~~~~~~~~~~~--~~l~~li~~~l~~dp~~Rps~~ell~hp~ 297 (321)
T 2c30_A 250 MKRLRDS------PPPKLKNSHKVS--PVLRDFLERMLVRDPQERATAQELLDHPF 297 (321)
T ss_dssp HHHHHHS------SCCCCTTGGGSC--HHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred HHHHhcC------CCCCcCccccCC--HHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 1211111 111111111111 22334445899999999999999998643
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=360.70 Aligned_cols=255 Identities=29% Similarity=0.486 Sum_probs=207.7
Q ss_pred ccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeec
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 252 (498)
.++|++.+.||+|+||.||+|++.+++.||+|++.... ...+.+.+|++++++++||||+++++++.+....++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 46789999999999999999998889999999986543 34567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~ 332 (498)
++++|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 88 ~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 161 (269)
T 4hcu_A 88 EHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 161 (269)
T ss_dssp TTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEecccccccccccccc
Confidence 99999999964 335689999999999999999999999 999999999999999999999999999986644332
Q ss_pred eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCC
Q 010891 333 HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411 (498)
Q Consensus 333 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (498)
.......||+.|+|||++.+..++.++||||||+++|+|++ |+.||...... +........ .....+
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~------~~~~~~~~~---~~~~~~--- 229 (269)
T 4hcu_A 162 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDISTG---FRLYKP--- 229 (269)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTT---CCCCCC---
T ss_pred ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHH------HHHHHHhcC---ccCCCC---
Confidence 22334557889999999998999999999999999999999 99999754321 111222111 111111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 412 ~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
.... ..+..++.+||+.||.+|||+.+++++|+..
T Consensus 230 -~~~~---~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l 264 (269)
T 4hcu_A 230 -RLAS---THVYQIMNHCWRERPEDRPAFSRLLRQLAEI 264 (269)
T ss_dssp -TTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CcCC---HHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence 1111 2234444589999999999999999999764
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=357.53 Aligned_cols=258 Identities=24% Similarity=0.399 Sum_probs=210.6
Q ss_pred HccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
..++|++.+.||+|+||.||+|+..++..||+|++.... ...+.+.+|++++.+++||||+++++++.+....++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 356899999999999999999998888899999986543 3346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+++++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 85 ISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp CTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred cCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 9999999999753 23589999999999999999999999 99999999999999999999999999999876554
Q ss_pred ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCC
Q 010891 332 SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNI 410 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (498)
........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...... +....... ......+.
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~---~~~~~~~~- 228 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS------EVVLKVSQ---GHRLYRPH- 228 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHHHT---TCCCCCCT-
T ss_pred hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH------HHHHHHHc---CCCCCCCC-
Confidence 443444567788999999998899999999999999999999 99999744321 11111111 11111111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 010891 411 ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEY 452 (498)
Q Consensus 411 ~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~~ 452 (498)
.... .+..++.+||+.||.+|||+.+++++|+....
T Consensus 229 ---~~~~---~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 229 ---LASD---TIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp ---TSCH---HHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred ---cChH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 1112 23344558999999999999999999987643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=369.59 Aligned_cols=249 Identities=25% Similarity=0.288 Sum_probs=202.2
Q ss_pred cCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCC---CCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNN---PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
++|++.+.||+|+||.||+|+.. +|+.||+|++.+. .......+..|+.++..++||||+++++++.+....|+||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57899999999999999999864 6899999998543 2234456888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||++||+|.+++.. .+.+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 85 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 85 EYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999999974 35689999999999999999999999 999999999999999999999999999986433
Q ss_pred CCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
.. ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...... .....+... . ..
T Consensus 158 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~~-~------~~ 223 (337)
T 1o6l_A 158 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELILME-E------IR 223 (337)
T ss_dssp TT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHC-C------CC
T ss_pred CC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH------HHHHHHHcC-C------CC
Confidence 22 2244568999999999999999999999999999999999999999753321 111111111 0 01
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRP-----KMSQVVRML 447 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RP-----t~~ell~~L 447 (498)
+ ....+. .+..++.+||..||.+|| ++.|+++|-
T Consensus 224 ~--p~~~s~--~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~ 262 (337)
T 1o6l_A 224 F--PRTLSP--EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 262 (337)
T ss_dssp C--CTTSCH--HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred C--CCCCCH--HHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence 1 111112 233344489999999999 999998764
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=373.67 Aligned_cols=259 Identities=27% Similarity=0.436 Sum_probs=206.0
Q ss_pred ccCCCccceEcccCcEEEEEEEEc--------CCcEEEEEEecCCCC-CchhHHHHHHHHHHcC-CCCCceEEEeEEEeC
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM--------NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHV-RHKNLVRLLGYCIEG 242 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~ 242 (498)
.++|.+.+.||+|+||.||+|++. ++..||||++..... ...+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 467899999999999999999752 356799999865432 2335688999999999 899999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEE
Q 010891 243 TQRILVYEYVNNGNLEQWLRGDMC------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI 310 (498)
Q Consensus 243 ~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll 310 (498)
...|+||||+++|+|.+++..... ....+++..++.++.||+.||.|||++ +|+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEE
Confidence 999999999999999999975421 224589999999999999999999999 99999999999999
Q ss_pred cCCCCeEEeeeccceecCCCCc-eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhh
Q 010891 311 DENFDAKISDFGLAKLLGAGKS-HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVN 388 (498)
Q Consensus 311 ~~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~ 388 (498)
+.++.+||+|||+++....... .......||+.|+|||++.+..|+.++|||||||++|||++ |..||.......
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--- 313 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--- 313 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---
Confidence 9999999999999997654322 12233567889999999999999999999999999999999 999997543322
Q ss_pred HHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 389 LVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
.. ..+..... +.... ... ..+..++.+||+.||.+|||+.|+++.|+..
T Consensus 314 ~~---~~~~~~~~------~~~~~-~~~---~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i 362 (370)
T 2psq_A 314 LF---KLLKEGHR------MDKPA-NCT---NELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362 (370)
T ss_dssp HH---HHHHTTCC------CCCCT-TSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH---HHHhcCCC------CCCCC-CCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11 11111111 11111 111 2334445589999999999999999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=372.71 Aligned_cols=254 Identities=24% Similarity=0.340 Sum_probs=204.3
Q ss_pred HccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCC------chhHHHHHHHHHHcCCCCCceEEEeEEEeCCe
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ------ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQ 244 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 244 (498)
+.++|.+.+.||+|+||+||+|+.. +|+.||+|.+...... ..+.+.+|+.++..++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 4568999999999999999999864 6899999998654332 24678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCC----CeEEee
Q 010891 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF----DAKISD 320 (498)
Q Consensus 245 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~----~~kL~D 320 (498)
.|+||||++||+|.+++. ..+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++ .+||+|
T Consensus 90 ~~lv~e~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 90 VVLILELVSGGELFDFLA----QKESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp EEEEEECCCSCBHHHHHT----TCSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 999999999999999996 346799999999999999999999999 999999999999998877 799999
Q ss_pred eccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhc
Q 010891 321 FGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLR 400 (498)
Q Consensus 321 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 400 (498)
||++....... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||...... +.+..+...
T Consensus 163 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~------~~~~~i~~~- 233 (361)
T 2yab_A 163 FGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANITAV- 233 (361)
T ss_dssp CSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHTT-
T ss_pred cCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhc-
Confidence 99999875432 234467999999999999999999999999999999999999999754321 111222111
Q ss_pred cccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 401 RSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
...+++.. ....+. .+..++.+||..||.+|||+.|+++|-
T Consensus 234 --~~~~~~~~--~~~~s~--~~~~li~~~L~~dP~~R~t~~e~l~hp 274 (361)
T 2yab_A 234 --SYDFDEEF--FSQTSE--LAKDFIRKLLVKETRKRLTIQEALRHP 274 (361)
T ss_dssp --CCCCCHHH--HTTSCH--HHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred --CCCCCchh--ccCCCH--HHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 10001000 011112 233344589999999999999999753
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=368.56 Aligned_cols=257 Identities=30% Similarity=0.473 Sum_probs=203.5
Q ss_pred HccCCCccceEcccCcEEEEEEEEc----CCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeE
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLM----NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI 246 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 246 (498)
..++|.+.+.||+|+||.||+|++. .+..||||++..... ...+.+.+|+.+++.++||||+++++++.++...|
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 3467899999999999999999863 455699999965433 23456889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecccee
Q 010891 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (498)
Q Consensus 247 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~ 326 (498)
+||||+++|+|.+++.. ..+.+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 127 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~ 200 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRV 200 (325)
T ss_dssp EEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred EEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence 99999999999999964 235699999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCce--eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhcccc
Q 010891 327 LGAGKSH--ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSE 403 (498)
Q Consensus 327 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (498)
....... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||...... +....+......
T Consensus 201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~------~~~~~~~~~~~~- 273 (325)
T 3kul_A 201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR------DVISSVEEGYRL- 273 (325)
T ss_dssp CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH------HHHHHHHTTCCC-
T ss_pred cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH------HHHHHHHcCCCC-
Confidence 7543221 2233456889999999998999999999999999999999 99999754321 111222211110
Q ss_pred CCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 404 DVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
.. .... ...+..++.+||..||.+|||+.++++.|+..
T Consensus 274 -----~~--~~~~--~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l 311 (325)
T 3kul_A 274 -----PA--PMGC--PHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311 (325)
T ss_dssp -----CC--CTTC--CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CC--CCCc--CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11 1111 12334445589999999999999999999865
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=357.11 Aligned_cols=280 Identities=39% Similarity=0.636 Sum_probs=221.0
Q ss_pred ccccHHHHHHHccCCCcc------ceEcccCcEEEEEEEEcCCcEEEEEEecCCC----CCchhHHHHHHHHHHcCCCCC
Q 010891 162 HWFTLRDLQSATNRFSKD------NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNP----GQADKDFRVEVEAIGHVRHKN 231 (498)
Q Consensus 162 ~~~~~~~~~~~~~~y~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpn 231 (498)
+.|++.++..++++|... +.||+|+||.||+|.. +++.||+|++.... ....+.+.+|+.+++.++|||
T Consensus 13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ 91 (307)
T 2nru_A 13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN 91 (307)
T ss_dssp EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence 347889999999988876 8999999999999976 78999999986532 223456889999999999999
Q ss_pred ceEEEeEEEeCCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEc
Q 010891 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID 311 (498)
Q Consensus 232 Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~ 311 (498)
|+++++++.+....++||||+++++|.+++.... ....+++..++.++.|++.||.|||+. +|+||||||+||+++
T Consensus 92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~ 167 (307)
T 2nru_A 92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLD 167 (307)
T ss_dssp BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEC
T ss_pred eEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEc
Confidence 9999999999999999999999999999997432 345699999999999999999999999 999999999999999
Q ss_pred CCCCeEEeeeccceecCCCCce-eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHH
Q 010891 312 ENFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLV 390 (498)
Q Consensus 312 ~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~ 390 (498)
.++.+||+|||++......... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||......... .
T Consensus 168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~--~ 244 (307)
T 2nru_A 168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL--L 244 (307)
T ss_dssp TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT--T
T ss_pred CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH--H
Confidence 9999999999999876543222 2334579999999998875 5889999999999999999999999765433211 1
Q ss_pred HHHHHHHhhc-cccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 391 EWLKMMVQLR-RSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 391 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
.+........ .....+++.+. .........+..++.+||+.||.+|||+.+++++|+..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l 304 (307)
T 2nru_A 245 DIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304 (307)
T ss_dssp HHHHHHHTTSCCHHHHSCSSCS-CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HHHHHhhhhhhhhhhhcccccc-ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1111111111 01111222222 22333445556666789999999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=361.85 Aligned_cols=262 Identities=28% Similarity=0.412 Sum_probs=202.0
Q ss_pred HccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCc---hhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQA---DKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
..++|++.+.||+|+||.||+|+. .+++.||+|++....... .+.+.+|+.++.+++||||+++++++.++...|+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence 457899999999999999999985 468999999985543332 3568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
||||+++++|.+++... +.+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 89 v~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 89 VMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp EEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred EEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence 99999999999999743 5699999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcC
Q 010891 328 GAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407 (498)
Q Consensus 328 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (498)
............||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ...... .... ..
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~--~~~~--~~ 231 (294)
T 4eqm_A 162 SETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS------IAIKHI--QDSV--PN 231 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH------HHHHHH--SSCC--CC
T ss_pred ccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHh--hccC--CC
Confidence 5443333445679999999999999999999999999999999999999997543211 001111 1100 00
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhcCCC
Q 010891 408 PNIETRPSTSALKRALLTALRCVDPDSDKRP-KMSQVVRMLESEEY 452 (498)
Q Consensus 408 ~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RP-t~~ell~~L~~~~~ 452 (498)
.........+ ..+..++.+||+.||.+|| +++++.+.|+....
T Consensus 232 ~~~~~~~~~~--~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 232 VTTDVRKDIP--QSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp HHHHSCTTSC--HHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred cchhcccCCC--HHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 0000111111 2233444589999999998 89999999987543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=366.65 Aligned_cols=259 Identities=15% Similarity=0.172 Sum_probs=206.7
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCeeEEEEe
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
.++|.+.+.||+|+||.||+|+. .+|+.||||++.... ..+.+..|+.+++.+ +||||+++++++.+....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46799999999999999999985 578999999986443 235688999999999 99999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCC-----eEEeeeccce
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD-----AKISDFGLAK 325 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~-----~kL~DfGla~ 325 (498)
|+ +++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++. +||+|||+++
T Consensus 86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 86 LL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred eC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99 99999999753 45799999999999999999999999 9999999999999998887 9999999999
Q ss_pred ecCCCCce------eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhh
Q 010891 326 LLGAGKSH------ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQL 399 (498)
Q Consensus 326 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 399 (498)
.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~ 238 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA 238 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence 86543321 123567999999999999999999999999999999999999999865443332222222111110
Q ss_pred ccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 400 RRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
... .......+ .+..++.+||+.||.+||++.++++.|+..
T Consensus 239 ~~~------~~~~~~~p----~~~~li~~~l~~~p~~RP~~~~l~~~l~~~ 279 (330)
T 2izr_A 239 TPI------EVLCENFP----EMATYLRYVRRLDFFEKPDYDYLRKLFTDL 279 (330)
T ss_dssp SCH------HHHTTTCH----HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CCH------HHHhccCh----HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence 000 00000111 344445589999999999999999988753
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=359.95 Aligned_cols=261 Identities=27% Similarity=0.409 Sum_probs=200.2
Q ss_pred HccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHc--CCCCCceEEEeEEEeC----Cee
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGH--VRHKNLVRLLGYCIEG----TQR 245 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~~~~----~~~ 245 (498)
..++|++.+.||+|+||+||+|++ +++.||||++... ....+..|.+++.. ++||||+++++++.+. ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 457899999999999999999987 7899999998542 34456667777766 7999999999987653 457
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH--------HccCCCeeecCCCCCCEEEcCCCCeE
Q 010891 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH--------EAIEPKVVHRDIKSSNILIDENFDAK 317 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH--------~~~~~~iiHrDikp~NIll~~~~~~k 317 (498)
|+||||+++|+|.++++ ...+++..++.++.|++.||.||| +. +|+||||||+|||++.++.+|
T Consensus 82 ~lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~k 153 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCC 153 (301)
T ss_dssp EEEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEE
T ss_pred EEehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEE
Confidence 99999999999999995 346999999999999999999999 77 999999999999999999999
Q ss_pred EeeeccceecCCCCcee---eecccccccccCcccccCC------CCCccchHHHHHHHHHHHHhC----------CCCC
Q 010891 318 ISDFGLAKLLGAGKSHI---TTRVMGTFGYVAPEYANSG------LLNEKSDVYSFGVVLLEAITG----------RYPV 378 (498)
Q Consensus 318 L~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvvl~elltg----------~~P~ 378 (498)
|+|||+++......... .....||+.|+|||++.+. .++.++|||||||++|||++| ..||
T Consensus 154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf 233 (301)
T 3q4u_A 154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233 (301)
T ss_dssp ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence 99999998765443322 2334799999999999876 455799999999999999999 8888
Q ss_pred CCCCCcchhhHHHHHHHHHhhccccCCcCCCCCC-CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 379 DYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIET-RPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
....+.... ... +........ ..+.... .........+..++.+||+.||.+|||+.++++.|+..
T Consensus 234 ~~~~~~~~~-~~~-~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 234 YDVVPNDPS-FED-MRKVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTTSCSSCC-HHH-HHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred cccCCCCcc-hhh-hhHHHhccC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 654332211 111 111111111 1111111 01122334555666689999999999999999999763
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=358.88 Aligned_cols=265 Identities=22% Similarity=0.310 Sum_probs=201.1
Q ss_pred HccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCC--chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
..++|++.+.||+|+||+||+|+..+|+.||+|++...... ....+.+|++++++++||||+++++++.++...++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 45789999999999999999999888999999998644322 2356889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+++ +|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++....
T Consensus 99 e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 99 EFMEK-DLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp ECCSE-EHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred cCCCC-CHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 99975 88888864 335699999999999999999999999 999999999999999999999999999998754
Q ss_pred CCceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCC---
Q 010891 330 GKSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV--- 405 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 405 (498)
.... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... ..+............
T Consensus 172 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~ 247 (311)
T 3niz_A 172 PVRS-YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL---PKIFSILGTPNPREWPQV 247 (311)
T ss_dssp CCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH---HHHHHHHCCCCTTTSGGG
T ss_pred Cccc-ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHHCCCChHHhhhh
Confidence 3322 334578999999998866 67899999999999999999999999765443221 111111100000000
Q ss_pred ---------cCCCCCCCCC----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 406 ---------VDPNIETRPS----TSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 406 ---------~~~~~~~~~~----~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
........+. .........++.+||..||++|||+.|+++|-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp 302 (311)
T 3niz_A 248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHP 302 (311)
T ss_dssp TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence 0000000000 00012334555689999999999999999864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-46 Score=368.67 Aligned_cols=266 Identities=27% Similarity=0.384 Sum_probs=203.0
Q ss_pred ccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCC----eeEEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT----QRILV 248 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~~~lv 248 (498)
.++|++.++||+|+||+||+|++ .++.||||++.... .....+..|+.++.+++||||+++++++.+.. ..|+|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEE-CCCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 46899999999999999999987 48999999985432 22234566899999999999999999998744 46999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHc-------cCCCeeecCCCCCCEEEcCCCCeEEeee
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEA-------IEPKVVHRDIKSSNILIDENFDAKISDF 321 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~-------~~~~iiHrDikp~NIll~~~~~~kL~Df 321 (498)
|||+++|+|.+++.. ..+++..++.++.|++.||.|||+. ..++|+||||||+|||++.++.+||+||
T Consensus 101 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF 175 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF 175 (322)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred EecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence 999999999999964 3489999999999999999999975 2448999999999999999999999999
Q ss_pred ccceecCCCCce-eeecccccccccCcccccC-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhh-------
Q 010891 322 GLAKLLGAGKSH-ITTRVMGTFGYVAPEYANS-----GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVN------- 388 (498)
Q Consensus 322 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~------- 388 (498)
|+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..........
T Consensus 176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~ 255 (322)
T 3soc_A 176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ 255 (322)
T ss_dssp TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence 999887544322 2334679999999999876 356678999999999999999999997543321111
Q ss_pred ---HHHHHHHHHhhccccCCcCCCCCC-CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 389 ---LVEWLKMMVQLRRSEDVVDPNIET-RPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 389 ---~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
...+... .... ...+.+.. .........+..++.+||+.||++|||+.|+++.|+..
T Consensus 256 ~~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l 316 (322)
T 3soc_A 256 HPSLEDMQEV-VVHK----KKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM 316 (322)
T ss_dssp SCCHHHHHHH-HTTS----CCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCchhhhhhh-hhcc----cCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 1111111 1111 11111111 11222334455666689999999999999999999764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=359.05 Aligned_cols=256 Identities=22% Similarity=0.388 Sum_probs=204.7
Q ss_pred HccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
..++|++.+.||+|+||+||+|++.++..||+|++.... ...+.+.+|++++..++||||+++++++.+....|+||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 456889999999999999999998888899999986543 3346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+++++|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 101 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 174 (283)
T 3gen_A 101 MANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 174 (283)
T ss_dssp CTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred cCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence 9999999999752 34699999999999999999999999 99999999999999999999999999998664432
Q ss_pred ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCC
Q 010891 332 SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNI 410 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (498)
........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...... +....+... .....+
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~------~~~~~~~~~---~~~~~~-- 243 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------ETAEHIAQG---LRLYRP-- 243 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH------HHHHHHHTT---CCCCCC--
T ss_pred cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh------HHHHHHhcc---cCCCCC--
Confidence 222333457888999999998899999999999999999998 99999754321 111122111 111111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 411 ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 411 ~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
.... ..+..++.+||+.||.+|||+.+++++|...
T Consensus 244 --~~~~---~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~ 278 (283)
T 3gen_A 244 --HLAS---EKVYTIMYSCWHEKADERPTFKILLSNILDV 278 (283)
T ss_dssp --TTCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CcCC---HHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence 1111 2334445589999999999999999999754
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=356.80 Aligned_cols=273 Identities=22% Similarity=0.259 Sum_probs=209.5
Q ss_pred ccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCC-CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCC--eeEEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT--QRILV 248 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--~~~lv 248 (498)
.++|.+.++||+|+||+||+|+.. +++.||||++.... ....+.+.+|++++++++||||+++++++.... ..|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 467899999999999999999864 48999999986433 233466889999999999999999999998765 77999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEE----cCCCCeEEeeeccc
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI----DENFDAKISDFGLA 324 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll----~~~~~~kL~DfGla 324 (498)
|||+++++|.+++.... ....+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 99999999999997542 223499999999999999999999999 99999999999999 78888999999999
Q ss_pred eecCCCCceeeecccccccccCccccc--------CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH
Q 010891 325 KLLGAGKSHITTRVMGTFGYVAPEYAN--------SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMM 396 (498)
Q Consensus 325 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 396 (498)
+....... .....||+.|+|||++. +..++.++|||||||++|||++|+.||........ ..+.+..+
T Consensus 164 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~ 239 (319)
T 4euu_A 164 RELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKI 239 (319)
T ss_dssp EECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGG--CHHHHHHH
T ss_pred eecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccch--hHHHHHHH
Confidence 98754432 23457999999999885 57889999999999999999999999975433221 11222222
Q ss_pred Hhhcccc------CCcC------CCC--CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCC
Q 010891 397 VQLRRSE------DVVD------PNI--ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYP 453 (498)
Q Consensus 397 ~~~~~~~------~~~~------~~~--~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~~~ 453 (498)
....... .... +.+ ...........+..++.+||+.||++|||+.|++++..+...+
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~ 310 (319)
T 4euu_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (319)
T ss_dssp HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence 2211100 0000 011 1112223333444455689999999999999999999876554
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=364.33 Aligned_cols=254 Identities=26% Similarity=0.344 Sum_probs=203.7
Q ss_pred HccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCC------chhHHHHHHHHHHcCCCCCceEEEeEEEeCCe
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ------ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQ 244 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 244 (498)
..++|.+.+.||+|+||.||+|+.. +|+.||+|.+...... ..+.+.+|+.+++.++||||+++++++.+...
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 3467999999999999999999864 5899999998654322 34678899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCC----CeEEee
Q 010891 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF----DAKISD 320 (498)
Q Consensus 245 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~----~~kL~D 320 (498)
.++||||+++++|.+++. ..+.+++..++.++.||+.||.|||+. +|+||||||+|||++.++ .+||+|
T Consensus 89 ~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~D 161 (326)
T 2y0a_A 89 VILILELVAGGELFDFLA----EKESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIID 161 (326)
T ss_dssp EEEEEECCCSCBHHHHHT----TSSCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEEcCCCCCHHHHHH----hcCCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence 999999999999999996 345799999999999999999999999 999999999999999887 799999
Q ss_pred eccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhc
Q 010891 321 FGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLR 400 (498)
Q Consensus 321 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 400 (498)
||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... +.+..+....
T Consensus 162 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~~~~~~ 233 (326)
T 2y0a_A 162 FGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANVSAVN 233 (326)
T ss_dssp CTTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHHTC
T ss_pred CCCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH------HHHHHHHhcC
Confidence 99999875432 233467999999999999999999999999999999999999999754321 1111111111
Q ss_pred cccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 401 RSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
. ...... ....+ ..+..++.+||..||.+|||+.|++++-
T Consensus 234 ~---~~~~~~--~~~~~--~~~~~li~~~L~~dP~~Rpt~~e~l~hp 273 (326)
T 2y0a_A 234 Y---EFEDEY--FSNTS--ALAKDFIRRLLVKDPKKRMTIQDSLQHP 273 (326)
T ss_dssp C---CCCHHH--HTTSC--HHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred C---CcCccc--cccCC--HHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence 0 000000 00111 2233444589999999999999999864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=385.65 Aligned_cols=261 Identities=23% Similarity=0.409 Sum_probs=209.5
Q ss_pred HHHHccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 169 LQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 169 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
+++..++|.+.+.||+|+||.||+|.+.++..||||++.... ...+.|.+|+.+|+.++||||+++++++. ....|+|
T Consensus 183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv 260 (454)
T 1qcf_A 183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYII 260 (454)
T ss_dssp SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEE
Confidence 345667899999999999999999998888999999996543 45678999999999999999999999986 5678999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+++|+|.++++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 261 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 261 TEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp ECCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred EeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 9999999999999743 123588999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (498)
...........+|..|+|||++....++.++|||||||+||||+| |+.||...... +....+..... ...
T Consensus 336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~------~~~~~i~~~~~---~~~ 406 (454)
T 1qcf_A 336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP------EVIRALERGYR---MPR 406 (454)
T ss_dssp CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHHHHHHTCC---CCC
T ss_pred CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCC---CCC
Confidence 332222233456789999999998999999999999999999999 99999754321 11222222111 111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 010891 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEY 452 (498)
Q Consensus 408 ~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~~ 452 (498)
+ .... ..+..++.+||+.||++|||+.+|++.|+....
T Consensus 407 ~----~~~~---~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~ 444 (454)
T 1qcf_A 407 P----ENCP---EELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT 444 (454)
T ss_dssp C----TTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred C----CCCC---HHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence 1 1111 234445558999999999999999999997653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=372.37 Aligned_cols=257 Identities=24% Similarity=0.303 Sum_probs=199.2
Q ss_pred ccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCC---CCchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCeeEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 247 (498)
.++|++.++||+|+||.||+|+.. +++.||+|++.+.. ....+.+..|..++.++ +||||+++++++.+....|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 357899999999999999999864 57899999986542 23345678899999887 89999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
||||++||+|.+++... +.+++..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 131 V~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEcCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 99999999999999743 5699999999999999999999999 9999999999999999999999999999863
Q ss_pred CCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcc--hhhHHHHHHHHHhhccccCC
Q 010891 328 GAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQS--EVNLVEWLKMMVQLRRSEDV 405 (498)
Q Consensus 328 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 405 (498)
.... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||....... .....+.+.......
T Consensus 204 ~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~----- 277 (396)
T 4dc2_A 204 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK----- 277 (396)
T ss_dssp CCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHC-----
T ss_pred ccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcc-----
Confidence 3222 22445789999999999999999999999999999999999999996432211 011111111111111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHHH
Q 010891 406 VDPNIETRPSTSALKRALLTALRCVDPDSDKRPKM------SQVVRML 447 (498)
Q Consensus 406 ~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~------~ell~~L 447 (498)
....+...+. .+..++.+||+.||.+||++ .|+++|-
T Consensus 278 ---~~~~p~~~s~--~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hp 320 (396)
T 4dc2_A 278 ---QIRIPRSLSV--KAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 320 (396)
T ss_dssp ---CCCCCTTSCH--HHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHST
T ss_pred ---ccCCCCcCCH--HHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCc
Confidence 1111111222 23344458999999999995 6777543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=374.37 Aligned_cols=263 Identities=21% Similarity=0.233 Sum_probs=208.5
Q ss_pred HHHHHHHccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCC---CCCchhHHHHHHHHHHcCCCCCceEEEeEEEe
Q 010891 166 LRDLQSATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNN---PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIE 241 (498)
Q Consensus 166 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 241 (498)
+.++....++|.+.++||+|+||+||+|+.. +++.||+|++.+. .......+.+|+.++..++||||+++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 4455566789999999999999999999864 5889999998542 12233458889999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeee
Q 010891 242 GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDF 321 (498)
Q Consensus 242 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~Df 321 (498)
....|+||||++||+|.+++.. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEecc
Confidence 9999999999999999999963 3589999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCceeeecccccccccCcccccCCC----CCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHH
Q 010891 322 GLAKLLGAGKSHITTRVMGTFGYVAPEYANSGL----LNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMV 397 (498)
Q Consensus 322 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 397 (498)
|+++.............+||+.|+|||++.+.. |+.++|||||||+||||++|+.||...... +....+.
T Consensus 213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~ 286 (410)
T 3v8s_A 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIM 286 (410)
T ss_dssp TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHH
T ss_pred ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh------hHHHHHH
Confidence 999987655444455678999999999997655 889999999999999999999999754321 1112221
Q ss_pred hhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHhc
Q 010891 398 QLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDK--RPKMSQVVRMLES 449 (498)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~--RPt~~ell~~L~~ 449 (498)
...... .++.....+.. +..++.+||..+|.+ ||++.|+++|--.
T Consensus 287 ~~~~~~-----~~p~~~~~s~~--~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f 333 (410)
T 3v8s_A 287 NHKNSL-----TFPDDNDISKE--AKNLICAFLTDREVRLGRNGVEEIKRHLFF 333 (410)
T ss_dssp THHHHC-----CCCTTCCCCHH--HHHHHHHHSSCGGGCTTSSCHHHHHTSGGG
T ss_pred hccccc-----cCCCcccccHH--HHHHHHHHccChhhhCCCCCHHHHhcCccc
Confidence 111000 11111122222 223334799999988 9999999987643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-45 Score=367.24 Aligned_cols=257 Identities=21% Similarity=0.303 Sum_probs=203.6
Q ss_pred HccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCC-----CCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCee
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNN-----PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQR 245 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 245 (498)
..++|++.+.||+|+||+||+|.. .+|+.||||++... .....+.+.+|+.+++.++||||+++++++.++...
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 346799999999999999999985 46899999998431 222456789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCC---eEEeeec
Q 010891 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD---AKISDFG 322 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~---~kL~DfG 322 (498)
|+||||+++++|.+++.........+++..+..++.||+.||.|||++ +|+||||||+|||++.++. +||+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCc
Confidence 999999999999998865433445689999999999999999999999 9999999999999987655 9999999
Q ss_pred cceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccc
Q 010891 323 LAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRS 402 (498)
Q Consensus 323 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (498)
++........ .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.... . +....+....
T Consensus 179 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~---~~~~~i~~~~-- 248 (351)
T 3c0i_A 179 VAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----E---RLFEGIIKGK-- 248 (351)
T ss_dssp TCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----H---HHHHHHHHTC--
T ss_pred ceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----H---HHHHHHHcCC--
Confidence 9998765332 2344679999999999999999999999999999999999999997531 1 1111111111
Q ss_pred cCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 403 EDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
....+.. ....+ ..+..++.+||..||++|||+.|++++
T Consensus 249 -~~~~~~~--~~~~s--~~~~~li~~~L~~dP~~R~s~~e~l~h 287 (351)
T 3c0i_A 249 -YKMNPRQ--WSHIS--ESAKDLVRRMLMLDPAERITVYEALNH 287 (351)
T ss_dssp -CCCCHHH--HTTSC--HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -CCCCccc--cccCC--HHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 0000000 01111 223344558999999999999999974
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=371.93 Aligned_cols=250 Identities=21% Similarity=0.287 Sum_probs=197.0
Q ss_pred ccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCC---CCchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCeeEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 247 (498)
.++|++.++||+|+||.||+|+.. +|+.||||++.... ....+.+..|..++..+ +||||+++++++.+....|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 468999999999999999999864 58999999985431 22345577899999988 79999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
||||++||+|.+++... +.+++..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 102 v~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeec
Confidence 99999999999999743 5699999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcC
Q 010891 328 GAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407 (498)
Q Consensus 328 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (498)
.... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...... +....+...
T Consensus 175 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~~-------- 239 (353)
T 3txo_A 175 ICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED------DLFEAILND-------- 239 (353)
T ss_dssp CC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHC--------
T ss_pred ccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH------HHHHHHHcC--------
Confidence 3222 2244568999999999999989999999999999999999999999754321 122222211
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHHH
Q 010891 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPKM------SQVVRML 447 (498)
Q Consensus 408 ~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~------~ell~~L 447 (498)
........+. .+..++.+||..||.+||++ .++++|-
T Consensus 240 -~~~~p~~~~~--~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp 282 (353)
T 3txo_A 240 -EVVYPTWLHE--DATGILKSFMTKNPTMRLGSLTQGGEHAILRHP 282 (353)
T ss_dssp -CCCCCTTSCH--HHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSG
T ss_pred -CCCCCCCCCH--HHHHHHHHHhhhCHHHccCCcccCCHHHHhhCC
Confidence 1111111112 23334458999999999998 8888654
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=364.10 Aligned_cols=255 Identities=25% Similarity=0.379 Sum_probs=200.8
Q ss_pred ccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
.++|++.+.||+|+||+||+|+.. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.++...|+|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999864 789999999854433 234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
|+++|+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..+...
T Consensus 86 ~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 158 (323)
T 3tki_A 86 YCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (323)
T ss_dssp CCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred cCCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccC
Confidence 999999999986 345699999999999999999999999 9999999999999999999999999999876432
Q ss_pred Cc-eeeecccccccccCcccccCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCC
Q 010891 331 KS-HITTRVMGTFGYVAPEYANSGLL-NEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408 (498)
Q Consensus 331 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (498)
.. ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........ ....+ ... .....+
T Consensus 159 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~----~~~---~~~~~~ 230 (323)
T 3tki_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDW----KEK---KTYLNP 230 (323)
T ss_dssp TEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHH----HTT---CTTSTT
T ss_pred CcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHH----hcc---cccCCc
Confidence 22 22345679999999999977665 7799999999999999999999975443221 11111 111 100000
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 409 NIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
.... ......++.+||..||.+|||+.|++++.-
T Consensus 231 ----~~~~--~~~~~~li~~~L~~dP~~R~t~~eil~h~~ 264 (323)
T 3tki_A 231 ----WKKI--DSAPLALLHKILVENPSARITIPDIKKDRW 264 (323)
T ss_dssp ----GGGS--CHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred ----cccC--CHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence 0111 122334555899999999999999987643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=375.99 Aligned_cols=256 Identities=21% Similarity=0.285 Sum_probs=203.0
Q ss_pred HHccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC--chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
...++|++.+.||+|+||+||+|.. .+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+....|+
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 3457899999999999999999975 57899999998654432 23568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEc---CCCCeEEeeeccc
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID---ENFDAKISDFGLA 324 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~---~~~~~kL~DfGla 324 (498)
||||++||+|.+++.. .+.+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++
T Consensus 88 v~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a 160 (444)
T 3soa_A 88 IFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLA 160 (444)
T ss_dssp EECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred EEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence 9999999999999974 35699999999999999999999999 999999999999998 4678999999999
Q ss_pred eecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccC
Q 010891 325 KLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSED 404 (498)
Q Consensus 325 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (498)
........ ......||+.|+|||++.+..|+.++|||||||++|+|++|..||...... +....+..... .
T Consensus 161 ~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~~--~ 231 (444)
T 3soa_A 161 IEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH------RLYQQIKAGAY--D 231 (444)
T ss_dssp BCCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHTCC--C
T ss_pred EEecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH------HHHHHHHhCCC--C
Confidence 87654332 234467999999999999999999999999999999999999999754321 11122221111 1
Q ss_pred CcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 405 VVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
...+ .....+. .+..++.+||+.||.+|||+.|++++-
T Consensus 232 ~~~~---~~~~~s~--~~~~li~~~L~~dP~~Rpta~e~L~hp 269 (444)
T 3soa_A 232 FPSP---EWDTVTP--EAKDLINKMLTINPSKRITAAEALKHP 269 (444)
T ss_dssp CCTT---TTTTSCH--HHHHHHHHHSCSSTTTSCCHHHHHHSC
T ss_pred CCcc---ccccCCH--HHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence 1111 1111122 233344589999999999999999863
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=358.66 Aligned_cols=250 Identities=24% Similarity=0.334 Sum_probs=194.3
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC--------------------------CchhHHHHHHHHHH
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--------------------------QADKDFRVEVEAIG 225 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~ 225 (498)
.++|.+.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+++++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 46899999999999999999985 4688999999865431 12356889999999
Q ss_pred cCCCCCceEEEeEEEe--CCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCC
Q 010891 226 HVRHKNLVRLLGYCIE--GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDI 303 (498)
Q Consensus 226 ~l~hpnIv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDi 303 (498)
+++||||+++++++.+ ....|+||||+++++|.+++ ....+++..++.++.||+.||.|||+. +|+||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dl 163 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDI 163 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCC
Confidence 9999999999999987 56889999999999998765 335799999999999999999999999 9999999
Q ss_pred CCCCEEEcCCCCeEEeeeccceecCCCCceeeecccccccccCcccccCCC---CCccchHHHHHHHHHHHHhCCCCCCC
Q 010891 304 KSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGL---LNEKSDVYSFGVVLLEAITGRYPVDY 380 (498)
Q Consensus 304 kp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~elltg~~P~~~ 380 (498)
||+|||++.++.+||+|||++........ ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999998754332 234467999999999997655 47889999999999999999999975
Q ss_pred CCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 381 GRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
... ......+.. ... .....+..+ ..+..++.+||+.||++|||+.|+++|
T Consensus 243 ~~~------~~~~~~~~~-~~~------~~~~~~~~~--~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 243 ERI------MCLHSKIKS-QAL------EFPDQPDIA--EDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp SSH------HHHHHHHHH-CCC------CCCSSSCCC--HHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred ccH------HHHHHHHhc-ccC------CCCCccccC--HHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 321 111111111 110 011111111 223344458999999999999999865
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=359.73 Aligned_cols=246 Identities=25% Similarity=0.326 Sum_probs=201.4
Q ss_pred cCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCC---CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
++|++.+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+....|+||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 57899999999999999999864 68999999985431 233456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||++||+|.+++.. .+.+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 86 e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 86 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999974 35689999999999999999999999 999999999999999999999999999987643
Q ss_pred CCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... +....+... .
T Consensus 159 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~i~~~---------~ 219 (318)
T 1fot_A 159 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYEKILNA---------E 219 (318)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHC---------C
T ss_pred c----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH------HHHHHHHhC---------C
Confidence 2 23467999999999999999999999999999999999999999754321 112222211 1
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRP-----KMSQVVRML 447 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RP-----t~~ell~~L 447 (498)
.......+. .+..++.+||..||.+|| ++.++++|-
T Consensus 220 ~~~p~~~~~--~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp 260 (318)
T 1fot_A 220 LRFPPFFNE--DVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP 260 (318)
T ss_dssp CCCCTTSCH--HHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSG
T ss_pred CCCCCCCCH--HHHHHHHHHhccCHHHcCCCcCCCHHHHhcCc
Confidence 111111112 233344489999999999 899998654
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=377.24 Aligned_cols=266 Identities=21% Similarity=0.236 Sum_probs=209.0
Q ss_pred cHHHHHHHccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCC---CCCchhHHHHHHHHHHcCCCCCceEEEeEEE
Q 010891 165 TLRDLQSATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNN---PGQADKDFRVEVEAIGHVRHKNLVRLLGYCI 240 (498)
Q Consensus 165 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 240 (498)
.+.++....++|++.++||+|+||+||+|+.. +++.||+|++.+. .......+.+|+.++..++||||++++++|.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 35566667789999999999999999999865 4789999998542 1222345889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEee
Q 010891 241 EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISD 320 (498)
Q Consensus 241 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~D 320 (498)
+....|+||||++||+|.+++.. ..+.+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~D 218 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD 218 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcc
Confidence 99999999999999999999974 235699999999999999999999999 999999999999999999999999
Q ss_pred eccceecCCCCceeeecccccccccCccccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 010891 321 FGLAKLLGAGKSHITTRVMGTFGYVAPEYAN-----SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKM 395 (498)
Q Consensus 321 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 395 (498)
||+++.............+||+.|+|||++. ...|+.++|||||||++|||++|+.||....... ....
T Consensus 219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~------~~~~ 292 (437)
T 4aw2_A 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGK 292 (437)
T ss_dssp CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHH
T ss_pred hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH------HHHh
Confidence 9999887655544455578999999999986 5679999999999999999999999997543221 1112
Q ss_pred HHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCC--CCCHHHHHHHHh
Q 010891 396 MVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDK--RPKMSQVVRMLE 448 (498)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~--RPt~~ell~~L~ 448 (498)
+...... ..-+.. ....+... ..++.+||..+|++ ||++.|+++|--
T Consensus 293 i~~~~~~--~~~p~~--~~~~s~~~--~dLi~~lL~~~~~r~~r~~~~eil~Hpf 341 (437)
T 4aw2_A 293 IMNHKER--FQFPTQ--VTDVSENA--KDLIRRLICSREHRLGQNGIEDFKKHPF 341 (437)
T ss_dssp HHTHHHH--CCCCSS--CCCSCHHH--HHHHHTTSSCGGGCTTTTTTHHHHTSGG
T ss_pred hhhcccc--ccCCcc--cccCCHHH--HHHHHHHhcccccccCCCCHHHHhCCCc
Confidence 1111100 000111 01122222 23334688777877 999999998643
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-45 Score=357.59 Aligned_cols=262 Identities=24% Similarity=0.395 Sum_probs=200.2
Q ss_pred ccCCCccceEcccCcEEEEEEEE-----cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeC--Cee
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-----MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG--TQR 245 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~ 245 (498)
.++|++.+.||+|+||+||+|++ .+++.||||++........+.+.+|++++.+++||||+++++++... ...
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 88 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 88 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence 46789999999999999999974 36889999999766555556789999999999999999999998653 558
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccce
Q 010891 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~ 325 (498)
++||||+++|+|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 89 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 89 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp EEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred EEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 9999999999999999753 23589999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCc--eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCC----------cchhhHHHHH
Q 010891 326 LLGAGKS--HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRP----------QSEVNLVEWL 393 (498)
Q Consensus 326 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~----------~~~~~~~~~~ 393 (498)
....... .......||..|+|||++.+..++.++||||||+++|||++|..||..... ..........
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHH
Confidence 7654322 122334578889999999999999999999999999999999999863210 0000000111
Q ss_pred HHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 394 KMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
...... .. ....... ...+..++.+||+.||++|||+.|+++.|+..
T Consensus 243 ~~~~~~---~~-----~~~~~~~--~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l 289 (295)
T 3ugc_A 243 ELLKNN---GR-----LPRPDGC--PDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289 (295)
T ss_dssp HHHHTT---CC-----CCCCTTC--CHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHhcc---Cc-----CCCCcCc--CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 111111 00 0111111 12344455589999999999999999999764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=364.34 Aligned_cols=248 Identities=25% Similarity=0.384 Sum_probs=200.3
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCC---CCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNN---PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
.++|.+.+.||+|+||.||+|.. .+++.||+|++... .......+.+|+.+++.++||||+++++++.+....++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 36899999999999999999985 57899999998532 122345688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+ +|+|.+++.. .+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 88 ~E~~-~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp ECCC-CEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred EECC-CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 9999 7899999864 35699999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCceeeecccccccccCcccccCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANSGLL-NEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (498)
... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......... ..+..
T Consensus 160 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~---------------~~i~~ 222 (336)
T 3h4j_B 160 DGN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF---------------KKVNS 222 (336)
T ss_dssp TSB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB---------------CCCCS
T ss_pred CCc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH---------------HHHHc
Confidence 432 2344679999999999988776 78999999999999999999999754322110 01111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 408 ~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.....+...+. .+..++.+||..||.+|||+.|++++-
T Consensus 223 ~~~~~p~~~s~--~~~~li~~~L~~dP~~Rpt~~eil~hp 260 (336)
T 3h4j_B 223 CVYVMPDFLSP--GAQSLIRRMIVADPMQRITIQEIRRDP 260 (336)
T ss_dssp SCCCCCTTSCH--HHHHHHHTTSCSSGGGSCCHHHHTTCH
T ss_pred CCCCCcccCCH--HHHHHHHHHcCCChhHCcCHHHHHhCh
Confidence 11111111222 233444589999999999999999754
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=373.54 Aligned_cols=258 Identities=26% Similarity=0.396 Sum_probs=204.7
Q ss_pred HHccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
...++|.+.+.||+|+||.||+|++. +++.||||.+...... ..+.|.+|++++++++||||+++++++.+....|+|
T Consensus 111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 34568899999999999999999875 6899999998654322 234688899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+++|+|.+++... ...+++..++.++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 191 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp EECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 9999999999999743 24589999999999999999999999 99999999999999999999999999998754
Q ss_pred CCCceee-ecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCc
Q 010891 329 AGKSHIT-TRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVV 406 (498)
Q Consensus 329 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (498)
....... ....+++.|+|||++.++.++.++|||||||++|||++ |..||....... .. ...... ....
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~---~~---~~~~~~---~~~~ 335 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ---TR---EFVEKG---GRLP 335 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH---HH---HHHHTT---CCCC
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HH---HHHHcC---CCCC
Confidence 4321111 12235778999999998899999999999999999998 999997543211 11 111111 1111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 407 DPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 407 ~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
.+ ...+. .+..++.+||+.||++|||+.++++.|+..
T Consensus 336 ~~----~~~~~---~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 372 (377)
T 3cbl_A 336 CP----ELCPD---AVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372 (377)
T ss_dssp CC----TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC----CCCCH---HHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 11 11112 333445589999999999999999999764
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=372.05 Aligned_cols=256 Identities=30% Similarity=0.477 Sum_probs=193.4
Q ss_pred ccCCCccceEcccCcEEEEEEEEc----CCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM----NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
.++|.+.+.||+|+||.||+|++. ++..||||++..... ...+.|.+|+.++.+++||||+++++++.+....|+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 467999999999999999999754 577899999865432 234568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
||||+++|+|.++++. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 124 v~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 124 VTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 9999999999999974 234699999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCcee--eecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccC
Q 010891 328 GAGKSHI--TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSED 404 (498)
Q Consensus 328 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (498)
....... .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... +....+.......
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~------~~~~~i~~~~~~~- 270 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ------DVIKAVDEGYRLP- 270 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH------HHHHHHHTTEECC-
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCCCC-
Confidence 5432211 122345788999999999999999999999999999998 99999754321 1112221111110
Q ss_pred CcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 405 VVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
........+..++.+||+.||.+|||+.++++.|+..
T Consensus 271 ---------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~ 307 (373)
T 2qol_A 271 ---------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307 (373)
T ss_dssp ---------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---------CCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence 0011112344455689999999999999999999765
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=368.04 Aligned_cols=254 Identities=21% Similarity=0.311 Sum_probs=202.9
Q ss_pred HHccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC--chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
...++|.+.+.||+|+||.||+|.. .+|+.||+|++...... ..+.+.+|+.+++.++||||+++++++.+....|+
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 4457899999999999999999985 46899999999654332 23568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCC---CCeEEeeeccc
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN---FDAKISDFGLA 324 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~---~~~kL~DfGla 324 (498)
||||+++|+|.+++. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.+ +.+||+|||++
T Consensus 106 v~e~~~gg~L~~~l~----~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a 178 (362)
T 2bdw_A 106 VFDLVTGGELFEDIV----AREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLA 178 (362)
T ss_dssp EECCCCSCBHHHHHT----TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEecCCCCCHHHHHH----HcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence 999999999999996 345799999999999999999999999 99999999999999865 45999999999
Q ss_pred eecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccC
Q 010891 325 KLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSED 404 (498)
Q Consensus 325 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (498)
....... .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||...... +....+..... .
T Consensus 179 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~------~~~~~i~~~~~--~ 248 (362)
T 2bdw_A 179 IEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RLYAQIKAGAY--D 248 (362)
T ss_dssp BCCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCC--C
T ss_pred eEecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCCC--C
Confidence 8765432 233467999999999999999999999999999999999999999754321 11122211110 0
Q ss_pred CcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 405 VVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
...+. ....+ ..+..++.+||..||++|||+.+++++
T Consensus 249 ~~~~~---~~~~~--~~~~~li~~~L~~dP~~R~t~~e~l~h 285 (362)
T 2bdw_A 249 YPSPE---WDTVT--PEAKSLIDSMLTVNPKKRITADQALKV 285 (362)
T ss_dssp CCTTG---GGGSC--HHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCccc---ccCCC--HHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 01111 223344458999999999999999976
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=370.33 Aligned_cols=268 Identities=26% Similarity=0.407 Sum_probs=209.9
Q ss_pred cHHHHHHHccCCCccceEcccCcEEEEEEEE------cCCcEEEEEEecCCCCC-chhHHHHHHHHHHcC-CCCCceEEE
Q 010891 165 TLRDLQSATNRFSKDNIIGDGGYGVVYRGQL------MNGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHV-RHKNLVRLL 236 (498)
Q Consensus 165 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpnIv~l~ 236 (498)
....++...++|.+.+.||+|+||.||+|++ .+++.||||++...... ..+.+.+|++++.++ +||||++++
T Consensus 13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 3556677789999999999999999999974 24578999999654332 235688999999999 899999999
Q ss_pred eEEEeCC-eeEEEEeecCCCCHHHHHhcccCC------------------------------------------------
Q 010891 237 GYCIEGT-QRILVYEYVNNGNLEQWLRGDMCD------------------------------------------------ 267 (498)
Q Consensus 237 ~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~------------------------------------------------ 267 (498)
+++.+.. ..++||||+++|+|.+++......
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 9998754 489999999999999999754211
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc-
Q 010891 268 --------------RGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS- 332 (498)
Q Consensus 268 --------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~- 332 (498)
...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++........
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 249 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence 12389999999999999999999999 999999999999999999999999999987644322
Q ss_pred eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCC
Q 010891 333 HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411 (498)
Q Consensus 333 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (498)
.......||+.|+|||++.+..++.++|||||||++|||++ |..||........ . ...+..... ....
T Consensus 250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~---~~~~~~~~~------~~~~ 318 (359)
T 3vhe_A 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--F---CRRLKEGTR------MRAP 318 (359)
T ss_dssp EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--H---HHHHHHTCC------CCCC
T ss_pred hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH--H---HHHHHcCCC------CCCC
Confidence 23344678999999999999999999999999999999998 9999976543321 1 111111111 0111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 412 ~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
. ... ..+..++.+||+.||.+|||+.|++++|+..
T Consensus 319 ~-~~~---~~l~~li~~~l~~dP~~Rps~~ell~~L~~~ 353 (359)
T 3vhe_A 319 D-YTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 353 (359)
T ss_dssp T-TCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C-CCC---HHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence 1 111 2334445589999999999999999999764
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=362.50 Aligned_cols=251 Identities=24% Similarity=0.327 Sum_probs=201.7
Q ss_pred ccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCC---CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
.++|.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|+.++..++|||||++++++.+....|+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 367899999999999999999854 58899999985422 23346688899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+.||+|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||++....
T Consensus 94 ~e~~~gg~L~~~l~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQ----QNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp ECCCTTEEHHHHHH----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 99999999999997 345799999999999999999999999 99999999999999999999999999999865
Q ss_pred CCCceeeecccccccccCcccccC---CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANS---GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV 405 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (498)
... .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||............ .......
T Consensus 167 ~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~---~~~~~~~----- 236 (384)
T 4fr4_A 167 RET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIV---HTFETTV----- 236 (384)
T ss_dssp TTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHH---HHHHHCC-----
T ss_pred CCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHH---HHHhhcc-----
Confidence 432 2345689999999999863 46899999999999999999999999755443322222 1111110
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCC-HHHHHHH
Q 010891 406 VDPNIETRPSTSALKRALLTALRCVDPDSDKRPK-MSQVVRM 446 (498)
Q Consensus 406 ~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt-~~ell~~ 446 (498)
.......+ ..+..++.+||..||.+||+ +.+++++
T Consensus 237 ----~~~p~~~s--~~~~~li~~lL~~dP~~R~s~~~~l~~h 272 (384)
T 4fr4_A 237 ----VTYPSAWS--QEMVSLLKKLLEPNPDQRFSQLSDVQNF 272 (384)
T ss_dssp ----CCCCTTSC--HHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred ----cCCCCcCC--HHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence 11111111 23344445899999999998 7777754
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-45 Score=381.86 Aligned_cols=260 Identities=28% Similarity=0.434 Sum_probs=203.3
Q ss_pred HHHccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 170 QSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 170 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
+...++|.+.+.||+|+||.||+|.+.++..||||++.... ...+.|.+|+.+|++++||||+++++++.+ ...|+||
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~ 257 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 257 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence 45567899999999999999999998888889999986543 345679999999999999999999999876 6789999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+++|+|.+++... ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 258 e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 258 EYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred hhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 999999999999643 224589999999999999999999999 999999999999999999999999999987654
Q ss_pred CCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (498)
..........+|..|+|||++.+..++.++|||||||+||||++ |+.||...... +.+..+....+ .
T Consensus 333 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~------~~~~~i~~~~~---~--- 400 (452)
T 1fmk_A 333 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQVERGYR---M--- 400 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHHHTTCC---C---
T ss_pred CceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCC---C---
Confidence 33222334457889999999998999999999999999999999 99999754321 11222221111 1
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 010891 409 NIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEY 452 (498)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~~ 452 (498)
......+ ..+..++.+||+.||++|||+.++++.|+....
T Consensus 401 --~~~~~~~--~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 401 --PCPPECP--ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp --CCCTTSC--HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred --CCCCCCC--HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 1111111 233445558999999999999999999987643
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=351.17 Aligned_cols=250 Identities=29% Similarity=0.482 Sum_probs=190.8
Q ss_pred ccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCC----CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPG----QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
.++|++.+.||+|+||.||+|.+ .++.||||++..... ...+.+.+|+++++.++||||+++++++.++...++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 36789999999999999999987 589999998865432 2346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCC---eeecCCCCCCEEEcC--------CCCeE
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK---VVHRDIKSSNILIDE--------NFDAK 317 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~---iiHrDikp~NIll~~--------~~~~k 317 (498)
|||+++++|.+++. ...+++..++.++.|++.||.|||+. + |+||||||+|||++. ++.+|
T Consensus 85 ~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k 156 (271)
T 3dtc_A 85 MEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKILK 156 (271)
T ss_dssp EECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred EEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcceE
Confidence 99999999999995 34699999999999999999999998 7 999999999999986 77899
Q ss_pred EeeeccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHH
Q 010891 318 ISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMV 397 (498)
Q Consensus 318 L~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 397 (498)
|+|||++....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ......
T Consensus 157 l~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~ 227 (271)
T 3dtc_A 157 ITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA------VAYGVA 227 (271)
T ss_dssp ECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH------HHHHHH
T ss_pred EccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHhhh
Confidence 99999998764432 224579999999999999999999999999999999999999997543211 111111
Q ss_pred hhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 398 QLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
. ... ...... ... ..+..++.+||+.||.+|||+.|++++|+.
T Consensus 228 ~-~~~----~~~~~~-~~~---~~~~~li~~~l~~~p~~Rps~~e~l~~L~~ 270 (271)
T 3dtc_A 228 M-NKL----ALPIPS-TCP---EPFAKLMEDCWNPDPHSRPSFTNILDQLTT 270 (271)
T ss_dssp T-SCC----CCCCCT-TCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred c-CCC----CCCCCc-ccC---HHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence 1 110 011111 111 234444558999999999999999999975
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=353.06 Aligned_cols=258 Identities=24% Similarity=0.361 Sum_probs=197.5
Q ss_pred cCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
++|++.+.||+|+||+||+|+..+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57899999999999999999988899999999864432 2235688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+++ +|.+++.. ..+.+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (288)
T ss_dssp CSE-EHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred cCC-CHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence 976 99999864 235689999999999999999999999 99999999999999999999999999998764332
Q ss_pred ceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhh-cccc------
Q 010891 332 SHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQL-RRSE------ 403 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~------ 403 (498)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+..+... ....
T Consensus 155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~ 227 (288)
T 1ob3_A 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD------QLMRIFRILGTPNSKNWPN 227 (288)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHHHCCCCTTTSTT
T ss_pred c-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHHHHCCCChhhchh
Confidence 1 2334578999999998865 468999999999999999999999997543211 11111111 1000
Q ss_pred ----CCcCCCCCC---------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 404 ----DVVDPNIET---------RPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 404 ----~~~~~~~~~---------~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
...++.+.. ....+ .....++.+||..||++|||+.|++++-
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dP~~Rpt~~e~l~hp 282 (288)
T 1ob3_A 228 VTELPKYDPNFTVYEPLPWESFLKGLD--ESGIDLLSKMLKLDPNQRITAKQALEHA 282 (288)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCC--HHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred hhcccccccccccccCccHHHHhhhcC--HHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 000111100 00111 2233455589999999999999998763
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=360.61 Aligned_cols=254 Identities=19% Similarity=0.271 Sum_probs=204.0
Q ss_pred HccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
+.++|.+.+.||+|+||+||+|... +++.||+|.+... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 81 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence 3568999999999999999999864 5889999988543 2334568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcC--CCCeEEeeeccceecC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE--NFDAKISDFGLAKLLG 328 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~--~~~~kL~DfGla~~~~ 328 (498)
|+++|+|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||++....
T Consensus 82 ~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~ 155 (321)
T 1tki_A 82 FISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred eCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence 9999999999964 234699999999999999999999999 9999999999999987 7899999999999875
Q ss_pred CCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (498)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... +.+..+..... ....
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~---~~~~ 224 (321)
T 1tki_A 156 PGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMNAEY---TFDE 224 (321)
T ss_dssp TTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCC---CCCH
T ss_pred CCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH------HHHHHHHcCCC---CCCh
Confidence 443 234467999999999999998999999999999999999999999754321 11122211110 0000
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 409 NIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
...+..+ ..+..++.+||..||.+|||+.|++++-
T Consensus 225 --~~~~~~s--~~~~~li~~~L~~dp~~Rpt~~e~l~hp 259 (321)
T 1tki_A 225 --EAFKEIS--IEAMDFVDRLLVKERKSRMTASEALQHP 259 (321)
T ss_dssp --HHHTTSC--HHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred --hhhccCC--HHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence 0001111 2334445589999999999999999865
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=356.37 Aligned_cols=257 Identities=24% Similarity=0.379 Sum_probs=192.1
Q ss_pred HHccCCCccceEcccCcEEEEEEEEcC----CcEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEeEEEeCCee
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQLMN----GTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQR 245 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 245 (498)
...++|++.+.||+|+||.||+|.... +..||+|++...... ..+.+.+|+.++++++||||+++++++. ++..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~ 90 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 90 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence 445789999999999999999997632 457999988654332 3356889999999999999999999984 5678
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccce
Q 010891 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~ 325 (498)
|+||||+++++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++
T Consensus 91 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 91 WIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp EEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccc
Confidence 9999999999999999742 34689999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccC
Q 010891 326 LLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSED 404 (498)
Q Consensus 326 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (498)
..............+|+.|+|||++.+..++.++|||||||++|||++ |..||....... .. ..+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~---~~i~~~~~--- 235 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VI---GRIENGER--- 235 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH---HHHHTTCC---
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HH---HHHHcCCC---
Confidence 775443333344567889999999998899999999999999999997 999997544322 11 11111111
Q ss_pred CcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 405 VVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
... ....+ ..+..++.+||+.||++|||+.+++++|+..
T Consensus 236 ---~~~--~~~~~--~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 274 (281)
T 1mp8_A 236 ---LPM--PPNCP--PTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274 (281)
T ss_dssp ---CCC--CTTCC--HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCC--CCCCC--HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 011 11111 2233445589999999999999999999864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=383.01 Aligned_cols=260 Identities=25% Similarity=0.405 Sum_probs=210.9
Q ss_pred HHHccCCCccceEcccCcEEEEEEEEcC-CcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 170 QSATNRFSKDNIIGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 170 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
+....+|.+.+.||+|+||.||+|.+.. +..||||++.... ...+.|.+|+.+|++++||||+++++++.+....|+|
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv 294 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence 3455678999999999999999998754 8899999986543 3467799999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+++|+|.+++... ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 295 ~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 295 TEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp EECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 9999999999999753 335689999999999999999999999 99999999999999999999999999999775
Q ss_pred CCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (498)
...........+|..|+|||++.+..++.++|||||||+||||++ |..||....... ..+ .+....+ .
T Consensus 370 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~---~~~~~~~---~-- 438 (495)
T 1opk_A 370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYE---LLEKDYR---M-- 438 (495)
T ss_dssp TCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHH---HHHTTCC---C--
T ss_pred CCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHH---HHHcCCC---C--
Confidence 443333333456789999999998999999999999999999999 999997544322 111 1111111 0
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 408 ~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
. ..... ...+..++.+||+.||.+|||+.++++.|+...
T Consensus 439 -~--~~~~~--~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 439 -E--RPEGC--PEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp -C--CCTTC--CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred -C--CCCCC--CHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 1 11111 123344455899999999999999999998764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=360.09 Aligned_cols=251 Identities=23% Similarity=0.342 Sum_probs=193.8
Q ss_pred ccCCCccceEcccCcEEEEEEEE----cCCcEEEEEEecCCC----CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCe
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL----MNGTAVAVKKLLNNP----GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQ 244 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 244 (498)
.++|++.+.||+|+||.||+|+. .+|+.||+|++.... ......+.+|+.+++.++||||+++++++.+...
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 35789999999999999999986 478999999996542 2233457789999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccc
Q 010891 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (498)
Q Consensus 245 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla 324 (498)
.|+||||+++++|.+++... +.+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~ 168 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLC 168 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred EEEEEeCCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcc
Confidence 99999999999999999743 5689999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccC
Q 010891 325 KLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSED 404 (498)
Q Consensus 325 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (498)
+...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.+..+....
T Consensus 169 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~~i~~~~---- 237 (327)
T 3a62_A 169 KESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK------KTIDKILKCK---- 237 (327)
T ss_dssp -----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHTC----
T ss_pred cccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCC----
Confidence 8643322 2234567999999999999999999999999999999999999999754321 1122222111
Q ss_pred CcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHh
Q 010891 405 VVDPNIETRPSTSALKRALLTALRCVDPDSDKRP-----KMSQVVRMLE 448 (498)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RP-----t~~ell~~L~ 448 (498)
....+..+ ..+..++.+||..||.+|| ++.|+++|--
T Consensus 238 -----~~~p~~~~--~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~ 279 (327)
T 3a62_A 238 -----LNLPPYLT--QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279 (327)
T ss_dssp -----CCCCTTSC--HHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGG
T ss_pred -----CCCCCCCC--HHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCc
Confidence 11111111 2233344589999999999 8889987654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=351.30 Aligned_cols=260 Identities=22% Similarity=0.335 Sum_probs=199.6
Q ss_pred cCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCC--chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
++|++.+.||+|+||+||+|+.. +++.||+|++...... ....+.+|+.++++++||||+++++++.++...++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57899999999999999999864 6899999999654332 23568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
|+++ +|.+++.. ..+.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~-~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 154 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSE-EHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred cCCC-CHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence 9976 66666653 346799999999999999999999999 9999999999999999999999999999987543
Q ss_pred CceeeecccccccccCcccccCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhcccc-CCc--
Q 010891 331 KSHITTRVMGTFGYVAPEYANSGL-LNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSE-DVV-- 406 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-- 406 (498)
.. ......||+.|+|||++.+.. ++.++|||||||++|||++|..||....... +.+..+....... ...
T Consensus 155 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~-----~~~~~i~~~~~~~~~~~~~ 228 (292)
T 3o0g_A 155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-----DQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH-----HHHHHHHHHHCCCCTTTCT
T ss_pred cc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH-----HHHHHHHHHhCCCChhhhh
Confidence 22 234457899999999987665 8999999999999999999998875443221 1222222111100 000
Q ss_pred -----------------CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 407 -----------------DPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 407 -----------------~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
.......+..+ .....++.+||+.||++|||+.|+++|--
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 285 (292)
T 3o0g_A 229 SMTKLPDYKPYPMYPATTSLVNVVPKLN--ATGRDLLQNLLKCNPVQRISAEEALQHPY 285 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCC--HHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred hhcccccccccccccCCcchhhcccccC--hHHHHHHHHHhccChhhCCCHHHHhcCcc
Confidence 00000011111 22334445899999999999999998643
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=368.25 Aligned_cols=254 Identities=20% Similarity=0.264 Sum_probs=204.4
Q ss_pred ccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
.++|.+.+.||+|+||.||+|... +|+.||+|.+..........+.+|+.++..++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 467999999999999999999864 6889999998655444456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcC--CCCeEEeeeccceecCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE--NFDAKISDFGLAKLLGA 329 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~--~~~~kL~DfGla~~~~~ 329 (498)
+++|+|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||++.....
T Consensus 130 ~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 130 LSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 999999999964 234689999999999999999999999 9999999999999974 57799999999998754
Q ss_pred CCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
... .....||+.|+|||++.+..++.++|||||||++|||++|..||...... +.+..+... .....+.
T Consensus 204 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~------~~~~~i~~~---~~~~~~~ 272 (387)
T 1kob_A 204 DEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETLQNVKRC---DWEFDED 272 (387)
T ss_dssp TSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHHC---CCCCCSS
T ss_pred Ccc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH------HHHHHHHhC---CCCCCcc
Confidence 432 33457999999999999999999999999999999999999999754321 112222211 1111111
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
. ....+ ..+..++.+||..||.+|||+.|++++-
T Consensus 273 ~--~~~~s--~~~~~li~~~L~~dP~~Rpt~~ell~hp 306 (387)
T 1kob_A 273 A--FSSVS--PEAKDFIKNLLQKEPRKRLTVHDALEHP 306 (387)
T ss_dssp T--TTTSC--HHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred c--cccCC--HHHHHHHHHHcCCChhHCcCHHHHhhCc
Confidence 1 11111 2334445589999999999999999864
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=350.61 Aligned_cols=255 Identities=29% Similarity=0.479 Sum_probs=206.8
Q ss_pred ccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeec
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 252 (498)
.++|++.+.||+|+||.||+|...+++.||+|++.... ...+.+.+|+++++.++||||+++++++.+....++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 46789999999999999999998888999999986543 23467899999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~ 332 (498)
++++|.+++... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++........
T Consensus 86 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 159 (267)
T 3t9t_A 86 EHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 159 (267)
T ss_dssp TTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH
T ss_pred CCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccc
Confidence 999999999742 35689999999999999999999999 999999999999999999999999999986543322
Q ss_pred eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCC
Q 010891 333 HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411 (498)
Q Consensus 333 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (498)
.......||+.|+|||++.+..++.++||||||+++|+|++ |+.||...... +....+... .....+
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~i~~~---~~~~~~--- 227 (267)
T 3t9t_A 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EVVEDISTG---FRLYKP--- 227 (267)
T ss_dssp HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTT---CCCCCC---
T ss_pred cccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHH------HHHHHHhcC---CcCCCC---
Confidence 22233467889999999998899999999999999999999 89999754321 111222111 111111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 412 ~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
..... .+..++.+||+.||.+|||+.+++++|+..
T Consensus 228 -~~~~~---~l~~li~~~l~~~p~~Rps~~~ll~~L~~l 262 (267)
T 3t9t_A 228 -RLAST---HVYQIMNHCWRERPEDRPAFSRLLRQLAEI 262 (267)
T ss_dssp -TTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -ccCcH---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11122 233445589999999999999999999764
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=374.98 Aligned_cols=253 Identities=30% Similarity=0.431 Sum_probs=203.4
Q ss_pred HHHccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCC-eeEEE
Q 010891 170 QSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT-QRILV 248 (498)
Q Consensus 170 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~-~~~lv 248 (498)
....++|.+.+.||+|+||.||+|.+ .|+.||||++.... ..+.|.+|+.+|++++||||+++++++.+.. ..|+|
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv 265 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 265 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence 34567889999999999999999987 57899999996543 4577999999999999999999999987765 78999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+++|+|.+++... ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 266 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 266 TEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp EECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 9999999999999754 233479999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (498)
.. .....+|+.|+|||++.+..++.++|||||||+||||++ |+.||........ . ..+....+ .
T Consensus 341 ~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~---~~i~~~~~---~-- 405 (450)
T 1k9a_A 341 ST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---V---PRVEKGYK---M-- 405 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH---H---HHHHTTCC---C--
T ss_pred cc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---H---HHHHcCCC---C--
Confidence 32 122357899999999999999999999999999999998 9999976543321 1 11111111 1
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 408 ~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
... .... ..+..++.+||+.||.+|||+.++++.|+..
T Consensus 406 -~~p-~~~~---~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i 443 (450)
T 1k9a_A 406 -DAP-DGCP---PAVYDVMKNCWHLDAATRPTFLQLREQLEHI 443 (450)
T ss_dssp -CCC-TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -CCC-CcCC---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111 1112 2334445589999999999999999998754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=362.67 Aligned_cols=255 Identities=24% Similarity=0.294 Sum_probs=199.5
Q ss_pred cCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCC---chhHHHHHHHHHHcC-CCCCceEEEeEEEeCCeeEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ---ADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv 248 (498)
++|++.+.||+|+||.||+|+.. +++.||+|++...... ..+.+..|+.++.++ +||||+++++++.+....|+|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56899999999999999999864 5889999999654322 234577899999988 899999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+++|+|.+++... +.+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 89 ~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp ECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 9999999999999743 4699999999999999999999999 99999999999999999999999999998643
Q ss_pred CCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcch---hhHHHHHHHHHhhccccCC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSE---VNLVEWLKMMVQLRRSEDV 405 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 405 (498)
... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||........ .........+.. ..
T Consensus 162 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~-~~---- 235 (345)
T 3a8x_A 162 RPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-KQ---- 235 (345)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH-CC----
T ss_pred CCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc-CC----
Confidence 222 224456899999999999999999999999999999999999999964321110 011111111111 11
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCH------HHHHHHH
Q 010891 406 VDPNIETRPSTSALKRALLTALRCVDPDSDKRPKM------SQVVRML 447 (498)
Q Consensus 406 ~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~------~ell~~L 447 (498)
...+...+. .+..++.+||..||.+||++ .++++|-
T Consensus 236 ----~~~p~~~s~--~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp 277 (345)
T 3a8x_A 236 ----IRIPRSLSV--KAASVLKSFLNKDPKERLGCHPQTGFADIQGHP 277 (345)
T ss_dssp ----CCCCTTSCH--HHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSG
T ss_pred ----CCCCCCCCH--HHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCC
Confidence 111111122 23334458999999999995 6777653
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=362.39 Aligned_cols=246 Identities=23% Similarity=0.259 Sum_probs=201.8
Q ss_pred cCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCC---CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
++|++.+.||+|+||.||+|+.. +|+.||+|++.... ....+.+.+|+.++..++||||+++++++.+....|+||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57899999999999999999864 68999999985432 233456888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+++|+|.+++... +.+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....
T Consensus 121 e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence 999999999999743 4699999999999999999999999 999999999999999999999999999997654
Q ss_pred CCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...... +....+.... ..
T Consensus 194 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~~~-------~~ 256 (350)
T 1rdq_E 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------QIYEKIVSGK-------VR 256 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCC-------CC
T ss_pred C----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH------HHHHHHHcCC-------CC
Confidence 3 23467999999999999999999999999999999999999999754321 1222222111 01
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHH
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRPK-----MSQVVRML 447 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt-----~~ell~~L 447 (498)
+ ....+. .+..++.+||..||.+||+ +.++++|-
T Consensus 257 ~--p~~~~~--~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~ 295 (350)
T 1rdq_E 257 F--PSHFSS--DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK 295 (350)
T ss_dssp C--CTTCCH--HHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred C--CCCCCH--HHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence 1 111111 2333445899999999998 89998754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=370.77 Aligned_cols=259 Identities=26% Similarity=0.398 Sum_probs=203.4
Q ss_pred ccCCCccceEcccCcEEEEEEEEc------CCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCee
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQR 245 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 245 (498)
.++|.+.+.||+|+||+||+|++. ++..||||++..... .....+.+|+.++.+++||||+++++++.+....
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 467899999999999999999842 467899999864432 2334688899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhccc---CCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCC---CeEEe
Q 010891 246 ILVYEYVNNGNLEQWLRGDM---CDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF---DAKIS 319 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~---~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~---~~kL~ 319 (498)
|+||||+++|+|.+++.... .....+++..++.++.||+.||.|||++ +|+||||||+|||++.++ .+||+
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~ 226 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 226 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEEC
Confidence 99999999999999997542 1234689999999999999999999999 999999999999999555 59999
Q ss_pred eeccceecCCCC-ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHH
Q 010891 320 DFGLAKLLGAGK-SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMV 397 (498)
Q Consensus 320 DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 397 (498)
|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++ |..||...... +....+.
T Consensus 227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~------~~~~~i~ 300 (367)
T 3l9p_A 227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVLEFVT 300 (367)
T ss_dssp CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHHHHH
T ss_pred CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHH
Confidence 999997542211 112334568999999999998999999999999999999998 99999754321 1112222
Q ss_pred hhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 398 QLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
..... ... ..... .+..++.+||+.||.+|||+.+++++|+..
T Consensus 301 ~~~~~------~~~-~~~~~---~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 301 SGGRM------DPP-KNCPG---PVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp TTCCC------CCC-TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCC------CCC-ccCCH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 11111 001 11112 234455589999999999999999999764
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-45 Score=355.44 Aligned_cols=259 Identities=25% Similarity=0.403 Sum_probs=211.0
Q ss_pred HHHccCCCccceEcccCcEEEEEEEEcC-CcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 170 QSATNRFSKDNIIGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 170 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
+...++|++.+.||+|+||.||+|.+.. +..||+|.+... ....+.+.+|+++++.++||||+++++++.+....|+|
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 4456789999999999999999998654 889999998643 33456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+++++|.+++... ....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 88 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 88 TEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp EECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred EEcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 9999999999999753 345699999999999999999999999 99999999999999999999999999998776
Q ss_pred CCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (498)
...........+|+.|+|||++.+..++.++||||||+++|+|++ |..||........ .+ .+.....
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~---~~---~~~~~~~------ 230 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YE---LLEKDYR------ 230 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HH---HHHTTCC------
T ss_pred CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH---HHhccCC------
Confidence 554444445668899999999998999999999999999999999 9999975443221 11 1111110
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 408 ~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
..... ... ..+..++.+||..||.+|||+.++++.|+..
T Consensus 231 ~~~~~-~~~---~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~ 269 (288)
T 3kfa_A 231 MERPE-GCP---EKVYELMRACWQWNPSDRPSFAEIHQAFETM 269 (288)
T ss_dssp CCCCT-TCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCC-CCC---HHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence 11111 111 2334445589999999999999999999764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=364.27 Aligned_cols=266 Identities=26% Similarity=0.365 Sum_probs=209.0
Q ss_pred HHHHHccCCCccceEcccCcEEEEEEEEc------CCcEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEeEEE
Q 010891 168 DLQSATNRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCI 240 (498)
Q Consensus 168 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 240 (498)
.+....++|.+.+.||+|+||.||+|+.. +++.||+|++...... ..+.+.+|+.+++.++||||+++++++.
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 34456789999999999999999999864 3488999998654332 2456889999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHccCCCeee
Q 010891 241 EGTQRILVYEYVNNGNLEQWLRGDMCD--------------------RGYLTWEARMKILLGTAKALAYLHEAIEPKVVH 300 (498)
Q Consensus 241 ~~~~~~lv~e~~~~g~L~~~l~~~~~~--------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiH 300 (498)
+....|+||||+++|+|.+++...... ...+++.+++.++.||+.||.|||++ +|+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence 999999999999999999999753211 25799999999999999999999999 9999
Q ss_pred cCCCCCCEEEcCCCCeEEeeeccceecCCCCc-eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCC
Q 010891 301 RDIKSSNILIDENFDAKISDFGLAKLLGAGKS-HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPV 378 (498)
Q Consensus 301 rDikp~NIll~~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~ 378 (498)
|||||+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 99999999999999999999999986543221 12234568999999999998899999999999999999999 99999
Q ss_pred CCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 010891 379 DYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEY 452 (498)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~~ 452 (498)
...... +....+... ... .... ... ..+..++.+||+.||.+|||+.+++++|+....
T Consensus 278 ~~~~~~------~~~~~~~~~-~~~-----~~~~-~~~---~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~ 335 (343)
T 1luf_A 278 YGMAHE------EVIYYVRDG-NIL-----ACPE-NCP---LELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 335 (343)
T ss_dssp TTSCHH------HHHHHHHTT-CCC-----CCCT-TCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCChH------HHHHHHhCC-CcC-----CCCC-CCC---HHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence 753321 111221111 110 1111 111 233444558999999999999999999987653
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=357.16 Aligned_cols=260 Identities=28% Similarity=0.417 Sum_probs=206.4
Q ss_pred HccCCCccceEcccCcEEEEEEEE------cCCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCe
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL------MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQ 244 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 244 (498)
..++|.+.+.||+|+||.||+|.. .++..||+|++..... ...+.+.+|+++++.++||||+++++++.+...
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 356789999999999999999975 2457899999865432 233568899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcccC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCC
Q 010891 245 RILVYEYVNNGNLEQWLRGDMC--------------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIK 304 (498)
Q Consensus 245 ~~lv~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDik 304 (498)
.++||||+++++|.+++..... ....+++..++.++.||+.||.|||++ +|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccc
Confidence 9999999999999999975422 123489999999999999999999999 99999999
Q ss_pred CCCEEEcCCCCeEEeeeccceecCCCCce-eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 010891 305 SSNILIDENFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGR 382 (498)
Q Consensus 305 p~NIll~~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~ 382 (498)
|+|||++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999977544322 2233467889999999998899999999999999999999 999997554
Q ss_pred CcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 383 PQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
.... .. .+..... ..... ... ..+..++.+||+.||.+|||+.+++++|+..
T Consensus 258 ~~~~---~~---~~~~~~~------~~~~~-~~~---~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~ 309 (314)
T 2ivs_A 258 PERL---FN---LLKTGHR------MERPD-NCS---EEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309 (314)
T ss_dssp GGGH---HH---HHHTTCC------CCCCT-TCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHH---HH---HhhcCCc------CCCCc-cCC---HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 3221 11 1111110 11111 111 2334445589999999999999999999864
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=367.32 Aligned_cols=262 Identities=27% Similarity=0.413 Sum_probs=208.0
Q ss_pred HHccCCCccceEcccCcEEEEEEEEc--------CCcEEEEEEecCCCCC-chhHHHHHHHHHHcC-CCCCceEEEeEEE
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQLM--------NGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHV-RHKNLVRLLGYCI 240 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpnIv~l~~~~~ 240 (498)
...++|.+.+.||+|+||.||+|+.. .+..||+|++...... ..+.+.+|++++.++ +||||+++++++.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 34578999999999999999999752 2357999999655332 235688999999999 9999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCE
Q 010891 241 EGTQRILVYEYVNNGNLEQWLRGDMC------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNI 308 (498)
Q Consensus 241 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NI 308 (498)
+....|+||||+++|+|.+++..... ....+++..++.++.||+.||.|||+. +|+||||||+||
T Consensus 146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI 222 (382)
T 3tt0_A 146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 222 (382)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceE
Confidence 99999999999999999999975431 124699999999999999999999999 999999999999
Q ss_pred EEcCCCCeEEeeeccceecCCCCc-eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcch
Q 010891 309 LIDENFDAKISDFGLAKLLGAGKS-HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSE 386 (498)
Q Consensus 309 ll~~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~ 386 (498)
|++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~-- 300 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-- 300 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--
Confidence 999999999999999987654322 22334567899999999999999999999999999999999 99999744321
Q ss_pred hhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 387 VNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
+....+...... ... .... ..+..++.+||+.||++|||+.|++++|+...
T Consensus 301 ----~~~~~~~~~~~~------~~~-~~~~---~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~ 351 (382)
T 3tt0_A 301 ----ELFKLLKEGHRM------DKP-SNCT---NELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 351 (382)
T ss_dssp ----HHHHHHHTTCCC------CCC-SSCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----HHHHHHHcCCCC------CCC-ccCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 222222211111 111 1112 23344455899999999999999999998753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=360.35 Aligned_cols=256 Identities=27% Similarity=0.459 Sum_probs=197.2
Q ss_pred ccCCCccceEcccCcEEEEEEEEc-CCc----EEEEEEecCCC-CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGT----AVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI 246 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 246 (498)
.++|++.+.||+|+||+||+|++. +++ .||+|.+.... ....+.+.+|+.++++++||||+++++++.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 357899999999999999999853 344 35888775433 244567999999999999999999999998754 78
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecccee
Q 010891 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (498)
Q Consensus 247 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~ 326 (498)
+|+||+.+|+|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~ 166 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeE
Confidence 999999999999999753 35699999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCce-eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccC
Q 010891 327 LGAGKSH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSED 404 (498)
Q Consensus 327 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (498)
....... ......||+.|+|||++.+..++.++|||||||++|||++ |+.||....... .... +.... .
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~---~~~~~---~ 237 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSI---LEKGE---R 237 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHH---HHTTC---C
T ss_pred ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HHHH---HHcCC---C
Confidence 7544322 2233457889999999999999999999999999999999 999997544322 1111 11111 0
Q ss_pred CcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 405 VVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
. ..... ....+..++.+||+.||.+|||+.+++++|+...
T Consensus 238 ~-----~~~~~--~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~ 277 (327)
T 3poz_A 238 L-----PQPPI--CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp C-----CCCTT--BCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHH
T ss_pred C-----CCCcc--CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence 0 01111 1123445556899999999999999999997653
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=373.29 Aligned_cols=265 Identities=22% Similarity=0.242 Sum_probs=207.2
Q ss_pred cHHHHHHHccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC---CCchhHHHHHHHHHHcCCCCCceEEEeEEE
Q 010891 165 TLRDLQSATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCI 240 (498)
Q Consensus 165 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 240 (498)
.+.+.....++|++.++||+|+||.||+|+. .+|+.||+|++.+.. ....+.+..|..++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 3455556678999999999999999999986 468999999985421 122345888999999999999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEee
Q 010891 241 EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISD 320 (498)
Q Consensus 241 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~D 320 (498)
+....|+||||++||+|.+++... ...+++..+..++.||+.||.|||++ +|+||||||+|||++.++++||+|
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~D 205 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLAD 205 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEee
Confidence 999999999999999999999742 24699999999999999999999999 999999999999999999999999
Q ss_pred eccceecCCCCceeeecccccccccCccccc-------CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 010891 321 FGLAKLLGAGKSHITTRVMGTFGYVAPEYAN-------SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWL 393 (498)
Q Consensus 321 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~ 393 (498)
||+++.............+||+.|+|||++. +..|+.++|||||||++|||++|+.||...... +..
T Consensus 206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~ 279 (412)
T 2vd5_A 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA------ETY 279 (412)
T ss_dssp CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHH
T ss_pred chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH------HHH
Confidence 9999987655443344568999999999886 467899999999999999999999999754321 111
Q ss_pred HHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCC---CCHHHHHHHHh
Q 010891 394 KMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKR---PKMSQVVRMLE 448 (498)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~R---Pt~~ell~~L~ 448 (498)
..+...... ...+... ...+. ....++.+||. +|.+| |++.|+++|--
T Consensus 280 ~~i~~~~~~--~~~p~~~--~~~s~--~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpf 330 (412)
T 2vd5_A 280 GKIVHYKEH--LSLPLVD--EGVPE--EARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330 (412)
T ss_dssp HHHHTHHHH--CCCC------CCCH--HHHHHHHTTSS-CGGGCTTTTTHHHHHTSGG
T ss_pred HHHHhcccC--cCCCccc--cCCCH--HHHHHHHHHcC-ChhhcCCCCCHHHHhcCCC
Confidence 121111100 0011111 11112 23334447998 99998 69999997653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=367.42 Aligned_cols=254 Identities=23% Similarity=0.329 Sum_probs=192.0
Q ss_pred ccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
.++|.+.+.||+|+||+||+|+.. +++.||+|++.... ...+.+.+|+.+++.++||||+++++++.+....|+||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 467999999999999999999864 78999999986543 2346688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCC--eEEeeeccceecCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD--AKISDFGLAKLLGA 329 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~--~kL~DfGla~~~~~ 329 (498)
+++|+|.+++.. .+.+++..+..++.|++.||.|||++ +|+||||||+|||++.++. +||+|||+++....
T Consensus 98 ~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 98 ASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred CCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999999964 34699999999999999999999999 9999999999999987765 99999999985432
Q ss_pred CCceeeecccccccccCcccccCCCCCcc-chHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANSGLLNEK-SDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (498)
.. .....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........ ....+...... ..
T Consensus 171 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~~~~~---~~---- 239 (361)
T 3uc3_A 171 HS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQRILSV---KY---- 239 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHHHHTT---CC----
T ss_pred cC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhcC---CC----
Confidence 21 2334579999999999988877665 8999999999999999999975443221 12222222111 10
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 409 NIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.+......+ ..+..++.+||..||.+|||+.|+++|-
T Consensus 240 ~~~~~~~~s--~~~~~li~~~L~~dP~~Rps~~ell~hp 276 (361)
T 3uc3_A 240 SIPDDIRIS--PECCHLISRIFVADPATRISIPEIKTHS 276 (361)
T ss_dssp CCCTTSCCC--HHHHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred CCCCcCCCC--HHHHHHHHHHccCChhHCcCHHHHHhCc
Confidence 111111111 2233444589999999999999999764
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=366.51 Aligned_cols=251 Identities=23% Similarity=0.309 Sum_probs=200.6
Q ss_pred HHccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCC---CCchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCee
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQR 245 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~ 245 (498)
...++|.+.+.||+|+||.||+|+.. +|+.||+|++.... ....+.+..|..++..+ +||||+++++++.+....
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 34578999999999999999999864 68999999985432 23345677899999876 999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccce
Q 010891 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~ 325 (498)
|+||||++||+|.+++... +.+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++
T Consensus 94 ~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 9999999999999999742 4699999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCC
Q 010891 326 LLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV 405 (498)
Q Consensus 326 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (498)
...... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...... +....+... .
T Consensus 167 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~~---~-- 234 (345)
T 1xjd_A 167 ENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE------ELFHSIRMD---N-- 234 (345)
T ss_dssp CCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHC---C--
T ss_pred hcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHHhC---C--
Confidence 643322 2244578999999999999999999999999999999999999999754321 111222111 1
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHH
Q 010891 406 VDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMS-QVVRM 446 (498)
Q Consensus 406 ~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~-ell~~ 446 (498)
+.+.. ..+. .+..++.+||..||.+||++. ++++|
T Consensus 235 --~~~p~--~~s~--~~~~li~~lL~~dp~~R~~~~~~i~~h 270 (345)
T 1xjd_A 235 --PFYPR--WLEK--EAKDLLVKLFVREPEKRLGVRGDIRQH 270 (345)
T ss_dssp --CCCCT--TSCH--HHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred --CCCCc--ccCH--HHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence 11111 1112 233344589999999999997 77654
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=348.39 Aligned_cols=261 Identities=17% Similarity=0.210 Sum_probs=207.7
Q ss_pred HccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCeeEEEE
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
..++|.+.+.||+|+||.||+|.. .+|+.||+|++.... ..+.+.+|+.++..+ +|+||+++++++.+....++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 456899999999999999999985 678999999885432 345688899999999 8999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCC-----eEEeeeccc
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD-----AKISDFGLA 324 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~-----~kL~DfGla 324 (498)
||+ +++|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++. +||+|||++
T Consensus 86 e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 86 DLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred Eec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 999 99999999743 34699999999999999999999999 9999999999999987776 999999999
Q ss_pred eecCCCCce------eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHh
Q 010891 325 KLLGAGKSH------ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQ 398 (498)
Q Consensus 325 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 398 (498)
+........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence 987544321 13446799999999999999999999999999999999999999986544333222222211111
Q ss_pred hccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 399 LRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 399 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
....... . .... ..+..++.+||+.||++|||+.++++.|+..
T Consensus 239 ~~~~~~~-----~-~~~~---~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~ 281 (298)
T 1csn_A 239 STPLREL-----C-AGFP---EEFYKYMHYARNLAFDATPDYDYLQGLFSKV 281 (298)
T ss_dssp HSCHHHH-----T-TTSC---HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred CccHHHH-----H-hhCc---HHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence 0000000 0 0111 2334445589999999999999999999764
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=360.00 Aligned_cols=254 Identities=26% Similarity=0.354 Sum_probs=188.6
Q ss_pred HHccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
.+.++|++.+.||+|+||.||+|+.. +++.||||++.... ..+.+.+|+.++.+++||||+++++++.+....++||
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 127 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL 127 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence 35678999999999999999999865 57899999986543 3456888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcC---CCCeEEeeecccee
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE---NFDAKISDFGLAKL 326 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~---~~~~kL~DfGla~~ 326 (498)
||+++|+|.+++. ..+.+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||+++.
T Consensus 128 e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 128 ELVTGGELFDRIV----EKGYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp CCCCSCBHHHHHT----TCSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EeCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 9999999999997 345699999999999999999999999 9999999999999975 88999999999987
Q ss_pred cCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCc
Q 010891 327 LGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVV 406 (498)
Q Consensus 327 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (498)
..... ......||+.|+|||++.+..++.++|||||||++|||++|..||........ ....+.... ....
T Consensus 201 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~~i~~~~--~~~~ 271 (349)
T 2w4o_A 201 VEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF-----MFRRILNCE--YYFI 271 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH-----HHHHHHTTC--CCCC
T ss_pred cCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH-----HHHHHHhCC--CccC
Confidence 64322 23446799999999999999999999999999999999999999975443211 111111111 0111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 407 DPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 407 ~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.+ .....+ ..+..++.+||..||++|||+.|++++-
T Consensus 272 ~~---~~~~~~--~~~~~li~~~L~~dP~~Rpt~~e~l~hp 307 (349)
T 2w4o_A 272 SP---WWDEVS--LNAKDLVRKLIVLDPKKRLTTFQALQHP 307 (349)
T ss_dssp TT---TTTTSC--HHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred Cc---hhhhCC--HHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 11 111111 2333445589999999999999999864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-45 Score=368.15 Aligned_cols=266 Identities=17% Similarity=0.246 Sum_probs=199.0
Q ss_pred HccCCCccceEcccCcEEEEEEEEcC------CcEEEEEEecCCCCCch-----------hHHHHHHHHHHcCCCCCceE
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLMN------GTAVAVKKLLNNPGQAD-----------KDFRVEVEAIGHVRHKNLVR 234 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~hpnIv~ 234 (498)
..++|.+.+.||+|+||.||+|.+.+ ++.||||++........ ..+..|+..+..++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999998754 47899999865432111 12334666777889999999
Q ss_pred EEeEEEeC----CeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEE
Q 010891 235 LLGYCIEG----TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI 310 (498)
Q Consensus 235 l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll 310 (498)
+++++... ...||||||+ +++|.+++.. ..+.+++..++.++.||+.||.|||+. +|+||||||+|||+
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~---~~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill 185 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA---NAKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEE
Confidence 99998875 4579999999 9999999975 235799999999999999999999999 99999999999999
Q ss_pred c--CCCCeEEeeeccceecCCCCce------eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 010891 311 D--ENFDAKISDFGLAKLLGAGKSH------ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 311 ~--~~~~~kL~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~ 382 (498)
+ .++.+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||+||||+||+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9 8899999999999876533211 1133569999999999999999999999999999999999999998533
Q ss_pred CcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 383 PQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
..... ......... ......+++.+.....+.. +..++..||..||.+||++.++++.|+..
T Consensus 266 ~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~~~~---~~~li~~cl~~~p~~RP~~~~l~~~l~~~ 327 (364)
T 3op5_A 266 KDPKY--VRDSKIRYR-ENIASLMDKCFPAANAPGE---IAKYMETVKLLDYTEKPLYENLRDILLQG 327 (364)
T ss_dssp TCHHH--HHHHHHHHH-HCHHHHHHHHSCTTCCCHH---HHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred cCHHH--HHHHHHHhh-hhHHHHHHHhcccccCHHH---HHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence 32211 111111000 0111111111111122223 33444579999999999999999988754
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=352.12 Aligned_cols=259 Identities=26% Similarity=0.397 Sum_probs=207.9
Q ss_pred HHHHccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 169 LQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 169 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
++...++|++.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+++++.++||||+++++++. .+..++|
T Consensus 8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 85 (279)
T 1qpc_A 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYII 85 (279)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEE
Confidence 345567899999999999999999998888899999986543 34567899999999999999999999986 4568999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+++++|.+++... ....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 86 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 86 TEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp EECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EecCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 9999999999999643 112589999999999999999999999 99999999999999999999999999999876
Q ss_pred CCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (498)
...........+|..|+|||++.+..++.++||||||+++|||++ |+.||...... +....+... ..
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~------~~~~~~~~~---~~--- 228 (279)
T 1qpc_A 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP------EVIQNLERG---YR--- 228 (279)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHHHTT---CC---
T ss_pred CcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH------HHHHHHhcc---cC---
Confidence 544333344567889999999998899999999999999999999 99999753321 111222111 11
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 408 ~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
.... ..... .+..++.+||+.||++|||+.++++.|+..
T Consensus 229 ~~~~-~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 267 (279)
T 1qpc_A 229 MVRP-DNCPE---ELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (279)
T ss_dssp CCCC-TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCc-ccccH---HHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 1111 11112 334445589999999999999999999764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=362.11 Aligned_cols=250 Identities=23% Similarity=0.285 Sum_probs=200.9
Q ss_pred ccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCC---CCCchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCeeEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNN---PGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 247 (498)
.++|++.+.||+|+||.||+|+.. +|+.||+|++... .....+.+..|..++..+ +||||+++++++.+....|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 467999999999999999999865 4789999998543 123345678899999988 89999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
||||++||+|.+++... +.+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 99 v~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999999743 4699999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcC
Q 010891 328 GAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407 (498)
Q Consensus 328 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (498)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...... +....+...
T Consensus 172 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~------~~~~~i~~~-------- 236 (353)
T 2i0e_A 172 IWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIMEH-------- 236 (353)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHC--------
T ss_pred ccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH------HHHHHHHhC--------
Confidence 3222 2244568999999999999999999999999999999999999999754321 122222211
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHHH
Q 010891 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPK-----MSQVVRML 447 (498)
Q Consensus 408 ~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt-----~~ell~~L 447 (498)
....+...+ ..+..++.+||..||.+||+ +.++++|-
T Consensus 237 -~~~~p~~~s--~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~ 278 (353)
T 2i0e_A 237 -NVAYPKSMS--KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHA 278 (353)
T ss_dssp -CCCCCTTSC--HHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSG
T ss_pred -CCCCCCCCC--HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCc
Confidence 111111122 22334445899999999995 58887653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=360.60 Aligned_cols=252 Identities=21% Similarity=0.363 Sum_probs=195.4
Q ss_pred ccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCC-------
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT------- 243 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------- 243 (498)
.++|++.+.||+|+||.||+|+.. +|+.||||++..... ...+.+.+|+.++++++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 457899999999999999999865 799999999965433 34467899999999999999999999986643
Q ss_pred --------------------------------------------------eeEEEEeecCCCCHHHHHhcccCCCCCCCH
Q 010891 244 --------------------------------------------------QRILVYEYVNNGNLEQWLRGDMCDRGYLTW 273 (498)
Q Consensus 244 --------------------------------------------------~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~ 273 (498)
..++||||+++++|.+++.... ......+
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~ 163 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREH 163 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccchhh
Confidence 3799999999999999997542 2234677
Q ss_pred HHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc-----------eeeecccccc
Q 010891 274 EARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS-----------HITTRVMGTF 342 (498)
Q Consensus 274 ~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~-----------~~~~~~~gt~ 342 (498)
..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++....... .......||+
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 240 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence 78999999999999999999 999999999999999999999999999998765421 1123357999
Q ss_pred cccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHH
Q 010891 343 GYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRA 422 (498)
Q Consensus 343 ~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (498)
.|+|||++.+..++.++|||||||++|||++|..|+. ........... . .... .........
T Consensus 241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~--------~~~~~~~~~~~---~------~~~~-~~~~~~~~~ 302 (332)
T 3qd2_B 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM--------ERVRIITDVRN---L------KFPL-LFTQKYPQE 302 (332)
T ss_dssp GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH--------HHHHHHHHHHT---T------CCCH-HHHHHCHHH
T ss_pred CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh--------HHHHHHHHhhc---c------CCCc-ccccCChhH
Confidence 9999999999999999999999999999999876642 11111111111 0 0000 001111233
Q ss_pred HHHHHHccCCCCCCCCCHHHHHHH
Q 010891 423 LLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 423 l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
..++.+||+.||++|||+.|++++
T Consensus 303 ~~li~~~l~~~p~~Rps~~~~l~~ 326 (332)
T 3qd2_B 303 HMMVQDMLSPSPTERPEATDIIEN 326 (332)
T ss_dssp HHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred HHHHHHHccCCCCcCCCHHHHhhc
Confidence 445568999999999999999975
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=363.11 Aligned_cols=209 Identities=26% Similarity=0.329 Sum_probs=182.3
Q ss_pred cccHHHHHHHccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCC-----CCCceEEE
Q 010891 163 WFTLRDLQSATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-----HKNLVRLL 236 (498)
Q Consensus 163 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----hpnIv~l~ 236 (498)
.+++.+.....++|.+.++||+|+||+||+|+. .+++.||||++... ......+..|+.+++.+. ||||++++
T Consensus 24 ~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 24 HFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp SCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 355666677889999999999999999999986 56889999998532 223355778999999986 99999999
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcC----
Q 010891 237 GYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE---- 312 (498)
Q Consensus 237 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~---- 312 (498)
+++...+..|+||||+ +++|.+++... ....+++..+..++.||+.||.|||+. +|+||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~ 176 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRN--NYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFE 176 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCC
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEcccccc
Confidence 9999999999999999 89999999754 334589999999999999999999999 9999999999999975
Q ss_pred ---------------------CCCeEEeeeccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHH
Q 010891 313 ---------------------NFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEA 371 (498)
Q Consensus 313 ---------------------~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~el 371 (498)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el 252 (360)
T 3llt_A 177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL 252 (360)
T ss_dssp EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred ccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence 789999999999875432 2346799999999999999999999999999999999
Q ss_pred HhCCCCCCCCC
Q 010891 372 ITGRYPVDYGR 382 (498)
Q Consensus 372 ltg~~P~~~~~ 382 (498)
++|+.||....
T Consensus 253 l~g~~pf~~~~ 263 (360)
T 3llt_A 253 YTGSLLFRTHE 263 (360)
T ss_dssp HHSSCSCCCSS
T ss_pred HHCCCCCCCCc
Confidence 99999997543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=358.66 Aligned_cols=268 Identities=23% Similarity=0.333 Sum_probs=205.8
Q ss_pred HccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEe----CCeeE
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIE----GTQRI 246 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~~ 246 (498)
..++|++.+.||+|+||.||+|+. .+++.||+|++........+.+.+|+.+++.++||||+++++++.. ....|
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 346899999999999999999986 6789999999866554556678899999999999999999999873 35779
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecccee
Q 010891 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (498)
Q Consensus 247 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~ 326 (498)
+||||+++|+|.+++.........+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++..
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 99999999999999976544557799999999999999999999999 999999999999999999999999999886
Q ss_pred cCCCCce--------eeecccccccccCcccccCCC---CCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 010891 327 LGAGKSH--------ITTRVMGTFGYVAPEYANSGL---LNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKM 395 (498)
Q Consensus 327 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 395 (498)
....... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||....... .....
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~---- 258 (317)
T 2buj_A 184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG-DSVAL---- 258 (317)
T ss_dssp SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT-SCHHH----
T ss_pred cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc-chhhH----
Confidence 5321110 012345799999999987654 7899999999999999999999995211000 00110
Q ss_pred HHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCCCc
Q 010891 396 MVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIPR 456 (498)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~~~~~~ 456 (498)
.... .. ........+ ..+..++.+||+.||.+|||+.+++++|+....+.+.
T Consensus 259 ~~~~--~~-----~~~~~~~~~--~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~ 310 (317)
T 2buj_A 259 AVQN--QL-----SIPQSPRHS--SALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310 (317)
T ss_dssp HHHC--C-------CCCCTTSC--HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred Hhhc--cC-----CCCccccCC--HHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence 0110 00 011111111 2334445589999999999999999999988765443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=346.91 Aligned_cols=252 Identities=29% Similarity=0.523 Sum_probs=199.1
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCch-------hHHHHHHHHHHcCCCCCceEEEeEEEeCCe
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQAD-------KDFRVEVEAIGHVRHKNLVRLLGYCIEGTQ 244 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-------~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 244 (498)
.++|++.+.||+|+||.||+|++ .+++.||+|++........ +.+.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 36789999999999999999986 4789999999865433221 56889999999999999999999986654
Q ss_pred eEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCC--eeecCCCCCCEEEcCCCC-----eE
Q 010891 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK--VVHRDIKSSNILIDENFD-----AK 317 (498)
Q Consensus 245 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--iiHrDikp~NIll~~~~~-----~k 317 (498)
++||||+++|+|.+++.. ....+++..++.++.|++.||.|||+. + |+||||||+|||++.++. +|
T Consensus 97 -~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp -EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred -eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEE
Confidence 799999999999999864 335799999999999999999999998 8 999999999999988776 99
Q ss_pred EeeeccceecCCCCceeeecccccccccCcccc--cCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 010891 318 ISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYA--NSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKM 395 (498)
Q Consensus 318 L~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 395 (498)
|+|||+++.... ......||+.|+|||++ ....++.++|||||||++|||++|+.||........ .....
T Consensus 170 l~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~ 241 (287)
T 4f0f_A 170 VADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI----KFINM 241 (287)
T ss_dssp ECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH----HHHHH
T ss_pred eCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH----HHHHH
Confidence 999999985433 23446799999999998 456688999999999999999999999975443321 11111
Q ss_pred HHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 396 MVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
..... . .+..... .. ..+..++.+||+.||.+|||+.++++.|+.
T Consensus 242 ~~~~~-~----~~~~~~~-~~---~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 286 (287)
T 4f0f_A 242 IREEG-L----RPTIPED-CP---PRLRNVIELCWSGDPKKRPHFSYIVKELSE 286 (287)
T ss_dssp HHHSC-C----CCCCCTT-SC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HhccC-C----CCCCCcc-cC---HHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence 11111 1 1111111 11 233444458999999999999999999975
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=361.46 Aligned_cols=265 Identities=25% Similarity=0.381 Sum_probs=206.2
Q ss_pred HHccCCCccceEcccCcEEEEEEEE------cCCcEEEEEEecCCC-CCchhHHHHHHHHHHcC-CCCCceEEEeEEEeC
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQL------MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEG 242 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~ 242 (498)
...++|.+.+.||+|+||.||+|+. .++..||+|++.... ....+.+.+|+.++.++ +||||+++++++.+.
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 3457899999999999999999985 245689999996543 23456789999999999 999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcccCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCC
Q 010891 243 TQRILVYEYVNNGNLEQWLRGDMCD-------------------RGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDI 303 (498)
Q Consensus 243 ~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDi 303 (498)
...|+||||+++|+|.+++...... ...+++..++.++.||+.||.|||+. +|+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCC
Confidence 9999999999999999999753211 13489999999999999999999999 9999999
Q ss_pred CCCCEEEcCCCCeEEeeeccceecCCCCc-eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q 010891 304 KSSNILIDENFDAKISDFGLAKLLGAGKS-HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYG 381 (498)
Q Consensus 304 kp~NIll~~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~ 381 (498)
||+|||++.++.+||+|||++........ .......||+.|+|||++.+..++.++|||||||++|||+| |..||...
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~ 278 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 278 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999999999987654332 22334568899999999988999999999999999999998 99999765
Q ss_pred CCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCC
Q 010891 382 RPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYP 453 (498)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~~~ 453 (498)
..... .. ...... ....... ... ..+..++.+||+.||.+|||+.+++++|+.....
T Consensus 279 ~~~~~--~~----~~~~~~-----~~~~~~~-~~~---~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 279 PVDAN--FY----KLIQNG-----FKMDQPF-YAT---EEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp CCSHH--HH----HHHHTT-----CCCCCCT-TCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred CcHHH--HH----HHHhcC-----CCCCCCC-CCC---HHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 43321 11 111111 0111111 111 2334445589999999999999999999876543
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=359.76 Aligned_cols=255 Identities=26% Similarity=0.443 Sum_probs=198.9
Q ss_pred cCCCccceEcccCcEEEEEEEEc-CCcE----EEEEEecCCC-CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTA----VAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
++|++.+.||+|+||+||+|++. +++. ||+|.+.... ......+.+|+.++..++||||+++++++. +...++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 57889999999999999999853 4443 7888775433 233456788999999999999999999986 466899
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
||||+.+|+|.+++... .+.+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++..
T Consensus 92 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCccccc
Confidence 99999999999999742 34689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCce-eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCC
Q 010891 328 GAGKSH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV 405 (498)
Q Consensus 328 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (498)
...... ......||..|+|||++.+..++.++|||||||++|||++ |+.||........ . ..+... ...
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~---~~~~~~---~~~ 236 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV---P---DLLEKG---ERL 236 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH---H---HHHHTT---CBC
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH---H---HHHHcC---CCC
Confidence 544322 2344568889999999998999999999999999999999 9999976543221 1 111111 111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 406 VDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 406 ~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
..+.. .. ..+..++.+||..||.+|||+.+++++|+...
T Consensus 237 ~~~~~-~~------~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 237 AQPQI-CT------IDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp CCCTT-BC------TTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred CCCCc-Cc------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111 01 12333445899999999999999999998764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=359.52 Aligned_cols=264 Identities=21% Similarity=0.384 Sum_probs=191.4
Q ss_pred HHHHHccCCCccceEcccCcEEEEEEEEcC-Cc---EEEEEEecCCC--CCchhHHHHHHHHHHcCCCCCceEEEeEEEe
Q 010891 168 DLQSATNRFSKDNIIGDGGYGVVYRGQLMN-GT---AVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIE 241 (498)
Q Consensus 168 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~---~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 241 (498)
++....++|++.+.||+|+||.||+|++.. +. .||||++.... ....+.+.+|++++++++||||+++++++.+
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 334556789999999999999999997533 32 79999886542 3344678899999999999999999999987
Q ss_pred CCee------EEEEeecCCCCHHHHHhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCC
Q 010891 242 GTQR------ILVYEYVNNGNLEQWLRGDMC--DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN 313 (498)
Q Consensus 242 ~~~~------~lv~e~~~~g~L~~~l~~~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~ 313 (498)
.... ++||||+++|+|.+++..... ....+++..++.++.|++.||.|||+. +|+||||||+|||++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCC
Confidence 7655 999999999999999964322 223589999999999999999999999 99999999999999999
Q ss_pred CCeEEeeeccceecCCCCce-eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHH
Q 010891 314 FDAKISDFGLAKLLGAGKSH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVE 391 (498)
Q Consensus 314 ~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~ 391 (498)
+.+||+|||+++........ ......+|+.|+|||.+.+..++.++|||||||++|||++ |..||........ .
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---~- 249 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI---Y- 249 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---H-
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH---H-
Confidence 99999999999876443221 2233457889999999999999999999999999999999 9999975443221 1
Q ss_pred HHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 392 WLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
........ ........ ..+..++.+||+.||.+|||+.++++.|+..
T Consensus 250 --~~~~~~~~--------~~~~~~~~--~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 296 (323)
T 3qup_A 250 --NYLIGGNR--------LKQPPECM--EEVYDLMYQCWSADPKQRPSFTCLRMELENI 296 (323)
T ss_dssp --HHHHTTCC--------CCCCTTCC--HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHHhcCCC--------CCCCCccC--HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 11111111 01111111 2344455589999999999999999988764
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=376.60 Aligned_cols=252 Identities=23% Similarity=0.273 Sum_probs=193.7
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCC---CCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNN---PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
.++|++.+.||+|+||.||+|+. .+|+.||||++... .......+..|+.+++.++||||+++++++.+.+..|+|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999985 46899999998542 223345677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHH-ccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE-AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
|||+++|+|.+++... +.+++..+..++.||+.||.|||+ . +|+||||||+||||+.++.+||+|||+++..
T Consensus 227 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 9999999999999743 569999999999999999999998 7 9999999999999999999999999999864
Q ss_pred CCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcC
Q 010891 328 GAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407 (498)
Q Consensus 328 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (498)
.... ......+||+.|+|||++.+..|+.++|||||||+||||++|+.||...... .....+... .
T Consensus 300 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~------~~~~~i~~~-~------ 365 (446)
T 4ejn_A 300 IKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------KLFELILME-E------ 365 (446)
T ss_dssp CC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHC-C------
T ss_pred cCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH------HHHHHHHhC-C------
Confidence 3322 2244578999999999999999999999999999999999999999754321 111111111 0
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhc
Q 010891 408 PNIETRPSTSALKRALLTALRCVDPDSDKRP-----KMSQVVRMLES 449 (498)
Q Consensus 408 ~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RP-----t~~ell~~L~~ 449 (498)
.......+ ..+..++.+||+.||.+|| |+.|+++|--.
T Consensus 366 --~~~p~~~~--~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f 408 (446)
T 4ejn_A 366 --IRFPRTLG--PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408 (446)
T ss_dssp --CCCCTTSC--HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred --CCCCccCC--HHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccc
Confidence 11111111 2233444589999999999 99999976543
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-44 Score=353.34 Aligned_cols=205 Identities=26% Similarity=0.419 Sum_probs=163.4
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
.++|++.+.||+|+||.||+|.. .+|+.||+|++..... ...+.+.+|+++++.++||||+++++++.+++..|+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 45789999999999999999974 4689999999865433 334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccC--CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 251 YVNNGNLEQWLRGDMC--DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~--~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|++ |+|.+++..... ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 599999964321 224589999999999999999999999 99999999999999999999999999999875
Q ss_pred CCCceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~ 382 (498)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 213 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN 213 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 4322 2334578999999999876 468999999999999999999999997543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=363.04 Aligned_cols=253 Identities=22% Similarity=0.329 Sum_probs=194.0
Q ss_pred ccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCC--chhHHHHHHHHHHcCCC--CCceEEEeEEEeCCeeEEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRH--KNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~~~~lv 248 (498)
.++|++.+.||+|+||.||+|...+++.||||++...... ..+.+.+|+.++..++| |||+++++++.++...|+|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 4679999999999999999999888999999998654332 23568899999999976 9999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
||+ .+++|.+++.. .+.+++.++..++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+++...
T Consensus 88 ~e~-~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp ECC-CSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EeC-CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 995 57899999974 35699999999999999999999999 999999999999997 5789999999998765
Q ss_pred CCCce-eeecccccccccCcccccC-----------CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH
Q 010891 329 AGKSH-ITTRVMGTFGYVAPEYANS-----------GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMM 396 (498)
Q Consensus 329 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 396 (498)
..... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... ...+...
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~~ 233 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAI 233 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHH
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----HHHHHHH
Confidence 43322 2345679999999999864 67899999999999999999999999743221 1111111
Q ss_pred HhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 397 VQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
.... . ..... .... ..+..++.+||+.||.+|||+.|++++.-
T Consensus 234 ~~~~--~---~~~~~--~~~~--~~l~~li~~~L~~dp~~Rpt~~e~l~hp~ 276 (343)
T 3dbq_A 234 IDPN--H---EIEFP--DIPE--KDLQDVLKCCLKRDPKQRISIPELLAHPY 276 (343)
T ss_dssp HCTT--S---CCCCC--CCSC--HHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred hcCC--c---ccCCc--ccCC--HHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence 1100 0 01111 1111 22334455899999999999999997653
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=354.77 Aligned_cols=262 Identities=27% Similarity=0.393 Sum_probs=207.9
Q ss_pred HHccCCCccceEcccCcEEEEEEEE------cCCcEEEEEEecCCCC-CchhHHHHHHHHHHcC-CCCCceEEEeEEEeC
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQL------MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHV-RHKNLVRLLGYCIEG 242 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~ 242 (498)
...++|.+.+.||+|+||.||+|++ .+++.||+|++..... ...+.+.+|+.++.++ +||||+++++++.++
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 99 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence 3457899999999999999999975 3467899999965443 2345688999999999 999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcccC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCE
Q 010891 243 TQRILVYEYVNNGNLEQWLRGDMC--------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNI 308 (498)
Q Consensus 243 ~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NI 308 (498)
...++||||+++|+|.+++..... ....+++..++.++.||+.||.|||++ +|+||||||+||
T Consensus 100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni 176 (313)
T 1t46_A 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI 176 (313)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceE
Confidence 999999999999999999975421 123589999999999999999999999 999999999999
Q ss_pred EEcCCCCeEEeeeccceecCCCCce-eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcch
Q 010891 309 LIDENFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSE 386 (498)
Q Consensus 309 ll~~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~ 386 (498)
|++.++.+||+|||++......... ......||+.|+|||++.+..++.++|||||||++|||++ |+.||........
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 256 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence 9999999999999999877544322 2334567889999999988999999999999999999999 9999975543221
Q ss_pred hhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 387 VNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
... ....... .... .... ..+..++.+||+.||.+|||+.+++++|+..
T Consensus 257 --~~~---~~~~~~~------~~~~-~~~~---~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 305 (313)
T 1t46_A 257 --FYK---MIKEGFR------MLSP-EHAP---AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305 (313)
T ss_dssp --HHH---HHHHTCC------CCCC-TTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HHH---HhccCCC------CCCc-ccCC---HHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence 111 1111100 1101 1111 2334445589999999999999999999764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=363.19 Aligned_cols=206 Identities=21% Similarity=0.247 Sum_probs=177.5
Q ss_pred ccCCCccceEccc--CcEEEEEEEEc-CCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 173 TNRFSKDNIIGDG--GYGVVYRGQLM-NGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 173 ~~~y~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
.++|++.+.||+| +||.||+|+.. +|+.||||++..... ...+.+.+|+.+++.++|||||++++++.++...|+
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3578999999999 99999999865 689999999965432 223567889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
||||+++|+|.+++... ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 104 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 99999999999999754 235699999999999999999999999 9999999999999999999999999998765
Q ss_pred CCCCc------eeeecccccccccCcccccC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCC
Q 010891 328 GAGKS------HITTRVMGTFGYVAPEYANS--GLLNEKSDVYSFGVVLLEAITGRYPVDYGRP 383 (498)
Q Consensus 328 ~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~P~~~~~~ 383 (498)
..... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.....
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 242 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 32211 11222478999999999987 6799999999999999999999999976443
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=357.48 Aligned_cols=255 Identities=26% Similarity=0.400 Sum_probs=191.4
Q ss_pred HccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCc---hhHHHHHHHHHHcCCCCCceEEEeEEEeCCe---
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQA---DKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQ--- 244 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~--- 244 (498)
..++|++.+.||+|+||.||+|+. .+++.||||++....... ...+.+|+.++.+++||||+++++++.....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 356899999999999999999985 678999999996654332 2467889999999999999999999876543
Q ss_pred -eEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecc
Q 010891 245 -RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (498)
Q Consensus 245 -~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGl 323 (498)
.|+||||+++++|.+++.. .+.+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGI 162 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred ccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccC
Confidence 3999999999999999974 35699999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCc--eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhcc
Q 010891 324 AKLLGAGKS--HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRR 401 (498)
Q Consensus 324 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 401 (498)
++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....+.. ..........
T Consensus 163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~ 236 (311)
T 3ork_A 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDP 236 (311)
T ss_dssp C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCC
T ss_pred cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCCC
Confidence 987654322 12334579999999999999999999999999999999999999997543211 1111111100
Q ss_pred ccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 402 SEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
..+........ ..+..++.+||+.||.+||++.+++.+
T Consensus 237 ----~~~~~~~~~~~---~~l~~li~~~l~~dP~~R~~~~~~l~~ 274 (311)
T 3ork_A 237 ----IPPSARHEGLS---ADLDAVVLKALAKNPENRYQTAAEMRA 274 (311)
T ss_dssp ----CCHHHHSTTCC---HHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred ----CCcccccCCCC---HHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence 00000000111 223344458999999999987776643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=366.78 Aligned_cols=253 Identities=21% Similarity=0.273 Sum_probs=189.6
Q ss_pred ccCCCcc-ceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCCchhHHHHHHHHHH-cCCCCCceEEEeEEEe----CCee
Q 010891 173 TNRFSKD-NIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIG-HVRHKNLVRLLGYCIE----GTQR 245 (498)
Q Consensus 173 ~~~y~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~hpnIv~l~~~~~~----~~~~ 245 (498)
.++|.+. ++||+|+||+||+|... +|+.||||++.. ...+.+|+.++. ..+||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 3456665 78999999999999854 688999999853 345778888874 4589999999999876 5678
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcC---CCCeEEeeec
Q 010891 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE---NFDAKISDFG 322 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~---~~~~kL~DfG 322 (498)
||||||++||+|.+++... ....+++..+..++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 135 ~lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG 209 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 209 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecc
Confidence 9999999999999999753 234699999999999999999999999 9999999999999997 7899999999
Q ss_pred cceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchh-hHHHHHHHHHhhcc
Q 010891 323 LAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEV-NLVEWLKMMVQLRR 401 (498)
Q Consensus 323 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~-~~~~~~~~~~~~~~ 401 (498)
+++...... .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||......... ..... +.. ..
T Consensus 210 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~---i~~-~~ 283 (400)
T 1nxk_A 210 FAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR---IRM-GQ 283 (400)
T ss_dssp TCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH---HHH-TC
T ss_pred cccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH---HHc-Cc
Confidence 998764332 234567999999999999999999999999999999999999999754432211 11111 111 11
Q ss_pred ccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 402 SEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
. ....+ . ....+ ..+..++.+||..||++|||+.|+++|.
T Consensus 284 ~-~~~~~--~-~~~~s--~~~~~li~~~L~~dP~~Rpt~~eil~hp 323 (400)
T 1nxk_A 284 Y-EFPNP--E-WSEVS--EEVKMLIRNLLKTEPTQRMTITEFMNHP 323 (400)
T ss_dssp C-CCCTT--T-TTTSC--HHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred c-cCCCc--c-cccCC--HHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 0 11111 1 11111 2233444589999999999999999864
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=359.34 Aligned_cols=255 Identities=26% Similarity=0.322 Sum_probs=199.6
Q ss_pred HHccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCCchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCeeEEE
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv 248 (498)
...++|++.+.||+|+||.||+|... +|+.||+|++..... ...+|++++.++ +||||+++++++.++...|+|
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 34567999999999999999999864 688999999965432 245688888887 799999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCC----CCeEEeeeccc
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN----FDAKISDFGLA 324 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~----~~~kL~DfGla 324 (498)
|||++||+|.+++.. .+.+++..+..++.||+.||.|||++ +|+||||||+|||+.++ +.+||+|||++
T Consensus 95 ~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a 167 (342)
T 2qr7_A 95 TELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFA 167 (342)
T ss_dssp ECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence 999999999999973 45799999999999999999999999 99999999999998543 34999999999
Q ss_pred eecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccC
Q 010891 325 KLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSED 404 (498)
Q Consensus 325 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (498)
........ .....+||+.|+|||++.+..|+.++|||||||++|||++|..||......... +.+..+.... .
T Consensus 168 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~---~~~~~i~~~~---~ 240 (342)
T 2qr7_A 168 KQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPE---EILARIGSGK---F 240 (342)
T ss_dssp EECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHH---HHHHHHHHCC---C
T ss_pred ccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHH---HHHHHHccCC---c
Confidence 97654332 234467999999999998888999999999999999999999999754332222 2222222111 1
Q ss_pred CcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 405 VVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.... ......+. .+..++.+||..||++|||+.++++|-
T Consensus 241 ~~~~--~~~~~~s~--~~~~li~~~L~~dP~~R~t~~~il~hp 279 (342)
T 2qr7_A 241 SLSG--GYWNSVSD--TAKDLVSKMLHVDPHQRLTAALVLRHP 279 (342)
T ss_dssp CCCS--TTTTTSCH--HHHHHHHHHTCSSTTTSCCHHHHTTSH
T ss_pred ccCc--cccccCCH--HHHHHHHHHCCCChhHCcCHHHHhcCC
Confidence 1111 11112222 233344589999999999999999754
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=347.12 Aligned_cols=262 Identities=25% Similarity=0.344 Sum_probs=196.3
Q ss_pred ccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCCc--hhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQA--DKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
.++|++.+.||+|+||+||+|+.. +|+.||+|++....... .+.+.+|+.++++++||||+++++++.+....++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 367999999999999999999864 58999999986544322 355788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+++++|.+++. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 82 e~~~~~~l~~~~~----~~~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 82 EYCDHTVLHELDR----YQRGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp ECCSEEHHHHHHH----TSSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EeCCCchHHHHHh----hhcCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 9999999999886 335699999999999999999999999 999999999999999999999999999987654
Q ss_pred CCceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHH-----------
Q 010891 330 GKSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMV----------- 397 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~----------- 397 (498)
... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... ..+....
T Consensus 155 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 230 (311)
T 4agu_A 155 PSD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL---YLIRKTLGDLIPRHQQVF 230 (311)
T ss_dssp ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCHHHHHHH
T ss_pred ccc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhccccccccccc
Confidence 322 2344579999999998865 67899999999999999999999999754332211 1111100
Q ss_pred hhc---cccCCcCCCCCC-----CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 398 QLR---RSEDVVDPNIET-----RPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 398 ~~~---~~~~~~~~~~~~-----~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
... ......++.... .+.. ...+..++.+||+.||.+|||+.|++++-
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~li~~~L~~dP~~Rpt~~ell~hp 286 (311)
T 4agu_A 231 STNQYFSGVKIPDPEDMEPLELKFPNI--SYPALGLLKGCLHMDPTERLTCEQLLHHP 286 (311)
T ss_dssp HTCGGGTTCCCCCCSSCCCHHHHCTTC--CHHHHHHHHHHCCSSTTTSCCHHHHHTSG
T ss_pred ccccccccCcCCCccccchhhhhcccc--cHHHHHHHHHHccCChhhcCCHHHHhcCh
Confidence 000 000111110000 0111 12234455689999999999999999864
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=355.72 Aligned_cols=256 Identities=27% Similarity=0.463 Sum_probs=195.4
Q ss_pred ccCCCccceEcccCcEEEEEEEEc-CCcE----EEEEEecCCC-CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTA----VAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI 246 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 246 (498)
.++|++.+.||+|+||.||+|++. +++. |++|.+.... ....+.+.+|+.++..++||||+++++++.++. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 367899999999999999999853 4443 5777775432 344567899999999999999999999998754 78
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecccee
Q 010891 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (498)
Q Consensus 247 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~ 326 (498)
+|+||+.+|+|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++.
T Consensus 93 ~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~ 166 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKL 166 (327)
T ss_dssp EEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence 999999999999999753 35699999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCce-eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccC
Q 010891 327 LGAGKSH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSED 404 (498)
Q Consensus 327 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (498)
....... ......||+.|+|||++.+..++.++|||||||++|||++ |..||....... ... .+.... .
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~---~~~~~~---~ 237 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS---ILEKGE---R 237 (327)
T ss_dssp -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHH---HHHTTC---C
T ss_pred ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHH---HHHcCC---C
Confidence 6443221 2233457889999999999999999999999999999999 999997544322 111 111111 0
Q ss_pred CcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 405 VVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
........ ..+..++.+||..||.+|||+.|+++.|+...
T Consensus 238 -----~~~~~~~~--~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 277 (327)
T 3lzb_A 238 -----LPQPPICT--IDVYMIMRKCWMIDADSRPKFRELIIEFSKMA 277 (327)
T ss_dssp -----CCCCTTBC--HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred -----CCCCccCC--HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence 01111111 23344555899999999999999999998764
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=348.78 Aligned_cols=254 Identities=25% Similarity=0.359 Sum_probs=197.3
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC-CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
.++|.+.+.||+|+||.||+|+. .++..||+|++.... ....+.+.+|+++++.++||||+++++++.+....|+|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 46789999999999999999985 468899999986543 3345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEE---cCCCCeEEeeeccceec
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLL 327 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll---~~~~~~kL~DfGla~~~ 327 (498)
|+++|+|.+++.........+++..++.++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||++...
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 9999999999965433456799999999999999999999999 99999999999999 45688999999999866
Q ss_pred CCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcC
Q 010891 328 GAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407 (498)
Q Consensus 328 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (498)
.... ......||+.|+|||++. ..++.++|||||||++|||++|+.||...... +....... ....
T Consensus 178 ~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~------~~~~~~~~-~~~~---- 243 (285)
T 3is5_A 178 KSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE------EVQQKATY-KEPN---- 243 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH-CCCC----
T ss_pred CCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH------HHHhhhcc-CCcc----
Confidence 4432 234467999999999886 46899999999999999999999999754321 11111111 1110
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 408 ~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
......+... .+..++.+||+.||++|||+.|++++
T Consensus 244 ~~~~~~~~~~---~~~~li~~~L~~dP~~Rps~~e~l~h 279 (285)
T 3is5_A 244 YAVECRPLTP---QAVDLLKQMLTKDPERRPSAAQVLHH 279 (285)
T ss_dssp CCC--CCCCH---HHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred cccccCcCCH---HHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111111222 23344558999999999999999875
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=385.62 Aligned_cols=262 Identities=28% Similarity=0.431 Sum_probs=209.3
Q ss_pred HHHHccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 169 LQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 169 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
+++..++|++.+.||+|+||.||+|.+.++..||||++.... ...+.|.+|+++|++++||||+++++++.+ ...|||
T Consensus 262 ~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv 339 (535)
T 2h8h_A 262 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 339 (535)
T ss_dssp SBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEe
Confidence 445667899999999999999999998888889999996543 345679999999999999999999999876 678999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+++|+|.++|... ....+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 340 ~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 340 TEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp ECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred eehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 9999999999999643 224589999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (498)
...........+|..|+|||++.+..++.++|||||||+||||++ |+.||...... +.+..+....+ .
T Consensus 415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~------~~~~~i~~~~~---~-- 483 (535)
T 2h8h_A 415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR------EVLDQVERGYR---M-- 483 (535)
T ss_dssp CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH------HHHHHHHTTCC---C--
T ss_pred CCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCC---C--
Confidence 322122223457789999999998899999999999999999999 99999754321 22222221111 1
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCC
Q 010891 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYP 453 (498)
Q Consensus 408 ~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~~~ 453 (498)
....... ..+..++.+||+.||++|||+.+|++.|+.....
T Consensus 484 ---~~~~~~~--~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~ 524 (535)
T 2h8h_A 484 ---PCPPECP--ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524 (535)
T ss_dssp ---CCCTTCC--HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCC
T ss_pred ---CCCCCCC--HHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhc
Confidence 0111111 2334455589999999999999999999976543
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=348.70 Aligned_cols=253 Identities=23% Similarity=0.370 Sum_probs=200.2
Q ss_pred ccCCCccceEcccCcEEEEEEEEc-CC-------cEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCe
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM-NG-------TAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQ 244 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 244 (498)
.++|.+.+.||+|+||+||+|... ++ ..||+|.+........+.+.+|+.+++.++||||+++++++.++..
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 467899999999999999999743 33 4799999866555566779999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCC--------e
Q 010891 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD--------A 316 (498)
Q Consensus 245 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~--------~ 316 (498)
.++||||+++|+|.+++... ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++. +
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred CEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCccccccccee
Confidence 99999999999999999753 23489999999999999999999999 9999999999999998887 9
Q ss_pred EEeeeccceecCCCCceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 010891 317 KISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKM 395 (498)
Q Consensus 317 kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 395 (498)
||+|||++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|..|+....... .....
T Consensus 161 kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~-----~~~~~ 230 (289)
T 4fvq_A 161 KLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ-----RKLQF 230 (289)
T ss_dssp EECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-----HHHHH
T ss_pred eeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH-----HHHHH
Confidence 9999999865432 233568999999999987 779999999999999999999665544332211 11111
Q ss_pred HHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCC
Q 010891 396 MVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYP 453 (498)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~~~ 453 (498)
... ... .... ... .+..++.+||+.||.+|||+.+++++|+....+
T Consensus 231 ~~~---~~~-~~~~-----~~~---~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 231 YED---RHQ-LPAP-----KAA---ELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp HHT---TCC-CCCC-----SSC---TTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred hhc---cCC-CCCC-----CCH---HHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 111 111 1111 111 233344589999999999999999999987544
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-44 Score=346.05 Aligned_cols=252 Identities=23% Similarity=0.290 Sum_probs=202.8
Q ss_pred HccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
..++|.+.+.||+|+||.||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+....|+|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 4567999999999999999999864 477899999977666667789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEE---cCCCCeEEeeeccceec
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLL 327 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll---~~~~~~kL~DfGla~~~ 327 (498)
|+++++|.+++.. ...+++..++.++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||++...
T Consensus 87 ~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~ 159 (277)
T 3f3z_A 87 LCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF 159 (277)
T ss_dssp CCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence 9999999999974 35689999999999999999999999 99999999999999 78899999999999887
Q ss_pred CCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcC
Q 010891 328 GAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407 (498)
Q Consensus 328 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (498)
..... .....||+.|+|||++.+. ++.++||||||+++|+|++|+.||...... +....+..... ..
T Consensus 160 ~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~----~~ 226 (277)
T 3f3z_A 160 KPGKM--MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDS------EVMLKIREGTF----TF 226 (277)
T ss_dssp CTTSC--BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCC----CC
T ss_pred cCccc--hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCCC----CC
Confidence 54432 3345799999999998764 899999999999999999999999753321 11111111100 00
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 408 ~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
+........ ..+..++.+||+.||.+|||+.+++++
T Consensus 227 ~~~~~~~~~---~~~~~li~~~l~~dp~~R~s~~~~l~h 262 (277)
T 3f3z_A 227 PEKDWLNVS---PQAESLIRRLLTKSPKQRITSLQALEH 262 (277)
T ss_dssp CHHHHTTSC---HHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred CchhhhcCC---HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000111 233444558999999999999999864
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=349.68 Aligned_cols=260 Identities=23% Similarity=0.411 Sum_probs=201.8
Q ss_pred cCCCccceEcccCcEEEEEEEE-----cCCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeC--Cee
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-----MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEG--TQR 245 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~ 245 (498)
++|++.+.||+|+||.||+|++ .+++.||+|++..... ...+.+.+|+++++.++||||+++++++.+. ...
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4588899999999999999983 4689999999965432 3446789999999999999999999999876 668
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccce
Q 010891 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~ 325 (498)
++||||+++|+|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccc
Confidence 9999999999999999643 35699999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCc--eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCC---------CcchhhHHHHHH
Q 010891 326 LLGAGKS--HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGR---------PQSEVNLVEWLK 394 (498)
Q Consensus 326 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~---------~~~~~~~~~~~~ 394 (498)
....... .......||..|+|||++.+..++.++|||||||++|+|++|..|+.... ............
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN 254 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence 8765432 22334568899999999999999999999999999999999999864210 111111111111
Q ss_pred HHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 395 MMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
....... .......+ ..+..++.+||+.||.+|||+.++++.|+.
T Consensus 255 ~~~~~~~--------~~~~~~~~--~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ 299 (302)
T 4e5w_A 255 TLKEGKR--------LPCPPNCP--DEVYQLMRKCWEFQPSNRTSFQNLIEGFEA 299 (302)
T ss_dssp HHHTTCC--------CCCCTTCC--HHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred HHhccCC--------CCCCCCCC--HHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 1111110 01111111 233444558999999999999999999975
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=358.44 Aligned_cols=272 Identities=18% Similarity=0.261 Sum_probs=200.5
Q ss_pred ccCCCccceEcccCcEEEEEEEEc----CCcEEEEEEecCCCCCc-----------hhHHHHHHHHHHcCCCCCceEEEe
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM----NGTAVAVKKLLNNPGQA-----------DKDFRVEVEAIGHVRHKNLVRLLG 237 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~hpnIv~l~~ 237 (498)
.++|.+.+.||+|+||.||+|... ++..||+|++....... ...+.+|+..+..++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 468999999999999999999865 57889999986554321 123567889999999999999999
Q ss_pred EEEe----CCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCC
Q 010891 238 YCIE----GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN 313 (498)
Q Consensus 238 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~ 313 (498)
++.+ ....|+||||+ +++|.+++... +.+++..++.++.||+.||.|||+. +|+||||||+|||++.+
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYK 187 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccC
Confidence 9988 78889999999 99999999743 3699999999999999999999999 99999999999999888
Q ss_pred C--CeEEeeeccceecCCCCce------eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcc
Q 010891 314 F--DAKISDFGLAKLLGAGKSH------ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQS 385 (498)
Q Consensus 314 ~--~~kL~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~ 385 (498)
+ .+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~ 267 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP 267 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence 7 9999999999876432211 1234579999999999999999999999999999999999999996432221
Q ss_pred hhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCCCcch
Q 010891 386 EVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIPRED 458 (498)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~~~~~~~~ 458 (498)
. ........... .... ............. .+..++.+||..||++|||+.++++.|+....+.+..+
T Consensus 268 ~-~~~~~~~~~~~-~~~~-~~~~~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~d 334 (345)
T 2v62_A 268 V-AVQTAKTNLLD-ELPQ-SVLKWAPSGSSCC---EIAQFLVCAHSLAYDEKPNYQALKKILNPHGIPLGPLD 334 (345)
T ss_dssp H-HHHHHHHHHHH-TTTH-HHHHHSCTTSCCH---HHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCCCCCCCC
T ss_pred H-HHHHHHHhhcc-cccH-HHHhhccccccHH---HHHHHHHHHhhcCcccCCCHHHHHHHHhccCCcccCCC
Confidence 1 11111111110 0000 0000000001122 33444458999999999999999999998776554433
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=350.23 Aligned_cols=261 Identities=25% Similarity=0.383 Sum_probs=195.8
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC---chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ---ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++...... ....+.+|+.+++.++||||+++++++.+....++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 45799999999999999999985 57899999999653322 335688899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+++++|.+++.........+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999975443456799999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (498)
... .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ............ . +
T Consensus 188 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~-~-----~ 256 (310)
T 2wqm_A 188 SKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIEQCD-Y-----P 256 (310)
T ss_dssp ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHHHHHHTTC-S-----C
T ss_pred CCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHHHHhhccc-C-----C
Confidence 332 2233457999999999999999999999999999999999999999754322 111112211111 1 1
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 409 NIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
......... .+..++.+||+.||.+|||+.+++++|+..
T Consensus 257 ~~~~~~~~~---~l~~li~~~l~~dp~~Rps~~~il~~l~~l 295 (310)
T 2wqm_A 257 PLPSDHYSE---ELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295 (310)
T ss_dssp CCCTTTSCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCcccccCH---HHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence 111111122 233444589999999999999999999764
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=360.99 Aligned_cols=264 Identities=25% Similarity=0.267 Sum_probs=200.0
Q ss_pred HHHHHccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCC-----CCCchhHHHHHHHHHHcCCCCCceEEEeEEEe
Q 010891 168 DLQSATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNN-----PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIE 241 (498)
Q Consensus 168 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 241 (498)
++..+.++|.+.+.||+|+||+||+|.. .++..||+|++... .....+.+.+|+++++.++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 4466788999999999999999999985 56889999988532 23445678999999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcccCC------------------------------------CCCCCHHHHHHHHHHHHH
Q 010891 242 GTQRILVYEYVNNGNLEQWLRGDMCD------------------------------------RGYLTWEARMKILLGTAK 285 (498)
Q Consensus 242 ~~~~~lv~e~~~~g~L~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~ia~ 285 (498)
....|+||||+++|+|.+++...... ...+++..++.++.||+.
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 99999999999999999999531111 112456788899999999
Q ss_pred HHHHHHHccCCCeeecCCCCCCEEEcCCC--CeEEeeeccceecCCCC---ceeeecccccccccCcccccC--CCCCcc
Q 010891 286 ALAYLHEAIEPKVVHRDIKSSNILIDENF--DAKISDFGLAKLLGAGK---SHITTRVMGTFGYVAPEYANS--GLLNEK 358 (498)
Q Consensus 286 aL~yLH~~~~~~iiHrDikp~NIll~~~~--~~kL~DfGla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~ 358 (498)
||.|||+. +|+||||||+|||++.++ .+||+|||++..+.... ........||+.|+|||++.+ ..++.+
T Consensus 180 ~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 256 (345)
T 3hko_A 180 ALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK 256 (345)
T ss_dssp HHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred HHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence 99999999 999999999999998776 89999999998764322 112345679999999999865 678999
Q ss_pred chHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCC
Q 010891 359 SDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRP 438 (498)
Q Consensus 359 sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RP 438 (498)
+|||||||++|||++|+.||...... +.......... ....+.. .... ..+..++.+||+.||.+||
T Consensus 257 ~DiwslG~il~el~~g~~pf~~~~~~------~~~~~~~~~~~--~~~~~~~--~~~~---~~~~~li~~~l~~~p~~Rp 323 (345)
T 3hko_A 257 CDAWSAGVLLHLLLMGAVPFPGVNDA------DTISQVLNKKL--CFENPNY--NVLS---PLARDLLSNLLNRNVDERF 323 (345)
T ss_dssp HHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCC--CTTSGGG--GGSC---HHHHHHHHHHSCSCTTTSC
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCChH------HHHHHHHhccc--ccCCccc--ccCC---HHHHHHHHHHcCCChhHCC
Confidence 99999999999999999999754321 11122111110 0000000 0011 2233444589999999999
Q ss_pred CHHHHHHHH
Q 010891 439 KMSQVVRML 447 (498)
Q Consensus 439 t~~ell~~L 447 (498)
|+.+++++-
T Consensus 324 s~~~~l~hp 332 (345)
T 3hko_A 324 DAMRALQHP 332 (345)
T ss_dssp CHHHHHHSH
T ss_pred CHHHHhcCh
Confidence 999999854
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=353.14 Aligned_cols=254 Identities=24% Similarity=0.339 Sum_probs=204.0
Q ss_pred HccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCC------chhHHHHHHHHHHcCCCCCceEEEeEEEeCCe
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ------ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQ 244 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 244 (498)
..++|.+.+.||+|+||.||+|+.. +|+.||+|.+...... ..+.+.+|+.++..++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3567999999999999999999864 6899999998654322 24668999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCC----CeEEee
Q 010891 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF----DAKISD 320 (498)
Q Consensus 245 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~----~~kL~D 320 (498)
.++||||+++++|.+++.. .+.+++..++.++.|++.||.|||+. +|+||||||+|||++.++ .+||+|
T Consensus 90 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~D 162 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID 162 (321)
T ss_dssp EEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred EEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEcc
Confidence 9999999999999999973 45689999999999999999999999 999999999999999888 799999
Q ss_pred eccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhc
Q 010891 321 FGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLR 400 (498)
Q Consensus 321 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 400 (498)
||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... +.+..+...
T Consensus 163 fg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~i~~~- 233 (321)
T 2a2a_A 163 FGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANITSV- 233 (321)
T ss_dssp CTTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHTT-
T ss_pred CccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhc-
Confidence 99998875432 233457999999999999999999999999999999999999999753321 111221111
Q ss_pred cccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 401 RSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.....+... ...+ ..+..++.+||..||++|||+.|++++-
T Consensus 234 --~~~~~~~~~--~~~~--~~~~~li~~~l~~dp~~Rps~~e~l~hp 274 (321)
T 2a2a_A 234 --SYDFDEEFF--SHTS--ELAKDFIRKLLVKETRKRLTIQEALRHP 274 (321)
T ss_dssp --CCCCCHHHH--TTCC--HHHHHHHHTTSCSSTTTSCCHHHHHHST
T ss_pred --ccccChhhh--cccC--HHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence 000000000 0111 2233445589999999999999999864
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=345.32 Aligned_cols=261 Identities=28% Similarity=0.439 Sum_probs=192.0
Q ss_pred HHccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCC--chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
+..++|++.+.||+|+||+||+|++. ..||+|++...... ..+.+.+|+.+++.++||||+++++++ .....++|
T Consensus 21 i~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv 97 (289)
T 3og7_A 21 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV 97 (289)
T ss_dssp CCTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred cCccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence 44578999999999999999999753 46999998654332 235688999999999999999999965 55678999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+++++|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 98 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 98 TQWCEGSSLYHHLHA---SETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp EECCCEEEHHHHHTT---C---CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred EEecCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccc
Confidence 999999999999964 335699999999999999999999999 99999999999999999999999999998654
Q ss_pred CCC-ceeeecccccccccCccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccC
Q 010891 329 AGK-SHITTRVMGTFGYVAPEYAN---SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSED 404 (498)
Q Consensus 329 ~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (498)
... ........||+.|+|||++. +..++.++|||||||++|+|++|+.||....... .. ..+........
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~----~~~~~~~~~~~ 245 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QI----IEMVGRGSLSP 245 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HH----HHHHHHTSCCC
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HH----HHHhcccccCc
Confidence 321 22234467999999999886 6778899999999999999999999997544321 11 11111111111
Q ss_pred CcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 405 VVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
. ......... ..+..++.+||+.||.+|||+.++++.|+...
T Consensus 246 ~--~~~~~~~~~---~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 246 D--LSKVRSNCP---KRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp C--TTSSCTTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred c--hhhccccCC---HHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 0 000011111 23444455899999999999999999998764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=351.10 Aligned_cols=267 Identities=28% Similarity=0.451 Sum_probs=201.1
Q ss_pred HHHHccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcC--CCCCceEEEeEEEeC----
Q 010891 169 LQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV--RHKNLVRLLGYCIEG---- 242 (498)
Q Consensus 169 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~hpnIv~l~~~~~~~---- 242 (498)
.....++|++.+.||+|+||.||+|+. +++.||||++... ....+..|.+++..+ +||||+++++++.+.
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 345668999999999999999999987 4899999998532 233455566666655 999999999999887
Q ss_pred CeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHcc-----CCCeeecCCCCCCEEEcCCCCeE
Q 010891 243 TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI-----EPKVVHRDIKSSNILIDENFDAK 317 (498)
Q Consensus 243 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~iiHrDikp~NIll~~~~~~k 317 (498)
...|+||||+++|+|.+++.. ..+++..++.++.|++.||.|||+.. .++|+||||||+|||++.++.+|
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 182 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCC 182 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEE
T ss_pred CceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEE
Confidence 788999999999999999964 35899999999999999999999752 44899999999999999999999
Q ss_pred EeeeccceecCCCCcee---eecccccccccCcccccCCCCCcc------chHHHHHHHHHHHHhC----------CCCC
Q 010891 318 ISDFGLAKLLGAGKSHI---TTRVMGTFGYVAPEYANSGLLNEK------SDVYSFGVVLLEAITG----------RYPV 378 (498)
Q Consensus 318 L~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------sDvwSlGvvl~elltg----------~~P~ 378 (498)
|+|||+++......... .....||+.|+|||++.+..++.+ +|||||||++|||++| +.||
T Consensus 183 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~ 262 (337)
T 3mdy_A 183 IADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPY 262 (337)
T ss_dssp ECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccH
Confidence 99999998765433221 224579999999999988776665 9999999999999999 6676
Q ss_pred CCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 379 DYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRP-STSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
....+.... . ..+........ ..+.+.... .......+..++.+||+.||.+|||+.+++++|+..
T Consensus 263 ~~~~~~~~~-~-~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 263 HDLVPSDPS-Y-EDMREIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp TTTSCSSCC-H-HHHHHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred hhhcCCCCc-h-hhhHHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 543322111 1 11111111111 112211111 113344455666689999999999999999999865
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=370.61 Aligned_cols=248 Identities=25% Similarity=0.411 Sum_probs=202.2
Q ss_pred ccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCC---CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
.++|.+.+.||+|+||.||+|+.. +|+.||||++.... ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 467899999999999999999864 79999999985432 22345688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+++|+|.+++. ..+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 95 ~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 95 MEYVSGGELFDYIC----KNGRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EECCSSEEHHHHTT----SSSSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EeCCCCCcHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 99999999999996 346799999999999999999999999 99999999999999999999999999999875
Q ss_pred CCCceeeecccccccccCcccccCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANSGLL-NEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (498)
... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....... ....+...
T Consensus 168 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~------~~~~i~~~-------- 231 (476)
T 2y94_A 168 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT------LFKKICDG-------- 231 (476)
T ss_dssp TTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH------HHHHHHTT--------
T ss_pred ccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH------HHHHHhcC--------
Confidence 432 2344679999999999988765 689999999999999999999997543321 11222111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 408 ~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
........+ ..+..++.+||..||.+|||+.|+++|
T Consensus 232 -~~~~p~~~s--~~~~~Li~~~L~~dP~~Rpt~~eil~h 267 (476)
T 2y94_A 232 -IFYTPQYLN--PSVISLLKHMLQVDPMKRATIKDIREH 267 (476)
T ss_dssp -CCCCCTTCC--HHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred -CcCCCccCC--HHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence 111111111 123344458999999999999999974
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=364.26 Aligned_cols=248 Identities=23% Similarity=0.326 Sum_probs=194.8
Q ss_pred cceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCCCCH
Q 010891 179 DNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNL 257 (498)
Q Consensus 179 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L 257 (498)
.+.||+|+||.||+|.. .+|+.||+|++........+.+.+|++++.+++||||+++++++.+....++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 57899999999999985 46899999999765545567799999999999999999999999999999999999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEE--cCCCCeEEeeeccceecCCCCceee
Q 010891 258 EQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI--DENFDAKISDFGLAKLLGAGKSHIT 335 (498)
Q Consensus 258 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll--~~~~~~kL~DfGla~~~~~~~~~~~ 335 (498)
.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+++....... .
T Consensus 174 ~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~ 245 (373)
T 2x4f_A 174 FDRIIDE---SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--L 245 (373)
T ss_dssp HHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--C
T ss_pred HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--c
Confidence 9998642 24589999999999999999999999 99999999999999 5678899999999998754432 2
Q ss_pred ecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCC
Q 010891 336 TRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPS 415 (498)
Q Consensus 336 ~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (498)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||...... +.+..+..... .. .. .....
T Consensus 246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~------~~~~~i~~~~~--~~-~~--~~~~~ 314 (373)
T 2x4f_A 246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA------ETLNNILACRW--DL-ED--EEFQD 314 (373)
T ss_dssp CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTCC--CS-CS--GGGTT
T ss_pred ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhccC--CC-Ch--hhhcc
Confidence 3357999999999999999999999999999999999999999754321 11222222111 00 00 00111
Q ss_pred HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 416 TSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 416 ~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.+ ..+..++.+||..||.+|||+.|++++-
T Consensus 315 ~~--~~~~~li~~~L~~dp~~Rps~~e~l~hp 344 (373)
T 2x4f_A 315 IS--EEAKEFISKLLIKEKSWRISASEALKHP 344 (373)
T ss_dssp SC--HHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred CC--HHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 11 2334445589999999999999999854
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=343.61 Aligned_cols=251 Identities=22% Similarity=0.325 Sum_probs=199.6
Q ss_pred ccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCC--chhHHHHHHHHHHcCCCCCceEEEeEEEeC--CeeEEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEG--TQRILV 248 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~~~lv 248 (498)
.++|.+.+.||+|+||.||+|++ +++.||+|++...... ..+.+.+|+.++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 35789999999999999999987 5899999998654332 335688999999999999999999999887 778999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCC--eeecCCCCCCEEEcCCCCeEEeeecccee
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK--VVHRDIKSSNILIDENFDAKISDFGLAKL 326 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--iiHrDikp~NIll~~~~~~kL~DfGla~~ 326 (498)
|||+++|+|.+++... ....+++..++.++.|++.||.|||+. + ++||||||+|||++.++.++|+|||++..
T Consensus 88 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp EECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred ecccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceee
Confidence 9999999999999753 233689999999999999999999998 7 99999999999999999999999998764
Q ss_pred cCCCCceeeecccccccccCcccccCCCCCc---cchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhcccc
Q 010891 327 LGAGKSHITTRVMGTFGYVAPEYANSGLLNE---KSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSE 403 (498)
Q Consensus 327 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (498)
... ....||+.|+|||++.+..++. ++|||||||++|||++|+.||...... ..........
T Consensus 163 ~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~~~~~~~~~~--- 227 (271)
T 3kmu_A 163 FQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNM------EIGMKVALEG--- 227 (271)
T ss_dssp TSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHH------HHHHHHHHSC---
T ss_pred ecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChH------HHHHHHHhcC---
Confidence 322 2346899999999998765544 799999999999999999999744321 1111111111
Q ss_pred CCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 404 DVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
..+..... .. ..+..++.+||+.||++|||+.++++.|+..
T Consensus 228 --~~~~~~~~-~~---~~~~~li~~~l~~~p~~Rps~~~il~~L~~l 268 (271)
T 3kmu_A 228 --LRPTIPPG-IS---PHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268 (271)
T ss_dssp --CCCCCCTT-CC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --CCCCCCCC-CC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence 11111111 11 2234444589999999999999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=343.78 Aligned_cols=251 Identities=25% Similarity=0.397 Sum_probs=181.5
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC---CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
.++|.+.+.||+|+||.||+|+. .+|+.||+|.+.... ....+.+.+|+.++..++||||+++++++.+....|+|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 35789999999999999999986 578999999985432 22346688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+++++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++....
T Consensus 90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 163 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK 163 (278)
T ss_dssp EECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence 9999999999999742 35689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (498)
..... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||......... .. ....
T Consensus 164 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---------~~------~~~~ 227 (278)
T 3cok_A 164 MPHEK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL---------NK------VVLA 227 (278)
T ss_dssp -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSS
T ss_pred CCCCc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH---------HH------Hhhc
Confidence 33221 23457999999999999999999999999999999999999999754432110 00 0001
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 409 NIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
........+ ..+..++.+||+.||++|||+.+++++-
T Consensus 228 ~~~~~~~~~--~~~~~li~~~l~~dp~~Rps~~~~l~h~ 264 (278)
T 3cok_A 228 DYEMPSFLS--IEAKDLIHQLLRRNPADRLSLSSVLDHP 264 (278)
T ss_dssp CCCCCTTSC--HHHHHHHHHHSCSSGGGSCCHHHHTTST
T ss_pred ccCCccccC--HHHHHHHHHHcccCHhhCCCHHHHhcCc
Confidence 111111111 2233445589999999999999998753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=359.12 Aligned_cols=257 Identities=26% Similarity=0.327 Sum_probs=202.7
Q ss_pred cCCCccceEcccCcEEEEEEEE----cCCcEEEEEEecCCC----CCchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCe
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL----MNGTAVAVKKLLNNP----GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQ 244 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~ 244 (498)
++|.+.+.||+|+||.||+|+. .+++.||||++.... ....+.+..|++++..+ +||||+++++++.+...
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5789999999999999999986 478999999985432 12345577799999999 79999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccc
Q 010891 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (498)
Q Consensus 245 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla 324 (498)
.++||||+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred EEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 99999999999999999743 4699999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCceeeecccccccccCcccccC--CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccc
Q 010891 325 KLLGAGKSHITTRVMGTFGYVAPEYANS--GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRS 402 (498)
Q Consensus 325 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (498)
+.+...........+||+.|+|||++.+ ..++.++|||||||+||||++|+.||........ ............
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~-- 282 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRILKSE-- 282 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHHHCC--
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHhccC--
Confidence 8765444444455789999999999875 4578999999999999999999999975433221 111112111110
Q ss_pred cCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHHhcC
Q 010891 403 EDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRP-----KMSQVVRMLESE 450 (498)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RP-----t~~ell~~L~~~ 450 (498)
+.. ....+. .+..++.+||..||.+|| |+.|++++.-..
T Consensus 283 -----~~~--~~~~~~--~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~ 326 (355)
T 1vzo_A 283 -----PPY--PQEMSA--LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 326 (355)
T ss_dssp -----CCC--CTTSCH--HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred -----CCC--CcccCH--HHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchh
Confidence 111 111112 233344589999999999 999999876543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=354.58 Aligned_cols=259 Identities=22% Similarity=0.332 Sum_probs=192.2
Q ss_pred cCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
++|.+.+.||+|+||+||+|+.. +++.||+|++...... ....+.+|+.+++.++||||+++++++.+....++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57899999999999999999864 6899999998644322 222455799999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
++ |+|.+++... ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 154 (324)
T ss_dssp CS-EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence 97 5999998752 35689999999999999999999999 99999999999999999999999999998654332
Q ss_pred ceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhcc-ccCCcCC-
Q 010891 332 SHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRR-SEDVVDP- 408 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~- 408 (498)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... . +..+..... .....-+
T Consensus 155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~---~~~i~~~~~~~~~~~~~~ 227 (324)
T 3mtl_A 155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEE---Q---LHFIFRILGTPTEETWPG 227 (324)
T ss_dssp ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---H---HHHHHHHHCCCCTTTSTT
T ss_pred -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---H---HHHHHHHhCCCChHhchh
Confidence 22334578999999998876 678999999999999999999999997543221 1 111111111 0000000
Q ss_pred -------------CCCC------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 409 -------------NIET------RPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 409 -------------~~~~------~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
.... .+..+ ..+..++.+||+.||.+|||+.|++++--
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dP~~R~t~~e~l~hp~ 284 (324)
T 3mtl_A 228 ILSNEEFKTYNYPKYRAEALLSHAPRLD--SDGADLLTKLLQFEGRNRISAEDAMKHPF 284 (324)
T ss_dssp GGGCHHHHHTCCCCCCCCCHHHHCTTSC--HHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred hhcchhhcccccccccchhhhhhcCCCC--HHHHHHHHHHcCcCcccCCCHHHHhcChh
Confidence 0000 00111 22344555899999999999999998543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=356.35 Aligned_cols=269 Identities=23% Similarity=0.371 Sum_probs=210.3
Q ss_pred cHHHHHHHccCCCccceEcccCcEEEEEEEEc------CCcEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEe
Q 010891 165 TLRDLQSATNRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLG 237 (498)
Q Consensus 165 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~ 237 (498)
...+++...++|.+.+.||+|+||.||+|... +++.||+|.+...... ....+.+|+.+++.++||||+++++
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 16 VPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred ChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 34455667789999999999999999999753 4688999998654332 2346889999999999999999999
Q ss_pred EEEeCCeeEEEEeecCCCCHHHHHhcccC------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEc
Q 010891 238 YCIEGTQRILVYEYVNNGNLEQWLRGDMC------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID 311 (498)
Q Consensus 238 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~ 311 (498)
++.+....++||||+++|+|.+++..... ....+++..++.++.||+.||.|||++ +|+||||||+|||++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~ 172 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVA 172 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEEC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEc
Confidence 99999999999999999999999964321 124578999999999999999999999 999999999999999
Q ss_pred CCCCeEEeeeccceecCCCCce-eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhH
Q 010891 312 ENFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNL 389 (498)
Q Consensus 312 ~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~ 389 (498)
.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 173 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----- 247 (322)
T 1p4o_A 173 EDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE----- 247 (322)
T ss_dssp TTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH-----
T ss_pred CCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHH-----
Confidence 9999999999999865433211 1223467899999999998999999999999999999999 88998753321
Q ss_pred HHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 010891 390 VEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEY 452 (498)
Q Consensus 390 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~~ 452 (498)
+.......... . .. ....+ ..+..++.+||+.||.+|||+.+++++|+....
T Consensus 248 -~~~~~~~~~~~----~--~~--~~~~~--~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 248 -QVLRFVMEGGL----L--DK--PDNCP--DMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp -HHHHHHHTTCC----C--CC--CTTCC--HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred -HHHHHHHcCCc----C--CC--CCCCC--HHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 11111111110 0 00 11111 223344458999999999999999999988654
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=343.62 Aligned_cols=254 Identities=21% Similarity=0.304 Sum_probs=202.4
Q ss_pred HccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC--chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
..++|++.+.||+|+||.||+|.. .+++.||+|++...... ..+.+.+|+.++++++||||+++++++.+....++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 357899999999999999999985 45899999998544322 335688899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCC---eEEeeeccce
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD---AKISDFGLAK 325 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~---~kL~DfGla~ 325 (498)
|||+++++|.+++... ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++. +||+|||++.
T Consensus 84 ~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~ 156 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI 156 (284)
T ss_dssp ECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence 9999999999998743 5699999999999999999999999 9999999999999987655 9999999998
Q ss_pred ecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCC
Q 010891 326 LLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV 405 (498)
Q Consensus 326 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (498)
....... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...... ........... ..
T Consensus 157 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~------~~~~~~~~~~~--~~ 226 (284)
T 3kk8_A 157 EVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RLYAQIKAGAY--DY 226 (284)
T ss_dssp ECCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCC--CC
T ss_pred EcccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh------HHHHHHHhccc--cC
Confidence 7654332 23467999999999999999999999999999999999999999754321 11112111111 11
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 406 VDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 406 ~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
..+. ...... .+..++.+||+.||++|||+.|++++-
T Consensus 227 ~~~~--~~~~~~---~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (284)
T 3kk8_A 227 PSPE--WDTVTP---EAKSLIDSMLTVNPKKRITADQALKVP 263 (284)
T ss_dssp CTTT--TTTSCH---HHHHHHHHHSCSSTTTSCCHHHHTTSH
T ss_pred Cchh--hcccCH---HHHHHHHHHcccChhhCCCHHHHhcCc
Confidence 1111 111122 233444589999999999999999754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=346.79 Aligned_cols=261 Identities=25% Similarity=0.317 Sum_probs=196.7
Q ss_pred HHccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC-----CCchhHHHHHHHHHHcCC---CCCceEEEeEEEe
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP-----GQADKDFRVEVEAIGHVR---HKNLVRLLGYCIE 241 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~ 241 (498)
...++|++.+.||+|+||+||+|+. .+++.||+|++.... ......+.+|+++++.++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 4567999999999999999999984 578999999985322 122345777888877764 9999999999987
Q ss_pred CC-----eeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCe
Q 010891 242 GT-----QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDA 316 (498)
Q Consensus 242 ~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~ 316 (498)
.. ..++||||+. ++|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 159 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTV 159 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCE
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCE
Confidence 65 5799999996 5999999754 234499999999999999999999999 99999999999999999999
Q ss_pred EEeeeccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH
Q 010891 317 KISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMM 396 (498)
Q Consensus 317 kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 396 (498)
||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... .+..+
T Consensus 160 kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~------~~~~i 231 (308)
T 3g33_A 160 KLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD------QLGKI 231 (308)
T ss_dssp EECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH------HHHHH
T ss_pred EEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHH
Confidence 999999998654332 2345679999999999999999999999999999999999999997543221 11222
Q ss_pred HhhccccC--CcCC-------CCCC---------CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 397 VQLRRSED--VVDP-------NIET---------RPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 397 ~~~~~~~~--~~~~-------~~~~---------~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
........ .... .+.. .+..+ ..+..++.+||+.||++|||+.|+++|-
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dP~~R~t~~e~l~h~ 298 (308)
T 3g33_A 232 FDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEME--ESGAQLLLEMLTFNPHKRISAFRALQHS 298 (308)
T ss_dssp HHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCC--HHHHHHHHHHTCSSTTTSCCHHHHHTST
T ss_pred HHHhCCCChhhccchhhccccccCCCCCCcHHHhCcccc--HHHHHHHHHHhcCCCccCCCHHHHhcCc
Confidence 21111000 0000 0000 00111 2333445589999999999999999763
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=346.61 Aligned_cols=255 Identities=25% Similarity=0.390 Sum_probs=198.5
Q ss_pred ccCCCccceEcccCcEEEEEEEEcC----CcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLMN----GTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
.++|.+.+.||+|+||+||+|.+.+ +..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+ ...|+
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4678999999999999999997543 23699998865432 234568899999999999999999999865 45689
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
||||+++++|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++...
T Consensus 90 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 90 IMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCccc
Confidence 99999999999999753 34689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCc
Q 010891 328 GAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVV 406 (498)
Q Consensus 328 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (498)
............+|+.|+|||++.+..++.++||||||+++|||++ |+.||........ .. .+..... ..
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~---~~---~~~~~~~---~~ 234 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV---IG---VLEKGDR---LP 234 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH---HH---HHHHTCC---CC
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH---HH---HHhcCCC---CC
Confidence 5443333344567889999999998899999999999999999998 9999975443221 11 1111111 00
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 407 DPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 407 ~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
.+ ..... .+..++.+||+.||++|||+.+++++|+..
T Consensus 235 ~~----~~~~~---~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 271 (281)
T 3cc6_A 235 KP----DLCPP---VLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271 (281)
T ss_dssp CC----TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC----CCCCH---HHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence 01 11112 233444589999999999999999999764
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=365.56 Aligned_cols=251 Identities=22% Similarity=0.342 Sum_probs=194.1
Q ss_pred cCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCC--CchhHHHHHHHHHHcCC--CCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVR--HKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~~~~lv~ 249 (498)
.+|.+.+.||+|+||.||+|...+++.||||++..... ...+.+.+|+.++..++ ||||+++++++......|+||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 46899999999999999999887899999999865433 23456889999999996 599999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
| +.+++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||+++.+..
T Consensus 136 E-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 136 E-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp E-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred e-cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9 568899999974 34689999999999999999999999 999999999999996 57999999999987654
Q ss_pred CCce-eeecccccccccCcccccC-----------CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHH
Q 010891 330 GKSH-ITTRVMGTFGYVAPEYANS-----------GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMV 397 (498)
Q Consensus 330 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 397 (498)
.... .....+||+.|+|||++.+ ..|+.++|||||||+||||++|+.||...... ...+....
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~~~~~~ 281 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAII 281 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHHHHHHH
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HHHHHHHh
Confidence 3322 2345679999999999865 46899999999999999999999999743321 11111111
Q ss_pred hhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 398 QLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
... ....+.... . ..+..++.+||+.||.+|||+.|++++.
T Consensus 282 ~~~-----~~~~~~~~~-~---~~~~~li~~~L~~dP~~Rps~~ell~hp 322 (390)
T 2zmd_A 282 DPN-----HEIEFPDIP-E---KDLQDVLKCCLKRDPKQRISIPELLAHP 322 (390)
T ss_dssp CTT-----SCCCCCCCS-C---HHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred Ccc-----ccCCCCccc-h---HHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence 110 011111111 1 2334445589999999999999999764
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=357.84 Aligned_cols=251 Identities=25% Similarity=0.351 Sum_probs=176.9
Q ss_pred cceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCC-CCCceEEEeEEEeCCeeEEEEeecCCCC
Q 010891 179 DNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-HKNLVRLLGYCIEGTQRILVYEYVNNGN 256 (498)
Q Consensus 179 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~~g~ 256 (498)
.+.||+|+||+||+|.. .+++.||||++... ....+.+|+.++..+. ||||+++++++.+....|+||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 47899999999999986 46899999998532 3456788999999997 9999999999999999999999999999
Q ss_pred HHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCC---CeEEeeeccceecCCCCce
Q 010891 257 LEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF---DAKISDFGLAKLLGAGKSH 333 (498)
Q Consensus 257 L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~---~~kL~DfGla~~~~~~~~~ 333 (498)
|.+++.. .+.+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||+++.......
T Consensus 93 L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~- 164 (325)
T 3kn6_A 93 LFERIKK----KKHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ- 164 (325)
T ss_dssp HHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-
Confidence 9999974 35799999999999999999999999 999999999999997765 799999999987654332
Q ss_pred eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcch-hhHHHHHHHHHhhccccCCcCCCCCC
Q 010891 334 ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSE-VNLVEWLKMMVQLRRSEDVVDPNIET 412 (498)
Q Consensus 334 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (498)
.....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||........ ....+.+..+. ......... .
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~---~~~~~~~~~--~ 239 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIK---KGDFSFEGE--A 239 (325)
T ss_dssp -------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHT---TTCCCCCSH--H
T ss_pred cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHH---cCCCCCCcc--c
Confidence 23446789999999999999999999999999999999999999975433211 11112222211 111000000 0
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 413 RPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 413 ~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
....+ ..+..++.+||..||.+|||+.|++++-
T Consensus 240 ~~~~s--~~~~~li~~~L~~dP~~Rpt~~ell~h~ 272 (325)
T 3kn6_A 240 WKNVS--QEAKDLIQGLLTVDPNKRLKMSGLRYNE 272 (325)
T ss_dssp HHTSC--HHHHHHHHHHHCCCTTTCCCTTTSTTCG
T ss_pred ccCCC--HHHHHHHHHHCCCChhHCCCHHHHhcCh
Confidence 00111 2333444589999999999999998654
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=346.83 Aligned_cols=260 Identities=21% Similarity=0.266 Sum_probs=194.6
Q ss_pred ccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCCc---hhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQA---DKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
.++|.+.+.||+|+||.||+|+.. +++.||+|++....... .+.+.+|+.++..++||||+++++++.++...|+|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999864 68899999986543222 35688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+++++|.+++... +.+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 113 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 9999999999999743 5699999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (498)
...........||+.|+|||++.+..++.++||||||+++|||++|+.||...... .+........ ..+
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~----~~~ 254 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAI----PRP 254 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCC----CCG
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCC----CCc
Confidence 44333344567999999999999999999999999999999999999999743211 1111111110 000
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhcCCCC
Q 010891 409 NIETRPSTSALKRALLTALRCVDPDSDKRP-KMSQVVRMLESEEYP 453 (498)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~~~cl~~dP~~RP-t~~ell~~L~~~~~~ 453 (498)
.......... +..++.+||+.||++|| |+.++++.|+.....
T Consensus 255 ~~~~~~~~~~---l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~ 297 (309)
T 2h34_A 255 STVRPGIPVA---FDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT 297 (309)
T ss_dssp GGTSTTCCTH---HHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred cccCCCCCHH---HHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence 0000111122 33344589999999999 999999999876433
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=353.50 Aligned_cols=248 Identities=25% Similarity=0.286 Sum_probs=190.9
Q ss_pred HccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCCch--hHHHHHHHHHHcC-CCCCceEEEeEEEeCCeeEE
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQAD--KDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 247 (498)
..++|++.++||+|+||+||+|++. +|+.||||++........ ..+..|+..+..+ +||||+++++++.++...|+
T Consensus 55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 4468999999999999999999865 799999999865433322 2344555555554 99999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
||||+ +++|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++...
T Consensus 135 v~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred EEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 99999 67999998753 35699999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcC
Q 010891 328 GAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407 (498)
Q Consensus 328 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (498)
.... ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.... . ...+... ...
T Consensus 208 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-----~----~~~~~~~-----~~~ 270 (311)
T 3p1a_A 208 GTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-----G----WQQLRQG-----YLP 270 (311)
T ss_dssp C--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----H----HHHHTTT-----CCC
T ss_pred ccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----H----HHHHhcc-----CCC
Confidence 5432 2334569999999999876 78999999999999999999977664211 0 1111110 000
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 408 ~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
+.+.. ... ..+..++.+||+.||++|||+.|++++-
T Consensus 271 ~~~~~-~~~---~~l~~li~~~L~~dP~~Rpt~~ell~hp 306 (311)
T 3p1a_A 271 PEFTA-GLS---SELRSVLVMMLEPDPKLRATAEALLALP 306 (311)
T ss_dssp HHHHT-TSC---HHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred ccccc-CCC---HHHHHHHHHHcCCChhhCcCHHHHHhCc
Confidence 00100 011 2344445589999999999999999753
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=351.96 Aligned_cols=267 Identities=28% Similarity=0.404 Sum_probs=207.8
Q ss_pred HHHHHHHccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHc--CCCCCceEEEeEEEeCC
Q 010891 166 LRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGH--VRHKNLVRLLGYCIEGT 243 (498)
Q Consensus 166 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~l~~~~~~~~ 243 (498)
+.....+.++|.+.+.||+|+||.||+|+. +|+.||||++... ....+..|++++.. ++||||+++++++....
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 334456778999999999999999999987 6899999998532 34567788888887 79999999999998875
Q ss_pred ----eeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH--------HccCCCeeecCCCCCCEEEc
Q 010891 244 ----QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH--------EAIEPKVVHRDIKSSNILID 311 (498)
Q Consensus 244 ----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH--------~~~~~~iiHrDikp~NIll~ 311 (498)
..|+||||+++|+|.+++.. ..+++..++.++.|++.||.||| +. +|+||||||+|||++
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~ 181 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVK 181 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEEC
T ss_pred CccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEEC
Confidence 78999999999999999964 35899999999999999999999 77 999999999999999
Q ss_pred CCCCeEEeeeccceecCCCCce---eeecccccccccCcccccCC------CCCccchHHHHHHHHHHHHhC--------
Q 010891 312 ENFDAKISDFGLAKLLGAGKSH---ITTRVMGTFGYVAPEYANSG------LLNEKSDVYSFGVVLLEAITG-------- 374 (498)
Q Consensus 312 ~~~~~kL~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwSlGvvl~elltg-------- 374 (498)
.++.+||+|||++......... ......||+.|+|||++.+. .++.++|||||||++|||++|
T Consensus 182 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~ 261 (342)
T 1b6c_B 182 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261 (342)
T ss_dssp TTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCccc
Confidence 9999999999999877554322 12345799999999998765 234689999999999999999
Q ss_pred --CCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCC-CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 375 --RYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETR-PSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 375 --~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
..||....+... ....+... .. .....+.+... ........+..++.+||+.||++|||+.+++++|+..
T Consensus 262 ~~~~p~~~~~~~~~-~~~~~~~~-~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 262 DYQLPYYDLVPSDP-SVEEMRKV-VC----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp CCCCTTTTTSCSSC-CHHHHHHH-HT----TSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccCccccCcCcc-cHHHHHHH-HH----HHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 788865433211 11111111 11 11112222111 1223444555666689999999999999999999865
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=362.72 Aligned_cols=244 Identities=25% Similarity=0.313 Sum_probs=188.2
Q ss_pred ccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCC---CchhHHHHHHHH-HHcCCCCCceEEEeEEEeCCeeEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG---QADKDFRVEVEA-IGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
.++|++.+.||+|+||.||+|+.. +++.||+|++.+... .....+..|..+ ++.++||||+++++++.+....|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357899999999999999999864 588999999865432 223345667766 567899999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
||||++||+|.+++... +.+++..+..++.||+.||.|||++ +|+||||||+|||++.+|.+||+|||+++..
T Consensus 117 v~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 99999999999999743 4689999999999999999999999 9999999999999999999999999999864
Q ss_pred CCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcC
Q 010891 328 GAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407 (498)
Q Consensus 328 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (498)
.... ......+||+.|+|||++.+..|+.++|||||||++|||++|..||..... .+....+...
T Consensus 190 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~------~~~~~~i~~~-------- 254 (373)
T 2r5t_A 190 IEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT------AEMYDNILNK-------- 254 (373)
T ss_dssp BCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH------HHHHHHHHHS--------
T ss_pred ccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHhc--------
Confidence 3222 224457899999999999999999999999999999999999999975322 1222222211
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH
Q 010891 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPKMS 441 (498)
Q Consensus 408 ~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ 441 (498)
.+...+..+. .+..++.+||..||.+||++.
T Consensus 255 -~~~~~~~~~~--~~~~li~~lL~~dp~~R~~~~ 285 (373)
T 2r5t_A 255 -PLQLKPNITN--SARHLLEGLLQKDRTKRLGAK 285 (373)
T ss_dssp -CCCCCSSSCH--HHHHHHHHHTCSSGGGSTTTT
T ss_pred -ccCCCCCCCH--HHHHHHHHHcccCHHhCCCCC
Confidence 1111122222 233344489999999999974
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=372.33 Aligned_cols=193 Identities=27% Similarity=0.428 Sum_probs=154.5
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC--chhHHHHHHHHHHcCCCCCceEEEeEEEeC-----Ce
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEG-----TQ 244 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~ 244 (498)
.++|++.+.||+|+||+||+|+. .+++.||||++...... ..+.+.+|+++|+.++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 46899999999999999999975 46899999999654322 335688999999999999999999998543 56
Q ss_pred eEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccc
Q 010891 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (498)
Q Consensus 245 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla 324 (498)
.|+||||+ +++|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||++
T Consensus 132 ~~lv~e~~-~~~L~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla 203 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFR----TPVYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLA 203 (458)
T ss_dssp EEEEECCC-SEEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEecc-ccchhhhcc----cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccc
Confidence 89999998 569999997 346799999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCc--------------------------eeeecccccccccCcccc-cCCCCCccchHHHHHHHHHHHHh
Q 010891 325 KLLGAGKS--------------------------HITTRVMGTFGYVAPEYA-NSGLLNEKSDVYSFGVVLLEAIT 373 (498)
Q Consensus 325 ~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvvl~ellt 373 (498)
+....... ...+..+||++|+|||++ .+..|+.++||||||||||||++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 204 RTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp BCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred hhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 87643211 123456899999999976 56779999999999999999999
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=362.35 Aligned_cols=203 Identities=26% Similarity=0.414 Sum_probs=164.3
Q ss_pred HHccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC--CchhHHHHHHHHHHcCC-CCCceEEEeEEEeCC--e
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVR-HKNLVRLLGYCIEGT--Q 244 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~--~ 244 (498)
...++|++.+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+.++..+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 4567899999999999999999975 5689999999864422 23345778999999997 999999999998644 6
Q ss_pred eEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccc
Q 010891 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (498)
Q Consensus 245 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla 324 (498)
.|+||||++ ++|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a 156 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS 156 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence 899999997 599999964 4689999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCC--------------------ceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 010891 325 KLLGAGK--------------------SHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 325 ~~~~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~ 382 (498)
+.+.... ....+..+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 235 (388)
T 3oz6_A 157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235 (388)
T ss_dssp EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 8764311 112344689999999998876 679999999999999999999999997543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=356.10 Aligned_cols=253 Identities=13% Similarity=0.173 Sum_probs=202.6
Q ss_pred HHccCCCccceEcccCcEEEEEE------EEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCC---CCCceEEEeEEEe
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRG------QLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR---HKNLVRLLGYCIE 241 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~------~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~ 241 (498)
...++|.+.+.||+|+||+||+| ...+++.||+|++... ...++..|++++..++ |+||+.+++++..
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 44578999999999999999999 3557899999998543 3556888888888886 9999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcccC-CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcC--------
Q 010891 242 GTQRILVYEYVNNGNLEQWLRGDMC-DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE-------- 312 (498)
Q Consensus 242 ~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~-------- 312 (498)
.+..|+||||+++|+|.+++..... ....+++..++.++.||+.||.|||++ +|+||||||+||||+.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCcccc
Confidence 9999999999999999999974322 345699999999999999999999998 9999999999999998
Q ss_pred ---CCCeEEeeeccceecCC-CCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhh
Q 010891 313 ---NFDAKISDFGLAKLLGA-GKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVN 388 (498)
Q Consensus 313 ---~~~~kL~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~ 388 (498)
++.+||+|||+++.+.. .........+||+.|+|||++.+..|+.++|||||||++|||+||+.||.......
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--- 292 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--- 292 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence 89999999999987542 22234455789999999999999999999999999999999999999996432211
Q ss_pred HHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCC-CCHHHHHHHHhcC
Q 010891 389 LVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKR-PKMSQVVRMLESE 450 (498)
Q Consensus 389 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~R-Pt~~ell~~L~~~ 450 (498)
......+...+.......++. .||+.+|.+| |++.++.+.|+..
T Consensus 293 ---------------~~~~~~~~~~~~~~~~~~~~~---~~l~~~p~~r~~~~~~l~~~l~~~ 337 (365)
T 3e7e_A 293 ---------------CKPEGLFRRLPHLDMWNEFFH---VMLNIPDCHHLPSLDLLRQKLKKV 337 (365)
T ss_dssp ---------------EEECSCCTTCSSHHHHHHHHH---HHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred ---------------eeechhccccCcHHHHHHHHH---HHcCCCCCCcchHHHHHHHHHHHH
Confidence 011122222233444444433 6999999999 5777777766643
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=350.94 Aligned_cols=261 Identities=21% Similarity=0.304 Sum_probs=196.3
Q ss_pred ccCCCcc-ceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCeeEEEE
Q 010891 173 TNRFSKD-NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 173 ~~~y~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
.++|.+. +.||+|+||.||+|.. .+++.||||++..........+.+|++++.++ +||||+++++++.+.+..|+||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4567874 7899999999999984 57899999999766655667889999999985 7999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCC---eEEeeecccee
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD---AKISDFGLAKL 326 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~---~kL~DfGla~~ 326 (498)
||+++|+|.+++... ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++. +||+|||++..
T Consensus 91 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 91 EKMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp ECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred EcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 999999999999743 4689999999999999999999999 9999999999999998776 99999999986
Q ss_pred cCCCCc------eeeecccccccccCcccccC-----CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcch---------
Q 010891 327 LGAGKS------HITTRVMGTFGYVAPEYANS-----GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSE--------- 386 (498)
Q Consensus 327 ~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~--------- 386 (498)
...... ......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 243 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACP 243 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCH
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccch
Confidence 532211 11223569999999999865 5688999999999999999999999975433210
Q ss_pred hhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 387 VNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.........+.. ... .. +.... ...+ ..+..++.+||..||.+|||+.|++++-
T Consensus 244 ~~~~~~~~~i~~-~~~-~~--~~~~~-~~~~--~~~~~li~~~L~~dP~~Rps~~e~l~hp 297 (316)
T 2ac3_A 244 ACQNMLFESIQE-GKY-EF--PDKDW-AHIS--CAAKDLISKLLVRDAKQRLSAAQVLQHP 297 (316)
T ss_dssp HHHHHHHHHHHH-CCC-CC--CHHHH-TTSC--HHHHHHHHHHSCSSTTTSCCHHHHHHST
T ss_pred hHHHHHHHHHhc-cCc-cc--Cchhc-ccCC--HHHHHHHHHHhhCChhhCCCHHHHhcCh
Confidence 000111111111 100 00 00000 0111 2234445589999999999999999864
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=348.63 Aligned_cols=253 Identities=25% Similarity=0.356 Sum_probs=200.9
Q ss_pred HccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
..++|.+.+.||+|+||.||+|+.. +|+.||+|++........+.+.+|+.++..++||||+++++++.+....|+|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 4568999999999999999999864 689999999976555455678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEE---cCCCCeEEeeeccceec
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLL 327 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll---~~~~~~kL~DfGla~~~ 327 (498)
|+++++|.+++.. .+.+++..+..++.|++.||.|||+. +|+||||||+||++ +.++.+||+|||++...
T Consensus 87 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~ 159 (304)
T 2jam_A 87 LVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKME 159 (304)
T ss_dssp CCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCC
T ss_pred cCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceec
Confidence 9999999999964 35689999999999999999999999 99999999999999 78899999999999764
Q ss_pred CCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcC
Q 010891 328 GAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407 (498)
Q Consensus 328 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (498)
... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... .....+.... ....
T Consensus 160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~i~~~~---~~~~ 227 (304)
T 2jam_A 160 QNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES------KLFEKIKEGY---YEFE 227 (304)
T ss_dssp CCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHCC---CCCC
T ss_pred CCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHcCC---CCCC
Confidence 332 233457999999999999999999999999999999999999999753321 1112222111 0011
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 408 ~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.. .....+ ..+..++.+||..||.+|||+.+++++-
T Consensus 228 ~~--~~~~~~--~~~~~li~~~l~~dp~~Rps~~~~l~h~ 263 (304)
T 2jam_A 228 SP--FWDDIS--ESAKDFICHLLEKDPNERYTCEKALSHP 263 (304)
T ss_dssp TT--TTTTSC--HHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred cc--ccccCC--HHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 11 111111 2233444589999999999999999754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=354.84 Aligned_cols=244 Identities=24% Similarity=0.330 Sum_probs=200.1
Q ss_pred HccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC--------chhHHHHHHHHHHcCCCCCceEEEeEEEeC
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ--------ADKDFRVEVEAIGHVRHKNLVRLLGYCIEG 242 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~ 242 (498)
..++|.+.+.||+|+||.||+|.. .+++.||||++...... ....+.+|+.+++.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 457899999999999999999974 56889999998654321 234577899999999999999999999999
Q ss_pred CeeEEEEeecCCC-CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeee
Q 010891 243 TQRILVYEYVNNG-NLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDF 321 (498)
Q Consensus 243 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~Df 321 (498)
...++||||+.+| +|.+++. ..+.+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df 174 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFID----RHPRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF 174 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHH----TCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEEeCCCCccHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence 9999999999776 9999997 345699999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCceeeecccccccccCcccccCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhc
Q 010891 322 GLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLL-NEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLR 400 (498)
Q Consensus 322 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 400 (498)
|++........ ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......
T Consensus 175 g~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------- 236 (335)
T 3dls_A 175 GSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------------- 236 (335)
T ss_dssp TTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------
T ss_pred ccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------
Confidence 99998755432 334679999999999988776 88999999999999999999999631110
Q ss_pred cccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 401 RSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.. .........+ ..+..++.+||+.||++|||+.+++++-
T Consensus 237 -~~----~~~~~~~~~~--~~l~~li~~~L~~dP~~Rps~~ell~hp 276 (335)
T 3dls_A 237 -VE----AAIHPPYLVS--KELMSLVSGLLQPVPERRTTLEKLVTDP 276 (335)
T ss_dssp -TT----TCCCCSSCCC--HHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred -Hh----hccCCCcccC--HHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 00 0111111111 2233444589999999999999999874
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=356.41 Aligned_cols=250 Identities=26% Similarity=0.359 Sum_probs=199.5
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCc---hhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQA---DKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
.++|.+.+.||+|+||+||+|+. .+|+.||||++....... .+.+.+|++++++++||||+++++++.++...|+|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 45688999999999999999985 578999999996543322 24688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+. |+|.+++... ...+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 133 ~e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 205 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205 (348)
T ss_dssp EECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence 99997 5888888642 35699999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCceeeecccccccccCccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYAN---SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV 405 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (498)
. .....||+.|+|||++. +..++.++|||||||++|||++|+.||...... ..+..+.....
T Consensus 206 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~------~~~~~~~~~~~---- 270 (348)
T 1u5q_A 206 P-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNES---- 270 (348)
T ss_dssp S-----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCC----
T ss_pred C-----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH------HHHHHHHhcCC----
Confidence 3 23457999999999884 577999999999999999999999999644321 11122221111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 406 VDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 406 ~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
+.......... +..++.+||+.||++|||+.+++++.--
T Consensus 271 --~~~~~~~~~~~---l~~li~~~l~~dP~~Rps~~~ll~h~~~ 309 (348)
T 1u5q_A 271 --PALQSGHWSEY---FRNFVDSCLQKIPQDRPTSEVLLKHRFV 309 (348)
T ss_dssp --CCCCCTTSCHH---HHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred --CCCCCCCCCHH---HHHHHHHHcccChhhCcCHHHHhhChhh
Confidence 11111111222 3334458999999999999999976543
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=361.13 Aligned_cols=265 Identities=26% Similarity=0.350 Sum_probs=206.0
Q ss_pred ccCCCccceEcccCcEEEEEEEE-----cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEE--eCCee
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-----MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCI--EGTQR 245 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~--~~~~~ 245 (498)
.++|++.+.||+|+||.||+|++ .+++.||||++........+.+.+|++++++++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 36789999999999999999984 468899999997665555567899999999999999999999987 45668
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccce
Q 010891 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~ 325 (498)
|+||||+++++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~ 175 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAK 175 (327)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCE
T ss_pred EEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccce
Confidence 9999999999999999753 23589999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCce--eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCc---------chhhHHHHHH
Q 010891 326 LLGAGKSH--ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQ---------SEVNLVEWLK 394 (498)
Q Consensus 326 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~---------~~~~~~~~~~ 394 (498)
........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ..........
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLE 255 (327)
T ss_dssp ECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHH
T ss_pred ecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHH
Confidence 87544322 223356888999999999889999999999999999999999998632110 0000111111
Q ss_pred HHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCC
Q 010891 395 MMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYP 453 (498)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~~~ 453 (498)
...... .... .... ...+..++.+||+.||.+|||+.+++++|+.....
T Consensus 256 ~~~~~~------~~~~--~~~~--~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 304 (327)
T 3lxl_A 256 LLEEGQ------RLPA--PPAC--PAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG 304 (327)
T ss_dssp HHHTTC------CCCC--CTTC--CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred Hhhccc------CCCC--CCcc--cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence 111100 0011 1111 12334445589999999999999999999876543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=345.45 Aligned_cols=248 Identities=28% Similarity=0.433 Sum_probs=197.4
Q ss_pred ccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCC---CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
.++|++.+.||+|+||+||+|... ++..||+|++.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 367899999999999999999754 57789999985422 12245688899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+++++|.+++... ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp ECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 9999999999999743 4689999999999999999999998 99999999999999999999999999986543
Q ss_pred CCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (498)
... .....||+.|+|||++.+..++.++||||||+++|+|++|..||...... +....+.... .
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~-------~ 224 (279)
T 3fdn_A 161 SSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISRVE-------F 224 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHTC-------C
T ss_pred ccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHH------HHHHHHHhCC-------C
Confidence 322 33457999999999999999999999999999999999999999743321 1112221111 0
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 409 NIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.+.. .... .+..++.+||+.||.+|||+.|++++-
T Consensus 225 ~~~~-~~~~---~~~~li~~~l~~~p~~Rps~~e~l~h~ 259 (279)
T 3fdn_A 225 TFPD-FVTE---GARDLISRLLKHNPSQRPMLREVLEHP 259 (279)
T ss_dssp CCCT-TSCH---HHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred CCCC-cCCH---HHHHHHHHHhccChhhCCCHHHHhhCc
Confidence 1111 1112 233344589999999999999999864
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=352.66 Aligned_cols=260 Identities=27% Similarity=0.433 Sum_probs=204.7
Q ss_pred HccCCCccceEcccCcEEEEEEEE--------cCCcEEEEEEecCCCC-CchhHHHHHHHHHHcC-CCCCceEEEeEEEe
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL--------MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHV-RHKNLVRLLGYCIE 241 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~ 241 (498)
..++|.+.+.||+|+||.||+|++ .++..||+|++..... ...+.+.+|++++.++ +||||+++++++.+
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 356899999999999999999986 3467899999865432 2335688999999999 99999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEE
Q 010891 242 GTQRILVYEYVNNGNLEQWLRGDMC------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNIL 309 (498)
Q Consensus 242 ~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIl 309 (498)
....|+||||+++|+|.+++..... ....+++..++.++.||+.||.|||+. +|+||||||+|||
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEE
Confidence 9999999999999999999975421 123489999999999999999999999 9999999999999
Q ss_pred EcCCCCeEEeeeccceecCCCCce-eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchh
Q 010891 310 IDENFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEV 387 (498)
Q Consensus 310 l~~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~ 387 (498)
++.++.+||+|||++......... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--- 266 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--- 266 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH---
Confidence 999999999999999987544322 2233467889999999988889999999999999999999 99999754321
Q ss_pred hHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 388 NLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
+....+...... .... ... ..+..++.+||..||.+|||+.++++.|+..
T Consensus 267 ---~~~~~~~~~~~~------~~~~-~~~---~~l~~li~~~l~~dp~~Rps~~ell~~L~~l 316 (334)
T 2pvf_A 267 ---ELFKLLKEGHRM------DKPA-NCT---NELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316 (334)
T ss_dssp ---HHHHHHHHTCCC------CCCT-TCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---HHHHHHhcCCCC------CCCc-cCC---HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 112222211111 1111 111 2334445589999999999999999999865
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=370.71 Aligned_cols=257 Identities=24% Similarity=0.302 Sum_probs=205.0
Q ss_pred ccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCC---CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
.++|.+.++||+|+||.||+|+.. +|+.||+|++.... ......+..|+.++..++||||+++++++.+....|+|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 467899999999999999999864 69999999985432 22345688899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||++||+|.+++.........+++..++.++.||+.||.|||++ +|+||||||+||||+.+|.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999976543456799999999999999999999999 99999999999999999999999999999875
Q ss_pred CCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (498)
..... ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||........ ..+........
T Consensus 341 ~~~~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~i~~~--------- 408 (543)
T 3c4z_A 341 AGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRVLEQ--------- 408 (543)
T ss_dssp TTCCC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHHHHHC---------
T ss_pred CCCcc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHHHhhc---------
Confidence 44322 3446899999999999999999999999999999999999999976432211 11221222111
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 010891 409 NIETRPSTSALKRALLTALRCVDPDSDKRPKM-----SQVVRM 446 (498)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~-----~ell~~ 446 (498)
....+...+. .+..++.+||..||.+||++ .++++|
T Consensus 409 ~~~~p~~~s~--~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H 449 (543)
T 3c4z_A 409 AVTYPDKFSP--ASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449 (543)
T ss_dssp CCCCCTTSCH--HHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred ccCCCcccCH--HHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence 1111111222 22334448999999999964 777754
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=348.55 Aligned_cols=254 Identities=29% Similarity=0.461 Sum_probs=193.1
Q ss_pred cCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecC
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ 253 (498)
++|++.+.||+|+||+||+|++ .++.||+|++... ...+.+.+|++++++++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 5788899999999999999987 5789999998532 34567899999999999999999999886 34799999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCC-eEEeeeccceecCCCCc
Q 010891 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD-AKISDFGLAKLLGAGKS 332 (498)
Q Consensus 254 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~-~kL~DfGla~~~~~~~~ 332 (498)
+|+|.+++.... ....+++..++.++.|+++||.|||+....+|+||||||+|||++.++. +||+|||++......
T Consensus 83 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 83 GGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 999999997432 2234788999999999999999999932129999999999999998887 799999999865432
Q ss_pred eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCC
Q 010891 333 HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIET 412 (498)
Q Consensus 333 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (498)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ........ .. .+....
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~~-~~-----~~~~~~ 227 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF----RIMWAVHN-GT-----RPPLIK 227 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH----HHHHHHHT-TC-----CCCCBT
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH----HHHHHHhc-CC-----CCCccc
Confidence 2334699999999999999999999999999999999999999975432211 11111111 11 011111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 413 RPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 413 ~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
.... .+..++.+||+.||.+|||+.+++++|+...
T Consensus 228 -~~~~---~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 262 (307)
T 2eva_A 228 -NLPK---PIESLMTRCWSKDPSQRPSMEEIVKIMTHLM 262 (307)
T ss_dssp -TCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred -ccCH---HHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence 1112 2334445899999999999999999998754
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=343.72 Aligned_cols=255 Identities=26% Similarity=0.417 Sum_probs=202.3
Q ss_pred ccCCCccc-eEcccCcEEEEEEEEc---CCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 173 TNRFSKDN-IIGDGGYGVVYRGQLM---NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 173 ~~~y~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
.++|.+.+ .||+|+||.||+|.+. ++..||+|++..... ...+.+.+|++++..++||||+++++++ ..+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 35566666 9999999999999743 578899999976433 2345688999999999999999999999 5567899
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
||||+++++|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++...
T Consensus 87 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp EEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 9999999999999964 345699999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCcee--eecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccC
Q 010891 328 GAGKSHI--TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSED 404 (498)
Q Consensus 328 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (498)
....... .....||+.|+|||++.+..++.++|||||||++|||++ |+.||....... . ...+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~---~~~i~~~~~--- 231 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---V---MAFIEQGKR--- 231 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---H---HHHHHTTCC---
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---H---HHHHhcCCc---
Confidence 5443322 223457899999999988889999999999999999998 999997544321 1 111111110
Q ss_pred CcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 405 VVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
+... ...+ ..+..++.+||+.||.+|||+.+++++|+..
T Consensus 232 ---~~~~--~~~~--~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~ 270 (287)
T 1u59_A 232 ---MECP--PECP--PELYALMSDCWIYKWEDRPDFLTVEQRMRAC 270 (287)
T ss_dssp ---CCCC--TTCC--HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCC--CCcC--HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 1111 1111 2333444589999999999999999999764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=351.09 Aligned_cols=267 Identities=27% Similarity=0.409 Sum_probs=209.3
Q ss_pred HHHHHHHccCCCccceEcccCcEEEEEEEE------cCCcEEEEEEecCCCCC-chhHHHHHHHHHHcC-CCCCceEEEe
Q 010891 166 LRDLQSATNRFSKDNIIGDGGYGVVYRGQL------MNGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHV-RHKNLVRLLG 237 (498)
Q Consensus 166 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpnIv~l~~ 237 (498)
...+....++|.+.+.||+|+||.||+|++ .+++.||+|++...... ..+.+.+|+.++.++ +||||+++++
T Consensus 19 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 19 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 445556678999999999999999999974 34688999999654332 235688999999999 7999999999
Q ss_pred EEEeCC-eeEEEEeecCCCCHHHHHhcccCC------------CCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCC
Q 010891 238 YCIEGT-QRILVYEYVNNGNLEQWLRGDMCD------------RGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIK 304 (498)
Q Consensus 238 ~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~~------------~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDik 304 (498)
++.... ..++||||+++|+|.+++...... ...+++..++.++.|++.||.|||+. +|+|||||
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dik 175 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 175 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCc
Confidence 988754 589999999999999999754221 22388999999999999999999999 99999999
Q ss_pred CCCEEEcCCCCeEEeeeccceecCCCCc-eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCC
Q 010891 305 SSNILIDENFDAKISDFGLAKLLGAGKS-HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGR 382 (498)
Q Consensus 305 p~NIll~~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~ 382 (498)
|+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 176 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 176 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 9999999999999999999987654332 22334568999999999999999999999999999999998 999997544
Q ss_pred CcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 383 PQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
.... . ...+..... ..... ... ..+..++.+||+.||.+|||+.+++++|+..
T Consensus 256 ~~~~--~---~~~~~~~~~------~~~~~-~~~---~~l~~li~~~l~~dp~~Rps~~ell~~L~~~ 308 (316)
T 2xir_A 256 IDEE--F---CRRLKEGTR------MRAPD-YTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308 (316)
T ss_dssp CSHH--H---HHHHHHTCC------CCCCT-TCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred hhHH--H---HHHhccCcc------CCCCC-CCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 3221 1 111111111 01111 111 2334445589999999999999999999864
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=355.41 Aligned_cols=259 Identities=25% Similarity=0.400 Sum_probs=200.6
Q ss_pred cCC-CccceEcccCcEEEEEEEE-----cCCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeC--Ce
Q 010891 174 NRF-SKDNIIGDGGYGVVYRGQL-----MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEG--TQ 244 (498)
Q Consensus 174 ~~y-~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--~~ 244 (498)
++| ++.+.||+|+||+||++.+ .+++.||||++..... ...+.+.+|+++++.++||||+++++++.+. ..
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 344 8899999999999998864 3688999999975533 2345688999999999999999999999884 67
Q ss_pred eEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccc
Q 010891 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (498)
Q Consensus 245 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla 324 (498)
.++||||+++|+|.+++.. ..+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a 181 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPR-----HSIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLA 181 (318)
T ss_dssp EEEEECCCTTCBHHHHGGG-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred EEEEEecccCCcHHHHHhh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcccc
Confidence 8999999999999999964 3489999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCce--eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCc---------chhhHHHHH
Q 010891 325 KLLGAGKSH--ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQ---------SEVNLVEWL 393 (498)
Q Consensus 325 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~---------~~~~~~~~~ 393 (498)
......... ......||..|+|||++.+..++.++|||||||++|+|++|+.||...... .........
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLT 261 (318)
T ss_dssp EECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHH
T ss_pred ccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHH
Confidence 987654322 233456888999999999989999999999999999999999998642110 011111111
Q ss_pred HHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 394 KMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
.... .... .... .... ..+..++.+||+.||.+|||+.++++.|+..
T Consensus 262 ~~~~---~~~~---~~~~-~~~~---~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 308 (318)
T 3lxp_A 262 ELLE---RGER---LPRP-DKCP---AEVYHLMKNCWETEASFRPTFENLIPILKTV 308 (318)
T ss_dssp HHHH---TTCC---CCCC-TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHh---cccC---CCCC-cccc---HHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence 1111 1110 0111 1111 2344455589999999999999999999764
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=341.85 Aligned_cols=262 Identities=20% Similarity=0.272 Sum_probs=199.4
Q ss_pred HHccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEE-EeCCeeEEE
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYC-IEGTQRILV 248 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-~~~~~~~lv 248 (498)
...++|++.+.||+|+||.||+|+. .+++.||||++.... ....+..|+.++..++|++++..+..+ .+....++|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 3457899999999999999999985 678999999875432 234588899999999988877666655 667888999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEE---cCCCCeEEeeeccce
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAK 325 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll---~~~~~~kL~DfGla~ 325 (498)
|||+ +++|.+++... ...+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||+++
T Consensus 84 ~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~ 156 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156 (296)
T ss_dssp EECC-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred EEcc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence 9999 99999999742 35699999999999999999999999 99999999999999 788999999999999
Q ss_pred ecCCCCce------eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhh
Q 010891 326 LLGAGKSH------ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQL 399 (498)
Q Consensus 326 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 399 (498)
........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..............+......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (296)
T 4hgt_A 157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236 (296)
T ss_dssp ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc
Confidence 87554321 123467999999999999999999999999999999999999999865443332222221111100
Q ss_pred ccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 400 RRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
... .... .... ..+..++.+||+.||++|||+.++++.|+..
T Consensus 237 ~~~-~~~~-----~~~~---~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 278 (296)
T 4hgt_A 237 TPI-EVLC-----KGYP---SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp SCH-HHHT-----TTSC---HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred chh-hhhh-----ccCC---HHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence 000 0000 0011 2344445589999999999999999998764
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=372.30 Aligned_cols=257 Identities=23% Similarity=0.308 Sum_probs=205.3
Q ss_pred HHccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCC---CCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeE
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNN---PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI 246 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 246 (498)
...++|.+.++||+|+||.||+|+. .+|+.||+|++... .......+.+|+++|..++||||+++++++.+....|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 3457799999999999999999986 46999999998542 1233456788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecccee
Q 010891 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (498)
Q Consensus 247 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~ 326 (498)
+||||++||+|.+++... ....+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 261 lVmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~ 335 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVH 335 (576)
T ss_dssp EEECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEeccccee
Confidence 999999999999999743 234599999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCc
Q 010891 327 LGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVV 406 (498)
Q Consensus 327 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (498)
...... ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||......... .......... .
T Consensus 336 ~~~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~--~~i~~~i~~~---~--- 405 (576)
T 2acx_A 336 VPEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EEVERLVKEV---P--- 405 (576)
T ss_dssp CCTTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH--HHHHHHHHHC---C---
T ss_pred cccCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH--HHHHHHhhcc---c---
Confidence 754432 33458999999999999999999999999999999999999999764432111 1111111111 0
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHHH
Q 010891 407 DPNIETRPSTSALKRALLTALRCVDPDSDKRP-----KMSQVVRML 447 (498)
Q Consensus 407 ~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RP-----t~~ell~~L 447 (498)
..+. ...+. .+..++.+||..||.+|| ++.|+++|-
T Consensus 406 -~~~p--~~~s~--~~~dLI~~lL~~dP~~R~g~~~~sa~eil~Hp 446 (576)
T 2acx_A 406 -EEYS--ERFSP--QARSLCSQLLCKDPAERLGCRGGSAREVKEHP 446 (576)
T ss_dssp -CCCC--TTSCH--HHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSG
T ss_pred -ccCC--ccCCH--HHHHHHHHhccCCHHHcCCCCCCCHHHHHhCh
Confidence 1111 11112 233344489999999999 789998753
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=352.05 Aligned_cols=268 Identities=24% Similarity=0.302 Sum_probs=197.0
Q ss_pred HHHccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC-----chhHHHHHHHHHHcCCCCCceEEEeEEEeCC
Q 010891 170 QSATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ-----ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT 243 (498)
Q Consensus 170 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 243 (498)
....++|.+.+.||+|+||.||+|+. .+|+.||||++...... ..+.+.+|++++..++||||+++++++.+..
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (346)
T 1ua2_A 6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS 85 (346)
T ss_dssp -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence 34467899999999999999999985 45899999998643221 1346788999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecc
Q 010891 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (498)
Q Consensus 244 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGl 323 (498)
..++||||+++ +|.+++.. ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 86 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (346)
T 1ua2_A 86 NISLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGL 158 (346)
T ss_dssp CCEEEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred ceEEEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEeccc
Confidence 99999999976 89998864 234688999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhh-cc
Q 010891 324 AKLLGAGKSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQL-RR 401 (498)
Q Consensus 324 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-~~ 401 (498)
++...... ......+||+.|+|||++.+ ..++.++|||||||++|||++|..||...... +.+..+... ..
T Consensus 159 a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~------~~~~~i~~~~~~ 231 (346)
T 1ua2_A 159 AKSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL------DQLTRIFETLGT 231 (346)
T ss_dssp GSTTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHHHCC
T ss_pred ceeccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHHHcCC
Confidence 98764332 22344679999999999865 45899999999999999999999998754321 111111111 11
Q ss_pred cc--CCcC----------CCCCCCCC----HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 402 SE--DVVD----------PNIETRPS----TSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 402 ~~--~~~~----------~~~~~~~~----~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
.. ...+ ......+. ......+..++.+||..||.+|||+.|++++.--..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~ 297 (346)
T 1ua2_A 232 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 297 (346)
T ss_dssp CCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred CChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhc
Confidence 10 0000 00000000 001123444555899999999999999998765443
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=340.30 Aligned_cols=261 Identities=20% Similarity=0.274 Sum_probs=203.0
Q ss_pred HccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEE-EeCCeeEEEE
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYC-IEGTQRILVY 249 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-~~~~~~~lv~ 249 (498)
..++|++.+.||+|+||.||+|+. .+|+.||+|++.... ..+.+..|+.++..++|++++..+.++ .+....++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 357899999999999999999985 679999999885543 335688999999999988876665554 5677889999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEE---cCCCCeEEeeecccee
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKL 326 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll---~~~~~~kL~DfGla~~ 326 (498)
||+ +++|.+++.. ....+++..++.++.|++.||.|||++ +|+||||||+|||+ +.++.+||+|||++..
T Consensus 85 e~~-~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 85 ELL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp ECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred Eec-CCCHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 999 8999999974 235699999999999999999999999 99999999999999 4889999999999998
Q ss_pred cCCCCce------eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhc
Q 010891 327 LGAGKSH------ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLR 400 (498)
Q Consensus 327 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 400 (498)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+.......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 237 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence 7554321 1234679999999999999999999999999999999999999998654333222222211111000
Q ss_pred cccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 401 RSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
...... .... ..+..++.+||+.||.+|||+.++++.|+..
T Consensus 238 -~~~~~~-----~~~~---~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~ 278 (296)
T 3uzp_A 238 -PIEVLC-----KGYP---SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 278 (296)
T ss_dssp -CHHHHT-----TTSC---HHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred -chHHHH-----hhCC---HHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence 000000 0011 2334445589999999999999999999764
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=344.54 Aligned_cols=258 Identities=25% Similarity=0.353 Sum_probs=202.6
Q ss_pred ccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCC--chhHHHHHHHHHHcCCCCCceEEEeEEEe--CCeeEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIE--GTQRIL 247 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~l 247 (498)
.++|++.+.||+|+||.||+|+.. +++.||+|++...... ..+.+.+|+.++++++||||+++++++.+ ....|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 467899999999999999999864 6899999998654332 33568899999999999999999998864 567899
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCC-----eeecCCCCCCEEEcCCCCeEEeeec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK-----VVHRDIKSSNILIDENFDAKISDFG 322 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~-----iiHrDikp~NIll~~~~~~kL~DfG 322 (498)
||||+++++|.+++.........+++..++.++.|++.||.|||+. + |+||||||+|||++.++.+||+|||
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg 161 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence 9999999999999976544556699999999999999999999998 7 9999999999999999999999999
Q ss_pred cceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccc
Q 010891 323 LAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRS 402 (498)
Q Consensus 323 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (498)
++........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... +....+.... .
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~i~~~~-~ 233 (279)
T 2w5a_A 162 LARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------ELAGKIREGK-F 233 (279)
T ss_dssp HHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTC-C
T ss_pred hheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH------HHHHHHhhcc-c
Confidence 9987643321 123457999999999999999999999999999999999999999754321 1111221111 1
Q ss_pred cCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 403 EDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
+.+... ... .+..++.+||+.||.+|||+.|+++++...
T Consensus 234 -----~~~~~~-~~~---~l~~li~~~l~~~p~~Rps~~~ll~~~~~~ 272 (279)
T 2w5a_A 234 -----RRIPYR-YSD---ELNEIITRMLNLKDYHRPSVEEILENPLIL 272 (279)
T ss_dssp -----CCCCTT-SCH---HHHHHHHHHTCSSGGGSCCHHHHHTSTTCC
T ss_pred -----ccCCcc-cCH---HHHHHHHHHcCCCcccCCCHHHHHhChhhh
Confidence 011111 112 233444589999999999999999987654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=352.75 Aligned_cols=263 Identities=21% Similarity=0.280 Sum_probs=204.0
Q ss_pred HHHHHHHccCCCcc-ceEcccCcEEEEEEEEc-CCcEEEEEEecCCCC--CchhHHHHHHHHHHcC-CCCCceEEEeEEE
Q 010891 166 LRDLQSATNRFSKD-NIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG--QADKDFRVEVEAIGHV-RHKNLVRLLGYCI 240 (498)
Q Consensus 166 ~~~~~~~~~~y~~~-~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~ 240 (498)
+...+.+.++|.+. +.||+|+||.||+|... +++.||+|++..... .....+.+|+.++..+ +||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~ 99 (327)
T 3lm5_A 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE 99 (327)
T ss_dssp SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence 34456777888887 89999999999999864 589999999865432 2346788999999999 5699999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcC---CCCeE
Q 010891 241 EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE---NFDAK 317 (498)
Q Consensus 241 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~---~~~~k 317 (498)
+....++||||+++|+|.+++... ....+++..++.++.|++.||.|||+. +|+||||||+|||++. ++.+|
T Consensus 100 ~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~k 174 (327)
T 3lm5_A 100 NTSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIK 174 (327)
T ss_dssp CSSEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEE
T ss_pred eCCeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEE
Confidence 999999999999999999998543 346799999999999999999999999 9999999999999988 78999
Q ss_pred EeeeccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHH
Q 010891 318 ISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMV 397 (498)
Q Consensus 318 L~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 397 (498)
|+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ....+.
T Consensus 175 L~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~ 246 (327)
T 3lm5_A 175 IVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE------TYLNIS 246 (327)
T ss_dssp ECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHH
T ss_pred EeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH------HHHHHH
Confidence 99999999765432 2334679999999999999999999999999999999999999997543211 111111
Q ss_pred hhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 398 QLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
.... ..........+ ..+..++.+||+.||++|||+.+++++--
T Consensus 247 ~~~~-----~~~~~~~~~~~--~~~~~li~~~L~~dP~~Rpt~~~ll~h~~ 290 (327)
T 3lm5_A 247 QVNV-----DYSEETFSSVS--QLATDFIQSLLVKNPEKRPTAEICLSHSW 290 (327)
T ss_dssp HTCC-----CCCTTTTTTSC--HHHHHHHHHHSCSSGGGSCCHHHHTTCGG
T ss_pred hccc-----ccCchhhcccC--HHHHHHHHHHcCCChhhCcCHHHHhCCHh
Confidence 1111 01111111111 22334445899999999999999997643
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=351.13 Aligned_cols=256 Identities=29% Similarity=0.476 Sum_probs=196.4
Q ss_pred ccCCCccceEcccCcEEEEEEEEcC-----CcEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLMN-----GTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI 246 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 246 (498)
.++|.+.+.||+|+||.||+|.... +..||+|++...... ....+.+|+.++..++||||+++++++.+....+
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 3567888999999999999997543 246999998654332 2346889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecccee
Q 010891 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (498)
Q Consensus 247 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~ 326 (498)
+||||+++|+|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.
T Consensus 123 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 123 IITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999999974 235699999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCce--eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhcccc
Q 010891 327 LGAGKSH--ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSE 403 (498)
Q Consensus 327 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (498)
....... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... +....+.....
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------~~~~~~~~~~~-- 268 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH------EVMKAINDGFR-- 268 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTTCC--
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH------HHHHHHHCCCc--
Confidence 6543211 1222356889999999999999999999999999999999 99999643321 11122211111
Q ss_pred CCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 404 DVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
. ... ..... .+..++.+||+.||.+||++.+++++|+..
T Consensus 269 -~---~~~-~~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 307 (333)
T 1mqb_A 269 -L---PTP-MDCPS---AIYQLMMQCWQQERARRPKFADIVSILDKL 307 (333)
T ss_dssp -C---CCC-TTCBH---HHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -C---CCc-ccCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0 000 11122 334445589999999999999999999764
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=351.14 Aligned_cols=257 Identities=26% Similarity=0.407 Sum_probs=199.3
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEE--EEEEecCCC-CCchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCeeEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAV--AVKKLLNNP-GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~v--avK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv 248 (498)
++|.+.+.||+|+||.||+|+. .++..+ |+|.+.... ....+.+.+|++++.++ +||||+++++++.+....|+|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 5788999999999999999974 456644 999886432 23446788999999999 999999999999999999999
Q ss_pred EeecCCCCHHHHHhccc------------CCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCe
Q 010891 249 YEYVNNGNLEQWLRGDM------------CDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDA 316 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~ 316 (498)
|||+++|+|.+++.... .....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeE
Confidence 99999999999997542 2235799999999999999999999999 99999999999999999999
Q ss_pred EEeeeccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHH
Q 010891 317 KISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKM 395 (498)
Q Consensus 317 kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~ 395 (498)
||+|||+++..... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||...... +....
T Consensus 182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~------~~~~~ 253 (327)
T 1fvr_A 182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA------ELYEK 253 (327)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHH
T ss_pred EEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHH------HHHHH
Confidence 99999999743221 11233457889999999998899999999999999999998 99999754321 11111
Q ss_pred HHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 396 MVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
+.. .. .... ....+ ..+..++.+||..||.+|||+.+++++|+...
T Consensus 254 ~~~---~~---~~~~--~~~~~--~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~ 299 (327)
T 1fvr_A 254 LPQ---GY---RLEK--PLNCD--DEVYDLMRQCWREKPYERPSFAQILVSLNRML 299 (327)
T ss_dssp GGG---TC---CCCC--CTTBC--HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhc---CC---CCCC--CCCCC--HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 111 10 0111 11111 23344455899999999999999999998643
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=341.99 Aligned_cols=252 Identities=24% Similarity=0.353 Sum_probs=199.1
Q ss_pred ccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCC------chhHHHHHHHHHHcCCCCCceEEEeEEEeCCee
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ------ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQR 245 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 245 (498)
.++|.+.+.||+|+||.||+|+.. +|+.||+|.+...... ..+.+.+|+.++++++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 457899999999999999999865 6899999998654321 346789999999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCC----CeEEeee
Q 010891 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF----DAKISDF 321 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~----~~kL~Df 321 (498)
++||||+++++|.+++.. ...+++..++.++.|++.||.|||+. +++||||||+||+++.++ .+||+||
T Consensus 84 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~df 156 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDF 156 (283)
T ss_dssp EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEec
Confidence 999999999999999974 34689999999999999999999999 999999999999998877 8999999
Q ss_pred ccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhcc
Q 010891 322 GLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRR 401 (498)
Q Consensus 322 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 401 (498)
|++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||...... +.+..+....
T Consensus 157 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~- 227 (283)
T 3bhy_A 157 GIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ------ETLTNISAVN- 227 (283)
T ss_dssp TTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTTC-
T ss_pred ccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchH------HHHHHhHhcc-
Confidence 9998765432 233456999999999999999999999999999999999999999754321 1111111111
Q ss_pred ccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 402 SEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
....... .... ...+..++.+||..||++|||+.+++++
T Consensus 228 --~~~~~~~--~~~~--~~~~~~li~~~l~~dp~~Rps~~~~l~h 266 (283)
T 3bhy_A 228 --YDFDEEY--FSNT--SELAKDFIRRLLVKDPKRRMTIAQSLEH 266 (283)
T ss_dssp --CCCCHHH--HTTC--CHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred --cCCcchh--cccC--CHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence 0000000 0011 1223444558999999999999999974
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=364.15 Aligned_cols=199 Identities=25% Similarity=0.378 Sum_probs=167.4
Q ss_pred HccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC--chhHHHHHHHHHHcCCCCCceEEEeEEEeC-----C
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEG-----T 243 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~ 243 (498)
+.++|.+.+.||+|+||.||+|.. .+++.||||++...... ..+.+.+|+++|+.++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 356899999999999999999985 45889999999654322 335688999999999999999999999876 5
Q ss_pred eeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecc
Q 010891 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (498)
Q Consensus 244 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGl 323 (498)
..|+||||++ ++|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+
T Consensus 104 ~~~lv~e~~~-~~L~~~~~----~~~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFK----TPIFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp CEEEEEECCS-EEHHHHHH----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecCC-cCHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCC
Confidence 6899999996 59999997 346699999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCc---------------------eeeecccccccccCcccc-cCCCCCccchHHHHHHHHHHHHhCCCCC
Q 010891 324 AKLLGAGKS---------------------HITTRVMGTFGYVAPEYA-NSGLLNEKSDVYSFGVVLLEAITGRYPV 378 (498)
Q Consensus 324 a~~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvvl~elltg~~P~ 378 (498)
++....... ...+..+||++|+|||++ ....|+.++|||||||++|||++|..||
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 998654321 123557899999999985 6677999999999999999999865544
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=348.84 Aligned_cols=265 Identities=25% Similarity=0.390 Sum_probs=197.3
Q ss_pred ccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCCc--hhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQA--DKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
.++|++.+.||+|+||.||+|+.. +|+.||+|++....... .+.+.+|+.+++.++||||+++++++.+....|+||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 357899999999999999999864 48999999986544332 345778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+++++|.+++. ....+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.....
T Consensus 104 e~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 104 EFVDHTILDDLEL----FPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp ECCSEEHHHHHHH----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecCCcchHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 9999999998875 335699999999999999999999999 999999999999999999999999999987644
Q ss_pred CCceeeecccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH-----------HH
Q 010891 330 GKSHITTRVMGTFGYVAPEYANSG-LLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKM-----------MV 397 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~-----------~~ 397 (498)
... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||........ ....... ..
T Consensus 177 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 253 (331)
T 4aaa_A 177 PGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ--LYHIMMCLGNLIPRHQELFN 253 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCHHHHHHHH
T ss_pred Ccc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCCChhhhhHhh
Confidence 322 23345799999999998765 789999999999999999999999975432211 1111000 00
Q ss_pred hhccccCCcCCCCCCCCCHH-----HHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 398 QLRRSEDVVDPNIETRPSTS-----ALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
..........+......... ....+..++.+||+.||++|||+.|++++-
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp 308 (331)
T 4aaa_A 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHD 308 (331)
T ss_dssp HCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred hccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCc
Confidence 00000111111111111110 112344555689999999999999999753
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=356.77 Aligned_cols=200 Identities=27% Similarity=0.436 Sum_probs=174.8
Q ss_pred ccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
.++|++.+.||+|+||.||+|+.. ++..||+|++..... ...+.+.+|+.+++.++||||+++++++.++...|+|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467999999999999999999864 689999999865432 233568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
|+++++|.+++... +.+++..+..++.|++.||.|||+.+ +|+||||||+|||++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999999743 46899999999999999999999832 8999999999999999999999999999754321
Q ss_pred CceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 010891 331 KSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYG 381 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~ 381 (498)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 233 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPP 233 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCC
T ss_pred ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 233457999999999999999999999999999999999999999754
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=343.71 Aligned_cols=250 Identities=25% Similarity=0.402 Sum_probs=203.5
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
.+.|.+.+.||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.++..++||||+++++++.+....|+|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 45688999999999999999975 4689999999865443 345678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
|+++++|.+++. .+.+++..+..++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++......
T Consensus 101 ~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 101 YLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred eCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 999999999995 35699999999999999999999999 9999999999999999999999999999887543
Q ss_pred CceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCC
Q 010891 331 KSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNI 410 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (498)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... .....+... . .+.+
T Consensus 173 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~-~-----~~~~ 239 (303)
T 3a7i_A 173 QI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPM------KVLFLIPKN-N-----PPTL 239 (303)
T ss_dssp BC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHS-C-----CCCC
T ss_pred cc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHH------HHHHHhhcC-C-----CCCC
Confidence 32 233457999999999999999999999999999999999999999743321 111111111 1 1111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 411 ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 411 ~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
... ... .+..++.+||+.||.+|||+.+++++.
T Consensus 240 ~~~-~~~---~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 240 EGN-YSK---PLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp CSS-CCH---HHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred ccc-cCH---HHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 111 112 233444589999999999999999764
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=351.08 Aligned_cols=259 Identities=20% Similarity=0.301 Sum_probs=190.8
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC--chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
.++|.+.+.||+|+||+||+|.. .+++.||||++...... ..+.+.+|+.+++.++||||+++++++.++...|+||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 46799999999999999999975 46899999998644322 2345778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEc-----CCCCeEEeeeccc
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID-----ENFDAKISDFGLA 324 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~-----~~~~~kL~DfGla 324 (498)
||+++ +|.+++.. .+.+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||++
T Consensus 113 e~~~~-~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 113 EYAEN-DLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp ECCSE-EHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred ecCCC-CHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 99975 99999974 35699999999999999999999999 999999999999994 4556999999999
Q ss_pred eecCCCCceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhh-ccc
Q 010891 325 KLLGAGKSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQL-RRS 402 (498)
Q Consensus 325 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~ 402 (498)
+....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... +.+..+... ...
T Consensus 185 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~~~~~~~~~ 257 (329)
T 3gbz_A 185 RAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI------DQLFKIFEVLGLP 257 (329)
T ss_dssp HHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHHHCCC
T ss_pred cccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH------HHHHHHHHHhCCC
Confidence 87653322 2344578999999999876 45899999999999999999999999754321 111111111 111
Q ss_pred cCCcC-------------CCCCCCCCHH------HHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 403 EDVVD-------------PNIETRPSTS------ALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 403 ~~~~~-------------~~~~~~~~~~------~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
....- +.... .... ....+..++.+||+.||.+|||+.|+++|-
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 320 (329)
T 3gbz_A 258 DDTTWPGVTALPDWKQSFPKFRG-KTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHP 320 (329)
T ss_dssp CTTTSTTGGGSTTCCTTCCCCCC-CCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred chhhhhhhhhhhhhhhhhhhhcc-ccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCc
Confidence 00000 00000 0000 012334555689999999999999999854
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-43 Score=342.33 Aligned_cols=255 Identities=27% Similarity=0.399 Sum_probs=199.3
Q ss_pred HccCCCccc-eEcccCcEEEEEEEE---cCCcEEEEEEecCCCCC--chhHHHHHHHHHHcCCCCCceEEEeEEEeCCee
Q 010891 172 ATNRFSKDN-IIGDGGYGVVYRGQL---MNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQR 245 (498)
Q Consensus 172 ~~~~y~~~~-~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 245 (498)
..++|.+.+ .||+|+||.||+|.+ .+++.||||++...... ..+.+.+|+++++.++||||+++++++ +....
T Consensus 14 ~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred cchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 346788887 999999999999964 34688999998654322 245788999999999999999999999 56778
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccce
Q 010891 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~ 325 (498)
++||||+++++|.+++.. .+.+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 93 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 999999999999999974 35699999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCcee--eecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccc
Q 010891 326 LLGAGKSHI--TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRS 402 (498)
Q Consensus 326 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (498)
......... .....||+.|+|||++.+..++.++||||||+++|+|++ |+.||...... +..........
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~- 238 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------EVTAMLEKGER- 238 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHHHTTCC-
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH------HHHHHHHcCCC-
Confidence 875543322 222456789999999988889999999999999999999 99999754321 11111111110
Q ss_pred cCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 403 EDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
+.... ... ..+..++.+||+.||.+|||+.++++.|+..
T Consensus 239 -----~~~~~-~~~---~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 277 (291)
T 1xbb_A 239 -----MGCPA-GCP---REMYDLMNLCWTYDVENRPGFAAVELRLRNY 277 (291)
T ss_dssp -----CCCCT-TCC---HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -----CCCCC-CCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11111 111 2334445589999999999999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=369.62 Aligned_cols=199 Identities=29% Similarity=0.339 Sum_probs=166.7
Q ss_pred HccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC--CCchhHHHHHHHHHHcCCCCCceEEEeEEEeC------
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG------ 242 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------ 242 (498)
..++|++.+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 357899999999999999999975 468999999996542 22345688899999999999999999999754
Q ss_pred CeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeec
Q 010891 243 TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFG 322 (498)
Q Consensus 243 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfG 322 (498)
...|+||||+++ +|.+.+.. .+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred CeEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEE
Confidence 456999999976 57777742 389999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 010891 323 LAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 323 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~ 382 (498)
+++..... ...+..+||+.|+|||++.+..|+.++|||||||+||||++|+.||....
T Consensus 210 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~ 267 (464)
T 3ttj_A 210 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 267 (464)
T ss_dssp CC-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eeeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99876543 22455789999999999999999999999999999999999999997543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=341.82 Aligned_cols=255 Identities=24% Similarity=0.354 Sum_probs=202.0
Q ss_pred HccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCC-CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
..++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.++...|+||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 3467899999999999999999864 68999999985433 233467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+++++|.+++. ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++.....
T Consensus 85 e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 85 EYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp ECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred EecCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 9999999999886 335699999999999999999999999 999999999999999999999999999987643
Q ss_pred CCc-eeeecccccccccCcccccCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcC
Q 010891 330 GKS-HITTRVMGTFGYVAPEYANSGLL-NEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407 (498)
Q Consensus 330 ~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (498)
... .......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||........ .... ..... ...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~----~~~~~---~~~- 228 (276)
T 2yex_A 158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSD----WKEKK---TYL- 228 (276)
T ss_dssp TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHH----HHTTC---TTS-
T ss_pred CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHH----hhhcc---ccc-
Confidence 221 22344679999999999987665 7899999999999999999999975443221 1111 11110 000
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 408 ~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
......+ .....++.+||+.||.+|||+.|++++.
T Consensus 229 ---~~~~~~~--~~~~~li~~~l~~~p~~Rps~~~il~~~ 263 (276)
T 2yex_A 229 ---NPWKKID--SAPLALLHKILVENPSARITIPDIKKDR 263 (276)
T ss_dssp ---TTGGGSC--HHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred ---CchhhcC--HHHHHHHHHHCCCCchhCCCHHHHhcCc
Confidence 0001111 2233445589999999999999998753
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=378.31 Aligned_cols=254 Identities=26% Similarity=0.416 Sum_probs=196.9
Q ss_pred cCCCccc-eEcccCcEEEEEEEEc---CCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 174 NRFSKDN-IIGDGGYGVVYRGQLM---NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 174 ~~y~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
+++.+.+ .||+|+||.||+|.+. ++..||||++..... ...+.+.+|+++|++++|||||++++++.+ +..|+|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 3444454 7999999999999753 466799999966433 345679999999999999999999999976 568999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+++|+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 414 ~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 999999999999964 345699999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCcee--eecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCC
Q 010891 329 AGKSHI--TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV 405 (498)
Q Consensus 329 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (498)
...... .....+|+.|+|||++.+..++.++|||||||+||||++ |+.||....... . ...+..... .
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~---~~~i~~~~~---~ 558 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---V---MAFIEQGKR---M 558 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---H---HHHHHTTCC---C
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---H---HHHHHcCCC---C
Confidence 332221 122346789999999999999999999999999999998 999997654322 1 112211111 1
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 406 VDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 406 ~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
...... ...+..++.+||+.||++|||+.++++.|+..
T Consensus 559 -----~~p~~~--~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~ 596 (613)
T 2ozo_A 559 -----ECPPEC--PPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 596 (613)
T ss_dssp -----CCCTTC--CHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred -----CCCCcC--CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 111111 12344455589999999999999999998763
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=348.03 Aligned_cols=264 Identities=23% Similarity=0.380 Sum_probs=195.9
Q ss_pred HHHHHccCCCccceEcccCcEEEEEEEEc----CCcEEEEEEecCCCCC--chhHHHHHHHHHHcCCCCCceEEEeEEEe
Q 010891 168 DLQSATNRFSKDNIIGDGGYGVVYRGQLM----NGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIE 241 (498)
Q Consensus 168 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 241 (498)
++....++|.+.+.||+|+||.||+|... ++..||+|.+...... ..+.+.+|+.++++++||||+++++++.+
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 33445678999999999999999999753 3458999998654332 23568899999999999999999999987
Q ss_pred CC-----eeEEEEeecCCCCHHHHHhccc--CCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCC
Q 010891 242 GT-----QRILVYEYVNNGNLEQWLRGDM--CDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF 314 (498)
Q Consensus 242 ~~-----~~~lv~e~~~~g~L~~~l~~~~--~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~ 314 (498)
.. ..++||||+++|+|.+++.... .....+++..++.++.||+.||.|||+. +|+||||||+|||++.++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTS
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCC
Confidence 54 3499999999999999995432 2345699999999999999999999999 999999999999999999
Q ss_pred CeEEeeeccceecCCCCce-eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHH
Q 010891 315 DAKISDFGLAKLLGAGKSH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEW 392 (498)
Q Consensus 315 ~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~ 392 (498)
.+||+|||++......... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||........ .
T Consensus 185 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~-- 259 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM---Y-- 259 (313)
T ss_dssp CEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---H--
T ss_pred cEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH---H--
Confidence 9999999999876443221 1233457889999999999999999999999999999999 8899975443221 1
Q ss_pred HHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 393 LKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 393 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
........ +.... ... ..+..++.+||..||.+|||+.+++++|+..
T Consensus 260 -~~~~~~~~------~~~~~-~~~---~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l 306 (313)
T 3brb_A 260 -DYLLHGHR------LKQPE-DCL---DELYEIMYSCWRTDPLDRPTFSVLRLQLEKL 306 (313)
T ss_dssp -HHHHTTCC------CCCBT-TCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHHHcCCC------CCCCc-ccc---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11111111 11111 111 2344445589999999999999999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=355.09 Aligned_cols=262 Identities=24% Similarity=0.383 Sum_probs=205.9
Q ss_pred HHccCCCccceEcccCcEEEEEEEEcC-C-----cEEEEEEecCCCCC-chhHHHHHHHHHHcC-CCCCceEEEeEEEeC
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQLMN-G-----TAVAVKKLLNNPGQ-ADKDFRVEVEAIGHV-RHKNLVRLLGYCIEG 242 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~ 242 (498)
...++|.+.+.||+|+||.||+|.... + ..||+|.+...... ..+.+.+|+.++..+ +||||+++++++.+.
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 122 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG 122 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC
Confidence 345789999999999999999998632 2 47999998654432 345688999999999 899999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcccC----------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcC
Q 010891 243 TQRILVYEYVNNGNLEQWLRGDMC----------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE 312 (498)
Q Consensus 243 ~~~~lv~e~~~~g~L~~~l~~~~~----------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~ 312 (498)
...++||||+++|+|.+++..... ....+++..++.++.||+.||.|||+. +|+||||||+|||++.
T Consensus 123 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~ 199 (333)
T 2i1m_A 123 GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTN 199 (333)
T ss_dssp SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEG
T ss_pred CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECC
Confidence 999999999999999999964321 134689999999999999999999999 9999999999999999
Q ss_pred CCCeEEeeeccceecCCCCc-eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHH
Q 010891 313 NFDAKISDFGLAKLLGAGKS-HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLV 390 (498)
Q Consensus 313 ~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~ 390 (498)
++.+||+|||++........ .......||+.|+|||++.+..++.++|||||||++|||++ |..||......... .
T Consensus 200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~--~ 277 (333)
T 2i1m_A 200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF--Y 277 (333)
T ss_dssp GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH--H
T ss_pred CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH--H
Confidence 99999999999987643322 22334567889999999988899999999999999999999 99999754432211 1
Q ss_pred HHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 391 EWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 391 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
....... . .... .... ..+..++.+||+.||.+|||+.+++++|+..
T Consensus 278 ----~~~~~~~--~---~~~~-~~~~---~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~ 324 (333)
T 2i1m_A 278 ----KLVKDGY--Q---MAQP-AFAP---KNIYSIMQACWALEPTHRPTFQQICSFLQEQ 324 (333)
T ss_dssp ----HHHHHTC--C---CCCC-TTCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ----HHHhcCC--C---CCCC-CCCC---HHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence 1111110 0 0001 1111 2334455589999999999999999999864
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=342.03 Aligned_cols=246 Identities=26% Similarity=0.407 Sum_probs=200.3
Q ss_pred cCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCC---CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
++|.+.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++..++||||+++++++.+....|+||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57899999999999999999864 57889999985421 223456889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+++++|.+++... +.+++..++.++.|++.||.|||+. +|+||||||+||+++.++.+||+|||++.....
T Consensus 94 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 94 EFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 999999999999743 4689999999999999999999999 999999999999999999999999999987643
Q ss_pred CCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
.. .....||+.|+|||++.+..++.++||||||+++|+|++|..||...... +....+... .
T Consensus 167 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~---------~ 228 (284)
T 2vgo_A 167 LR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT------ETHRRIVNV---------D 228 (284)
T ss_dssp SC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHTT---------C
T ss_pred cc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh------HHHHHHhcc---------c
Confidence 22 23457999999999999999999999999999999999999999753321 111111111 1
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
.......+. .+..++.+||..||.+|||+.+++++
T Consensus 229 ~~~~~~~~~--~~~~li~~~l~~~p~~Rps~~~ll~h 263 (284)
T 2vgo_A 229 LKFPPFLSD--GSKDLISKLLRYHPPQRLPLKGVMEH 263 (284)
T ss_dssp CCCCTTSCH--HHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred cCCCCcCCH--HHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence 111111112 23344458999999999999999974
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=370.65 Aligned_cols=253 Identities=23% Similarity=0.341 Sum_probs=202.8
Q ss_pred HccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCC---CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
..++|++.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+....|+
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4568999999999999999999864 78999999986543 2345678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEE---cCCCCeEEeeeccc
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLA 324 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll---~~~~~~kL~DfGla 324 (498)
||||+.+|+|.+++. ..+.+++..+..++.||+.||.|||++ +|+||||||+|||+ +.++.+||+|||++
T Consensus 104 v~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 176 (484)
T 3nyv_A 104 VGEVYTGGELFDEII----SRKRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS 176 (484)
T ss_dssp EECCCCSCBHHHHHH----TCSCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred EEecCCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence 999999999999997 346799999999999999999999999 99999999999999 56789999999999
Q ss_pred eecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccC
Q 010891 325 KLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSED 404 (498)
Q Consensus 325 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (498)
....... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||...... +.+..+......
T Consensus 177 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~~-- 245 (484)
T 3nyv_A 177 THFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY------DILKKVEKGKYT-- 245 (484)
T ss_dssp HHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCC--
T ss_pred EEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHcCCCC--
Confidence 8765432 2344679999999999876 6999999999999999999999999754321 112222211100
Q ss_pred CcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 405 VVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.........+ ..+..++.+||..||.+|||+.|+++|-
T Consensus 246 ---~~~~~~~~~s--~~~~~li~~~L~~dp~~R~s~~e~l~h~ 283 (484)
T 3nyv_A 246 ---FELPQWKKVS--ESAKDLIRKMLTYVPSMRISARDALDHE 283 (484)
T ss_dssp ---CCSGGGGGSC--HHHHHHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred ---CCCcccccCC--HHHHHHHHHHCCCChhHCcCHHHHhhCh
Confidence 0111111111 2233444589999999999999999754
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=341.71 Aligned_cols=251 Identities=24% Similarity=0.395 Sum_probs=202.7
Q ss_pred HHccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEe--------
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIE-------- 241 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-------- 241 (498)
...++|++.+.||+|+||.||+|+.. +++.||+|++.... +.+.+|++++..++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 45568999999999999999999875 78999999986542 457789999999999999999998864
Q ss_pred --------CCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCC
Q 010891 242 --------GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN 313 (498)
Q Consensus 242 --------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~ 313 (498)
....++||||+++++|.+++... ....+++..++.++.|++.||.|||+. +|+||||||+|||++.+
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR--RGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDT 158 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHG--GGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEET
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCC
Confidence 44579999999999999999754 235699999999999999999999999 99999999999999999
Q ss_pred CCeEEeeeccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 010891 314 FDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWL 393 (498)
Q Consensus 314 ~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~ 393 (498)
+.+||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||.. . ....
T Consensus 159 ~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~-----~---~~~~ 228 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE-----T---SKFF 228 (284)
T ss_dssp TEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH-----H---HHHH
T ss_pred CCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh-----H---HHHH
Confidence 9999999999988754432 2345699999999999999999999999999999999999988741 1 1111
Q ss_pred HHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCC
Q 010891 394 KMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYP 453 (498)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~~~ 453 (498)
..... ..+... .... +..++.+||+.||.+|||+.|++++|......
T Consensus 229 ~~~~~---------~~~~~~-~~~~---~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 229 TDLRD---------GIISDI-FDKK---EKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HHHHT---------TCCCTT-SCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred HHhhc---------cccccc-CCHH---HHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 11111 011111 1122 33444589999999999999999999876543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=350.38 Aligned_cols=250 Identities=21% Similarity=0.323 Sum_probs=202.0
Q ss_pred ccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCC---CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
.++|.+.+.||+|+||.||+++.. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+....|+|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 467899999999999999999864 578999999854422 2345688899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+++++|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++....
T Consensus 120 ~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 120 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp ECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999999999874 25689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (498)
.... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... +........ ..
T Consensus 193 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~------~~~~~~~~~---~~---- 258 (335)
T 2owb_A 193 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLRIKKN---EY---- 258 (335)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHT---CC----
T ss_pred cCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHH------HHHHHHhcC---CC----
Confidence 3322 233467999999999999999999999999999999999999999753321 111111111 10
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 409 NIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.+. ...+ ..+..++.+||+.||++|||+.|++++-
T Consensus 259 ~~~--~~~~--~~~~~li~~~l~~dp~~Rps~~ell~~~ 293 (335)
T 2owb_A 259 SIP--KHIN--PVAASLIQKMLQTDPTARPTINELLNDE 293 (335)
T ss_dssp CCC--TTSC--HHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred CCC--ccCC--HHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence 111 1111 1233344589999999999999999753
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=353.36 Aligned_cols=256 Identities=23% Similarity=0.353 Sum_probs=185.2
Q ss_pred HccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCC-CCCceEEEeEEE--------e
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-HKNLVRLLGYCI--------E 241 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~--------~ 241 (498)
...+|++.++||+|+||.||+|++ .+++.||+|++........+.+.+|+.++.++. ||||+++++++. .
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 346889999999999999999985 468999999986655555567889999999995 999999999994 3
Q ss_pred CCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCC--eeecCCCCCCEEEcCCCCeEEe
Q 010891 242 GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK--VVHRDIKSSNILIDENFDAKIS 319 (498)
Q Consensus 242 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--iiHrDikp~NIll~~~~~~kL~ 319 (498)
....++||||+. |+|.+++.... ..+.+++..++.++.||+.||.|||+. + |+||||||+|||++.++.+||+
T Consensus 106 ~~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~ 180 (337)
T 3ll6_A 106 QAEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLC 180 (337)
T ss_dssp SEEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBC
T ss_pred CceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEe
Confidence 345799999995 69999986432 345799999999999999999999998 8 9999999999999999999999
Q ss_pred eeccceecCCCCce-----------eeecccccccccCcccc---cCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcc
Q 010891 320 DFGLAKLLGAGKSH-----------ITTRVMGTFGYVAPEYA---NSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQS 385 (498)
Q Consensus 320 DfGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~ 385 (498)
|||++......... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||.......
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~ 260 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR 260 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH
Confidence 99999876543211 11135699999999998 56778999999999999999999999996432211
Q ss_pred hhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 386 EVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
.. .. . .. ..+ ....... +..++.+||+.||.+|||+.|++++|+...
T Consensus 261 ------~~---~~--~-~~-~~~---~~~~~~~---~~~li~~~l~~~p~~Rps~~e~l~~l~~~~ 307 (337)
T 3ll6_A 261 ------IV---NG--K-YS-IPP---HDTQYTV---FHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307 (337)
T ss_dssp -----------------CC-CCT---TCCSSGG---GHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------hh---cC--c-cc-CCc---ccccchH---HHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 00 00 0 00 000 0111111 333445899999999999999999997653
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=366.73 Aligned_cols=252 Identities=24% Similarity=0.332 Sum_probs=196.6
Q ss_pred HccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCC--CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
+.++|++.+.||+|+||+||+|+.. ++..||+|++.... ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3567999999999999999999864 68899999986543 23356788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCC---CCeEEeeeccce
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN---FDAKISDFGLAK 325 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~---~~~kL~DfGla~ 325 (498)
|||+++|+|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.+ +.+||+|||++.
T Consensus 115 ~e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~ 187 (494)
T 3lij_A 115 MECYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187 (494)
T ss_dssp EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence 9999999999998643 5689999999999999999999999 99999999999999764 559999999998
Q ss_pred ecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCC
Q 010891 326 LLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV 405 (498)
Q Consensus 326 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (498)
...... .....+||+.|+|||++. +.|+.++|||||||++|+|++|..||...... +.+..+..... .
T Consensus 188 ~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~---~ 255 (494)
T 3lij_A 188 VFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ------EILRKVEKGKY---T 255 (494)
T ss_dssp ECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCC---C
T ss_pred ECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCC---C
Confidence 875432 234467999999999886 46999999999999999999999999754321 12222221111 0
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 406 VDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 406 ~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
... ......+. .+..++.+||..||.+|||+.|+++|
T Consensus 256 ~~~--~~~~~~s~--~~~~li~~~L~~dp~~R~s~~e~l~h 292 (494)
T 3lij_A 256 FDS--PEWKNVSE--GAKDLIKQMLQFDSQRRISAQQALEH 292 (494)
T ss_dssp CCS--GGGTTSCH--HHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred CCc--hhcccCCH--HHHHHHHHHCCCChhhCccHHHHhcC
Confidence 110 11111112 23334458999999999999999965
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=342.45 Aligned_cols=249 Identities=23% Similarity=0.328 Sum_probs=197.4
Q ss_pred HccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCC--chhHHHHHHHHHHcC-CCCCceEEEeEEEeCCeeEE
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~l 247 (498)
..++|++.+.||+|+||+||+|... +++.||+|++...... ....+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4567999999999999999999864 7899999998654332 345678899999999 99999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCC--------------
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN-------------- 313 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~-------------- 313 (498)
||||+++++|.+++.........+++..++.++.||+.||.|||++ +|+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999975433346799999999999999999999999 99999999999999844
Q ss_pred -----CCeEEeeeccceecCCCCceeeecccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcchh
Q 010891 314 -----FDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSG-LLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEV 387 (498)
Q Consensus 314 -----~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~ 387 (498)
..+||+|||++....... ...||+.|+|||++.+. .++.++|||||||++|+|++|..|+....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~----- 235 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD----- 235 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-----
Confidence 479999999999875432 23589999999998765 66789999999999999999987764321
Q ss_pred hHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 388 NLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
. ...... ... +.+... ... .+..++.+||+.||++|||+.+++++-
T Consensus 236 ~----~~~~~~-~~~-----~~~~~~-~~~---~~~~li~~~l~~dp~~Rps~~~ll~h~ 281 (289)
T 1x8b_A 236 Q----WHEIRQ-GRL-----PRIPQV-LSQ---EFTELLKVMIHPDPERRPSAMALVKHS 281 (289)
T ss_dssp H----HHHHHT-TCC-----CCCSSC-CCH---HHHHHHHHHTCSSGGGSCCHHHHHTCT
T ss_pred H----HHHHHc-CCC-----CCCCcc-cCH---HHHHHHHHHhCCCcccCCCHHHHhhCh
Confidence 1 111111 111 111111 112 233444589999999999999998764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=356.73 Aligned_cols=255 Identities=28% Similarity=0.445 Sum_probs=189.6
Q ss_pred CCCccceEcccCcEEEEEEEEc--CC--cEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEe-CCeeEEE
Q 010891 175 RFSKDNIIGDGGYGVVYRGQLM--NG--TAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIE-GTQRILV 248 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv 248 (498)
.|.+.+.||+|+||+||+|++. ++ ..||+|.+..... ...+.+.+|+.++++++||||+++++++.+ +...++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4677889999999999999753 22 3689998864332 334678999999999999999999998764 4678999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+++|+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++...
T Consensus 170 ~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence 999999999999974 335688999999999999999999999 99999999999999999999999999998764
Q ss_pred CCCce---eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccC
Q 010891 329 AGKSH---ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSED 404 (498)
Q Consensus 329 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (498)
..... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||........ .. ..... ..
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~---~~---~~~~~---~~ 314 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TV---YLLQG---RR 314 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH---HH---HHHTT---CC
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH---HH---HHHcC---CC
Confidence 33211 1233467889999999999999999999999999999999 6777765443221 11 11111 11
Q ss_pred CcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 405 VVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
...+ ..... .+..++.+||+.||++|||+.++++.|+...
T Consensus 315 ~~~p----~~~~~---~l~~li~~cl~~dp~~RPs~~ell~~L~~i~ 354 (373)
T 3c1x_A 315 LLQP----EYCPD---PLYEVMLKCWHPKAEMRPSFSELVSRISAIF 354 (373)
T ss_dssp CCCC----TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCC----CCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111 11122 3344455899999999999999999998753
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=356.82 Aligned_cols=270 Identities=22% Similarity=0.264 Sum_probs=205.7
Q ss_pred ccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCC--eeEEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT--QRILV 248 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--~~~lv 248 (498)
.++|.+.++||+|+||+||+|++. +|+.||||++..... ...+.+.+|++++++++||||+++++++.+.. ..|+|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 467899999999999999999864 489999999864332 33466788999999999999999999998765 77999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEE----cCCCCeEEeeeccc
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI----DENFDAKISDFGLA 324 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll----~~~~~~kL~DfGla 324 (498)
|||+++|+|.+++.... ....+++..++.++.||+.||.|||+. +|+||||||+|||+ +.++.+||+|||++
T Consensus 88 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp ECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred EecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 99999999999997542 223499999999999999999999999 99999999999999 77888999999999
Q ss_pred eecCCCCceeeecccccccccCcccccC--------CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH
Q 010891 325 KLLGAGKSHITTRVMGTFGYVAPEYANS--------GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMM 396 (498)
Q Consensus 325 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 396 (498)
+...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..+.+..+
T Consensus 164 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~--~~~~~~~~ 239 (396)
T 4eut_A 164 RELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRR--NKEVMYKI 239 (396)
T ss_dssp EECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTT--CHHHHHHH
T ss_pred eEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccc--hHHHHHHH
Confidence 9875432 2334679999999998864 5678899999999999999999999974332211 11222222
Q ss_pred Hhhcccc------CCcCC------CCC--CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 397 VQLRRSE------DVVDP------NIE--TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 397 ~~~~~~~------~~~~~------~~~--~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
....... ..... .+. ..........+..++.+||+.||++|||+.++++.+...
T Consensus 240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i 307 (396)
T 4eut_A 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (396)
T ss_dssp HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence 2211110 00000 111 111223333344455689999999999999999988764
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=348.02 Aligned_cols=271 Identities=22% Similarity=0.300 Sum_probs=202.8
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC--chhHHHHHHHHHHcCCCCCceEEEeEEEe--------
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIE-------- 241 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-------- 241 (498)
.++|++.+.||+|+||.||+|+. .+|+.||+|++...... ....+.+|+.+++.++||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 36799999999999999999986 57899999998554332 24568889999999999999999999987
Q ss_pred CCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeee
Q 010891 242 GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDF 321 (498)
Q Consensus 242 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~Df 321 (498)
....|+||||+++ +|.+.+.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCC-CHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccc
Confidence 3468999999975 88888764 235699999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCc---eeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHH
Q 010891 322 GLAKLLGAGKS---HITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMV 397 (498)
Q Consensus 322 Gla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 397 (498)
|+++.+..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ....+....
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~~~~ 245 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH---QLALISQLC 245 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHHHHH
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHH---HHHHHHHHh
Confidence 99987653221 22344678999999998865 568999999999999999999999997543221 111111111
Q ss_pred hhccccCCcCCCC-------------CCCCCHHH-------HHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCCCC
Q 010891 398 QLRRSEDVVDPNI-------------ETRPSTSA-------LKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIP 455 (498)
Q Consensus 398 ~~~~~~~~~~~~~-------------~~~~~~~~-------~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~~~~~ 455 (498)
.......-+.. ........ ...+..++.+||..||++|||+.|++++---...+.+
T Consensus 246 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 321 (351)
T 3mi9_A 246 --GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP 321 (351)
T ss_dssp --CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred --CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence 11000000000 00011110 1124455568999999999999999987654444433
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=342.22 Aligned_cols=255 Identities=28% Similarity=0.448 Sum_probs=196.3
Q ss_pred cCCCccceEcccCcEEEEEEEEcC----CcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEE-eCCeeEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLMN----GTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCI-EGTQRIL 247 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-~~~~~~l 247 (498)
.+|.+.+.||+|+||+||+|.+.+ ...||+|.+..... ...+.+.+|+.++++++||||+++++++. .+...++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 468889999999999999997532 23689998865333 23356889999999999999999999865 4567899
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
||||+++|+|.+++.. ....+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+++..
T Consensus 105 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccc
Confidence 9999999999999974 345689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCc---eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhcccc
Q 010891 328 GAGKS---HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSE 403 (498)
Q Consensus 328 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (498)
..... .......||+.|+|||.+.+..++.++||||||+++|+|++ |.+||........ . ...... .
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~---~---~~~~~~---~ 249 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---T---VYLLQG---R 249 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH---H---HHHHTT---C
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH---H---HHHhcC---C
Confidence 44321 11233567889999999999999999999999999999999 5555654332221 1 111111 1
Q ss_pred CCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 404 DVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
....+ ..... .+..++.+||+.||++|||+.++++.|+..
T Consensus 250 ~~~~~----~~~~~---~l~~li~~~l~~~p~~Rps~~ell~~L~~~ 289 (298)
T 3f66_A 250 RLLQP----EYCPD---PLYEVMLKCWHPKAEMRPSFSELVSRISAI 289 (298)
T ss_dssp CCCCC----TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CCCCC----ccCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 11111 11122 234445589999999999999999999864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=342.21 Aligned_cols=250 Identities=30% Similarity=0.443 Sum_probs=193.1
Q ss_pred ccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeC-CeeEEEEee
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG-TQRILVYEY 251 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-~~~~lv~e~ 251 (498)
.++|++.+.||+|+||.||+|+. +|+.||+|.+... ...+.+.+|+.++..++||||+++++++.+. ...++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 46789999999999999999987 5899999998643 3456789999999999999999999997654 478999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+++++|.+++... ....+++..++.++.|++.||.|||+. +++||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~- 170 (278)
T 1byg_A 97 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 170 (278)
T ss_dssp CTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred CCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc-
Confidence 9999999999743 122378999999999999999999999 9999999999999999999999999999865432
Q ss_pred ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCC
Q 010891 332 SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNI 410 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (498)
.....+++.|+|||++.+..++.++||||||+++|+|++ |+.||....... .. ..+. ... ....
T Consensus 171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~---~~~~---~~~---~~~~ 235 (278)
T 1byg_A 171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV---PRVE---KGY---KMDA 235 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HH---HHHT---TTC---CCCC
T ss_pred ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HH---HHHh---cCC---CCCC
Confidence 223457899999999998999999999999999999998 999997543221 11 1111 110 0111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 411 ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 411 ~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
.. .... .+..++.+||+.||.+|||+.++++.|+..
T Consensus 236 ~~-~~~~---~l~~li~~~l~~~p~~Rps~~~l~~~L~~i 271 (278)
T 1byg_A 236 PD-GCPP---AVYEVMKNCWHLDAAMRPSFLQLREQLEHI 271 (278)
T ss_dssp CT-TCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cc-cCCH---HHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence 11 1122 333444589999999999999999998764
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=354.66 Aligned_cols=261 Identities=15% Similarity=0.220 Sum_probs=201.4
Q ss_pred ccCCCccceEcccCcEEEEEEEEcC---------CcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceE---------
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLMN---------GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVR--------- 234 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~--------- 234 (498)
.++|.+.+.||+|+||.||+|+... ++.||+|.+... +.+.+|++++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 3689999999999999999998653 789999998643 46888999999999999987
Q ss_pred ------EEeEEEe-CCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCC
Q 010891 235 ------LLGYCIE-GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSN 307 (498)
Q Consensus 235 ------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~N 307 (498)
+++++.. +...|+||||+ +++|.+++... ....+++..++.++.||+.||.|||++ +|+||||||+|
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N 189 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN 189 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence 6777776 68889999999 99999999753 235699999999999999999999999 99999999999
Q ss_pred EEEcCCC--CeEEeeeccceecCCCCce------eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCC
Q 010891 308 ILIDENF--DAKISDFGLAKLLGAGKSH------ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVD 379 (498)
Q Consensus 308 Ill~~~~--~~kL~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~ 379 (498)
||++.++ .+||+|||+++.+...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||.
T Consensus 190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 9999998 8999999999876432211 1234579999999999999999999999999999999999999997
Q ss_pred CCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 380 YGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
...+.. ..+........ ................... +..++.+||+.||.+|||+.++++.|+..
T Consensus 270 ~~~~~~-~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~---l~~li~~~l~~dp~~Rps~~~l~~~L~~~ 334 (352)
T 2jii_A 270 NCLPNT-EDIMKQKQKFV--DKPGPFVGPCGHWIRPSET---LQKYLKVVMALTYEEKPPYAMLRNNLEAL 334 (352)
T ss_dssp GGTTCH-HHHHHHHHHHH--HSCCCEECTTSCEECCCHH---HHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred cCCcCH-HHHHHHHHhcc--CChhhhhhhccccCCCcHH---HHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence 544222 11222111111 1111111111111111223 33444579999999999999999999764
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=343.51 Aligned_cols=250 Identities=21% Similarity=0.323 Sum_probs=201.9
Q ss_pred ccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCC---CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
.++|.+.+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 467899999999999999999864 578899998854432 2335688899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+++++|.+++.. .+.+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++....
T Consensus 94 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 94 LELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 999999999999864 25689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (498)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...... +....... ..
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~---~~----- 231 (294)
T 2rku_A 167 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLK------ETYLRIKK---NE----- 231 (294)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHT---TC-----
T ss_pred cCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHhh---cc-----
Confidence 3322 233457999999999999989999999999999999999999999754321 11111111 11
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 409 NIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.......+ ..+..++.+||+.||++|||+.+++++.
T Consensus 232 -~~~~~~~~--~~~~~li~~~l~~~p~~Rps~~~ll~~~ 267 (294)
T 2rku_A 232 -YSIPKHIN--PVAASLIQKMLQTDPTARPTINELLNDE 267 (294)
T ss_dssp -CCCCTTSC--HHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred -CCCccccC--HHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence 11111111 1233444589999999999999999754
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=346.93 Aligned_cols=263 Identities=24% Similarity=0.372 Sum_probs=203.7
Q ss_pred ccCCCccceEcccCcEEEEEEEE-----cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCC--ee
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-----MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT--QR 245 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~--~~ 245 (498)
.++|++.+.||+|+||.||+|++ .+++.||+|++........+.+.+|+++++.++||||+++++++.... ..
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 119 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 119 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence 35688999999999999999974 368899999997765555677999999999999999999999987653 67
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccce
Q 010891 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~ 325 (498)
++||||+++++|.+++... ...+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 120 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 120 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp EEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 9999999999999999753 34689999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCcee--eecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCC---------CcchhhHHHHHH
Q 010891 326 LLGAGKSHI--TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGR---------PQSEVNLVEWLK 394 (498)
Q Consensus 326 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~---------~~~~~~~~~~~~ 394 (498)
......... .....+|..|+|||++.+..++.++|||||||++|||++|..||.... ..........+.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHH
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHH
Confidence 875443221 223457888999999988889999999999999999999999886321 000000011111
Q ss_pred HHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 395 MMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
...... .. ....... ...+..++.+||+.||++|||+.++++.|+..
T Consensus 274 ~~~~~~--~~-----~~~~~~~--~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l 320 (326)
T 2w1i_A 274 ELLKNN--GR-----LPRPDGC--PDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320 (326)
T ss_dssp HHHHTT--CC-----CCCCTTC--CHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred HHhhcC--CC-----CCCCCcc--cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 111110 00 0111111 12344455589999999999999999998764
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=357.82 Aligned_cols=204 Identities=23% Similarity=0.357 Sum_probs=157.4
Q ss_pred ccCCCc-cceEcccCcEEEEEEEEc---CCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEe--CCeeE
Q 010891 173 TNRFSK-DNIIGDGGYGVVYRGQLM---NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIE--GTQRI 246 (498)
Q Consensus 173 ~~~y~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~ 246 (498)
.+.|.+ +++||+|+||+||+|+.. +++.||+|++... .....+.+|+.+|+.++||||+++++++.. ....|
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 345666 468999999999999865 5788999998543 234568899999999999999999999965 67889
Q ss_pred EEEeecCCCCHHHHHhcccC-----CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEE----cCCCCeE
Q 010891 247 LVYEYVNNGNLEQWLRGDMC-----DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI----DENFDAK 317 (498)
Q Consensus 247 lv~e~~~~g~L~~~l~~~~~-----~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll----~~~~~~k 317 (498)
+||||+. ++|.+++..... ....+++..++.++.||+.||.|||+. +|+||||||+|||| +.++.+|
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEE
Confidence 9999996 489888853211 223599999999999999999999999 99999999999999 6788999
Q ss_pred EeeeccceecCCCCc--eeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 010891 318 ISDFGLAKLLGAGKS--HITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 318 L~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~ 382 (498)
|+|||+++....... ......+||+.|+|||++.+ ..++.++|||||||+||||++|+.||....
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 240 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence 999999987654321 22344689999999998877 459999999999999999999999997543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=355.01 Aligned_cols=266 Identities=21% Similarity=0.326 Sum_probs=195.7
Q ss_pred HHHccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeC------
Q 010891 170 QSATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG------ 242 (498)
Q Consensus 170 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------ 242 (498)
+...++|++.+.||+|+||+||+|+. .+|+.||||++...... ..+|+++++.++||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 45668899999999999999999985 57899999998654322 33699999999999999999998543
Q ss_pred --------------------------------CeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 010891 243 --------------------------------TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYL 290 (498)
Q Consensus 243 --------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yL 290 (498)
...++||||++ |+|.+.+.........+++..+..++.||+.||.||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34789999997 588888865444567899999999999999999999
Q ss_pred HHccCCCeeecCCCCCCEEEc-CCCCeEEeeeccceecCCCCceeeecccccccccCcccccCC-CCCccchHHHHHHHH
Q 010891 291 HEAIEPKVVHRDIKSSNILID-ENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSG-LLNEKSDVYSFGVVL 368 (498)
Q Consensus 291 H~~~~~~iiHrDikp~NIll~-~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl 368 (498)
|+. +|+||||||+|||++ .++.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++
T Consensus 158 H~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il 232 (383)
T 3eb0_A 158 HSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF 232 (383)
T ss_dssp HTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred HHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence 998 999999999999997 688999999999997754432 3345789999999988764 599999999999999
Q ss_pred HHHHhCCCCCCCCCCcchhhHHHHHHH--------HHhhcc-ccCCcCCCCCCCC-----CHHHHHHHHHHHHHccCCCC
Q 010891 369 LEAITGRYPVDYGRPQSEVNLVEWLKM--------MVQLRR-SEDVVDPNIETRP-----STSALKRALLTALRCVDPDS 434 (498)
Q Consensus 369 ~elltg~~P~~~~~~~~~~~~~~~~~~--------~~~~~~-~~~~~~~~~~~~~-----~~~~~~~~l~~~~~cl~~dP 434 (498)
|||++|+.||....... .+...+.. +..... .....-+...... .......+..++.+||..||
T Consensus 233 ~ell~g~~pf~~~~~~~--~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 310 (383)
T 3eb0_A 233 GELILGKPLFSGETSID--QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP 310 (383)
T ss_dssp HHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred HHHHhCCCCCCCCChHH--HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence 99999999997543221 11111110 000000 0000001100000 00011224445558999999
Q ss_pred CCCCCHHHHHHHH
Q 010891 435 DKRPKMSQVVRML 447 (498)
Q Consensus 435 ~~RPt~~ell~~L 447 (498)
.+|||+.|+++|-
T Consensus 311 ~~R~t~~e~l~hp 323 (383)
T 3eb0_A 311 DLRINPYEAMAHP 323 (383)
T ss_dssp GGSCCHHHHHTSG
T ss_pred hhCCCHHHHhcCH
Confidence 9999999999653
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=353.90 Aligned_cols=256 Identities=23% Similarity=0.317 Sum_probs=193.5
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC--chhHHHHHHHHHHcCCCCCceEEEeEEEeCC------
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT------ 243 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------ 243 (498)
.++|.+.+.||+|+||.||+|.. .+|+.||||++...... ..+.+.+|+++++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 57899999999999999999986 56899999998554322 2356788999999999999999999998653
Q ss_pred eeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecc
Q 010891 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (498)
Q Consensus 244 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGl 323 (498)
..|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 8899999964 4589999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhc--
Q 010891 324 AKLLGAGKSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLR-- 400 (498)
Q Consensus 324 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-- 400 (498)
++..... .+..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+..+....
T Consensus 175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~l~~i~~~~g~ 244 (367)
T 1cm8_A 175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD------QLKEIMKVTGT 244 (367)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHHHCC
T ss_pred ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHHhcCC
Confidence 9976432 344679999999998876 789999999999999999999999997543211 111111100
Q ss_pred -------------------cccCCcCCCCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 401 -------------------RSEDVVDPNIE-TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 401 -------------------~~~~~~~~~~~-~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
.........+. ..+..+ .....++.+||..||.+|||+.|+++|---
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f 311 (367)
T 1cm8_A 245 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNAS--PLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311 (367)
T ss_dssp CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCC--HHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred CCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCC--HHHHHHHHHHccCChhHCCCHHHHhcChHH
Confidence 00000011111 011111 233444558999999999999999987543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=352.74 Aligned_cols=270 Identities=24% Similarity=0.300 Sum_probs=198.7
Q ss_pred cHHHHHHHccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCc-----------hhHHHHHHHHHHcCCCCCce
Q 010891 165 TLRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQA-----------DKDFRVEVEAIGHVRHKNLV 233 (498)
Q Consensus 165 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~hpnIv 233 (498)
.+.++....++|.+.+.||+|+||.||+|...+|+.||||++....... .+.+.+|+.++++++||||+
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 92 (362)
T 3pg1_A 13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNIL 92 (362)
T ss_dssp HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCcc
Confidence 4667888999999999999999999999988889999999985432221 25688999999999999999
Q ss_pred EEEeEEEeC-----CeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCE
Q 010891 234 RLLGYCIEG-----TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNI 308 (498)
Q Consensus 234 ~l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NI 308 (498)
++++++... ...|+||||+. |+|.+++.. ....+++..+..++.||+.||.|||+. +|+||||||+||
T Consensus 93 ~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NI 165 (362)
T 3pg1_A 93 GLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNI 165 (362)
T ss_dssp CCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGE
T ss_pred ceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHE
Confidence 999998542 36799999997 589998874 345799999999999999999999999 999999999999
Q ss_pred EEcCCCCeEEeeeccceecCCCCceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchh
Q 010891 309 LIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEV 387 (498)
Q Consensus 309 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~ 387 (498)
|++.++.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......
T Consensus 166 l~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-- 241 (362)
T 3pg1_A 166 LLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN-- 241 (362)
T ss_dssp EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--
T ss_pred EEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH--
Confidence 99999999999999998654322 2334679999999998876 779999999999999999999999997543211
Q ss_pred hHHHHHHHHHhhccccC--------------CcC---CCCCCCC----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 388 NLVEWLKMMVQLRRSED--------------VVD---PNIETRP----STSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 388 ~~~~~~~~~~~~~~~~~--------------~~~---~~~~~~~----~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
.+..+........ ... ....... .......+..++.+||+.||.+|||+.|++++
T Consensus 242 ----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 317 (362)
T 3pg1_A 242 ----QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH 317 (362)
T ss_dssp ----HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred ----HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence 1111111000000 000 0000000 00001224445558999999999999999987
Q ss_pred Hhc
Q 010891 447 LES 449 (498)
Q Consensus 447 L~~ 449 (498)
---
T Consensus 318 p~f 320 (362)
T 3pg1_A 318 PYF 320 (362)
T ss_dssp GGG
T ss_pred chh
Confidence 543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=368.16 Aligned_cols=253 Identities=23% Similarity=0.318 Sum_probs=199.9
Q ss_pred HccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCC--CCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNN--PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
..++|.+.+.||+|+||+||+|+.. +++.||||++... .......+.+|++++++++||||+++++++.+....|+|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 4568999999999999999999864 6899999998532 223456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEc---CCCCeEEeeeccce
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID---ENFDAKISDFGLAK 325 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~---~~~~~kL~DfGla~ 325 (498)
|||+.+|+|.+++... +.+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+|||+++
T Consensus 100 ~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 172 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (486)
T ss_dssp ECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred EEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence 9999999999999643 5699999999999999999999999 999999999999995 45679999999998
Q ss_pred ecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCC
Q 010891 326 LLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV 405 (498)
Q Consensus 326 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (498)
...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||...... +.+..+......
T Consensus 173 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~~~i~~~~~~--- 240 (486)
T 3mwu_A 173 CFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY------DILKRVETGKYA--- 240 (486)
T ss_dssp TBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCCC---
T ss_pred ECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCCCC---
Confidence 664432 2344679999999999876 5999999999999999999999999754321 122222211110
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 406 VDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 406 ~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.........+ ..+..++.+||..||.+|||+.+++++-
T Consensus 241 --~~~~~~~~~s--~~~~~li~~~L~~dp~~R~t~~~~l~hp 278 (486)
T 3mwu_A 241 --FDLPQWRTIS--DDAKDLIRKMLTFHPSLRITATQCLEHP 278 (486)
T ss_dssp --SCSGGGGGSC--HHHHHHHHHHTCSSTTTSCCHHHHHHCH
T ss_pred --CCCcccCCCC--HHHHHHHHHHcCCChhhCcCHHHHhcCH
Confidence 0111111111 2233444589999999999999999863
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=362.60 Aligned_cols=256 Identities=22% Similarity=0.338 Sum_probs=190.9
Q ss_pred HHHccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC--------CCchhHHHHHHHHHHcCCCCCceEEEeEEE
Q 010891 170 QSATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP--------GQADKDFRVEVEAIGHVRHKNLVRLLGYCI 240 (498)
Q Consensus 170 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~ 240 (498)
....++|.+.+.||+|+||+||+|.. .+++.||||++.... ......+.+|+.+|++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 35578999999999999999999975 458999999985431 112235889999999999999999999975
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCC---CeE
Q 010891 241 EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF---DAK 317 (498)
Q Consensus 241 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~---~~k 317 (498)
....|+||||+++|+|.+++. ..+.+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .+|
T Consensus 211 -~~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 211 -AEDYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp -SSEEEEEEECCTTCBGGGGTS----SSCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEE
T ss_pred -cCceEEEEEcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEE
Confidence 456799999999999999886 346799999999999999999999999 999999999999997544 599
Q ss_pred EeeeccceecCCCCceeeecccccccccCccccc---CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH
Q 010891 318 ISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYAN---SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLK 394 (498)
Q Consensus 318 L~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~ 394 (498)
|+|||+++..... ......+||+.|+|||++. ...|+.++|||||||++|+|++|+.||........ +...
T Consensus 283 l~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~-- 356 (419)
T 3i6u_A 283 ITDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQ-- 356 (419)
T ss_dssp ECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHH--
T ss_pred EeecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHH--
Confidence 9999999876432 2234568999999999885 36788999999999999999999999975433221 1111
Q ss_pred HHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 395 MMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
+.. .... ..+.. .... ...+..++.+||..||++|||+.|+++|-
T Consensus 357 -i~~-~~~~--~~~~~--~~~~--~~~~~~li~~~L~~dP~~Rps~~e~l~hp 401 (419)
T 3i6u_A 357 -ITS-GKYN--FIPEV--WAEV--SEKALDLVKKLLVVDPKARFTTEEALRHP 401 (419)
T ss_dssp -HHT-TCCC--CCHHH--HTTS--CHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred -Hhc-CCCC--CCchh--hccc--CHHHHHHHHHHccCChhHCcCHHHHhCCc
Confidence 111 1000 00000 0011 12344455589999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=350.53 Aligned_cols=259 Identities=24% Similarity=0.362 Sum_probs=204.1
Q ss_pred HHHHHHccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCCc--------hhHHHHHHHHHHcC-CCCCceEEE
Q 010891 167 RDLQSATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQA--------DKDFRVEVEAIGHV-RHKNLVRLL 236 (498)
Q Consensus 167 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l-~hpnIv~l~ 236 (498)
.......++|.+.+.||+|+||.||+|++. +|+.||||++....... .+.+.+|+.++..+ +||||++++
T Consensus 87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~ 166 (365)
T 2y7j_A 87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLI 166 (365)
T ss_dssp HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEE
T ss_pred hhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEE
Confidence 344556788999999999999999999874 69999999986543221 24577899999999 899999999
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCe
Q 010891 237 GYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDA 316 (498)
Q Consensus 237 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~ 316 (498)
+++......|+||||+++++|.+++.. ...+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+
T Consensus 167 ~~~~~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 167 DSYESSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEBSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred EEEeeCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence 999999999999999999999999974 35699999999999999999999999 99999999999999999999
Q ss_pred EEeeeccceecCCCCceeeecccccccccCcccccC------CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHH
Q 010891 317 KISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANS------GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLV 390 (498)
Q Consensus 317 kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~ 390 (498)
||+|||++..+.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......
T Consensus 240 kl~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~------ 311 (365)
T 2y7j_A 240 RLSDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI------ 311 (365)
T ss_dssp EECCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------
T ss_pred EEEecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH------
Confidence 999999998875432 2344679999999998853 36889999999999999999999999753221
Q ss_pred HHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 391 EWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 391 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
..+..+...... .........+ ..+..++.+||..||++|||+.+++++-
T Consensus 312 ~~~~~i~~~~~~-----~~~~~~~~~~--~~~~~li~~~L~~dP~~Rps~~ell~hp 361 (365)
T 2y7j_A 312 LMLRMIMEGQYQ-----FSSPEWDDRS--STVKDLISRLLQVDPEARLTAEQALQHP 361 (365)
T ss_dssp HHHHHHHHTCCC-----CCHHHHSSSC--HHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred HHHHHHHhCCCC-----CCCcccccCC--HHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence 111111111100 0000000111 2234445589999999999999999863
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=341.50 Aligned_cols=254 Identities=26% Similarity=0.369 Sum_probs=198.4
Q ss_pred HHccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
...++|++.+.||+|+||.||+|... +|+.||+|.+... ...+.+.+|+.++..++||||+++++++.+....|+||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 34578999999999999999999864 5899999998653 34567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+++++|.+++.. ....+++..++.++.|++.||.|||+. +++|+||||+||+++.++.+||+|||++.....
T Consensus 104 e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 104 EYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD 177 (314)
T ss_dssp ECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred ecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence 99999999999963 235699999999999999999999999 999999999999999999999999999987654
Q ss_pred CCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ........ . .+.
T Consensus 178 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~-~-----~~~ 244 (314)
T 3com_A 178 TMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR------AIFMIPTN-P-----PPT 244 (314)
T ss_dssp TBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHS-C-----CCC
T ss_pred hcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcC-C-----Ccc
Confidence 322 2334579999999999999999999999999999999999999997533211 11111111 1 011
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
+......+ ..+..++.+||..||.+|||+.+++++-
T Consensus 245 ~~~~~~~~--~~l~~li~~~l~~dp~~Rpt~~~ll~~~ 280 (314)
T 3com_A 245 FRKPELWS--DNFTDFVKQCLVKSPEQRATATQLLQHP 280 (314)
T ss_dssp CSSGGGSC--HHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred cCCcccCC--HHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 11111111 2334445589999999999999999754
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=340.35 Aligned_cols=255 Identities=27% Similarity=0.394 Sum_probs=197.4
Q ss_pred CCCccceEcccCcEEEEEEEEc-CC---cEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCee-EEE
Q 010891 175 RFSKDNIIGDGGYGVVYRGQLM-NG---TAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQR-ILV 248 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~-~lv 248 (498)
.|.+.++||+|+||+||+|.+. ++ ..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 4566789999999999999753 22 3799999865433 2345688999999999999999999999876665 999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+.+|+|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++.+||+|||+++...
T Consensus 102 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 175 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL 175 (298)
T ss_dssp ECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred EecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence 999999999999974 345689999999999999999999999 99999999999999999999999999998654
Q ss_pred CCCc---eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCC
Q 010891 329 AGKS---HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV 405 (498)
Q Consensus 329 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (498)
.... .......||+.|+|||.+.+..++.++|||||||++|+|++|..|+....... ..... ...... .
T Consensus 176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~--~~~~~---~~~~~~---~ 247 (298)
T 3pls_A 176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF--DLTHF---LAQGRR---L 247 (298)
T ss_dssp TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG--GHHHH---HHTTCC---C
T ss_pred CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH--HHHHH---hhcCCC---C
Confidence 3221 12233568899999999999999999999999999999999666654333222 11111 111110 0
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 406 VDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 406 ~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
... ..... .+..++.+||+.||.+|||+.++++.|+..
T Consensus 248 ---~~~-~~~~~---~l~~li~~~l~~~p~~Rps~~~ll~~l~~~ 285 (298)
T 3pls_A 248 ---PQP-EYCPD---SLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285 (298)
T ss_dssp ---CCC-TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCC-ccchH---HHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence 000 11112 334445589999999999999999999764
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=336.51 Aligned_cols=250 Identities=25% Similarity=0.393 Sum_probs=193.3
Q ss_pred HccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCC---CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
..++|.+.+.||+|+||.||+|+.. +|+.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+....|+
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3468999999999999999999865 68999999985432 2334578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
||||+++++|.+++... +.+++..+..++.|++.||.|||++ +++||||||+||+++.++.+||+|||++...
T Consensus 89 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 99999999999999743 4689999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCceeeecccccccccCcccccCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCc
Q 010891 328 GAGKSHITTRVMGTFGYVAPEYANSGLL-NEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVV 406 (498)
Q Consensus 328 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (498)
.... ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...... ......... ..
T Consensus 162 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~---~~-- 228 (276)
T 2h6d_A 162 SDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP------TLFKKIRGG---VF-- 228 (276)
T ss_dssp CC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHC---CC--
T ss_pred CCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------HHHHHhhcC---cc--
Confidence 5432 2234578999999999987765 68999999999999999999999753221 111111111 00
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 407 DPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 407 ~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
... ...+ ..+..++.+||+.||.+|||+.+++++-
T Consensus 229 --~~~--~~~~--~~l~~li~~~l~~~p~~Rps~~~~l~h~ 263 (276)
T 2h6d_A 229 --YIP--EYLN--RSVATLLMHMLQVDPLKRATIKDIREHE 263 (276)
T ss_dssp --CCC--TTSC--HHHHHHHHHHTCSSGGGSCCHHHHHHSH
T ss_pred --cCc--hhcC--HHHHHHHHHHccCChhhCCCHHHHHhCh
Confidence 011 1111 2233444589999999999999999863
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=338.06 Aligned_cols=254 Identities=29% Similarity=0.432 Sum_probs=196.1
Q ss_pred CCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecC
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ 253 (498)
.|....+||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++.+....++||||++
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 102 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP 102 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence 345556999999999999985 5688999999977666666789999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcC-CCCeEEeeeccceecCCCCc
Q 010891 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE-NFDAKISDFGLAKLLGAGKS 332 (498)
Q Consensus 254 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~-~~~~kL~DfGla~~~~~~~~ 332 (498)
+++|.+++.... ....+++..+..++.|++.||.|||+. +|+||||||+||+++. ++.+||+|||++........
T Consensus 103 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 103 GGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp EEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 999999997532 223567889999999999999999999 9999999999999987 89999999999987654321
Q ss_pred eeeecccccccccCcccccCCC--CCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCC
Q 010891 333 HITTRVMGTFGYVAPEYANSGL--LNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNI 410 (498)
Q Consensus 333 ~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (498)
......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||........ ..... .... ..+.+
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~----~~~~~-~~~~-----~~~~~ 247 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA----AMFKV-GMFK-----VHPEI 247 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH----HHHHH-HHHC-----CCCCC
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH----HHHhh-cccc-----ccccc
Confidence 233457999999999987643 88999999999999999999999964322111 11111 1111 11111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 411 ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 411 ~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
... ... .+..++.+||+.||++|||+.+++++-
T Consensus 248 ~~~-~~~---~~~~li~~~l~~dp~~Rps~~~ll~~~ 280 (295)
T 2clq_A 248 PES-MSA---EAKAFILKCFEPDPDKRACANDLLVDE 280 (295)
T ss_dssp CTT-SCH---HHHHHHHHTTCSSTTTSCCHHHHHTSG
T ss_pred ccc-CCH---HHHHHHHHHccCChhhCCCHHHHhcCh
Confidence 111 112 233444589999999999999998753
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=342.90 Aligned_cols=255 Identities=22% Similarity=0.322 Sum_probs=197.4
Q ss_pred HccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
..++|++.+.||+|+||.||+|+.. +++.||+|.+........+.+..|+.++..++||||+++++++.+....++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4578999999999999999999865 588999999976666667789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
|+++++|.+++... ...+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170 (302)
T ss_dssp CCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH
T ss_pred eCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCcccccc
Confidence 99999999998642 35699999999999999999999999 9999999999999999999999999998643211
Q ss_pred CceeeecccccccccCcccc-----cCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCC
Q 010891 331 KSHITTRVMGTFGYVAPEYA-----NSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV 405 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (498)
. .......||+.|+|||++ .+..++.++||||||+++|+|++|..||...... ...........
T Consensus 171 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~~~~---- 239 (302)
T 2j7t_A 171 L-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSDP---- 239 (302)
T ss_dssp H-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCC----
T ss_pred c-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHH------HHHHHHhccCC----
Confidence 1 112335799999999988 4678899999999999999999999999754321 11111111111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 406 VDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 406 ~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
+........ ...+..++.+||+.||.+|||+.+++++-
T Consensus 240 --~~~~~~~~~--~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 277 (302)
T 2j7t_A 240 --PTLLTPSKW--SVEFRDFLKIALDKNPETRPSAAQLLEHP 277 (302)
T ss_dssp --CCCSSGGGS--CHHHHHHHHHHSCSCTTTSCCHHHHTTST
T ss_pred --cccCCcccc--CHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 011101111 12233444589999999999999998764
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=339.86 Aligned_cols=249 Identities=25% Similarity=0.377 Sum_probs=194.9
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEe----CCeeE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIE----GTQRI 246 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~~ 246 (498)
..|.+.+.||+|+||.||+|.. .++..||+|++..... ...+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 3467788999999999999985 4578899999864332 234568899999999999999999999875 35679
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCC--eeecCCCCCCEEEc-CCCCeEEeeecc
Q 010891 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK--VVHRDIKSSNILID-ENFDAKISDFGL 323 (498)
Q Consensus 247 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--iiHrDikp~NIll~-~~~~~kL~DfGl 323 (498)
+||||+++++|.+++... +.+++..++.++.||+.||.|||+. + |+||||||+|||++ .++.+||+|||+
T Consensus 106 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~ 178 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGL 178 (290)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred EEEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence 999999999999999743 5689999999999999999999998 7 99999999999997 789999999999
Q ss_pred ceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhcccc
Q 010891 324 AKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSE 403 (498)
Q Consensus 324 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (498)
+....... .....||+.|+|||++.+ .++.++|||||||++|+|++|+.||....... ...........
T Consensus 179 ~~~~~~~~---~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~~~~~~~~~~~-- 247 (290)
T 1t4h_A 179 ATLKRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QIYRRVTSGVK-- 247 (290)
T ss_dssp GGGCCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----HHHHHHTTTCC--
T ss_pred cccccccc---cccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH-----HHHHHHhccCC--
Confidence 97544332 334579999999998874 58999999999999999999999997543221 11111111100
Q ss_pred CCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 404 DVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
..... ..... .+..++.+||+.||.+|||+.+++++-
T Consensus 248 ---~~~~~-~~~~~---~l~~li~~~l~~dp~~Rps~~ell~h~ 284 (290)
T 1t4h_A 248 ---PASFD-KVAIP---EVKEIIEGCIRQNKDERYSIKDLLNHA 284 (290)
T ss_dssp ---CGGGG-GCCCH---HHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred ---ccccC-CCCCH---HHHHHHHHHccCChhhCCCHHHHhhCc
Confidence 00111 11112 344455589999999999999999763
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=349.47 Aligned_cols=268 Identities=25% Similarity=0.397 Sum_probs=194.9
Q ss_pred ccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHH--HHcCCCCCceEEEeEEEe-----CCee
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEA--IGHVRHKNLVRLLGYCIE-----GTQR 245 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~hpnIv~l~~~~~~-----~~~~ 245 (498)
.++|++.+.||+|+||.||+|+. +++.||||++... ....+..|.++ +..++||||+++++.+.. ....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 87 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY 87 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence 36789999999999999999976 7899999998532 23445555555 445899999999986543 2356
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHcc------CCCeeecCCCCCCEEEcCCCCeEEe
Q 010891 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI------EPKVVHRDIKSSNILIDENFDAKIS 319 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~------~~~iiHrDikp~NIll~~~~~~kL~ 319 (498)
++||||+++|+|.+++... .+++..++.++.||+.||.|||+.. .++|+||||||+|||++.++.+||+
T Consensus 88 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~ 162 (336)
T 3g2f_A 88 LLVMEYYPNGSLXKYLSLH-----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS 162 (336)
T ss_dssp EEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred EEEEecCCCCcHHHHHhhc-----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence 8999999999999999643 3588999999999999999999763 3389999999999999999999999
Q ss_pred eeccceecCCCCc-------eeeecccccccccCcccccC-------CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcc
Q 010891 320 DFGLAKLLGAGKS-------HITTRVMGTFGYVAPEYANS-------GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQS 385 (498)
Q Consensus 320 DfGla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~ 385 (498)
|||+++.+..... ......+||+.|+|||++.+ ..++.++|||||||++|||++|..||.......
T Consensus 163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~ 242 (336)
T 3g2f_A 163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242 (336)
T ss_dssp CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence 9999987653221 11234579999999999876 456778999999999999999988765433221
Q ss_pred hhh-----------HHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 386 EVN-----------LVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 386 ~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
... ..+.+............+.... .........+..++.+||+.||++|||+.|+++.|+...
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAW--KENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTC--CCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHhhhcccCCCchHHHHHhhhcccccCCCCCccc--ccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 110 0011111111111111111111 112223334555666899999999999999999998754
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=347.73 Aligned_cols=257 Identities=25% Similarity=0.411 Sum_probs=195.8
Q ss_pred HHHHccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcC-CCCCceEEEeEEEe-----
Q 010891 169 LQSATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIE----- 241 (498)
Q Consensus 169 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~----- 241 (498)
+....++|++.+.||+|+||.||+|+. .+|+.||+|++.... ...+.+.+|+.++.++ +||||+++++++..
T Consensus 19 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 97 (326)
T 2x7f_A 19 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 97 (326)
T ss_dssp CCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--C
T ss_pred ccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCcc
Confidence 344578899999999999999999986 468999999986433 3456788999999998 89999999999987
Q ss_pred -CCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEee
Q 010891 242 -GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISD 320 (498)
Q Consensus 242 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~D 320 (498)
....|+||||+++++|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~D 172 (326)
T 2x7f_A 98 MDDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVD 172 (326)
T ss_dssp CCCEEEEEEECCTTEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECC
T ss_pred ccceEEEEEEcCCCCcHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEee
Confidence 46789999999999999999754 235689999999999999999999999 999999999999999999999999
Q ss_pred eccceecCCCCceeeecccccccccCccccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 010891 321 FGLAKLLGAGKSHITTRVMGTFGYVAPEYAN-----SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKM 395 (498)
Q Consensus 321 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 395 (498)
||++....... .......||+.|+|||++. +..++.++|||||||++|+|++|..||....... ....
T Consensus 173 fg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~ 245 (326)
T 2x7f_A 173 FGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR------ALFL 245 (326)
T ss_dssp CTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHH
T ss_pred CcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH------HHHH
Confidence 99998764322 1233457999999999986 5678999999999999999999999996443211 1111
Q ss_pred HHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 396 MVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.... . .+.......... +..++.+||..||.+|||+.+++++-
T Consensus 246 ~~~~-~-----~~~~~~~~~~~~---l~~li~~~l~~dp~~Rps~~~ll~hp 288 (326)
T 2x7f_A 246 IPRN-P-----APRLKSKKWSKK---FQSFIESCLVKNHSQRPATEQLMKHP 288 (326)
T ss_dssp HHHS-C-----CCCCSCSCSCHH---HHHHHHHHCCSSGGGSCCHHHHHTSH
T ss_pred hhcC-c-----cccCCccccCHH---HHHHHHHHhccChhhCCCHHHHhhCh
Confidence 1111 1 111111111222 33344589999999999999999854
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=366.21 Aligned_cols=254 Identities=24% Similarity=0.322 Sum_probs=199.1
Q ss_pred HHccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCC-------------CchhHHHHHHHHHHcCCCCCceEEE
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG-------------QADKDFRVEVEAIGHVRHKNLVRLL 236 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~hpnIv~l~ 236 (498)
.+.++|.+.+.||+|+||+||+|+.. +++.||+|++..... ...+.+.+|+.++++++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 35678999999999999999999864 578999999865331 2345688999999999999999999
Q ss_pred eEEEeCCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCC--
Q 010891 237 GYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF-- 314 (498)
Q Consensus 237 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~-- 314 (498)
+++.+....|+||||+++|+|.+++.. .+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~ 185 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSL 185 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCC
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCC
Confidence 999999999999999999999999974 35699999999999999999999999 999999999999998876
Q ss_pred -CeEEeeeccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 010891 315 -DAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWL 393 (498)
Q Consensus 315 -~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~ 393 (498)
.+||+|||++....... .....+||+.|+|||++. +.|+.++|||||||++|+|++|..||...... +.+
T Consensus 186 ~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~------~~~ 256 (504)
T 3q5i_A 186 LNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ------DII 256 (504)
T ss_dssp SSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHH
T ss_pred ccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH------HHH
Confidence 69999999999875432 234467999999999987 46899999999999999999999999754321 122
Q ss_pred HHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 394 KMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
..+..... .. ........+ ..+..++.+||..||.+|||+.|++++-
T Consensus 257 ~~i~~~~~---~~--~~~~~~~~s--~~~~~li~~~L~~dp~~R~t~~e~l~h~ 303 (504)
T 3q5i_A 257 KKVEKGKY---YF--DFNDWKNIS--DEAKELIKLMLTYDYNKRCTAEEALNSR 303 (504)
T ss_dssp HHHHHCCC---CC--CHHHHTTSC--HHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHHcCCC---CC--CccccCCCC--HHHHHHHHHHcCCChhHCCCHHHHhcCH
Confidence 22221110 00 000001111 2233444589999999999999999754
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=362.45 Aligned_cols=244 Identities=16% Similarity=0.212 Sum_probs=187.1
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCC---CCCchhHHHHHH---HHHHcCCCCCceEEE-------eE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNN---PGQADKDFRVEV---EAIGHVRHKNLVRLL-------GY 238 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~hpnIv~l~-------~~ 238 (498)
.++|.+.+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+ ++++.++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46788999999999999999984 57999999998643 233446788999 555566899999998 66
Q ss_pred EEeCC-----------------eeEEEEeecCCCCHHHHHhcccC---CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCe
Q 010891 239 CIEGT-----------------QRILVYEYVNNGNLEQWLRGDMC---DRGYLTWEARMKILLGTAKALAYLHEAIEPKV 298 (498)
Q Consensus 239 ~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~i 298 (498)
+.+.+ ..|+||||+ +|+|.+++..... ....+++..++.|+.||+.||.|||++ +|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence 66553 278999999 6799999974311 112344688889999999999999999 99
Q ss_pred eecCCCCCCEEEcCCCCeEEeeeccceecCCCCceeeecccccccccCcccccCC-----------CCCccchHHHHHHH
Q 010891 299 VHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSG-----------LLNEKSDVYSFGVV 367 (498)
Q Consensus 299 iHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwSlGvv 367 (498)
+||||||+||||+.++.+||+|||+++.... .....+| +.|+|||++.+. .|+.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986432 2344678 999999999877 89999999999999
Q ss_pred HHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 368 LLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 368 l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
||||++|+.||......... ..+... ....+ ..+..++.+||+.||++|||+.|++++
T Consensus 303 l~elltg~~Pf~~~~~~~~~---------------~~~~~~----~~~~~--~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGS---------------EWIFRS----CKNIP--QPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHSSCCC------CCS---------------GGGGSS----CCCCC--HHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHCCCCCcccccccch---------------hhhhhh----ccCCC--HHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 99999999999643321110 001100 01111 223344458999999999999999964
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=380.38 Aligned_cols=250 Identities=23% Similarity=0.276 Sum_probs=202.1
Q ss_pred HccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCC---CCCchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCeeE
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNN---PGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRI 246 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~ 246 (498)
..++|++.++||+|+||.||+|+. .+++.||||++... .....+.+..|..++..+ +||||+.+++++.+.+.+|
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 456899999999999999999985 45889999998642 223345678899999988 7999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecccee
Q 010891 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (498)
Q Consensus 247 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~ 326 (498)
|||||++||+|.+++... +.+++..+..++.||+.||.|||+. +|+||||||+||||+.++.+||+|||+++.
T Consensus 419 lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 999999999999999743 5699999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCc
Q 010891 327 LGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVV 406 (498)
Q Consensus 327 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (498)
..... ......+||+.|+|||++.+..|+.++|||||||+||||++|+.||..... .+....+..
T Consensus 492 ~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~------~~~~~~i~~-------- 556 (674)
T 3pfq_A 492 NIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE------DELFQSIME-------- 556 (674)
T ss_dssp CCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH------HHHHHHHHS--------
T ss_pred cccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH------HHHHHHHHh--------
Confidence 54332 224457899999999999999999999999999999999999999975432 122222221
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 010891 407 DPNIETRPSTSALKRALLTALRCVDPDSDKRPKM-----SQVVRM 446 (498)
Q Consensus 407 ~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~-----~ell~~ 446 (498)
.....+...+. .+..++.+||..||.+||++ .||++|
T Consensus 557 -~~~~~p~~~s~--~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h 598 (674)
T 3pfq_A 557 -HNVAYPKSMSK--EAVAICKGLMTKHPGKRLGCGPEGERDIKEH 598 (674)
T ss_dssp -SCCCCCTTSCH--HHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred -CCCCCCccCCH--HHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence 11111112222 23344458999999999997 888754
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=347.75 Aligned_cols=259 Identities=26% Similarity=0.399 Sum_probs=199.2
Q ss_pred ccCCCccceEcccCcEEEEEEEE------cCCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCee
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL------MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQR 245 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 245 (498)
.++|.+.+.||+|+||.||+|++ .++..||||++..... .....+.+|+.++++++||||+++++++.+....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 46899999999999999999973 3577899999864432 2345688899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHhcccC---CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcC---CCCeEEe
Q 010891 246 ILVYEYVNNGNLEQWLRGDMC---DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE---NFDAKIS 319 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~---~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~---~~~~kL~ 319 (498)
|+||||+++++|.+++..... ....+++..++.++.|++.||.|||+. +|+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999975421 124589999999999999999999999 9999999999999984 4469999
Q ss_pred eeccceecCCCCc-eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHH
Q 010891 320 DFGLAKLLGAGKS-HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMV 397 (498)
Q Consensus 320 DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 397 (498)
|||++........ .......||+.|+|||++.+..++.++|||||||++|+|++ |..||...... +....+.
T Consensus 186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~------~~~~~~~ 259 (327)
T 2yfx_A 186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ------EVLEFVT 259 (327)
T ss_dssp CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------HHHHHHH
T ss_pred ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH------HHHHHHh
Confidence 9999976533221 22334568999999999988899999999999999999998 99999754321 1112221
Q ss_pred hhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 398 QLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 398 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
..... ... ..... .+..++.+||+.||.+|||+.+++++|+..
T Consensus 260 ~~~~~------~~~-~~~~~---~l~~li~~~l~~dp~~Rps~~~ll~~l~~~ 302 (327)
T 2yfx_A 260 SGGRM------DPP-KNCPG---PVYRIMTQCWQHQPEDRPNFAIILERIEYC 302 (327)
T ss_dssp TTCCC------CCC-TTCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred cCCCC------CCC-CCCCH---HHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 11110 111 11112 334445589999999999999999999864
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=356.64 Aligned_cols=251 Identities=10% Similarity=0.038 Sum_probs=177.5
Q ss_pred cCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCC---chhHHHHHH---HHHHcCCCCCceEEE-------eEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ---ADKDFRVEV---EAIGHVRHKNLVRLL-------GYC 239 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~---~~l~~l~hpnIv~l~-------~~~ 239 (498)
.+|.+.+.||+|+||+||+|++. +|+.||||++...... ..+.+++|+ .+|+. +||||++++ +++
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehhe
Confidence 35888999999999999999854 7899999999765432 234567774 45555 799988865 454
Q ss_pred EeC-----------------CeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHH------HHHHHHHHHHHHHHHHccCC
Q 010891 240 IEG-----------------TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEAR------MKILLGTAKALAYLHEAIEP 296 (498)
Q Consensus 240 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~------~~i~~~ia~aL~yLH~~~~~ 296 (498)
... ...|+||||++ |+|.+++.... ..+.+..+ ..++.||+.||+|||++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~--- 213 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQSK--- 213 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHHHC---
Confidence 433 34799999998 89999997531 23445555 77889999999999999
Q ss_pred CeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCceeeecccccccccCcccccC--CCCCccchHHHHHHHHHHHHhC
Q 010891 297 KVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANS--GLLNEKSDVYSFGVVLLEAITG 374 (498)
Q Consensus 297 ~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg 374 (498)
+|+||||||+||||+.++.+||+|||+++..... .....||+.|+|||++.+ ..|+.++|||||||+||||++|
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999976432 224567799999999987 7899999999999999999999
Q ss_pred CCCCCCCCCcchhhHHHHHHHHHhhccccCCc--CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 375 RYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVV--DPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 375 ~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
+.||....+..... .......... ...+......+ ..+..++.+||+.||++|||+.+++++
T Consensus 290 ~~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dP~~Rpt~~e~l~h 353 (371)
T 3q60_A 290 FLPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLP--DFVKTLIGRFLNFDRRRRLLPLEAMET 353 (371)
T ss_dssp SCSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCC--HHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred CCCCCCcCcccccc--------hhhhhhhhccccccchhhccCCC--HHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 99998654321100 0000000000 11111111222 233344458999999999999999864
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=353.10 Aligned_cols=262 Identities=26% Similarity=0.354 Sum_probs=193.7
Q ss_pred cCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeC------CeeE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG------TQRI 246 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~~~~ 246 (498)
.+|.+.+.||+|+||.||+|++. +|+.||||++.... ..+.+|+++|+.++||||+++++++... ...+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 46888999999999999999864 58999999986543 2234699999999999999999998642 2367
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCC-CCeEEeeeccce
Q 010891 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN-FDAKISDFGLAK 325 (498)
Q Consensus 247 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~-~~~kL~DfGla~ 325 (498)
+||||+++ +|.+++.........+++..+..++.||+.||.|||++ +|+||||||+||||+.+ +.+||+|||+++
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999976 77777654333456799999999999999999999998 99999999999999965 568999999999
Q ss_pred ecCCCCceeeecccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH--------
Q 010891 326 LLGAGKSHITTRVMGTFGYVAPEYANSG-LLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMM-------- 396 (498)
Q Consensus 326 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~-------- 396 (498)
.+..... ....+||+.|+|||++.+. .|+.++|||||||+||||++|+.||....... .+.+.+...
T Consensus 206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~~lg~p~~~~~ 281 (420)
T 1j1b_A 206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQI 281 (420)
T ss_dssp ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCHHHH
T ss_pred hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHH
Confidence 7654322 3346799999999988664 79999999999999999999999997543211 112211110
Q ss_pred Hhhc-cccCCcCCCCCCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 397 VQLR-RSEDVVDPNIETRP-----STSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 397 ~~~~-~~~~~~~~~~~~~~-----~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.... .......+.....+ .......+..++.+||..||.+|||+.|+++|-
T Consensus 282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp 338 (420)
T 1j1b_A 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS 338 (420)
T ss_dssp HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence 0000 00001111111100 000112344555689999999999999999764
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=344.23 Aligned_cols=195 Identities=25% Similarity=0.388 Sum_probs=172.0
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCC-CCCceEEEeEEEe--CCeeEEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-HKNLVRLLGYCIE--GTQRILV 248 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~--~~~~~lv 248 (498)
.++|++.+.||+|+||+||+|+. .+++.||+|++.. ...+.+.+|+.+++.++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 36799999999999999999975 5789999999853 33567889999999997 9999999999988 6678999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCC-CeEEeeeccceec
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF-DAKISDFGLAKLL 327 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~-~~kL~DfGla~~~ 327 (498)
|||+++++|.+++. .+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||+++..
T Consensus 112 ~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~ 181 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY 181 (330)
T ss_dssp EECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEc
Confidence 99999999999985 288999999999999999999999 999999999999999776 8999999999876
Q ss_pred CCCCceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 010891 328 GAGKSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 328 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~ 382 (498)
..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 182 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~ 235 (330)
T 3nsz_A 182 HPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 235 (330)
T ss_dssp CTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred CCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 54332 334579999999999876 779999999999999999999999996544
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=357.54 Aligned_cols=261 Identities=20% Similarity=0.253 Sum_probs=204.4
Q ss_pred HccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCC-CCceEEEeEEEeCCeeEEEE
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRH-KNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~~~lv~ 249 (498)
+.++|.+.++||+|+||.||+|++ .+++.||||++..... ...+..|++++..++| ++|..+..++.+....+|||
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 357899999999999999999985 5689999998754432 3458889999999977 56666777778888999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEE---cCCCCeEEeeecccee
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKL 326 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll---~~~~~~kL~DfGla~~ 326 (498)
||+ +++|.+++.. ....+++..++.|+.||+.||.|||++ +|+||||||+|||| +.++.+||+|||+++.
T Consensus 83 e~~-g~sL~~ll~~---~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~ 155 (483)
T 3sv0_A 83 DLL-GPSLEDLFNF---CSRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK 155 (483)
T ss_dssp ECC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ECC-CCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence 999 9999999974 235699999999999999999999999 99999999999999 6889999999999998
Q ss_pred cCCCCce------eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhc
Q 010891 327 LGAGKSH------ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLR 400 (498)
Q Consensus 327 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 400 (498)
+...... ......||+.|+|||++.+..++.++|||||||+||||++|+.||..............+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (483)
T 3sv0_A 156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT 235 (483)
T ss_dssp CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS
T ss_pred ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc
Confidence 7554321 1225679999999999999999999999999999999999999998655433332222222111111
Q ss_pred cccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 401 RSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
....+.. ... ..+..++.+||+.||++||++.+|++.|+..
T Consensus 236 ~~~~l~~------~~p---~~l~~li~~cl~~dP~~RPs~~el~~~L~~l 276 (483)
T 3sv0_A 236 SIEALCR------GYP---TEFASYFHYCRSLRFDDKPDYSYLKRLFRDL 276 (483)
T ss_dssp CHHHHHT------TSC---HHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred cHHHHhc------CCc---HHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence 1000000 011 2344455589999999999999999888653
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=357.79 Aligned_cols=266 Identities=21% Similarity=0.257 Sum_probs=201.5
Q ss_pred HHccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCC--------CCCceEEEeEEE-
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR--------HKNLVRLLGYCI- 240 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------hpnIv~l~~~~~- 240 (498)
...++|.+.++||+|+||+||+|+. .+++.||||++... ....+.+.+|+.+++.++ ||||+++++++.
T Consensus 34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 3457899999999999999999975 46889999998543 223456888999999885 788999999988
Q ss_pred ---eCCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCC---
Q 010891 241 ---EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF--- 314 (498)
Q Consensus 241 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~--- 314 (498)
+....|+||||+ +++|.+++... ....+++..++.++.||+.||.|||+++ +|+||||||+||||+.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~ 187 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYI 187 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhh
Confidence 556889999999 66777777543 3356999999999999999999999853 799999999999999775
Q ss_pred ----------------------------------------------CeEEeeeccceecCCCCceeeecccccccccCcc
Q 010891 315 ----------------------------------------------DAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPE 348 (498)
Q Consensus 315 ----------------------------------------------~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE 348 (498)
.+||+|||++...... ....+||+.|+|||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE 263 (397)
T 1wak_A 188 RRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHH
T ss_pred hhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCCh
Confidence 8999999999876532 33457999999999
Q ss_pred cccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccc------------cCCcCC--CC----
Q 010891 349 YANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRS------------EDVVDP--NI---- 410 (498)
Q Consensus 349 ~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~--~~---- 410 (498)
++.+..++.++|||||||+||||++|+.||..............+..+...... ...... .+
T Consensus 264 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 343 (397)
T 1wak_A 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343 (397)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence 999999999999999999999999999999765443322222222222211110 000000 00
Q ss_pred C-------------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 411 E-------------TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 411 ~-------------~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
. ..........+..++.+||+.||++|||+.|+++|
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h 392 (397)
T 1wak_A 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH 392 (397)
T ss_dssp CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence 0 01122333445566669999999999999999976
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-42 Score=354.17 Aligned_cols=263 Identities=25% Similarity=0.332 Sum_probs=193.7
Q ss_pred ccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCe------eE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQ------RI 246 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~------~~ 246 (498)
..+|.+.++||+|+||+||+|+...+..||+|++...... ..+|+++++.++||||+++++++..... .+
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 114 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN 114 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence 4578999999999999999999877778999998654322 2369999999999999999999965433 78
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEc-CCCCeEEeeeccce
Q 010891 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID-ENFDAKISDFGLAK 325 (498)
Q Consensus 247 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~-~~~~~kL~DfGla~ 325 (498)
+||||+++ ++.+.+.........+++..+..++.||+.||.|||+. +|+||||||+|||++ .++.+||+|||+++
T Consensus 115 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 115 LVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 99999977 44444432222456799999999999999999999999 999999999999999 79999999999999
Q ss_pred ecCCCCceeeecccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH--------
Q 010891 326 LLGAGKSHITTRVMGTFGYVAPEYANSG-LLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMM-------- 396 (498)
Q Consensus 326 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~-------- 396 (498)
....... .....||+.|+|||++.+. .|+.++|||||||++|||++|+.||....... .+...+...
T Consensus 191 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g~p~~~~~ 266 (394)
T 4e7w_A 191 ILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID--QLVEIIKVLGTPSREQI 266 (394)
T ss_dssp ECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHH
T ss_pred cccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHHH
Confidence 8754332 3346789999999988654 69999999999999999999999997543221 111111100
Q ss_pred Hhhc-cccCCcCCCCCCCC-----CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 397 VQLR-RSEDVVDPNIETRP-----STSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 397 ~~~~-~~~~~~~~~~~~~~-----~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.... ......-+.....+ .......+..++.+||..||.+|||+.|+++|-
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp 323 (394)
T 4e7w_A 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHP 323 (394)
T ss_dssp HHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSG
T ss_pred HhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcCh
Confidence 0000 00000000100000 000112344555589999999999999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=375.52 Aligned_cols=246 Identities=28% Similarity=0.407 Sum_probs=192.3
Q ss_pred ceEcccCcEEEEEEEEc---CCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCC
Q 010891 180 NIIGDGGYGVVYRGQLM---NGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNN 254 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (498)
+.||+|+||.||+|.+. .++.||||++..... ...+.+.+|+++|.+++|||||++++++.+ +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999642 467899999865432 234679999999999999999999999964 568999999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc--
Q 010891 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS-- 332 (498)
Q Consensus 255 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~-- 332 (498)
|+|.+++.. ...+++..++.|+.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.+.....
T Consensus 454 g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~ 526 (635)
T 4fl3_A 454 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526 (635)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred CCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence 999999973 35699999999999999999999999 999999999999999999999999999987654332
Q ss_pred eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCC
Q 010891 333 HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411 (498)
Q Consensus 333 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (498)
.......||+.|+|||++.+..++.++|||||||+||||++ |+.||...... +....+...... ...
T Consensus 527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~------~~~~~i~~~~~~------~~p 594 (635)
T 4fl3_A 527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------EVTAMLEKGERM------GCP 594 (635)
T ss_dssp --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHHHTTCCC------CCC
T ss_pred ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCCC------CCC
Confidence 12233457889999999999999999999999999999998 99999754321 111222211111 111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 412 ~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
. ... ..+..++.+||+.||++|||+.+|++.|+.
T Consensus 595 ~-~~~---~~l~~li~~cl~~dP~~RPs~~~l~~~L~~ 628 (635)
T 4fl3_A 595 A-GCP---REMYDLMNLCWTYDVENRPGFAAVELRLRN 628 (635)
T ss_dssp T-TCC---HHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred C-CCC---HHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence 1 111 234445558999999999999999999975
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=345.51 Aligned_cols=263 Identities=23% Similarity=0.384 Sum_probs=183.9
Q ss_pred HHHccCCCccceEcccCcEEEEEEE-EcCCcEEEEEEecCCC-CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 170 QSATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 170 ~~~~~~y~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
....++|.+.+.||+|+||.||+|. ..+++.||||++.... ....+.+.+|+.++..++||||+++++++...+..++
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 90 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL 90 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence 3446789999999999999999997 4468999999885433 2334568889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhccc----CCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecc
Q 010891 248 VYEYVNNGNLEQWLRGDM----CDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~----~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGl 323 (498)
||||+++++|.+++.... .....+++..++.++.||+.||.|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 999999999999996421 1245699999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCc----eeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHh
Q 010891 324 AKLLGAGKS----HITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQ 398 (498)
Q Consensus 324 a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 398 (498)
+........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~~ 241 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL------MLTLQ 241 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH------HHHHT
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH------HHHhc
Confidence 976543211 11234579999999998865 56899999999999999999999999765432211 00111
Q ss_pred hccccCCc----CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 399 LRRSEDVV----DPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 399 ~~~~~~~~----~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
....... ++... ..... .+..++.+||+.||.+|||+.+++++
T Consensus 242 -~~~~~~~~~~~~~~~~-~~~~~---~~~~li~~~l~~dp~~Rps~~~ll~h 288 (303)
T 2vwi_A 242 -NDPPSLETGVQDKEML-KKYGK---SFRKMISLCLQKDPEKRPTAAELLRH 288 (303)
T ss_dssp -SSCCCTTC-----CCC-CCCCH---HHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred -cCCCccccccccchhh-hhhhH---HHHHHHHHHccCChhhCcCHHHHhhC
Confidence 1111000 00110 11112 23344458999999999999999875
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=337.88 Aligned_cols=256 Identities=23% Similarity=0.330 Sum_probs=186.7
Q ss_pred HccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCc-h-hHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQA-D-KDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~-~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
..++|++.+.||+|+||+||+|+. .+|+.||+|++....... . +.+.++...++.++||||+++++++.++...++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 357899999999999999999986 578999999986543222 1 2344555568888999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+++ +|.+++.........+++..++.++.|++.||.|||++. +|+||||||+|||++.++.+||+|||++....
T Consensus 85 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 85 MELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred Eehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 999974 998888654445578999999999999999999999853 89999999999999999999999999998765
Q ss_pred CCCceeeecccccccccCcccc----cCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYA----NSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSED 404 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (498)
.... .....||+.|+|||++ .+..++.++|||||||++|+|++|+.||....... ..+........
T Consensus 162 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~~~~--- 231 (290)
T 3fme_A 162 DDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-----QQLKQVVEEPS--- 231 (290)
T ss_dssp ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-----HHHHHHHHSCC---
T ss_pred cccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-----HHHHHHhccCC---
Confidence 4322 2334699999999995 56778999999999999999999999997433211 11111111111
Q ss_pred CcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 405 VVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
+......... .+..++.+||+.||++|||+.|++++
T Consensus 232 ---~~~~~~~~~~---~~~~li~~~l~~~p~~Rpt~~e~l~h 267 (290)
T 3fme_A 232 ---PQLPADKFSA---EFVDFTSQCLKKNSKERPTYPELMQH 267 (290)
T ss_dssp ---CCCCTTTSCH---HHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred ---CCcccccCCH---HHHHHHHHHhhcChhhCcCHHHHHhC
Confidence 1111111122 33444558999999999999999874
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=355.25 Aligned_cols=200 Identities=21% Similarity=0.282 Sum_probs=173.0
Q ss_pred HccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCCchhHHHHHHHHHHcC------CCCCceEEEeEEEeCCe
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHV------RHKNLVRLLGYCIEGTQ 244 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~hpnIv~l~~~~~~~~~ 244 (498)
...+|++.+.||+|+||+||+|... +++.||||++... ......+..|+.++..+ +|+||+++++++.....
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 4568999999999999999999754 5899999998643 22234577788888776 57899999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCC--eEEeeec
Q 010891 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD--AKISDFG 322 (498)
Q Consensus 245 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~--~kL~DfG 322 (498)
.|+||||+. ++|.+++... ....+++..+..++.||+.||.|||+. +|+||||||+||||+.++. +||+|||
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKN--KFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred EEEEEeccC-CCHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecc
Confidence 999999995 6999999754 334589999999999999999999999 9999999999999999987 9999999
Q ss_pred cceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 010891 323 LAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 323 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~ 382 (498)
+++..... ....+||+.|+|||++.+..|+.++|||||||+||||++|..||....
T Consensus 248 ~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~ 303 (429)
T 3kvw_A 248 SSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED 303 (429)
T ss_dssp TCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence 99875432 234679999999999999999999999999999999999999997543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=336.23 Aligned_cols=253 Identities=22% Similarity=0.284 Sum_probs=195.7
Q ss_pred HccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCC----CCchhHHHHHHHHHHcCCCCCceEEEeEEE--eCCe
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNP----GQADKDFRVEVEAIGHVRHKNLVRLLGYCI--EGTQ 244 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~--~~~~ 244 (498)
..++|.+.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+++++.++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 347899999999999999999985 468899999985432 233467889999999999999999999985 4467
Q ss_pred eEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccc
Q 010891 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (498)
Q Consensus 245 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla 324 (498)
.|+||||++++ |.+++... ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~ 156 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVA 156 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred EEEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccc
Confidence 89999999876 88877643 345799999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCC-ceeeecccccccccCcccccCCC--CCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhcc
Q 010891 325 KLLGAGK-SHITTRVMGTFGYVAPEYANSGL--LNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRR 401 (498)
Q Consensus 325 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 401 (498)
....... ........||+.|+|||++.+.. ++.++||||||+++|||++|+.||..... .+....+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~------~~~~~~i~~~-- 228 (305)
T 2wtk_C 157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI------YKLFENIGKG-- 228 (305)
T ss_dssp EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH------HHHHHHHHHC--
T ss_pred cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH------HHHHHHHhcC--
Confidence 8765322 22234457999999999987643 47899999999999999999999975332 1111221111
Q ss_pred ccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 402 SEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
. ........ ..+..++.+||+.||.+|||+.|++++.
T Consensus 229 -~------~~~~~~~~--~~l~~li~~~l~~dp~~Rps~~~ll~~~ 265 (305)
T 2wtk_C 229 -S------YAIPGDCG--PPLSDLLKGMLEYEPAKRFSIRQIRQHS 265 (305)
T ss_dssp -C------CCCCSSSC--HHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred -C------CCCCCccC--HHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence 0 01111111 2233444589999999999999999764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=341.31 Aligned_cols=257 Identities=26% Similarity=0.405 Sum_probs=193.4
Q ss_pred ccCCCccceEcccCcEEEEEEEEc--CCc--EEEEEEecCCC---CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCee
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM--NGT--AVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQR 245 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 245 (498)
.++|++.+.||+|+||+||+|++. +++ .||+|++.... ....+.+.+|++++.+++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 467899999999999999999753 233 68999886542 233467889999999999999999999998755 8
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccce
Q 010891 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~ 325 (498)
++||||+++++|.+++... .+.+++..++.++.|++.||.|||++ +++||||||+|||++.++.+||+|||++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~ 169 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR 169 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccc
Confidence 9999999999999999753 24589999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCce--eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccc
Q 010891 326 LLGAGKSH--ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRS 402 (498)
Q Consensus 326 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (498)
........ ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...... +.+........
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~------~~~~~~~~~~~- 242 (291)
T 1u46_A 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEGE- 242 (291)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSCC-
T ss_pred cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH------HHHHHHHccCC-
Confidence 87544322 1233567889999999988889999999999999999999 99999754321 11122211110
Q ss_pred cCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 403 EDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
........+ ..+..++.+||+.||.+|||+.+++++|+...
T Consensus 243 ------~~~~~~~~~--~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 243 ------RLPRPEDCP--QDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp ------CCCCCTTCC--HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred ------CCCCCcCcC--HHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 011111111 23344445899999999999999999998754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=349.27 Aligned_cols=197 Identities=29% Similarity=0.344 Sum_probs=162.9
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC--chhHHHHHHHHHHcCCCCCceEEEeEEEeCC------
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT------ 243 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~------ 243 (498)
.++|.+.+.||+|+||.||+|.. .+++.||||++...... ..+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46899999999999999999975 46889999998654322 2356788999999999999999999998654
Q ss_pred eeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecc
Q 010891 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (498)
Q Consensus 244 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGl 323 (498)
..|+||||+++ +|.+++. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 104 ~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 173 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 173 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ceEEEEEcCCC-CHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeec
Confidence 77999999975 8888885 2488999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 010891 324 AKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYG 381 (498)
Q Consensus 324 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~ 381 (498)
++...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 174 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 229 (371)
T 2xrw_A 174 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGT 229 (371)
T ss_dssp ------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred cccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 98764322 234467999999999999999999999999999999999999999754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=343.21 Aligned_cols=255 Identities=22% Similarity=0.338 Sum_probs=196.1
Q ss_pred HHccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC--------CchhHHHHHHHHHHcCCCCCceEEEeEEEe
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--------QADKDFRVEVEAIGHVRHKNLVRLLGYCIE 241 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 241 (498)
...++|.+.+.||+|+||.||+|.. .+++.||||.+..... .....+.+|+++++.++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 3457899999999999999999986 4588999999854321 122458889999999999999999999876
Q ss_pred CCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCC---eEE
Q 010891 242 GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD---AKI 318 (498)
Q Consensus 242 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~---~kL 318 (498)
+. .|+||||+++++|.+++. ....+++..++.++.||+.||.|||++ +|+||||||+|||++.++. +||
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl 158 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 158 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHS----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEE
T ss_pred Cc-eEEEEecCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEE
Confidence 54 899999999999999996 345799999999999999999999999 9999999999999987665 999
Q ss_pred eeeccceecCCCCceeeecccccccccCcccc---cCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 010891 319 SDFGLAKLLGAGKSHITTRVMGTFGYVAPEYA---NSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKM 395 (498)
Q Consensus 319 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 395 (498)
+|||++....... ......||+.|+|||++ ....++.++|||||||++|+|++|..||........ +...+
T Consensus 159 ~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~-- 232 (322)
T 2ycf_A 159 TDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQI-- 232 (322)
T ss_dssp CCCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHH--
T ss_pred ccCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHH--
Confidence 9999998765432 23346799999999986 356789999999999999999999999975443221 11111
Q ss_pred HHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 396 MVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.. .... ..+... ... ...+..++.+||..||++|||+.+++++-
T Consensus 233 -~~-~~~~--~~~~~~--~~~--~~~~~~li~~~l~~dP~~Rps~~~~l~h~ 276 (322)
T 2ycf_A 233 -TS-GKYN--FIPEVW--AEV--SEKALDLVKKLLVVDPKARFTTEEALRHP 276 (322)
T ss_dssp -HH-TCCC--CCHHHH--TTS--CHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred -Hh-Cccc--cCchhh--hhc--CHHHHHHHHHHcccCHhhCCCHHHHhhCc
Confidence 11 1000 000000 001 12344455589999999999999998753
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-42 Score=347.18 Aligned_cols=263 Identities=24% Similarity=0.305 Sum_probs=199.0
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEeEEEeC-----Cee
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEG-----TQR 245 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~~ 245 (498)
.++|++.+.||+|+||.||+|.. .+++.||||++...... ..+.+.+|++++.+++||||+++++++... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 46899999999999999999985 46889999999654332 235688999999999999999999999765 367
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccce
Q 010891 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~ 325 (498)
|+||||+. |+|.+++.. +.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceE
Confidence 99999997 599999963 3599999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCce--eeecccccccccCccccc-CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhcc-
Q 010891 326 LLGAGKSH--ITTRVMGTFGYVAPEYAN-SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRR- 401 (498)
Q Consensus 326 ~~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~- 401 (498)
........ .....+||+.|+|||++. +..++.++|||||||++|+|++|+.||.......... .+........
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---~i~~~~~~~~~ 253 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN---HILGILGSPSQ 253 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHH---HHHHHHCSCCH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHH---HHHHHhCCCCH
Confidence 76543221 124468999999999764 5568999999999999999999999997654332211 1100000000
Q ss_pred --------------ccCCcCCCCC----CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 402 --------------SEDVVDPNIE----TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 402 --------------~~~~~~~~~~----~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
.......... ..+.. ...+..++.+||+.||.+|||+.|++++---
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~ 317 (364)
T 3qyz_A 254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNA--DSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317 (364)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTS--CHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCC--CHHHHHHHHHHcCCChhhCCCHHHHhcCcch
Confidence 0000000000 00111 1234445558999999999999999987543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=340.16 Aligned_cols=200 Identities=24% Similarity=0.331 Sum_probs=173.4
Q ss_pred HccCCCccceEcccCcEEEEEEEE--cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCC------CceEEEeEEEeCC
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL--MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHK------NLVRLLGYCIEGT 243 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp------nIv~l~~~~~~~~ 243 (498)
..++|++.+.||+|+||.||+|.. .+++.||+|++... ....+.+.+|++++..++|+ +|+++++++.+..
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 457899999999999999999976 36889999998543 22345678899999988665 4999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcC-----------
Q 010891 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE----------- 312 (498)
Q Consensus 244 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~----------- 312 (498)
..|+||||+ +++|.+++... ....+++..+..++.||+.||.|||++ +|+||||||+|||++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~ 164 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKI 164 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC---
T ss_pred cEEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcc
Confidence 999999999 88999999754 234689999999999999999999999 9999999999999987
Q ss_pred --------CCCeEEeeeccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 010891 313 --------NFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 313 --------~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~ 382 (498)
++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 165 KRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp -CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred ccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 678999999999875432 234579999999999999999999999999999999999999997543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=336.85 Aligned_cols=254 Identities=24% Similarity=0.328 Sum_probs=200.5
Q ss_pred HccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCC---------chhHHHHHHHHHHcCC-CCCceEEEeEEE
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ---------ADKDFRVEVEAIGHVR-HKNLVRLLGYCI 240 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-hpnIv~l~~~~~ 240 (498)
..++|.+.+.||+|+||.||+|... +|+.||||++...... ..+.+.+|++++.++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3568999999999999999999864 6899999998654321 1245778999999995 999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEee
Q 010891 241 EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISD 320 (498)
Q Consensus 241 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~D 320 (498)
+....++||||+++++|.+++.. ...+++..++.++.||+.||.|||+. +++||||||+||+++.++.+||+|
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred cCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEec
Confidence 99999999999999999999974 35689999999999999999999999 999999999999999999999999
Q ss_pred eccceecCCCCceeeecccccccccCccccc------CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH
Q 010891 321 FGLAKLLGAGKSHITTRVMGTFGYVAPEYAN------SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLK 394 (498)
Q Consensus 321 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~ 394 (498)
||++....... ......||+.|+|||++. ...++.++||||||+++|+|++|+.||...... ....
T Consensus 168 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~ 239 (298)
T 1phk_A 168 FGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM------LMLR 239 (298)
T ss_dssp CTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHH
T ss_pred ccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHH------HHHH
Confidence 99998865432 233457999999999884 457889999999999999999999999753221 1111
Q ss_pred HHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 395 MMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.+.... . ....+. .. .....+..++.+||+.||.+|||+.+++++-
T Consensus 240 ~~~~~~-~-~~~~~~---~~--~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~ 285 (298)
T 1phk_A 240 MIMSGN-Y-QFGSPE---WD--DYSDTVKDLVSRFLVVQPQKRYTAEEALAHP 285 (298)
T ss_dssp HHHHTC-C-CCCTTT---GG--GSCHHHHHHHHHHCCSSGGGSCCHHHHTTSG
T ss_pred HHhcCC-c-ccCccc---cc--ccCHHHHHHHHHHccCCcccCCCHHHHHhCh
Confidence 111111 0 000010 00 1112334445589999999999999998754
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=345.85 Aligned_cols=259 Identities=19% Similarity=0.298 Sum_probs=202.3
Q ss_pred ccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCc---h--------------hHHHHHHHHHHcCCCCCceEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQA---D--------------KDFRVEVEAIGHVRHKNLVRL 235 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~--------------~~~~~E~~~l~~l~hpnIv~l 235 (498)
.++|.+.+.||+|+||.||+|+. +|+.||+|++....... . +.+.+|+.++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999988 99999999985322111 1 678999999999999999999
Q ss_pred EeEEEeCCeeEEEEeecCCCCHHHH------HhcccCCCCCCCHHHHHHHHHHHHHHHHHHHH-ccCCCeeecCCCCCCE
Q 010891 236 LGYCIEGTQRILVYEYVNNGNLEQW------LRGDMCDRGYLTWEARMKILLGTAKALAYLHE-AIEPKVVHRDIKSSNI 308 (498)
Q Consensus 236 ~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiHrDikp~NI 308 (498)
++++.+.+..++||||+++|+|.++ +... ....+++..++.++.|++.||.|||+ . +|+||||||+||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Ni 183 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNI 183 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhE
Confidence 9999999999999999999999998 4321 25679999999999999999999999 8 999999999999
Q ss_pred EEcCCCCeEEeeeccceecCCCCceeeecccccccccCcccccCC-CCCc-cchHHHHHHHHHHHHhCCCCCCCCCCcch
Q 010891 309 LIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSG-LLNE-KSDVYSFGVVLLEAITGRYPVDYGRPQSE 386 (498)
Q Consensus 309 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDvwSlGvvl~elltg~~P~~~~~~~~~ 386 (498)
|++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|||++|+.||.......
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~- 259 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV- 259 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH-
T ss_pred EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH-
Confidence 9999999999999999886543 23446799999999999877 6766 9999999999999999999997554321
Q ss_pred hhHHHHHHHHHhhccccCCcCC-CC----C------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 387 VNLVEWLKMMVQLRRSEDVVDP-NI----E------TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~~-~~----~------~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
+....+... ........ .. . .....+ ..+..++.+||+.||.+|||+.|++++--
T Consensus 260 ----~~~~~i~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~li~~~L~~dP~~Rps~~e~l~hp~ 325 (348)
T 2pml_X 260 ----ELFNNIRTK-NIEYPLDRNHFLYPLTNKKSTCSNNFLS--NEDIDFLKLFLRKNPAERITSEDALKHEW 325 (348)
T ss_dssp ----HHHHHHTSC-CCCCCCSSSSSTTTTCC--------CCC--HHHHHHHHHHCCSSGGGSCCHHHHHTSGG
T ss_pred ----HHHHHHhcc-CcCCccchhhhhccccccccccchhhcC--HHHHHHHHHHccCChhhCCCHHHHhcCcc
Confidence 111111111 00000000 00 0 001111 23344455899999999999999998643
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-43 Score=353.65 Aligned_cols=259 Identities=26% Similarity=0.337 Sum_probs=181.8
Q ss_pred HccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC--chhHHHHHHHHHHcCCCCCceEEEeEEEeC------
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEG------ 242 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------ 242 (498)
..++|++.+.||+|+||.||+|.. .+|+.||||++...... ..+.+.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 347899999999999999999974 56899999998654322 335678899999999999999999998754
Q ss_pred CeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeec
Q 010891 243 TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFG 322 (498)
Q Consensus 243 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfG 322 (498)
...|+||||+ +++|.+++.. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC--
T ss_pred CeEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecc
Confidence 5679999999 7899998853 4699999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhcc
Q 010891 323 LAKLLGAGKSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRR 401 (498)
Q Consensus 323 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 401 (498)
+++..... ....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .+..+.....
T Consensus 178 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~l~~i~~~~g 247 (367)
T 2fst_X 178 LARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID------QLKLILRLVG 247 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHHHC
T ss_pred cccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHHHhC
Confidence 99875432 344679999999999876 789999999999999999999999997543211 1111111100
Q ss_pred cc------CCc----------CCCCCCCCCHH-----HHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 402 SE------DVV----------DPNIETRPSTS-----ALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 402 ~~------~~~----------~~~~~~~~~~~-----~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
.. .+. -+... ..... .......++.+||..||.+|||+.|+++|---.
T Consensus 248 ~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~ 316 (367)
T 2fst_X 248 TPGAELLKKISSESARNYIQSLTQMP-KMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 316 (367)
T ss_dssp SCCHHHHTTCCCHHHHHHHHTSCCCC-CCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred CCCHHHHHHhhhHHHHHHHhccCCCC-CCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhh
Confidence 00 000 00000 00000 012234455589999999999999999875443
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=335.04 Aligned_cols=254 Identities=27% Similarity=0.426 Sum_probs=189.5
Q ss_pred HccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEe---------
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIE--------- 241 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--------- 241 (498)
..++|++.+.||+|+||.||+|+. .+++.||+|++... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 356799999999999999999986 47899999998532 2234568889999999999999999998865
Q ss_pred ----CCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeE
Q 010891 242 ----GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAK 317 (498)
Q Consensus 242 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~k 317 (498)
....|+||||+++|+|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+|
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~k 156 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVK 156 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEE
Confidence 35679999999999999999742 34578899999999999999999999 999999999999999999999
Q ss_pred EeeeccceecCCCC-------------ceeeecccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCC
Q 010891 318 ISDFGLAKLLGAGK-------------SHITTRVMGTFGYVAPEYANSG-LLNEKSDVYSFGVVLLEAITGRYPVDYGRP 383 (498)
Q Consensus 318 L~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~ 383 (498)
|+|||++....... ........||+.|+|||++.+. .++.++|||||||++|||++ ||...
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~-- 231 (303)
T 1zy4_A 157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTG-- 231 (303)
T ss_dssp ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSH--
T ss_pred EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCc--
Confidence 99999998654321 1122345799999999998764 78999999999999999998 55421
Q ss_pred cchhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 384 QSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.+.......+.. ......+.+. ......+..++.+||+.||.+|||+.+++++-
T Consensus 232 ---~~~~~~~~~~~~---~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 285 (303)
T 1zy4_A 232 ---MERVNILKKLRS---VSIEFPPDFD----DNKMKVEKKIIRLLIDHDPNKRPGARTLLNSG 285 (303)
T ss_dssp ---HHHHHHHHHHHS---TTCCCCTTCC----TTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSS
T ss_pred ---hhHHHHHHhccc---cccccCcccc----ccchHHHHHHHHHHHhcCcccCcCHHHHhCCC
Confidence 111222222211 1111111111 11112233444589999999999999999863
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=347.60 Aligned_cols=205 Identities=25% Similarity=0.306 Sum_probs=172.8
Q ss_pred HHHHccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCCchhHHHHHHHHHHcCC-CC-----CceEEEeEEEe
Q 010891 169 LQSATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-HK-----NLVRLLGYCIE 241 (498)
Q Consensus 169 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hp-----nIv~l~~~~~~ 241 (498)
.....++|.+.+.||+|+||+||+|... +++.||||++... ......+..|+.++..++ |+ +|+++++++..
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~ 127 (382)
T 2vx3_A 49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF 127 (382)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence 3445689999999999999999999854 6889999998643 222355777888888874 55 49999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEc--CCCCeEEe
Q 010891 242 GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID--ENFDAKIS 319 (498)
Q Consensus 242 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~--~~~~~kL~ 319 (498)
....|+||||+. ++|.+++... ....+++..+..++.|++.||.|||.+ ..+|+||||||+|||++ .++.+||+
T Consensus 128 ~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 128 RNHLCLVFEMLS-YNLYDLLRNT--NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp TTEEEEEEECCC-CBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred CCceEEEEecCC-CCHHHHHhhc--CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 999999999996 5999999754 234589999999999999999999942 22899999999999995 47889999
Q ss_pred eeccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 010891 320 DFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 320 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~ 382 (498)
|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 204 DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~ 262 (382)
T 2vx3_A 204 DFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262 (382)
T ss_dssp CCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred eccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999987532 234679999999999999999999999999999999999999997543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=341.99 Aligned_cols=272 Identities=23% Similarity=0.303 Sum_probs=190.1
Q ss_pred HHHHHccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCe--
Q 010891 168 DLQSATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQ-- 244 (498)
Q Consensus 168 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~-- 244 (498)
......++|.+.+.||+|+||.||+|+. .+|+.||||++.... .....+..+++.+..++||||+++++++.....
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 3456678999999999999999999986 468999999986543 333456778888999999999999999976433
Q ss_pred -----eEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH--HccCCCeeecCCCCCCEEEcC-CCCe
Q 010891 245 -----RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH--EAIEPKVVHRDIKSSNILIDE-NFDA 316 (498)
Q Consensus 245 -----~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH--~~~~~~iiHrDikp~NIll~~-~~~~ 316 (498)
.++||||+++ +|.+.+.........+++..+..++.|++.||.||| +. +|+||||||+|||++. ++.+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~ 171 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTL 171 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEE
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcE
Confidence 7899999976 666655443335567899999999999999999999 87 9999999999999997 8999
Q ss_pred EEeeeccceecCCCCceeeecccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 010891 317 KISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSG-LLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKM 395 (498)
Q Consensus 317 kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~ 395 (498)
||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||........ +......
T Consensus 172 kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~~~~~~~ 247 (360)
T 3e3p_A 172 KLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ--LHEIVRV 247 (360)
T ss_dssp EECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHH
T ss_pred EEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH--HHHHHHH
Confidence 9999999987654332 3345789999999988654 589999999999999999999999975432211 1111110
Q ss_pred H--------Hhhccc---cCCcCCC-C-----CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 396 M--------VQLRRS---EDVVDPN-I-----ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 396 ~--------~~~~~~---~~~~~~~-~-----~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
. ...... ....... . ...........+..++.+||+.||.+|||+.|+++|--
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~ 317 (360)
T 3e3p_A 248 LGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPY 317 (360)
T ss_dssp HCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGG
T ss_pred cCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcc
Confidence 0 000000 0000000 0 00000011234455556899999999999999998643
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-41 Score=334.98 Aligned_cols=260 Identities=25% Similarity=0.343 Sum_probs=197.7
Q ss_pred HccCCCccceEcccCcEEEEEEEE--cCCcEEEEEEecCCC--CCchhHHHHHHHHHHcC---CCCCceEEEeEEE----
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL--MNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHV---RHKNLVRLLGYCI---- 240 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~---- 240 (498)
..++|++.+.||+|+||.||+|+. .+|+.||+|++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999987 468899999885432 22234567788777766 8999999999987
Q ss_pred -eCCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEe
Q 010891 241 -EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKIS 319 (498)
Q Consensus 241 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~ 319 (498)
.....++||||++ |+|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence 4567899999997 5999999754 234589999999999999999999999 99999999999999999999999
Q ss_pred eeccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhh
Q 010891 320 DFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQL 399 (498)
Q Consensus 320 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 399 (498)
|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... . +..+...
T Consensus 163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~---~~~i~~~ 234 (326)
T 1blx_A 163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD---Q---LGKILDV 234 (326)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---H---HHHHHHH
T ss_pred cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH---H---HHHHHHH
Confidence 999998654321 2334678999999999999999999999999999999999999997543211 1 1111111
Q ss_pred ccc---cCCc--------------CCCC-CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 400 RRS---EDVV--------------DPNI-ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 400 ~~~---~~~~--------------~~~~-~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
... .... .... ......+. .+..++.+||+.||.+|||+.+++++-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~li~~~L~~dP~~Rpt~~e~l~hp 298 (326)
T 1blx_A 235 IGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDE--LGKDLLLKCLTFNPAKRISAYSALSHP 298 (326)
T ss_dssp HCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCH--HHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred cCCCCcccCccccccchhhhcccCcchhhhccccCCH--HHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence 000 0000 0000 00111122 233444589999999999999999754
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=341.44 Aligned_cols=255 Identities=21% Similarity=0.236 Sum_probs=171.0
Q ss_pred HccCCCccc-eEcccCcEEEEEEEEc-CCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEe----CCee
Q 010891 172 ATNRFSKDN-IIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIE----GTQR 245 (498)
Q Consensus 172 ~~~~y~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~ 245 (498)
..++|.+.+ +||+|+||+||+|... +|+.||||++... ..........+..+.||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 456788854 6999999999999865 6899999998542 2222333344667799999999999976 4557
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcC---CCCeEEeeec
Q 010891 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE---NFDAKISDFG 322 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~---~~~~kL~DfG 322 (498)
++||||+++|+|.+++... ....+++..++.++.||+.||.|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 102 ~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg 176 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFG 176 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccc
Confidence 9999999999999999753 234699999999999999999999999 9999999999999976 4559999999
Q ss_pred cceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccc
Q 010891 323 LAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRS 402 (498)
Q Consensus 323 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (498)
++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.......... .+......
T Consensus 177 ~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~~~~~~ 247 (336)
T 3fhr_A 177 FAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP------GMKRRIRL 247 (336)
T ss_dssp TCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred cceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh------hHHHhhhc
Confidence 998765322 334578999999999998899999999999999999999999997543221100 00000000
Q ss_pred cCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 403 EDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.....+......... .+..++.+||..||.+|||+.|++++-
T Consensus 248 ~~~~~~~~~~~~~~~---~~~~li~~~L~~dP~~Rpt~~ell~hp 289 (336)
T 3fhr_A 248 GQYGFPNPEWSEVSE---DAKQLIRLLLKTDPTERLTITQFMNHP 289 (336)
T ss_dssp ---CCCTTTSTTCCH---HHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred cccccCchhhccCCH---HHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence 000001111111122 233444589999999999999999854
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=342.54 Aligned_cols=258 Identities=21% Similarity=0.321 Sum_probs=195.5
Q ss_pred HHHHHccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCC--chhHHHHHHHHHHcCC--CCCceEEEeEEEeCC
Q 010891 168 DLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVR--HKNLVRLLGYCIEGT 243 (498)
Q Consensus 168 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~ 243 (498)
.+....++|++.+.||+|+||.||+|...+++.||+|++...... ..+.+.+|+.++.+++ ||||+++++++.+..
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred eeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence 344556789999999999999999999888999999998654322 3456889999999997 599999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecc
Q 010891 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (498)
Q Consensus 244 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGl 323 (498)
..|+||| +.+++|.+++.. ...+++..++.++.|++.||.|||+. +|+||||||+|||+++ +.+||+|||+
T Consensus 102 ~~~lv~e-~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~ 172 (313)
T 3cek_A 102 YIYMVME-CGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGI 172 (313)
T ss_dssp EEEEEEC-CCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred EEEEEEe-cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccc
Confidence 9999999 558899999974 35689999999999999999999999 9999999999999965 7999999999
Q ss_pred ceecCCCCce-eeecccccccccCcccccC-----------CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHH
Q 010891 324 AKLLGAGKSH-ITTRVMGTFGYVAPEYANS-----------GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVE 391 (498)
Q Consensus 324 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~ 391 (498)
+......... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... .
T Consensus 173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----~ 247 (313)
T 3cek_A 173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----S 247 (313)
T ss_dssp SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----H
T ss_pred cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-----H
Confidence 9876443221 2234579999999999865 478899999999999999999999997543211 1
Q ss_pred HHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 392 WLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
.+....... ....+.... .. .+..++.+||+.||.+|||+.|++++.-
T Consensus 248 ~~~~~~~~~-----~~~~~~~~~-~~---~l~~li~~~l~~dp~~Rps~~ell~h~~ 295 (313)
T 3cek_A 248 KLHAIIDPN-----HEIEFPDIP-EK---DLQDVLKCCLKRDPKQRISIPELLAHPY 295 (313)
T ss_dssp HHHHHHCTT-----SCCCCCCCS-CH---HHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred HHHHHHhcc-----cccCCcccc-hH---HHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence 111111100 001111111 12 2334445899999999999999997643
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=339.81 Aligned_cols=202 Identities=26% Similarity=0.397 Sum_probs=170.6
Q ss_pred HccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEeEEEeC-----Ce
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEG-----TQ 244 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~ 244 (498)
+.++|.+.+.||+|+||.||+|+.. +|+.||||++...... ....+.+|+.+++.++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3578999999999999999999864 6899999999643322 234678899999999999999999988764 67
Q ss_pred eEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccc
Q 010891 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (498)
Q Consensus 245 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla 324 (498)
.|+||||+. ++|.+++.. +.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLA 159 (353)
T ss_dssp EEEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccc
Confidence 899999996 599999864 4589999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCce---------eeecccccccccCccccc-CCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 010891 325 KLLGAGKSH---------ITTRVMGTFGYVAPEYAN-SGLLNEKSDVYSFGVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 325 ~~~~~~~~~---------~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltg~~P~~~~~ 382 (498)
......... .....+||+.|+|||++. +..++.++|||||||++|+|++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 876532211 122357899999999875 4789999999999999999999999997543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=342.19 Aligned_cols=262 Identities=23% Similarity=0.360 Sum_probs=198.8
Q ss_pred HHHHHHccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCC--CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCe
Q 010891 167 RDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQ 244 (498)
Q Consensus 167 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 244 (498)
.++....++|++.+.||+|+||.||+|+... .||+|++.... ....+.+.+|+.++++++||||+++++++.+...
T Consensus 26 ~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 26 QEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp GGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred ccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence 3445566889999999999999999998743 49999885432 2334567889999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccc
Q 010891 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (498)
Q Consensus 245 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla 324 (498)
.++||||+++++|.+++.. ....+++..++.++.||+.||.|||+. +|+||||||+|||++ ++.+||+|||++
T Consensus 104 ~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 104 LAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLF 176 (319)
T ss_dssp EEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred eEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCc
Confidence 9999999999999999964 234689999999999999999999999 999999999999998 679999999998
Q ss_pred eecCCCC----ceeeecccccccccCcccccC---------CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHH
Q 010891 325 KLLGAGK----SHITTRVMGTFGYVAPEYANS---------GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVE 391 (498)
Q Consensus 325 ~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~ 391 (498)
....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...... .
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~------~ 250 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAE------A 250 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHH------H
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------H
Confidence 7653211 111233468999999998864 45789999999999999999999999754321 1
Q ss_pred HHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCC
Q 010891 392 WLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEY 452 (498)
Q Consensus 392 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~~ 452 (498)
....+.... .+.......... +..++.+||+.||.+|||+.++++.|+....
T Consensus 251 ~~~~~~~~~------~~~~~~~~~~~~---l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~ 302 (319)
T 2y4i_B 251 IIWQMGTGM------KPNLSQIGMGKE---ISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302 (319)
T ss_dssp HHHHHHTTC------CCCCCCSSCCTT---HHHHHHHHHCSSTTTSCCHHHHHHHHTTC--
T ss_pred HHHHhccCC------CCCCCcCCCCHH---HHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence 111221111 111111111122 3334458999999999999999999988653
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=371.24 Aligned_cols=259 Identities=24% Similarity=0.374 Sum_probs=200.8
Q ss_pred HHHHccCCCccceEcccCcEEEEEEEEcC----CcEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEeEEEeCC
Q 010891 169 LQSATNRFSKDNIIGDGGYGVVYRGQLMN----GTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT 243 (498)
Q Consensus 169 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 243 (498)
.....++|.+.+.||+|+||.||+|.+.. +..||+|++...... ..+.+.+|+.++++++||||+++++++. ++
T Consensus 385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 34456789999999999999999998632 467999988654332 2356889999999999999999999985 46
Q ss_pred eeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecc
Q 010891 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (498)
Q Consensus 244 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGl 323 (498)
..|+||||+++|+|.+++... ...+++..++.++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~ 537 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGL 537 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCC
Confidence 689999999999999999742 34689999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccc
Q 010891 324 AKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRS 402 (498)
Q Consensus 324 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (498)
++..............||+.|+|||++.+..++.++|||||||++|||++ |..||...... +.+..+......
T Consensus 538 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~------~~~~~i~~~~~~ 611 (656)
T 2j0j_A 538 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN------DVIGRIENGERL 611 (656)
T ss_dssp CCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHHTCCC
T ss_pred CeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHH------HHHHHHHcCCCC
Confidence 98765444333344567889999999998899999999999999999997 99999754321 112222211111
Q ss_pred cCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 403 EDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
.. ....+ ..+..++.+||+.||.+|||+.++++.|+..
T Consensus 612 ------~~--~~~~~--~~l~~li~~~l~~dP~~RPs~~el~~~L~~i 649 (656)
T 2j0j_A 612 ------PM--PPNCP--PTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649 (656)
T ss_dssp ------CC--CTTCC--HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ------CC--Ccccc--HHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11 11111 2334445589999999999999999999764
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=338.62 Aligned_cols=202 Identities=27% Similarity=0.388 Sum_probs=166.3
Q ss_pred HccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEE----------
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCI---------- 240 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~---------- 240 (498)
..++|.+.+.||+|+||.||+|... +++.||+|++........+.+.+|+++++.++||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 3578999999999999999999865 48999999987655555567889999999999999999999874
Q ss_pred ----eCCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEc-CCCC
Q 010891 241 ----EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID-ENFD 315 (498)
Q Consensus 241 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~-~~~~ 315 (498)
+....|+||||++ |+|.+++. .+.+++..++.++.|++.||.|||++ +|+||||||+|||++ +++.
T Consensus 89 ~~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~ 159 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLV 159 (320)
T ss_dssp --CCSCSEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTE
T ss_pred ccccccCceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCe
Confidence 3467899999997 59999995 35689999999999999999999999 999999999999997 5679
Q ss_pred eEEeeeccceecCCCCc--eeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 010891 316 AKISDFGLAKLLGAGKS--HITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 316 ~kL~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~ 382 (498)
+||+|||+++....... .......||..|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 229 (320)
T 2i6l_A 160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229 (320)
T ss_dssp EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence 99999999987643211 12334568999999998755 789999999999999999999999997543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=331.31 Aligned_cols=254 Identities=23% Similarity=0.321 Sum_probs=200.5
Q ss_pred HHHccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCC--CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeE
Q 010891 170 QSATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI 246 (498)
Q Consensus 170 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 246 (498)
....++|++.+.||+|+||.||+|+.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+....+
T Consensus 18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 97 (287)
T 2wei_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY 97 (287)
T ss_dssp HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence 345678999999999999999999864 68999999985432 234567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCC---CCeEEeeecc
Q 010891 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN---FDAKISDFGL 323 (498)
Q Consensus 247 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~---~~~kL~DfGl 323 (498)
+||||+++++|.+++... ..+++..++.++.||+.||.|||+. +++||||||+||+++.+ +.+||+|||+
T Consensus 98 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~ 170 (287)
T 2wei_A 98 IVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGL 170 (287)
T ss_dssp EEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred EEEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCc
Confidence 999999999999998643 4689999999999999999999999 99999999999999754 4699999999
Q ss_pred ceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhcccc
Q 010891 324 AKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSE 403 (498)
Q Consensus 324 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (498)
+........ .....||+.|+|||++.+. ++.++||||||+++|+|++|..||...... +....+......
T Consensus 171 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~- 240 (287)
T 2wei_A 171 STCFQQNTK--MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEY------DILKRVETGKYA- 240 (287)
T ss_dssp GGTBCCCSS--CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHCCCC-
T ss_pred ceeecCCCc--cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcCCCC-
Confidence 986644321 2335689999999988764 899999999999999999999999754321 112222211110
Q ss_pred CCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 404 DVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
.........+ ..+..++.+||..||.+|||+.|++++
T Consensus 241 ----~~~~~~~~~~--~~~~~li~~~l~~dp~~Rps~~ell~h 277 (287)
T 2wei_A 241 ----FDLPQWRTIS--DDAKDLIRKMLTFHPSLRITATQCLEH 277 (287)
T ss_dssp ----CCSGGGTTSC--HHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred ----CCchhhhhcC--HHHHHHHHHHcccChhhCcCHHHHhcC
Confidence 0111111111 223344558999999999999999985
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=341.72 Aligned_cols=257 Identities=26% Similarity=0.326 Sum_probs=194.7
Q ss_pred HccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCc--hhHHHHHHHHHHcCCCCCceEEEeEEEeCCee---
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQA--DKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQR--- 245 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~--- 245 (498)
..++|.+.+.||+|+||.||+|.. .+|+.||||++....... .+.+.+|+.+++.++||||+++++++......
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 457899999999999999999985 468999999996543322 35688899999999999999999999877655
Q ss_pred ---EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeec
Q 010891 246 ---ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFG 322 (498)
Q Consensus 246 ---~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfG 322 (498)
|+||||+. ++|.+++. ..+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg 189 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG 189 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred eeEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecC
Confidence 99999997 58988874 3489999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhcc
Q 010891 323 LAKLLGAGKSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRR 401 (498)
Q Consensus 323 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 401 (498)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+..+.....
T Consensus 190 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~~~~ 259 (371)
T 4exu_A 190 LARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD------QLTQILKVTG 259 (371)
T ss_dssp CC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHHHC
T ss_pred cccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHHHhC
Confidence 99865432 334678999999998877 789999999999999999999999997543211 1111111000
Q ss_pred c---------------------cCCcCCCC-CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 402 S---------------------EDVVDPNI-ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 402 ~---------------------~~~~~~~~-~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
. .......+ ...+.. ...+..++.+||+.||++|||+.|++++---.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~ 328 (371)
T 4exu_A 260 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRA--SPQAADLLEKMLELDVDKRLTAAQALTHPFFE 328 (371)
T ss_dssp CCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTS--CHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred CCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhcccc--ChHHHHHHHHHCCCChhhcCCHHHHhcCcccc
Confidence 0 00000000 000011 12344455589999999999999999875443
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=350.53 Aligned_cols=255 Identities=25% Similarity=0.331 Sum_probs=186.3
Q ss_pred cCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCeeEEEEeec
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVYEYV 252 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~~ 252 (498)
+.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.++..+ +||||+++++++.++...|+||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 455667899999999998777778999999998542 235577899999876 8999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCC---CCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCC-------------CCe
Q 010891 253 NNGNLEQWLRGDMCDRGY---LTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN-------------FDA 316 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~---l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~-------------~~~ 316 (498)
+ |+|.+++......... ..+..++.++.||+.||.|||++ +|+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 6999999754221111 13335678999999999999999 99999999999999754 489
Q ss_pred EEeeeccceecCCCCce---eeecccccccccCcccccC-------CCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcc
Q 010891 317 KISDFGLAKLLGAGKSH---ITTRVMGTFGYVAPEYANS-------GLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQS 385 (498)
Q Consensus 317 kL~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~ 385 (498)
||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999987654322 1234579999999999865 678999999999999999999 999996433211
Q ss_pred hhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 386 EVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
. . +.... .. .+.............+..++.+||+.||.+|||+.++++|-
T Consensus 248 -~---~----i~~~~--~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp 297 (434)
T 2rio_A 248 -S---N----IIRGI--FS--LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297 (434)
T ss_dssp -H---H----HHHTC--CC--CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred -H---H----HhcCC--CC--cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCC
Confidence 1 1 11111 00 01111122223334455566689999999999999999754
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=338.94 Aligned_cols=247 Identities=26% Similarity=0.397 Sum_probs=188.3
Q ss_pred HHHHHccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC------chhHHHHHHHHHHcC----CCCCceEEE
Q 010891 168 DLQSATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ------ADKDFRVEVEAIGHV----RHKNLVRLL 236 (498)
Q Consensus 168 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~hpnIv~l~ 236 (498)
+.....++|.+.+.||+|+||.||+|+. .+++.||+|++...... ....+..|+.++.++ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 4456778999999999999999999974 56889999998654332 223456789999888 899999999
Q ss_pred eEEEeCCeeEEEEee-cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEc-CCC
Q 010891 237 GYCIEGTQRILVYEY-VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID-ENF 314 (498)
Q Consensus 237 ~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~-~~~ 314 (498)
+++.+.+..++|||| +.+++|.+++.. .+.+++..++.++.||+.||.|||+. +|+||||||+||+++ .++
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRG 177 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTT
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCC
Confidence 999999999999999 789999999974 34699999999999999999999999 999999999999999 889
Q ss_pred CeEEeeeccceecCCCCceeeecccccccccCcccccCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 010891 315 DAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLL-NEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWL 393 (498)
Q Consensus 315 ~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~ 393 (498)
.+||+|||++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... +
T Consensus 178 ~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~-- 244 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--------E-- 244 (312)
T ss_dssp EEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------H--
T ss_pred eEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------H--
Confidence 99999999999875432 334569999999998876655 458999999999999999999996310 0
Q ss_pred HHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 394 KMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
.... ........+ ..+..++.+||+.||++|||+.|++++-
T Consensus 245 --~~~~---------~~~~~~~~~--~~~~~li~~~l~~~p~~Rps~~e~l~~~ 285 (312)
T 2iwi_A 245 --ILEA---------ELHFPAHVS--PDCCALIRRCLAPKPSSRPSLEEILLDP 285 (312)
T ss_dssp --HHHT---------CCCCCTTSC--HHHHHHHHHHTCSSTTTSCCHHHHHHST
T ss_pred --Hhhh---------ccCCcccCC--HHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 0110 001111111 2233445589999999999999999864
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=342.11 Aligned_cols=266 Identities=19% Similarity=0.239 Sum_probs=197.1
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCC-----------CCCceEEEeEEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-----------HKNLVRLLGYCI 240 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpnIv~l~~~~~ 240 (498)
.++|.+.+.||+|+||+||+|+. .+++.||||++... ....+.+..|+.++.+++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 36799999999999999999985 56899999998532 223456788999998886 899999999988
Q ss_pred eCC----eeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEc-----
Q 010891 241 EGT----QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID----- 311 (498)
Q Consensus 241 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~----- 311 (498)
... ..++||||+ +++|.+++... ....+++..++.++.||+.||.|||+++ +|+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHh--hccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCC
Confidence 654 789999999 88999999754 3355999999999999999999999843 899999999999994
Q ss_pred -CCCCeEEeeeccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHH
Q 010891 312 -ENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLV 390 (498)
Q Consensus 312 -~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~ 390 (498)
..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||............
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 4457999999999876532 23357999999999999999999999999999999999999999754432211111
Q ss_pred HHHHHHHhhccc----------------------cCCcCCCC---------CCCCCHHHHHHHHHHHHHccCCCCCCCCC
Q 010891 391 EWLKMMVQLRRS----------------------EDVVDPNI---------ETRPSTSALKRALLTALRCVDPDSDKRPK 439 (498)
Q Consensus 391 ~~~~~~~~~~~~----------------------~~~~~~~~---------~~~~~~~~~~~~l~~~~~cl~~dP~~RPt 439 (498)
..+..+...... ..+..... ...........+..++.+||+.||++|||
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 327 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD 327 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence 112221111000 00000000 00112233344555666999999999999
Q ss_pred HHHHHHHHh
Q 010891 440 MSQVVRMLE 448 (498)
Q Consensus 440 ~~ell~~L~ 448 (498)
+.|++++--
T Consensus 328 ~~ell~hp~ 336 (373)
T 1q8y_A 328 AGGLVNHPW 336 (373)
T ss_dssp HHHHHTCGG
T ss_pred HHHHhhChh
Confidence 999998643
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-41 Score=338.53 Aligned_cols=200 Identities=23% Similarity=0.332 Sum_probs=171.7
Q ss_pred HccCCCccceEcccCcEEEEEEEEc-CC-cEEEEEEecCCCCCchhHHHHHHHHHHcCCCCC------ceEEEeEEEeCC
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLM-NG-TAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN------LVRLLGYCIEGT 243 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn------Iv~l~~~~~~~~ 243 (498)
..++|.+.+.||+|+||+||+|... ++ ..||+|++... ....+.+..|+.+++.++|++ ++.+++++....
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 4578999999999999999999863 34 68999998543 233456788999999987665 999999999999
Q ss_pred eeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEE-------------
Q 010891 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILI------------- 310 (498)
Q Consensus 244 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll------------- 310 (498)
..|+||||+ +++|.+++... ....+++..++.++.||+.||.|||++ +|+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~ 169 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHK 169 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred eEEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccc
Confidence 999999999 66888887643 335699999999999999999999999 99999999999999
Q ss_pred ------cCCCCeEEeeeccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 010891 311 ------DENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 311 ------~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~ 382 (498)
+.++.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 170 SCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 56789999999999875432 234579999999999999999999999999999999999999997543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=335.84 Aligned_cols=258 Identities=25% Similarity=0.367 Sum_probs=175.5
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC-chhHHHHHHH-HHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ-ADKDFRVEVE-AIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~E~~-~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
.++|.+.+.||+|+||.||+|.. .+|+.||||++...... ....+..|+. +++.++||||+++++++.+.+..++||
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 46789999999999999999986 46899999999654332 2234555665 677789999999999999999999999
Q ss_pred eecCCCCHHHHHhccc-CCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 250 EYVNNGNLEQWLRGDM-CDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~-~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
||+++ +|.+++.... .....+++..+..++.|++.||.|||+.. +|+||||||+|||++.++.+||+|||+++...
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 99975 8888875321 12467999999999999999999999853 89999999999999999999999999998764
Q ss_pred CCCceeeecccccccccCcccc----cCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYA----NSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSED 404 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (498)
... ......||+.|+|||++ .+..++.++|||||||++|+|++|+.||....... ..+ .....
T Consensus 178 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--------~~~---~~~~~ 244 (327)
T 3aln_A 178 DSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF--------DQL---TQVVK 244 (327)
T ss_dssp ------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------------CCCCC
T ss_pred ccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--------HHH---HHHhc
Confidence 332 12334799999999998 56678999999999999999999999997432110 000 01111
Q ss_pred CcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 405 VVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
...+.+...........+..++.+||+.||.+|||+.+++++
T Consensus 245 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 286 (327)
T 3aln_A 245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH 286 (327)
T ss_dssp SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence 111111110000011233444558999999999999999864
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=340.59 Aligned_cols=252 Identities=24% Similarity=0.386 Sum_probs=199.2
Q ss_pred HHHHHHccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC------chhHHHHHHHHHHcCC--CCCceEEEe
Q 010891 167 RDLQSATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ------ADKDFRVEVEAIGHVR--HKNLVRLLG 237 (498)
Q Consensus 167 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--hpnIv~l~~ 237 (498)
.+.....++|++.+.||+|+||.||+|.. .+++.||||++...... ..+.+..|+.+++.++ ||||+++++
T Consensus 36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 34456678999999999999999999975 56899999998654322 2245677999999996 599999999
Q ss_pred EEEeCCeeEEEEeecCC-CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEc-CCCC
Q 010891 238 YCIEGTQRILVYEYVNN-GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID-ENFD 315 (498)
Q Consensus 238 ~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~-~~~~ 315 (498)
++.+....++|||++.+ ++|.+++.. .+.+++..++.++.||+.||.|||+. +|+||||||+|||++ +++.
T Consensus 116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~ 188 (320)
T 3a99_A 116 WFERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGE 188 (320)
T ss_dssp EEECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTE
T ss_pred EEecCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCC
Confidence 99999999999999976 899999974 35689999999999999999999999 999999999999999 7889
Q ss_pred eEEeeeccceecCCCCceeeecccccccccCcccccCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH
Q 010891 316 AKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLL-NEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLK 394 (498)
Q Consensus 316 ~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~ 394 (498)
+||+|||++....... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.... .
T Consensus 189 ~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--------~--- 254 (320)
T 3a99_A 189 LKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------E--- 254 (320)
T ss_dssp EEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------H---
T ss_pred EEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--------h---
Confidence 9999999998875432 334579999999998876655 688999999999999999999996321 0
Q ss_pred HHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 395 MMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
.... .... ....+ ..+..++.+||+.||++|||+.+++++--...
T Consensus 255 -~~~~---~~~~------~~~~~--~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~ 299 (320)
T 3a99_A 255 -IIRG---QVFF------RQRVS--SECQHLIRWCLALRPSDRPTFEEIQNHPWMQD 299 (320)
T ss_dssp -HHHC---CCCC------SSCCC--HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSS
T ss_pred -hhcc---cccc------cccCC--HHHHHHHHHHccCChhhCcCHHHHhcCHhhcC
Confidence 0110 0001 11111 22334445899999999999999998654433
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=345.59 Aligned_cols=251 Identities=25% Similarity=0.339 Sum_probs=185.6
Q ss_pred ccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCeeEEEEee
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
..+|.+.++||+|+||+||.....+|+.||||++.... ...+.+|+++|+.+ +|||||++++++.+....|+||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 34688899999999999766556789999999995432 23466799999999 899999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcC-----CCCeEEeeecccee
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE-----NFDAKISDFGLAKL 326 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~-----~~~~kL~DfGla~~ 326 (498)
+. |+|.+++.... ..+.+..++.++.||+.||.|||+. +|+||||||+|||++. ...+||+|||+++.
T Consensus 100 ~~-g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 100 CA-ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp CS-EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred CC-CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 96 59999997532 2345556778999999999999999 9999999999999953 34688999999987
Q ss_pred cCCCCc--eeeecccccccccCccccc---CCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhc
Q 010891 327 LGAGKS--HITTRVMGTFGYVAPEYAN---SGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLR 400 (498)
Q Consensus 327 ~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~ 400 (498)
...... ......+||+.|+|||++. ...++.++|||||||++|||++ |..||....... ..... .
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-------~~~~~--~ 243 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-------ANILL--G 243 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-------HHHHT--T
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-------HHHHh--c
Confidence 654322 2234467999999999987 4667889999999999999999 999996432211 01110 0
Q ss_pred cccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 401 RSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
. ....... +.......+..++.+||+.||.+|||+.++++|-
T Consensus 244 ~---~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp 285 (432)
T 3p23_A 244 A---CSLDCLH--PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHP 285 (432)
T ss_dssp C---CCCTTSC--TTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTST
T ss_pred c---CCccccC--ccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCc
Confidence 0 0001111 1112222334455689999999999999999653
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=332.48 Aligned_cols=256 Identities=26% Similarity=0.327 Sum_probs=193.4
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC--chhHHHHHHHHHHcCCCCCceEEEeEEEeCCe-----
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQ----- 244 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~----- 244 (498)
.++|.+.+.||+|+||.||+|.. .+|+.||||++...... ..+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 46789999999999999999985 46899999999654322 23567889999999999999999999987654
Q ss_pred -eEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecc
Q 010891 245 -RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (498)
Q Consensus 245 -~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGl 323 (498)
.|+||||+. ++|.+++. ..+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 172 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGL 172 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTC
T ss_pred eEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeeccc
Confidence 499999997 58887764 2489999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhc--
Q 010891 324 AKLLGAGKSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLR-- 400 (498)
Q Consensus 324 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-- 400 (498)
+...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....... .+..+....
T Consensus 173 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~------~~~~i~~~~~~ 242 (353)
T 3coi_A 173 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD------QLTQILKVTGV 242 (353)
T ss_dssp TTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH------HHHHHHHHHCB
T ss_pred ccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHHHhCC
Confidence 9865432 234578999999998876 678999999999999999999999997543211 111111100
Q ss_pred -------------------cccCCcCCCCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 401 -------------------RSEDVVDPNIE-TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 401 -------------------~~~~~~~~~~~-~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
.........+. ..+..+ ..+..++.+||+.||++|||+.+++++---.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~ 310 (353)
T 3coi_A 243 PGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRAS--PQAADLLEKMLELDVDKRLTAAQALTHPFFE 310 (353)
T ss_dssp CCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSC--HHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred CCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcC--HHHHHHHHHHcCCCcccCCCHHHHhcCcchh
Confidence 00000011111 111111 2334444589999999999999999865433
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=328.32 Aligned_cols=252 Identities=26% Similarity=0.374 Sum_probs=177.8
Q ss_pred ccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCCc--hhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQA--DKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
.++|++.+.||+|+||.||+|+.. +|+.||||++....... .+.+..+..+++.++||||+++++++.++...|+||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 367889999999999999999864 68999999996543322 123445556788889999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHH-ccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE-AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
||+ ++.+..++.. ....+++..++.++.|++.||.|||+ . +|+||||||+|||++.++.+||+|||++....
T Consensus 104 e~~-~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 176 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLV 176 (318)
T ss_dssp CCC-SEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecc-CCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhcc
Confidence 999 5566665542 23568999999999999999999998 6 89999999999999999999999999998664
Q ss_pred CCCceeeecccccccccCccccc-----CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhcccc
Q 010891 329 AGKSHITTRVMGTFGYVAPEYAN-----SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSE 403 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (498)
... ......||+.|+|||++. ...++.++|||||||++|||++|+.||....... +.+........
T Consensus 177 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~~-- 247 (318)
T 2dyl_A 177 DDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-----EVLTKVLQEEP-- 247 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHHHHHHSCC--
T ss_pred CCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-----HHHHHHhccCC--
Confidence 432 223457999999999984 5678999999999999999999999997533221 11122221111
Q ss_pred CCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 404 DVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
+.+......+ ..+..++.+||+.||.+|||+.+++++
T Consensus 248 ----~~~~~~~~~~--~~l~~li~~~l~~dp~~Rps~~~ll~h 284 (318)
T 2dyl_A 248 ----PLLPGHMGFS--GDFQSFVKDCLTKDHRKRPKYNKLLEH 284 (318)
T ss_dssp ----CCCCSSSCCC--HHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred ----CCCCccCCCC--HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1111111111 123344458999999999999999864
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=314.89 Aligned_cols=232 Identities=14% Similarity=0.110 Sum_probs=179.1
Q ss_pred HccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCCc---hhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQA---DKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
..++|++.+.||+|+||.||+|+.. +++.||||++....... .+.+.+|+.++..++||||+++++++.+++..|+
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence 4578999999999999999999864 48999999986554332 2568899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
||||++|++|.+++.. + ....++..++.|++.||.|||++ +|+||||||+|||++.++.+||+++|
T Consensus 109 v~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 109 VAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-----
Confidence 9999999999999952 2 35567889999999999999999 99999999999999999999997443
Q ss_pred CCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcC
Q 010891 328 GAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407 (498)
Q Consensus 328 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (498)
|++ .++.++|||||||++|||++|+.||.......... ...........
T Consensus 175 ----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~--------~~~~~~~~~~~ 223 (286)
T 3uqc_A 175 ----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA--------PAERDTAGQPI 223 (286)
T ss_dssp ----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE--------ECCBCTTSCBC
T ss_pred ----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH--------HHHHHhccCCC
Confidence 343 37889999999999999999999998654322100 00000000000
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 408 ~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
+.....+..+ ..+..++.+||+.||++| |+.|+++.|+...
T Consensus 224 ~~~~~~~~~~--~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~ 264 (286)
T 3uqc_A 224 EPADIDRDIP--FQISAVAARSVQGDGGIR-SASTLLNLMQQAT 264 (286)
T ss_dssp CHHHHCTTSC--HHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred ChhhcccCCC--HHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence 0000001111 223344458999999999 9999999998754
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=355.18 Aligned_cols=238 Identities=24% Similarity=0.344 Sum_probs=187.1
Q ss_pred HccCCCccceEcccCcEEEEEEEEc--CCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCe----
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLM--NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQ---- 244 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~---- 244 (498)
..++|++.+.||+|+||+||+|.+. +|+.||||++..... .....+..|+.++.+++||||+++++++.....
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 4578999999999999999999875 589999998865432 233468899999999999999999999987655
Q ss_pred -eEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecc
Q 010891 245 -RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (498)
Q Consensus 245 -~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGl 323 (498)
.||||||++|++|.+++.. .+++..++.++.||+.||.|||++ +|+||||||+|||++.+ .+||+|||+
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp EEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred eeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEeccc
Confidence 6999999999999987742 599999999999999999999999 99999999999999986 999999999
Q ss_pred ceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhcccc
Q 010891 324 AKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSE 403 (498)
Q Consensus 324 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (498)
++..... ....||+.|+|||++.+.. +.++|||||||+||+|++|..||.......
T Consensus 228 a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~------------------ 283 (681)
T 2pzi_A 228 VSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG------------------ 283 (681)
T ss_dssp CEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS------------------
T ss_pred chhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc------------------
Confidence 9876543 3457999999999987654 889999999999999999998876321100
Q ss_pred CCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCH-HHHHHHHh
Q 010891 404 DVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKM-SQVVRMLE 448 (498)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~-~ell~~L~ 448 (498)
.. ...+.......+..++.+||+.||.+||+. +++.+.|.
T Consensus 284 -~~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~ 324 (681)
T 2pzi_A 284 -LP----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT 324 (681)
T ss_dssp -CC----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred -cc----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence 00 000101111233445558999999999964 44544443
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=357.29 Aligned_cols=202 Identities=29% Similarity=0.443 Sum_probs=172.9
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEe------CCee
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIE------GTQR 245 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~------~~~~ 245 (498)
++|++.+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|++++.+++||||+++++++.. +...
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 6899999999999999999975 5689999998865422 234568899999999999999999998765 6777
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCC---eEEeeec
Q 010891 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD---AKISDFG 322 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~---~kL~DfG 322 (498)
|+||||+++|+|.+++.... ....+++..++.++.|++.||.|||+. +|+||||||+|||++.++. +||+|||
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccc
Confidence 99999999999999997532 234689999999999999999999999 9999999999999997765 9999999
Q ss_pred cceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 010891 323 LAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYG 381 (498)
Q Consensus 323 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~ 381 (498)
++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~ 226 (676)
T 3qa8_A 170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226 (676)
T ss_dssp CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcc
Confidence 998765433 234467999999999999999999999999999999999999999743
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=310.28 Aligned_cols=231 Identities=19% Similarity=0.256 Sum_probs=176.4
Q ss_pred ccCCCcc-ceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHH-HcCCCCCceEEEeEEEe----CCee
Q 010891 173 TNRFSKD-NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAI-GHVRHKNLVRLLGYCIE----GTQR 245 (498)
Q Consensus 173 ~~~y~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~hpnIv~l~~~~~~----~~~~ 245 (498)
.++|.+. +.||+|+||.||+|.. .+++.||+|++.. ...+.+|+.++ +.++||||+++++++.+ ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 3567776 7899999999999985 5689999999853 35677889888 66699999999999987 6778
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcC---CCCeEEeeec
Q 010891 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE---NFDAKISDFG 322 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~---~~~~kL~DfG 322 (498)
|+||||+++|+|.+++... ....+++..++.++.|++.||.|||+. +|+||||||+|||++. ++.+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg 165 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 165 (299)
T ss_dssp EEEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccc
Confidence 9999999999999999753 334699999999999999999999999 9999999999999998 7889999999
Q ss_pred cceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccc
Q 010891 323 LAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRS 402 (498)
Q Consensus 323 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (498)
++.... +..++.++|||||||++|||++|+.||........ .....
T Consensus 166 ~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~-----------~~~~~ 211 (299)
T 3m2w_A 166 FAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SPGMK 211 (299)
T ss_dssp TCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC------------------CCSC
T ss_pred cccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh-----------hHHHH
Confidence 997542 24467899999999999999999999974332110 00000
Q ss_pred cCCcCCCCCCCCC--HHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 403 EDVVDPNIETRPS--TSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 403 ~~~~~~~~~~~~~--~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
............. ......+..++.+||+.||.+|||+.|++++.
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp 258 (299)
T 3m2w_A 212 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 258 (299)
T ss_dssp CSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred HHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence 1111111111100 00112334445589999999999999999754
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=332.52 Aligned_cols=243 Identities=16% Similarity=0.201 Sum_probs=178.0
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC---CchhHHHHHHHHHHcCCC-CCc----------------
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG---QADKDFRVEVEAIGHVRH-KNL---------------- 232 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-pnI---------------- 232 (498)
..|...++||+|+||+||+|++ .+|+.||||++..... ...+.+.+|+.+++.++| +|.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 4577789999999999999984 5699999999863332 235678999999999977 221
Q ss_pred -----eEEEeEEEe-----CCeeEEEEeecCCCCHHHHHhcc---cCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCee
Q 010891 233 -----VRLLGYCIE-----GTQRILVYEYVNNGNLEQWLRGD---MCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVV 299 (498)
Q Consensus 233 -----v~l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~ii 299 (498)
..++.++.. ....+++|+++ +++|.+++... ......+++..++.++.||+.||.|||++ +|+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ii 233 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLV 233 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Ccc
Confidence 111111221 12356777766 67999998421 11345588889999999999999999999 999
Q ss_pred ecCCCCCCEEEcCCCCeEEeeeccceecCCCCceeeecccccccccCcccc----------cCCCCCccchHHHHHHHHH
Q 010891 300 HRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYA----------NSGLLNEKSDVYSFGVVLL 369 (498)
Q Consensus 300 HrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDvwSlGvvl~ 369 (498)
||||||+||||+.++.+||+|||+++..... ....+| +.|+|||++ .+..|+.++|||||||++|
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ 308 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY 308 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999999999875432 344678 999999998 6667889999999999999
Q ss_pred HHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 370 EAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 370 elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
||++|+.||......... ...+. .....+ ..+..++.+||+.||++|||+.+++++
T Consensus 309 elltg~~Pf~~~~~~~~~---------------~~~~~----~~~~~~--~~~~~li~~~l~~dP~~Rpt~~~~l~~ 364 (413)
T 3dzo_A 309 WIWCADLPNTDDAALGGS---------------EWIFR----SCKNIP--QPVRALLEGFLRYPKEDRLLPLQAMET 364 (413)
T ss_dssp HHHHSSCCCCTTGGGSCS---------------GGGGS----SCCCCC--HHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred HHHHCCCCCCCcchhhhH---------------HHHHh----hcccCC--HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 999999999754321110 01111 111111 233444458999999999998888653
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=325.81 Aligned_cols=191 Identities=18% Similarity=0.206 Sum_probs=162.2
Q ss_pred ccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCC--------CchhHHHHHHHHHHcCC---------CCCceEE
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPG--------QADKDFRVEVEAIGHVR---------HKNLVRL 235 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---------hpnIv~l 235 (498)
.++|++.+.||+|+||+||+|+. +|+.||||++..... ...+.+.+|+.+++.++ ||||+++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46789999999999999999987 789999999965432 22367888999998885 8888888
Q ss_pred EeEEE------------------------------eCCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHH
Q 010891 236 LGYCI------------------------------EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAK 285 (498)
Q Consensus 236 ~~~~~------------------------------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~ 285 (498)
.+++. +....|+||||+++|++.+.+.. +.+++..+..++.||+.
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHH
Confidence 77653 26788999999999987776632 46899999999999999
Q ss_pred HHHHHH-HccCCCeeecCCCCCCEEEcCCC--------------------CeEEeeeccceecCCCCceeeecccccccc
Q 010891 286 ALAYLH-EAIEPKVVHRDIKSSNILIDENF--------------------DAKISDFGLAKLLGAGKSHITTRVMGTFGY 344 (498)
Q Consensus 286 aL~yLH-~~~~~~iiHrDikp~NIll~~~~--------------------~~kL~DfGla~~~~~~~~~~~~~~~gt~~y 344 (498)
||.||| ++ +|+||||||+||||+.++ .+||+|||+|+..... ..+||+.|
T Consensus 173 aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y 243 (336)
T 2vuw_A 173 SLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCT
T ss_pred HHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecc
Confidence 999999 88 999999999999999887 8999999999876532 24799999
Q ss_pred cCcccccCCCCCccchHHHHHHH-HHHHHhCCCCCC
Q 010891 345 VAPEYANSGLLNEKSDVYSFGVV-LLEAITGRYPVD 379 (498)
Q Consensus 345 ~aPE~~~~~~~~~~sDvwSlGvv-l~elltg~~P~~ 379 (498)
+|||++.+.. +.++||||||++ .+++++|..||.
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~ 278 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYS 278 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCc
Confidence 9999998766 889999998777 778888999884
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.1e-33 Score=299.60 Aligned_cols=185 Identities=17% Similarity=0.090 Sum_probs=132.3
Q ss_pred eEcccCcEEEEEEE-EcCCcEEEEEEecCCCCC----------chhHHHHHHHHHHcC-CCCCceEEEeEEEeCCeeEEE
Q 010891 181 IIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQ----------ADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 181 ~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~----------~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv 248 (498)
.++.|++|.+..++ ...|+.|++|.+...... ..++|.+|+++|+++ .|+||++++++++++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 46677888777764 556899999998654211 124688999999999 799999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||++|++|.++|. ..++++.. +|+.||+.||+|||++ |||||||||+||||+++|.+||+|||+|+...
T Consensus 321 MEyv~G~~L~d~i~----~~~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~ 390 (569)
T 4azs_A 321 MEKLPGRLLSDMLA----AGEEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTP 390 (569)
T ss_dssp EECCCSEEHHHHHH----TTCCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred EecCCCCcHHHHHH----hCCCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence 99999999999997 34667654 5899999999999999 99999999999999999999999999998765
Q ss_pred CCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYP 377 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P 377 (498)
... ......+||+.|||||++.+. +..++|+||+|+++++|.++..+
T Consensus 391 ~~~-~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 391 QDC-SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCC-ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 433 234557899999999998764 56789999999998887665444
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-29 Score=267.87 Aligned_cols=185 Identities=17% Similarity=0.239 Sum_probs=147.3
Q ss_pred CccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCc--------hhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 177 SKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQA--------DKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 177 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
...++||+|+||+||+|+. .+..+++|+........ .+.+.+|++++++++||||+++..++...+..|||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3457899999999999954 67899999875433221 23478999999999999999666666677888999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+++++|.+++.. +..++.|++.||.|||++ +|+||||||+|||++. .+||+|||+++...
T Consensus 418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~ 480 (540)
T 3en9_A 418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN 480 (540)
T ss_dssp EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence 999999999999863 458999999999999999 9999999999999999 99999999999875
Q ss_pred CCCcee------eecccccccccCcccccC--CCCCccchHHHHHHHHHHHHhCCCCCC
Q 010891 329 AGKSHI------TTRVMGTFGYVAPEYANS--GLLNEKSDVYSFGVVLLEAITGRYPVD 379 (498)
Q Consensus 329 ~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~sDvwSlGvvl~elltg~~P~~ 379 (498)
...... ....+||+.|||||++.. ..|+..+|+||..+-..+-+.++.+|.
T Consensus 481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 532211 235789999999999977 668888999999999988888877763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.1e-25 Score=219.44 Aligned_cols=154 Identities=17% Similarity=0.114 Sum_probs=122.2
Q ss_pred HHHHHHHccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCC------------------chhHHHHHHHHHHcC
Q 010891 166 LRDLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQ------------------ADKDFRVEVEAIGHV 227 (498)
Q Consensus 166 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------------~~~~~~~E~~~l~~l 227 (498)
+..+......|.+.+.||+|+||.||+|.+.+|+.||+|.+...... ....+.+|+.+++++
T Consensus 82 l~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l 161 (282)
T 1zar_A 82 LHRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL 161 (282)
T ss_dssp HHHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhc
Confidence 34445556677788999999999999998877999999998543221 234588999999999
Q ss_pred CCCCceEEEeEEEeCCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCC
Q 010891 228 RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSN 307 (498)
Q Consensus 228 ~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~N 307 (498)
+ | +++++++.. +..|+||||++|++|.+ +.. .....++.|++.||.|||+. +|+||||||+|
T Consensus 162 ~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~N 223 (282)
T 1zar_A 162 Q--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYN 223 (282)
T ss_dssp T--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTS
T ss_pred c--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHH
Confidence 9 4 555555443 55699999999999988 421 23457999999999999999 99999999999
Q ss_pred EEEcCCCCeEEeeeccceecCCCCceeeecccccccccCcccccC
Q 010891 308 ILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANS 352 (498)
Q Consensus 308 Ill~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 352 (498)
||++ ++.+||+|||+++. +..|+|||++..
T Consensus 224 ILl~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 224 VLVS-EEGIWIIDFPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp EEEE-TTEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred EEEE-CCcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence 9999 99999999999974 345789998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.84 E-value=4.9e-21 Score=184.03 Aligned_cols=138 Identities=20% Similarity=0.218 Sum_probs=107.7
Q ss_pred CCCccceEcccCcEEEEEEEE-cCCcE--EEEEEecCCCCCc------------------------hhHHHHHHHHHHcC
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-MNGTA--VAVKKLLNNPGQA------------------------DKDFRVEVEAIGHV 227 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~~------------------------~~~~~~E~~~l~~l 227 (498)
-|.+.+.||+|+||.||+|.. .+|+. ||||++....... ...+..|+.+|..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 467889999999999999986 68999 9999874432110 12477899999999
Q ss_pred CCCCc--eEEEeEEEeCCeeEEEEeecCC-C----CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH-HccCCCee
Q 010891 228 RHKNL--VRLLGYCIEGTQRILVYEYVNN-G----NLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH-EAIEPKVV 299 (498)
Q Consensus 228 ~hpnI--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH-~~~~~~ii 299 (498)
.|+++ ..++++ ...+|||||+.+ | +|.++... .++..+..++.|++.||.||| +. +|+
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---giv 193 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---ELV 193 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CEE
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CEE
Confidence 88764 334432 356899999942 3 77776532 224567789999999999999 88 999
Q ss_pred ecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 300 HRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 300 HrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
||||||+|||++. .++|+|||+|....
T Consensus 194 HrDlkp~NILl~~--~~~liDFG~a~~~~ 220 (258)
T 1zth_A 194 HADLSEYNIMYID--KVYFIDMGQAVTLR 220 (258)
T ss_dssp CSSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred eCCCCHHHEEEcC--cEEEEECcccccCC
Confidence 9999999999998 99999999998653
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.72 E-value=1.2e-18 Score=174.71 Aligned_cols=145 Identities=14% Similarity=0.082 Sum_probs=102.9
Q ss_pred HHHHccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCC--------------chhHH--------HHHHHHHHc
Q 010891 169 LQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQ--------------ADKDF--------RVEVEAIGH 226 (498)
Q Consensus 169 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------~~~~~--------~~E~~~l~~ 226 (498)
+..-..-|++.+.||+|+||.||+|...+|+.||||++...... ..... ..|...|.+
T Consensus 90 L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r 169 (397)
T 4gyi_A 90 HAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA 169 (397)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence 33333448999999999999999999889999999987432100 00111 235666666
Q ss_pred CCCCCceEEEeEEEeCCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCC
Q 010891 227 VRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSS 306 (498)
Q Consensus 227 l~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~ 306 (498)
+.+.++.-..-+... ..+|||||++|++|..+.. ......++.|++.+|.|||.. +||||||||.
T Consensus 170 L~~~gv~vp~p~~~~--~~~LVME~i~G~~L~~l~~----------~~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~ 234 (397)
T 4gyi_A 170 LYEEGFPVPEPIAQS--RHTIVMSLVDALPMRQVSS----------VPDPASLYADLIALILRLAKH---GLIHGDFNEF 234 (397)
T ss_dssp HHHTTCSCCCEEEEE--TTEEEEECCSCEEGGGCCC----------CSCHHHHHHHHHHHHHHHHHT---TEECSCCSTT
T ss_pred HHhcCCCCCeeeecc--CceEEEEecCCccHhhhcc----------cHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHH
Confidence 644443221111122 2379999999988865432 123457889999999999998 9999999999
Q ss_pred CEEEcCCCC----------eEEeeeccceecC
Q 010891 307 NILIDENFD----------AKISDFGLAKLLG 328 (498)
Q Consensus 307 NIll~~~~~----------~kL~DfGla~~~~ 328 (498)
|||+++++. +.|+||+-+....
T Consensus 235 NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 235 NILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp SEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred HEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 999988773 8999999887543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.46 E-value=2.9e-13 Score=129.65 Aligned_cols=146 Identities=13% Similarity=0.059 Sum_probs=114.8
Q ss_pred HHccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCC-CCCceEEEeEEEeCCeeEEEE
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-HKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~ 249 (498)
.....|.+...++.|+++.||++.. +++.+++|............+.+|+.+++.+. +.++.++++++.+....|+||
T Consensus 11 ~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 11 KLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp HHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred HHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 3445788888899999999999975 47899999886432233456889999999884 677888999999888999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHcc-----------------------------------
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI----------------------------------- 294 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~----------------------------------- 294 (498)
||++|.+|.+.+. +......++.+++++|..||+..
T Consensus 90 e~i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 90 SEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp ECCSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EecCCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 9999999987641 11223478899999999999810
Q ss_pred ---------------------CCCeeecCCCCCCEEEcCCCCeEEeeecccee
Q 010891 295 ---------------------EPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (498)
Q Consensus 295 ---------------------~~~iiHrDikp~NIll~~~~~~kL~DfGla~~ 326 (498)
.+.++|+|++|.|||++++..+.|+||+.+..
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13699999999999998765667999998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.31 E-value=3.7e-12 Score=121.27 Aligned_cols=129 Identities=19% Similarity=0.143 Sum_probs=97.2
Q ss_pred cccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCC--ceEEEeEEEeCCeeEEEEeecCCCCHHHH
Q 010891 183 GDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN--LVRLLGYCIEGTQRILVYEYVNNGNLEQW 260 (498)
Q Consensus 183 g~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~~~~~~~~~lv~e~~~~g~L~~~ 260 (498)
+.|..+.||++...+|..+++|..... ....+..|+.+++.+.+.+ +.++++++..++..++||||++|.+|.
T Consensus 29 ~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-- 103 (264)
T 1nd4_A 29 IGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-- 103 (264)
T ss_dssp CTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--
T ss_pred cCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--
Confidence 455669999998767888999987543 2356788999999885444 456888888878889999999998884
Q ss_pred HhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHcc----------------------------------------------
Q 010891 261 LRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI---------------------------------------------- 294 (498)
Q Consensus 261 l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~---------------------------------------------- 294 (498)
... .. ...++.+++..|..||+..
T Consensus 104 ~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (264)
T 1nd4_A 104 SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFAR 173 (264)
T ss_dssp TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHH
T ss_pred cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHH
Confidence 210 11 2356777888888888641
Q ss_pred ---------CCCeeecCCCCCCEEEcCCCCeEEeeecccee
Q 010891 295 ---------EPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (498)
Q Consensus 295 ---------~~~iiHrDikp~NIll~~~~~~kL~DfGla~~ 326 (498)
.+.++|+|++|.|||+++++.+.|+|||.+..
T Consensus 174 l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 174 LKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 11399999999999998776677999998864
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.13 E-value=8.3e-11 Score=117.95 Aligned_cols=142 Identities=13% Similarity=0.171 Sum_probs=106.6
Q ss_pred ccceEcccCcEEEEEEEEcCCcEEEEEEec--CCCC-CchhHHHHHHHHHHcCC--CCCceEEEeEEEeC---CeeEEEE
Q 010891 178 KDNIIGDGGYGVVYRGQLMNGTAVAVKKLL--NNPG-QADKDFRVEVEAIGHVR--HKNLVRLLGYCIEG---TQRILVY 249 (498)
Q Consensus 178 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~~-~~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~---~~~~lv~ 249 (498)
..+.|+.|.++.||+.... +..+++|+.. .... .....+.+|+.+++.|. +..+.+++.++.+. ...|+||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3567999999999999764 4678888764 2221 22356888999999986 45578888888776 3479999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHcc-----------------------------------
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI----------------------------------- 294 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~----------------------------------- 294 (498)
||++|..+.+.. ...++..+...++.+++..|+.||+..
T Consensus 121 e~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (359)
T 3dxp_A 121 EFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI 194 (359)
T ss_dssp ECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred EecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence 999997774311 123678888999999999999999731
Q ss_pred --------------------CCCeeecCCCCCCEEEcCCCC--eEEeeecccee
Q 010891 295 --------------------EPKVVHRDIKSSNILIDENFD--AKISDFGLAKL 326 (498)
Q Consensus 295 --------------------~~~iiHrDikp~NIll~~~~~--~kL~DfGla~~ 326 (498)
.+.++|+|+++.|||++.++. +.|+||+.+..
T Consensus 195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 247999999999999997754 68999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.10 E-value=6.8e-11 Score=115.74 Aligned_cols=183 Identities=17% Similarity=0.197 Sum_probs=122.6
Q ss_pred cceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcC-CCCC--ceEEEeEEEeCC---eeEEEEeec
Q 010891 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKN--LVRLLGYCIEGT---QRILVYEYV 252 (498)
Q Consensus 179 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpn--Iv~l~~~~~~~~---~~~lv~e~~ 252 (498)
.+.++.|.+..||+.. ..+++|..... .....+.+|+++|+.+ .+.. +.+++....... ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4569999999999863 45888875322 2345688899999887 3333 334444433333 348999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHcc--------------------------------------
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI-------------------------------------- 294 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-------------------------------------- 294 (498)
+|.+|.+... ..++..++..++.+++..|+.||+..
T Consensus 99 ~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (304)
T 3sg8_A 99 KGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK 172 (304)
T ss_dssp CCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred CCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence 9988865432 23677888889999999999999610
Q ss_pred -----------------CCCeeecCCCCCCEEEcC--CCCeEEeeeccceecCCCCceeeecccccccc---cCcccccC
Q 010891 295 -----------------EPKVVHRDIKSSNILIDE--NFDAKISDFGLAKLLGAGKSHITTRVMGTFGY---VAPEYANS 352 (498)
Q Consensus 295 -----------------~~~iiHrDikp~NIll~~--~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y---~aPE~~~~ 352 (498)
.+.++|+|++|.||++++ ...+.|+||+.+...... .. ......+ ..|+....
T Consensus 173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~D----l~~~~~~~~~~~~~~~~~ 247 (304)
T 3sg8_A 173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-ND----FISLMEDDEEYGMEFVSK 247 (304)
T ss_dssp HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HH----HHTTCCTTTSCCHHHHHH
T ss_pred HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HH----HHHHHhhccccCHHHHHH
Confidence 246899999999999998 456889999998764221 11 0011111 22322110
Q ss_pred -----CCC---------CccchHHHHHHHHHHHHhCCCCC
Q 010891 353 -----GLL---------NEKSDVYSFGVVLLEAITGRYPV 378 (498)
Q Consensus 353 -----~~~---------~~~sDvwSlGvvl~elltg~~P~ 378 (498)
+.. ....+.|++|.++|.+.+|..+|
T Consensus 248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 111 12258999999999999998776
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.61 E-value=1.8e-07 Score=89.41 Aligned_cols=135 Identities=19% Similarity=0.128 Sum_probs=98.3
Q ss_pred eEcccCcE-EEEEEEEc-CCcEEEEEEecCCCCCchhHHHHHHHHHHcCC-CCCceEEEeEEEeCCeeEEEEeecCCCCH
Q 010891 181 IIGDGGYG-VVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-HKNLVRLLGYCIEGTQRILVYEYVNNGNL 257 (498)
Q Consensus 181 ~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~e~~~~g~L 257 (498)
.+..|..| .||+.... ++..+++|+-.. .....+..|...|+.+. +-.+.++++++.+.+..|+|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 45566665 68987643 456788887642 23456888999998873 32366788888888999999999999888
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHcc-------------------------------------------
Q 010891 258 EQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI------------------------------------------- 294 (498)
Q Consensus 258 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~------------------------------------------- 294 (498)
.+..... ......++.+++..|.-||...
T Consensus 108 ~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 108 FQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred cccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 8765421 1233456677777777777520
Q ss_pred ------------CCCeeecCCCCCCEEEcCCCCeEEeeecccee
Q 010891 295 ------------EPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (498)
Q Consensus 295 ------------~~~iiHrDikp~NIll~~~~~~kL~DfGla~~ 326 (498)
.+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 12379999999999999877778999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.58 E-value=2.7e-07 Score=90.18 Aligned_cols=137 Identities=16% Similarity=0.149 Sum_probs=97.0
Q ss_pred cceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCC---CceEEEeEEE-eCCeeEEEEeecCC
Q 010891 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHK---NLVRLLGYCI-EGTQRILVYEYVNN 254 (498)
Q Consensus 179 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hp---nIv~l~~~~~-~~~~~~lv~e~~~~ 254 (498)
.+.++.|....||+. |..+++|+-. .......+..|+++|+.|.+. .+.+++.++. ..+..|+||||++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 456889999999987 5678888742 122345688999999998642 2556666664 34557899999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHc-----------------------------------------
Q 010891 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEA----------------------------------------- 293 (498)
Q Consensus 255 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~----------------------------------------- 293 (498)
.+|.+..- ..++..+...++.+++..|..||+.
T Consensus 98 ~~l~~~~~------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~ 171 (306)
T 3tdw_A 98 QILGEDGM------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY 171 (306)
T ss_dssp EECHHHHH------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred eECchhhh------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence 88876321 1245556666666666666666652
Q ss_pred ----------------cCCCeeecCCCCCCEEEcC---CCC-eEEeeeccceec
Q 010891 294 ----------------IEPKVVHRDIKSSNILIDE---NFD-AKISDFGLAKLL 327 (498)
Q Consensus 294 ----------------~~~~iiHrDikp~NIll~~---~~~-~kL~DfGla~~~ 327 (498)
..+.++|+|+++.|||++. ++. +.|+||+.+..-
T Consensus 172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 1235699999999999987 455 489999988753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.43 E-value=3e-07 Score=91.64 Aligned_cols=80 Identities=10% Similarity=-0.021 Sum_probs=54.8
Q ss_pred cceE-cccCcEEEEEEEEc-------CCcEEEEEEecCCC---CCchhHHHHHHHHHHcCC-C--CCceEEEeEEEeC--
Q 010891 179 DNII-GDGGYGVVYRGQLM-------NGTAVAVKKLLNNP---GQADKDFRVEVEAIGHVR-H--KNLVRLLGYCIEG-- 242 (498)
Q Consensus 179 ~~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--pnIv~l~~~~~~~-- 242 (498)
.+.| +.|....+|+.... ++..+++|...... ......+..|+.+++.|. + -.+.+++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88999999998754 26778888654322 112345778898888873 2 3466777777654
Q ss_pred -CeeEEEEeecCCCCHH
Q 010891 243 -TQRILVYEYVNNGNLE 258 (498)
Q Consensus 243 -~~~~lv~e~~~~g~L~ 258 (498)
...|+||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3468999999886543
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.27 E-value=6.7e-06 Score=80.99 Aligned_cols=142 Identities=17% Similarity=0.273 Sum_probs=81.4
Q ss_pred ceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcC-----CCCCceEEE-e--EEEeCCeeEEEEee
Q 010891 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-----RHKNLVRLL-G--YCIEGTQRILVYEY 251 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~l~-~--~~~~~~~~~lv~e~ 251 (498)
+.|+.|..+.||+....+| .+++|+.... ...+..|+.++..| ..|.++... + +....+..++||+|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4466677899999987544 5889988542 23344455555544 235544311 1 22346678999999
Q ss_pred cCCCCHH--------------HHHhcccCCC----------CCCCHHHH-------------------------------
Q 010891 252 VNNGNLE--------------QWLRGDMCDR----------GYLTWEAR------------------------------- 276 (498)
Q Consensus 252 ~~~g~L~--------------~~l~~~~~~~----------~~l~~~~~------------------------------- 276 (498)
++|..+. ..||...... ..-.|...
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986431 1122111100 01122211
Q ss_pred HHHHHHHHHHHHHHHH----------ccCCCeeecCCCCCCEEEcCCCCeEEeeecccee
Q 010891 277 MKILLGTAKALAYLHE----------AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (498)
Q Consensus 277 ~~i~~~ia~aL~yLH~----------~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~ 326 (498)
..+...+..++.+|+. ...+.++|+|+++.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 1111234446667763 1345899999999999998888999999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.22 E-value=4.8e-06 Score=84.23 Aligned_cols=75 Identities=20% Similarity=0.192 Sum_probs=49.7
Q ss_pred cceEcccCcEEEEEEEEc-CCcEEEEEEecCCCC-------CchhHHHHHHHHHHcCCC--CCce-EEEeEEEeCCeeEE
Q 010891 179 DNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPG-------QADKDFRVEVEAIGHVRH--KNLV-RLLGYCIEGTQRIL 247 (498)
Q Consensus 179 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--pnIv-~l~~~~~~~~~~~l 247 (498)
.+.||.|.++.||+++.. +++.+++|....... .....+..|.+++..+.. |..+ +++.+ +....++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467999999999999643 468899997643211 123456779988887732 4433 55543 3455689
Q ss_pred EEeecCCC
Q 010891 248 VYEYVNNG 255 (498)
Q Consensus 248 v~e~~~~g 255 (498)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999774
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.16 E-value=8.8e-06 Score=78.48 Aligned_cols=78 Identities=23% Similarity=0.313 Sum_probs=57.1
Q ss_pred CCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCC--C-CceEEEeEEEeCCeeEEEEee
Q 010891 175 RFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRH--K-NLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--p-nIv~l~~~~~~~~~~~lv~e~ 251 (498)
...-.+.+|.|..+.||+.+..+|+.|++|+...........|..|+..|+.|.- + .+.+++++. ..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 4445678999999999999999999999998755544445568889999888732 1 234455432 34789999
Q ss_pred cCCCC
Q 010891 252 VNNGN 256 (498)
Q Consensus 252 ~~~g~ 256 (498)
++++.
T Consensus 92 l~~~~ 96 (288)
T 3f7w_A 92 VDERP 96 (288)
T ss_dssp CCCCC
T ss_pred ecccC
Confidence 98764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.96 E-value=2.6e-05 Score=76.07 Aligned_cols=139 Identities=14% Similarity=0.145 Sum_probs=91.1
Q ss_pred cceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCC---CCCceEEEeEEEeCCeeEEEEeecCCC
Q 010891 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR---HKNLVRLLGYCIEGTQRILVYEYVNNG 255 (498)
Q Consensus 179 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~l~~~~~~~~~~~lv~e~~~~g 255 (498)
.+.|+.|.+..+|+... ++..+++|..... ....+..|+..|+.|. ...+.+++.++...+..|+||||++|.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 46799999999999975 5778899976432 3456888999888873 356778888888788899999999987
Q ss_pred CHH--------H---HHhcccCCC----------C--------CCCHHHHH---HHHH----------------HHHHHH
Q 010891 256 NLE--------Q---WLRGDMCDR----------G--------YLTWEARM---KILL----------------GTAKAL 287 (498)
Q Consensus 256 ~L~--------~---~l~~~~~~~----------~--------~l~~~~~~---~i~~----------------~ia~aL 287 (498)
.+. . .|+...... + .-+|.... ++.. .++..+
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 541 1 223211100 0 11354321 1111 111111
Q ss_pred -HHHHH-ccCCCeeecCCCCCCEEEcCCCCeEEeeec
Q 010891 288 -AYLHE-AIEPKVVHRDIKSSNILIDENFDAKISDFG 322 (498)
Q Consensus 288 -~yLH~-~~~~~iiHrDikp~NIll~~~~~~kL~DfG 322 (498)
..|.. ...|.++|+|+.+.|++++.++ +.|.||.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 22321 1257899999999999999887 8899984
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.85 E-value=5.3e-05 Score=77.20 Aligned_cols=78 Identities=12% Similarity=0.160 Sum_probs=49.5
Q ss_pred CCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCceeeecccc--cccccCcccccCCC---CCccchHHHHHHHHH
Q 010891 295 EPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMG--TFGYVAPEYANSGL---LNEKSDVYSFGVVLL 369 (498)
Q Consensus 295 ~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~---~~~~sDvwSlGvvl~ 369 (498)
.+.++|+|+++.|||++.++ ++|+||+.+..-.... .... ..+ ...|++|+...... -....++......+|
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-Dla~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-DIGA-YLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-HHHH-HHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-HHHH-HHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 45899999999999999876 9999999997632110 0000 111 13466666553211 112345668888888
Q ss_pred HHHhCC
Q 010891 370 EAITGR 375 (498)
Q Consensus 370 elltg~ 375 (498)
+.+++.
T Consensus 308 ~~y~~~ 313 (420)
T 2pyw_A 308 NLFNKR 313 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 888754
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.69 E-value=0.00061 Score=66.35 Aligned_cols=159 Identities=12% Similarity=0.104 Sum_probs=88.3
Q ss_pred cHHHHHHHccCCCc-----cceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCC-----CCCceE
Q 010891 165 TLRDLQSATNRFSK-----DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-----HKNLVR 234 (498)
Q Consensus 165 ~~~~~~~~~~~y~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----hpnIv~ 234 (498)
+..++.....+|.+ .+.|+.|....+|+....+| .+++|..... .....+..|+.++..|. -|.++.
T Consensus 8 ~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~~ 84 (322)
T 2ppq_A 8 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLP 84 (322)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCcccC
Confidence 34555555556655 24467788899999987555 6888887542 12345666777777663 343332
Q ss_pred EE-e--EEEeCCeeEEEEeecCCCCHH-----H---------HHhcccC--CCC---CC---CHHHHHH-----------
Q 010891 235 LL-G--YCIEGTQRILVYEYVNNGNLE-----Q---------WLRGDMC--DRG---YL---TWEARMK----------- 278 (498)
Q Consensus 235 l~-~--~~~~~~~~~lv~e~~~~g~L~-----~---------~l~~~~~--~~~---~l---~~~~~~~----------- 278 (498)
.. + +....+..+++|+|++|..+. . .++.... ... .. .|.....
T Consensus 85 ~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~ 164 (322)
T 2ppq_A 85 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 164 (322)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred CCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhh
Confidence 11 0 112345678999999885431 1 1221100 000 01 1222110
Q ss_pred -HHHHHHHHHHHHHHc----cCCCeeecCCCCCCEEEcCCCCeEEeeecccee
Q 010891 279 -ILLGTAKALAYLHEA----IEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (498)
Q Consensus 279 -i~~~ia~aL~yLH~~----~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~ 326 (498)
+...+...+.+++.. ....++|+|+.+.|||++++..+.|+||+.+..
T Consensus 165 ~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 165 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 011244556666542 134799999999999999876568999998864
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00016 Score=69.93 Aligned_cols=139 Identities=13% Similarity=0.084 Sum_probs=75.4
Q ss_pred cceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCc-eEEEeEEEeCCeeEEEEeec-CCCC
Q 010891 179 DNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL-VRLLGYCIEGTQRILVYEYV-NNGN 256 (498)
Q Consensus 179 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~e~~-~~g~ 256 (498)
.+.|+.|....+|+. ..+++|+....... .-....|+.+++.+..-++ .+++++ +.+.-++|+||+ +|.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 578999999999998 55888877543221 1224567777776632222 345543 344457899999 6644
Q ss_pred HHH------------------HHhcccCCC-CCCCH-HHHHHHHH--------------HHHHHHHHHHH-----ccCCC
Q 010891 257 LEQ------------------WLRGDMCDR-GYLTW-EARMKILL--------------GTAKALAYLHE-----AIEPK 297 (498)
Q Consensus 257 L~~------------------~l~~~~~~~-~~l~~-~~~~~i~~--------------~ia~aL~yLH~-----~~~~~ 297 (498)
|.. -||...... ..... .....+.. .+...+..|.. ...+.
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 321 011110000 00111 11111111 11111111111 12345
Q ss_pred eeecCCCCCCEEEcCCCCeEEeeecccee
Q 010891 298 VVHRDIKSSNILIDENFDAKISDFGLAKL 326 (498)
Q Consensus 298 iiHrDikp~NIll~~~~~~kL~DfGla~~ 326 (498)
++|+|+.+.||+ ..++.+.|+||..+..
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 899999999999 5566889999998875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.54 E-value=0.00041 Score=68.01 Aligned_cols=143 Identities=15% Similarity=0.084 Sum_probs=73.5
Q ss_pred ceEcccCcEE-EEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCC--CCceEEEeEEEeCCeeEEEEeecCCCC
Q 010891 180 NIIGDGGYGV-VYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRH--KNLVRLLGYCIEGTQRILVYEYVNNGN 256 (498)
Q Consensus 180 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~~~~lv~e~~~~g~ 256 (498)
+.|+.|+... +|+....+|..+++|...... ...+..|+.++..+.. -.+.+++.+..+ .-+++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~--~g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHA--RGLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETT--TTEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCC--CCEEEEeeCCCcc
Confidence 3566665554 667654346777777543321 1334556666666632 224456655332 2378999998777
Q ss_pred HHHHHhcccC-------------------C---CCCCCHHHHH-------H-------------HHHHHHHHHHHHHH--
Q 010891 257 LEQWLRGDMC-------------------D---RGYLTWEARM-------K-------------ILLGTAKALAYLHE-- 292 (498)
Q Consensus 257 L~~~l~~~~~-------------------~---~~~l~~~~~~-------~-------------i~~~ia~aL~yLH~-- 292 (498)
+.+++..... . ...+...... . ....+...+..|..
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 7655532110 0 0112111100 0 00111122233321
Q ss_pred -ccCCCeeecCCCCCCEEEcCC----CCeEEeeeccceec
Q 010891 293 -AIEPKVVHRDIKSSNILIDEN----FDAKISDFGLAKLL 327 (498)
Q Consensus 293 -~~~~~iiHrDikp~NIll~~~----~~~kL~DfGla~~~ 327 (498)
...+.++|+|+.+.||+++.+ +.+.|+||+.+..-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 124479999999999999874 67999999998753
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.47 E-value=0.0008 Score=65.69 Aligned_cols=143 Identities=15% Similarity=0.109 Sum_probs=82.0
Q ss_pred ceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCC--ceEEEeE-----EEeCCeeEEEEeec
Q 010891 180 NIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN--LVRLLGY-----CIEGTQRILVYEYV 252 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn--Iv~l~~~-----~~~~~~~~lv~e~~ 252 (498)
..|+ |....||+....+|+.+++|...... .....+..|..++..|.... +.+++.. ....+..+++|+|+
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4577 88889999877677789999875332 23456777888877763211 3333332 22345668899999
Q ss_pred CCCCHH-----H------H---HhcccC-----CCCCCCHHHH----HHH---------------HHHHHHHHHHHHHc-
Q 010891 253 NNGNLE-----Q------W---LRGDMC-----DRGYLTWEAR----MKI---------------LLGTAKALAYLHEA- 293 (498)
Q Consensus 253 ~~g~L~-----~------~---l~~~~~-----~~~~l~~~~~----~~i---------------~~~ia~aL~yLH~~- 293 (498)
+|..+. . . +|.... ....+++... ..+ ...+...+..+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 875321 1 1 121110 0111222211 011 11112223333322
Q ss_pred ---cCCCeeecCCCCCCEEEcCCCCeEEeeecccee
Q 010891 294 ---IEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (498)
Q Consensus 294 ---~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~ 326 (498)
....++|+|+++.|||++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234689999999999999 4 899999998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.33 E-value=0.00049 Score=70.21 Aligned_cols=72 Identities=15% Similarity=0.200 Sum_probs=49.0
Q ss_pred cceEcccCcEEEEEEEEcC--------CcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCc-eEEEeEEEeCCeeEEEE
Q 010891 179 DNIIGDGGYGVVYRGQLMN--------GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL-VRLLGYCIEGTQRILVY 249 (498)
Q Consensus 179 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~ 249 (498)
.+.|+.|....||+....+ +..+++|+.... .....+..|+.++..|...++ .++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4578889899999998643 478888877332 122456679988888743333 566665532 3899
Q ss_pred eecCCCC
Q 010891 250 EYVNNGN 256 (498)
Q Consensus 250 e~~~~g~ 256 (498)
||++|.+
T Consensus 152 e~l~G~~ 158 (429)
T 1nw1_A 152 EYIPSRP 158 (429)
T ss_dssp CCCCEEE
T ss_pred EEeCCcc
Confidence 9998643
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.0012 Score=67.68 Aligned_cols=74 Identities=12% Similarity=0.090 Sum_probs=47.4
Q ss_pred cceEcccCcEEEEEEEEcC-CcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCc-eEEEeEEEeCCeeEEEEeecCCCC
Q 010891 179 DNIIGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL-VRLLGYCIEGTQRILVYEYVNNGN 256 (498)
Q Consensus 179 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~e~~~~g~ 256 (498)
.+.|+.|-...+|+....+ +..+++|+....... .-+...|..++..|...++ .++++++. + .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence 4568888899999998754 478888876432211 1123578888888865444 46777662 2 35999998744
Q ss_pred H
Q 010891 257 L 257 (498)
Q Consensus 257 L 257 (498)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.18 E-value=0.0011 Score=66.41 Aligned_cols=143 Identities=15% Similarity=0.116 Sum_probs=82.7
Q ss_pred cceEcccCcEEEEEEEEc--------CCcEEEEEEecCCCCCchhHHHHHHHHHHcCC-CCCceEEEeEEEeCCeeEEEE
Q 010891 179 DNIIGDGGYGVVYRGQLM--------NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-HKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 179 ~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~ 249 (498)
.+.|.-|-...+|+.... +++.+++|+.-. .......+.+|..+++.|. +.-..++++++.+ .+||
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~ 129 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE 129 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence 356777888899998764 247888887522 2223456678999888773 3223456666543 2999
Q ss_pred eecCCCCHHH--------------H---HhcccCC-CCCCC--HHHHHHHHHHHH-------------------HHHHHH
Q 010891 250 EYVNNGNLEQ--------------W---LRGDMCD-RGYLT--WEARMKILLGTA-------------------KALAYL 290 (498)
Q Consensus 250 e~~~~g~L~~--------------~---l~~~~~~-~~~l~--~~~~~~i~~~ia-------------------~aL~yL 290 (498)
||++|.+|.. . ||..... ..... +.+..++..++. ..+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 9998854421 1 1211111 11122 344554544432 223344
Q ss_pred HHc-----cCCCeeecCCCCCCEEEcCC----CCeEEeeecccee
Q 010891 291 HEA-----IEPKVVHRDIKSSNILIDEN----FDAKISDFGLAKL 326 (498)
Q Consensus 291 H~~-----~~~~iiHrDikp~NIll~~~----~~~kL~DfGla~~ 326 (498)
... ....++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 322 13368999999999999876 7899999998864
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.04 E-value=0.00071 Score=67.39 Aligned_cols=73 Identities=14% Similarity=0.020 Sum_probs=42.8
Q ss_pred cceEcccCcEEEEEEEEcC---------CcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCC-ceEEEeEEEeCCeeEEE
Q 010891 179 DNIIGDGGYGVVYRGQLMN---------GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN-LVRLLGYCIEGTQRILV 248 (498)
Q Consensus 179 ~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~l~~~~~~~~~~~lv 248 (498)
.+.|+.|....+|+....+ +..+++|+..... ....+...|..+++.+...+ ..++++.+ . -++|
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v 112 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI 112 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence 3567888888999997643 2678888664321 11123456888888774333 33566543 2 3789
Q ss_pred EeecCCCC
Q 010891 249 YEYVNNGN 256 (498)
Q Consensus 249 ~e~~~~g~ 256 (498)
|||++|..
T Consensus 113 ~e~i~G~~ 120 (369)
T 3c5i_A 113 EEWLYGDP 120 (369)
T ss_dssp EECCCSEE
T ss_pred EEEecCCc
Confidence 99998753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.02 E-value=0.0066 Score=55.13 Aligned_cols=103 Identities=16% Similarity=0.080 Sum_probs=67.3
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCcee
Q 010891 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (498)
Q Consensus 255 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 334 (498)
-+|.+.|.. -+.+|+++++|.++.|.+.+|.-+-... .-..+=+.|..|+|..+|.+.+.+ +.+.
T Consensus 33 vSL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------- 97 (229)
T 2yle_A 33 LSLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD--------- 97 (229)
T ss_dssp EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C------------
T ss_pred ccHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc---------
Confidence 389999975 3578999999999999999987652211 111233457999999999998764 2111
Q ss_pred eecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCC
Q 010891 335 TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYP 377 (498)
Q Consensus 335 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P 377 (498)
.....+.|||... ...+.+.=|||||++||..+--..|
T Consensus 98 ----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 ----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred ----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1122456888763 3446788899999999999875554
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0062 Score=59.85 Aligned_cols=32 Identities=25% Similarity=0.367 Sum_probs=28.4
Q ss_pred CCCeeecCCCCCCEEEcCCCCeEEeeecccee
Q 010891 295 EPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (498)
Q Consensus 295 ~~~iiHrDikp~NIll~~~~~~kL~DfGla~~ 326 (498)
...++|+|+.+.||+++.++.+.|+||+.+..
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 34799999999999999888899999988865
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=96.32 E-value=0.0021 Score=42.07 Aligned_cols=25 Identities=16% Similarity=0.341 Sum_probs=12.5
Q ss_pred HHHHHHHHHHHHHHHHhhheeeeee
Q 010891 20 VLIVICLAVVFVVILGVSLWLTFRK 44 (498)
Q Consensus 20 i~~~i~~~~~~~~~l~~~~~~~~rr 44 (498)
|.+++++|+++++++++++|+.+||
T Consensus 12 IA~gVVgGv~~v~ii~~~~~~~~RR 36 (44)
T 2l2t_A 12 IAAGVIGGLFILVIVGLTFAVYVRR 36 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEEeehHHHHHHHHHHHHHHHHhhh
Confidence 4555555555555554444444444
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.22 E-value=0.018 Score=58.35 Aligned_cols=142 Identities=12% Similarity=0.117 Sum_probs=83.3
Q ss_pred cceEcccCcEEEEEEEEcC--------CcEEEEEEecCCCCCchhHHHHHHHHHHcCC-CCCceEEEeEEEeCCeeEEEE
Q 010891 179 DNIIGDGGYGVVYRGQLMN--------GTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-HKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 179 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~lv~ 249 (498)
.+.|..|-...+|+....+ +..+++++..... ...-+..+|..+++.+. +.-..++++.+ . -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEE
Confidence 3567778888999998653 5788888753322 22223456888887774 22234555533 2 37899
Q ss_pred eecCCCCHHH--------------H---HhcccC---------CCCCCCHHHHHHHHHHH-------------------H
Q 010891 250 EYVNNGNLEQ--------------W---LRGDMC---------DRGYLTWEARMKILLGT-------------------A 284 (498)
Q Consensus 250 e~~~~g~L~~--------------~---l~~~~~---------~~~~l~~~~~~~i~~~i-------------------a 284 (498)
||++|..|.. . ||.... ...+..+.+...+..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 9999865311 1 111111 11122234433333222 2
Q ss_pred HHHHHHHHc---------------------cCCCeeecCCCCCCEEEcCCCCeEEeeecccee
Q 010891 285 KALAYLHEA---------------------IEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (498)
Q Consensus 285 ~aL~yLH~~---------------------~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~ 326 (498)
..+.+|... ....++|+|+.+.||+ +.++.+.|+||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 233333321 1236899999999999 7788999999998864
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.98 E-value=0.002 Score=42.30 Aligned_cols=25 Identities=12% Similarity=0.333 Sum_probs=12.3
Q ss_pred HHHHHHHHHHHHHHHHhhheeeeee
Q 010891 20 VLIVICLAVVFVVILGVSLWLTFRK 44 (498)
Q Consensus 20 i~~~i~~~~~~~~~l~~~~~~~~rr 44 (498)
|.+++++|+++++++++++|+.+||
T Consensus 13 IA~gVVgGv~~~~ii~~~~~~~~RR 37 (44)
T 2ks1_B 13 IATGMVGALLLLLVVALGIGLFMRR 37 (44)
T ss_dssp STHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred EEeehhHHHHHHHHHHHHHHHHhhh
Confidence 4455555555555544444444444
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=94.72 E-value=0.017 Score=37.65 Aligned_cols=14 Identities=21% Similarity=0.724 Sum_probs=5.4
Q ss_pred HHHHHHHHHHHHHHH
Q 010891 20 VLIVICLAVVFVVIL 34 (498)
Q Consensus 20 i~~~i~~~~~~~~~l 34 (498)
|.+++ +|+++++++
T Consensus 14 Ia~~v-VGvll~vi~ 27 (44)
T 2jwa_A 14 IISAV-VGILLVVVL 27 (44)
T ss_dssp HHHHH-HHHHHHHHH
T ss_pred hHHHH-HHHHHHHHH
Confidence 33333 334333333
|
| >2k9y_A Ephrin type-A receptor 2; receptor tyrosine kinase, membrane protein, dimeric transmembrane domain, ephrin receptor, ATP-binding, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.50 E-value=0.025 Score=36.65 Aligned_cols=27 Identities=22% Similarity=0.351 Sum_probs=12.9
Q ss_pred hHHHHHHHHHHHHHHHHHhhheeeeee
Q 010891 18 LWVLIVICLAVVFVVILGVSLWLTFRK 44 (498)
Q Consensus 18 ~~i~~~i~~~~~~~~~l~~~~~~~~rr 44 (498)
.+|++++++|+++++++++.+|+++||
T Consensus 13 ~~I~~~vv~Gv~ll~~iv~~~~~~~rR 39 (41)
T 2k9y_A 13 LAVIGGVAVGVVLLLVLAGVGFFIHRR 39 (41)
T ss_dssp THHHHHHHHHHHHHHHHHHHHHSSSSS
T ss_pred EEEEeehhHHHHHHHHHHHHheeEeee
Confidence 345555555555544233334444444
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.43 E-value=0.53 Score=47.04 Aligned_cols=30 Identities=27% Similarity=0.427 Sum_probs=25.3
Q ss_pred CeeecCCCCCCEEE------cCCCCeEEeeecccee
Q 010891 297 KVVHRDIKSSNILI------DENFDAKISDFGLAKL 326 (498)
Q Consensus 297 ~iiHrDikp~NIll------~~~~~~kL~DfGla~~ 326 (498)
.++|+|+.+.|||+ +++..++++||-+|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 36799999999999 4567799999998864
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=89.21 E-value=0.69 Score=41.88 Aligned_cols=114 Identities=10% Similarity=0.101 Sum_probs=78.7
Q ss_pred CCCCceEEEeEEEeCCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHH-HHHHccCCCeeecCCCCC
Q 010891 228 RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALA-YLHEAIEPKVVHRDIKSS 306 (498)
Q Consensus 228 ~hpnIv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~-yLH~~~~~~iiHrDikp~ 306 (498)
.||++ -..+-.+++.+.+.++.-+++.=+..++ .++...+++++.+|+.... +++. -+|--|.|+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~ 113 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE 113 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence 68888 3444466777777777664543334443 2778999999999888766 5553 477789999
Q ss_pred CEEEcCCCCeEEeeeccceecCCCCceeeecccccccccCcccccCCCCCccchHH-HHHHHHHHHHhCCCCCC
Q 010891 307 NILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVY-SFGVVLLEAITGRYPVD 379 (498)
Q Consensus 307 NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvw-SlGvvl~elltg~~P~~ 379 (498)
||+++.++.++|.-.|+-. -++|.-+. ..|.| .+=|++..++.++..|+
T Consensus 114 NL~f~~~~~p~i~hRGi~~------------------~lpP~e~~------ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 114 NLMFNRALEPFFLHVGVKE------------------SLPPDEWD------DERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GEEECTTCCEEESCCEETT------------------TBSSCSCC------HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred eEEEeCCCcEEEEEcCCcc------------------cCCCCCCC------HHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999997776542 23343211 12433 47788889999887774
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=88.73 E-value=0.23 Score=31.38 Aligned_cols=10 Identities=0% Similarity=0.408 Sum_probs=4.3
Q ss_pred HHHHHHHHHH
Q 010891 20 VLIVICLAVV 29 (498)
Q Consensus 20 i~~~i~~~~~ 29 (498)
.+.+|+++++
T Consensus 12 aIAGiVvG~v 21 (38)
T 2k1k_A 12 EIVAVIFGLL 21 (38)
T ss_dssp HHHHHHHHHH
T ss_pred ceeeeehHHH
Confidence 3444444443
|
| >2l8s_A Integrin alpha-1; transmembrane region, detergent micelle, CE adhesion; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.26 E-value=0.3 Score=33.26 Aligned_cols=27 Identities=26% Similarity=0.656 Sum_probs=16.9
Q ss_pred cchhhHHHHHHHHHHHHHHHH-Hhhhee
Q 010891 14 IGMQLWVLIVICLAVVFVVIL-GVSLWL 40 (498)
Q Consensus 14 ~g~~~~i~~~i~~~~~~~~~l-~~~~~~ 40 (498)
.+..+|++++.+++++++++| ++++|-
T Consensus 5 ~~vp~WiIi~svl~GLLLL~Lii~~LwK 32 (54)
T 2l8s_A 5 GRVPLWVILLSAFAGLLLLMLLILALWK 32 (54)
T ss_dssp CCCCTHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccCchHHHHHHHHHHHHHHHHHHHHHHH
Confidence 356788877777666666554 445553
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=87.93 E-value=0.39 Score=43.38 Aligned_cols=121 Identities=9% Similarity=0.133 Sum_probs=82.2
Q ss_pred HHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCCC-CHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCe
Q 010891 220 EVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNG-NLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKV 298 (498)
Q Consensus 220 E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~i 298 (498)
|+.+|. ..||+++.. .+-.+.+.+.+.++.-+.+ ++.. ++ .++...+++++.+|+....++++.
T Consensus 36 el~LL~-~~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik-------~~~~~eKlr~l~ni~~l~~~~~~r----- 100 (215)
T 4ann_A 36 LMYLLE-QHSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK-------SFTKNEKLRYLLNIKNLEEVNRTR----- 100 (215)
T ss_dssp GGGGGG-SCCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG-------GSCHHHHHHHHHHGGGGGGGGGSS-----
T ss_pred HHHHHh-ccCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH-------hcCHHHHHHHHHHHHHHHHHhcCc-----
Confidence 334433 378999877 5666667766666655433 2222 32 377899999999999888666543
Q ss_pred eecCCCCCCEEEcCCCCeEEeeeccceecCCCCceeeecccccccccCcccccCCCCCccch-HHHHHHHHHHHHhCCCC
Q 010891 299 VHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSD-VYSFGVVLLEAITGRYP 377 (498)
Q Consensus 299 iHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sD-vwSlGvvl~elltg~~P 377 (498)
+|--|.|+||+++.++.+++.-.|+-.. ++|.- ++ ..| .-.+=|++..+++++..
T Consensus 101 ~tf~L~P~NL~f~~~~~p~i~~RGik~~------------------l~P~~-----~~-ee~fL~qyKAliiall~~K~~ 156 (215)
T 4ann_A 101 YTFVLAPDELFFTRDGLPIAKTRGLQNV------------------VDPLP-----VS-EAEFLTRYKALVICAFNEKQS 156 (215)
T ss_dssp EECCCSGGGEEECTTSCEEESCCEETTT------------------BSCCC-----CC-HHHHHHHHHHHHHHHHCTTCC
T ss_pred eEEEEecceEEEcCCCCEEEEEccCccC------------------CCCCC-----CC-HHHHHHHHHHHHHHHHcCCCC
Confidence 6778999999999999999977665321 23321 11 123 34577899999999988
Q ss_pred CC
Q 010891 378 VD 379 (498)
Q Consensus 378 ~~ 379 (498)
|+
T Consensus 157 Fe 158 (215)
T 4ann_A 157 FD 158 (215)
T ss_dssp HH
T ss_pred HH
Confidence 85
|
| >2knc_A Integrin alpha-IIB; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.91 E-value=0.42 Score=32.64 Aligned_cols=28 Identities=14% Similarity=0.488 Sum_probs=17.7
Q ss_pred ccchhhHHHHHHHHHHHHHHHH-Hhhhee
Q 010891 13 YIGMQLWVLIVICLAVVFVVIL-GVSLWL 40 (498)
Q Consensus 13 ~~g~~~~i~~~i~~~~~~~~~l-~~~~~~ 40 (498)
.-+..+|++++.++++++++.| ++++|.
T Consensus 7 ~~~vp~wiIi~svl~GLllL~li~~~LwK 35 (54)
T 2knc_A 7 ERAIPIWWVLVGVLGGLLLLTILVLAMWK 35 (54)
T ss_dssp TTTCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCcchHHHHHHHHHHHHHHHHHHHHHHH
Confidence 3456788877777666666554 445553
|
| >1iij_A ERBB-2 receptor protein-tyrosine kinase; alpha-helix-PI-bulge-alpha-helix, signaling protein; NMR {Synthetic} SCOP: j.35.1.1 | Back alignment and structure |
|---|
Probab=86.78 E-value=0.27 Score=30.24 Aligned_cols=18 Identities=22% Similarity=0.405 Sum_probs=7.1
Q ss_pred HHHHHHHHHHHHHHHHhhh
Q 010891 20 VLIVICLAVVFVVILGVSL 38 (498)
Q Consensus 20 i~~~i~~~~~~~~~l~~~~ 38 (498)
|.+++++ +++++++++++
T Consensus 10 IaagVvg-lll~vii~l~~ 27 (35)
T 1iij_A 10 IIATVVG-VLLFLILVVVV 27 (35)
T ss_dssp HHHHHHH-HHHHHHHTTTT
T ss_pred eHHHHHH-HHHHHHHHHHh
Confidence 3344433 44444443333
|
| >2k1a_A Integrin alpha-IIB; single-PASS transmembrane segment, alternative splicing, calcium, cell adhesion, cleavage on PAIR of basic residues; NMR {Homo sapiens} PDB: 2k9j_A | Back alignment and structure |
|---|
Probab=85.63 E-value=0.6 Score=30.14 Aligned_cols=27 Identities=15% Similarity=0.532 Sum_probs=17.0
Q ss_pred ccchhhHHHHHHHHHHHHHHHH-Hhhhe
Q 010891 13 YIGMQLWVLIVICLAVVFVVIL-GVSLW 39 (498)
Q Consensus 13 ~~g~~~~i~~~i~~~~~~~~~l-~~~~~ 39 (498)
..+..+|++++.++++++++.+ ++++|
T Consensus 5 ~~~vp~wiIi~s~l~GLllL~li~~~Lw 32 (42)
T 2k1a_A 5 ERAIPIWWVLVGVLGGLLLLTILVLAMW 32 (42)
T ss_dssp CCCCCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred cCCcchHHHHHHHHHHHHHHHHHHHHHH
Confidence 3456788877777666666554 44445
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=81.47 E-value=0.93 Score=29.52 Aligned_cols=32 Identities=19% Similarity=0.029 Sum_probs=19.5
Q ss_pred hhhHHHHHHHHHHHHHHHHHhhheeeeeecccc
Q 010891 16 MQLWVLIVICLAVVFVVILGVSLWLTFRKKKSR 48 (498)
Q Consensus 16 ~~~~i~~~i~~~~~~~~~l~~~~~~~~rr~~~~ 48 (498)
.-.-+++++++ +++++++..++|.++|++++|
T Consensus 12 IA~gVVgGv~~-v~ii~~~~~~~~RRRr~~~kr 43 (44)
T 2l2t_A 12 IAAGVIGGLFI-LVIVGLTFAVYVRRKSIKKKR 43 (44)
T ss_dssp HHHHHHHHHHH-HHHHHHHHHHHHHTTCSSCCC
T ss_pred EEEeehHHHHH-HHHHHHHHHHHhhhhhhhhcc
Confidence 33345555544 444557778888888886644
|
| >2knc_B Integrin beta-3; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=80.84 E-value=1.2 Score=33.30 Aligned_cols=22 Identities=18% Similarity=0.458 Sum_probs=11.2
Q ss_pred HHHHHHHHHHHHHHHHHhhhee
Q 010891 19 WVLIVICLAVVFVVILGVSLWL 40 (498)
Q Consensus 19 ~i~~~i~~~~~~~~~l~~~~~~ 40 (498)
+|+++|+++++++.++++++|.
T Consensus 12 ~Iv~gvi~gilliGllllliwk 33 (79)
T 2knc_B 12 VVLLSVMGAILLIGLAALLIWK 33 (79)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHHHHHHHHH
Confidence 3445555555554444555554
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=80.27 E-value=0.16 Score=52.05 Aligned_cols=62 Identities=6% Similarity=0.039 Sum_probs=18.9
Q ss_pred CccceEcccCcEEEEEEEEcC-CcEEEE------EEecCCC--CCchhHHHHHHHHHHcCCCCCceEEEeEEEe
Q 010891 177 SKDNIIGDGGYGVVYRGQLMN-GTAVAV------KKLLNNP--GQADKDFRVEVEAIGHVRHKNLVRLLGYCIE 241 (498)
Q Consensus 177 ~~~~~lg~G~~g~Vy~~~~~~-~~~vav------K~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 241 (498)
.+.+.|| ||.||+|.+.. ..+||+ |...... .+....+.+|..++..++|||+++.+++...
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 3456776 99999998643 357888 6654322 2223467789999999999999999887653
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 498 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-75 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-70 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-69 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 8e-69 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-68 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-67 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-66 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-65 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-64 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-64 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-63 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-63 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-63 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-62 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-62 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-61 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-61 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-60 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-60 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-60 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-60 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-59 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 8e-59 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-58 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-58 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-58 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-58 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-57 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-56 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-54 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-54 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-53 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-52 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-51 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-50 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-50 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-48 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-48 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-47 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-47 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-47 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-46 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-46 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-46 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-46 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-45 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-45 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-45 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-44 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-43 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-43 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-43 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-42 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-41 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-40 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-35 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 9e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-21 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 237 bits (605), Expect = 1e-75
Identities = 74/287 (25%), Positives = 127/287 (44%), Gaps = 22/287 (7%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLV 233
+ + IG G +G VY+G+ AV + + Q + F+ EV + RH N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 234 RLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEA 293
+GY Q +V ++ +L L + I TA+ + YLH
Sbjct: 68 LFMGYSTAP-QLAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLH-- 121
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK-SHITTRVMGTFGYVAPEYA-- 350
++HRD+KS+NI + E+ KI DFGLA + SH ++ G+ ++APE
Sbjct: 122 -AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRM 180
Query: 351 -NSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409
+ + +SDVY+FG+VL E +TG+ P +N + + MV + P+
Sbjct: 181 QDKNPYSFQSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVG----RGYLSPD 230
Query: 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIPR 456
+ S + K C+ D+RP Q++ +E +P+
Sbjct: 231 LSKVRS-NCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSLPK 276
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (568), Expect = 3e-70
Identities = 70/275 (25%), Positives = 121/275 (44%), Gaps = 22/275 (8%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLV 233
+ + IG G +G+V+ G +N VA+K + +++DF E E + + H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 234 RLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEA 293
+L G C+E LV+E++ +G L +LR E + + L + +AYL E
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF---AAETLLGMCLDVCEGMAYLEE- 119
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSG 353
V+HRD+ + N L+ EN K+SDFG+ + + + +T + +PE +
Sbjct: 120 --ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 354 LLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETR 413
+ KSDV+SFGV++ E + R SEV + + + P + +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV--------VEDISTGFRLYKPRLAS- 228
Query: 414 PSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448
C + RP S+++R L
Sbjct: 229 ------THVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 1e-69
Identities = 70/275 (25%), Positives = 115/275 (41%), Gaps = 22/275 (8%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLV 233
+G G +G V+ G T VAVK L + F E + ++H+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 234 RLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEA 293
RL + ++ EY+ NG+L +L+ LT + + A+ +A++ E
Sbjct: 72 RLYAVVTQE-PIYIITEYMENGSLVDFLKT--PSGIKLTINKLLDMAAQIAEGMAFIEE- 127
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSG 353
+HRD++++NIL+ + KI+DFGLA+L+ + + APE N G
Sbjct: 128 --RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 354 LLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETR 413
KSDV+SFG++L E +T G EV + L R +V P+
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV--------IQNLERGYRMVRPD---- 233
Query: 414 PSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448
+ + C + RP + +LE
Sbjct: 234 ---NCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 8e-69
Identities = 75/291 (25%), Positives = 125/291 (42%), Gaps = 30/291 (10%)
Query: 182 IGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIE 241
IG G +G V+RG+ G VAVK ++ + E+ +RH+N++ + +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIF-SSREERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 242 G----TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI--- 294
TQ LV +Y +G+L +L R +T E +K+ L TA LA+LH I
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIVGT 123
Query: 295 --EPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI---TTRVMGTFGYVAPEY 349
+P + HRD+KS NIL+ +N I+D GLA + I +GT Y+APE
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 350 ANSGL------LNEKSDVYSFGVVLLEAITGRYP----VDYGRPQSEVNLVEWLKMMVQL 399
+ + +++D+Y+ G+V E DY P ++ + ++
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRK 243
Query: 400 RRSEDVVDPNIETRPSTSALKRALLT-ALRCVDPDSDKRPKMSQVVRMLES 449
E + PNI R + R + C + R ++ + L
Sbjct: 244 VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 219 bits (558), Expect = 3e-68
Identities = 79/303 (26%), Positives = 126/303 (41%), Gaps = 39/303 (12%)
Query: 164 FTLRDLQSATNRFSK---------DNIIGDGGYGVVYRGQLM----NGTAVAVKKLLNNP 210
FT D A F+K + +IG G +G V G L VA+K L +
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 211 GQAD-KDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRG 269
+ +DF E +G H N++ L G + T +++ E++ NG+L+ +LR + G
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND---G 123
Query: 270 YLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329
T + +L G A + YL + VHRD+ + NIL++ N K+SDFGL++ L
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180
Query: 330 GKSHITTR----VMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQS 385
S T + APE SDV+S+G+V+ E ++ P
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER-----PYW 235
Query: 386 EVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVR 445
++ + + + Q R P L C D + RPK Q+V
Sbjct: 236 DMTNQDVINAIEQDYRLP----------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285
Query: 446 MLE 448
L+
Sbjct: 286 TLD 288
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 5e-67
Identities = 54/273 (19%), Positives = 114/273 (41%), Gaps = 22/273 (8%)
Query: 176 FSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRL 235
+ +G G +GVV G+ VA+K + ++ +F E + + ++ H+ LV+L
Sbjct: 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQL 64
Query: 236 LGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIE 295
G C + ++ EY+ NG L +L R + +++ +A+ YL
Sbjct: 65 YGVCTKQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYLES--- 118
Query: 296 PKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLL 355
+ +HRD+ + N L+++ K+SDFGL++ + + + + PE
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 356 NEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPS 415
+ KSD+++FGV++ E + SE + + + P++ +
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSET--------AEHIAQGLRLYRPHLAS--- 227
Query: 416 TSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448
++ C +D+RP ++ +
Sbjct: 228 ----EKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 9e-66
Identities = 74/290 (25%), Positives = 120/290 (41%), Gaps = 27/290 (9%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLV 233
+ +G G +G V+ G T VA+K L + + F E + + +RH+ LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 75
Query: 234 RLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEA 293
+L E +V EY++ G+L +L+G+ YL + + A +AY+
Sbjct: 76 QLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETG--KYLRLPQLVDMAAQIASGMAYVER- 131
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSG 353
VHRD++++NIL+ EN K++DFGLA+L+ + + APE A G
Sbjct: 132 --MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 189
Query: 354 LLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETR 413
KSDV+SFG++L E T G EV D V+
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---------------LDQVERGYRMP 234
Query: 414 PSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE-----SEEYPIPRED 458
+ +C + ++RP + LE +E P E+
Sbjct: 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 284
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 7e-65
Identities = 63/306 (20%), Positives = 119/306 (38%), Gaps = 38/306 (12%)
Query: 169 LQSATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKL-LNNPGQADKDFRVEVEAIGH 226
++ + F K + +G G GVV++ +G +A K + L E++ +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 227 VRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKA 286
+V G + + E+++ G+L+Q L G + + K+ + K
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKG 116
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVA 346
L YL E + K++HRD+K SNIL++ + K+ DFG++ L + +GT Y++
Sbjct: 117 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMS 171
Query: 347 PEYANSGLLNEKSDVYSFGVVLLEAITGRYPVD---------------YGRPQSEVNLVE 391
PE + +SD++S G+ L+E GRYP+ G
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231
Query: 392 WL------------KMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPK 439
M + +V+ PS +C+ + +R
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291
Query: 440 MSQVVR 445
+ Q++
Sbjct: 292 LKQLMV 297
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 1e-64
Identities = 76/290 (26%), Positives = 126/290 (43%), Gaps = 29/290 (10%)
Query: 167 RDLQSATNRFSKDNI-IGDGGYGVVYRGQLM---NGTAVAVKKLLNNPGQAD-KDFRVEV 221
+ L + +I +G G +G V +G VA+K L +AD ++ E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 222 EAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILL 281
+ + + + +VRL+G C + +LV E G L ++L G R + ++L
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLH 116
Query: 282 GTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR--VM 339
+ + YL E VHRD+ + N+L+ AKISDFGL+K LGA S+ T R
Sbjct: 117 QVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173
Query: 340 GTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQL 399
+ APE N + +SDV+S+GV + EA++ P ++ E + + Q
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK-----PYKKMKGPEVMAFIEQG 228
Query: 400 RRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449
+R +E P AL+ C + RP V + + +
Sbjct: 229 KR--------MECPPECPPELYALM--SDCWIYKWEDRPDFLTVEQRMRA 268
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 3e-64
Identities = 74/276 (26%), Positives = 110/276 (39%), Gaps = 28/276 (10%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLV 233
IG G +G V G G VAVK + + F E + +RH NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 63
Query: 234 RLLGYCIEGTQRI-LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE 292
+LLG +E + +V EY+ G+L +LR R L + +K L +A+ YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG 121
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANS 352
VHRD+ + N+L+ E+ AK+SDFGL K S + APE
Sbjct: 122 ---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALRE 174
Query: 353 GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIET 412
+ KSDV+SFG++L E + P +V V ++ ++ +
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV--VPRVEKGYKMDAPDGCPP----- 227
Query: 413 RPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448
C D+ RP Q+ LE
Sbjct: 228 --------AVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 206 bits (525), Expect = 1e-63
Identities = 66/277 (23%), Positives = 118/277 (42%), Gaps = 22/277 (7%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL 232
+ + +G G YG VY G VAVK L + + ++F E + ++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNL 75
Query: 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE 292
V+LLG C ++ E++ GNL +LR C+R ++ + + + A+ YL +
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANS 352
+HRD+ + N L+ EN K++DFGL++L+ + APE
Sbjct: 134 ---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190
Query: 353 GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIET 412
+ KSDV++FGV+L E T G S+V ++++ +
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---------------YELLEKDYRM 235
Query: 413 RPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449
++ C + RP +++ + E+
Sbjct: 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 1e-63
Identities = 73/280 (26%), Positives = 120/280 (42%), Gaps = 30/280 (10%)
Query: 179 DNIIGDGGYGVVYRGQLMN----GTAVAVKKLLNNPGQAD-KDFRVEVEAIGHVRHKNLV 233
+ +IG G +G VY G L++ AVK L + F E + H N++
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91
Query: 234 RLLGYCIEG-TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE 292
LLG C+ ++V Y+ +G+L + + T + + L AK + +L
Sbjct: 92 SLLGICLRSEGSPLVVLPYMKHGDLRNF---IRNETHNPTVKDLIGFGLQVAKGMKFLAS 148
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS---HITTRVMGTFGYVAPEY 349
K VHRD+ + N ++DE F K++DFGLA+ + + H T ++A E
Sbjct: 149 ---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 350 ANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409
+ KSDV+SFGV+L E +T P P +VN + ++Q RR
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLLQ----- 255
Query: 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449
L+C P ++ RP S++V + +
Sbjct: 256 -----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 290
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 205 bits (522), Expect = 6e-63
Identities = 78/311 (25%), Positives = 117/311 (37%), Gaps = 46/311 (14%)
Query: 166 LRDLQSATNRFSKDNIIGDGGYGVVYRGQLMN------GTAVAVKKL-LNNPGQADKDFR 218
L L+ N IG+G +G V++ + T VAVK L DF+
Sbjct: 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64
Query: 219 VEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRG--------------- 263
E + + N+V+LLG C G L++EY+ G+L ++LR
Sbjct: 65 REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124
Query: 264 -----DMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKI 318
L+ ++ I A +AYL E K VHRD+ + N L+ EN KI
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKI 181
Query: 319 SDFGLAKLL-GAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYP 377
+DFGL++ + A ++ PE +SDV+++GVVL E +
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241
Query: 378 VDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKR 437
YG EV V D NI P + C R
Sbjct: 242 PYYGMAHEEV--------------IYYVRDGNILACPE-NCPLELYNLMRLCWSKLPADR 286
Query: 438 PKMSQVVRMLE 448
P + R+L+
Sbjct: 287 PSFCSIHRILQ 297
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 1e-62
Identities = 70/284 (24%), Positives = 123/284 (43%), Gaps = 29/284 (10%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNGT-----AVAVKKLLNNPGQADK-DFRVEVEAIGHV 227
+ ++ +IG G +G VY+G L + VA+K L + + DF E +G
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 228 RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKAL 287
H N++RL G + +++ EY+ NG L+++LR G + + +L G A +
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGM 123
Query: 288 AYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG--KSHITTRVMGTFGYV 345
YL VHRD+ + NIL++ N K+SDFGL+++L ++ T+ +
Sbjct: 124 KYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 346 APEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV 405
APE + SDV+SFG+V+ E +T + EV
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---------------MKA 225
Query: 406 VDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449
++ ++C + +RPK + +V +L+
Sbjct: 226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK 269
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 1e-62
Identities = 68/282 (24%), Positives = 115/282 (40%), Gaps = 24/282 (8%)
Query: 171 SATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLL--NNPGQADKDFRVEVEAIGHV 227
S + IG G YG + + +G + K+L + + EV + +
Sbjct: 1 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60
Query: 228 RHKNLVRLLGYCIEGTQRIL--VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAK 285
+H N+VR I+ T L V EY G+L + +R YL E ++++
Sbjct: 61 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 286 ALAYLHE--AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
AL H V+HRD+K +N+ +D + K+ DFGLA++L S +GT
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPY 179
Query: 344 YVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSE 403
Y++PE N NEKSD++S G +L E P + E + + +
Sbjct: 180 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT------AFSQKELAGKIREGKF-- 231
Query: 404 DVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVR 445
I R S ++ R ++ RP + +++
Sbjct: 232 ----RRIPYRYSDEL--NEII--TRMLNLKDYHRPSVEEILE 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 4e-61
Identities = 72/285 (25%), Positives = 114/285 (40%), Gaps = 32/285 (11%)
Query: 170 QSATNRFSK-DNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNN--PGQADKDFRVEVEAIG 225
S RF K D IG G + VY+G VA +L + + F+ E E +
Sbjct: 4 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLK 63
Query: 226 HVRHKNLVRLLGYCIEGTQR----ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILL 281
++H N+VR + +LV E + +G L+ +L+ + +
Sbjct: 64 GLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCR 119
Query: 282 GTAKALAYLHEAIEPKVVHRDIKSSNILI-DENFDAKISDFGLAKLLGAGKSHITTRVMG 340
K L +LH P ++HRD+K NI I KI D GLA L ++ V+G
Sbjct: 120 QILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVIG 175
Query: 341 TFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLR 400
T ++APE +E DVY+FG+ +LE T YP E R
Sbjct: 176 TPEFMAPEMYEEKY-DESVDVYAFGMCMLEMATSEYPYS-----------ECQNAAQIYR 223
Query: 401 RSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVR 445
R V P + + +K + C+ + D+R + ++
Sbjct: 224 RVTSGVKPASFDKVAIPEVKEII---EGCIRQNKDERYSIKDLLN 265
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 6e-61
Identities = 70/300 (23%), Positives = 116/300 (38%), Gaps = 40/300 (13%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPGQAD-KDFRVEVEAIGH 226
NR S +G G +G V VAVK L + + + E++ + +
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 227 V-RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMC--------------DRGYL 271
+ H N+V LLG C G +++ EY G+L +LR D L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 272 TWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331
E + AK +A+L +HRD+ + NIL+ KI DFGLA+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 332 SH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLV 390
++ + ++APE + + +SDV+S+G+ L E + G P
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-FY 258
Query: 391 EWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450
+ +K ++ E C D D KRP Q+V+++E +
Sbjct: 259 KMIKEGFRMLSPEHAPA-------------EMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (508), Expect = 1e-60
Identities = 66/305 (21%), Positives = 115/305 (37%), Gaps = 45/305 (14%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMN------GTAVAVKKLLNNPGQAD-KDFRVEVEAIGH 226
++G G +G V VAVK L ++ + E++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 227 V-RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRG-------------------DMC 266
+ H+N+V LLG C L++EY G+L +LR +
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 267 DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326
D LT+E + AK + +L VHRD+ + N+L+ KI DFGLA+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 327 LGAGKSHIT-TRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQS 385
+ + +++ ++APE G+ KSDV+S+G++L E + G P
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273
Query: 386 EVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVR 445
N + ++ ++ + + + C DS KRP +
Sbjct: 274 A-NFYKLIQNGFKMDQPFYATE-------------EIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 446 MLESE 450
L +
Sbjct: 320 FLGCQ 324
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 1e-60
Identities = 69/279 (24%), Positives = 115/279 (41%), Gaps = 30/279 (10%)
Query: 178 KDNIIGDGGYGVVYRGQLMN---GTAVAVKKLLNNPGQAD--KDFRVEVEAIGHVRHKNL 232
+D +G G +G V +G VAVK L N + E + + + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE 292
VR++G C E +LV E G L ++L ++ + ++++ + + YL E
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYLEE 125
Query: 293 AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTR--VMGTFGYVAPEYA 350
VHRD+ + N+L+ AKISDFGL+K L A +++ + + APE
Sbjct: 126 ---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 351 NSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNI 410
N + KSDV+SFGV++ EA + P + E M+ + R +
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQK-----PYRGMKGSEVTAMLEKGER--------M 229
Query: 411 ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449
L+ C D + RP + V L +
Sbjct: 230 GCPAGCPREMYDLM--NLCWTYDVENRPGFAAVELRLRN 266
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 198 bits (504), Expect = 3e-60
Identities = 64/280 (22%), Positives = 111/280 (39%), Gaps = 34/280 (12%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQAD---KDFRVEVEAIGHVR 228
FS IG G +G VY + + N VA+KK+ + Q++ +D EV + +R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALA 288
H N ++ G + LV EY + + L + G + LA
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLA 129
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPE 348
YLH ++HRD+K+ NIL+ E K+ DFG A ++ +GT ++APE
Sbjct: 130 YLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANSFVGTPYWMAPE 181
Query: 349 YA---NSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV 405
+ G + K DV+S G+ +E + P + + M L
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPP------------LFNMNAMSALYHIAQN 229
Query: 406 VDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVR 445
P +++ + + + C+ RP +++
Sbjct: 230 ESPALQSGHWSEYFRNFV---DSCLQKIPQDRPTSEVLLK 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 7e-60
Identities = 69/292 (23%), Positives = 122/292 (41%), Gaps = 37/292 (12%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNG---TAVAVKKLLNNPGQAD-KDFRVEVEAIGHV-R 228
N ++IG+G +G V + ++ A+K++ + D +DF E+E + +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMC------------DRGYLTWEAR 276
H N++ LLG C L EY +GNL +LR L+ +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 277 MKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITT 336
+ A+ + YL + + +HRD+ + NIL+ EN+ AKI+DFGL++ T
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184
Query: 337 RVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMM 396
++A E N + SDV+S+GV+L E ++ P + E + +
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAELYEKL 239
Query: 397 VQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448
Q R E ++ + E +C +RP +Q++ L
Sbjct: 240 PQGYRLEKPLNCDDE----------VYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 5e-59
Identities = 69/276 (25%), Positives = 117/276 (42%), Gaps = 31/276 (11%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLN---NPGQADKDFRVEVEAIGHVRH 229
F +G G +G VY + + +A+K L + R EVE H+RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
N++RL GY + T+ L+ EY G + + L+ + + A AL+Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSY 121
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEY 349
H +V+HRDIK N+L+ + KI+DFG + S T + GT Y+ PE
Sbjct: 122 CHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTTLCGTLDYLPPEM 175
Query: 350 ANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409
+ +EK D++S GV+ E + G+ P + Q + ++ +E D
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD-- 233
Query: 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVR 445
L++ R + + +RP + +V+
Sbjct: 234 -------------LIS--RLLKHNPSQRPMLREVLE 254
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 8e-59
Identities = 64/279 (22%), Positives = 118/279 (42%), Gaps = 27/279 (9%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN 231
+ + +GDG +G VY+ Q A K + + +D+ VE++ + H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
+V+LL ++ E+ G ++ + LT + T AL YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLE---LERPLTESQIQVVCKQTLDALNYLH 127
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYA- 350
+ K++HRD+K+ NIL + D K++DFG++ + + GT ++APE
Sbjct: 128 DN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVM 183
Query: 351 ----NSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVV 406
+ K+DV+S G+ L+E P E+N + L + +
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIE------PPHHELNPMRVLLKIAKSEP----- 232
Query: 407 DPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVR 445
P + S+ + L +C++ + D R SQ+++
Sbjct: 233 -PTLAQPSRWSSNFKDFLK--KCLEKNVDARWTTSQLLQ 268
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 1e-58
Identities = 64/276 (23%), Positives = 109/276 (39%), Gaps = 25/276 (9%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL-LNNPGQADKDFRVEVEAIGHVRHKN 231
+ +G+G YG V + AVAVK + + ++ + E+ + H+N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
+V+ G+ EG + L EY + G L + + + + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG-KSHITTRVMGTFGYVAPEYA 350
+ HRDIK N+L+DE + KISDFGLA + + + ++ GT YVAPE
Sbjct: 121 GI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 351 NSG-LLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409
E DV+S G+VL + G P D + + + ++P
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS--------CQEYSDWKEKKTYLNP- 228
Query: 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVR 445
+ ALL + + + R + + +
Sbjct: 229 ---WKKIDSAPLALLH--KILVENPSARITIPDIKK 259
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 2e-58
Identities = 67/274 (24%), Positives = 120/274 (43%), Gaps = 24/274 (8%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKN 231
++++ IG G G VY + G VA++++ + E+ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
+V L + G + +V EY+ G+L D+ + + +AL +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLT-----DVVTETCMDEGQIAAVCRECLQALEFLH 133
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYAN 351
+V+HRDIKS NIL+ + K++DFG + +S +T V GT ++APE
Sbjct: 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVT 189
Query: 352 SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411
K D++S G++ +E I G P N + L ++ P ++
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYL------NENPLRALYLIATNGT------PELQ 237
Query: 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVR 445
SA+ R L RC+D D +KR ++++
Sbjct: 238 NPEKLSAIFRDFLN--RCLDMDVEKRGSAKELLQ 269
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (489), Expect = 2e-58
Identities = 63/281 (22%), Positives = 114/281 (40%), Gaps = 27/281 (9%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMN----GTAVAVKKLLNNPGQADKD-FRVEVEAIGHVR 228
R IG+G +G V++G M+ AVA+K N + ++ F E +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALA 288
H ++V+L+G E ++ E G L + + L + + + ALA
Sbjct: 67 HPHIVKLIGVITEN-PVWIIMELCTLGELRSF---LQVRKYSLDLASLILYAYQLSTALA 122
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPE 348
YL + VHRDI + N+L+ N K+ DFGL++ + + ++ ++APE
Sbjct: 123 YLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 349 YANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408
N SDV+ FGV + E + P V + + + R
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVK-----PFQGVKNNDVIGRIENGER------- 227
Query: 409 NIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449
+ P+ +L+ +C D +RP+ +++ L +
Sbjct: 228 -LPMPPNCPPTLYSLM--TKCWAYDPSRRPRFTELKAQLST 265
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 7e-58
Identities = 74/297 (24%), Positives = 129/297 (43%), Gaps = 34/297 (11%)
Query: 176 FSKDNIIGDGGYGVVYRGQLMN-----GTAVAVKKL-LNNPGQADKDFRVEVEAIGHVRH 229
F K ++G G +G VY+G + VA+K+L +A+K+ E + V +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
++ RLLG C+ T +++ L+ + + + + + AK + Y
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNY 126
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG-KSHITTRVMGTFGYVAPE 348
L + ++VHRD+ + N+L+ KI+DFGLAKLLGA K + ++A E
Sbjct: 127 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 349 YANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408
+ +SDV+S+GV + E +T G P SE+ L + E + P
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI--------SSILEKGERLPQP 235
Query: 409 NIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES-----EEYPIPREDRR 460
I T + ++C D+D RPK +++ + Y + + D R
Sbjct: 236 PICT-------IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDER 285
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 4e-57
Identities = 70/284 (24%), Positives = 111/284 (39%), Gaps = 30/284 (10%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQL----MNGTAVAVKKL---LNNPGQADKDFRVEVEAIGH 226
+GDG +GVV RG+ +VAVK L + + +A DF EV A+
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 227 VRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKA 286
+ H+NL+RL G + ++ V E G+L +G+ + + A+
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDR---LRKHQGHFLLGTLSRYAVQVAEG 123
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH--ITTRVMGTFGY 344
+ YL + +HRD+ + N+L+ KI DFGL + L H + F +
Sbjct: 124 MGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 345 VAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSED 404
APE + + SD + FGV L E T G S++ L + K +L R ED
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-LHKIDKEGERLPRPED 239
Query: 405 VVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448
++C + RP + L
Sbjct: 240 CPQ-------------DIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 190 bits (483), Expect = 1e-56
Identities = 65/335 (19%), Positives = 126/335 (37%), Gaps = 31/335 (9%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL 232
+ + +G G +GVV+R G A K ++ + R E++ + +RH L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE 292
V L + + +++YE+++ G L + + + ++ + ++ + K L ++HE
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKV---ADEHNKMSEDEAVEYMRQVCKGLCHMHE 142
Query: 293 AIEPKVVHRDIKSSNILI--DENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYA 350
VH D+K NI+ + + K+ DFGL L +S T GT + APE A
Sbjct: 143 N---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVA 197
Query: 351 NSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNI 410
+ +D++S GV+ ++G P N E L+ + + +
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFG------GENDDETLRNVKSCD-----WNMDD 246
Query: 411 ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM-------LESEEYPIPREDRRRRR 463
S + + + + D + R + Q + + IP + R
Sbjct: 247 SAFSGISEDGKDFIR--KLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIR 304
Query: 464 NQAGASEAESQRESSDTDKNENPESRLKTRRNQQS 498
+ + N S K R + S
Sbjct: 305 DSIKTKYDAWPEPLPPLGRISNYSSLRKHRPQEYS 339
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 1e-54
Identities = 65/298 (21%), Positives = 120/298 (40%), Gaps = 32/298 (10%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMN------GTAVAVKKLLNNPGQADK-DFRVEVEAIGH 226
+ + +G G +G+VY G T VA+K + ++ +F E +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 227 VRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLR------GDMCDRGYLTWEARMKIL 280
++VRLLG +G +++ E + G+L+ +LR + + +++
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS-HITTRVM 339
A +AYL+ K VHRD+ + N ++ E+F KI DFG+ + + + +
Sbjct: 140 GEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 340 GTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQL 399
+++PE G+ SDV+SFGVVL E T G +V
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV------------ 244
Query: 400 RRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIPRE 457
V++ + +P + C + RP +++ ++ E P RE
Sbjct: 245 --LRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 6e-54
Identities = 72/298 (24%), Positives = 124/298 (41%), Gaps = 41/298 (13%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQL--------MNGTAVAVKKLLNNPGQAD-KDFRVEVEAI 224
+R +G+G +G V + T VAVK L ++ + D D E+E +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 225 GHV-RHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMC------------DRGYL 271
+ +HKN++ LLG C + ++ EY + GNL ++L+ L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 272 TWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331
+ + + A+ + YL K +HRD+ + N+L+ E+ KI+DFGLA+ +
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 332 SHITTRVM-GTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLV 390
+ T ++APE + +SDV+SFGV+L E T G P E L
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--LF 247
Query: 391 EWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448
+ LK ++ + + + + C +RP Q+V L+
Sbjct: 248 KLLKEGHRMDKPSNCTN-------------ELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 8e-53
Identities = 71/298 (23%), Positives = 117/298 (39%), Gaps = 39/298 (13%)
Query: 174 NRFSKDNIIGDGGYGVVYRG------QLMNGTAVAVKKLLNNPGQAD-KDFRVEVEAIGH 226
+R +G G +G V + VAVK L ++ + E++ + H
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 227 -VRHKNLVRLLGYCIE-GTQRILVYEYVNNGNLEQWLRGDMCD------------RGYLT 272
H N+V LLG C + G +++ E+ GNL +LR + + +LT
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 273 WEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332
E + AK + +L K +HRD+ + NIL+ E KI DFGLA+ +
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 333 HI-TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVE 391
++ ++APE + +SDV+SFGV+L E + P V + E
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDE 244
Query: 392 WLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449
++ D T L C + +RP S++V L +
Sbjct: 245 EFCRRLKEGTRMRAPDYTTP---------EMYQTMLDCWHGEPSQRPTFSELVEHLGN 293
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 178 bits (452), Expect = 4e-52
Identities = 55/336 (16%), Positives = 125/336 (37%), Gaps = 32/336 (9%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL 232
+ + +G G +GVV+R G K + + E+ + + H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE 292
+ L + + +L+ E+++ G L + + ++ + + + L ++HE
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHE 145
Query: 293 AIEPKVVHRDIKSSNILIDENFDA--KISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYA 350
+VH DIK NI+ + + KI DFGLA L I T + APE
Sbjct: 146 H---SIVHLDIKPENIMCETKKASSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEIV 200
Query: 351 NSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNI 410
+ + +D+++ GV+ ++G P + +E L+ + + + +
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGLSPFA------GEDDLETLQNVKRCD-----WEFDE 249
Query: 411 ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVR--------MLESEEYPIPREDRRRR 462
+ S S + + + + KR + + + P R ++ R+
Sbjct: 250 DAFSSVSPEAKDFIK--NLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQ 307
Query: 463 RNQAGASEAESQRESSDTDKNENPESRLKTRRNQQS 498
+ + ++ + + + N + + + + Q
Sbjct: 308 KIKEKYADWPAPQPAIGRIANFSSLRKHRPQEYQIY 343
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 8e-51
Identities = 59/284 (20%), Positives = 108/284 (38%), Gaps = 29/284 (10%)
Query: 175 RFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKD---FRVEVEAIGHVRHK 230
F I+G+G + V + L A+K L + E + + + H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 231 NLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYL 290
V+L + + Y NG L +++ G AL YL
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYI----RKIGSFDETCTRFYTAEIVSALEYL 124
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA-GKSHITTRVMGTFGYVAPEY 349
H ++HRD+K NIL++E+ +I+DFG AK+L K +GT YV+PE
Sbjct: 125 HG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 350 ANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409
+ SD+++ G ++ + + G P N + +++L + +
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPPFR------AGNEYLIFQKIIKL-------EYD 228
Query: 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYP 453
+ A R L+ + + D+ KR ++ + +P
Sbjct: 229 FPEKFFPKA--RDLVE--KLLVLDATKRLGCEEMEGYGPLKAHP 268
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 2e-50
Identities = 51/312 (16%), Positives = 117/312 (37%), Gaps = 29/312 (9%)
Query: 175 RFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVR 234
++ +G G +G+V+R + + K + G + E+ + RH+N++
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILH 65
Query: 235 LLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI 294
L + ++++E+++ ++ + + L + + +AL +LH
Sbjct: 66 LHESFESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLH--- 119
Query: 295 EPKVVHRDIKSSNILID--ENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANS 352
+ H DI+ NI+ + KI +FG A+ L G + Y APE
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQH 177
Query: 353 GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIET 412
+++ +D++S G ++ ++G P Q +++ + +E + E
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---------QIIENIMNAE--YTFDEEA 226
Query: 413 RPSTSALKRALLTALRCVDPDSDKRPKMSQVVR------MLESEEYPIPREDRRRRRNQA 466
S + R + + R S+ ++ +E + R + RR
Sbjct: 227 FKEISIEAMDFVD--RLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHT 284
Query: 467 GASEAESQRESS 478
+ + S+
Sbjct: 285 LIKKDLNMVVSA 296
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (432), Expect = 9e-50
Identities = 61/288 (21%), Positives = 119/288 (41%), Gaps = 30/288 (10%)
Query: 163 WFTLRDLQSATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKD-FRVE 220
W D++ + + +++G G + V + VA+K + + + E
Sbjct: 1 WKQAEDIR---DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENE 57
Query: 221 VEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKIL 280
+ + ++H N+V L G L+ + V+ G L + ++G+ T +++
Sbjct: 58 IAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLI 113
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLLGAGKSHITTR 337
A+ YLH + +VHRD+K N+L DE+ ISDFGL+K+ G + +
Sbjct: 114 FQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLST 168
Query: 338 VMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMV 397
GT GYVAPE ++ D +S GV+ + G P + N + + ++
Sbjct: 169 ACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY------DENDAKLFEQIL 222
Query: 398 QLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVR 445
+ + + S + + ++ D +KR Q ++
Sbjct: 223 KAE-----YEFDSPYWDDISDSAKDFIR--HLMEKDPEKRFTCEQALQ 263
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 166 bits (420), Expect = 2e-48
Identities = 69/287 (24%), Positives = 126/287 (43%), Gaps = 31/287 (10%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQAD---KDFRVEVEAIGHVR 228
++R+ I+G GG V+ + L VAVK L + + FR E + +
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 229 HKNLVRLLGYCIE----GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTA 284
H +V + G +V EYV+ L + G +T + ++++
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADAC 121
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI--TTRVMGTF 342
+AL + H+ ++HRD+K +NI+I K+ DFG+A+ + + + T V+GT
Sbjct: 122 QALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 343 GYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRS 402
Y++PE A ++ +SDVYS G VL E +TG P + V V+
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT------GDSPVSVAYQHVR---- 228
Query: 403 EDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPK-MSQVVRMLE 448
ED + P+ ++ L + L+ + + + R + +++ L
Sbjct: 229 EDPIPPSARHEGLSADLDAVV---LKALAKNPENRYQTAAEMRADLV 272
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 165 bits (418), Expect = 5e-48
Identities = 62/286 (21%), Positives = 111/286 (38%), Gaps = 39/286 (13%)
Query: 175 RFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL---------LNNPGQADKDFRVEVEAI 224
+ I+G G VV R AVK + + + EV+ +
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 225 GHVR-HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGT 283
V H N+++L T LV++ + G L +L ++ L+ + KI+
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRAL 119
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
+ + LH+ +VHRD+K NIL+D++ + K++DFG + L G+ V GT
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCGTPS 174
Query: 344 YVAPEYA------NSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMV 397
Y+APE N ++ D++S GV++ + G P + L+M++
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW------HRKQMLMLRMIM 228
Query: 398 QLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQV 443
S + L++ R + KR +
Sbjct: 229 S-----GNYQFGSPEWDDYSDTVKDLVS--RFLVVQPQKRYTAEEA 267
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 164 bits (416), Expect = 2e-47
Identities = 50/287 (17%), Positives = 96/287 (33%), Gaps = 29/287 (10%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL 232
NR+ IG G +G +Y G + G VA+K +E + ++
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLE--CVKTKHPQLHIESKIYKMMQGGVG 64
Query: 233 VRLLGYCI-EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
+ + +C EG ++V E + + + + + + + + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLEDLFNF----CSRKFSLKTVLLLADQMISRIEYIH 120
Query: 292 EAIEPKVVHRDIKSSNILI---DENFDAKISDFGLAKLLGAGKSHI------TTRVMGTF 342
+HRD+K N L+ + I DFGLAK ++H + GT
Sbjct: 121 SK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 343 GYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRS 402
Y + + + D+ S G VL+ G P + + +
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA-------ATKRQKYERISE 230
Query: 403 EDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449
+ + P + L C D +P S + ++ +
Sbjct: 231 KKMSTPIEVLCKGYPSEFATYLN--FCRSLRFDDKPDYSYLRQLFRN 275
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 166 bits (420), Expect = 2e-47
Identities = 64/277 (23%), Positives = 107/277 (38%), Gaps = 32/277 (11%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKD------FRVEVEAIGH 226
N FS IIG GG+G VY + G A+K L + + R+ + +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 227 VRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKA 286
+V + + + + +N G+L L G +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILG 119
Query: 287 LAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVA 346
L ++H VV+RD+K +NIL+DE+ +ISD GLA K H + +GT GY+A
Sbjct: 120 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMA 173
Query: 347 PEYANSGL-LNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV 405
PE G+ + +D +S G +L + + G P + + + +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL----------- 222
Query: 406 VDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQ 442
+E S S R+LL + D ++R
Sbjct: 223 -TMAVELPDSFSPELRSLLE--GLLQRDVNRRLGCLG 256
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 162 bits (411), Expect = 5e-47
Identities = 60/286 (20%), Positives = 111/286 (38%), Gaps = 21/286 (7%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLL--NNPGQADKDFRVEVEAIGHVRHKN 231
++ IG+G YGVVY+ Q G A+KK+ E+ + ++H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
+V+L + +LV+E+++ + G L LL +AY H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYAN 351
+ +V+HRD+K N+LI+ + KI+DFGLA+ G T ++ +
Sbjct: 118 D---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 352 SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD---- 407
S + D++S G + E + G ++ + + + +V +
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 408 ----PNIETRPSTSALKRALLTAL----RCVDPDSDKRPKMSQVVR 445
E P S LK + + + + D ++R Q +
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 2e-46
Identities = 67/287 (23%), Positives = 117/287 (40%), Gaps = 33/287 (11%)
Query: 170 QSATNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL------LNNPGQADKDFRVEVE 222
++ + + +G G + VV + + G A K + + G + +D EV
Sbjct: 6 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 223 AIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG 282
+ ++H N++ L T IL+ E V G L + + ++ LT E + L
Sbjct: 66 ILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDF----LAEKESLTEEEATEFLKQ 121
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDA----KISDFGLAKLLGAGKSHITTRV 338
+ YLH ++ H D+K NI++ + KI DFGLA + G +
Sbjct: 122 ILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKNI 176
Query: 339 MGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQ 398
GT +VAPE N L ++D++S GV+ ++G P Q E L +
Sbjct: 177 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANVSA 230
Query: 399 LRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVR 445
+ + E +TSAL + + R + D KR + ++
Sbjct: 231 VN-----YEFEDEYFSNTSALAKDFIR--RLLVKDPKKRMTIQDSLQ 270
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 2e-46
Identities = 67/306 (21%), Positives = 121/306 (39%), Gaps = 27/306 (8%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQAD-KDFRVEVEAIGHVRHK 230
R++ + IG+G YG+V +N VA+KK+ Q + E++ + RH+
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 231 NLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYL 290
N++ + T + Y+ + L + +L+ + L + L Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLY-KLLKTQHLSNDHICYFLYQILRGLKYI 125
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHIT--TRVMGTFGYVAPE 348
H A V+HRD+K SN+L++ D KI DFGLA++ H T + T Y APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 349 YANSGLL-NEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLK------------- 394
+ + D++S G +L E ++ R ++N + +
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 395 ---MMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451
L P P+ + LL + + + KR ++ Q + E+
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD--KMLTFNPHKRIEVEQALAHPYLEQ 300
Query: 452 YPIPRE 457
Y P +
Sbjct: 301 YYDPSD 306
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 4e-46
Identities = 66/277 (23%), Positives = 104/277 (37%), Gaps = 30/277 (10%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKD---FRVEVEAIGHV-R 228
F ++G G +G V+ + A+K L + D D VE +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 229 HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALA 288
H L + V EY+N G+L ++ L
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQ 117
Query: 289 YLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPE 348
+LH +V+RD+K NIL+D++ KI+DFG+ K G + T GT Y+APE
Sbjct: 118 FLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPE 173
Query: 349 YANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408
N D +SFGV+L E + G+ P Q E L ++M +P
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH---GQDEEELFHSIRMD----------NP 220
Query: 409 NIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVR 445
A + LL ++ + +KR + +R
Sbjct: 221 FYPRWLEKEA--KDLL--VKLFVREPEKRLGVRGDIR 253
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (404), Expect = 8e-46
Identities = 64/300 (21%), Positives = 110/300 (36%), Gaps = 27/300 (9%)
Query: 175 RFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLL--NNPGQADKDFRVEVEAIGHVRHKN 231
F K IG+G YGVVY+ + + G VA+KK+ E+ + + H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
+V+LL + LV+E+++ + D + L + LA+ H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFM---DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 292 EAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYAN 351
+V+HRD+K N+LI+ K++DFGLA+ G T V+ +
Sbjct: 120 S---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 352 SGLLNEKSDVYSFGVVLLEAITGRYPVD--------------YGRPQSEVNLVEWLKMMV 397
+ D++S G + E +T R G P V
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 398 QLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM--LESEEYPIP 455
+ + + P R+LL+ + + D +KR + + P+P
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLS--QMLHYDPNKRISAKAALAHPFFQDVTKPVP 294
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 2e-45
Identities = 59/294 (20%), Positives = 109/294 (37%), Gaps = 24/294 (8%)
Query: 169 LQSATNRFSKDNIIGDGGYGVVYRGQLM--NGTAVAVKKLLNNPGQADKDFRVEVEA--- 223
L A ++ IG+G YG V++ + + G VA+K++ G+ E
Sbjct: 2 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 61
Query: 224 --IGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMC--DRGYLTWEARMKI 279
+ H N+VRL C + +++Q L + + E +
Sbjct: 62 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDM 121
Query: 280 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVM 339
+ + L +LH +VVHRD+K NIL+ + K++DFGLA++ + T V+
Sbjct: 122 MFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVV 176
Query: 340 GTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLV--------- 390
T Y APE D++S G + E + ++ +
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236
Query: 391 -EWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQV 443
+W + + R++ + T + L+C+ + KR
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 3e-45
Identities = 67/296 (22%), Positives = 117/296 (39%), Gaps = 28/296 (9%)
Query: 180 NIIGDGGYGVVYRGQLMN-GTAVAVKKLLNNPGQADKD-----FRVEVEAIGHVRHKNLV 233
+ +G+G + VY+ + N VA+KK+ KD E++ + + H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 234 RLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEA 293
LL + LV++++ + LT +L T + L YLH+
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVII----KDNSLVLTPSHIKAYMLMTLQGLEYLHQ- 118
Query: 294 IEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANS- 352
++HRD+K +N+L+DEN K++DFGLAK G+ T +V T Y APE
Sbjct: 119 --HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGA 175
Query: 353 GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLV----------EWLKMMVQLRRS 402
+ D+++ G +L E + + ++ + +W M
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 403 EDVVDPNIETRPSTSALKRALLTAL-RCVDPDSDKRPKMSQVVRM--LESEEYPIP 455
P I SA LL + + R +Q ++M + P P
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP 291
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 7e-45
Identities = 64/295 (21%), Positives = 113/295 (38%), Gaps = 43/295 (14%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKD------FRVEVEAIGH 226
+++ ++G GG+G VY G + + VA+K + + + +EV +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 227 VR--HKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTA 284
V ++RLL + +L+ E + +RG L E
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF---ITERGALQEELARSFFWQVL 120
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDEN-FDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
+A+ + H V+HRDIK NILID N + K+ DFG LL K + T GT
Sbjct: 121 EAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRV 174
Query: 344 YVAPEY-ANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRS 402
Y PE+ + V+S G++L + + G P
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP---------------------FEHD 213
Query: 403 EDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYPIPRE 457
E+++ + R S+ + L+ C+ RP ++ ++ +P+E
Sbjct: 214 EEIIRGQVFFRQRVSSECQHLIR--WCLALRPSDRPTFEEIQNHPWMQDVLLPQE 266
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 2e-44
Identities = 59/289 (20%), Positives = 112/289 (38%), Gaps = 29/289 (10%)
Query: 175 RFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLV 233
++ +IG+G +GVVY+ +L +G VA+KK+L + + E++ + + H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD----KRFKNRELQIMRKLDHCNIV 76
Query: 234 RLLGYCIEGTQR------ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKAL 287
RL + ++ LV +YV + L + ++L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYS-RAKQTLPVIYVKLYMYQLFRSL 135
Query: 288 AYLHEAIEPKVVHRDIKSSNILID-ENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVA 346
AY+H + HRDIK N+L+D + K+ DFG AK L G+ +++ + +
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY-ICSRYYRAP 191
Query: 347 PEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWL-------KMMVQL 399
+ DV+S G VL E + G+ ++ + + ++
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 400 RRSEDVVDPNIETRPSTSALKRALLTAL-----RCVDPDSDKRPKMSQV 443
+ P I+ P T + R ++ R +
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 154 bits (390), Expect = 1e-43
Identities = 65/283 (22%), Positives = 112/283 (39%), Gaps = 39/283 (13%)
Query: 164 FTLRDLQSATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKD---FRV 219
++L+D F +G G +G V+ + NG A+K L K
Sbjct: 1 YSLQD-------FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTND 53
Query: 220 EVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKI 279
E + V H ++R+ G + Q ++ +Y+ G L +
Sbjct: 54 ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSL----LRKSQRFPNPVAKFY 109
Query: 280 LLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVM 339
AL YLH +++RD+K NIL+D+N KI+DFG AK + +T +
Sbjct: 110 AAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLC 162
Query: 340 GTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQL 399
GT Y+APE ++ N+ D +SFG+++ E + G P M
Sbjct: 163 GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT------------MKTY 210
Query: 400 RRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQ 442
+ +++ + P + + LL+ R + D +R Q
Sbjct: 211 EK---ILNAELRFPPFFNEDVKDLLS--RLITRDLSQRLGNLQ 248
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 1e-43
Identities = 59/290 (20%), Positives = 111/290 (38%), Gaps = 27/290 (9%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLL--NNPGQADKDFRVEVEAIGHVRHK 230
++ K IG+G YG V++ + VA+K++ ++ E+ + ++HK
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 231 NLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYL 290
N+VRL + LV+E+ + + + G L E L K L +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYF----DSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYA 350
H V+HRD+K N+LI+ N + K+++FGLA+ G + V+ +
Sbjct: 118 HS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 351 NSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEV-----------NLVEWLKMMVQL 399
+ L + D++S G + E P+ G + +W M
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 400 RRSEDVVDPN----IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVR 445
+ P + P +A R LL + + +R + ++
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQ--NLLKCNPVQRISAEEALQ 282
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 151 bits (383), Expect = 6e-43
Identities = 46/289 (15%), Positives = 86/289 (29%), Gaps = 31/289 (10%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRH-KN 231
+ IG+G +GV++ G L+N VA+K R E +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTG 62
Query: 232 LVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH 291
+ + + EG +LV + + + + + + +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL----CGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 292 EAIEPKVVHRDIKSSNILIDENFD-----AKISDFGLAKLLGAGKSHI------TTRVMG 340
E +V+RDIK N LI + DFG+ K + + G
Sbjct: 119 EK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 341 TFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLR 400
T Y++ + + D+ + G V + + G P + + E + Q
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ-- 233
Query: 401 RSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449
P E + R + D P + +
Sbjct: 234 -----STPLRELCAGFPEEFYKYMHYARNLAF--DATPDYDYLQGLFSK 275
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-42
Identities = 61/333 (18%), Positives = 117/333 (35%), Gaps = 36/333 (10%)
Query: 181 IIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHV-RHKNLVRLLGY 238
++G G G V + A+K L Q R EVE + ++VR++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDV 73
Query: 239 C----IEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI 294
++V E ++ G L ++ T +I+ +A+ YLH
Sbjct: 74 YENLYAGRKCLLIVMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSI- 130
Query: 295 EPKVVHRDIKSSNILIDENFD---AKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYAN 351
+ HRD+K N+L K++DFG AK + S T T YVAPE
Sbjct: 131 --NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVLG 186
Query: 352 SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411
++ D++S GV++ + G P M R PN E
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL------AISPGMKTRIRMGQYEFPNPE 240
Query: 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQV------VRMLESEEYPIPREDRRRRRNQ 465
+ +K + + + +R +++ ++ + + P+ + +
Sbjct: 241 WSEVSEEVKMLI---RNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKE 297
Query: 466 AGASEAESQRESSDTDKNENPESRLKTRRNQQS 498
E + T + + + ++K + +
Sbjct: 298 RWEDVKEEMTSALATMRVDYEQIKIKKIEDASN 330
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 5e-41
Identities = 60/317 (18%), Positives = 116/317 (36%), Gaps = 43/317 (13%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLL--NNPGQADKDFRVEVEAIGHVRHK 230
+++ K IG G +G V++ + G VA+KK+L N E++ + ++H+
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 231 NLVRLLGYCIEGTQRI--------LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLG 282
N+V L+ C LV+++ + T +++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL----SNVLVKFTLSEIKRVM-- 123
Query: 283 TAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS---HITTRVM 339
L L+ K++HRD+K++N+LI + K++DFGLA+ K+ + T +
Sbjct: 124 -QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 340 GTFGYVAPE-YANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLV-------- 390
T Y PE D++ G ++ E T + Q ++ L+
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242
Query: 391 -EWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTAL------RCVDPDSDKRPKMSQV 443
E + E + + R LK + + + D +R
Sbjct: 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
Query: 444 VRMLESE---EYPIPRE 457
L + P+P +
Sbjct: 303 ---LNHDFFWSDPMPSD 316
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-40
Identities = 57/287 (19%), Positives = 107/287 (37%), Gaps = 23/287 (8%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLN--NPGQADKDFRVEVEAIGHVRHK 230
+ +G G YG V G VA+KKL K E+ + H+RH+
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 231 NLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYL 290
N++ LL ++ G + L + ++ K L Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 291 HEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYA 350
H ++HRD+K N+ ++E+ + KI DFGLA+ S +T V+ +
Sbjct: 138 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD---SEMTGYVVTRWYRAPEVIL 191
Query: 351 NSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLV----------EWLKMMVQLR 400
N + D++S G ++ E ITG+ ++ + ++
Sbjct: 192 NWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 251
Query: 401 RSEDVVDPNIETRPSTSALKRALLTAL----RCVDPDSDKRPKMSQV 443
++ P +E + S L A A+ + + D+++R +
Sbjct: 252 KNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-38
Identities = 68/273 (24%), Positives = 101/273 (36%), Gaps = 29/273 (10%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKD---FRVEVEAIGHVRH 229
N F ++G G +G V + G A+K L A + E + + RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
L L + V EY N G L L + T E AL Y
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV----FTEERARFYGAEIVSALEY 120
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEY 349
LH VV+RDIK N+++D++ KI+DFGL K + + GT Y+APE
Sbjct: 121 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEV 176
Query: 350 ANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409
D + GVV+ E + GR P Y + + +L E++ P
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPF-YNQDHER---------LFELILMEEIRFP- 225
Query: 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQ 442
+ S ++LL + D +R
Sbjct: 226 ----RTLSPEAKSLLA--GLLKKDPKQRLGGGP 252
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 136 bits (342), Expect = 1e-36
Identities = 56/238 (23%), Positives = 91/238 (38%), Gaps = 15/238 (6%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKD---FRVEVEAIGHVRH 229
++F + +G G +G V + +G A+K L K E + V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
LV+L + + +V EYV G + L G + Y
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL----RRIGRFSEPHARFYAAQIVLTFEY 156
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEY 349
LH +++RD+K N+LID+ +++DFG AK T + GT +APE
Sbjct: 157 LHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKR----VKGRTWTLCGTPEALAPEI 209
Query: 350 ANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407
S N+ D ++ GV++ E G P +P + K+ S D+ D
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKD 267
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 2e-35
Identities = 68/280 (24%), Positives = 112/280 (40%), Gaps = 31/280 (11%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQLM----NGTAVAVKKL----LNNPGQADKDFRVEVEAIG 225
F ++G G YG V+ + + G A+K L + + + R E + +
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 226 HVRHK-NLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTA 284
H+R LV L T+ L+ +Y+N G L L R T +
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS----QRERFTEHEVQIYVGEIV 139
Query: 285 KALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGY 344
AL +LH+ +++RDIK NIL+D N ++DFGL+K A ++ GT Y
Sbjct: 140 LALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY 196
Query: 345 VAPEYANSGL--LNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRS 402
+AP+ G ++ D +S GV++ E +TG P ++ + S
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-----------S 245
Query: 403 EDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQ 442
++ SAL + L+ R + D KR
Sbjct: 246 RRILKSEPPYPQEMSALAKDLIQ--RLLMKDPKKRLGCGP 283
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 129 bits (326), Expect = 2e-34
Identities = 57/299 (19%), Positives = 110/299 (36%), Gaps = 46/299 (15%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-HKN 231
+ + +G G Y V+ + N V VK L K + E++ + ++R N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPN 91
Query: 232 LVRLLGYCIEGTQR--ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
++ L + R LV+E+VNN + +Q + LT + KAL Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDY 144
Query: 290 LHEAIEPKVVHRDIKSSNILID-ENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPE 348
H ++HRD+K N++ID E+ ++ D+GLA+ G+ + + + + PE
Sbjct: 145 CHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPE 199
Query: 349 -YANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEV-------------------- 387
+ + + D++S G +L I + P +G +
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY 259
Query: 388 ---NLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQV 443
+ ++ + R + E + S L + + D R +
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLD--KLLRYDHQSRLTAREA 316
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 9e-34
Identities = 62/288 (21%), Positives = 110/288 (38%), Gaps = 23/288 (7%)
Query: 173 TNRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQAD--KDFRVEVEAIGHVRH 229
R+ + +G G YG V G VAVKKL K E+ + H++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
+N++ LL + +L ++ LT + ++ + L Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEY 349
+H ++HRD+K SN+ ++E+ + KI DFGLA+ +T V +
Sbjct: 137 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAPEIM 190
Query: 350 ANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLV----------EWLKMMVQL 399
N N+ D++S G ++ E +TGR ++ L+ K+ +
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 400 RRSEDVVDPNIETRPSTSALKRALLTAL----RCVDPDSDKRPKMSQV 443
R+ + + A A+ + + DSDKR +Q
Sbjct: 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 4e-31
Identities = 69/307 (22%), Positives = 110/307 (35%), Gaps = 48/307 (15%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKL---LNNPGQADKDFRVEVEAIGHVRH 229
R+ IG G G+V + VA+KKL N A K E+ + V H
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA-KRAYRELVLMKCVNH 75
Query: 230 KNLVRLLGYCI------EGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGT 283
KN++ LL E LV E ++ + + L E +L
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-------QMELDHERMSYLLYQM 128
Query: 284 AKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHITTRVMGTFG 343
+ +LH ++HRD+K SNI++ + KI DFGLA+ AG S + T + T
Sbjct: 129 LCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRY 183
Query: 344 YVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLV---------EWLK 394
Y APE E D++S G ++ E + + + N V E++K
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243
Query: 395 MMVQLRRSEDVVDPNIETRPSTSALKRALLTAL----------------RCVDPDSDKRP 438
+ R+ P +L A + + D KR
Sbjct: 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI 303
Query: 439 KMSQVVR 445
+ ++
Sbjct: 304 SVDDALQ 310
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (293), Expect = 1e-29
Identities = 39/241 (16%), Positives = 85/241 (35%), Gaps = 18/241 (7%)
Query: 174 NRFSKDNIIGDGGYGVVYRGQ-LMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL 232
R+ +G G + V+ + ++N T VA+K + + + E++ + V +
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADN 71
Query: 233 VRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMC------------DRGYLTWEARMKIL 280
+ ++L + N + + + +I
Sbjct: 72 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131
Query: 281 LGTAKALAYLHEAIEPKVVHRDIKSSNILID-ENFDAKISDFGLAKLLGAGKSHIT-TRV 338
L Y+H ++H DIK N+L++ + + +A L A T
Sbjct: 132 KQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 189
Query: 339 MGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQ 398
+ T Y +PE +D++S ++ E ITG + + S + + +++
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249
Query: 399 L 399
L
Sbjct: 250 L 250
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 89.5 bits (221), Expect = 2e-21
Identities = 29/159 (18%), Positives = 51/159 (32%), Gaps = 21/159 (13%)
Query: 180 NIIGDGGYGVVYRGQLMNGTAVAVK----------KLLNNPGQADKDFRVEVEAIGHVRH 229
++G+G V+ VK K+ D F V
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 230 KNLVRLLGYCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAY 289
+ L +L G + VY + N L + + R + +L + +A
Sbjct: 66 RALQKLQGLAV-----PKVYAWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEVAK 118
Query: 290 LHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328
+ +VH D+ N+L+ E I DF + +G
Sbjct: 119 FY---HRGIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVG 153
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 498 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.75 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.2 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.73 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.2 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.95 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.76 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=418.18 Aligned_cols=255 Identities=28% Similarity=0.451 Sum_probs=196.9
Q ss_pred cCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecC
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ 253 (498)
++|++.+.||+|+||+||+|++.+++.||||++... ....++|.+|++++++++|||||++++++.+++..|+||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 468889999999999999999988999999998653 3445779999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCce
Q 010891 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333 (498)
Q Consensus 254 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~ 333 (498)
+|+|.+++.. ....+++..++.++.|||.||.|||++ +|+||||||+||||++++.+||+|||+++........
T Consensus 84 ~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 84 HGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp TCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence 9999999874 335689999999999999999999999 9999999999999999999999999999887655444
Q ss_pred eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCC
Q 010891 334 ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETR 413 (498)
Q Consensus 334 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 413 (498)
......||+.|+|||++.+..|+.++|||||||+||||+|+..|+...... .+.+..+... .....+.
T Consensus 158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-----~~~~~~i~~~---~~~~~p~---- 225 (263)
T d1sm2a_ 158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----SEVVEDISTG---FRLYKPR---- 225 (263)
T ss_dssp -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-----HHHHHHHHHT---CCCCCCT----
T ss_pred eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH-----HHHHHHHHhc---CCCCCcc----
Confidence 444567999999999999999999999999999999999965444332221 1222222221 1111111
Q ss_pred CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 414 PSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 414 ~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
... ..+..++.+||+.||++|||+.|++++|+..
T Consensus 226 ~~~---~~l~~li~~cl~~~p~~Rps~~~il~~L~~i 259 (263)
T d1sm2a_ 226 LAS---THVYQIMNHCWKERPEDRPAFSRLLRQLAEI 259 (263)
T ss_dssp TSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ccC---HHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 111 2344555689999999999999999999854
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-54 Score=423.89 Aligned_cols=251 Identities=25% Similarity=0.387 Sum_probs=206.6
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
.++|++.+.||+|+||+||+|+. .+|+.||||++........+.+.+|++++++++|||||++++++.+++..|+||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 35799999999999999999974 56999999999766555667799999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
++||+|.+++.. +.+++.++..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+.+....
T Consensus 99 ~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~ 170 (293)
T d1yhwa1 99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (293)
T ss_dssp CTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred cCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence 999999998853 3599999999999999999999999 99999999999999999999999999999875443
Q ss_pred ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCC
Q 010891 332 SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (498)
. .....+||+.|+|||++.+..|+.++|||||||++|||+||+.||...... +.+........ +.+.
T Consensus 171 ~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~~~~~~~------~~~~ 237 (293)
T d1yhwa1 171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL------RALYLIATNGT------PELQ 237 (293)
T ss_dssp C-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHHCS------CCCS
T ss_pred c-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH------HHHHHHHhCCC------CCCC
Confidence 2 244568999999999999999999999999999999999999999754321 11122221111 1111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 412 ~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
.....+. .+..++.+||+.||.+|||+.|+++|
T Consensus 238 ~~~~~s~--~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 238 NPEKLSA--IFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp SGGGSCH--HHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CcccCCH--HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111222 23334448999999999999999875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-55 Score=422.86 Aligned_cols=261 Identities=28% Similarity=0.466 Sum_probs=200.4
Q ss_pred HHHccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCC--CCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 170 QSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNN--PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 170 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
++..++|++.+.||+|+||+||+|++. ..||||++... .....+.|.+|+++|.+++|||||++++++.+ ...++
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l 80 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI 80 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence 445678999999999999999999753 46999998543 23345679999999999999999999998754 56899
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
||||+++|+|.++|.. ....+++..+..++.||++||+|||++ +|+||||||+||||+.++.+||+|||+|+..
T Consensus 81 v~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~ 154 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVK 154 (276)
T ss_dssp EEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred EEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeec
Confidence 9999999999999974 335699999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCc-eeeecccccccccCcccccC---CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhcccc
Q 010891 328 GAGKS-HITTRVMGTFGYVAPEYANS---GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSE 403 (498)
Q Consensus 328 ~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (498)
..... .......||+.|||||++.+ ..|+.++|||||||+||||+||+.||....+.... ........
T Consensus 155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~------~~~~~~~~-- 226 (276)
T d1uwha_ 155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI------IFMVGRGY-- 226 (276)
T ss_dssp -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH------HHHHHHTS--
T ss_pred cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH------HHHHhcCC--
Confidence 54322 23445689999999999854 45899999999999999999999999765432211 11111111
Q ss_pred CCcCCCCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 404 DVVDPNIE-TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 404 ~~~~~~~~-~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
..+.+. .....+ ..+..++.+||+.||++|||+.|++++|+...
T Consensus 227 --~~p~~~~~~~~~~--~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~ 271 (276)
T d1uwha_ 227 --LSPDLSKVRSNCP--KAMKRLMAECLKKKRDERPLFPQILASIELLA 271 (276)
T ss_dssp --CCCCGGGSCTTCC--HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred --CCCcchhccccch--HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 111111 111111 23334455899999999999999999998654
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-55 Score=419.63 Aligned_cols=252 Identities=24% Similarity=0.364 Sum_probs=200.2
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
++|++.+.||+|+||+||+|+. .+|+.||||++..... ...+.+.+|+++|++++|||||++++++.+++..||||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 5789999999999999999986 4689999999865432 3345689999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+++|+|.++|. ..+.+++..+..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+|+......
T Consensus 85 ~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 85 CSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 99999999986 346799999999999999999999999 99999999999999999999999999999865433
Q ss_pred c-eeeecccccccccCcccccCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 332 S-HITTRVMGTFGYVAPEYANSGLL-NEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 332 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
. ...+..+||+.|||||++.+..+ +.++|||||||+||||+||+.||......... . ..... .....
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~----~~~~~---~~~~~--- 226 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-Y----SDWKE---KKTYL--- 226 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-H----HHHHT---TCTTS---
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-H----HHHhc---CCCCC---
Confidence 2 23455789999999999987765 67899999999999999999999754432211 1 11111 11000
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
......+ .....++.+||+.||++|||+.|+++|
T Consensus 227 -~~~~~~s--~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 227 -NPWKKID--SAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp -TTGGGSC--HHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -CccccCC--HHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence 0011111 223334458999999999999999765
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=417.31 Aligned_cols=246 Identities=28% Similarity=0.445 Sum_probs=202.5
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCC---CCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNN---PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
++|++.+.||+|+||+||+|+. .+++.||+|++.+. .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 4689999999999999999986 46889999998532 2234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+++|+|.+++.. .+.+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+|.....
T Consensus 86 Ey~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred eecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence 99999999999974 35699999999999999999999999 999999999999999999999999999987654
Q ss_pred CCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
.. ....+||+.|||||++.+..|+.++|||||||+||||++|+.||...... +.+..+.. ..
T Consensus 159 ~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~---~~------ 220 (263)
T d2j4za1 159 SR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ------ETYKRISR---VE------ 220 (263)
T ss_dssp CC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHT---TC------
T ss_pred Cc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH------HHHHHHHc---CC------
Confidence 32 34467999999999999999999999999999999999999999754321 11222211 11
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
...+...+. .+..++.+||+.||++|||+.|+++|
T Consensus 221 ~~~p~~~s~--~~~~li~~~L~~dp~~R~t~~eil~h 255 (263)
T d2j4za1 221 FTFPDFVTE--GARDLISRLLKHNPSQRPMLREVLEH 255 (263)
T ss_dssp CCCCTTSCH--HHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CCCCccCCH--HHHHHHHHHccCCHhHCcCHHHHHcC
Confidence 111111222 22334458999999999999999974
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-54 Score=419.02 Aligned_cols=259 Identities=26% Similarity=0.417 Sum_probs=208.8
Q ss_pred HHHHccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 169 LQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 169 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
+++..++|++.+.||+|+||+||+|++.+++.||||++... ....+.|.+|++++++++|||||++++++.+ +..|+|
T Consensus 8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv 85 (272)
T d1qpca_ 8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (272)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred eecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence 34556789999999999999999999888899999998654 3445679999999999999999999998754 567999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+++|+|.+++... ....+++..++.|+.||++||.|||++ +|+||||||+||||++++.+||+|||+|+...
T Consensus 86 ~Ey~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp EECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEeCCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEcc
Confidence 9999999999988643 224599999999999999999999999 99999999999999999999999999999887
Q ss_pred CCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (498)
...........||+.|+|||++.++.|+.++|||||||+||||+||..|+....... +.+..+.. ......+
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~-----~~~~~i~~---~~~~~~p 232 (272)
T d1qpca_ 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP-----EVIQNLER---GYRMVRP 232 (272)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHHHHT---TCCCCCC
T ss_pred CCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH-----HHHHHHHh---cCCCCCc
Confidence 655555556779999999999999999999999999999999999766654332211 11222211 1111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 409 NIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
. .... .+..++.+||+.||++|||+.++++.|+.
T Consensus 233 ---~-~~~~---~l~~li~~cl~~~P~~Rpt~~ei~~~L~~ 266 (272)
T d1qpca_ 233 ---D-NCPE---ELYQLMRLCWKERPEDRPTFDYLRSVLED 266 (272)
T ss_dssp ---T-TCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---c-cChH---HHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence 1 1122 33445558999999999999999998874
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.5e-55 Score=424.11 Aligned_cols=261 Identities=25% Similarity=0.379 Sum_probs=212.5
Q ss_pred HHHccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 170 QSATNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 170 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
++..++|++.+.||+|+||+||+|++. +|+.||||++... ....++|.+|+++|++++|||||+++++|.+++..|+|
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEE
Confidence 445678999999999999999999864 5889999998644 34467799999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+++|+|.+++... ....+++..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+|+...
T Consensus 92 ~E~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 92 TEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp EECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred eecccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecC
Confidence 9999999999999753 346799999999999999999999999 99999999999999999999999999999776
Q ss_pred CCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (498)
...........||+.|+|||++.+..|+.++|||||||++|||++|..||....... .....+.... .+
T Consensus 167 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~-----~~~~~i~~~~------~~ 235 (287)
T d1opja_ 167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-----QVYELLEKDY------RM 235 (287)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-----HHHHHHHTTC------CC
T ss_pred CCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH-----HHHHHHhcCC------CC
Confidence 555444555678999999999999999999999999999999999887765443321 1111111111 11
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 409 NIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
... ...+ ..+..++.+||+.||++|||+.|+++.|+...
T Consensus 236 ~~~--~~~~--~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 236 ERP--EGCP--EKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp CCC--TTCC--HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCC--ccch--HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 111 1111 23444555899999999999999999998654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=417.97 Aligned_cols=256 Identities=25% Similarity=0.358 Sum_probs=192.2
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC--chhHHHHHHHHHHcCCCCCceEEEeEEEe--CCeeEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIE--GTQRILV 248 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~--~~~~~lv 248 (498)
++|++.+.||+|+||+||+|+. .+|+.||||++...... ..+.+.+|++++++++|||||++++++.+ +..+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5799999999999999999985 56899999998654332 23568899999999999999999999865 4567999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHcc--CCCeeecCCCCCCEEEcCCCCeEEeeecccee
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI--EPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~--~~~iiHrDikp~NIll~~~~~~kL~DfGla~~ 326 (498)
|||+++|+|.+++......++.+++..++.++.||+.||.|||+.. ..+|+||||||+||||+.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 9999999999999765445678999999999999999999999871 11399999999999999999999999999987
Q ss_pred cCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCc
Q 010891 327 LGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVV 406 (498)
Q Consensus 327 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (498)
+.... ......+||+.|||||++.+..|+.++|||||||++|||+||+.||...... +........ ..
T Consensus 164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~------~~~~~i~~~-~~---- 231 (269)
T d2java1 164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK------ELAGKIREG-KF---- 231 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHT-CC----
T ss_pred cccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH------HHHHHHHcC-CC----
Confidence 65433 2244578999999999999999999999999999999999999999753321 111222111 11
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 407 DPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 407 ~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
+.+... ...+ +..++.+||+.||.+|||+.|+++|
T Consensus 232 -~~~~~~-~s~~---l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 232 -RRIPYR-YSDE---LNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp -CCCCTT-SCHH---HHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -CCCCcc-cCHH---HHHHHHHHcCCChhHCcCHHHHHhC
Confidence 111111 1122 3334458999999999999999875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-53 Score=408.59 Aligned_cols=253 Identities=23% Similarity=0.403 Sum_probs=210.3
Q ss_pred cCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecC
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVN 253 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~ 253 (498)
++|++.++||+|+||+||+|++.+++.||||++.... ...++|.+|+.++++++|||||++++++.++...++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 5789999999999999999999888899999987543 345689999999999999999999999999999999999999
Q ss_pred CCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCce
Q 010891 254 NGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSH 333 (498)
Q Consensus 254 ~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~ 333 (498)
+|+|.+++... ...+++..++.++.|+++||.|||+. +|+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 83 NGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence 99999998643 35689999999999999999999999 9999999999999999999999999999877655444
Q ss_pred eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCC
Q 010891 334 ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIET 412 (498)
Q Consensus 334 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (498)
......||+.|+|||++.+..|+.++|||||||++|||+| |+.||...... +....... ......+.
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~------~~~~~i~~---~~~~~~p~--- 224 (258)
T d1k2pa_ 157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS------ETAEHIAQ---GLRLYRPH--- 224 (258)
T ss_dssp CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH------HHHHHHHT---TCCCCCCT---
T ss_pred eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH------HHHHHHHh---CCCCCCcc---
Confidence 4455679999999999999999999999999999999998 89999754321 11222221 11111111
Q ss_pred CCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 413 RPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 413 ~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
... ..+..++.+||+.||++|||+.+++++|..
T Consensus 225 -~~~---~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 225 -LAS---EKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp -TCC---HHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred -ccc---HHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 111 233445558999999999999999999964
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-54 Score=418.39 Aligned_cols=252 Identities=25% Similarity=0.347 Sum_probs=204.5
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeec
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 252 (498)
+.|++.+.||+|+||+||+|++ .+|+.||||++........+.+.+|+++|++++|||||++++++.+++..|+||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 4689999999999999999985 468999999997766666778999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~ 332 (498)
++|+|.+++... .+.+++.++..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 92 ~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~- 164 (288)
T d2jfla1 92 AGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI- 164 (288)
T ss_dssp TTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-
T ss_pred CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCc-
Confidence 999999998642 35699999999999999999999999 99999999999999999999999999998653321
Q ss_pred eeeecccccccccCcccc-----cCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcC
Q 010891 333 HITTRVMGTFGYVAPEYA-----NSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVD 407 (498)
Q Consensus 333 ~~~~~~~gt~~y~aPE~~-----~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 407 (498)
......+||+.|+|||++ .+..|+.++|||||||+||||+||+.||....+... +....... .
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~------~~~i~~~~-~----- 232 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV------LLKIAKSE-P----- 232 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------HHHHHHSC-C-----
T ss_pred ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH------HHHHHcCC-C-----
Confidence 123346799999999988 356789999999999999999999999976543221 11111111 0
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 408 PNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 408 ~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
+.+......+ ..+..++.+||+.||++|||+.|+++|
T Consensus 233 ~~~~~~~~~s--~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 233 PTLAQPSRWS--SNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp CCCSSGGGSC--HHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred CCCCccccCC--HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 1111111111 223334458999999999999999875
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-54 Score=429.11 Aligned_cols=201 Identities=27% Similarity=0.434 Sum_probs=178.2
Q ss_pred HccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
..++|++.+.||+|+||+||+|+. .+|+.||+|++..... ...+.+.+|+.+|++++|||||+++++|.+..+.|+||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 457899999999999999999985 4689999999865433 33457889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHH-ccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE-AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
||++||+|.+++... +.+++..+..++.|++.||.|||+ + +|+||||||+||||+.++.+||+|||+|+...
T Consensus 84 Ey~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp ECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EcCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 999999999999743 569999999999999999999996 5 89999999999999999999999999998754
Q ss_pred CCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~ 382 (498)
.. ..+..+||+.|+|||++.+..|+.++|||||||++|||++|+.||....
T Consensus 157 ~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 157 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp HH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred CC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 32 2345689999999999999999999999999999999999999997654
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.2e-53 Score=416.56 Aligned_cols=255 Identities=29% Similarity=0.463 Sum_probs=193.3
Q ss_pred cCCCccceEcccCcEEEEEEEEcC-C---cEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLMN-G---TAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
++|++.++||+|+||+||+|++.. + ..||||++..... ...+.|.+|+++|++++|||||++++++.+++..|+|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence 467788999999999999998632 3 3688998865433 2345799999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+++|+|.+++.. ..+.+++.++..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++...
T Consensus 106 ~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEcc
Confidence 999999999999874 345799999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCcee----eecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhcccc
Q 010891 329 AGKSHI----TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSE 403 (498)
Q Consensus 329 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (498)
...... .....||+.|||||++.++.|+.++|||||||+||||+| |+.||...... +.+..+....+.
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~------~~~~~i~~~~~~- 252 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ------DVINAIEQDYRL- 252 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTTCCC-
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCCC-
Confidence 432211 222468999999999999999999999999999999998 89999754321 122222211111
Q ss_pred CCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 404 DVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
...... ...+..++.+||+.||++|||+.|+++.|+..
T Consensus 253 -------~~~~~~--~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~ 290 (299)
T d1jpaa_ 253 -------PPPMDC--PSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290 (299)
T ss_dssp -------CCCTTC--CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -------CCCccc--hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 111111 12334455589999999999999999998754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-53 Score=419.55 Aligned_cols=254 Identities=24% Similarity=0.371 Sum_probs=189.1
Q ss_pred HHccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEE
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
.+.+.|++.+.||+|+||+||+|+. .+|+.||||++..... .....+.+|+++|++++|||||++++++.+++..|||
T Consensus 6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp CGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3567899999999999999999986 4689999999865433 2334578899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEc---CCCCeEEeeeccce
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID---ENFDAKISDFGLAK 325 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~---~~~~~kL~DfGla~ 325 (498)
|||++||+|.++|. ..+.+++..+..++.||+.||.|||++ +|+||||||+|||+. +++.+||+|||+|+
T Consensus 86 mE~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~ 158 (307)
T d1a06a_ 86 MQLVSGGELFDRIV----EKGFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158 (307)
T ss_dssp ECCCCSCBHHHHHH----TCSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC----
T ss_pred EeccCCCcHHHhhh----cccCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeE
Confidence 99999999999997 346799999999999999999999999 999999999999994 57899999999998
Q ss_pred ecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCC
Q 010891 326 LLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV 405 (498)
Q Consensus 326 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (498)
...... .....+||+.|||||++.+..|+.++|||||||+||||++|+.||...... +....... ....
T Consensus 159 ~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i~~---~~~~ 227 (307)
T d1a06a_ 159 MEDPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDA------KLFEQILK---AEYE 227 (307)
T ss_dssp ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHT---TCCC
T ss_pred EccCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHhc---cCCC
Confidence 765432 234468999999999999999999999999999999999999999753321 11111111 1111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 406 VDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 406 ~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
... ...+..+. .+..++.+||+.||++|||+.|+++|
T Consensus 228 ~~~--~~~~~~s~--~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 228 FDS--PYWDDISD--SAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp CCT--TTTTTSCH--HHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCC--ccccCCCH--HHHHHHHHHccCCHhHCcCHHHHhcC
Confidence 111 11112222 23344458999999999999999986
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-53 Score=414.11 Aligned_cols=249 Identities=22% Similarity=0.335 Sum_probs=200.0
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCC---CCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNN---PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
++|++.+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 4689999999999999999986 56899999998532 2234467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||++||+|.+++.. .+.+++..+..++.|++.||.|||++ +|+||||||+|||+++++.+||+|||+|+.+..
T Consensus 88 Ey~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred EccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence 99999999999874 35799999999999999999999999 999999999999999999999999999998754
Q ss_pred CC-ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCC
Q 010891 330 GK-SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408 (498)
Q Consensus 330 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (498)
.. .......+||+.|+|||++.+..|+.++|||||||+||||++|+.||...... +....+.. .. .
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i~~---~~----~ 227 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY------LIFQKIIK---LE----Y 227 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHT---TC----C
T ss_pred CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH------HHHHHHHc---CC----C
Confidence 32 22344568999999999999999999999999999999999999999754321 11122211 11 1
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 409 NIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
.+. ...+. .+..++.+||+.||.+|||++|++.+
T Consensus 228 ~~p--~~~s~--~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 228 DFP--EKFFP--KARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp CCC--TTCCH--HHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred CCC--ccCCH--HHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 111 11122 23344458999999999999997543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-53 Score=406.87 Aligned_cols=245 Identities=25% Similarity=0.392 Sum_probs=192.9
Q ss_pred CccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEe----CCeeEEEE
Q 010891 177 SKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIE----GTQRILVY 249 (498)
Q Consensus 177 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~----~~~~~lv~ 249 (498)
++.+.||+|+||+||+|++ .+++.||+|++..... ...+.|.+|+++|++++|||||++++++.+ ...+|+||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 5667899999999999986 4688999999865432 234568899999999999999999999875 35679999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCC--eeecCCCCCCEEEc-CCCCeEEeeecccee
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPK--VVHRDIKSSNILID-ENFDAKISDFGLAKL 326 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~--iiHrDikp~NIll~-~~~~~kL~DfGla~~ 326 (498)
||+++|+|.+++... +.+++..+..++.||+.||.|||++ + |+||||||+||||+ +++.+||+|||+|+.
T Consensus 92 E~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred eCCCCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 999999999999743 5699999999999999999999997 6 99999999999996 578999999999986
Q ss_pred cCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCc
Q 010891 327 LGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVV 406 (498)
Q Consensus 327 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (498)
.... .....+||+.|||||++.+ .|+.++|||||||+||||++|+.||....... .....+.....
T Consensus 165 ~~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-----~~~~~i~~~~~----- 230 (270)
T d1t4ha_ 165 KRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QIYRRVTSGVK----- 230 (270)
T ss_dssp CCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----HHHHHHTTTCC-----
T ss_pred ccCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH-----HHHHHHHcCCC-----
Confidence 4432 2345689999999999875 59999999999999999999999997443221 11111111100
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 407 DPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 407 ~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
.+.+. ...... +..++.+||++||++|||+.|+++|
T Consensus 231 ~~~~~-~~~~~~---~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 231 PASFD-KVAIPE---VKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp CGGGG-GCCCHH---HHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CcccC-ccCCHH---HHHHHHHHccCCHhHCcCHHHHhCC
Confidence 01111 111222 3334458999999999999999875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-52 Score=406.59 Aligned_cols=255 Identities=27% Similarity=0.422 Sum_probs=202.7
Q ss_pred ccCCCccce-EcccCcEEEEEEEEc---CCcEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 173 TNRFSKDNI-IGDGGYGVVYRGQLM---NGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 173 ~~~y~~~~~-lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
.++|.+.+. ||+|+||+||+|.+. ++..||||++...... ..+.|.+|+++|++++|||||++++++.+ +..||
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 345677774 999999999999643 4567999999654433 34679999999999999999999999865 56899
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
||||+++|+|.+++.. .+..+++..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.+
T Consensus 86 vmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcc
Confidence 9999999999999864 345799999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCcee--eecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccC
Q 010891 328 GAGKSHI--TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSED 404 (498)
Q Consensus 328 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (498)
....... .....||+.|+|||++.++.++.++|||||||++|||+| |+.||...... +....+....+
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~------~~~~~i~~~~~--- 230 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP------EVMAFIEQGKR--- 230 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH------HHHHHHHTTCC---
T ss_pred cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHH------HHHHHHHcCCC---
Confidence 6543322 234568999999999999999999999999999999998 99999754432 11122221111
Q ss_pred CcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 405 VVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
+..+ +..+ ..+..++.+||+.||++|||+.++++.|+..
T Consensus 231 ---~~~p--~~~~--~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~ 269 (285)
T d1u59a_ 231 ---MECP--PECP--PELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269 (285)
T ss_dssp ---CCCC--TTCC--HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---CCCC--CcCC--HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1111 1111 2333455589999999999999999988753
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.9e-52 Score=418.04 Aligned_cols=253 Identities=22% Similarity=0.339 Sum_probs=206.1
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
.++|++.+.||+|+||+||+|+. .+|+.||||++........+.+.+|+.+|++++|||||++++++.+++..||||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 35899999999999999999985 56899999999766555556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcC--CCCeEEeeeccceecCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE--NFDAKISDFGLAKLLGA 329 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~--~~~~kL~DfGla~~~~~ 329 (498)
++||+|.+++.. ..+.+++..+..++.||+.||.|||++ +|+||||||+|||++. ++.+||+|||+++.+..
T Consensus 105 ~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheeccc
Confidence 999999999963 345699999999999999999999999 9999999999999964 67899999999998765
Q ss_pred CCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
... .....||+.|||||++.+..|+.++|||||||++|||++|+.||...... +.+..+.... ......
T Consensus 179 ~~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i~~~~---~~~~~~ 247 (350)
T d1koaa2 179 KQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD------ETLRNVKSCD---WNMDDS 247 (350)
T ss_dssp TSC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTC---CCSCCG
T ss_pred ccc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC---CCCCcc
Confidence 432 34467999999999999999999999999999999999999999744321 2222222211 111111
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
. ....+ ..+..++.+||..||++|||+.|+++|
T Consensus 248 ~--~~~~s--~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 248 A--FSGIS--EDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp G--GGGCC--HHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred c--ccCCC--HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 01111 123334458999999999999999987
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-53 Score=416.98 Aligned_cols=260 Identities=25% Similarity=0.397 Sum_probs=203.6
Q ss_pred HHccCCCccceEcccCcEEEEEEEEcC-C-----cEEEEEEecCCC-CCchhHHHHHHHHHHcC-CCCCceEEEeEEEeC
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQLMN-G-----TAVAVKKLLNNP-GQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEG 242 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~ 242 (498)
...++|++.++||+|+||+||+|++.. + ..||+|++.... ......+.+|+.+|.++ +|||||++++++.+.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 113 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 113 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence 345689999999999999999998543 2 369999886543 33446788999999998 899999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcccC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCC
Q 010891 243 TQRILVYEYVNNGNLEQWLRGDMC-------------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDI 303 (498)
Q Consensus 243 ~~~~lv~e~~~~g~L~~~l~~~~~-------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDi 303 (498)
+..|+||||+++|+|.++|+.... ....+++..++.++.||++||.|||++ +|+||||
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDl 190 (325)
T d1rjba_ 114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL 190 (325)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccC
Confidence 999999999999999999975421 124589999999999999999999999 9999999
Q ss_pred CCCCEEEcCCCCeEEeeeccceecCCCCce-eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCC
Q 010891 304 KSSNILIDENFDAKISDFGLAKLLGAGKSH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYG 381 (498)
Q Consensus 304 kp~NIll~~~~~~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~ 381 (498)
||+|||++.++.+||+|||+|+........ ......||+.|||||++.++.|+.++|||||||+||||+| |+.||...
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876544332 3345678999999999999999999999999999999998 89999754
Q ss_pred CCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHh
Q 010891 382 RPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLE 448 (498)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~ 448 (498)
..... + ..+.... . .+.. +...+ ..+..++.+||+.||++|||++||+++|.
T Consensus 271 ~~~~~--~----~~~~~~~--~---~~~~--p~~~~--~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 271 PVDAN--F----YKLIQNG--F---KMDQ--PFYAT--EEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCSHH--H----HHHHHTT--C---CCCC--CTTCC--HHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CHHHH--H----HHHHhcC--C---CCCC--CCcCC--HHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 43321 1 1111111 1 1111 11111 23344455899999999999999999995
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.5e-52 Score=417.51 Aligned_cols=252 Identities=20% Similarity=0.274 Sum_probs=205.7
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeec
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYV 252 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~ 252 (498)
++|++.+.||+|+||+||+|+. .+|+.||||++........+.+.+|+.+|++++|||||++++++.++...|||||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 5799999999999999999985 579999999987655445567889999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEc--CCCCeEEeeeccceecCCC
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID--ENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~--~~~~~kL~DfGla~~~~~~ 330 (498)
+||+|.+++.. ....+++.+++.|+.||+.||.|||++ +|+||||||+||||+ .++.+||+|||+|..+...
T Consensus 109 ~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 109 SGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC
Confidence 99999998863 335699999999999999999999999 999999999999997 6789999999999987654
Q ss_pred CceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCC
Q 010891 331 KSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNI 410 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (498)
.. .....||+.|+|||++.+..|+.++|||||||+||||+||+.||...... +.+..+.... .....
T Consensus 183 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~---~~~~~-- 249 (352)
T d1koba_ 183 EI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL------ETLQNVKRCD---WEFDE-- 249 (352)
T ss_dssp SC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH------HHHHHHHHCC---CCCCS--
T ss_pred Cc--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhCC---CCCCc--
Confidence 32 34467999999999999999999999999999999999999999754321 1122222111 11111
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 411 ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 411 ~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
......+. .+..++.+||..||.+|||+.|+++|
T Consensus 250 ~~~~~~s~--~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 250 DAFSSVSP--EAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp STTTTSCH--HHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred ccccCCCH--HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 11112222 23344458999999999999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.4e-53 Score=413.77 Aligned_cols=246 Identities=26% Similarity=0.357 Sum_probs=198.6
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCc---hhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQA---DKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
..|+..+.||+|+||+||+|+. .+|+.||||++....... .+.+.+|+++|++++|||||++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4589999999999999999985 568899999986554332 246888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
|||.+|+|..++. .++.+++..+..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+|.....
T Consensus 95 E~~~~g~l~~~~~----~~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCCCchHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 9999999987765 346799999999999999999999999 999999999999999999999999999986543
Q ss_pred CCceeeecccccccccCcccccC---CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCc
Q 010891 330 GKSHITTRVMGTFGYVAPEYANS---GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVV 406 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 406 (498)
....+||+.|||||++.+ +.|+.++|||||||++|||++|+.||...... +.+........
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~------~~~~~i~~~~~----- 231 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM------SALYHIAQNES----- 231 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH------HHHHHHHHSCC-----
T ss_pred -----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH------HHHHHHHhCCC-----
Confidence 234679999999999853 56899999999999999999999999753321 11122121111
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 407 DPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 407 ~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
+.+........ +..++.+||+.||.+|||+.|+++|
T Consensus 232 -~~~~~~~~s~~---~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 232 -PALQSGHWSEY---FRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp -CCCSCTTSCHH---HHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred -CCCCCCCCCHH---HHHHHHHHCcCChhHCcCHHHHHhC
Confidence 11111111222 3334448999999999999999975
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=407.67 Aligned_cols=258 Identities=28% Similarity=0.410 Sum_probs=201.7
Q ss_pred HccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
..++|++.+.||+|+||+||+|++.+++.||||++... ....+.|.+|+.++++++|||||++++++.+ +..++||||
T Consensus 15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey 92 (285)
T d1fmka3 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 92 (285)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred CHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence 34679999999999999999999988889999998543 3455779999999999999999999999854 568999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+++|+|.+++... ....+++.+++.++.||+.||+|||+. +|+||||||+||||+.++.+||+|||+++......
T Consensus 93 ~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 93 MSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp CTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred cCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 9999999998654 234699999999999999999999999 99999999999999999999999999998775554
Q ss_pred ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCC
Q 010891 332 SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (498)
........||+.|+|||++.++.++.++|||||||+||||+||..||....... +.+..+..... ...
T Consensus 168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~-----~~~~~i~~~~~------~~~- 235 (285)
T d1fmka3 168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----EVLDQVERGYR------MPC- 235 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----HHHHHHHTTCC------CCC-
T ss_pred ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH-----HHHHHHHhcCC------CCC-
Confidence 444455679999999999999999999999999999999999777765443221 22222221111 111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 412 ~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
....+ ..+..++.+||+.||++|||+.+|+++|+...
T Consensus 236 -~~~~~--~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 236 -PPECP--ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp -CTTSC--HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred -CcccC--HHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence 11111 23444556899999999999999999998754
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-52 Score=402.17 Aligned_cols=246 Identities=28% Similarity=0.396 Sum_probs=193.5
Q ss_pred ceEcccCcEEEEEEEEcC---CcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEeecCC
Q 010891 180 NIIGDGGYGVVYRGQLMN---GTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEYVNN 254 (498)
Q Consensus 180 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~ 254 (498)
++||+|+||+||+|.+.+ ++.||||++..... ...+.|.+|+++|++++|||||+++++|.+ +..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 579999999999997543 46899999864332 234579999999999999999999999865 567899999999
Q ss_pred CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCcee
Q 010891 255 GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKSHI 334 (498)
Q Consensus 255 g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~~~ 334 (498)
|+|.+++.. ...+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.+.......
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence 999999973 45699999999999999999999999 99999999999999999999999999999876543332
Q ss_pred --eecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCC
Q 010891 335 --TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIE 411 (498)
Q Consensus 335 --~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 411 (498)
.....||+.|||||++.+..|+.++|||||||++|||+| |+.||...... +....+... .. +..+
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~------~~~~~i~~~---~~---~~~p 232 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS------EVTAMLEKG---ER---MGCP 232 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH------HHHHHHHTT---CC---CCCC
T ss_pred ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH------HHHHHHHcC---CC---CCCC
Confidence 234579999999999999999999999999999999998 89999754321 111222111 11 1111
Q ss_pred CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 412 TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 412 ~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
. ..+. .+..++.+||+.||++|||+.+|++.|+.
T Consensus 233 ~-~~~~---~~~~li~~cl~~dp~~RPs~~~i~~~L~~ 266 (277)
T d1xbba_ 233 A-GCPR---EMYDLMNLCWTYDVENRPGFAAVELRLRN 266 (277)
T ss_dssp T-TCCH---HHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred c-ccCH---HHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence 1 1122 23345558999999999999999988865
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=401.21 Aligned_cols=256 Identities=28% Similarity=0.455 Sum_probs=196.1
Q ss_pred cCCCccceEcccCcEEEEEEEEcCC-----cEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLMNG-----TAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
+.|++.++||+|+||+||+|.+.+. ..||||++...... ...+|.+|++++++++|||||++++++.+....++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4578889999999999999986432 47999998654333 23468899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
||||+.+++|.+++.. ....+++.++..++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 87 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEecccCcchhhhhc---ccccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcc
Confidence 9999999999998864 345799999999999999999999999 9999999999999999999999999999876
Q ss_pred CCCCc--eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCC
Q 010891 328 GAGKS--HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV 405 (498)
Q Consensus 328 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (498)
..... .......||+.|||||++.++.|+.++|||||||+||||++|..||....... +.+..+....+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~-----~~~~~i~~~~~---- 231 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-----EVMKAINDGFR---- 231 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH-----HHHHHHHTTCC----
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH-----HHHHHHhccCC----
Confidence 54322 22334568999999999999999999999999999999999776665433221 11222221111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 406 VDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 406 ~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
+.... ..+ ..+..++.+||+.||++|||+.||++.|+..
T Consensus 232 --~~~~~-~~~---~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 270 (283)
T d1mqba_ 232 --LPTPM-DCP---SAIYQLMMQCWQQERARRPKFADIVSILDKL 270 (283)
T ss_dssp --CCCCT-TCB---HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred --CCCch-hhH---HHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence 11111 111 2344455689999999999999999999754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-52 Score=404.99 Aligned_cols=253 Identities=26% Similarity=0.349 Sum_probs=203.7
Q ss_pred HccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC------CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCe
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG------QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQ 244 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 244 (498)
+.++|++.+.||+|+||+||+|+. .+|+.||||++..... ...+.+.+|+++|++++|||||++++++.+...
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 356899999999999999999986 5689999999854322 124678999999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCC----CeEEee
Q 010891 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF----DAKISD 320 (498)
Q Consensus 245 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~----~~kL~D 320 (498)
.||||||+++|+|.+++.. .+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++ .+||+|
T Consensus 88 ~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~D 160 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIID 160 (293)
T ss_dssp EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecc
Confidence 9999999999999999974 35699999999999999999999999 999999999999998776 499999
Q ss_pred eccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhc
Q 010891 321 FGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLR 400 (498)
Q Consensus 321 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 400 (498)
||++........ .....||+.|+|||++.+..|+.++|||||||+||||++|+.||...... +.+..+....
T Consensus 161 fG~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~------~~~~~i~~~~ 232 (293)
T d1jksa_ 161 FGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ------ETLANVSAVN 232 (293)
T ss_dssp CTTCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHTTC
T ss_pred hhhhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH------HHHHHHHhcC
Confidence 999998754432 34467999999999999999999999999999999999999999754321 1112221111
Q ss_pred cccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 401 RSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
. .... ...+..+. .+..++.+||+.||.+|||+.|+++|
T Consensus 233 ~---~~~~--~~~~~~s~--~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 233 Y---EFED--EYFSNTSA--LAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp C---CCCH--HHHTTSCH--HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred C---CCCc--hhcCCCCH--HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0000 00011111 23344458999999999999999875
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=410.27 Aligned_cols=248 Identities=25% Similarity=0.287 Sum_probs=203.7
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCC---CCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNN---PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
++|++.+.||+|+||.||+|+. .+|+.||||++.+. .....+.+.+|+.+|++++||||+++++++.+.+.+|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5799999999999999999985 57999999998543 2234566889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||++||+|.+++.. .+.+++..+..++.||+.||.|||++ +|+||||||+|||++.+|.+||+|||+|+....
T Consensus 85 ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 85 EYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp ECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 99999999999974 35689999999999999999999999 999999999999999999999999999987643
Q ss_pred CCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
.. ......+||+.|+|||++.+..|+.++|||||||+||||++|+.||...... +....+... . ..
T Consensus 158 ~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~------~~~~~i~~~-~------~~ 223 (337)
T d1o6la_ 158 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE------RLFELILME-E------IR 223 (337)
T ss_dssp TT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHC-C------CC
T ss_pred CC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH------HHHHHHhcC-C------CC
Confidence 32 2345578999999999999999999999999999999999999999754321 112222111 1 11
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRPK-----MSQVVRM 446 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt-----~~ell~~ 446 (498)
+ +...+.. +..++.+||++||.+||+ +.|+++|
T Consensus 224 ~--p~~~s~~--~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 224 F--PRTLSPE--AKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp C--CTTSCHH--HHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred C--CccCCHH--HHHHHHhhccCCchhhcccccccHHHHHcC
Confidence 1 1122222 233445899999999994 8999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-52 Score=402.72 Aligned_cols=257 Identities=24% Similarity=0.375 Sum_probs=193.7
Q ss_pred HHccCCCccceEcccCcEEEEEEEEcC----CcEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEeEEEeCCee
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQLMN----GTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQR 245 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~ 245 (498)
+..++|++.+.||+|+||+||+|++.. +..||||++...... ..+.|.+|++++++++|||||++++++. ++..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 345789999999999999999997532 456899988554333 2356899999999999999999999986 4678
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccce
Q 010891 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~ 325 (498)
|+||||+++|+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+||+++.++.+||+|||+|+
T Consensus 83 ~iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp EEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhe
Confidence 999999999999998864 345799999999999999999999999 99999999999999999999999999999
Q ss_pred ecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccC
Q 010891 326 LLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSED 404 (498)
Q Consensus 326 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 404 (498)
..............||+.|+|||++.+..|+.++|||||||++|||+| |..||....... +. ..+.....
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~---~~i~~~~~--- 227 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VI---GRIENGER--- 227 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HH---HHHHTTCC---
T ss_pred eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HH---HHHHcCCC---
Confidence 876544444555678999999999999999999999999999999998 889997654332 11 11111111
Q ss_pred CcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 405 VVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 405 ~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
+ ..++..+ ..+..++.+||+.||++|||+.||+++|+..
T Consensus 228 ---~--~~~~~~~--~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i 266 (273)
T d1mp8a_ 228 ---L--PMPPNCP--PTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266 (273)
T ss_dssp ---C--CCCTTCC--HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred ---C--CCCCCCC--HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 1 1111111 2334445589999999999999999999753
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.2e-51 Score=403.07 Aligned_cols=245 Identities=25% Similarity=0.341 Sum_probs=201.9
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCC---CCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNN---PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
++|++.+.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+.+++.++|||||++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 4589999999999999999986 56999999998532 2334567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||++||+|..++.. ...+++..+..++.||+.||.|||++ +|+||||||+||||+.+|.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence 99999999999973 45688999999999999999999999 999999999999999999999999999998754
Q ss_pred CCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
. ....+||+.|||||++.+..|+.++|||||||+||||++|+.||...... +.+..... ..
T Consensus 157 ~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~i~~---~~------ 217 (316)
T d1fota_ 157 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM------KTYEKILN---AE------ 217 (316)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHH---CC------
T ss_pred c----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHH------HHHHHHHc---CC------
Confidence 3 33468999999999999999999999999999999999999999754321 11222211 11
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRP-----KMSQVVRM 446 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RP-----t~~ell~~ 446 (498)
...++..+. .+..++.+||..||.+|+ |++++++|
T Consensus 218 ~~~p~~~s~--~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 218 LRFPPFFNE--DVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp CCCCTTSCH--HHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCCCCCH--HHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence 111111222 233344489999999996 89999876
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-51 Score=402.03 Aligned_cols=267 Identities=26% Similarity=0.358 Sum_probs=209.5
Q ss_pred HHHHHHHccCCCccceEcccCcEEEEEEEEc------CCcEEEEEEecCCCCC-chhHHHHHHHHHHcCCCCCceEEEeE
Q 010891 166 LRDLQSATNRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHVRHKNLVRLLGY 238 (498)
Q Consensus 166 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~l~~~ 238 (498)
+.+++...++|++.+.||+|+||+||+|++. +++.||||++...... ..+.|.+|+++|++++||||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence 3455667789999999999999999999863 3578999998654433 24569999999999999999999999
Q ss_pred EEeCCeeEEEEeecCCCCHHHHHhcccC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCe
Q 010891 239 CIEGTQRILVYEYVNNGNLEQWLRGDMC--------------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKV 298 (498)
Q Consensus 239 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~i 298 (498)
+.+....++||||+.+|+|.++|..... ....+++..++.|+.|++.||+|||++ +|
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KF 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TC
T ss_pred eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---Ce
Confidence 9999999999999999999999964211 123489999999999999999999999 99
Q ss_pred eecCCCCCCEEEcCCCCeEEeeeccceecCCCCc-eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCC-C
Q 010891 299 VHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS-HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGR-Y 376 (498)
Q Consensus 299 iHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~-~ 376 (498)
+||||||+||||+.++.+||+|||+|+....... ...+...||+.|+|||++.+..|+.++|||||||++|||++|. .
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence 9999999999999999999999999987644322 2234467899999999999999999999999999999999996 4
Q ss_pred CCCCCCCcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 377 PVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 377 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
||...... +.+..+..... +... ...+ ..+..++.+||+.||++||||.||+++|+...
T Consensus 242 p~~~~~~~------e~~~~v~~~~~------~~~p--~~~~--~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 242 PYYGMAHE------EVIYYVRDGNI------LACP--ENCP--LELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTTSCHH------HHHHHHHTTCC------CCCC--TTCC--HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCHH------HHHHHHHcCCC------CCCC--ccch--HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 66543221 12222221111 1111 1111 23445556899999999999999999998754
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-50 Score=403.48 Aligned_cols=245 Identities=23% Similarity=0.262 Sum_probs=201.7
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCC---CCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNN---PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 249 (498)
++|++++.||+|+||+||+|+. .+|+.||||++... .....+.+.+|+++|+.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 4799999999999999999986 46999999998532 2233456889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGA 329 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~ 329 (498)
||+.+|+|.+++... +.+++..+..++.||+.||.|||++ +||||||||+||||+.++.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred ccccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence 999999999999743 5699999999999999999999999 999999999999999999999999999998754
Q ss_pred CCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 330 GKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 330 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
. ....+||+.|||||++.+..|+.++|||||||+||||+||+.||...... ..+..+... .
T Consensus 194 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~------~~~~~i~~~---~------ 254 (350)
T d1rdqe_ 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI------QIYEKIVSG---K------ 254 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHC---C------
T ss_pred c----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH------HHHHHHhcC---C------
Confidence 3 33467999999999999999999999999999999999999999754321 122222211 1
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRP-----KMSQVVRM 446 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RP-----t~~ell~~ 446 (498)
.......+. .+..++.+||..||.+|+ |+.++++|
T Consensus 255 ~~~p~~~s~--~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 255 VRFPSHFSS--DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CCCCTTCCH--HHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CCCCccCCH--HHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence 111111112 233344489999999994 89999975
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1e-50 Score=393.62 Aligned_cols=257 Identities=26% Similarity=0.385 Sum_probs=196.5
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCc---hhHHHHHHHHHHcCCCCCceEEEeEEEeCC----e
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQA---DKDFRVEVEAIGHVRHKNLVRLLGYCIEGT----Q 244 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~ 244 (498)
.++|++.+.||+|+||+||+|+. .+|+.||||++....... ...+.+|+++++.++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 57899999999999999999985 579999999997654332 346889999999999999999999988653 3
Q ss_pred eEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccc
Q 010891 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (498)
Q Consensus 245 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla 324 (498)
.||||||++|++|.+++.. .+.+++.+++.++.||+.||.|||++ +|+||||||+|||++.++..+|+|||++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhh
Confidence 7999999999999999873 35799999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCc--eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccc
Q 010891 325 KLLGAGKS--HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRS 402 (498)
Q Consensus 325 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (498)
........ ......+||+.|+|||++.+..|+.++|||||||++|||+||+.||....+. +.+........
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~~~~~~~- 231 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV------SVAYQHVREDP- 231 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHHHHHCCC-
T ss_pred hhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH------HHHHHHHhcCC-
Confidence 87643322 2344568999999999999999999999999999999999999999754321 11111111111
Q ss_pred cCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCC-CHHHHHHHHhc
Q 010891 403 EDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRP-KMSQVVRMLES 449 (498)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RP-t~~ell~~L~~ 449 (498)
. +.....+..+. .+..++.+||++||++|| |++++++.|..
T Consensus 232 ---~-~~~~~~~~~s~--~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 232 ---I-PPSARHEGLSA--DLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp ---C-CGGGTSSSCCH--HHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred ---C-CCchhccCCCH--HHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 0 11111112222 233344489999999999 89999887754
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-51 Score=392.12 Aligned_cols=250 Identities=30% Similarity=0.452 Sum_probs=193.5
Q ss_pred ccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEe-CCeeEEEEee
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIE-GTQRILVYEY 251 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~e~ 251 (498)
.++|++.+.||+|+||.||+|++ .|+.||||++... ...+.|.+|++++++++|||||++++++.+ ....|+||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 35688899999999999999988 5889999998543 345779999999999999999999999865 4668999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+++|+|.++|... ....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 156 (262)
T ss_dssp CTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred cCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC-
Confidence 9999999999643 223589999999999999999999999 9999999999999999999999999999875432
Q ss_pred ceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCCC
Q 010891 332 SHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPNI 410 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (498)
.....+|+.|+|||++.++.++.++|||||||++|||+| |+.||...... ++...+ . .. ..+.+
T Consensus 157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i---~---~~---~~~~~ 221 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRV---E---KG---YKMDA 221 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHH---T---TT---CCCCC
T ss_pred ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHH---H---cC---CCCCC
Confidence 233568999999999999999999999999999999998 67777654332 222221 1 11 11122
Q ss_pred CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 411 ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 411 ~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
... .... +..++.+||+.||.+|||+.+++++|+..
T Consensus 222 ~~~-~~~~---~~~li~~cl~~dP~~Rps~~~l~~~L~~i 257 (262)
T d1byga_ 222 PDG-CPPA---VYEVMKNCWHLDAAMRPSFLQLREQLEHI 257 (262)
T ss_dssp CTT-CCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred Ccc-CCHH---HHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 111 1223 33445589999999999999999999754
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.2e-50 Score=404.28 Aligned_cols=249 Identities=24% Similarity=0.300 Sum_probs=197.0
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC---CchhHHH---HHHHHHHcCCCCCceEEEeEEEeCCeeE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG---QADKDFR---VEVEAIGHVRHKNLVRLLGYCIEGTQRI 246 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~---~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 246 (498)
++|++.++||+|+||.||+|+. .+|+.||||++..... .....+. .|+.+++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 5799999999999999999986 4699999999843211 1122233 3577788889999999999999999999
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecccee
Q 010891 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (498)
Q Consensus 247 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~ 326 (498)
+||||++||+|.++|.. ...+++..+..++.||+.||.|||++ +|+||||||+||||+.+|.+||+|||+|+.
T Consensus 84 ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence 99999999999999974 35689999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCceeeecccccccccCccccc-CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCC
Q 010891 327 LGAGKSHITTRVMGTFGYVAPEYAN-SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV 405 (498)
Q Consensus 327 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (498)
+.... ....+||+.|+|||++. +..|+.++|||||||+||||+||+.||..........+ .....
T Consensus 157 ~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~-------~~~~~---- 222 (364)
T d1omwa3 157 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-------DRMTL---- 222 (364)
T ss_dssp CSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH-------HHHSS----
T ss_pred cCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HHhcc----
Confidence 76543 34467999999999986 45799999999999999999999999976544322111 11111
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 010891 406 VDPNIETRPSTSALKRALLTALRCVDPDSDKRPK-----MSQVVRM 446 (498)
Q Consensus 406 ~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt-----~~ell~~ 446 (498)
......+...+. .+..++.+||..||++||| ++|+++|
T Consensus 223 -~~~~~~~~~~s~--~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 223 -TMAVELPDSFSP--ELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp -SCCCCCCSSSCH--HHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred -cCCCCCCCCCCH--HHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence 111111112222 2333445899999999999 7999865
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.3e-50 Score=389.26 Aligned_cols=251 Identities=25% Similarity=0.347 Sum_probs=201.4
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCc---------hhHHHHHHHHHHcCC-CCCceEEEeEEEeC
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQA---------DKDFRVEVEAIGHVR-HKNLVRLLGYCIEG 242 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~---------~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~ 242 (498)
++|++.+.||+|+||+||+|+. .+|+.||||++....... .+.+.+|+.++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6899999999999999999985 578999999986543321 124778999999996 99999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeec
Q 010891 243 TQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFG 322 (498)
Q Consensus 243 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfG 322 (498)
+..||||||+++|+|.++|.. .+.+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCT
T ss_pred cceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccch
Confidence 999999999999999999974 35799999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCceeeecccccccccCccccc------CCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH
Q 010891 323 LAKLLGAGKSHITTRVMGTFGYVAPEYAN------SGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMM 396 (498)
Q Consensus 323 la~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~ 396 (498)
+++...... .....+||+.|+|||++. ...++.++||||+||+||||++|+.||...... ......
T Consensus 156 ~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~------~~~~~i 227 (277)
T d1phka_ 156 FSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM------LMLRMI 227 (277)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHH
T ss_pred heeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH------HHHHHH
Confidence 999876543 234468999999999874 345788999999999999999999999754321 111111
Q ss_pred HhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 397 VQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
... .. ....+ .....+ ..+..++.+||+.||.+|||+.|+++|
T Consensus 228 ~~~-~~-~~~~~---~~~~~s--~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 228 MSG-NY-QFGSP---EWDDYS--DTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp HHT-CC-CCCTT---TGGGSC--HHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred HhC-CC-CCCCc---ccccCC--HHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 111 11 11111 111111 233444558999999999999999876
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-50 Score=398.03 Aligned_cols=254 Identities=27% Similarity=0.469 Sum_probs=197.1
Q ss_pred cCCCccceEcccCcEEEEEEEEc-CCc----EEEEEEecCC-CCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM-NGT----AVAVKKLLNN-PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 247 (498)
.+|++.++||+|+||+||+|.+. +|+ .||+|++... .....+.|.+|++++++++|||||+++++|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 46899999999999999999753 343 5899988643 334557799999999999999999999999875 5678
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLL 327 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~ 327 (498)
+|||+.+|+|.+++.. ....+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence 8999999999998875 345799999999999999999999999 9999999999999999999999999999987
Q ss_pred CCCCce-eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhccccCC
Q 010891 328 GAGKSH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDV 405 (498)
Q Consensus 328 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (498)
...... ......||+.|+|||++.++.|+.++|||||||+||||+| |..||....... +... +....+ .
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~~---i~~~~~---~ 232 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSI---LEKGER---L 232 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHHH---HHHTCC---C
T ss_pred ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHHH---HHcCCC---C
Confidence 544332 2334578999999999999999999999999999999998 788887543322 1111 111111 1
Q ss_pred cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 406 VDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 406 ~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
..+...+ ..+..++.+||..||.+|||+.|++++|+..
T Consensus 233 -----~~p~~~~--~~~~~li~~cl~~dP~~RPs~~eil~~l~~~ 270 (317)
T d1xkka_ 233 -----PQPPICT--IDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270 (317)
T ss_dssp -----CCCTTBC--HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCcccC--HHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence 1111111 2334455589999999999999999998753
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=397.02 Aligned_cols=267 Identities=26% Similarity=0.392 Sum_probs=197.2
Q ss_pred HHHHHHHccCCCccceEcccCcEEEEEEEEc------CCcEEEEEEecCCCCC-chhHHHHHHHHHHcC-CCCCceEEEe
Q 010891 166 LRDLQSATNRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHV-RHKNLVRLLG 237 (498)
Q Consensus 166 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpnIv~l~~ 237 (498)
...+++..++|++.+.||+|+||.||+|++. +++.||||++...... ..+.+..|..++.++ +||||+.+++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 3445566688999999999999999999753 3468999998654332 335677788888776 7899999999
Q ss_pred EEEeC-CeeEEEEeecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCC
Q 010891 238 YCIEG-TQRILVYEYVNNGNLEQWLRGDMC------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIK 304 (498)
Q Consensus 238 ~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDik 304 (498)
++.+. ...++||||+++|+|.++|+.... ....+++..+..++.||+.||.|||++ +|+|||||
T Consensus 85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlK 161 (299)
T d1ywna1 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA 161 (299)
T ss_dssp EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCC
T ss_pred eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCC
Confidence 98764 568999999999999999975321 134589999999999999999999999 99999999
Q ss_pred CCCEEEcCCCCeEEeeeccceecCCCCc-eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCC-CCCCCCC
Q 010891 305 SSNILIDENFDAKISDFGLAKLLGAGKS-HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGR-YPVDYGR 382 (498)
Q Consensus 305 p~NIll~~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~-~P~~~~~ 382 (498)
|+||||++++.+||+|||+|+....... ......+||+.|+|||++.+..++.++|||||||++|||+||. .||....
T Consensus 162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999987654332 2234467999999999999999999999999999999999975 5676443
Q ss_pred CcchhhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 383 PQSEVNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 383 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
.... +. ..+..... +.... ... ..+..++.+||+.||++|||+.|++++|+..
T Consensus 242 ~~~~--~~---~~~~~~~~------~~~~~-~~~---~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i 294 (299)
T d1ywna1 242 IDEE--FC---RRLKEGTR------MRAPD-YTT---PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294 (299)
T ss_dssp CSHH--HH---HHHHHTCC------CCCCT-TCC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHH--HH---HHHhcCCC------CCCCc-cCC---HHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 3221 11 11111111 11111 111 2344455689999999999999999999753
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-50 Score=398.69 Aligned_cols=251 Identities=21% Similarity=0.252 Sum_probs=195.9
Q ss_pred ccCCCcc-ceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHc-CCCCCceEEEeEEEe----CCee
Q 010891 173 TNRFSKD-NIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGH-VRHKNLVRLLGYCIE----GTQR 245 (498)
Q Consensus 173 ~~~y~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~hpnIv~l~~~~~~----~~~~ 245 (498)
.++|.+. ++||+|+||+||+|+. .+++.||||++.. .+.+.+|+.++.+ ++|||||+++++|.+ +..+
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 4578876 4699999999999985 5689999999853 3567889998765 589999999999876 4668
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcC---CCCeEEeeec
Q 010891 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE---NFDAKISDFG 322 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~---~~~~kL~DfG 322 (498)
|||||||+||+|.++|... ....+++.++..++.||+.||+|||++ +|+||||||+|||++. ++.+||+|||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccc
Confidence 9999999999999999743 235699999999999999999999999 9999999999999985 5679999999
Q ss_pred cceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccc
Q 010891 323 LAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRS 402 (498)
Q Consensus 323 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (498)
+|+...... .....+||+.|||||++.+..|+.++|||||||+||+|+||+.||......... ..+..
T Consensus 160 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~------~~~~~---- 227 (335)
T d2ozaa1 160 FAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS------PGMKT---- 227 (335)
T ss_dssp TCEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------------
T ss_pred eeeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH------HHHHH----
Confidence 999875443 234568999999999999999999999999999999999999999754332211 11111
Q ss_pred cCCcCCCCCCCCCH--HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 403 EDVVDPNIETRPST--SALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 403 ~~~~~~~~~~~~~~--~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
.+.......+... .-...+..++.+||..||++|||+.|+++|
T Consensus 228 -~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 228 -RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp -CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred -HHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence 1111111111111 111233444558999999999999999985
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-50 Score=396.98 Aligned_cols=253 Identities=18% Similarity=0.263 Sum_probs=202.6
Q ss_pred HccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
+.++|++.+.||+|+||+||+|.. .+|+.||||.+.... .....+.+|+++|+.++|||||++++++.+++.+|||||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 357899999999999999999986 468899999986542 233457899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCC--CCeEEeeeccceecC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDEN--FDAKISDFGLAKLLG 328 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~--~~~kL~DfGla~~~~ 328 (498)
||+||+|.+++.. ....+++.++..++.||+.||.|||++ +|+||||||+|||++.+ ..+||+|||+++...
T Consensus 82 ~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 82 FISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred cCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccc
Confidence 9999999999964 234699999999999999999999999 99999999999999854 589999999999875
Q ss_pred CCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (498)
... ......||+.|+|||.+.+..|+.++|||||||++|+|++|..||...... +.+..+... ...++.
T Consensus 156 ~~~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~------~~~~~i~~~---~~~~~~ 224 (321)
T d1tkia_ 156 PGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ------QIIENIMNA---EYTFDE 224 (321)
T ss_dssp TTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH------HHHHHHHHT---CCCCCH
T ss_pred cCC--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH------HHHHHHHhC---CCCCCh
Confidence 433 234467999999999999999999999999999999999999999754321 111222111 100000
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 409 NIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
. ..+..+. .+..++.+||..||.+|||+.|+++|
T Consensus 225 ~--~~~~~s~--~~~~li~~~L~~dp~~R~s~~eil~h 258 (321)
T d1tkia_ 225 E--AFKEISI--EAMDFVDRLLVKERKSRMTASEALQH 258 (321)
T ss_dssp H--HHTTSCH--HHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred h--hccCCCH--HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0011111 23344458999999999999999985
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=398.75 Aligned_cols=248 Identities=23% Similarity=0.319 Sum_probs=198.7
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCC---CCCchhHHHHHHHHHH-cCCCCCceEEEeEEEeCCeeEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNN---PGQADKDFRVEVEAIG-HVRHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~hpnIv~l~~~~~~~~~~~lv 248 (498)
++|++.+.||+|+||+||+|+. .+|+.||||++.+. .....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 4689999999999999999985 46899999999542 1233445666777665 68999999999999999999999
Q ss_pred EeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecC
Q 010891 249 YEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLG 328 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~ 328 (498)
|||+++|+|.+++.. .+.+++.++..++.||+.||.|||++ +|+||||||+|||+++++.+||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence 999999999999974 35689999999999999999999999 99999999999999999999999999998765
Q ss_pred CCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDP 408 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (498)
... ...+..+||+.|+|||++.+..|+.++|||||||++|||++|+.||...... +.+..+.. . . +
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~~~i~~-~--~----~ 220 (320)
T d1xjda_ 155 LGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE------ELFHSIRM-D--N----P 220 (320)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHH-C--C----C
T ss_pred ccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH------HHHHHHHc-C--C----C
Confidence 433 2244568999999999999999999999999999999999999999754321 11111111 1 1 1
Q ss_pred CCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHH-HHHHH
Q 010891 409 NIETRPSTSALKRALLTALRCVDPDSDKRPKMS-QVVRM 446 (498)
Q Consensus 409 ~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~-ell~~ 446 (498)
.++ ...+. .+..++.+||..||.+|||+. ++++|
T Consensus 221 ~~p--~~~s~--~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 221 FYP--RWLEK--EAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp CCC--TTSCH--HHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred CCC--ccCCH--HHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence 111 11122 233344489999999999995 77653
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-50 Score=389.74 Aligned_cols=254 Identities=27% Similarity=0.400 Sum_probs=192.0
Q ss_pred cCCCccceEcccCcEEEEEEEEcC--C--cEEEEEEecCCC---CCchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLMN--G--TAVAVKKLLNNP---GQADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRI 246 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 246 (498)
++|++.+.||+|+||+||+|++.. + ..||||++.... ....+.|.+|+.+|++++|||||++++++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 568999999999999999997532 2 378999886543 2334578999999999999999999999975 5678
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecccee
Q 010891 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (498)
Q Consensus 247 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~ 326 (498)
+||||+++|+|.+++... .+.+++..++.++.||+.||.|||++ +|+||||||+||||+.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhh
Confidence 999999999999988653 34699999999999999999999999 999999999999999999999999999998
Q ss_pred cCCCCce--eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHhhcccc
Q 010891 327 LGAGKSH--ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSEVNLVEWLKMMVQLRRSE 403 (498)
Q Consensus 327 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 403 (498)
....... ......||..|+|||++.+..++.++|||||||++|||+| |+.||...... +.+..+.... .
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~------~~~~~i~~~~--~ 232 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS------QILHKIDKEG--E 232 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH------HHHHHHHTSC--C
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH------HHHHHHHhCC--C
Confidence 7554332 2233568899999999999999999999999999999998 89999743321 2222222111 1
Q ss_pred CCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 404 DVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 404 ~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
.+... ...+.. +..++.+||+.||++|||+.||++.|..
T Consensus 233 ---~~~~~-~~~~~~---l~~li~~cl~~dp~~RPt~~ei~~~L~~ 271 (273)
T d1u46a_ 233 ---RLPRP-EDCPQD---IYNVMVQCWAHKPEDRPTFVALRDFLLE 271 (273)
T ss_dssp ---CCCCC-TTCCHH---HHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ---CCCCc-ccccHH---HHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 11111 111222 3344558999999999999999999875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-50 Score=392.63 Aligned_cols=264 Identities=28% Similarity=0.385 Sum_probs=197.6
Q ss_pred cCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHH--HHHHHHcCCCCCceEEEeEEEeCC----eeEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRV--EVEAIGHVRHKNLVRLLGYCIEGT----QRIL 247 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~--E~~~l~~l~hpnIv~l~~~~~~~~----~~~l 247 (498)
.+|.+.+.||+|+||+||+|++ +|+.||||++... ..+.+.. |+..+..++|||||++++++.+.+ ..|+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4677889999999999999986 7899999998532 2333434 555556789999999999998653 5799
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHcc-----CCCeeecCCCCCCEEEcCCCCeEEeeec
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI-----EPKVVHRDIKSSNILIDENFDAKISDFG 322 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-----~~~iiHrDikp~NIll~~~~~~kL~DfG 322 (498)
||||+++|+|.++|+. ..+++..++.++.|+|.||+|||+.. .++|+||||||+||||+.++.+||+|||
T Consensus 79 v~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 9999999999999974 35899999999999999999999631 3499999999999999999999999999
Q ss_pred cceecCCCCce---eeecccccccccCcccccCCC------CCccchHHHHHHHHHHHHhCCCCCCCCCCcchh------
Q 010891 323 LAKLLGAGKSH---ITTRVMGTFGYVAPEYANSGL------LNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEV------ 387 (498)
Q Consensus 323 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~------ 387 (498)
+++........ .....+||+.|+|||++.+.. ++.++|||||||+||||+||..||.........
T Consensus 154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccc
Confidence 99987544322 234568999999999987643 677899999999999999999887532211100
Q ss_pred --hHHHHHHHHHhhccccCCcCCCCCCCC-CHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 388 --NLVEWLKMMVQLRRSEDVVDPNIETRP-STSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 388 --~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
.....+..... ....++.+.... .......+..++.+||..||++|||+.||+++|+..
T Consensus 234 ~~~~~~~~~~~~~----~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i 295 (303)
T d1vjya_ 234 SDPSVEEMRKVVC----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295 (303)
T ss_dssp SSCCHHHHHHHHT----TSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccchHHHHHHHHh----ccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence 01111111111 112223332221 223444566677799999999999999999999754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-49 Score=385.72 Aligned_cols=267 Identities=25% Similarity=0.403 Sum_probs=201.2
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
++|++.+.||+|+||+||+|+. .+|+.||||++..... ...+.+.+|+++|++++|||||++++++.++.+.|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 4789999999999999999985 5699999999954432 235678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
|+.+ ++.+++... ....+++..+..++.||+.||.|||++ +||||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~-~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSE-EHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCC-chhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence 9965 555555432 345699999999999999999999999 9999999999999999999999999999876543
Q ss_pred CceeeecccccccccCcccccCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHh-hccccCCcC-
Q 010891 331 KSHITTRVMGTFGYVAPEYANSGL-LNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQ-LRRSEDVVD- 407 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~- 407 (498)
. .......||+.|+|||++.... ++.++|||||||++|+|++|+.||....... .+..+.. .........
T Consensus 156 ~-~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~------~~~~i~~~~~~~~~~~~~ 228 (298)
T d1gz8a_ 156 V-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID------QLFRIFRTLGTPDEVVWP 228 (298)
T ss_dssp S-BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHHHCCCCTTTST
T ss_pred c-ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH------HHHHHHHhcCCCchhhcc
Confidence 3 2234467999999999876654 5889999999999999999999997543211 1111111 111110000
Q ss_pred ---------CCCC--CC-------CCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH--HhcCCCCCC
Q 010891 408 ---------PNIE--TR-------PSTSALKRALLTALRCVDPDSDKRPKMSQVVRM--LESEEYPIP 455 (498)
Q Consensus 408 ---------~~~~--~~-------~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~--L~~~~~~~~ 455 (498)
.... .. +..+ ..+..++.+||..||.+|||+.|+++| +++...|+|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s--~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p~p 294 (298)
T d1gz8a_ 229 GVTSMPDYKPSFPKWARQDFSKVVPPLD--EDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294 (298)
T ss_dssp TGGGSTTCCTTSCCCCCCCHHHHSTTCC--HHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred ccccccccccccccccccchhhhccCCC--HHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCCCC
Confidence 0000 00 1111 223344558999999999999999987 555544443
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=388.02 Aligned_cols=255 Identities=24% Similarity=0.278 Sum_probs=192.8
Q ss_pred ccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC-----chhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 178 KDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ-----ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 178 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
.+++||+|+||+||+|+. .+|+.||||++...... ..+.+.+|+.+|++++|||||++++++.++++.|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 357899999999999985 56899999998543322 234688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+.++++..++. ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 82 METDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp CSEEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred hcchHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCc
Confidence 98887776654 346689999999999999999999999 99999999999999999999999999998765433
Q ss_pred ceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccc---cCCcC
Q 010891 332 SHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRS---EDVVD 407 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 407 (498)
.. ....+||+.|+|||++.+ ..|+.++|||||||++|||+||..||...... + .+..+...... ....+
T Consensus 155 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~---~---~l~~i~~~~~~~~~~~~~~ 227 (299)
T d1ua2a_ 155 RA-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL---D---QLTRIFETLGTPTEEQWPD 227 (299)
T ss_dssp CC-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---H---HHHHHHHHHCCCCTTTSSS
T ss_pred cc-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHH---H---HHHHHHHhcCCCChhhccc
Confidence 22 334679999999998864 56899999999999999999999999754321 1 11222211100 00000
Q ss_pred -------CCCCCCC--CH-----HHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 408 -------PNIETRP--ST-----SALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 408 -------~~~~~~~--~~-----~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
......+ .. .....+..++.+||..||++|||+.|+|+|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 228 MCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp TTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 0000000 00 001234445568999999999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-49 Score=388.35 Aligned_cols=256 Identities=25% Similarity=0.393 Sum_probs=198.1
Q ss_pred cCCCccceEcccCcEEEEEEEEc-CCc--EEEEEEecCC-CCCchhHHHHHHHHHHcC-CCCCceEEEeEEEeCCeeEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLM-NGT--AVAVKKLLNN-PGQADKDFRVEVEAIGHV-RHKNLVRLLGYCIEGTQRILV 248 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~lv 248 (498)
++|++.++||+|+||+||+|++. +|. .||||++... .....+.|.+|+++|.++ +|||||++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 57888999999999999999854 444 5788887543 333456799999999999 799999999999999999999
Q ss_pred EeecCCCCHHHHHhccc------------CCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCe
Q 010891 249 YEYVNNGNLEQWLRGDM------------CDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDA 316 (498)
Q Consensus 249 ~e~~~~g~L~~~l~~~~------------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~ 316 (498)
|||+++|+|.++|+... .....+++..++.++.||+.||.|||+. +|+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCce
Confidence 99999999999997531 2346799999999999999999999999 99999999999999999999
Q ss_pred EEeeeccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCC-CCCCCCCcchhhHHHHHHH
Q 010891 317 KISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRY-PVDYGRPQSEVNLVEWLKM 395 (498)
Q Consensus 317 kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~-P~~~~~~~~~~~~~~~~~~ 395 (498)
||+|||+++...... ......||..|+|||.+.++.|+.++|||||||++|||++|.. ||..... .+.+..
T Consensus 167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~------~~~~~~ 238 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC------AELYEK 238 (309)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH------HHHHHH
T ss_pred EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCH------HHHHHH
Confidence 999999998654321 1234568999999999999999999999999999999999765 5643221 111111
Q ss_pred HHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 396 MVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
+. .... +.. ....+ ..+..++.+||+.||++||||.||+++|+..
T Consensus 239 i~---~~~~---~~~--~~~~~--~~~~~li~~cl~~dP~~RPs~~eil~~L~~i 283 (309)
T d1fvra_ 239 LP---QGYR---LEK--PLNCD--DEVYDLMRQCWREKPYERPSFAQILVSLNRM 283 (309)
T ss_dssp GG---GTCC---CCC--CTTBC--HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HH---hcCC---CCC--CccCC--HHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11 1111 111 11111 2233344589999999999999999998765
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-50 Score=391.94 Aligned_cols=261 Identities=27% Similarity=0.414 Sum_probs=201.5
Q ss_pred HHccCCCccceEcccCcEEEEEEEEcC--------CcEEEEEEecCCCCC-chhHHHHHHHHHHcC-CCCCceEEEeEEE
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQLMN--------GTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHV-RHKNLVRLLGYCI 240 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpnIv~l~~~~~ 240 (498)
+..++|++.+.||+|+||.||+|+... +..||||++...... ...++.+|...+.++ +|||||+++++|.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 345789999999999999999997422 347999998665432 335688899999888 8999999999999
Q ss_pred eCCeeEEEEeecCCCCHHHHHhcccC------------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCE
Q 010891 241 EGTQRILVYEYVNNGNLEQWLRGDMC------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNI 308 (498)
Q Consensus 241 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NI 308 (498)
++...++||||+++|+|.++|..... ....+++.+++.++.||+.||.|||+. +|+||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccce
Confidence 99999999999999999999975421 234689999999999999999999999 999999999999
Q ss_pred EEcCCCCeEEeeeccceecCCCCc-eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHh-CCCCCCCCCCcch
Q 010891 309 LIDENFDAKISDFGLAKLLGAGKS-HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAIT-GRYPVDYGRPQSE 386 (498)
Q Consensus 309 ll~~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~ellt-g~~P~~~~~~~~~ 386 (498)
|++.++.+||+|||+++....... .......||+.|+|||.+.++.|+.++|||||||++|||++ |..||......
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~-- 244 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-- 244 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH--
Confidence 999999999999999997754332 22344679999999999999999999999999999999998 68888643321
Q ss_pred hhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcC
Q 010891 387 VNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESE 450 (498)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~ 450 (498)
.+. ..+.... . +..+.. ... .+..++.+||+.||++|||+.||++.|+..
T Consensus 245 -~~~---~~i~~~~---~---~~~p~~-~~~---~l~~li~~cl~~dP~~Rps~~eil~~L~~i 294 (299)
T d1fgka_ 245 -ELF---KLLKEGH---R---MDKPSN-CTN---ELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294 (299)
T ss_dssp -HHH---HHHHTTC---C---CCCCSS-CCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -HHH---HHHHcCC---C---CCCCcc-chH---HHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence 111 1111111 1 111111 112 234455589999999999999999999754
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-49 Score=386.39 Aligned_cols=252 Identities=28% Similarity=0.439 Sum_probs=197.5
Q ss_pred cceEcccCcEEEEEEEEcCC----cEEEEEEecCCC-CCchhHHHHHHHHHHcCCCCCceEEEeEEEe-CCeeEEEEeec
Q 010891 179 DNIIGDGGYGVVYRGQLMNG----TAVAVKKLLNNP-GQADKDFRVEVEAIGHVRHKNLVRLLGYCIE-GTQRILVYEYV 252 (498)
Q Consensus 179 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv~e~~ 252 (498)
.++||+|+||+||+|++.++ ..||||++.... ....+.|.+|+++|++++|||||++++++.+ +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 57899999999999986432 368999986433 2344679999999999999999999999876 46889999999
Q ss_pred CCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCCc
Q 010891 253 NNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGKS 332 (498)
Q Consensus 253 ~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~~ 332 (498)
++|+|.+++.. ....+++..++.++.|++.||.|||+. +|+||||||+||||++++.+||+|||+++.......
T Consensus 112 ~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~ 185 (311)
T d1r0pa_ 112 KHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185 (311)
T ss_dssp TTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred ecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence 99999999874 334678899999999999999999999 999999999999999999999999999997654332
Q ss_pred e---eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccCCcCCC
Q 010891 333 H---ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSEDVVDPN 409 (498)
Q Consensus 333 ~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 409 (498)
. ......||+.|+|||.+.+..++.++||||||++||||+||..||....... +....+.... ....+.
T Consensus 186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-----~~~~~i~~g~---~~~~p~ 257 (311)
T d1r0pa_ 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----DITVYLLQGR---RLLQPE 257 (311)
T ss_dssp CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHHHHTTC---CCCCCT
T ss_pred ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-----HHHHHHHcCC---CCCCcc
Confidence 2 2233578999999999999999999999999999999999888886433221 1112222111 111111
Q ss_pred CCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCC
Q 010891 410 IETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEE 451 (498)
Q Consensus 410 ~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~ 451 (498)
.... .+..++.+||+.||++|||+.||+++|+...
T Consensus 258 ----~~~~---~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~ 292 (311)
T d1r0pa_ 258 ----YCPD---PLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292 (311)
T ss_dssp ----TCCH---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----cCcH---HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 1122 3344556899999999999999999998763
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-49 Score=390.30 Aligned_cols=261 Identities=26% Similarity=0.359 Sum_probs=206.1
Q ss_pred HHccCCCccceEcccCcEEEEEEEE------cCCcEEEEEEecCCCCC-chhHHHHHHHHHHcC-CCCCceEEEeEEEeC
Q 010891 171 SATNRFSKDNIIGDGGYGVVYRGQL------MNGTAVAVKKLLNNPGQ-ADKDFRVEVEAIGHV-RHKNLVRLLGYCIEG 242 (498)
Q Consensus 171 ~~~~~y~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~ 242 (498)
...++|++.++||+|+||.||+|++ .+++.||||++...... ....|.+|+.++.++ +|||||++++++.+.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 4457889999999999999999975 34678999999754433 334688999999999 799999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHhcccC--------------CCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCE
Q 010891 243 TQRILVYEYVNNGNLEQWLRGDMC--------------DRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNI 308 (498)
Q Consensus 243 ~~~~lv~e~~~~g~L~~~l~~~~~--------------~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NI 308 (498)
...++||||+++|+|.++++.... ....+++..+..++.||+.||+|||++ +++||||||+||
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NI 176 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNI 176 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeecccccccc
Confidence 999999999999999999975421 223689999999999999999999999 999999999999
Q ss_pred EEcCCCCeEEeeeccceecCCCCc-eeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCC-CCCCCCcch
Q 010891 309 LIDENFDAKISDFGLAKLLGAGKS-HITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYP-VDYGRPQSE 386 (498)
Q Consensus 309 ll~~~~~~kL~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P-~~~~~~~~~ 386 (498)
|++.++.+||+|||+++....... ......+||+.|+|||++.++.++.++|||||||++|||+|+..| |........
T Consensus 177 l~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~ 256 (311)
T d1t46a_ 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256 (311)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred cccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence 999999999999999998765433 334456899999999999999999999999999999999995444 543333221
Q ss_pred hhHHHHHHHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 387 VNLVEWLKMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
+..+..... . +... .... ..+..++.+||+.||.+||||.|++++|+.
T Consensus 257 ------~~~~i~~~~--~---~~~~-~~~~---~~l~~Li~~cl~~dP~~RPs~~~il~~L~~ 304 (311)
T d1t46a_ 257 ------FYKMIKEGF--R---MLSP-EHAP---AEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304 (311)
T ss_dssp ------HHHHHHHTC--C---CCCC-TTSC---HHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ------HHHHHhcCC--C---CCCc-cccc---HHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 111111111 1 1111 1111 234445558999999999999999999975
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-49 Score=391.07 Aligned_cols=266 Identities=23% Similarity=0.371 Sum_probs=209.0
Q ss_pred HHHHccCCCccceEcccCcEEEEEEEEc------CCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEe
Q 010891 169 LQSATNRFSKDNIIGDGGYGVVYRGQLM------NGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIE 241 (498)
Q Consensus 169 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~ 241 (498)
+++..++|++.+.||+|+||+||+|.+. +++.||||++..... .....|.+|++++++++|||||++++++..
T Consensus 15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 3445578899999999999999999752 357899999864432 223458899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHhccc------CCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCC
Q 010891 242 GTQRILVYEYVNNGNLEQWLRGDM------CDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFD 315 (498)
Q Consensus 242 ~~~~~lv~e~~~~g~L~~~l~~~~------~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~ 315 (498)
....++||||+++|+|.+++.... .....+++..+..++.|++.||.|||++ +|+||||||+||||+.+++
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~ 171 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT 171 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCC
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCce
Confidence 999999999999999999986421 1224578999999999999999999999 9999999999999999999
Q ss_pred eEEeeeccceecCCCCce-eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCC-CCCCCCCCcchhhHHHHH
Q 010891 316 AKISDFGLAKLLGAGKSH-ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGR-YPVDYGRPQSEVNLVEWL 393 (498)
Q Consensus 316 ~kL~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~-~P~~~~~~~~~~~~~~~~ 393 (498)
+||+|||+++........ ......||+.|+|||.+.++.++.++|||||||+||||+||. .||..... .+.+
T Consensus 172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~------~~~~ 245 (308)
T d1p4oa_ 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN------EQVL 245 (308)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH------HHHH
T ss_pred EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH------HHHH
Confidence 999999999876543322 233457999999999999999999999999999999999985 66653321 2223
Q ss_pred HHHHhhccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCC
Q 010891 394 KMMVQLRRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYP 453 (498)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~~~ 453 (498)
..+...... .. ....+ ..+..++.+||+.||++|||+.+|+++|+....+
T Consensus 246 ~~i~~~~~~------~~--p~~~~--~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 246 RFVMEGGLL------DK--PDNCP--DMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp HHHHTTCCC------CC--CTTCC--HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred HHHHhCCCC------CC--cccch--HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 332221111 11 11111 2344455589999999999999999999876443
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-50 Score=387.54 Aligned_cols=242 Identities=24% Similarity=0.384 Sum_probs=194.0
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC------chhHHHHHHHHHHcCC--CCCceEEEeEEEeCC
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ------ADKDFRVEVEAIGHVR--HKNLVRLLGYCIEGT 243 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--hpnIv~l~~~~~~~~ 243 (498)
.++|++.++||+|+||+||+|+. .+|+.||||++...... ....+.+|+.+|++++ |||||++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 46899999999999999999985 56899999998643221 1234678999999986 899999999999999
Q ss_pred eeEEEEeecCC-CCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcC-CCCeEEeee
Q 010891 244 QRILVYEYVNN-GNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE-NFDAKISDF 321 (498)
Q Consensus 244 ~~~lv~e~~~~-g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~-~~~~kL~Df 321 (498)
..|+||||+.+ +++.+++.. ...+++.++..++.||+.||.|||++ +|+||||||+|||++. ++.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred eEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcc
Confidence 99999999976 688888863 35699999999999999999999999 9999999999999985 479999999
Q ss_pred ccceecCCCCceeeecccccccccCcccccCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhc
Q 010891 322 GLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLL-NEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLR 400 (498)
Q Consensus 322 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 400 (498)
|+|+...... .+..+||+.|+|||++.+..+ +.++|||||||+||||++|+.||.... .+..
T Consensus 156 G~a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~-- 218 (273)
T d1xwsa_ 156 GSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIR-- 218 (273)
T ss_dssp TTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHH--
T ss_pred ccceeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHhh--
Confidence 9998764432 345689999999999876654 677999999999999999999996311 1111
Q ss_pred cccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHH
Q 010891 401 RSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRML 447 (498)
Q Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L 447 (498)
... ..+...+. .+..++.+||..||++|||+.|+++|-
T Consensus 219 -~~~------~~~~~~s~--~~~~li~~~L~~dp~~R~s~~eil~hp 256 (273)
T d1xwsa_ 219 -GQV------FFRQRVSS--ECQHLIRWCLALRPSDRPTFEEIQNHP 256 (273)
T ss_dssp -CCC------CCSSCCCH--HHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred -ccc------CCCCCCCH--HHHHHHHHHccCCHhHCcCHHHHhcCH
Confidence 111 11111222 223344489999999999999999863
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=4.6e-49 Score=383.79 Aligned_cols=257 Identities=24% Similarity=0.339 Sum_probs=197.5
Q ss_pred cCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEee
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYEY 251 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~ 251 (498)
++|++.+.||+|+||+||+|++.+|+.||||++..... ...+.+.+|+.+|++++|||||++++++.+++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 58999999999999999999988999999999955432 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCCC
Q 010891 252 VNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAGK 331 (498)
Q Consensus 252 ~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~~ 331 (498)
+.++.+..+.. ..+.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~~~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred ehhhhHHHHHh----hcCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence 98877766664 446799999999999999999999998 99999999999999999999999999998765433
Q ss_pred ceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhh-cccc------
Q 010891 332 SHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQL-RRSE------ 403 (498)
Q Consensus 332 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-~~~~------ 403 (498)
. ......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||....... .+..+... ....
T Consensus 155 ~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~------~~~~i~~~~~~~~~~~~~~ 227 (286)
T d1ob3a_ 155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD------QLMRIFRILGTPNSKNWPN 227 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHHHCCCCTTTSTT
T ss_pred c-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHH------HHHHHHHhhCCCChhhccc
Confidence 2 2344579999999998865 567999999999999999999999997543211 11111111 0000
Q ss_pred --C--CcCCCC---------CCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 404 --D--VVDPNI---------ETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 404 --~--~~~~~~---------~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
. ...... ......+ ..+..++.+||..||++|||+.|+++|
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~s--~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 228 VTELPKYDPNFTVYEPLPWESFLKGLD--ESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp GGGSTTCCTTCCCCCCCCGGGTCCSCC--HHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred hhhhhhcccccccccCcchhhhcccCC--HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 000000 0011112 233344558999999999999999865
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-48 Score=379.46 Aligned_cols=258 Identities=24% Similarity=0.329 Sum_probs=194.4
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cC-CcEEEEEEecCC--CCCchhHHHHHHHHHHcC---CCCCceEEEeEEEe----
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MN-GTAVAVKKLLNN--PGQADKDFRVEVEAIGHV---RHKNLVRLLGYCIE---- 241 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l---~hpnIv~l~~~~~~---- 241 (498)
.++|++.+.||+|+||+||+|++ .+ ++.||||++... .......+.+|+.+|+.| +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 36899999999999999999986 34 567999998543 222334566788777665 89999999999863
Q ss_pred -CCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEee
Q 010891 242 -GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISD 320 (498)
Q Consensus 242 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~D 320 (498)
....+++|||++++++...... ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred cCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence 3467999999988776655442 445689999999999999999999999 999999999999999999999999
Q ss_pred eccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhc
Q 010891 321 FGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLR 400 (498)
Q Consensus 321 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 400 (498)
||+++..... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||....+.. .+..+....
T Consensus 160 fg~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~------~~~~i~~~~ 231 (305)
T d1blxa_ 160 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD------QLGKILDVI 231 (305)
T ss_dssp CCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHHH
T ss_pred hhhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH------HHHHHHHhh
Confidence 9999865332 23445689999999999999999999999999999999999999997543221 112221111
Q ss_pred ccc---C---------------CcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 401 RSE---D---------------VVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 401 ~~~---~---------------~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
... . ...+........+.. ...++.+||..||++|||+.|+++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~--~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDEL--GKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp CCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHH--HHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred CCCchhcccccccchhhhhccccccchhhccccCCHH--HHHHHHHHCcCChhHCcCHHHHhcC
Confidence 000 0 000000011112222 2334458999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-46 Score=368.90 Aligned_cols=268 Identities=22% Similarity=0.258 Sum_probs=197.5
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCC--CCCchhHHHHHHHHHHcCCCCCceEEEeEEEe--------
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNN--PGQADKDFRVEVEAIGHVRHKNLVRLLGYCIE-------- 241 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-------- 241 (498)
.++|++.+.||+|+||+||+|++ .+|+.||||++... .....+.+.+|+++|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 37899999999999999999986 57999999998543 23344678899999999999999999999865
Q ss_pred CCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeee
Q 010891 242 GTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDF 321 (498)
Q Consensus 242 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~Df 321 (498)
..+.|+||||+.++.+..+.. ....+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred CceEEEEEeccCCCccchhhh----cccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeec
Confidence 345799999998876665543 445689999999999999999999999 9999999999999999999999999
Q ss_pred ccceecCCCCce---eeecccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHH
Q 010891 322 GLAKLLGAGKSH---ITTRVMGTFGYVAPEYANSG-LLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMV 397 (498)
Q Consensus 322 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~ 397 (498)
|++......... .....+||+.|+|||++.+. .|+.++|||||||++|||++|+.||....... ....+.
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~------~~~~i~ 235 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH------QLALIS 235 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHH
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHH------HHHHHH
Confidence 999876543221 22335799999999988654 78999999999999999999999997543211 111211
Q ss_pred hhcc-ccCCcCC-------------CCCCCCCHHH-------HHHHHHHHHHccCCCCCCCCCHHHHHHHHhcCCCC
Q 010891 398 QLRR-SEDVVDP-------------NIETRPSTSA-------LKRALLTALRCVDPDSDKRPKMSQVVRMLESEEYP 453 (498)
Q Consensus 398 ~~~~-~~~~~~~-------------~~~~~~~~~~-------~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~~~~~ 453 (498)
.... ....... .......... ......++.+||..||++|||+.|+++|--....+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p 312 (318)
T d3blha1 236 QLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 312 (318)
T ss_dssp HHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSS
T ss_pred HhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCC
Confidence 1111 0000000 0000111111 11223455689999999999999999885443333
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=377.30 Aligned_cols=258 Identities=27% Similarity=0.365 Sum_probs=189.7
Q ss_pred CCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCceEEEeEEEeC------CeeEE
Q 010891 175 RFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNLVRLLGYCIEG------TQRIL 247 (498)
Q Consensus 175 ~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~------~~~~l 247 (498)
+|+..++||+|+||+||+|++ .+|+.||||++..... .+.+|+++|++++||||++++++|... .++||
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 578889999999999999986 4699999999965432 234699999999999999999998643 35789
Q ss_pred EEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCC-CeEEeeecccee
Q 010891 248 VYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF-DAKISDFGLAKL 326 (498)
Q Consensus 248 v~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~-~~kL~DfGla~~ 326 (498)
||||++++ +.+.+.........+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++.
T Consensus 97 v~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhh
Confidence 99999765 4444432222456799999999999999999999998 999999999999999775 899999999998
Q ss_pred cCCCCceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH--------HH
Q 010891 327 LGAGKSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKM--------MV 397 (498)
Q Consensus 327 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~--------~~ 397 (498)
...... ....+||+.|+|||.+.+ ..|+.++|||||||++|||++|+.||........ +....+. ..
T Consensus 173 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~--l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 173 LVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTREQIR 248 (350)
T ss_dssp CCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHHHHHHHCCCCHHHHH
T ss_pred ccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH--HHHHHHHhCCChHHhhh
Confidence 754432 334679999999997754 5799999999999999999999999975432111 1111100 00
Q ss_pred hhccc-cCCcCCCCC-------CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 398 QLRRS-EDVVDPNIE-------TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 398 ~~~~~-~~~~~~~~~-------~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
..... ....-+... ..+..+ .....++.+||..||++|||+.|+|+|
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s--~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTP--PEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSC--HHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred hhccchhhccccccccCchhhhcccCCC--HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 00000 000000000 011111 223344558999999999999999976
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-46 Score=376.60 Aligned_cols=203 Identities=28% Similarity=0.396 Sum_probs=168.8
Q ss_pred HccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC-CchhHHHHHHHHHHcCCCCCceEEEeEEEeCC----ee
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG-QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT----QR 245 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----~~ 245 (498)
++.+|++++.||+|+||+||+|.. .+|+.||||++..... ...+.+.+|+.+|++++||||+++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 346899999999999999999975 5799999999965432 23456889999999999999999999997653 23
Q ss_pred EEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccce
Q 010891 246 ILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAK 325 (498)
Q Consensus 246 ~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~ 325 (498)
+++++|+.+|+|.+++.. ..+++..+..++.||+.||.|||++ +||||||||+||||++++.+||+|||++.
T Consensus 86 ~~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp EEEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCcee
Confidence 455666779999999963 3599999999999999999999999 99999999999999999999999999998
Q ss_pred ecCCCCce--eeecccccccccCcccc-cCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Q 010891 326 LLGAGKSH--ITTRVMGTFGYVAPEYA-NSGLLNEKSDVYSFGVVLLEAITGRYPVDYGR 382 (498)
Q Consensus 326 ~~~~~~~~--~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~ 382 (498)
........ .....+||+.|+|||++ .+..++.++||||+||++|||++|+.||....
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~ 217 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 217 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCC
Confidence 76443221 23446799999999988 45678899999999999999999999997543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-46 Score=371.78 Aligned_cols=253 Identities=25% Similarity=0.325 Sum_probs=199.7
Q ss_pred cCCCccceEcccCcEEEEEEEE----cCCcEEEEEEecCCC----CCchhHHHHHHHHHHcCCC-CCceEEEeEEEeCCe
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL----MNGTAVAVKKLLNNP----GQADKDFRVEVEAIGHVRH-KNLVRLLGYCIEGTQ 244 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~ 244 (498)
++|++.+.||+|+||+||+|+. .+|+.||||++.... ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 5699999999999999999974 247899999985432 2234567889999999966 899999999999999
Q ss_pred eEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccc
Q 010891 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (498)
Q Consensus 245 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla 324 (498)
.+++|||+.+|+|.+++... +.+++..+..++.||+.||.|||+. +|+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence 99999999999999999743 4578899999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCceeeecccccccccCcccccCC--CCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccc
Q 010891 325 KLLGAGKSHITTRVMGTFGYVAPEYANSG--LLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRS 402 (498)
Q Consensus 325 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 402 (498)
+.+............||+.|+|||.+.+. .++.++|||||||+||||++|+.||........... .......
T Consensus 177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~--i~~~~~~---- 250 (322)
T d1vzoa_ 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE--ISRRILK---- 250 (322)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH--HHHHHHH----
T ss_pred hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHhccc----
Confidence 98765554445567899999999988654 578899999999999999999999976554332211 1111111
Q ss_pred cCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 010891 403 EDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRP-----KMSQVVRM 446 (498)
Q Consensus 403 ~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RP-----t~~ell~~ 446 (498)
.........+ ..+..++.+||++||++|| |++|+++|
T Consensus 251 -----~~~~~~~~~s--~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 251 -----SEPPYPQEMS--ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp -----CCCCCCTTSC--HHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred -----CCCCCcccCC--HHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence 0111111112 2333344589999999999 58999874
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-46 Score=374.12 Aligned_cols=258 Identities=24% Similarity=0.342 Sum_probs=190.8
Q ss_pred HccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC--chhHHHHHHHHHHcCCCCCceEEEeEEEeCC-----
Q 010891 172 ATNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEGT----- 243 (498)
Q Consensus 172 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~----- 243 (498)
..++|++.+.||+|+||+||+|.. .+|+.||||++...... ..+.+.+|+++|+.++|||||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 357899999999999999999985 46999999999654322 2356888999999999999999999998654
Q ss_pred -eeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeec
Q 010891 244 -QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFG 322 (498)
Q Consensus 244 -~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfG 322 (498)
+.|+||||+ +.+|..+++. +.+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred ceEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccc
Confidence 569999999 6688887742 4699999999999999999999999 99999999999999999999999999
Q ss_pred cceecCCCCceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH-----
Q 010891 323 LAKLLGAGKSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMM----- 396 (498)
Q Consensus 323 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~----- 396 (498)
+|+..... .+..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .......
T Consensus 167 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~~ 240 (346)
T d1cm8a_ 167 LARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL--KEIMKVTGTPPA 240 (346)
T ss_dssp TCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCCCCH
T ss_pred ceeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHH--HHHHhccCCCcH
Confidence 99976543 344679999999998865 56789999999999999999999999754321111 0000000
Q ss_pred --Hh----------hccccCCcCCCCC-CCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 397 --VQ----------LRRSEDVVDPNIE-TRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 397 --~~----------~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
.. ...........+. .....+. ....++.+||..||.+|||+.|+|+|
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 241 EFVQRLQSDEAKNYMKGLPELEKKDFASILTNASP--LAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCH--HHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHhhhcchhhhhhhccCCcccccchHHhccCCCH--HHHHHHHHHCcCChhHCcCHHHHhcC
Confidence 00 0000000001110 0111122 23344558999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-45 Score=361.10 Aligned_cols=259 Identities=20% Similarity=0.248 Sum_probs=193.8
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCc-eEEEeEEEeCCeeEEEEe
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL-VRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~e 250 (498)
.++|++.+.||+|+||+||+|++ .+|+.||||++.... ..+.+..|+++++.++|+|+ +.+.+++.++...++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 36899999999999999999985 568999999886543 23468889999999987665 555666678888999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEc---CCCCeEEeeeccceec
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILID---ENFDAKISDFGLAKLL 327 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~---~~~~~kL~DfGla~~~ 327 (498)
|+ +++|.+.+.. ..+.+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+||+|||+|+.+
T Consensus 84 ~~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 84 LL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred Ec-CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 99 5577776653 345799999999999999999999999 999999999999985 3557999999999987
Q ss_pred CCCCce------eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhcc
Q 010891 328 GAGKSH------ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRR 401 (498)
Q Consensus 328 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 401 (498)
...... .....+||+.|||||++.+..++.++|||||||++|||+||+.||.................... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~-~~ 235 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-ST 235 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH-HS
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC-CC
Confidence 544321 23346799999999999999999999999999999999999999976544332221111111100 00
Q ss_pred ccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 402 SEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 402 ~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
... .+ ....+. .+..++.+||+.||++||++.++.+.|+.
T Consensus 236 ~~~----~~-~~~~p~---~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 275 (299)
T d1ckia_ 236 PIE----VL-CKGYPS---EFATYLNFCRSLRFDDKPDYSYLRQLFRN 275 (299)
T ss_dssp CHH----HH-TTTSCH---HHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred Chh----Hh-ccCCCH---HHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence 000 00 001112 23344458999999999999988777764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=359.31 Aligned_cols=258 Identities=22% Similarity=0.324 Sum_probs=201.8
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCC--CchhHHHHHHHHHHcCCCCCceEEEeEEEeCCeeEEEEe
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPG--QADKDFRVEVEAIGHVRHKNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e 250 (498)
++|++++.||+|+||+||+|++ .+|+.||||++..... ...+.+.+|+.+|+.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999985 5789999999854432 234678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccceecCCC
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLAKLLGAG 330 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~~~~~ 330 (498)
++.+++|..++. ..+.+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||.++.....
T Consensus 82 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred eccccccccccc----cccccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence 999999988886 446789999999999999999999999 9999999999999999999999999999987544
Q ss_pred CceeeecccccccccCcccccCC-CCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhhccccC-----
Q 010891 331 KSHITTRVMGTFGYVAPEYANSG-LLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQLRRSED----- 404 (498)
Q Consensus 331 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 404 (498)
... .....+++.|+|||++.+. .++.++|||||||++|||++|+.||..+.... +.+..+........
T Consensus 155 ~~~-~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~~ 228 (292)
T d1unla_ 155 VRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-----DQLKRIFRLLGTPTEEQWP 228 (292)
T ss_dssp CSC-CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH-----HHHHHHHHHHCCCCTTTCT
T ss_pred Ccc-ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHH-----HHHHHHHhhcCCCChhhhh
Confidence 322 3345678999999988765 46899999999999999999999986544322 12222211111000
Q ss_pred --------C-------cCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 010891 405 --------V-------VDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRM 446 (498)
Q Consensus 405 --------~-------~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~ 446 (498)
. ...........+. ....++.+||+.||.+|||++|+|+|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNA--TGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp TGGGSTTCCCCCCCCTTCCCTTTSTTCCH--HHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred hhhhcccccccccccccchhhhccccCCH--HHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0000001111122 23344458999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.3e-45 Score=360.24 Aligned_cols=259 Identities=17% Similarity=0.209 Sum_probs=203.2
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCC-CCceEEEeEEEeCCeeEEEEe
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRH-KNLVRLLGYCIEGTQRILVYE 250 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~l~~~~~~~~~~~lv~e 250 (498)
.++|++.+.||+|+||+||+|++ .+|+.||||++.... ....++.|++.+..+.| +|++.+++++.++...++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 57899999999999999999985 468999999875432 34567889999999965 899999999999999999999
Q ss_pred ecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcC-----CCCeEEeeeccce
Q 010891 251 YVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDE-----NFDAKISDFGLAK 325 (498)
Q Consensus 251 ~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~-----~~~~kL~DfGla~ 325 (498)
|+ +++|.+++.. ....+++..+..++.|++.||.|||++ +|+||||||+|||++. ++.+||+|||+|+
T Consensus 82 ~~-~~~l~~~~~~---~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 82 LL-GPSLEDLLDL---CGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred ec-CCCHHHHHHh---hccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeE
Confidence 99 7899999864 335699999999999999999999999 9999999999999964 5789999999999
Q ss_pred ecCCCCce------eeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHhh
Q 010891 326 LLGAGKSH------ITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVEWLKMMVQL 399 (498)
Q Consensus 326 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 399 (498)
.+...... .....+||+.|||||++.+..++.++|||||||++|||+||+.||..............+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 87543211 233467999999999999999999999999999999999999999865554433322222221111
Q ss_pred ccccCCcCCCCCCCCCHHHHHHHHHHHHHccCCCCCCCCCHHHHHHHHhc
Q 010891 400 RRSEDVVDPNIETRPSTSALKRALLTALRCVDPDSDKRPKMSQVVRMLES 449 (498)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~~ell~~L~~ 449 (498)
...... . ...+.+ +..++..|+..+|++||+++.+.+.|+.
T Consensus 235 ~~~~~l-~-----~~~p~~---l~~ii~~~~~~~~~~rP~y~~l~~~l~~ 275 (293)
T d1csna_ 235 TPLREL-C-----AGFPEE---FYKYMHYARNLAFDATPDYDYLQGLFSK 275 (293)
T ss_dssp SCHHHH-T-----TTSCHH---HHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred CChHHh-c-----CCCCHH---HHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence 111000 0 011123 3333447999999999999988877754
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.4e-45 Score=364.38 Aligned_cols=195 Identities=25% Similarity=0.378 Sum_probs=169.1
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCC-CCCceEEEeEEEeC--CeeEEEE
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-HKNLVRLLGYCIEG--TQRILVY 249 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~--~~~~lv~ 249 (498)
++|++.++||+|+||+||+|+. .+|+.||||++... ..+.+.+|+++|..++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999986 56899999998543 3567889999999995 99999999999853 5689999
Q ss_pred eecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCC-CeEEeeeccceecC
Q 010891 250 EYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENF-DAKISDFGLAKLLG 328 (498)
Q Consensus 250 e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~-~~kL~DfGla~~~~ 328 (498)
||+.+++|..+. +.+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||+|+...
T Consensus 112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred eecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceecc
Confidence 999999987653 3589999999999999999999999 999999999999998655 59999999999875
Q ss_pred CCCceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCC
Q 010891 329 AGKSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYGRP 383 (498)
Q Consensus 329 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~~~ 383 (498)
.... ....+||+.|+|||.+.+ ..++.++|||||||++|||++|+.||.....
T Consensus 182 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~ 235 (328)
T d3bqca1 182 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235 (328)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred CCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCch
Confidence 4432 344679999999998765 4589999999999999999999999976544
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-44 Score=361.74 Aligned_cols=197 Identities=29% Similarity=0.328 Sum_probs=160.3
Q ss_pred ccCCCccceEcccCcEEEEEEEEc-CCcEEEEEEecCCCCC--chhHHHHHHHHHHcCCCCCceEEEeEEEe------CC
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIE------GT 243 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~------~~ 243 (498)
.++|++.++||+|+||+||+|++. +|+.||||++...... ....+.+|+.++++++|||||+++++|.. ..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 478999999999999999999864 6999999999654332 23458899999999999999999999964 36
Q ss_pred eeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeecc
Q 010891 244 QRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGL 323 (498)
Q Consensus 244 ~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGl 323 (498)
+.|+||||+.+ ++.+.+. ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+|++|||+
T Consensus 96 ~~~iv~Ey~~~-~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 96 DVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp EEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred eeEEEEeccch-HHHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhh
Confidence 78999999966 4555553 3489999999999999999999999 999999999999999999999999999
Q ss_pred ceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 010891 324 AKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYG 381 (498)
Q Consensus 324 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~ 381 (498)
++...... ..+..+||+.|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 166 ~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~ 221 (355)
T d2b1pa1 166 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_dssp -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred hhcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCC
Confidence 98765432 344567999999999999999999999999999999999999999754
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-45 Score=362.95 Aligned_cols=197 Identities=28% Similarity=0.398 Sum_probs=165.9
Q ss_pred ccCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCC--chhHHHHHHHHHHcCCCCCceEEEeEEEeC-----Ce
Q 010891 173 TNRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQ--ADKDFRVEVEAIGHVRHKNLVRLLGYCIEG-----TQ 244 (498)
Q Consensus 173 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-----~~ 244 (498)
.++|++.+.||+|+||+||+|+. .+|+.||||++...... ..+.+.+|+++|++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 56899999999999999999985 57999999998654332 234678899999999999999999998643 34
Q ss_pred eEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeEEeeeccc
Q 010891 245 RILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAKISDFGLA 324 (498)
Q Consensus 245 ~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~kL~DfGla 324 (498)
.+++|+|+.+|+|.+++. .+.+++..+..++.||+.||.|||++ +|+||||||+|||++.++.+|++|||++
T Consensus 97 ~~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC---
T ss_pred eEEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchh
Confidence 467778888999999995 34699999999999999999999999 9999999999999999999999999999
Q ss_pred eecCCCCceeeecccccccccCcccccC-CCCCccchHHHHHHHHHHHHhCCCCCCCC
Q 010891 325 KLLGAGKSHITTRVMGTFGYVAPEYANS-GLLNEKSDVYSFGVVLLEAITGRYPVDYG 381 (498)
Q Consensus 325 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwSlGvvl~elltg~~P~~~~ 381 (498)
..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...
T Consensus 169 ~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~ 222 (348)
T d2gfsa1 169 RHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 222 (348)
T ss_dssp -CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred cccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCC
Confidence 76532 2334679999999998655 45789999999999999999999999754
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-39 Score=327.78 Aligned_cols=264 Identities=19% Similarity=0.213 Sum_probs=188.0
Q ss_pred cCCCccceEcccCcEEEEEEEE-cCCcEEEEEEecCCCCCchhHHHHHHHHHHcCC-----------CCCceEEEeEEEe
Q 010891 174 NRFSKDNIIGDGGYGVVYRGQL-MNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-----------HKNLVRLLGYCIE 241 (498)
Q Consensus 174 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------hpnIv~l~~~~~~ 241 (498)
++|+++++||+|+||+||+|+. .+|+.||||++.... ...+.+.+|+++++.++ ||||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 4699999999999999999986 579999999996432 22356778998888775 5789999998764
Q ss_pred --CCeeEEEEeecCCCCH-HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHH-ccCCCeeecCCCCCCEEEcCCCC--
Q 010891 242 --GTQRILVYEYVNNGNL-EQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHE-AIEPKVVHRDIKSSNILIDENFD-- 315 (498)
Q Consensus 242 --~~~~~lv~e~~~~g~L-~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~-~~~~~iiHrDikp~NIll~~~~~-- 315 (498)
....+++|+++..+.. ..+.... ....+++..+..++.||+.||.|||+ . +|+||||||+||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~ 166 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKY--EHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPE 166 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTT
T ss_pred ccccceeeeeeecccccccccccccc--cccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCccc
Confidence 3556677777655443 3333222 45678999999999999999999998 6 9999999999999987654
Q ss_pred ----eEEeeeccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHHHHHHHhCCCCCCCCCCcchhhHHH
Q 010891 316 ----AKISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYGRPQSEVNLVE 391 (498)
Q Consensus 316 ----~kL~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvvl~elltg~~P~~~~~~~~~~~~~~ 391 (498)
+||+|||.+...... ....+||+.|+|||++.+..|+.++|||||||++++|++|+.||............+
T Consensus 167 ~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 167 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred ccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 999999999875432 344679999999999999999999999999999999999999997543322211111
Q ss_pred HHHHHHhh-ccc-----------------cCCcC--CCC-----------CCCCCHHHHHHHHHHHHHccCCCCCCCCCH
Q 010891 392 WLKMMVQL-RRS-----------------EDVVD--PNI-----------ETRPSTSALKRALLTALRCVDPDSDKRPKM 440 (498)
Q Consensus 392 ~~~~~~~~-~~~-----------------~~~~~--~~~-----------~~~~~~~~~~~~l~~~~~cl~~dP~~RPt~ 440 (498)
.+...... ... ..... ... ..............++.+||..||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 11111110 000 00000 000 011122334455566669999999999999
Q ss_pred HHHHHHH
Q 010891 441 SQVVRML 447 (498)
Q Consensus 441 ~ell~~L 447 (498)
+|+|+|-
T Consensus 323 ~e~L~Hp 329 (362)
T d1q8ya_ 323 GGLVNHP 329 (362)
T ss_dssp HHHHTCG
T ss_pred HHHhcCc
Confidence 9999863
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=1.5e-25 Score=203.38 Aligned_cols=169 Identities=16% Similarity=0.134 Sum_probs=120.7
Q ss_pred CCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCC-----c-------------hhHHHHHHHHHHcCCCCCceEEEe
Q 010891 176 FSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQ-----A-------------DKDFRVEVEAIGHVRHKNLVRLLG 237 (498)
Q Consensus 176 y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----~-------------~~~~~~E~~~l~~l~hpnIv~l~~ 237 (498)
+.++++||+|+||+||+|+..+|+.||||++...... . ......|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 3567899999999999999889999999987432110 0 012345888999999999999886
Q ss_pred EEEeCCeeEEEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHccCCCeeecCCCCCCEEEcCCCCeE
Q 010891 238 YCIEGTQRILVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAIEPKVVHRDIKSSNILIDENFDAK 317 (498)
Q Consensus 238 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~~~~iiHrDikp~NIll~~~~~~k 317 (498)
+. ..+++|||+++..+.+ ++......++.|++.+|.|||++ +|+||||||+|||++++ .++
T Consensus 82 ~~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEE
T ss_pred ec----CCEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEE
Confidence 53 2379999998865432 34445678999999999999999 99999999999999976 599
Q ss_pred EeeeccceecCCCCceeeecccccccccCcccccCCCCCccchHHHHHHH
Q 010891 318 ISDFGLAKLLGAGKSHITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVV 367 (498)
Q Consensus 318 L~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwSlGvv 367 (498)
|+|||+|.....+....... ..... -.+.+ .+.|+.++|+||..--
T Consensus 143 liDFG~a~~~~~~~~~~~l~--rd~~~-~~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 143 IIDFPQSVEVGEEGWREILE--RDVRN-IITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp ECCCTTCEETTSTTHHHHHH--HHHHH-HHHHH-HHHHCCCCCHHHHHHH
T ss_pred EEECCCcccCCCCCcHHHHH--HHHHH-HHHHH-cCCCCCcccHHHHHHH
Confidence 99999998765332111000 00000 00111 2567889999996543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.75 E-value=1.9e-08 Score=93.47 Aligned_cols=149 Identities=13% Similarity=0.076 Sum_probs=103.2
Q ss_pred HHHHHccCCCccceEcccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCC-CCCceEEEeEEEeCCeeE
Q 010891 168 DLQSATNRFSKDNIIGDGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-HKNLVRLLGYCIEGTQRI 246 (498)
Q Consensus 168 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~ 246 (498)
++...-..|+..+..+-++.+.||+... +++.+++|+...........+.+|...+..+. +=-+.+++.++.+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 4555556777655544444578999864 56778889886554445556788888887763 323567778888888899
Q ss_pred EEEeecCCCCHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHHcc--------------------------------
Q 010891 247 LVYEYVNNGNLEQWLRGDMCDRGYLTWEARMKILLGTAKALAYLHEAI-------------------------------- 294 (498)
Q Consensus 247 lv~e~~~~g~L~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH~~~-------------------------------- 294 (498)
+||++++|.++.+.... ......++.++++.+..||+..
T Consensus 87 lv~~~l~G~~~~~~~~~---------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEECCSSEEHHHHTTT---------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred EEEEecccccccccccc---------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence 99999999888765421 1112335566666666666420
Q ss_pred ------------------------CCCeeecCCCCCCEEEcCCCCeEEeeecccee
Q 010891 295 ------------------------EPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (498)
Q Consensus 295 ------------------------~~~iiHrDikp~NIll~~~~~~kL~DfGla~~ 326 (498)
.+.++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 12479999999999999876667999998863
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.20 E-value=3.1e-06 Score=77.51 Aligned_cols=131 Identities=18% Similarity=0.138 Sum_probs=85.4
Q ss_pred eEcccCc-EEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCC--CCceEEEeEEEeCCeeEEEEeecCCCCH
Q 010891 181 IIGDGGY-GVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRH--KNLVRLLGYCIEGTQRILVYEYVNNGNL 257 (498)
Q Consensus 181 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~l~~~~~~~~~~~lv~e~~~~g~L 257 (498)
.+..|.. +.||+....++..+++|...... ...+..|+..++.+.. -.+.+++.+..+++..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4555654 68999987778788888764432 3456778888877632 2356678888888888999999988654
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH----------------------------------------------
Q 010891 258 EQWLRGDMCDRGYLTWEARMKILLGTAKALAYLH---------------------------------------------- 291 (498)
Q Consensus 258 ~~~l~~~~~~~~~l~~~~~~~i~~~ia~aL~yLH---------------------------------------------- 291 (498)
.+. .... ..++.+++..|.-||
T Consensus 94 ~~~---------~~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (255)
T d1nd4a_ 94 LSS---------HLAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL 161 (255)
T ss_dssp TTS---------CCCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred ccc---------cccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence 321 0110 111222223333333
Q ss_pred -----Hcc----CCCeeecCCCCCCEEEcCCCCeEEeeecccee
Q 010891 292 -----EAI----EPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (498)
Q Consensus 292 -----~~~----~~~iiHrDikp~NIll~~~~~~kL~DfGla~~ 326 (498)
... .+.++|+|+.|.|||++++..+-|+||+.+..
T Consensus 162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 211 22489999999999999876678999998753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.73 E-value=5.9e-05 Score=73.70 Aligned_cols=76 Identities=18% Similarity=0.148 Sum_probs=48.5
Q ss_pred cceEcccCcEEEEEEEEc-CCcEEEEEEecCC-------CCCchhHHHHHHHHHHcC-CC-C-CceEEEeEEEeCCeeEE
Q 010891 179 DNIIGDGGYGVVYRGQLM-NGTAVAVKKLLNN-------PGQADKDFRVEVEAIGHV-RH-K-NLVRLLGYCIEGTQRIL 247 (498)
Q Consensus 179 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l-~h-p-nIv~l~~~~~~~~~~~l 247 (498)
.+.||.|....||+.... +++.|+||.-... ..........|.+.|+.+ .+ | .+.+++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 357899999999999754 4678999965321 112234456688888766 22 3 34556544 4556689
Q ss_pred EEeecCCCC
Q 010891 248 VYEYVNNGN 256 (498)
Q Consensus 248 v~e~~~~g~ 256 (498)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997754
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.20 E-value=0.00059 Score=64.47 Aligned_cols=137 Identities=15% Similarity=0.098 Sum_probs=78.6
Q ss_pred cEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCCC-----CCceEEE--eEEEeCCeeEEEEeecCCCCH--
Q 010891 187 YGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVRH-----KNLVRLL--GYCIEGTQRILVYEYVNNGNL-- 257 (498)
Q Consensus 187 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-----pnIv~l~--~~~~~~~~~~lv~e~~~~g~L-- 257 (498)
--.||+++..+|+.|++|..... ....+++..|...+..|.. +..+..- ..+......+.++++++|..+
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred cceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCC
Confidence 35899999889999999987543 3345678888888877632 2111111 123345667889999876321
Q ss_pred ---HHH---------Hhcc----c-CCCCCCCHH-------------------HHHHHHHHHHHHHHHHHHc----cCCC
Q 010891 258 ---EQW---------LRGD----M-CDRGYLTWE-------------------ARMKILLGTAKALAYLHEA----IEPK 297 (498)
Q Consensus 258 ---~~~---------l~~~----~-~~~~~l~~~-------------------~~~~i~~~ia~aL~yLH~~----~~~~ 297 (498)
..+ ++.. . ..+..+++. ....+...+...+..+... ...+
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCce
Confidence 111 1110 0 011111111 1112222233333344332 2457
Q ss_pred eeecCCCCCCEEEcCCCCeEEeeecccee
Q 010891 298 VVHRDIKSSNILIDENFDAKISDFGLAKL 326 (498)
Q Consensus 298 iiHrDikp~NIll~~~~~~kL~DfGla~~ 326 (498)
+||+|+.+.|||++++ ..++||+.+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred eecCCCCcccEEEeCC--ceEEechhccc
Confidence 8999999999999753 56899998864
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.95 E-value=0.0016 Score=60.81 Aligned_cols=159 Identities=9% Similarity=0.030 Sum_probs=83.3
Q ss_pred cHHHHHHHccCCCccceEc-----ccCcEEEEEEEEcCCcEEEEEEecCCCCCchhHHHHHHHHHHcCC-----CCCceE
Q 010891 165 TLRDLQSATNRFSKDNIIG-----DGGYGVVYRGQLMNGTAVAVKKLLNNPGQADKDFRVEVEAIGHVR-----HKNLVR 234 (498)
Q Consensus 165 ~~~~~~~~~~~y~~~~~lg-----~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----hpnIv~ 234 (498)
+.+++.....+|.+++... .|---+.|+.+..+|+ +++|++... ...+++..|++++..|. .|..+.
T Consensus 4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~--~~~~~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCC--CCHHHHHHHHHHHHhhhhccccccccce
Confidence 5677888888898865543 5556788999876654 888887443 23345666777777763 232222
Q ss_pred EEe---EEEeCCeeEEEEeecCCCCHH-----H---------HHhcccC------CCCCCCH-----------------H
Q 010891 235 LLG---YCIEGTQRILVYEYVNNGNLE-----Q---------WLRGDMC------DRGYLTW-----------------E 274 (498)
Q Consensus 235 l~~---~~~~~~~~~lv~e~~~~g~L~-----~---------~l~~~~~------~~~~l~~-----------------~ 274 (498)
..+ +..-....+.++.++.+.... . .++.... ......+ .
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcch
Confidence 111 122234455666666553211 0 1110000 0000000 0
Q ss_pred HHHHHHHHHHHHHHHHHH-ccCCCeeecCCCCCCEEEcCCCCeEEeeecccee
Q 010891 275 ARMKILLGTAKALAYLHE-AIEPKVVHRDIKSSNILIDENFDAKISDFGLAKL 326 (498)
Q Consensus 275 ~~~~i~~~ia~aL~yLH~-~~~~~iiHrDikp~NIll~~~~~~kL~DfGla~~ 326 (498)
.....+..+...+.-.+. ....++||+|+.+.||+++.+...-|.||+.+..
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 011112222222222221 1244799999999999999987778999998863
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.76 E-value=0.0027 Score=61.49 Aligned_cols=73 Identities=16% Similarity=0.205 Sum_probs=48.4
Q ss_pred cceEcccCcEEEEEEEEcCC--------cEEEEEEecCCCCCchhHHHHHHHHHHcCCCCCc-eEEEeEEEeCCeeEEEE
Q 010891 179 DNIIGDGGYGVVYRGQLMNG--------TAVAVKKLLNNPGQADKDFRVEVEAIGHVRHKNL-VRLLGYCIEGTQRILVY 249 (498)
Q Consensus 179 ~~~lg~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~l~~~~~~~~~~~lv~ 249 (498)
.+.|+-|-.=.+|+....++ ..|.+++.- . ....-...+|..+++.+.--++ .++++++.+ .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence 35788888899999986543 456666553 2 2223355678888888743344 467777643 6899
Q ss_pred eecCCCCH
Q 010891 250 EYVNNGNL 257 (498)
Q Consensus 250 e~~~~g~L 257 (498)
||++|..|
T Consensus 121 efi~g~~l 128 (395)
T d1nw1a_ 121 EYIPSRPL 128 (395)
T ss_dssp CCCCEEEC
T ss_pred EEeccccC
Confidence 99987543
|